PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Xu, C; Wang, YF; Tu, Q; Zhang, ZY; Chen, MR; Mwangi, J; Li, YX; Jin, Y; Zhao, XD; Lai, R				Xu, Cheng; Wang, Yunfei; Tu, Qiu; Zhang, Zhiye; Chen, Mengrou; Mwangi, James; Li, Yaxiong; Jin, Yang; Zhao, Xudong; Lai, Ren			Targeting surface nucleolin induces autophagy-dependent cell death in pancreatic cancer via AMPK activation	ONCOGENE			English	Article							DEFENSE PEPTIDE LL-37; IN-VIVO; GROWTH; GEMCITABINE; THERAPY; PROLIFERATION; MECHANISMS; RESISTANCE; APOPTOSIS; PROMOTES	Pancreatic cancer remains one of the deadliest human cancers despite current advances in conventional therapeutics including surgery and adjuvant therapies. Here, we showed that LZ1, a peptide derived from a snake venom cathelicidin, significantly inhibited growth of pancreatic cancer cells by inducing autophagy-dependent cell death both in vitro and in vivo. The LZ1-induced cell death was blocked by pharmacological or genetic inhibition of autophagy. In orthotopic model of pancreatic cancer, systemic administration of LZ1 (1-4 mg/kg) exhibited remarkable antitumor efficacy, significantly prolonged mice survival, and showed negligible adverse effects by comparison with gemcitabine (20 mg/kg). Mechanistic studies revealed that LZ1 acts through binding to nucleolin, whose expression on cell surface is frequently increased in pancreatic cancer cells. LZ1 binding triggers degradation of surface-expressed nucleolin. This leads to activation of 5'-AMP kinase which results in suppression of mTORC1 activity and induction of autophagic flux. These data suggest that LZ1, targeting nucleolin-AMPK-autophagy axis, is a promising lead for the development of therapeutic agents against pancreatic cancer.	[Xu, Cheng; Wang, Yunfei; Tu, Qiu; Zhang, Zhiye; Mwangi, James; Zhao, Xudong; Lai, Ren] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Key Lab Bioact Peptides Yunnan Prov, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China; [Xu, Cheng; Wang, Yunfei; Mwangi, James] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming 650204, Yunnan, Peoples R China; [Chen, Mengrou; Lai, Ren] Nanjing Agr Univ, Life Sci Coll, Nanjing 210095, Jiangsu, Peoples R China; [Mwangi, James; Lai, Ren] Chinese Acad Sci, Sino African Joint Res Ctr, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China; [Li, Yaxiong] Kunming Med Univ, Yanan Affiliated Hosp, Dept Cardiovasc Surg, Kunming 650041, Yunnan, Peoples R China; [Jin, Yang] Oslo Univ Hosp, Inst Canc Genet & Informat, Oslo, Norway	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing Agricultural University; Chinese Academy of Sciences; Kunming Institute of Zoology; Kunming Medical University; University of Oslo	Zhao, XD; Lai, R (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Key Lab Bioact Peptides Yunnan Prov, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China.; Lai, R (corresponding author), Nanjing Agr Univ, Life Sci Coll, Nanjing 210095, Jiangsu, Peoples R China.; Lai, R (corresponding author), Chinese Acad Sci, Sino African Joint Res Ctr, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China.; Jin, Y (corresponding author), Oslo Univ Hosp, Inst Canc Genet & Informat, Oslo, Norway.	yangj@ibv.uio.no; zhaoxudong@mail.kiz.ac.cn; rlai@mail.kiz.ac.cn	Jin, Yang/GXF-7896-2022	Jin, Yang/0000-0002-7996-048X; zhao, zhao xu dong/0000-0001-9126-7365; Zhang, Zhiye/0000-0002-1661-2277	National Natural Science Foundation of China [21761142002, 81770464]; Ministry of Science and Technology [2018ZX09301043-003]; Chinese Academy of Science [QYZDJ-SSWSMC012, SAJC201606]; Chinese Academy of Science (West Light Foundation); Chinese Academy of Science (Youth Innovation Promotion Association) [2017432]; Yunnan Provincial Science and Technology Department [2017FB038, 2015BC005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese Academy of Science(Chinese Academy of Sciences); Chinese Academy of Science (West Light Foundation); Chinese Academy of Science (Youth Innovation Promotion Association); Yunnan Provincial Science and Technology Department	This work was supported by National Natural Science Foundation of China (21761142002 and 81770464), Ministry of Science and Technology (2018ZX09301043-003), Chinese Academy of Science (QYZDJ-SSWSMC012, SAJC201606, the West Light Foundation and Youth Innovation Promotion Association (2017432)) and Yunnan Provincial Science and Technology Department (2017FB038, 2015BC005).	Benedetti E, 2015, ONCOTARGET, V6, P42091, DOI 10.18632/oncotarget.5990; Berger CM, 2015, BIOCHIMIE, V113, P78, DOI 10.1016/j.biochi.2015.03.023; Cavalcante LD, 2014, EUR J PHARMACOL, V741, P8, DOI [10.1010/j.ejphar.2014.07.041, 10.1016/j.ejphar.2014.07.041]; CHEN CM, 1991, J BIOL CHEM, V266, P7754; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Destouches D, 2011, CANCER RES, V71, P3296, DOI 10.1158/0008-5472.CAN-10-3459; Dhanabal M, 1999, J BIOL CHEM, V274, P11721, DOI 10.1074/jbc.274.17.11721; FANG SH, 1993, EXP CELL RES, V208, P48, DOI 10.1006/excr.1993.1221; Farin K, 2011, CANCER RES, V71, P2140, DOI 10.1158/0008-5472.CAN-10-2887; Galzio R, 2012, J CELL BIOCHEM, V113, P571, DOI 10.1002/jcb.23381; Gilles ME, 2016, CANCER RES, V76, P7181, DOI 10.1158/0008-5472.CAN-16-0300; Goldshmit Y, 2014, ONCOTARGET, V5, P8602, DOI 10.18632/oncotarget.2343; Hamma-Kourbali Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-212; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He XQ, 2016, EBIOMEDICINE, V13, P248, DOI 10.1016/j.ebiom.2016.10.022; Hidalgo M, 2015, PANCREATOLOGY, V15, P8, DOI 10.1016/j.pan.2014.10.001; Hovanessian AG, 2006, CELL RES, V16, P174, DOI 10.1038/sj.cr.7310024; Huang Y, 2006, BLOOD, V107, P3564, DOI 10.1182/blood-2005-07-2961; Khanbolooki S, 2006, MOL CANCER THER, V5, P2251, DOI 10.1158/1535-7163.MCT-06-0075; Kim MP, 2008, CLIN CANCER RES, V14, P1284, DOI 10.1158/1078-0432.CCR-07-2247; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Krust B, 2001, P NATL ACAD SCI USA, V98, P14090, DOI 10.1073/pnas.221467298; Krust B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-333; Li FF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01565-6; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nazli O, 2000, HEPATO-GASTROENTEROL, V47, P1750; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Paglin S, 2001, CANCER RES, V61, P439; Palmieri D, 2015, P NATL ACAD SCI USA, V112, P9418, DOI 10.1073/pnas.1507087112; Qin JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9471; Ren SX, 2012, CANCER RES, V72, P6512, DOI 10.1158/0008-5472.CAN-12-2359; Reyes-Reyes EM, 2010, CANCER RES, V70, P8617, DOI 10.1158/0008-5472.CAN-10-0920; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shen SS, 2012, AUTOPHAGY, V8, P1, DOI 10.4161/auto.8.1.16618; Shi S, 2012, CANCER LETT, V317, P127, DOI 10.1016/j.canlet.2011.11.029; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang H, 2013, EUR J PHARMACOL, V707, P1, DOI 10.1016/j.ejphar.2013.03.028; Wu WKK, 2010, INT J CANCER, V127, P1741, DOI 10.1002/ijc.25489; Yang AN, 2018, CANCER DISCOV, V8, P276, DOI 10.1158/2159-8290.CD-17-0952; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zhou ST, 2012, CANCER LETT, V323, P115, DOI 10.1016/j.canlet.2012.02.017	50	27	28	6	34	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2019	38	11					1832	1844		10.1038/s41388-018-0556-x	http://dx.doi.org/10.1038/s41388-018-0556-x			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HO7XX	30356139				2022-12-26	WOS:000461164400004
J	Jiang, L; Liu, XQ; Ma, QY; Yang, Q; Gao, L; Li, HD; Wang, JN; Wei, B; Wen, JG; Li, J; Wu, YG; Meng, XM				Jiang, Ling; Liu, Xue-Qi; Ma, Qiuying; Yang, Qin; Gao, Li; Li, Hai-Di; Wang, Jia-Nan; Wei, Biao; Wen, Jiagen; Li, Jun; Wu, Yong-Gui; Meng, Xiao-Ming			hsa-miR-500a-3P alleviates kidney injury by targeting MLKL-mediated necroptosis in renal epithelial cells	FASEB JOURNAL			English	Article						miRNA; inflammation; exosome; RIPK1; programmed cell death	MICRORNAS; PROTECTS; ACTIVATION; DEATH	MLKL is a central mediator for necroptosis. Its knockout significantly relieves acute kidney injury (AKI). However, its upstream regulatory mechanism in AKI has not been fully elucidated. We recently reviewed how microRNAs (miRNAs), a type of well-studied epigenetic regulator, play critical roles in AKI. Here, we evaluated miRNAs that potentially target MLKL and evaluated their function in human tubular epithelial cells in response to toxic and ischemic insults. TargetScan analysis showed that miR-194-5P, miR-338-3P, miR-500a-3P, and miR-577 had MLKL binding sites. Although all 4 miRNAs are reduced in AKI, our data show that only hsa-miR-500a-3P was significantly suppressed in cisplatin-treated human tubular epithelial (HK2) cells. We further found that hsa-miR-500a-3P alleviated cisplatin-induced HK2 cell death, which was confirmed by transmission electron microscopy and flow cytometry. In addition, overexpression of hsa-miR-500a-3P decreased kidney injury molecule-1 mRNA and protein levels. Real-time PCR, ELISA, and immunofluorescence data show that hsa-miR-500a-3P protected against inflammatory response, evidenced by decreased monocyte chemotactic protein-1 and proinflammatory cytokines TNF- and IL-8. Further, hsa-miR-500a-3P attenuated P65 NF-B phosphorylation and promoter activity. Mechanistically, luciferase reporter assay showed that hsa-miR-500a-3P bound the 3UTR of MLKL, thereby suppressing phosphorylation and membrane translocation of MLKL. In agreement with these findings, we identified that overexpression of hsa-miR-500a-3P attenuated cell injury and the inflammatory response in response to sodium azide treatment in an in vitro model. Results show that circulating exosomes from patients with AKI down-regulated miR-500a-3P, which suppressed cell injury and inflammation in HK2 cells. hsa-miR-500a-3P alleviated toxic and ischemic insults that were triggered by cell necroptosis and the inflammatory response in human HK2 cells by targeting MLKL. This may serve as a novel therapeutic target for treatment of AKI.Jiang, L., Liu, X.-Q., Ma, Q., Yang, Q., Gao, L., Li, H.-D., Wang, J.-N., Wei, B., Wen, J., Li, J., Wu, Y.-G., Meng, X.-M. hsa-miR-500a-3P alleviates kidney injury by targeting MLKL-mediated necroptosis in renal epithelial cells.	[Jiang, Ling; Liu, Xue-Qi; Wu, Yong-Gui] Anhui Med Univ, Dept Nephrol, Affiliated Hosp 1, Hefei 230000, Anhui, Peoples R China; [Jiang, Ling; Liu, Xue-Qi; Ma, Qiuying; Yang, Qin; Gao, Li; Li, Hai-Di; Wang, Jia-Nan; Wei, Biao; Wen, Jiagen; Li, Jun; Meng, Xiao-Ming] Anhui Med Univ, Sch Pharm, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China; [Wen, Jiagen; Li, Jun; Meng, Xiao-Ming] Anhui Med Univ, Anhui Inst Innovat Drugs, Hefei, Anhui, Peoples R China; [Wen, Jiagen; Li, Jun; Meng, Xiao-Ming] Anhui Med Univ, Key Lab Major Autoimmune Dis, Hefei, Anhui, Peoples R China; [Wen, Jiagen; Li, Jun; Meng, Xiao-Ming] Minist Educ, Key Lab Antiinflammatory & Immune Med, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Wu, YG (corresponding author), Anhui Med Univ, Dept Nephrol, Affiliated Hosp 1, Hefei 230000, Anhui, Peoples R China.; Meng, XM (corresponding author), Anhui Med Univ, Sch Pharm, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.	wuyonggui@medmail.com.cn; mengxiaoming@ahmu.edu.cn		Meng, Xiao-ming/0000-0002-1166-561X	National Natural Science Foundation of China (NSFC) [81570623]; Science and Technological Fund of Anhui Province for Outstanding Youth of China [1608085J07]; Training Program Foundation for the Talents by Anhui Education Commission Grant [gxyqZD2017021]; Training Program for Excellent Young Scientist Foundation of the NSFC of Anhui Medical University [GJYQ-1404]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technological Fund of Anhui Province for Outstanding Youth of China; Training Program Foundation for the Talents by Anhui Education Commission Grant; Training Program for Excellent Young Scientist Foundation of the NSFC of Anhui Medical University	The authors thank Austin Cape (ASJ Editors Academia Scholarly Journals (ASJ) Editors (Atlanta, GA, USA) for careful reading. This study was supported by National Natural Science Foundation of China (NSFC) Grant 81570623, Science and Technological Fund of Anhui Province for Outstanding Youth of China Grant 1608085J07, Training Program Foundation for the Talents by Anhui Education Commission Grant gxyqZD2017021, and by Training Program for Excellent Young Scientist Foundation of the NSFC of Anhui Medical University Grant GJYQ-1404. The authors declare no conflicts of interest.	Afonso MB, 2018, CELL DEATH DIFFER, V25, P857, DOI 10.1038/s41418-017-0019-x; Bhatt K, 2016, AM J PHYSIOL-RENAL, V310, pF109, DOI 10.1152/ajprenal.00387.2015; Bhattacharya S, 2016, ONCOGENE, V35, P5282, DOI 10.1038/onc.2016.68; Cai ZY, 2014, NAT CELL BIOL, V16, P200, DOI 10.1038/ncb2908; Cosar E, 2016, FERTIL STERIL, V106, P402, DOI 10.1016/j.fertnstert.2016.04.013; Galluzzi L, 2017, ANNU REV PATHOL-MECH, V12, P103, DOI 10.1146/annurev-pathol-052016-100247; Gao L, 2018, LAB INVEST, V98, P911, DOI 10.1038/s41374-018-0052-5; Gao L, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00479; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Jiang CL, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0568-3; Karpman D, 2017, NAT REV NEPHROL, V13, P545, DOI 10.1038/nrneph.2017.98; Kim YS, 2016, ONCOTARGET, V7, P42261, DOI 10.18632/oncotarget.9950; Linkermann A, 2016, KIDNEY INT, V89, P46, DOI 10.1016/j.kint.2015.10.008; Linkermann A, 2013, J AM SOC NEPHROL, V24, P1545, DOI 10.1681/ASN.2012121169; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Liu WJ, 2018, P NATL ACAD SCI USA, V115, pE1475, DOI 10.1073/pnas.1716959115; Lv LL, 2018, J AM SOC NEPHROL, V29, P919, DOI 10.1681/ASN.2017050523; Meng XM, 2018, LAB INVEST, V98, P63, DOI 10.1038/labinvest.2017.120; Meng XM, 2018, LAB INVEST, V98, P79, DOI 10.1038/labinvest.2017.115; Mulay SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10274; Pavkovic M, 2016, PHARMACOL THERAPEUT, V163, P48, DOI 10.1016/j.pharmthera.2016.03.016; Ren G. L., 2018, J CELL PHYSL; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Stahl A. L., 2017, PEDIAT NEPHROL; von Massenhausen A, 2018, NEPHRON, V140, P144, DOI 10.1159/000490807; Wang S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.37; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Xu YF, 2015, J AM SOC NEPHROL, V26, P2647, DOI 10.1681/ASN.2014080741; Yang TS, 2018, REDOX BIOL, V15, P159, DOI 10.1016/j.redox.2017.11.025; Zhang L, 2015, ONCOTARGET, V6, P2483, DOI 10.18632/oncotarget.2800	31	54	54	2	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3523	3535		10.1096/fj.201801711R	http://dx.doi.org/10.1096/fj.201801711R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30365367	Bronze			2022-12-26	WOS:000459794800035
J	Adrian-Segarra, JM; Sreenivasan, K; Gajawada, P; Lorchner, H; Braun, T; Poling, J				Adrian-Segarra, Juan M.; Sreenivasan, Krishnamoorthy; Gajawada, Praveen; Loerchner, Holger; Braun, Thomas; Poeling, Jochen			The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; cytokine; signal transduction; STAT3; protein-protein interaction; LIFR; oncostatin M; OSM; OSMR	LEUKEMIA-INHIBITORY FACTOR; CILIARY NEUROTROPHIC FACTOR; FACTOR-RECEPTOR; CRYSTAL-STRUCTURE; TRANSDUCING RECEPTOR; FACTOR LIF; BINDING; MURINE; GENES; CELLS	The pleiotropic interleukin-6 (IL-6)-type cytokine oncostatin M (OSM) signals in multiple cell types, affecting processes such as cell differentiation, hematopoiesis, and inflammation. In humans, OSM exerts its effects through activation of either of two different heterodimeric receptor complexes, formed by glycoprotein 130 (gp130) and either OSM receptor (OSMR) or leukemia inhibitory factor receptor (LIFR). In contrast, the mouse OSM orthologue acts mainly through dimers containing OSMR and gp130 and shows limited activity through mouse LIFR. Despite their structural similarity, neither human nor mouse OSM signal through the other species' OSMR. The molecular basis for such species-specific signaling, however, remains poorly understood. To identify key molecular features of OSM that determine receptor activation in humans and mice, we generated chimeric mouse-human cytokines. Replacing regions within binding site III of murine OSM with the human equivalents showed that the cytokine's AB loop was critical for receptor selection. Substitutions of individual amino acids within this region demonstrated that residues Asn-37, Thr-40, and Asp-42 of the murine cytokine were responsible for limited LIFR activation and absence of human OSMR/LIFR signaling. In human OSM, Lys-44 appeared to be the main residue preventing mouse OSMR activation. Our data reveal that individual amino acids within the AB loop of OSM determine species-specific activities. These mutations might reflect a key step in the evolutionary process of this cytokine, in which receptor promiscuity gives way to ligand-receptor specialization.	[Adrian-Segarra, Juan M.; Sreenivasan, Krishnamoorthy; Gajawada, Praveen; Loerchner, Holger; Braun, Thomas; Poeling, Jochen] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Ludwigstr 43, D-61231 Bad Nauheim, Germany; [Loerchner, Holger; Braun, Thomas; Poeling, Jochen] German Ctr Cardiovasc Res DZHK, Partner Site Rhein Main, Frankfurt, Germany	Max Planck Society; German Centre for Cardiovascular Research	Braun, T; Poling, J (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Ludwigstr 43, D-61231 Bad Nauheim, Germany.; Braun, T; Poling, J (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Rhein Main, Frankfurt, Germany.	thomas.braun@mpi-bn.mpg.de; jochen.poeling@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008	Braun, Thomas/0000-0002-6165-4804; Sreenivasan, Krishnamoorthy/0000-0001-8771-5911; Adrian-Segarra, Juan M./0000-0002-3712-0554	Max Planck Society; Excellence Initiative "Cardiopulmonary System" (ECCPS); DFG collaborative research center Pulmonary Hypertension and Core Pulmonale Grants [5E61213, TP A02]; Foundation Leducq [3CVD01]; German Center for Cardiovascular Research; European Research Area Network on Cardiovascular Diseases Grant CLARIFY	Max Planck Society(Max Planck SocietyFoundation CELLEX); Excellence Initiative "Cardiopulmonary System" (ECCPS)(German Research Foundation (DFG)); DFG collaborative research center Pulmonary Hypertension and Core Pulmonale Grants; Foundation Leducq(Leducq Foundation); German Center for Cardiovascular Research; European Research Area Network on Cardiovascular Diseases Grant CLARIFY	This work was supported by the Max Planck Society; the Excellence Initiative "Cardiopulmonary System" (ECCPS); DFG collaborative research center Pulmonary Hypertension and Core Pulmonale Grants 5E61213, TP A02, and B02; Foundation Leducq Grant 3CVD01; the German Center for Cardiovascular Research; and European Research Area Network on Cardiovascular Diseases Grant CLARIFY. The authors declare that they have no conflicts of interest with the contents of this article.	Aakre CD, 2015, CELL, V163, P594, DOI 10.1016/j.cell.2015.09.055; Adrian-Segarra JM, 2018, J BIOL CHEM, V293, P7017, DOI 10.1074/jbc.RA118.001920; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Broxmeyer HE, 2007, EXP HEMATOL, V35, P78, DOI 10.1016/j.exphem.2007.01.028; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Deller MC, 2000, STRUCT FOLD DES, V8, P863, DOI 10.1016/S0969-2126(00)00176-3; Derouet D, 2004, P NATL ACAD SCI USA, V101, P4827, DOI 10.1073/pnas.0306178101; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Drechsler J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043155; Ehlers M, 1996, J INTERF CYTOK RES, V16, P569, DOI 10.1089/jir.1996.16.569; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GIOVANNINI M, 1993, CYTOGENET CELL GENET, V64, P240, DOI 10.1159/000133586; Hanington PC, 2007, DEV COMP IMMUNOL, V31, P817, DOI 10.1016/j.dci.2006.12.001; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; Hermanns HM, 2015, CYTOKINE GROWTH F R, V26, P545, DOI 10.1016/j.cytogfr.2015.07.006; Hermanns HM, 1999, J IMMUNOL, V163, P6651; HIRANO T, 1985, P NATL ACAD SCI USA, V82, P5490, DOI 10.1073/pnas.82.16.5490; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Ichihara M, 1997, BLOOD, V90, P165; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; JEFFERY E, 1993, CYTOKINE, V5, P107, DOI 10.1016/1043-4666(93)90048-A; Juan TSC, 2009, VET PATHOL, V46, P124, DOI 10.1354/vp.46-1-124; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; KALLESTAD JC, 1991, J BIOL CHEM, V266, P8940; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; LAYTON MJ, 1994, J BIOL CHEM, V269, P29891; Lemmon AR, 2002, P NATL ACAD SCI USA, V99, P10516, DOI 10.1073/pnas.162224399; Lindberg RA, 1998, MOL CELL BIOL, V18, P3357, DOI 10.1128/MCB.18.6.3357; Liongue C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-120; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; MCDONALD NQ, 1995, EMBO J, V14, P2689, DOI 10.1002/j.1460-2075.1995.tb07269.x; Milholland B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15183; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Rappsilber J, 2000, ANAL CHEM, V72, P267, DOI 10.1021/ac991081o; Richards Carl D, 2013, ISRN Inflamm, V2013, P512103, DOI 10.1155/2013/512103; RICHARDS CD, 1993, J IMMUNOL, V150, P5596; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; ROSE TM, 1993, GENOMICS, V17, P136, DOI 10.1006/geno.1993.1294; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; SHIELDS DC, 1995, CYTOKINE, V7, P679, DOI 10.1006/cyto.1995.0080; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Sreenivasan K, 2017, METHODS MOL BIOL, V1556, P343, DOI 10.1007/978-1-4939-6771-1_19; Varadarajan N, 2009, NAT PROTOC, V4, P893, DOI 10.1038/nprot.2009.60; Vasse M, 1999, ARTERIOSCL THROM VAS, V19, P1835, DOI 10.1161/01.ATV.19.8.1835; Vollmer S, 2009, HEPATOLOGY, V50, P253, DOI 10.1002/hep.22928; Walker EC, 2016, J BIOL CHEM, V291, P21703, DOI 10.1074/jbc.M116.748483; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Wang YP, 2000, J BIOL CHEM, V275, P25273, DOI 10.1074/jbc.M002296200; YIN TG, 1993, J IMMUNOL, V151, P2555; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	62	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20181	20199		10.1074/jbc.RA118.004375	http://dx.doi.org/10.1074/jbc.RA118.004375			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30373773	Green Published, hybrid			2022-12-26	WOS:000454685900025
J	Hudson, NO; Whitby, FG; Buck-Koehntop, BA				Hudson, Nicholas O.; Whitby, Frank G.; Buck-Koehntop, Bethany A.			Structural insights into methylated DNA recognition by the C-terminal zinc fingers of the DNA reader protein ZBTB38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; zinc finger; X-ray crystallography; DNA methylation; protein-DNA interaction; DNA reader; methyl-CpG binding protein; transcriptional regulation; zinc finger and BTB domain-containing protein	HISTONE DEACETYLASE; TRANSCRIPTIONAL REPRESSOR; CPG METHYLATION; BINDING; CIBZ; DISEASE; EPIGENOME; PROGRAM; COMPLEX; SYSTEM	Methyl-CpG-binding proteins (MBPs) are selective readers of DNA methylation that play an essential role in mediating cellular transcription processes in both normal and diseased cells. This physiological function of MBPs has generated significant interest in understanding the mechanisms by which these proteins read and interpret DNA methylation signals. Zinc finger and BTB domain-containing 38 (ZBTB38) represents one member of the zinc finger (ZF) family of MBPs. We recently demonstrated that the C-terminal ZFs of ZBTB38 exhibit methyl-selective DNA binding within the ((A/G)TmCG(G/A)(mC/T)(G/A)) context both in vitro and within cells. Here we report the crystal structure of the first four C-terminal ZBTB38 ZFs (ZFs 6-9) in complex with the previously identified methylated consensus sequence at 1.75 resolution. From the structure, methyl-selective binding is preferentially localized at the 5 mCpG site of the bound DNA, which is facilitated through a series of base-specific interactions from residues within the -helices of ZF7 and ZF8. ZF6 and ZF9 primarily stabilize ZF7 and ZF8 to facilitate the core base-specific interactions. Further structural and biochemical analyses, including solution NMR spectroscopy and electrophoretic mobility gel shift assays, revealed that the C-terminal ZFs of ZBTB38 utilize an alternative mode of mCpG recognition from the ZF MBPs structurally evaluated to date. Combined, these findings provide insight into the mechanism by which this ZF domain of ZBTB38 selectively recognizes methylated CpG sites and expands our understanding of how ZF-containing proteins can interpret this essential epigenetic mark.	[Hudson, Nicholas O.; Buck-Koehntop, Bethany A.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Whitby, Frank G.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Buck-Koehntop, BA (corresponding author), Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.	koehntop@chem.utah.edu	Buck-Koehntop, Bethany A./ABI-2583-2020		National Science Foundation [MCB-1715370]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by MCB-1715370 from the National Science Foundation. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by NIGMS, National Institutes of Health (including P41GM103393). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allers J, 2001, J MOL BIOL, V311, P75, DOI 10.1006/jmbi.2001.4857; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Buck-Koehntop BA, 2013, EPIGENETICS-US, V8, P131, DOI 10.4161/epi.23632; Buck-Koehntop BA, 2012, P NATL ACAD SCI USA, V109, P15229, DOI 10.1073/pnas.1213726109; Buck-Koehntop BA, 2012, FEBS LETT, V586, P734, DOI 10.1016/j.febslet.2012.01.045; Cai YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033156; Defossez PA, 2011, PROG MOL BIOL TRANSL, V101, P377, DOI 10.1016/B978-0-12-387685-0.00012-3; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Fournier A, 2012, BRIEF FUNCT GENOMICS, V11, P251, DOI 10.1093/bfgp/elr040; Hashimoto H, 2017, MOL CELL, V66, P711, DOI 10.1016/j.molcel.2017.05.004; Hashimoto H, 2016, NUCLEIC ACIDS RES, V44, P10165, DOI 10.1093/nar/gkw766; Hashimoto H, 2014, GENE DEV, V28, P2304, DOI 10.1101/gad.250746.114; Horowitz S, 2012, J BIOL CHEM, V287, P41576, DOI 10.1074/jbc.R112.418574; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Jin ZL, 2018, GENES DIS, V5, P1, DOI 10.1016/j.gendis.2018.01.002; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Liu YW, 2014, NUCLEIC ACIDS RES, V42, P4859, DOI 10.1093/nar/gku134; Liu YW, 2013, TRENDS BIOCHEM SCI, V38, P177, DOI 10.1016/j.tibs.2012.12.005; Liu YW, 2012, GENE DEV, V26, P2374, DOI 10.1101/gad.202200.112; Lv J, 2012, NUCLEIC ACIDS RES, V40, pD1030, DOI 10.1093/nar/gkr1169; Mandel-Gutfreund Y, 1998, J MOL BIOL, V277, P1129, DOI 10.1006/jmbi.1998.1660; Miotto B, 2014, CELL REP, V7, P575, DOI 10.1016/j.celrep.2014.03.030; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nikolova EN, 2018, BIOCHEMISTRY-US, V57, P2109, DOI [10.1021/acs.biochem.8600065, 10.1021/acs.biochem.8b00065]; Nishii T, 2012, J BIOL CHEM, V287, P12417, DOI 10.1074/jbc.M111.333856; Oikawa Y, 2008, J BIOL CHEM, V283, P14242, DOI 10.1074/jbc.M802257200; Oikawa Y, 2011, CELL RES, V21, P1578, DOI 10.1038/cr.2011.90; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pozner A, 2018, J MOL BIOL, V430, P258, DOI 10.1016/j.jmb.2017.12.014; Ren R, 2018, CURR OPIN STRUC BIOL, V53, P88, DOI 10.1016/j.sbi.2018.06.004; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sansom OJ, 2007, NAT CLIN PRACT ONCOL, V4, P305, DOI 10.1038/ncponc0812; Sasai N, 2005, GENES CELLS, V10, P871, DOI 10.1111/j.1365-2443.2005.00885.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segal DJ, 2006, J MOL BIOL, V363, P405, DOI 10.1016/j.jmb.2006.08.016; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Weber A, 2008, EMBO J, V27, P1563, DOI 10.1038/emboj.2008.85; Xiong YC, 2017, NUCLEIC ACIDS RES, V45, pD888, DOI 10.1093/nar/gkw1123; Yesselman JD, 2015, PROTEINS, V83, P403, DOI 10.1002/prot.24724; Yin YM, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2239; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Zandarashvili L, 2015, FEBS LETT, V589, P1748, DOI 10.1016/j.febslet.2015.05.022; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhu H, 2016, NAT REV GENET, V17, P551, DOI 10.1038/nrg.2016.83; Zou XQ, 2012, NUCLEIC ACIDS RES, V40, P2747, DOI 10.1093/nar/gkr1057	57	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19835	19843		10.1074/jbc.RA118.005147	http://dx.doi.org/10.1074/jbc.RA118.005147			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30355731	Green Published, hybrid			2022-12-26	WOS:000454294900027
J	Bousquet, PJ; Lefeuvre, D; Tuppin, P; BenDiane, MK; Rocchi, M; Bouee-Benhamiche, E; Viguier, J; Le Bihan-Benjamin, C				Bousquet, Philippe Jean; Lefeuvre, Delphine; Tuppin, Philippe; BenDiane, Marc Karim; Rocchi, Mathieu; Bouee-Benhamiche, Elsa; Viguier, Jerome; Le Bihan-Benjamin, Christine			Cancer care and public health policy evaluations in France: Usefulness of the national cancer cohort	PLOS ONE			English	Article							ADMINISTRATIVE DATABASE; COLORECTAL-CANCER; LUNG; ALGORITHMS; BREAST; COLON; PROSTATE; SNIIRAM	Background In the context of the national Cancer Plans of France that have changed the healthcare landscape, it has become necessary to better document and assess the related actions, and to promote research and understanding. The national cancer cohort, an exhaustive population-based cohort, was set up on the basis of the National Health Data System (SNDS) by the French National Cancer Institute. Objectives The aim is to describe the French national cancer cohort. Methods All people living in France (67 million population) with universal insurance coverage and diagnosed, treated or followed up for a cancer, such as survivors, are included and will be followed up for 25 years. It contains all healthcare consumptions and reimbursements (i.e. hospitalization, outpatient care, medication...) since 2010. Every year, around 650 000 new cases are included. Results From 2010 to 2015, 6.2 million subjects have been included. Most subjects were entered in 2010, in 2015 it concerned 0.6 million. In 2015, the median age was 65 [54-76]; 51% were women. The primary cancer organ could be attributed with certitude to 87% of the people. The most frequent locations were skin (16%), breast (15%), prostate (12%), colon-rectum (11%) and lung (9%). In 2015, 40% of included subjects underwent surgery for cancer, 16% chemotherapy at hospital and 11% at least one session of radiotherapy. Conclusion Based on SNDS, the cancer cohort has been designed to study cancer care use in the short-, medium- and long-term, and evaluate healthcare and public health policies.	[Bousquet, Philippe Jean; Lefeuvre, Delphine; Rocchi, Mathieu; Bouee-Benhamiche, Elsa; Le Bihan-Benjamin, Christine] French Natl Canc Inst INCa, Publ Hlth & Healthcare Div, Survey Monitoring & Assessment Dept, Inst Natl Canc, Boulogne Billancourt, France; [Bousquet, Philippe Jean; BenDiane, Marc Karim] Fac Med, Econ & Social Sci Hlth Care Syst & Soc, Marseille, France; [Tuppin, Philippe] DEPP, Caisse Natl Assurance Malad Travailleurs Salaries, Paris, France; [Viguier, Jerome] French Natl Canc Inst INCa, Publ Hlth & Healthcare Div, Inst Natl Canc, Boulogne Billancourt, France	Institut National du Cancer (INCA) France; UDICE-French Research Universities; Aix-Marseille Universite; Institut National du Cancer (INCA) France	Bousquet, PJ (corresponding author), French Natl Canc Inst INCa, Publ Hlth & Healthcare Div, Survey Monitoring & Assessment Dept, Inst Natl Canc, Boulogne Billancourt, France.; Bousquet, PJ (corresponding author), Fac Med, Econ & Social Sci Hlth Care Syst & Soc, Marseille, France.	pjbousquet@institutcancer.fr	Bendiane, Marc-Karim/M-7060-2019; Bendiane, Marc-Karim K/F-5414-2010; Bousquet, Philippe Jean/AAW-8608-2021; Bousquet, Jean/O-4221-2019	Bendiane, Marc-Karim K/0000-0003-4329-8807; Bousquet, Philippe Jean/0000-0002-0217-5483; 	French national cancer institute	French national cancer institute(Institut National du Cancer (INCA) France)	The study and the Cancer cohort are self-funded by the French national cancer institute.	Ajrouche A, 2017, PHARMACOEPIDEM DR S, V26, P935, DOI 10.1002/pds.4225; Bousquet PJ, 2017, REV EPIDEMIOL SANTE, V65, pS236, DOI 10.1016/j.respe.2017.04.057; Cnamts, 2017, METH REP PATH REP DE; Colonna M, 2014, ESTIMATION PREVALENC; Cowppli-Bony A, 2016, SURVIE PERSONNES A 1; Creighton N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011161; Doat S, 2016, REV EPIDEMIOL SANTE, V64, P145, DOI 10.1016/j.respe.2015.12.020; Goldsbury D, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0417-5; INCa, 2003, PLAN CANC 2003 2007; INCa, 2013, CONS TRAIT CANC PRES; INCA, 2013, ALG SEL HOSP LIEES P; INCa, 2009, PLAN CANC 2009 2013; INCa, 2014, PROGR NAT RED TAB 20; Institut National du Cancer (INCa), 2015, PLAN CANC 2014 2019; Jehannin-Ligier K, 2017, PROJECTION INCIDENCE; Kehl KL, 2015, J GERIATR ONCOL, V6, P202, DOI 10.1016/j.jgo.2015.01.005; Kern DM, 2017, PRAGMAT OBS RES, V8, P149, DOI 10.2147/POR.S140579; Kudjawu YC, 2016, LUNG CANCER, V95, P44, DOI 10.1016/j.lungcan.2016.02.016; Kudjawu YC, 2015, CANCER EPIDEMIOL, V39, P877, DOI 10.1016/j.canep.2015.10.002; Le Bihan-Benjamin C, 2017, PRESERVATION FERTILI; Lefeuvre Delphine, 2017, Clin Breast Cancer, V17, pe191, DOI 10.1016/j.clbc.2017.01.008; Maroun R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162864; Monnereau A., 2016, SURVIE PERSONNES A 2; Neumann A, 2012, DIABETOLOGIA, V55, P1953, DOI 10.1007/s00125-012-2538-9; Nordstrom BL, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00018; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Tuppin P, 2017, REV EPIDEMIOL SANTE, V65, pS149, DOI 10.1016/j.respe.2017.05.004; Tuppin P, 2014, PROG UROL, V24, P572, DOI 10.1016/j.purol.2014.03.004; Tuppin P, 2017, B CANCER, V104, P524, DOI 10.1016/j.bulcan.2017.01.010; Tuppin P, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-48; Warren JL, 2002, MED CARE, V40, P3; Whyte JL, 2015, MED CARE, V53, pe49, DOI 10.1097/MLR.0b013e318289c3fb	32	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206448	10.1371/journal.pone.0206448	http://dx.doi.org/10.1371/journal.pone.0206448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379946	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700117
J	Pallikkuth, S; Pahwa, R; Kausalya, B; Saravanan, S; Pan, L; Vignesh, R; Lqbal, S; Solomon, SS; Murugavel, KG; Poongulali, S; Kumarasamy, N; Pahwa, S				Pallikkuth, Suresh; Pahwa, Rajendra; Kausalya, Bagavathi; Saravanan, Shanmugam; Pan, Li; Vignesh, R.; Lqbal, Syed; Solomon, Sunil S.; Murugavel, Kailapuri G.; Poongulali, Selvamuthu; Kumarasamy, Nagalingeswaran; Pahwa, Savita			Cardiac morbidity in HIV infection is associated with checkpoint inhibitor LAG-3 on CD4 T cells	PLOS ONE			English	Article							CLASS-II EXPRESSION; CARDIOVASCULAR-DISEASE; IMMUNE ACTIVATION; DILATED CARDIOMYOPATHY; MACROPHAGE ACTIVATION; NEGATIVE REGULATION; EFFECTOR FUNCTION; PD-1; RECEPTOR; EXHAUSTION	Recent findings point to a role of Checkpoint Inhibitor (CPI) receptors at the tissue level in immune homeostasis. Here we investigated the role of CPI molecules on immune cells in relation to cardiac function. Participants recruited in Chennai, India consisted of HIV+ ART naive viremic (Gp1 n = 102), HIV+ on ART, virologically suppressed (Gp2, n = 172) and HIV negative healthy controls (Gp3, n = 64). A cross-sectional analysis of cardiac function, arterial resistance and immunologic assessment of CPI expressing T cells was performed. Data indicate that ART naive exhibited cardiac function impairment and greater arterial stiffness than the other groups. Frequencies of CD4+ T cells expressing LAG-3 and PD1 were higher in ART naive while TIGIT and TIM3 were similar among the patient groups. LAG-3+, PD1+ and dual LAG-3+PD1+ CD4 T cells were inversely correlated with cardiac function and arterial elasticity and directly with arterial stiffness in ART naive participants and with arterial elasticity in virally suppressed group on ART. We conclude that HIV induced upregulation of LAG-3 singly or in combination with PD1 in immune cells may regulate cardiac health and warrant mechanistic investigations. The implications of these findings have bearing for the potential utility of anti-LAG-3 immunotherapy for cardiac dysfunction in chronic HIV infection.	[Pallikkuth, Suresh; Pahwa, Rajendra; Pan, Li; Pahwa, Savita] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Kausalya, Bagavathi; Saravanan, Shanmugam; Vignesh, R.; Lqbal, Syed; Solomon, Sunil S.; Murugavel, Kailapuri G.; Poongulali, Selvamuthu; Kumarasamy, Nagalingeswaran] YRG CARE, Madras, Tamil Nadu, India; [Solomon, Sunil S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	University of Miami; Johns Hopkins University	Pahwa, S (corresponding author), Univ Miami, Miller Sch Med, Miami, FL 33136 USA.	Spahwa@med.miami.edu	Pahwa, Savita/AAA-4900-2019; Solomon, Sunil Suhas/P-6907-2019; Syed Iqbal, Hussain/L-6515-2016; Saravanan, Shanmugam/GOG-9024-2022; Ramachandran, Vignesh/G-6525-2016; Kumarasasmy, Nagalingeswaran/AAB-7348-2021	Pahwa, Savita/0000-0002-4470-4216; Syed Iqbal, Hussain/0000-0003-0410-7051; Saravanan, Shanmugam/0000-0002-5991-8022; Ramachandran, Vignesh/0000-0001-5805-9169; 	National Institutes of Health [R21AI106373]; Indian Council for Medical Research, New Delhi, India [ECD/NTF/17/2013-14]; Miami Center for AIDS Research [P30AI073961]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI106373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indian Council for Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); Miami Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (R21AI106373) to SP, the Indian Council for Medical Research, New Delhi, India (ECD/NTF/17/2013-14) to NK and the Miami Center for AIDS Research (P30AI073961) to SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMEDANSARI A, 1988, TRANSPLANTATION, V45, P972, DOI 10.1097/00007890-198805000-00027; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Andrews LP, 2017, IMMUNOL REV, V276, P80, DOI 10.1111/imr.12519; Annunziato F, 1997, EUR J IMMUNOL, V27, P2239, DOI 10.1002/eji.1830270918; Attanasio J, 2016, IMMUNITY, V44, P1052, DOI 10.1016/j.immuni.2016.04.022; Baban B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124059; Baban B, 2014, AM J HYPERTENS, V27, P846, DOI 10.1093/ajh/hpt269; Baban B, 2013, HYPERTENSION, V61, P95, DOI 10.1161/HYPERTENSIONAHA.111.00028; Bae J, 2014, J IMMUNOL, V193, P3101, DOI 10.4049/jimmunol.1401025; Baker JV, 2015, HIV MED, V16, P109, DOI 10.1111/hiv.12239; Ballocca F, 2017, TRENDS CARDIOVAS MED, V27, P558, DOI 10.1016/j.tcm.2017.06.005; Baumeister SH, 2016, ANNU REV IMMUNOL, V34, P539, DOI 10.1146/annurev-immunol-032414-112049; Burton BR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5741; CAFORIO ALP, 1990, J AUTOIMMUN, V3, P187, DOI 10.1016/0896-8411(90)90140-N; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Camisaschi C, 2010, J IMMUNOL, V184, P6545, DOI 10.4049/jimmunol.0903879; Clayton KL, 2015, J VIROL, V89, P3723, DOI 10.1128/JVI.00006-15; Durham NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109080; Dyrhol-Riise AM, 2001, CLIN IMMUNOL, V101, P169, DOI 10.1006/clim.2001.5101; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Glesby Marshall J, 2017, Top Antivir Med, V24, P127; Golden D, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88628; Grome HN, 2017, AIDS RES HUM RETROV, V33, P181, DOI [10.1089/aid.2016.0113, 10.1089/AID.2016.0113]; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Hileman CO, 2017, CURR HIV-AIDS REP, V14, P93, DOI 10.1007/s11904-017-0356-x; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Holloway CJ, 2017, CURR OPIN HIV AIDS, V12, P509, DOI 10.1097/COH.0000000000000420; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Huang RY, 2015, ONCOTARGET, V6, P27359, DOI 10.18632/oncotarget.4751; Huard B, 1997, P NATL ACAD SCI USA, V94, P5744, DOI 10.1073/pnas.94.11.5744; HUARD B, 1995, EUR J IMMUNOL, V25, P2718, DOI 10.1002/eji.1830250949; HUFNAGEL G, 1991, EUR HEART J, V12, P137, DOI 10.1093/eurheartj/12.suppl_D.137; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; JALKANEN S, 1986, SCIENCE, V233, P556, DOI 10.1126/science.3726548; Joller N, 2011, J IMMUNOL, V186, P1338, DOI 10.4049/jimmunol.1003081; Kurtulus S, 2015, J CLIN INVEST, V125, P4053, DOI 10.1172/JCI81187; Li N, 2004, J IMMUNOL, P173; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Liang BT, 2008, J IMMUNOL, V180, P5916, DOI 10.4049/jimmunol.180.9.5916; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Longenecker CT, 2016, CURR OPIN HIV AIDS, V11, P216, DOI 10.1097/COH.0000000000000227; MANTOVANI A, 1989, IMMUNOL TODAY, V10, P370, DOI 10.1016/0167-5699(89)90270-3; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Mozaffari MS, 2013, AM J CARDIOVASC DIS, V3, P180; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Pinto DSM, 2017, CURRENT CARDIOLOGY R; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Scala E, 1998, J IMMUNOL, V161, P489; Thelemann C, 2016, EUR J IMMUNOL, V46, P656, DOI 10.1002/eji.201545945; Tian XL, 2015, J IMMUNOL, V194, P3873, DOI 10.4049/jimmunol.1402176; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Turnis ME, 2015, EUR J IMMUNOL, V45, P1892, DOI 10.1002/eji.201344413; Utay NS, 2016, CURR OPIN HIV AIDS, V11, P131, DOI 10.1097/COH.0000000000000242; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; WANG YC, 1991, HUM IMMUNOL, V31, P123, DOI 10.1016/0198-8859(91)90015-2; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Waugh KA, 2016, J IMMUNOL, V197, P1477, DOI 10.4049/jimmunol.1600589; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Woo SR, 2010, EUR J IMMUNOL, V40, P1768, DOI 10.1002/eji.200939874; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450; Wykes MN, 2017, NATURE REV IMMUNOLOG; Yagi T, 1998, J ACQ IMMUN DEF SYND, V18, P307, DOI 10.1097/00042560-199808010-00001; Zarour HM, 2016, CLIN CANCER RES, V22, P1856, DOI 10.1158/1078-0432.CCR-15-1849	67	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206256	10.1371/journal.pone.0206256	http://dx.doi.org/10.1371/journal.pone.0206256			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379878	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700097
J	Wang, W; Zhang, DY; Wen, H; Wang, QH; Peng, C; Gao, JH				Wang, Wei; Zhang, Dayan; Wen, Huan; Wang, Qihao; Peng, Cheng; Gao, Jihai			Soil fungal biodiversity and pathogen identification of rotten disease in Aconitum carmichaelii (Fuzi) roots	PLOS ONE			English	Article							SOLANI; AGENT	Aconitum carmichaelii, commonly known as Fuzi, is a typical traditional Chinese medicine (TCM) herb that has been grown for more than one thousand years in China. Although root rot disease has been seriously threatening this crop in recent years, few studies have investigated root rot disease in Fuzi, and no pathogens have been identified. In this study, fungal libraries from rhizosphere soils were constructed by internal transcribed spacer (ITS) sequencing using the HiSeq 2500 high-throughput platform. A total of 948,843 tags were obtained from 17 soil samples, and these corresponded to 195,583,495 nt. At 97% identity, the libraries yielded 12,266 operational taxonomic units (OTUs), of which 97.5% could be annotated. In sick soils, Athelia, Mucor and Mortierella were the dominant fungi, comprising 10.3%, 10.1% and 7.7% of the fungal community, respectively. These fungi showed 2.6-, 1.53- to 6.31- and 1.38- to 2.65-fold higher enrichment in sick soils compared with healthy soils, and their high densities reduced the fungal richness in the areas surrounding the rotted Fuzi roots. An abundance analysis suggested that A. rolfsii and Mucor racemosus, as the dominant pathogens, might play important roles in the invading Fuzi tissue, and Phoma adonidicola could be another pathogenic fungus of root rot. In contrast, Mortierella chlamydospora, Penicillium simplicissimum, Epicoccum nigrum, Cyberlindnera saturnus and Rhodotorula ingeniosa might antagonize root rot pathogens in sick soils. In addition, A. rolfsii was further verified as a main pathogen of Fuzi root rot disease through hypha purification, morphological observation, molecular identification and an infection test. These results provide theoretical guidance for the prevention and treatment of Fuzi root rot disease.	[Wang, Wei; Zhang, Dayan; Wen, Huan; Wang, Qihao; Peng, Cheng; Gao, Jihai] Chengdu Univ Tradit Chinese Med, Pharm Coll, Key Lab Systemat Res Dev & Utilizat Chinese Med R, Minist Educ,Key Lab Standardizat Chinese Herbal M, Chengdu, Sichuan, Peoples R China	Chengdu University of Traditional Chinese Medicine	Peng, C; Gao, JH (corresponding author), Chengdu Univ Tradit Chinese Med, Pharm Coll, Key Lab Systemat Res Dev & Utilizat Chinese Med R, Minist Educ,Key Lab Standardizat Chinese Herbal M, Chengdu, Sichuan, Peoples R China.	peng_cutcm@126.com; gaojihaiwuwei@163.com		Peng, Cheng/0000-0003-3303-906X	Key Research Project of National Natural Science Foundation of China [81630101]; National Development and Reform Commission standardization project [ZYBZH-C-SC-51]; Comprehensive development and regional development of herbal medicine in Sichuan Provincial Administration of traditional Chinese Medicine [2016ZY008]; Scientific Research Funds of Chengdu University of Traditional Chinese Medicine [ZRYY1612, 030029050]	Key Research Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Development and Reform Commission standardization project; Comprehensive development and regional development of herbal medicine in Sichuan Provincial Administration of traditional Chinese Medicine; Scientific Research Funds of Chengdu University of Traditional Chinese Medicine	This work was supported by Key Research Project of National Natural Science Foundation of China (81630101), National Development and Reform Commission standardization project (ZYBZH-C-SC-51), Comprehensive development and regional development of herbal medicine in Sichuan Provincial Administration of traditional Chinese Medicine (2016ZY008), Scientific Research Funds of Chengdu University of Traditional Chinese Medicine (ZRYY1612 and 030029050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075072, 10.1371/journal.pone.0053810]; Blaya J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158048; Blaya J, 2015, J SCI FOOD AGR, V95, P2354, DOI 10.1002/jsfa.7300; Borrego-Benjumea A, 2014, PHYTOPATHOLOGY, V104, P403, DOI 10.1094/PHYTO-08-13-0231-R; El-Tarabily KA, 2004, J APPL MICROBIOL, V96, P69, DOI 10.1046/j.1365-2672.2003.02043.x; Gao Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149408; Ghosh R, 2017, SCI REP-UK, V7, DOI 10.1038/srep42737; Halleen F, 2006, STUD MYCOL, P227, DOI 10.3114/sim.55.1.227; Hilber-Bodmer M, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-016-0908-z; Hossain MM, 2007, PLANT CELL PHYSIOL, V48, P1724, DOI 10.1093/pcp/pcm144; Jeon CS, 2013, PLANT PATHOLOGY J, V29, P440, DOI 10.5423/PPJ.NT.07.2013.0073; Koutb Mostafa, 2010, Mycobiology, V38, P286, DOI 10.4489/MYCO.2010.38.4.286; Kumar A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171323; Kwon Jin-Hyeuk, 2005, Mycobiology, V33, P240, DOI 10.4489/MYCO.2005.33.4.240; Larena I, 2004, INT J FOOD MICROBIOL, V94, P161, DOI 10.1016/j.ijfoodmicro.2004.01.007; Maseko B, 2007, MYCOL RES, V111, P1321, DOI 10.1016/j.mycres.2007.08.011; Miao CP, 2016, J GINSENG RES, V40, P127, DOI 10.1016/j.jgr.2015.06.004; Pastor N, 2012, J ENVIRON MANAGE, V95, pS332, DOI 10.1016/j.jenvman.2011.03.037; Singhuber J, 2009, J ETHNOPHARMACOL, V126, P18, DOI 10.1016/j.jep.2009.07.031; Song JY, 2014, MYCOBIOLOGY, V42, P174, DOI 10.5941/MYCO.2014.42.2.174; Tai CJ, 2015, PLANTA MED, V81, P1017, DOI 10.1055/s-0035-1546183; Wunsch MJ, 2011, PHYTOPATHOLOGY, V101, P594, DOI 10.1094/PHYTO-04-10-0107; Zhou GH, 2015, J ETHNOPHARMACOL, V160, P173, DOI 10.1016/j.jep.2014.11.043	23	6	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205891	10.1371/journal.pone.0205891	http://dx.doi.org/10.1371/journal.pone.0205891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379951	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700078
J	Abi-Rached, L; Gouret, P; Yeh, JH; Di Cristofaro, J; Pontarotti, P; Picard, C; Paganini, J				Abi-Rached, Laurent; Gouret, Philippe; Yeh, Jung-Hua; Di Cristofaro, Julie; Pontarotti, Pierre; Picard, Christophe; Paganini, Julien			Immune diversity sheds light on missing variation in worldwide genetic diversity panels	PLOS ONE			English	Article							CLASS-I; GENOMICS; TRANSPLANTATION; DATABASE; DISEASE; IMPACT	Defining worldwide human genetic variation is a critical step to reveal how genome plasticity contributes to disease. Yet, there is currently no metric to assess the representativeness and completeness of current and widely used data on genetic variation. We show here that Human Leukocyte Antigen (HLA) genes can serve as such metric as they are both the most polymorphic and the most studied genetic system. As a test case, we investigated the 1,000 Genomes Project panel. Using high-accuracy in silico HLA typing, we find that over 20% of the common HLA variants and over 70% of the rare HLA variants are missing in this reference panel for worldwide genetic variation, due to undersampling and incomplete geographical coverage, in particular in Oceania and West Asia. Because common and rare variants both contribute to disease, this study thus illustrates how HLA diversity can detect and help fix incomplete sampling and hence accelerate efforts to draw a comprehensive overview of the genetic variation that is relevant to health and disease.	[Abi-Rached, Laurent; Yeh, Jung-Hua; Pontarotti, Pierre] Aix Marseille Univ, AP HM, IHU Mediterranee Infect, IRD,MEPHI, Marseille, France; [Abi-Rached, Laurent; Yeh, Jung-Hua; Pontarotti, Pierre] CNRS, Marseille, France; [Gouret, Philippe; Pontarotti, Pierre; Paganini, Julien] XEGEN Co, Gemenos, France; [Di Cristofaro, Julie; Picard, Christophe] Etab Francais Sang, PACA Corse, Biol Grp Sanguins, Marseille, France; [Di Cristofaro, Julie; Picard, Christophe] Aix Marseille Univ, CNRS, Biol Grp Sanguins, EFS,ADES, Marseille, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; UDICE-French Research Universities; Aix-Marseille Universite	Abi-Rached, L (corresponding author), Aix Marseille Univ, AP HM, IHU Mediterranee Infect, IRD,MEPHI, Marseille, France.; Abi-Rached, L (corresponding author), CNRS, Marseille, France.; Paganini, J (corresponding author), XEGEN Co, Gemenos, France.	laurent.abi-rached@univ-amu.fr; julien.paganini@xegen.fr	, pontarotti/ABB-1753-2021	Di Cristofaro, Julie/0000-0001-7867-6455	ATIP-Avenir grant; French Government under the "Investissements d'avenir" (Investments for the Future) program [10-IAHU-03]	ATIP-Avenir grant; French Government under the "Investissements d'avenir" (Investments for the Future) program(French National Research Agency (ANR))	This work was supported by an ATIP-Avenir grant to L.A-R and by the French Government under the "Investissements d'avenir" (Investments for the Future) program managed by the Agence Nationale de la Recherche (ANR, fr: National Agency for Research), (reference: Mediterranee Infection 10-IAHU-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Aronson SJ, 2015, NATURE, V526, P336, DOI 10.1038/nature15816; Bahcall OG, 2016, NAT REV GENET, V17, DOI 10.1038/nrg.2016.121; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Caulfield C, 2017, 100000 GENOMES PROJE, DOI [10.6084/m9.figshare.4530893.v3, DOI 10.6084/M9.FIGSHARE.4530893.V3]; Choudhury A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00663-9; Dendrou CA, 2018, NAT REV IMMUNOL, V18, P325, DOI 10.1038/nri.2017.143; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; Goldstein DB, 2005, NATURE, V437, P1241, DOI 10.1038/4371241a; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Gourraud PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097282; Gragert L, 2013, HUM IMMUNOL, V74, P1313, DOI 10.1016/j.humimm.2013.06.025; Li X, 2017, NATURE, V550, P239, DOI 10.1038/nature24267; Long T, 2017, NAT GENET, V49, P568, DOI 10.1038/ng.3809; Magalon J, 2014, TRANSFUSION, V54, P1046, DOI 10.1111/trf.12379; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Nielsen R, 2017, NATURE, V541, P302, DOI 10.1038/nature21347; Pagani L, 2016, NATURE, V538, P238, DOI 10.1038/nature19792; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Ren EC, 2000, TRANSPLANT P, V32, P1541, DOI 10.1016/S0041-1345(00)01319-1; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Ruggeri L, 1999, BLOOD, V94, P333, DOI 10.1182/blood.V94.1.333.413a31_333_339; Scott DA, 2017, NAT MED, V23, P1095, DOI 10.1038/nm.4377; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Telenti A, 2016, P NATL ACAD SCI USA, V113, P11901, DOI 10.1073/pnas.1613365113; Wetterstrand K., 2017, DNA SEQUENCING COSTS; Wickham H., 2016, GGPLOT2 ELEGANT GRAP	28	33	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206512	10.1371/journal.pone.0206512	http://dx.doi.org/10.1371/journal.pone.0206512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365549	Green Submitted, Green Published, gold			2022-12-26	WOS:000448448700059
J	Clements, J; Sanchez-Sedillo, B; Bradfield, CA; Groves, RL				Clements, Justin; Sanchez-Sedillo, Benjamin; Bradfield, Christopher A.; Groves, Russell L.			Transcriptomic analysis reveals similarities in genetic activation of detoxification mechanisms resulting from imidacloprid and chlorothalonil exposure	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; LEPTINOTARSA-DECEMLINEATA; CROSS-RESISTANCE; MANAGEMENT	The Colorado potato beetle, Leptinotarsa decemlineata (Say), is an agricultural pest of commercial potatoes in parts of North America, Europe, and Asia. Plant protection strategies within this geographic range employ a variety of pesticides to combat not only the insect, but also plant pathogens. Previous research has shown that field populations of Leptinotarsa decemlineata have a chronological history of resistance development to a suite of insecticides, including the Group 4A neonicotinoids. The aim of this study is to contextualize the transcriptomic response of Leptinotarsa decemlineata when exposed to the neonicotinoid insecticide imidacloprid, or the fungicides boscalid or chlorothalonil, in order to determine whether these compounds induce similar detoxification mechanisms. We found that chlorothalonil and imidacloprid induced similar patterns of transcript expression, including the upregulation of a cytochrome p450 and a UDP-glucuronosyltransferase transcript, which belong to protein families associated with xenobiotic metabolism. Further, transcriptomic responses varied among individuals within the same treatment group, suggesting individual insects' responses vary within a population and may cope with chemical stressors in a variety of manners.	[Clements, Justin; Sanchez-Sedillo, Benjamin; Groves, Russell L.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Bradfield, Christopher A.] Univ Wisconsin, Dept Oncol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Groves, RL (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	groves@entomology.wisc.edu	Clements, Justin/Q-6248-2018	Clements, Justin/0000-0001-5482-7984	United States Department of Agriculture National Institute of Food and Agriculture [12105364]; Wisconsin Potato Industry Board; University of Wisconsin-Madison Bioinformatics Research Center	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Wisconsin Potato Industry Board; University of Wisconsin-Madison Bioinformatics Research Center	This research was partially supported by a combination of funding from: (1) United States Department of Agriculture National Institute of Food and Agriculture (https://nifa.usda.gov/) Postdoctoral Fellowship Grant 12105364 JC, CB and (2) support from the Wisconsin Potato Industry Board RG.; The authors would like to acknowledge support from the Wisconsin Potato and Vegetable Growers Association and the associated agricultural community. We would also like to acknowledge support from the University of Wisconsin-Madison Bioinformatics Research Center.	Alyokhin A, 2008, AM J POTATO RES, V85, P395, DOI 10.1007/s12230-008-9052-0; BASF, 2015, END FUNG; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Casida JE, 2011, J AGR FOOD CHEM, V59, P2923, DOI 10.1021/jf102438c; Clements J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31663-4; Clements J, 2017, PESTIC BIOCHEM PHYS, V135, P35, DOI 10.1016/j.pestbp.2016.07.001; Clements J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147844; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dunley JE, 2000, J ECON ENTOMOL, V93, P955, DOI 10.1603/0022-0493-93.3.955; EPA. R. E. D, 1999, R E D FACTS CHLOR; FORGASH AJ, 1985, MASS AGR EXP ST RE B, P33; Gott RC, 2017, J ECON ENTOMOL, V110, P667, DOI 10.1093/jee/tox041; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HARE JD, 1990, ANNU REV ENTOMOL, V35, P81, DOI 10.1146/annurev.en.35.010190.000501; Hsu JC, 2006, J ECON ENTOMOL, V99, P931, DOI 10.1603/0022-0493-99.3.931; Huseth AS, 2013, J ECON ENTOMOL, V106, P2491, DOI 10.1603/EC13277; Jager T, 2011, ENV SCI TECHNOLOGY, V45, P2529; Kaplanoglu E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01961-4; Liu ZW, 2005, P NATL ACAD SCI USA, V102, P8420, DOI 10.1073/pnas.0502901102; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; Medina P, 2002, ARCH INSECT BIOCHEM, V51, P91, DOI 10.1002/arch.10053; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sparks TC, 2015, PESTIC BIOCHEM PHYS, V121, P122, DOI 10.1016/j.pestbp.2014.11.014; Syngenta, 2015, BRAV FUNG; Tomizawa M, 2009, ACCOUNTS CHEM RES, V42, P260, DOI 10.1021/ar800131p; USDA, USDA NAT AGR STAT SE; WEBER DC, 1994, ADVANCES IN POTATO PEST, P54; Yu S.J., 2015, TOXICOLOGY BIOCH INS, Vsecond, DOI 10.1201/b18164; Zhu F, 2016, SCI REPORTS, P2042; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048	30	8	9	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0205881	10.1371/journal.pone.0205881	http://dx.doi.org/10.1371/journal.pone.0205881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359414	Green Submitted, gold, Green Published			2022-12-26	WOS:000448438400029
J	Mostafaei, F; Tai, A; Omari, E; Song, YQ; Christian, J; Paulson, E; Hall, W; Erickson, B; Li, XA				Mostafaei, Farshad; Tai, An; Omari, Eenas; Song, Yingqiu; Christian, James; Paulson, Eric; Hall, William; Erickson, Beth; Li, X. Allen			Variations of MRI-assessed peristaltic motions during radiation therapy	PLOS ONE			English	Article							4-DIMENSIONAL COMPUTED-TOMOGRAPHY; RESPIRATORY MOTION; PANCREATIC-CANCER; BOWEL MOTION; RADIOTHERAPY; MOVEMENT; PROSTATE; MODELS	Purpose Understanding complex abdominal organ motion is essential for motion management in radiation therapy (RT) of abdominal tumors. This study investigates abdominal motion induced by respiration and peristalsis, during various time durations relevant to RT, using various CT and MRI techniques acquired under free breathing (FB) and breath hold (BH). Methods A series of CT and MRI images acquired with various techniques under free breathing and/ or breath hold from 37 randomly-selected pancreatic or liver cancer patients were analyzed to assess the motion in various time frames. These data include FB 4DCT from 15 patients (for motion in time duration of 5 sec), FB 2D cine-MRI from 4 patients (time duration of 1.7 min, 1 second acquisition time per slice), FB cine-MRI acquired using MR-Linac from 6 patients in various fractions (acquisition time is less than 0.6 seconds per slice), FB 4DMRI from 2 patients (time duration of 2 min), respiration-gated T-2 with gating at the end expiration (time duration of 3-5 min), and BH T-1 with multiphase dynamic contrast in acquisition times of 17 seconds for each of five phases (pre-contrast, arterial, venous, portal venous and delayed post-contrast) from 10 patients. Motions of various organs including gallbladder (GB) and liver were measured based on these MRI data. The GB motion includes both respiration and peristalsis, while liver motion is primarily respiration. By subtracting liver motion (respiration) from GB motion (respiration and peristalsis), the peristaltic motion, along with small residual motion, was obtained. Results From cine-MRI, the residual motion beyond the respiratory motion was found to be up to 0.6 cm in superior-inferior (SI) and 0.55 cm in anterior-posterior (AP) directions. From 2D cine-MRI acquired by the MR-Linac, different peristaltic motions were found from different fractions for each patient. The peristaltic motion was found to vary between 0.3-1 cm. From BH T-1 phase images, the average motions that were primarily due to peristalsis movements were found to be 1.2 cm in SI, 0.7 cm in AP, and 0.9 cm in left-right (LR) directions. The average motions assessed from 4DCT were 1.0 cm in SI and 0.3 cm in AP directions, which were generally smaller than the motions assessed from cine-MRI, i.e., 1.8 cm in SI and 0.6 cm in AP directions, for the same patients. However, average motions from 4DMRI, which are coming from respiratory were measured to be 1.5, 0.5, and 0.4 cm in SI, AP, and LR directions, respectively. Conclusion The abdominal motion due to peristalsis can be similar in magnitude to respiratory motion as assessed. These motions can be irregular and persistent throughout the imaging and RT delivery procedures, and should be considered together with respiratory motion during RT for abdominal tumors.	[Mostafaei, Farshad; Tai, An; Omari, Eenas; Song, Yingqiu; Christian, James; Paulson, Eric; Hall, William; Erickson, Beth; Li, X. Allen] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA; [Song, Yingqiu] Huazhong Univ Sci & Technol, Union Hosp Canc Ctr, Wuhan, Hubei, Peoples R China	Medical College of Wisconsin; Huazhong University of Science & Technology	Li, XA (corresponding author), Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA.	alli@mcw.edu		Li, X/0000-0003-2260-0245	Elekta Inc.; MCW Cancer Center Meinerz Foundation	Elekta Inc.; MCW Cancer Center Meinerz Foundation	This work was partially supported by Elekta Inc. and by MCW Cancer Center Meinerz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Koste JRVS, 2015, MED PHYS, V42, P1640, DOI 10.1118/1.4914401; Feng M, 2009, INT J RADIAT ONCOL, V74, P884, DOI 10.1016/j.ijrobp.2009.02.003; Gerscovich EO, 2001, J ULTRAS MED, V20, P597; Goldstein SD, 2010, INT J RADIAT ONCOL, V76, P597, DOI 10.1016/j.ijrobp.2009.06.009; HARAUZ G, 1979, J NUCL MED, V20, P733; Heerkens HD, 2014, RADIOTHER ONCOL, V111, P252, DOI 10.1016/j.radonc.2014.03.002; Jayachandran P, 2010, INT J RADIAT ONCOL, V76, P603, DOI 10.1016/j.ijrobp.2009.06.029; KORIN HW, 1992, MAGNET RESON MED, V23, P172, DOI 10.1002/mrm.1910230118; Kumagai M, 2009, INT J RADIAT ONCOL, V73, P1276, DOI 10.1016/j.ijrobp.2008.10.055; Li XA, 2007, INT J RADIAT ONCOL, V68, P581, DOI 10.1016/j.ijrobp.2006.12.024; Li XA, 2006, MED PHYS, V33, P145, DOI 10.1118/1.2147743; Mageras G S, 2001, J Appl Clin Med Phys, V2, P191, DOI 10.1120/1.1409235; McClelland JR, 2011, PHYS MED BIOL, V56, P251, DOI 10.1088/0031-9155/56/1/015; Mickevicius NJ, 2017, PHYS MED BIOL, V62, P2910, DOI 10.1088/1361-6560/aa54f2; Mori S, 2009, RADIOTHER ONCOL, V92, P231, DOI 10.1016/j.radonc.2008.12.015; Nakamoto Y, 2004, NUCL MED COMMUN, V25, P221, DOI 10.1097/00006231-200403000-00002; Ozhasoglu C, 2002, INT J RADIAT ONCOL, V52, P1389, DOI 10.1016/S0360-3016(01)02789-4; Paulson ES, 2015, MED PHYS, V42, P28, DOI 10.1118/1.4896096; ROSS CS, 1990, INT J RADIAT ONCOL, V18, P671, DOI 10.1016/0360-3016(90)90076-V; Ruan D, 2009, PHYS MED BIOL, V54, P4777, DOI 10.1088/0031-9155/54/15/009; Sheng Y, 2017, INT J RADIAT ONCOL, V98, P473, DOI 10.1016/j.ijrobp.2017.02.089; Shimizu S, 1999, RADIOTHER ONCOL, V50, P367, DOI 10.1016/S0167-8140(98)00140-6; Singh AK, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-33; Sonke JJ, 2008, INT J RADIAT ONCOL, V70, P590, DOI 10.1016/j.ijrobp.2007.08.067; Wysocka B, 2010, INT J RADIAT ONCOL, V77, P53, DOI 10.1016/j.ijrobp.2009.04.046; Xie YQ, 2008, INT J RADIAT ONCOL, V72, P236, DOI 10.1016/j.ijrobp.2008.04.051	26	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0205917	10.1371/journal.pone.0205917	http://dx.doi.org/10.1371/journal.pone.0205917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359413	gold, Green Submitted, Green Published			2022-12-26	WOS:000448438400033
J	Osuagwu, ES; Olaifa, E				Osuagwu, Eze Simpson; Olaifa, Eseoghene			Effects of oil spills on fish production in the Niger Delta	PLOS ONE			English	Article							CONTAMINATED SITES; TIME-SERIES; CHALLENGES; POLLUTION; IMPACTS	The Niger Delta region is the oil producing area of Nigeria, which consists of highly diverse ecosystems that are supportive of numerous species of terrestrial and aquatic fauna and flora. Crude oil spills endanger fish hatcheries in coastal water and also contaminate valuable fish. This study examines the effects of oil spills on fish production in the Niger Delta of Nigeria from 1981-2015 using an estimable Cobb Douglas production function. The findings suggest that oil production and spills negatively affect fish production, while farm labour has a positive effect on fish production. On the other hand, fishery loan exerts a negative effect on fish production and this could be ascribed to the bottlenecks in accessing these loans. This study corroborates the findings in literature on the negative concomitance of oil spills and fish production and suggests a cautious approach to oil exploration activities for a sustainable development in the region.	[Osuagwu, Eze Simpson; Olaifa, Eseoghene] Covenant Univ, Dept Econ & Dev Studies, Ota, Nigeria; [Osuagwu, Eze Simpson] Int Inst Dev Studies, Wilmington, DE 19802 USA	Covenant University	Osuagwu, ES (corresponding author), Covenant Univ, Dept Econ & Dev Studies, Ota, Nigeria.; Osuagwu, ES (corresponding author), Int Inst Dev Studies, Wilmington, DE 19802 USA.	eze.osuagwu@covenantuniversity.edu.ng	Osuagwu, Eze Simpson/S-9363-2017	Osuagwu, Eze Simpson/0000-0003-2255-3899				Abdullahi U., 2010, BUSINESS EC J, V6, DOI [10.4172/21516219, DOI 10.4172/21516219]; Adejumo TO., 2013, INT J BUSINESS SOCIA, V4, P279; Agahlino S. O, 2000, GEOSTUDIES FORUM, V1, P11; Agliardi E, 2017, STOCH ENV RES RISK A, V31, P1389, DOI 10.1007/s00477-016-1258-y; Akpokodje J., 2015, ENV EC, V6, P68; Aliyu A., 2011, INT J STAT APPL, V2, P120; Aluko M. A. O., 2004, Journal of Human Ecology, V15, P63; Aminu U., 2012, INT J SOCIAL SCI ED, V2, P115; Anejionu OCD, 2015, RESOUR POLICY, V45, P65, DOI 10.1016/j.resourpol.2015.03.012; Anetor FO, 2016, J EC SUSTAINABLE DEV, V7, P131; Awosika L.F., 1995, GLOBAL CLIMATE CHANG; Baird J., 2010, NEWSWEEK, P27; Bronwen M, 1999, THE PRICE OF OIL; Carroll J, 2018, MAR POLLUT BULL, V126, P63, DOI 10.1016/j.marpolbul.2017.10.069; Department of Petroleum Resources Statistical Bulletin, 2002, DEP PETR RES STAT B; Department of Petroleum Resources Statistical Bulletin, 2016, DEP PETR RES STAT B; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Ekanem J., 2015, J AGR SUSTAINABILITY, V8, P14; Ekpenyong N.S., 2015, STUD SOCIOL SCI, V6, P1, DOI [10.3968/6399, DOI 10.3968/6399]; Elum ZA, 2016, ENVIRON SCI POLLUT R, V23, P12880, DOI 10.1007/s11356-016-6864-1; FAO, 2017, FISH AQ STAT GLOB PR; Food and Agricultural Organisation, 2003, FAO REL NEW GLOB EST; GRANGER CWJ, 1981, J ECONOMETRICS, V16, P121, DOI 10.1016/0304-4076(81)90079-8; Iyayi F., 2004, INTEGRATED APPROACH; Kadafa A. A., 2012, Civil and Environmental Research, V2, P38; Kadafa A.A., 2012, GLOB J SCI FRONTIER, V12, P19; Langangen O, 2017, MAR POLLUT BULL, V119, P102, DOI 10.1016/j.marpolbul.2017.03.037; Nevalainen M, 2017, MAR POLLUT BULL, V114, P90, DOI 10.1016/j.marpolbul.2016.08.064; Nwilo P. C., 2008, C P INT C NIG STAT O, P164; Nwosu FO, 2010, RESEARCHER, V2, p87 90; Odalonu B H, 2015, MEDITERRANEAN J SOCI, V6, pS2; Odjuvwuederhie Emmanuel I, 2006, J CENT EUR AGRIC, V7, P41; Ogbija T. E., 2015, Journal of Environment and Earth Science, V5, P72; Ogwu F.A., 2015, INT J SCI RES INNOVA, V2, P60; Ojakorotu V, 2006, AFR J CONFL RESOLUT, V6, P85; Ojimba T. P., 2012, Journal of Development and Agricultural Economics, V4, P346; Osabohien R., 2017, 4 COV U INT C E GOV; Paul I. A., 2015, GLOBAL J HUMAN SOCIA, V15, P17; Plessl C, 2017, ENVIRON SCI POLLUT R, V24, P19767, DOI 10.1007/s11356-017-9518-z; Sam K, 2017, LAND USE POLICY, V64, P133, DOI 10.1016/j.landusepol.2017.01.051; Sam K, 2017, SCI TOTAL ENVIRON, V579, P1323, DOI 10.1016/j.scitotenv.2016.11.126; Sekunmade A. B., 2005, J AGR MANAGEMENT RUR, V2, P51; World Bank, 2011, NIG SOC ASS AFCW2; World Bank, 1995, ENV EC STUD NIG DELT, P22; Zabbey N, 2017, SCI TOTAL ENVIRON, V586, P952, DOI 10.1016/j.scitotenv.2017.02.075	45	29	29	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0205114	10.1371/journal.pone.0205114	http://dx.doi.org/10.1371/journal.pone.0205114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359365	Green Published, Green Submitted, gold			2022-12-26	WOS:000448438400013
J	Hart, GR; Roffman, DA; Decker, R; Deng, J				Hart, Gregory R.; Roffman, David A.; Decker, Roy; Deng, Jun			A multi-parameterized artificial neural network for lung cancer risk prediction	PLOS ONE			English	Article							FOLLOW-UP; PROMOTER HYPERMETHYLATION; MUTATIONS; MORTALITY; DIAGNOSIS; BENEFITS; PROJECT; MODELS; HARMS	The objective of this study is to train and validate a multi-parameterized artificial neural network (ANN) based on personal health information to predict lung cancer risk with high sensitivity and specificity. The 1997-2015 National Health Interview Survey adult data was used to train and validate our ANN, with inputs: gender, age, BMI, diabetes, smoking status, emphysema, asthma, race, Hispanic ethnicity, hypertension, heart diseases, vigorous exercise habits, and history of stroke. We identified 648 cancer and 488,418 non-cancer cases. For the training set the sensitivity was 79.8% (95% CI, 75.9%-83.6%), specificity was 79.9% (79.8%-80.1%), and AUC was 0.86 (0.85-0.88). For the validation set sensitivity was 75.3% (68.9%-81.6%), specificity was 80.6% (80.3%-80.8%), and AUC was 0.86 (0.84-0.89). Our results indicate that the use of an ANN based on personal health information gives high specificity and modest sensitivity for lung cancer detection, offering a cost-effective and non-invasive clinical tool for risk stratification.	[Hart, Gregory R.; Roffman, David A.; Decker, Roy; Deng, Jun] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Roffman, David A.] Sun Nucl Corp, Melbourne, FL USA	Yale University	Deng, J (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA.	jun.deng@yale.edu		Hart, Gregory/0000-0003-0576-7430	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [R01EB022589]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB022589] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Research reported in this publication was supported by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health under Award Number R01EB022589. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; American Cancer Society, 2016, LUNG CANC; American Cancer Society , 2017, KEY STAT LUNG CANC; American Cancer Society, 2017, CANC FACTS FIG 2017; Andoni A, 2014, P 31 INT C MACH LEAR; [Anonymous], 2017, EPI TOOLS CALCULATE; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Beau-Faller M, 2009, BRIT J CANCER, V100, P985, DOI 10.1038/sj.bjc.6604925; Belinsky SA, 2006, CANCER RES, V66, P3338, DOI 10.1158/0008-5472.CAN-05-3408; BRETT GZ, 1969, BRIT MED J, V4, P260, DOI 10.1136/bmj.4.5678.260; Centers for Disease Control and Prevention, 2017, WHAT AR RISK FACT LU; Centers for Disease Control and Prevention, 2017, NHIS DAT QUEST REL D; Centers for Disease Control and Prevention, 2017, LUNG CANC RAT RAC ET; Centers for Disease Control and Prevention, 2017, WHAT SCREEN TEST AR; Centers for Disease Control and Prevention, 2017, NHIS NAT HLTH INT SU; Chen PC, 2011, STROKE, V42, P3034, DOI 10.1161/STROKEAHA.111.615534; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Doria-Rose VP, 2011, CURR MULTIDISC ONCOL, P53; Doria-Rose VP, 2009, CANCER-AM CANCER SOC, V115, P5007, DOI 10.1002/cncr.24545; Duan P, 2015, SCI REP-UK, V5, DOI 10.1038/srep16938; Sanz MTG, 2011, CLIN TRANSL ONCOL, V13, P728, DOI 10.1007/s12094-011-0723-9; Gray EP, 2016, CLIN LUNG CANCER, V17, P95, DOI 10.1016/j.cllc.2015.11.007; Hazelton WD, 2012, RISK ANAL, V32, pS99, DOI 10.1111/j.1539-6924.2011.01681.x; Hulbert A, 2017, CLIN CANCER RES, V23, P1998, DOI 10.1158/1078-0432.CCR-16-1371; Infante M, 2009, AM J RESP CRIT CARE, V180, P445, DOI 10.1164/rccm.200901-0076OC; Iyen-Omofoman B, 2013, THORAX, V68, P451, DOI 10.1136/thoraxjnl-2012-202348; Katki HA, 2016, JAMA-J AM MED ASSOC, V315, P2300, DOI 10.1001/jama.2016.6255; Kemp RA, 2007, J THORAC ONCOL, V2, P993, DOI 10.1097/JTO.0b013e318158d488; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Kubik AK, 2000, CANCER, V89, P2363, DOI 10.1002/1097-0142(20001201)89:11+<2363::AID-CNCR9>3.0.CO;2-W; Lindgren A, 2003, AM J EPIDEMIOL, V158, P442, DOI 10.1093/aje/kwg179; Macdonald IK, 2017, TRENDS CANCER, V3, P198, DOI 10.1016/j.trecan.2017.02.003; Manser RL, 2003, THORAX, V58, P784, DOI 10.1136/thorax.58.9.784; MAO L, 1994, CANCER RES, V54, P1634; Marcus PM, 2006, J NATL CANCER I, V98, P748, DOI 10.1093/jnci/djj207; Meza R, 2008, CANCER CAUSE CONTROL, V19, P317, DOI 10.1007/s10552-007-9094-5; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; Nardi-Agmon I, 2017, LUNG CANCER-TARGETS, V8, P31, DOI 10.2147/LCTT.S104205; Nolen BM, 2015, CANCER PREV RES, V8, P111, DOI 10.1158/1940-6207.CAPR-14-0210; Palcic B, 2002, CYTOMETRY, V50, P168, DOI 10.1002/cyto.10065; Pedersen Jesper H, 2009, J Thorac Oncol, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Pegna AL, 2009, LUNG CANCER, V64, P34, DOI 10.1016/j.lungcan.2008.07.003; Radosevich AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110157; Raviv S, 2011, AM J RESP CRIT CARE, V183, P1138, DOI 10.1164/rccm.201008-1274CI; Roffman D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19907-9; Shead DA, 2017, NCCN GUIDELINES PATI; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Spitz MR, 2008, CANCER PREV RES, V1, P250, DOI 10.1158/1940-6207.CAPR-08-0060; Stanford University, 2015, MULT NEUR NETW; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Tammemagi CM, 2011, JNCI-J NATL CANCER I, V103, P1058, DOI 10.1093/jnci/djr173; Tockman MS, 1997, CLIN CANC RES, V3; Zhu LH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003528	56	28	29	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205264	10.1371/journal.pone.0205264	http://dx.doi.org/10.1371/journal.pone.0205264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356283	Green Submitted, Green Published, gold			2022-12-26	WOS:000448434000047
J	Wang, Q; Wu, HL; Zhou, J; Pei, SR; Li, J; Cai, YY; Shang, J				Wang, Qian; Wu, Huali; Zhou, Jia; Pei, Siran; Li, Jing; Cai, Yuanyuan; Shang, Jing			Involvement of the central hypothalamic-pituitary-adrenal axis in hair growth and melanogenesis among different mouse strains	PLOS ONE			English	Article							ASSESSING ANTIDEPRESSANT ACTIVITY; CHRONIC RESTRAINT STRESS; TAIL SUSPENSION TEST; COMPREHENSIVE GUIDE; ALOPECIA-AREATA; ANIMAL-MODEL; SKIN; CORTISOL; EXPRESSION; BEHAVIOR	Stress has been demonstrated to play an important role in hair follicle function and the pathogenesis of some hair disorders. The central hypothalamic-pituitary-adrenal (HPA) axis is activated by stress stimuli, synthesizes and releases various components and eventually induces the pathogenesis and recurrence of peripheral diseases. Our aim is to compare the different responses under exposure of stress in hair follicle function among different mouse strains, and to detect the involvement of the central HPA axis after stress in hair follicle growth and melanogenesis. In this study, we exposed different mouse strains (C57BL/6, CBA/J, C3H/HeN, BALB/c and ICR) to a 21-day chronic restraint stress protocol and selected C57BL/6, CBA/J and BALB/c mice for further study because of their significant behavioral alterations. Then, we evaluated and compared the different responses and sensitivity to chronic restraint stress in hair follicle function and central HPA axis among the selected strains. The results showed that expression of POMC, CRF and GR mRNA and protein and serum levels of corticosterone were inhibited in response to stress. These findings suggested that chronic restraint stress may inhibit hair follicle growth and melanogenesis via regulating the key elements of the central HPA axis. In addition, the results revealed different mouse strains exhibit different responses in the central HPA axis and hair follicle after stress exposure. C57BL/6 might be the most sensitive strain among the three strains tested as well as an appropriate strain to study possible pathophysiological mechanisms by which the nervous system influences skin function and screen dermatological drugs suitable for psychotherapy. We believe the current study will provide some useful information for researchers who are interested in the bidirectional communication between the nervous and skin systems and the management of stress-induced cutaneous diseases.	[Wang, Qian; Wu, Huali; Zhou, Jia; Pei, Siran; Li, Jing; Cai, Yuanyuan; Shang, Jing] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Wang, Qian; Wu, Huali; Zhou, Jia; Pei, Siran; Li, Jing; Cai, Yuanyuan; Shang, Jing] China Pharmaceut Univ, Jiangsu Key Lab TCM Evaluat & Translat Res, Nanjing, Jiangsu, Peoples R China; [Shang, Jing] Chinese Acad Sci, Northwest Inst Plateau Biol, Qinghai Key Lab Tibetan Med Pharmacol & Safety Ev, Xining, Qinghai, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; Chinese Academy of Sciences	Shang, J (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.; Shang, J (corresponding author), China Pharmaceut Univ, Jiangsu Key Lab TCM Evaluat & Translat Res, Nanjing, Jiangsu, Peoples R China.; Shang, J (corresponding author), Chinese Acad Sci, Northwest Inst Plateau Biol, Qinghai Key Lab Tibetan Med Pharmacol & Safety Ev, Xining, Qinghai, Peoples R China.	shangjing21cn@163.com			Megaprojects of Science Research for the 12th Five-Year Plan of China [2011ZX09401-007]; National Science and Technology Infrastructure Program of China [2012BAI30B001]; One Hundred Person Project of The Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province [2015-ZJ-733]	Megaprojects of Science Research for the 12th Five-Year Plan of China; National Science and Technology Infrastructure Program of China; One Hundred Person Project of The Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province	This work was supported by Megaprojects of Science Research for the 12th Five-Year Plan of China (2011ZX09401-007 to JS), National Science and Technology Infrastructure Program of China (2012BAI30B001 to JS), One Hundred Person Project of The Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province (2015-ZJ-733 to JS).	Anisman H, 2001, BEHAV NEUROSCI, V115, P443, DOI 10.1037/0735-7044.115.2.443; Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; Bergler-Czop B, 2017, J EUR ACAD DERMATOL, V31, P1555, DOI 10.1111/jdv.14346; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Carola V, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00259; Costin GE, 2007, FASEB J, V21, P976, DOI 10.1096/fj.06-6649rev; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Dedovic K, 2009, NEUROIMAGE, V47, P864, DOI 10.1016/j.neuroimage.2009.05.074; Faraday MM, 2002, PHYSIOL BEHAV, V75, P507, DOI 10.1016/S0031-9384(02)00645-5; Flaisher-Grinberg S, 2010, PUBMED, V1, P10, DOI DOI 10.HTTPS://D0I.0RG/10.3389/FPSYT.2010.00010; Hall JMF, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/403908; HTTPS, PUBMED, P98283, DOI DOI 10.1371/J0URNAL.P0NE.0098283; Jacobson L, 2014, COMPR PHYSIOL, V4, P715, DOI 10.1002/cphy.c130036; Jafferany Mohammad, 2007, Prim Care Companion J Clin Psychiatry, V9, P203; Jiang W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06956-9; Jozic I, 2015, J INVEST DERMATOL, V135, P1469, DOI 10.1038/jid.2015.56; Jung YH, 2014, BIOMOL THER, V22, P453, DOI 10.4062/biomolther.2014.058; Kariagina A, 2004, ENDOCRINOLOGY, V145, P104, DOI 10.1210/en.2003-0669; Katayama M, 2007, EXP DERMATOL, V16, P553, DOI 10.1111/j.1600-0625.2007.00558.x; Kim JE, 2013, ACTA DERM-VENEREOL, V93, P387, DOI 10.2340/00015555-1557; Kimyai-Asadi A, 2001, J CUTAN MED SURG, V5, P140, DOI 10.1007/s102270000016; Klenerova V, 2001, CELL MOL NEUROBIOL, V21, P91, DOI 10.1023/A:1007177430146; Kuhn H, 2017, J AM ACAD DERMATOL, V76, P779, DOI 10.1016/j.jaad.2016.11.013; Lopez-Rubalcava C, 2000, NEUROPSYCHOPHARMACOL, V22, P191, DOI 10.1016/S0893-133X(99)00100-1; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nardi AE, 2005, BMJ-BRIT MED J, V331, P1084, DOI 10.1136/bmj.331.7524.1084-a; O'Brien KM, 2017, HEALTH PSYCHOL OPEN, V4, DOI 10.1177/2055102917695176; O'Mahony CM, 2011, PHARMACOL BIOCHEM BE, V97, P690, DOI 10.1016/j.pbb.2010.11.012; O'Mahony CM, 2010, BEHAV BRAIN RES, V213, P148, DOI 10.1016/j.bbr.2010.04.038; Ongenae K, 2006, J EUR ACAD DERMATOL, V20, P1, DOI 10.1111/j.1468-3083.2005.01369.x; Pang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098283; PATACCHIOLI FR, 1990, BEHAV BRAIN RES, V37, P185, DOI 10.1016/0166-4328(90)90093-T; Paus R, 2006, TRENDS IMMUNOL, V27, P32, DOI 10.1016/j.it.2005.10.002; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Paus R, 2011, PIGM CELL MELANOMA R, V24, P89, DOI 10.1111/j.1755-148X.2010.00808.x; Pertsov SS, 2009, B EXP BIOL MED+, V148, P735, DOI 10.1007/s10517-010-0804-8; Peters EMJ, 2004, AM J PATHOL, V165, P259, DOI 10.1016/S0002-9440(10)63294-4; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; PuglisiAllegra S, 1997, PROG NEUROBIOL, V51, P637, DOI 10.1016/S0301-0082(97)00008-7; RIVIER C, 1991, BIOL REPROD, V45, P523, DOI 10.1095/biolreprod45.4.523; Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Skobowiat C, 2013, GENE, V530, P1, DOI 10.1016/j.gene.2013.08.035; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; SLOMINSKI A, 1994, J INVEST DERMATOL, V102, P862, DOI 10.1111/1523-1747.ep12382606; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383; Staufenbiel SM, 2013, PSYCHONEUROENDOCRINO, V38, P1220, DOI 10.1016/j.psyneuen.2012.11.015; STERU L, 1987, PROG NEURO-PSYCHOPH, V11, P659; Thom E, 2016, PUBMED, V15, P1001, DOI DOI 10.1093/GER0NT/GNU174; Thom E, 2016, J DRUGS DERMATOL, V15, P1001; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Watts AG, 2005, FRONT NEUROENDOCRIN, V26, P109, DOI 10.1016/j.yfrne.2005.09.001; Wu HAH, 2010, BEHAV BRAIN RES, V213, P94, DOI 10.1016/j.bbr.2010.04.041; Yilmazer-Hanke DM, 2008, BEHAV PHARMACOL, V19, P403, DOI 10.1097/FBP.0b013e32830dc0de; Yin DL, 2006, J NEUROIMMUNOL, V177, P11, DOI 10.1016/j.jneuroim.2006.05.004; Zhang XQ, 2009, J INVEST DERMATOL, V129, P1527, DOI 10.1038/jid.2008.371; Zhao X, 2013, NEUROSCIENCE, V246, P82, DOI 10.1016/j.neuroscience.2013.04.046	60	2	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0202955	10.1371/journal.pone.0202955	http://dx.doi.org/10.1371/journal.pone.0202955			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356231	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000005
J	Moragas, M; Distefano, M; Mecikovsky, D; Caillaud, SA; Cernadas, C; Bologna, R; Aulicino, P; Mangano, A				Moragas, Matfas; Distefano, Maximiliano; Mecikovsky, Debora; Caillaud, Solange Arazi; Cernadas, Carolina; Bologna, Rosa; Aulicino, Paula; Mangano, Andrea			Impact of the time to achieve viral control on the dynamics of circulating HIV-1 reservoir in vertically infected children with long-term sustained virological suppression: A longitudinal study	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; LATENT RESERVOIR; T-CELLS; IN-VIVO; RALTEGRAVIR INTENSIFICATION; DECAY DYNAMICS; LOW-FREQUENCY; DNA; REPLICATION; RNA	Objective Determine the decay rate of HIV-1 DNA reservoir in vertically infected children during sustained viral suppression (VS) and how it is affected by the age at VS. Methods This study included 37 HIV-1 vertically infected children on suppressive antiretroviral therapy for at least 4 years. Children were grouped according to the age of antiretroviral therapy initiation (<= 0.5 or >0.5 yrs) and to the age at VS (<= 1.5, between >1.5 and 4, and >4 years). Decay of cell-associated HIV-1 DNA (CA-HIV-DNA) level and 2-long terminal repeats (2LTR) circles frequency were analyzed over 4 years of viral suppression using piecewise linear mixed-effects model with two splines and logistic regression, respectively. Results CA-HIV-DNA in peripheral blood mononuclear cells had a significant decay during the first two years of VS [-0.26 (95% CI: -0.43, -0.09) log(10) copies per one million cells (cpm)/year], and subsequently reached a plateau [-0.06 (95% CI: -0.15, 0.55) log io cpm/year]. The initial decay was higher in children who achieved VS by 1.5 years of age compared to those who achieved VS between >1.5 and 4 years and those after 4 years of age: -0.51 (95% CI:-0.94, -0.07), -0.35 (95% CI:-0.83, 0.14), and -0.21 (95% CI:-0.39, -0.02) log io cpm PBMC/year, respectively. The 2-LTR circles frequency decayed significantly, from 82.9% at pre-VS to 37.5% and 28.1% at 2 and 4 years of VS, respectively (P = .0009). Conclusions These data highlight that achieving VS during the first 18 months of life limit the establishment of HIV-1 reservoirs, reinforcing the clinical benefit of very early effective therapy in children.	[Moragas, Matfas; Distefano, Maximiliano; Aulicino, Paula; Mangano, Andrea] Hosp Pediat Prof Dr Juan P Garrahan, Lab Biol Celular & Retrovirus, CONICET, Buenos Aires, DF, Argentina; [Mecikovsky, Debora; Caillaud, Solange Arazi; Bologna, Rosa] Hosp Pediat Prof Dr Juan P Garrahan, Serv Epidemiol & Infectol, Buenos Aires, DF, Argentina; [Cernadas, Carolina] Hosp Pediat Prof Dr Juan P Garrahan, DireccionAsociada Docencia & Invest, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Hospital de Pediatria Doctor Juan Garrahan; Hospital de Pediatria Doctor Juan Garrahan; Hospital de Pediatria Doctor Juan Garrahan	Mangano, A (corresponding author), Hosp Pediat Prof Dr Juan P Garrahan, Lab Biol Celular & Retrovirus, CONICET, Buenos Aires, DF, Argentina.	amangano@garrahan.gov.ar			Fondo Nacional para Ciencia y Tecnologia (FONCYT) [PICT 2014-1373]; Fundacion Garrahan, Direccion Asociada de Docencia e Investigacion Hospital de Pediatria	Fondo Nacional para Ciencia y Tecnologia (FONCYT)(FONCyT); Fundacion Garrahan, Direccion Asociada de Docencia e Investigacion Hospital de Pediatria	This work was supported by Fondo Nacional para Ciencia y Tecnologia (FONCYT) [grant number PICT 2014-1373], http://www.agencia.mincyt.gob.ar/foncyt.php. DM was a recipient of a fellowship from Fundacion Garrahan, Direccion Asociada de Docencia e Investigacion Hospital de Pediatria 'Prof. Dr Juan P. Garrahan', http://www.garrahan.gov.ar/.PA and AM are researchers from CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas), Buenos Aires, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurpibul L, 2007, ANTIVIR THER, V12, P1247; Avettand-Fenoel V, 2008, J CLIN VIROL, V42, P399, DOI 10.1016/j.jcv.2008.03.013; Avettand-Fenoel V, 2016, CLIN MICROBIOL REV, V29, P859, DOI 10.1128/CMR.00015-16; Besson GJ, 2014, CLIN INFECT DIS, V59, P1312, DOI 10.1093/cid/ciu585; Bitnun A, 2014, CLIN INFECT DIS, V59, P1012, DOI 10.1093/cid/ciu432; Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Cahn P, 2014, LANCET INFECT DIS, V14, P572, DOI 10.1016/S1473-3099(14)70736-4; Chiappini E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-140; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Frange P, 2016, LANCET HIV, V3, pE49, DOI 10.1016/S2352-3018(15)00232-5; Gandhi RT, 2012, JAIDS-J ACQ IMM DEF, V59, P229, DOI 10.1097/QAI.0b013e31823fd1f2; Imamichi H, 2016, P NATL ACAD SCI USA, V113, P8783, DOI 10.1073/pnas.1609057113; Jones LE, 2007, JAIDS-J ACQ IMM DEF, V45, P483, DOI 10.1097/QAI.0b013e3180654836; Kiselinova M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005472; Koelsch KK, 2008, J INFECT DIS, V197, P411, DOI 10.1086/525283; Laanani M, 2015, CLIN INFECT DIS, V60, P1715, DOI 10.1093/cid/civ171; Malatinkova E, 2015, J CLIN MICROBIOL, V53, P699, DOI 10.1128/JCM.03087-14; Martinez-Bonet M, 2015, CLIN INFECT DIS, V61, P1169, DOI 10.1093/cid/civ456; Noel N, 2016, J VIROL, V90, P6148, DOI 10.1128/JVI.00419-16; Panther LA, 1999, J MED VIROL, V58, P165, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;165::AID-JMV11&gt;3.0.CO;2-1; Pasternak AO, 2008, J CLIN MICROBIOL, V46, P2206, DOI 10.1128/JCM.00055-08; Persaud D, 2000, J CLIN INVEST, V105, P995, DOI 10.1172/JCI9006; Persaud D, 2014, JAMA PEDIATR, V168, P1138, DOI 10.1001/jamapediatrics.2014.1560; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Persaud D, 2012, AIDS, V26, P1483, DOI 10.1097/QAD.0b013e3283553638; Pierson TC, 2002, J VIROL, V76, P4138, DOI 10.1128/JVI.76.8.4138-4144.2002; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Sharkey M, 2005, J VIROL, V79, P5203, DOI 10.1128/JVI.79.8.5203-5210.2005; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; U.S. Department of Health and Human Services, 2016, GUID US ANT AG PED H; Uprety P, 2015, CLIN INFECT DIS, V61, P1862, DOI 10.1093/cid/civ688; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wamalwa D, 2016, AIDS, V30, P2303, DOI 10.1097/QAD.0000000000001158; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2007, ANT THER HIV INF INF	43	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0205579	10.1371/journal.pone.0205579	http://dx.doi.org/10.1371/journal.pone.0205579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352067	Green Published, Green Submitted, gold			2022-12-26	WOS:000448076200011
J	Troy, DM; Attwood, AS; Maynard, OM; Scott-Samuel, NE; Hickman, M; Woods, A; Munafo, MR				Troy, David M.; Attwood, Angela S.; Maynard, Olivia M.; Scott-Samuel, Nicholas E.; Hickman, Matthew; Woods, Andy; Munafo, Marcus R.			Effect of glass shape on the pouring accuracy of liquid volume	PLOS ONE			English	Article							ALCOHOL; CONSUMPTION; JUDGMENTS; DIMENSIONS; PERCEPTION; HEALTH	Background The shape of glassware may exacerbate or counteract biases in perceived volume, which may lead people to misjudge the pouring of alcoholic drinks. The aim of these studies was to investigate the effect of glass shape on the pouring accuracy of liquid volume. Methods In Study 1, using an online computerised task, participants (n = 211) were asked to pour liquid in glasses in a within-subjects design with factors of glass shape (straight, curved) and requested percentage fullness (10, 20, 25, 30, 40, 50, 60, 70, 75, 80, 90%). Curve estimations were carried out to determine if errors followed a linear or non-linear relationship. In Study 2, in a real world experimental study, participants (n = 96) were asked to pour water to the midpoint of pint glasses in a within-subjects design with one factor of glass shape (straight, curved, tulip, inverted). Differences between poured amounts were analysed using one-way repeated measures ANOVA. Results In Study 1, participants under-poured in curved glasses compared to straight glasses at all requested amounts. In Study 2, participants under-poured in curved (p < 0.001, dz = 1.51) and tulip (p < 0.001, dz = 0.59) glasses compared to straight glasses. Findings were inconclusive as to whether or not a difference was present between pourings in inverted and straight glasses. Participants displayed a tendency to under-pour in all glasses relative to requested amounts in both studies. Conclusions The shape of glassware appears to influence the pouring accuracy of liquid. Pouring in tulip and curved glasses was more inaccurate compared to straight glasses, possibly due to the height of liquid within the glass and volume changing in a non-linear relationship.	[Troy, David M.; Hickman, Matthew] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Attwood, Angela S.; Maynard, Olivia M.; Munafo, Marcus R.] Univ Bristol, MRC IEU, Bristol, Avon, England; [Attwood, Angela S.; Maynard, Olivia M.; Munafo, Marcus R.] Univ Bristol, UK Ctr Tobacco & Alcohol Studies, Bristol, Avon, England; [Attwood, Angela S.; Maynard, Olivia M.; Scott-Samuel, Nicholas E.; Munafo, Marcus R.] Univ Bristol, Sch Psychol Sci, Bristol, Avon, England; [Woods, Andy] Univ Oxford, Dept Expt Psychol, Crossmodal Res Lab, Oxford, England	University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of Oxford	Troy, DM (corresponding author), Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England.	david.troy@bristol.ac.uk	Attwood, Angela S/F-7071-2011; Hickman, Matthew/Y-2400-2019; Munafo, Marcus/AAE-2306-2020	Attwood, Angela S/0000-0003-3696-4349; Hickman, Matthew/0000-0001-9864-459X; Munafo, Marcus/0000-0002-4049-993X; Troy, David/0000-0003-0897-2704; Scott-Samuel, Nicholas/0000-0002-8270-8437; Maynard, Olivia/0000-0002-9048-6627	Medical Research Council [MC_UU_12013/6]; National Institute for Health Research School of Public Health Research [IS-SPH-0211-10031]; NIHR; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; National Institute for Health Research, under UK Clinical Research Collaboration; Medical Research Council; MRC [G0800612, MR/K023233/1, MC_UU_12013/6, MR/L022206/1, MC_UU_00011/7, G0802736] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research School of Public Health Research; NIHR(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research, under UK Clinical Research Collaboration(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (https://www.mrc.ac.uk/, MC_UU_12013/6) received by MRM and the National Institute for Health Research School of Public Health Research (http://sphr.nihr.ac.uk/, IS-SPH-0211-10031) received by MRM and MH. The SPHR is funded by the NIHR. SPHR is a partnership between the Universities of Sheffield, Bristol, Cambridge, Exeter, University College London; the London School for Hygiene and Tropical Medicine; the LiLaC collaboration between the Universities of Liverpool and Lancaster and Fuse; the Centre for Translational Research in Public Health, a collaboration between Newcastle, Durham, Northumbria, Sunderland and Teeside Universities. DMT, OMM, ASA and MRM are members of the UK Centre for Tobacco and Alcohol Studies, a UKCRC Public Health Research: Centre of Excellence. Funding from British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwood AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043007; British Medical Association, 2008, ALC MIS TACKL UK EP; Chandon P, 2009, J MARKETING RES, V46, P739, DOI 10.1509/jmkr.46.6.739; FRAYMAN BJ, 1981, PERCEPT PSYCHOPHYS, V29, P56, DOI 10.3758/BF03198840; Gueguen N, 2004, PERCEPT MOTOR SKILL, V99, P34, DOI 10.2466/PMS.99.5.34-38; Hollands JG, 2000, PSYCHOL REV, V107, P500, DOI 10.1037/0033-295X.107.3.500; HUANG CD, 2003, ECONOMETRIC MODELS A; Kersbergen I, 2018, ADDICTION, V113, P1598, DOI 10.1111/add.14228; Lanier SA, 2005, PHYSIOL BEHAV, V83, P821, DOI 10.1016/j.physbeh.2004.10.004; PEARSON R G, 1964, Percept Mot Skills, V18, P889; Pechey R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3068-z; Pechey R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144536; PIAGET J, 1967, CONTEMP PSYCHOL, V12, P532, DOI 10.1037/007869; PIAGET J, 1968, SCIENCE, V162, P976, DOI 10.1126/science.162.3857.976; Piaget J., 1960, CHILDS CONCEPTION GE; PIAGET J., 1969, MECHS PERCEPTION; Raghubir P, 1999, J MARKETING RES, V36, P313, DOI 10.2307/3152079; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Stafford LD, 2017, J PUBLIC HEALTH-HEID, V25, P147, DOI 10.1007/s10389-016-0770-3; Stafford LD, 2012, FOOD QUAL PREFER, V24, P218, DOI 10.1016/j.foodqual.2011.10.012; Troy DM, 2017, EUR J PUBLIC HEALTH, V27, P352, DOI 10.1093/eurpub/ckw142; Troy David M, 2015, Pilot Feasibility Stud, V1, P27; VAREY CA, 1990, J EXP PSYCHOL HUMAN, V16, P613, DOI 10.1037/0096-1523.16.3.613; World Health Organization, 2012, EUR ACT PLAN RED HAR; Yang S, 2005, J RETAILING, V81, P269, DOI 10.1016/j.jretai.2004.11.003	26	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0204562	10.1371/journal.pone.0204562	http://dx.doi.org/10.1371/journal.pone.0204562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX8WQ	30352072	Green Published, gold, Green Submitted			2022-12-26	WOS:000448076200004
J	Hua, Y; Yang, YL; Li, Q; He, XY; Zhu, W; Wang, JY; Gan, XQ				Hua, Yue; Yang, Yilin; Li, Qian; He, Xinyu; Zhu, Wei; Wang, Jiyong; Gan, Xiaoqing			Oligomerization of Frizzled and LRP5/6 protein initiates intracellular signaling for the canonical WNT/beta-catenin pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; receptor endocytosis; Wnt signaling; cancer; tumor development; Frizzled; hepatoma; LRP5; 6; SFRP2; signalosome	WNT; LRP6; INHIBITION; ACTIVATION; DOMAIN; SFRP2; SIGNALOSOME; SELECTIVITY; DRIVEN; BINDS	Upon binding to the canonical WNT glycoproteins, Frizzled family receptors (FZDs) and low-density lipoprotein receptor-related protein 5/6 (LRP5/6) undergo a series of polymerizations on the cell surface that elicit canonical WNT/-catenin signaling. The hyperactivation of WNT/-catenin signaling is the major cause of tumorigenesis, but the mechanism in tumors such as hepatoma remains unclear. Here, we observed that WNT3A manifested the hyperactivity in -catenin-dependent signaling after binding to FZD's competitive inhibitory molecule secreted Frizzled-related protein 2 (SFRP2). To understand the mechanism of FZDs in the presence of SFRP2, we explored how FZDs can bind and activate the LRP5/6 signalosome independently of WNT glycoproteins. Our findings further revealed that oligomerizations of FZDs and LRP5/6 can integrate the cytoplasmic protein Dishevelled into the LRP5/6 signalosome, resulting in a robust activation of ligand-independent -catenin signaling. We propose that besides WNT-bridged FZD-WNT-LRP5/6 protein complexes, the homo- and hetero-oligomerizations of WNT receptors may contribute to the formation of the LRP5/6 signalosome on the cell surface. Of note, we identified four highly expressed FZDs in the hepatoma cell line HepG2, all of which significantly promoted ligand-independent LRP5/-catenin signaling. As FZDs are ectopically expressed in numerous tumors, our findings may provide a new perspective on tumor pathologies. Furthermore, the results in our study suggest that the composition and stoichiometry of FZDs and LRP5/6 within the LRP5/6 signalosome may tune the selection of bound WNT glycoproteins and configure downstream WNT/-catenin signaling.	[Hua, Yue; Yang, Yilin; Li, Qian; He, Xinyu; Zhu, Wei; Wang, Jiyong; Gan, Xiaoqing] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, POB 240, Shanghai 200032, Peoples R China	Fudan University	Wang, JY; Gan, XQ (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, POB 240, Shanghai 200032, Peoples R China.	jiyongwang73@gmail.com; xiaoqinggan@fudan.edu.cn			National Natural Science Foundation of China (NSFC) [31471317, 31671466]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NSFC) Grants 31471317 and 31671466. The authors declare that they have no conflicts of interest with the contents of this article.	Bienz M, 2014, TRENDS BIOCHEM SCI, V39, P487, DOI 10.1016/j.tibs.2014.08.006; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Brinkmann EM, 2016, J BIOL CHEM, V291, P13730, DOI 10.1074/jbc.M116.733766; Chan KKS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010313; Chen JX, 2014, CELL SIGNAL, V26, P1068, DOI 10.1016/j.cellsig.2013.12.020; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Esteve P, 2011, DEVELOPMENT, V138, P4179, DOI 10.1242/dev.065839; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; Feng Q, 2015, J CELL PHYSIOL, V230, P1170, DOI 10.1002/jcp.24853; Gammons MV, 2016, J CELL SCI, V129, P3892, DOI 10.1242/jcs.195685; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Miki T, 2011, STEM CELL REV REP, V7, P836, DOI 10.1007/s12015-011-9275-1; Murillo-Garzon V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04042-w; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Ren DN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7906; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; Saito-Diaz K, 2018, DEV CELL, V44, P566, DOI 10.1016/j.devcel.2018.02.013; Schinner S, 2009, HORM METAB RES, V41, P159, DOI 10.1055/s-0028-1119408; Schulte G, 2015, EUR J PHARMACOL, V763, P191, DOI 10.1016/j.ejphar.2015.05.031; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Sugiyama Y, 2013, DEV BIOL, V384, P181, DOI 10.1016/j.ydbio.2013.10.008; Takagi H, 2008, J GASTROENTEROL, V43, P378, DOI 10.1007/s00535-008-2170-0; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; von Marschall Z, 2010, BIOCHEM BIOPH RES CO, V400, P299, DOI 10.1016/j.bbrc.2010.08.043; Xavier CP, 2014, CELL SIGNAL, V26, P94, DOI 10.1016/j.cellsig.2013.09.016; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zeng CM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051543; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	41	33	36	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19710	19724		10.1074/jbc.RA118.004434	http://dx.doi.org/10.1074/jbc.RA118.004434			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30361437	Green Published, hybrid			2022-12-26	WOS:000454294900018
J	Ohlemacher, SI; Xu, YQ; Kober, DL; Malik, M; Nix, JC; Brett, TJ; Henderson, JP				Ohlemacher, Shannon I.; Xu, Yiquan; Kober, Daniel L.; Malik, Mahnoor; Nix, Jay C.; Brett, Tom J.; Henderson, Jeffrey P.			YbtT is a low-specificity type II thioesterase that maintains production of the metallophore yersiniabactin in pathogenic enterobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						siderophore; biosynthesis; crystallography; mass spectrometry (MS); Escherichia coli (E; coli); metal uptake; metallophore; thioesterase; virulence; yersiniabactin; editing thioesterase	CARRIER PROTEIN DOMAINS; ESCHERICHIA-COLI; SIDEROPHORE YERSINIABACTIN; SUBSTRATE-SPECIFICITY; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; CHAIN RELEASE; BIOSYNTHESIS; SYNTHETASE; GENES	Clinical isolates of Yersinia, Klebsiella, and Escherichia coli frequently secrete the small molecule metallophore yersiniabactin (Ybt), which passivates and scavenges transition metals during human infections. YbtT is encoded within the Ybt biosynthetic operon and is critical for full Ybt production in bacteria. However, its biosynthetic function has been unclear because it is not essential for Ybt production by the in vitro reconstituted nonribosomal peptide synthetase/polyketide synthase (NRPS/PKS) pathway. Here, we report the structural and biochemical characterization of YbtT. YbtT structures at 1.4-1.9 resolution possess a serine hydrolase catalytic triad and an associated substrate chamber with features similar to those previously reported for low-specificity type II thioesterases (TEIIs). We found that YbtT interacts with the two major Ybt biosynthetic proteins, HMWP1 (high-molecular-weight protein 1) and HMWP2 (high-molecular-weight protein 2), and hydrolyzes a variety of aromatic and acyl groups from their phosphopantetheinylated carrier protein domains. In vivo YbtT titration in uropathogenic E. coli revealed a distinct optimum for Ybt production consistent with a tradeoff between clearing both stalled inhibitory intermediates and productive Ybt precursors from HMWP1 and HMWP2. These results are consistent with a model in which YbtT maintains cellular Ybt biosynthesis by removing nonproductive, inhibitory thioesters that form aberrantly at multiple sites on HMWP1 and HMWP2.	[Ohlemacher, Shannon I.; Xu, Yiquan; Malik, Mahnoor; Henderson, Jeffrey P.] Washington Univ, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Ohlemacher, Shannon I.; Xu, Yiquan; Malik, Mahnoor; Henderson, Jeffrey P.] Washington Univ, Div Infect Dis, St Louis, MO 63110 USA; [Ohlemacher, Shannon I.; Xu, Yiquan; Kober, Daniel L.; Malik, Mahnoor; Brett, Tom J.; Henderson, Jeffrey P.] Washington Univ, Dept Internal Med, St Louis, MO 63110 USA; [Kober, Daniel L.; Brett, Tom J.] Washington Univ, Div Pulm & Crit Care Med, St Louis, MO 63110 USA; [Kober, Daniel L.; Brett, Tom J.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Nix, Jay C.] Lawrence Berkeley Natl Lab, Adv Light Source, Mol Biol Consortium, Berkeley, CA 94720 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Brett, TJ (corresponding author), Box 8052,660 South Euclid St, St Louis, MO 63110 USA.; Henderson, JP (corresponding author), Box 8051,660 South Euclid St, St Louis, MO 63110 USA.	tbrett@wustl.edu; hendersonj@wustl.edu	Brett, Thomas/AAC-9147-2019; Henderson, Jeffrey P/D-3337-2015	Brett, Thomas/0000-0002-6871-6676; Kober, Daniel/0000-0001-8657-9348	National Institutes of Health Training Grant from NIAID [5T32AI007172-35]; National Science Foundation Graduate Research Fellowship Program [DGE-1143954]; National Institutes of Health [T32GM007067, R01HL119813]; American Heart Association [15PRE22110004, 17PRE32780001]; Summer Focus Program; National Institutes of Health from NIDDK [R01DK099534, R01DK111930]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	National Institutes of Health Training Grant from NIAID; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Summer Focus Program; National Institutes of Health from NIDDK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Training Grant 5T32AI007172-35 from NIAID and National Science Foundation Graduate Research Fellowship Program DGE-1143954.; Supported by National Institutes of Health T32GM007067 and American Heart Association Grants 15PRE22110004 and 17PRE32780001.; Supported by the Summer Focus Program, run by the Young Scientist Program at Washington University.; Recipient of National Institutes of Health Grant R01HL119813.; Recipient of National Institutes of Health Grants R01DK099534 and R01DK111930 from NIDDK.	ACHSTETTER T, 1981, ARCH BIOCHEM BIOPHYS, V207, P445, DOI 10.1016/0003-9861(81)90052-7; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Butler AR, 1999, CHEM BIOL, V6, P287, DOI 10.1016/S1074-5521(99)80074-X; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Chen DQ, 2009, BIOCHEMISTRY-US, V48, P511, DOI 10.1021/bi802207t; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Claxton HB, 2009, J BIOL CHEM, V284, P5021, DOI 10.1074/jbc.M808604200; Copeland R. A., 2002, ENZYMES, P109; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dorrestein PC, 2006, BIOCHEMISTRY-US, V45, P12756, DOI 10.1021/bi061169d; Drake EJ, 2016, NATURE, V529, P235, DOI 10.1038/nature16163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P11637, DOI 10.1021/bi9812571; Geoffroy VA, 2000, INFECT IMMUN, V68, P4452, DOI 10.1128/IAI.68.8.4452-4461.2000; Gulick AM, 2018, NAT PROD REP, V35, P1156, DOI 10.1039/c8np00044a; Guntaka NS, 2017, ACS CHEM BIOL, V12, P2598, DOI 10.1021/acschembio.7b00479; Harvey BM, 2006, CHEMBIOCHEM, V7, P1435, DOI 10.1002/cbic.200500474; Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keating TA, 2000, BIOCHEMISTRY-US, V39, P4729, DOI 10.1021/bi992923g; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Koh EI, 2017, NAT CHEM BIOL, V13, P1016, DOI [10.1038/nchembio.2441, 10.1038/NCHEMBIO.2441]; Kotowska M, 2014, APPL MICROBIOL BIOT, V98, P7735, DOI 10.1007/s00253-014-5952-8; Kotowska M, 2009, APPL ENVIRON MICROB, V75, P887, DOI 10.1128/AEM.01371-08; Kozlikova B, 2014, BIOINFORMATICS, V30, P2684, DOI 10.1093/bioinformatics/btu364; Leduc D, 2007, J BACTERIOL, V189, P7112, DOI 10.1128/JB.00755-07; Liu TG, 2006, CHEM BIOL, V13, P945, DOI 10.1016/j.chembiol.2006.07.006; Lv HT, 2011, J PROTEOME RES, V10, P5547, DOI 10.1021/pr200756n; Mady ASA, 2011, MOL BIOSYST, V7, P1999, DOI 10.1039/c1mb05044c; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meier JL, 2009, CHEM SOC REV, V38, P2012, DOI 10.1039/b805115c; Meluzzi D, 2008, BIOORG MED CHEM LETT, V18, P3107, DOI 10.1016/j.bmcl.2007.10.104; Meneely KM, 2012, BIOCHEMISTRY-US, V51, P9002, DOI 10.1021/bi3011016; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Miller MC, 2010, MICROBIOL-SGM, V156, P2226, DOI 10.1099/mic.0.037945-0; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulyani S, 2010, CHEMBIOCHEM, V11, P266, DOI 10.1002/cbic.200900600; Ohlemacher SI, 2017, J CLIN INVEST, V127, P4018, DOI 10.1172/JCI92464; Perry RD, 2011, MICROBES INFECT, V13, P808, DOI 10.1016/j.micinf.2011.04.008; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Reimmann C, 2004, J BACTERIOL, V186, P6367, DOI 10.1128/JB.186.19.6367-6373.2004; Ritchie MK, 2016, J BIOL CHEM, V291, P3520, DOI 10.1074/jbc.M115.702597; Robinson AE, 2018, J BIOL CHEM, V293, P14953, DOI 10.1074/jbc.RA118.004483; Robinson AE, 2018, FUTURE MICROBIOL, V13, P813, DOI 10.2217/fmb-2017-0295; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Suo ZC, 2000, P NATL ACAD SCI USA, V97, P14188, DOI 10.1073/pnas.260495697; Suo ZC, 2001, P NATL ACAD SCI USA, V98, P99, DOI 10.1073/pnas.021537498; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tronnet S, 2016, INFECT IMMUN, V84, P3358, DOI 10.1128/IAI.00659-16; Whicher JR, 2011, J BIOL CHEM, V286, P22558, DOI 10.1074/jbc.M110.213512; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43	59	9	9	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19572	19585		10.1074/jbc.RA118.005752	http://dx.doi.org/10.1074/jbc.RA118.005752			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30355735	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000454294900007
J	Kordbacheh, A; Wallace, RL; Walsh, EJ				Kordbacheh, Azar; Wallace, Robert L.; Walsh, Elizabeth J.			Evidence supporting cryptic species within two sessile microinvertebrates, Limnias melicerta and L. ceratophylli (Rotifera, Gnesiotrocha)	PLOS ONE			English	Article							MORPHOLOGICAL STASIS; GENETIC DIFFERENTIATION; BRACHIONUS-CALYCIFLORUS; DNA-SEQUENCES; BIOGEOGRAPHICAL PATTERNS; POPULATION-STRUCTURE; LIFE-HISTORY; DIVERSITY; COMPLEX; MONOGONONTA	Microorganisms, including rotifers, are thought to be capable of long distance dispersal. Therefore, they should show little population genetic structure due to high gene flow. Nevertheless, substantial genetic structure has been reported among populations of many taxa. In rotifers, genetic studies have focused on planktonic taxa leaving sessile groups largely unexplored. Here, we used COI gene and ITS region sequences to study genetic structure and delimit cryptic species in two sessile species (Limnias melicerta [32 populations]; L. ceratophylli [21 populations]). Among populations, ITS region sequences were less variable as compared to those of the COI gene (ITS; L. melicerta: 0-3.1% and L. ceratophylli: 0-4.4%; COI; L. melicerta: 0-22.7% and L. ceratophylli: 0-21.7%). Moreover, L. melicerta and L. ceratophylli were not resolved in phylogenetic analyses based on ITS sequences. Thus, we used COI sequences for species delimitation. Bayesian Species Delimitation detected nine putative cryptic species within L. melicerta and four putative cryptic species for L. ceratophylli. The genetic distance in the COI gene was 0-15.4% within cryptic species of L. melicerta and 0.5-0.6% within cryptic species of L. ceratophylli. Among cryptic species, COI genetic distance ranged 8.1-21.9% for L. melicerta and 15.1-21.2% for L. ceratophylli. The correlation between geographic and genetic distance was weak or lacking; thus geographic isolation cannot be considered a strong driver of genetic variation. In addition, geometric morphometric analyses of trophi did not show significant variation among cryptic species. In this study we used a conservative approach for species delimitation, yet we were able to show that species diversity in these sessile rotifers is underestimated.	[Kordbacheh, Azar; Walsh, Elizabeth J.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Wallace, Robert L.] Ripon Coll, Dept Biol, Ripon, WI USA	University of Texas System; University of Texas El Paso	Kordbacheh, A (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	azar1985k@gmail.com	Walsh, Elizabeth/AAK-4653-2020	Walsh, Elizabeth/0000-0002-6719-6883; Kordbacheh, Azar/0000-0001-5804-4805	National Science Foundation [DEB 1257068, 1257116]; National Institutes on Minority Health and Health Disparities a component of the National Institutes of Health (NIH) [2G12MD007592]; Sigma Xi [G2012162274]; Dodson Research Grant from University of Texas at El Paso	National Science Foundation(National Science Foundation (NSF)); National Institutes on Minority Health and Health Disparities a component of the National Institutes of Health (NIH); Sigma Xi; Dodson Research Grant from University of Texas at El Paso	This research was supported by grants from National Science Foundation (DEB 1257068 EJW, 1257116 to RLW). Funds from these grants were used by the authors to conceive the study design, collect and analyze data, and prepare the manuscript for publication. https://www.nsf.gov/.National Institutes on Minority Health and Health Disparities (2G12MD007592) [a component of the National Institutes of Health (NIH)]. Funds from this grant were used by the authors for data collection and analysis. https://www.nimhd.nih.gov/.Sigma Xi Grants-in-Aid of Research (G2012162274 to AK). Funds from this grant were used for data collection. https://www.sigmaxi.org/programs/grants-in-aid. Dodson Research Grant from University of Texas at El Paso to AK (2014 and 2015). Funds from this grant were used for data collection. https://www.utep.edu/graduate/_Files/dodson-research-grantdetailsinstructions. pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Anitha P.S., 2006, Journal of the Marine Biological Association of India, V48, P6; Arora J, 2003, ZOOL STUD, V42, P239; Artois T, 2011, BIOGEOGRAPHY MICROSC; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banik Sukanta, 1995, Environment and Ecology (Kalyani), V13, P56; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; BIRKY CW, 1989, GENETICS, V121, P613; BOILEAU MG, 1992, J EVOLUTION BIOL, V5, P25, DOI 10.1046/j.1420-9101.1992.5010025.x; BURTON RS, 1981, EVOLUTION, V35, P1192, DOI 10.1111/j.1558-5646.1981.tb04989.x; Campillo S, 2005, HYDROBIOLOGIA, V546, P181, DOI 10.1007/s10750-005-4120-7; Cavalcanti MJ, 1999, ZOOL STUD, V38, P287; Chao A, 2006, OIKOS, V114, P479, DOI 10.1111/j.2006.0030-1299.14814.x; Cieplinski A, 2018, HYDROBIOLOGIA; Ciros-Perez J, 2001, J PLANKTON RES, V23, P1311, DOI 10.1093/plankt/23.12.1311; Cornils A, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-19; Cubitt C., 1871, MON MICROSC J, V6, P165; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Derycke S, 2006, GENETICA, V128, P307, DOI 10.1007/s10709-006-6944-0; Derycke S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-1; Domel JS, 2017, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00139; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; DUMONT HJ, 1983, HYDROBIOLOGIA, V104, P19, DOI 10.1007/BF00045948; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Eastman JM, 2011, SYST BIOL, V60, P503, DOI 10.1093/sysbio/syr020; Eaton TD, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew099; Fenchel T, 2005, AQUAT MICROB ECOL, V41, P49, DOI 10.3354/ame041049; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Finnegan AK, 2013, HEREDITY, V111, P34, DOI 10.1038/hdy.2013.17; Flot JF, 2010, MOL ECOL RESOUR, V10, P162, DOI 10.1111/j.1755-0998.2009.02732.x; Fluker BL, 2014, EVOLUTION, V68, P3199, DOI 10.1111/evo.12505; Foissner W, 2008, BIODIVERS CONSERV, V17, P345, DOI 10.1007/s10531-007-9254-7; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2007, ZOOL SCR, V36, P361, DOI 10.1111/j.1463-6409.2007.00281.x; Fontaneto D, 2007, HYDROBIOLOGIA, V583, P297, DOI 10.1007/s10750-007-0573-1; Fontaneto D, 2015, MAR BIODIVERS, V45, P433, DOI 10.1007/s12526-015-0319-7; Fontaneto D, 2012, EVOL BIOL, V39, P262, DOI 10.1007/s11692-012-9161-z; Fontaneto D, 2011, HYDROBIOLOGIA, V662, P27, DOI 10.1007/s10750-010-0481-7; Fontanillas E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-95; Frisch D, 2013, BIOL INVASIONS, V15, P817, DOI 10.1007/s10530-012-0329-3; FU Y, 1991, J EXP MAR BIOL ECOL, V151, P29, DOI 10.1016/0022-0981(91)90013-M; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gabaldon C, 2017, HYDROBIOLOGIA, V796, P7, DOI 10.1007/s10750-016-2723-9; Geospiza. com, 2014, FINCHTV; Gilbert JJ, 2005, HYDROBIOLOGIA, V546, P257, DOI 10.1007/s10750-005-4205-3; Giribet G, 1996, MOL BIOL EVOL, V13, P76, DOI 10.1093/oxfordjournals.molbev.a025573; Gomez A, 2002, EVOLUTION, V56, P1431; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Gosse P., 1856, PHILOS T ROY SOC LON, V146, P419; Groben R, 2016, MARINE MICROBIOME UN, P187, DOI [10.1007/978-3-319-33000-6_6, DOI 10.1007/978-3-319-33000-6_6]; Guil N., 2011, BIOGEOGRAPHY MICROSC, P284; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gumiere T, 2016, J BIOGEOGR, V43, P2016, DOI 10.1111/jbi.12775; Hahn MW, 2016, ISME J, V10, P1642, DOI 10.1038/ismej.2015.237; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hwang DS, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-13; Jersabek CD, 2011, CANDIDATE ROTIFERA P; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kim HJ, 2017, FISHERIES SCI, V83, P65, DOI 10.1007/s12562-016-1045-1; Kimpel D, 2015, FRESHWATER BIOL, V60, P1364, DOI 10.1111/fwb.12574; Kon T, 2007, MOL PHYLOGENET EVOL, V44, P53, DOI 10.1016/j.ympev.2006.12.007; Kordbacheh A, 2017, ZOOL J LINN SOC-LOND, V181, P757, DOI 10.1093/zoolinnean/zlx027; Krajicek M, 2016, ZOOL SCR, V45, P671, DOI 10.1111/zsc.12183; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kutikova LA, 1995, HYDROBIOLOGIA, V313, P133, DOI 10.1007/BF00025942; Lahr DJG, 2014, BIOESSAYS, V36, P950, DOI 10.1002/bies.201400056; Lavoue S, 2011, P ROY SOC B-BIOL SCI, V278, P1003, DOI 10.1098/rspb.2010.1639; Leasi F, 2013, ZOOL J LINN SOC-LOND, V168, P17, DOI 10.1111/zoj.12020; Lee CE, 2002, HYDROBIOLOGIA, V480, P111, DOI 10.1023/A:1021293203512; Lee PLM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0920; Li L, 2010, J PLANKTON RES, V32, P951, DOI 10.1093/plankt/fbq014; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Malekzadeh-Viayeh R, 2014, ZOOL J LINN SOC-LOND, V170, P233, DOI 10.1111/zoj.12106; Mazaris AD, 2010, J BIOGEOGR, V37, P1341, DOI 10.1111/j.1365-2699.2010.02294.x; McGovern TM, 2003, MOL ECOL, V12, P1207, DOI 10.1046/j.1365-294X.2003.01758.x; Meksuwan P, 2015, ZOOL SCR, V44, P562, DOI 10.1111/zsc.12114; Michaloudi E, 2017, HYDROBIOLOGIA, V796, P19, DOI 10.1007/s10750-016-2924-2; Miller M.A., 2010, P GAT COMP ENV WORKS; Mills Scott, 2017, Hydrobiologia, V796, P39, DOI 10.1007/s10750-016-2725-7; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Obertegger U, 2018, ZOOL SCR, V47, P122, DOI 10.1111/zsc.12264; Obertegger U, 2014, FRESHWATER BIOL, V59, P2413, DOI 10.1111/fwb.12447; Obertegger U, 2012, FRESHWATER BIOL, V57, P1545, DOI 10.1111/j.1365-2427.2012.02815.x; Ojanguren-Affilastro AA, 2016, MOL PHYLOGENET EVOL, V94, P159, DOI 10.1016/j.ympev.2015.08.007; Papakostas S, 2016, SYST BIOL, V65, P508, DOI 10.1093/sysbio/syw016; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rannala B, 2003, GENETICS, V164, P1645; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Richards VP, 2012, BIODIVERS CONSERV, V21, P343, DOI 10.1007/s10531-011-0186-x; Rohlf FJ, 2015, HYSTRIX, V26, P9, DOI 10.4404/hystrix-26.1-11264; Rousselet C., 1889, Journal Quekett Club, Viii, P338; Rousselet CF., 1909, J QUEKETT MICROSCOPI, V2, P465; RUSSO CAM, 1994, MAR BIOL, V119, P267, DOI 10.1007/BF00349566; Salerno JL, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw109; SALT GW, 1978, T AM MICROSC SOC, V97, P469, DOI 10.2307/3226164; Sarma SSS, 2017, HYDROBIOLOGIA, V796, P181, DOI 10.1007/s10750-017-3184-5; Schauer R, 2010, ISME J, V4, P159, DOI 10.1038/ismej.2009.106; Schroder T, 2007, HYDROBIOLOGIA, V593, P129, DOI 10.1007/s10750-007-9066-5; Schroder T, 2010, FRESHWATER BIOL, V55, P2570, DOI 10.1111/j.1365-2427.2010.02487.x; SEGERS H, 1993, HYDROBIOLOGIA, V250, P39, DOI 10.1007/BF00007494; Segers H, 1996, HYDROBIOLOGIA, V323, P169, DOI 10.1007/BF00007845; Segers H, 1997, HYDROBIOLOGIA, V354, P165, DOI 10.1023/A:1003166911731; Segers Hendrik, 2007, Zootaxa, V1564, P1; Shaw KL, 2002, P NATL ACAD SCI USA, V99, P16122, DOI 10.1073/pnas.242585899; Slapeta J, 2005, P ROY SOC B-BIOL SCI, V272, P2073, DOI 10.1098/rspb.2005.3195; Sorensen MV, 2006, MOL PHYLOGENET EVOL, V40, P585, DOI 10.1016/j.ympev.2006.04.001; STEMBERGER RS, 1981, CAN J FISH AQUAT SCI, V38, P721, DOI 10.1139/f81-095; Stopar K, 2010, MOL PHYLOGENET EVOL, V57, P417, DOI 10.1016/j.ympev.2010.07.004; Takeda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074088; Tatem J., 1868, J QUEKETT MICROSCOPI, V1, P124, DOI DOI 10.5962/BHL.PART.3580; Teittinen A, 2015, AQUAT MICROB ECOL, V75, P239, DOI 10.3354/ame01759; Upreti N, 2012, RES REV A, V1, P1; WALLACE RL, 1983, HYDROBIOLOGIA, V104, P379, DOI 10.1007/BF00045995; WALLACE RL, 1986, ECOLOGY, V67, P314, DOI 10.2307/1938575; WALLACE RL, 2006, ROTIFERA, V1; Wallace RL, 2018, ZOOTAXA, V4442, P307, DOI 10.11646/zootaxa.4442.2.7; Wallace RL, 2010, AQUAT ECOL-SAN DIEGO, P173, DOI 10.1016/B978-0-12-374855-3.00008-X; Walsh EJ, 2009, INT VER THEOR ANGEW, V30, P1046; WALSH EJ, 1989, HYDROBIOLOGIA, V186, P157, DOI 10.1007/BF00048908; Walsh EJ, 2017, HYDROBIOLOGIA, V796, P265, DOI 10.1007/s10750-016-2712-z; Weisrock DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009883; Wen XL, 2016, J PLANKTON RES, V38, P478, DOI 10.1093/plankt/fbw006; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; Wright H. G. S., 1954, Microscope, V10, P13; Xavier JR, 2010, MOL PHYLOGENET EVOL, V56, P13, DOI 10.1016/j.ympev.2010.03.030; Xia XH, 2017, J HERED, V108, P431, DOI 10.1093/jhered/esx033; Xiang XL, 2011, MOL ECOL, V20, P3027, DOI 10.1111/j.1365-294X.2011.05147.x; Xiao JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015067; Yang H, 2018, ZOOMORPHOLOGY, V137, P1, DOI 10.1007/s00435-017-0371-x; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhan AB, 2010, MOL ECOL, V19, P4678, DOI 10.1111/j.1365-294X.2010.04837.x; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	136	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205203	10.1371/journal.pone.0205203	http://dx.doi.org/10.1371/journal.pone.0205203			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379825	Green Submitted, Green Published, gold			2022-12-26	WOS:000448823700032
J	Laborde, ND; Leslie, J; Krogstad, E; Morar, N; Mutero, P; Etima, J; Woodrow, K; van der Straten, A				Laborde, Nicole D.; Leslie, Jonah; Krogstad, Emily; Morar, Neetha; Mutero, Prisca; Etima, Juliane; Woodrow, Kim; van der Straten, Ariane			Perceptions of the "Fabric" - An exploratory study of a novel multi-purpose technology among women in Sub Saharan Africa	PLOS ONE			English	Article							CLINICAL-TRIAL; HIV PREVENTION; DRUG-DELIVERY; ACCEPTABILITY; ADHERENCE; TENOFOVIR; FIBERS; CONDOM	Background HIV and pregnancy prevention are dual health priorities for women, and particularly in sub-Saharan Africa. Drug-eluting fibers offer a dosage form that combines HIV prevention and contraception, but early understanding of end-user perspectives is critical to avoid misalignment between products being developed and preferred product attributes. Methods Focus group discussions (FGDs) were conducted in South Africa, Uganda and Zimbabwe, among 55 women who had used vaginal products in previous trials. Participants were given the opportunity to feel a sample of electrospun nanofiber (the fabric), see how it dissolves, and give feedback on shape, size and other attributes. Women were also asked to compare the fabric to vaginal gel and film. Results Three key themes regarding the acceptability of the fabric emerged: 1) look and feel of the product undissolved vs. undissolved, 2) expected effect on sex, and 3) convenience and ease of use. Upon being presented with the fabric, women were initially distrustful, seeing it as undesirable for vaginal insertion. Women generally approved of the product once they saw it dissolve. However, they stressed the importance of the product not interfering with sex by altering the vaginal environment. Women also reacted favorably to the perceived convenience of the fabric, particularly with regards to storage and transport, perceived ease of insertion and use, and dosing regimen. Conclusion Multipurpose prevention technologies, and nanofibers in particular, should be developed with an eye to minimizing impact on sex while maximizing convenience, and presented in such a way as to emphasize non-abrasiveness and ease of dissolution.	[Laborde, Nicole D.; Leslie, Jonah; Krogstad, Emily; van der Straten, Ariane] RTI Int, Womens Global Hlth Imperat, San Francisco, CA 94104 USA; [Krogstad, Emily; Woodrow, Kim] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Morar, Neetha] South Africa Med Res Council, Durban, South Africa; [Mutero, Prisca] UZ UCSF Collaborat Res Programme, Harare, Zimbabwe; [Etima, Juliane] Makerere Univ Johns Hopkins Univ Res Unit, Kampala, Uganda; [van der Straten, Ariane] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA 94122 USA	Research Triangle Institute; University of Washington; University of Washington Seattle; University of Zimbabwe; University of California System; University of California San Francisco	van der Straten, A (corresponding author), RTI Int, Womens Global Hlth Imperat, San Francisco, CA 94104 USA.; van der Straten, A (corresponding author), Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA 94122 USA.	ariane@rti.org		Mudzingwa, Emily/0000-0003-2736-8350; van der Straten, Ariane/0000-0001-8536-648X	Bill and Melinda Gates Foundation [OPP1110945]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the Bill and Melinda Gates Foundation (OPP1110945, P.I. Kim Woodrow). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, DED VERS 7 5 WEB APP; Ariane van der Straten AM, 2018, MTN ANN M WASH DC; Ball C, 2015, DRUG DELIVERY AND DEVELOPMENT OF ANTI-HIV MICROBICIDES, P459; Ball C, 2014, ANTIMICROB AGENTS CH, V58, P4855, DOI 10.1128/AAC.02564-14; Ballard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037410; Blakney AK, 2014, INT J NANOMED, V9, P2967, DOI 10.2147/IJN.S61664; Blakney AK, 2013, ANTIVIR RES, V100, pS9, DOI 10.1016/j.antiviral.2013.09.022; Brady M, 2014, BJOG-INT J OBSTET GY, V121, P70, DOI 10.1111/1471-0528.12844; Chimbiri AM, 2007, SOC SCI MED, V64, P1102, DOI 10.1016/j.socscimed.2006.10.012; Corneli A, 2016, JAIDS-J ACQ IMM DEF, V71, P452, DOI 10.1097/QAI.0000000000000880; Fernandez-Romero JA, 2015, TRENDS MICROBIOL, V23, P429, DOI 10.1016/j.tim.2015.02.006; HIV/ AIDS JUNPo, 2014, GAP REP GEN; Krogstad EA, 2014, INT J PHARMACEUT, V475, P282, DOI 10.1016/j.ijpharm.2014.08.039; Laborde ND, 2018, AIDS BEHAV, V22, P437, DOI 10.1007/s10461-017-1977-1; Luecke EH, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20875; MacPhail C, 2001, SOC SCI MED, V52, P1613, DOI 10.1016/S0277-9536(00)00272-0; Minnis AM, 2018, AIDS BEHAV, V22, P2662, DOI 10.1007/s10461-018-2078-5; Minnis AM, 2013, AIDS BEHAV, V17, P737, DOI 10.1007/s10461-012-0333-8; Morrow KM, 2014, ARCH SEX BEHAV, V43, P1459, DOI 10.1007/s10508-013-0235-5; Romano JW, 2014, BJOG-INT J OBSTET GY, V121, P15, DOI 10.1111/1471-0528.12850; Sedgh G AL, 2016, UNMET NEED CONTRACEP; Straten Avd, 2016, HIV PREP FORMULATION; Tolley EE, 2013, ANTIVIR RES, V100, pS54, DOI 10.1016/j.antiviral.2013.09.029; van der Straten A, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25094; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; Weinrib R, 2018, AIDS BEHAV, V22, P133, DOI 10.1007/s10461-017-1911-6; Woodsong C, 2015, ADV DRUG DELIV REV, DOI [10.1016/j, DOI 10.1016/J]	27	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0204821	10.1371/journal.pone.0204821	http://dx.doi.org/10.1371/journal.pone.0204821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY7VH	30379839	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700020
J	Law, BS; Brassil, T; Gonsalves, L; Roe, P; Truskinger, A; McConville, A				Law, Bradley S.; Brassil, Traecey; Gonsalves, Leroy; Roe, Paul; Truskinger, Anthony; McConville, Anna			Passive acoustics and sound recognition provide new insights on status and resilience of an iconic endangered marsupial (koala Phascolarctos cinereus) to timber harvesting	PLOS ONE			English	Article							NEW-SOUTH-WALES; SPECIES DISTRIBUTION MODEL; RETENTION FORESTRY; PORT STEPHENS; HABITAT USE; BIODIVERSITY; MANAGEMENT; MAMMALS; EASTERN; AREA	Retention forestry aims to mitigate impacts of native forestry on biodiversity, but data are limited on its effectiveness for threatened species. We used acoustics to investigate the resilience of a folivorous marsupial, the koala Phascolarctos cinereus, to timber harvesting where a key mitigation practice is landscape exclusion of harvesting. We deployed acoustic recorders at 171 sites to record male bellows (similar to 14,640 hours) for use in occupancy modelling and for comparisons of bellow rate (bellows night(-1)). Surveys targeted modelled medium-high quality habitat, with sites stratified by time since logging and logging intensity, including old growth as a reference. After scanning recordings with software to identify koala bellows, we found a high probability of detection (0.45 per night), but this varied with minimum temperature and recorder type. Naive occupancy was similar to 64% across a broad range of forests, which was at least five times more than expected based on previous surveys using alternative methods. After accounting for imperfect detection, probability of occupancy was influenced by elevation (-ve), cover of important browse trees (+ve), landscape NDVI (+ve) and extent of recent wildfire (-ve, but minor effect). Elevation was the most influential variable, though the relationship was non-linear and low occupancy was most common at tableland elevations (> 1000 m). Neither occupancy nor bellow rate were influenced by timber harvesting intensity, time since harvesting or local landscape extent of harvesting or old growth. Extrapolation of occupancy across modelled habitat indicates that the hinterland forests of north-east NSW support a widespread, though likely low density koala population that is considerably larger than previously estimated. Retention forestry has a significant role to play in mitigating harvesting impacts on biodiversity, including for forest specialists, but localised studies are needed to optimise prescriptions for koalas.	[Law, Bradley S.; Brassil, Traecey; Gonsalves, Leroy] NSW Dept Primary Ind, Forest Sci Unit, Locked Bag 5123, Parramatta, NSW, Australia; [Roe, Paul; Truskinger, Anthony] Queensland Univ Technol, Sci & Engn Fac, Brisbane, Qld, Australia; [McConville, Anna] EchoEcol, Crescent Head, NSW, Australia	NSW Department of Primary Industries; Queensland University of Technology (QUT)	Law, BS (corresponding author), NSW Dept Primary Ind, Forest Sci Unit, Locked Bag 5123, Parramatta, NSW, Australia.	brad.law@dpi.nsw.gov.au		Law, Bradley/0000-0002-3991-3865; Truskinger, Anthony/0000-0003-1110-1483	NSW Department of Primary Industries	NSW Department of Primary Industries	This work was supported by the NSW Department of Primary Industries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Anna McConville is affiliated to EchoEcology. EchoEcology provided support in the form of salary for author AM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author was koala call verification and is articulated in the 'author contributions' section.	Adams-Hosking C, 2016, DIVERS DISTRIB, V22, P249, DOI 10.1111/ddi.12400; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Australian Koala Foundation, 2008, UNPUBL REPORT; Beyer HL, 2018, J APPL ECOL, V55, P1966, DOI 10.1111/1365-2664.13127; Bicknell JE, 2014, CURR BIOL, V24, pR1119, DOI 10.1016/j.cub.2014.10.067; Binns DL, 1991, THESIS; Briscoe NJ, 2016, GLOBAL CHANGE BIOL, V22, P2425, DOI 10.1111/gcb.13280; Charlton BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070279; Charlton BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045420; Chaudhary A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23954; Close Robert, 2017, Australian Zoologist, V38, P272, DOI 10.7882/AZ.2015.001; Demarais S, 2017, FOREST ECOL MANAG, V385, P308, DOI 10.1016/j.foreco.2016.10.006; Ellis W, 2011, BEHAV ECOL, V22, P372, DOI 10.1093/beheco/arq216; Ellis W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130657; Ellis W, 2013, AUST MAMMAL, V35, P160, DOI 10.1071/AM12023; Ellis WAH, 2009, BEHAV ECOL SOCIOBIOL, V63, P1181, DOI 10.1007/s00265-009-0761-2; Fedrowitz K, 2014, J APPL ECOL, V51, P1669, DOI 10.1111/1365-2664.12289; Florence RG, 1996, ECOLOGY AND SILVICUL; Gustafsson L, 2012, BIOSCIENCE, V62, P633, DOI 10.1525/bio.2012.62.7.6; Hagens SV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199396; Hines J., 2006, PRESENCE2 SOFTWARE E; Jathanna D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133233; Jurskis V, 1997, 34 STAT FOR NSW; Kavanagh RP, 2007, WILDLIFE RES, V34, P94, DOI 10.1071/WR06126; Kavanagh Rodney P., 2012, Ecological Management & Restoration, V13, P297, DOI 10.1111/emr.12005; KAVANAGH RP, 1995, WILDLIFE RES, V22, P359, DOI 10.1071/WR9950359; Kavanagh RP, 1995, FOREST RESOURCES SER, V26; Kavanagh RP, 2006, PAC CONS BIOL, P18, DOI [10.1016/j.foreco.2018.01.048, DOI 10.1016/J.FORECO.2018.01.048]; King G. C., 1985, Australian Forestry, V48, P54; Krockenberger AK, 1993, THESIS; Law B, 2017, ECOL EVOL, V7, P7475, DOI 10.1002/ece3.3300; Law B, 2013, WILDLIFE RES, V40, P470, DOI 10.1071/WR13105; LEUNING R, 1991, OECOLOGIA, V88, P504, DOI 10.1007/BF00317712; Lindenmayer DB, 2006, BIOL CONSERV, V131, P433, DOI 10.1016/j.biocon.2006.02.019; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lunney D, 2002, BIOL CONSERV, V106, P101, DOI 10.1016/S0006-3207(01)00233-6; Lunney D., 2015, P LINNEAN SOC NEW S, V137, P57; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MAJER JD, 1992, AUST J ECOL, V17, P383, DOI 10.1111/j.1442-9993.1992.tb00821.x; Maron M, 2013, CONSERV LETT, V6, P359, DOI 10.1111/conl.12007; Matthews A, 2016, AUST MAMMAL, V38, P91, DOI 10.1071/AM14010; McAlpine C, 2015, BIOL CONSERV, V192, P226, DOI 10.1016/j.biocon.2015.09.020; McAlpine CA, 2006, BIOL CONSERV, V132, P153, DOI 10.1016/j.biocon.2006.03.021; Mitchell P., 1990, P171; Moore BD, 2004, ECOL MONOGR, V74, P553, DOI 10.1890/03-4038; Moore BD, 2010, ECOLOGY, V91, P3165, DOI 10.1890/09-1714.1; Nicholls A. O., 1994, Pacific Conservation Biology, V1, P177; NSW NPWS, 1994, 3 NSW NPWS; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Phillips S, 2000, WILDLIFE RES, V27, P509, DOI 10.1071/WR98087; Phillips S, 2000, WILDLIFE RES, V27, P1, DOI 10.1071/WR98054; Predavec M, 2015, AUST MAMMAL, V37, P182, DOI 10.1071/AM15001; Putz FE, 2012, CONSERV LETT, V5, P296, DOI 10.1111/j.1755-263X.2012.00242.x; Roberts P., 1998, THESIS U NEW ENGLAND; Slade Christopher, 2017, Australian Zoologist, V39, P359, DOI 10.7882/AZ.2016.011; Smith AP, 2004, CONSERVATION OF AUTRALIA'S, SECOND EDITION, P591; Smith AP, 1994, TERRESTRIAL FAUNA GR; SMITH M, 1980, AUST WILDLIFE RES, V7, P13; Stalenberg E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113930; Tobler MW, 2018, BIOL CONSERV, V220, P245, DOI 10.1016/j.biocon.2018.02.015; Towsey M, 2012, BIOACOUSTICS, V21, P107, DOI 10.1080/09524622.2011.648753; Tumer J, 2008, FOREST ECOL MANAG, V255, P1701, DOI 10.1016/j.foreco.2007.11.038; Wardlaw TJ, 2018, FOREST ECOL MANAG, V409, P694, DOI 10.1016/j.foreco.2017.11.060; Wintle BA, 2005, J WILDLIFE MANAGE, V69, P905, DOI 10.2193/0022-541X(2005)069[0905:EADWDI]2.0.CO;2; Wright PA, 1971, MEMORIES BUSHWACKER; Yip DA, 2017, AVIAN CONSERV ECOL, V12, DOI 10.5751/ACE-00997-120111; Youngentob KN, 2015, DIVERS DISTRIB, V21, P977, DOI 10.1111/ddi.12332	68	20	21	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205075	10.1371/journal.pone.0205075	http://dx.doi.org/10.1371/journal.pone.0205075			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379836	gold, Green Submitted, Green Published			2022-12-26	WOS:000448823700026
J	Yamamoto, N; Hirata, T; Izumi, G; Nakazawa, A; Fukuda, S; Neriishi, K; Arakawa, T; Takamura, M; Harada, M; Hirota, Y; Koga, K; Wada-Hiraike, O; Fujii, T; Irahara, M; Osuga, Y				Yamamoto, Naoko; Hirata, Tetsuya; Izumi, Gentaro; Nakazawa, Akari; Fukuda, Shinya; Neriishi, Kazuaki; Arakawa, Tomoko; Takamura, Masashi; Harada, Miyuki; Hirota, Yasushi; Koga, Kaori; Wada-Hiraike, Osamu; Fujii, Tomoyuki; Irahara, Minoru; Osuga, Yutaka			A survey of public attitudes towards third-party reproduction in Japan in 2014	PLOS ONE			English	Article							OOCYTE DONATION; GESTATIONAL SURROGACY; DONOR CONCEPTION; EGG DONATION; OPINION; TRANSPLANTATION; PREGNANCIES; TECHNOLOGY; COMMITTEE; OUTCOMES	Objective The objective of this study was to examine public attitudes towards third-party reproduction and the disclosure of conception through third-party reproduction. Methods We conducted the web-based survey for the public attitude towards third-party reproduction in February 2014. Twenty-five hundred people were recruited with equal segregation of age (20s, 30s, 40s, and 50s) and gender. We analyzed the association between gender, age, infertility, and ethical view using a questionnaire regarding donor sperm, donor oocyte, donor embryo, gestational surrogacy, and disclosure to offspring. Results Of the respondents, 36.2% approved and 26.6% disapproved of gamete or embryo donation. The frequency of those who approved was lowest in females in the 50-59 year age group, and was significantly higher in males or females with infertility. Secondly, 40.9% approved and 21.8% disapproved of gestational surrogacy. The frequency of those who approved gestational surrogacy was higher in males or females with infertility. Thirdly, 46.3% of respondents agreed and 20.4% disagreed with "offspring have the right to know their origin". Those who disagreed were primarily in the 50-59 year age group of both genders, and disagreement was significantly higher in the infertility group compared with non-infertility group. Conclusion In this study, public attitudes were affected by gender, age, and experience of infertility. These study findings are important in understanding the attitude towards third-party reproduction and disclosure to the offspring. Respondents having indecisive attitudes were >30%, which might indicate an increased requirement for information and education to enhance the discussion on the ethical consensus on third-party reproduction in Japan.	[Yamamoto, Naoko; Hirata, Tetsuya; Izumi, Gentaro; Nakazawa, Akari; Fukuda, Shinya; Neriishi, Kazuaki; Arakawa, Tomoko; Takamura, Masashi; Harada, Miyuki; Hirota, Yasushi; Koga, Kaori; Wada-Hiraike, Osamu; Fujii, Tomoyuki; Osuga, Yutaka] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo, Japan; [Irahara, Minoru] Tokushima Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, Tokushima, Japan	University of Tokyo; Tokushima University	Hirata, T (corresponding author), Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo, Japan.	thira-tky@umin.ac.jp	Koga, Kaori/ABA-5601-2020; Hirota, Yasushi/AAD-8713-2020	Koga, Kaori/0000-0002-5057-4120; Hirota, Yasushi/0000-0003-0241-9780; Hirata, Tetsuya/0000-0002-9975-6208	Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology; Japan Agency for Medical Research and Development	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study is partly supported by grants from the Ministry of Health, Labour and Welfare, the Ministry of Education, Culture, Sports, Science and Technology and the Japan Agency for Medical Research and Development.	Brannstrom M, 2017, EXPERT OPIN BIOL TH, V17, P1105, DOI 10.1080/14712598.2017.1347633; Brannstrom M, 2015, LANCET, V385, P607, DOI 10.1016/S0140-6736(14)61728-1; Chliaoutakis JE, 2002, HUM REPROD, V17, P2187, DOI 10.1093/humrep/17.8.2187; Dyer S, 2016, HUM REPROD, V31, P1588, DOI 10.1093/humrep/dew082; Hibino Y, 2013, ENVIRON HEALTH PREV, V18, P477, DOI 10.1007/s12199-013-0345-7; Higher Education in Japan, PAMPHL MIN ED CULT S; KAZEM R, 1995, HUM REPROD, V10, P1543, DOI 10.1093/HUMREP/10.6.1543; Kisu I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156179; Kisu I, 2011, EUR J OBSTET GYN R B, V158, P135, DOI 10.1016/j.ejogrb.2011.04.037; Kushnir VA, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.11.1022; Minai J, 2007, EUR J OBSTET GYN R B, V132, P193, DOI 10.1016/j.ejogrb.2006.08.016; Pennings G, 2017, HUM REPROD, V32, P969, DOI 10.1093/humrep/dex056; Saito H, 2018, REPROD MED BIOL, V17, P20, DOI 10.1002/rmb2.12074; Savasi VM, 2016, HUM REPROD UPDATE, V22, P620, DOI 10.1093/humupd/dmw012; Semba Y, 2010, BIOETHICS, V24, P348, DOI 10.1111/j.1467-8519.2009.01780.x; Stobel-Richter Y, 2009, FERTIL STERIL, V92, P124, DOI 10.1016/j.fertnstert.2008.05.015; Storgaard M, 2017, BJOG-INT J OBSTET GY, V124, P561, DOI 10.1111/1471-0528.14257; Suzuki K, 2006, EUR J OBSTET GYN R B, V126, P39, DOI 10.1016/j.ejogrb.2005.07.030; Suzuki K, 2011, INT J FERTIL STERIL, V5, P78; Svanberg AS, 2003, HUM REPROD, V18, P1107, DOI 10.1093/humrep/deg222; Testa G, 2018, AM J TRANSPLANT, V18, P1270, DOI 10.1111/ajt.14737; Woo I, 2017, FERTIL STERIL, V108, P993, DOI 10.1016/j.fertnstert.2017.09.014	22	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0198499	10.1371/journal.pone.0198499	http://dx.doi.org/10.1371/journal.pone.0198499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379816	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700001
J	Schott, CR; Ludwig, L; Mutsaers, AJ; Foster, RA; Wood, GA				Schott, Courtney R.; Ludwig, Latasha; Mutsaers, Anthony J.; Foster, Robert A.; Wood, Geoffrey A.			The autophagy inhibitor spautin-1, either alone or combined with doxorubicin, decreases cell survival and colony formation in canine appendicular osteosarcoma cells	PLOS ONE			English	Article							COMBINATION CHEMOTHERAPY; DOGS; AMPUTATION; CARBOPLATIN; CISPLATIN; ADJUVANT; THERAPY; APOPTOSIS; SURGERY; EFFICACY	Dogs diagnosed with appendicular osteosarcoma typically succumb to metastatic disease within a year of diagnosis. The current standard of care for curative intent, amputation followed by adjuvant chemotherapy, increases survival time but chemoresistance is a major contributor to mortality. Unfortunately, the mechanisms driving the progression of metastatic disease and the development of chemoresistance are unknown. One theory is that autophagy may contribute to chemoresistance by providing neoplastic cells with a mechanism to survive chemotherapy treatment. Our objective was to evaluate the effect of combining an autophagy inhibitor with a standard chemotherapeutic drug on response to chemotherapy in canine appendicular osteosarcoma cells. We hypothesized that combining the autophagy inhibitor spautin-1 with doxorubicin treatment would enhance chemoresponsiveness. Using commercial (D17) and primary cell lines derived from 1 degrees and 2 degrees sites of osteosarcoma, we showed that this combination treatment enhances cell killing and inhibits colony formation. Our findings support the theory that autophagy contributes to chemoresistance in canine appendicular osteosarcoma and indicate that adding an autophagy inhibitor to the standard of care has the potential to improve outcome.	[Schott, Courtney R.; Ludwig, Latasha; Foster, Robert A.; Wood, Geoffrey A.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada; [Mutsaers, Anthony J.] Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON, Canada; [Mutsaers, Anthony J.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON, Canada	University of Guelph; University of Guelph; University of Guelph	Wood, GA (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada.	gewood@uoguelph.ca	Wood, Geoffrey/ABB-2052-2021	Wood, Geoffrey/0000-0003-1756-8607; Mutsaers, Anthony/0000-0002-7965-7149; Schott, Courtney/0000-0003-2147-6297	Pet Trust	Pet Trust	This work was funded by a grant to GAW by the Pet Trust (https://ovc.uoguelph.ca/pettrust).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2014, J AM ANIM HOSP ASSOC, V50, P12, DOI 10.5326/JAAHA-MS-5958; [Anonymous], 2021, LANG ENV STAT COMP; Bacon NJ, 2008, JAVMA-J AM VET MED A, V232, P1504, DOI 10.2460/javma.232.10.1504; Bailey D, 2003, J VET INTERN MED, V17, P199, DOI 10.1892/0891-6640(2003)017&lt;0199:CADCCF&gt;2.3.CO;2; Barnard RA, 2014, AUTOPHAGY, V10, P1415, DOI 10.4161/auto.29165; Berg J, 1997, CANCER, V79, P1343, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1343::AID-CNCR11>3.0.CO;2-#; BERG J, 1995, J AM VET MED ASSOC, V206, P1555; Berg J, 1996, VET CLIN N AM-SMALL, V26, P111, DOI 10.1016/S0195-5616(96)50010-0; Bergman PJ, 1996, J VET INTERN MED, V10, P76, DOI 10.1111/j.1939-1676.1996.tb02031.x; Botter SM, 2014, CURR OPIN PHARMACOL, V16, P15, DOI 10.1016/j.coph.2014.02.002; Chen SA, 2014, MOL CELL BIOL, V34, P3435, DOI 10.1128/MCB.01383-13; Chittaranjan Suganthi, 2015, Cold Spring Harb Protoc, V2015, P743, DOI 10.1101/pdb.prot086256; Choi KS, 2012, EXP MOL MED, V44, P109, DOI 10.3858/emm.2012.44.2.033; Chun R, 2005, J AM ANIM HOSP ASSOC, V41, P382, DOI 10.5326/0410382; Correa RJM, 2014, CARCINOGENESIS, V35, P1951, DOI 10.1093/carcin/bgu049; Dag O, 2017, ONEWAYTESTS R PACKAG; Davis LE, 2013, PEDIATR BLOOD CANCER, V60, P1313, DOI 10.1002/pbc.24512; Ferraresi A, 2017, MOL CARCINOGEN, V56, P1164, DOI 10.1002/mc.22582; Fox J., 2019, R COMPANION APPL REG, V.; Frimberger AE, 2016, J AM ANIM HOSP ASSOC, V52, P149, DOI 10.5326/JAAHA-MS-6315; Frommolt P, 2010, IC50 STANDARDIZED HI; Frommolt P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-475; Hahn KA, 1997, J CANCER RES CLIN, V123, P34, DOI 10.1007/BF01212612; Han LJ, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0275-0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horie R, 2016, INT J ONCOL, V48, P37, DOI 10.3892/ijo.2015.3227; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kent MS, 2004, J VET INTERN MED, V18, P540, DOI 10.1892/0891-6640(2004)18&lt;540:ACADAA&gt;2.0.CO;2; Kim C, 2017, CAN VET J, V58, P1059; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Kirpensteijn J, 2002, ANTICANCER RES, V22, P2765; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kozicki AR, 2015, VET COMP ONCOL, V13, P229, DOI 10.1111/vco.12040; KRAEGEL SA, 1991, J AM VET MED ASSOC, V199, P1057; Kurzman ID, 1995, CLIN CANCER RES, V1, P1595; Lane AE, 2012, AUST VET J, V90, P69, DOI 10.1111/j.1751-0813.2011.00878.x; Laver T, 2018, VET COMP ONCOL, V16, pE23, DOI 10.1111/vco.12328; Lee TG, 2015, INT J CANCER, V136, P2717, DOI 10.1002/ijc.29320; Lei Y, 2016, ONCOGENE, V35, P4698, DOI 10.1038/onc.2016.11; Liu JL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020191; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Llewellyn KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176919; London C, 2012, VET COMP ONCOL, V10, P194, DOI 10.1111/j.1476-5829.2011.00275.x; London CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124889; Marley K, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-74; Mason NJ, 2016, CLIN CANCER RES, V22, P4380, DOI 10.1158/1078-0432.CCR-16-0088; Massimini M, 2017, VET PATHOL, V54, P405, DOI 10.1177/0300985816681409; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mauldin GN, 1988, J VET, P177; McMahon M, 2011, J VET INTERN MED, V25, P511, DOI 10.1111/j.1939-1676.2011.0697.x; Moore AS, 2007, J VET INTERN MED, V21, P783, DOI 10.1892/0891-6640(2007)21[783:DABFTT]2.0.CO;2; OGILVIE GK, 1993, J AM VET MED ASSOC, V202, P304; Paoloni MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011013; Park JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100819; Parks A, 2015, PEERJ, V3, DOI 10.7717/peerj.1314; Peters G.-J., 2018, USERFRIENDLYSCIENCE, DOI 10.17605/osf.io/txequ; Philips B, 2009, J AM ANIM HOSP ASSOC, V45, P33, DOI 10.5326/0450033; Qiang L, 2016, AUTOPHAGY, V12, P357, DOI 10.1080/15548627.2015.1110667; Rodriguez CO, 2014, ADV EXP MED BIOL, V804, P237, DOI 10.1007/978-3-319-04843-7_13; Salabei JK, 2014, J BIOCH, V451, P375; Schmidt AF, 2013, PREV VET MED, V112, P414, DOI 10.1016/j.prevetmed.2013.08.011; Selmic LE, 2014, J VET INTERN MED, V28, P554, DOI 10.1111/jvim.12313; Shao S, 2014, INT J ONCOL, V44, P1661, DOI 10.3892/ijo.2014.2313; SHAPIRO W, 1988, J AM VET MED ASSOC, V192, P507; Skorupski KA, 2016, VET COMP ONCOL, V14, P81, DOI 10.1111/vco.12069; Solano JD, 2013, EUR J MED CHEM, V60, P350, DOI 10.1016/j.ejmech.2012.12.021; STRAW RC, 1991, J VET INTERN MED, V5, P205, DOI 10.1111/j.1939-1676.1991.tb00950.x; Tang Y LZ, 2014, J CLIN EXP CARDIOLOG, V5, P308, DOI [10.4172/2155-9880.1000308, DOI 10.4172/2155-9880.1000308]; THOMPSON JP, 1992, J AM VET MED ASSOC, V200, P531; Vakifahmetoglu-Norberg H, 2013, GENE DEV, V27, P1718, DOI 10.1101/gad.220897.113; Visonneau S, 1999, CLIN CANCER RES, V5, P1868; Vlahava VM, 2015, CELL SIGNAL, V27, P1253, DOI 10.1016/j.cellsig.2015.03.002; Wen J, 2015, BREAST CANCER RES TR, V149, P619, DOI 10.1007/s10549-015-3283-9; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Xiao J, 2016, MOL MED, V22, P643, DOI 10.2119/molmed.2016.00034; Xu XC, 2017, TOXICOL LETT, V280, P206, DOI 10.1016/j.toxlet.2017.08.081; Zhao DX, 2014, MOL MED REP, V9, P1975, DOI 10.3892/mmr.2014.2055; Zhou ST, 2012, CANCER LETT, V323, P115, DOI 10.1016/j.canlet.2012.02.017	78	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206427	10.1371/journal.pone.0206427	http://dx.doi.org/10.1371/journal.pone.0206427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372478	gold, Green Published, Green Submitted			2022-12-26	WOS:000448641200038
J	Gupta, D; Dwivedi, AK; Tripathi, M				Gupta, Deepmala; Dwivedi, Arvind Kumar; Tripathi, Madhu			Taxonomic validation of five fish species of subfamily Barbinae from the Ganga river system of northern India using traditional and truss analyses	PLOS ONE			English	Article							PUNTIUS-SARANA HAMILTON; GEOMETRIC MORPHOMETRICS; TELEOSTEI CYPRINIDAE; CYPRINIFORMES CYPRINIDAE; COASTAL WATERS; WESTERN-GHATS; OLIVE BARB; SRI-LANKA; IDENTIFICATION; GENUS	Morphometric differences were investigated among five fish species of subfamily Barbinae from the Ganga river system through traditional morphometrics and the truss network system. Species taken into account were Puntius chola (Hamilton 1822), Puntius sophore (Hamilton 1822), Pethia ticto (Hamilton 1822), Pethia conchonius (Hamilton 1822) and Systomus sarana (Hamilton 1822). Although, taxonomists carefully examine external body features to discriminate these species, there is still a risk of misidentification during a visual assessment. In the present study, the traditional morphological analysis included 22 morphometric measurements and 10 meristic counts. Truss network system of 14 landmarks was interconnected to yield 91 distance variables. The principal component analysis (PCA), discriminant function analysis (DFA) and cluster analysis (CA) were employed in order to determine morphometric variations. In traditional analysis, 29 characters out of 32 were found significant (p<0.05). Eight principal components were extracted through PCA explaining 85.30% of the total variance in samples, DFA correctly classified 100.0% of original grouped cases and 100.0% of cross-validated grouped cases. Truss analysis showed that all the 90 characters were significant (p<0.05). PCA extracted four principal components explaining 96.45% of the total variance. DFA correctly classified 96.1% of original grouped cases and 92.1% of cross-validated grouped cases. The results acquired from the traditional as well as truss analyses indicate significant morphometric heterogeneity. However, variations are not the same for the two different methods (traditional and truss) employed for the analyses. Shape differences among species were evident from relative warps (RW) supporting truss network analysis. Geometric morphometric methods (GMM), but limited use of Procrustes methods revealed even very small dissimilarity between groups. In spite of determining the morphometric differentiation among species, the present study also provides a useful insight on the application and complementary role of truss analysis with traditional morphometric analysis in the correct classification of the selected species.	[Gupta, Deepmala; Tripathi, Madhu] Univ Lucknow, Dept Zool, Lucknow, Uttar Pradesh, India; [Dwivedi, Arvind Kumar] Wildlife Inst India, Dehra Dun, Uttarakhand, India	Lucknow University; Wildlife Institute of India	Tripathi, M (corresponding author), Univ Lucknow, Dept Zool, Lucknow, Uttar Pradesh, India.	drmtripathi@gmail.com	Dwivedi, Arvind/AAP-9727-2020	Dwivedi, Arvind/0000-0003-4407-5752				Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Akter S, 2016, AQUAC RES, V47, P228, DOI 10.1111/are.12484; Akyol O., 2002, ACTA ADRIAT, V42, P3; Ambak M A., 1983, FRESHWATER FISHES PE, P284; [Anonymous], 2010, FRESHWATER FISHES IN; Balaraj S, 2012, J MED ALLIED SCI, V2, P49; Barriga-Sosa IDLA, 2004, J APPL ICHTHYOL, V20, P7, DOI 10.1111/j.1439-0426.2004.00445.x; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Brahman LK, 2014, INT J BIOL BIOMOL AG, V8, P180; Cavalcanti MJ, 1999, ZOOL STUD, V38, P287; Champasri T., 2008, Pakistan Journal of Biological Sciences, V11, P525, DOI 10.3923/pjbs.2008.525.531; Champasri T., 2007, Pakistan Journal of Biological Sciences, V10, P4383, DOI 10.3923/pjbs.2007.4383.4390; Chen GJ, 2005, J VERTEBR PALEONTOL, V25, P492, DOI 10.1671/0272-4634(2005)025[0492:ANCCRT]2.0.CO;2; Choudhury S., 2011, Ecoscan, P233; Choudhury S., 2013, J PHARM BIOL SCI, V5, P1; CORTES M T, 1968, Anales de la Escuela Nacional de Ciencias Biologicas Mexico, V15, P185; CORTI M, 1988, CAN J FISH AQUAT SCI, V45, P1548, DOI 10.1139/f88-183; Cracraft J., 1989, P28; Datta Munshi JS, 1988, NATURAL HIST FISHES, P178; Day F, 1878, FISHES INDIA BEING N, VII; De Silva MPKSK, 2010, J NATL SCI FOUND SRI, V38, P15, DOI 10.4038/jnsfsr.v38i1.1722; Dobzhansky Th, 1970, GENETICS EVOLUTIONAR, DOI [10.3923/pjbs.2007.4383.4390, DOI 10.3923/PJBS.2007.4383.4390]; Durand JD, 2002, MOL PHYLOGENET EVOL, V22, P91, DOI 10.1006/mpev.2001.1040; Erguden D, 2005, TURK J VET ANIM SCI, V29, P727; Fang F, 2003, COPEIA, P714; Fernando G, 2011, SRI LANKA J AQUAT SC, V16, P1; Froese Rainer, 2016, SPECIES PUNTIUS FISH; Gentilli A, 2009, HERPETOL J, V19, P69; Gopakumar K, 1999, NATL FRESHWATER AQUA, P75; Habib, 2005, ASIAN FISH SCI, V18, P307; Hamilton F, 1981, ACCOUNT FISHES FOUND, P310; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Jayaram K.C., 1991, Records of the Zoological Survey of India Occasional Paper, V135, P1; Jena J, 2008, AQUACULTURE, V280, P154, DOI 10.1016/j.aquaculture.2008.05.003; Jenkins RE, 1971, CONTRIB ZOOL, V90, P15; Karakousis Yiannis, 1993, Cybium, V17, P229; Katwate U, 2014, ZOOTAXA, V3846, P235, DOI 10.11646/zootaxa.3846.2.4; Kortmulder K, 1972, COMP STUDY COLOUR PA; Kotalawala AB, 1992, VIDYODAYA J SCI, V4, P39; Kottelat M., 1989, Aquarien- und Terrarien-Zeitschrift, V42, P472; Kottelat M, 2013, RAFFLES B ZOOL, P1; Kullander SO, 2005, COPEIA, P290, DOI 10.1643/CI-04-138R1; LACHENBRUCH PA, 1967, BIOMETRICS, V23, P639, DOI 10.2307/2528418; Lal KK, 2015, INDIAN J FISH, V62, P10; MacLeod N., 2002, MORPHOLOGY SHAPE PHY, P45; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Mamuris Z, 1998, J FISH BIOL, V52, P107, DOI 10.1006/jfbi.1997.0565; Marcus LF, 1990, SPECIAL PUBLICATION, V2, P77; Mekkawy I.A.A., 1997, Journal of the Egyptian German Society of Zoology, V22, P93; Mekkawy IAA, 1991, ASSIUT VET MED J, V26, P35; Koch NM, 2015, ZOOL SCR, V44, P463, DOI 10.1111/zsc.12120; Mutanen M, 2007, SYST ENTOMOL, V32, P371, DOI 10.1111/j.1365-3113.2006.00372.x; Nagpure N.S., 2003, Nucleus (Calcutta), V46, P110; Negi RK, 2018, MITOCHONDRIAL DNA A, V29, P256, DOI 10.1080/24701394.2016.1275598; Negi RK, 2016, INT J MOL ZOOLOGY, V6, P1, DOI [10.5376/ijmz.2016.06.0002, DOI 10.5376/IJMZ.2016.06.0002]; Pallavi, 2012, MITOCHONDR DNA, V23, P477, DOI 10.3109/19401736.2012.710209; Pethiyagoda R, 1995, RAFFLES B ZOOL S, V12, P127; Pethiyagoda R, 2013, ZOOTAXA, V3646, P199, DOI 10.11646/zootaxa.3646.2.9; Pethiyagoda R, 2012, ICHTHYOL EXPLOR FRES, V23, P69; Plamoottil M, 2016, INT J RES BIOSCIENCE, V4, P1; Poulet N, 2005, AQUAT SCI, V67, P122, DOI 10.1007/s00027-004-0772-z; Raghavan Rajeev, 2013, Journal of Threatened Taxa, V5, P4932; Rahman M. M., 2014, INT J FISHERIES AQUA, V1, P163; Rainboth W.J., 1996, FAO SPECIES IDENTIFI; Rainboth WJ, 1996, TAXONOMY SYSTEMATICS; Raja M., 2017, J PHYLOGENETICS EVOL, V5, P184, DOI [10.4172/2329-9002.1000184, DOI 10.4172/2329-9002.1000184]; Rajasekaran N, 2016, ASIAN J MULTIDISCIP, V4, P55; Rajasekaran N, 2014, INT J PURE APP BIOSC, V2, P55; Rema Devi K., 2010, J THREAT TAXA, V2, P1121, DOI [10.11609/JoTT.o2505.1121-9, DOI 10.11609/JOTT.O2505.1121-9, DOI 10.11609/J0TT.02505.1121-9]; Rohlf F. J, 2006, TPSDIG2 VERS 2 1; Rohlf F. James, 1993, Monografias del Museo Nacional de Ciencias Naturales, V1993, P131; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1990, SPECIAL PUBLICATION, P380; Ryman N, 1987, POPULATION GENETICS, P1; Sajina AM, 2011, FISH RES, V108, P100, DOI 10.1016/j.fishres.2010.12.006; Saroniya RK, 2016, EUR J BIOTECHNOL BIO, V4, P42; Saroniya RK, 2013, BIOLIFE, V1, P144; SCHUT J, 1984, NETH J ZOOL, V34, P159; Shantakumar M., 2006, Zoos Print Journal, V21, P2279; Siddik M., 2016, Journal of Aquaculture Research and Development, V7, P411; Simon KD, 2010, J ZHEJIANG UNIV-SC B, V11, P871, DOI 10.1631/jzus.B1000054; Snedecor GW, 1980, STAT METHODS, V7th; Srivastava G. J, 1980, FISHES UP BIHAR; Stiasny MLJ, 1996, INTERRELATIONSHIP FI; STRAUSS RE, 1982, SYST ZOOL, V31, P113, DOI 10.2307/2413032; STRAUSS RE, 1985, SYST ZOOL, V34, P381, DOI 10.2307/2413203; Sukham S, 2015, INT J RES FISH AQUAC, V5, P156; Talwar P.K., 1991, INLAND FISHERIES IND, V1; Talwar P K, 1992, INLAND FISHES INDIA, V1, P1177; Turan C, 2004, ICES J MAR SCI, V61, P774, DOI 10.1016/j.icesjms.2004.05.001; Turan Cemal, 1999, Turkish Journal of Zoology, V23, P259; VLADYKOV VADIM D., 1934, TRANS ROY CANADIAN INST, V20, P99; Weitzman SH, 1975, SMITHSONIAN CONTRIBU, V186, P1; WIMBERGER PH, 1992, BIOL J LINN SOC, V45, P197, DOI 10.1111/j.1095-8312.1992.tb00640.x; Yang CT, 2009, ENVIRON BIOL FISH, V86, P145, DOI 10.1007/s10641-007-9283-9; Zafar M., 2002, PAKISTAN J BIOL SCI, V5, P733; Zar JH, 1984, BIOSTAT ANAL, P620	100	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206031	10.1371/journal.pone.0206031	http://dx.doi.org/10.1371/journal.pone.0206031			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365551	Green Submitted, gold, Green Published			2022-12-26	WOS:000448448700022
J	Xie, H; Jiao, Y; Fan, QH; Hai, MM; Yang, J; Hu, ZJ; Yang, Y; Shuai, JW; Chen, G; Liu, RC; Liu, LY				Xie, Hang; Jiao, Yang; Fan, Qihui; Hai, Miaomiao; Yang, Jiaen; Hu, Zhijian; Yang, Yue; Shuai, Jianwei; Chen, Guo; Liu, Ruchuan; Liu, Liyu			Modeling three-dimensional invasive solid tumor growth in heterogeneous microenvironment under chemotherapy	PLOS ONE			English	Article							CELLULAR-AUTOMATON MODEL; DRUG-RESISTANCE; MATHEMATICAL-MODEL; IN-VITRO; CANCER; SIMULATION; HYPOXIA; TIRAPAZAMINE; EVOLUTION; HALLMARKS	A systematic understanding of the evolution and growth dynamics of invasive solid tumors in response to different chemotherapy strategies is crucial for the development of individually optimized oncotherapy. Here, we develop a hybrid three-dimensional (3D) computational model that integrates pharmacokinetic model, continuum diffusion-reaction model and discrete cell automaton model to investigate 3D invasive solid tumor growth in heterogeneous microenvironment under chemotherapy. Specifically, we consider the effects of heterogeneous environment on drug diffusion, tumor growth, invasion and the drug-tumor interaction on individual cell level. We employ the hybrid model to investigate the evolution and growth dynamics of avascular invasive solid tumors under different chemotherapy strategies. Our simulations indicate that constant dosing is generally more effective in suppressing primary tumor growth than periodic dosing, due to the resulting continuous high drug concentration. In highly heterogeneous microenvironment, the malignancy of the tumor is significantly enhanced, leading to inefficiency of chemotherapies. The effects of geometrically-confined microenvironment and non-uniform drug dosing are also investigated. Our computational model, when supplemented with sufficient clinical data, could eventually lead to the development of efficient in silico tools for prognosis and treatment strategy optimization.	[Xie, Hang; Hai, Miaomiao; Yang, Jiaen; Hu, Zhijian; Chen, Guo; Liu, Ruchuan; Liu, Liyu] Chongqing Univ, Coll Phys, Chongqing, Peoples R China; [Jiao, Yang] Arizona State Univ, Mat Sci & Engn, Tempe, AZ USA; [Fan, Qihui] Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, Beijing, Peoples R China; [Yang, Yue] Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Dept Thorac Surg 2,Sch Oncol,Beijing Canc Hosp &, Beijing, Peoples R China; [Shuai, Jianwei] Xiamen Univ, Dept Phys, Xiamen, Peoples R China	Chongqing University; Arizona State University; Arizona State University-Tempe; Chinese Academy of Sciences; Institute of Physics, CAS; Peking University; Xiamen University	Liu, RC (corresponding author), Chongqing Univ, Coll Phys, Chongqing, Peoples R China.	phyliurc@cqu.edu.cn; lyliu@cqu.edu.cn	Xie, Hang/C-4192-2017	Xie, Hang/0000-0001-7849-7422; Yang, Jia-En/0000-0003-4682-1237; Chen, Guo/0000-0003-1524-4334	National Natural Science Foundation of China [11474345, 11674043, 11604030]; State Key Development Program for Basic Research of China [2013CB837200]; Arizona State University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Arizona State University	This work was supported by Grant No. 11474345 and 11674043, and 11604030 issued by the National Natural Science Foundation of China, Grant No. 2013CB837200 issued by the State Key Development Program for Basic Research of China, and the Start-Up fund issued by Arizona State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Husari M, 2014, J MATH BIOL, V69, P839, DOI 10.1007/s00285-013-0719-x; Alam N, DISTRIBUTED COMPUTIN, P503; Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Arfken G. B., 2012, MATH METHODS PHYS CO; Barish S, 2017, P NATL ACAD SCI USA, V114, pE6277, DOI 10.1073/pnas.1703355114; Becker M, 2017, B MATH BIOL, V79, P2394, DOI 10.1007/s11538-017-0334-x; Bradshaw-Pierce EL, 2007, CLIN CANCER RES, V13, P2768, DOI 10.1158/1078-0432.CCR-06-2362; BROWN JM, 1993, BRIT J CANCER, V67, P1163, DOI 10.1038/bjc.1993.220; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Chen DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109934; Coffey DS, 1998, NAT MED, V4, P882, DOI 10.1038/nm0898-882; Cristini V, 2005, CLIN CANCER RES, V11, P6772, DOI 10.1158/1078-0432.CCR-05-0852; Cristini V, 2003, J MATH BIOL, V46, P191, DOI 10.1007/s00285-002-0174-6; Cussler E. L, 2009, DIFFUSION MASS TRANS; Deisboeck TS, 2011, ANNU REV BIOMED ENG, V13, P127, DOI 10.1146/annurev-bioeng-071910-124729; Drasdo D, 2005, PHYS BIOL, V2, P133, DOI 10.1088/1478-3975/2/3/001; DuFort E. C., 1953, MATH TABLES OTHER AI, V7, P135, DOI [10.2307/2002754, DOI 10.2307/2002754]; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Foo J, 2014, J THEOR BIOL, V355, P10, DOI 10.1016/j.jtbi.2014.02.025; FREI E, 1980, AM J MED, V69, P585, DOI 10.1016/0002-9343(80)90472-6; Frieboes HB, 2006, CANCER RES, V66, P1597, DOI 10.1158/0008-5472.CAN-05-3166; Fu F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004142; Gallaher J. A, 2017, BIORXIV, DOI [10.1101/128959, DOI 10.1101/128959]; Ganguly R, 2007, CELL PROLIFERAT, V40, P338, DOI 10.1111/j.1365-2184.2007.00434.x; Gatenby RA, 2003, NATURE, V421, P321, DOI 10.1038/421321a; Gatenby RA, 1996, CANCER RES, V56, P5745; Gerlee P, 2008, J THEOR BIOL, V250, P705, DOI 10.1016/j.jtbi.2007.10.038; Gerlee P, 2010, MATH BIOSCI ENG, V7, P385, DOI 10.3934/mbe.2010.7.385; Gevertz J. L., 2015, APPL DYNAMICAL SYSTE, V158, P1; Gevertz J. L, 2011, COMPUTATIONAL MATH M, V2011; Gevertz J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041914; Gevertz J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051910; Gevertz JL, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036010; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Greene J, 2014, B MATH BIOL, V76, P627, DOI 10.1007/s11538-014-9936-8; Hadjiandreou MM, 2014, IEEE T BIO-MED ENG, V61, P415, DOI 10.1109/TBME.2013.2280189; Hainaut P, 2013, CURR OPIN ONCOL, V25, P50, DOI 10.1097/CCO.0b013e32835b651e; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hicks KO, 2003, CANCER RES, V63, P5970; Jackson TL, 2000, MATH BIOSCI, V164, P17, DOI 10.1016/S0025-5564(99)00062-0; Jiao Y, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052707; Jiao Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002314; JUSKO WJ, 1973, J PHARMACOKINET BIOP, V1, P175, DOI 10.1007/BF01062346; Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000; Kazmi N, 2012, IEEE ACM T COMPUT BI, V9, P1595, DOI 10.1109/TCBB.2012.118; Kerbel RS, 2002, ANN ONCOL, V13, P12, DOI 10.1093/annonc/mdf093; Kim Y, 2007, MATH MOD METH APPL S, V17, P1773, DOI 10.1142/S0218202507002479; Kim Y, 2010, B MATH BIOL, V72, P1029, DOI 10.1007/s11538-009-9481-z; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; Komarova NL, 2007, THEOR POPUL BIOL, V72, P523, DOI 10.1016/j.tpb.2007.08.003; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Lavi O, 2012, DRUG RESIST UPDATE, V15, P90, DOI 10.1016/j.drup.2012.01.003; Liu ZJ, 2016, MATH COMPUT SIMULAT, V124, P1, DOI 10.1016/j.matcom.2015.12.007; LOKICH J, 1982, CANCER, V50, P2731, DOI 10.1002/1097-0142(19821215)50:12<2731::AID-CNCR2820501206>3.0.CO;2-P; Lorz A, 2015, B MATH BIOL, V77, P1, DOI 10.1007/s11538-014-0046-4; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Picco N, 2017, CANCER RES, V77, P5409, DOI 10.1158/0008-5472.CAN-17-0835; Powathil GG, 2012, J THEOR BIOL, V308, P1, DOI 10.1016/j.jtbi.2012.05.015; Quaranta V, SEMINARS CANC BIOL, P338; Rejniak KA, 2012, MATH MED BIOL, V29, P1, DOI 10.1093/imammb/dqr029; Robertson-Tessi M, 2015, CANCER RES, V75, P1567, DOI 10.1158/0008-5472.CAN-14-1428; Schmitz JE, 2002, COMPUT MATH METHOD M, V4, P223, DOI [DOI 10.1080/1027366031000086674, 10.1080/1027366031000086674]; Shah AB, 2016, MATH BIOSCI ENG, V13, P1185, DOI 10.3934/mbe.2016038; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Simbawa E, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/3676295; Stein AM, 2007, BIOPHYS J, V92, P356, DOI 10.1529/biophysj.106.093468; Thurber GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024696; Torquato S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015017; van de Ven AL, 2012, AIP ADV, V2, DOI 10.1063/1.3699060; Van Liedekerke P, 2015, COMPUT PART MECH, V2, P401, DOI 10.1007/s40571-015-0082-3; Wares JR, 2015, MATH BIOSCI ENG, V12, P1237, DOI 10.3934/mbe.2015.12.1237; Winner K. R. K, PACIFIC S BIOCOMPUTI, P611; Winner KRK, 2016, CANCER RES, V76, P1320, DOI 10.1158/0008-5472.CAN-15-1620; Zhang XL, 2005, BIOTECHNOL PROGR, V21, P1289, DOI 10.1021/bp050003l; Zhong WR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011916; Zuleyha A, 2017, PHYSICA A, V486, P901, DOI 10.1016/j.physa.2017.05.096	79	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206292	10.1371/journal.pone.0206292	http://dx.doi.org/10.1371/journal.pone.0206292			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365511	Green Submitted, Green Published, gold			2022-12-26	WOS:000448448700039
J	Bonkovsky, HL; Barnhart, HX; Foureau, DM; Steuerwald, N; Lee, WM; Gut, JZ; Fontana, RJ; Hayashi, PJ; Chalasani, N; Navarro, VM; Odin, J; Stolz, A; Watkins, PB; Serrano, J				Bonkovsky, Herbert L.; Barnhart, Huiman X.; Foureau, David M.; Steuerwald, Nury; Lee, William M.; Gut, Jiezhun; Fontana, Robert J.; Hayashi, Paul J.; Chalasani, Naga; Navarro, Victor M.; Odin, Joseph; Stolz, Andrew; Watkins, Paul B.; Serrano, Jose		US Drug-Induced Liver Injury Netwo; Acute Liver Failure Study Grp	Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group	PLOS ONE			English	Article							CAUSALITY ASSESSMENT	Changes in levels of cytokines and chemokines have been proposed as possible biomarkers of tissue injury, including liver injury due to drugs. Recently, in acute drug-induced liver injury (DILI), we showed that 19 of 27 immune analytes were differentially expressed and that disparate patterns of immune responses were evident. Lower values of serum albumin (< 2.8 g/dL) and lower levels of only four analytes, namely, IL-9, IL-17, PDGF-bb, and RANTES, were highly predictive of early death [accuracy = 96%]. The goals of this study were to assess levels of the same 27 immune analytes in larger numbers of subjects to learn whether the earlier findings would be confirmed in new and larger cohorts of subjects, compared with a new cohort of healthy controls. We studied 127 subjects with acute DILI enrolled into the US DILIN. We also studied 118 subjects with severe acute liver injury of diverse etiologies, enrolled into the ALF SG registry of subjects. Controls comprised 63 de-identified subjects with no history of liver disease and normal liver tests. Analytes associated with poor outcomes [death before 6 months, n = 32 of the total of 232 non-acetaminophen (Apap) subjects], were lower serum albumin [2.6 vs 3.0 g/dL] and RANTES [6,458 vs 8,999 pg/mL] but higher levels of IL-6 [41 vs 18], IL-8 [78 vs 48], and MELD scores [30 vs 24]. Similar patterns were observed for outcome of death/liver transplant within 6 months. A model that included only serum albumin < 2.8 g/dL and RANTES below its median value of 11,349 had 83% (or 81%) accuracy for predicting early death (or early death/liver transplant) in 127 subjects from DILIN. No patterns of serum immune analytes were reflective of the etiologies of acute liver failure, but there were cytokine patterns that predicted prognosis in both acute DILI and ALF.	[Bonkovsky, Herbert L.] Wake Forest Univ, Bowman Gray Sch Med, Dept Med, Winston Salem, NC 27103 USA; [Barnhart, Huiman X.; Gut, Jiezhun] Duke Univ, Sch Med, Durham, NC USA; [Foureau, David M.; Steuerwald, Nury] Atrium Hlth, Levine Canc Ctr, Charlotte, NC USA; [Foureau, David M.; Steuerwald, Nury] Atrium Hlth, Dept Res, Charlotte, NC USA; [Lee, William M.] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA; [Fontana, Robert J.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Hayashi, Paul J.; Watkins, Paul B.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27515 USA; [Chalasani, Naga] IUPUI, Dept Med, Indianapolis, IN USA; [Navarro, Victor M.] A Einstein Med Ctr, Dept Med, Philadelphia, PA USA; [Odin, Joseph] Icahn Sch Med Mt Sinai, Dept Med, Med Ctr, New York, NY 10029 USA; [Stolz, Andrew] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA; [Serrano, Jose] NIDDK, Bethesda, MD 20892 USA	Wake Forest University; Wake Forest Baptist Medical Center; Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Indiana University System; Indiana University-Purdue University Indianapolis; Icahn School of Medicine at Mount Sinai; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bonkovsky, HL (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Med, Winston Salem, NC 27103 USA.	hbonkovsky@me.com	Bonkovsky, Herbert L./AAH-1892-2021; , wife/ABH-2499-2020	Bonkovsky, Herbert L./0000-0001-7387-3230; 	NIDDK [U01-DK065176, DK065184, DK065193, DK065201, DK065211, DK065238, DK082992, DK083020, DK083023, DK083027, DK100928]; CTSA [DK100928, UL1 RR025761, UL1 RR025747, UL1 RR024986, DK065176, UL1 TR001420]; NIDDK/NIH [U01DK065211, U01DK065184, U01DK065201, U01DK083020, U01DK083027, U01DK100928, U01DK065176]; Intramural Research Program of the NIH, National Cancer Institute;  [U01 DK58369]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK100928, U01DK083027, U01DK065201, U01DK065184, U24DK065176, U01DK065176, U01DK065211, U01DK083020] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural Research Program of the NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded as a cooperative agreement with the NIDDK under grant numbers: U01-DK065176, DK065184, DK065193, DK065201, DK065211, DK065238, DK082992, DK083020, DK083023, DK083027 and DK100928. The Acute Liver Failure Study Group is supported by U01 DK58369 to UT Southwestern Medical Center. Additional funding is provided by CTSA grants UL1 RR025761 (Indiana), UL1 RR025747 (UNC), UL1 RR024986 (UMich), DK065176 (Duke), DK100928 (Icahn Schl. of Medicine at Mount Sinai), and UL1 TR001420 (Wake Forest University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The US DILIN is supported by the following cooperative agreements with NIDDK/NIH: U01DK065211 (Indiana University Purdue University, Indianapolis), U01DK065184 (University of Michigan, Ann Arbor), U01DK065201 (University of North Carolina, Chapel Hill, NC), U01DK083020 (University of Southern California, University of California-Los Angeles, Pfleger Liver Institute), U01DK083027 (Albert Einstein Medical Center, Philadelphia), U01DK100928 (Icahn School of Medicine at Mount Sinai, New York City), U01DK065176 (Duke Clinical Research Institute, Durham, NC).; This study was supported in part by the Intramural Research Program of the NIH, National Cancer Institute.	Bachmann M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00161; Chalasani N, 2017, AM J GASTROENTEROL, V112, P1382, DOI 10.1038/ajg.2017.215; Chalasani N, 2015, GASTROENTEROLOGY, V148, P1340, DOI 10.1053/j.gastro.2015.03.006; Chalasani N, 2008, GASTROENTEROLOGY, V135, P1924, DOI 10.1053/j.gastro.2008.09.011; Church RJ, 2019, HEPATOLOGY, V69, P760, DOI 10.1002/hep.29802; Elsegood CL, 2015, HEPATOLOGY, V62, P1272, DOI 10.1002/hep.27977; Fontana RJ, 2009, DRUG SAFETY, V32, P55, DOI 10.2165/00002018-200932010-00005; Hayashi PH, 2017, HEPATOLOGY, V66, P1275, DOI 10.1002/hep.29283; Ju C, 2016, CELL MOL IMMUNOL, V13, P316, DOI 10.1038/cmi.2015.104; Kleiner DE, 2014, HEPATOLOGY, V59, P661, DOI 10.1002/hep.26709; Kobayashi M, 2012, J APPL TOXICOL, V32, P823, DOI 10.1002/jat.2731; Kobayashi M, 2010, TOXICOLOGY, V275, P50, DOI 10.1016/j.tox.2010.05.011; Li JZ, 2010, J IMMUNOTOXICOL, V7, P157, DOI 10.3109/15476910903501748; Liu Y, 2015, INNATE IMMUN-LONDON, V21, P587, DOI 10.1177/1753425914566205; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Pachkoria K, 2008, J HEPATOL, V49, P107, DOI 10.1016/j.jhep.2008.03.017; Puengel T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184694; Rochon J, 2008, HEPATOLOGY, V48, P1175, DOI 10.1002/hep.22442; Rockey DC, 2010, HEPATOLOGY, V51, P2117, DOI 10.1002/hep.23577; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Steuerwald NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081974	23	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206389	10.1371/journal.pone.0206389	http://dx.doi.org/10.1371/journal.pone.0206389			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359443	Green Submitted, Green Published, gold			2022-12-26	WOS:000448438400075
J	Chai, SC; Foley, EM; Arjmandi, BH				Chai, Sheau C.; Foley, Elizabeth M.; Arjmandi, Bahram H.			Anti-atherogenic properties of vitamin E, aspirin, and their combination	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BONE-MINERAL DENSITY; CARDIOVASCULAR EVENTS; ACETYLSALICYLIC-ACID; LIPID-PEROXIDATION; PRIMARY PREVENTION; ATHEROSCLEROSIS; RISK; CHOLESTEROL; DISEASE	The present study was designed to assess the extent to which vitamin E and aspirin individually or in combination prevent and/or reverse bone loss and atherosclerotic lesion formation in orchidectomized aged rats. Forty-nine 12-month old male Sprague-Dawley rats were either sham-operated (Sham, one group) or orchidectomized (Orx, four groups) and fed a control diet for 120 days to establish bone loss and atherosclerotic lesions. Thereafter, rats were assigned to the various treatment groups (n = 9 to 10 per group): 1) Sham and 2) Orx groups received AIN93M, containing 75 IU vitamin E and served as control, and the other three Orx groups received either 3) 500 IU vitamin E, 4) 500 mg aspirin, or 5) 500 IU vitamin E + 500 mg aspirin per kg diet for 90 days. After 90 days of treatment, rats were sacrificed, necropsied, and tissues were collected for analyses. Results show that 500 IU vitamin E was able to reduce the development of atherosclerosis lesion formation and aortic streak area compared to Orx control. More importantly, 500 mg aspirin completely reversed the fatty streak area and made the atherosclerotic lesions disappear. Vitamin E and aspirin were not able to reverse bone loss as shown by whole body, lumbar and femoral bone mineral content and bone mineral density due to gonadal hormone deficiency. Instead, 500 mg aspirin somewhat increased the trabecular separation while decreased trabecular thickness compared to Orx control. Our findings suggest that both, vitamin E and aspirin exert anti-atherogenic effects and aspirin is more effective than vitamin E in preventing atherosclerosis lesions in Orx rats.	[Chai, Sheau C.] Univ Delaware, Coll Hlth Sci, Dept Behav Hlth & Nutr, Newark, DE 19716 USA; [Foley, Elizabeth M.; Arjmandi, Bahram H.] Florida State Univ, Coll Human Sci, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA; [Foley, Elizabeth M.; Arjmandi, Bahram H.] Florida State Univ, Coll Human Sci, CAENRA, Tallahassee, FL 32306 USA	University of Delaware; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Chai, SC (corresponding author), Univ Delaware, Coll Hlth Sci, Dept Behav Hlth & Nutr, Newark, DE 19716 USA.	scchai@udel.edu	Arjmandi, Bahram/GRY-0474-2022; Foley, Elizabeth M./ABE-4460-2020	Foley, Elizabeth M./0000-0002-0518-5089; Arjmandi, Bahram/0000-0003-1358-0238				Ahmad NS, 2005, CLIN EXP PHARMACOL P, V32, P761, DOI 10.1111/j.1440-1681.2005.04264.x; Alsop RJ, 2014, SOFT MATTER, V10, P4275, DOI 10.1039/c4sm00372a; Arjmandi BH, 2002, J NUTR BIOCHEM, V13, P543, DOI 10.1016/S0955-2863(02)00199-7; Auger C, 2002, J NUTR, V132, P1207, DOI 10.1093/jn/132.6.1207; Aydilek N, 2005, J VET MED A, V52, P436, DOI 10.1111/j.1439-0442.2005.00764.x; Bauer DC, 1996, J BONE MINER RES, V11, P29; Bavry AA, 2017, CLIN CARDIOL, V40, P732, DOI 10.1002/clc.22724; Bhasin S, 1998, J CLIN ENDOCR METAB, V83, P3435, DOI 10.1210/jc.83.10.3440; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381; Cai ZW, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0014-5; Carbone LD, 2003, J BONE MINER RES, V18, P1795, DOI 10.1359/jbmr.2003.18.10.1795; Chai SC, 2011, AGING CLIN EXP RES, V23, P11, DOI 10.3275/6762; Chai SC, 2008, AGING CLIN EXP RES, V20, P521; Chen Zhi-wen, 2011, Zhonghua Yi Xue Za Zhi, V91, P925; Chin KY, 2017, J OSTEOPOROS, V2017, DOI 10.1155/2017/3710959; Christoffersen B, 2006, INT J OBESITY, V30, P1288, DOI 10.1038/sj.ijo.0803261; Ebeling PR, 2008, NEW ENGL J MED, V358, P1474, DOI 10.1056/NEJMcp0707217; Eidelman RS, 2004, ARCH INTERN MED, V164, P1552, DOI 10.1001/archinte.164.14.1552; Feresin RG, 2013, J OSTEOPOROS, V2013, DOI 10.1155/2013/825985; Fonseca H, 2014, SPORTS MED, V44, P37, DOI 10.1007/s40279-013-0100-7; Forslund T, 2014, EUR J CLIN PHARMACOL, V70, P1477, DOI 10.1007/s00228-014-1739-1; Fortmann SP, 2013, ANN INTERN MED, V159, P824, DOI 10.7326/0003-4819-159-12-201312170-00729; Fuhrman B, 2000, J NUTR, V130, P1124; Ginaldi Lia, 2005, Immun Ageing, V2, P14, DOI 10.1186/1742-4933-2-14; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Hodis HN, 2002, CIRCULATION, V106, P1453, DOI 10.1161/01.CIR.0000029092.99946.08; Hurtubise J, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0632-z; Jain Samta, 2016, Perm J, V20, P60, DOI 10.7812/TPP/14-190; Jiang Q, 2014, FREE RADICAL BIO MED, V72, P76, DOI 10.1016/j.freeradbiomed.2014.03.035; Jockenhovel F, 1999, METABOLISM, V48, P590, DOI 10.1016/S0026-0495(99)90056-2; Johnson SA, 2016, FOOD FUNCT, V7, P1628, DOI [10.1039/c5fo01066g, 10.1039/C5FO01066G]; Kaplan M, 2001, J NUTR, V131, P2082, DOI 10.1093/jn/131.8.2082; Leopold JA, 2015, CORONARY ARTERY DIS, V26, P176, DOI 10.1097/MCA.0000000000000187; Lerner UH, 2006, J DENT RES, V85, P596, DOI 10.1177/154405910608500704; Li H, 1999, CARCINOGENESIS, V20, P425, DOI 10.1093/carcin/20.3.425; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lisowska B, 2018, DRUG DES DEV THER, V12, P1753, DOI 10.2147/DDDT.S164562; Liu HX, 2015, J ZHEJIANG UNIV-SC B, V16, P10, DOI 10.1631/jzus.B1400172; Lonn E, 2002, DIABETES CARE, V25, P1919, DOI 10.2337/diacare.25.11.1919; Lucas EA, 2006, J MED FOOD, V9, P77, DOI 10.1089/jmf.2006.9.77; Mahmoud AN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175283; Mozaffarian D, 2015, CIRCULATION, V131, P434, DOI 10.1161/CIR.0000000000000157; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Myung SK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f10; Niki E, 2014, FREE RADICAL BIO MED, V66, P3, DOI 10.1016/j.freeradbiomed.2013.03.022; Pignone M, 2007, AM J PREV MED, V32, P403, DOI 10.1016/j.amepre.2007.01.010; Puri R, 2016, ARTERIOSCL THROM VAS, V36, P2220, DOI 10.1161/ATVBAHA.116.307601; Rao KVN, 1996, CARCINOGENESIS, V17, P1435, DOI 10.1093/carcin/17.7.1435; Rao PNP, 2008, J PHARM PHARM SCI, V11, P81, DOI 10.18433/J3T886; Sethi A, 2011, BASIC CLIN PHARMACOL, V108, P371, DOI 10.1111/j.1742-7843.2010.00663.x; Smith BJ, 2005, CALCIFIED TISSUE INT, V76, P272, DOI 10.1007/s00223-004-0269-8; Suzuki J, 2011, INT HEART J, V52, P266, DOI 10.1536/ihj.52.266; Tarantino E, 2016, PHARMACOL RES, V107, P415, DOI 10.1016/j.phrs.2016.04.001; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; Vestergaard P, 2012, OSTEOPOROSIS INT, V23, P1255, DOI 10.1007/s00198-011-1692-0; Vestergaard P, 2012, INT J CARDIOL, V160, P36, DOI 10.1016/j.ijcard.2011.03.026; Wei JS, 2015, MOL MED REP, V12, P1717, DOI 10.3892/mmr.2015.3637; Whitlock EP, 2016, ANN INTERN MED, V164, P826, DOI 10.7326/M15-2112; Yamaza T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002615; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Zmyslowski A, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0579-2	62	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206315	10.1371/journal.pone.0206315	http://dx.doi.org/10.1371/journal.pone.0206315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359442	Green Submitted, gold, Green Published			2022-12-26	WOS:000448438400065
J	Khunger, M; Patil, PD; Khunger, A; Li, M; Hu, B; Rakshit, S; Basu, A; Pennell, N; Stevenson, JP; Elson, P; Panchabhai, TS; Velcheti, V				Khunger, Monica; Patil, Pradnya Dinkar; Khunger, Arjun; Li, Manshi; Hu, Bo; Rakshit, Sagar; Basu, Arnab; Pennell, Nathan; Stevenson, James P.; Elson, Paul; Panchabhai, Tanmay S.; Velcheti, Vamsidhar			Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; PROGNOSTIC VALUE; BIOMARKERS; DOCETAXEL; OUTCOMES; RATIO	Background The absolute neutrophil count (ANC), absolute lymphocyte count (ALC), absolute monocyte count (AMC) and neutrophil to lymphocyte ratio (NLR) are known markers of inflammation. We evaluated whether ANC, ALC, AMC and NLR, both before and after treatment with nivolumab, are indicative markers of overall survival (OS) and evaluated change in NLR as a predictive marker of response in non -small cell lung cancer (NSCLC) patients treated with nivolumab. Methods A total of 109 patients with advanced NSCLC treated with nivolumab were included. ANC, ALC, AMC and NLR were examined at initiation of nivolumab therapy and after two cycles. The prognostic role of ANC, ALC, AMC and NLR with OS and changes in NLR ratio were examined with Kaplan-Meier curves and proportional hazard model. Result Post-treatment NLR >= 5 after two cycles of nivolumab was associated with poor OS (median OS in NLR = <5 vs NLR = >= 5 was 29.1 (16.2-40.9) vs 24.2(16.1-36.2) months respectively, p<0.001). In addition NLR increased in non-responders after two cycles of nivolumab by 6.6 +/- 21.8 as compared to responders (p = 0.027). Conclusions Post-treatment ANC, ALC and NLR are independent prognostic factors in NSCLC patients treated with nivolumab. Changes in NLR can be an early biomarker for response in NSCLC patients treated with nivolumab.	[Khunger, Monica; Rakshit, Sagar] Cleveland Clin, Dept Internal Med, Cleveland, OH 44106 USA; [Patil, Pradnya Dinkar; Khunger, Arjun; Pennell, Nathan; Stevenson, James P.; Velcheti, Vamsidhar] Cleveland Clin, Dept Hematol & Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA; [Li, Manshi; Hu, Bo; Elson, Paul] Cleveland Clin Fdn, Dept Quantitate Hlth Sci, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Basu, Arnab] Univ Southern Calif, Dept Hematol & Oncol, Los Angeles, CA USA; [Panchabhai, Tanmay S.] St Josephs Hosp, Norton Thorac Inst, Phoenix, AZ USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Southern California; St. Joseph's Hospital and Medical Center	Velcheti, V (corresponding author), Cleveland Clin, Dept Hematol & Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA.	velchev@ccf.org	Malhotra, Monica K/AAA-7008-2019; Basu, Arnab/O-9175-2019; Pennell, Nathan/AAH-9303-2021; khunger, arjun/AAQ-8973-2021	Pennell, Nathan/0000-0002-1458-0064; Malhotra, Monica Khunger/0000-0002-2625-1049				Bagley SJ, 2017, LUNG CANCER, V106, P1, DOI 10.1016/j.lungcan.2017.01.013; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brzezianska E, 2006, MUTAT RES-FUND MOL M, V599, P26, DOI 10.1016/j.mrfmmm.2005.12.013; Carbognin L, 2016, ONCOLOGIST, V21, P283, DOI 10.1634/theoncologist.2015-0307; Dirican N, 2017, CLIN RESPIR J, V11, P789, DOI 10.1111/crj.12417; Feng W, 2016, ONCOTARGET, V7, P7227, DOI 10.18632/oncotarget.6979; Ferrucci PF, 2015, BRIT J CANCER, V112, P1904, DOI 10.1038/bjc.2015.180; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gilbert DC, 2016, BRIT J CANCER, V114, P134, DOI 10.1038/bjc.2015.448; Goodman AM, 2017, MOL CANCER THER, DOI [10.1097/CCO.0000000000000263, DOI 10.1097/CCO.0000000000000263]; Hagerling C, 2016, SEMINARS IMMUNOLOGY; Hauselmann I, 2016, CANCER RES, V76, P5302, DOI 10.1158/0008-5472.CAN-16-0784; Horne ZD, 2011, J SURG RES, V171, P1, DOI 10.1016/j.jss.2011.03.068; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang BW, 2016, ANN ONCOL, V27, P494, DOI 10.1093/annonc/mdv610; Lim SY, 2016, ONCOGENE; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Moses K, 2016, SEMINARS IMMUNOLOGY; Nguyen N, 2016, HEAD NECK-J SCI SPEC; Remon J, 2016, CURR OPIN ONCOL, V28, P122, DOI 10.1097/CCO.0000000000000263; Sanmamed MF, 2017, ANN ONCOL, V28, P1988, DOI 10.1093/annonc/mdx190; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Vareki SM, 2017, CRIT REV ONCOL HEMAT, V116, P116, DOI 10.1016/j.critrevonc.2017.06.001; Walsh TG, 2015, PLATELETS, V26, P199, DOI 10.3109/09537104.2014.909022; Yuan JD, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0107-3; Zeng DQ, 2016, ONCOTARGET, V7, P13765, DOI 10.18632/oncotarget.7282	27	39	40	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0197743	10.1371/journal.pone.0197743	http://dx.doi.org/10.1371/journal.pone.0197743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359383	Green Submitted, Green Published, gold			2022-12-26	WOS:000448438400001
J	Mohamed, ABO; Kelchtermans, H; Konings, J; van Daal, J; Al Marzouki, A; Harakeh, S; De Laat, B				Mohamed, Abdulrahman B. O.; Kelchtermans, Hilde; Konings, Joke; van Daal, Jamilla; Al Marzouki, Anas; Harakeh, Steve; De Laat, Bas			The effects of oral contraceptive usage on thrombin generation and activated protein C resistance in Saudi women, with a possible impact of the body mass index	PLOS ONE			English	Article							VENOUS THROMBOSIS; RISK; COAGULATION; THROMBOEMBOLISM; DETERMINANTS; SYSTEM	Background and objectives The effect of oral contraceptive (OC) usage on coagulation has been studied worldwide. However, no such studies have been conducted in Saudi Arabia on Saudi women using OCs. The aim of this study was to investigate the effects of OC-induced changes of thrombin generation (TG) in the absence and presence of activated protein C (APC) or thrombomodulin (TM) in Saudi women. Methods A total of 115 adult women, 47 on oral contraception (OC users) and 68 controls (not using OCs) were recruited from the obstetrics-gynecology outpatient clinic in Saudi Arabia. OCs that were used in this study include the following: Marvelon, Gynera, Cerrazetem, Yasmine, Microlut, Gracial and Diane. The plasma calibrated automated thrombinography (CAT) was used to determine TG which was expressed as endogenous thrombin potential (ETP; nM/ min), lag time (min), peak (nM) and time-to-peak (ttpeak; min). In the presence of TM or APC, TG parameters were expressed relative to the parameters in the absence of TM or APC. Results and conclusion As in other populations, our study demonstrated that OC usage induced prothrombotic changes in plasma of Saudi women, including resistance to the inhibitory actions of TM and APC. More specifically, OC usage in our population predominantly influenced TG and APC/ TM sensitivity in overweight and obese individuals, a finding that needs confirmation in large cohort studies. The effects of APC and TM on TG parameters showed a positive association, and the correlation coefficients were higher in OC users for both ETP and peak values.	[Mohamed, Abdulrahman B. O.] King Abdulaziz Univ, Dept Pharmacol, Jeddah, Saudi Arabia; [Mohamed, Abdulrahman B. O.; Kelchtermans, Hilde; Konings, Joke; van Daal, Jamilla; De Laat, Bas] Maastricht Univ, Synapse Res Inst, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Kelchtermans, Hilde; Konings, Joke; De Laat, Bas] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [Al Marzouki, Anas] King Abdulaziz Univ, Dept Obstet Gynecol, Jeddah, Saudi Arabia; [Harakeh, Steve] King Abdulaziz Univ, King Fand Med Res Ctr, Special Infect Agents Unit, Jeddah, Saudi Arabia	King Abdulaziz University; Maastricht University; Maastricht University; King Abdulaziz University; King Abdulaziz University	Kelchtermans, H (corresponding author), Maastricht Univ, Synapse Res Inst, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.; Kelchtermans, H (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands.	H.Kelchtermans@thrombin.com		Kelchtermans, Hilde/0000-0002-2724-3438				Abdel-Fattah M, 2007, J FAM COMMUNITY MED, V14, P103; Al-Turki HA, 2011, HEALTH CARE WOMEN IN, V32, P134, DOI 10.1080/07399332.2010.536280; Alhenc-Gelas M, 2004, J THROMB HAEMOST, V2, P1594, DOI 10.1111/j.1538-7836.2004.00894.x; Bloemen S, 2017, J APPL LAB MED, V2, P150, DOI 10.1373/jalm.2017.023630; Conard J, 1999, HUM REPROD UPDATE, V5, P672, DOI 10.1093/humupd/5.6.672; Dahlback B, 2005, FEBS LETT, V579, P3310, DOI 10.1016/j.febslet.2005.03.001; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Deguchi H, 2005, J THROMB HAEMOST, V3, P935, DOI 10.1111/j.1538-7836.2005.01335.x; Dielis AWJH, 2008, J THROMB HAEMOST, V6, P125; Dinger JC, 2007, CONTRACEPTION, V75, P344, DOI 10.1016/j.contraception.2006.12.019; Farheen A., 2013, INT J CURR RES REV, V5, P26; Gennari LC, 2006, THROMB RES, V118, P269, DOI 10.1016/j.thromres.2005.07.022; GERSTMAN BB, 1991, AM J EPIDEMIOL, V133, P32, DOI 10.1093/oxfordjournals.aje.a115799; Heinemann LAJ, 2010, CONTRACEPTION, V81, P401, DOI 10.1016/j.contraception.2009.12.014; Hemker HC, 2009, THROMB HAEMOSTASIS, V101, P171, DOI 10.1160/TH08-09-0562; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Iftikhar R, 2015, PATIENT PREFER ADHER, V9, P401, DOI 10.2147/PPA.S67171; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Kemmeren JM, 2001, BRIT MED J, V323, P131, DOI 10.1136/bmj.323.7305.131; Kemmeren JM, 2004, BLOOD, V103, P927, DOI 10.1182/blood-2003-04-1285; Kluft C, 1997, THROMB HAEMOSTASIS, V78, P315; Mahboub SM, 2015, INT J HEALTHC SCI, V2, P331; Oslakovic S, 2014, CLIN APPL THROMB-HEM, V20, P448, DOI 10.1177/1076029612463426; Quehenberger P, 1996, THROMB HAEMOSTASIS, V76, P729; Rosendaal FR, 2003, J THROMB HAEMOST, V1, P1371, DOI 10.1046/j.1538-7836.2003.00264.x; Rosing J, 1997, BRIT J HAEMATOL, V97, P233, DOI 10.1046/j.1365-2141.1997.192707.x; Rosing J, 1999, LANCET, V354, P2036, DOI 10.1016/S0140-6736(99)06092-4; Seeger JD, 2007, OBSTET GYNECOL, V110, P587, DOI 10.1097/01.AOG.0000279448.62221.a8; Spitzer WO, 1996, BRIT MED J, V312, P83; Tans G, 2003, BRIT J HAEMATOL, V122, P465, DOI 10.1046/j.1365-2141.2003.04443.x; Tans G, 2000, THROMB HAEMOSTASIS, V84, P15, DOI 10.1055/s-0037-1613960; Tchaikovski S, 2006, WOMENS HEALTH, V2, P771, DOI [10.2217/17455057.2.5.761, 10.2217/1745509X.2.5.771]; Tchaikovski SN, 2007, THROMB HAEMOSTASIS, V98, P1350, DOI 10.1160/TH07-07-0439; Vandenbroucke JP, 2001, NEW ENGL J MED, V344, P1527, DOI 10.1056/NEJM200105173442007; VESSEY M, 1986, BRIT MED J, V292, P526, DOI 10.1136/bmj.292.6519.526; Winkler UH, 1998, CONTRACEPTION, V57, P203, DOI 10.1016/S0010-7824(98)00020-1	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206376	10.1371/journal.pone.0206376	http://dx.doi.org/10.1371/journal.pone.0206376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359453	Green Submitted, Green Published, gold			2022-12-26	WOS:000448438400072
J	Palleria, C; Iannone, L; Leporini, C; Citraro, R; Manti, A; Caminiti, M; Gigliotti, P; Grembiale, RD; L'Andolina, M; Muccari, G; Naturale, MD; Olivo, D; Mariano, GP; Pellegrini, R; Varcasia, G; Abdalla, K; Russo, E; Ursini, F; De Sarro, G				Palleria, Caterina; Iannone, Luigi; Leporini, Christian; Citraro, Rita; Manti, Antonia; Caminiti, Maurizio; Gigliotti, Pietro; Grembiale, Rosa Daniela; L'Andolina, Massimo; Muccari, Giuseppe; Naturale, Maria Diana; Olivo, Domenico; Mariano, Giuseppa Pagano; Pellegrini, Roberta; Varcasia, Giuseppe; Abdalla, Karim; Russo, Emilio; Ursini, Francesco; De Sarro, Giovambattista			Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP)	PLOS ONE			English	Article							DRUG-REACTIONS; BRITISH SOCIETY; ARTHRITIS; RISK; REGISTER; DISEASES	Introduction Post-marketing surveillance activities (namely pharmacovigilance) are crucial to favor the early detection of unexpected adverse events (AEs) and/or serious adverse reactions (SAES). Indeed, spontaneous reporting of AEs has been demonstrated to underestimate the number of events in different clinical settings. Aim of the present study is to report the preliminary data of a Regional (Calabria, Italy) Pharmacovigilance Program (CBPP) aimed at improving AEs' reporting associated with biologics use in rheumatology. Materials and methods We developed a simple, cost-effective pharmacovigilance program based on regular training sessions for physicians (stimulated reporting), periodical phone calls by a clinical pharmacologist aimed at identifying new events and stimulating self-awareness and encouraging reporting to the physician during the subsequent follow-up visit for minor AEs. To test this approach, all consecutive patients undergoing treatment with one biologic agent at eight rheumatology centers during a two-years period were invited to participate. Collected AEs were compared to the number of AEs spontaneously reported for the same molecules in the same centers before starting the protocol. Results During the study period, 399 patients (245 females; mean age: 58 +/- 11 years) were started on treatment with biologics for active RA (n = 211, 52.9%), PsA (n = 119, 29.8%) or AS (n = 69, 17.3%) at eight rheumatology centers. A total of 125 AEs (31.3%) and 9 SAEs (2.3%) were reported during the two-years study period. In the control cohort (comprising 368 consecutive patients started on treatment with bDMARDs during a two-years period before CBPP study) only 42 (11.4%) AEs and no SAEs were reported (p < 0.0001). The most common AEs were injection site reactions and skin disorders. Conclusions In conclusion, our study provides further evidence of a critical role of active pharmacovigilance in detection, reporting and analysis of AEs in rheumatology.	[Palleria, Caterina; Iannone, Luigi; Leporini, Christian; Citraro, Rita; Manti, Antonia; Grembiale, Rosa Daniela; Naturale, Maria Diana; Russo, Emilio; Ursini, Francesco; De Sarro, Giovambattista] Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy; [Caminiti, Maurizio; Gigliotti, Pietro; L'Andolina, Massimo; Muccari, Giuseppe; Olivo, Domenico; Mariano, Giuseppa Pagano; Pellegrini, Roberta; Varcasia, Giuseppe; Ursini, Francesco] ACRR, Catanzaro, Italy; [Caminiti, Maurizio; Mariano, Giuseppa Pagano] Grande Osped Metropolitano Bianchi Melacrino More, Rheumatol Unit, Reggio Di Calabria, Italy; [Gigliotti, Pietro] Azienda Osped Prov Cosenza, Rheumatol Outpatient Clin, Cosenza, Italy; [L'Andolina, Massimo] Azienda Sanit Prov Vibo Valentia, Rheumatol Outpatient Clin, Vibo Valentia, Italy; [Muccari, Giuseppe] Azienda Osped Pugliese Ciaccio, Rheumatol Outpatient Clin, Catanzaro, Italy; [Olivo, Domenico] Azienda Sanit Prov Crotone, Rheumatol Outpatient Clin, Crotone, Italy; [Pellegrini, Roberta] Azienda Osped SS Annunziata, Rheumatol Unit, Cosenza, Italy; [Varcasia, Giuseppe] Osped Castrovillari, Rheumatol Unit, Castrovillari, Italy; [Abdalla, Karim] Univ Catanzaro Magna Graecia, Dept Med & Surg Sci, Catanzaro, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro	Russo, E (corresponding author), Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy.	erusso@unicz.it	Ursini, Francesco/AAC-5725-2022; Russo, Emilio/G-5241-2010; Ursini, Francesco/K-5632-2016	Russo, Emilio/0000-0002-1279-8123; Ursini, Francesco/0000-0001-8194-8642; Iannone, Luigi Francesco/0000-0003-3598-0195	Italian Medicine Agency (AIFA); Regione Calabria	Italian Medicine Agency (AIFA); Regione Calabria(Regione Calabria)	This project has been funded by the Italian Medicine Agency (AIFA) and Regione Calabria, which are kindly acknowledged.	Biagi C, 2013, EUR J CLIN PHARMACOL, V69, P237, DOI 10.1007/s00228-012-1321-7; Brown PM, 2016, NAT REV RHEUMATOL, V12, P731, DOI 10.1038/nrrheum.2016.175; Burmester GR, 2017, NAT REV RHEUMATOL, V13, P443, DOI 10.1038/nrrheum.2017.95; Carmona L, 2005, REUMATOL CLIN, V1, P95, DOI 10.1016/S1699-258X(05)72722-4; Carnovale C, 2016, EXPERT OPIN DRUG SAF, V15, P131, DOI 10.1517/14740338.2016.1131816; Carnovale C, 2014, EXPERT OPIN DRUG SAF, V13, pS1, DOI 10.1517/14740338.2014.928692; Clavel G, 2017, JOINT BONE SPINE, V84, P671, DOI 10.1016/j.jbspin.2017.03.002; Dayer JM, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00293; Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935; Fornasier G, 2018, INT J CLIN PHARM; Fracchiolla NS, 2018, HEMATOL ONCOL, V36, P299, DOI 10.1002/hon.2451; Gawert L, 2011, RHEUMATOLOGY, V50, P152, DOI 10.1093/rheumatology/keq300; Gartlehner G, 2006, J RHEUMATOL, V33, P2398; Gossec L, 2015, ANN RHEUM DIS, V75, P499, DOI DOI 10.1136/ANNRHEUMDIS-2014-206485; Haas JS, 2012, AM J MANAG CARE, V18, pe423; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Hazes JMW, 2011, NAT REV RHEUMATOL, V7, P381, DOI 10.1038/nrrheum.2011.78; Lapadula G, 2011, REUMATISMO, V63, P155, DOI 10.4081/reumatismo.2011.155; Lin TC, 2018, ARTHRIT CARE RES, V70, P724, DOI 10.1002/acr.23346; Lopez-Olivo MA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007356.pub2; Mazzitello C, 2013, J PHARMACOL PHARMACO, V4, pS20, DOI 10.4103/0976-500X.120942; Okuda Y, 2008, BIOL-TARGETS THER, V2, P75; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Palleria C, 2013, J PHARMACOL PHARMACO, V4, pS66, DOI 10.4103/0976-500X.120955; Patane M, 2013, ADV PHARMACOL SCI, V2013, DOI 10.1155/2013/313858; Poudel DR, 2017, PHARMACOEPIDEM DR S, V26, P635, DOI 10.1002/pds.4184; Rutherford AI, 2018, RHEUMATOLOGY, V57, P997, DOI 10.1093/rheumatology/key023; Scavone C, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00607; Schiff M, 2011, RHEUMATOLOGY, V50, P437, DOI 10.1093/rheumatology/keq287; Smolen JS, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.1; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; van der Heijde D, 2017, ANN RHEUM DIS, V76, P978, DOI 10.1136/annrheumdis-2016-210770; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P2886, DOI 10.1002/art.22864	33	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205134	10.1371/journal.pone.0205134	http://dx.doi.org/10.1371/journal.pone.0205134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356301	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000031
J	Zhang, J; Finlaison, DS; Frost, MJ; Gestier, S; Gu, XN; Hall, J; Jenkins, C; Parrish, K; Read, AJ; Srivastava, M; Rose, K; Kirkland, PD				Zhang, Jing; Finlaison, Deborah S.; Frost, Melinda J.; Gestier, Sarah; Gu, Xingnian; Hall, Jane; Jenkins, Cheryl; Parrish, Kate; Read, Andrew J.; Srivastava, Mukesh; Rose, Karrie; Kirkland, Peter D.			Identification of a novel nidovirus as a potential cause of large scale mortalities in the endangered Bellinger River snapping turtle (Myuchelys georgesi)	PLOS ONE			English	Article							SEQUENCE; VIRUS; CHYTRIDIOMYCOSIS; HERPESVIRUS; POLYMERASE; GENERATION; TIME	In mid-February 2015, a large number of deaths were observed in the sole extant population of an endangered species of freshwater snapping turtle, Myuchelys georgesi, in a coastal river in New South Wales, Australia. Mortalities continued for approximately 7 weeks and affected mostly adult animals. More than 400 dead or dying animals were observed and population surveys conducted after the outbreak had ceased indicated that only a very small proportion of the population had survived, severely threatening the viability of the wild population. At necropsy, animals were in poor body condition, had bilateral swollen eyelids and some animals had tan foci on the skin of the ventral thighs. Histological examination revealed peri-orbital, splenic and nephric inflammation and necrosis. A virus was isolated in cell culture from a range of tissues. Nucleic acid sequencing of the virus isolate has identified the entire genome and indicates that this is a novel nidovirus that has a low level of nucleotide similarity to recognised nidoviruses. Its closest relatives are nidoviruses that have recently been described in pythons and lizards, usually in association with respiratory disease. In contrast, in the affected turtles, the most significant pathological changes were in the kidneys. Real time PCR assays developed to detect this virus demonstrated very high virus loads in affected tissues. In situ hybridisation studies confirmed the presence of viral nucleic acid in tissues in association with pathological changes. Collectively these data suggest that this virus is the likely cause of the mortalities that now threaten the survival of this species. Bellinger River Virus is the name proposed for this new virus.	[Zhang, Jing; Finlaison, Deborah S.; Frost, Melinda J.; Gestier, Sarah; Gu, Xingnian; Parrish, Kate; Read, Andrew J.; Srivastava, Mukesh; Kirkland, Peter D.] Elizabeth Macarthur Agr Inst, Virol Lab, Menangle, NSW, Australia; [Hall, Jane; Rose, Karrie] Taronga Conservat Soc Australia, Australian Registry Wildlife Hlth, Bradleys Head Rd, Mosman, NSW, Australia; [Jenkins, Cheryl] Elizabeth Macarthur Agr Inst, Microbiol & Parasitol, Menangle, NSW, Australia		Kirkland, PD (corresponding author), Elizabeth Macarthur Agr Inst, Virol Lab, Menangle, NSW, Australia.	peter.kirkland@dpi.nsw.gov.au	Hall, Jane/ABC-6552-2021; Kirkland, Peter/AAC-6731-2019; Finlaison, Deborah/AAU-8998-2021; Read, Andrew J/I-6999-2012; Jenkins, Cheryl/N-1937-2015	Hall, Jane/0000-0001-9310-5140; Finlaison, Deborah/0000-0003-2639-4880; Read, Andrew J/0000-0002-2421-4287; Jenkins, Cheryl/0000-0002-5966-072X; Parrish, Kate/0000-0001-5216-8532	NSW Office of Environment and Heritage; NSW Department of Primary Industries; Taronga Conservation Society Australia; NSW Local Lands Services	NSW Office of Environment and Heritage; NSW Department of Primary Industries; Taronga Conservation Society Australia; NSW Local Lands Services	The NSW Office of Environment and Heritage, NSW Department of Primary Industries, NSW Local Lands Services and Taronga Conservation Society Australia provided considerable financial support for the initial investigation of the disease outbreak and field survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge staff of the NSW Office of Environment and Heritage, particularly Gerry McGilvray and Shane Ruming for their coordination of the disease response. The NSW Office of Environment and Heritage, NSW Department of Primary Industries, NSW Local Lands Services and Taronga Conservation Society Australia provided considerable financial and logistical support. We also thank Bellingen Shire Council, Dr Mark Crane and his staff at Bellingen Veterinary Hospital, Adam Skidmore, and Paul Thompson and herpetology staff from Taronga, and ecologist Bruce Chessman for their considerable contributions to the disease response. The willingness of Scott Ginn and colleagues from the Australian Museum, Sydney to provide valuable tissues from archived M. georgesi is greatly appreciated. We are indebted to the staff of virology laboratory who assisted with sample preparation, cell culture and virus isolation studies and for assistance with the PCR assays.	Adams MJ, 2017, ARCH VIROL, V162, P2505, DOI 10.1007/s00705-017-3358-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baird A, 2016, DIS AQUAT ORGAN, V119, P37, DOI 10.3354/dao02970; BARRON AL, 1970, ARCH GES VIRUSFORSCH, V32, P389, DOI 10.1007/BF01250067; Batts WN, 2012, J GEN VIROL, V93, P1247, DOI 10.1099/vir.0.041210-0; Beerens N, 2007, J VIROL, V81, P9426, DOI 10.1128/JVI.00747-07; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bodewes R, 2014, J GEN VIROL, V95, P2480, DOI 10.1099/vir.0.068700-0; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BREDENBEEK PJ, 1990, NUCLEIC ACIDS RES, V18, P1825, DOI 10.1093/nar/18.7.1825; BRIERLEY I, 1995, J GEN VIROL, V76, P1885, DOI 10.1099/0022-1317-76-8-1885; Chong S. Y., 1987, Singapore Veterinary Journal, V10, P78; Degremont L, 2013, AQUACULTURE, V408, P51, DOI 10.1016/j.aquaculture.2013.05.025; Dervas E, 2017, J VIROL, V91, DOI [10.1128/JVI.00718-17, 10.1128/jvi.00718-17]; Essbauer S, 2001, J VET MED B, V48, P403, DOI 10.1046/j.1439-0450.2001.00473.x; Faisal M, J AQUATIC ANIM HLTH, V28, P131; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Gilad O, 2003, J GEN VIROL, V84, P2661, DOI 10.1099/vir.0.19323-0; Granzow H, 2001, J GEN VIROL, V82, P2849, DOI 10.1099/0022-1317-82-12-2849; Gu XN, 2014, J VET DIAGN INVEST, V26, P18, DOI 10.1177/1040638713516622; Hoon-Hanks LL, 2018, VIROLOGY, V517, P77, DOI 10.1016/j.virol.2017.12.008; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Liu L, 2015, INTERVIROLOGY, V58, P197, DOI 10.1159/000437354; Marschang RE, 2011, VIRUSES-BASEL, V3, P2087, DOI 10.3390/v3112087; Marschang RE, 2016, KLEINTIERE HEIMTIERE, V44, P1, DOI [10.15654/TPK-151067, DOI 10.15654/TPK-151067]; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; O'Dea MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165209; Okumura H, 1968, CANCER CELLS CULTURE, P292; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; Schutze H, 2001, J GEN VIROL, V82, P2849, DOI [10.1099/0022-1317-82-12-2849, DOI 10.1099/0022-1317-82-12-2849]; Shi M, 2018, NATURE, V556, P197, DOI 10.1038/s41586-018-0012-7; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Spencer RJ, 2018, BIOL CONSERV, V221, P190, DOI 10.1016/j.biocon.2018.03.009; Spencer RJ, 2014, ECOL RES, V29, P767, DOI 10.1007/s11284-014-1169-7; Stenglein MD, 2014, MBIO, V5, DOI 10.1128/mBio.01484-14; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Uccellini L, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-144; Van Der Saag MR, 2017, MED VET ENTOMOL, V31, P263, DOI 10.1111/mve.12231; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zirkel F, 2013, J VIROL, V87, P6346, DOI 10.1128/JVI.00416-13; Zirkel F, 2011, MBIO, V2, DOI 10.1128/mBio.00077-11	46	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205209	10.1371/journal.pone.0205209	http://dx.doi.org/10.1371/journal.pone.0205209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356240	gold, Green Published, Green Submitted			2022-12-26	WOS:000448434000042
J	Couture-Cossette, A; Carignan, A; Mercier, A; Desruisseaux, C; Valiquette, L; Pepin, J				Couture-Cossette, Antoine; Carignan, Alex; Mercier, Adam; Desruisseaux, Claudine; Valiquette, Louis; Pepin, Jacques			Secular trends in incidence of invasive beta-hemolytic streptococci and efficacy of adjunctive therapy in Quebec, Canada, 1996-2016	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; INTRAVENOUS IMMUNOGLOBULIN THERAPY; GROUP-A; CLINICAL-FEATURES; WESTERN NORWAY; GROUP-B; INFECTIONS; DISEASE; PYOGENES; EPIDEMIOLOGY	Objectives To examine secular changes in the incidence of invasive beta-hemolytic streptococcal infections, and to assess the efficacy of immunoglobulins and clindamycin as adjunctive therapies in the management of Streptococcus pyogenes infections. Methods Retrospective cohort study of all cases of invasive group A (GAS), B (GBS), C or G (GCGS) streptococcal infections managed in a Canadian tertiary center from 1996-2016. Population incidence was measured for diabetics and non-diabetics. Adjusted odds ratios (AOR) and their 95% confidence intervals (CI) were calculated by logistic regression. Results 741 cases were identified (GAS: 249; GBS: 304; GCGS: 188). While the incidence of invasive GAS infections fluctuated with no clear trend, incidence of invasive GBS and GCGS increased over time and were 8.4 and 6.3 times higher in diabetics. Mortality of invasive GAS infections decreased from 16% (6/37) in 1996-2001 to 4% (4/97) in 2011-15. Among patients with GAS infections, clindamycin administered concomitantly with a beta-lactam within 24 hours of admission decreased mortality (AOR: 0.04, 95%CI: 0.003-0.55, P= 0.02. Immunoglobulins had no such effect (AOR: 1.66, 95%CI: 0.16-17.36, P= 0.67). The protective effect of clindamycin was similar in patients with pneumonia/empyema compared to all others. Conclusion Incidence of GBS and GCGS infections increased due to an expansion of the high-risk population (elderly diabetics), but also rose in non-diabetics. No such secular change was seen for invasive GAS infections. The decrease in mortality in patients with invasive GAS infections presumably reflects better case-management. Adjunctive clindamycin reduced mortality in invasive GAS infections; immunoglobulins did not, but power was limited. The highest mortality was seen in patients with GAS pneumonia/empyema, for whom clindamycin was protective but underused.	[Couture-Cossette, Antoine; Carignan, Alex; Mercier, Adam; Desruisseaux, Claudine; Valiquette, Louis; Pepin, Jacques] Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ, Canada; [Couture-Cossette, Antoine] Hop Maison Neuve Rosemont, Montreal, PQ, Canada; [Mercier, Adam] Hop Charles Lemoyne, Longueuil, PQ, Canada	University of Sherbrooke; Universite de Montreal; University of Sherbrooke	Couture-Cossette, A (corresponding author), Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ, Canada.; Couture-Cossette, A (corresponding author), Hop Maison Neuve Rosemont, Montreal, PQ, Canada.	antoine.couture-cossette@usherbrooke.ca	Valiquette, Louis/J-5836-2019	Valiquette, Louis/0000-0002-8300-8416; Couture-Cossette, Antoine/0000-0002-5630-8245; Carignan, Alex/0000-0001-6648-8203				Andreoni F, 2017, J INFECT DIS, V215, P269, DOI 10.1093/infdis/jiw229; [Anonymous], STREPT TOX SHOCK SYN; Broyles LN, 2009, CLIN INFECT DIS, V48, P706, DOI 10.1086/597035; Bureau d'information et d'etudes en sante des populations, METH OV CONT PAG; Carapetis JR, 2014, CLIN INFECT DIS, V59, P358, DOI 10.1093/cid/ciu304; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Darenberg J, 2003, CLIN INFECT DIS, V37, P333, DOI 10.1086/376630; Ekelund K, 2005, CLIN MICROBIOL INFEC, V11, P569, DOI 10.1111/j.1469-0691.2005.01169.x; Institut National de Sante Publique du Quebec, 2011, EP DESCR MAL OBL EV; Kadri SS, 2017, CLIN INFECT DIS, V64, P877, DOI 10.1093/cid/ciw871; Kaul R, 1999, CLIN INFECT DIS, V28, P800, DOI 10.1086/515199; Kaul R, 1997, AM J MED, V103, P18, DOI 10.1016/S0002-9343(97)00160-5; Kittang BR, 2011, CLIN MICROBIOL INFEC, V17, P358, DOI 10.1111/j.1469-0691.2010.03253.x; Lamagni TL, 2008, J CLIN MICROBIOL, V46, P2359, DOI 10.1128/JCM.00422-08; Lamb LEM, 2015, LANCET INFECT DIS, V15, P109, DOI 10.1016/S1473-3099(14)70922-3; Lambertsen LM, 2014, CLIN MICROBIOL INFEC, V20, pO216, DOI 10.1111/1469-0691.12378; Lewthwaite P, 2002, SCAND J INFECT DIS, V34, P83, DOI 10.1080/00365540110077209; Linner A, 2014, CLIN INFECT DIS, V59, P851, DOI 10.1093/cid/ciu449; Mead P B, 2000, Infect Dis Obstet Gynecol, V8, P217, DOI 10.1155/S1064744900000302; Mehta S, 2006, CHEST, V130, P1679, DOI 10.1016/S0012-3692(15)50887-8; Mulla ZD, 2003, SOUTH MED J, V96, P968, DOI 10.1097/01.SMJ.0000051060.95210.9A; Muller MP, 2003, ARCH INTERN MED, V163, P467, DOI 10.1001/archinte.163.4.467; Nelson GE, 2016, CLIN INFECT DIS, V63, P478, DOI 10.1093/cid/ciw248; Nuccitelli Annalisa, 2015, Ther Adv Vaccines, V3, P76, DOI 10.1177/2051013615579869; Oppegaard O, 2015, CLIN MICROBIOL INFEC, V21, P171, DOI 10.1016/j.cmi.2014.08.019; Osowicki J, 2018, VACCINE, V36, P3397, DOI 10.1016/j.vaccine.2018.02.068; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Saab J, 2012, PATHOLOGY, V44, P567, DOI 10.1097/PAT.0b013e3283582983; Schrage B, 2006, CLIN INFECT DIS, V43, P743, DOI 10.1086/507037; Shah SS, 2009, CLIN INFECT DIS, V49, P1369, DOI 10.1086/606048; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; Statistics Canada, 1991, APP CAN STAND POP; Stevens DL, 2014, CLIN INFECT DIS, V59, P147, DOI [10.1093/cid/ciu444, 10.1093/cid/ciu296]; Takahashi T, 2010, CLIN MICROBIOL INFEC, V16, P1097, DOI 10.1111/j.1469-0691.2009.03047.x; Waddington CS, 2014, J INFECTION, V69, pS63, DOI 10.1016/j.jinf.2014.08.005	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206289	10.1371/journal.pone.0206289	http://dx.doi.org/10.1371/journal.pone.0206289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352091	gold, Green Submitted, Green Published			2022-12-26	WOS:000448076200045
J	Dosso, JA; Kingstone, A				Dosso, Jill A.; Kingstone, Alan			Social modulation of object-directed but not image-directed actions	PLOS ONE			English	Article							PERIPERSONAL SPACE; REAL; ATTENTION; BRAIN; INFORMATION; INTENTIONS; PERCEPTION; MEMORY; 2D	There has recently been an increased research focus on the influence of social factors on human cognition, attention, and action. While this represents an important step towards an ecologically valid description of real-world behaviour, this work has primarily examined dyads interacting with virtual stimuli i.e. on-screen images of objects. Though differences between actions to images and real items are known, their relative sensitivity to social factors is largely unknown. We argue that because images and real items elicit different neural representations, patterns of attention, and hand actions, a direct comparison between the magnitude of social effects while interacting with images and real objects is demanded. We examined patterns of reaching as individuals performed a shape-matching game. Images and real objects were used as stimuli, and social context was manipulated via the proximity of an observer. We found that social context interacted with stimulus type to modulate behaviour. Specifically, there was a delay in reaching for distant objects when a participant was facing another individual but this social effect only occurred when the stimuli were real objects. Our data suggest that even when images and real objects are arranged to share the affordance of reachability, they differ in their sensitivity to social influences. Therefore, the measurement of social effects using on-screen stimuli may poorly predict the social effects of actions directed towards real objects. Accordingly, generalizations between these two domains should be treated with caution.	[Dosso, Jill A.; Kingstone, Alan] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Dosso, JA (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	jill.dosso@psych.ubc.ca		Dosso, Jill/0000-0003-1570-9496	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-04319]; Social Sciences and Humanities Research Council (SSHRC) [435-2013-2200]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN-2016-04319) to AK., http://www.nserc-crsng.gc.ca/index_eng.asp; Social Sciences and Humanities Research Council (SSHRC) Insight Grant to AK (435-2013-2200), http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansuini C, 2015, NEUROSCIENTIST, V21, P126, DOI 10.1177/1073858414533827; Ansuini C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00815; Becchio C, 2008, CONSCIOUS COGN, V17, P557, DOI 10.1016/j.concog.2007.03.003; Becchio C, 2010, CURR DIR PSYCHOL SCI, V19, P183, DOI 10.1177/0963721410370131; Brennan AA, 2015, PSYCHON B REV, V22, P1076, DOI 10.3758/s13423-014-0765-4; Brodeur MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010773; Bushong B, 2010, AM ECON REV, V100, P1556, DOI 10.1257/aer.100.4.1556; Chainay H, 2001, COGNITIVE NEUROPSYCH, V18, P175, DOI 10.1080/02643290042000062; Chen J, 2015, PSYCHOL SCI, V26, P58, DOI 10.1177/0956797614556776; Clery J, 2015, NEUROPSYCHOLOGIA, V70, P313, DOI 10.1016/j.neuropsychologia.2014.10.022; DAVIDOFF J, 1994, BRAIN COGNITION, V24, P1, DOI 10.1006/brcg.1994.1001; di Pellegrino G, 2015, NEUROPSYCHOLOGIA, V66, P126, DOI 10.1016/j.neuropsychologia.2014.11.011; Eskenazi T, 2013, Q J EXP PSYCHOL, V66, P1026, DOI 10.1080/17470218.2012.725058; Ferri F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015855; Freud E, 2018, CORTEX, V98, P34, DOI 10.1016/j.cortex.2017.02.020; Freud E, 2015, PSYCHON B REV, V22, P1377, DOI 10.3758/s13423-015-0803-x; Gallivan JP, 2011, J NEUROSCI, V31, P9599, DOI 10.1523/JNEUROSCI.0080-11.2011; Georgiou I, 2007, COGNITION, V102, P415, DOI 10.1016/j.cognition.2006.01.008; Gerhard TM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00827; Gianelli C, 2013, PSYCHOL RES-PSYCH FO, V77, P40, DOI 10.1007/s00426-011-0401-0; Gobel MS, 2015, COGNITION, V136, P359, DOI 10.1016/j.cognition.2014.11.040; Gomez MA, 2018, PSYCHOL SCI, V29, P206, DOI 10.1177/0956797617730599; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Hayward DA, 2017, CAN J EXP PSYCHOL, V71, P212, DOI 10.1037/cep0000117; HENRY FM, 1960, RES QUART, V31, P448, DOI 10.1080/10671188.1960.10762052; Holmes SA, 2013, BRAIN COGNITION, V82, P18, DOI 10.1016/j.bandc.2013.02.005; Hosang S, 2016, EXP BRAIN RES, V234, P945, DOI 10.1007/s00221-015-4521-4; Inkpen KM, 2002, COLLABORATION TABLET; Karl JM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00208; Karlinsky A., 2017, P 39 ANN C COGN SCI, P2377; Kirk D., 2012, P SIGCHI C HUM FACT, P159, DOI DOI 10.1145/2207676.2207699; Laidlaw KEW, 2011, P NATL ACAD SCI USA, V108, P5548, DOI 10.1073/pnas.1017022108; LATANE B, 1981, AM PSYCHOL, V36, P343, DOI 10.1037/0003-066X.36.4.343; Maister L, 2015, NEUROPSYCHOLOGIA, V70, P455, DOI 10.1016/j.neuropsychologia.2014.10.027; Manera V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054949; Manera V, 2011, EXP BRAIN RES, V211, P547, DOI 10.1007/s00221-011-2649-4; Morris M. R., 2004, Computer Supported Cooperative Work Conference Proceedings, P262, DOI 10.1145/1031607.1031648; Muller H, 2013, INT J RES MARK, V30, P304, DOI 10.1016/j.ijresmar.2013.03.001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliva M, 2017, I-PERCEPTION, V8, DOI 10.1177/2041669517692814; Ozana A, 2018, ATTEN PERCEPT PSYCHO, V80, P564, DOI 10.3758/s13414-017-1443-1; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Pellencin E, 2018, CORTEX, V104, P163, DOI 10.1016/j.cortex.2017.08.033; Perani D, 2001, NEUROIMAGE, V14, P749, DOI 10.1006/nimg.2001.0872; Pesquita A, 2016, P NATL ACAD SCI USA, V4-9; Saccone EJ, 2018, ATTEN PERCEPT PSYCHO, V80, P54, DOI 10.3758/s13414-017-1413-7; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Snow JC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00837; Snow JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00130; Squires SD, 2016, EXP BRAIN RES, V234, P963, DOI 10.1007/s00221-015-4518-z; Sun HM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00443; Szpak A, 2016, COGN NEUROSCI-UK, V7, P45, DOI 10.1080/17588928.2015.1048677; Szpak A, 2015, NEUROPSYCHOLOGIA, V70, P462, DOI 10.1016/j.neuropsychologia.2014.10.008; Teneggi C, 2013, CURR BIOL, V23, P406, DOI 10.1016/j.cub.2013.01.043; Terrenghi L, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P1157; Truong G, 2017, J EXP PSYCHOL HUMAN, V43, P192, DOI 10.1037/xhp0000295; Truong G, 2013, COGN AFFECT BEHAV NE, V13, P803, DOI 10.3758/s13415-013-0174-6; Wahn B, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00669; Whalen T, 2006, P 1 IEEE INT WORK HO, P177, DOI [10.1109/TABLETOP.2006.10, DOI 10.1109/TABLETOP.2006.10]; Wild KS, 2012, J AUTISM DEV DISORD, V42, P1739, DOI 10.1007/s10803-011-1417-4; Yu AB, 2014, J EXP PSYCHOL HUMAN, V40, P1861, DOI 10.1037/a0037397	61	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0205830	10.1371/journal.pone.0205830	http://dx.doi.org/10.1371/journal.pone.0205830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX8WQ	30352061	Green Published, Green Submitted, gold			2022-12-26	WOS:000448076200018
J	Su, F; Ahn, S; Saha, A; DiGiovanni, J; Kolonin, MG				Su, Fei; Ahn, Songyeon; Saha, Achinto; DiGiovanni, John; Kolonin, Mikhail G.			Adipose stromal cell targeting suppresses prostate cancer epithelial-mesenchymal transition and chemoresistance	ONCOGENE			English	Article							TUMOR PROGRESSION; TISSUE; OBESITY	Fat tissue, overgrowing in obesity, promotes the progression of various carcinomas. Clinical and animal model studies indicate that adipose stromal cells (ASC), the progenitors of adipocytes, are recruited by tumors and promote tumor growth as tumor stromal cells. Here, we investigated the role of ASC in cancer chemoresistance and invasiveness, the attributes of tumor aggressiveness. By using human cell co-culture models, we demonstrate that ASC induce epithelial-mesenchymal transition (EMT) in prostate cancer cells. Our results for the first time demonstrate that ASC interaction renders cancer cells more migratory and resistant to docetaxel, cabazitaxel, and cisplatin chemotherapy. To confirm these findings in vivo, we compared cancer aggressiveness in lean and obese mice grafted with prostate tumors. We show that obesity promotes EMT in cancer cells and tumor invasion into the surrounding fat tissue. A hunter-killer peptide D-CAN, previously developed for targeted ASC ablation, suppressed the obesity-associated EMT and cancer progression. Importantly, cisplatin combined with D-CAN was more effective than cisplatin alone in suppressing growth of mouse prostate cancer allografts and xenografts even in non-obese mice. Our data demonstrate that ASC promote tumor aggressiveness and identify them as a target of combination cancer therapy.	[Su, Fei; Kolonin, Mikhail G.] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med Prevent Dis, Brown Fdn, Houston, TX 77030 USA; [Ahn, Songyeon; Saha, Achinto; DiGiovanni, John] Univ Texas Austin, Dell Pediat Res Inst, Div Pharmacol & Toxicol, Austin, TX 78723 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Austin	Kolonin, MG (corresponding author), Univ Texas Hlth Sci Ctr Houston, Inst Mol Med Prevent Dis, Brown Fdn, Houston, TX 77030 USA.	mikhail.g.kolonin@uth.tmc.edu		Kolonin, Mikhail/0000-0002-3743-7869; SU, FEI/0000-0001-5834-4074	NIH [R01 CA196259, R21 CA216745]; Harry E. Bovay, Jr. Foundation; NATIONAL CANCER INSTITUTE [R21CA216745, R01CA196259] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harry E. Bovay, Jr. Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH grant R01 CA196259 (to JD and MK), R21 CA216745 (to MK) and the Harry E. Bovay, Jr. Foundation.	Daquinag AC, 2015, CELL DEATH DIFFER, V22, P351, DOI 10.1038/cdd.2014.148; Daquinag AC, 2017, MOL THER-ONCOLYTICS, V6, P1, DOI 10.1016/j.omto.2017.05.003; Daquinag AC, 2016, MOL THER, V24, P34, DOI 10.1038/mt.2015.155; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Eheman C, 2012, CANCER-AM CANCER SOC, V118, P2338, DOI 10.1002/cncr.27514; Jung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2766; Kandul NP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13100; Lengyel E, 2018, TRENDS CANCER, V4, P374, DOI 10.1016/j.trecan.2018.03.004; Lu YS, 2017, BIOCHEM BIOPH RES CO, V494, P719, DOI 10.1016/j.bbrc.2017.10.118; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Duong MN, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0569-0; Nowicka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081859; Orecchioni S, 2013, CANCER RES, V73, P5880, DOI 10.1158/0008-5472.CAN-13-0821; Park J, 2014, NAT REV ENDOCRINOL, V10, P455, DOI 10.1038/nrendo.2014.94; Rowan BG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089595; Saha A, 2017, CANCER RES, V77, P5158, DOI [10.1158/0008-5472.CAN-17-0284, 10.1158/0008-5472.can-17-0284]; Saha A, 2016, ONCOTARGET, V7, P25194, DOI 10.18632/oncotarget.7535; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tan EHP, 2018, ONCOGENE, V37, P2067, DOI 10.1038/s41388-017-0109-8; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang Y, 2012, CANCER RES, V72, P5198, DOI 10.1158/0008-5472.CAN-12-0294; Zhang Y, 2009, CANCER RES, V69, P5259, DOI 10.1158/0008-5472.CAN-08-3444	22	45	46	5	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2019	38	11					1979	1988		10.1038/s41388-018-0558-8	http://dx.doi.org/10.1038/s41388-018-0558-8			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HO7XX	30361686	Green Accepted			2022-12-26	WOS:000461164400014
J	Mosler, EL; Lukac, N; Flegar, D; Fadljevic, M; Radanovic, I; Cvija, H; Kelava, T; Ivcevic, S; Sucur, A; Markotic, A; Katavic, V; Marusic, A; Grcevic, D; Kovacic, N				Mosler, Elvira Lazic; Lukac, Nina; Flegar, Darja; Fadljevic, Martina; Radanovic, Igor; Cvija, Hrvoje; Kelava, Tomislav; Ivcevic, Sanja; Sucur, Alan; Markotic, Antonio; Katavic, Vedran; Marusic, Ana; Grcevic, Danka; Kovacic, Natasa			Fas receptor induces apoptosis of synovial bone and cartilage progenitor populations and promotes bone loss in antigen-induced arthritis	FASEB JOURNAL			English	Article						mesenchymal cells; osteoprogenitors; osteoblasts; rheumatoid arthritis	COLLAGEN-INDUCED ARTHRITIS; IN-VIVO; LIGAND; CELLS; DIFFERENTIATION; MACROPHAGES; INDUCTION; SYSTEM; OSTEOBLASTS; TOLERANCE	Rheumatoid arthritis (RA) is an inflammatory joint disease that eventually leads to permanent bone and cartilage destruction. Fas has already been established as the regulator of inflammation in RA, but its role in bone formation under arthritic conditions is not completely defined. The aim of this study was to assess the effect of Fas inactivation on the bone damage during murine antigen-induced arthritis. Subchondral bone of wild-type (WT) and Fas-knockout (Fas(-/-)) mice was evaluated by histomorphometry and microcomputerized tomography. Proportions of synovial bone and cartilage progenitors were assessed by flow cytometry. Synovial bone and cartilage progenitors were purified by fluorescence-activated cell sorting and expression of Fas and Fas-induced apoptosis were analyzed in vitro. Results showed that Fas(-/-) mice developed attenuated arthritis characterized by preserved epiphyseal bone and cartilage. A proportion of the earliest CD200(+) bone and cartilage progenitors was reduced in WT mice with arthritis and was unaltered in Fas(-/-) mice. During osteoblastic differentiation in vitro, CD200(+) cells express the highest levels of Fas and are removed by Fas ligation. These results suggest that Fas-induced apoptosis of early CD200(+) osteoprogenitor population represents potential mechanism underlying the impaired bone formation in arthritis, so their preservation may represent the bone-protective mechanism during arthritis.Lazi Mosler, E., Luka, N., Flegar, D., Fadljevi, M., Radanovi, I., Cvija, H., Kelava, T., Ivevi, S., Suur, A., Markoti, A., Katavi, V., Marui, A., Grevi, D., Kovai, N. Fas receptor induces apoptosis of synovial bone and cartilage progenitor populations and promotes bone loss in antigen-induced arthritis.	[Mosler, Elvira Lazic; Lukac, Nina; Flegar, Darja; Fadljevic, Martina; Radanovic, Igor; Cvija, Hrvoje; Kelava, Tomislav; Ivcevic, Sanja; Sucur, Alan; Markotic, Antonio; Katavic, Vedran; Grcevic, Danka; Kovacic, Natasa] Univ Zagreb, Sch Med, Croatian Inst Brain Res, Lab Mol Immunol, Zagreb, Croatia; [Lukac, Nina; Katavic, Vedran; Kovacic, Natasa] Univ Zagreb, Sch Med, Dept Anat, Salata 11, HR-10000 Zagreb, Croatia; [Flegar, Darja; Kelava, Tomislav; Sucur, Alan; Grcevic, Danka] Univ Zagreb, Sch Med, Dept Physiol & Immunol, Zagreb, Croatia; [Mosler, Elvira Lazic] Gen Hosp Dr Ivo Pedisic, Dept Dermatol & Venerol, Sisak, Croatia; [Mosler, Elvira Lazic] Catholic Univ Croatia, Dept Nursing, Zagreb, Croatia; [Ivcevic, Sanja] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Markotic, Antonio] Univ Clin Hosp Mostar, Ctr Clin Pharmacol, Mostar, Bosnia & Herceg; [Marusic, Ana] Univ Split, Sch Med, Dept Res Biomed & Hlth, Split, Croatia	University of Zagreb; University of Zagreb; University of Zagreb; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Mostar; University of Split	Kovacic, N (corresponding author), Univ Zagreb, Sch Med, Dept Anat, Salata 11, HR-10000 Zagreb, Croatia.	natasa.kovacic@mef.hr	Sucur, Alan/AAB-9952-2021; Grcevic, Danka/AAS-1666-2021; Kovacic, Natasa/AAA-4598-2021; Markotic, Antonio/AAB-1086-2020; Marusic, Ana/E-7683-2013; markotic, antonio/ABD-9539-2020	Grcevic, Danka/0000-0002-2365-8249; Markotic, Antonio/0000-0002-0410-542X; Marusic, Ana/0000-0001-6272-0917; Kovacic, Natasa/0000-0001-6042-2107; Lazic Mosler, Elvira/0000-0003-3186-6280; Radanovic, Igor/0000-0002-9486-4867	Croatian Science Foundation [7406, 5699]; Scientific Center of Excellence for Reproductive and Regenerative Medicine - European Union through the European Regional Development Fund [KK01.1.1.01.0008, KK01.1.1.01.0007]; Croatian Ministry of Science, Education and Sports [1080229-0140]	Croatian Science Foundation; Scientific Center of Excellence for Reproductive and Regenerative Medicine - European Union through the European Regional Development Fund; Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	The authors thank Katerina Zrinski-Petrovic (Laboratory for Molecular Immunology) for her technical assistance and Ivan Kresimir Lukic (Bjelovar University of Applied Sciences, Bjelovar, Croatia) for advice regarding statistical analysis. The authors thank the Laboratory for Mineralized Tissues, School of Medicine at the University of Zagreb, for access to the 1076 SkyScan mu CT instrument. This work was supported by Croatian Science Foundation Grants 7406 and 5699, the Scientific Center of Excellence for Reproductive and Regenerative Medicine (Project "Reproductive and Regenerative Medicine-Exploration of New Platforms and Potentials") Grant KK01.1.1.01.0008, Research Centre of Excellence of Fundamental Clinical and Translational Neuroscience, and CoRE-Neuro Grant KK01.1.1.01.0007, both funded by the European Union through the European Regional Development Fund, and Croatian Ministry of Science, Education and Sports Grant 1080229-0140. The authors declare no conflicts of interest.	Adachi M, 1996, P NATL ACAD SCI USA, V93, P2131, DOI 10.1073/pnas.93.5.2131; ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Amouzegar A, 2017, STEM CELLS, V35, P1532, DOI 10.1002/stem.2611; Askenasy N, 2005, BLOOD, V105, P1396, DOI 10.1182/blood-2004-06-2364; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Calmon-Hamaty F, 2015, CYTOKINE, V75, P228, DOI 10.1016/j.cyto.2014.10.004; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Conover WJ, 1999, PRACTICAL NONPARAMET; DANIEL PT, 1994, J IMMUNOL, V152, P5624; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Fujisawa K, 1996, J CLIN INVEST, V98, P271, DOI 10.1172/JCI118789; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; Garcia S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2941; Grcevic D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00417; Hartgring SAY, 2006, ANN RHEUM DIS, V65, P69, DOI 10.1136/ard.2006.058479; Huang QQ, 2014, ARTHRITIS RHEUMATOL, V66, P68, DOI 10.1002/art.38198; Jagger AL, 2012, J AUTOIMMUN, V38, P29, DOI 10.1016/j.jaut.2011.11.015; Katavic V, 2003, J IMMUNOL, V170, P1540, DOI 10.4049/jimmunol.170.3.1540; Kim SH, 2002, MOL THER, V6, P584, DOI 10.1006/mthe.2002.0712; Kovacic N, 2007, J IMMUNOL, V178, P3379, DOI 10.4049/jimmunol.178.6.3379; Kovacic N, 2010, LAB INVEST, V90, P402, DOI 10.1038/labinvest.2009.144; Krause U., 2011, MESENCHYMAL STEM CEL; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Lazic E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3872; Li XL, 2006, P NATL ACAD SCI USA, V103, P17432, DOI 10.1073/pnas.0607939103; Lotito APN, 2007, AUTOIMMUN REV, V6, P253, DOI 10.1016/j.autrev.2006.08.010; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; Malemud CJ, 2009, OPEN ACCESS RHEUMATO, V1, P133; Malemud Charles J, 2013, J Clin Cell Immunol, V4, P160; Malemud Charles J., 2011, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V10, P78; Matijasevic MI, 2016, CLIN EXP IMMUNOL, V186, P321, DOI 10.1111/cei.12862; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Odobasic D, 2008, IMMUNOLOGY, V124, P503, DOI 10.1111/j.1365-2567.2007.02802.x; Ostendorf B, 2003, ARTHRITIS RHEUM-US, V48, P157, DOI 10.1002/art.10753; Paquet J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3774; Park H, 2005, J IMMUNOL, V175, P7193, DOI 10.4049/jimmunol.175.11.7193; Peng SL, 2006, RHEUMATOLOGY, V45, P26, DOI 10.1093/rheumatology/kei113; Petrovic-Rackov L, 2006, CLIN RHEUMATOL, V25, P448, DOI 10.1007/s10067-005-0106-0; Rapp HT, 2004, ARTHRITIS RES THER, V6, pR404, DOI 10.1186/ar1205); Schedel J, 2002, ARTHRITIS RHEUM, V46, P1512, DOI 10.1002/art.10309; Schett G, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2571; Sucur A, 2014, INT ORTHOP, V38, P1893, DOI 10.1007/s00264-014-2386-y; Van Parijs L, 1998, SCIENCE, V280, P243; Walsh NC, 2010, IMMUNOL REV, V233, P301, DOI 10.1111/j.0105-2896.2009.00857.x; Wu XJ, 2003, ENDOCRINOLOGY, V144, P5545, DOI 10.1210/en.2003-0296; Zhang HD, 1997, J CLIN INVEST, V100, P1951, DOI 10.1172/JCI119726	51	6	7	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3330	3342		10.1096/fj.201801426R	http://dx.doi.org/10.1096/fj.201801426R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30383451	Bronze			2022-12-26	WOS:000459794800021
J	Perla, V; Nadimi, M; Reddy, R; Hankins, GR; Nimmakayala, P; Harris, RT; Valluri, J; Sirbu, C; Reddy, UK				Perla, Venu; Nadimi, Marjan; Reddy, Rishi; Hankins, Gerald R.; Nimmakayala, Padma; Harris, Robert T.; Valluri, Jagan; Sirbu, Cristian; Reddy, Umesh K.			Effect of ghost pepper on cell proliferation, apoptosis, senescence and global proteomic profile in human renal adenocarcinoma cells	PLOS ONE			English	Article							DNA-DAMAGE; MASS-SPECTROMETRY; CANCER; PROTEIN; COMPLEX; EXPRESSION; CALCIUM; CAPSICUM; PATHWAY; KINASE	Chili peppers are an important constituent of many foods and contain medicinally valuable compounds, such as capsaicin and dihydrocapsaicin. As various dietary botanicals have anticancer properties, this study was aimed to examine the effect of Ghost pepper (Bhut Jolo-kia), one of the hottest chili peppers in the world, on cell proliferation, apoptosis, senescence and the global proteomic profile in human renal cell adenocarcinoma in vitro. 769-P human renal adenocarcinoma cells were cultured on RPMI 1640 media supplemented with fetal bovine serum (10%) and antibiotic-antimycotic solution (1%). Treatment stock solutions were prepared in ethanol. Cell proliferation was tested with phenol red-free media with capsaicin (0-400 mu M), dihydrocapsaicin (0-400 mu M), capsaicin + dihydrocapsaicin (5:1), and dry Ghost peppers (0-3 g L-1) for 24, 48 and 72 h. Polycaspase and senescence associated-betagalactosidase (SA-beta-gal) activities were tested with capsaicin (400 mu M), dihydrocapsaicin (400 mu M), capsaicin (400 mu M) + dihydrocapsaicin (80 mu M), and ghost pepper (3 g L-1) treatments. Global proteomic profile of cells in control and ghost pepper treatment (3 g L-1) was analyzed after 6 h by a shotgun proteomic approach using tandem mass spectrometry. At 24 h after treatment (24 HAT), relative to control, cell proportion with capsaicin (400 mu M), dihydrocapsaicin (400 mu M), capsaicin (400 mu M) + dihydrocapsaicin (80 mu M), and ghost pepper (3 g L-1) treatments was reduced to 36%, 18%, 33% and 20%, respectively, and further reduced at 48 and 72 HAT. All treatments triggered an early polycaspase response. SA-beta-gal activity was normal or suppressed with all treatments. About 68,220 protein isoforms were identified by shotgun proteomic approach. Among these, about 8.2% were significantly affected by ghost pepper. Ghost pepper regulated various proteins involved in intrinsic and extrinsic apoptotic pathways, Ras, Rb/E2F, p53, TGF-beta, WNT-beta catenin, and calcium induced cell death pathways. Ghost pepper also induced changes in proteins related to methylation, acetylation, genome stability, cell cycle check points, carbohydrate, protein and other metabolism and cellular mechanisms. Ghost pepper exhibited antiproliferation activity by inducing apoptosis through a complex network of proteins in human renal cell adenocarcinoma in vitro.	[Perla, Venu; Nadimi, Marjan; Reddy, Rishi; Hankins, Gerald R.; Nimmakayala, Padma; Harris, Robert T.; Reddy, Umesh K.] West Virginia State Univ, Gus R Douglass Land Grant Inst, Institute, WV 25112 USA; [Perla, Venu; Nadimi, Marjan; Reddy, Rishi; Hankins, Gerald R.; Nimmakayala, Padma; Harris, Robert T.; Reddy, Umesh K.] West Virginia State Univ, Dept Biol, Institute, WV 25112 USA; [Valluri, Jagan] Marshall Univ, Dept Biol Sci, One John Marshall Dr, Huntington, WV USA; [Sirbu, Cristian] Charleston Area Med Ctr, Ctr Canc Res, Charleston, WV USA	West Virginia State University; West Virginia State University; Marshall University	Hankins, GR; Nimmakayala, P; Reddy, UK (corresponding author), West Virginia State Univ, Gus R Douglass Land Grant Inst, Institute, WV 25112 USA.; Hankins, GR; Nimmakayala, P; Reddy, UK (corresponding author), West Virginia State Univ, Dept Biol, Institute, WV 25112 USA.	ghankins@wvstateu.edu; padma@wvstateu.edu; ureddy@wvstateu.edu		Reddy, Umesh/0000-0003-4611-7143	USDA-NIFA [2017-38821-26432]; WV-INBRE Center for Natural Products Research (NIH) [P1400846]; NIH [5P20GM103434-13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103434] Funding Source: NIH RePORTER	USDA-NIFA(United States Department of Agriculture (USDA)); WV-INBRE Center for Natural Products Research (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by USDA-NIFA (Contract No. 2017-38821-26432) and a grant from WV-INBRE Center for Natural Products Research (NIH), sub-award No. P1400846 and NIH Prime award No. 5P20GM103434-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to BioProximity, LLC, Chantilly, VA for shotgun proteomic analysis. This work was supported by USDA-NIFA (Contract No. 2017-38821-26432) and a grant from WV-INBRE Center for Natural Products Research (NIH), sub-award No. P1400846 and NIH Prime award No. 5P20GM103434-13.	Acharya U, 2003, SCIENCE, V299, P1740, DOI 10.1126/science.1080549; Aits S, 2013, LYSOSOMAL CELL DEATH; Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Avdic V, 2011, STRUCTURE, V19, P101, DOI 10.1016/j.str.2010.09.022; Bazrgar M, 2014, EUR J OBSTET GYN R B, V175, P152, DOI 10.1016/j.ejogrb.2014.01.010; Bazwinsky-Wutschke I, 2014, J PINEAL RES, V56, P439, DOI 10.1111/jpi.12135; Bjornson RD, 2008, J PROTEOME RES, V7, P293, DOI 10.1021/pr0701198; Bley K, 2012, TOXICOL PATHOL, V40, P847, DOI 10.1177/0192623312444471; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Budanov Andrei V, 2014, Subcell Biochem, V85, P337, DOI 10.1007/978-94-017-9211-0_18; Budhavarapu VN, 2012, CELL CYCLE, V11, P2030, DOI 10.4161/cc.20643; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Colombo SL, 2011, P NATL ACAD SCI USA, V108, P21069, DOI 10.1073/pnas.1117500108; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Daniel M, 2015, J EXP BIOL, V218, P59, DOI 10.1242/jeb.107110; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Doostzadeh-Cizeron J, 2000, J BIOL CHEM, V275, P25336, DOI 10.1074/jbc.M000793200; Eliezer Y, 2014, J BIOL CHEM, V289, P8182, DOI 10.1074/jbc.M113.532739; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; GOVINDARAJAN VS, 1991, CRIT REV FOOD SCI, V29, P435, DOI 10.1080/10408399109527536; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Grullich C, 2000, J BIOL CHEM, V275, P8650, DOI 10.1074/jbc.275.12.8650; Guinness Book of World Records, 2006, HOTT SPIC; Guo HS, 2014, BIOCHEM BIOPH RES CO, V450, P1370, DOI 10.1016/j.bbrc.2014.06.134; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; HOFFMAN PG, 1983, J AGR FOOD CHEM, V31, P1326, DOI 10.1021/jf00120a044; Howlader N, 2014, SEER CANC STAT REV; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Itahana K., 2007, METHOD MOL BIOL, V2007, P21, DOI DOI 10.1385/1-59745-361-7:21; Johnson W, 2007, INT J TOXICOL, V26, P3, DOI 10.1080/10915810601163939; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kaji H, 2001, P NATL ACAD SCI USA, V98, P3837, DOI 10.1073/pnas.061358098; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Kinnaird A, 2015, J MOL MED, V93, P127, DOI 10.1007/s00109-014-1250-2; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Kumar AV, 2014, INT J CANCER, V135, P2579, DOI 10.1002/ijc.28921; Lai D, 2012, BIOSCIENCE REP, V32, P361, DOI 10.1042/BSR20110125; Lam AKM, 2013, FEBS LETT, V587, P3782, DOI 10.1016/j.febslet.2013.10.031; Lauden L, 2014, J INVEST DERMATOL, V134, P1675, DOI 10.1038/jid.2014.20; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Li BY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-239; Lin H- K, CYTOPLASMIC PML FUNC, P205, DOI [10.1038/nature02783, DOI 10.1038/NATURE02783]; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Lin-Moshier Y, 2013, J BIOL CHEM, V288, P355, DOI 10.1074/jbc.M112.405761; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Ma B, 2013, J BIOL CHEM, V288, P17552, DOI 10.1074/jbc.M113.453985; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; MARCUS F, 1986, BIOCHEM BIOPH RES CO, V135, P374, DOI 10.1016/0006-291X(86)90005-7; Mathur R, 2000, CURR SCI INDIA, V79, P287; Mayilyan KR, 2012, PROTEIN CELL, V3, P487, DOI 10.1007/s13238-012-2924-6; Meghvansi MK, 2010, J ETHNOPHARMACOL, V132, P1, DOI 10.1016/j.jep.2010.08.034; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Nguyen TB, 2002, J BIOL CHEM, V277, P41960, DOI 10.1074/jbc.M203951200; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Phan RT, 2007, NAT IMMUNOL, V8, P1132, DOI 10.1038/ni1508; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; Ramzi CS CK, 1998, ROBBINS PATHOLOGIC B; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reddy UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086393; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sanatombi K, 2008, NOT BOT HORTI AGROBO, V36, P89; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; Slotta DJ, 2010, PROTEOMICS, V10, P3035, DOI 10.1002/pmic.200900370; Sun Y, 2014, BIOCHEM BIOPH RES CO, V450, P1, DOI 10.1016/j.bbrc.2014.05.045; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Tang TD, 2009, J BIOL CHEM, V284, P5414, DOI 10.1074/jbc.M807797200; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Verone AR, 2013, CARCINOGENESIS, V34, P1737, DOI 10.1093/carcin/bgt126; Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang J, 2009, NAT STRUCT MOL BIOL, V16, P987, DOI 10.1038/nsmb.1645; Wang X, 2001, CANCER RES, V61, P7417; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu CC, 2006, MUTAT RES-FUND MOL M, V601, P71, DOI 10.1016/j.mrfmmm.2006.06.015; Wutka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095605; Xiao W, 1998, NUCLEIC ACIDS RES, V26, P3908, DOI 10.1093/nar/26.17.3908; Xie Q, 2005, J BIOL CHEM, V280, P19673, DOI 10.1074/jbc.M409517200; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zhou YN, 2005, WORLD J GASTROENTERO, V11, P3468, DOI 10.3748/wjg.v11.i22.3468; Zhou Z, 2013, J BIOL CHEM, V288, P18134, DOI 10.1074/jbc.M113.456962; Zimmerman ZF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008086; Zois CE, 2014, BIOCHEM PHARMACOL, V92, P3, DOI 10.1016/j.bcp.2014.09.001	98	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206183	10.1371/journal.pone.0206183	http://dx.doi.org/10.1371/journal.pone.0206183			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379886	Green Submitted, Green Published, gold			2022-12-26	WOS:000448823700094
J	Shen, Y; Chaigne-Delalande, B; Lee, RWJ; Losert, W				Shen, Yang; Chaigne-Delalande, Benjamin; Lee, Richard W. J.; Losert, Wolfgang			CytoBinning: Immunological insights from multi-dimensional data	PLOS ONE			English	Article							FLOW-CYTOMETRY DATA; RARE CELL-POPULATIONS; REGULATORY T-CELLS; AUTOMATED IDENTIFICATION; PRACTICAL APPROACH; VISUALIZATION; ALGORITHM; HIERARCHY	New cytometric techniques continue to push the boundaries of multi-parameter quantitative data acquisition at the single-cell level particularly in immunology and medicine. Sophisticated analysis methods for such ever higher dimensional datasets are rapidly emerging, with advanced data representations and dimensional reduction approaches. However, these are not yet standardized and clinical scientists and cell biologists are not yet experienced in their interpretation. More fundamentally their range of statistical validity is not yet fully established. We therefore propose a new method for the automated and unbiased analysis of high-dimensional single cell datasets that is simple and robust, with the goal of reducing this complex information into a familiar 2D scatter plot representation that is of immediate utility to a range of biomedical and clinical settings. Using publicly available flow cytometry and mass cytometry datasets we demonstrate that this method (termed CytoBinning), recapitulates the results of traditional manual cytometric analyses and leads to new and testable hypotheses.	[Shen, Yang; Losert, Wolfgang] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Shen, Yang; Chaigne-Delalande, Benjamin] NEI, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Lee, Richard W. J.] Univ Bristol, Fac Hlth Sci, Translat Hlth Sci, Bristol, Avon, England; [Lee, Richard W. J.] Moorfields Eye Hosp Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res Biomed Res Ctr, Inflammat & Immunotherapy Theme, London, England; [Lee, Richard W. J.] UCL, Inst Ophthalmol, London, England	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Bristol; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Losert, W (corresponding author), Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA.	wlosert@umd.edu		Lee, Richard/0000-0002-9480-6843	National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology, UK; AFOSR grant [FA9550-16-1-0052]; National Institutes of Health, National Eye Institute intramural research program; National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust, UK	National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology, UK; AFOSR grant(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Institutes of Health, National Eye Institute intramural research program; National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust, UK	R.W.J.L. was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, UK. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health. W.L. was partially supported by AFOSR grant FA9550-16-1-0052. Y.S. and B.C.D. were supported by the National Institutes of Health, National Eye Institute intramural research program. The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R.W.J.L. was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust, UK and UCL Institute of Ophthalmology, UK. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health. W.L. was partially supported by AFOSR grant FA9550-16-1-0052. Y.S. and B.C.D. were supported by the National Institutes of Health, National Eye Institute intramural research program. The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Aghaeepour N, 2012, CYTOM PART A, V81A, P1022, DOI 10.1002/cyto.a.22209; Aghaeepour N, 2012, BIOINFORMATICS, V28, P1009, DOI 10.1093/bioinformatics/bts082; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Anchang B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003664; Bashashati Ali, 2009, Advances in Bioinformatics, V2009, P584603, DOI 10.1155/2009/584603; Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Beyer K, 1999, LECT NOTES COMPUT SC, V1540, P217; Bialek NSGSAGTW, 2005, ESTIMATING MUTUAL IN; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chattopadhyay PK, 2015, AM J TRANSPLANT, V15, P1155, DOI 10.1111/ajt.13193; Chattopadhyay PK, 2012, METHODS, V57, P251, DOI 10.1016/j.ymeth.2012.02.009; Finak G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20686; Finak G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003806; Ge Y, 2012, BIOINFORMATICS, V28, P2052, DOI 10.1093/bioinformatics/bts300; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Kvistborg P, 2015, IMMUNITY, V42, P591, DOI 10.1016/j.immuni.2015.04.006; Lin L, 2015, CYTOM PART A, V87A, P675, DOI 10.1002/cyto.a.22623; Lo K, 2008, CYTOM PART A, V73A, P321, DOI 10.1002/cyto.a.20531; Lo K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-145; Malek M, 2015, BIOINFORMATICS, V31, P606, DOI 10.1093/bioinformatics/btu677; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mosmann TR, 2014, CYTOM PART A, V85, P422, DOI 10.1002/cyto.a.22445; Naim I, 2014, CYTOM PART A, V85, P408, DOI 10.1002/cyto.a.22446; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Nicol B, 2017, J AUTOIMMUN, V645, DOI [10.1002/cyto.a.22625, DOI 10.1002/CYTO.A.22625]; O'Neill K, 2014, BIOINFORMATICS, V30, P1329, DOI 10.1093/bioinformatics/btt770; Orlova DY, 2018, NAT REV IMMUNOL, V18, P77, DOI 10.1038/nri.2017.150; Pitoiset F, 2018, CYTOMETRY B; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Qian Y, 2010, CYTOM PART B-CLIN CY, V78B, pS69, DOI 10.1002/cyto.b.20554; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rebhahn JA, 2016, CYTOM PART A, V89A, P59, DOI 10.1002/cyto.a.22740; Roederer M, 2001, CYTOMETRY, V45, P47, DOI 10.1002/1097-0320(20010901)45:1<47::AID-CYTO1143>3.0.CO;2-A; Saeys Y, 2016, NAT REV IMMUNOL, V16, P449, DOI 10.1038/nri.2016.56; Santegoets SJAM, 2015, CANCER IMMUNOL IMMUN, V64, P1271, DOI 10.1007/s00262-015-1729-x; Spidlen J, 2012, CYTOM PART A, V81A, P727, DOI 10.1002/cyto.a.22106; Spidlen J, 2008, CYTOM PART A, V73A, P1151, DOI 10.1002/cyto.a.20637; Tung JW, 2007, CLIN LAB MED, V27, P453, DOI 10.1016/j.cll.2007.05.001; Van Gassen S, 2016, CYTOM PART A, V89A, P22, DOI 10.1002/cyto.a.22734; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; Wong MT, 2016, IMMUNITY, V45, P442, DOI 10.1016/j.immuni.2016.07.007	42	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205291	10.1371/journal.pone.0205291	http://dx.doi.org/10.1371/journal.pone.0205291			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379838	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700038
J	Singh, A; Vancura, A; Woycicki, RK; Hogan, DJ; Hendrick, AG; Nowacki, M				Singh, Aditi; Vancura, Adrienne; Woycicki, Rafal K.; Hogan, Daniel J.; Hendrick, Alan G.; Nowacki, Mariusz			Determination of the presence of 5-methylcytosine in Paramecium tetraurelia	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; EUKARYOTIC DNA METHYLATION; LOW-DOSE DECITABINE; DROSOPHILA-MELANOGASTER; MAMMALIAN DEVELOPMENT; CYTOSINE METHYLATION; IMATINIB MESYLATE; MACRONUCLEAR DNA; PHASE-II; METHYLTRANSFERASES	5-methylcytosine DNA methylation regulates gene expression and developmental programming in a broad range of eukaryotes. However, its presence and potential roles in ciliates, complex single-celled eukaryotes with germline-somatic genome specialization via nuclear dimorphism, are largely uncharted. While canonical cytosine methyltransferases have not been discovered in published ciliate genomes, recent studies performed in the stichotrichous ciliate Oxytricha trifallax suggest de novo cytosine methylation during macronuclear development. In this study, we applied bisulfite genome sequencing, DNA mass spectrometry and antibody-based fluorescence detection to investigate the presence of DNA methylation in Paramecium tetraurelia. While the antibody-based methods suggest cytosine methylation, DNA mass spectrometry and bisulfite sequencing reveal that levels are actually below the limit of detection. Our results suggest that Paramecium does not utilize 5-methylcytosine DNA methylation as an integral part of its epigenetic arsenal.	[Singh, Aditi; Vancura, Adrienne; Woycicki, Rafal K.; Nowacki, Mariusz] Univ Bern, Inst Cell Biol, Baltzerstr 4, Bern, Switzerland; [Singh, Aditi] Univ Bern, Grad Sch Cellular & Biomed Sci, Freiestr 1, Bern, Switzerland; [Hogan, Daniel J.] Tocagen Inc, San Diego, CA USA; [Hendrick, Alan G.] Storm Therapeut Ltd, Moneta Bldg,Babraham Res Campus, Cambridge, England	University of Bern; University of Bern; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Nowacki, M (corresponding author), Univ Bern, Inst Cell Biol, Baltzerstr 4, Bern, Switzerland.	mariusz.nowacki@izb.unibe.ch	Singh, Aditi/ABZ-0850-2022; Woycicki, Rafal/P-4973-2019; Woycicki, Rafal Kazimierz/D-1398-2011; Nowacki, Mariusz/E-4485-2011	Singh, Aditi/0000-0001-7840-9058; Vancura, Adrienne/0000-0002-7990-0559; Hendrick, Alan/0000-0002-8604-0462; Woycicki, Rafal/0000-0001-7991-7150; Nowacki, Mariusz/0000-0003-4894-2905	European Research Council (ERC) [260358 "EPIGENOME", 681178 "G-EDIT"]; Swiss National Science Foundation [31003A_146257, 31003A_166407]; National Center of Competence in Research (NCCR) RNA and Disease; Tocagen Incorporated; Storm Therapeutics Limited	European Research Council (ERC)(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) RNA and Disease(Swiss National Science Foundation (SNSF)); Tocagen Incorporated; Storm Therapeutics Limited	This research was supported by grants from the European Research Council (ERC) (260358 "EPIGENOME" and 681178 "G-EDIT"), the Swiss National Science Foundation (31003A_146257 and 31003A_166407), and from the National Center of Competence in Research (NCCR) RNA and Disease. Daniel J. Hogan is employed by Tocagen Incorporated. Alan G. Hendrick is employed by Storm Therapeutics Limited. Tocagen Incorporated and Storm Therapeutics Limited provided support in the form of salaries for authors [DJH and AGH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Andrews S., 2015, TRIM GALORE WRAPPER; Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; AU KYM, 1990, EUR J PROTISTOL, V26, P25, DOI 10.1016/S0932-4739(11)80386-X; Beisson J., 2010, COLD SPRING HARB PRO, V2010; Beisson J, 2010, EMERGING MODEL ORGANISMS: LABORATORY MANUAL, VOL 2, P1, DOI 10.1101/pdb.emo140; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 1997, TRENDS GENET, V13, P469, DOI 10.1016/S0168-9525(97)01310-3; Bracht JR, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r99; Bulic A, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-5; Capuano F, 2014, ANAL CHEM, V86, P3697, DOI 10.1021/ac500447w; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; Chekhun V. F., 2007, MOL CANC THERAPEUTIC; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Colot V, 1999, BIOESSAYS, V21, P402, DOI 10.1002/(SICI)1521-1878(199905)21:5<402::AID-BIES7>3.3.CO;2-2; Coyne RS, 2012, BIOL CELL, V104, P309, DOI 10.1111/boc.201100057; CUMMINGS DJ, 1974, BIOCHIM BIOPHYS ACTA, V374, P1, DOI 10.1016/0005-2787(74)90194-4; Ehrlich M, 2003, J CELL BIOCHEM, V88, P899, DOI 10.1002/jcb.10464; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; He GM, 2011, ANNU REV PLANT BIOL, V62, P411, DOI 10.1146/annurev-arplant-042110-103806; Hodges E., 2011, MOL CELL; How-Kit A., 2015, PLANT MOL BIOL; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Ignarski M, 2014, NUCLEIC ACIDS RES, V42, P11952, DOI 10.1093/nar/gku874; Issa JPJ, 2005, J CLIN ONCOL, V23, P3948, DOI 10.1200/JCO.2005.11.981; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; Juranek S, 2003, NUCLEIC ACIDS RES, V31, P1387, DOI 10.1093/nar/gkg233; Krueger F., 2011, BIOINFORMATICS; Krueger F, 2018, GITHUB PROJECT; KWOK FWK, 1989, DEVELOPMENT, V105, P559; Lepere G, 2009, NUCLEIC ACIDS RES, V37, P903, DOI 10.1093/nar/gkn1018; Lim DHK, 2010, ADV GENET, V70, P145, DOI [10.1016/B978-0-12-380866-0.60006-X, 10.1016/S0065-2660(10)70006-7]; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oki Y, 2007, CANCER, V109, P899, DOI 10.1002/cncr.22470; Olesen A., 2014, ECOSAL PLUS; PALACIOS G, 1994, CELL BIOL INT, V18, P223, DOI 10.1006/cbir.1994.1067; Riggs AD, 2002, CYTOGENET GENOME RES, V99, P17, DOI 10.1159/000071569; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; SALVINI M, 1984, EXPERIENTIA, V40, P1401, DOI 10.1007/BF01951912; Schaefer CB, 2007, SCIENCE, V316, P398, DOI 10.1126/science.1137544; Schneider C. A., 2012, NATURE METHODS; Schwab M., 2011, ENCY CANC, P1070; Schwab M., 2009, ENCY CANC, P282; van Delft P., 2017, CHEMBIOCHEM; Walsh CP, 2006, CURR TOP MICROBIOL, V301, P283; Wenzel D, 2011, GENESIS, V49, P647, DOI 10.1002/dvg.20762; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	52	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206667	10.1371/journal.pone.0206667	http://dx.doi.org/10.1371/journal.pone.0206667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379964	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700142
J	Garau, M; Cabrera, J; Ottati, G; Caorsi, H; Martinez, FG; Acosta, N; Aunchayna, MH; Gadola, L; Noboa, O				Garau, Mariela; Cabrera, Jimena; Ottati, Gabriela; Caorsi, Hena; Martinez, Francisco Gonzalez; Acosta, Nelson; Aunchayna, Maria Haydee; Gadola, Liliana; Noboa, Oscar			Temporal trends in biopsy proven glomerular disease in Uruguay, 1990-2014	PLOS ONE			English	Article							RENAL BIOPSY; REGISTRY; EPIDEMIOLOGY; FREQUENCY; GLOMERULONEPHRITIS; POPULATION; EXPERIENCE; DIAGNOSIS; WORLDWIDE; ADULTS	Our aim is to describe variations in the incidence rates of glomerular disease diagnosed by renal biopsies performed in Uruguay over the last 25 years in relation to sex, age, clinical presentation and histological diagnosis. We analyzed all renal biopsies performed in Uruguay during the 25 years period and estimated incidence rates per million people per year (pmp/yr) for the population older than 14 years. Mann Kendall's trend analysis was used to assess incidence trends. In order to identify changes in trends, we compared annual incidence rates with the Joinpoint method. From 1990 to 2014, 3390 biopsies of native kidneys corresponding to glomerular disease were performed in patients older than 14 years. The average biopsy rate was 58 per pmp/yr. The glomerular disease incidence rate increased progressively over the period (p<0.05). Trends analysis over five-year periods demonstrated a progressive increase of IgA nephropathy (3.08 pmp/yr 1990-1994 to 12.53 pmp/yr 2010-2014 p<0.05), membranous nephropathy (2.38 pmp/yr 1990-1994 to 8.04 pmp/yr 2010-2014 p<0.05) and lupus nephritis (4,23 pmp/yr 1990-1994 to 7,81 pmp/yr 2010-2014 p<0.05). There was a change in the trend of focal segmental glomerular sclerosis (FSGS) which increased until 1996 and decreased afterwards. The incidence rates of glomerular disease have doubled globally in the last quarter of a century in Uruguay, mainly related to the increase of IgA nephropathy, membranous nephropathy and lupus nephritis. There was a change in the slope of the incidence rate of FSGS.	[Garau, Mariela] Univ Republica, Fac Med, Dept Metodos Cuantitat, Montevideo, Uruguay; [Garau, Mariela; Cabrera, Jimena; Ottati, Gabriela; Caorsi, Hena; Martinez, Francisco Gonzalez; Acosta, Nelson; Aunchayna, Maria Haydee; Gadola, Liliana; Noboa, Oscar] Uruguayan Registry Glomerulopathies, Montevideo, Uruguay; [Ottati, Gabriela; Caorsi, Hena; Martinez, Francisco Gonzalez; Gadola, Liliana; Noboa, Oscar] Univ Republica, Hosp Clin, Fac Med, Ctr Nefrol, Montevideo, Uruguay; [Aunchayna, Maria Haydee] Univ Republica, Fac Med, Hosp Clin, Dept Anat Patol, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Noboa, O (corresponding author), Uruguayan Registry Glomerulopathies, Montevideo, Uruguay.; Noboa, O (corresponding author), Univ Republica, Hosp Clin, Fac Med, Ctr Nefrol, Montevideo, Uruguay.	onoboa@hc.edu.uy	Noboa, Oscar/Q-8150-2019	Noboa, Oscar/0000-0002-0975-9924	Fondo Nacional de Recursos	Fondo Nacional de Recursos	Fondo Nacional de Recursos is a public entity that funds registry development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work.	[Anonymous], 2 ENC NAC FACT RIESG; Braun N, 2011, INT UROL NEPHROL, V43, P1117, DOI 10.1007/s11255-011-9955-4; Briganti EM, 2001, NEPHROL DIAL TRANSPL, V16, P1364, DOI 10.1093/ndt/16.7.1364; Chang JH, 2009, NEPHROL DIAL TRANSPL, V24, P2406, DOI 10.1093/ndt/gfp091; Valencia VC, 2014, GAC MED MEX, V150, P403; Fiorentino M, 2016, AM J NEPHROL, V43, P1, DOI 10.1159/000444026; Gesualdo L, 2004, KIDNEY INT, V66, P890, DOI 10.1111/j.1523-1755.2004.00831.x; Gonzalez C, REGISTRO URUGUAYO DI; Hanko JB, 2009, NEPHROL DIAL TRANSPL, V24, P3050, DOI 10.1093/ndt/gfp254; Iseki K, 2004, KIDNEY INT, V66, P914, DOI 10.1111/j.1523-1755.2004.00836.x; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Maixnerova D, 2015, J NEPHROL, V28, P39, DOI 10.1007/s40620-014-0090-z; Mazzuchi N, 2005, NEFROLOGIA, V25, P113; McGrogan A, 2011, NEPHROL DIAL TRANSPL, V26, P414, DOI 10.1093/ndt/gfq665; Ministerio de Salud Publica, 2006, 1 ENC NAC FACT RIESG; Murugapandian S, 2016, MEDICINE, V95, pE3699; O'Shaughnessy MM, 2017, CLIN J AM SOC NEPHRO, V12, P614, DOI 10.2215/CJN.10871016; Orta-Sibu N, 2002, PEDIATR NEPHROL, V17, P566, DOI 10.1007/s00467-002-0892-4; Pesce F, 2010, NEPHROL DIAL TRANSPL, V25, P334, DOI 10.1093/ndt/gfp620; Polito MG, 2010, NEPHROL DIAL TRANSPL, V25, P490, DOI 10.1093/ndt/gfp355; Rivera F, 2002, NEPHROL DIAL TRANSPL, V17, P1594, DOI 10.1093/ndt/17.9.1594; Rychlik I, 2004, NEPHROL DIAL TRANSPL, V19, P3040, DOI 10.1093/ndt/gfh521; Schena FP, 1997, NEPHROL DIAL TRANSPL, V12, P418, DOI 10.1093/ndt/12.3.418; Sim JJ, 2016, AM J KIDNEY DIS, V68, P533, DOI 10.1053/j.ajkd.2016.03.416; Simon P, 2004, KIDNEY INT, V66, P905, DOI 10.1111/j.1523-1755.2004.00834.x; Statistical Product and Service Solutions (SPSS) for Windows, 2006, STAT PROD SERV SOL S; Statistical Research and Applications Branch National Cancer Institute, 2014, JOINP REGR PROGR VER JOINP REGR PROGR VER; Sugiyama H, 2013, CLIN EXP NEPHROL, V17, P155, DOI 10.1007/s10157-012-0746-8; Swaminathan S, 2006, CLIN J AM SOC NEPHRO, V1, P483, DOI 10.2215/CJN.00710805; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Zanetti R, 2015, EUR J CANCER, V51, P1082, DOI 10.1016/j.ejca.2013.10.008	31	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206637	10.1371/journal.pone.0206637	http://dx.doi.org/10.1371/journal.pone.0206637			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372492	gold, Green Published, Green Submitted			2022-12-26	WOS:000448641200050
J	Bunz, O; Mese, K; Zhang, WL; Piwowarczyk, A; Ehrhardt, A				Bunz, Oskar; Mese, Kemal; Zhang, Wenli; Piwowarczyk, Andree; Ehrhardt, Anja			Effect of cold atmospheric plasma (CAP) on human adenoviruses is adenovirus type-dependent	PLOS ONE			English	Article							VECTOR DIVERSITY; VIRUS; STABILITY; PH	More than 70 human adenovirus types were identified divided into 7 different species (A-G). Diseases caused by human adenoviruses are type-dependent and can range from mild to severe respiratory infections, gastrointestinal infections or eye infections such as epidemic keratoconjunctivitis. Unfortunately there is no specific anti-adenovirus therapy available. Here we addressed the question whether treatment with cold atmospheric plasma (CAP) for anti-adenoviral therapy such as virus-mediated ulcerations may be feasible. CAP has already been explored for the treatment of dermatological diseases such as chronic wounds. To investigate whether CAP is an effective antiviral tool, purified human adenovirus types derived from different human adenovirus species (HAdV -4, -5, -20, -35, -37, -50) tagged with luciferase were treated with defined dosages of plasma. The CAP treatment was varied by incrementally increasing the time span of CAP treatment. After CAP treatment, the virus containing solution was added to eukaryotic cells and the viral load was determined by measurement of luciferase expression levels. Through the plasma treatment the adenovirus driven luciferase expression directly correlating with adenovirus transduction efficiencies could be reduced for HAdV-5 and HAdV-37. Plasma treatment had no influence on adenovirus derived luciferase expression levels for HAdV-4 and HAdV-50 and it even had a positive effect on luciferase expression levels for HAdV-20 and HAdV-35. These results suggest that CAP has a type dependent effect on adenoviruses and that infectivity can be even increased for certain adenovirus types. Further studies should address the mechanisms behind this phenomenon. In summary we demonstrate that CAP may represent an interesting option for antiviral treatment in a virus type dependent manner.	[Bunz, Oskar] Witten Herdecke Univ, Fac Hlth, Ctr Biomed Educ & Res ZBAF, Inst Immunol,Sch Med, Witten, Germany; [Bunz, Oskar; Piwowarczyk, Andree] Witten Herdecke Univ, Fac Hlth, Sch Dent, Dept Prosthodont, Witten, Germany; [Mese, Kemal; Zhang, Wenli; Ehrhardt, Anja] Witten Herdecke Univ, Fac Hlth, Ctr Biomed Educ & Res ZBAF, Inst Virol & Microbiol,Sch Human Med, Witten, Germany		Ehrhardt, A (corresponding author), Witten Herdecke Univ, Fac Hlth, Ctr Biomed Educ & Res ZBAF, Inst Virol & Microbiol,Sch Human Med, Witten, Germany.	anja.ehrhardt@uni-wh.de		zhang, wenli/0000-0002-6243-6286	Faculty of Health at Witten/Herdecke University, Germany	Faculty of Health at Witten/Herdecke University, Germany	This research received funding from the internal grant program (PhD and Dr. rer. nat. Program Biomedicine) of the Faculty of Health at Witten/Herdecke University, Germany.	Aboubakr HA, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/20/204001; Aboubakr HA, 2015, APPL ENVIRON MICROB, V81, P3612, DOI 10.1128/AEM.00054-15; Ahlfeld B. L., 2015, MBLO, V6, P1, DOI DOI 10.1128/MBI0.02300-14; Alekseev O, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.2.2; Barton A, 2013, PLASMA MED, V3; Chutsirimongkol C., 2014, PLASMA MED, V4; Haertel B, 2014, BIOMOL THER, V22, P477, DOI 10.4062/biomolther.2014.105; Isbary G, 2014, CLIN PLASMA MED, V2, P50, DOI 10.1016/j.cpme.2014.07.001; Jackowski J, 2017, DIAGNOSTIK THERAPIEO; Jager L, 2009, NAT PROTOC, V4, P547, DOI 10.1038/nprot.2009.4; Lenaerts L, 2008, REV MED VIROL, V18, P357, DOI 10.1002/rmv.589; Li F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186373; NASZ I, 1971, J INFECT DIS, V124, P214, DOI 10.1093/infdis/124.2.214; Rexroad J, 2006, J PHARM SCI-US, V95, P237, DOI 10.1002/jps.20496; Rexroad J, 2006, J PHARM SCI-US, V95, P1469, DOI 10.1002/jps.20617; SALLAY K, 1973, J PERIODONTOL, V44, P712, DOI 10.1902/jop.1973.44.11.712; Weiss M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130350; Weltmann KD, 2010, PURE APPL CHEM, V82, P1223, DOI 10.1351/PAC-CON-09-10-35; Zhang WL, 2017, VIRUS GENES, V53, P675, DOI 10.1007/s11262-017-1487-2; Zhang WL, 2017, CELL REP, V19, P1698, DOI 10.1016/j.celrep.2017.05.008; Zimmermann JL, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/50/505201	21	20	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0202352	10.1371/journal.pone.0202352	http://dx.doi.org/10.1371/journal.pone.0202352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365500	Green Submitted, Green Published, gold			2022-12-26	WOS:000448448700003
J	Nye, J; Sturgill, D; Athwal, R; Dalal, Y				Nye, Jonathan; Sturgill, David; Athwal, Rajbir; Dalal, Yamini			HJURP antagonizes CENP-A mislocalization driven by the H3.3 chaperones HIRA and DAXX	PLOS ONE			English	Article							CENTROMERE PROTEIN-A; DE-NOVO KINETOCHORE; HISTONE CHAPERONE; READ ALIGNMENT; HUMAN CANCERS; DEPOSITION; REPLICATION; EXPRESSION; CELLS; NUCLEOSOMES	The centromere specific histone H3 variant CENP-A/CENH3 specifies where the kinetochore is formed in most eukaryotes. Despite tight regulation of CENP-A levels in normal cells, overexpression of CENP-A is a feature shared by various types of solid tumors and results in its mislocalization to non-centromeric DNA. How CENP-A is assembled ectopically and the consequences of this mislocalization remain topics of high interest. Here, we report that in human colon cancer cells, the H3.3 chaperones HIRA and DAXX promote ectopic CENP-A deposition. Moreover, the correct balance between levels of the centromeric chaperone HJURP and CENP-A is essential to preclude ectopic assembly by H3.3 chaperones. In addition, we find that ectopic localization can recruit kinetochore components, and correlates with mitotic defects and DNA damage in G1 phase. Finally, CENP-A occupancy at the 8q24 locus is also correlated with amplification and overexpression of the MYC gene within that locus. Overall, these data provide insights into the causes and consequences of histone variant mislocalization in human cancer cells.	[Nye, Jonathan; Sturgill, David; Athwal, Rajbir; Dalal, Yamini] NCI, Chromatin Struct & Epigenet Mechanisms Unit, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dalal, Y (corresponding author), NCI, Chromatin Struct & Epigenet Mechanisms Unit, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	dalaly@mail.nih.gov		Dalal, Yamini/0000-0002-7655-6182; Walkiewicz, Marcin/0000-0003-3710-0876; Sturgill, David/0000-0002-7902-3605	Intramural Research Program of the National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIABC011206] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All authors were funded by the Intramural Research Program of the National Cancer Institute, NIH. The funders (namely, US taxpayers), had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Amato A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-119; Athwal RK, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-2; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; de Oca RM, 2015, MOL ONCOL, V9, P657, DOI 10.1016/j.molonc.2014.11.002; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Elsasser SJ, 2012, NATURE, V491, P560, DOI 10.1038/nature11608; Filipescu D, 2017, GENE DEV, V31, P463, DOI 10.1101/gad.290924.116; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Forus A, 2001, CANCER GENET CYTOGEN, V131, P13, DOI 10.1016/S0165-4608(01)00516-7; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Gascoigne KE, 2013, CHROMOSOME RES, V21, P407, DOI 10.1007/s10577-013-9368-6; Gieni RS, 2008, J CELL BIOCHEM, V104, P2027, DOI 10.1002/jcb.21767; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gonzalez M, 2014, GENETICS, V198, P1433, DOI 10.1534/genetics.114.171173; Henikoff S, 2005, CURR OPIN GENET DEV, V15, P177, DOI 10.1016/j.gde.2005.01.004; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Hu BH, 2017, ONCOTARGETS THER, V10, P2601, DOI 10.2147/OTT.S127738; Huang WF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148618; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lacoste N, 2014, MOL CELL, V53, P631, DOI 10.1016/j.molcel.2014.01.018; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017794; McClintock B, 1938, GENETICS, V23, P315; Mendiburo MJ, 2011, SCIENCE, V334, P686, DOI 10.1126/science.1206880; Bui M, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0124-6; Niikura Y, 2015, DEV CELL, V32, P589, DOI 10.1016/j.devcel.2015.01.024; Nye Jonathan, 2018, F1000Res, V7, P141, DOI 10.12688/f1000research.12833.1; Olszak AM, 2011, NAT CELL BIOL, V13, P799, DOI 10.1038/ncb2272; Pchelintsev NA, 2013, CELL REP, V3, P1012, DOI 10.1016/j.celrep.2013.03.026; Qiu JJ, 2013, TUMOR BIOL, V34, P2971, DOI 10.1007/s13277-013-0860-6; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Ricketts MD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8711; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Shrestha RL, 2017, ONCOTARGET, V8, P46781, DOI 10.18632/oncotarget.18108; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Sirvent N, 2000, GENE CHROMOSOME CANC, V29, P117, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1014>3.0.CO;2-Q; Sun X, 2016, INT J CANCER, V139, P899, DOI 10.1002/ijc.30133; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Tomonaga T, 2003, CANCER RES, V63, P3511; Wu Q, 2012, LUNG CANCER, V77, P407, DOI 10.1016/j.lungcan.2012.04.007; Yu ZL, 2015, DEV CELL, V32, P68, DOI 10.1016/j.devcel.2014.11.030; Zhang HL, 2017, MOL CELL, V65, P272, DOI 10.1016/j.molcel.2016.11.030; Zhang WG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12619; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao HQ, 2016, J AM CHEM SOC, V138, P13207, DOI 10.1021/jacs.6b05355; Zhou D, 2017, ONCOTARGET, V8, P43978, DOI 10.18632/oncotarget.16701	57	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0205948	10.1371/journal.pone.0205948	http://dx.doi.org/10.1371/journal.pone.0205948			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365520	Green Submitted, Green Published, gold			2022-12-26	WOS:000448448700016
J	Bawazer, W; Lashin, A; Kinawy, MM				Bawazer, Waleed; Lashin, Aref; Kinawy, Mostafa M.			Characterization of a fractured basement reservoir using high-resolution 3D seismic and logging datasets: A case study of the Sab'atayn Basin, Yemen	PLOS ONE			English	Article							MARIB-SHABOWAH BASIN; DEPOSITIONAL-ENVIRONMENTS; MATURATION; PETROLEUM; SHALES; ROCKS	The Sab'atayn Basin is one of the most prolific Mesozoic hydrocarbon basins located in central Yemen. It has many oil producing fields including the Habban Field with oil occurrences in fractured basement rocks. A comprehensive seismic analysis of fractured basement reservoirs was performed to identify the structural pattern and mechanism of hydrocarbon entrapment and reservoir characteristics. A 3D post-stack time migration seismic cube and logging data of 20 wells were used and several 2D seismic sections were constructed and interpreted. Depth structure maps were generated for the basement reservoir and overlying formations. The top of the basement reservoir is dissected by a set of NW-SE step-like normal faults (Najd Fault System) and to a lesser extent, by secondary NNE-SSW oriented faults (Hadramauwt System). The Najd Fault System is dominant and dissects the reservoir in the middle of the field into two prospective uplifts. The northern and northeastern areas constitute the deep-seated downthrown side of the reservoir. Hydrocarbon emplacement is through the fault juxtaposition of the fractured basement against the organic shale source rock of the overlying Madbi Formation. Hydrocarbons are hosted in basement horsts formed by fault-controlled blocks and overlain by the regional seal of the Sab'atayn Formation. The basement reservoir rock is mainly composed of granite, quartz-feldspar, weathered silica, and mica minerals. Fractures were identified from the outcrops, cores, image logs, and the petrophysical analysis. Hydrocarbon saturation was observed in the upper and middle parts of the reservoir, more specifically in front of the highly fractured sections. The fracture porosity was less than 5% and the dead oil had an API gravity of 40 degrees with no H2S or CO2. In conclusion, the structural highs of the Habban Field are of interest because most oil producing wells are drilled into them. We recommend extending the drilling and development activities in these uplifts.	[Bawazer, Waleed; Lashin, Aref; Kinawy, Mostafa M.] King Saud Univ, Coll Engn, Petr & Nat Gas Engn Dept, Riyadh, Saudi Arabia; [Lashin, Aref] Benha Univ, Fac Sci, Geol Dept, Banha, Egypt; [Kinawy, Mostafa M.] Al Azhar Univ, Fac Engn, Min & Petr Engn Dept, Cairo, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Benha University; Egyptian Knowledge Bank (EKB); Al Azhar University	Lashin, A (corresponding author), King Saud Univ, Coll Engn, Petr & Nat Gas Engn Dept, Riyadh, Saudi Arabia.; Lashin, A (corresponding author), Benha Univ, Fac Sci, Geol Dept, Banha, Egypt.	arlashin@ksu.edu.sa	Lashin, Aref/E-8686-2019	Lashin, Aref/0000-0002-1834-3234	Deanship of Scientific Research at King Saud University [RG-1435-070]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors extend their sincere appreciations to the Deanship of Scientific Research at King Saud University for funding the Research Group (RG-1435-070).	Abd El Rahman A., 2004, EGYPT ANN GEOL SURV, VXXVII, P459; Aguilera R., 1995, NATURALLY FRACTURED; Aguilera R, 1998, LEADING EDGE, P31; Ahlbranft TS, 2002, US GEOL SURVEY B G, V2202-G, P28; Alaug AS, 2011, IRAN J EARTH SCI, V3, P134; Angerer E, 2011, 73 EAGE C EXH VIENN; As-Saruri M. A., 2014, AAPG MEMOIR, V106, P757; Bellahsen N, 2003, EARTH PLANET SC LETT, V216, P365, DOI 10.1016/S0012-821X(03)00516-8; Beydoun Z., 1998, REPUBLIC YEMEN, V34, P245; Bosence DWJ, 1997, MAR PETROL GEOL, V14, P611, DOI 10.1016/S0264-8172(97)00039-1; BOSWORTH W., 2012, GEOLOGICAL SOC SPECI, V374, P333; Boyeldieu C, 1982, OFFSH S E AS 1982 C; Chopra S, 2007, CSPG CSEG CONV CALG; Csato I, 2005, AAPG ANN CONV DALL, P1; Dennis J.G., 1967, AM ASS PETROLEUM GEO, V7, P196; EGGLESTON WS, 1948, AAPG BULL, V32, P1352; EGPC, 1996, GULF SUEZ OIL FIELDS; El Sharawy M, 2015, ADV APPL SCI RES, V6, P17; Gutmanis J, 2010, HYDROCARBON PRODUCTI, P40; Hakimi MH, 2011, GEOARABIA, V16, P47; Hakimi MH, 2015, MAR PETROL GEOL, V59, P202, DOI 10.1016/j.marpetgeo.2014.08.002; Hakimi MH, 2014, MAR PETROL GEOL, V50, P185, DOI 10.1016/j.marpetgeo.2013.09.012; Jafri MK, 2017, EXPLOR GEOPHYS, V48, P430, DOI 10.1071/EG15112; Khanbari K., 2000, THESIS U PARIS SUD F, P221; Koning T, 1984, P 13 ANN CONV MAY 29; Koning T, 2003, SPECIAL PUBLICATION, V214; Koning T, 2007, CSPG CSEG CONV; Landes K.K., 1960, AAPG BULL, V44, P1682; MELLO UT, 1995, MAR PETROL GEOL, V12, P697, DOI 10.1016/0264-8172(95)93596-V; Mohammed A., 2010, J GEOGR GEOL, V2, P119, DOI [10.5539/jgg.v2n1p119, DOI 10.5539/jgg.v2n1p119]; Nawab R, 2006, SPE INT OIL GAS C EX; Neff P, 2014, AAPG INT C EXH IST T; Neff P, 2011, 73 EAGE C EXH VIENN; Nelson R.A., 2001, GEOLOGIC ANAL NATURA, P323; North FK, 1990, PETROLEUM GEOLOGY; OMV, 2005, INTERNAL REPORT, P62; PAN CH, 1982, AAPG BULL, V66, P1597; Petford N, 2003, GEOL SOC SPEC PUBL, V214, P1, DOI 10.1144/GSL.SP.2003.214.01.01; Price NJ, 1990, ANAL GEOLOGICAL STRU, P520; Ranalli G, 1976, LECT RHEOLOGY EART 1, V76-1, P157; Rasmus JC, 1982, DETERMINING TYPE FLU, V2673; REDFERN P, 1995, BASIN RES, V7, P337, DOI 10.1111/j.1365-2117.1995.tb00121.x; Rotevatn A, 2014, GEOL SOC SPEC PUBL, V374, P79, DOI 10.1144/SP374.12; Sanders CAE, 2003, GEOL SOC SPEC PUBL, V214, P221, DOI 10.1144/GSL.SP.2003.214.01.13; Schlumberger, 1972, LOG INT; Schlumberger, 1989, LOG INT PRINC APPL; Schutter SR, 2003, GEOL SOC SPEC PUBL, V214, P7, DOI 10.1144/GSL.SP.2003.214.01.02; Seaborne TR, 1996, MAR PETROL GEOL, V13, P963, DOI 10.1016/S0264-8172(96)00017-7; Selim SM, 2012, AAPG ANN CONV EXH DE; Serra O, 1984, FUNDAMENTALS WELL LO, P423; Tari G, 2016, SPE INT PETR EXH C A, P15; Venningen R, 2013, EGU GEN ASS C, V15, P4464; Walden A, 1998, IEEE T GEOSCI REMOTE, V6, P287; Waldren W, 1995, SPE MIDDL E OIL TECH	54	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206079	10.1371/journal.pone.0206079	http://dx.doi.org/10.1371/journal.pone.0206079			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359402	gold, Green Published, Green Submitted			2022-12-26	WOS:000448438400043
J	Karvemo, S; Meurling, S; Berger, D; Hoglund, J; Laurila, A				Karvemo, Simon; Meurling, Sara; Berger, David; Hoglund, Jacob; Laurila, Anssi			Effects of host species and environmental factors on the prevalence of Batrachochytrium dendrobatidis in northern Europe	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; DISEASE RISK; LANDSCAPE CHARACTERISTICS; INFECTIOUS-DISEASE; CHYTRIDIOMYCOSIS; PATHOGEN; FOREST; DYNAMICS; ECOLOGY; FROGS	The fungal pathogen Batrachochytrium dendrobatidis (Bd) poses a major threat to amphibian populations. To assist efforts to address such threats, we examined differences in Bd host infection prevalence among amphibian species and its relations to both local environmental factors in breeding habitats and landscape variables measured at three scales (500, 2000 and 5000 m radii) around breeding sites in southernmost Sweden. We sampled 947 anurans of six species in 31 ponds and assessed their infection status. We then examined correlations of infection prevalence with canopy cover, pond perimeter and pH (treated as local-scale pond characteristics), and the number of ponds, area of arable land, area of mature forest, number of resident people and presence of sea within the three radii (treated as landscape variables). The Bd infection prevalence was very low, 0.5-1.0%, in two of the six anuran species (Bufo bufo and Rana temporaria), and substantially higher (13-64%) in the other four (Bombina bombina, Bufotes variabilis, Epidalea calamita, Rana arvalis). In the latter four species Bd infection prevalence was positively associated with ponds' pH (site range: 5.3-8.1), and negatively associated with areas of mature forest and/or wetlands in the surroundings. Our results show that the infection dynamics of Bd are complex and associated with host species, local pond characteristics and several landscape variables at larger spatial scales. Knowledge of environmental factors associated with Bd infections and differences in species' susceptibility may help to counter further spread of the disease and guide conservation action plans, especially for the most threatened species.	[Karvemo, Simon; Meurling, Sara; Berger, David; Hoglund, Jacob; Laurila, Anssi] Uppsala Univ, Dept Ecol & Genet Anim Ecol, Uppsala, Sweden	Uppsala University	Karvemo, S (corresponding author), Uppsala Univ, Dept Ecol & Genet Anim Ecol, Uppsala, Sweden.	simon.karvemo@ebc.uu.se	Kärvemo, Simon/ABC-1564-2020	Karvemo, Simon/0000-0003-0954-7312	Carl Trygger's Foundation [15:220, KF17:14]; Formas - Swedish Research Council for sustainable development [215-2014-594]	Carl Trygger's Foundation; Formas - Swedish Research Council for sustainable development	This work was supported by Carl Trygger's Foundation 15:220 and KF17:14 (JH). http://www.carltryggersstiftelse.se/, and Formas - Swedish Research Council for sustainable development 215-2014-594 (JH). http://www.formas.se/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2010, ECOL APPL, V20, P289, DOI 10.1890/08-2319.1; Allison P.D., 2008, P SAS GLOBAL FORUM, V360, P1; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; [Anonymous], 2018, MUMIN MULTIMODEL INF; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Arnold E.N., 2002, FIELD GUIDE REPTILES; Becker CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048205; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Beyer SE, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00263.1; Blomquist SM, 2009, HERPETOL CONSERV BIO, V4, P142; Blooi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181051; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brem F., 2007, FIELD SAMPLING PROTO; Cedhagen T, 1991, GROD OCH KRALDJUR NO; Chestnut T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106790; Cohen JM, 2016, P NATL ACAD SCI USA, V113, pE3359, DOI 10.1073/pnas.1521657113; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; D'Aoust-Messier AM, 2015, DIS AQUAT ORGAN, V113, P149, DOI 10.3354/dao02837; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Duffus ALJ, 2010, HERPETOL J, V20, P117; ELMBERG J, 1990, CAN J ZOOL, V68, P121, DOI 10.1139/z90-017; Fu MJ, 2017, IMMUNOGENETICS, V69, P529, DOI 10.1007/s00251-017-1008-4; Garner TWJ, 2005, EMERG INFECT DIS, V11, P1639; GASCON C, 2007, AMPHIBIAN CONSERVATI; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Gervasi SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167882; Gillespie TR, 2005, J APPL ECOL, V42, P699, DOI 10.1111/j.1365-2664.2005.01049.x; Gjertsen AK, 2007, REMOTE SENS ENVIRON, V110, P420, DOI 10.1016/j.rse.2006.08.018; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hallengren A, CHYTRIDIOMYKOSIS HOT; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Heard GW, 2015, ECOL LETT, V18, P853, DOI 10.1111/ele.12463; Horwitz P, 2005, INT J PARASITOL, V35, P725, DOI 10.1016/j.ijpara.2005.03.002; Hossack BR, 2010, J HERPETOL, V44, P253, DOI 10.1670/09-058.1; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Karvemo S, 2014, FOREST ECOL MANAG, V334, P232, DOI 10.1016/j.foreco.2014.09.011; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Knapp RA, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00028.1; Kosch TA, 2013, MOL ECOL RESOUR, V13, P230, DOI 10.1111/1755-0998.12041; Kownacki A, 2006, BOREAL ENVIRON RES, V11, P481; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Lips KR, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0465; Morse S.S., 2001, PLAGUES POLITICS INF, P7; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Muths E, 2008, BIOL CONSERV, V141, P1484, DOI 10.1016/j.biocon.2008.03.011; Niemuth ND, 2010, WETLANDS, V30, P1053, DOI 10.1007/s13157-010-0111-1; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Padgett-Flohr GE, 2010, ECOGRAPHY, V33, P688, DOI 10.1111/j.1600-0587.2009.05994.x; Pauza MD, 2010, DIS AQUAT ORGAN, V92, P193, DOI 10.3354/dao02212; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pullen KD, 2010, DIS AQUAT ORGAN, V91, P9, DOI 10.3354/dao02249; R Core Team, 2018, R LANG ENV STAT COMP; READING CJ, 1991, J ZOOL, V225, P201, DOI 10.1111/j.1469-7998.1991.tb03811.x; Reese H, 2003, AMBIO, V32, P542, DOI 10.1639/0044-7447(2003)032[0542:CEOFVU]2.0.CO;2; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Richter-Boix A, 2011, MOL ECOL, V20, P1582, DOI 10.1111/j.1365-294X.2011.05025.x; Rideout BA, 2017, ECOHEALTH, V14, pS42, DOI 10.1007/s10393-016-1132-x; Rollins-Smith LA, 2017, DEV COMP IMMUNOL, V66, P111, DOI 10.1016/j.dci.2016.07.002; Roznik EA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13472; Saenz D, 2015, URBAN ECOSYST, V18, P333, DOI 10.1007/s11252-014-0398-4; Scheele BC, 2015, ANIM CONSERV, V18, P480, DOI 10.1111/acv.12199; Schmeller DS, 2014, CURR BIOL, V24, P176, DOI 10.1016/j.cub.2013.11.032; Schock DM, 2010, DIS AQUAT ORGAN, V92, P231, DOI 10.3354/dao02134; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; Shahan JL, 2017, LANDSCAPE ECOL, V32, P971, DOI 10.1007/s10980-017-0500-4; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Smith MA, 2005, ECOGRAPHY, V28, P110; Spitzen-Van der Sluijs A, 2014, CONSERV BIOL, V28, P1302, DOI 10.1111/cobi.12281; Strauss A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076035; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tabachnick WJ, 2010, J EXP BIOL, V213, P946, DOI 10.1242/jeb.037564; Tavernini S, 2008, LIMNOLOGICA, V38, P63, DOI 10.1016/j.limno.2007.08.001; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Westling A, 2015, ROD LISTADE ARTER SV; Wilcox Bruce A., 2005, EcoHealth, V2, P244, DOI 10.1007/s10393-005-8961-3; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Xie GY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160746	82	21	21	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0199852	10.1371/journal.pone.0199852	http://dx.doi.org/10.1371/journal.pone.0199852			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359384	Green Submitted, Green Published, gold			2022-12-26	WOS:000448438400003
J	Figueroa, RI; de Bustos, A; Cuadrado, A				Figueroa, Rosa, I; de Bustos, Alfredo; Cuadrado, Angeles			A novel FISH technique for labeling the chromosomes of dinoflagellates in suspension	PLOS ONE			English	Article							GENE-EXPRESSION; DNA-SEQUENCES; CELL-CYCLE; GENOME; NUCLEAR; HYBRIDIZATION; ORGANIZATION; BEHAVIOR	Dinoflagellates possess some of the largest known genomes. However, the study of their chromosomes is complicated by their similar size and their inability to be distinguished by traditional banding techniques. Dinoflagellate chromosomes lack nucleosomes and are present in a liquid crystalline state. In addition, approaches such as fluorescent in situ hybridization (FISH) are problematic because chromosomes are difficult to isolate from the nuclear membrane, which in dinoflagellates remains intact, also during mitosis. Here we describe a novel, reliable and effective technique to study dinoflagellate chromosomes by physical mapping of repetitive DNA sequences in chromosomes in suspension (FISH-IS), rather than on a microscope slide. A suspension of non-fixed chromosomes was achieved by lysing the cells and destabilizing the nuclear envelope. This treatment resulted in the release of the permanently condensed chromosomes in a high-quality chromosomal suspension. Nevertheless, slide preparations of the chromosomes were not suitable for conventional FISH because the nuclear integrity and chromosomal morphology was destroyed. Our newly developed, simple and efficient FISH-IS technique employs fluorescently labeled, synthetic short sequence repeats that are hybridized with suspended, acetic-acid-pretreated chromosomes for 1 h at room temperature. The method can be successfully used to discriminate single chromosomes or specific chromosomal regions, depending on the specificity of the repeat sequences used as probes. The combination of FISH-IS and flow sorting will improve genomic studies of dinoflagellates, overcoming the difficulties posed by their huge genomes, including long stretches of non-coding sequences in multiple copies and the presence of high-copy-number tandem gene arrays.	[Figueroa, Rosa, I] IEO, Subida Radio Faro 50, Vigo, Spain; [de Bustos, Alfredo; Cuadrado, Angeles] UAH, Dept Biomed & Biotecnol, Madrid, Spain	Universidad de Alcala	Cuadrado, A (corresponding author), UAH, Dept Biomed & Biotecnol, Madrid, Spain.	angeles.cuadrado@uah.es	De Bustos Rodríguez, Alfredo/H-4256-2015; Cuadrado, Angeles/H-3470-2015; Figueroa, Rosa Isabel/M-7598-2015	De Bustos Rodríguez, Alfredo/0000-0001-9127-8830; Cuadrado, Angeles/0000-0003-0089-5249; Figueroa, Rosa Isabel/0000-0001-9944-7993	Spanish National Project DIANAS [CTM2017-86066-R]; FORMAS (Sweden) [2010-824]	Spanish National Project DIANAS; FORMAS (Sweden)(Swedish Research Council Formas)	The present work was funded the Spanish National Project DIANAS (CTM2017-86066-R) and a FORMAS (Sweden) grant (2010-824) to R.I.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverca E, 2007, CYTOGENET GENOME RES, V116, P224, DOI 10.1159/000098191; Aranda M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39734; Bhaud Y, 2000, J CELL SCI, V113, P1231; Brand LE, 2012, HARMFUL ALGAE, V14, P156, DOI 10.1016/j.hal.2011.10.020; Brind'Amour J, 2011, NAT METHODS, V8, P484, DOI [10.1038/NMETH.1601, 10.1038/nmeth.1601]; Capal P, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0124-8; Cho Y, 2011, HARMFUL ALGAE, V10, P235, DOI 10.1016/j.hal.2010.10.003; Chow MH, 2010, EUKARYOT CELL, V9, P1577, DOI 10.1128/EC.00026-10; COSTAS E, 1987, CHROMOSOMA, V95, P435, DOI 10.1007/BF00333995; Costas E, 2005, CYTOGENET GENOME RES, V109, P268, DOI 10.1159/000082409; Cremer T, 2018, BIOCHEMISTRY-MOSCOW+, V83, P313, DOI 10.1134/S000629791804003X; Cuadrado A, SCI REPORTS; Cuadrado A, 1994, CHROMOSOME RES, V2, P331, DOI 10.1007/BF01552727; Dapena C, 2015, PROTIST, V166, P146, DOI 10.1016/j.protis.2015.01.001; de la Espina SMD, 2005, EUR J CELL BIOL, V84, P137, DOI 10.1016/j.ejcb.2005.01.002; Dolezel J, 2012, FUNCT INTEGR GENOMIC, V12, P397, DOI 10.1007/s10142-012-0293-0; Drechsler H, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120140; Fojtova M, 2010, CHROMOSOMA, V119, P485, DOI 10.1007/s00412-010-0272-y; Giorgi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057994; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; HAAPALA OK, 1974, HEREDITAS, V78, P141; He H, 2001, INT J RADIAT BIOL, V77, P787, DOI 10.1080/09553000110047546; Hoppenrath M, 2014, KLEINE SENCHENBER RE, V54, P1; Figueroa RI, 2014, PROTIST, V165, P343, DOI 10.1016/j.protis.2014.04.001; Lin S, 2011, RES MICROBIOL, V162, P427; Lin SJ, 2015, SCIENCE, V350, P691, DOI 10.1126/science.aad0408; LIVOLANT F, 1980, CHROMOSOMA, V80, P97, DOI 10.1007/BF00327568; Ma YZ, 2005, GENES GENET SYST, V80, P35, DOI 10.1266/ggs.80.35; MATERA AG, 1992, HUM MOL GENET, V1, P535, DOI 10.1093/hmg/1.7.535; Place AR, 2012, HARMFUL ALGAE, V14, P179, DOI 10.1016/j.hal.2011.10.021; RAAP AK, 1986, CYTOMETRY, V7, P235, DOI 10.1002/cyto.990070303; SHAPIRO IM, 1978, EXP CELL RES, V115, P411, DOI 10.1016/0014-4827(78)90296-3; Shoguchi E, 2013, CURR BIOL, V23, P1399, DOI 10.1016/j.cub.2013.05.062; Soyer-Gobillar MO., 2008, METHODS MOL BIOL, V463; Soyer-Gobillard MO, 2015, INT MICROBIOL, V18, P209, DOI 10.2436/20.1501.01.252; Wisecaver JH, 2011, ANNU REV MICROBIOL, V65, P369, DOI 10.1146/annurev-micro-090110-102841	36	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0204382	10.1371/journal.pone.0204382	http://dx.doi.org/10.1371/journal.pone.0204382			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356238	gold, Green Submitted, Green Published			2022-12-26	WOS:000448434000008
J	Wu, X; Zhang, KW; Chen, YN; Wang, R; Chen, L; Zhang, AL; Hu, B				Wu, Xing; Zhang, Kangwei; Chen, Yini; Wang, Ren; Chen, Lei; Zhang, Aili; Hu, Bing			Theoretical and experimental study of dual-fiber laser ablation for prostate cancer	PLOS ONE			English	Article							INDUCED INTERSTITIAL THERMOTHERAPY; RADIOFREQUENCY ABLATION; TEMPERATURE; THERAPY	Single-fiber laser treatment of the prostate has been widely accepted in the clinic due to its minimal invasiveness and high controllability. However, for large tumors, multiple insertions of the laser probe would be needed to achieve full coverage of the tumor, increasing the complexity of the treatment and occasionally resulting in the incomplete killing of tumor cells due to a mismatch between the planned insertion location and the actual probe insertion location. Treatment with a dual-fiber laser results in greater lesion coverage following a single insertion of the probe, with the lesion coverage being even greater than the sum of the coverage of two sequential insertion of a single-fiber laser probe, potentially reducing treatment time and clinical complications. Both theoretical and experimental analyses have been performed to evaluate the proposed dual-fiber laser treatment. A finite element model was established to simulate the treatment process. The simulation results indicated that there is a clear difference between the ablation coverage created using dual-fiber laser ablation and that created using the superposition of sequential single-fiber laser ablation. In addition, the coverage is dependent on the spacing distance between the two fibers. Both ex vivo and in vivo canine prostate tissues were treated by dual-fiber laser ablation, with lesions analyzed by magnetic resonance imaging (MRI), ultrasound imaging, and pathology. The results demonstrate that dual-fiber laser ablation can markedly increase the range of the ablation zone when compared with single-fiber modes. The safety and feasibility of dual-fiber laser treatment has been confirmed, and a treatment plan using dual-fiber laser ablation has also been proposed.	[Wu, Xing; Chen, Yini; Wang, Ren; Chen, Lei; Hu, Bing] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Ultrasound Med, Shanghai, Peoples R China; [Wu, Xing; Chen, Yini; Wang, Ren; Chen, Lei; Hu, Bing] Shanghai Inst Ultrasound Med, Shanghai, Peoples R China; [Zhang, Kangwei; Zhang, Aili] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hu, B (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Ultrasound Med, Shanghai, Peoples R China.; Hu, B (corresponding author), Shanghai Inst Ultrasound Med, Shanghai, Peoples R China.; Zhang, AL (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China.	zhangaili@sjtu.edu.cn; binghu_stan@163.com		Zhang, Kangwei/0000-0003-1005-3678	National Natural Science Foundation of China [NSFC51476101, 51521005]; Shanghai Science and Technology Commission of Shanghai Municipality [16441903100]; Ministry of Science and Technology of China [2016YFC0106200]; clinical support department capacity building project [SHDC22015001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); clinical support department capacity building project	This work was supported by the National Natural Science Foundation of China (NSFC51476101, 51521005), the Shanghai Science and Technology Commission of Shanghai Municipality (16441903100), the Ministry of Science and Technology of China (2016YFC0106200), and a clinical support department capacity building project (SHDC22015001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (NSFC5147 6101, 51521005), the Shanghai Science and Technology Commission of Shanghai Municipality (16441903100), the Ministry of Science and Technology of China (2016YFC0106200), and a clinical support department capacity building project (SHDC22015001). We would like to thank Wei Liu for his assistance with the experiments and American Journal Experts (AJE) for helping with language editing.	Ahmed HU, 2012, LANCET ONCOL, V13, P622, DOI 10.1016/S1470-2045(12)70121-3; Berjano EJ, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-24; Da Rosa M R, 2011, Cancer Imaging, V11 Spec No A, pS3, DOI 10.1102/1470-7330.2011.9003; Di Matteo F, 2013, GASTROINTEST ENDOSC, V78, P750, DOI 10.1016/j.gie.2013.04.178; Diller KR, 2010, ANN NY ACAD SCI, V888, P153; Duck F.A., 1990, MED PHYS, V18; Jiang SC, 2005, LASER MED SCI, V20, P122, DOI 10.1007/s10103-005-0359-5; Lee Ted, 2014, Rev Urol, V16, P55; Marqa MF, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-45; MCKENZIE AL, 1990, PHYS MED BIOL, V35, P1175, DOI 10.1088/0031-9155/35/9/001; Mohammed Y, 2005, BIOMED ENG ONLINE, V4, P1; Oto A, 2013, RADIOLOGY, V267, P932, DOI 10.1148/radiol.13121652; PANESCU D, 1995, IEEE T BIO-MED ENG, V42, P879, DOI 10.1109/10.412649; Raz O, 2010, EUR UROL, V58, P173, DOI 10.1016/j.eururo.2010.03.006; Saccomandi P, 2011, IEEE ENG MED BIO, P5585, DOI 10.1109/IEMBS.2011.6091351; Saccomandi P, 2012, IEEE T BIO-MED ENG, V59, P2958, DOI 10.1109/TBME.2012.2210895; Wenger H, 2014, CURR OPIN UROL, V24, P236, DOI 10.1097/MOU.0000000000000044	17	7	7	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206065	10.1371/journal.pone.0206065	http://dx.doi.org/10.1371/journal.pone.0206065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356335	Green Submitted, gold, Green Published			2022-12-26	WOS:000448434000071
J	Divino, V; Mallick, R; DeKoven, M; Krishnarajah, G				Divino, Victoria; Mallick, Rajiv; DeKoven, Mitch; Krishnarajah, Girishanthy			The economic burden of CIDP in the United States: A case-control study	PLOS ONE			English	Article							INFLAMMATORY DEMYELINATING POLYNEUROPATHY; MANAGEMENT; GUIDELINE; COSTS; PAIN	Background Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare neurological disorder of the peripheral nervous system. The economic burden of CIDP is not well understood. Objectives To assess the economic and clinical burden of CIDP and to compare the incremental burden relative to a matched control group without CIDP. Methods This retrospective case-control analysis was conducted using data from the IQVIA Real-World Data Adjudicated Claims. Adults newly diagnosed with CIDP between 7/1/2010 and 6/30/2014 were identified and direct matched to controls without CIDP. Baseline characteristics were assessed and compared over a 6-month pre-index period. Healthcare resource use, costs and clinical characteristics were assessed and compared over a 2-year followup. Total cost differences over the 2-year follow-up were compared between matched cohorts using a generalized estimating equation model. Results The final sample comprised a total of 790 cases matched to 790 controls. Over the 2-year follow-up, cases more frequently experienced neuropathic pain, back pain and osteoarthritis and more commonly utilized opioids, anti-convulsants and anti-depressants. Compared to controls, more cases had >1 hospitalization (26.2% vs. 9.0%), and cases had a higher mean number of outpatient prescription fills (62.8 vs. 32.0) and physician office visits (34.7 vs. 13.0) (all p<0.0001). Cases had 7.5x higher mean total costs ($116,330 vs. $15,586, p<0.0001). Important cost drivers were costs for outpatient ancillary, radiology and HCPCS drugs (mean $76,366 vs. $4,292) and costs for inpatient care (mean $16,357 vs. $2,862) (both p<0.0001). Among cases, CIDP therapy (inclusive of both outpatient pharmacy and medical claims) accounted for 51.2% of mean total costs. After further adjusting for baseline clinical characteristics, cases were associated with a 6.1x increase in total costs compared to controls (p<0.0001). Conclusions Our findings suggest a substantial clinical and economic burden among patients with CI DP relative to matched controls over a 2-year follow-up.	[Divino, Victoria; DeKoven, Mitch] IQVIA, Hlth Econ & Outcomes Res, Fairfax, VA 22034 USA; [Mallick, Rajiv; Krishnarajah, Girishanthy] CSL Behring, Global Hlth Econ & Reimbursement Strategy, King Of Prussia, PA USA	IQVIA; CSL	Divino, V (corresponding author), IQVIA, Hlth Econ & Outcomes Res, Fairfax, VA 22034 USA.	victoria.divino@iqvia.com		Mallick, Rajiv/0000-0002-0273-9680	CSL Behring, King of Prussia, PA	CSL Behring, King of Prussia, PA	This study was financially supported by CSL Behring, King of Prussia, PA. Rajiv Mallick and Girishanthy Krishnarajah are employees and shareholders of CSL Behring. CSL Behring provided support in the form of salaries for authors RM and GK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Victoria Divino and Mitch DeKoven are employees of IQVIA. IQVIA provided support in the form of salaries for authors VD and MD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen JA, 2015, NEUROLOGY, V85, P498, DOI 10.1212/WNL.0000000000001833; Bostick GP, 2015, PAIN MED, V16, P1361, DOI 10.1111/pme.12702; Bouchard C, 1999, NEUROLOGY, V52, P498, DOI 10.1212/WNL.52.3.498; Centers for Disease Control and Prevention, GUID PRESCR OP CHRON; Cigna, 2017, CIGN DRUG BIOL COV P; CORNBLATH DR, 1991, NEUROLOGY, V41, P617; Gorson KC, 2015, NEUROLOGY, V85, P488, DOI 10.1212/WNL.0000000000001838; Gorson KC, 2012, THER ADV NEUROL DISO, V5, P359, DOI 10.1177/1756285612457215; Guptill JT, 2014, MUSCLE NERVE, V50, P47, DOI 10.1002/mus.24109; Koller H, 2005, NEW ENGL J MED, V352, P1343, DOI 10.1056/nejmra041347; Laughlin RS, 2009, NEUROLOGY, V73, P39, DOI 10.1212/WNL.0b013e3181aaea47; Le Masson G, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.923; Luthra R., 2014, AM J PHARM BENEFIST, V6, pE41; Mahdi-Rogers M, 2014, EUR J NEUROL, V21, P34, DOI 10.1111/ene.12245; McNicol ED, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006146.pub2; Merkies ISJ, 2016, EUR NEUROL, V75, P199, DOI 10.1159/000445347; Patwa HS, 2012, NEUROLOGY, V78, P1009, DOI 10.1212/WNL.0b013e31824de293; United Healthcare, 2017, IMM GLOB IVIG SCIG; Van den Bergh PYK, 2010, EUR J NEUROL, V17, P356, DOI 10.1111/j.1468-1331.2009.02930.x	19	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206205	10.1371/journal.pone.0206205	http://dx.doi.org/10.1371/journal.pone.0206205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352101	Green Published, Green Submitted, gold			2022-12-26	WOS:000448076200038
J	Kim, J; Pyo, S; Yoon, DW; Lee, S; Lim, JY; Heo, JS; Lee, S; Shin, C				Kim, Jinkwan; Pyo, Sangshin; Yoon, Dae Wui; Lee, Seungkwan; Lim, Ja-Yun; Heo, June Seok; Lee, Seungku; Shin, Chol			The co-existence of elevated high sensitivity C-reactive protein and homocysteine levels is associated with increased risk of metabolic syndrome: A 6-year follow-up study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; INFLAMMATION; INTERLEUKIN-6; METAANALYSIS; INSULIN; MARKER	Accumulating evidence has revealed that both high sensitivity C-reactive protein (hsCRP) and homocysteine (HCY) are associated with increased risk of metabolic syndrome (MetS) and cardiovascular disease. However, it is unclear whether the coexistence of these conditions accelerates the risk of metabolic syndrome (MetS). We hypothesized that the combination of high sensitivity C-reactive protein (hsCRP) and homocysteine (HCY) levels could exacerbate the development of MetS in a large prospective cohort study. We selected data from 3,170 individuals (1,614 men and 1,556 women) who participated in the Korean Genome and Epidemiology Study. Participants with high hsCRP and HCY levels were categorized into quartiles. MetS was defined based on the criteria of the modified National Cholesterol Education Program, Adult Treatment Panel III. The prevalence of MetS was higher in participants with concurrent high hsCRP and HCY compared to those with low hsCRP and HCY levels. The incidence of MetS at the 6-year follow-up was the highest in participants with concomitant high hsCRP and HCY levels, regardless of obesity. Even after adjusting for potential confounding factors including body mass index in a multivariate logistic regression model, subjects with elevated hsCRP and HCY levels had a 2.50-fold increased risk of developing MetS at the six-year follow-up compared to those who did not have high hsCRP and HCY level. MetS is more prevalent in the concurrent presence of elevated hsCRP and HCY levels. The combination of the two conditions may contribute to an increased risk of MetS, but these factors may not be synergistic.	[Kim, Jinkwan] Jungwon Univ, Coll Hlth Sci, Dept Biomed Lab Sci, Geo San, South Korea; [Pyo, Sangshin; Lee, Seungkwan; Lim, Ja-Yun; Heo, June Seok] Korea Univ, Coll Hlth Sci, Dept Integrated Biomed & Life Sci, Seoul, South Korea; [Yoon, Dae Wui; Lee, Seungku; Shin, Chol] Korea Univ, Ansan Hosp, Inst Human Genom Study, Ansan, South Korea; [Shin, Chol] Korea Univ, Dept Internal Med, Div Pulm & Critical Care Med, Ansan Hosp, Ansan, South Korea	Jungwon University; Korea University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Shin, C (corresponding author), Korea Univ, Ansan Hosp, Inst Human Genom Study, Ansan, South Korea.; Shin, C (corresponding author), Korea Univ, Dept Internal Med, Div Pulm & Critical Care Med, Ansan Hosp, Ansan, South Korea.	chol-shin@korea.ac.kr	Lee, SeungKu/GSN-5012-2022	Lee, SeungKu/0000-0001-5120-5557; shin, chol/0000-0002-2928-8576	Korea Centers for Disease Control and Prevention [2007-E71001-00, 2008-E71001-00, 2009-E71002-00, 2010-E71001-00, 2011-E71004-00, 2012-E71005-00, 2013-E71005-00, 2014-E71003-00]	Korea Centers for Disease Control and Prevention	This research was supported by a fund (Grant 2007-E71001-00, 2008-E71001-00, 2009-E71002-00, 2010-E71001-00, 2011-E71004-00, 2012-E71005-00, 2013-E71005-00, 2014-E71003-00) from the Korea Centers for Disease Control and Prevention.	Al Rifai M, 2015, ATHEROSCLEROSIS, V239, P629, DOI 10.1016/j.atherosclerosis.2015.02.011; Alexander DD, 2013, J AM COLL NUTR, V32, P339, DOI 10.1080/07315724.2013.839909; Bjorck J, 2006, METABOLISM, V55, P1007, DOI 10.1016/j.metabol.2006.03.010; Bray GA, 2006, ENDOCRINE, V29, P109, DOI 10.1385/ENDO:29:1:109; Brooks GC, 2010, AM J CARDIOL, V106, P56, DOI 10.1016/j.amjcard.2010.02.017; Choi J, 2013, OBES REV, V14, P232, DOI 10.1111/obr.12003; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Devaraj S, 2013, CLIN CHEM, V59, P617, DOI 10.1373/clinchem.2012.187617; Devaraj S, 2009, CURR OPIN LIPIDOL, V20, P182, DOI 10.1097/MOL.0b013e32832ac03e; Ferreira I, 2005, ARCH INTERN MED, V165, P42, DOI 10.1001/archinte.165.1.42; Francisco G, 2006, CLIN CHIM ACTA, V369, P1, DOI 10.1016/j.cca.2005.12.027; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Hannibal L, 2017, MOL ASPECTS MED, V53, P36, DOI 10.1016/j.mam.2016.11.003; Jean-Louis G, 2009, Minerva Pneumol, V48, P277; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kim JA, 2006, J KOREAN MED SCI, V21, P1048, DOI 10.3346/jkms.2006.21.6.1048; Kim Y, 2017, INT J EPIDEMIOL, V46, P1350, DOI 10.1093/ije/dyx105; Kumar A, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0233-z; Lentz SR, 2004, CLEV CLIN J MED, V71, P729, DOI 10.3949/ccjm.71.9.729; Mangoni AA, 2002, AM J MED, V112, P556, DOI 10.1016/S0002-9343(02)01021-5; Markanday A, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv098; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Murakami S, 2017, LIFE SCI, V186, P80, DOI 10.1016/j.lfs.2017.08.008; Nabipour I, 2009, J ENDOCRINOL INVEST, V32, P406, DOI 10.1007/BF03346476; Nakamura H, 2008, DIABETES RES CLIN PR, V79, P330, DOI 10.1016/j.diabres.2007.09.004; Nishida K, 2017, CARDIOVASC RES, V113, P389, DOI 10.1093/cvr/cvx012; Oron-Herman M, 2003, METABOLISM, V52, P1491, DOI 10.1016/S0026-0495(03)00262-2; Park HS, 2005, DIABETES RES CLIN PR, V69, P29, DOI 10.1016/j.diabres.2004.11.007; Ridker PM, 2016, J AM COLL CARDIOL, V67, P712, DOI 10.1016/j.jacc.2015.11.037; Ridker PM, 2004, CIRCULATION, V109, P2818, DOI 10.1161/01.CIR.0000132467.45278.59; Rifai N, 2005, CLIN CHEM, V51, P504, DOI 10.1373/clinchem.2004.044990; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Song YQ, 2009, DIABETES, V58, P1921, DOI 10.2337/db09-0087; Sreckovic B, 2017, DIABETES METAB SYND, V11, P179, DOI 10.1016/j.dsx.2016.08.026; Timpson NJ, 2005, LANCET, V366, P1954, DOI 10.1016/S0140-6736(05)67786-0; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wang XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113148; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zampetaki A, 2012, CIRC RES, V110, P508, DOI 10.1161/CIRCRESAHA.111.247445	43	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206157	10.1371/journal.pone.0206157	http://dx.doi.org/10.1371/journal.pone.0206157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352089	gold, Green Published, Green Submitted			2022-12-26	WOS:000448076200031
J	Tanihara, F; Hirata, M; Nguyen, NT; Le, QA; Hirano, T; Takemoto, T; Nakai, M; Fuchimoto, D; Otoi, T				Tanihara, Fuminori; Hirata, Maki; Nhien Thi Nguyen; Quynh Anh Le; Hirano, Takayuki; Takemoto, Tatsuya; Nakai, Michiko; Fuchimoto, Dai-ichiro; Otoi, Takeshige			Generation of a TP53-modified porcine cancer model by CRISPR/Cas9-mediated gene modification in porcine zygotes via electroporation	PLOS ONE			English	Article							PIG; TUMORIGENESIS; XENOGRAFT	TP53 (which encodes p53) is one of the most frequently mutated genes in cancers. In this study, we generated TP53-mutant pigs by gene editing via electroporation of the Cas9 protein (GEEP), a process that involves introducing the Cas9 protein and single-guide RNA (sgRNA) targeting exon 3 and intron 4 of TP53 into in vitro-fertilized zygotes. Zygotes modified by the sgRNAs were transferred to recipients, two of which gave birth to a total of 11 piglets. Of those 11 piglets, 9 survived. Molecular genetic analysis confirmed that 6 of 9 live piglets carried mutations in TP53, including 2 piglets with no wild-type (WT) sequences and 4 genetically mosaic piglets with WT sequences. One mosaic piglet had 142 and 151 bp deletions caused by a combination of the two sgRNAs. These piglets were continually monitored for 16 months and three of the genome-edited pigs (50%) exhibited various tumor phenotypes that we presumed were caused by TP53 mutations. Two mutant pigs with no WT sequences developed mandibular osteosarcoma and nephroblastoma. The mosaic pig with a deletion between targeting sites of two sgRNAs exhibited malignant fibrous histiocytoma. Tumor phenotypes of TP53 mosaic mutant pigs have not been previously reported. Our results indicated that the mutations caused by gene editing successfully induced tumor phenotypes in both TP53 mosaic- and bi-allelic mutant pigs.	[Tanihara, Fuminori; Hirata, Maki; Nhien Thi Nguyen; Quynh Anh Le; Hirano, Takayuki; Otoi, Takeshige] Tokushima Univ, Fac Biosci & Bioind, Lab Anim Reprod, Tokushima, Japan; [Takemoto, Tatsuya] Tokushima Univ, Inst Adv Med Sci, Div Embryol, Tokushima, Japan; [Nakai, Michiko; Fuchimoto, Dai-ichiro] Natl Agr & Food Res Org NARO, Div Anim Sci, Anim Biotechnol Unit, Inst Agrobiol Sci, Ibaraki, Japan	Tokushima University; Tokushima University; National Agriculture & Food Research Organization - Japan	Tanihara, F (corresponding author), Tokushima Univ, Fac Biosci & Bioind, Lab Anim Reprod, Tokushima, Japan.	tanihara@tokushima-u.ac.jp	Le, Anh Quynh/CAG-5710-2022		"Funds for the Development of Human Resources in Science and Technology" under MEXT, through the "Home for Innovative Researchers and Academic Knowledge Users (HIRAKU)" consortium; JSPS KAKENHI [JP17H03938, JP17K19325]; SATREPS (Science and Technology Research Partnership for Sustainable Development)	"Funds for the Development of Human Resources in Science and Technology" under MEXT, through the "Home for Innovative Researchers and Academic Knowledge Users (HIRAKU)" consortium; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SATREPS (Science and Technology Research Partnership for Sustainable Development)	This study was supported in part by "Funds for the Development of Human Resources in Science and Technology" under MEXT, through the "Home for Innovative Researchers and Academic Knowledge Users (HIRAKU)" consortium (to F.T.), JSPS KAKENHI Grant Numbers JP17H03938 and JP17K19325 (to T.O. and F.T.), and as a research project funded by SATREPS (Science and Technology Research Partnership for Sustainable Development) (to. T.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam SJ, 2007, ONCOGENE, V26, P1038, DOI 10.1038/sj.onc.1209892; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Fan NN, 2013, J GENET GENOMICS, V40, P67, DOI 10.1016/j.jgg.2012.07.014; Flisikowska T, 2014, J APPL GENET, V55, P53, DOI 10.1007/s13353-013-0182-9; Flisikowska T, 2013, TRANSGENIC RES, V22, P673, DOI 10.1007/s11248-013-9720-9; Flisikowska T, 2012, GASTROENTEROLOGY, V143, P1173, DOI 10.1053/j.gastro.2012.07.110; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Hansen K, 2012, JOVE-J VIS EXP, DOI 10.3791/3304; Hidalgo J, 2005, UROLOGY, V65, P872, DOI 10.1016/j.urology.2004.12.002; Do LTK, 2015, REPROD BIOL, V15, P86, DOI 10.1016/j.repbio.2015.01.002; Leuchs S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043323; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li X, 2006, CARDIOVASC INTER RAD, V29, P420, DOI 10.1007/s00270-005-0099-8; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Luo YL, 2012, J INHERIT METAB DIS, V35, P695, DOI 10.1007/s10545-012-9475-0; Luo YL, 2012, TRANSGENIC RES, V21, P671, DOI 10.1007/s11248-011-9563-1; Luo YL, 2011, TRANSGENIC RES, V20, P975, DOI 10.1007/s11248-010-9472-8; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malkin D, 2011, CANCER, V2, P475, DOI [10.1177/1947601911413466, DOI 10.1177/1947601911413466]; McCalla-Martin AC, 2010, TRANSGENIC RES, V19, P869, DOI 10.1007/s11248-010-9362-0; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Reymond MA, 2000, EUR J SURG ONCOL, V26, P393, DOI 10.1053/ejso.1999.0905; Saalfrank A, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.19; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; SANDISON AT, 1968, CANCER, V21, P727, DOI 10.1002/1097-0142(196804)21:4&lt;727::AID-CNCR2820210426&gt;3.0.CO;2-3; Schook LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128864; Selek L, 2014, J NEUROSCI METH, V221, P159, DOI 10.1016/j.jneumeth.2013.10.002; Shen YF, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1327-0; Sieren JC, 2014, J CLIN INVEST, V124, P4052, DOI 10.1172/JCI75447; Tan WF, 2016, TRANSGENIC RES, V25, P273, DOI 10.1007/s11248-016-9932-x; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tanihara F, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600803; TANIMOTO T, 1988, VET PATHOL, V25, P330, DOI 10.1177/030098588802500418; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Williamson MM, 2006, AUST VET J, V84, P202, DOI 10.1111/j.1751-0813.2006.tb12799.x	37	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206360	10.1371/journal.pone.0206360	http://dx.doi.org/10.1371/journal.pone.0206360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352075	Green Published, Green Submitted, gold			2022-12-26	WOS:000448076200048
J	Wagner, S; Vlachogiannis, G; Brandon, AD; Valenti, M; Box, G; Jenkins, L; Mancusi, C; Self, A; Manodoro, F; Assiotis, I; Robinson, P; Chauhan, R; Rust, AG; Matthews, N; Eason, K; Khan, K; Starling, N; Cunningham, D; Sadanandam, A; Isacke, CM; Kirkin, V; Valeri, N; Whittaker, SR				Wagner, Steve; Vlachogiannis, Georgios; Brandon, Alexis De Haven; Valenti, Melanie; Box, Gary; Jenkins, Liam; Mancusi, Caterina; Self, Annette; Manodoro, Floriana; Assiotis, Ioannis; Robinson, Penny; Chauhan, Ritika; Rust, Alistair G.; Matthews, Nik; Eason, Kate; Khan, Khurum; Starling, Naureen; Cunningham, David; Sadanandam, Anguraj; Isacke, Clare M.; Kirkin, Vladimir; Valeri, Nicola; Whittaker, Steven R.			Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer	ONCOGENE			English	Article							NF-KAPPA-B; INTRINSIC RESISTANCE; PLUS IRINOTECAN; DOSE-ESCALATION; INFLAMMATION; DRIVEN; COLON; FLUOROURACIL; ACTIVATION; LEUCOVORIN	Despite showing clinical activity in BRAF-mutant melanoma, the MEK inhibitor (MEKi) trametinib has failed to show clinical benefit in KRAS-mutant colorectal cancer. To identify mechanisms of resistance to MEKi, we employed a pharmacogenomic analysis of MEKi-sensitive versus MEKi-resistant colorectal cancer cell lines. Strikingly, interferon- and inflammatory-related gene sets were enriched in cell lines exhibiting intrinsic and acquired resistance to MEK inhibition. The bromodomain inhibitor JQ1 suppressed interferon-stimulated gene (ISG) expression and in combination with MEK inhibitors displayed synergistic effects and induced apoptosis in MEKi-resistant colorectal cancer cell lines. ISG expression was confirmed in patient-derived organoid models, which displayed resistance to trametinib and were resensitized by JQ1 co-treatment. In in vivo models of colorectal cancer, combination treatment significantly suppressed tumor growth. Our findings provide a novel explanation for the limited response to MEK inhibitors in KRAS-mutant colorectal cancer, known for its inflammatory nature. Moreover, the high expression of ISGs was associated with significantly reduced survival of colorectal cancer patients. Excitingly, we have identified novel therapeutic opportunities to overcome intrinsic and acquired resistance to MEK inhibition in colorectal cancer.	[Wagner, Steve; Brandon, Alexis De Haven; Valenti, Melanie; Box, Gary; Mancusi, Caterina; Self, Annette; Kirkin, Vladimir; Whittaker, Steven R.] Inst Canc Res, Div Canc Therapeut, London, England; [Vlachogiannis, Georgios; Eason, Kate; Sadanandam, Anguraj; Valeri, Nicola] Inst Canc Res, Div Mol Pathol, London, England; [Jenkins, Liam; Isacke, Clare M.] Inst Canc Res, Breast Canc Now Res Ctr, London, England; [Manodoro, Floriana; Assiotis, Ioannis; Robinson, Penny; Chauhan, Ritika; Rust, Alistair G.; Matthews, Nik] Inst Canc Res, Tumour Profiling Unit, London, England; [Khan, Khurum; Starling, Naureen; Cunningham, David; Valeri, Nicola] Royal Marsden NHS Fdn Trust, Dept Med, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Whittaker, SR (corresponding author), Inst Canc Res, Div Canc Therapeut, London, England.	steven.whittaker@icr.ac.uk	Whittaker, Steven/AAS-9874-2020	Rust, Alistair/0000-0001-7287-192X; Sadanandam, Anguraj/0000-0001-8485-5150; valeri, nicola/0000-0002-5426-5683; Starling, Naureen/0000-0002-1496-6792; Eason, Katherine/0000-0001-6903-9067; Cunningham, David/0000-0001-5158-1069; Kirkin, Vladimir/0000-0002-8049-3663; Isacke, Clare/0000-0002-9222-3345; Whittaker, Steven/0000-0001-9062-7947; Jenkins, Liam/0000-0002-0560-0182	Institute of Cancer Research start-up funds; Cancer Research UK (Cancer Research UK) [C2739/A22897]; Biotechnology and Biological Sciences Research Council (BBSRC CASE Studentship) [1650206]; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at the Royal Marsden NHS Foundation Trust; Institute of Cancer Research [A62, A100, A101, A159]; Cancer Research UK [CEA A18052]; European Union FP7 [CIG 334261]; NIHR BRC at the Royal Marsden NHS Foundation Trust; BBSRC [1650206] Funding Source: UKRI	Institute of Cancer Research start-up funds; Cancer Research UK (Cancer Research UK); Biotechnology and Biological Sciences Research Council (BBSRC CASE Studentship)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at the Royal Marsden NHS Foundation Trust; Institute of Cancer Research; Cancer Research UK(Cancer Research UK); European Union FP7(European Commission); NIHR BRC at the Royal Marsden NHS Foundation Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work has been funded by the Institute of Cancer Research start-up funds (to SRW), Cancer Research UK (Cancer Research UK grant number C2739/A22897 to VK, Cancer Research UK Cancer Therapeutics Unit), Biotechnology and Biological Sciences Research Council (BBSRC CASE Studentship 1650206 to LJ and CMI), by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at the Royal Marsden NHS Foundation Trust, and the Institute of Cancer Research (grant numbers A62, A100, A101, A159), Cancer Research UK (grant number CEA A18052) and the European Union FP7 (grant number CIG 334261) to NV. KE, AS, KK, NS, and DC acknowledge support from the NIHR BRC at the Royal Marsden NHS Foundation Trust, and the Institute of Cancer Research.	Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Ancrile BB, 2008, MOL INTERV, V8, P22, DOI 10.1124/mi.8.1.6; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Berthon C, 2016, LANCET HAEMATOL, V3, pE186, DOI 10.1016/S2352-3026(15)00247-1; Boutin AT, 2017, GENE DEV, V31, P370, DOI 10.1101/gad.293449.116; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105; De Raedt T, 2014, NATURE, V514, P247, DOI 10.1038/nature13561; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gelfo V, 2016, ONCOTARGET, V7, P72167, DOI 10.18632/oncotarget.12354; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Golay HG, 2014, EXPERT REV ANTICANC, V14, P869, DOI 10.1586/14737140.2014.928596; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hickish T, 2017, LANCET ONCOL, V18, P192, DOI 10.1016/S1470-2045(17)30006-2; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Infante JR, 2012, LANCET ONCOL, V13, P773, DOI 10.1016/S1470-2045(12)70270-X; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; KNIGHT DM, 1993, MOL IMMUNOL, V30, P1443, DOI 10.1016/0161-5890(93)90106-L; Lewin J, 2018, J CLIN ONCOL, V36, P3007, DOI 10.1200/JCO.2018.78.2292; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Ma YF, 2017, CLIN CANCER RES, V23, P2027, DOI 10.1158/1078-0432.CCR-16-0453; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NAGARKATTI M, 1990, J IMMUNOL, V144, P4898; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Romano M, 2016, ANTICANCER RES, V36, P1447; Roumeliotis TI, 2017, CELL REP, V20, P2201, DOI 10.1016/j.celrep.2017.08.010; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Shouval DS, 2016, GASTROENTEROLOGY, V151, P1100, DOI 10.1053/j.gastro.2016.08.055; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Vlachogiannis G, 2018, SCIENCE, V359, P920, DOI 10.1126/science.aao2774; Whittaker SR, 2004, CANCER RES, V64, P262, DOI 10.1158/0008-5472.CAN-03-0110; Whittaker SR, 2013, CANCER DISCOV, V3, P350, DOI 10.1158/2159-8290.CD-12-0470; Wislez M, 2006, CANCER RES, V66, P4198, DOI 10.1158/0008-5472.CAN-05-3842; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zawistowski JS, 2017, CANCER DISCOV, V7, P302, DOI 10.1158/2159-8290.CD-16-0653; Zou Z, 2014, ONCOGENE, V33, P2395, DOI 10.1038/onc.2013.179	53	22	22	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2019	38	10					1717	1733		10.1038/s41388-018-0554-z	http://dx.doi.org/10.1038/s41388-018-0554-z			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN8DD	30353166	Green Published, hybrid			2022-12-26	WOS:000460423800011
J	Roberts, JT; Barb, AW				Roberts, Jacob T.; Barb, Adam W.			A single amino acid distorts the Fc receptor IIIb/CD16b structure upon binding immunoglobulin G1 and reduces affinity relative to CD16a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-linked glycosylation; posttranslational modification (PTM); X-ray crystallography; protein-protein interaction; IgG; molecular dynamics; monoclonal antibody; fragment crystallizable region; immunity	NATURAL-KILLER-CELLS; DEPENDENT CELLULAR CYTOTOXICITY; N-LINKED OLIGOSACCHARIDE; GAMMA-RIIIA; THERAPEUTIC ANTIBODIES; POLYMORPHISM INFLUENCES; IGG; EXPRESSION; FUCOSE; COMPLEX	Therapeutic mAbs engage Fc receptor III (CD16) to elicit a protective cell-mediated response and destroy the target tissue. Newer drugs designed to bind CD16a with increased affinity surprisingly also elicit protective CD16b-mediated responses. However, it is unclear why IgG binds CD16a with more than 10-fold higher affinity than CD16b even though these receptors share more than 97% identity. Here we identified one residue, Gly-129, that contributes to the greater IgG binding affinity of CD16a. The CD16b variant D129G bound IgG1 Fc with 2-fold higher affinity than CD16a and with 90-fold higher affinity than the WT. Conversely, the binding affinity of CD16a-G129D was decreased 128-fold relative to WT CD16a and comparably to that of WT CD16b. The interaction of IgG1 Fc with CD16a, but not with CD16b, is known to be sensitive to the composition of the asparagine-linked carbohydrates (N-glycans) attached to the receptor. CD16a and CD16b-D129G displaying minimally processed oligomannose N-glycans bound to IgG1 Fc with about 5.2-fold increased affinity compared with variants with highly processed complex-type N-glycans. CD16b and the CD16a-G129D variant exhibited a smaller 1.9-fold affinity increase with oligomannose N-glycans. A model of glycosylated CD16b bound to IgG1 Fc determined to 2.2 resolution combined with a 250-ns all-atom molecular dynamics simulation showed that the larger Asp-129 residue deformed the Fc-binding surface. These results reveal how Asp-129 in CD16b affects its binding affinity for IgG1 Fc and suggest that antibodies engineered to engage CD16b with high affinity must accommodate the Asp-129 side chain.	[Roberts, Jacob T.; Barb, Adam W.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, 4210 Mol Biol Bldg, Ames, IA 50011 USA	Iowa State University	Barb, AW (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, 4210 Mol Biol Bldg, Ames, IA 50011 USA.	abarb@iastate.edu		Barb, Adam/0000-0003-3290-8649	NIGMS, National Institutes of Health [R01 GM115489]; Roy J. Carver Department of Biochemistry, Biophysics, and Molecular Biology at Iowa State University; Department of Energy [GUP-48455]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115489] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Roy J. Carver Department of Biochemistry, Biophysics, and Molecular Biology at Iowa State University; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health under Award R01 GM115489, the Roy J. Carver Department of Biochemistry, Biophysics, and Molecular Biology at Iowa State University, and by the Department of Energy for synchrotron time at the Argonne National Laboratory Advanced Photon Source (GUP-48455). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the Department of Energy.	Barb AW, 2012, BIOCHEMISTRY-US, V51, P4618, DOI 10.1021/bi300319q; Battella S, 2016, J LEUKOCYTE BIOL, V99, P87, DOI 10.1189/jlb.5VMR0415-141R; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; CLARKSON SB, 1988, J EXP MED, V167, P408, DOI 10.1084/jem.167.2.408; Congy-Jolivet N, 2008, CANCER RES, V68, P976, DOI 10.1158/0008-5472.CAN-07-6523; Davoine F, 2002, J ALLERGY CLIN IMMUN, V109, P463, DOI 10.1067/mai.2002.121952; deHaas M, 1996, J IMMUNOL, V156, P2948; Dekkers G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00877; Edberg JC, 1997, J IMMUNOL, V159, P3849; EDBERG JC, 1990, J IMMUNOL, V144, P4729; Falconer DJ, 2018, ACS CHEM BIOL, V13, P2179, DOI 10.1021/acschembio.8b00342; Ferrara C, 2006, J BIOL CHEM, V281, P5032, DOI 10.1074/jbc.M510171200; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Golay J, 2013, BLOOD, V122, P3482, DOI 10.1182/blood-2013-05-504043; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Hayes JM, 2017, MOL CELL PROTEOMICS, V16, P1770, DOI 10.1074/mcp.M117.066944; Hayes JM, 2014, CURR TOP MICROBIOL, V382, P165, DOI 10.1007/978-3-319-07911-0_8; KIMBERLY RP, 1989, J IMMUNOL, V142, P3923; Koene HR, 1997, BLOOD, V90, P1109, DOI 10.1182/blood.V90.3.1109.1109_1109_1114; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; Meknache N, 2009, J IMMUNOL, V182, P2542, DOI 10.4049/jimmunol.0801665; Mellor JD, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-1; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; NAGLER A, 1989, J IMMUNOL, V143, P3183; Natsume A, 2006, J BIOCHEM, V140, P359, DOI 10.1093/jb/mvj157; Niwa R, 2005, CLIN CANCER RES, V11, P2327, DOI 10.1158/1078-0432.CCR-04-2263; Oboshi W, 2016, HUM IMMUNOL, V77, P165, DOI 10.1016/j.humimm.2015.11.001; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Patel KR, 2018, J BIOL CHEM, V293, P3477, DOI 10.1074/jbc.RA117.001207; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; RAVETCH JV, 1989, J EXP MED, V170, P481, DOI 10.1084/jem.170.2.481; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Reusch D, 2015, GLYCOBIOLOGY, V25, P1325, DOI 10.1093/glycob/cwv065; Robinson JI, 2018, P NATL ACAD SCI USA, V115, pE72, DOI 10.1073/pnas.1707856115; SALMON JE, 1992, J CLIN INVEST, V89, P1274, DOI 10.1172/JCI115712; Shibata-Koyama M, 2009, GLYCOBIOLOGY, V19, P126, DOI 10.1093/glycob/cwn110; Shibata-Koyama M, 2009, EXP HEMATOL, V37, P309, DOI 10.1016/j.exphem.2008.11.006; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; STANLEY P, 1975, P NATL ACAD SCI USA, V72, P3323, DOI 10.1073/pnas.72.9.3323; Subedi GP, 2018, J BIOL CHEM, V293, P16842, DOI 10.1074/jbc.RA118.004998; Subedi GP, 2016, MABS-AUSTIN, V8, P1512, DOI 10.1080/19420862.2016.1218586; Subedi GP, 2014, STRUCTURE, V22, P1478, DOI 10.1016/j.str.2014.08.002; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Thomann M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134949; Yagi H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21145-y	49	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19899	19908		10.1074/jbc.RA118.005273	http://dx.doi.org/10.1074/jbc.RA118.005273			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30361439	Green Published, hybrid			2022-12-26	WOS:000454294900033
J	Babic, NC; Ropert, T; Musil, B				Babic, Nenad Cus; Ropert, Tadevz; Musil, Bojan			Revealing faces: Gender and cultural differences in facial prominence of selfies	PLOS ONE			English	Article							ISM; BEHAVIORS; WOMEN	An international sample of 2754 selfies uploaded to Instagram that form part of the Selfiecity (www.selfiecity.net) research project (selfies originating from Bangkok, Berlin, London, Moscow, New York, and Sao Paolo) were examined to assess the existence of facial prominence differences in depictions of males and females and the variability of facial prominence among cultures. Results show that gender stereotypical bias resulting in greater facial prominence in depictions of men is present in selfies. The control of image creation and selection for publication by the persons presented in the images do not diminish this gender based bias. Also, when gender is controlled, significant differences exist in facial prominence among different cultures. Comparisons with various socio-cultural indicators indicate possible correlations of gender stereotypical bias to self-expression values, freedom of choice, people's influence on government's decisions, protection of freedom of speech and people's influence on issues in the professional and communal environment. This research does not find a correlation of gender based bias in selfies with gender equality or inequality measures among cultures.	[Babic, Nenad Cus; Ropert, Tadevz; Musil, Bojan] Univ Maribor, Fac Arts, Maribor, Slovenia	University of Maribor	Babic, NC (corresponding author), Univ Maribor, Fac Arts, Maribor, Slovenia.	nenad.babic@um.si		Cus Babic, Nenad/0000-0002-3580-2068				[Anonymous], 2015, HUM DEV REP 2015; ARCHER D, 1983, J PERS SOC PSYCHOL, V45, P725, DOI 10.1037/0022-3514.45.4.725; Bruno N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124999; Bruno N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055141; Cheek NN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153592; Doring N, 2016, COMPUT HUM BEHAV, V55, P955, DOI 10.1016/j.chb.2015.10.001; Duggan M., 2015, MOBILE MESSAGING SOC, DOI [10.1080/17475759.2012.728771, DOI 10.1080/17475759.2012.728771]; Fox J, 2015, PERS INDIV DIFFER, V76, P161, DOI 10.1016/j.paid.2014.12.017; Frosh P, 2015, INT J COMMUN-US, V9, P1607; Hofstede G., 2001, CULTURES CONSEQUENCE; Huang CM, 2013, INT J PSYCHOL, V48, P334, DOI 10.1080/00207594.2011.649285; Konrath S, 2012, PSYCHOL WOMEN QUART, V36, P476, DOI 10.1177/0361684312455317; Levesque MJ, 1999, SEX ROLES, V41, P241, DOI 10.1023/A:1018806329197; Manovich L, 2015, POSTDIGITAL AESTHETI; Matthes J, 2016, SEX ROLES, V75, P314, DOI 10.1007/s11199-016-0617-y; Matthews JL, 2007, SEX ROLES, V57, P515, DOI 10.1007/s11199-007-9276-3; McLaughlin TL, 1999, SEX ROLES, V40, P61, DOI 10.1023/A:1018878317017; Musil B, 2017, FRONT PSYCHOL, V8, DOI [10.3389/fpsyg.2017.00082/full, DOI 10.3389/FPSYG.2017.00082/FULL]; NIGRO GN, 1988, PSYCHOL WOMEN QUART, V12, P225, DOI 10.1111/j.1471-6402.1988.tb00938.x; Prieler M., 2016, ASIAN PERSPECTIVES D, P52; Prieler M, 2014, SEX ROLES; Qiu L, 2015, COMPUT HUM BEHAV, V52, P443, DOI 10.1016/j.chb.2015.06.032; Rose J, 2012, COMMUN Q, V60, P588, DOI 10.1080/01463373.2012.725005; SCHWARZ N, 1989, EUR J SOC PSYCHOL, V19, P311, DOI 10.1002/ejsp.2420190405; Smith L.R., 2012, J INTERCULTURAL COMM, V41, P279, DOI DOI 10.1080/17475759.2012.728771; Sorokowski P, 2015, PERS INDIV DIFFER, V85, P123, DOI 10.1016/j.paid.2015.05.004; Szillis U, 2007, INT J INTERNET SCI, V2, P3; Tailor P., 2014, MORE HALF MILLENNIAL; Welzel C, 2013, FREEDOM RISING: HUMAN EMPOWERMENT AND THE QUEST FOR EMANCIPATION, P1; World Values Survey Association, 2014, WORLD VAL SURV WAV 6; ZUCKERMAN M, 1986, J NONVERBAL BEHAV, V10, P215, DOI 10.1007/BF00987481; ZUCKERMAN M, 1994, J PERS SOC PSYCHOL, V66, P86, DOI 10.1037/0022-3514.66.1.86	32	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205893	10.1371/journal.pone.0205893	http://dx.doi.org/10.1371/journal.pone.0205893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY7VH	30379895	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700079
J	Bouallegui, Y; Ben Younes, R; Oueslati, R; Sheehan, D				Bouallegui, Younes; Ben Younes, Ridha; Oueslati, Ridha; Sheehan, David			Redox proteomic insights into involvement of clathrin-mediated endocytosis in silver nanoparticles toxicity to Mytilus galloprovincialis	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; INDUCED OXIDATIVE STRESS; VON-WILLEBRAND-FACTOR; HEAT-SHOCK PROTEINS; DIGESTIVE GLAND; ENDOPLASMIC-RETICULUM; AQUATIC ANIMALS; UPTAKE PATHWAYS; DRUG-DELIVERY; EXPOSURE TIME	Clathrin-mediated endocytosis is a major mode of nanoparticle (NP) internalization into cells. However, influence of internalization routes on nanoparticle toxicity is poorly understood. Here, we assess the impact of blocking clathrin-mediated endocytosis upon silver NP (AgNP) toxicity to gills and digestive glands of the mussel Mytilusgalloprovincialis using the uptake inhibitor, amantadine. Animals were exposed for 12h to AgNP (< 50 nm) in the presence and absence of amantadine. Labeling of oxidative protein modifications, either thiol oxidation, carbonyl formation or both in two-dimensional electrophoresis separations revealed 16 differentially affected abundance spots. Amongst these, twelve hypothetical proteins were successfully identified by peptide mass fingerprinting (MALDI TOF-MS/MS). The proteins identified are involved in buffering redox status or in cytoprotection. We conclude that blockade of clathrin-mediated endocytosis protected against NP toxicity, suggesting this uptake pathway facilitates toxicity. Lysosomal degradation and autophagy are major mechanisms that might be induced to mitigate NP toxicity.	[Bouallegui, Younes; Ben Younes, Ridha; Oueslati, Ridha] Univ Carthage, Sci Fac Bizerte, Res Unit Immunomicrobiol Environm & Carcinogensis, Bizerte, Tunisia; [Sheehan, David] Univ Coll Cork, Sch Biochem & Cell Biol, Prote Res Grp, Cork, Ireland; [Sheehan, David] Khalifa Univ Sci & Technol, Dept Chem, Abu Dhabi, U Arab Emirates	Universite de Carthage; University College Cork; Khalifa University of Science & Technology	Bouallegui, Y (corresponding author), Univ Carthage, Sci Fac Bizerte, Res Unit Immunomicrobiol Environm & Carcinogensis, Bizerte, Tunisia.; Sheehan, D (corresponding author), Univ Coll Cork, Sch Biochem & Cell Biol, Prote Res Grp, Cork, Ireland.; Sheehan, D (corresponding author), Khalifa Univ Sci & Technol, Dept Chem, Abu Dhabi, U Arab Emirates.	bouallegui_younes@outlook.com; david.sheehan@ku.ac.ae	Sheehan, David/ABB-5315-2020; YOUNES, Ridha BEN/G-7349-2016; Bouallagui, Younes/I-6562-2019	Bouallagui, Younes/0000-0001-8410-0671; Ben Younes, Ridha/0000-0002-0641-5640				Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; Barmo C, 2013, AQUAT TOXICOL, V132, P9, DOI 10.1016/j.aquatox.2013.01.014; Baty JW, 2005, BIOCHEM J, V389, P785, DOI 10.1042/BJ20050337; Bouallegui Y, 2018, BIOMARKERS, V23, P277, DOI [10.1080/1354750x.2017.1409803, 10.1080/1354750X.2017.1409803]; Bouallegui Y, 2018, DRUG CHEM TOXICOL, V41, P169, DOI 10.1080/01480545.2017.1329317; Bouallegui Y, 2017, TOXICOL MECH METHOD, V27, P582, DOI 10.1080/15376516.2017.1337258; Bouallegui Y, 2017, J IMMUNOTOXICOL, V14, P116, DOI 10.1080/1547691X.2017.1335810; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canesi L, 2016, SCI TOTAL ENVIRON, V565, P933, DOI 10.1016/j.scitotenv.2016.01.085; Canesi L, 2012, MAR ENVIRON RES, V76, P16, DOI 10.1016/j.marenvres.2011.06.005; Chaudhuri AR, 2006, MECH AGEING DEV, V127, P849, DOI 10.1016/j.mad.2006.08.006; Cole C, 2014, MAR ENVIRON RES, V96, P29, DOI 10.1016/j.marenvres.2013.09.003; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Dimitriadis VK, 2004, J MOL HISTOL, V35, P501, DOI 10.1023/B:HIJO.0000045952.87268.76; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; dos Santos T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024438; Fabbri E., 2008, ISJ, V5, P135; Gao P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133913; Gomes T, 2014, MAR ENVIRON RES, V101, P208, DOI 10.1016/j.marenvres.2014.07.004; Gomes T, 2013, AQUAT TOXICOL, V136, P79, DOI 10.1016/j.aquatox.2013.03.021; Grosvik BE, 2006, AQUAT TOXICOL, V79, P334, DOI 10.1016/j.aquatox.2006.07.003; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Katsumiti A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129039; Khan FR, 2015, NANOTOXICOLOGY, V9, P493, DOI 10.3109/17435390.2014.948519; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Leopold N, 2003, J PHYS CHEM B, V107, P5723, DOI 10.1021/jp027460u; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Luo GP, 2012, ACTA HAEMATOL-BASEL, V128, P158, DOI 10.1159/000339426; McDonagh B, 2007, PROTEOMICS, V7, P3395, DOI 10.1002/pmic.200700241; Mezni A, 2014, MATER CHEM PHYS, V147, P496, DOI 10.1016/j.matchemphys.2014.05.022; Mezni A, 2014, J PHYS CHEM C, V118, P17956, DOI 10.1021/jp5038188; Moore MN, 2006, ENVIRON INT, V32, P967, DOI 10.1016/j.envint.2006.06.014; Moore MN, 2008, AUTOPHAGY, V4, P254, DOI 10.4161/auto.5528; Moore MN, 2007, AQUAT TOXICOL, V84, P80, DOI 10.1016/j.aquatox.2007.06.007; Moore MN, 2008, METHOD ENZYMOL, V451, P581, DOI 10.1016/S0076-6879(08)03233-3; Moore MN, 2006, AUTOPHAGY, V2, P217, DOI 10.4161/auto.2663; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Peyvandi F, 2011, BLOOD TRANSFUS-ITALY, V9, pS3, DOI 10.2450/2011.002S; Pinsino A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14492; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rainville LC, 2014, ANALYST, V139, P1678, DOI 10.1039/c3an02160b; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rocha TL, 2016, AQUAT TOXICOL, V177, P306, DOI 10.1016/j.aquatox.2016.06.003; Rostam MA, 2015, CLIN EXP PHARMACOL P, V42, P117, DOI 10.1111/1440-1681.12335; Schnicker NJ, 2016, J BIOL CHEM, V291, P13360, DOI 10.1074/jbc.M116.725432; Sheehan D, 2006, BIOCHEM BIOPH RES CO, V349, P455, DOI 10.1016/j.bbrc.2006.08.124; Moretti AIS, 2017, ARCH BIOCHEM BIOPHYS, V617, P106, DOI 10.1016/j.abb.2016.11.007; Tedesco S., 2010, CURR CHEM BIOL, V4, P151; Theuerkorn M, 2011, CURR OPIN PHARMACOL, V11, P281, DOI 10.1016/j.coph.2011.03.007; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang L, 2013, ISJ-INVERT SURVIV J, V10, P77; Watson P, 2005, ADV DRUG DELIVER REV, V57, P43, DOI 10.1016/j.addr.2004.05.003; Weisz OA, 2003, TRAFFIC, V4, P57, DOI 10.1034/j.1600-0854.2003.40201.x; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Yamada A, 2000, J MOL BIOL, V295, P169, DOI 10.1006/jmbi.1999.3349; Zhao X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117414	59	9	9	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0205765	10.1371/journal.pone.0205765	http://dx.doi.org/10.1371/journal.pone.0205765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372447	Green Submitted, Green Published, gold			2022-12-26	WOS:000448641200014
J	Chao, CY; Mani, MP; Jaganathan, SK				Chao, Cui Yan; Mani, Mohan Prasath; Jaganathan, Saravana Kumar			Engineering electrospun multicomponent polyurethane scaffolding platform comprising grapeseed oil and honey/propolis for bone tissue regeneration	PLOS ONE			English	Article							HONEY; NANOFIBERS; MEMBRANE	Essential oils play an important role in reducing the pain and inflammation caused by bone fracture.In this study, a scaffold was electrospun based on polyurethane (PU), grape seed oil, honey and propolis for bone tissue-engineering applications. The fiber diameter of the electrospun PU/grape seed oil scaffold and PU/grape seed oil/honey/propolis scaffold were observed to be reduced compared to the pristine PU control. FTIR analysis revealed the existence of grape seed oil, honey and propolis in PU identified by CH band peak shift and also hydrogen bond formation. The contact angle of PU/grape seed oil scaffold was found to increase owing to hydrophobic nature and the contact angle for the PU/grape seed/honey oil/propolis scaffold were decreased because of hydrophilic nature. Further, the prepared PU/grape seed oil and PU/grape seed oil/honey/propolis scaffold showed enhanced thermal stability and reduction in surface roughness than the control as revealed in thermogravi-metric analysis (TGA) and atomic force microscopy (AFM) analysis. Further, the developed nanocomposite scaffold displayed delayed blood clotting time than the pristine PU in the activated prothrombin time (APTT) and partial thromboplastin time (PT) assay. The hemolytic assay and cytocompatibility studies revealed that the electrospun PU/grape seed oil and PU/grape seed oil/honey/propolis scaffold possess non-toxic behaviour to red blood cells (RBC) and human fibroblast cells (HDF) cells indicating better blood compatibility and cell viability rates. Hence, the newly developed electrospun nanofibrous composite scaffold with desirable characteristics might be used as an alternative candidate for bone tissue engineering applications.	[Chao, Cui Yan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Rehabil Med, Xian, Shaanxi, Peoples R China; [Mani, Mohan Prasath] Univ Teknol Malaysia, Fac Engn, Sch Biomed Engn & Hlth Sci, Skudai, Malaysia; [Jaganathan, Saravana Kumar] Ton Duc Thang Univ, Dept Management Sci & Technol Dev, Ho Chi Minh City, Vietnam; [Jaganathan, Saravana Kumar] Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam; [Jaganathan, Saravana Kumar] Univ Teknol Malaysia, Fac Engn, IJNUTM Cardiovasc Engn Ctr, Sch Biomed Engn & Hlth Sci, Skudai, Malaysia	Xi'an Jiaotong University; Universiti Teknologi Malaysia; Ton Duc Thang University; Ton Duc Thang University; Universiti Teknologi Malaysia	Jaganathan, SK (corresponding author), Ton Duc Thang Univ, Dept Management Sci & Technol Dev, Ho Chi Minh City, Vietnam.; Jaganathan, SK (corresponding author), Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam.; Jaganathan, SK (corresponding author), Univ Teknol Malaysia, Fac Engn, IJNUTM Cardiovasc Engn Ctr, Sch Biomed Engn & Hlth Sci, Skudai, Malaysia.	saravana@tdtu.edu.vn	Jaganathan, Saravana Kumar/N-2385-2017	Jaganathan, Saravana Kumar/0000-0002-2785-137X	Ministry of Higher Education Malaysia [Q.J130000.2545.17H00, Q.J130000.2545.20H00]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	This work was supported by the Ministry of Higher Education Malaysia with the Grant no. Q.J130000.2545.17H00 and Q.J130000.2545.20H00.	Abdal-hay A, 2013, EUR POLYM J, V49, P1314, DOI 10.1016/j.eurpolymj.2013.02.004; Awal A, 2011, COMPOS PART B-ENG, V42, P1220, DOI 10.1016/j.compositesb.2011.02.011; Ayyar M, 2018, BIOMED ENG-BIOMED TE, V63, P245, DOI 10.1515/bmt-2017-0022; Balaji A, 2016, INT J NANOMED, V11, P4339, DOI 10.2147/IJN.S112265; BRIGHTON CT, 1995, CLIN ORTHOP RELAT R, P223; Eteraf-Oskouei T, 2013, IRAN J BASIC MED SCI, V16, P731; FERNYHOUGH JC, 1992, SPINE, V17, P1474, DOI 10.1097/00007632-199212000-00006; Garavaglia J, 2016, NUTR METAB INSIGHTS, V9, DOI [10.4137/NMI.S32910, 10.4137/nmi.s32910]; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Hajizadeh Farhad, 2018, J Contemp Dent Pract, V19, P47; Hernandez-Jimenez A, 2009, J AGR FOOD CHEM, V57, P10798, DOI 10.1021/jf903465p; Jaganathan S, 2009, J APIPRODUCT APIMEDI, V1, P29, DOI [DOI 10.3896/IBRA.4.01.2.02, 10.3896/IBRA.4.01.2.02]; Jaganathan SK, 2018, J POLYM RES, V25, DOI 10.1007/s10965-018-1543-1; Jaganathan SK, 2017, J MATER SCI, V52, P10673, DOI 10.1007/s10853-017-1286-0; Jaganathan SK, 2017, POLYMERS-BASEL, V9, DOI 10.3390/polym9050163; Jaganathan SK, 2011, MED HYPOTHESES, V76, P535, DOI 10.1016/j.mehy.2010.12.011; Jaganathan SK, 2009, BIOMED RES INT, V2009; JHerting DC, 1963, VITAMIN E CONTENT VE; Kim JI, 2014, MAT SCI ENG C-MATER, V44, P52, DOI 10.1016/j.msec.2014.07.062; Kurek-Gorecka A, 2014, MOLECULES, V19, P78, DOI 10.3390/molecules19010078; Lamba N.M.K., 1998, POLYURETHANES BIOMED, V1st; Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005; Ma ZW, 2011, BIOMACROMOLECULES, V12, P3265, DOI 10.1021/bm2007218; Mi HY, 2014, J BIOMED MATER RES B, V102, P1434, DOI 10.1002/jbm.b.33122; Miculescu F, 2017, ACS SUSTAIN CHEM ENG, V5, P8491, DOI 10.1021/acssuschemeng.7b02314; Miguel SP, 2017, POLYMERS-BASEL, V9, DOI 10.3390/polym9050183; Nasajpour A, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201703437; Nasajpour A, 2017, NANO LETT, V17, P6235, DOI 10.1021/acs.nanolett.7b02929; Nguyen TBL, 2012, J BIOMATER APPL, V27, P255, DOI 10.1177/0885328211401932; Oomah BD, 1998, J AGR FOOD CHEM, V46, P4017, DOI 10.1021/jf980412f; Rao PV, 2016, REV BRAS FARMACOGN, V26, P657, DOI 10.1016/j.bjp.2016.01.012; Reneker DH, 2008, POLYMER, V49, P2387, DOI 10.1016/j.polymer.2008.02.002; Ribeiro C, 2015, J BIOMED MATER RES A, V103, P2260, DOI 10.1002/jbm.a.35367; Salifu AA, 2017, J BIOMED MATER RES A, V105, P1911, DOI 10.1002/jbm.a.36058; Santangelo Carmela, 2007, Ann Ist Super Sanita, V43, P394; Szycher M., 1991, HIGH PERFORMANCE BIO; Thakur VK, 2014, ACS APPL MATER INTER, V6, P9349, DOI 10.1021/am501726d; Unnithan AR, 2012, COLLOID SURFACE A, V415, P454, DOI 10.1016/j.colsurfa.2012.09.029; Voicu SI, 2016, ACS SUSTAIN CHEM ENG, V4, P1765, DOI 10.1021/acssuschemeng.5b01756; Wagh VD, 2013, ADV PHARM SCI, V2013; Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002; Wheeler MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05726; Wutticharoenmongkol P, 2006, MACROMOL BIOSCI, V6, P70, DOI 10.1002/mabi.200500150; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645; Yilmaz Y, 2006, J FOOD COMPOS ANAL, V19, P41, DOI 10.1016/J.JFCA.2004.10.009; Yusoff KM, EFFICACY HONEY DRESS; Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k	47	31	32	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0205699	10.1371/journal.pone.0205699	http://dx.doi.org/10.1371/journal.pone.0205699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372449	Green Submitted, Green Published, gold			2022-12-26	WOS:000448641200011
J	Parolini, M; Possenti, CD; Romano, A; Caprioli, M; Rubolini, D; Saino, N				Parolini, Marco; Possenti, Cristina Daniela; Romano, Andrea; Caprioli, Manuela; Rubolini, Diego; Saino, Nicola			Physiological increase of yolk testosterone level does not affect oxidative status and telomere length in gull hatchlings	PLOS ONE			English	Article							PRIMARY SEX-RATIO; MATERNAL TESTOSTERONE; ANTIOXIDANT CAPACITY; HANDICAP HYPOTHESIS; AVIAN EMBRYOS; ZEBRA FINCH; STRESS; GROWTH; CHICKS; SURVIVAL	Conditions experienced during early-life can cause the onset of oxidative stress, resulting in pervasive effects on diverse life-history traits, including lifespan. In birds, maternally-transferred egg substances may exert positive or negative influence over the offspring phenotype. Among these, testosterone can upregulate the bioavailability of certain antioxidants but simultaneously promotes the production of pro-oxidants, leading to an oxidative stress situation, which is one of the main forces causing telomere attrition However, no study has investigated the role of this androgen on telomere dynamics in birds and little is known about the effects of yolk testosterone on oxidative status in early-life of these species. We physiologically increased the levels of yolk testosterone by in ovo injections in yellow-legged gull (Larus michahellis) to evaluate the effects induced by this androgen on hatchlings plasma total antioxidant capacity, amount of pro-oxidant molecules and telomere length at hatching. Testosterone supplementation did not increase hatchling body growth, did not result in the overproduction of pro-oxidant molecules nor a reduction of antioxidant capacity. Accordingly, telomere length at hatching was not affected by testosterone treatment, although hatchlings from the third-laid eggs showed shorter telomeres than their siblings from first- and secondlaid eggs, independently of testosterone treatment. Our results suggest that injection of physiological levels of testosterone does not induce oxidative stress to hatchlings and, consequently do not affect telomere dynamics during early post-natal periods.	[Parolini, Marco; Possenti, Cristina Daniela; Romano, Andrea; Caprioli, Manuela; Rubolini, Diego; Saino, Nicola] Univ Milan, Dept Environm Sci & Policy, Milan, Italy; [Romano, Andrea] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	University of Milan; University of Lausanne	Parolini, M (corresponding author), Univ Milan, Dept Environm Sci & Policy, Milan, Italy.	marco.parolini@unimi.it	Romano, Andrea/A-2780-2017; Rubolini, Diego/F-2851-2011	Romano, Andrea/0000-0002-0945-6018; Rubolini, Diego/0000-0003-2703-5783; Parolini, Marco/0000-0003-0226-1709				Alonso-Alvarez C, 2008, J EVOLUTION BIOL, V21, P1789, DOI 10.1111/j.1420-9101.2008.01591.x; Alonso-Alvarez C, 2009, P ROY SOC B-BIOL SCI, V276, P2093, DOI 10.1098/rspb.2008.1891; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Badas EP, 2015, J EVOLUTION BIOL, V28, P896, DOI 10.1111/jeb.12615; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Boonekamp JJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3287; Noguera JC, 2011, BIOL LETTERS, V7, P93, DOI 10.1098/rsbl.2010.0421; Correa SM, 2011, HORM BEHAV, V59, P556, DOI 10.1016/j.yhbeh.2011.02.009; Dimova EG, 2008, GENET MOL BIOL, V31, P396, DOI 10.1590/S1415-47572008000300002; Eising CM, 2003, GEN COMP ENDOCR, V132, P241, DOI 10.1016/S0016-6480(03)00090-X; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; Giraudeau M, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0676; Goerlich VC, 2009, GEN COMP ENDOCR, V163, P184, DOI 10.1016/j.ygcen.2009.01.004; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Haussmann MF, 2012, P ROY SOC B-BIOL SCI, V279, P1447, DOI 10.1098/rspb.2011.1913; Haussmann MF, 2010, CURR ZOOL, V56, P714, DOI 10.1093/czoolo/56.6.714; Henriksen R, 2011, NEUROSCI BIOBEHAV R, V35, P1484, DOI 10.1016/j.neubiorev.2011.04.010; Herborn KA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3151; HOYT DF, 1987, J EXP ZOOL, P127; Kim SY, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0211; Lee JCI, 2010, MOL CELL PROBE, V24, P27, DOI 10.1016/j.mcp.2009.08.003; Lipar JL, 2000, P ROY SOC B-BIOL SCI, V267, P2005, DOI 10.1098/rspb.2000.1242; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Monaghan P, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2016.0446; Monaghan P, 2014, J EXP BIOL, V217, P57, DOI 10.1242/jeb.090043; Mougeot F, 2009, P ROY SOC B-BIOL SCI, V276, P1093, DOI 10.1098/rspb.2008.1570; Muriel J, 2013, GEN COMP ENDOCR, V194, P175, DOI 10.1016/j.ygcen.2013.09.013; Navara KJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P550, DOI 10.1086/501054; Navara KJ, 2005, PHYSIOL BIOCHEM ZOOL, V78, P570, DOI 10.1086/430689; Noguera JC, 2016, SCI REP; Parolini M, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170098; Parolini M, 2017, J EXP BIOL, V220, P625, DOI 10.1242/jeb.145235; Pilz KM, 2004, HORM BEHAV, V46, P179, DOI 10.1016/j.yhbeh.2004.03.004; Pinson SE, 2011, GEN COMP ENDOCR, V174, P195, DOI 10.1016/j.ygcen.2011.08.020; Podlas K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056672; Podmokla E, 2018, BIOL REV, V93, P1499, DOI 10.1111/brv.12406; Possenti CD, 2016, HORM BEHAV, V80, P58, DOI 10.1016/j.yhbeh.2016.01.007; Romano M, 2008, J EVOLUTION BIOL, V21, P1626, DOI 10.1111/j.1420-9101.2008.01599.x; Royle NJ, 2003, FUNCT ECOL, V17, P472, DOI 10.1046/j.1365-2435.2003.00752.x; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V59, P344, DOI 10.1007/s00265-005-0057-0; Rubolini D, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-24; Rutkowska J, 2006, ANIM BEHAV, V71, P1283, DOI 10.1016/j.anbehav.2005.07.025; Schwabl H, 1996, COMP BIOCHEM PHYS A, V114, P271, DOI 10.1016/0300-9629(96)00009-6; Stier A, 2015, OECOLOGIA, V179, P999, DOI 10.1007/s00442-015-3429-9; Surai P. F., 2002, NATURAL ANTIOXIDANTS; Tobler M, 2009, J EXP BIOL, V212, P89, DOI 10.1242/jeb.020826; Veiga JP, 2004, HORM BEHAV, V46, P47, DOI 10.1016/j.yhbeh.2004.01.007; VLECK CM, 1980, AM ZOOL, V20, P405; VLECK CM, 1987, J EXP ZOOL, P111; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2	54	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206503	10.1371/journal.pone.0206503	http://dx.doi.org/10.1371/journal.pone.0206503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365552	Green Published, gold			2022-12-26	WOS:000448448700058
J	Timm, ME; Majdani, O; Weller, T; Windeler, M; Lenarz, T; Buchner, A; Salcher, RB				Timm, Max Eike; Majdani, Omid; Weller, Tobias; Windeler, Mayra; Lenarz, Thomas; Buechner, Andreas; Salcher, Rolf Benedikt			Patient specific selection of lateral wall cochlear implant electrodes based on anatomical indication ranges	PLOS ONE			English	Article							INSERTION DEPTH; LENGTH; CORTI; ORGAN	Objectives The aim of this study was to identify anatomical indication ranges for different lateral wall cochlear implant electrodes to support surgeons in the preoperative preparation. Methods 272 patients who were implanted with a FLEX20, FLEX24, FLEX28, or a custom-made device (CMD) were included in this study. The cochlear duct length (CDL) and basal cochlear diameter (length A) were measured within preoperative imaging data. The parameter A was then employed to additionally compute CDL estimates using literature approaches. Moreover, the inserted electrode length (IEL) and insertion angle (IA) were measured in postoperative CT data. By combining the preoperative measurements with the IA data, the covered cochlea length (CCL) and relative cochlear coverage (CC) were determined for each cochlea. Results The measurements of the CDL show comparable results to previous studies. While CDL measurements and estimations cover similar ranges overall, severe deviations occur in individual cases. The electrode specific IEL and CCL are fairly consistent and increase with longer electrodes, but relatively wide ranges of electrode specific CCvalues were found due to the additional dependence on the respective CDL. Using the correlation of IEL and CCL across electrode arrays, CDL ranges for selected arrays were developed (FLEX24:31.3-34.4, FLEX28:36.2-40.1, FLEXsoft:40.6-44.9). Conclusions Our analysis shows that electrode specific CCvaries due to the CDL variation. Preoperative measurement of the CDL allows for an individualized implant length selection yielding optimized stimulation and a reduced risk of intraoperative trauma. The CDL, as derived from preoperative CT imaging studies, can help the implant surgeon select the appropriate electrode array to maximize the patient's outcomes.	[Timm, Max Eike; Majdani, Omid; Weller, Tobias; Windeler, Mayra; Lenarz, Thomas; Buechner, Andreas; Salcher, Rolf Benedikt] Hannover Med Sch, Dept Otorhinolaryngol, Cluster Excellence Hearing4all, Hannover, Germany	Hannover Medical School	Timm, ME (corresponding author), Hannover Med Sch, Dept Otorhinolaryngol, Cluster Excellence Hearing4all, Hannover, Germany.	timm.max@mh-hannover.de			German ministry for research and education (BMBF) [FKZ 13GW0160B]; MED-EL Deutschland GmbH	German ministry for research and education (BMBF)(Federal Ministry of Education & Research (BMBF)); MED-EL Deutschland GmbH	This study was supported by the German ministry for research and education (BMBF) under FKZ 13GW0160B "my-CI" and MED-EL Deutschland GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MedEl Deutschland GmbH paid for scientific congress charge, traveling and hotel costs for Max Eike Timm and Thomas Lenarz. No other author received specific funding for this work.	Adunka O, 2005, ARCH OTOLARYNGOL, V131, P488, DOI 10.1001/archotol.131.6.488; Alexiades G, 2015, OTOL NEUROTOL, V36, P904, DOI 10.1097/MAO.0000000000000620; Avci E, 2014, J COMP NEUROL, V522, P3245, DOI 10.1002/cne.23594; Biedron S, 2010, OTOL NEUROTOL, V31, P731, DOI 10.1097/MAO.0b013e3181d27b5e; BREDBERG G, 1987, ACTA OTO-LARYNGOL, P7; Buchner A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174900; Cakir A, 2016, OTOL NEUROTOL, V37, P1560, DOI 10.1097/MAO.0000000000001245; Clark GM, 2003, AIP SER MOD AC SIG, P160; De Seta D, 2016, OTOLARYNG HEAD NECK, V155, P485, DOI 10.1177/0194599816645774; Dhanasingh A, 2017, HEARING RES, V356, P93, DOI 10.1016/j.heares.2017.10.005; Erixon E, 2009, OTOL NEUROTOL, V30, P14, DOI 10.1097/MAO.0b013e31818a08e8; Escude Bernard, 2006, Audiol Neurootol, V11 Suppl 1, P27, DOI 10.1159/000095611; FrankeTrieger A, 2014, OTOL NEUROTOL; Hardy M, 1938, AM J ANAT, V62, P291, DOI 10.1002/aja.1000620204; Ketten DR, 1998, ANN OTO RHINOL LARYN, V107, P1; Koch RW, 2017, J OTOLARYNGOL-HEAD N, V46, P1, DOI [10.1186/S90463-016-0180-0, DOI 10.1186/S90463-016-0180-0]; Lee J, 2010, AUDIOL NEURO-OTOL, V15, P323, DOI 10.1159/000289571; Lexow GJ, 2016, INT J COMPUT ASS RAD, V11, P1855, DOI 10.1007/s11548-016-1374-7; Liu YK, 2017, ACTA OTO-LARYNGOL, V137, P119, DOI 10.1080/00016489.2016.1221132; Meng J, 2016, OTOL NEUROTOL, V37, P1307, DOI 10.1097/MAO.0000000000001189; Miller JD, 2007, J ACOUST SOC AM, V121, pEL151, DOI 10.1121/1.2710746; Mistrik P, 2016, EUR ANN OTORHINOLARY, V133, pS68, DOI 10.1016/j.anorl.2016.05.001; O'Connell BP, 2017, LARYNGOSCOPE, V127, P2352, DOI 10.1002/lary.26467; O'Connell BP, 2016, OTOL NEUROTOL, V37, P1016, DOI 10.1097/MAO.0000000000001125; Pelliccia P, 2014, ACTA OTORHINOLARYNGO, V34, P42; Rivas A, 2017, OTOL NEUROTOL, V38, P339, DOI 10.1097/MAO.0000000000001329; Rubinstein JT, COCHLEAR IMPLANTS EN, P444; ULEHLOVA L, 1987, HEARING RES, V28, P149, DOI 10.1016/0378-5955(87)90045-1; Van Der Marel KS, 2014, EAR HEARING, V35, P9; Verbist BM, 2009, ANATOMIC CONSIDERATI; Walby AP, ANN OTOL RHINOL LA 1, V94, P393; Wright A, 2009, HAIR CELL DISTRIBUTI, P6489; Wurfel W, 2014, HEARING RES, V316, P65, DOI 10.1016/j.heares.2014.07.013; Wysocki J, 1999, HEARING RES, V135, P39, DOI 10.1016/S0378-5955(99)00088-X	34	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206435	10.1371/journal.pone.0206435	http://dx.doi.org/10.1371/journal.pone.0206435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365565	Green Published, Green Submitted, gold			2022-12-26	WOS:000448448700053
J	Acheson, ES; Kerr, JT				Acheson, Emily Sohanna; Kerr, Jeremy Thomas			Nets versus spraying: A spatial modelling approach reveals indoor residual spraying targets Anopheles mosquito habitats better than mosquito nets in Tanzania	PLOS ONE			English	Article							NORTHERN TANZANIA; MALARIA VECTORS; DISTRIBUTIONS; AFRICA	The global implementation of malaria interventions has averted hundreds of millions of clinical malaria cases in the last decade. This study assesses predicted Anopheles mosquito distributions across the United Republic of Tanzania before large-scale insecticide-treated net (ITN) rollouts and indoor residual spraying (IRS) initiatives to determine whether mosquito net usage by children under the age of five and IRS are targeted to areas where historical evidence indicates mosquitoes thrive. Demographic and Health Surveys data from 2011-2012 and 2015-2016 include detailed measurements of mosquito net and IRS use across Tanzania. Anopheline data are far less intensively collected, but we constructed a Maxent-built baseline mosquito habitat suitability (MHS) map (AUC = 0.872) with Tanzanian Anopheles occurrence records from 1999-2003. This MHS model was tested against independently-observed georeferenced Plasmodium falciparum cases from the Malaria Atlas Project, with similar to 87% of cases from 1999-2003 (n = 107) and similar to 84% of cases from 1985-2012 (n = 919) occurring in areas of high predicted suitability for mosquitoes. We compared the validated MHS with subsequent malaria interventions using mixed effects logistic regression. Specifically, we assessed whether Anopheles habitat suitability related to the frequency that >= 1 child in a household reportedly slept under a mosquito net when that intervention later became widely available, and whether IRS was reportedly applied to dwellings over a one-year period. There was no evidence that mosquito net use the night before the survey related to MHS from 2011-2012 and marginally significant evidence (p<0.05) from 2015-2016 (beta = 1.466, 95% C.I. = 0.848-2.103, marginal R-2 = 0.020, respectively). However, the likelihood of IRS treatments rose relatively strongly in the 12 months prior to both surveys (beta = 13.466, 95% C.I. = 10.488-16.456, marginal R-2 = 0.144, and beta = 6.817, 95% C.I. = 5.439-8.303, marginal R-2 = 0.136, respectively). IRS treatments have therefore been targeted more effectively than mosquito nets toward areas where anopheline habitat suitability was previously found to be high.	[Acheson, Emily Sohanna] Univ British Columbia, Dept Geog, Vancouver, BC, Canada; [Kerr, Jeremy Thomas] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	University of British Columbia; University of Ottawa	Acheson, ES (corresponding author), Univ British Columbia, Dept Geog, Vancouver, BC, Canada.	emily.acheson@gmail.com			Natural Sciences and Engineering Research Council (NSERC); NSERC	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Sciences and Engineering Research Council (NSERC) Vanier Canada Graduate Scholarship (www.vanier.gc.ca/) to ESA, and through an NSERC Discovery Grant (www.nserc-crsng.gc.ca) for JTK. The funders had no role in study design, data collection, analysis, manuscript preparation, or the decision to publish.	Acheson ES, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0841-x; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bonner K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-73; Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111; Centers for Disease Control (CDC), 2016, MAL INF PROPH COUNTR; Chaix B, 2005, J EPIDEMIOL COMMUN H, V59, P517, DOI 10.1136/jech.2004.025478; Chandonait P., 2015, TANZANIA SUPPLEMENTA; Demographic and Health Survey (DHS), 2013, TANZ HIV AIDS MAL IN; Hamainza B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1143-7; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268; Kulkarni MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009396; LandScan, 2017, LANDSCAN OAK RIDG NA; Li BY, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-77; Magadi M, 2011, HEALTH PLACE, V17, P1067, DOI 10.1016/j.healthplace.2011.06.004; Marchant T, 2010, CAN MED ASSOC J, V182, P152, DOI 10.1503/cmaj.090268; Mtega WP, 2013, INT J INF COMMUN TEC, V3, P64; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; National Bureau of Statistics (NBS), 2016, TANZ FIG 2015; [NBS] National Bureau of Statistics, 2013, TANZ FIG 2012; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Oxborough RM, 2016, MALAR J, V15; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Perez-Heydrich C, 2013, DHS SPATIAL ANALYST, V8, P1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; President's Malaria Initiative (PMI), 2016, FIGHT MAL SAV LIV TA; Protopopoff N, 2015, PLOS ONE; Rowland M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069516; RTI International, 2011, TANZ VECT CONTR SCAL; Sheikh MT, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0228-2; Tanzania T., 2015, DEMOGRAPHIC HLTH SUR, V2016, P24; The United States Agency for International Development (USAID), 2009, SCAL IND RES SPRAYIN; West PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001630; West PA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-273; WHO, 2016, WORLD MAL REP 2016; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; World Bank, 2016, GDP PER CAP CURR US; 2013, WORLD MAL REP 2013, P1	37	2	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205270	10.1371/journal.pone.0205270	http://dx.doi.org/10.1371/journal.pone.0205270			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356290	Green Published, Green Submitted, gold			2022-12-26	WOS:000448434000049
J	Schneider, J; Murali, N; Taylor, GW; Levine, JD				Schneider, Jonathan; Murali, Nihal; Taylor, Graham W.; Levine, Joel D.			Can Drosophila melanogaster tell who's who?	PLOS ONE			English	Article							VISUAL-ACUITY; NEURONS; IMAGES	Drosophila melanogaster are known to live in a social but cryptic world of touch and odours, but the extent to which they can perceive and integrate static visual information is a hotly debated topic. Some researchers fixate on the limited resolution of D. melanogaste's optics, others on their seemingly identical appearance; yet there is evidence of individual recognition and surprising visual learning in flies. Here, we apply machine learning and show that individual D. melanogaster are visually distinct. We also use the striking similarity of Drosophila's visual system to current convolutional neural networks to theoretically investigate D. melanogaste's capacity for visual understanding. We find that, despite their limited optical resolution, D. melanogaste's neuronal architecture has the capability to extract and encode a rich feature set that allows flies to re-identify individual conspecifics with surprising accuracy. These experiments provide a proof of principle that Drosophila inhabit a much more complex visual world than previously appreciated.	[Schneider, Jonathan; Levine, Joel D.] Univ Toronto, Mississauga, ON, Canada; [Schneider, Jonathan; Taylor, Graham W.] Univ Guelph, Sch Engn, Guelph, ON, Canada; [Schneider, Jonathan; Taylor, Graham W.; Levine, Joel D.] Canadian Inst Adv Res, Toronto, ON, Canada; [Murali, Nihal] Birla Inst Technol & Sci, Pilani, Rajasthan, India; [Taylor, Graham W.] Vector Inst Artificial Intelligence, Toronto, ON, Canada	University of Toronto; University Toronto Mississauga; University of Guelph; Canadian Institute for Advanced Research (CIFAR); Birla Institute of Technology & Science Pilani (BITS Pilani)	Levine, JD (corresponding author), Univ Toronto, Mississauga, ON, Canada.; Levine, JD (corresponding author), Canadian Inst Adv Res, Toronto, ON, Canada.	joel.levine@utoronto.ca		Levine, Joel/0000-0002-6254-6274; Murali, Nihal/0000-0002-7347-1685	CIFAR (Catalyst Grant); CIFAR; NSERC [436126]; CFI [31943]; CIHR; MITACS	CIFAR (Catalyst Grant); CIFAR(Canadian Institute for Advanced Research (CIFAR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFI(Canada Foundation for Innovation); CIHR(Canadian Institutes of Health Research (CIHR)); MITACS	This work received funding from CIFAR (Catalyst Grant) to JS, GWT, and JDL; CIFAR to GWT and JDL; NSERC (#436126) and CFI (#31943) to GT; NSERC and CIHR to JDL; and MITACS to NM. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battesti M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2480; Bengio Y., 2015, STDP BIOLOGICALLY PL; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Cadieu CF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003963; Caves EM, 2018, TRENDS ECOL EVOL, V33, P358, DOI 10.1016/j.tree.2018.03.001; Caves EM, 2018, METHODS ECOL EVOL, V9, P793, DOI 10.1111/2041-210X.12911; Chrabaszcz Patryk, 2017, ARXIV170708819; Ding WG, 2016, COMPUT ELECTRON AGR, V123, P17, DOI 10.1016/j.compag.2016.02.003; Dyer AG, 2005, J EXP BIOL, V208, P4709, DOI 10.1242/jeb.01929; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Geurten BRH, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00365; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Juusola M, 2017, ELIFE, V6, DOI 10.7554/eLife.26117; Kacsoh BZ, 2017, BIORXIV; Keles MF, 2017, CURR BIOL, V27, P680, DOI 10.1016/j.cub.2017.01.012; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Mery F, 2009, CURR BIOL, V19, P730, DOI 10.1016/j.cub.2009.02.064; Raghu SV, 2013, J COMP NEUROL, V521, P252, DOI 10.1002/cne.23208; Romero-Ferrero F, 2018, ARXIV180304351; Sabour S, 2017, ADV NEURAL INFORM PR, P3859; Schneider J, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0749; Schneider J, 2012, P NATL ACAD SCI USA, V109, P17174, DOI 10.1073/pnas.1121252109; Simon AF, 2012, GENES BRAIN BEHAV, V11, P243, DOI 10.1111/j.1601-183X.2011.00740.x; Takemura S, 2017, ELIFE, V6, DOI 10.7554/eLife.26975; Tripp B, 2018, NEUROIMAGE, V180, P114, DOI 10.1016/j.neuroimage.2017.12.079; Wu M, 2016, ELIFE, V5, DOI 10.7554/eLife.21022; Yurkovic A, 2006, P NATL ACAD SCI USA, V103, P17519, DOI 10.1073/pnas.0608211103; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53	29	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205043	10.1371/journal.pone.0205043	http://dx.doi.org/10.1371/journal.pone.0205043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356241	gold, Green Published, Green Submitted			2022-12-26	WOS:000448434000025
J	Xu, CC; Su, JS; Chen, SH				Xu, Chengcheng; Su, Jinshu; Chen, Shuhui			Exploring efficient grouping algorithms in regular expression matching	PLOS ONE			English	Article								Background Regular expression matching (REM) is widely employed as the major tool for deep packet inspection (DPI) applications. For automatic processing, the regular expression patterns need to be converted to a deterministic finite automata (DFA). However, with the ever-increasing scale and complexity of pattern sets, state explosion problem has brought a great challenge to the DFA based regular expression matching. Rule grouping is a direct method to solve the state explosion problem. The original rule set is divided into multiple disjoint groups, and each group is compiled to a separate DFA, thus to significantly restrain the severe state explosion problem when compiling all the rules to a single DFA. Objective For practical implementation, the total number of DFA states should be as few as possible, thus the data structures of these DFAs can be deployed on fast on-chip memories for rapid access. In addition, to support fast pattern update in some applications, the time cost for grouping should be as small as possible. In this study, we aimed to propose an efficient grouping method, which generates as few states as possible with as little time overhead as possible. Methods When compiling multiple patterns into a single DFA, the number of DFA states is usually greater than the total number of states when compiling each pattern to a separate DFA. This is mainly caused by the semantic overlaps among different rules. By quantifying the interaction values for each pair of rules, the rule grouping problem can be reduced to the maximum k-cut graph partitioning problem. Then, we propose a heuristic algorithm called the one-step greedy (OSG) algorithm to solve this NP-hard problem. What's more, a subroutine named the heuristic initialization (HI) algorithm is devised to further optimize the grouping algorithms. Results We employed three practical rule sets for the experimental evaluation. Results show that the OSG algorithm outperforms the state-of-the-art grouping solutions regarding both the total number of DFA states and time cost for grouping. The HI subroutine also demonstrates its significant optimization effect on the grouping algorithms. Conclusions The DFA state explosion problem has became the most challenging issue in the regular expression matching applications. Rule grouping is a practical direction by dividing the original rule sets into multiple disjoint groups. In this paper, we investigate the current grouping solutions, and propose a compact and efficient grouping algorithm. Experiments conducted on practical rule sets demonstrate the superiority of our proposal.	[Xu, Chengcheng; Su, Jinshu; Chen, Shuhui] Natl Univ Def Technol, Coll Comp, Changsha, Hunan, Peoples R China; [Su, Jinshu] Natl Key Lab Parallel & Distributed Proc, Changsha, Hunan, Peoples R China; [Xu, Chengcheng] Naval Univ Engn, Natl Key Lab Sci & Technol Vessel Integrated Powe, Wuhan, Hubei, Peoples R China	National University of Defense Technology - China; Wuhan Naval University of Engineering	Xu, CC (corresponding author), Natl Univ Def Technol, Coll Comp, Changsha, Hunan, Peoples R China.; Xu, CC (corresponding author), Naval Univ Engn, Natl Key Lab Sci & Technol Vessel Integrated Powe, Wuhan, Hubei, Peoples R China.	xuchengcheng@nudt.edu.cn			National Natural Science Foundation of China [61379148]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Grant 61379148 (http://www.nsfc.gov.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO AV, 1975, COMMUN ACM, V18, P333, DOI 10.1145/360825.360855; Allauzen C, 1999, TR9911 U MARN VALL I; [Anonymous], 2014, BRO INTRUSION DETECT; [Anonymous], 2009, APPL LAYER PACKET CL; Arora S, 1999, J COMPUT SYST SCI, V58, P193, DOI 10.1006/jcss.1998.1605; Becchi M., 2007, P 3 ACM IEEE S ARCH, P145, DOI DOI 10.1145/1323548.1323573; Becchi M., 2008, P 4 ACM IEEE S ARCH, P50, DOI DOI 10.1145/1477942.1477950; Becchi M., 2007, P 2007 ACM CONEXT C, P1; Becchi M, 2007, IEEE INFOCOM SER, P1064, DOI 10.1109/INFCOM.2007.128; Becchi M, 2013, ACM T ARCHIT CODE OP, V10, DOI 10.1145/2445572.2445576; Brodie BC, ACM SIGARCH COMPUTER, V34; Elsner U, 1997, GRAPH PARTITIONING A; Fang Yu, 2006, ACM/IEEE Symposium on Architectures for Networking and Communications Systems (ANCS 2006), P93, DOI 10.1109/ANCS.2006.4579527; Ficara D, 2011, IEEE ACM T NETWORK, V19, P683, DOI 10.1109/TNET.2010.2089639; Ficara D, 2008, ACM SIGCOMM COMP COM, V38, P29, DOI 10.1145/1452335.1452339; Fjallstrom P.-O., 1998, ALGORITHMS GRAPH PAR, V3; IBM, 2012, POWEREN PME PUBL PAT; JOHNSON DS, 1989, OPER RES, V37, P865, DOI 10.1287/opre.37.6.865; Kernighan B. W., 1970, Bell System Technical Journal, V49, P291; Kong S., 2008, PROC 4 INT C SECUR P, P1, DOI DOI 10.1145/1460877.1460879; Kumar Sailesh, 2006, ACM/IEEE Symposium on Architectures for Networking and Communications Systems (ANCS 2006), P81, DOI 10.1109/ANCS.2006.4579526; Kumar S, 2006, ACM SIGCOMM COMP COM, V36, P339, DOI 10.1145/1151659.1159952; Ledesma S, 2008, SIMULATED ANNEALING; Luchaup D, 2014, IEEE INFOCOM SER, P531, DOI 10.1109/INFOCOM.2014.6847977; Rohrer J., 2009, P 7 IEEEACM INT C HA, P147; Wheeler JW., 2004, INVESTIGATION MAX CU; WILLIAMS RD, 1991, CONCURRENCY-PRACT EX, V3, P457, DOI 10.1002/cpe.4330030502; XU CC, 2016, IEEE COMMUN SURV TUT, V18, P2991, DOI DOI 10.1109/C0MST.2016.2566669	28	5	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206068	10.1371/journal.pone.0206068	http://dx.doi.org/10.1371/journal.pone.0206068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356262	gold, Green Submitted, Green Published			2022-12-26	WOS:000448434000072
J	Bahadur, KCK; Dias, GM; Veeramani, A; Swanton, CJ; Fraser, D; Steinke, D; Lee, E; Wittmen, H; Farber, JM; Dunfield, K; McCann, K; Anand, M; Campbell, M; Rooney, N; Raine, NE; Van Acker, R; Hanner, R; Pascoel, S; Sherif, S; Benton, TG; Fraser, EDG				Bahadur, Krishna K. C.; Dias, Goretty M.; Veeramani, Anastasia; Swanton, Clarence J.; Fraser, David; Steinke, Dirk; Lee, Elizabeth; Wittmen, Hannah; Farber, Jeffrey M.; Dunfield, Kari; McCann, Kevin; Anand, Madhur; Campbell, Malcolm; Rooney, Neil; Raine, Nigel E.; Van Acker, Rene; Hanner, Robert; Pascoel, Samantha; Sherif, Shayan; Benton, Tim G.; Fraser, Evan D. G.			When too much isn't enough: Does current food production meet global nutritional needs?	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CLIMATE-CHANGE; FATTY-ACIDS; DIETARY; SUSTAINABILITY; MORTALITY; LIVESTOCK; HEALTH; RISK	Sustainably feeding the next generation is often described as one of the most pressing "grand challenges" facing the 21st century. Generally, scholars propose addressing this problem by increasing agricultural production, investing in technology to boost yields, changing diets, or reducing food waste. In this paper, we explore whether global food production is nutritionally balanced by comparing the diet that nutritionists recommend versus global agricultural production statistics. Results show that the global agricultural system currently overproduces grains, fats, and sugars while production of fruits and vegetables and protein is not sufficient to meet the nutritional needs of the current population. Correcting this imbalance could reduce the amount of arable land used by agriculture by 51 million ha globally but would increase total land used for agriculture by 407 million ha and increase greenhouse gas emissions. For a growing population, our calculations suggest that the only way to eat a nutritionally balanced diet, save land and reduce greenhouse gas emissions is to consume and produce more fruits and vegetables as well as transition to diets higher in plant-based protein. Such a move will help protect habitats and help meet the Sustainable Development Goals.	[Bahadur, Krishna K. C.; Pascoel, Samantha; Fraser, Evan D. G.] Univ Guelph, Dept Geog Environm & Geomat, Guelph, ON, Canada; [Dias, Goretty M.; Veeramani, Anastasia] Univ Waterloo, Sch Environm Enterprise & Dev, Waterloo, ON, Canada; [Swanton, Clarence J.; Lee, Elizabeth; Van Acker, Rene] Univ Guelph, Dept Plant Agr, Guelph, ON, Canada; [Fraser, David] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC, Canada; [Steinke, Dirk; McCann, Kevin; Hanner, Robert] Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada; [Wittmen, Hannah] Univ British Columbia, Ctr Sustainable Food Syst, Vancouver, BC, Canada; [Farber, Jeffrey M.] Univ Guelph, Canadian Res Inst Food Safety, Guelph, ON, Canada; [Dunfield, Kari; Anand, Madhur; Rooney, Neil; Raine, Nigel E.] Univ Guelph, Sch Environm Sci, Guelph, ON, Canada; [Campbell, Malcolm] Univ Guelph, Off Res, Guelph, ON, Canada; [Campbell, Malcolm] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Sherif, Shayan] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada; [Benton, Tim G.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Fraser, Evan D. G.] Univ Guelph, Arrell Food Inst, Guelph, ON, Canada	University of Guelph; University of Waterloo; University of Guelph; University of British Columbia; University of Guelph; University of British Columbia; University of Guelph; University of Guelph; University of Guelph; University of Guelph; University of Guelph; University of Leeds; University of Guelph	Bahadur, KCK (corresponding author), Univ Guelph, Dept Geog Environm & Geomat, Guelph, ON, Canada.	krishnak@uoguelph.ca	Raine, Nigel/AAK-6425-2020; Benton, Tim G/C-6493-2009	Raine, Nigel/0000-0001-6343-2829; Benton, Tim G/0000-0002-7448-1973; Rooney, Neil/0000-0003-4360-4034; Fraser, Evan/0000-0001-5124-488X; KC, Krishna Bahadur/0000-0003-3966-2928	Canada First Research Excellent Fund [000054]; Food from thought: Agricultural Systems for a Healthy Planet Initiative	Canada First Research Excellent Fund; Food from thought: Agricultural Systems for a Healthy Planet Initiative	This work was supported by Food from thought: Agricultural Systems for a Healthy Planet Initiative, by the Canada First Research Excellent Fund. Grant number 000054 to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aleksandrowicz L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165797; Alexander P, 2017, GLOB FOOD SECUR-AGR, V15, P22, DOI 10.1016/j.gfs.2017.04.001; [Anonymous], 2017, SUST DEV KNOWL PLATF; Bahadur KCK, 2017, COGENT FOOD AGR, V3, DOI 10.1080/23311932.2017.1309739; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Carbon Brief, 2016, ONL 5 YEARS LEFT 1 5; Chaplot V, 2016, GEODERMA, V271, P10, DOI 10.1016/j.geoderma.2016.02.010; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; de Haas Y, 2016, ADV ANIM BIOSCI, V7, P196, DOI [10.1017/S2040470016000121, DOI 10.1017/S2040470016000121]; de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978; Dehghan M, 2017, LANCET, V390, P2050, DOI [10.1016/S0140-6736(17)32252-3, 10.1016/s0140-6736(17)32252-3]; Delgado C, 2001, OUTLOOK AGR, V30, P27, DOI 10.5367/000000001101293427; Despommier D, 2013, TRENDS BIOTECHNOL, V31, P388, DOI 10.1016/j.tibtech.2013.03.008; Dias G, LIFE CYCLE ASSESSMEN; FAO, 2018, EM SUE AGR; FAO Food and Agriculture Organization UN., 2006, LIVESTOCKS LONG SHAD; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food and Agriculture Organization of the United Nations (FAO), YIELD NUTR VAL COMM; Food and Agriculture Organization of the United Nations (FAO), TECHN CONV FACT AGR; Food and Agriculture Organization of the United Nations (FAO), 2016, FAOSTAT FOOD SUPPL L; Fraser EDG, 2016, SOLUTION J, V7, P10; Fraser E, 2016, TRENDS FOOD SCI TECH, V48, P78, DOI 10.1016/j.tifs.2015.11.006; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gustavsson J., 2011, GLOBAL FOOD LOSSES F; Hamley S, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0254-5; Harvard School of Public Health, NUTR SOURC FISH FRIE; Harvard School of Public Health, HLTH EAT PLAT HLTH E; Health Canada, NUTR VAL SOM COMM FO; Health Canada, 2016, CAN FOOD GUID; Health Canada, CHOOS FOODS; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jason C, 2004, WORLD AGR ENV COMMOD; Kamei CLA, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-015-0430-2; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Martinet V, 2007, ECOL ECON, V64, P411, DOI 10.1016/j.ecolecon.2007.02.036; Muller A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01410-w; Murray CJL, LOW RISK DIET VS AVA; National Health Service (UK), WHAT SHOULD MY DAIL; NESTLE M, 1993, INT J HEALTH SERV, V23, P483, DOI 10.2190/32F2-2PFB-MEG7-8HPU; Nestle M., 2013, FOOD POLITICS FOOD I, V3; Obersteiner M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501499; Pagnutti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075890; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pimentel D, 2003, AM J CLIN NUTR, V78, p660S, DOI 10.1093/ajcn/78.3.660S; Pomeroy RS, 1995, OCEAN COAST MANAGE, V27, P143, DOI 10.1016/0964-5691(95)00042-9; Poore J, 2018, SCIENCE, V360, P987, DOI 10.1126/science.aaq0216; Ramsden CE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1246; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Rimas A, 2009, BEEF UNTOLD STORY MI; Ripple WJ, 2014, NAT CLIM CHANGE, V4, P2, DOI 10.1038/nclimate2081; Rizvi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200781; Ruviaro CF, 2015, J CLEAN PROD, V96, P435, DOI 10.1016/j.jclepro.2014.01.037; Sima Pro LCA Software, 2021, DEV PRE SUST; Smith P, 2016, NAT CLIM CHANGE, V6, P42, DOI [10.1038/nclimate2870, 10.1038/NCLIMATE2870]; Specht K, 2014, AGR HUM VALUES, V31, P33, DOI 10.1007/s10460-013-9448-4; Springmann M, 2016, P NATL ACAD SCI USA, V113, P4146, DOI 10.1073/pnas.1523119113; Taylor JF, 2017, J ANIM SCI, V95, P161, DOI 10.2527/asasmw.2017.331; The University of Michigan, INT HLTH HEAL FOODS; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Tyedmers PH, 2005, AMBIO, V34, P635, DOI 10.1639/0044-7447(2005)034[0635:FGFF]2.0.CO;2; U.S. Department of Agriculture, 2017, EST CAL NEEDS PER DA; United Nations (UN) Climate Change, CLIM CHANG PAR AGR; US Department of Agriculture Agricultural Research Service, 2019, USDA NATL NUTR DATAB; US Department of Health and Human Services and USDA, 2015, DIET GUID AM 2015 20; Veeramani A, 2017, J CLEAN PROD, V162, P1398, DOI 10.1016/j.jclepro.2017.06.025	66	75	75	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0205683	10.1371/journal.pone.0205683	http://dx.doi.org/10.1371/journal.pone.0205683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352069	Green Submitted, Green Published, gold			2022-12-26	WOS:000448076200013
J	Kamminga, S; van der Meijden, E; Feltkamp, MCW; Zaaijer, HL				Kamminga, Sergio; van der Meijden, Els; Feltkamp, Mariet C. W.; Zaaijer, Hans L.			Seroprevalence of fourteen human polyomaviruses determined in blood donors	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SPINULOSA-ASSOCIATED POLYOMAVIRUS; TRANSPLANT RECIPIENT; INFECTION; POPULATION; PREVALENCE; STABILITY; SEROLOGY; VIREMIA; RATES	The polyomavirus family currently includes thirteen human polyomavirus (HPyV) species. In immunocompromised and elderly persons HPyVs are known to cause disease, such as progressive multifocal leukoencephalopathy (JCPyV), haemorrhagic cystitis and nephropathy (BKPyV), Merkel cell carcinoma (MCPyV), and trichodysplasia spinulosa (TSPyV). Some recently discovered polyomaviruses are of still unknown prevalence and pathogenic potential. Because HPyVs infections persist and might be transferred by blood components to immunocompromised patients, we studied the seroprevalence of fourteen polyomaviruses in adult Dutch blood donors. For most polyomaviruses the observed seroprevalence was high (60-100%), sometimes slightly increasing or decreasing with age. Seroreactivity increased with age for JCPyV, HPyV6 and HPyV7 and decreased for BKPyV and TSPyV. The most recently identified polyomaviruses HPyV12, NJPyV and LIPyV showed low overall seroprevalence (-5%) and low seroreactivity, questioning their human tropism. Altogether, HPyV infections are common in Dutch blood donors, with an average of nine polyomaviruses per subject.	[Kamminga, Sergio; Zaaijer, Hans L.] Sanquin Res, Dept Blood Borne Infect, Amsterdam, Netherlands; [Kamminga, Sergio; van der Meijden, Els; Feltkamp, Mariet C. W.] Leiden Univ, Dept Med Microbiol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kamminga, S (corresponding author), Sanquin Res, Dept Blood Borne Infect, Amsterdam, Netherlands.; Kamminga, S (corresponding author), Leiden Univ, Dept Med Microbiol, Med Ctr, Leiden, Netherlands.	S.Kamminga@sanquin.nl	Feltkamp, Mariet/A-3788-2010	Feltkamp, Mariet/0000-0001-5993-9846; Kamminga, Sergio/0000-0003-2758-5603	Sanquin Blood Supply Foundation [PPO 15-04]	Sanquin Blood Supply Foundation	This project was supported by Sanquin Blood Supply Foundation, PPO 15-04 (https://www.sanquin.org/research) to HLZ and MCWF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2018, J CLIN VIROL, V101, P34, DOI 10.1016/j.jcv.2018.01.013; Cason C, 2018, J NEUROVIROL, V24, P314, DOI 10.1007/s13365-017-0612-2; DeCaprio JA, 2013, NAT REV MICROBIOL, V11, P264, DOI 10.1038/nrmicro2992; Dehority WN, 2017, J MED VIROL, V89, P926, DOI 10.1002/jmv.24706; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Feltkamp MCW, 2013, J GEN VIROL, V94, P482, DOI 10.1099/vir.0.048462-0; Fondain M, 2018, J EUR ACAD DERMATOL, V32, P1292, DOI 10.1111/jdv.14798; Foster JH, 2018, PEDIATR TRANSPLANT, V22, DOI 10.1111/petr.13141; Gaboriaud P, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0026-0; Gedvilaite A, 2017, J GEN VIROL, V98, P3060, DOI 10.1099/jgv.0.000948; Gheit T, 2017, VIROLOGY, V506, P45, DOI 10.1016/j.virol.2017.03.007; Gossai A, 2016, AM J EPIDEMIOL, V183, P61, DOI 10.1093/aje/kwv155; Hirsch HH, 2005, TRANSPLANTATION, V79, P1277, DOI 10.1097/01.TP.0000156165.83160.09; Ho JH, 2015, J INFECT DIS, V211, P1560, DOI 10.1093/infdis/jiu524; Kamminga S, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01566-17, 10.1128/jcm.01566-17]; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Keijzers M, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0418-6; Khan ZM, 2014, J VIROL, V88, P6100, DOI 10.1128/JVI.03455-13; Korup S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058021; Lim ES, 2014, EMERG INFECT DIS, V20, P1559, DOI 10.3201/eid2009.140561; Mishra N, 2014, J INFECT DIS, V210, P1595, DOI 10.1093/infdis/jiu250; Moens U, 2017, INFECT GENET EVOL, V54, P18, DOI 10.1016/j.meegid.2017.06.011; Moens U, 2013, REV MED VIROL, V23, P250, DOI 10.1002/rmv.1747; Nguyen KD, 2017, J AM ACAD DERMATOL, V76, P932, DOI 10.1016/j.jaad.2016.11.035; Nicol JTJ, 2013, CLIN VACCINE IMMUNOL, V20, P363, DOI 10.1128/CVI.00438-12; Norkiene M, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0187-z; Rennspiess D, 2015, J THORAC ONCOL, V10, P360, DOI 10.1097/JTO.0000000000000390; Reuwer AQ, 2017, ACTA NEUROL SCAND, V136, P37, DOI 10.1111/ane.12840; Schwab N, 2017, NEUROLOGY, V88, P1197, DOI 10.1212/WNL.0000000000003739; Siebrasse EA, 2016, EMERG INFECT DIS, V22, P24, DOI 10.3201/eid2201.151384; Sroller V, 2016, J MED VIROL, V88, P1254, DOI 10.1002/jmv.24440; Sroller V, 2014, J MED VIROL, V86, P1560, DOI 10.1002/jmv.23841; Teramoto S, 2011, PEDIATR INFECT DIS J, V30, P918, DOI 10.1097/INF.0b013e3182252148; van der Meijden E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081078; van der Meijden E, 2011, EMERG INFECT DIS, V17, P1355, DOI 10.3201/eid1708.110114; Vennegoor A, 2015, MULT SCLER J, V21, P1600, DOI 10.1177/1352458514567728; Waterboer T, 2006, J IMMUNOL METHODS, V309, P200, DOI 10.1016/j.jim.2005.11.008; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Wunderink HF, 2017, J CLIN VIROL, V90, P46, DOI 10.1016/j.jcv.2017.03.015	39	55	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206273	10.1371/journal.pone.0206273	http://dx.doi.org/10.1371/journal.pone.0206273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352098	Green Published, gold, Green Submitted			2022-12-26	WOS:000448076200044
J	Plough, LV; Ogburn, MB; Fitzgerald, CL; Geranio, R; Marafino, GA; Richie, KD				Plough, Louis, V; Ogburn, Matthew B.; Fitzgerald, Catherine L.; Geranio, Rose; Marafino, Gabriella A.; Richie, Kimberly D.			Environmental DNA analysis of river herring in Chesapeake Bay: A powerful tool for monitoring threatened keystone species	PLOS ONE			English	Article							ALEWIFE ALOSA-PSEUDOHARENGUS; ESTIMATING SITE OCCUPANCY; DETECTION PROBABILITIES; ANADROMOUS ALEWIFE; ABUNDANCE; EDNA; CONSERVATION; PATTERNS; RATES; QUANTIFICATION	Environmental DNA (eDNA) sampling has emerged as a powerful tool to detect and quantify species abundance in aquatic environments. However, relatively few studies have compared the performance of eDNA-based abundance estimates to traditional catch or survey approaches in the field. Here, we have developed and field-tested a qPCR assay to detect eDNA from alewife and blueback herring (collectively known as 'river herring'), comparing eDNA-based presence and abundance data to traditional methods of quantification (ichthyoplankton sampling and adult observations). Overall, the qPCR assay showed very high target specificity in lab trials, and was successful in detecting river herring for 11/12 Chesapeake Bay tributaries in spring 2015 and 2016, with 106 out of 445 samples exhibiting positive eDNA hits. We found a strong correlation between eDNA abundance and ichthyoplankton count data (Spearman's Rho = 0.52), and Phi-tests (correlation of presence/absence data) showed higher correlation between eDNA and ichthyoplankton data (Phi = 0.45) than adult data (Phi = 0.35). Detection probability was significantly lower on western vs. eastern shore tributaries of Chesapeake Bay, and blueback herring and alewife were more likely detected on the western and eastern shores, respectively. Temporal patterns of eDNA abundance over the spring spawning season revealed that alewife were present in high abundances weeks ahead of blueback herring, which aligns with known differences in spawning behavior of the species. In summary, the eDNA abundance data corresponded well to other field methods and has great potential to assist future monitoring efforts of river herring abundance and habitat use.	[Plough, Louis, V; Fitzgerald, Catherine L.; Geranio, Rose] Univ Maryland, Ctr Environm Sci, Horn Point Lab, Cambridge, MD 21613 USA; [Ogburn, Matthew B.; Marafino, Gabriella A.; Richie, Kimberly D.] Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA	University System of Maryland; University of Maryland Center for Environmental Science; Smithsonian Institution; Smithsonian Environmental Research Center	Plough, LV (corresponding author), Univ Maryland, Ctr Environm Sci, Horn Point Lab, Cambridge, MD 21613 USA.	lplough@umces.edu	; Plough, Louis/E-1413-2014	Richie, Kimberly/0000-0002-8535-9420; Fitzgerald, Catherine/0000-0002-9913-7984; Plough, Louis/0000-0001-5572-9649; Ogburn, Matthew/0000-0001-5417-555X	University of Maryland Center for Environmental Science; National Fish and Wildlife Foundation [45567, 50023]; Smithsonian Institution Office of the Undersecretary for Science and Office of the Provost	University of Maryland Center for Environmental Science; National Fish and Wildlife Foundation; Smithsonian Institution Office of the Undersecretary for Science and Office of the Provost	Funding support was provided by the University of Maryland Center for Environmental Science to LVP, National Fish and Wildlife Foundation awards #45567 and #50023 to MO, and the Smithsonian Institution Office of the Undersecretary for Science and Office of the Provost. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able K. W., 1998, 1 YEAR LIFE ESTUARIN; Able KW, 2014, NORTHEAST NAT, V21, P192, DOI 10.1656/045.021.0207; ASMFC (Atlantic States Marine Fisheries Commission), 1202 ASMFC, V1; Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Baker DGL, 2016, PEERJ, V4, DOI 10.7717/peerj.1832; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bohl RJ, 2009, T AM FISH SOC, V138, P768, DOI 10.1577/T08-149.1; Boswell KM, 2008, N AM J FISH MANAGE, V28, P799, DOI 10.1577/M07-116.1; Bowen BR, 2008, J FISH BIOL, V72, P1188, DOI 10.1111/j.1095-8649.2007.01785.x; Cao Y, 2001, CAN J FISH AQUAT SCI, V58, P1782, DOI 10.1139/cjfas-58-9-1782; Carr IM, 2009, BIOINFORMATICS, V25, P3244, DOI 10.1093/bioinformatics/btp583; Chambert T, 2018, ECOL EVOL, V8, P3468, DOI 10.1002/ece3.3764; Coggins LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108302; CRAWFORD RH, 1986, CAN J ZOOL, V64, P1902, DOI 10.1139/z86-285; de Souza LS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165273; Doi H, 2017, FRESHWATER BIOL, V62, P30, DOI 10.1111/fwb.12846; Ebner BC, 2013, J FISH BIOL, V82, P1592, DOI 10.1111/jfb.12096; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Faragher R. A., 1997, FISH RIVERS STRESS N, P251; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hall CJ, 2012, BIOSCIENCE, V62, P723, DOI 10.1525/bio.2012.62.8.5; Hall CJ, 2011, LANDSCAPE ECOL, V26, P95, DOI 10.1007/s10980-010-9539-1; Hasselman DJ, 2016, CAN J FISH AQUAT SCI, V73, P951, DOI 10.1139/cjfas-2015-0402; Hightower Joseph E., 1996, North American Journal of Fisheries Management, V16, P257, DOI 10.1577/1548-8675(1996)016<0257:HTIAOA>2.3.CO;2; Holmes JA, 2006, ICES J MAR SCI, V63, P543, DOI 10.1016/j.icesjms.2005.08.015; Hughes JB, 2015, N AM J FISH MANAGE, V35, P229, DOI 10.1080/02755947.2014.992558; Hughes RM, 2002, N AM J FISH MANAGE, V22, P1229, DOI 10.1577/1548-8675(2002)022<1229:EDNTEF>2.0.CO;2; Iversen LL, 2015, BIOL CONSERV, V192, P479, DOI 10.1016/j.biocon.2015.09.024; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Jordan F, 2008, ENVIRON BIOL FISH, V81, P313, DOI 10.1007/s10641-007-9202-0; Kahle D, 2013, R J, V5, P144; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; King RS, 2005, ECOL APPL, V15, P137, DOI 10.1890/04-0481; Klauda R, 1998, ENVIRON MONIT ASSESS, V51, P299, DOI 10.1023/A:1005903822990; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Kubecka J, 2012, FISH RES, V123, P1, DOI 10.1016/j.fishres.2011.11.013; Kubecka J, 2009, FISH RES, V96, P1, DOI 10.1016/j.fishres.2008.09.021; Lacoursiere-Roussel A, 2016, MOL ECOL RESOUR, V16, P1401, DOI 10.1111/1755-0998.12522; Lacoursiere-Roussel A, 2016, J APPL ECOL, V53, P1148, DOI 10.1111/1365-2664.12598; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Limburg KE, 2009, BIOSCIENCE, V59, P955, DOI 10.1525/bio.2009.59.11.7; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Loesch J. G., 1987, INT S COMM STRAT AN, V1, P97; Lucas MC, 2000, FISH FISH, V1, P283, DOI 10.1046/j.1467-2979.2000.00028.x; Lyon JP, 2014, CAN J FISH AQUAT SCI, V71, P878, DOI 10.1139/cjfas-2013-0287; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; MARASCUILO LA, 1967, PSYCHOL BULL, V67, P401, DOI 10.1037/h0020421; Martin F. D., 1978, DEV FISHES MIDATLANT; Mordecai RS, 2011, J APPL ECOL, V48, P56, DOI 10.1111/j.1365-2664.2010.01921.x; Murdy EO, 1996, FISHES CHESAPEAKE BA; Ogburn MB, 2017, N AM J FISH MANAGE, V37, P1083, DOI 10.1080/02755947.2017.1339649; Ogburn MB, 2017, T AM FISH SOC, V146, P22, DOI 10.1080/00028487.2016.1235612; Palkovacs EP, 2014, EVOL APPL, V7, P212, DOI 10.1111/eva.12111; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Pope KL, 2010, INLAND FISHERIES MANAGEMENT IN NORTH AMERICA, THIRD EDITION, P325; R Core Team, 2021, R LANGUAGE ENV STAT; Reid SM, 2017, J APPL ICHTHYOL, V33, P1083, DOI 10.1111/jai.13463; Renshaw MA, 2015, MOL ECOL RESOUR, V15, P168, DOI 10.1111/1755-0998.12281; RICHKUS WA, 1974, J FISH RES BOARD CAN, V31, P1485, DOI 10.1139/f74-178; Riley D., 1991, HABITAT REQUIREMENTS, DOI DOI 10.1-10.29; Sassoubre LM, 2016, ENVIRON SCI TECHNOL, V50, P10456, DOI 10.1021/acs.est.6b03114; Smith CD, 2015, J FISH WILDL MANAG, V6, P371, DOI 10.3996/022015-JFWM-011; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; TAKAHARA T, 2012, PLOS ONE, V7; Thompson WL, 2004, SAMPLING RARE ELUSIV; Thomsen PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165252; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Uphoff J, 2017, MARINE ESTUARINE FIN; Walter JF, 2003, FISH B-NOAA, V101, P414; West DC, 2010, CAN J FISH AQUAT SCI, V67, P1211, DOI 10.1139/F10-059; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Wilcox TM, 2015, CONSERV GENET RESOUR, V7, P639, DOI 10.1007/s12686-015-0465-z; YAMAMOTO S, 2017, SCI REP UK, V7	84	10	10	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0205578	10.1371/journal.pone.0205578	http://dx.doi.org/10.1371/journal.pone.0205578			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383750	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600019
J	Ali, MES; Nuhait, AO; Alabdulkarem, A; Almuzaiqer, R				Ali, Mohamed El-Sayed; Nuhait, Abdullah O.; Alabdulkarem, Abdullah; Almuzaiqer, Redhwan			Free convection heat transfer inside square water-filled shallow enclosures	PLOS ONE			English	Article							TURBULENT NATURAL-CONVECTION; LAMINAR; FLUID	Experimental study on free convection heat transfer was carried out inside shallow square enclosures filled with water. Two enclosures were used with size L x L x H (m(3)), where L and H are the side length and the inside thickness of the enclosure, respectively. Two different aspect ratios, kappa = L/H, 7.143 and 12.0 were used. Constant heat flux boundary condition was applied at the bottom surface and stream of ambient air was applied at the top surface. Different values of constant heat fluxes were used as boundary conditions. For each aspect ratio of the enclosure, average Nusselt numbers were developed and correlated with the modified Rayleigh number. The results show that the heat transfer coefficient increases with the modified Rayleigh number with observed overlapping region between the two aspect ratios. A general overall correlation was developed using the aspect ratio as a parameter. The results also show that at the overlapping zone, the Nusselt number decreases as the aspect ratio increases for the fixed modified Rayleigh number.	[Ali, Mohamed El-Sayed; Nuhait, Abdullah O.; Alabdulkarem, Abdullah; Almuzaiqer, Redhwan] King Saud Univ, Coll Engn, Mech Engn Dept, Riyadh, Saudi Arabia	King Saud University	Ali, MES (corresponding author), King Saud Univ, Coll Engn, Mech Engn Dept, Riyadh, Saudi Arabia.	mali@ksu.edu.sa	Ali, Mohamed/E-3986-2014; Alabdulkarem, Abdullah/GQR-0895-2022	Ali, Mohamed/0000-0001-8149-8098; Ebaid Ali Ahmed, Mohamed/0000-0001-9817-8306	Deanship of Scientific Research at King Saud University [RGP-080]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through the research group project No RGP-080". The role of the funder is to pay for the material, workshop, measurement devices, publication charges (in case of acceptance) and some incentives to the following authors: Mohamed E. Ali, Abdullah O. Nuhait and Redhwan Almuzaiqer.; The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this work through the Research Group Project No. (RGP-080).	Ali M, 2013, INT J THERM SCI, V63, P115, DOI 10.1016/j.ijthermalsci.2012.07.008; Aydin O, 1999, INT J HEAT MASS TRAN, V42, P2345, DOI 10.1016/S0017-9310(98)00319-6; Bejan, 1984, CONVECTION HEAT TRAN; Calcagni B, 2005, APPL THERM ENG, V25, P2522, DOI 10.1016/j.applthermaleng.2004.11.032; Cioni S, 1996, DYNAM ATMOS OCEANS, V24, P117, DOI 10.1016/0377-0265(95)00453-X; Corcione M, 2003, INT J THERM SCI, V42, P199, DOI 10.1016/S1290-0729(02)00019-4; Deng QH, 2008, INT J HEAT MASS TRAN, V51, P5949, DOI 10.1016/j.ijheatmasstransfer.2008.04.062; GANZAROLLI MM, 1995, INT J HEAT MASS TRAN, V38, P1063, DOI 10.1016/0017-9310(94)00217-J; INABA H, 1984, INT J HEAT MASS TRAN, V27, P1127, DOI 10.1016/0017-9310(84)90040-1; Kline SJ, 1953, MECH ENG, V75, P3, DOI DOI 10.1016/J.CHAOS.2005.11.046; KUYPER RA, 1993, INT J HEAT MASS TRAN, V36, P2899, DOI 10.1016/0017-9310(93)90109-J; Leong WH, 1999, INT J HEAT MASS TRAN, V42, P1979, DOI 10.1016/S0017-9310(98)00299-3; MARKATOS NC, 1984, INT J HEAT MASS TRAN, V27, P755, DOI 10.1016/0017-9310(84)90145-5; MOFFAT RJ, 1988, EXP THERM FLUID SCI, V1, P3, DOI 10.1016/0894-1777(88)90043-X; Nakano A, 1998, CHEM ENG J, V71, P175, DOI 10.1016/S1385-8947(98)00136-3; NOVEMBER M, 1987, INT J HEAT MASS TRAN, V30, P2433, DOI 10.1016/0017-9310(87)90233-X; OSTRACH S, 1988, J HEAT TRANS-T ASME, V110, P1175, DOI 10.1115/1.3250619; William D., 2003, MAT SCI ENG INTRO, P660	18	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0204251	10.1371/journal.pone.0204251	http://dx.doi.org/10.1371/journal.pone.0204251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379848	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700011
J	Choi, JH; Li, Y; Kim, SH; Jin, R; Kim, YH; Choi, W; You, IC; Yoon, KC				Choi, Jung Han; Li, Ying; Kim, Seon Ho; Jin, Rujun; Kim, Yung Hui; Choi, Won; You, In Cheon; Yoon, Kyung Chul			The influences of smartphone use on the status of the tear film and ocular surface	PLOS ONE			English	Article							DRY EYE DISEASE; CORNEAL EPITHELIAL-CELLS; INDUCED OXIDATIVE STRESS; COMPUTER VISION SYNDROME; BLUE-LIGHT; DISPLAY; SUPPLEMENTATION; MALONALDEHYDE; SYMPTOMS; DYNAMICS	Purpose To investigate the influences of smartphone use on ocular symptoms, status of the tear film, and oxidative stress indices in the tears and at the ocular surface. Methods Eighty healthy volunteers were enrolled in the study. Subjective symptoms and asthenopia were evaluated using the ocular surface disease index (OSDI), visual analogue scale (VAS), and computer vision syndrome (CVS) score before and after smartphone or computer display (control) use. The status of the tear film was evaluated using fluorescein film break-up time (FBUT), non-invasive keratograph break up time (NIKBUT), Schirmer score, keratoepitheliopathy (KEP), and tear meniscus height (TMH). Oxidative stress markers in the tear film including hexanoyl lysine (HEL), 4-hydroxy-2-nonenal (4-HNE), malondialdehyde (MDA), and 8-oxo-2'-deoxyguanosine (8-OHdG) in the tear film were measured using ELISA. Reactive oxygen species (ROS) at the ocular surface were measured through 2',7'-dichloro-dihydrofluorescein diacetate. All measurements were conducted at baseline, and after use for 1 and 4 h. Results All parameters showed no significant group-wise differences at baseline. Scores of OSDI, VAS, fatigue, burning sensation, and dryness showed significant increases after 1 and 4 h of smartphone use compared with those at baseline (all P < 0.05). The smartphone group showed higher OSDI, fatigue, burning, and dryness scores than the control group at 4 h. Smartphone use showed significantly decreased FBUT and NIBUT at 4 h than those at baseline (P < 0.01). In the smartphone group, the concentration of HEL significantly increased at 4 h compared with that at baseline and 1 h (P < 0.01). Both groups showed increased ROS with higher value in the smartphone group versus the control group at 4 h (P < 0.01). Conclusions Smartphone use could not only aggravate subjective symptom indices such as the OSDI, VAS, and CVS but also induce tear film instability and oxidative stress indices in the tears and at the ocular surface.	[Choi, Jung Han; Li, Ying; Jin, Rujun; Kim, Yung Hui; Choi, Won; Yoon, Kyung Chul] Chonnam Natl Univ, Dept Ophthalmol, Med Sch & Hosp, Gwangju, South Korea; [Kim, Seon Ho] MSC Res Inst, Gwangju, South Korea; [Kim, Seon Ho] Kim Seon Ho Eye Clin, Gwangju, South Korea; [Jin, Rujun; Yoon, Kyung Chul] Chonnam Natl Univ, Dept Biomed Sci, Gwangju, South Korea; [Jin, Rujun; Yoon, Kyung Chul] Chonnam Natl Univ, Ctr Creat Biomed Scientists, Gwangju, South Korea; [You, In Cheon] Chonbuk Natl Univ, Dept Ophthalmol, Med Sch & Hosp, Jeonju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Jeonbuk National University	Yoon, KC (corresponding author), Chonnam Natl Univ, Dept Ophthalmol, Med Sch & Hosp, Gwangju, South Korea.; Yoon, KC (corresponding author), Chonnam Natl Univ, Dept Biomed Sci, Gwangju, South Korea.; Yoon, KC (corresponding author), Chonnam Natl Univ, Ctr Creat Biomed Scientists, Gwangju, South Korea.	kcyoon@jnu.ac.kr		Kim, Yung Hui/0000-0002-0766-4454	Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science [2017R1A2B4003367]; Chonnam National University Hospital Biomedical Research Institute [CRI13906-22, CRI16020-1]	Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science; Chonnam National University Hospital Biomedical Research Institute	The study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science (https://www.nrf.re.kr/), ICT & Future Planning (http://english.msip.go.kr) (2017R1A2B4003367) and the Chonnam National University Hospital Biomedical Research Institute (http://www.cnuhcrin.com) (CRI13906-22 and CRI16020-1). The funders had no role in study design, data collection or analysis, in the decision to publish, or in manuscript preparation. The authors have no proprietary or commercial interest in any material described in this article.	Abdelfattah NS, 2015, CORNEA, V34, pS48, DOI 10.1097/ICO.0000000000000570; Alim-Marvasti A, 2016, NEW ENGL J MED, V374, P2502, DOI 10.1056/NEJMc1514294; Ames SL, 2005, OPTOMETRY VISION SCI, V82, P168, DOI 10.1097/01.OPX.0000156307.95086.6; Argiles M, 2015, INVEST OPHTH VIS SCI, V56, P6679, DOI 10.1167/iovs.15-16967; Bababekova Y, 2011, OPTOMETRY VISION SCI, V88, P795, DOI 10.1097/OPX.0b013e3182198792; Baek J, 2015, CORNEA, V34, P1209, DOI 10.1097/ICO.0000000000000575; Cardona G, 2011, CURR EYE RES, V36, P190, DOI 10.3109/02713683.2010.544442; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; Denoyer A, 2012, OPHTHALMOLOGY, V119, P1811, DOI 10.1016/j.ophtha.2012.03.004; Dogru M, 2001, OPHTHALMOLOGY, V108, P586, DOI 10.1016/S0161-6420(00)00599-6; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Gipson IK, 2007, OCUL SURF, V5, P179; Gowrisankaran S, 2015, WORK, V52, P303, DOI 10.3233/WOR-152162; Heo JY, 2017, J PSYCHIATR RES, V87, P61, DOI 10.1016/j.jpsychires.2016.12.010; Hirota M, 2013, OPTOMETRY VISION SCI, V90, P650, DOI 10.1097/OPX.0b013e31829962ec; Kato Y, 2000, BIOCHEM BIOPH RES CO, V274, P389, DOI 10.1006/bbrc.2000.3150; Kawabata F, 2011, BIOMED RES-TOKYO, V32, P387, DOI 10.2220/biomedres.32.387; Kim Dong Ju, 2017, Korean J Ophthalmol, V31, P388, DOI 10.3341/kjo.2016.0095; Kim J, 2016, OPHTHAL EPIDEMIOL, V23, P269, DOI 10.3109/09286586.2015.1136652; Kojima T, 2011, AM J OPHTHALMOL, V152, P933, DOI 10.1016/j.ajo.2011.05.025; Lee HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161041; Lee HS, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0213-5; Lee JB, 2014, INVEST OPHTH VIS SCI, V55, P4119, DOI 10.1167/iovs.13-13441; Moon JH, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0364-4; Niwano Y, 2014, BRIT J OPHTHALMOL, V98, P990, DOI 10.1136/bjophthalmol-2014-305205; Parihar J K S, 2016, Med J Armed Forces India, V72, P270, DOI 10.1016/j.mjafi.2016.03.016; Rosenfield M, 2011, OPHTHAL PHYSL OPT, V31, P502, DOI 10.1111/j.1475-1313.2011.00834.x; ROSSIGNOL AM, 1987, J OCCUP ENVIRON MED, V29, P112; Sen A, 2007, J Hum Ergol (Tokyo), V36, P45; Shen MX, 2008, AM J OPHTHALMOL, V145, P801, DOI 10.1016/j.ajo.2007.12.024; Singh R, 2005, BRIT J OPHTHALMOL, V89, P1655, DOI 10.1136/bjo.2005.073916; Tian L, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/8013621; TSUBOTA K, 1995, ARCH OPHTHALMOL-CHIC, V113, P155, DOI 10.1001/archopht.1995.01100020037025; Uchino M, 2013, AM J OPHTHALMOL, V156, P759, DOI 10.1016/j.ajo.2013.05.040; Wu HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105575; Yoon KC, 2007, CORNEA, V26, P431, DOI 10.1097/ICO.0b013e31803dcda2; Yoon KC, 2010, INVEST OPHTH VIS SCI, V51, P643, DOI 10.1167/iovs.09-3425	38	50	52	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206541	10.1371/journal.pone.0206541	http://dx.doi.org/10.1371/journal.pone.0206541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379901	Green Published, gold			2022-12-26	WOS:000448823700128
J	Patrnogic, J; Castillo, JC; Shokal, U; Yadav, S; Kenney, E; Heryanto, C; Ozakman, Y; Eleftherianos, I				Patrnogic, Jelena; Castillo, Julio Cesar; Shokal, Upasana; Yadav, Shruti; Kenney, Eric; Heryanto, Christa; Ozakman, Yaprak; Eleftherianos, Ioannis			Pre-exposure to non-pathogenic bacteria does not protect Drosophila against the entomopathogenic bacterium Photorhabdus	PLOS ONE			English	Article							RED FLOUR BEETLE; IMMUNE-RESPONSE; IMD PATHWAY; PATHOGENICITY; MELANOGASTER; SPECIFICITY; LUMINESCENS; MUTUALISM; MODEL; HOST	Immune priming in insects involves an initial challenge with a non-pathogenic microbe or exposure to a low dose of pathogenic microorganisms, which provides a certain degree of protection against a subsequent pathogenic infection. The protective effect of insect immune priming has been linked to the activation of humoral or cellular features of the innate immune response during the preliminary challenge, and these effects might last long enough to promote the survival of the infected animal. The fruit fly Drosophila melanogaster is a superb model to dissect immune priming processes in insects due to the availability of molecular and genetic tools, and the comprehensive understanding of the innate immune response in this organism. Previous investigations have indicated that the D. melanogaster immune system can be primed efficiently. Here we have extended these studies by examining the result of immune priming against two potent entomopathogenic bacteria, Photorhabdus luminescens and P. asymbiotica. We have found that rearing D. melanogasteron diet containing a non-pathogenic strain of Escherichia colialone or in combination with Micrococcus lute us upregulates the antibacterial peptide immune response in young adult flies, but it does not prolong fly life span. Also, subsequent intrathoracic injection with P. luminescens or P. asymbiotica triggers the Immune deficiency and Toll signaling pathways in flies previously exposed to a live or heat-killed mix of the non-pathogenic bacteria, but the immune activation fails to promote fly survival against the pathogens. These findings suggest that immune priming in D. melanogaster, and probably in other insects, is determined by the type of microbes involved as well as the mode of microbial exposure, and possibly requires a comprehensive and precise alteration of immune signaling and function to provide efficient protection against pathogenic infection.	[Patrnogic, Jelena; Castillo, Julio Cesar; Shokal, Upasana; Yadav, Shruti; Kenney, Eric; Heryanto, Christa; Ozakman, Yaprak; Eleftherianos, Ioannis] George Washington Univ, Dept Biol Sci, Infect & Innate Immun Lab, Washington, DC 20052 USA; [Castillo, Julio Cesar] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Eleftherianos, I (corresponding author), George Washington Univ, Dept Biol Sci, Infect & Innate Immun Lab, Washington, DC 20052 USA.	ioannise@gwu.edu	Sachar, upasana/G-2702-2017; Patrnogić, Jelena/AAV-3993-2021; Castillo, Julio C./AAC-3869-2020	Sachar, upasana/0000-0003-3850-4661; Castillo, Julio C./0000-0002-6921-810X; Eleftherianos, Ioannis/0000-0002-4822-3110				Aymeric JL, 2010, MOL IMMUNOL, V47, P2342, DOI 10.1016/j.molimm.2010.05.012; Chambers MC, 2012, CURR OPIN IMMUNOL, V24, P10, DOI 10.1016/j.coi.2011.11.003; Christofi Theodoulakis, 2013, F1000Res, V2, P76, DOI 10.12688/f1000research.2-76.v1; Clarke DJ, 2008, CELL MICROBIOL, V10, P2159, DOI 10.1111/j.1462-5822.2008.01209.x; Cooper D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00539; Costa SCP, 2010, MICROBES INFECT, V12, P182, DOI 10.1016/j.micinf.2009.12.003; Eleftherianos I, 2006, INSECT BIOCHEM MOLEC, V36, P517, DOI 10.1016/j.ibmb.2006.04.001; Eleftherianos I, 2014, INFECT IMMUN, V82, P4169, DOI 10.1128/IAI.02318-14; Eleftherianos I, 2010, TRENDS MICROBIOL, V18, P552, DOI 10.1016/j.tim.2010.09.006; Evans JD, 2004, J ECON ENTOMOL, V97, P752, DOI 10.1603/0022-0493(2004)097[0752:BPIAIR]2.0.CO;2; Ffrench-Constant R, 2003, FEMS MICROBIOL REV, V26, P433, DOI 10.1111/j.1574-6976.2003.tb00625.x; Freeman ZN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003201; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Gerrard JG, 2017, CURR TOP MICROBIOL, V402, P179, DOI 10.1007/82_2016_56; Hallem EA, 2007, CURR BIOL, V17, P898, DOI 10.1016/j.cub.2007.04.027; Issa N, 2018, MOL CELL, V69, P539, DOI 10.1016/j.molcel.2018.01.029; Joyce SA, 2006, CURR OPIN MICROBIOL, V9, P127, DOI 10.1016/j.mib.2006.01.004; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longdon B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073833; Masri Leila, 2014, Trends Immunol, V35, P471, DOI 10.1016/j.it.2014.08.005; Mikonranta L, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-23; Milutinovic B, 2016, ZOOLOGY, V119, P254, DOI 10.1016/j.zool.2016.03.006; Milutinovic B, 2014, J INNATE IMMUN, V6, P306, DOI 10.1159/000355211; Miyashita A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130486; Moreno-Garcia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133240; Patrnogic J, 2018, GENE; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Rodou A, 2010, TOXINS, V2, P1250, DOI 10.3390/toxins2061250; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Schmid-Hempel P, 2005, BIOESSAYS, V27, P1026, DOI 10.1002/bies.20282; ter Braak B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073600; Vlisidou I, 2012, ADV EXP MED BIOL, V710, P49, DOI 10.1007/978-1-4419-5638-5_6; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507	34	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205256	10.1371/journal.pone.0205256	http://dx.doi.org/10.1371/journal.pone.0205256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379824	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700034
J	Zeng, JH; Liang, XZ; Lan, HH; Zhu, X; Liang, XY				Zeng, Jiang-Hui; Liang, Xu-Zhi; Lan, Hui-Hua; Zhu, Xu; Liang, Xiu-Yun			The biological functions of target genes in pan-cancers and cell lines were predicted by miR-375 microarray data from GEO database and bioinformatics	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; TYROSINE AMINOTRANSFERASE; MICRORNA GENES; HUMAN LIVER; APOPTOSIS; VASORIN; PROTEIN; GROWTH; RADIOSENSITIVITY	Background MicroRNA is endogenous non-coding small RNA that negative regulate and control gene expression, and increasing evidence links microRNA to oncogenesis and the pathogenesis of cancer. The goal of this study was to explore the potential molecular mechanism of miR375 in various cancers. Methods MiR-375 overexpression in different tumor cell lines was probed with microarray data from Gene Expression Omnibus (GEO). The common target genes of miR-375 were obtained by Robust Rank Aggregation (RRA), and identified by miRWalk2.0 software for target gene prediction. Additionally, we directed in silico analysis including Protein-Protein Interactions (PPI) analysis, gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways annotations to provide a summary of the function of miR375 in various carcinomas. Eventually, data was obtained from The Cancer Genome Atlas (TCGA) were utilized for a validation in 7 cancers. Results The nine miR-375 related chips were acquired by the GEO data. The 5 down regulated genes came from 9 available microarray datasets, which overlapped with the potential target genes predicted by miRWalk2.0 software. The target genes were intensely enriched in amino acid biosynthetic and metabolic process from biological process (GO) and Cysteine and methionine metabolism (KEGG analysis). In view of these approaches, VASN, MAT2B, HERPUD1, TPAPPC6B and TAT are probably the most important miR-375 targets. In addition, miR-375 was negatively correlated with MAT2B, which was verified in 5 tumors of TCGA. Conclusion In summary, this study based on common target genes provides an innovative perspective for exploring the molecular mechanism of miR-375 in human tumors.	[Zeng, Jiang-Hui; Zhu, Xu; Liang, Xiu-Yun] Guangxi Med Univ, Nanning Peoples Hosp 2, Affiliated Hosp 3, Dept Clin Lab, Nanning, Guangxi Zhuang, Peoples R China; [Liang, Xu-Zhi] Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, Nanning, Guangxi Zhuang, Peoples R China; [Lan, Hui-Hua] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Clin Lab, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University	Zhu, X (corresponding author), Guangxi Med Univ, Nanning Peoples Hosp 2, Affiliated Hosp 3, Dept Clin Lab, Nanning, Guangxi Zhuang, Peoples R China.	617438231@qq.com						Belal C, 2012, HUM MOL GENET, V21, P963, DOI 10.1093/hmg/ddr502; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Blin K, 2015, NUCLEIC ACIDS RES, V43, pD160, DOI 10.1093/nar/gku1180; Brunet S, 2014, TRAFFIC, V15, P803, DOI 10.1111/tra.12183; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Clark E, 2017, ONCOTARGET, V8, P27569, DOI 10.18632/oncotarget.15174; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Huang AX, 2015, INT J BIOL SCI, V11, P961, DOI 10.7150/ijbs.11943; Huang WT, 2016, ONCOTARGETS THER, V9, P5163, DOI 10.2147/OTT.S108828; Huang WT, 2016, ONCOTARGETS THER, V9, P5061, DOI 10.2147/OTT.S111431; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ibrahim SA, 2014, FEBS J, V281, P5009, DOI 10.1111/febs.13026; Ikeda Y, 2004, P NATL ACAD SCI USA, V101, P10732, DOI 10.1073/pnas.0404117101; Jin EZ, 2015, INT J CLIN EXP PATHO, V8, P13928; Jin Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144187; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim JM, 2017, RNA BIOL, V14, P926, DOI 10.1080/15476286.2017.1311455; Kolde R, 2012, BIOINFORMATICS, V28, P573, DOI 10.1093/bioinformatics/btr709; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lassalle S, 2016, ONCOTARGET, V7, P30461, DOI 10.18632/oncotarget.8458; Latreille M, 2015, J MOL MED, V93, P1159, DOI 10.1007/s00109-015-1296-9; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lei Y, 2016, INT J ONCOL, V49, P981, DOI 10.3892/ijo.2016.3603; Li SH, 2015, ONCOTARGET, V6, P10045, DOI 10.18632/oncotarget.6631; Liu HT, 2016, ROLES MICRORNAS RELA; Liu SL, 2016, EUR REV MED PHARMACO, V20, P3223; Lo TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075628; Loher P, 2012, BIOINFORMATICS, V28, P3322, DOI 10.1093/bioinformatics/bts615; Luo J, 2014, MIR 375 SUPPRESSES I, V2014, DOI [10.1155/2014/374598, DOI 10.1155/2014/374598]; Maldonado LY, 2018, EXP BIOL MED, V243, P107, DOI 10.1177/1535370217740860; Mao L, 2016, INVOLVEMENT MICRORNA; Maragkakis M, 2011, NUCLEIC ACIDS RES, V39, pW145, DOI 10.1093/nar/gkr294; Marin-Valencia I, 2018, J MED GENET, V55, P48, DOI 10.1136/jmedgenet-2017-104627; Mehere P, 2010, PROTEIN CELL, V1, P1023, DOI 10.1007/s13238-010-0128-5; Nandi SS, 2016, DIABETES, V65, P3075, DOI 10.2337/db16-0023; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Papageorgiou L, 2016, BIOCHEM PHARMACOL, V117, P78, DOI 10.1016/j.bcp.2016.08.014; Paredes F, 2016, FREE RADICAL BIO MED, V90, P206, DOI 10.1016/j.freeradbiomed.2015.11.024; Patnaik SK, 2015, J THORAC ONCOL, V10, pE53, DOI 10.1097/JTO.0000000000000539; Peng H, 2015, AM J PATHOL, V185, P1135, DOI 10.1016/j.ajpath.2014.12.016; Peng H, 2013, HEPATOLOGY, V57, P2299, DOI 10.1002/hep.26258; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Shao YE, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/519705; Shen Y, 2013, BRIT J CANCER, V109, P92, DOI 10.1038/bjc.2013.308; Song LL, 2015, MED SCI MONITOR, V21, P2210, DOI 10.12659/MSM.893859; Streiner DL, 2018, J CLIN PSYCHOPHARM, V38, P5, DOI 10.1097/JCP.0000000000000828; Tomasi ML, 2017, ONCOTARGET, V8, P78851, DOI 10.18632/oncotarget.20234; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Vejnar CE, 2013, NUCLEIC ACIDS RES, V41, pW165, DOI 10.1093/nar/gkt430; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XZ, 2016, J PHARMACOL SCI, V130, P78, DOI 10.1016/j.jphs.2015.12.001; WANG Y, 2016, MOL CANCER, V15; Wei YP, 2016, TUMOR BIOL, V37, P12555, DOI 10.1007/s13277-016-5121-z; Xia M, 2010, J BIOL CHEM, V285, P20015, DOI 10.1074/jbc.M109.094821; Xu LL, 2016, ONCOTARGET, V7, P40644, DOI 10.18632/oncotarget.9811; Xu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099516; Yang L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174839; Ye XM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-134; Ye Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198055; Yonemori K, 2017, CANCER SCI, V108, P124, DOI 10.1111/cas.13119; Zaharie F, 2015, J GASTROINTEST LIVER, V24, P435, DOI 10.15403/jgld.2014.1121.244.375; Zhang B, 2017, CELL PHYSIOL BIOCHEM, V42, P2105, DOI 10.1159/000479913	68	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206689	10.1371/journal.pone.0206689	http://dx.doi.org/10.1371/journal.pone.0206689			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379973	Green Submitted, gold, Green Published			2022-12-26	WOS:000448823700144
J	Shukla, PS; Borza, T; Critchley, AT; Hiltz, D; Norrie, J; Prithiviraj, B				Shukla, Pushp Sheel; Borza, Tudor; Critchley, Alan T.; Hiltz, David; Norrie, Jeff; Prithiviraj, Balakrishnan			Ascophyllum nodosum extract mitigates salinity stress in Arabidopsis thaliana by modulating the expression of miRNA involved in stress tolerance and nutrient acquisition	PLOS ONE			English	Article							SMALL RNAS; REGULATED MICRORNAS; GENE-EXPRESSION; SALT TOLERANCE; PLANT; DROUGHT; GROWTH; TRANSCRIPTION; RESPONSES; SEAWEED	Ascophyllum nodosum extract (ANE) contains bioactive compounds that improve the growth of Arabidopsis in experimentally-induced saline conditions; however, the molecular mechanisms through which ANE elicits tolerance to salinity remain largely unexplored. Micro RNAs (miRNAs) are key regulators of gene expression, playing crucial roles in plant growth, development, and stress tolerance. Next generation sequencing of miRNAs from leaves of control Arabidopsis and from plants subjected to three treatments (ANE, NaCl and ANE+NaCl) was used to identify ANE-responsive miRNA in the absence and presence of saline conditions. Differential gene expression analysis revealed that ANE had a strong effect on miRNAs expression in both conditions. In the presence of salinity, ANE tended to reduce the up-regulation or the down-regulation trend induced caused by NaCl in miRNAs such as ath-miR396a-5p, ath-miR399, ath-miR2111b and ath-miR827. To further uncover the effects of ANE, the expression of several target genes of a number of ANE-responsive miRNAs was analyzed by qPCR. NaCl, but not ANE, down-regulated miR396a-5p, which negatively regulated the expression of AtGRF7 leading to a higher expression of AtDREB2a and AtRD29 in the presence of ANE+NaCl, as compared to ANE alone. ANE+NaCl initially reduced and then enhanced the expression of ath-miR169g-5p, while the expression of the target genes AtNFYA1 and ATNFYA2, known to be involved in the salinity tolerance mechanism, was increased as compared to ANE or to NaCl treatments. ANE and ANE+NaCl modified the expression of ath-miR399, ath-miR827, ath-miR2111b, and their target genes AtUBC24, AtWAK2, AtSYG1 and At3g27150, suggesting a role of ANE in phosphate homeostasis. In vivo and in vitro experiments confirmed the improved growth of Arabidopsis in presence of ANE, in saline conditions and in phosphate-deprived medium, further substantiating the influence of ANE on a variety of essential physiological processes in Arabidopsis including salinity tolerance and phosphate uptake.	[Shukla, Pushp Sheel; Borza, Tudor; Prithiviraj, Balakrishnan] Dalhousie Univ, Marine Bioprod Res Lab, Dept Plant Food & Environm Sci, Truro, NS, Canada; [Critchley, Alan T.; Hiltz, David; Norrie, Jeff] Acadian Seaplants Ltd, Res & Dev, Dartmouth, NS, Canada	Dalhousie University; Acadian Seaplants Limited	Prithiviraj, B (corresponding author), Dalhousie Univ, Marine Bioprod Res Lab, Dept Plant Food & Environm Sci, Truro, NS, Canada.	bprithiviraj@dal.ca	Critchley, Alan/AAB-1467-2019; Shukla, Pushp/AAA-9115-2020; Borza, Tudor/A-8510-2012; Borza, Tudor/M-4937-2019; Critchley, Alan/AAL-1706-2020; shukla, pushp s/I-3954-2014; shukla, pushp s/CAJ-2133-2022	Critchley, Alan/0000-0003-1704-458X; Borza, Tudor/0000-0002-2527-6551; Borza, Tudor/0000-0002-2527-6551; Critchley, Alan/0000-0003-1704-458X; Prithiviraj, Balakrishnan/0000-0002-9822-5261; Shukla, Pushp Sheel/0000-0002-0515-7870	Natural Sciences and Engineering Research Council of Canada [459260-13]; Accelerate Cluster grant from Mitacs, Canada [IT08347]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Accelerate Cluster grant from Mitacs, Canada	This project was supported partly by Collaborative Research and Development (CRD) grant (459260-13) from Natural Sciences and Engineering Research Council of Canada and Accelerate Cluster grant (IT08347) from Mitacs, Canada, awarded to Balakrishnan Prithiviraj. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salary for authors [PSS, TB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Agarwal PK, 2013, MOL BIOTECHNOL, V54, P102, DOI 10.1007/s12033-012-9538-3; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Ariel F, 2015, TRENDS PLANT SCI, V20, P362, DOI 10.1016/j.tplants.2015.03.003; Ariel F, 2010, PLANT CELL, V22, P2171, DOI 10.1105/tpc.110.074823; Barciszewska-Pacak M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00410; Battacharyya D, 2015, SCI HORTIC-AMSTERDAM, V196, P39, DOI 10.1016/j.scienta.2015.09.012; Blunden G, 1996, J APPL PHYCOL, V8, P535, DOI 10.1007/BF02186333; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Cao X, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1130; Chen Yung-Chia Ariel, 2015, Curr Mol Biol Rep, V1, P10; Chien CH, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav042; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Dai Xinbin, 2011, Nucleic Acids Res, V39, pW155, DOI 10.1093/nar/gkr319; Doerner P, 2008, CURR OPIN PLANT BIOL, V11, P536, DOI 10.1016/j.pbi.2008.05.006; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Galvan-Ampudia CS, 2011, CURR OPIN PLANT BIOL, V14, P296, DOI 10.1016/j.pbi.2011.03.019; Grattan S. R., 1999, HANDB PLANT CROP STR, V2, P203, DOI DOI 10.1201/9780824746728.CH9; Guerra D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00057; Hasegawa PM, 2013, ENVIRON EXP BOT, V92, P19, DOI 10.1016/j.envexpbot.2013.03.001; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jithesh MN, 2012, HORTSCIENCE, V47, P704, DOI 10.21273/HORTSCI.47.6.704; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kawa D, 2016, PLANT PHYSIOL, V172, P690, DOI 10.1104/pp.16.00712; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Khan W, 2009, J PLANT GROWTH REGUL, V28, P386, DOI 10.1007/s00344-009-9103-x; Khraiwesh Basel, 2012, Biochim Biophys Acta, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kim ED, 2012, TRENDS PLANT SCI, V17, P16, DOI 10.1016/j.tplants.2011.10.008; Kim JS, 2010, PLANTA, V232, P545, DOI 10.1007/s00425-010-1189-7; Kim JS, 2012, PLANT CELL, V24, P3393, DOI 10.1105/tpc.112.100933; Koevoets IT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01335; Kruszka K, 2014, J EXP BOT, V65, P6123, DOI 10.1093/jxb/eru353; Kruszka K, 2012, J PLANT PHYSIOL, V169, P1664, DOI 10.1016/j.jplph.2012.03.009; Lee WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127526; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061289; Liang G, 2010, PLANT SIGNAL BEHAV, V5, P1257, DOI 10.4161/psb.5.10.12608; Liu DM, 2009, PHYSIOL PLANTARUM, V136, P223, DOI 10.1111/j.1399-3054.2009.01229.x; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu TY, 2014, TRENDS PLANT SCI, V19, P647, DOI 10.1016/j.tplants.2014.06.004; Liu X, 2015, GENOM PROTEOM BIOINF, V13, P137, DOI 10.1016/j.gpb.2015.02.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu XY, 2008, BIOCHEM BIOPH RES CO, V368, P458, DOI 10.1016/j.bbrc.2008.02.007; Matsui A, 2013, INT J MOL SCI, V14, P22642, DOI 10.3390/ijms141122642; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nair P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-643; Naya L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084416; Nazar R, 2011, J PLANT PHYSIOL, V168, P807, DOI 10.1016/j.jplph.2010.11.001; Nigam D, 2015, GENE, V555, P127, DOI 10.1016/j.gene.2014.10.054; Pandey C, 2015, METALLOMICS, V7, P857, DOI [10.1039/c5mt00013k, 10.1039/C5MT00013K]; Pandey R, 2014, PLOS ONE, V9; Paul S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00232; Peng MS, 2007, PLANT J, V50, P320, DOI 10.1111/j.1365-313X.2007.03050.x; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Pieczynski M, 2013, PLANT BIOTECHNOL J, V11, P459, DOI 10.1111/pbi.12032; Prithiviraj B, 2011, U.S. Patent Application, Patent No. [12/936,074, 12936074]; Rausch C, 2002, PLANTA, V216, P23, DOI 10.1007/s00425-002-0921-3; Rayirath P, 2009, PLANTA, V230, P135, DOI 10.1007/s00425-009-0920-8; Rayorath P, 2008, J PLANT GROWTH REGUL, V27, P370, DOI 10.1007/s00344-008-9063-6; Rayorath P, 2008, J APPL PHYCOL, V20, P423, DOI 10.1007/s10811-007-9280-6; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; Roy SJ, 2011, CURR OPIN PLANT BIOL, V14, P232, DOI 10.1016/j.pbi.2011.03.002; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Shukla PS, 2018, AOB PLANTS, V10, DOI 10.1093/aobpla/plx051; Subramanian S, 2011, EUR J PLANT PATHOL, V131, P237, DOI 10.1007/s10658-011-9802-6; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Van Oosten MJ, 2017, CHEM BIOL TECHNOL AG, V4, DOI 10.1186/s40538-017-0089-5; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wally OSD, 2013, J PLANT GROWTH REGUL, V32, P324, DOI 10.1007/s00344-012-9301-9; Wang YN, 2009, J PLANT PHYSIOL, V166, P1637, DOI 10.1016/j.jplph.2009.04.009; Xie FL, 2015, J EXP BOT, V66, P789, DOI 10.1093/jxb/eru437; Xu MY, 2014, J EXP BOT, V65, P89, DOI 10.1093/jxb/ert353; Yadav NS, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-188; Yang FX, 2009, J PLANT BIOL, V52, P475, DOI 10.1007/s12374-009-9061-7; Zhang BH, 2015, J EXP BOT, V66, P1749, DOI 10.1093/jxb/erv013; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang XZ, 2004, CROP SCI, V44, P1737, DOI 10.2135/cropsci2004.1737; Zhang XZ, 1999, CROP SCI, V39, P545, DOI 10.2135/cropsci1999.0011183X003900020040x; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhu C, 2011, PHYSIOL PLANTARUM, V143, P1, DOI 10.1111/j.1399-3054.2011.01477.x	87	27	29	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206221	10.1371/journal.pone.0206221	http://dx.doi.org/10.1371/journal.pone.0206221			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372454	Green Published, Green Submitted, gold			2022-12-26	WOS:000448641200028
J	Mau, V; Arye, G; Gross, A				Mau, Vivian; Arye, Gilboa; Gross, Amit			Wetting properties of poultry litter and derived hydrochar	PLOS ONE			English	Article							SOIL-WATER REPELLENCY; HYDROTHERMAL CARBONIZATION; CONTACT-ANGLE; ORGANIC-MATTER; SEWAGE-SLUDGE; GAS EMISSIONS; BIOCHAR; COMBUSTION; BIOMASS; ENERGY	Detailed assessment of hydrochar wetting properties, which could provide an essential understanding of underlying mechanisms during its application to soils, is lacking. We characterized hydrochar produced from hydrothermal carbonization (HTC) performed on poultry litter at various temperatures and for different times in terms of hydrophobicity and surface free energy properties. Hydrochar was more hydrophobic than untreated poultry litter, and its hydrophobicity increased with increasing HTC temperature (contact angle > 130 degrees). These changes were correlated with degradation of hemicellulose and cellulose. Hydrochar produced at 250 degrees C contained mostly lignin and displayed high hydrophobicity over both prolonged wetting periods and repeated wetting cycles. Surface free energy was calculated using the Owens-Wendt-Rabel-Kaelble and Wu models, with the latter resulting in lower standard errors. The surface free energy decreased as HTC treatment severity increased from 26 mJ/m(2) in the poultry litter to 8 mJ/m(2 )after treatment at 250 degrees C for 60 min. The dispersive component fraction of the surface free energy increased with increasing treatment severity. This study demonstrated that changes in the physical composition of hydrochar due to increased treatment severity increase its hydrophobicity and decrease its surface free energy. Moreover, due to non-persistent hydrophobicity, hydrochar produced at temperatures lower than 250 degrees C will likely not show adverse effects on soils.	[Mau, Vivian; Gross, Amit] Ben Gurion Univ Negev, Zuckerberg Inst Water Res, Dept Environm Hydrol & Microbiol, Campus Sde Boger, Midreshet Ben Gurion, Israel; [Arye, Gilboa] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Campus Sde Boger, Midreshet Ben Gurion, Israel	Ben Gurion University; Ben Gurion University	Arye, G (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Campus Sde Boger, Midreshet Ben Gurion, Israel.	aryeg@bgu.ac.il	GROSS, AMIT/F-1464-2012	Mau, Vivian/0000-0002-8923-3649	Israeli Ministry of Environmental Protection [132-2-1]; Rosenzweig-Coopersmith Foundation; Israeli Ministry of National Infrastructures, Energy and Water Resources [216-01-044]; Israeli Ministry of Science and Technology [3-14568]; Rieger Foundation; Zuckerberg Scholarship Fund for Students at the Zuckerberg Institute for Water Research	Israeli Ministry of Environmental Protection; Rosenzweig-Coopersmith Foundation; Israeli Ministry of National Infrastructures, Energy and Water Resources; Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); Rieger Foundation; Zuckerberg Scholarship Fund for Students at the Zuckerberg Institute for Water Research	This study was funded by the Israeli Ministry of Environmental Protection (132-2-1, http://www.sviva.gov.il), and the Rosenzweig-Coopersmith Foundation. Vivian Mau received financial support from the Israeli Ministry of National Infrastructures, Energy and Water Resources (216-01-044, http://archive.energy.gov.il), the Israeli Ministry of Science and Technology (3-14568, https://www.gov.il/en/Departments/ministry_ of_ science_ and_ technology), the Rieger Foundation, and the Zuckerberg Scholarship Fund for Students at the Zuckerberg Institute for Water Research (http://in.bgu.ac.il/en/bidr/ziwr/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2013, GEODERMA, V202, P183, DOI 10.1016/j.geoderma.2013.03.003; Agegnehu G, 2015, SOIL RES, V53, P1, DOI 10.1071/SR14118; Ankom Technology, 2017, 6 ANK TECHN, P2; Ankom technology, 2017, 5 ANK TECHN, P2; Ankom technology, 2016, 8 ANK TECHN, P2; [Anonymous], 1970, USDA AGR HDB; Arye G, 2007, SOIL SCI SOC AM J, V71, P692, DOI 10.2136/sssaj2006.0239; Bachmann J, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002143; Bachmann J, 2000, J HYDROL, V231, P66, DOI 10.1016/S0022-1694(00)00184-0; Barrow CJ, 2012, APPL GEOGR, V34, P21, DOI 10.1016/j.apgeog.2011.09.008; BJORK H, 1995, FUEL, V74, P1887, DOI 10.1016/0016-2361(95)80024-C; Cantrell KB, 2012, BIORESOURCE TECHNOL, V107, P419, DOI 10.1016/j.biortech.2011.11.084; Chan KY, 2008, AUST J SOIL RES, V46, P437, DOI 10.1071/SR08036; Eibisch N, 2015, GEODERMA, V245, P31, DOI 10.1016/j.geoderma.2015.01.009; Ellerbrock RH, 2005, SOIL SCI SOC AM J, V69, P57, DOI 10.2136/sssaj2005.0057; Funke A, 2010, BIOFUEL BIOPROD BIOR, V4, P160, DOI 10.1002/bbb.198; Gasco G, 2018, WASTE MANAGE, V79, P395, DOI 10.1016/j.wasman.2018.08.015; Gault J., 2015, ANAL IMPLEMENTATION; Goebel MO, 2005, GEODERMA, V128, P80, DOI 10.1016/j.geoderma.2004.12.016; Goebel MO, 2004, SOIL SCI SOC AM J, V68, P383, DOI 10.2136/sssaj2004.0383; He C, 2013, APPL ENERG, V111, P257, DOI 10.1016/j.apenergy.2013.04.084; Horne DJ, 2000, J HYDROL, V231, P35, DOI 10.1016/S0022-1694(00)00181-5; Jeffery S, 2011, AGR ECOSYST ENVIRON, V144, P175, DOI 10.1016/j.agee.2011.08.015; KAELBLE DH, 1970, J ADHESION, V2, P66, DOI 10.1080/0021846708544582; Kambo HS, 2015, RENEW SUST ENERG REV, V45, P359, DOI 10.1016/j.rser.2015.01.050; Kambo HS, 2014, APPL ENERG, V135, P182, DOI 10.1016/j.apenergy.2014.08.094; Lal R, 2009, AGRON SUSTAIN DEV, V29, P113, DOI 10.1051/agro:2008044; Lehmann J., 2015, BIOCHAR ENV MANAGEME, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Libra JA, 2011, BIOFUELS-UK, V2, P71, DOI [10.4155/bfs.10.81, 10.4155/BFS.10.81]; Maimon A, 2017, CHEMOSPHERE, V184, P1012, DOI 10.1016/j.chemosphere.2017.06.080; Mau V, 2018, APPL ENERG, V213, P510, DOI 10.1016/j.apenergy.2017.11.033; Mau V, 2016, BIORESOURCE TECHNOL, V219, P632, DOI 10.1016/j.biortech.2016.08.027; OSHIDA Y, 1992, J MATER SCI-MATER M, V3, P306, DOI 10.1007/BF00705298; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; Peterson AA, 2008, ENERG ENVIRON SCI, V1, P32, DOI 10.1039/b810100k; Bach QV, 2015, FUEL PROCESS TECHNOL, V140, P297, DOI 10.1016/j.fuproc.2015.09.013; RUYTER HP, 1982, FUEL, V61, P1182, DOI 10.1016/0016-2361(82)90017-5; Schimmelpfennig S, 2014, AGR ECOSYST ENVIRON, V191, P39, DOI 10.1016/j.agee.2014.03.027; Shang J, 2008, J COLLOID INTERF SCI, V328, P299, DOI 10.1016/j.jcis.2008.09.039; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; Takaya CA, 2016, CHEMOSPHERE, V145, P518, DOI 10.1016/j.chemosphere.2015.11.052; TRETINNIKOV ON, 1994, LANGMUIR, V10, P1606, DOI 10.1021/la00017a047; United States Department of Agriculture. Foreign Agricultural Service, 2017, LIV POULTR WORLD MAR; Wiedner K, 2013, BIOMASS BIOENERG, V59, P264, DOI 10.1016/j.biombioe.2013.08.026; Williams CM, 2013, POULT DEV REV, P50, DOI DOI 10.1016/J.BIORTECH.2016.08.027; WU S, 1971, J POLYM SCI POL SYM, P19; Xing XJ, 2016, BIORESOURCES, V11, P9190, DOI 10.15376/biores.11.4.9190-9204; Zaini IN, 2017, FUEL PROCESS TECHNOL, V160, P109, DOI 10.1016/j.fuproc.2017.02.020; Zhao PT, 2014, ENERG CONVERS MANAGE, V78, P815, DOI 10.1016/j.enconman.2013.11.026	49	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206299	10.1371/journal.pone.0206299	http://dx.doi.org/10.1371/journal.pone.0206299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365507	Green Published, gold, Green Submitted			2022-12-26	WOS:000448448700041
J	Kuntze, G; Nettel-Aguirre, A; Ursulak, G; Robu, I; Bowerl, N; Goldstein, S; Emery, CA				Kuntze, Gregor; Nettel-Aguirre, Alberto; Ursulak, Gina; Robu, Ion; Bowerl, Nicole; Goldstein, Simon; Emery, Carolyn A.			Multi-joint gait clustering for children and youth with diplegic cerebral palsy	PLOS ONE			English	Article							DEVIATION INDEX; SPASTIC DIPLEGIA; DECISION-MAKING; PROFILE SCORE; CROUCH GAIT; PATTERNS; CLASSIFICATION; MANAGEMENT; PATHOLOGY	Background Clinical management of children and youth with cerebral palsy (CP) is increasingly supported by computerized gait analysis. Methods have been developed to reduce the complexity of interpreting biomechanical data and quantify meaningful movement patterns. However, few methods are inclusive of multiple joints and planes of motion, and consider the entire duration of gait phases; potentially limiting insight into this heterogeneous pathology. The objective of this study was to assess the implementation of k-means clustering to determine clusters of participants with CP based on multi-joint gait kinematics. Methods Barefoot walking kinematics were analyzed for a historical cohort (2007-2015) of 37 male and female children and youth with spastic diplegic CP [male n = 21; female n = 16; median age = 12 (range 5-25) years; Gross Motor Function Classification System Level I n = 17 and Level ll n = 20]. Mean stance phase hip (sagittal, coronal, transverse), knee (sagittal), and ankle (sagittal) kinematics were time (101 data points), mean and range normalized. Normalized kinematics data vectors (505 data points) for all participants were then combined in a single data matrix M (37x505 data points). K-means clustering was conducted 10 times for all data in M (2-5 seeds, 50 repetitions). Cluster quality was assessed using the mean Silhouette value M and cluster repeatability. The mean kinematic patterns of each cluster were explored with respect to a dataset of normally developing (ND) children using Statistical Parametric Mapping (SPM, alpha 0.05). Differences in potentially confounding variables (age, height, weight, walking speed) between clusters (C) were assessed individually in SPSS (IBM, USA) using Kruskal-Wallis H tests (alpha 0.05). Results Four clusters (n(1) = 5, n(2) = 12, n(3) = 12, n(4) = 8) provided the largest possible data separation based on high cluster repeatability (96.8% across 10 repetitions) and comparatively greater cluster quality [(s) over bar (SD), 0.275 (0.152)]. Participant data with low cluster quality values displayed a tendency toward lower cluster allocation repeatability. Distinct kinematic differences between clusters and ND data were observable. Specifically, C1 displayed a unique continuous hip abduction and external rotation pattern. In contrast, participants in C2 moved from hip adduction (loading response) to abduction (mid to terminal stance) and featured a unique ankle plantarflexor pattern during pre-swing. C3 was characterized by gait deviations in the sagittal plane of the hip, knee and ankle only. C4 displayed evidence for the most substantial hip and knee extension, and ankle plantarflexion deficit from midstance to preswing. Discussion K-means clustering enabled the determination of up to four kinematic clusters of individuals with spastic diplegic CP using multi-joint angles without a priori data reduction. A cluster boundary effect was demonstrated by the Silhouette value, where data with values approaching zero were more likely to change cluster allocation. Exploratory analyses using SPM revealed significant differences across joints and between clusters indicating the formation of clinically meaningful clusters. Further work is needed to determine the effects of including further topographical classifications of CP, additional biomechanical data, and the sensitivity to clinical interventions to assess the potential for informing clinical decision-making.	[Kuntze, Gregor; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Nettel-Aguirre, Alberto] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB, Canada; [Ursulak, Gina; Robu, Ion] Alberta Childrens Prov Gen Hosp, CH Riddell Movement Assessment Ctr, Calgary, AB, Canada; [Bowerl, Nicole] Univ Calgary, Schulich Sch Engn, Calgary, AB, Canada; [Goldstein, Simon] Alberta Childrens Prov Gen Hosp, Sect Pediat Orthopaed Surg, Calgary, AB, Canada	University of Calgary; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Calgary; Alberta Childrens Hospital; University of Calgary	Kuntze, G (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.	gkuntze@ucalgary.ca	Kuntze, Gregor/AAH-3158-2022; Kuntze, Gregor/AFM-0700-2022; Nettel-Aguirre, Alberto/ABB-9412-2021; Emery, Carolyn/AAI-2761-2020	Nettel-Aguirre, Alberto/0000-0001-6604-0652; Kuntze, Gregor/0000-0001-6674-7981; Emery, Carolyn Ann/0000-0002-9499-6691	Vi Riddell Pediatric Rehabilitation Research Program [Alberta Children's Hospital Foundation (ACHF)]; Alberta Innovates Technology Futures; ACHF; Vi Riddell Pediatric Rehabilitation Research Program	Vi Riddell Pediatric Rehabilitation Research Program [Alberta Children's Hospital Foundation (ACHF)]; Alberta Innovates Technology Futures; ACHF; Vi Riddell Pediatric Rehabilitation Research Program	This work was supported by the Vi Riddell Pediatric Rehabilitation Research Program [Alberta Children's Hospital Foundation (ACHF)] and Alberta Innovates Technology Futures. C Emery holds a Chair in Pediatric Rehabilitation supported by ACHF.; The authors would like to thank Dr. Elizabeth Condliffe for her invaluable insights in reviewing this manuscript. This work was supported by the Vi Riddell Pediatric Rehabilitation Research Program and Alberta Innovates Technology Futures.	Baker R, 2009, GAIT POSTURE, V30, P265, DOI 10.1016/j.gaitpost.2009.05.020; CDC, 2017, CER PALSY DAT STAT C; Chang FM, 2010, ORTHOP CLIN N AM, V41, P489, DOI 10.1016/j.ocl.2010.06.009; Cook RE, 2003, J PEDIATR ORTHOPED, V23, P292, DOI 10.1097/00004694-200305000-00004; Desloovere K, 2006, GAIT POSTURE, V24, P302, DOI 10.1016/j.gaitpost.2005.10.008; Dobson F, 2007, GAIT POSTURE, V25, P140, DOI 10.1016/j.gaitpost.2006.01.003; Fukunaga K., 2013, INTRO STAT PATTERN R; Goldstein Murray, 2001, Developmental Medicine and Child Neurology, V43, P563, DOI 10.1017/S0012162201001025; Kamruzzaman J, 2006, IEEE T BIO-MED ENG, V53, P2479, DOI 10.1109/TBME.2006.883697; Kedem P, 2016, CURR OPIN PEDIATR, V28, P55, DOI 10.1097/MOP.0000000000000316; McMulkin ML, 2015, GAIT POSTURE, V41, P608, DOI 10.1016/j.gaitpost.2015.01.005; Narayanan Unni G, 2012, J Pediatr Orthop, V32 Suppl 2, pS172, DOI 10.1097/BPO.0b013e31825eb2a6; Nieuwenhuys A, 2017, DEV MED CHILD NEUROL, V59, P750, DOI 10.1111/dmcn.13404; Nieuwenhuys A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169834; Nieuwenhuys A, 2016, DEV MED CHILD NEUROL, V58, P306, DOI 10.1111/dmcn.12892; Palisano RJ, 2009, PHYS OCCUP THER PEDI, V29, P133, DOI 10.1080/01942630902784746; Pataky TC, 2010, J BIOMECH, V43, P1976, DOI 10.1016/j.jbiomech.2010.03.008; Rasmussen HM, 2015, GAIT POSTURE, V42, P133, DOI 10.1016/j.gaitpost.2015.04.019; Rodda J, 2001, EUR J NEUROL, V8, P98, DOI 10.1046/j.1468-1331.2001.00042.x; Rodda JM, 2004, J BONE JOINT SURG BR, V86B, P251, DOI 10.1302/0301-620X.86B2.13878; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rozumalski A, 2009, GAIT POSTURE, V30, P155, DOI 10.1016/j.gaitpost.2009.05.010; Schwartz MH, 2008, GAIT POSTURE, V28, P351, DOI 10.1016/j.gaitpost.2008.05.001; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Wren TAL, 2011, GAIT POSTURE, V34, P364, DOI 10.1016/j.gaitpost.2011.06.002; Wren TAL, 2011, GAIT POSTURE, V34, P149, DOI 10.1016/j.gaitpost.2011.03.027	27	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205174	10.1371/journal.pone.0205174	http://dx.doi.org/10.1371/journal.pone.0205174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356242	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000037
J	Zahed, F; Berniker, M				Zahed, Fatemeh; Berniker, Max			Visual feedback of hand and target location does not explain the tendency for straight adapted reaches	PLOS ONE			English	Article							ENERGY-COST; ADAPTATION; REPRESENTATIONS; TRAJECTORIES; MOVEMENTS; DYNAMICS; SYSTEM	Subjects in laboratory settings exhibit straight hand paths-typified by the minimum jerk path-even in the presence of a learned but disturbing force field. At the same time it is known that in this setting, visual feedback strongly influences reaches, biasing them to be straight. Here we examine whether or not this bias can account for the straightness of movements made in a force field. We ran three curl field experiments to investigate how the lack of visual feedback influences adapted reaches. In a first experiment, hand position was displayed at the beginning and at the end of each trial, but extinguished during movement, and the hand was passively brought back to the home location. In the second experiment, visual feedback of neither the hand nor the target was provided, and targets were haptically rendered as "dimples." In order to provide extended practice, a third experiment was run with a single target and an active reach back to the home location. In all three cases we found minor changes in the adapted reaches relative to control groups that had full visual feedback. Our subjects adopted trajectories that were better explained by minimum jerk paths over those that minimize effort. The results indicate that for point-to-point reaching movements the visual feedback, or lack there of, cannot explain why reaches appear to be straight, even after adapting to a perturbing force field.	[Zahed, Fatemeh; Berniker, Max] Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zahed, F (corresponding author), Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60607 USA.	szahed3@uic.edu		Zahed, Fatemeh/0000-0002-1065-568X				ABEND W, 1982, BRAIN, V105, P331, DOI 10.1093/brain/105.2.331; Alexander RM, 1997, BIOL CYBERN, V76, P97, DOI 10.1007/s004220050324; Arce F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004214; Batcho CS, 2016, NEUROSCIENCE, V337, P267, DOI 10.1016/j.neuroscience.2016.09.020; Berniker M, 2009, P NATL ACAD SCI; Berniker M, 2015, FRONT COMPUT NEUROSC, V9, DOI [10.3389/fncom.7015.00032, 10.3389/fncom.2015.00032]; Berniker M, 2014, J NEUROPHYSIOL, V112, P2791, DOI 10.1152/jn.00615.2013; Berniker M, 2014, J NEUROPHYSIOL, V111, P1165, DOI 10.1152/jn.00493.2013; Berniker M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053759; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Dingwell JB, 2004, J NEUROPHYSIOL, V91, P1158, DOI 10.1152/jn.00704.2003; Farshchiansadegh A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004861; FLANAGAN JR, 1995, J NEUROPHYSIOL, V74, P2174, DOI 10.1152/jn.1995.74.5.2174; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Franklin DW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001336; Haggard P, 1996, J EXP PSYCHOL HUMAN, V22, P42, DOI 10.1037/0096-1523.22.1.42; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; HOGAN N, 1984, J NEUROSCI, V4, P2745; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Kistemaker DA, 2014, J NEUROPHYSIOL, V112, P1815, DOI 10.1152/jn.00291.2014; Kistemaker DA, 2010, J NEUROPHYSIOL, V104, P2985, DOI 10.1152/jn.00483.2010; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; MIALL RC, 1995, EXP BRAIN RES, V103, P421; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Nagengast AJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000419; Nakano E, 1999, J NEUROPHYSIOL, V81, P2140, DOI 10.1152/jn.1999.81.5.2140; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Sergio LE, 1998, EXP BRAIN RES, V122, P157, DOI 10.1007/s002210050503; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Spong MW, 1989, ROBOT DYNAMICS AND C, Vxvi; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; WOLPERT DM, 1995, EXP BRAIN RES, V103, P460	34	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206116	10.1371/journal.pone.0206116	http://dx.doi.org/10.1371/journal.pone.0206116			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356285	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000073
J	Kazmierczak, K; Liang, JS; Yuan, CC; Yadav, S; Sitbon, YH; Walz, K; Ma, WK; Irving, TC; Cheah, JX; Gomes, AV; Szczesna-Cordary, D				Kazmierczak, Katarzyna; Liang, Jingsheng; Yuan, Chen-Ching; Yadav, Sunil; Sitbon, Yoel H.; Walz, Katherina; Ma, Weikang; Irving, Thomas C.; Cheah, Jenice X.; Gomes, Aldrin V.; Szczesna-Cordary, Danuta			Slow-twitch skeletal muscle defects accompany cardiac dysfunction in transgenic mice with a mutation in the myosin regulatory light chain	FASEB JOURNAL			English	Article						cardioskeletal myopathy; muscle proteomics; R58Q-RLC mutation; X-ray diffraction	CROSS-BRIDGE KINETICS; HYPERTROPHIC CARDIOMYOPATHY; CA2+ BINDING; PHOSPHORYLATION; MODEL; IDENTIFICATION; DIAGNOSIS; MYOPATHY; DISEASE; FIBERS	Myosin light chain 2 (MYL2) gene encodes the myosin regulatory light chain (RLC) simultaneously in heart ventricles and in slow-twitch skeletal muscle. Using transgenic mice with cardiac-specific expression of the human R58Q-RLC mutant, we sought to determine whether the hypertrophic cardiomyopathy phenotype observed in papillary muscles (PMs) of R58Q mice is also manifested in slow-twitch soleus (SOL) muscles. Skinned SOL muscles and ventricular PMs of R58Q animals exhibited lower contractile force that was not observed in the fast-twitch extensor digitorum longus muscles of R58Q vs. wild-type-RLC mice, but mutant animals did not display gross muscle weakness in vivo. Consistent with SOL muscle abnormalities in R58Q vs. wild-type mice, myosin ATPase staining revealed a decreased proportion of fiber type I/type II only in SOL muscles but not in the extensor digitorum longus muscles. The similarities between SOL muscles and PMs of R58Q mice were further supported by quantitative proteomics. Differential regulation of proteins involved in energy metabolism, cell-cell interactions, and protein-protein signaling was concurrently observed in the hearts and SOL muscles of R58Q mice. In summary, even though R58Q expression was restricted to the heart of mice, functional similarities were clearly observed between the hearts and slow-twitch skeletal muscle, suggesting that MYL2 mutated models of hypertrophic cardiomyopathy may be useful research tools to study the molecular, structural, and energetic mechanisms of cardioskeletal myopathy associated with myosin RLC.Kazmierczak, K., Liang, J., Yuan, C.-C., Yadav, S., Sitbon, Y. H., Walz, K., Ma, W., Irving, T. C., Cheah, J. X., Gomes, A. V., Szczesna-Cordary, D. Slow-twitch skeletal muscle defects accompany cardiac dysfunction in transgenic mice with a mutation in the myosin regulatory light chain.	[Kazmierczak, Katarzyna; Liang, Jingsheng; Yuan, Chen-Ching; Yadav, Sunil; Sitbon, Yoel H.; Szczesna-Cordary, Danuta] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave,RMSB 6113, Miami, FL 33136 USA; [Walz, Katherina] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Dr John T Macdonald Fdn,Dept Human Genet, Miami, FL 33136 USA; [Ma, Weikang; Irving, Thomas C.] IIT, Dept Biol Sci, Chicago, IL 60616 USA; [Cheah, Jenice X.; Gomes, Aldrin V.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of Miami; University of Miami; Illinois Institute of Technology; University of California System; University of California Davis	Szczesna-Cordary, D (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave,RMSB 6113, Miami, FL 33136 USA.	dszczesna@miami.edu	Ma, Weikang/AAA-4847-2021	Ma, Weikang/0000-0001-9535-7114; Cheah, Jenice/0000-0002-0453-7433	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL123255, HL096819]; NIH National Institute of General Medical Sciences [9P41-GM103622]; American Heart Association [15PRE23020006, 17PRE33650085]; Department of Energy Office of Science [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); Department of Energy Office of Science(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Clemer Abad (Mouse Behavioral Core, University of Miami) for technical assistance. This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL123255 (to D.S.-C.) and HL096819 (to A.V.G.), NIH National Institute of General Medical Sciences Grant 9P41-GM103622 (to T.C.I.), and American Heart Association Grants 15PRE23020006 (to C.C.-Y.) and 17PRE33650085 (to S.Y.). This research used resources from the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357. Mass spectrometry was conducted with the use of the Q-Exactive Plus at the University of California, Davis Proteomic Core Facility. The authors declare no conflicts of interest.	Abraham TP, 2009, CARDIOVASC RES, V82, P84, DOI 10.1093/cvr/cvp016; Al-Salam S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086994; Alfares AA, 2015, GENET MED, V17, P880, DOI [10.1038/gim.2014.205, 10.1038/gim.2015.16]; Barth PG, 1998, NEUROMUSCULAR DISORD, V8, P296, DOI 10.1016/S0960-8966(98)00028-5; Bers DM, 2011, HEART RHYTHM, V8, P1101, DOI 10.1016/j.hrthm.2011.01.030; Bonetto A, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.101; CAFORIO ALP, 1989, J AM COLL CARDIOL, V14, P1464, DOI 10.1016/0735-1097(89)90383-5; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; de Boer Rudolf A, 2010, Curr Heart Fail Rep, V7, P1, DOI 10.1007/s11897-010-0004-x; Flavigny J, 1998, J MOL MED-JMM, V76, P208, DOI 10.1007/s001090050210; Geeves MA, 2002, NATURE, V415, P129, DOI 10.1038/415129a; Gomes AV, 2015, J MUSCLE RES CELL M, V36, P447, DOI 10.1007/s10974-015-9434-0; Greenberg MJ, 2010, P NATL ACAD SCI USA, V107, P17403, DOI 10.1073/pnas.1009619107; Greenberg MJ, 2009, J MOL CELL CARDIOL, V46, P108, DOI 10.1016/j.yjmcc.2008.09.126; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Gu RC, 2018, CELL PHYSIOL BIOCHEM, V46, P351, DOI 10.1159/000488435; Huang W, 2014, J MOL CELL CARDIOL, V74, P318, DOI 10.1016/j.yjmcc.2014.06.011; Kabaeva ZT, 2002, EUR J HUM GENET, V10, P741, DOI 10.1038/sj.ejhg.5200872; Kampourakis T, 2018, J MOL CELL CARDIOL, V117, P72, DOI 10.1016/j.yjmcc.2018.02.009; Karabina A, 2015, ARCH BIOCHEM BIOPHYS, V580, P14, DOI 10.1016/j.abb.2015.06.014; Karwi QG, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00068; Kerrick WGL, 2009, FASEB J, V23, P855, DOI 10.1096/fj.08-118182; Marian AJ, 2017, CIRC RES, V121, P749, DOI 10.1161/CIRCRESAHA.117.311059; Marston SB, 2001, J MUSCLE RES CELL M, V22, P1, DOI 10.1023/A:1010355716511; Mettikolla P, 2011, J THEOR BIOL, V284, P71, DOI 10.1016/j.jtbi.2011.06.014; Millman BM, 1998, PHYSIOL REV, V78, P359, DOI 10.1152/physrev.1998.78.2.359; Morner S, 2003, J MOL CELL CARDIOL, V35, P841, DOI 10.1016/S0022-2828(03)00146-9; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Obata K, 2005, BIOCHEM BIOPH RES CO, V338, P1299, DOI 10.1016/j.bbrc.2005.10.083; Oberg AL, 2008, J PROTEOME RES, V7, P225, DOI 10.1021/pr700734f; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Seidman CE, 1998, BASIC RES CARDIOL, V93, P13; Szczesna D, 2001, J BIOL CHEM, V276, P7086, DOI 10.1074/jbc.M009823200; Szczesna Danuta, 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P187, DOI 10.2174/1568006033481474; Szczesna-Cordary D, 2005, J CELL SCI, V118, P3675, DOI 10.1242/jcs.02492; Szczesna-Cordary D, 2004, J BIOL CHEM, V279, P3535, DOI 10.1074/jbc.M307092200; Tolosano E, 2002, DNA CELL BIOL, V21, P297, DOI 10.1089/104454902753759717; Vafiadaki E, 2014, FEBS J, V281, P3261, DOI 10.1111/febs.12859; Van Ry PM, 2015, MOL THER, V23, P1285, DOI 10.1038/mt.2015.105; Vianey-Saban C, 1998, CLIN CHIM ACTA, V269, P43, DOI 10.1016/S0009-8981(97)00185-X; Wang D., 2011, MOL CELL PROTEOMICS, V10; Wang L, 2013, J MOL CELL CARDIOL, V62, P153, DOI 10.1016/j.yjmcc.2013.05.012; Wang Y, 2006, J MOL BIOL, V361, P286, DOI 10.1016/j.jmb.2006.06.018; Weterman MAJ, 2013, BRAIN, V136, P282, DOI 10.1093/brain/aws293; Williams CD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0697; Yuan CC, 2018, P NATL ACAD SCI USA, V115, pE2338, DOI 10.1073/pnas.1716925115; Yuan CC, 2017, CARDIOVASC RES, V113, P1124, DOI 10.1093/cvr/cvx060; Yuan CC, 2015, P NATL ACAD SCI USA, V112, pE4138, DOI 10.1073/pnas.1505819112; Zhang L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/831092; Zhou ZQ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00240; Zolk O, 2006, CARDIOVASC RES, V70, P410, DOI 10.1016/j.cardiores.2005.12.021	53	7	7	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3152	3166		10.1096/fj.201801402R	http://dx.doi.org/10.1096/fj.201801402R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30365366	Green Published, Bronze			2022-12-26	WOS:000459794800007
J	Brumshtein, B; Esswein, SR; Sawaya, MR; Rosenberg, G; Ly, AT; Landau, M; Eisenberg, DS				Brumshtein, Boris; Esswein, Shannon R.; Sawaya, Michael R.; Rosenberg, Gregory; Ly, Alan T.; Landau, Meytal; Eisenberg, David S.			Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; antibody; crystallography; electron microscopy (EM); protein aggregation; light chain (LC); light-chain amyloidosis (AL); steric zipper; thioflavin T (ThT); variable domain (VL)	ALPHA-SYNUCLEIN STRAINS; FIBRIL FORMATION; PROTEINS; DESIGN; NOMENCLATURE; AGGREGATION; INSULIN; SUITE; AL-09; STATE	Systemic light-chain amyloidosis (AL) is a human disease caused by overexpression of monoclonal immunoglobulin light chains that form pathogenic amyloid fibrils. These amyloid fibrils deposit in tissues and cause organ failure. Proteins form amyloid fibrils when they partly or fully unfold and expose segments capable of stacking into -sheets that pair and thereby form a tight, dehydrated interface. These structures, termed steric zippers, constitute the spines of amyloid fibrils. Here, using a combination of computational (with ZipperDB and Boston University ALBase), mutational, biochemical, and protein structural analyses, we identified segments within the variable domains of Ig light chains that drive the assembly of amyloid fibrils in AL. We demonstrate that there are at least two such segments and that each one can drive amyloid fibril assembly independently of the other. Our analysis revealed that peptides derived from these segments form steric zippers featuring a typical dry interface with high-surface complementarity and occupy the same spatial location of the Greek-key immunoglobulin fold in both and variable domains. Of note, some predicted steric-zipper segments did not form amyloid fibrils or assembled into fibrils only when removed from the whole protein. We conclude that steric-zipper propensity must be experimentally validated and that the two segments identified here may represent therapeutic targets. In addition to elucidating the molecular pathogenesis of AL, these findings also provide an experimental approach for identifying segments that drive fibril formation in other amyloid diseases.	[Brumshtein, Boris; Esswein, Shannon R.; Sawaya, Michael R.; Rosenberg, Gregory; Ly, Alan T.; Eisenberg, David S.] Univ Calif Los Angeles, DOE Inst, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Brumshtein, Boris; Esswein, Shannon R.; Sawaya, Michael R.; Rosenberg, Gregory; Ly, Alan T.; Eisenberg, David S.] Univ Calif Los Angeles, DOE Inst, Howard Hughes Med Inst, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Landau, Meytal] Technion Israel Inst Technol, Dept Biol, IL-3200003 Haifa, Israel	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Technion Israel Institute of Technology	Eisenberg, DS (corresponding author), Univ Calif Los Angeles, DOE Inst, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.; Eisenberg, DS (corresponding author), Univ Calif Los Angeles, DOE Inst, Howard Hughes Med Inst, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu	Landau, Meytal/AAF-3479-2021; Landau, Meytal/J-3075-2012	Landau, Meytal/0000-0002-1743-3430; Landau, Meytal/0000-0002-1743-3430; Esswein, Shannon/0000-0002-5142-0190; Sawaya, Michael/0000-0003-0874-9043; Eisenberg, David/0000-0003-2432-5419	National Institutes of Health from the NIA [1R01AG048120-01]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055052, P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048120, RF1AG048120] Funding Source: NIH RePORTER	National Institutes of Health from the NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grant 1R01AG048120-01 from the NIA and the Howard Hughes Medical Institute. D.S.E. is an equity holder of ADRx, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams D, 2013, THER ADV NEUROL DISO, V6, P129, DOI 10.1177/1756285612470192; Andrich K, 2017, J BIOL CHEM, V292, P2328, DOI 10.1074/jbc.M116.750323; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Baden EM, 2008, J BIOL CHEM, V283, P30950, DOI 10.1074/jbc.M804822200; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Baden EM, 2009, CURR PROTEIN PEPT SC, V10, P500, DOI 10.2174/138920309789351949; Bellotti V, 2000, J STRUCT BIOL, V130, P280, DOI 10.1006/jsbi.2000.4248; Blancas-Mejia LM, 2015, BIOPHYS CHEM, V207, P13, DOI 10.1016/j.bpc.2015.07.005; Blancas-Mejia LM, 2013, ANNU REV BIOCHEM, V82, P745, DOI 10.1146/annurev-biochem-072611-130030; Bodi K, 2009, AMYLOID, V16, P1, DOI 10.1080/13506120802676781; Brumshtein B, 2014, J BIOL CHEM, V289, P27513, DOI 10.1074/jbc.M114.585638; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; BUXBAUM J, 1986, J CLIN INVEST, V78, P798, DOI 10.1172/JCI112643; DAHLIN DC, 1950, AM J PATHOL, V26, P581; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Eisenberg DS, 2017, ANNU REV BIOCHEM, V86, P69, DOI 10.1146/annurev-biochem-061516-045104; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; FRASER PE, 1991, J NEUROSCI RES, V28, P474, DOI 10.1002/jnr.490280404; FRASER PE, 1991, BIOPHYS J, V60, P1190, DOI 10.1016/S0006-3495(91)82154-3; GLENNER GG, 1971, SCIENCE, V172, P1150, DOI 10.1126/science.172.3988.1150; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; HOBBS JR, 1973, P ROY SOC MED, V66, P705, DOI 10.1177/003591577306600751; Hora M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181799; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Jones H.B., 1848, PHIL T ROY SOC LOND, V138, P55, DOI DOI 10.1098/RSTL.1848.0003; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Kyle RA, 2011, AMYLOID, V18, P6, DOI 10.3109/13506129.2011.574354001; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lefranc MP, 2001, EXP CLIN IMMUNOGENET, V18, P242, DOI 10.1159/000049203; Lefranc MP, 2001, EXP CLIN IMMUNOGENET, V18, P161, DOI 10.1159/000049195; MARCHALONIS JJ, 1989, FASEB J, V3, P2469, DOI 10.1096/fasebj.3.13.2509274; Martin DJ, 2010, AMYLOID, V17, P129, DOI 10.3109/13506129.2010.530081; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melki R, 2015, J PARKINSON DIS, V5, P217, DOI 10.3233/JPD-150543; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Olsen KE, 1998, BIOCHEM BIOPH RES CO, V251, P642, DOI 10.1006/bbrc.1998.9508; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Piehl DW, 2017, BIOMOL NMR ASSIGN, V11, P45, DOI 10.1007/s12104-016-9718-3; Piehl DW, 2017, ACS OMEGA, V2, P712, DOI 10.1021/acsomega.6b00494; Pinney JH, 2013, BRIT J HAEMATOL, V161, P525, DOI 10.1111/bjh.12286; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; RICHARDSON JS, 1992, BIOPHYS J, V63, P1186, DOI 10.1016/S0006-3495(92)81696-X; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall J, 1999, METHOD ENZYMOL, V309, P204; Wechalekar AD, 2016, LANCET, V387, P2641, DOI 10.1016/S0140-6736(15)01274-X; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	58	18	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19659	19671		10.1074/jbc.RA118.004142	http://dx.doi.org/10.1074/jbc.RA118.004142			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30355736	Green Published, hybrid			2022-12-26	WOS:000454294900014
J	Chen, LT; Ren, MW				Chen, Longtao; Ren, Mingwu			Multi-appearance segmentation and extended 0-1 programming for dense small object tracking	PLOS ONE			English	Article							MULTITARGET TRACKING; ALGORITHM; IMPLEMENTATION; GREEDY; MHT; SET	Aiming to address dense small object tracking, we propose an image-to-trajectory framework including tracking and detection, where Track-Oriented Multiple Hypothesis Tracking (TOMHT) is revised for tracking. Unlike common cases of multi-object tracking, merged detections and the greater number of objects make dense small object tracking a more challenging problem. Firstly, we handle frequent merged detections through the aspects of detection and hypothesis selection. To tackle merged detection, we revise Local Contrast Method(LCM) and propose a multi-appearance variant, which exploits tree-like topological information and realizes one threshold for one object. Meanwhile, one-to-many constraint is employed via the proposed extended 0-1 programming, which enables hypothesis selection to handle track exclusions caused by merged detections. Secondly, to alleviate the high complexity caused by dense objects, we consider batch optimization and more rigorous and precise pruning technologies. Specifically, we propose autocorrelation based motion score test and two-stage hypotheses pruning. Experimental results are presented to verify the strength of our methods, which indicates speed and performance advantages of our tracker.	[Chen, Longtao; Ren, Mingwu] Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China	Nanjing University of Science & Technology	Ren, MW (corresponding author), Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China.	mingwuren@163.com			National R&D Program for Major Research Instruments [61727802]; National Natural Science Foundation of China [61703209]; China Postdoctoral Science Foundation [2014M561654]	National R&D Program for Major Research Instruments; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National R&D Program for Major Research Instruments (Grant No. 61727802), by the National Natural Science Foundation of China (Grant No. 61703209) and by the China Postdoctoral Science Foundation (Grant No. 2014M561654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Shalom Y, 2007, IEEE T AERO ELEC SYS, V43, P392, DOI 10.1109/TAES.2007.357141; Berclaz J, 2011, IEEE T PATTERN ANAL, V33, P1806, DOI 10.1109/TPAMI.2011.21; Blackman S.S., 1999, DESIGN ANAL MODERN T; Blackman SS, 2004, IEEE AERO EL SYS MAG, V19, P5, DOI 10.1109/MAES.2004.1263228; Capponi A, 2004, IEEE T AERO ELEC SYS, V40, P1398, DOI 10.1109/TAES.2004.1386892; Chen CLP, 2014, IEEE T GEOSCI REMOTE, V52, P574, DOI 10.1109/TGRS.2013.2242477; Cox IJ, 1996, IEEE T PATTERN ANAL, V18, P138, DOI 10.1109/34.481539; Deb S, 1997, IEEE T AERO ELEC SYS, V33, P523, DOI 10.1109/7.575891; DEMOS GC, 1990, P SOC PHOTO-OPT INS, V1305, P297, DOI 10.1117/12.21598; Henriques JF, 2011, IEEE I CONF COMP VIS, P2470, DOI 10.1109/ICCV.2011.6126532; Jeong S, 2008, IEEE T AERO ELEC SYS, V44, P748, DOI 10.1109/TAES.2008.4560218; Jian-Yu Hsieh, 2007, Proceedings of the Fifth IASTED International Conference on Circuits, Signals, and Systems, P1, DOI 10.1145/1329125.1329139; Khan Z, 2005, PROC CVPR IEEE, P605; Kim C, 2015, IEEE I CONF COMP VIS, P4696, DOI 10.1109/ICCV.2015.533; Kim S, 2012, PATTERN RECOGN, V45, P393, DOI 10.1016/j.patcog.2011.06.009; Kirubarajan T, 2004, P IEEE, V92, P536, DOI 10.1109/JPROC.2003.823149; Koch W, 1997, IEEE T AERO ELEC SYS, V33, P883, DOI 10.1109/7.599263; Koch W, 1997, IEE CONF PUBL, P729, DOI 10.1049/cp:19971772; Leung H, 1999, IEEE T AERO ELEC SYS, V35, P663, DOI 10.1109/7.766946; Milan A., 2015, ARXIV150401942CS; MOREFIELD CL, 1977, IEEE T AUTOMAT CONTR, V22, P302, DOI 10.1109/TAC.1977.1101500; Murphey RA, 2010, DIMACS SERIES DISCRE, V40, P277; Perea F, 2011, IEEE T AERO ELEC SYS, V47, P1915, DOI 10.1109/TAES.2011.5937273; Pirsiavash H, 2011, PROC CVPR IEEE, P1201, DOI 10.1109/CVPR.2011.5995604; REID DB, 1979, IEEE T AUTOMAT CONTR, V24, P843, DOI 10.1109/TAC.1979.1102177; Ren XY, 2014, IEEE T AERO ELEC SYS, V50, P86, DOI 10.1109/TAES.2013.120041; Ristic B, 2011, IEEE T SIGNAL PROCES, V59, P3452, DOI 10.1109/TSP.2011.2140111; Robertson AJ, 2001, COMPUT OPTIM APPL, V19, P145, DOI 10.1023/A:1011285402433; Stiefelhagen R., 2006, INT EV WORKSH CLASS, P1; Wei YT, 2016, PATTERN RECOGN, V58, P216, DOI 10.1016/j.patcog.2016.04.002; Wu Z, 2011, PROC CVPR IEEE, P1185, DOI 10.1109/CVPR.2011.5995515; Zhang LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006286.pub2	33	2	3	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206168	10.1371/journal.pone.0206168	http://dx.doi.org/10.1371/journal.pone.0206168			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379889	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700092
J	Chun, KA; Kocarnik, JM; Hardikar, SS; Robinson, JR; Berndt, SI; Chan, AT; Figueiredo, JC; Lindor, NM; Song, M; Schoen, RE; Hayes, RB; Potter, JD; Nassir, R; Bezieau, S; Le Marchand, L; Slattery, ML; White, E; Peters, U; Newcomb, PA				Chun, Kelsey A.; Kocarnik, Jonathan M.; Hardikar, Sheetal S.; Robinson, Jamaica R.; Berndt, Sonja, I; Chan, Andrew T.; Figueiredo, Jane C.; Lindor, Noralane M.; Song, Mingyang; Schoen, Robert E.; Hayes, Richard B.; Potter, John D.; Nassir, Rami; Bezieau, Stephane; Le Marchand, Loic; Slattery, Martha L.; White, Emily; Peters, Ulrike; Newcomb, Polly A.			Leptin gene variants and colorectal cancer risk: Sex-specific associations	PLOS ONE			English	Article							ESTROGEN-RECEPTOR BETA; PLASMA ADIPONECTIN; COLON-CANCER; SERUM LEPTIN; BODY-MASS; ENCODING ADIPONECTIN; INSULIN-RESISTANCE; OBESITY; POLYMORPHISMS; EXPRESSION	Background High levels of serum leptin and low levels of serum adiponectin are strongly correlated with obesity, a well-established risk factor for colorectal cancer (CRC). Growing evidence suggests that dysregulation of leptin and adiponectin levels may play an etiological role in colorectal carcinogenesis. We evaluated 20 candidate variants in 4 genes previously shown to alter serum leptin and adiponectin levels for associations with obesity (BMI>30 kg/m(2)) and CRC risk. Methods We analyzed 6,246 CRC cases and 7,714 population-based controls from 11 studies within the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO). Associations of each variant with obesity or CRC were evaluated using multivariate logistic regression models stratified by sex and adjusted for age, a study variable, and the first three principal components of genetic ancestry. Gene-specific False Discovery Rate (FDR)-adjusted p-values <0.05 denoted statistical significance. Results Two variants in the leptin gene showed statistically significant associations with CRC among women: LEP rs2167270 (OR = 1.13, 95% CI: 1.06-1.21) and LEP rs4731426 (OR = 1.09, 95% CI: 1.02-1.17). These associations remained significant after adjustment for obesity, suggesting that leptin SNPs may influence CRC risk independent of obesity. We observed statistically significant interactions of the leptin variants with hormone replacement therapy (HRT) for CRC risk; these variant associations were strengthened when analyses were restricted to post-menopausal women with low estrogen exposure, as estimated by 'never use' of HRT and/or non-obese BMI. No variants were associated with CRC among men. Conclusions Leptin gene variants may exhibit sex-specific associations with CRC risk. Endogenous and exogenous estrogen exposure may modify the association between these variants, leptin levels, and CRC risk.	[Chun, Kelsey A.; Kocarnik, Jonathan M.; Hardikar, Sheetal S.; Robinson, Jamaica R.; Potter, John D.; White, Emily; Peters, Ulrike; Newcomb, Polly A.] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA; [Kocarnik, Jonathan M.; Robinson, Jamaica R.] Univ Washington, Inst Translat Hlth Sci, Seattle, WA 98195 USA; [Hardikar, Sheetal S.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Berndt, Sonja, I] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Chan, Andrew T.; Song, Mingyang] Massachusetts Gen Hosp, Div Gastroenterol, Cambridge, MA USA; [Chan, Andrew T.; Song, Mingyang] Harvard Med Sch, Cambridge, MA USA; [Figueiredo, Jane C.] Univ Southern Calif, Dept Prevent Med, Los Angeles, CA USA; [Figueiredo, Jane C.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Lindor, Noralane M.] Mayo Clin, Dept Hlth Sci Res, Scottsdale, AZ USA; [Song, Mingyang] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA; [Song, Mingyang] Harvard Med Sch, Boston, MA USA; [Song, Mingyang] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Schoen, Robert E.] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [Hayes, Richard B.] NYU, Sch Med, Dept Populat Hlth, Div Epidemiol, New York, NY USA; [Potter, John D.; White, Emily; Peters, Ulrike; Newcomb, Polly A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Nassir, Rami] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Bezieau, Stephane] Univ Nantes, Serv Genet Med, Nantes, France; [Le Marchand, Loic] Univ Hawaii, Canc Ctr, Epidemiol Program, Honolulu, HI 96822 USA; [Slattery, Martha L.] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Salt Lake City, UT USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; University of Southern California; Cedars Sinai Medical Center; Mayo Clinic; Mayo Clinic Phoenix; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University; University of Washington; University of Washington Seattle; University of California System; University of California Davis; Nantes Universite; Cancer Research Center of Hawaii; University of Hawaii System; Utah System of Higher Education; University of Utah	Chun, KA (corresponding author), Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA.	kchun@fredhutch.org	Nassir, Rami/ABC-2996-2021; Robinson, Jamaica/AAB-2024-2020	Hayes, Richard/0000-0002-0918-661X	National Institutes of Health (NIH) [P30 CA015704]; National Cancer Institute (NCI) [3 P30 CA015704-41S1]; NCI [KL2 TR000421, U01 CA137088, R01 CA059045];  [K05 CA152715]; NATIONAL CANCER INSTITUTE [K05CA152715, K07CA222060, U01CA167551, U01CA137088, T32CA094880, P30CA015704] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000421] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Institutes of Health (NIH) P30 CA015704; National Cancer Institute (NCI) 3 P30 CA015704-41S1; K05 CA152715 (PN); NCI KL2 TR000421 (JK); U01 CA137088 (UP); R01 CA059045 (UP).	Adams KF, 2007, AM J EPIDEMIOL, V166, P36, DOI 10.1093/aje/kwm049; Al-Harithy RN, 2012, ONCOL LETT, V3, P176, DOI 10.3892/ol.2011.443; Aleksandrova K, 2012, CANCER RES, V72, P5328, DOI 10.1158/0008-5472.CAN-12-0465; [Anonymous], 2000, WHO TECHN REP SER; Arita Y, 2012, BIOCHEM BIOPH RES CO, V425, P560, DOI 10.1016/j.bbrc.2012.08.024; Arpaci F, 2002, TUMORI, V88, P147, DOI 10.1177/030089160208800213; Baumgartner RN, 1999, OBES RES, V7, P141, DOI 10.1002/j.1550-8528.1999.tb00695.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Chia VM, 2007, CANCER EPIDEM BIOMAR, V16, P2697, DOI 10.1158/1055-9965.EPI-07-0467; Cleary Margot P, 2009, Front Biosci (Schol Ed), V1, P329, DOI 10.2741/e30; Dasgupta S, 2015, ADIPOCYTE, V4, P135, DOI 10.4161/21623945.2014.975538; Fan SH, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-15; Foley EF, 2000, CANCER RES, V60, P245; Gialamas SP, 2011, METABOLISM, V60, P1530, DOI 10.1016/j.metabol.2011.03.020; Guo X, 2015, GENET TEST MOL BIOMA, V19, P9, DOI 10.1089/gtmb.2014.0238; Guo XQ, 2006, DIABETES, V55, P1723, DOI 10.2337/db05-0428; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Hardwick JCH, 2001, GASTROENTEROLOGY, V121, P79, DOI 10.1053/gast.2001.25490; Havel PJ, 2004, DIABETES, V53, pS143, DOI 10.2337/diabetes.53.2007.S143; Hoffmeister M, 2007, BRIT J CANCER, V97, P1486, DOI 10.1038/sj.bjc.6604066; Hoffstedt J, 2002, HORM METAB RES, V34, P355, DOI 10.1055/s-2002-33466; Hu XQ, 2015, ANN HUM BIOL, V42, P560, DOI 10.3109/03014460.2014.1002532; Hu XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126012; Joshi RK, 2014, WORLD J GASTROENTERO, V20, P7941, DOI 10.3748/wjg.v20.i24.7941; Kaklamani VG, 2008, JAMA-J AM MED ASSOC, V300, P1523, DOI 10.1001/jama.300.13.1523; Kim AY, 2010, MOL ENDOCRINOL, V24, P1441, DOI 10.1210/me.2009-0498; Kraus WL, 1997, J STEROID BIOCHEM, V63, P175, DOI 10.1016/S0960-0760(97)00089-7; Kumor A, 2009, INT J COLORECTAL DIS, V24, P275, DOI 10.1007/s00384-008-0605-y; Laumen H, 2009, DIABETES, V58, P984, DOI 10.2337/db07-1646; Li YX, 2015, ARCH MED RES, V46, P38, DOI 10.1016/j.arcmed.2014.11.012; Liu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027301; Liu PC, 2014, TUMOR BIOL, V35, P8133, DOI 10.1007/s13277-014-2088-5; Lukanova A, 2006, CANCER EPIDEM BIOMAR, V15, P401, DOI 10.1158/1055-9965.EPI-05-0836; Ma Y., 2013, PLOS ONE, V8; Marcello MA, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/173218; Marginean C, 2016, MEDICINE, V95; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; MCMICHAEL AJ, 1980, J NATL CANCER I, V65, P1201; Menzaghi C, 2002, DIABETES, V51, P2306, DOI 10.2337/diabetes.51.7.2306; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Ong KL, 2010, EUR J ENDOCRINOL, V163, P251, DOI 10.1530/EJE-10-0251; Partida-Perez M, 2010, CANCER BIOMARK, V7, P117, DOI 10.3233/CBM-2010-0154; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Prakash J, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.154773; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Roszkowska-Gancarz M, 2012, ENDOKRYNOL POL, V63, P439; Rudolph A, 2012, BRIT J CANCER, V107, P831, DOI 10.1038/bjc.2012.323; Shahid A, 2015, J BIOSCIENCES, V40, P521, DOI 10.1007/s12038-015-9536-2; Shen MQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151455; Slattery ML, 2008, INT J CANCER, V122, P1611, DOI 10.1002/ijc.23135; Song MY, 2013, CANCER PREV RES, V6, P875, DOI 10.1158/1940-6207.CAPR-13-0169; Stattin P, 2003, ONCOL REP, V10, P2015; Tae CH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-811; Tamakoshi K, 2005, ONCOLOGY-BASEL, V68, P454, DOI 10.1159/000086988; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Terry PD, 2002, GUT, V51, P191, DOI 10.1136/gut.51.2.191; Tso AWK, 2006, DIABETOLOGIA, V49, P1806, DOI 10.1007/s00125-006-0324-2; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Wang DY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14283; Wang YT, 2007, CANCER CAUSE CONTROL, V18, P793, DOI 10.1007/s10552-007-9009-5; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Williams C, 2016, CANCER LETT, V372, P48, DOI 10.1016/j.canlet.2015.12.009; Xu XT, 2011, J DIGEST DIS, V12, P234, DOI 10.1111/j.1751-2980.2011.00504.x; Yamaji T, 2010, CANCER RES, V70, P5430, DOI 10.1158/0008-5472.CAN-10-0178; Ye CC, 2013, INT J MED SCI, V10, P1113, DOI 10.7150/ijms.6843; Yi Kyong W, 2012, OBESITY, V16, P2393	69	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206519	10.1371/journal.pone.0206519	http://dx.doi.org/10.1371/journal.pone.0206519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379922	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700125
J	Ho, R; Song, LD; Choi, JA; Jee, D				Ho, Ra; Song, Lina D.; Choi, Jin A.; Jee, Donghyun			The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea	PLOS ONE			English	Article							SUBFOVEAL CHOROIDAL NEOVASCULARIZATION; PHOTODYNAMIC THERAPY; VISUAL IMPAIRMENT; NATURAL-HISTORY; ECONOMIC BURDEN; CLINICAL-TRIAL; RANIBIZUMAB; VERTEPORFIN; BEVACIZUMAB; AFLIBERCEPT	Background Interventions that can facilitate early diagnosis of age-related macular degeneration (AMD) will facilitate early treatment and improve clinical outcomes but there has been concerns about additional medical costs to the health care system. An examination through a retina fundus photography by a non-specialist has been suggested as a potential cost-effective alternative to a direct examination by a specialist, but limited scientific data exists on the cost-effectiveness of screening strategies for AMD. Our objective is to conduct an economic evaluation of various population-wide screening strategies for AMD among the South Korean population. Methods and findings Using a Markov cohort model, we evaluated the cost-effectiveness of four AMD screening strategies (opportunistic examination, opportunistic treatment, systematic photography, and systematic examination) in comparison with status quo (no screening) for South Korean adults. We projected a life time horizon to study a hypothetical cohort of 100,00 persons of age 40 with and without AMD at baseline. The outcome measures were quality-adjusted life-years (QALYs) gained, cost from the societal perspective, and the incremental cost-effectiveness ratio (ICER) of each strategy. Interventions were evaluated at a willingness-to-pay (WTP) threshold of 30,000,000 KRW ($27,538) per QALY gained. Deterministic and probabilistic sensitivity analyses were conducted to address the model uncertainty. Opportunistic examination was strongly dominated because it generated fewer expected QALYs but incurred greater expected cost than the other screening strategies. The mean lifetime expected costs were 289,013 KRW, 363,692 KRW, 9,351,964 KRW, and 12,309,783 KRW, and the mean QALYs gained were 37.73, 37.75, 40.47, 40.68, for no screening, opportunistic treatment, systematic photography, and systematic examination, respectively. The results were most sensitive to the utility weight of mild AMD, the probability of complication from treatment, the cost of being in mild AMD, and the probability of recovery from complication. After eliminating the two weakly dominated strategies, systematic photography was cost-effective at the ICER of 3,310,448 KRW per QALY in comparison to status quo. Conclusions Under the WTP threshold of 30,000,000 KRW per QALY, systematic photography is cost-effective for screening AMD in South Korean adults. Systematic examination by ophthalmologists generates more expected QALY and cost compared to systematic photography.	[Ho, Ra] Catholic Univ Korea, Bucheon St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Bucheon, South Korea; [Song, Lina D.] Harvard Univ, PhD Program Hlth Policy, Cambridge, MA 02138 USA; [Choi, Jin A.; Jee, Donghyun] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Harvard University; Catholic University of Korea	Jee, D (corresponding author), Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	donghyunjee@catholic.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HC16C2299, HI17C1234]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC16C2299 and HI17C1234). The content is solely the responsibility of the authors and does not necessarily represent the official views of the KHIDI.	Arnold J, 2001, AM J OPHTHALMOL, V131, P541; Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Brown GC, 2000, ARCH OPHTHALMOL-CHIC, V118, P47; Brown MM, 2006, CURR OPIN OPHTHALMOL, V17, P257; Brown MM, 2001, OPHTHALMOLOGY, V108, P643, DOI 10.1016/S0161-6420(00)00635-7; Chan CKW, 2015, OPHTHALMOLOGY, V122, P2278, DOI 10.1016/j.ophtha.2015.06.050; CHIANG YP, 1992, MILBANK Q, V70, P319, DOI 10.2307/3350062; Cruess AF, 2008, PHARMACOECONOMICS, V26, P57, DOI 10.2165/00019053-200826010-00006; Elshout M, 2014, GRAEF ARCH CLIN EXP, V252, P1911, DOI 10.1007/s00417-014-2641-3; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jain S, 2006, EYE, V20, P471, DOI 10.1038/sj.eye.6701916; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1439, DOI 10.1001/archopht.119.10.1439; La TY, 2014, CURR EYE RES, V39, P1232, DOI 10.3109/02713683.2014.907431; Lin DY, 2002, AM J OPHTHALMOL, V134, P204, DOI 10.1016/S0002-9394(02)01522-2; Loewenstein A, 2007, RETINA-J RET VIT DIS, V27, P873, DOI 10.1097/IAE.0b013e318050d2ec; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Meads C, 2003, Health Technol Assess, V7, pv; Moja L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011230.pub2; Myers CE, 2014, OPHTHALMOLOGY, V121, P1949, DOI 10.1016/j.ophtha.2014.04.040; National Health Insurance Service (NHIS) K, HLTH INS GUID; Newsom RSB, 2001, BRIT J OPHTHALMOL, V85, P173, DOI 10.1136/bjo.85.2.173; Park JH, 2008, INT J CARDIOL, V128, P392, DOI 10.1016/j.ijcard.2007.04.114; Pascolini D, 2004, OPHTHAL EPIDEMIOL, V11, P67, DOI 10.1076/opep.11.2.67.28158; Patel JJ, 2012, J EVAL CLIN PRACT, V18, P247, DOI 10.1111/j.1365-2753.2010.01546.x; Peto T, 2012, CURR DIABETES REP, V12, P338, DOI 10.1007/s11892-012-0285-4; Prescott G, 2014, BRIT J OPHTHALMOL, V98, P1042, DOI 10.1136/bjophthalmol-2013-304338; Rein DB, 2006, ARCH OPHTHALMOL-CHIC, V124, P1754, DOI 10.1001/archopht.124.12.1754; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schmid MK, 2015, BRIT J OPHTHALMOL, V99, P141, DOI 10.1136/bjophthalmol-2014-305149; Sharma S, 2000, CAN J OPHTHALMOL, V35, P267, DOI 10.1016/S0008-4182(00)80077-0; Singh A, 2007, EYE, V21, P302, DOI 10.1038/sj.eye.6702565; Smith DH, 2004, BRIT J OPHTHALMOL, V88, P1107, DOI 10.1136/bjo.2003.023986; Stein Joshua D, 2013, Trans Am Ophthalmol Soc, V111, P56; Sternberg P, 2004, AM J OPHTHALMOL, V137, P483, DOI 10.1016/j.ajo.2003.11.023; Tamura H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133628; van Katwyk S, 2017, VALUE HEALTH, V20, P1034, DOI 10.1016/j.jval.2017.04.015; Wang JJ, 2000, CLIN EXP OPHTHALMOL, V28, P268, DOI 10.1046/j.1442-9071.2000.00315.x; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Wright SE, 2000, CLIN EXP OPHTHALMOL, V28, P140, DOI 10.1046/j.1442-9071.2000.00296.x; Yazdi MH, 2015, EXPERT OPIN BIOL TH, V15, P1349, DOI 10.1517/14712598.2015.1057565	45	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206690	10.1371/journal.pone.0206690	http://dx.doi.org/10.1371/journal.pone.0206690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379971	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700145
J	Hogberg, U; Andersson, J; Squier, W; Hogberg, G; Fellman, V; Thiblin, I; Wester, K				Hogberg, Ulf; Andersson, Jacob; Squier, Waney; Hogberg, Goren; Fellman, Vineta; Thiblin, Ingemar; Wester, Knut			Epidemiology of subdural haemorrhage during infancy: A population-based register study	PLOS ONE			English	Article							BENIGN EXTERNAL HYDROCEPHALUS; TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; SUBARACHNOID SPACES; FLUID COLLECTION; YOUNG-CHILDREN; HEMATOMA; ENLARGEMENT; COMPLICATIONS; PREVALENCE	Objectives To analyse subdural haemorrhage (SDH) during infancy in Sweden by incidence, SDH category, diagnostic distribution, age, co-morbidity, mortality, and maternal and perinatal risk factors; and its association with accidents and diagnosis of abuse. Methods A Swedish population-based register study comprising infants born between 1997 and 2014, 0-1 years of age, diagnosed with SDH-diagnoses according to the (International Classification of Diseases, 10th version (ICD10), retrieved from the National Patient Register and linked to the Medical Birth Register and the Death Cause Register. Outcome measures were: 1) Incidence and distribution, 2) co-morbidity, 3) fall accidents by SDH category, 4) risk factors for all SDHs in the two age groups, 0-6 and 7-365 days, and for ICD10 SDH subgroups: S06.5 (traumatic SDH), I62.0 (acute nontraumatic), SDH and abuse diagnosis. Results Incidence of SDH was 16.5 per 100 000 infants (n = 306). Median age was 2.5 months. For infants older than one week, the median age was 3.5 months. Case fatality was 6.5%. Male sex was overrepresented for all SDH subgroups. Accidental falls were reported in 1/3 of the cases. One-fourth occurred within 0-6 days, having a perinatal risk profile. For infants aged 7-365 days, acute nontraumatic SDH was associated with multiple birth, preterm birth, and small-for-gestational age. Fourteen percent also had an abuse diagnosis, having increased odds of being born preterm, and being small-for-gestational age. Conclusions The incidence was in the range previously reported. SDH among newborns was associated with difficult birth and neonatal morbidity. Acute nontraumatic SDH and SDH with abuse diagnosis had similar perinatal risk profiles. The increased odds for acute nontraumatic SDH in twins, preterm births, neonatal convulsions or small-for-gestational age indicate a perinatal vulnerability for SDH beyond 1st week of life. The association between prematurity/small-for-gestational age and abuse diagnosis is intriguing and not easily understood.	[Hogberg, Ulf] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Andersson, Jacob; Thiblin, Ingemar] Uppsala Univ, Dept Surg Sci, Forens Med, Uppsala, Sweden; [Squier, Waney] Univ Oxford, John Radcliffe Hosp, Dept Neuropathol, Oxford, England; [Hogberg, Goren] Karolinska Inst, Child & Adolescent Psychiat Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Fellman, Vineta] Lund Univ, Dept Clin Sci, Pediat, Lund, Sweden; [Fellman, Vineta] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Fellman, Vineta] Folkhalsan Res Ctr, Helsinki, Finland; [Wester, Knut] Univ Bergen, Dept Clin Med, Bergen, Norway; [Wester, Knut] Haukeland Hosp, Dept Neurosurg, Bergen, Norway	Uppsala University; Uppsala University; University of Oxford; Karolinska Institutet; Lund University; University of Helsinki; Folkhalsan Research Center; University of Bergen; University of Bergen; Haukeland University Hospital	Hogberg, U (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	ulf.hogberg@kbh.uu.se		Hogberg, Ulf/0000-0002-2121-7511; Andersson, Jacob/0000-0001-8266-1926; Wester, Knut/0000-0001-8489-3931				[Anonymous], 1992, INT CLASS DIS; Arbogast KB, 2005, PEDIATRICS, V116, P180, DOI 10.1542/peds.2004-2671; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Dlamini N, 2010, NEUROSURG CLIN N AM, V21, P511, DOI 10.1016/j.nec.2010.03.006; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Elinder G, 2018, ACTA PAEDIATR, V107, P3, DOI 10.1111/apa.14473; Gabaeff SC, 2013, LEGAL MED-TOKYO, V15, P177, DOI 10.1016/j.legalmed.2012.12.003; Ghosh PS, 2011, CLIN PEDIATR, V50, P897, DOI 10.1177/0009922811406435; Gilbert R, 2012, LANCET, V379, P758, DOI 10.1016/S0140-6736(11)61087-8; Gout A, 1997, ARCH PEDIATRIE, V4, P983, DOI 10.1016/S0929-693X(97)86096-4; GUTHKELCH AN, 1953, BMJ-BRIT MED J, V1, P233, DOI 10.1136/bmj.1.4804.233; Hellbusch LC, 2007, J NEUROSURG, V107, P119, DOI 10.3171/PED-07/08/119; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; Hogberg U, 2018, EUR J PUBLIC HEALTH, V28, P641, DOI 10.1093/eurpub/cky062; Ingraham FD, 1944, J PEDIATR-US, V24, P1, DOI 10.1016/S0022-3476(44)80138-X; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; KAPILA A, 1982, RADIOLOGY, V142, P669, DOI 10.1148/radiology.142.3.6977789; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2014, PEDIATRICS, V134, pE773, DOI 10.1542/peds.2013-3903; Larionov SN, 2008, CHILD NERV SYST, V24, P437, DOI 10.1007/s00381-007-0496-1; Lee HC, 2018, CHILD NERV SYST, V34, P235, DOI 10.1007/s00381-017-3583-y; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; Lorente-Pozo S, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00063; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; McNeely PD, 2006, AM J NEURORADIOL, V27, P1725; Medina LS, 2001, AM J NEURORADIOL, V22, P564; Miller D, 2015, AM J FOREN MED PATH, V36, P111, DOI 10.1097/PAF.0000000000000152; Miller R, 2010, AM J FOREN MED PATH, V31, P165, DOI 10.1097/PAF.0b013e3181d96a8e; Minkowitz B, 2017, J PEDIATR ORTHOPED, V37, P23, DOI 10.1097/BPO.0000000000000587; Minns RA, 2005, ARCH DIS CHILD, V90, P883, DOI 10.1136/adc.2004.060657; MORI K, 1993, CHILD NERV SYST, V9, P282, DOI 10.1007/BF00306274; Myhre MC, 2007, ACTA PAEDIATR, V96, P1159, DOI 10.1111/j.1651-2227.2007.00356.x; PARENT AD, 1992, PEDIATR NEUROSURG, V18, P266, DOI 10.1159/000120674; Piatt J H Jr, 1999, Neurosurg Focus, V7, pe4; Ravid S, 2003, PEDIATR NEUROL, V28, P139, DOI 10.1016/S0887-8994(02)00500-3; Rooks VJ, 2008, AM J NEURORADIOL, V29, P1082, DOI 10.3174/ajnr.A1004; Scheimberg I, 2013, PEDIATR DEVEL PATHOL, V16, P149, DOI 10.2350/12-08-1232-OA.1; Squier W, 2016, DEV MED CHILD NEUROL, V58, P1223, DOI 10.1111/dmcn.13202; Squier W, 2009, FORENSIC SCI INT, V187, P6, DOI 10.1016/j.forsciint.2009.02.005; Swedish National Board of Health and Welfare, 2016, HLTH REG STOCKH; Swedish National Board of Health and Welfare, 2016, SWED PAT REG; Swedish National Board of Health and Welfare, 2003, RES REP EPC, P112; Tavani F, 2003, NEURORADIOLOGY, V45, P253, DOI 10.1007/s00234-003-0946-8; TILL K, 1968, BRIT MED J, V3, P400, DOI 10.1136/bmj.3.5615.400; Torres-Cuevas I, 2017, REDOX BIOL, V12, P674, DOI 10.1016/j.redox.2017.03.011; Tucker J, 2016, J NEUROSURG-PEDIATR, V18, P16, DOI 10.3171/2015.12.PEDS15600; Vinchon M, 2010, CHILD NERV SYST, V26, P1195, DOI 10.1007/s00381-010-1105-2; Wiig US, 2017, PEDIATR NEUROL, V73, P36, DOI 10.1016/j.pediatrneurol.2017.04.018; Wittschieber D, 2015, AM J NEURORADIOL, V36, P432, DOI 10.3174/ajnr.A3989; Zahl SM, 2011, NEUROSURG REV, V34, P417, DOI 10.1007/s10143-011-0327-4	52	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206340	10.1371/journal.pone.0206340	http://dx.doi.org/10.1371/journal.pone.0206340			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379890	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700102
J	Radojevic, M; Jankovic, B; Jovanovic, V; Stojiljkovic, D; Manic, N				Radojevic, Milos; Jankovic, Bojan; Jovanovic, Vladimir; Stojiljkovic, Dragoslava; Manic, Nebojsa			Comparative pyrolysis kinetics of various biomasses based on model-free and DAEM approaches improved with numerical optimization procedure	PLOS ONE			English	Article							ACTIVATION-ENERGY MODEL; PARAMETERS; CONVERSION; CELLULOSE	The pyrolysis process of various types of biomass (agricultural and wood by-products) in non-isothermal conditions using simultaneous thermal analyses (STA) was investigated. Devolatilization kinetics was implemented through combined application of model-free methods and DAEM (distributed activation energy model) using Gaussian distribution functions of activation energies. Results obtained were used in the curve prediction of the rate of mass loss against temperature at various heating rates by numerical optimization. The possible calculation of biomass samples behavior under pyrolytic conditions as the summation of their pseudo-components, hemicelluloses, cellulose, and lignin is also explored. The differences between experimental and calculated data are less than 3.20% offering a quality test of applicability of proposed model on the kinetic studies of a wide range of biomass samples. It seems that the most physically realistic model is the decomposition of biomass in three reactions, depending on the composition of the biomass regarding hemicelluloses, cellulose, and lignin. Kinetic model applied here may serve as a starting point to build more complex models capable of describing the thermal behavior of plant materials during thermochemical processing.	[Radojevic, Milos; Jovanovic, Vladimir; Stojiljkovic, Dragoslava; Manic, Nebojsa] Univ Belgrade, Fac Mech Engn, Fuel & Combust Lab, Belgrade, Serbia; [Jankovic, Bojan] Univ Belgrade, Inst Nucl Sci Vinca, Dept Phys Chem, Belgrade, Serbia	University of Belgrade; University of Belgrade	Manic, N (corresponding author), Univ Belgrade, Fac Mech Engn, Fuel & Combust Lab, Belgrade, Serbia.	nmanic@mas.bg.ac.rs	Manic, Nebojsa/AAG-8130-2021; Radojevic, Milos/AAF-9382-2019; Stojiljkovic, Dragoslava/R-8387-2017	Manic, Nebojsa/0000-0002-2801-8195; Radojevic, Milos/0000-0002-6958-9517; Stojiljkovic, Dragoslava/0000-0002-7527-7712; Jovanovic, Vladimir/0000-0001-9929-8545; Jankovic, Bojan/0000-0001-7520-1972				Abdelouahed L, 2017, J THERM ANAL CALORIM, V129, P1201, DOI 10.1007/s10973-017-6212-9; Aboyade AO, 2011, THERMOCHIM ACTA, V517, P81, DOI 10.1016/j.tca.2011.01.035; Akahira T., 1971, RES REP CHIBA I TECH, V1971, P22, DOI DOI 10.1038/S41598-021-84083-2; [Anonymous], 2015, 169482015 EN ISO; [Anonymous], 2017, 147802017 EN ISO; [Anonymous], 2015, 181342015 EN ISO; [Anonymous], 2015, 181252017 EN ISO; [Anonymous], 2015, 1722512014 EN ISO; ANTAL MJ, 1995, IND ENG CHEM RES, V34, P703, DOI 10.1021/ie00042a001; Basu P, 2010, BIOMASS GASIFICATION AND PYROLYSIS: PRACTICAL DESIGN AND THEORY, P1; BRADBURY AGW, 1979, J APPL POLYM SCI, V23, P3271, DOI 10.1002/app.1979.070231112; Burnham AK, 2007, J THERM ANAL CALORIM, V89, P479, DOI 10.1007/s10973-006-8486-1; Burnham AK, 1999, ENERG FUEL, V13, P1, DOI 10.1021/ef9800765; Caballero JA, 1997, J ANAL APPL PYROL, V42, P159, DOI 10.1016/S0165-2370(97)00015-6; Cai JM, 2014, RENEW SUST ENERG REV, V36, P236, DOI 10.1016/j.rser.2014.04.052; Cai JM, 2013, GREEN CHEM, V15, P1331, DOI 10.1039/c3gc36958g; Ceylan S, 2014, BIORESOURCE TECHNOL, V156, P182, DOI 10.1016/j.biortech.2014.01.040; COATS AW, 1964, NATURE, V201, P68, DOI 10.1038/201068a0; CONESA JA, 1995, THERMOCHIM ACTA, V254, P175, DOI 10.1016/0040-6031(94)02102-T; Crombie K, 2013, GCB BIOENERGY, V5, P122, DOI 10.1111/gcbb.12030; Demirbas A, 2010, ENERG SOURCE PART A, V32, P172, DOI 10.1080/15567030802464388; Di Blasi C, 2008, PROG ENERG COMBUST, V34, P47, DOI 10.1016/j.pecs.2006.12.001; Faaij A., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P343, DOI 10.1007/s11027-005-9004-7; FRIEDMAN HL, 1964, J POLYM SCI POL SYM, P183; Inglesby MK, 2006, EFFECT CHEM FRACTION, P192; James AK, 2012, ENERGIES, V5, P3856, DOI 10.3390/en5103856; Karakosta Charikleia, 2011, International Journal of Energy and Environment, V2, P71; Kenney KL, 2013, BIOFUELS-UK, V4, P111, DOI [10.4155/BFS.12.83, 10.4155/bfs.12.83]; KISSINGER HE, 1957, ANAL CHEM, V29, P1702, DOI 10.1021/ac60131a045; Luque R, 2008, ENERG ENVIRON SCI, V1, P542, DOI 10.1039/b807094f; Mavhengere P, 2016, J S AFR I MIN METALL, V116, P55; McKendry P, 2002, BIORESOURCE TECHNOL, V83, P37, DOI 10.1016/S0960-8524(01)00118-3; McLauglin H., 2010, BIOCHAR REVOLUTION T, P89; Mehrabian R, 2012, FUEL, V93, P567, DOI 10.1016/j.fuel.2011.09.054; Mohan D, 2006, ENERG FUEL, V20, P848, DOI 10.1021/ef0502397; Obernberger I, 2004, BIOMASS BIOENERG, V27, P653, DOI 10.1016/j.biombioe.2003.07.006; Rezaiyan J., 2005, GASIFICATION TECHNOL; Sommariva S, 2010, FUEL, V89, P318, DOI 10.1016/j.fuel.2009.07.023; Soria-Verdugo A, 2014, ENERG CONVERS MANAGE, V86, P1045, DOI 10.1016/j.enconman.2014.06.074; Soria-Verdugo A, 2013, ENERG CONVERS MANAGE, V65, P239, DOI 10.1016/j.enconman.2012.08.017; Uslu A, 2008, ENERGY, V33, P1206, DOI 10.1016/j.energy.2008.03.007; White JE, 2011, J ANAL APPL PYROL, V91, P1, DOI 10.1016/j.jaap.2011.01.004; Wu WX, 2014, ENERG FUEL, V28, P3916, DOI 10.1021/ef5005896; Yang HP, 2007, FUEL, V86, P1781, DOI 10.1016/j.fuel.2006.12.013; Yang XW, 2014, BIORESOURCE TECHNOL, V163, P335, DOI 10.1016/j.biortech.2014.04.040; Zhang LH, 2010, ENERG CONVERS MANAGE, V51, P969, DOI 10.1016/j.enconman.2009.11.038	46	29	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206657	10.1371/journal.pone.0206657	http://dx.doi.org/10.1371/journal.pone.0206657			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379972	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700141
J	Rhead, B; Brorson, IS; Berge, T; Adams, C; Quach, H; Moen, SM; Berg-Hansen, P; Celius, EG; Sangurdekar, DP; Bronson, PG; Lea, RA; Burnard, S; Maltby, VE; Scott, RJ; Lechner-Scott, J; Harbo, HF; Bos, SD; Barcellos, LF				Rhead, Brooke; Brorson, Ina S.; Berge, Tone; Adams, Cameron; Quach, Hong; Moen, Stine Marit; Berg-Hansen, Pal; Celius, Elisabeth Gulowsen; Sangurdekar, Dipen P.; Bronson, Paola G.; Lea, Rodney A.; Burnard, Sean; Maltby, Vicki E.; Scott, Rodney J.; Lechner-Scott, Jeannette; Harbo, Hanne F.; Bos, Steffan D.; Barcellos, Lisa F.			Increased DNA methylation of SLFN12 in CD4(+) and CD8(+) T cells from multiple sclerosis patients	PLOS ONE			English	Article							PLACEBO-CONTROLLED PHASE-3; WIDE ASSOCIATION; ORAL BG-12; EPIGENOME; GENOME; PACKAGE; SITES	DNA methylation is an epigenetic mark that is influenced by environmental factors and is associated with changes to gene expression and phenotypes. It may link environmental exposures to disease etiology or indicate important gene pathways involved in disease pathogenesis. We identified genomic regions that are differentially methylated in T cells of patients with relapsing remitting multiple sclerosis (MS) compared to healthy controls. DNA methylation was assessed at 450,000 genomic sites in CD4(+) and CD8(+) T cells purified from peripheral blood of 94 women with MS and 94 healthy women, and differentially methylated regions were identified using bumphunter. Differential DNA methylation was observed near four loci: MOG/ZFP57, HLA-DRB1, NINJ2/LOC100049716, and SLFN12. Increased methylation of the first exon of the SLFN12 gene was observed in both T cell subtypes and remained present after restricting analyses to samples from patients who had never been on treatment or had been off treatment for more than 2.5 years. Genes near the regions of differential methylation in T cells were assessed for differential expression in whole blood samples from a separate population of 1,329 women with MS and 97 healthy women. Gene expression of HLA-DRB1, NINJ2, and SLFN12 was observed to be decreased in whole blood in MS patients compared to controls. We conclude that T cells from MS patients display regions of differential DNA methylation compared to controls, and corresponding gene expression differences are observed in whole blood. Two of the genes that showed both methylation and expression differences, NINJ2 and SLFN12, have not previously been implicated in MS. SLFN12 is a particularly compelling target of further research, as this gene is known to be down-regulated during T cell activation and up-regulated by type I interferons (IFNs), which are used to treat MS.	[Rhead, Brooke; Barcellos, Lisa F.] Univ Calif Berkeley, Computat Biol Grad Grp, Berkeley, CA 94720 USA; [Rhead, Brooke; Adams, Cameron; Quach, Hong; Barcellos, Lisa F.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Genet Epidemiol & Genom Lab, Berkeley, CA 94720 USA; [Brorson, Ina S.; Moen, Stine Marit; Berg-Hansen, Pal; Harbo, Hanne F.; Bos, Steffan D.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Brorson, Ina S.; Berge, Tone; Moen, Stine Marit; Berg-Hansen, Pal; Celius, Elisabeth Gulowsen; Harbo, Hanne F.; Bos, Steffan D.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Berge, Tone] Oslo Metropolitan Univ, Dept Mech Elect & Chem Engn, Oslo, Norway; [Moen, Stine Marit] MS Ctr Hakadal, Hakadal, Norway; [Celius, Elisabeth Gulowsen] Univ Oslo, Fac Med, Inst Hlth & Soc, Oslo, Norway; [Sangurdekar, Dipen P.] Biogen Inc, Translat & Integrat Analyt, 14 Cambridge Ctr, Cambridge, MA 02142 USA; [Bronson, Paola G.] Biogen Inc, Stat Genet & Genet Epidemiol, 14 Cambridge Ctr, Cambridge, MA 02142 USA; [Lea, Rodney A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Lea, Rodney A.; Burnard, Sean; Maltby, Vicki E.; Scott, Rodney J.; Lechner-Scott, Jeannette] Hunter Med Res Inst, Ctr Informat Based Med, Newcastle, NSW, Australia; [Burnard, Sean; Scott, Rodney J.] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW, Australia; [Maltby, Vicki E.; Lechner-Scott, Jeannette] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia; [Scott, Rodney J.] John Hunter Hosp, Pathol North, Mol Genet, Newcastle, NSW, Australia; [Lechner-Scott, Jeannette] John Hunter Hosp, Dept Neurol, Newcastle, NSW, Australia	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Oslo; University of Oslo; Oslo Metropolitan University (OsloMet); University of Oslo; Biogen; Biogen; Queensland University of Technology (QUT); Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Newcastle; John Hunter Hospital; John Hunter Hospital	Barcellos, LF (corresponding author), Univ Calif Berkeley, Computat Biol Grad Grp, Berkeley, CA 94720 USA.; Barcellos, LF (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Genet Epidemiol & Genom Lab, Berkeley, CA 94720 USA.	lbarcellos@berkeley.edu	Celius, Elisabeth Gulowsen/S-1387-2019; Scott, Rodney/B-2827-2013	Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Lea, Rodney/0000-0002-1148-5862; Brorson, Ina/0000-0001-6691-9413; Lechner-Scott, Jeannette/0000-0002-3850-447X; Bronson, Paola/0000-0001-9996-9812; Rhead, Brooke/0000-0002-1839-4883; Burnard, Sean/0000-0003-2149-3556; Scott, Rodney/0000-0001-7724-3404	National Institute of Neurological Disorders and Stroke [F31NS096885]; National Institute of Environmental Health Sciences [R01ES017080]; Norwegian Research Council [240102]; South-Eastern Norway Regional Health Authority [39961]; "Legatet til Henrik Homans Minde"; Sanofi Genzyme; Canadian Institutes of Health Research; Multiple Sclerosis Research Australia; Odd Fellow Medisinske Fond; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS096885] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Norway Regional Health Authority; "Legatet til Henrik Homans Minde"; Sanofi Genzyme(Sanofi-AventisGenzyme Corporation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Research Australia; Odd Fellow Medisinske Fond; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by grant number F31NS096885 from the National Institute of Neurological Disorders and Stroke (https://www.ninds.nih.gov/), R01ES017080 from the National Institute of Environmental Health Sciences (https://www.niehs.nih.gov/), 240102 from the Norwegian Research Council (https://www.forskningsradet.no/), and 39961 from South-Eastern Norway Regional Health Authority (https://www.helse-sorost.no/south-eastern-norway-regional-health-authority), as well as unrestricted research grants from "Legatet til Henrik Homans Minde" (https://www.unifor.no/Fund.aspx? fund= 59) and Sanofi Genzyme (https://www.sanofigenzyme.com/en/), a travel grant from "Odd Fellow Medisinske Fond" (https://www.oddfellow.no/), and fellowships from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) and Multiple Sclerosis Research Australia (https://msra.org.au/).The funder provided support in the form of salaries for authors D.P.S. and P.G.B., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Baranzini SE, 2013, AM J HUM GENET, V92, P854, DOI 10.1016/j.ajhg.2013.04.019; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Birdwell CE, 2014, J VIROL, V88, P11442, DOI 10.1128/JVI.00972-14; Bojesen SE, 2017, THORAX, V72, P646, DOI 10.1136/thoraxjnl-2016-208789; Bos SD, 2015, PLOS ONE, P1, DOI [10.7910/DVN/27694.Funding, DOI 10.7910/DVN/27694.FUNDING]; Calabrese R, 2012, MULT SCLER J, V18, P299, DOI 10.1177/1352458511421055; Casper J, 2018, NUCLEIC ACIDS RES, V46, pD762, DOI 10.1093/nar/gkx1020; Chitnis T, 2007, INT REV NEUROBIOL, V79, P43, DOI 10.1016/S0074-7742(07)79003-7; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fetahu IS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00164; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Graves MC, 2014, MULT SCLER J, V20, P1033, DOI 10.1177/1352458513516529; Handel AE, 2010, J NEUROIMMUNOL, V223, P120, DOI 10.1016/j.jneuroim.2010.03.002; Huseby ES, 2012, FRONT IMMUNOL, V3, P1, DOI [10.3389/fimmu.2012.00001, DOI 10.3389/FIMMU.2012.00001]; IMSGC, 2017, BIORXIV, P1; Jaffe AE, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0808-5; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Janson PCJ, 2011, J IMMUNOL, V186, P92, DOI 10.4049/jimmunol.1000960; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaidery NA, 2013, NEUROTHERAPEUTICS, V10, P698, DOI 10.1007/s13311-013-0211-8; Kaskow BJ, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029025; Kulis M, 2010, ADV GENET, V70, P1, DOI [10.1016/B978-0-12-380866-0.60001-0_1, DOI 10.1016/B978-0-12-380866-0.60001-0_1]; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lin XY, 2016, EPIGENOMICS-UK, V8, P1117, DOI 10.2217/epi-2016-0017; Long H, 2016, J AUTOIMMUN, V74, P118, DOI 10.1016/j.jaut.2016.06.020; Maltby VE, 2017, CLIN EPIGENETICS CLI, V9, P1, DOI [10.1186/s13148-016-0308-0, DOI 10.1186/S13148-016-0308-0]; Maltby VE, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0152-7; Marabita F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14788-w; Mavrommatis E, 2013, J INTERF CYTOK RES, V33, P206, DOI 10.1089/jir.2012.0133; McCartney DL, 2016, GENOM DATA, V9, P22, DOI 10.1016/j.gdata.2016.05.012; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Nakagawa K, 2018, INT IMMUNOL, V30, P69, DOI 10.1093/intimm/dxx079; Neven KY, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0395-0; North ML, 2018, ALLERGY, V73, P196, DOI 10.1111/all.13263; Olsson T, 2017, NAT REV NEUROL, V13, P25, DOI 10.1038/nrneurol.2016.187; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002142; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Puck Alexander, 2015, Results Immunol, V5, P23, DOI 10.1016/j.rinim.2015.10.001; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Putnik M, 2016, MOL BIOL REP, V43, P141, DOI 10.1007/s11033-016-3946-6; Quarles RH, 1997, J MOL NEUROSCI, V8, P1, DOI 10.1007/BF02736858; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Sun ZF, 2015, EPIGENOMICS-UK, V7, P813, DOI 10.2217/epi.15.21; Teschler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084180; Wahl S, 2017, NATURE, V541, P81, DOI 10.1038/nature20784; Wu J, 2012, GCRMA BACKGROUND ADJ, P2200	55	27	30	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206511	10.1371/journal.pone.0206511	http://dx.doi.org/10.1371/journal.pone.0206511			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379917	Green Submitted, Green Published, gold			2022-12-26	WOS:000448823700124
J	Rocha-Brischiliari, SC; Andrade, L; Nihei, OK; Brischiliari, A; Hortelan, MD; Carvalho, MDD; Pelloso, SM				Rocha-Brischiliari, Sheila Cristina; Andrade, Luciano; Nihei, Oscar Kenji; Brischiliari, Adriano; Hortelan, Michele dos Santos; de Barros Carvalho, Maria Dalva; Pelloso, Sandra Marisa			Spatial distribution of breast cancer mortality: Socioeconomic disparities and access to treatment in the state of Parana, Brazil	PLOS ONE			English	Article							STAGE; CARE	Introduction Breast cancer remains an important public health problem that is responsible for high morbidity and mortality rates, especially in developing countries. Objective To analyze the socioeconomic and access disparities related to breast cancer mortality in 399 cities in the state of Parana, Brazil. Methods Ecological, descriptive and analytical cross-sectional study based on secondary data from the Mortality Information System from 2009 to 2012 in the state of Parana. Breast cancer mortality rate was calculated considering the mortality cases and women population of each municipality, both based on women older than 20 years old. Moran global and local analyses were used to verify the presence of spatial autocorrelation and spatial regression modeling (Spatial Lag-SAR) with the purpose of analyzing the association between socioeconomic indicators, access and mortality rates for breast cancer. Results Significant positive spatial autocorrelation was found for breast cancer mortality rates (I = 0.5432, p = 0.001). In the spatial regression analysis, the model explained 61% of the variance of the mortality rates for breast cancer. The mortality rate for breast cancer was negatively associated with the illiteracy rate (Coefficient = -0.0279) and positively associated with the access index (Coefficient = 12.9525). Conclusion The lower illiteracy rate has not been sufficient to reduce the specific mortality rate by breast cancer, and the higher the score of accessibility to cancer services, the higher the specific mortality due to breast cancer. The results show that in the state of Parana, the problem is not related to a lack of education of the patients or the distance walked, but rather with the organization of services. These conclusions have important political implications on the organization and quality of the services provided for the diagnosis and treatment of breast cancer in the state of Parana.	[Rocha-Brischiliari, Sheila Cristina] Univ Estadual Maringa, Hlth Sci Ctr, Maringa, Parana, Brazil; [Andrade, Luciano] Univ Estadual Maringa, Dept Med, Maringa, Parana, Brazil; [Nihei, Oscar Kenji] State Univ West Parana, Dept Nursing, Foz Do Iguacu, Parana, Brazil; [Brischiliari, Adriano] Univ Estadual Maringa, Dept Nursing, Maringa, Parana, Brazil; [Hortelan, Michele dos Santos] State Univ West Parana, Publ Hlth Reg Frontier, Foz Do Iguacu, Parana, Brazil; [de Barros Carvalho, Maria Dalva] Univ Estadual Maringa, Dept Post Grad Hlth Sci, Maringa, Parana, Brazil; [Pelloso, Sandra Marisa] Univ Estadual Maringa, Dept Post Grad Hlth Sci & Nursing, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual do Oeste do Parana; Universidade Estadual de Maringa; Universidade Estadual do Oeste do Parana; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Rocha-Brischiliari, SC (corresponding author), Univ Estadual Maringa, Hlth Sci Ctr, Maringa, Parana, Brazil.	sheila.brischiliari@gmail.com	Carvalho, Maria Dalva/AAK-8411-2021; Hortelan, Michele dos Santos/AAN-6311-2020	Carvalho, Maria Dalva/0000-0002-1377-3331; 				Aguiar Fernanda Pinheiro, 2013, Cad. saúde colet., V21, P197; [Anonymous], 2010, ESRI ALGORITHMS USED; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin L, 2013, SPATIAL ECONOMETRICS; Anselin L., 1998, GEOGRAPHICAL INFORM; Brantley-Sieders DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045238; Brazilian Institute of Geography and Statistics, 2015, MAPS BAS REF CART BA; Cecilio AP, 2015, BREAST CANCER-TARGET, V7, P43, DOI 10.2147/BCTT.S50361; Chi G, 2008, POPUL RES POLICY REV, V27, P17, DOI 10.1007/s11113-007-9051-8; Chien LC, 2013, SPAT SPATIO-TEMPORAL, V5, P27, DOI 10.1016/j.sste.2013.03.002; de Campos FG, 2009, CAD SAUDE PUBLICA, V25, P77, DOI 10.1590/S0102-311X2009000100008; Di Sibio A, 2016, CANCER EPIDEMIOL, V44, pS110, DOI 10.1016/j.canep.2016.08.010; Druck S, 2004, ANALISE ESPACIAL DAD; Efrain Porto Tapiquen, 2015, GEOGR SIG EST AMB; Government of State of Parana, 2009, PLAN DIR REG; Herrmann C, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1660-8; Hu KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158951; *IBGE, 2010, EST; INCA. Institute Nacional de Cancer Jose Alencar Gomes da Silva. Estimate / 2018-Cancer Incidence in Brazil. Institute Nacional de Cancer Jose Alencar Gomes da Silva, 2017, EST 2018 CANC INC BR; Institute de Pesquisa Econornica Aplicada (IPEA), 2016, ATL DES HUM BRAS; Institute Paranaense de Desenvolvimento Economic e Social (IPARDES), 2009, TIP MUN PAR 2 IND DE; International Agency of Research Cancer World Health Organization, 2012, GLOBOCAN 2012 EST CA; Justo N, 2013, ONCOLOGIST, V18, P248, DOI 10.1634/theoncologist.2012-0373; Khan-Gates JA, 2015, WOMEN HEALTH ISS, V25, P482, DOI 10.1016/j.whi.2015.05.010; Krempi AP, 2004, THESIS; Lee BL, 2012, LANCET ONCOL, V13, pE95, DOI 10.1016/S1470-2045(11)70323-0; Lopez-Abente G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-535; Lundqvist Adam, 2016, Eur J Public Health, V26, P804, DOI 10.1093/eurpub/ckw070; Luo W, 2003, ENVIRON PLANN B, V30, P865, DOI 10.1068/b29120; Madhu B, 2016, J CLIN DIAGN RES, V10, pLC20, DOI 10.7860/JCDR/2016/19042.7666; Markossian TW, 2014, HEALTH SERV RES, V49, P2; Ministry of Health, 2010, VIT STAT MORT; Parise CA, 2016, RACIAL ETHNIC HLTH D; Parise CA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-449; Perobelli Fernando Salgueiro, 2006, Rev. econ. contemp., V10, P61; QGIS Development Team, 2016, QGIS A FREE OP SOURC; Rayne S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-016-1959-4; Rego IKP, 2013, REV BRASILEIRA CANC, V59, P379; Santos AE, 2005, 7 BRAZ S GEOINF CAMP; Santos Raíla de Souza, 2011, Esc. Anna Nery, V15, P410; Seneviratne S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2027-4; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tatalovich Z, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0025-5; Towne SD, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-18; Unger-Saldana K, 2014, WORLD J CLIN ONCOL, V5, P465, DOI 10.5306/wjco.v5.i3.465; Vo A, 2015, 21 AM C INF SYST PUE; WHO, 2010, INT STAT CLASS DIS R; World Health Organization (WHO): Health Impact Assessment (HIA), 2016, DET HLTH; Zhou HB, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0013-y	49	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205253	10.1371/journal.pone.0205253	http://dx.doi.org/10.1371/journal.pone.0205253			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY7VH	30379833	Green Submitted, Green Published, gold			2022-12-26	WOS:000448823700033
J	Lana, RS; Michalsky, EM; Lopes, LO; Lara-Silva, FO; Nascimento, JL; Pinheiro, LC; Franca-Silva, JC; Mendes, TSC; Fortes-Dias, CL; Dias, ES				Lana, Rosana S.; Michalsky, Erika M.; Lopes, Livia O.; Lara-Silva, Fabiana O.; Nascimento, Jeiza L.; Pinheiro, Leticia C.; Franca-Silva, Joao C.; Mendes, Telma S. C.; Fortes-Dias, Consuelo L.; Dias, Edelberto S.			Ecoepidemiological aspects of visceral leishmaniasis in an endemic area in the Steel Valley in Brazil: An ecological approach with spatial analysis	PLOS ONE			English	Article							PHLEBOTOMINE SAND FLIES; DIPTERA PSYCHODIDAE PHLEBOTOMINAE; LUTZOMYIA-LONGIPALPIS DIPTERA; MINAS-GERAIS; CUTANEOUS LEISHMANIASIS; SANDFLIES DIPTERA; MATO-GROSSO; EPIDEMIOLOGIC ASPECTS; NATURAL INFECTION; INFANTUM-CHAGASI	Leishmaniases are a group of infectious diseases transmitted by phlebotomine sand flies, and their distribution depends on the presence of vectors, parasites, reservoirs and susceptible hosts in the same environment. In the last decades, visceral leishmaniasis (VL) has become urbanized and reached economically important cities in countries within the transmission zone. Our study was conducted in one of those cities-lpatinga-in the state of Minas Gerais, Brazil, where the first autochthonous case of VL dates back to 2011. Since no data regarding the epidemiological triad of VL (etiological agent/vector/domestic reservoir) were available for this city, we characterized the local entomological fauna, identified the presence of specific Leishmania DNA in the captured phlebotomine sand flies, and assessed the incidence of canine and human VL. For the entomological survey, we set twenty light traps in ten districts of the city with reports of human and canine VL. The insect captures were performed monthly, during one year, starting in March 2015. A total of 1501 specimens of phlebotomine sand flies belonging to 16 distinct species were captured, with predominance (61.9%) of Lutzomyia longipalpis. Leishmania infantum DNA was detected in L. longipalpis and in Evandromyia cortelezzii test samples. A total of 9,136 dogs were examined, 1,355 of which (14.8%) were serologically positive for VL. The cases were georeferenced and the data were plotted in thematic maps, along with human cases of VL registered by the local Department of Health, during the study period. Our results confirm that the VL transmission cycle is active in Ipatinga, with the presence of vectors carrying Leishmania DNA, canine and human cases of the disease. Spatial analysis allowed for the observation of a positive relationship between canine and human cases of VL and the identification of areas with high priority for control actions in the city. The mapping of high-risk areas, together with an epidemiological study in urban areas, is fundamental to improve the efficacy of the Program for Surveillance and Control of VL (PSCVL) in Brazil.	[Lana, Rosana S.; Michalsky, Erika M.; Lopes, Livia O.; Lara-Silva, Fabiana O.; Nascimento, Jeiza L.; Dias, Edelberto S.] Fundacao Oswaldo Cruz, Inst Rene Rachou, Lab Leishmanioses, Belo Horizonte, MG, Brazil; [Pinheiro, Leticia C.] Fundacao Oswaldo Cruz, Inst Rene Rachou, Nucleo Estudos Saude PUbl & Envelhecimento, Belo Horizonte, MG, Brazil; [Franca-Silva, Joao C.] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Leishmanioses, Belo Horizonte, MG, Brazil; [Mendes, Telma S. C.] Secretaria Municipal Saude, Dept Vigilancia Saude, Ipatinga, MG, Brazil; [Fortes-Dias, Consuelo L.] Fundacao Ezequiel Dias, Pesquisa & Desenvolvimento, Lab Enzimol, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Dias, ES (corresponding author), Fundacao Oswaldo Cruz, Inst Rene Rachou, Lab Leishmanioses, Belo Horizonte, MG, Brazil.; Fortes-Dias, CL (corresponding author), Fundacao Ezequiel Dias, Pesquisa & Desenvolvimento, Lab Enzimol, Belo Horizonte, MG, Brazil.	consuelo.latorre@funed.mg.gov.br; edel@minas.fiocruz.br	Fortes-Dias, Consuelo/AAK-6897-2020; Fortes-Dias, Consuelo L/I-4896-2012; Fortes-Dias, Consuelo Latorre/U-9962-2019; Pinheiro, Letícia Cavalari/ABE-5950-2021; Michalsky, Erika/AAD-5896-2022	Fortes-Dias, Consuelo L/0000-0002-4494-5108; Fortes-Dias, Consuelo Latorre/0000-0002-4494-5108; Pinheiro, Letícia Cavalari/0000-0001-6229-9202; Michalsky, Erika/0000-0002-6224-3417; Dias, Edelberto/0000-0002-2370-5113	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [CDS-APQ-01611-14]; Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES) through the Graduation Programme in Health Science of Instituto Rene Rachou/Fundacao Oswaldo Cruz	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES) through the Graduation Programme in Health Science of Instituto Rene Rachou/Fundacao Oswaldo Cruz	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) grant number CDS-APQ-01611-14 (ESD) and Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES) through the Graduation Programme in Health Science of Instituto Rene Rachou/Fundacao Oswaldo Cruz.	ALENCAR J. E., 1991, DOENCAS INFECCIOSAS, P706; Alencar JE, 1959, THESIS; Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 2017, R LANG ENV STAT COMP, V55, P275; [Anonymous], 2006, SIST INF AGR NOT SIN; Barata RA, 2005, REV SOC BRAS MED TRO, V38, P421, DOI 10.1590/S0037-86822005000500012; Barata RA, 2004, MEM I OSWALDO CRUZ, V99, P481, DOI 10.1590/S0074-02762004000500004; Barata RA, 2011, REV SOC BRAS MED TRO, V44, P136, DOI 10.1590/S0037-86822011005000003; BRANDAOFILHO SP, 1994, MEM I OSWALDO CRUZ, V89, P445, DOI 10.1590/S0074-02761994000300028; Brasil. Atlas do Desenvolvimento Humano dos Municipios, 2013, PROGR NAC UN DES; Brito MG, 2001, MANUAL CONDUTAS BASI; Camargo-Neves VLF, 2001, CAD SAUDE PUBLICA, V17, P1263, DOI DOI 10.1590/S0102-311X2001000500026; Carvalho GML, 2008, VECTOR-BORNE ZOONOT, V8, P407, DOI 10.1089/vbz.2007.0180; Cruz I., 2002, T R SOC TROP MED HYG, V96, pS185, DOI DOI 10.1016/S0035-9203(02)90074-X; Dantas-Torres F, 2006, REV SOC BRAS MED TRO, V39, P352, DOI 10.1590/S0037-86822006000400007; de Souza CM, 2004, MEM I OSWALDO CRUZ, V99, P795, DOI 10.1590/S0074-02762004000800003; de Souza CF, 2008, CAD SAUDE PUBLICA, V24, P1454, DOI 10.1590/S0102-311X2008000600026; Deane L. d. M., 1956, THESIS; DEANE L M, 1955, Rev Bras Malariol Doencas Trop, V7, P131; DEANE LEONIDaS M., 1962, REV INST MED TROP SAO PAULO, V4, P198; Deane LM, 1955, HOSPITAL, V48, P61; Dias ES, 2007, REV SOC BRAS MED TRO, V40, P49, DOI 10.1590/S0037-86822007000100009; Dos Santos SO, 1998, MED VET ENTOMOL, V12, P315, DOI 10.1046/j.1365-2915.1998.00104.x; Santos Soraya Oliveira dos, 2003, Rev. Soc. Bras. Med. Trop., V36, P633; Elkhoury ANSM, 2005, VIGILANCIA CONTROLE, P24; FORATTINI OSWALDO P., 1960, REV INST MED TROP SAO PAULO, V2, P195; Galati E. A. B., 2003, FLEBOTOMINEOS BRASIL, P23; Galati EAB, 1996, REV SAUDE PUBL, V30, P115, DOI 10.1590/S0034-89101996000200002; Galati EAB, 1995, B DIR MALARIOL SAN A, V35, P133; Galati EAB, 2003, FLEBOTOMINEOS BRASIL, P53, DOI DOI 10.1590/S0085-56262003000200017; IBGE-Instituto Brasileiro de Geografia e Estatistica Censo Demografico 2010 Instituto Brasileiro de Geografia e Estatistica, 2010, I BRAS GEOGR EST CEN; Killick-Kendrick R., 1991, Parassitologia (Rome), V33, P321; Lana RS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/385493; Lara-Silva FD, 2015, ACTA TROP, V148, P128, DOI 10.1016/j.actatropica.2015.04.002; Lara-Silva FO, 2014, BIOMED RES INT, V2014, P7; LIMA LC, 1986, REV SAUDE PUBL, V20, P102, DOI 10.1590/S0034-89101986000100008; Lyra MR, 2015, REV INST MED TROP SP, V57, P451, DOI 10.1590/S0036-46652015000500016; Margonari C, 2006, MEM I OSWALDO CRUZ, V101, P31, DOI 10.1590/S0074-02762006000100007; Michalsky Érika Monteiro, 2011, Rev. Soc. Bras. Med. Trop., V44, P58, DOI 10.1590/S0037-86822011000100014; Michalsky EM, 2009, MEM I OSWALDO CRUZ, V104, P56, DOI 10.1590/S0074-02762009000100009; Ministerio da Saude, 2011, 012011 CGDTCGLABDEVI; Ministerio da Saude, 2009, GUIA VIGILANCIA EPID, V7; de Araujo VEM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002540; Miranda JC, 2002, MEM I OSWALDO CRUZ, V97, P185, DOI 10.1590/S0074-02762002000200006; Missawa NA, 2007, MEM I OSWALDO CRUZ, V102, P913, DOI 10.1590/S0074-02762007000800004; Missawa NA, 2006, REV SOC BRAS MED TRO, V39, P337, DOI 10.1590/S0037-86822006000400004; Monteiro EM, 2005, REV SOC BRAS MED TRO, V38, P147, DOI 10.1590/S0037-86822005000200004; Michalsky EM, 2007, VET PARASITOL, V147, P67, DOI 10.1016/j.vetpar.2007.03.004; Montoya-Lerma J, 2003, ACTA TROP, V85, P19, DOI 10.1016/S0001-706X(02)00189-4; Moreno EC, 2005, REV SOC BRAS MED TRO, V38, P456, DOI 10.1590/S0037-86822005000600002; Oliveira AG, 2012, J MED ENTOMOL, V49, P43, DOI 10.1603/ME11082; Oliveira CL, 2001, CAD SAUDE PUBLICA, V7, P1231; Oliveira Neto M P, 1986, Mem Inst Oswaldo Cruz, V81, P303, DOI 10.1590/S0074-02761986000300006; Paiva BR, 2006, ACTA TROP, V99, P252, DOI 10.1016/j.actatropica.2006.08.009; Panamerican Health Organization, 2018, LEISHMANIASIS EPIDEM, V6, P2; Pugedo H, 2005, REV SOC BRAS MED TRO, V38, P70, DOI 10.1590/S0037-86822005000100017; Ramiro MJ, 2003, VACCINE, V21, P2474, DOI 10.1016/S0264-410X(03)00032-X; Rangel EF, 2008, CAD SAUDE PUBLICA, V24, P2948, DOI 10.1590/S0102-311X2008001200025; Rosa J, 2012, ACTA TROP, V123, P128, DOI 10.1016/j.actatropica.2012.04.008; Saraiva L, 2009, J MED ENTOMOL, V46, P1159, DOI 10.1603/033.046.0525; Secretaria de Turismo de Minas Gerais, 2013, CIRC TUR MIN GER; Silva JR, 1957, LEISHM VISC CAL; SINAN . Sisteme de informacao de Agarvos e Notificacao, PROP LIST CAS DOENC; Soares Maria Regiane Araujo, 2010, Cad Saude Publica, V26, P2409, DOI 10.1590/S0102-311X2010001200019; Soares RPP, 2003, AN ACAD BRAS CIENC, V75, P301, DOI 10.1590/S0001-37652003000300005; Tanure A, 2015, REV INST MED TROP SP, V57, P321, DOI 10.1590/S0036-46652015000400008; Teodoro Ueslei, 2003, Cad. Saúde Pública, V19, P1801, DOI 10.1590/S0102-311X2003000600024; Tonelli GB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178628; VANEYS GJJM, 1992, MOL BIOCHEM PARASIT, V51, P133, DOI 10.1016/0166-6851(92)90208-2; VASCONCELOS IAB, 1994, AM J TROP MED HYG, V50, P158, DOI 10.4269/ajtmh.1994.50.158; Vianna EN, 2016, MEM I OSWALDO CRUZ, V111, P302, DOI 10.1590/0074-02760150366; WHO, 2010, LEISHM BACKGR INF; WHO, 2015, LEISHMANIASIS; Ximenes MDFD, 1999, MEM I OSWALDO CRUZ, V94, P427, DOI 10.1590/S0074-02761999000400001	75	12	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2018	13	10							e0206452	10.1371/journal.pone.0206452	http://dx.doi.org/10.1371/journal.pone.0206452			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7AD	30376577	gold, Green Submitted, Green Published			2022-12-26	WOS:000448752400013
J	Bristow, CC; Kojima, N; Lee, SJ; Leon, SR; Ramos, LB; Konda, KA; Brown, B; Caceres, CF; Klausner, JD				Bristow, Claire C.; Kojima, Noah; Lee, Sung-Jae; Leon, Segundo R.; Ramos, Lourdes B.; Konda, Kelika A.; Brown, Brandon; Caceres, Carlos F.; Klausner, Jeffrey D.			HIV and syphilis testing preferences among men who have sex with men and among transgender women in Lima, Peru	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; CONJOINT-ANALYSIS; TREPONEMAL ANTIBODIES; ACCEPTABILITY; FEASIBILITY	Background Men who have sex with men (MSM) and transgender women in Peru are at high risk for acquiring syphilis and HIV infection. The World Health Organization highly recommends screening for HIV and syphilis to reduce morbidity and mortality associated with untreated infections. We aimed to identify factors associated with dual testing preferences for HIV and syphilis infection among MSM and transgender women in Lima, Peru. Methods We used conjoint analysis, an innovative method for systematically estimating consumer preferences. We created eight hypothetical test profiles varying across six dichotomous attributes: cost (free vs. $4), potential for false positive syphilis result (no false positive vs. some risk of false positive), time-to-result (20 minutes vs. 1 week), blood draw method (finger prick vs. venipuncture), test type (rapid vs. laboratory), and number of draws (1 vs. 2). We fit a conjoint analysis model for each participant using a simple main effects ANOVA. Attribute importance values were calculated using percentages from relative ranges in the attribute's utility values. Results were summarized across participants and averages were reported. Results We recruited 415 MSM/transgender women over 18 years of age from two STD clinics in Lima, Peru. No potential for syphilis false positive result (no false positive vs. some potential for false positive) had the largest average impact on willingness to use the test and on aver- age accounted for 23.8% of test type preference, followed by cost (free vs. similar to USD$4; 21.6%), time to results (20 minutes vs. 1 week; 17.4%), number of blood draws (1 draw vs. 2 draws; 13.8%), method of blood draw (fingerprick vs. venipuncture; 13.7%), and test type (rapid POC vs. laboratory; 9.7%). Conclusion MSM/transgender women in Peru prioritized accuracy, cost, timeliness and number of blood draws for HIV and syphilis testing. Implementing a low cost, accurate, rapid and dual testing strategy for HIV and syphilis could improve screening uptake and accessibility of testing to accelerate time to treatment.	[Bristow, Claire C.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kojima, Noah; Lee, Sung-Jae; Konda, Kelika A.; Klausner, Jeffrey D.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Leon, Segundo R.; Ramos, Lourdes B.; Caceres, Carlos F.] Univ Peruana Cayetano Heredia, Sch Publ Hlth, Lima, Peru; [Leon, Segundo R.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Brown, Brandon] Univ Calif Riverside, Dept Med, Riverside, CA 92521 USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle; University of California System; University of California Riverside	Bristow, CC (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	cbristow@ucsd.edu	Bristow, Claire/AAG-1990-2021; Ramos, Lourdes/GQO-7541-2022; Leon, Segundo Ramos/J-3058-2019	Bristow, Claire/0000-0002-0680-1218; Leon, Segundo Ramos/0000-0002-5630-5714; Caceres, Carlos F./0000-0002-8101-0790; Ramos Cordova, Lourdes Beatriz/0000-0002-9132-4902; Kojima, Noah/0000-0002-3667-9719	NIH - NIH/NIAID R-01 study [1R01AI099727-01]; NIH/NIAID through [T32AI007384, K01AI136725]; Fogarty International Center of the National Institutes of Health (NIH) [D43TW009343]; University of California Global Health Institute (UCGHI); National Institute of Mental Health [5K01MH085503, P30MH058107]; UCLA AIDS Institute; UCLA Center for AIDS Research [AI28697]; UCLA Clinical and Translational Science Institute; NCRR; NCATS [UL1TR000124]; NIH - Fogarty International Center [R25TW009345]; National Institute of Mental Health; NIH Office of the Director; Office of Women's Health; Office of AIDS Research; FOGARTY INTERNATIONAL CENTER [D43TW009343, R25TW009345] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697, K01AI136725, R01AI099727, T32AI007384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH085503, P30MH058107] Funding Source: NIH RePORTER	NIH - NIH/NIAID R-01 study; NIH/NIAID through; Fogarty International Center of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of California Global Health Institute (UCGHI); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UCLA AIDS Institute; UCLA Center for AIDS Research; UCLA Clinical and Translational Science Institute; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH - Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Women's Health; Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the NIH funded though NIH/NIAID R-01 study #1R01AI099727-01. CCB's time was supported but NIH/NIAID through grant numbers T32AI007384 and K01AI136725. NK is supported by the Fogarty International Center of the National Institutes of Health (NIH) under award #D43TW009343 and the University of California Global Health Institute (UCGHI). Dr. Lee's time on this manuscript was supported by the National Institute of Mental Health (5K01MH085503 & P30MH058107), UCLA AIDS Institute, UCLA Center for AIDS Research (AI28697), and the UCLA Clinical and Translational Science Institute, NCRR and NCATS (UL1TR000124). Segundo R Leon was also supported by NIH research training grant #R25TW009345 funded by the Fogarty International Center, the National Institute of Mental Health, the NIH Office of the Director, the Office of Women's Health and the Office of AIDS Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or UCGHI.	Binnicker MJ, 2011, CLIN INFECT DIS, V52, P274, DOI 10.1093/cid/ciq127; Castro AR, 2010, SEX TRANSM INFECT, V86, P532, DOI 10.1136/sti.2010.042937; Castro AR, 2010, J CLIN MICROBIOL, V48, P4615, DOI 10.1128/JCM.00624-10; Silva AMD, 2017, REV SAUDE PUBL, V51, DOI [10.1590/s1518-8787.2017051000243, 10.1590/S1518-8787.2017051000243]; Garcia PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066905; KLAUSNER JD, 2007, CURRENT DIAGNOSIS TR; Kojima N, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2332-x; Kuhfeld W.F, 2010, MARKETING RES METHOD, V9; Kuhfeld W.F., 2010, SAS; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Lee SJ, 2012, INT J STD AIDS, V23, P235, DOI 10.1258/ijsa.2011.011189; Lee SJ, 2013, AIDS CARE, V25, P1592, DOI 10.1080/09540121.2013.793272; Lipsitz MC, 2014, INT J STD AIDS, V25, P325, DOI 10.1177/0956462413507443; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Marshall P, 2002, J AM STAT ASSOC, V97, P674, DOI 10.1198/016214502388618410; Naidu Narinder Kaur, 2012, Asian J Transfus Sci, V6, P32, DOI 10.4103/0973-6247.95048; Numbeo, HIST DAT COST LIV YE; Perez-Brumer AG, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21462; Phillips KA, 2002, HEALTH SERV RES, V37, P1681, DOI 10.1111/1475-6773.01115; Pollock L, 2016, GLOB PUBLIC HEALTH, V11, P981, DOI 10.1080/17441692.2016.1167932; Sanchez J, 2009, JAIDS-J ACQ IMM DEF, V51, pS47, DOI 10.1097/QAI.0b013e3181a2671d; Silva-Santisteban A, 2016, J INT AIDS SOC, V19, P65, DOI 10.7448/IAS.19.3.20799; Strasser S, 2012, JAIDS-J ACQ IMM DEF, V61, pE40, DOI 10.1097/QAI.0b013e318267bc94; Tabet S, 2002, AIDS, V16, P1271, DOI 10.1097/00002030-200206140-00010; Tang EC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008552; Dinh TH, 2013, SEX TRANSM DIS, V40, P846, DOI 10.1097/OLQ.0000000000000042; Tucker JD, 2013, CURR OPIN INFECT DIS, V26, P73, DOI 10.1097/QCO.0b013e32835c21b0; WHO, 2015, CONSOLIDATED GUIDELI; World Health Organization, 2016, GLOBAL HLTH SECTOR S; Zoni AC, 2013, INT J INFECT DIS, V17, pE84, DOI 10.1016/j.ijid.2012.07.021	30	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206204	10.1371/journal.pone.0206204	http://dx.doi.org/10.1371/journal.pone.0206204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372465	Green Published, Green Submitted, gold			2022-12-26	WOS:000448641200027
J	Marzec, L; Raghavan, S; Banaei-Kashani, F; Creasy, S; Melanson, EL; Lange, L; Ghosh, D; Rosenberg, MA				Marzec, Lucas; Raghavan, Sridharan; Banaei-Kashani, Farnoush; Creasy, Seth; Melanson, Edward L.; Lange, Leslie; Ghosh, Debashis; Rosenberg, Michael A.			Device-measured physical activity data for classification of patients with ventricular arrhythmia events: A pilot investigation	PLOS ONE			English	Article							LIFE-SPACE MOBILITY; SEDENTARY BEHAVIOR; FEATURE-EXTRACTION; TIME-SERIES; IMPLANTABLE DEVICES; PACEMAKER; PREDICTION; MORTALITY; EXERCISE; WOMEN	Low levels of physical activity are associated with increased mortality risk, especially in cardiac patients, but most studies are based on self-report. Cardiac implantable electronic devices (CIEDs) offer an opportunity to collect data for longer periods of time. However, there is limited agreement on the best approaches for quantification of activity measures due to the time series nature of the data. We examined physical activity time series data from 235 subjects with CIEDs and at least 365 days of uninterrupted measures. Summary statistics for raw daily physical activity (minutes/day), including statistical moments (e.g., mean, standard deviation, skewness, kurtosis), time series regression coefficients, frequency domain components, and forecasted predicted values, were calculated for each individual, and used to predict occurrence of ventricular tachycardia (VT) events as recorded by the device. In unsupervised analyses using principal component analysis, we found that while certain features tended to cluster near each other, most provided a reasonable spread across activity space without a large degree of redundancy. In supervised analyses, we found several features that were associated with the outcome (P < 0.05) in univariable and multivariable approaches, but few were consistent across models. Using a machine-learning approach in which the data was split into training and testing sets, and models ranging in complexity from simple univariable logistic regression to ensemble decision trees were fit, there was no improvement in classification of risk over naive methods for any approach. Although standard approaches identified summary features of physical activity data that were correlated with risk of VT, machine-learning approaches found that none of these features provided an improvement in classification. Future studies are needed to explore and validate methods for feature extraction and machine learning in classification of that no competing interests exist. VT risk based on device-measured activity.	[Marzec, Lucas; Raghavan, Sridharan; Banaei-Kashani, Farnoush; Creasy, Seth; Melanson, Edward L.; Lange, Leslie; Ghosh, Debashis; Rosenberg, Michael A.] Univ Colorado, Colorado Ctr Personalized Med, Sch Med, Individualized Data Anal Org, Aurora, CO 80045 USA; [Marzec, Lucas] Kaiser Permanente Colorado, Div Cardiol, Lafayette, CA USA; [Raghavan, Sridharan] Vet Affairs Eastern Colorado Hlth Care Syst, Denver, CO USA; [Raghavan, Sridharan] Univ Colorado, Sch Med, Div Gen Internal Med, Aurora, CO USA; [Banaei-Kashani, Farnoush] Univ Colorado, Coll Engn & Appl Sci, Denver, CO 80202 USA; [Creasy, Seth; Melanson, Edward L.] Univ Colorado, Sch Med, Div Endocrinol Diabet Metab, Aurora, CO USA; [Melanson, Edward L.] Univ Colorado, Sch Med, Div Geriatr Med, Aurora, CO USA; [Melanson, Edward L.] VA Eastern Colorado Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Denver, CO USA; [Ghosh, Debashis] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Rosenberg, Michael A.] Univ Colorado, Sch Med, Div Cardiac Electrophysiol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Geriatric Research Education & Clinical Center; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Rosenberg, MA (corresponding author), Univ Colorado, Colorado Ctr Personalized Med, Sch Med, Individualized Data Anal Org, Aurora, CO 80045 USA.; Rosenberg, MA (corresponding author), Univ Colorado, Sch Med, Div Cardiac Electrophysiol, Aurora, CO 80045 USA.	michael.a.rosenberg@ucdenver.edu	Melanson, Edward L/AAY-9224-2021	Rosenberg, Michael/0000-0002-6708-1648; Ghosh, Debashis/0000-0001-6618-1316	National Institutes of Health/NHLBI [MAR: 5K23 HL127296]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL127296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	National Institutes of Health/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was produced by collaborative efforts by the Individualized Data Analysis Organization of the Colorado Center for Personalized Medicine (analyzemydata.org), and is supported by grants from the National Institutes of Health/NHLBI (MAR: 5K23 HL127296).	Antos SA, 2014, J NEUROSCI METH, V231, P22, DOI 10.1016/j.jneumeth.2013.09.015; Boehmer JP, 2015, HEART FAIL CLIN, V11, P191, DOI 10.1016/j.hfc.2014.12.001; Butte NF, 2014, MED SCI SPORT EXER, V46, P1216, DOI 10.1249/MSS.0000000000000209; Censi F, 2017, INT J CARDIOL, V234, P48, DOI 10.1016/j.ijcard.2017.02.074; Cepeda M, 2018, MATURITAS, V110, P41, DOI 10.1016/j.maturitas.2018.01.016; Ciconte G, 2017, EUROPACE, V19, P1101, DOI 10.1093/europace/euw181; Cowie MR, 2013, EUR HEART J, V34, P2472, DOI 10.1093/eurheartj/eht083; Cruz-Ramirez N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092866; Ebrille E, 2015, MAYO CLIN PROC, V90, P202, DOI 10.1016/j.mayocp.2014.11.011; Fukusaki C, 2016, J STRENGTH COND RES, V30, P208, DOI 10.1519/JSC.0000000000001062; Garrigue S, 2002, PACE, V25, P883, DOI 10.1046/j.1460-9592.2002.t01-1-00883.x; Goldstein BA, 2017, EUR HEART J, V38, P1805, DOI 10.1093/eurheartj/ehw302; Grams ME, 2011, AM J KIDNEY DIS, V57, P44, DOI 10.1053/j.ajkd.2010.05.013; Guiry JJ, 2014, MED ENG PHYS, V36, P670, DOI 10.1016/j.medengphy.2014.02.009; Hastie T, 2009, ELEMENTS STAT LEARNI; Hjorth MF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-808; Huang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep32448; Jensen MH, 2013, DIABETES TECHNOL THE, V15, P538, DOI 10.1089/dia.2013.0069; Kramer DB, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004659; Kramer DB, 2017, EUROPACE, V19, P1841, DOI 10.1093/europace/euw267; Kramer DB, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001775; Leung SK, 1996, PACE, V19, P1664, DOI 10.1111/j.1540-8159.1996.tb03203.x; Mackey DC, 2016, J AM GERIATR SOC, V64, P2226, DOI 10.1111/jgs.14474; Mackey DC, 2014, J AM GERIATR SOC, V62, P1288, DOI 10.1111/jgs.12892; Martin-Martinez D, 2010, IEEE ENG MED BIO, P2383, DOI 10.1109/IEMBS.2010.5627206; MCALISTER HF, 1989, PACE, V12, P486, DOI 10.1111/j.1540-8159.1989.tb02686.x; Moridani Mohammad Karimi, 2016, Journal of Medical Engineering & Technology, V40, P87, DOI 10.3109/03091902.2016.1139201; O'Brien WJ, 2017, EUR J SPORT SCI, V17, P922, DOI 10.1080/17461391.2017.1323952; O'Connell SE, 2014, ANN HUM BIOL, V41, P1, DOI 10.3109/03014460.2013.827737; Ostendorf DM, 2018, OBESITY, V26, P53, DOI 10.1002/oby.22052; Padeletti L, 2006, PACE, V29, P34, DOI 10.1111/j.1540-8159.2006.00301.x; Phinyomark A, 2014, COMPUT METH PROG BIO, V117, P247, DOI 10.1016/j.cmpb.2014.06.013; Pujdak Krzysztof, 2016, Herzschrittmacherther Elektrophysiol, V27, P341; Raatikainen MJP, 2016, EUROPACE, V18, P1, DOI 10.1093/europace/euw244; Raymond MJ, 2018, AGING CLIN EXP RES, V30, P1005, DOI 10.1007/s40520-017-0857-x; ROBERTS DH, 1995, PACE, V18, P65, DOI 10.1111/j.1540-8159.1995.tb02477.x; Roislien J, 2013, STAT MED, V32, P3660, DOI 10.1002/sim.5797; Rowlands AV, 2018, MED SCI SPORT EXER, V50, P1508, DOI 10.1249/MSS.0000000000001588; Samuels MA, 2016, COMPUT METHOD BIOMEC, V19, P1046, DOI 10.1080/10255842.2015.1091886; Tomson TT, 2015, EXPERT REV MED DEVIC, V12, P7, DOI 10.1586/17434440.2014.953059; Yang HM, 2017, COMPUT INTEL NEUROSC, V2017, DOI 10.1155/2017/9478952; Zeitzer JM, 2018, J GERONTOL A-BIOL, V73, P682, DOI 10.1093/gerona/glw250	42	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206153	10.1371/journal.pone.0206153	http://dx.doi.org/10.1371/journal.pone.0206153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY5SG	30372463	Green Submitted, Green Published, gold			2022-12-26	WOS:000448641200024
J	Wang, AJ; Shu, XY; Niu, XY; Zhao, WJ; Ai, P; Li, P; Zheng, AP				Wang, Aijun; Shu, Xinyue; Niu, Xianyu; Zhao, Wenjuan; Ai, Peng; Li, Ping; Zheng, Aiping			Comparison of gene co-networks analysis provide a systems view of rice (Oryza sativa L.) response to Tilletia horrida infection	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; PLANT DEFENSE; STRESS; RESISTANCE; REVEALS; EFFECTORS; BIOLOGY; DISEASE; FUNGI; ACID	The biotrophic soil-borne fungus Tilletia horrida causes rice kernel smut, an important disease affecting the production of rice male sterile lines in most hybrid rice growing regions of the world. There are no successful ways of controlling this disease and there has been little study of mechanisms of resistance to T. horrida. Based on transcriptional data of different infection time points, we found 23, 782 and 23, 718 differentially expressed genes (fragments per kilobase of transcript sequence per million, FPKM >1) in Jiangcheng 3A (resistant to T. horrida) and 9311A (susceptible to T. horrida), respectively. In order to illuminate the differential responses of the two rice male sterile lines to T. horrida, we identified gene co-expression modules using the method of weighted gene co-expression network analysis (WGCNA) and compared the different biological functions of gene co-expression networks in key modules at different infection time points. The results indicated that gene co-expression networks in the two rice genotypes were different and that genes contained in some modules of the two groups may play important roles in resistance to T. horrida, such as DTH8 and OsHop/Sti1a. Furthermore, these results provide a global view of the responses of two different phenotypes to T. horrida, and assist our understanding of the regulation of expression changes after T. horrida infection.	[Wang, Aijun; Shu, Xinyue; Niu, Xianyu; Zhao, Wenjuan; Ai, Peng; Li, Ping; Zheng, Aiping] Sichuan Agr Univ, Rice Res Inst, Chengdu, Sichuan, Peoples R China; [Wang, Aijun; Shu, Xinyue; Niu, Xianyu; Zhao, Wenjuan; Li, Ping; Zheng, Aiping] Sichuan Agr Univ, Key Lab Sichuan Crop Major Dis, Chengdu, Sichuan, Peoples R China; [Wang, Aijun; Shu, Xinyue; Niu, Xianyu; Zhao, Wenjuan; Li, Ping; Zheng, Aiping] Sichuan Agr Univ, Minist Educ, Key Lab Southwest Crop Gene Resource & Genet Impr, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Zheng, AP (corresponding author), Sichuan Agr Univ, Rice Res Inst, Chengdu, Sichuan, Peoples R China.; Zheng, AP (corresponding author), Sichuan Agr Univ, Key Lab Sichuan Crop Major Dis, Chengdu, Sichuan, Peoples R China.; Zheng, AP (corresponding author), Sichuan Agr Univ, Minist Educ, Key Lab Southwest Crop Gene Resource & Genet Impr, Yaan, Sichuan, Peoples R China.	apzh0602@gmail.com		wang, aijun/0000-0002-2985-5796	Chongqing Municipal Education Commission [KJ15012017]; National Natural Science Foundation [31400130]	Chongqing Municipal Education Commission; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the scientific and technological research program of the Chongqing Municipal Education Commission (KJ15012017) and the National Natural Science Foundation (31400130).	Anders S, 2012, DIFFERENTIAL EXPRESS, V15, P322; ANDERS S, 2010, GENOME BIOL, V11; Azami-Sardooei Z, 2010, PHYSIOL MOL PLANT P, V75, P23, DOI 10.1016/j.pmpp.2010.08.001; Bagnaresi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051609; Bakkeren G, 2008, FUNGAL GENET BIOL, V45, pS15, DOI 10.1016/j.fgb.2008.04.005; Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Berri S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-120; Brooks SA, 2009, PLANT DIS, V93, P1202, DOI 10.1094/PDIS-93-11-1202; Cai JJ, 2010, GENOME BIOL EVOL, V2, P815, DOI 10.1093/gbe/evq064; Carris LM, 2006, ANNU REV PHYTOPATHOL, V44, P113, DOI 10.1146/annurev.phyto.44.070505.143402; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Chen ShengJun, 2011, Acta Agriculturae Zhejiangensis, V23, P572; Chen Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep33258; CHILDS KL, 2011, PLOS ONE, V6; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Du LQ, 2009, NATURE, V457, P1154, DOI 10.1038/nature07612; Freudenberg K., 1968, Q REV BIOL, V46, P171; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Furlong LI, 2013, TRENDS GENET, V29, P150, DOI 10.1016/j.tig.2012.11.004; Garg R, 2017, PLANT J, V91, P1088, DOI 10.1111/tpj.13621; Guo L, 2016, NEW PHYTOL, V211, P527, DOI 10.1111/nph.13912; Hardie DG, 1999, ANNU REV PLANT PHYS, V50, P97, DOI 10.1146/annurev.arplant.50.1.97; Kadarmideen HN, 2011, MOL BIOSYST, V7, P235, DOI 10.1039/c0mb00190b; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kim KilHyun, 2015, Plant Breeding and Biotechnology, V3, P197, DOI 10.9787/PBB.2015.3.3.197; Kumar A, 2015, FUNCT INTEGR GENOMIC, V15, P425, DOI 10.1007/s10142-014-0431-y; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee I, 2011, P NATL ACAD SCI USA, V108, P18548, DOI 10.1073/pnas.1110384108; Lee KJ, 2015, PLANT GROWTH REGUL, V77, P67, DOI 10.1007/s10725-015-0036-z; Liu JY, 2015, MOL PLANT, V8, P689, DOI 10.1016/j.molp.2015.03.012; Medina IR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156006; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Nutan KK, 2017, FUNCT INTEGR GENOMIC, V17, P69, DOI 10.1007/s10142-016-0529-5; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Rosen EY, 2011, NEURON, V71, P1030, DOI 10.1016/j.neuron.2011.07.021; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Sriroopreddy R, 2018, FUNCT INTEGR GENOMIC, V18, P113, DOI 10.1007/s10142-017-0579-3; Thatcher LF, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3192-2; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Wang AiJun, 2018, Acta Phytopathologica Sinica, V48, P297; Wang JX, 2014, FUNCT INTEGR GENOMIC, V14, P431, DOI 10.1007/s10142-014-0370-7; Wang N, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00621-15; Weisshaar B, 1998, CURR OPIN PLANT BIOL, V1, P251, DOI 10.1016/S1369-5266(98)80113-1; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Winden KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020763; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; ZHANG JC, 2016, SCI REP UK, V6; Zhang JF, 2018, FUNCT INTEGR GENOMIC, V18, P545, DOI 10.1007/s10142-018-0607-y; Zhang JF, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01422; Zhang SJ, 2009, J INTEGR PLANT BIOL, V51, P167, DOI 10.1111/j.1744-7909.2008.00763.x; Zhang YW, 2018, FUNCT INTEGR GENOMIC, V18, P261, DOI 10.1007/s10142-017-0588-2; Zhao L, 2013, FUNCT INTEGR GENOMIC, V13, P75, DOI 10.1007/s10142-012-0301-4; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	61	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0202309	10.1371/journal.pone.0202309	http://dx.doi.org/10.1371/journal.pone.0202309			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372430	Green Published, gold, Green Submitted			2022-12-26	WOS:000448641200002
J	Rios-Navarro, C; Gavara, J; Vidal, V; Bonanad, C; Racugno, P; Bayes-Genis, A; Minana, G; Husser, O; Oltra, R; Nunez, J; Chorro, FJ; Bodi, V; Ruiz-Sauri, A				Rios-Navarro, Cesar; Gavara, Jose; Vidal, Veronica; Bonanad, Clara; Racugno, Paolo; Bayes-Genis, Antoni; Minana, Gema; Husser, Oliver; Oltra, Ricardo; Nunez, Julio; Chorro, Francisco J.; Bodi, Vicente; Ruiz-Sauri, Amparo			Characterization and implications of the dynamics of eosinophils in blood and in the infarcted myocardium after coronary reperfusion	PLOS ONE			English	Article							PREDICTION; THROMBUS; EDEMA; DEATH; RATIO; SOON	Objective We characterized the dynamics of eosinophils in blood and in the infarcted myocardium in patients and in a swine model of reperfused myocardial infarction (MI). The association of eosinophil dynamics with various outcomes was assessed. Methods Serial eosinophil count and pre-discharge cardiac magnetic resonance were carried out in a prospective series of 620 patients with a first ST-elevation MI. In a swine model of reperfused MI, the dynamics of circulating eosinophils and their presence in the infarcted myocardium were determined. In autopsies from chronic MI patients, eosinophils were quantified. Results Patient eosinophil count sharply decreased 12h post-reperfusion compared to arrival. A lower minimum eosinophil count was associated with more extensive edema, microvascular obstruction, and infarct size as measured by cardiac magnetic resonance, and also with a higher rate of cardiac events (death, re-infarction, or heart failure) during follow-up. In the experimental model, eosinophil count boosted during ischemia and dropped back immediately post-reperfusion. Myocardial samples revealed progressive eosinophil migration into the infarcted myocardium, especially areas with microvascular obstruction. Markers of eosinophil maturation and survival (interleukin-5), degranulation (eosinophil cationic protein) and migration (eotoxin-1) were detected in the blood of patients, and in porcine myocardium. Eosinophil infiltration was detected in autopsies from chronic MI patients. Conclusion Eosinopenia post-MI was associated with an impaired cardiac structure and adverse events. The decay in circulating eosinophils soon after reperfusion mirrors their migration into the infarcted myocardium, as reflected by their presence in heart samples from swine and patients. Further studies are needed to understanding this unexplored pathway and its therapeutic implications.	[Rios-Navarro, Cesar; Gavara, Jose; Bonanad, Clara; Racugno, Paolo; Minana, Gema; Nunez, Julio; Chorro, Francisco J.; Bodi, Vicente; Ruiz-Sauri, Amparo] Inst Hlth Res INCLIVA, Valencia, Spain; [Rios-Navarro, Cesar; Gavara, Jose; Bonanad, Clara; Racugno, Paolo; Minana, Gema; Nunez, Julio; Chorro, Francisco J.; Bodi, Vicente] Hosp Clin Univ, Cardiol Dept, Valencia, Spain; [Vidal, Veronica; Minana, Gema; Nunez, Julio; Chorro, Francisco J.; Bodi, Vicente] Univ Valencia, Sch Med, Med Dept, Valencia, Spain; [Bayes-Genis, Antoni] Hosp Badalona Germans Trias & Pujol, Cardiol Dept, Badalona, Spain; [Bayes-Genis, Antoni] Hosp Badalona Germans Trias & Pujol, Heart Failure Unit, Badalona, Spain; [Bayes-Genis, Antoni; Minana, Gema; Nunez, Julio; Chorro, Francisco J.; Bodi, Vicente] Ctr Invest Biomed Red Cardiovasc CIBER CV, Madrid, Spain; [Husser, Oliver] St Johannes Hosp, Dept Cardiol, Dortmund, Germany; [Oltra, Ricardo] Hosp Clin Univ Valencia, Intens Care Unit, Valencia, Spain; [Ruiz-Sauri, Amparo] Univ Valencia, Sch Med, Pathol Dept, Valencia, Spain	University of Valencia; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; St. Johannes Hospital; Hospital Clinic Universitari de Valencia; University of Valencia	Bodi, V (corresponding author), Inst Hlth Res INCLIVA, Valencia, Spain.; Bodi, V (corresponding author), Hosp Clin Univ, Cardiol Dept, Valencia, Spain.; Bodi, V (corresponding author), Univ Valencia, Sch Med, Med Dept, Valencia, Spain.; Bodi, V (corresponding author), Ctr Invest Biomed Red Cardiovasc CIBER CV, Madrid, Spain.	vicente.bodi@uv.es	Bayes-Genis, Antonio/AAV-9422-2021; Doñate, Jose Gavara/AAB-8137-2019; Ríos-Navarro, Cesar/AAB-3875-2019; Saurí, Amparo Ruiz/R-5395-2018; Racugno, Paolo/AAB-3490-2019; Chorro, Francisco J/AAB-6766-2020	Bayes-Genis, Antonio/0000-0002-3044-197X; Doñate, Jose Gavara/0000-0002-3483-7066; Ríos-Navarro, Cesar/0000-0002-6405-6279; 	Generalitat Valenciana [GV/2018/116]; Instituto de Salud Carlos III [PI17/01836, PIE15/00013, CB16/11/00486]; Fondo Europeo de Desarrollo Regional (FEDER) [PI17/01836, PIE15/00013, CB16/11/00486]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government)	This work was supported by the 'Instituto de Salud Carlos III and co-funded by Fondo Europeo de Desarrollo Regional (FEDER)' [grant numbers PI17/01836, PIE15/00013, and CB16/11/00486] and Generalitat Valenciana [GV/2018/116].	Blanchard C, 2009, ADV IMMUNOL, V101, P81, DOI 10.1016/S0065-2776(08)01003-1; Bodi V, 2016, RADIOLOGY, V278, P54, DOI 10.1148/radiol.2015142674; Bodi V, 2009, REV ESP CARDIOL, V62, P1109, DOI 10.1016/S0300-8932(09)72379-6; Bonanad C, 2016, EUR J RADIOL, V85, P585, DOI 10.1016/j.ejrad.2015.12.012; Brambatti M, 2017, J AM COLL CARDIOL, V70, P2363, DOI 10.1016/j.jacc.2017.09.023; Davoine F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00570; Diny NL, 2016, EUR J IMMUNOL, V46, P2749, DOI 10.1002/eji.201646557; Fernandez-Jimenez R, 2015, J AM COLL CARDIOL, V66, P816, DOI 10.1016/j.jacc.2015.06.023; FISHBEIN MC, 1978, CHEST, V73, P843, DOI 10.1378/chest.73.6.843; Forteza MJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1975167; Haley KJ, 2000, CIRCULATION, V102, P2185; Husser O, 2011, INFLAMMATION, V34, P73, DOI 10.1007/s10753-010-9209-0; Jacobsen EA, 2007, J ALLERGY CLIN IMMUN, V119, P1313, DOI 10.1016/j.jaci.2007.03.043; Jiang P, 2015, CORONARY ARTERY DIS, V26, P101, DOI 10.1097/MCA.0000000000000186; Konishi T, 2017, J ATHEROSCLER THROMB, V24, P827, DOI 10.5551/jat.37937; Meyerholz DK, 2009, TOXICOL PATHOL, V37, P249, DOI 10.1177/0192623308329342; Monmeneu JV, 2009, REV ESP CARDIOL, V62, P858, DOI 10.1016/S0300-8932(09)72068-8; Niccoli G, 2016, EUR HEART J, V37, P1024, DOI 10.1093/eurheartj/ehv484; Niccoli G, 2010, ATHEROSCLEROSIS, V211, P606, DOI 10.1016/j.atherosclerosis.2010.02.038; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Possa SS, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00046; Rios-Navarro C, 2018, REV ESP CARDIOL, V71, P440, DOI 10.1016/j.rec.2017.06.019; Sakai T, 2009, INT HEART J, V50, P267, DOI 10.1536/ihj.50.267; Shiyovich A, 2017, TEX HEART I J, V44, P176, DOI 10.14503/THIJ-16-5768; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Toor IS, 2012, THROMB RES, V130, P607, DOI 10.1016/j.thromres.2012.05.033; Echevarria LU, 2017, INT J CHRONIC OBSTR, V12, P885, DOI 10.2147/COPD.S115969; Xia GL, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4980251	29	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206344	10.1371/journal.pone.0206344	http://dx.doi.org/10.1371/journal.pone.0206344			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365558	gold, Green Published, Green Submitted			2022-12-26	WOS:000448448700044
J	Rodriguez-Arias, M; Montagud-Romero, S; Carrion, AMG; Ferrer-Perez, C; Perez-Villalba, A; Marco, E; Gallardo, ML; Viveros, MP; Minarro, J				Rodriguez-Arias, Marta; Montagud-Romero, Sandra; Guardia Carrion, Ana Maria; Ferrer-Perez, Carmen; Perez-Villalba, Ana; Marco, Eva; Lopez Gallardo, Meritxell; Viveros, Maria-Paz; Minarro, Jose			Social stress during adolescence activates long-term microglia inflammation insult in reward processing nuclei	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; DEFEAT STRESS; IMMUNE-SYSTEM; INDIVIDUAL-DIFFERENCES; MONOCYTE TRAFFICKING; BEHAVIORAL-RESPONSES; PREFRONTAL CORTEX; DEPRESSION-LIKE; MESSENGER-RNA; COCAINE	The experience of social stress during adolescence is associated with higher vulnerability to drug use. Increases in the acquisition of cocaine self-administration, in the escalation of cocaine-seeking behavior, and in the conditioned rewarding effects of cocaine have been observed in rodents exposed to repeated social defeat (RSD). In addition, prolonged or severe stress induces a proinflammatory state with microglial activation and increased cytokine production. The aim of the present work was to describe the long-term effects induced by RSD during adolescence on the neuroinflammatory response and synaptic structure by evaluating different glial and neuronal markers. In addition to an increase in the conditioned rewarding effects of cocaine, our results showed that RSD in adolescence produced inflammatory reactivity in microglia that is prolonged into adulthood, affecting astrocytes and neurons of two reward-processing areas of the brain (the prelimbic cortex, and the nucleus accumbens core). Considered as a whole these results suggest that social stress experience modulates vulnerability to suffer a loss of glia-supporting functions and neuronal functional synaptic density due to drug consumption in later life.	[Rodriguez-Arias, Marta; Montagud-Romero, Sandra; Ferrer-Perez, Carmen; Perez-Villalba, Ana; Minarro, Jose] Univ Valencia, Fac Psychol, Dept Psychobiol, Valencia, Spain; [Guardia Carrion, Ana Maria; Lopez Gallardo, Meritxell; Viveros, Maria-Paz] Univ Complutense Madrid, Fac Med, Dept Physiol, Madrid, Spain; [Marco, Eva] Univ Complutense Madrid, Fac Biol Sci, Dept Anim Physiol, Madrid, Spain	University of Valencia; Complutense University of Madrid; Complutense University of Madrid	Rodriguez-Arias, M (corresponding author), Univ Valencia, Fac Psychol, Dept Psychobiol, Valencia, Spain.	marta.rodriguez@uv.es	/AAN-8627-2020; Romero, Sandra Montagud/AAF-9408-2021; Rodriguez-Arias, Marta/B-5163-2011; Viveros, Maria-Paz/S-6855-2016; Marco, Eva M./Q-3870-2019; Minarro, Jose/B-4414-2011; Ferrer-Pérez, Carmen/AAQ-9428-2020; Marco, Eva M./ABH-3257-2020; GALLARDO, MERITXELL LOPEZ/ABG-2960-2020; Perez, Ana/L-9214-2014	Romero, Sandra Montagud/0000-0002-3380-7252; Viveros, Maria-Paz/0000-0002-4119-4636; Minarro, Jose/0000-0002-5731-7821; Ferrer-Pérez, Carmen/0000-0002-8890-4869; Marco, Eva M./0000-0002-2457-475X; GALLARDO, MERITXELL LOPEZ/0000-0002-9291-623X; Perez, Ana/0000-0002-5330-2374; Rodriguez-Arias, Marta/0000-0002-1121-8879	Ministerio de Economia y Competitividad (MINECO), Direccion General de Investigacion [PSI2014-51847-R, PSI 2017-83023-R]; Instituto de Salud Carlos III, Red de Trastornos Adictivos (RTA) [RETICS RD2012/0028/0021, RD16/0017/0007]; Union Europea, Fondos FEDER "A way to build Europe" [GRUPOS UCM-BSCH 951579]	Ministerio de Economia y Competitividad (MINECO), Direccion General de Investigacion; Instituto de Salud Carlos III, Red de Trastornos Adictivos (RTA); Union Europea, Fondos FEDER "A way to build Europe"	This work was supported by Ministerio de Economia y Competitividad (MINECO), Direccion General de Investigacion, PSI2014-51847-R to JM and PSI 2017-83023-R to MR; Instituto de Salud Carlos III, Red de Trastornos Adictivos (RTA) (RETICS RD2012/0028/0021 to MPV; RD16/0017/0007 to JM) and Union Europea, Fondos FEDER "A way to build Europe"; GRUPOS UCM-BSCH 951579 to MPV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Araya-Callis C, 2012, PSYCHOPHARMACOLOGY, V224, P209, DOI 10.1007/s00213-012-2741-x; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Bollinger JL, 2016, BRAIN BEHAV IMMUN, V52, P88, DOI 10.1016/j.bbi.2015.10.003; Boyson CO, 2014, J NEUROSCI, V34, P6659, DOI 10.1523/JNEUROSCI.3942-13.2014; Boyson CO, 2011, PSYCHOPHARMACOLOGY, V218, P257, DOI 10.1007/s00213-011-2266-8; Braun K, 2009, NEUROSCIENCE, V160, P629, DOI 10.1016/j.neuroscience.2009.02.074; Burke AR, 2017, NEUROSCI BIOBEHAV R, V76, P280, DOI 10.1016/j.neubiorev.2017.01.018; Burke AR, 2015, PSYCHOPHARMACOLOGY, V232, P3067, DOI 10.1007/s00213-015-3947-5; Burke AR, 2010, BRAIN RES, V1352, P147, DOI 10.1016/j.brainres.2010.06.062; Buwalda B, 1999, J NEUROENDOCRINOL, V11, P513; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Arenas MC, 2014, PHYSIOL BEHAV, V133, P152, DOI 10.1016/j.physbeh.2014.05.028; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Christoffel DJ, 2011, REV NEUROSCIENCE, V22, P535, DOI 10.1515/RNS.2011.044; Covington HE, 2005, PSYCHOPHARMACOLOGY, V183, P331, DOI 10.1007/s00213-005-0190-5; Covington HE, 2005, NEUROPSYCHOPHARMACOL, V30, P310, DOI 10.1038/sj.npp.1300587; Covington HE, 2001, PSYCHOPHARMACOLOGY, V158, P388, DOI 10.1007/s002130100858; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; Czeh B, 2006, NEUROPSYCHOPHARMACOL, V31, P1616, DOI 10.1038/sj.npp.1300982; Reguilon MD, 2017, EUR J PHARMACOL, V799, P48, DOI 10.1016/j.ejphar.2017.01.039; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2018, PHYSIOL REV, V98, P477, DOI 10.1152/physrev.00039.2016; Diz-Chaves Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-71; Ellenbroek BA, 2005, EUR J PHARMACOL, V526, P251, DOI 10.1016/j.ejphar.2005.09.032; Enoch MA, 2006, ANN NY ACAD SCI, V1094, P193, DOI 10.1196/annals.1376.019; Fernandez-Arjona MD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00235; Frick LR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/608654; GarciaSegura LM, 1996, FRONT NEUROENDOCRIN, V17, P180, DOI 10.1006/frne.1996.0005; Gasche Y, 2001, J CEREBR BLOOD F MET, V21, P1393, DOI 10.1097/00004647-200112000-00003; Geier C, 2009, PHARMACOL BIOCHEM BE, V93, P212, DOI 10.1016/j.pbb.2009.01.021; Gomes FV, 2015, SCHIZOPHR RES, V164, P155, DOI 10.1016/j.schres.2015.01.015; Gusel'nikova VV, 2015, ACTA NATURAE, V7, P42, DOI 10.32607/20758251-2015-7-2-42-47; Hammels C, 2015, NEUROSCI BIOBEHAV R, V59, P111, DOI 10.1016/j.neubiorev.2015.10.006; Hinwood M, 2012, CEREB CORTEX, V22, P1442, DOI 10.1093/cercor/bhr229; Hinwood M, 2013, CEREB CORTEX, V23, P1784, DOI 10.1093/cercor/bhs151; Hodes GE, 2014, P NATL ACAD SCI USA, V111, P16136, DOI 10.1073/pnas.1415191111; Holly EN, 2016, J NEUROSCI, V36, P4093, DOI 10.1523/JNEUROSCI.2232-15.2016; Huntingford F.A., 1987, ANIMAL CONFLICT; Hymel KA, 2014, BEHAV PHARMACOL, V25, P599, DOI 10.1097/FBP.0000000000000074; Jauregui-Huerta F, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00159; Jeon SW, 2018, J INFLAMM RES, V11, P179, DOI 10.2147/JIR.S141033; Katsu M, 2010, J CEREBR BLOOD F MET, V30, P1939, DOI 10.1038/jcbfm.2010.45; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim YK, 2017, BEHAV BRAIN RES, V329, P6, DOI 10.1016/j.bbr.2017.04.020; Koob GF, 2012, HAND CLINIC, V106, P137, DOI 10.1016/B978-0-444-52002-9.00009-7; Koob GF, 2010, BRAIN RES, V1314, P3, DOI 10.1016/j.brainres.2009.11.008; Kreisel T, 2014, MOL PSYCHIATR, V19, P699, DOI 10.1038/mp.2013.155; Lambert K G, 2000, Stress, V3, P275, DOI 10.3109/10253890009001133; Land BB, 2009, P NATL ACAD SCI USA, V106, P19168, DOI 10.1073/pnas.0910705106; Lee Oi Sun, 2013, [Journal of Korea Academia-Industrial cooperation Society, 한국산학기술학회논문지], V14, P2749, DOI 10.5762/KAIS.2013.14.6.2749; Leussis MP, 2008, SYNAPSE, V62, P185, DOI 10.1002/syn.20483; Liu Y, 2015, MOL NUTR FOOD RES, V59, P1130, DOI 10.1002/mnfr.201400753; Logrip ML, 2012, NEUROPHARMACOLOGY, V62, P552, DOI 10.1016/j.neuropharm.2011.07.007; Lucassen PJ, 2014, ACTA NEUROPATHOL, V127, P109, DOI 10.1007/s00401-013-1223-5; Lumley LA, 2000, PHARMACOL BIOCHEM BE, V67, P433, DOI 10.1016/S0091-3057(00)00382-8; Maldonado C, 2006, BEHAV PHARMACOL, V17, P119, DOI 10.1097/01.fbp.0000190685.84984.ec; Mantsch JR, 2016, NEUROPSYCHOPHARMACOL, V41, P335, DOI 10.1038/npp.2015.142; McCormick CM, 2012, HIPPOCAMPUS, V22, P1300, DOI 10.1002/hipo.20966; McKim DB, 2016, J NEUROSCI, V36, P2590, DOI 10.1523/JNEUROSCI.2394-15.2016; McLaughlin JP, 2006, NEUROPSYCHOPHARMACOL, V31, P1241, DOI 10.1038/sj.npp.1300872; Meerlo P, 2002, STRESS, V5, P15, DOI 10.1080/102538902900012323; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Miller AH, 2015, JAMA PSYCHIAT, V72, P527, DOI 10.1001/jamapsychiatry.2015.22; Montagud-Romero S, 2016, PROG NEURO-PSYCHOPH, V71, P144, DOI 10.1016/j.pnpbp.2016.07.008; Montagud-Romero S, 2016, PROG NEURO-PSYCHOPH, V70, P39, DOI 10.1016/j.pnpbp.2016.04.016; Montagud-Romero S, 2015, PHARMACOL BIOCHEM BE, V135, P1, DOI 10.1016/j.pbb.2015.05.008; Montagud-Romero S, 2017, PSYCHOPHARMACOLOGY, V234, P2063, DOI 10.1007/s00213-017-4612-y; Montagud-Romero S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092576; NICHOLS NR, 1990, MOL BRAIN RES, V7, P1, DOI 10.1016/0169-328X(90)90066-M; OCALLAGHAN JP, 1991, J NEUROCHEM, V57, P860, DOI 10.1111/j.1471-4159.1991.tb08230.x; Paxinos G. F, MOUSE BRAIN STEREOTA; Perez-Villalba A, 2018, J NEUROSCI, V38, P814, DOI 10.1523/JNEUROSCI.2276-17.2017; Pesarico AP, 2017, J PSYCHIATR RES, V94, P78, DOI 10.1016/j.jpsychires.2017.06.012; Powell K, 2006, NATURE, V442, P865, DOI 10.1038/442865a; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Reader BF, 2015, NEUROSCIENCE, V289, P429, DOI 10.1016/j.neuroscience.2015.01.001; Rodriguez-Arias M, 1998, EUR NEUROPSYCHOPHARM, V8, P95, DOI 10.1016/S0924-977X(97)00051-5; Rodriguez-Arias M, 2012, ADDICTIONS PATHOPHYS, P227; Rodriguez-Arias M, 2013, DRUG USE ABUSE SIGNS, P133; Rodriguez-Arias M, 2017, ADDICT BIOL, V22, P129, DOI 10.1111/adb.12301; Rodriguez-Arias M, 2009, PHYSIOL BEHAV, V96, P620, DOI 10.1016/j.physbeh.2008.12.011; Rodriguez-Espinosa N, 2015, PSYCHOPHARMACOLOGY, V232, P57, DOI 10.1007/s00213-014-3632-0; Sarnat HB, 2015, CELL TISSUE RES, V359, P279, DOI 10.1007/s00441-014-1988-4; Scharfman HE, 2014, NEUROBIOL DIS, V72, P180, DOI 10.1016/j.nbd.2014.07.004; Scofield MD, 2016, BIOL PSYCHIAT, V80, P207, DOI 10.1016/j.biopsych.2015.12.022; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; SHARMA HS, 1992, NEUROSCIENCE, V48, P889, DOI 10.1016/0306-4522(92)90277-9; Sinha R, 2011, PSYCHOPHARMACOLOGY, V218, P69, DOI 10.1007/s00213-011-2263-y; Spear L, 2000, ALCOHOL RES HEALTH, V24, P115; Sterlemann V, 2010, HIPPOCAMPUS, V20, P540, DOI 10.1002/hipo.20655; Sugama S, 2007, NEUROSCIENCE, V146, P1388, DOI 10.1016/j.neuroscience.2007.02.043; Tian WM, 2009, MATRIX BIOL, V28, P148, DOI 10.1016/j.matbio.2009.02.002; Tidey JW, 1997, PSYCHOPHARMACOLOGY, V130, P203, DOI 10.1007/s002130050230; TORNATZKY W, 1993, PHYSIOL BEHAV, V53, P983, DOI 10.1016/0031-9384(93)90278-N; Ttofi MM, 2016, SCHOOL PSYCHOL QUART, V31, P8, DOI 10.1037/spq0000120; Tynan RJ, 2010, BRAIN BEHAV IMMUN, V24, P1058, DOI 10.1016/j.bbi.2010.02.001; Vidal J, 2011, BEHAV PROCESS, V87, P176, DOI 10.1016/j.beproc.2011.03.004; Vidal-Infer A, 2012, PHARMACOL BIOCHEM BE, V102, P124, DOI 10.1016/j.pbb.2012.03.031; Wake H, 2011, NEURON GLIA BIOL, V7, P47, DOI 10.1017/S1740925X12000063; Walker FR, 2014, BRAIN BEHAV IMMUN, V37, P1, DOI 10.1016/j.bbi.2013.12.010; Walker FR, 2013, CURR DRUG TARGETS, V14, P1262; Watt MJ, 2009, BEHAV NEUROSCI, V123, P564, DOI 10.1037/a0015752; Weber MD, 2017, NEUROPSYCHOPHARMACOL, V42, P46, DOI 10.1038/npp.2016.102; Wohleb ES, 2014, BIOL PSYCHIAT, V75, P970, DOI 10.1016/j.biopsych.2013.11.029; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Wohleb ES, 2012, PSYCHONEUROENDOCRINO, V37, P1491, DOI 10.1016/j.psyneuen.2012.02.003; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011	109	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206421	10.1371/journal.pone.0206421	http://dx.doi.org/10.1371/journal.pone.0206421			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3KA	30365534	gold, Green Published, Green Submitted			2022-12-26	WOS:000448448700051
J	Hewlett, SE; Smoleniec, JDD; Wareham, DM; Pyne, TM; Barron, AB				Hewlett, Susie E.; Smoleniec, Jacqueline D. Delahunt; Wareham, Deborah M.; Pyne, Thomas M.; Barron, Andrew B.			Biogenic amine modulation of honey bee sociability and nestmate affiliation	PLOS ONE			English	Article							VOLES MICROTUS-OCHROGASTER; DIVISION-OF-LABOR; BEHAVIORAL GREGARIZATION; PARTNER PREFERENCES; DOPAMINE-RECEPTORS; NUCLEUS-ACCUMBENS; SOCIAL-CONTEXT; OCTOPAMINE; TROPHALLAXIS; EXPRESSION	Biogenic amines modulate a range of social behaviours, including sociability and mechanisms of group cohesion, in both vertebrates and invertebrates. Here, we tested if the biogenic amines modulate honey bee (Apis mellifera) sociability and nestmate affiliation. We examined the consequences of treatments with biogenic amines, agonists and antagonists on a bee's approach to, and subsequent social interactions with, conspecifics in both naturally hive-reared bees and isolated bees. We used two different treatment methods. Bees were first treated topically with compounds dissolved in the solvent dimethylformamide (dMF) applied to the dorsal thorax, but dMF had a significant effect on the locomotion and behaviour of the bees during the behavioural test that interfered with their social responses. Our second method used microinjection to deliver biogenic amines to the head capsule via the ocellar tract. Microinjection of dopamine and a dopamine antagonist had strong effects on bee sociability, likelihood of interaction with bees, and nestmate affiliation. Octopamine treatment reduced social interaction with other bees, and serotonin increased the likelihood of social interactions. HPLC measurements showed that isolation reduced brain levels of biogenic amines compared to hive-reared bees. Our findings suggest that dopamine is an important neurochemical component of social motivation in bees. This finding advances a comparative understanding of the processes of social evolution.	[Hewlett, Susie E.; Smoleniec, Jacqueline D. Delahunt; Pyne, Thomas M.; Barron, Andrew B.] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [Wareham, Deborah M.] Macquarie Univ, Dept Hlth Profess, Sydney, NSW, Australia	Macquarie University; Macquarie University	Hewlett, SE; Barron, AB (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia.	susiehewlett@gmail.com; andrew.barron@mq.edu.au	Hewlett, Susie/HGB-3463-2022	Barron, Andrew/0000-0002-8135-6628	Macquarie University; international Macquarie Research Excellence Scholarship (iMQRES)	Macquarie University; international Macquarie Research Excellence Scholarship (iMQRES)	SEH was funded by Macquarie University with an international Macquarie Research Excellence Scholarship (iMQRES). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi AM, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00371; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; Aragona BJ, 2003, J NEUROSCI, V23, P3483, DOI 10.1523/jneurosci.23-08-03483.2003; Banerjee SB, 2013, EUR J NEUROSCI, V38, P3731, DOI 10.1111/ejn.12378; Barron AB, 2007, J INSECT PHYSIOL, V53, P187, DOI 10.1016/j.jinsphys.2006.11.009; Beggs KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026809; Beggs KT, 2009, CURR BIOL, V19, P1206, DOI 10.1016/j.cub.2009.05.051; Behrends A, 2012, J EXP BIOL, V215, P1076, DOI 10.1242/jeb.063297; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; BLENAU W, 1995, COMP BIOCHEM PHYS B, V112, P377, DOI 10.1016/0305-0491(95)00098-4; Boulay R, 2000, J EXP BIOL, V203, P513; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bubak AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166417; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Cattelan S, 2017, ANIM BEHAV, V127, P109, DOI 10.1016/j.anbehav.2017.03.009; CHEN JF, 1994, NEUROCHEM INT, V25, P355, DOI 10.1016/0197-0186(94)90143-0; Fernandez M, 2018, NEUROSCIENCE, V370, P148, DOI 10.1016/j.neuroscience.2017.07.013; Gil M, 2005, J EXP BIOL, V208, P671, DOI 10.1242/jeb.01474; Gingrich B, 2000, BEHAV NEUROSCI, V114, P173, DOI 10.1037/0735-7044.114.1.173; Goodson JL, 2012, P NATL ACAD SCI USA, V109, P10685, DOI 10.1073/pnas.1203394109; Goodson JL, 2009, SCIENCE, V325, P862, DOI 10.1126/science.1174929; Goodson JL, 2009, P NATL ACAD SCI USA, V106, P8737, DOI 10.1073/pnas.0811821106; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Guo XJ, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00080; Harlow BYHF, 1965, P NATL ACAD SCI USA, V54, P90; Hewlett SE, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.173054; Kamhi JF, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00074; Kelly AM, 2015, BEHAV BRAIN RES, V280, P101, DOI 10.1016/j.bbr.2014.12.004; Klappenbach M, 2013, NEUROBIOL LEARN MEM, V106, P230, DOI 10.1016/j.nlm.2013.09.011; Knuth ED, 2007, BRAIN RES, V1128, P139, DOI 10.1016/j.brainres.2006.10.054; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Leblois A, 2010, J NEUROSCI, V30, P5730, DOI 10.1523/JNEUROSCI.5974-09.2010; Lenschow M, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00014; Ma ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08036; Ma ZY, 2011, P NATL ACAD SCI USA, V108, P3882, DOI 10.1073/pnas.1015098108; Mayack C, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0820; McQuillan HJ, 2012, J COMP PHYSIOL A, V198, P753, DOI 10.1007/s00359-012-0745-y; Meer RKV, 2008, NATURWISSENSCHAFTEN, V95, P1155, DOI 10.1007/s00114-008-0432-6; MORITZ RFA, 1986, INSECT SOC, V33, P26, DOI 10.1007/BF02224032; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Mustard JA, 2003, MOL BRAIN RES, V113, P67, DOI 10.1016/S0169-328X(03)00091-3; Mustard JA, 2010, J INSECT PHYSIOL, V56, P422, DOI 10.1016/j.jinsphys.2009.11.018; Naiem ES, 1999, J COMP PHYSIOL B, V169, P271, DOI 10.1007/s003600050221; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Nouvian M, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2653; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; Purves D, 2012, NEUROSCIENCE; Raghanti MA, 2018, P NATL ACAD SCI USA, DOI [10.1073/pnas.1717666115, DOI 10.1073/PNAS.1717666115]; Reim T, 2014, INSECT MOL BIOL, V23, P833, DOI 10.1111/imb.12130; Robinson GE, 1999, NATURE, V399, P534, DOI 10.1038/21095; Rogers SM, 2004, J EXP BIOL, V207, P3603, DOI 10.1242/jeb.01183; Rogers SM, 2003, J EXP BIOL, V206, P3991, DOI 10.1242/jeb.00648; Scheiner R, 2002, BEHAV BRAIN RES, V136, P545, DOI 10.1016/S0166-4328(02)00205-X; Scheiner R, 2001, BEHAV BRAIN RES, V120, P67, DOI 10.1016/S0166-4328(00)00359-4; Schulz DJ, 1999, J COMP PHYSIOL A, V184, P481, DOI 10.1007/s003590050348; Solvi C, 2016, SCIENCE, V353, P1529, DOI 10.1126/science.aaf4454; Sovik E, 2016, JOVE-J VIS EXP, DOI 10.3791/54695; Sovik E, 2015, ADV INSECT PHYSIOL, V48, P189, DOI 10.1016/bs.aiip.2014.12.006; Sovik E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064920; Trabace L, 2012, ACTA NEUROPSYCHIATR, V24, P286, DOI 10.1111/j.1601-5215.2011.00627.x; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Vergoz V, 2009, P NATL ACAD SCI USA, V106, P20930, DOI 10.1073/pnas.0907563106; Verlinden H, 2010, J INSECT PHYSIOL, V56, P868, DOI 10.1016/j.jinsphys.2010.03.003; Wada-Katsumata A, 2011, J EXP BIOL, V214, P1707, DOI 10.1242/jeb.051565; Waddell S, 2016, CURR BIOL, V26, pR109, DOI 10.1016/j.cub.2015.12.023; Wang ZX, 1999, BEHAV NEUROSCI, V113, P602, DOI 10.1037/0735-7044.113.3.602; Ward A., 2016, SOCIALITY BEHAV GROU; WILLIAMS JR, 1992, HORM BEHAV, V26, P339, DOI 10.1016/0018-506X(92)90004-F; WOODRUFF GN, 1974, J PHARM PHARMACOL, V26, P740, DOI 10.1111/j.2042-7158.1974.tb09363.x; Xu L, 2017, INSECT MOL BIOL, V26, P1, DOI 10.1111/imb.12266; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	74	9	9	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0205686	10.1371/journal.pone.0205686	http://dx.doi.org/10.1371/journal.pone.0205686			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359390	gold, Green Published			2022-12-26	WOS:000448438400023
J	Wikstrom, JD; Lundeberg, L; Frohm-Nilsson, M; Girnita, A				Wikstrom, Jakob D.; Lundeberg, Lena; Frohm-Nilsson, Margareta; Girnita, Ada			Differences in cutaneous melanoma treatment and patient satisfaction	PLOS ONE			English	Article							MALIGNANT-MELANOMA; DIAGNOSIS; CANCER; BIOPSY; DELAY; MANAGEMENT	Although clinical guidelines exist, the management of patients with cutaneous melanoma (CM) is a complex process that may vary between different care providers with potential dysfunctions ultimately mirrored in the overall patient satisfaction. The aim of the present study was to investigate the CM management as related to lead times, surgical quality and diagnosis communication with the hypothesis that the care may differ between providers and disparities may impact patient satisfaction. Medical records of 181 patients were retrospectively analyzed with parallel patient satisfaction evaluation by telephone interviews. Overall mean lead times from initial diagnosis until completion of all surgery and histopathology reports were 80-100 days and delays occurred at every step of the process. General practitioners performed excision biopsies faster however this was mitigated by slower histopathology processing. University level CM care showed less lag time between excision biopsy, wide local excision for thick melanomas and histopathology confirmation. University level care operated with twice the surgical margin as compared to general practitioners and non-university level specialists. Male patients had larger excision biopsy margins and significantly shorter lead times than female patients. Patient satisfaction rates were generally higher in the academic hospitals as compared to general practitioners and non-university dermatology clinics. Surprisingly, there was no correlation between lead times and patient satisfaction. Taken together, CM show substantial variation and caution should be practiced when using patient satisfaction as a quality indicator.	[Wikstrom, Jakob D.; Lundeberg, Lena; Frohm-Nilsson, Margareta; Girnita, Ada] Karolinska Inst, Karolinska Univ Hosp, Dept Med Solna, Dermatol & Venereol Unit, Stockholm, Sweden; [Girnita, Ada] Karolinska Inst, Canc Ctr Karolinska, Karolinska Univ Hosp, Dept Oncol & Pathol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Wikstrom, JD; Frohm-Nilsson, M; Girnita, A (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Med Solna, Dermatol & Venereol Unit, Stockholm, Sweden.; Girnita, A (corresponding author), Karolinska Inst, Canc Ctr Karolinska, Karolinska Univ Hosp, Dept Oncol & Pathol, Stockholm, Sweden.	jakob.wikstrom@ki.se; margareta.frohm-nilsson@ki.se; ada.girnita@ki.se	Girnita, Ada/AAC-4518-2020	Wikstrom, Jakob/0000-0002-4287-1774				Al-Shakhli H, 2006, J PLAST RECONSTR AES, V59, P479, DOI 10.1016/j.bjps.2005.01.010; [Anonymous], 2016, STAND VARDF HUDM; [Anonymous], 2014, DEL CANC CAR; [Anonymous], 2014, MAL MEL NAT VARDPR; Bichakjian CK, 2011, J AM ACAD DERMATOL, V65, P1032, DOI 10.1016/j.jaad.2011.04.031; Cox NH, 2008, BRIT J DERMATOL, V158, P1293, DOI 10.1111/j.1365-2133.2008.08519.x; Di Palo MT, 1997, ARTHRIT CARE RES, V10, P422, DOI 10.1002/art.1790100610; Dummer R, 2012, ANN ONCOL, V23, P86, DOI 10.1093/annonc/mds229; Figg WD, 2010, J CLIN ONCOL, V28, P3630, DOI 10.1200/JCO.2009.24.6389; Frida Hjalte UP, 2005, 20091 IHE, P1; Garbe C, 2016, EUR J CANCER, V63, P201, DOI 10.1016/j.ejca.2016.05.005; Hajdarevic S, 2014, DERMAT RES PRACT, V2014, DOI 10.1155/2014/294287; HIEKEN TJ, 2013, INT J SURG ONCOL, DOI DOI 10.1155/2013/196493; Hjalte F PU, 2009, PRODUKTIONSBORTFALL; Joosse A, 2011, J INVEST DERMATOL, V131, P719, DOI 10.1038/jid.2010.354; Kaiser S, 2014, J SURG ONCOL, V109, P775, DOI 10.1002/jso.23580; Kerns MJJ, 2008, J CUTAN PATHOL, V35, P1093, DOI 10.1111/j.1600-0560.2007.00943.x; Lott JP, 2015, JAMA DERMATOL, V151, P731, DOI 10.1001/jamadermatol.2015.119; Lyth J, 2015, BRIT J DERMATOL, V172, P700, DOI 10.1111/bjd.13483; Mahadevan D, 2014, CANCER CHEMOTH PHARM, V73, P467, DOI 10.1007/s00280-013-2372-x; Martin RCG, 2005, AM J SURG, V190, P913, DOI 10.1016/j.amjsurg.2005.08.020; McKenna DB, 2002, BRIT J DERMATOL, V147, P48, DOI 10.1046/j.1365-2133.2002.04815.x; MeInnes DK, 2008, CANCER-AM CANCER SOC, V113, P1471, DOI 10.1002/cncr.23713; Metzger S, 1998, MELANOMA RES, V8, P181, DOI 10.1097/00008390-199804000-00014; Moreno-Ramirez D, 2014, J AM ACAD DERMATOL, V71, P507, DOI 10.1016/j.jaad.2014.04.049; Murchie P, 2012, FAM PRACT, V29, P69, DOI 10.1093/fampra/cmr044; National care program Malignant Melanoma 2017, 2017, REG CANC SYD; Porter ME, 2009, NEW ENGL J MED, V361, P109, DOI 10.1056/NEJMp0904131; Schofield PE, 2003, ANN ONCOL, V14, P48, DOI 10.1093/annonc/mdg010; Sheth N, 2010, CLIN EXP DERMATOL, V35, P599, DOI 10.1111/j.1365-2230.2009.03639.x; Sladden MJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004835.pub2; Sondak VK, 2012, J CLIN ONCOL, V30, P2177, DOI 10.1200/JCO.2011.41.3849	32	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0205517	10.1371/journal.pone.0205517	http://dx.doi.org/10.1371/journal.pone.0205517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359387	Green Published, gold, Green Submitted			2022-12-26	WOS:000448438400018
J	van Dommelen, P; Koledova, E; Wit, JM				van Dommelen, Paula; Koledova, Ekaterina; Wit, Jan M.			Effect of adherence to growth hormone treatment on 0-2 year catch-up growth in children with growth hormone deficiency	PLOS ONE			English	Article							GH SECRETION CAPACITIES; MATHEMATICAL-MODEL; PREDICTION MODELS; AUTO-INJECTOR; THERAPY; EASYPOD(TM); HEIGHT	Background Quantifying the association between adherence and the growth response to growth hormone (GH) treatment is hampered by suboptimal methods of measuring adherence, confounders associated with the growth response, and restriction of the outcome parameters to yearly growth velocities. Aim To investigate the effect of adherence on the two-year growth response to GH treatment in prepubertal children with idiopathic isolated growth hormone deficiency (GHD) participating in the easypod connect observational study (ECOS), a 5-year, Phase IV open-label study to continuously assess real-world adherence via the easypod electronic drug-delivery device. Patients and methods Outcome measures were change in height standard deviation score (AHSDS), index of responsiveness (loR), and parameters of two catch-up growth (CUG) curve functions (monomolecular growth curve and second degree polynomial) with adj-HSDS (HSDS minus Target height (TH) SDS) as dependent variable. Inclusion criteria were GHD, naive to GH treatment, known TH, age <10y in girls and <12y in boys, >= 3 measurements, HSDS <-2 at start, complete data on growth and adherence in the first and second year. Linear regression analyses were performed to test the association between adherence (continuous and high vs. low) and the outcome measures, also adjusted for potential clinical confounders (age at start, adj-HSDS at start, birth weight SDS, gestational age (<37 weeks vs >= 37 weeks), GH dose, GH max (n = 58)). The formula of loR already adjusts for confounders. Results In total, 95 patients complied with the inclusion criteria. The strongest associations were found between high adherence in the second year (>= 91% as cut-off value) and loR 2y (+0.62), and average adherence and high adherence (>= 78%) in the first two years and Delta HSDS 0-2y (+0.11 SD per 1 injection/week, and +0.34 SD for high vs. low adherence). Conclusion Suboptimal adherence negatively affected the growth response in the first two years of GH treatment.	[van Dommelen, Paula] TNO, Dept Child Hlth, Leiden, Netherlands; [Koledova, Ekaterina] Merck KGaA, Global Med Safety & CMO, Darmstadt, Germany; [Wit, Jan M.] Leiden Univ Med Ctr, Dept Pediat, Leiden, Netherlands	Netherlands Organization Applied Science Research; Merck KGaA; Leiden University; Leiden University Medical Center (LUMC)	van Dommelen, P (corresponding author), TNO, Dept Child Hlth, Leiden, Netherlands.	paula.vandommelen@tno.nl		Van Dommelen, Paula/0000-0001-5546-6244	Merck KGaA, Darmstadt, Germany	Merck KGaA, Darmstadt, Germany(Merck & Company)	This study was sponsored by Merck KGaA, Darmstadt, Germany. Medical writing assistance was provided by David Candlish, inScience Communications, Tattenhall, UK, and sponsored by Merck KGaA, Darmstadt, Germany. The data collection was performed via the easypodTM electronic drug-delivery device, which is a product of Merck KGaA. Also, physician data entry of outcome measures were retrospectively and prospectively collected by Merck KGaA. This data collection was part of the ECOS study, which was conducted in accordance with the principles of the Declaration of Helsinki, Good Clinical Practice (ICH-GCP E6) guidelines and applicable national legal and regulatory requirements. The ECOS study was published in Endocrine Connections (Koledova E, Stoyanov G, Ovbude L, Davies PSW (2018) Adherence and long-term growth outcomes: results from the easypod (TM) connect observational study (ECOS) in paediatric patients with growth disorders. Endocr Connect. 7: 914-923). Post hoc analysis on the ECOS study was performed by PvD from TNO. TNO is an independent RTO from the Netherlands founded by law. TNO's professionals put their knowledge and experience to work in creating smart solutions to complex issues. These innovations help to sustainably strengthen social wellbeing and industrial competitiveness. The core values of TNO are integrity, independence, professionalism, and engagement with society. TNO's Code of Conduct, published on the website of TNO (https://www.tno.nl/en/about-tno/mission-and-strategy/tno-code), contains a chapter on scientific integrity. Research is conducted without any undue influence from commercial or other interests. Merck KGaA provided support in the form of salaries for author PvD, but did not have any additional role in performing the post hoc analysis. Merck has provided the ECOS data to TNO for this post hoc analysis. Manuscript was reviewed according to Merck publication procedures. The specific roles of all authors are articulated in the 'author contributions' section.	Ayala-Estrada A, 2016, HORM RES PAEDIAT, V86, P76; Aydin BK, 2014, ENDOCR PRACT, V20, P46, DOI 10.4158/EP13194.OR; Bang P, 2011, HORM RES PAEDIAT, V75, P335, DOI 10.1159/000322878; BOERSMA B, 1994, ACTA PAEDIATR, V83, P1097, DOI 10.1111/j.1651-2227.1994.tb12994.x; Bozzola M, 2014, HORM RES PAEDIAT, V81, P331, DOI 10.1159/000357975; Breiman L., 1984, CLASSIFICATION REGRE; Cutfield WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016223; Dahlgren J, 2007, CURR MED RES OPIN, V23, P1649, DOI 10.1185/030079907X210589; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; De Pedro S, 2016, GROWTH HORM IGF RES, V26, P32, DOI 10.1016/j.ghir.2015.12.002; Fisher BG, 2013, HORM RES PAEDIAT, V79, P189, DOI 10.1159/000350251; Haverkamp F, 2012, PEDIATR ENDOCR REV P, V10, P199; Hermanussen M, 2003, HORM RES, V59, P180, DOI 10.1159/000069321; Kapoor RR, 2008, ARCH DIS CHILD, V93, P147, DOI 10.1136/adc.2006.114249; Koledova E, 2018, ENDOCRINE CONNECTION; Koledova E, 2018, ENDOCR CONNECT, V7, P914, DOI 10.1530/EC-18-0172; Kristrom B, 1997, J CLIN ENDOCR METAB, V82, P2889, DOI 10.1210/jc.82.9.2889; Kristrom B, 2002, HORM RES, V57, P66, DOI 10.1159/000058104; Lion FX, 2010, CURR DRUG THER, V5, P271, DOI 10.2174/157488510792927474; Mohr DC, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1602; Mohseni S, 2018, J PEDIATR ENDOCR MET, V31, P13, DOI 10.1515/jpem-2017-0157; Nicolino M, EASYPOD CONNECT OBSE, P1; Ranke MB, 1999, J CLIN ENDOCR METAB, V84, P1174, DOI 10.1210/jc.84.4.1174; Ranke MB., 2007, GROWTH HORMONE THERA; Rodriguez-Arnao M, 2016, HORM RES PAEDIAT, V86, P381; Schonau E, 2001, EUR J ENDOCRINOL, V144, P13, DOI 10.1530/eje.0.1440013; Stoyanov G, 2016, CANADIAN INTERIM ANA; Tauber M, 2008, ANN ENDOCRINOL-PARIS, V69, P511, DOI 10.1016/j.ando.2008.04.003; van Dommelen P., 2018, ENDOCRINE REV ENDOCR, V39, P2; van Dongen N, 2012, PATIENT PREFER ADHER, V6, P547, DOI 10.2147/PPA.S33157; Westphal O, 2008, ACTA PAEDIATR, V97, P1698, DOI 10.1111/j.1651-2227.2008.01053.x; Wikland KA, 2000, PEDIATR RES, V48, P475, DOI 10.1203/00006450-200010000-00010; Wit JM, 2013, HORM RES PAEDIAT, V79, P257, DOI 10.1159/000351025	33	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206009	10.1371/journal.pone.0206009	http://dx.doi.org/10.1371/journal.pone.0206009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356273	gold, Green Published, Green Submitted			2022-12-26	WOS:000448434000067
J	Hancock, AM; Frostig, RD				Hancock, Aneeka M.; Frostig, Ron D.			Hypertension prevents a sensory stimulation- based collateral therapeutic from protecting the cortex from impending ischemic stroke damage in a spontaneously hypersensitive rat model	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; HYPERTROPHY; DYSFUNCTION; ARTERIOLES; INFARCTION; OCCLUSION; PRESSURE; CHLORIDE; ARTERY	Assessing potential stroke treatments in the presence of risk factors can improve screening of treatments prior to clinical trials and is important in testing the efficacy of treatments in different patient populations. Here, we test our non-invasive, nonpharmacological sensory stimulation treatment in the presence of the main risk factor for ischemic stroke, hypertension. Utilizing functional imaging, blood flow imaging, and histology, we assessed spontaneously hypertensive rats (SHRs) pre- and post-permanent middle cerebral artery occlusion (pMCAO). Experimental groups included a treatment SHR group (sensory-stimulated group), control untreated SHR group (no sensory stimulation), and a treated (sensory-stimulated) Wistar-Kyoto normotensive group. Unlike our previous studies, which showed sensory-based complete protection from impending ischemic cortical stroke damage in rats as seen in the treated Wistar-Kyoto group, we found that SHRs at 24hr post-pMCAO lacked evoked cortical activation, had a significant reduction in blood flow within the MCA, and sustained very large infarcts regardless of whether they received stimulation treatment. If translatable, this work highlights a potential need for a combined treatment plan when delivering sensory stimulation treatment in this patient population.	[Hancock, Aneeka M.; Frostig, Ron D.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Frostig, Ron D.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92717 USA; [Frostig, Ron D.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Frostig, RD (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.; Frostig, RD (corresponding author), Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92717 USA.; Frostig, RD (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.	rfrostig@uci.edu			NIH [NS066001]; Leducq Foundation [15CVD02]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation)	This work was supported by by NIH, grant# NS066001 and Leducq Foundation, grant # 15CVD02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Air EL, 2007, DIABETES CARE, V30, P3131, DOI 10.2337/dc06-1537; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; BARONE FC, 1992, NEUROSCI BIOBEHAV R, V16, P219, DOI 10.1016/S0149-7634(05)80182-4; BAUMBACH GL, 1988, AM J PATHOL, V133, P464; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BRINT S, 1988, J CEREBR BLOOD F MET, V8, P474, DOI 10.1038/jcbfm.1988.88; BRONNER LL, 1995, NEW ENGL J MED, V333, P1392, DOI 10.1056/NEJM199511233332106; Calcinaghi N, 2013, STROKE, V44, P1957, DOI 10.1161/STROKEAHA.111.000185; Capone C, 2012, J NEUROSCI, V32, P4878, DOI 10.1523/JNEUROSCI.6262-11.2012; Capone C, 2011, AM J PHYSIOL-HEART C, V300, pH397, DOI 10.1152/ajpheart.00679.2010; Chen-Bee CH, 2007, J NEUROSCI, V27, P4572, DOI 10.1523/JNEUROSCI.0326-07.2007; Choi B, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2341196; COYLE P, 1982, ANAT REC, V203, P397, DOI 10.1002/ar.1092030309; COYLE P, 1986, HYPERTENSION, V8, P67; Dahlof B, 2007, AM J CARDIOL, V100, p17J, DOI 10.1016/j.amjcard.2007.05.010; Davis MF, 2013, JOVE-J VIS EXP, DOI 10.3791/50418; Davis MF, 2011, STROKE, V42, P792, DOI 10.1161/STROKEAHA.110.607135; Didion SP, 2000, STROKE, V31, P760, DOI 10.1161/01.STR.31.3.760; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Faraco G, 2013, HYPERTENSION, V62, P810, DOI 10.1161/HYPERTENSIONAHA.113.01063; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; GIBO H, 1981, J NEUROSURG, V54, P151, DOI 10.3171/jns.1981.54.2.0151; Goldlust EJ, 1996, STROKE, V27, P1657, DOI 10.1161/01.STR.27.9.1657; GRABOWSKI M, 1993, J HYPERTENS, V11, P1363, DOI 10.1097/00004872-199312000-00007; Hancock Aneeka M, 2013, J Neurol Disord, V1, P135; Harazny JM, 2007, HYPERTENSION, V50, P623, DOI 10.1161/HYPERTENSIONAHA.107.090779; Iadecola C, 2008, CELL METAB, V7, P476, DOI 10.1016/j.cmet.2008.03.010; JACEWICZ M, 1992, HYPERTENSION, V19, P47, DOI 10.1161/01.HYP.19.1.47; Jennings JR, 2005, NEUROLOGY, V64, P1358, DOI 10.1212/01.WNL.0000158283.28251.3C; Johansson BB, 1999, CLIN EXP PHARMACOL P, V26, P563, DOI 10.1046/j.1440-1681.1999.03081.x; Kazama K, 2003, AM J PHYSIOL-HEART C, V285, pH1890, DOI 10.1152/ajpheart.00464.2003; Lay CC, 2014, EUR J NEUROSCI, V40, P3413, DOI 10.1111/ejn.12723; Lay CC, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001255; Lay CC, 2011, J NEUROSCI, V31, P11495, DOI 10.1523/JNEUROSCI.1741-11.2011; Lay CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011270; Liebeskind DS, 2008, STROKE, V39, P538; Lima FO, 2010, STROKE, V41, P2316, DOI 10.1161/STROKEAHA.110.592303; Lip GYH, 2000, CIRCULATION, V101, P218, DOI 10.1161/01.CIR.101.3.218; MANGIARUA EI, 1992, J HYPERTENS, V10, P1183, DOI 10.1097/00004872-199210000-00011; Messerli FH, 2007, LANCET, V370, P591, DOI 10.1016/S0140-6736(07)61299-9; Nishimura Y, 2000, STROKE, V31, P2478, DOI 10.1161/01.STR.31.10.2478; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Thom S, 1997, EUR HEART J, V18, pE2, DOI 10.1016/S0195-668X(97)90001-4; Tice FD, 1996, AM HEART J, V132, P621, DOI 10.1016/S0002-8703(96)90247-1; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Wang-Fischer Y, 2009, MANUAL OF STROKE MOD	51	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206291	10.1371/journal.pone.0206291	http://dx.doi.org/10.1371/journal.pone.0206291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352082	Green Published, gold, Green Submitted			2022-12-26	WOS:000448076200046
J	Lu, S; Yu, YF; Fu, SJ; Ren, HY				Lu, Shun; Yu, Yongfeng; Fu, Shijun; Ren, Hongye			Cost-effectiveness of ALK testing and first-line crizotinib therapy for non-small-cell lung cancer in China	PLOS ONE			English	Article							MAINTENANCE THERAPY; CHEMOTHERAPY; BEVACIZUMAB; EPIDEMIOLOGY; SURVEILLANCE; CARBOPLATIN; PACLITAXEL; DIAGNOSIS; SURVIVAL; OUTCOMES	Introduction Anaplastic lymphoma kinase (ALK) rearrangement gene testing is used increasingly to identify patients with advanced non-small-cell lung cancer (NSCLC) who are most likely to benefit from crizotinib. This study was to evaluate the cost-effectiveness of the ALK tests followed by crizotinib compared to the standard chemotherapy in advanced NSCLC from the Chinese healthcare system perspective. Methods A 10-year Markov model was constructed to compare the costs and quality-adjusted life-years (QALYs) of crizotinib with standard chemotherapy, guided by the ALK rearrangement tests: next-generation sequencing (NGS) panel tests and multiplex polymerase chain reaction (PCR) testing. The health states included progression-free survival (PFS), progressed survival, and death. The costs examined included cost of drugs (pemetrexed, standard chemotherapy, salvage chemotherapy, and crizotinib), follow-up, palliative care, supportive care, severe adverse events, and ALK rearrangement testing. Results Under Patient Assistance Program (PAP), the model demonstrated that the patients using NGS panel tests spent US $31,388 and gained 0.780 QALYs, whereas patients using multiplex PCR spent US $31,362 and gained 0.780 QALYs, respectively. The incremental cost-effectiveness ratios of crizotinib with PAP compared to the control strategy were projected at $14,384 (NGS) and $13,740 (multiplex PCR) per QALY gained, respectively. Sensitivity analyses showed the utility of PFS and the costs of crizotinib and pemetrexed were the most impactful factors on the model outcomes. The results were robust to changes in all parameters. Conclusion ALK-rearrangement test positive followed by crizotinib may be cost-effective compared to standard chemotherapy from the Chinese healthcare system perspective when PAP was available.	[Lu, Shun; Yu, Yongfeng] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China; [Fu, Shijun; Ren, Hongye] Pfizer China Inc, Pfizer China Med Dept, Beijing, Peoples R China	Shanghai Jiao Tong University; Pfizer	Lu, S (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China.	shun.lu@me.com	Lu, Shun/ABF-8341-2021		Pfizer China Medical Department	Pfizer China Medical Department	This research was funded by Pfizer China Medical Department. The study sponsor had no interference with the study design, data collection or writing of the manuscript. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Calhoun EA, 2001, ONCOLOGIST, V6, P441, DOI 10.1634/theoncologist.6-5-441; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Carlson JJ, 2008, LUNG CANCER, V61, P405, DOI 10.1016/j.lungcan.2007.12.023; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Felip E, 2005, ANN ONCOL, V16, P28, DOI 10.1093/annonc/mdi821; Goulart B, 2011, VALUE HEALTH, V14, P836, DOI 10.1016/j.jval.2011.04.004; Hayashi H, 2012, ANN ONCOL, V23, P1537, DOI 10.1093/annonc/mdr487; Hong QY, 2015, CANCER-AM CANCER SOC, V121, P3080, DOI 10.1002/cncr.29584; Lin DM, 2017, J THORAC ONCOL, V12, pS500, DOI 10.1016/j.jtho.2016.11.606; Lu S, 2016, ASCO ANNUAL MEETING; Lu S, 2016, PHARMACOGENOMICS, V17, P985, DOI 10.2217/pgs-2016-0017; Nafees B, 2017, ASIA-PAC J CLIN ONCO, V13, pE195, DOI 10.1111/ajco.12477; Nafees B, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-84; Navada S, 2006, J CLIN ONCOL, V24, p384S; Novello S, 2016, ANN ONCOL, V27, pv1, DOI 10.1093/annonc/mdw326; Oser MG, 2015, LANCET ONCOL, V16, pE165, DOI 10.1016/S1470-2045(14)71180-5; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Pirker R, 2009, LANCET, V373, P1525, DOI 10.1016/S0140-6736(09)60569-9; Ramalingam SS, 2008, J CLIN ONCOL, V26, P60, DOI 10.1200/JCO.2007.13.1144; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Surveillance Epidemiology and End Results (SEER) Program, 2015, SURV EP END RESEER; Walters S, 2013, THORAX, V68, P551, DOI 10.1136/thoraxjnl-2012-202297; William WN, 2009, CHEST, V136, P701, DOI 10.1378/chest.08-2968; Wu B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-984; Wu B, 2010, VALUE HEALTH, V13, P592, DOI 10.1111/j.1524-4733.2010.00733.x; Zeng XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048323; Zhang XJ, 2011, CHEST, V140, P117, DOI 10.1378/chest.10-2745	34	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0205827	10.1371/journal.pone.0205827	http://dx.doi.org/10.1371/journal.pone.0205827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352060	Green Published, gold, Green Submitted			2022-12-26	WOS:000448076200017
J	Pavan, S; Curci, PL; Zuluaga, DL; Blanco, E; Sonnante, G				Pavan, Stefano; Curci, Pasquale L.; Zuluaga, Diana L.; Blanco, Emanuela; Sonnante, Gabriella			Genotyping-by-sequencing highlights patterns of genetic structure and domestication in artichoke and cardoon	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; CYNARA-SCOLYMUS; POPULATION-STRUCTURE; NUMBER; DNA; DIVERSITY; SOFTWARE; COMPLEX; HUMANS	Exploiting the biodiversity of crops and their wild relatives is fundamental for maintaining and increasing food security. The species Cynara cardunculus includes three taxa: the globe artichoke, one of the most important Mediterranean vegetables, the leafy cardoon, and the wild cardoon. In this study, genotyping by sequencing (GBS) was successfully applied to reveal thousands of polymorphisms in a C. cardunculus germplasm collection, including 65 globe artichoke, 9 leafy cardoon, and 21 wild cardoon samples. The collection showed a strong population structure at K = 2, separating the globe artichoke from the leafy and wild cardoon. At higher K values, further substructures were observed, in which the wild cardoon was separated from the leafy cardoon, and the latter included the Spanish wild cardoons, while the wild sample from Portugal was admixed. Moreover, subpopulations within the globe artichoke set were highlighted. Structure analysis restricted to the globe artichoke dataset pointed out genetic differentiation between the "Catanesi"typology and all the other samples (K = 2). At higher values of K, the separation of the "Catanesi" group still held true, and green headed landraces from Apulia region, Italy ("Green Apulian") formed a distinct subpopulation. "Romaneschi"artichoke types fell in a variable group with admixed samples, indicating that they should not be considered as a genetically uniform typology. The results of principal component analysis and Neighbor-Joining hierarchical clustering were consistent with structure results, and in addition provided a measure of genetic relationships among individual genotypes. Both analyses attributed the wild material from Spain and Portugal to the cultivated cardoon group, supporting the idea that this might be indeed a feral form of the leafy cardoon. Different reproductive habit and possibly selective pressure led to a slower LD decay in artichoke compared to cardoon. Genotyping by sequencing has proven a reliable methodology to obtain valuable SNPs and assess population genetics in C. cardunculus.	[Pavan, Stefano] Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy; [Pavan, Stefano] Natl Res Council CNR, Inst Biomed Technol, Bari, Italy; [Curci, Pasquale L.; Zuluaga, Diana L.; Blanco, Emanuela; Sonnante, Gabriella] CNR, Inst Biosci & Bioresources, Bari, Italy; [Curci, Pasquale L.] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Curci, Pasquale L.] VIB Ctr Plant Syst Biol, Ghent, Belgium	Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Sonnante, G (corresponding author), CNR, Inst Biosci & Bioresources, Bari, Italy.	gabriella.sonnante@ibbr.cnr.it	Blanco, Emanuela/ABF-8934-2020; pavan, stefano/AAA-4927-2020	Pavan, Stefano/0000-0002-3666-7291; BLANCO, EMANUELA/0000-0001-9541-7148	project BiodiverSO - PSR Puglia 2014-2020 [10.2]; project BiodiverSO - PSR Puglia 2007-2013 [214/4]	project BiodiverSO - PSR Puglia 2014-2020; project BiodiverSO - PSR Puglia 2007-2013	This work was funded by project BiodiverSO - PSR Puglia 2007-2013 Mis. 214/4 subaz. a) to GS, and project BiodiverSO - PSR Puglia 2014-2020 Mis.10.2 to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquadro A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05085-7; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Calabrese N, 2012, ACTA HORTIC, V942, P153, DOI 10.17660/ActaHortic.2012.942.18; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Christaki E., 2012, INT J APPL SCI TECHN, V2, P64; Costabile A, 2010, BRIT J NUTR, V104, P1007, DOI 10.1017/S0007114510001571; Curci PL, 2016, MOL ECOL RESOUR, V16, P562, DOI 10.1111/1755-0998.12457; Curci PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120589; D'hoop BB, 2010, THEOR APPL GENET, V121, P1151, DOI 10.1007/s00122-010-1379-5; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dempewolf H, 2008, GENET RESOUR CROP EV, V55, P1141, DOI 10.1007/s10722-008-9315-0; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Foury C., 1989, ACTA HORTIC, V242, P155; Fu YB, 2011, PLANT GENOME-US, V4, P226, DOI 10.3835/plantgenome2011.08.0022; Gatto A, 2013, ANN BOT-LONDON, V112, P855, DOI 10.1093/aob/mct150; Gebhardt R, 1997, TOXICOL APPL PHARM, V144, P279, DOI 10.1006/taap.1997.8130; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Hamblin MT, 2014, CROP SCI, V54, P2603, DOI 10.2135/cropsci2014.02.0160; Hammer K., 1992, SEEDS CATALOGUE CROP, P173; Hellwege EM, 2000, P NATL ACAD SCI USA, V97, P8699, DOI 10.1073/pnas.150043797; Hyten DL, 2007, GENETICS, V175, P1937, DOI 10.1534/genetics.106.069740; Laghetti G, 2011, GENET RESOUR CROP EV, V58, P139, DOI 10.1007/s10722-010-9622-0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; MARIE D, 1993, BIOL CELL, V78, P41, DOI 10.1016/0248-4900(93)90113-S; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; Negro D, 2012, J FOOD SCI, V77, pC244, DOI 10.1111/j.1750-3841.2011.02531.x; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Nimmakayala P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-767; Pagnotta M.A., 2014, GENOMICS PLANT GENET, P559, DOI [10.1007/978-94-007-7572-5_23, DOI 10.1007/978-94-007-7572-5_23]; Pagnotta MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178770; Pavan S, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2016.11.0115; Pavan S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3429-0; Pignone D, 2004, GENET RESOUR CROP EV, V51, P577, DOI 10.1023/B:GRES.0000024786.01004.71; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Porceddu E, 1976, ATT 2 C INT STUD CAR, P1105; Pritchard JK, 2000, GENETICS, V155, P945; Raboin LM, 2008, THEOR APPL GENET, V116, P701, DOI 10.1007/s00122-007-0703-1; Rafalski A, 2004, TRENDS GENET, V20, P103, DOI 10.1016/j.tig.2003.12.002; Rival L, 2008, CURR ANTHROPOL, V49, P1116, DOI 10.1086/593119; Rottenberg A, 1996, GENET RESOUR CROP EV, V43, P53, DOI 10.1007/BF00126940; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saxena RK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01537-2; Scaglione D, 2016, SCI REP-UK, V6, DOI 10.1038/srep19427; Scaglione D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-3; Sonnante G., 2003, Plant Genetic Resources: Characterization and Utilization, V1, P125, DOI 10.1079/PGR200319; Sonnante G, 2010, PLANT PHYSIOL, V153, P1; Sonnante G, 2008, GENET RESOUR CROP EV, V55, P1029, DOI 10.1007/s10722-008-9310-5; Sonnante G, 2007, ANN BOT-LONDON, V100, P1095, DOI 10.1093/aob/mcm127; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Verma S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17512; Vos PG, 2017, THEOR APPL GENET, V130, P123, DOI 10.1007/s00122-016-2798-8; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WIKLUND A, 1992, BOT J LINN SOC, V109, P75, DOI 10.1111/j.1095-8339.1992.tb00260.x	58	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0205988	10.1371/journal.pone.0205988	http://dx.doi.org/10.1371/journal.pone.0205988			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352087	Green Submitted, Green Published, gold			2022-12-26	WOS:000448076200020
J	Fu, XH; Xu, MK; Song, YB; Li, YQ; Zhang, HW; Zhang, JH; Zhang, CG				Fu, Xuanhe; Xu, Mingkai; Song, Yubo; Li, Yongqiang; Zhang, Huiwen; Zhang, Jinghai; Zhang, Chenggang			Enhanced interaction between SEC2 mutant and TCR V induces MHC II-independent activation of T cells via PKC/NF-B and IL-2R/STAT5 signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interleukin; NF-B (NF-KB); STAT transcription factor; signaling; signal transduction; IL-2; staphylococcal enterotoxin C2; superantigen; T-cell receptor; T-cell activation	KINASE C-THETA; RECEPTOR; SUPERANTIGEN; GENE; TRANSDUCTION; EXPRESSION; INHIBITOR; CD28	SEC2, a major histocompatibility complex class II (MHC II)-dependent T-cell mitogen, binds MHC II and T-cell receptor (TCR) Vs to induce effective co-stimulating signals for clonal T-cell expansion. We previously characterized a SEC2 mutant with increased recognition of TCR Vs, ST-4, which could intensify NF-B signaling transduction, leading to IL-2 production and T-cell activation. In this study, we found that in contrast to SEC2, ST-4 could induce murine CD4(+) T-cell proliferation in a V8.2- and V8.3-specific manner in the absence of MHC II+ antigen-presenting cells (APCs). Furthermore, although IL-2 secretion in response to either SEC2 or ST-4 stimulation was accompanied by up-regulation of protein kinase C (PKC), inhibitor of B (IB), and IB kinase (IKK/), IB, and NF-B in mouse splenocytes, only ST-4 could activate CD4(+) T cells in the absence of MHC II+ APCs through the PKC/NF-B signaling pathway. The PKC inhibitor AEB071 significantly suppressed SEC2/ST-4-induced T-cell proliferation, CD69 and CD25 expression, and IL-2 secretion with or without MHC II+ APCs. Further, SEC2/ST-4-induced changes in PKC/NF-B signaling were significantly relieved by AEB071 in a dose-dependent manner. Using Lck siRNA, we found that Lck controlled SEC2/ST-4-induced phosphorylation of PKC. We also demonstrated that the IL-2R/STAT5 pathway is essential for SEC2/ST-4-induced T-cell activation. Collectively, our data demonstrate that an enhanced ST-4-TCR interaction can compensate for lack of MHC II and stimulate MHC II-free CD4(+) T-cell proliferation via PKC/NF-B and IL-2R/STAT5 signaling pathways. Compared with SEC2, intensified PKC/NF-B and IL-2R/STAT5 signals induced by ST-4 lead to enhanced T-cell activation. The results of this study will facilitate better understanding of TCR-based immunotherapies for cancer.	[Fu, Xuanhe; Xu, Mingkai; Song, Yubo; Li, Yongqiang; Zhang, Huiwen; Zhang, Chenggang] Chinese Acad Sci, Inst Appl Ecol, 72 WenHua Rd, Shenyang 110016, Liaoning, Peoples R China; [Fu, Xuanhe; Zhang, Jinghai] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, 103 WenHua Rd, Shenyang 110016, Liaoning, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Shenyang Pharmaceutical University	Xu, MK (corresponding author), Chinese Acad Sci, Inst Appl Ecol, 72 WenHua Rd, Shenyang 110016, Liaoning, Peoples R China.; Zhang, JH (corresponding author), Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, 103 WenHua Rd, Shenyang 110016, Liaoning, Peoples R China.	mkxu@iae.ac.cn; zhangjinghai@foxmail.com	zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022		Strategic Priority Research Program of the Chinese Academy of Sciences Grant [XDA12020225]; Science and Technology Plan Projects of Shenyang City [Z17-7-013, Y17-4-003]	Strategic Priority Research Program of the Chinese Academy of Sciences Grant; Science and Technology Plan Projects of Shenyang City	This work was supported by Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA12020225 and Science and Technology Plan Projects of Shenyang City Grants Z17-7-013 and Y17-4-003. The authors declare that they have no conflicts of interest with the contents of this article.	Andersen PS, 2001, J BIOL CHEM, V276, P33452, DOI 10.1074/jbc.M103750200; Arad G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001149; BAIER G, 1993, J BIOL CHEM, V268, P4997; BOHACH GA, 1990, CRIT REV MICROBIOL, V17, P251, DOI 10.3109/10408419009105728; Bours V, 1992, Curr Top Microbiol Immunol, V182, P411; Brezar V, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00530; Bueno C, 2006, IMMUNITY, V25, P67, DOI 10.1016/j.immuni.2006.04.012; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Evenou JP, 2009, J PHARMACOL EXP THER, V330, P792, DOI 10.1124/jpet.109.153205; FRASER JD, 1992, J EXP MED, V175, P1131, DOI 10.1084/jem.175.4.1131; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Fu XH, 2017, TOXICOL APPL PHARM, V333, P51, DOI 10.1016/j.taap.2017.08.006; Hashimoto-Tane A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00255; HOVDE CJ, 1990, MOL GEN GENET, V220, P329; Isakov N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00273; Kaempfer R, 2013, TOXINS, V5, P1531, DOI 10.3390/toxins5091531; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Krakauer T, 2013, TOXINS, V5, P1629, DOI 10.3390/toxins5091629; Kuroda K, 1996, J IMMUNOL, V157, P1422; Lamphear JG, 1998, J IMMUNOL, V160, P2107; Lando PA, 1996, J IMMUNOL, V157, P2857; Li LY, 2017, P NATL ACAD SCI USA, V114, pE5891, DOI 10.1073/pnas.1701990114; Liu Y, 2012, LETT APPL MICROBIOL, V55, P362, DOI 10.1111/j.1472-765X.2012.03303.x; Liu YH, 2000, J BIOL CHEM, V275, P3603, DOI 10.1074/jbc.275.5.3603; Marti F, 2006, J EXP MED, V203, P479, DOI 10.1084/jem.20051637020206c; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Newton DW, 1998, INT J MOL MED, V1, P157; Parmar KM, 2005, J BIOL CHEM, V280, P26714, DOI 10.1074/jbc.C500144200; Rajasekaran K, 2013, NAT IMMUNOL, V14, P1127, DOI 10.1038/ni.2708; Saito T, 2010, FEBS LETT, V584, P4865, DOI 10.1016/j.febslet.2010.11.036; Shatrova AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167215; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Thebault S, 2004, MOL IMMUNOL, V40, P931, DOI 10.1016/j.molimm.2003.10.014; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Xu MK, 2011, CANCER IMMUNOL IMMUN, V60, P705, DOI 10.1007/s00262-011-0986-6; Yamasaki S, 1997, J BIOL CHEM, V272, P14787, DOI 10.1074/jbc.272.23.14787; Yokosuka T, 2010, CURR TOP MICROBIOL, V340, P81, DOI 10.1007/978-3-642-03858-7_5; Zhang GJ, 2016, TOXICOL APPL PHARM, V313, P1, DOI 10.1016/j.taap.2016.10.009; Zhang SK, 2015, INT J CLIN EXP MED, V8, P15146; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163	46	17	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19771	19784		10.1074/jbc.RA118.003668	http://dx.doi.org/10.1074/jbc.RA118.003668			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30352872	Green Published, hybrid			2022-12-26	WOS:000454294900022
J	Maziarz, M; Leyme, A; Marivin, A; Luebbers, A; Patel, PP; Chen, Z; Sprang, SR; Garcia-Marcos, M				Maziarz, Marcin; Leyme, Anthony; Marivin, Arthur; Luebbers, Alex; Patel, Prachi P.; Chen, Zhe; Sprang, Stephen R.; Garcia-Marcos, Mikel			Atypical activation of the G protein G(q) by the oncogenic mutation Q209P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); heterotrimeric G protein; melanoma; signal transduction; cancer biology; GTPase; cell signaling; GNAQ; oncogenesis; uveal melanoma	SMALL-MOLECULE INHIBITORS; UVEAL MELANOMA; G-ALPHA; TREATMENT OPTIONS; HIGH-THROUGHPUT; GTP HYDROLYSIS; GNAQ; REVEALS; BETA; G-ALPHA(Q)	The causative role of G protein-coupled receptor (GPCR) pathway mutations in uveal melanoma (UM) has been well-established. Nearly all UMs bear an activating mutation in a GPCR pathway mediated by G proteins of the G(q/11) family, driving tumor initiation and possibly metastatic progression. Thus, targeting this pathway holds therapeutic promise for managing UM. However, direct targeting of oncogenic G(q/11) mutants, present in approximate to 90% of UMs, is complicated by the belief that these mutants structurally resemble active G(q/11) WT. This notion is solidly founded on previous studies characterizing G mutants in which a conserved catalytic glutamine (Gln-209 in G(q)) is replaced by leucine, which leads to GTPase function deficiency and constitutive activation. Whereas Q209L accounts for approximately half of GNAQ mutations in UM, Q209P is as frequent as Q209L and also promotes oncogenesis, but has not been characterized at the molecular level. Here, we characterized the biochemical and signaling properties of G(q) Q209P and found that it is also GTPase-deficient and activates downstream signaling as efficiently as G(q) Q209L. However, G(q) Q209P had distinct molecular and functional features, including in the switch II region of G(q) Q209P, which adopted a conformation different from that of G(q) Q209L or active WT G(q), resulting in altered binding to effectors, G, and regulators of G-protein signaling (RGS) proteins. Our findings reveal that the molecular properties of G(q) Q209P are fundamentally different from those in other active G(q) proteins and could be leveraged as a specific vulnerability for the approximate to 20% of UMs bearing this mutation.	[Maziarz, Marcin; Leyme, Anthony; Marivin, Arthur; Luebbers, Alex; Patel, Prachi P.; Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K, Boston, MA 02118 USA; [Chen, Zhe] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Sprang, Stephen R.] Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA	Boston University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Montana System; University of Montana	Garcia-Marcos, M (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K, Boston, MA 02118 USA.	mgm1@bu.edu	patel, prachi/GRY-0386-2022	Chen, Zhe/0000-0002-1668-4051	National Institutes of Health [R01GM108733, R01 GM130120, R21MH118745, R01DK46371]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM130120, R01GM108733, R01GM105993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH118745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants R01GM108733, R01 GM130120, and R21MH118745 (to M. G.-M.) and R01DK46371 (to S. R. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Amaro A, 2017, CANCER METAST REV, V36, P109, DOI 10.1007/s10555-017-9663-3; Anger T, 2004, J BIOL CHEM, V279, P3906, DOI 10.1074/jbc.M309496200; Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Augsburger JJ, 2009, AM J OPHTHALMOL, V148, P119, DOI 10.1016/j.ajo.2009.01.023; Basse MJ, 2013, NUCLEIC ACIDS RES, V41, pD824, DOI 10.1093/nar/gks1002; Berg T, 2008, CURR OPIN DRUG DISC, V11, P666; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Carvajal RD, 2017, BRIT J OPHTHALMOL, V101, P38, DOI 10.1136/bjophthalmol-2016-309034; Chen X, 2017, CANCER CELL, V31, P685, DOI 10.1016/j.ccell.2017.04.002; Chidiac P, 1999, BIOCHEM PHARMACOL, V58, P39, DOI 10.1016/S0006-2952(99)00080-5; Chidiac P, 1999, J BIOL CHEM, V274, P19639, DOI 10.1074/jbc.274.28.19639; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Chua V, 2017, MOL CANCER RES, V15, P501, DOI 10.1158/1541-7786.MCR-17-0007; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Damato B, 2012, EYE, V26, P1157, DOI 10.1038/eye.2012.126; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Field MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02428-w; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Griewank KG, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00971.x; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Hu Q, 2018, CELL, V173, P1254, DOI 10.1016/j.cell.2018.03.018; Huang JLY, 2015, CANCER RES, V75, P3384, DOI 10.1158/0008-5472.CAN-14-3229; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Johansson P, 2016, ONCOTARGET, V7, P4624, DOI 10.18632/oncotarget.6614; Johnston CA, 2006, BIOCHEMISTRY-US, V45, P11390, DOI 10.1021/bi0613832; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kaliki S, 2015, INDIAN J OPHTHALMOL, V63, P93, DOI 10.4103/0301-4738.154367; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828; Kusters-Vandevelde HVN, 2015, BRAIN PATHOL, V25, P209, DOI 10.1111/bpa.12241; Kujala E, 2003, INVEST OPHTH VIS SCI, V44, P4651, DOI 10.1167/iovs.03-0538; Kusters-Vandevelde HVN, 2015, PATHOL ONCOL RES, V21, P439, DOI 10.1007/s12253-014-9841-3; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Leyme A, 2017, P NATL ACAD SCI USA, V114, pE10319, DOI 10.1073/pnas.1707992114; Luke JJ, 2015, PIGM CELL MELANOMA R, V28, P135, DOI 10.1111/pcmr.12304; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Marivin A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad2429; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Maziarz M, 2017, METHOD CELL BIOL, V142, P145, DOI 10.1016/bs.mcb.2017.08.001; Moore AR, 2018, CELL REP, V22, P2455, DOI 10.1016/j.celrep.2018.01.081; Moore AR, 2016, NAT GENET, V48, P675, DOI 10.1038/ng.3549; Nance MR, 2013, STRUCTURE, V21, P438, DOI 10.1016/j.str.2012.12.016; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Onken MD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6852; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Pereira PR, 2013, CLIN OPHTHALMOL, V7, P1669, DOI 10.2147/OPTH.S28863; Posokhova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076973; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Rettenmaier TJ, 2014, P NATL ACAD SCI USA, V111, P18590, DOI 10.1073/pnas.1415365112; Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Scheschonka A, 2000, MOL PHARMACOL, V58, P719, DOI 10.1124/mol.58.4.719; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Stols L, 2007, PROTEIN EXPRES PURIF, V53, P396, DOI 10.1016/j.pep.2007.01.013; Tang W, 2006, J BIOL CHEM, V281, P4746, DOI 10.1074/jbc.M510573200; Taylor VG, 2016, J BIOL CHEM, V291, P5138, DOI 10.1074/jbc.M115.712075; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Thomas CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023197; van de Nes JAP, 2017, J INVEST DERMATOL, V137, P2033, DOI 10.1016/j.jid.2017.04.022; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vaque JP, 2013, MOL CELL, V49, P94, DOI 10.1016/j.molcel.2012.10.018; Virgili G, 2007, OPHTHALMOLOGY, V114, P2309, DOI 10.1016/j.ophtha.2007.01.032; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; Yoo JH, 2016, CANCER CELL, V29, P889, DOI 10.1016/j.ccell.2016.04.015; Yu FX, 2014, CANCER CELL, V25, P822, DOI 10.1016/j.ccr.2014.04.017	79	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19586	19599		10.1074/jbc.RA118.005291	http://dx.doi.org/10.1074/jbc.RA118.005291			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30352874	hybrid, Green Published			2022-12-26	WOS:000454294900008
J	Ojelabi, OA; Lloyd, KP; De Zutter, JK; Carruthers, A				Ojelabi, Ogooluwa A.; Lloyd, Kenneth P.; De Zutter, Julie K.; Carruthers, Anthony			Red wine and green tea flavonoids are cis-allosteric activators and competitive inhibitors of glucose transporter 1 (GLUT1)-mediated sugar uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose transport; structure-function; membrane transport; allosteric regulation; oligomerization	TRANSPORTER OLIGOMERIC STRUCTURE; BRUSH-BORDER-MEMBRANE; GLUCOSE-UPTAKE; SEQUENCE DETERMINANTS; CELLULAR UPTAKE; BINDING-SITES; QUERCETIN; GLUT1; CATECHINS; MECHANISMS	The antioxidant- and flavonoid-rich contents of red wine and green tea are reported to offer protection against cancer, cardiovascular disease, and diabetes. Some studies, however, show that flavonoids inhibit GLUT1-mediated, facilitative glucose transport, raising the possibility that their interaction with GLUT1 and subsequent downstream effects on carbohydrate metabolism may also impact health. The present study explores the structure-function relationships of flavonoid-GLUT1 interactions. We find that low concentrations of flavonoids act as cis-allosteric activators of sugar uptake, whereas higher concentrations competitively inhibit sugar uptake and noncompetitively inhibit sugar exit. Studies with heterologously expressed human GLUT1, -3, or -4 reveal that quercetin-GLUT1 and -GLUT4 interactions are stronger than quercetin-GLUT3 interactions, that epicatechin gallate (ECG) is more selective for GLUT1, and that epigallocatechin gallate (EGCG) is less GLUT isoform-selective. Docking studies suggest that only one flavonoid can bind to GLUT1 at any instant, but sugar transport and ligand-binding studies indicate that human erythrocyte GLUT1 can bind at least two flavonoid molecules simultaneously. Quercetin and EGCG are each characterized by positive, cooperative binding, whereas ECG shows negative cooperative binding. These findings support recent studies suggesting that GLUT1 forms an oligomeric complex of interacting, allosteric, alternating access transporters. We discuss how modulation of facilitative glucose transporters could contribute to the protective actions of the flavonoids against diabetes and Alzheimer's disease.	[Ojelabi, Ogooluwa A.; Lloyd, Kenneth P.; De Zutter, Julie K.; Carruthers, Anthony] Univ Massachusetts, Med Sch, Grad Sch Biomed Sci, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Carruthers, A (corresponding author), 364 Plantat St,LRB Rm 926, Worcester, MA 01605 USA.	anthony.carruthers@umassmed.edu			National Institutes of Health [DK36081, DK44888]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036081, R01DK044888, R56DK036081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK36081 and DK44888. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BASKETTER DA, 1978, J PHYSIOL-LONDON, V278, P389, DOI 10.1113/jphysiol.1978.sp012311; CARRUTHERS A, 1991, BIOCHEMISTRY-US, V30, P3907, DOI 10.1021/bi00230a015; Cermak R, 2004, BRIT J NUTR, V91, P849, DOI 10.1079/BJN20041128; Choi JY, 2002, NEUROTOXICOLOGY, V23, P367, DOI 10.1016/S0161-813X(02)00079-7; Choi YT, 2001, LIFE SCI, V70, P603, DOI 10.1016/S0024-3205(01)01438-2; Cloherty EK, 2001, BIOCHEMISTRY-US, V40, P15549, DOI 10.1021/bi015586w; Cloherty EK, 1996, BIOCHEMISTRY-US, V35, P10411, DOI 10.1021/bi953077m; Cunningham P, 2006, J BIOL CHEM, V281, P5797, DOI 10.1074/jbc.M509422200; Day AJ, 2000, FEBS LETT, V468, P166, DOI 10.1016/S0014-5793(00)01211-4; De Zutter JK, 2013, J BIOL CHEM, V288, P20734, DOI 10.1074/jbc.M113.469023; Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; Gee JM, 2000, J NUTR, V130, P2765, DOI 10.1093/jn/130.11.2765; Graybill C, 2006, BIOCHEMISTRY-US, V45, P8096, DOI 10.1021/bi060398x; Hamakawa H, 2013, ADV EXP MED BIOL, V765, P73, DOI 10.1007/978-1-4614-4989-8_11; Hamill S, 1999, BIOCHEMISTRY-US, V38, P16974, DOI 10.1021/bi9918792; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; HELGERSON AL, 1987, J BIOL CHEM, V262, P5464; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Hung CH, 2015, MOL NUTR FOOD RES, V59, P1905, DOI 10.1002/mnfr.201500144; Jeon SY, 2003, BIOORG MED CHEM LETT, V13, P3905, DOI 10.1016/j.bmcl.2003.09.018; Johnston K, 2005, FEBS LETT, V579, P1653, DOI 10.1016/j.febslet.2004.12.099; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; Kao Y, 2000, AM J CLIN NUTR, V72, P1232; Kerry NL, 1997, ATHEROSCLEROSIS, V135, P93, DOI 10.1016/S0021-9150(97)00156-1; Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022; Kuhnau J, 1976, World Rev Nutr Diet, V24, P117; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; Li N, 2011, J AGR FOOD CHEM, V59, P6082, DOI 10.1021/jf200203n; Liu Y, 2012, MOL CANCER THER, V11, P1672, DOI 10.1158/1535-7163.MCT-12-0131; Lloyd KP, 2018, J MEMBRANE BIOL, V251, P131, DOI 10.1007/s00232-017-0006-7; Lloyd KP, 2017, J BIOL CHEM, V292, P21035, DOI 10.1074/jbc.M117.815589; Mandel S, 2004, FREE RADICAL BIO MED, V37, P304, DOI 10.1016/j.freeradbiomed.2004.04.012; Martinez-Perez C, 2016, BRIT J CANCER, V114, P905, DOI 10.1038/bjc.2016.6; McDonald MS, 1998, J AGR FOOD CHEM, V46, P368, DOI 10.1021/jf970677e; Moreira L, 2013, EXP CELL RES, V319, P1784, DOI 10.1016/j.yexcr.2013.05.001; Naftalin RJ, 2003, BRIT J PHARMACOL, V140, P487, DOI 10.1038/sj.bjp.0705460; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Nishimuro H, 2015, NUTRIENTS, V7, P2345, DOI 10.3390/nu7042345; Ojelabi OA, 2016, J BIOL CHEM, V291, P26762, DOI 10.1074/jbc.M116.759175; Perez A, 2011, BIOCHEMISTRY-US, V50, P8834, DOI 10.1021/bi200748b; Prinz Heino, 2010, J Chem Biol, V3, P37, DOI 10.1007/s12154-009-0029-3; Robichaud T, 2011, BIOCHEMISTRY-US, V50, P3137, DOI 10.1021/bi1020327; Segel I. H., 1975, ENZYME KINETICS BEHA, P379; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Sirk TW, 2009, J AGR FOOD CHEM, V57, P6720, DOI 10.1021/jf900951w; Strobel P, 2005, BIOCHEM J, V386, P471, DOI 10.1042/BJ20040703; Sultzman LA, 1999, BIOCHEMISTRY-US, V38, P6640, DOI 10.1021/bi990130o; Sutherland BA, 2006, J NUTR BIOCHEM, V17, P291, DOI 10.1016/j.jnutbio.2005.10.005; Szablewski L, 2013, BBA-REV CANCER, V1835, P164, DOI 10.1016/j.bbcan.2012.12.004; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Tsuneki Hiroshi, 2004, BMC Pharmacology, V4, P18, DOI 10.1186/1471-2210-4-18; Uekusa Y, 2007, J AGR FOOD CHEM, V55, P9986, DOI 10.1021/jf0712402; Vaidyanathan JB, 2003, J PHARMACOL EXP THER, V307, P745, DOI 10.1124/jpet.103.054296; Vera JC, 2001, BIOCHEMISTRY-US, V40, P777, DOI 10.1021/bi001660j; Vollers SS, 2012, J BIOL CHEM, V287, P42533, DOI 10.1074/jbc.M112.369587; Walgren RA, 2000, J PHARMACOL EXP THER, V294, P837; Wolffram S, 2002, J NUTR, V132, P630, DOI 10.1093/jn/132.4.630; Wu LY, 2004, EUR J NUTR, V43, P116, DOI 10.1007/s00394-004-0450-x; Yang CG, 2016, MOLECULES, V21, DOI 10.3390/molecules21121660; Yang CS, 2008, MOL NUTR FOOD RES, V52, pS139, DOI 10.1002/mnfr.200700234; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	67	15	15	7	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19823	19834		10.1074/jbc.RA118.002326	http://dx.doi.org/10.1074/jbc.RA118.002326			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30361436	Green Published, hybrid			2022-12-26	WOS:000454294900026
J	Unlu, I; Lu, YY; Wang, XZ				Unlu, Irem; Lu, Yanyan; Wang, Xiaozhong			The cyclic phosphodiesterase CNP and RNA cyclase RtcA fine-tune noncanonical XBP1 splicing during ER stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-box binding protein 1 (XBP1); signaling; RNA splicing; unfolded protein response (UPR); stress response; gene regulation; RNA processing; CNP; RtcA; RtcB; Trpt1	UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; TRANSCRIPTION FACTOR; LIGASE; MECHANISM; CLP1; PROTEOSTASIS; 2'-PHOSPHATE; ACTIVATION	The activity of X box-binding protein 1 (XBP1), a master transcriptional regulator of endoplasmic reticulum (ER) homeostasis and the unfolded protein response (UPR), is controlled by a two-step noncanonical splicing reaction in the cytoplasm. The first step of nuclease cleavage by inositol-requiring enzyme 1 (IRE1), a protein kinase/endoribonuclease, is conserved in all eukaryotic cells. The second step of RNA ligation differs biochemically among species. In yeast, tRNA ligase 1 (Trl1) and tRNA 2-phosphotransferase 1 (Tpt1) act through a 5-PO4/3-OH pathway. In metazoans, RNA 2,3-cyclic phosphate and 5-OH ligase (RtcB) ligate XBP1 exons via a 3-PO4/5-OH reaction. Although RtcB has been identified as the primary RNA ligase, evidence suggests that yeast-like ligase components may also operate in mammals. In this study, using mouse and human cell lines along with in vitro splicing assays, we investigated whether these components contribute to XBP1 splicing during ER stress. We found that the mammalian 2-phosphotransferase Trpt1 does not contribute to XBP1 splicing even in the absence of RtcB. Instead, we found that 2,3-cyclic nucleotide phosphodiesterase (CNP) suppresses RtcB-mediated XBP1 splicing by hydrolyzing 2,3-cyclic phosphate into 2-phosphate on the cleaved exon termini. By contrast, RNA 3-terminal cyclase (RtcA), which converts 2-phosphate back to 2,3-cyclic phosphate, facilitated XBP1 splicing by increasing the number of compatible RNA termini for RtcB. Taken together, our results provide evidence that CNP and RtcA fine-tune XBP1 output during ER stress.	[Unlu, Irem; Lu, Yanyan; Wang, Xiaozhong] Northwestern Univ, Dept Mol Biosci, 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA	Northwestern University	Wang, XZ (corresponding author), Northwestern Univ, Dept Mol Biosci, 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA.	awang@northwestern.edu		Wang, Xiaozhong/0000-0003-0219-0752	NIGMS, National Institutes of Health [5R01GM120307]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120307] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant 5R01GM120307 (to X. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; Culver GM, 1997, J BIOL CHEM, V272, P13203, DOI 10.1074/jbc.272.20.13203; Das U, 2013, RNA, V19, P1355, DOI 10.1261/rna.039917.113; DRUMMOND GI, 1962, J BIOL CHEM, V237, P3535; Englert M, 2011, P NATL ACAD SCI USA, V108, P1290, DOI 10.1073/pnas.1018307108; FILIPOWICZ W, 1983, NUCLEIC ACIDS RES, V11, P1405, DOI 10.1093/nar/11.5.1405; Filipowicz Witold, 2016, Postepy Biochem, V62, P327; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; Hanada T, 2013, NATURE, V495, P474, DOI 10.1038/nature11923; Harding HP, 2008, RNA, V14, P225, DOI 10.1261/rna.859908; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Hu QD, 2003, CELL MOL LIFE SCI, V60, P1725, DOI 10.1007/s00018-003-3107-7; Jurkin J, 2014, EMBO J, V33, P2922, DOI 10.15252/embj.201490332; Kakiuchi C, 2003, NAT GENET, V35, P171, DOI 10.1038/ng1235; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Kosmaczewski SG, 2015, P NATL ACAD SCI USA, V112, P8451, DOI 10.1073/pnas.1502948112; Kosmaczewski SG, 2014, EMBO REP, V15, P1278, DOI 10.15252/embr.201439531; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; Liu SY, 2013, CNS NEUROSCI THER, V19, P229, DOI 10.1111/cns.12064; Lu YY, 2014, MOL CELL, V55, P758, DOI 10.1016/j.molcel.2014.06.032; Lu YY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp686; MCCRAITH SM, 1990, MOL CELL BIOL, V10, P1049, DOI 10.1128/MCB.10.3.1049; Oakes SA, 2015, ANNU REV PATHOL-MECH, V10, P173, DOI 10.1146/annurev-pathol-012513-104649; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Oishi N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.108; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Popow J, 2012, CELL MOL LIFE SCI, V69, P2657, DOI 10.1007/s00018-012-0944-2; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Ramirez A, 2008, RNA, V14, P1737, DOI 10.1261/rna.1142908; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sado M, 2009, BRAIN RES, V1257, P16, DOI 10.1016/j.brainres.2008.11.104; Sawaya R, 2003, J BIOL CHEM, V278, P43928, DOI 10.1074/jbc.M307839200; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Schwer B, 2008, RNA, V14, P204, DOI 10.1261/rna.858108; Sha HB, 2011, TRENDS ENDOCRIN MET, V22, P374, DOI 10.1016/j.tem.2011.05.002; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Song YQ, 2015, NAT NEUROSCI, V18, P817, DOI 10.1038/nn.4019; Spinelli SL, 1997, RNA, V3, P1388; Tanaka N, 2011, J BIOL CHEM, V286, P7727, DOI 10.1074/jbc.C111.219022; Valenzuela V, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.8; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; VOGEL US, 1988, J NEUROCHEM, V50, P1667, DOI 10.1111/j.1471-4159.1988.tb02461.x; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Weitzer S, 2015, WIRES RNA, V6, P47, DOI 10.1002/wrna.1255; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410	64	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19365	19376		10.1074/jbc.RA118.004872	http://dx.doi.org/10.1074/jbc.RA118.004872			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30355738	Green Published, hybrid			2022-12-26	WOS:000453537300018
J	Barron, D; Ball, G; Robins, M; Sunderland, C				Barron, Donald; Ball, Graham; Robins, Matthew; Sunderland, Caroline			Artificial neural networks and player recruitment in professional soccer	PLOS ONE			English	Article							MATCH-PLAY; PERFORMANCE; GAME; IDENTIFICATION; STATISTICS; EVOLUTION; FOOTBALL; TALENT; LEAGUE	The aim was to objectively identify key performance indicators in professional soccer that influence outfield players' league status using an artificial neural network. Mean technical performance data were collected from 966 outfield players' (mean SD; age: 25 +/- 4yr, 1.81 +/-) 90-minute performances in the English Football League. ProZone's MatchViewer system and online databases were used to collect data on 347 indicators assessing the total number, accuracy and consistency of passes, tackles, possessions regained, clearances and shots. Players were assigned to one of three categories based on where they went on to complete most of their match time in the following season: group 0 (n = 209 players) went on to play in a lower soccer league, group 1 (n = 637 players) remained in the Football League Championship, and group 2 (n = 120 players) consisted of players who moved up to the English Premier League. The models created correctly predicted between 61.5% and 78.8% of the players' league status. The model with the highest average test performance was for group 0 v 2 (U21 international caps, international caps, median tackles, percentage of first time passes unsuccessful upper quartile, maximum dribbles and possessions gained minimum) which correctly predicted 78.8% of the players' league status with a test error of 8.3%. To date, there has not been a published example of an objective method of predicting career trajectory in soccer. This is a significant development as it highlights the potential for machine learning to be used in the scouting and recruitment process in a professional soccer environment.	[Barron, Donald] Univ Suffolk, Sch Sci Technol & Engn, Ipswich, Suffolk, England; [Ball, Graham] Nottingham Trent Univ, John van Geest Canc Res Ctr, Sch Sci & Technol, Nottingham, England; [Robins, Matthew] Univ Chichester, Inst Sport, Chichester, England; [Sunderland, Caroline] Nottingham Trent Univ, Sport Hlth & Performance Enhancement Res Ctr, Sch Sci & Technol, Nottingham, England	Nottingham Trent University; University of Chichester; Nottingham Trent University	Barron, D (corresponding author), Univ Suffolk, Sch Sci Technol & Engn, Ipswich, Suffolk, England.	d.barron2@uos.ac.uk	Sunderland, Caroline/I-4416-2012	Sunderland, Caroline/0000-0001-7484-1345; Ball, Graham/0000-0001-5828-7129				Almeida CH, 2014, J HUM KINET, V41, P203, DOI 10.2478/hukin-2014-0048; Amatria M, 2016, J HUM KINET, V54, P163, DOI 10.1515/hukin-2016-0047; Andrzejewski M, 2016, INT J PERF ANAL SPOR, V16, P817, DOI 10.1080/24748668.2016.11868930; Barnsley R. H., 1992, INT REV SOCIOL SPORT, V27, P77, DOI [DOI 10.1177/101269029202700105, 10.1177/101269029202700105]; Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3; Bradley Paul, 2007, INT J PERF ANAL SPOR, V7, P117, DOI DOI 10.1080/24748668.2007.11868415; Bradley PS, 2013, HUM MOVEMENT SCI, V32, P808, DOI 10.1016/j.humov.2013.06.002; Bush M, 2015, HUM MOVEMENT SCI, V39, P1, DOI 10.1016/j.humov.2014.10.003; Calvin M., 2013, NOWHERE MEN UNKNOWN; Carling C, 2013, SPORTS MED, V43, P655, DOI 10.1007/s40279-013-0055-8; Castellano J, 2012, J HUM KINET, V31, P139, DOI 10.2478/v10078-012-0015-7; Collet C, 2013, J SPORT SCI, V31, P123, DOI 10.1080/02640414.2012.727455; Dellal A, 2011, EUR J SPORT SCI, V11, P51, DOI 10.1080/17461391.2010.481334; Dellal A, 2010, INT SPORTMED J, V11, P278; Franck E, 2014, INT J SPORT FINANC, V9, P193; Helsen WF, 2000, J SPORT SCI, V18, P727; Iyer SR, 2009, EXPERT SYST APPL, V36, P5510, DOI 10.1016/j.eswa.2008.06.088; Lago-Penas C, 2011, J SPORT SCI MED, V10, P465; Lancashire LJ, 2008, ARTIF INTELL MED, V43, P99, DOI 10.1016/j.artmed.2008.03.001; Liu HY, 2015, J SPORT SCI, V33, P1205, DOI 10.1080/02640414.2015.1022578; Paliwal M, 2009, EXPERT SYST APPL, V36, P2, DOI 10.1016/j.eswa.2007.10.005; Perarnau Marti, 2014, PEP CONFIDENTIAL INS; Ruiz-Ruiz C, 2013, EUR J SPORT SCI, V13, P241, DOI 10.1080/17461391.2011.606834; Saikia H, 2012, INT J PERF ANAL SPOR, V12, P75, DOI 10.1080/24748668.2012.11868584; Salkind N. J, 2010, ENCY RES DESIGN, V1, DOI 10.4135/9781412961288.n35.SAGEPublicationsInc; Sarmento H, 2014, J SPORT SCI, V32, P1831, DOI 10.1080/02640414.2014.898852; Taylor JB, 2004, INT J PERFORM ANAL S, V4, P81, DOI DOI 10.1080/24748668.2004.11868294; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; Vaeyens R, 2007, J MOTOR BEHAV, V39, P395, DOI 10.3200/JMBR.39.5.395-408; Wallace JL, 2014, J SCI MED SPORT, V17, P223, DOI 10.1016/j.jsams.2013.03.016; WILLIAMS AM, 1994, RES Q EXERCISE SPORT, V65, P127, DOI 10.1080/02701367.1994.10607607; Williams AM, 1998, RES Q EXERCISE SPORT, V69, P111, DOI 10.1080/02701367.1998.10607677; Williams AM, 2000, J SPORT SCI, V18, P657, DOI 10.1080/02640410050120041	33	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205818	10.1371/journal.pone.0205818	http://dx.doi.org/10.1371/journal.pone.0205818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY7VH	30379858	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000448823700073
J	Chakraborty, R; Tyagi, K; Kundu, S; Rahaman, I; Singha, D; Chandra, K; Patnaik, S; Kumar, V				Chakraborty, Rajasree; Tyagi, Kaomud; Kundu, Shantanu; Rahaman, Iftikar; Singha, Devkant; Chandra, Kailash; Patnaik, Srinivas; Kumar, Vikas			The complete mitochondrial genome of Melon thrips, Thrips palmi (Thripinae): Comparative analysis	PLOS ONE			English	Article							INSECTA THYSANOPTERA; GENE REARRANGEMENTS; CONTROL REGION; EVOLUTION; DNA; SEQUENCE; PHYLOGENY; ALIGNMENT; SOFTWARE; INSIGHTS	The melon thrips, Thrips palmi is a serious pest and vector for plant viruses on a wide range of economically important crops. DNA barcoding evidenced the presence of cryptic diversity in T. palmi and that warrants exhaustive molecular studies. Our present study is on decoding the first complete mitochondrial genome of T. palmi (15,333 bp) through next-generation sequencing (NGS). The T. palmi mt genome contains 37 genes, including 13 Protein coding genes (PCGs), two ribosomal RNA (rRNAs), 22 transfer RNA (tRNAs), and two control regions (CRs). The majority strand of T. palmi revealed 78.29% A+T content, and 21.72% G+C content with positive AT skew (0.09) and negative GC skew (-0.06). The ATN initiation codons were observed in 12 PCGs except for cox/ which have unique start codon (TTG). The relative synonymous codon usage (RSCU) analysis revealed Phe, Leu, Ile, Tyr, Asn, Lys and Met were the most frequently used amino acids in all PCGs. The codon (CGG) which is assigned to Arginine in most insects but absent in T. palmi. The Ka/ Ks ratio ranges from 0.078 in cox/ to 0.913 in atp8. We observed the typical cloverleaf secondary structure in most of the tRNA genes with a few exceptions; absence of DHU stem and loop in trnV and trnS, absence of DHU loop in trnE, lack of T-arm and loop in trnN. The T. palmi gene order (GO) was compared with ancestral GO and observed an extensive gene arrangement in PCGs, tRNAs and rRNAs. The cox2 gene was separated from the gene block `cox2-trnL2 in T. palmi as compared with the other thrips mt genomes, including ancestor GO. Further, the nad1, trnQ, trnC, trnL1, trnV, trnF, rrnS, and rrnL were inversely transpositioned in T. palmi GO. The gene blocks 'trnQ-trnS2-trnD' and 'trnN-trnE-trnS1-trnL1' seems to be genus specific. The T. palmi mt genome contained 24 intergenic spacer regions and 12 overlapping regions. The 62 bp of CR2 shows the similarity with CR1 indicating a possible duplication. The occurrence of multiple CRs in thrips mt genomes seems to be a derived trait which needs further investigation. Although, the study depicted extensive gene rearrangements in T. palmi mt genome, but the negative GC skew reflects only strand asymmetry. Both the ML and BI phylogenetic trees revealed the close relationships of Thrips with Scirtothrips as compared to Frankliniella. Thus, more IGImt genomes of the diverse thrips species are required to understand the in-depth phylogenetic and evolutionary relationships.	[Chakraborty, Rajasree; Tyagi, Kaomud; Kundu, Shantanu; Rahaman, Iftikar; Singha, Devkant; Chandra, Kailash; Kumar, Vikas] Zool Survey India, Mol Systemat Div, Ctr DNA Taxon, Kolkata, W Bengal, India; [Chakraborty, Rajasree; Patnaik, Srinivas] Deemed Univ, Sch Biotechnol, KIIT, Bhubaneswar, Odisha, India	Zoological survey of India; Kalinga Institute of Industrial Technology (KIIT)	Kumar, V (corresponding author), Zool Survey India, Mol Systemat Div, Ctr DNA Taxon, Kolkata, W Bengal, India.	vikaszsi77@gmail.com	CHANDRA, KAILASH/AAU-5395-2020	CHANDRA, KAILASH/0000-0001-9076-5442; Tyagi, Kaomud/0000-0003-1064-9826; Kumar, Vikas/0000-0002-0215-0120; SINGHA, DEVKANT/0000-0002-0670-520X; Kundu, Dr. Shantanu/0000-0002-5488-4433	Ministry of Environment, Forest and Climate Change: Zoological Survey of India	Ministry of Environment, Forest and Climate Change: Zoological Survey of India	This research was funded by the Ministry of Environment, Forest and Climate Change: Zoological Survey of India, Core Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Albrecht-Buehler G, 2006, P NATL ACAD SCI USA, V103, P17828, DOI 10.1073/pnas.0605553103; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bernt M, 2007, BIOINFORMATICS, V23, P2957, DOI 10.1093/bioinformatics/btm468; BHATTI JS, 1980, SYST ENTOMOL, V5, P109, DOI 10.1111/j.1365-3113.1980.tb00404.x; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Buckman RS, 2013, SYST ENTOMOL, V38, P123, DOI 10.1111/j.1365-3113.2012.00650.x; Cameron SL, 2007, J MOL EVOL, V65, P589, DOI 10.1007/s00239-007-9042-8; Chen L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25338-3; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Dickey AM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1672-4; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Hao YJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07977-0; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Iftikhar R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146014; Kim SR, 2009, MOL BIOL REP, V36, P1871, DOI 10.1007/s11033-008-9393-2; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2012, INT J BIOL SCI, V8, P93, DOI 10.7150/ijbs.8.93; Li XJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1234-9; Liu HR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04617-5; Liu YQ, 2008, ACTA BIOCH BIOPH SIN, V40, P693, DOI [10.1111/j.1745-7270.2008.00449.x, 10.1093/abbs/40.8.693]; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Mound L. A, 2002, THRIPS TOSPOVIRUSES, P379; Nikolaou C, 2006, GENE, V381, P34, DOI 10.1016/j.gene.2006.06.010; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2014, FIGTREE VERSION 1 4, P17833, DOI [10.1073/pnas.0605553103, DOI 10.1073/PNAS.0605553103]; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Shao RF, 2003, MOL BIOL EVOL, V20, P362, DOI 10.1093/molbev/msg045; Shen X, 2007, GENE, V403, P98, DOI 10.1016/j.gene.2007.06.021; Singh D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188077; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; ThripsWiki, THRIPSWIKI PROV INF; Tyagi K, 2017, THRIPS EC IMPORTANCE, P1; Tyagi Kaomud, 2016, Halteres, V7, P64, DOI 10.5281/zenodo.54896; Tyagi RK, 2017, SCI REP-UK, V7, DOI 10.1038/srep41083; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Yan DK, 2014, GENOMICS, V104, P306, DOI 10.1016/j.ygeno.2014.08.003; Yan DK, 2012, GENE, V506, P117, DOI 10.1016/j.gene.2012.06.022; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; Zhou J, 2013, PHYTOPATHOLOGY, V103, P966, DOI 10.1094/PHYTO-12-12-0322-R	54	15	16	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0199404	10.1371/journal.pone.0199404	http://dx.doi.org/10.1371/journal.pone.0199404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379813	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700003
J	Fujiwara, M; Backstrom, JD; Woodward, RT				Fujiwara, Masami; Backstrom, Jesse D.; Woodward, Richard T.			A coupled recreational anglers' decision and fish population dynamics model	PLOS ONE			English	Article							DRUM SCIAENOPS-OCELLATUS; GULF-OF-MEXICO; RED DRUM; UNITED-STATES; FISHERIES MANAGEMENT; BENEFIT TRANSFER; RESOURCE; BEHAVIOR; GROWTH	The effective management of fish populations requires understanding of both the biology of the species being managed and the behavior of the humans who harvest those species. For many marine fisheries, recreational harvests represent a significant portion of the total fishing mortality. For such fisheries, therefore, a model that captures the dynamics of angler choices and the fish population would be a valuable tool for fisheries management. In this study, we provide such a model, focusing on red drum and spotted seatrout, which are the two of the main recreational fishing targets in the Gulf of Mexico. The biological models are in the form of vector autoregressive models. The anglers' decision model takes the discrete choice approach, in which anglers first decide whether to go fishing and then determine the location to fish based on the distance and expected catch of two species of fish if they decide to go fishing. The coupled model predicts that, under the level of fluctuation in the abundance of the two species experienced in the past 35 years, the number of trips that might be taken by anglers fluctuates moderately. This fluctuation is magnified as the cost of travel decreases because the anglers can travel long distance to seek better fishing conditions. On the other hand, as the cost of travel increases, their preference to fish in nearby areas increases regardless of the expected catch in other locations and variation in the trips taken declines. The model demonstrates the importance of incorporating anglers' decision processes in understanding the changes in a fishing effort level. Although the model in this study still has a room for further improvement, it can be used for more effective management of fish and potentially other populations.	[Fujiwara, Masami] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Backstrom, Jesse D.; Woodward, Richard T.] Texas A&M Univ, Dept Agr Econ, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Fujiwara, M (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	fujiware@tamu.edu	Fujiwara, Masami/C-3115-2012	Fujiwara, Masami/0000-0002-9255-6043; Woodward, Richard/0000-0001-6185-9255	 [NA14OAR4170102]		Research was supported by an Institutional Grant (NA14OAR4170102) to the Texas Sea Grant, Texas A&M University (MF, RTW), http://texasseagrant.org/.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Beckman D. W., 1988, US NATL MARINE FISHE, V87, P17; Brinson AA, 2016, FISH RES, V179, P213, DOI 10.1016/j.fishres.2016.03.008; Brown-Peterson N., 1988, U S Fish and Wildlife Service Fishery Bulletin, V86, P373; Carson EW, 2014, FISH RES, V151, P191, DOI 10.1016/j.fishres.2013.11.012; CAULKINS PP, 1986, AM J AGR ECON, V68, P291, DOI 10.2307/1241430; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Dundas SJ, 2018, MAR RESOUR ECON, V33, P1, DOI 10.1086/694752; Fenichel EP, 2013, FISH FISH, V14, P137, DOI 10.1111/j.1467-2979.2012.00456.x; Flaherty-Walia KE, 2015, ESTUAR COAST, V38, P353, DOI 10.1007/s12237-014-9821-6; Fujiwara M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166479; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Haab T. C., 2002, VALUING ENV NATURAL; Haab TC, 2002, J ENVIRON MANAGE, V66, P67, DOI 10.1006/jema.2002.0575; HAUSMAN JA, 1995, J PUBLIC ECON, V56, P1, DOI 10.1016/0047-2727(93)01415-7; Hendon J. Read, 2002, Gulf of Mexico Science, V20, P91; Hilborn R, 2007, FISH FISH, V8, P285, DOI 10.1111/j.1467-2979.2007.00263_2.x; Holmes EE, 2012, R J, V4, P11; Johnston FD, 2010, CAN J FISH AQUAT SCI, V67, P1897, DOI 10.1139/F10-113; Johnston RJ, 2014, ENVIRON RESOUR ECON, V59, P337, DOI 10.1007/s10640-013-9730-3; Lee MY, 2017, MAR RESOUR ECON, V32, P191, DOI 10.1086/690676; Lovell SJ, 2014, FISH B-NOAA, V112, P243, DOI 10.7755/FB.112.4.1; Lowerre-Barbieri SK, 2016, ECOL APPL, V26, P979, DOI 10.1890/15-0497; Martinez-Andrade F., 2015, MARINE RESOURCE MONI; MATLAB, 2015, MATLAB VER 8 5; McFadden D., 1974, FRONTIERS ECONOMETRI; Moeltner K, 2014, AM J AGR ECON, V96, P469, DOI 10.1093/ajae/aat115; MRIP, MAR RECR INF PROGR; Overstreet R.M., 1983, GULF RES REPT S, V1, P45; Rooker JR, 2010, MAR ECOL PROG SER, V407, P187, DOI 10.3354/meps08605; Rooker JR, 1997, MAR ECOL PROG SER, V158, P139, DOI 10.3354/meps158139; Smith MD, 2010, P NATL ACAD SCI USA, V107, P18300, DOI 10.1073/pnas.0907365107; Stunz GW, 2002, MAR ECOL PROG SER, V238, P227, DOI 10.3354/meps238227; Sutinen JG, 2003, MAR POLICY, V27, P471, DOI 10.1016/S0308-597X(03)00079-4; Tseng YP, 2006, DEMOGRAPHICS PARTICI	35	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206537	10.1371/journal.pone.0206537	http://dx.doi.org/10.1371/journal.pone.0206537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY7VH	30379924	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700127
J	Jun, DY; Kim, SY; Na, JC; Lee, HH; Kim, J; Yoon, YE; Hong, SJ; Han, WK				Jun, Dae-Young; Kim, Sook Young; Na, Joon Chae; Lee, Hyung Ho; Kim, Jeehoon; Yoon, Young Eun; Hong, Sung Joon; Han, Woong Kyu			Tubular organotypic culture model of human kidney	PLOS ONE			English	Article							IN-VITRO EXPANSION; STEM-CELLS; PROGENITORS; ORGANOIDS; DIFFERENTIATION; IDENTIFICATION; NEPHROTOXICITY; NEPHROPATHY; DISEASE; MOUSE	Cell-culture methods that simplify the inherent complexities of the kidney have not sufficiently reproduced its true characteristics. Although reports indicate that organoid methodology surpasses traditional cell culture in terms of reproducing the nature of organs, the study of human kidney organoids have been confined to pluripotent stem cells. Furthermore, it has not yet progressed beyond the developmental state of embryonic kidney even after complicate additional differentiation processes. We here describe the kidney organotypic culture method that uses adult whole kidney tissues but mainly differentiates into tubular cells. This model was validated based on the retention of key kidney organotypic-specific features: 1) expression of Tamm-Horsfall protein; 2) dome-like organoid configurations, implying directed transport of solutes and water influx; and 3) organoid expression of neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) in response to nephrotoxic injury (i.e., gentamicin and cisplatin exposure). This 3D-structured organoid prototype of the human renal tubule may have applications in developing patient-specific treatments for kidney diseases.	[Jun, Dae-Young; Kim, Sook Young; Na, Joon Chae; Kim, Jeehoon; Hong, Sung Joon; Han, Woong Kyu] Yonsei Univ, Urol Sci Inst, Dept Urol, Coll Med, Seoul, South Korea; [Lee, Hyung Ho] Natl Hlth Insurance Serv Ilsan Hosp, Dept Urol, Gyeonggi Do, South Korea; [Yoon, Young Eun] Hanyang Univ, Dept Urol, Coll Med, Seoul, South Korea; [Hong, Sung Joon; Han, Woong Kyu] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System; National Health Insurance Service; Hanyang University; Yonsei University; Yonsei University Health System	Han, WK (corresponding author), Yonsei Univ, Urol Sci Inst, Dept Urol, Coll Med, Seoul, South Korea.; Han, WK (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea.	hanwk@yuhs.ac	Na, Joon Chae/GNW-2299-2022	Na, Joon Chae/0000-0003-4449-8472; Lee, Hyung Ho/0000-0003-4160-0216; Hong, Sung Joon/0000-0001-9869-065X; Han, Woong Kyu/0000-0002-2527-4046; Yoon, Young Eun/0000-0001-8059-6649	National Research Foundation - Korean government (MEST) [NRF-2015R1D1A1A02062166]	National Research Foundation - Korean government (MEST)	Woong Kyu Han was financially supported by a National Research Foundation grant (NRF-2015R1D1A1A02062166) funded by the Korean government (MEST), http://www.nrf.re.kr/index.	Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bartfeld S, 2015, GASTROENTEROLOGY, V148, P126, DOI 10.1053/j.gastro.2014.09.042; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Chua CW, 2014, NAT CELL BIOL, V16, P951, DOI 10.1038/ncb3047; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hirsch HH, 2005, TRANSPLANTATION, V79, P1277, DOI 10.1097/01.TP.0000156165.83160.09; Hisha H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03224; Huch M, 2015, DEVELOPMENT, V142, P3113, DOI 10.1242/dev.118570; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kale S, 2000, NAT BIOTECHNOL, V18, P954, DOI 10.1038/79439; Kaminski MM, 2016, NAT CELL BIOL, V18, P1269, DOI 10.1038/ncb3437; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Lopez-Novoa JM, 2011, KIDNEY INT, V79, P33, DOI 10.1038/ki.2010.337; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Nadauld LD, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0428-9; Nanduri LSY, 2014, STEM CELL REP, V3, P957, DOI 10.1016/j.stemcr.2014.09.015; Nishikawa M, 2012, BIOCHEM BIOPH RES CO, V417, P897, DOI 10.1016/j.bbrc.2011.12.071; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; PENNICA D, 1987, SCIENCE, V236, P83, DOI 10.1126/science.3453112; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Rookmaaker MB, 2015, NAT REV NEPHROL, V11, P546, DOI 10.1038/nrneph.2015.118; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schrezenmeier EV, 2017, ACTA PHYSIOL, V219, P554, DOI 10.1111/apha.12764; SIKRI KL, 1981, J ANAT, V132, P597; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; VALENTICH JD, 1979, J CELL PHYSIOL, V100, P291, DOI 10.1002/jcp.1041000210; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Yamanaka K, 2012, CLIN TRANSPLANT, V26, P20, DOI 10.1111/j.1399-0012.2012.01636.x; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	50	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206447	10.1371/journal.pone.0206447	http://dx.doi.org/10.1371/journal.pone.0206447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379927	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700116
J	Yap, J; Fox, R; Narsia, N; Pinheiro-Maia, S; Pounds, R; Woodman, C; Luesley, D; Ganesan, R; Kehoe, S; Dawson, C				Yap, Jason; Fox, Richard; Narsia, Natalie; Pinheiro-Maia, Sonia; Pounds, Rachel; Woodman, Ciaran; Luesley, David; Ganesan, Raji; Kehoe, Sean; Dawson, Christopher			Under expression of the Sonic Hedgehog receptor, Patched1 (PTCH1), is associated with an increased risk of local recurrence in squamous cell carcinoma of the vulva arising on a background of Lichen Sclerosus	PLOS ONE			English	Article							SIGNALING MOLECULES; PATHWAY ACTIVATION; DRUG-RESISTANCE; PREDICTS; GENE	Objective Dysregulation of the Hedgehog (Hh) pathway has been described in a variety of cancers, including cervical cancer, a disease which shares a common aetiology with vulval squamous cell carcinoma (VSCC). Here, we investigate a large number of primary VSCC cases for evidence of Hedgehog pathway activation and examine the implications of pathway activity on clinical outcomes in a cohort of patients with primary VSCC. Methods Archival histology blocks containing VSCC and histologically normal adjacent epithelium were retrieved from a cohort of 91 patients who underwent treatment for primary VSCC. Immunohistochemistry staining was undertaken to assess for the expression of key Hh pathway components (SHH, PTCH1, GLI1). A competing risks statistical model was used to evaluate the implications of the levels of key Hh pathway components on clinical outcomes. Results We show that 92% of primary VSCC cases over-expressed one or more components of the Hh signalling pathway when compared to the adjacent normal epithelium. While expression of SHH and GLI1 did not correlate with any clinicopathological criteria, over- or underexpression of PTCH1 was associated with a reduced or increased risk of developing a local disease recurrence, respectively. In VSCC arising on a background of Lichen Sclerosus, the risk of local recurrence was potentiated in cases where PTCH1 was under-expressed. Conclusions Our findings reveal, for the first time, that the Hh pathway is activated in VSCC and that PTCH1 expression can be used as a biomarker to stratify patients and inform clinicians of the risk of their local recurrence, particularly in cases of VSCC associated with LS.	[Yap, Jason; Fox, Richard; Narsia, Natalie; Pinheiro-Maia, Sonia; Pounds, Rachel; Woodman, Ciaran; Luesley, David; Kehoe, Sean; Dawson, Christopher] Univ Birmingham, Inst Canc & Genom Sci, Birmingham Canc Res UK Canc Ctr, Birmingham, W Midlands, England; [Yap, Jason; Luesley, David; Kehoe, Sean] City Hosp, Pan Birmingham Gynaecol Canc Ctr, Birmingham, W Midlands, England; [Narsia, Natalie] Palacky Univ, Dept Clin & Mol Pathol, Olomouc, Moravia, Czech Republic; [Narsia, Natalie] Palacky Univ, Lab Mol Pathol, Olomouc, Moravia, Czech Republic; [Ganesan, Raji] Birmingham Womens NHS Fdn Trust, Dept Histopathol, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; Palacky University Olomouc; Palacky University Olomouc	Yap, J; Dawson, C (corresponding author), Univ Birmingham, Inst Canc & Genom Sci, Birmingham Canc Res UK Canc Ctr, Birmingham, W Midlands, England.; Yap, J (corresponding author), City Hosp, Pan Birmingham Gynaecol Canc Ctr, Birmingham, W Midlands, England.	j.yap@bham.ac.uk; dawsoncw10@yahoo.com			Royal College of Obstetricians and Gynaecologist, UK	Royal College of Obstetricians and Gynaecologist, UK	This work was supported by a consumable funded by the Royal College of Obstetricians and Gynaecologist, UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood SX, 2015, CANCER CELL, V27, P342, DOI 10.1016/j.ccell.2015.02.002; Atwood SX, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a013581; Cancer Research UK (CRUK), 2014, VULVAL CANCER INCIDE; Chen H, 2016, ONCOL LETT, V12, P2664, DOI 10.3892/ol.2016.4932; Collins SI, 2009, CANCER RES, V69, P3828, DOI 10.1158/0008-5472.CAN-08-3099; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; HANNA A, 2016, MOL CANCER, V15, P15660; HEAPS JM, 1990, GYNECOL ONCOL, V38, P309, DOI 10.1016/0090-8258(90)90064-R; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Leonard S, 2016, GYNECOL ONCOL, V143, P414, DOI 10.1016/j.ygyno.2016.09.001; Leprieur EG, 2016, CLIN LUNG CANCER, V17, P301, DOI 10.1016/j.cllc.2015.12.007; Port RJ, 2013, J PATHOL, V231, P367, DOI 10.1002/path.4245; Powell JJ, 1999, LANCET, V353, P1777, DOI 10.1016/S0140-6736(98)08228-2; Samarzija I, 2012, BIOCHEM BIOPH RES CO, V425, P64, DOI 10.1016/j.bbrc.2012.07.051; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Sharpe HJ, 2015, CANCER CELL, V27, P327, DOI 10.1016/j.ccell.2015.02.001; Steg AD, 2012, MOL CANCER THER, V11, P1587, DOI 10.1158/1535-7163.MCT-11-1058; te Grootenhuis NC, 2018, GYNECOL ONCOL, V148, P622, DOI 10.1016/j.ygyno.2017.11.006; Vishnoi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34377; Wang YF, 2012, HEAD NECK-J SCI SPEC, V34, P1556, DOI 10.1002/hed.21958; Wang YQ, 2016, J CANCER, V7, P2067, DOI 10.7150/jca.15786; Whitson RJ, 2018, NAT MED, V24, P271, DOI 10.1038/nm.4476; Xuan YH, 2006, MODERN PATHOL, V19, P1139, DOI 10.1038/modpathol.3800600; Yap JKW, 2017, BJOG-INT J OBSTET GY, V124, P946, DOI 10.1111/1471-0528.14560; Yap JKW, 2016, GYNECOL ONCOL, V142, P420, DOI 10.1016/j.ygyno.2016.06.019	27	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206553	10.1371/journal.pone.0206553	http://dx.doi.org/10.1371/journal.pone.0206553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379908	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700129
J	Edwards, ED; Woolly, EF; McLellan, RM; Keyzers, RA				Edwards, Eric D.; Woolly, Ethan F.; McLellan, Rose M.; Keyzers, Robert A.			Non-detection of honeybee hive contamination following Vespula wasp baiting with protein containing fipronil	PLOS ONE			English	Article							BEES APIS-MELLIFERA; NEW-ZEALAND; HYMENOPTERA VESPIDAE; PESTICIDE-RESIDUES; ENVIRONMENTAL FATE; MOTOR CHANGES; SOCIAL WASPS; LC-MS/MS; VULGARIS; BEHAVIOR	Introduced wasps (Vespula germanica and V. vulgaris) are costly invertebrate pests in New Zealand, with large impacts on the local ecology and economy. Wasps eat honeybees (Apis mellifera), which has potentially devastating effects on hive health, as well as agricultural and horticultural industries. Vespex bait, which contains fipronil in a proteinaceous carrier, has recently been introduced for wasp control. In over a decade of reported trials, honeybees have never been observed foraging on Vespex, likely because the bait contains no sugars to serve as a bee food source. However, the potential for the control agent fipronil to enter beehives has not been tested. Therefore, here, we investigated this using a liquid chromatography-mass spectrometry assay of fipronil and two of its environmental break-down and metabolic derivatives, fipronil desulfinyl and fipronil sulfone. We did not detect fipronil in any of the worker bee, bee larva, honey or pollen samples (n = 120 per product) collected from 30 hives over a 2-year period. Furthermore, although we detected fipronil desulfinyl in one honeybee sample, this is thought to have originated from a single individual, representing a rare occurrence of intoxication, and there was no evidence that Vespex was the toxicant source. There was also no evidence of trophallactic transfer of fipronil or its derivatives in any of the hives sampled. Previous studies have reported the impairment of individual bee performance at fipronil doses similar to the detection limit of our study. However, our results provide confidence that if undetectable intoxication was occurring, it would involve an acute exposure for those few individuals affected, with minimal impairment to colonies. Therefore, we conclude that the use of Vespex in the vicinity of honeybees does not result in significant hive uptake while effectively reducing wasp pressure on honeybee colonies.	[Edwards, Eric D.] Dept Conservat, Wellington, New Zealand; [Woolly, Ethan F.; McLellan, Rose M.; Keyzers, Robert A.] Victoria Univ Wellington, Sch Chem & Phys Sci, Wellington, New Zealand; [Keyzers, Robert A.] Victoria Univ Wellington, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand	Victoria University Wellington; Victoria University Wellington	Edwards, ED (corresponding author), Dept Conservat, Wellington, New Zealand.; Keyzers, RA (corresponding author), Victoria Univ Wellington, Sch Chem & Phys Sci, Wellington, New Zealand.; Keyzers, RA (corresponding author), Victoria Univ Wellington, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand.	eedwards@doc.govt.nz; rob.keyzers@vuw.ac.nz	Keyzers, Robert Alexander/K-2144-2015	Keyzers, Robert Alexander/0000-0002-7658-7421; Edwards, Eric/0000-0002-2211-7184; McLellan, Rose/0000-0003-4002-9740	New Zealand Department of Conservation; School of Chemical and Physical Sciences, Victoria University of Wellington, New Zealand	New Zealand Department of Conservation; School of Chemical and Physical Sciences, Victoria University of Wellington, New Zealand	EDE and RAK were funded by the New Zealand Department of Conservation (http://www.doc.govt.nz/) and RAK received additional funds from School of Chemical and Physical Sciences (https://www.victoria.ac.nz/scps), Victoria University of Wellington, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aajoud A, 2006, J AGR FOOD CHEM, V54, P5055, DOI 10.1021/jf0604081; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Aufauvre J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091686; Beggs J, 2001, BIOL CONSERV, V99, P17, DOI 10.1016/S0006-3207(00)00185-3; Beggs JR, 2011, BIOCONTROL, V56, P505, DOI 10.1007/s10526-011-9389-z; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Bonoan RE, 2017, ECOL ENTOMOL, V42, P195, DOI 10.1111/een.12375; Bovi TS, 2018, AN ACAD BRAS CIENC, V90, P239, DOI 10.1590/0001-3765201820150191; Butler CG, 1940, J EXP BIOL, V17, P253; Carabajal MD, 2016, MICROCHEM J, V128, P34, DOI 10.1016/j.microc.2016.03.006; Carrillo Marcela Pedraza, 2013, Acta Sci., Anim. Sci., V35, P431, DOI 10.4025/actascianimsci.v35i4.18683; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; CLAPPERTON BK, 1989, NEW ZEAL J ZOOL, V16, P325, DOI 10.1080/03014223.1989.10422897; COELHO JR, 1995, FUNCT ECOL, V9, P171, DOI 10.2307/2390561; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; DONOVAN BJ, 1984, NEW ZEAL J ZOOL, V11, P417, DOI 10.1080/03014223.1984.10428256; Durham EW, 2002, PEST MANAG SCI, V58, P799, DOI 10.1002/ps.523; Edwards E, 2017, INT J PEST MANAGE, V63, P266, DOI 10.1080/09670874.2017.1308581; El Hassani AK, 2005, PHARMACOL BIOCHEM BE, V82, P30, DOI 10.1016/j.pbb.2005.07.008; Farji-Brener Alejandro G., 1998, Ecologia Austral, V8, P237; Foote D, 2011, HCSU028 U HAW; Giorio C, 2021, ENVIRON SCI POLLUT R, V28, P11716, DOI 10.1007/s11356-017-0394-3; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Gunasekara AS, 2007, J PESTIC SCI, V32, P189, DOI 10.1584/jpestics.R07-02; Howarth FG, 1985, IMPACTS ALIEN LAND A, P149; ICH(INTERNATIONALCOUNCILFOR HARMONISATION), 2005, VALIDATION ANALYTICA; Kairo G, 2017, ENVIRON TOXICOL CHEM, V36, P2345, DOI 10.1002/etc.3773; Kairo G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08380-5; Kasiotis KM, 2014, SCI TOTAL ENVIRON, V485, P633, DOI 10.1016/j.scitotenv.2014.03.042; Lester P., 2013, N SCI REV, V70, P56; Lunardi JS, 2017, SOCIOBIOLOGY, V64, P50, DOI 10.13102/sociobiology.v64i1.1190; MacBean C, 2012, PESTICIDE MANUAL WOR, V16th; MacIntyre P., 2015, INT PEST CONTROL, V57, P162; Masciocchi Maité, 2010, Rev. Soc. Entomol. Argent., V69, P267; Matthews RW, 2000, AUST J ENTOMOL, V39, P177, DOI 10.1046/j.1440-6055.2000.00173.x; Mayer DF, 1999, J APICULT RES, V38, P191, DOI 10.1080/00218839.1999.11101009; MOLLER H, 1991, NEW ZEAL J ZOOL, V18, P171, DOI 10.1080/03014223.1991.10757964; Nahar Naznin, 2015, Journal of Entomology and Zoology Studies, V3, P65; Ngim KK, 2000, J AGR FOOD CHEM, V48, P4661, DOI 10.1021/jf9913007; Nunes-Silva P, 2019, INSECT SOC, V66, P15, DOI 10.1007/s00040-018-0660-5; Paradis D, 2014, ANAL BIOANAL CHEM, V406, P621, DOI 10.1007/s00216-013-7483-z; Pisa L, 2021, ENVIRON SCI POLLUT R, V28, P11749, DOI 10.1007/s11356-017-0341-3; Renzi MT, 2016, ECOTOX ENVIRON SAFE, V127, P205, DOI 10.1016/j.ecoenv.2016.01.028; Roat TC, 2013, ARCH ENVIRON CON TOX, V64, P456, DOI 10.1007/s00244-012-9849-1; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Schmickl T, 2004, APIDOLOGIE, V35, P249, DOI 10.1051/apido:2004019; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Spradbery JP, 1973, WASPS ACCOUNT BIOL N; Thomas CR., 1960, NZ DEP SCI IND RES I, V27; Toft RJ, 1998, ECOL ENTOMOL, V23, P90, DOI 10.1046/j.1365-2311.1998.00100.x; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Walker GP, 2011, P 6 INT WORKSH MAN D, P234; Walse SS, 2004, J ENVIRON MONITOR, V6, P58, DOI 10.1039/b307304a; Wilson EE, 2009, P NATL ACAD SCI USA, V106, P12809, DOI 10.1073/pnas.0902979106; Zaluski R, 2015, ENVIRON TOXICOL CHEM, V34, P1062, DOI 10.1002/etc.2889	59	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206385	10.1371/journal.pone.0206385	http://dx.doi.org/10.1371/journal.pone.0206385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372501	Green Submitted, gold, Green Published			2022-12-26	WOS:000448641200036
J	Medenica, S; Garalejic, E; Arsic, B; Medjo, B; Jovic, DB; Abazovic, D; Vukovic, R; Zarkovic, M				Medenica, Sanja; Garalejic, Eliana; Arsic, Biljana; Medjo, Biljana; Jovic, Dragana Bojovic; Abazovic, Dzihan; Vukovic, Rade; Zarkovic, Milos			Follicular fluid thyroid autoantibodies, thyrotropin, free thyroxine levels and assisted reproductive technology outcome	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; CONTROLLED OVARIAN HYPERSTIMULATION; ANTITHYROID ANTIBODIES; SUBCLINICAL HYPOTHYROIDISM; EUTHYROID WOMEN; EMBRYO-TRANSFER; LEVOTHYROXINE TREATMENT; AUTOIMMUNE-THYROIDITIS; STIMULATING HORMONE; PREGNANT-WOMEN	Objective Although there are substantial data linking thyroid autoimmunity (TAI) and infertility, data regarding assisted reproductive technology (ART) outcomes and TAI markers in follicular fluid (FF) of women undergoing ART are scarce. Objective of the study was to assess the association of the levels of thyroid autoantibodies in FF and ART outcome expressed as the achieved pregnancies. Methods This study enrolled 52 women undergoing ART (26 TAI positive subjects and 26 age and body mass index matched TAI negative controls). Blood samples were drawn before the initiation of protocol for controlled ovarian stimulation, and thyrotropin (TSH), free triiodothyronine (fT(3)), free thyroxine (fT(4)), thyroid peroxidase antibodies (TPOAbs) and thyroglobulin antibodies (TgAbs) levels were measured. TSH, fT(4), TPOAbs, TgAbs and progesterone levels were also measured in FF. Results There were no significant differences between the groups regarding mean levels of FF TSH and FF fT(4). Statistically significant correlation was discovered regarding the levels of serum and FF TPOAbs (0,961, p<0.001 in TAI positive, 0,438, p = 0.025 in TAI negative group) and TgAbs (0,945, p<0.001 in TAI positive, 0,554, p = 0.003 in TAI negative group). Pregnancies rates per initiated cycle and per embryotransfer cycle were significantly different between TAI positive and TAI negative group, (30.8% vs 61.5%), p = 0.026 and (34.8% vs 66.7%), p = 0.029, respectively. Multivariate analysis showed that TAI positive women had less chance to achieve pregnancy (p = 0.004, OR = 0.036, 95% CI 0.004-0.347). Conclusions Higher levels of thyroid autoantibodies in FF of TAI positive women are strongly correlated with serum levels and may have effect on the post-implantation embryo development.	[Medenica, Sanja] Clin Ctr Montenegro, Dept Endocrinol, Internal Med Clin, Podgorica, Montenegro; [Garalejic, Eliana; Arsic, Biljana; Jovic, Dragana Bojovic] Clin Gynecol & Obstet Narodni Front, Vitro Fertilisat Dept, Belgrade, Serbia; [Garalejic, Eliana; Medjo, Biljana; Zarkovic, Milos] Univ Belgrade, Sch Med, Belgrade, Serbia; [Medjo, Biljana] Univ Childrens Hosp, Pediat Intens Care Unit, Belgrade, Serbia; [Abazovic, Dzihan] Emergency Med Ctr Montenegro, Podgorica, Montenegro; [Vukovic, Rade] Mother & Child Healthcare Inst Serbia Dr VukanCup, Dept Endocrinol, Belgrade, Serbia; [Zarkovic, Milos] Clin Ctr Serbia, Dept Thyroid Gland Dis, Clin Endocrinol Diabet & Metab Dis, Belgrade, Serbia	University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Medenica, S (corresponding author), Clin Ctr Montenegro, Dept Endocrinol, Internal Med Clin, Podgorica, Montenegro.	medenicasanja@gmail.com	Jović, Dragana Bojović/AAQ-1303-2020; Vukovic, Rade/H-3344-2019	Vukovic, Rade/0000-0002-1592-4105; Dzihan, Abazovic/0000-0002-7676-458X				Aghajanova L, 2009, REPROD BIOMED ONLINE, V18, P337, DOI 10.1016/S1472-6483(10)60091-0; BOGNER U, 1995, EUR J ENDOCRINOL, V132, P69, DOI 10.1530/eje.0.1320069; Busnelli A, 2016, ENDOCR PRACT, V22, P389, DOI 10.4158/EP15933.OR; Bussen S, 2000, HUM REPROD, V15, P545, DOI 10.1093/humrep/15.3.545; Cedikova M, 2012, Ceska Gynekol, V77, P471; Chai J, 2014, CLIN ENDOCRINOL, V80, P122, DOI 10.1111/cen.12220; Chen LL, 2011, CLIN ENDOCRINOL, V74, P513, DOI 10.1111/j.1365-2265.2010.03974.x; Cho Moon Kyoung, 2015, Clin Exp Reprod Med, V42, P131, DOI 10.5653/cerm.2015.42.4.131; Demidenko E, 2007, STAT MED, V26, P3385, DOI 10.1002/sim.2771; GLINOER D, 1991, J CLIN ENDOCR METAB, V73, P421, DOI 10.1210/jcem-73-2-421; GLINOER D, 1994, J CLIN ENDOCR METAB, V79, P197, DOI 10.1210/jcem.79.1.8027226; Kaprara A, 2008, HORM-INT J ENDOCRINO, V7, P294, DOI 10.14310/horm.2002.1210; Kelkar RL, 2005, J REPROD IMMUNOL, V66, P53, DOI 10.1016/j.jri.2005.02.003; Kilic S, 2008, GYNECOL ENDOCRINOL, V24, P649, DOI 10.1080/09513590802531112; Kim CH, 1998, AM J REPROD IMMUNOL, V40, P2; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Kutteh WH, 1999, HUM REPROD, V14, P2886, DOI 10.1093/humrep/14.11.2886; Lee YL, 2009, FERTIL STERIL, V91, P2104, DOI 10.1016/j.fertnstert.2008.07.1704; Lukaszuk K, 2015, J ENDOCRINOL INVEST, V38, P1335, DOI 10.1007/s40618-015-0377-5; Magri F, 2013, THYROID, V23, P1312, DOI 10.1089/thy.2013.0022; Metcalfe RA, 1997, AUTOIMMUNITY, V25, P65, DOI 10.3109/08916939708996272; Monteleone P, 2011, AM J REPROD IMMUNOL, V66, P108, DOI 10.1111/j.1600-0897.2010.00961.x; Muller AF, 1999, FERTIL STERIL, V71, P30, DOI 10.1016/S0015-0282(98)00394-X; Negro R, 2006, J CLIN ENDOCR METAB, V91, P2587, DOI 10.1210/jc.2005-1603; Poppe K, 2004, J CLIN ENDOCR METAB, V89, P3808, DOI 10.1210/jc.2004-0105; Poppe K, 2002, THYROID, V12, P997, DOI 10.1089/105072502320908330; Poppe K, 2007, CLIN ENDOCRINOL, V66, P309, DOI 10.1111/j.1365-2265.2007.02752.x; Reimand K, 2001, J REPROD IMMUNOL, V51, P167, DOI 10.1016/S0165-0378(01)00075-4; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40; Sakar MN, 2016, J OBSTET GYNAECOL, V36, P213, DOI 10.3109/01443615.2015.1049253; Sowinski J, 2015, GYNECOL ENDOCRINOL, V31, P116, DOI 10.3109/09513590.2014.964200; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; STAGNAROGREEN A, 1990, JAMA-J AM MED ASSOC, V264, P1422, DOI 10.1001/jama.264.11.1422; Stavreus Evers Anneli, 2012, Front Endocrinol (Lausanne), V3, P50, DOI 10.3389/fendo.2012.00050; Tan S, 2014, EUR J ENDOCRINOL, V170, P495, DOI 10.1530/EJE-13-0790; THANGARATINAM S, 2011, BMJ-BRIT MED J, V342, DOI DOI 10.1136/BMJ.D2616; Toulis KA, 2010, EUR J ENDOCRINOL, V162, P643, DOI 10.1530/EJE-09-0850; van den Boogaard E, 2011, HUM REPROD UPDATE, V17, P605, DOI 10.1093/humupd/dmr024; Velkeniers B, 2013, HUM REPROD UPDATE, V19, P251, DOI 10.1093/humupd/dms052; Vissenberg R, 2015, HUM REPROD UPDATE, V21, P378, DOI 10.1093/humupd/dmv004; Weetman A., 2000, AUTOIMMUNITY THYROID; Yang Junjuan, 2015, Zhonghua Fu Chan Ke Za Zhi, V50, P652; Zarkovic M, 2011, HORM METAB RES, V43, P970, DOI 10.1055/s-0031-1291273; Zhang SS, 1997, MOL HUM REPROD, V3, P555, DOI 10.1093/molehr/3.7.555; Zhong YP, 2012, INT J MED SCI, V9, P121, DOI 10.7150/ijms.3467	45	8	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206652	10.1371/journal.pone.0206652	http://dx.doi.org/10.1371/journal.pone.0206652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372494	Green Submitted, Green Published, gold			2022-12-26	WOS:000448641200053
J	Arulraj, T; Barik, D				Arulraj, Theinmozhi; Barik, Debashis			Mathematical modeling identifies Lck as a potential mediator for PD-1 induced inhibition of early TCR signaling	PLOS ONE			English	Article							T-CELL-ACTIVATION; PROTEIN-TYROSINE-PHOSPHATASE; IFN-GAMMA; CANCER-IMMUNOTHERAPY; KINASE-ACTIVITY; CO-STIMULATION; REGULATORY T; EXPRESSION; PHOSPHORYLATION; SENSITIVITY	Programmed cell death-1 (PD-1) is an inhibitory immune checkpoint receptor that negatively regulates the functioning of T cell. Although the direct targets of PD 1 were not identified, its inhibitory action on the TCR signaling pathway was known much earlier. Recent experiments suggest that the PD 1 inhibits the TCR and CD28 signaling pathways at a very early stage - at the level of phosphorylation of the cytoplasmic domain of TCR and CD28 receptors. Here, we develop a mathematical model to investigate the influence of inhibitory effect of PD 1 on the activation of early TCR and CD28 signaling molecules. Proposed model recaptures several quantitative experimental observations of PD 1 mediated inhibition. Model simulations show that PD 1 imposes a net inhibitory effect on the Lck kinase. Further, the inhibitory effect of PD 1 on the activation of TCR signaling molecules such as Zap70 and SLP76 is significantly enhanced by the PD 1 mediated inhibition of Lck. These results suggest a critical role for Lck as a mediator for PD 1 induced inhibition of TCR signaling network. Multi parametric sensitivity analysis explores the effect of parameter uncertainty on model simulations.	[Arulraj, Theinmozhi] Univ Hyderabad, Ctr Syst Biol, Sch Life Sci, Cent Univ PO, Hyderabad, Telangana, India; [Barik, Debashis] Univ Hyderabad, Sch Chem, Cent Univ PO, Hyderabad, Telangana, India	University of Hyderabad; University of Hyderabad	Barik, D (corresponding author), Univ Hyderabad, Sch Chem, Cent Univ PO, Hyderabad, Telangana, India.	dbariksc@uohyd.ac.in	Barik, Debashis/D-3632-2018	Barik, Debashis/0000-0003-1681-1273; Arulraj, Theinmozhi/0000-0002-7258-7512	Science and Engineering Research Board, Department of Science and Technology (India) [EMR/2015/001899]	Science and Engineering Research Board, Department of Science and Technology (India)(Department of Science & Technology (India))	The work was supported by funding from the Science and Engineering Research Board, Department of Science and Technology (India), grant no. EMR/2015/001899. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko K, 2015, BRIT J CANCER, V112, P1501, DOI 10.1038/bjc.2015.101; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Bally APR, 2016, J IMMUNOL, V196, P2431, DOI 10.4049/jimmunol.1502643; Barik D, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005230; Barua D, 2007, BIOPHYS J, V92, P2290, DOI 10.1529/biophysj.106.093484; Beatty GL, 2015, CLIN CANCER RES, V21, P687, DOI 10.1158/1078-0432.CCR-14-1860; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Beyersdorf N, 2015, IMMUNOTARGETS THER, V4, P111, DOI 10.2147/ITT.S61647; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; Carbo A, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00031; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Chakraborty AK, 2010, NAT REV IMMUNOL, V10, P59, DOI 10.1038/nri2688; Chalancon G, 2012, TRENDS GENET, V28, P221, DOI 10.1016/j.tig.2012.01.006; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Cheng XX, 2013, J BIOL CHEM, V288, P11771, DOI 10.1074/jbc.M112.448126; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Chiang GG, 2001, J BIOL CHEM, V276, P23173, DOI 10.1074/jbc.M101219200; Choi J, 1998, J HYDROL, V209, P297, DOI 10.1016/S0022-1694(98)00093-6; Cotari JW, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003240; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; DECHERT U, 1994, J BIOL CHEM, V269, P5602; Dey A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188623; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fey D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0990; Francois P, 2013, P NATL ACAD SCI USA, V110, pE888, DOI 10.1073/pnas.1300752110; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Gong C, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0320; Gonzalez PA, 2005, P NATL ACAD SCI USA, V102, P4824, DOI 10.1073/pnas.0500922102; Guinn BA, 2007, MOL THER, V15, P1065, DOI 10.1038/sj.mt.6300138; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Hong T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002122; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Hui EF, 2014, NAT STRUCT MOL BIOL, V21, P133, DOI 10.1038/nsmb.2762; Huse M, 2009, J CELL SCI, V122, P1269, DOI 10.1242/jcs.042762; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Jiang Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.162; Jutz S, 2016, J IMMUNOL METHODS, V430, P10, DOI 10.1016/j.jim.2016.01.007; Khattri R, 1999, J IMMUNOL, V162, P5784; Kittisopikul M, 2010, P NATL ACAD SCI USA, V107, P13300, DOI 10.1073/pnas.1003975107; Klammt C, 2015, NAT IMMUNOL, V16, P961, DOI 10.1038/ni.3231; Klocke K, 2016, EUR J IMMUNOL, V46, P770; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Lipniacki T, 2008, J THEOR BIOL, V254, P110, DOI 10.1016/j.jtbi.2008.05.001; Mariani L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.13; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Menk AV, 2018, CELL REP, V22, P1509, DOI 10.1016/j.celrep.2018.01.040; Michot JM, 2016, EUR J CANCER, V54, P139, DOI 10.1016/j.ejca.2015.11.016; Miskov-Zivanov N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004217; Mondino A, 1996, P NATL ACAD SCI USA, V93, P2245, DOI 10.1073/pnas.93.6.2245; Mukherjee S, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai9062; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Patsoukis N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002796; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Rohrs JA, 2016, CELL MOL BIOENG, V9, P351, DOI 10.1007/s12195-016-0438-7; Rossy J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00167; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Seet BT, 2007, EMBO J, V26, P678, DOI 10.1038/sj.emboj.7601535; Serre R, 2016, CANCER RES, V76, P4931, DOI 10.1158/0008-5472.CAN-15-3567; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; SUGIMOTO S, 1993, J BIOL CHEM, V268, P22771; Tian XJ, 2013, BIOPHYS J, V105, P1079, DOI 10.1016/j.bpj.2013.07.011; Tkach KE, 2014, ELIFE, V3, DOI 10.7554/eLife.01944; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; van Griensven A, 2006, J HYDROL, V324, P10, DOI 10.1016/j.jhydrol.2005.09.008; Viricel C, 2015, J MOL GRAPH MODEL, V57, P131, DOI 10.1016/j.jmgm.2015.01.015; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wang X, 2016, ONCOTARGETS THER, V9, P5023, DOI 10.2147/OTT.S105862; WATTS JD, 1994, J BIOL CHEM, V269, P29520; Wei F, 2013, P NATL ACAD SCI USA, V110, pE2480, DOI 10.1073/pnas.1305394110; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zi ZK, 2005, FEBS LETT, V579, P1101, DOI 10.1016/j.febslet.2005.01.009; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	88	16	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206232	10.1371/journal.pone.0206232	http://dx.doi.org/10.1371/journal.pone.0206232			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356330	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000082
J	Sully, EA; Madziyire, MG; Riley, T; Moore, AM; Crowell, M; Nyandoro, MT; Madzima, B; Chipato, T				Sully, Elizabeth A.; Madziyire, Mugove Gerald; Riley, Taylor; Moore, Ann M.; Crowell, Marjorie; Nyandoro, Margaret Tambudzai; Madzima, Bernard; Chipato, Tsungai			Abortion in Zimbabwe: A national study of the incidence of induced abortion, unintended pregnancy and post-abortion care in 2016	PLOS ONE			English	Article							UNSAFE ABORTION	Background Zimbabwe has the highest contraceptive prevalence rate in sub-Saharan Africa, but also one of the highest maternal mortality ratios in the world. Little is known, however, about the incidence of abortion and post-abortion care (PAC) in Zimbabwe. Access to legal abortion is rare, and limited to circumstances of rape, incest, fetal impairment, or to save the woman's life. Objectives This paper estimates a) the national provision of PAC, b) the first-ever national incidence of induced abortion in Zimbabwe, and c) the proportion of pregnancies that are unintended. Methods We use the Abortion Incidence Complications Method (AICM), which indirectly estimates the incidence of induced abortion by obtaining a national estimate of PAC cases, and then estimates what proportion of all induced abortions in the country would result in women receiving PAC. Three national surveys were conducted in 2016: a census of health facilities with PAC capacity (n = 227), a prospective survey of women seeking abortion-related care in a nationally-representative sample of those facilities (n = 127 facilities), and a purposive sample of experts knowledgeable about abortion in Zimbabwe (n = 118). The estimate of induced abortion, along with census and Demographic Health Survey data was used to estimate unintended pregnancy. Results There were an estimated 25,245 PAC patients treated in Zimbabwe in 2016, but there were critical gaps in their care, including stock-outs of essential PAC medicines at half of facilities. Approximately 66,847 induced abortions (uncertainty interval (UI): 54,000-86,171) occurred in Zimbabwe in 2016, which translates to a national rate of 17.8 (UI: 14.4-22.9) abortions per 1,000 women 15-49. Overall, 40% of pregnancies were unintended in 2016, and one-quarter of all unintended pregnancies ended in abortion. Conclusion Zimbabwe has one of the lowest abortion rates in sub-Saharan Africa, likely due to high rates of contraceptive use. There are gaps in the health care system affecting the provision of quality PAC, potentially due to the prolonged economic crisis. These findings can inform and improve policies and programs addressing unsafe abortion and PAC in Zimbabwe.	[Sully, Elizabeth A.; Riley, Taylor; Moore, Ann M.; Crowell, Marjorie] Guttmacher Inst, New York, NY 10038 USA; [Madziyire, Mugove Gerald; Chipato, Tsungai] UZCHS CTU, Harare, Zimbabwe; [Nyandoro, Margaret Tambudzai; Madzima, Bernard] Zimbabwe Minist Hlth & Child Care, Harare, Zimbabwe		Sully, EA (corresponding author), Guttmacher Inst, New York, NY 10038 USA.	esully@guttmacher.org	Madziyire, Mugove G/P-3402-2017	Madziyire, Mugove G/0000-0002-9450-3180; Riley, Taylor/0000-0002-4963-0455; Sully, Elizabeth/0000-0002-0736-2237	Swedish International Development Cooperation Agency; UK Aid from the UK Government; Dutch Ministry of Foreign Affairs; Guttmacher Center for Population Research Innovation and Dissemination (NIH) [5 R24 HD074034]	Swedish International Development Cooperation Agency; UK Aid from the UK Government(CGIAR); Dutch Ministry of Foreign Affairs; Guttmacher Center for Population Research Innovation and Dissemination (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was made possible by the Swedish International Development Cooperation Agency, UK Aid from the UK Government and the Dutch Ministry of Foreign Affairs. Additional support was provided by the Guttmacher Center for Population Research Innovation and Dissemination (NIH grant 5 R24 HD074034). The findings and conclusions contained in the study are those of the authors and do not necessarily reflect the positions and policies of the donors.	[Anonymous], 2007, ZIMBABWE MATERNAL PE; Bankole A, 2015, INT PERSPECT SEX R H, V41, P170, DOI 10.1363/4117015; Basinga P, 2012, STUD FAMILY PLANN, V43, P11, DOI 10.1111/j.1728-4465.2012.00298.x; Center for Reproductive Rights, 2017, WORLDS AB LAWS 2017; Chipato T, 2014, NAT GUID COMPR AB CA; Chiweshe M, 2017, FEM PSYCHOL, V27, P203, DOI 10.1177/0959353517699234; Crush J, 2008, GENDER MIGRATION REM; Ganatra B, 2017, LANCET, V390, P2372, DOI 10.1016/S0140-6736(17)31794-4; Harlap S, 1980, HUMAN EMBRYONIC FETA, P145; Henshaw SK, 1998, INT FAM PLAN PERSPEC, V24, P156, DOI 10.2307/2991973; Keogh SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133933; Leridon H., 1977, HUMAN FERTILITY BASI; Levandowski BA, 2013, INT PERSPECT SEX R H, V39, P88, DOI 10.1363/3908813; Madziyire MG, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019658; Maternowska MC, 2015, REPROD HEALTH MATTER, V22, P16, DOI 10.1016/S0968-8080(14)43792-3; Mohamed SF, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0621-1; Moore AM, 2018, PAA 2018 ANN M APR 2; Moore AM, 2015, POP ASS AM 2015 ANN; Polis CB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173639; Prada E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165812; Sedgh G, 2016, LANCET, V388, P258, DOI 10.1016/S0140-6736(16)30380-4; Sedgh G, 2015, INT PERSPECT SEX R H, V41, P11, DOI 10.1363/4101115; Sedgh G, 2011, STUD FAMILY PLANN, V42, P147, DOI 10.1111/j.1728-4465.2011.00275.x; Singh S, 2005, INT FAM PLAN PERSPEC, V31, P183, DOI 10.1363/3118305; Singh S, 2010, METHODOLOGIES ESTIMA; Singh S, 2006, LANCET, V368, P1887, DOI 10.1016/S0140-6736(06)69778-X; Singh S, 2010, INT PERSPECT SEX R H, V36, P16, DOI 10.1363/ipsrh.36.016.10; Tuncalp O, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001993.pub2; WHO, WHO SAF AB TECHN POL; World Bank, 2016, MACR POV OUTL ZIMB; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Yoon Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154506; Zimbabwe National Statistics Agency and ICF International, 2016, ZIMB DEM HLTH SURV 2; Zimbabwe National Statistics Agency (ZIMSTAT), 2012, ZIMB CENS 2012 NAT R; ZimbabweMinistry ofHealth and ChildWelfare, 2013, EXP ACC POST CAR ZIM; Zimstat, 2013, POV POV DAT LIN AN Z	36	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205239	10.1371/journal.pone.0205239	http://dx.doi.org/10.1371/journal.pone.0205239			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3FL	30356264	Green Submitted, gold, Green Published			2022-12-26	WOS:000448434000045
J	Alkarakooly, Z; Al-Anbaky, QA; Kannan, K; Ali, N				Alkarakooly, Zeiyad; Al-Anbaky, Qudes A.; Kannan, Krishnaswamy; Ali, Nawab			Metabolic reprogramming by Dichloroacetic acid potentiates photodynamic therapy of human breast adenocarcinoma MCF-7 cells	PLOS ONE			English	Article							5-AMINOLEVULINIC ACID; ATP SECRETION; CANCER; DEATH; APOPTOSIS; RADIOTHERAPY; IMMUNOTHERAPY; CYTOTOXICITY; INCREASES; CARCINOMA	Aberrant glycolytic metabolism is one of the hallmarks of carcinogenesis and therefore reversal of metabolic transformation is a promising drug target in cancer treatment strategies. Dichloroacetic acid (DCA) is known to target the glycolytic pathway in cancer cells and facilitates reversal of metabolic transformation from aerobic cytosolic accumulation of pyruvic acid, "the Warburg effect", to mitochondrial oxidative phosphorylation. Recently, combination therapy particularly involving photodynamic therapy (PDT) has received considerable attention in oncology. We hypothesized that if DCA and PDT are combined, they might potentiate mitochondrial dysfunction and induce apoptosis by a reactive oxygen species (ROS) dependent pathway. We used MCF-7 cells as our in vitro model and 5-aminolevulinic acid (5-ALA) dependent PDT therapy to test our hypothesis. We found that combinatorial treatment of MCF-7 cells with PDT and DCA not only increased cell growth inhibition, but also affected mitochondrial membrane integrity perhaps via production of ROS, and enhanced apoptosis. Further, our results on ATP release during the combined treatment demonstrate that immunogenic cell death (ICD) is likely to be a potential mechanism by which PDT and DCA induce cancer cell death. Taken together, our study suggests a novel way of sensitizing MCF-7 cells for accelerated induction of apoptosis and ICD in these cells. The findings included in this study might have direct relevance in breast cancer treatment strategies.	[Alkarakooly, Zeiyad; Al-Anbaky, Qudes A.] Univ Diyala, Coll Sci, Dept Biol, Diyala, Iraq; [Alkarakooly, Zeiyad; Al-Anbaky, Qudes A.; Kannan, Krishnaswamy; Ali, Nawab] Univ Arkansas, Dept Biol, Coll Arts Letters & Sci, Little Rock, AR 72204 USA	University of Diyala; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Ali, N (corresponding author), Univ Arkansas, Dept Biol, Coll Arts Letters & Sci, Little Rock, AR 72204 USA.	nali@ualr.edu		Ali, Nawab/0000-0002-0995-4965	Center for Advanced Surface Engineering (CASE, Tunable Team), under the National Science Foundation [IIA-1457888]; Arkansas EPSCoR Program; Arkansas Space Grant Consortium, NASA-EPSCoR	Center for Advanced Surface Engineering (CASE, Tunable Team), under the National Science Foundation; Arkansas EPSCoR Program; Arkansas Space Grant Consortium, NASA-EPSCoR	The authors are thankful for the partial financial support by the Center for Advanced Surface Engineering (CASE, Tunable Team), under the National Science Foundation Grant No. IIA-1457888 and the Arkansas EPSCoR Program. A partial support from Arkansas Space Grant Consortium, NASA-EPSCoR is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-anbaky Q, 2016, INT J TOXICOL, V35, P672, DOI 10.1177/1091581816659661; Ayyanathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039949; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Bloy N, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.954929; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Brix N, 2017, IMMUNOL REV, V280, P249, DOI 10.1111/imr.12573; Chen G, 2013, CANCER IMMUNOL IMMUN, V62, P203, DOI 10.1007/s00262-012-1388-0; Dai YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092962; Date M, 2004, LIVER INT, V24, P142, DOI 10.1111/j.1478-3231.2004.00902.x; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; ESTAQUIER J, 1995, J EXP MED, V182, P1759, DOI 10.1084/jem.182.6.1759; Galluzzi L, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26536; Galluzzi L, 2012, EMBO J, V31, P1055, DOI 10.1038/emboj.2012.2; Garg AD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00588; Garg AD, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1386829; Garg AD, 2014, PHOTOCH PHOTOBIO SCI, V13, P474, DOI 10.1039/c3pp50333j; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Golden EB, 2012, FRONT ONCOL, V2, P1, DOI [10.3389/fonc.2012.00088, 10.3389/fonc.2012.00153]; Golding JP, 2013, BRIT J CANCER, V109, P976, DOI 10.1038/bjc.2013.391; GOMER CJ, 1989, RADIAT RES, V120, P1, DOI 10.2307/3577632; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hodge JW GC, 1984, ONCOLOGY WILLISTON P, V22; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalbasi A, 2013, J CLIN INVEST, V123, P2756, DOI 10.1172/JCI69219; Kannan A, 2016, ONCOTARGET, V7, P6576, DOI 10.18632/oncotarget.5878; Kepp O, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.955691; Kilaparty SP, 2016, CELL STRESS CHAPERON, V21, P593, DOI 10.1007/s12192-016-0684-6; Kinnaird A, 2016, NAT REV CANCER, V16, P694, DOI 10.1038/nrc.2016.82; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Kuangda Lu CH, 2018, NATURE BIOMEDICAL EN, V1, P1; Kwitniewski M, 2009, INT J CANCER, V125, P1721, DOI 10.1002/ijc.24488; Lamberti MJ, 2013, PHYTOMEDICINE, V20, P1007, DOI 10.1016/j.phymed.2013.04.018; Lu KD, 2018, NAT BIOMED ENG, V2, P600, DOI 10.1038/s41551-018-0203-4; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Martins I, 2014, CELL DEATH DIFFER, V21, P79, DOI 10.1038/cdd.2013.75; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Mokdad AH, 2017, JAMA-J AM MED ASSOC, V317, P388, DOI 10.1001/jama.2016.20324; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ngiow SF, 2015, CANCER CELL, V27, P437, DOI 10.1016/j.ccell.2015.03.015; Ohashi T, 2013, INT J CANCER, V133, P1107, DOI 10.1002/ijc.28114; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Papandreou I, 2011, INT J CANCER, V128, P1001, DOI 10.1002/ijc.25728; Peng Q, 1997, CANCER-AM CANCER SOC, V79, P2282; Penkert J, 2016, ONCOTARGET, V7, P67626, DOI 10.18632/oncotarget.11759; Raju I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067126; Ribas A, 2015, NEW ENGL J MED, V373, P1490, DOI 10.1056/NEJMp1510079; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sharman WM, 1999, DRUG DISCOV TODAY, V4, P507, DOI 10.1016/S1359-6446(99)01412-9; Sun RC, 2010, BREAST CANCER RES TR, V120, P253, DOI 10.1007/s10549-009-0435-9; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Vatner RE, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00325; Verbrugge I, 2012, CANCER RES, V72, P3163, DOI 10.1158/0008-5472.CAN-12-0210; WARBURG O, 1956, SCIENCE, V124, P269; Weichselbaum RR, 2017, NAT REV CLIN ONCOL, V14, P365, DOI 10.1038/nrclinonc.2016.211; Wong JYY, 2008, GYNECOL ONCOL, V109, P394, DOI 10.1016/j.ygyno.2008.01.038	60	7	8	8	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206182	10.1371/journal.pone.0206182	http://dx.doi.org/10.1371/journal.pone.0206182			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352078	Green Published, gold, Green Submitted			2022-12-26	WOS:000448076200035
J	Campa, A; Ferreira, JJ				Campa, Ana; Jose Ferreira, Juan			Genetic diversity assessed by genotyping by sequencing (GBS) and for phenological traits in blueberry cultivars	PLOS ONE			English	Article							SOUTHERN HIGHBUSH BLUEBERRY; RABBITEYE BLUEBERRY; VACCINIUM; HEALTH; COLLECTION; SELECTION	Blueberry is a small fruit crop which includes a complex group of different Vaccinium species of various ploidy levels. Commercial blueberries have been grown in Europe most recently, so there is not much information available about their adaptation into new regions. In this work we investigated adaptation to the environmental conditions of northern Spain, in terms of flowering and ripening seasons, of a set of 70 blueberry cultivars including several of the most important cultivated American species (V. corymbosum, V. virgatum, V. macrocarpon and V. uliginosum) in order to identify which types are best-suited in this geographical area of Europe. Most materials showed high chilling requirements for flowering under local conditions, while materials with low-chilling requirements showed problems in the maturation process of the flowers. Most cultivars were early or mid-season while a relative lack of lateseason cultivars was observed. GBS was used for the analysis of genetic diversity in this sample of 70 cultivars. A total of 5255 SNP markers were obtained and a cluster analysis revealed three main groups associated with the ploidy level of the species. A Principal Component Analysis revealed a grouping of the V. corymbosum cultivars according to their chilling requirements. A total of 29 SNPs were identified as being highly informative for diversity analysis and potentially useful for cultivar identification and for breeding purposes. The results obtained from this research should contribute to the expansion of this crop, as well as providing data about genetic diversity useful for the preservation of genetic resources or for future breeding programs.	[Campa, Ana; Jose Ferreira, Juan] SERIDA, Area Hort & Forest Crops, Plant Genet, Asturias, Spain	Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA	Campa, A (corresponding author), SERIDA, Area Hort & Forest Crops, Plant Genet, Asturias, Spain.	acampa@serida.org	Ferreira, Juan Jose/J-9470-2016; Negrillo, Ana Campa/C-2768-2017	Ferreira, Juan Jose/0000-0002-8782-8868; Negrillo, Ana Campa/0000-0003-3970-9079	INIA- Ministerio Economia y Competitividad (Spanish Government) [RTA2013-00076]; State Investigation Agency (AEI)-Spain [DR13-0222]; FEDER funds; European Regional Development Fund (FEDER)-EU	INIA- Ministerio Economia y Competitividad (Spanish Government); State Investigation Agency (AEI)-Spain; FEDER funds(European Commission); European Regional Development Fund (FEDER)-EU	This work was supported by grant RTA2013-00076 from INIA- Ministerio Economia y Competitividad (Spanish Government), co-financed with FEDER funds. Ana Campa is recipient of a salary (DR13-0222) from the State Investigation Agency (AEI)-Spain, co-financed with the European Regional Development Fund (FEDER)-EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUNA M, 1993, GENOME, V36, P971, DOI 10.1139/g93-127; BALLINGTON JR, 1990, HORTSCIENCE, V25, P711, DOI 10.21273/HORTSCI.25.6.711; Ballington JR, 2001, HORTSCIENCE, V36, P213, DOI 10.21273/HORTSCI.36.2.213; Bian Y, 2014, MOL BREEDING, V34, P675, DOI 10.1007/s11032-014-0066-7; Boches P, 2006, J AM SOC HORTIC SCI, V131, P674, DOI 10.21273/JASHS.131.5.674; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brevis PA, 2008, J AM SOC HORTIC SCI, V133, P427, DOI 10.21273/JASHS.133.3.427; Camp W. H., 1942, BRITTONIA, V4, P205, DOI 10.2307/2804714; Camp W. H., 1945, BRITTONIA, V5, P203, DOI 10.2307/2804880; Covarrubias-Pazaran G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2802-3; COVILLE F. V., 1937, Yearbook of the United States Department of Agriculture, P559; COVILLE FV, 1916, NATL GEO MAG     JUN, V29, P535; Die JV, 2013, MOL BREEDING, V32, P493, DOI 10.1007/s11032-013-9893-1; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ehlenfeldt MK, 2001, HORTSCIENCE, V36, P133, DOI 10.21273/HORTSCI.36.1.133; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Food and Agriculture Organization of the United Nations, FAOSTAT DAT; Galletta G.J., 1996, FRUIT BREEDING VOLUM, P1; Griffin PC, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-19; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Hamon P, 2017, MOL PHYLOGENET EVOL, V109, P351, DOI 10.1016/j.ympev.2017.02.009; Hiirsalmi H, 1985, ACTA HORTIC, V165, P71; Johnson SA, 2013, ANTI-CANCER AGENT ME, V13, P1142, DOI 10.2174/18715206113139990137; Kalt W., 1997, HortTechnology, V7, P216; Kassambara A., 2017, EXTRACT VISUALIZE RE; Kobayashi F, 2016, BREEDING SCI, V66, P213, DOI 10.1270/jsbbs.66.213; LANDER E S, 1988, Genomics, V2, P231; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leisner CP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179417; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lobos GA, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00782; LUBY JJ, 1986, HORTSCIENCE, V21, P1240; Luedeling E, 2011, INT J BIOMETEOROL, V55, P411, DOI 10.1007/s00484-010-0352-y; Lyrene PM, 2000, HORTSCIENCE, V35, P956, DOI 10.21273/HORTSCI.35.5.956; Lyrene PM, 2003, EUPHYTICA, V133, P27, DOI 10.1023/A:1025608408727; LYRENE PM, 1985, HORTSCIENCE, V20, P407; LYRENE PM, 1981, EUPHYTICA, V30, P505, DOI 10.1007/BF00034016; Mainland CM, 2012, INT J FRUIT SCI, V12, P4, DOI 10.1080/15538362.2011.619117; McCallum S, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0443-5; MOORE JN, 1965, EUPHYTICA, V14, P39; ORTIZ R, 1992, EUPHYTICA, V61, P241, DOI 10.1007/BF00039664; Polashock J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-165; Prior RL, 1998, J AGR FOOD CHEM, V46, P2686, DOI 10.1021/jf980145d; R Development Core Team, 2016, R LANG ENV STAT COMP; Retamales JB, 2012, CROP PROD SCI HORTIC, P1, DOI 10.1079/9781845939045.0000; Rodriguez-Mateos A, 2014, J AGR FOOD CHEM, V62, P3842, DOI 10.1021/jf403757g; Rowland LJ, 2010, SCI HORTIC-AMSTERDAM, V125, P779, DOI 10.1016/j.scienta.2010.05.008; Schlautman B, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-017-0765-y; SHARPE R. H., 1953, Proceedings of the Florida State Horticultural Society, 1953, P188; SHARPE R. H., 1959, PROC FLORIDA STATE HORT SOC, V72, P308; SHARPE RH, 1976, HORTSCIENCE, V11, P65; Song GQ, 2013, PLANT CELL REP, V32, P1759, DOI 10.1007/s00299-013-1489-z; Subash S, 2014, NEURAL REGEN RES, V9, P1557, DOI 10.4103/1673-5374.139483; Trehane J., 2012, BLUEBERRIES CRANBERR; Yang B, 2015, CURR OPIN FOOD SCI, V2, P36, DOI 10.1016/j.cofs.2015.01.002; Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002	56	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206361	10.1371/journal.pone.0206361	http://dx.doi.org/10.1371/journal.pone.0206361			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352107	gold, Green Published, Green Submitted			2022-12-26	WOS:000448076200049
J	Hirakata, T; Lee, HC; Ohba, M; Saeki, K; Okuno, T; Murakami, A; Matsuda, A; Yokomizo, T				Hirakata, Toshiaki; Lee, Hyeon-Cheol; Ohba, Mai; Saeki, Kazuko; Okuno, Toshiaki; Murakami, Akira; Matsuda, Akira; Yokomizo, Takehiko			Dietary-3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating T(h)2 immune responses	FASEB JOURNAL			English	Article						eicosanoid; inflammation; hay fever; lipidomics; fish oil	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; FISH-OIL SUPPLEMENTATION; PROSTAGLANDIN D-2; MURINE MODEL; RESOLVIN D1; MAST-CELLS; HIGH-RISK; EOSINOPHILS; INFLAMMATION; RECEPTOR	Allergic conjunctivitis (AC) is one of the most common ocular surface diseases in the world. In AC, T helper type 2 (T(h)2) immune responses play central roles in orchestrating inflammatory responses. However, the roles of lipid mediators in the onset and progression of AC remain to be fully explored. Although previous reports have shown the beneficial effects of supplementation of -3 fatty acids in asthma or atopic dermatitis, the underlying molecular mechanisms are poorly understood. In this study, a diet rich in -3 fatty acids alleviated AC symptoms in both early and late phases without affecting T(h)2 immune responses, but rather by altering the lipid mediator profiles. The -3 fatty acids completely suppressed scratching behavior toward the eyes, an allergic reaction provoked by itch. Although total serum IgE levels and the expression levels of T(h)2 cytokines and chemokines in the conjunctiva were not altered by -3 fatty acids, eosinophil infiltration into the conjunctiva was dramatically suppressed. The levels of -6-derived proinflammatory lipid mediators, including those with chemoattractant properties for eosinophils, were markedly reduced in the conjunctivae of -3 diet-fed mice. Dietary -3 fatty acids can alleviate a variety of symptoms of AC by altering the lipid mediator profile.Hirakata, T., Lee, H.-C., Ohba, M., Saeki, K., Okuno, T., Murakami, A., Matsuda, A., Yokomizo, T. Dietary -3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating T(h)2 immune responses.	[Hirakata, Toshiaki; Murakami, Akira; Matsuda, Akira] Juntendo Univ, Grad Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo, Japan; [Hirakata, Toshiaki; Lee, Hyeon-Cheol; Ohba, Mai; Saeki, Kazuko; Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Grad Sch Med, Dept Biochem, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan	Juntendo University; Juntendo University	Yokomizo, T (corresponding author), Juntendo Univ, Grad Sch Med, Dept Biochem, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.	yokomizo-tky@umin.ac.jp	Yokomizo, Takehiko/P-5673-2016; Matsuda, Akira/A-9981-2010; Lee-Okada, Hyeon-Cheol/AAQ-4520-2021	Yokomizo, Takehiko/0000-0002-5219-1553; Matsuda, Akira/0000-0002-0792-3663; Lee-Okada, Hyeon-Cheol/0000-0002-5493-8112	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)/Japan Society for the Promotion of Sport (KAKENHI) [18K16246, 15K08316, 18K06923, 15KK0320, 16K08596, 16K11303, 15H05904, 15H04708, 18H02627]; Naito Foundation; Ono Medical Research Foundation; Uehara Memorial Foundation; Mitsubishi Foundation; Takeda Science Foundation [S1311011]; Foundation of Strategic Research Projects in Private Universities from MEXT [S1311011]; Atopy Research Center at the Juntendo University Graduate School of Medicine	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)/Japan Society for the Promotion of Sport (KAKENHI); Naito Foundation(Naito Memorial Foundation); Ono Medical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation of Strategic Research Projects in Private Universities from MEXT; Atopy Research Center at the Juntendo University Graduate School of Medicine	The authors thank members of the Laboratory of Morphology and Image Analysis Research Support Center at the Juntendo University Graduate School of Medicine for technical assistance with microscopy. This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)/Japan Society for the Promotion of Sport Grants-in-Aid for Scientific Research (KAKENHI) (18K16246 to H.-C.L.; 15K08316 and 18K06923 to K.S.; 15KK0320 and 16K08596 to T.O.; 16K11303 to A. Matsuda; and 15H05904, 15H04708, and 18H02627 to T.Y.), and grants from the Naito Foundation, the Ono Medical Research Foundation, the Uehara Memorial Foundation, the Mitsubishi Foundation, the Takeda Science Foundation, and, in part, by Grant-in-Aid S1311011 from the Foundation of Strategic Research Projects in Private Universities from MEXT, and institutional grants for Environmental and Gender-Specific Medicine and the Atopy Research Center at the Juntendo University Graduate School of Medicine. The authors declare no conflicts of interest.	ABELSON MB, 1983, ARCH OPHTHALMOL-CHIC, V101, P555; Andoh T, 2007, J INVEST DERMATOL, V127, P2042, DOI 10.1038/sj.jid.5700810; Andoh T, 2012, EXP EYE RES, V98, P97, DOI 10.1016/j.exer.2012.03.021; Aoki H, 2008, BIOCHEM BIOPH RES CO, V367, P509, DOI 10.1016/j.bbrc.2008.01.012; Asada Y, 2015, INVEST OPHTH VIS SCI, V56, P5194, DOI 10.1167/iovs.15-16563; BALLAS Z, 1993, SURV OPHTHALMOL, V38, P141, DOI 10.1016/0039-6257(93)90038-9; Beermann C, 2016, NUTRITION, V32, P1165, DOI 10.1016/j.nut.2016.04.004; Best KP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4443; Bisgaard H, 2016, NEW ENGL J MED, V375, P2530, DOI 10.1056/NEJMoa1503734; Biteman B, 2007, FASEB J, V21, P2257, DOI 10.1096/fj.06-7918com; Bohm E, 2004, J BIOL CHEM, V279, P7663, DOI 10.1074/jbc.M310270200; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; Ciaccio CE, 2014, ANN ALLERG ASTHMA IM, V112, P191, DOI 10.1016/j.anai.2014.01.009; CLUTTERBUCK EJ, 1989, BLOOD, V73, P1504; Costa JJ, 1997, JAMA-J AM MED ASSOC, V278, P1815, DOI 10.1001/jama.278.22.1815; D'Vaz N, 2012, PEDIATRICS, V130, P674, DOI 10.1542/peds.2011-3104; Devenny A, 2004, BMJ-BRIT MED J, V329, P489, DOI 10.1136/bmj.38139.666447.F7; Devereux G, 2005, J ALLERGY CLIN IMMUN, V115, P1109, DOI 10.1016/j.jaci.2004.12.1139; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Dunstan JA, 2003, J ALLERGY CLIN IMMUN, V112, P1178, DOI 10.1016/j.jaci.2003.09.009; Farjadian S, 2016, CYTOKINE, V85, P61, DOI 10.1016/j.cyto.2016.06.002; Fogarty A, 2000, CLIN EXP ALLERGY, V30, P615, DOI 10.1046/j.1365-2222.2000.00766.x; Foiles AM, 2016, PEDIAT ALLERG IMM-UK, V27, P156, DOI 10.1111/pai.12515; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Giudetti AM, 2012, PROSTAG OTH LIPID M, V99, P57, DOI 10.1016/j.prostaglandins.2012.09.006; Grant GE, 2009, PROSTAG OTH LIPID M, V89, P98, DOI 10.1016/j.prostaglandins.2009.05.002; Guidera AC, 2001, OPHTHALMOLOGY, V108, P936, DOI 10.1016/S0161-6420(00)00538-8; Hansen S, 2017, J ALLERGY CLIN IMMUN, V139, P104, DOI 10.1016/j.jaci.2016.02.042; Hashimoto T, 2003, J OCUL PHARMACOL TH, V19, P569, DOI 10.1089/108076803322660486; Hodges RR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36124; Ishida W, 2012, GRAEF ARCH CLIN EXP, V250, P289, DOI 10.1007/s00417-011-1695-8; Kari O, 2010, J ASTHMA ALLERGY, V3, P149, DOI 10.2147/JAA.S13705; Keane-Myers A, 2001, Curr Allergy Asthma Rep, V1, P550, DOI 10.1007/s11882-001-0064-9; Kim N, 2016, EUR J IMMUNOL, V46, P81, DOI 10.1002/eji.201545673; Kitaura M, 1996, J BIOL CHEM, V271, P7725, DOI 10.1074/jbc.271.13.7725; Kunisawa J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09750; Kunisawa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032094; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Leonardi Andrea, 2002, Curr Allergy Asthma Rep, V2, P325, DOI 10.1007/s11882-002-0061-7; Lippestad M, 2017, INVEST OPHTH VIS SCI, V58, P4530, DOI 10.1167/iovs.17-21914; Livne-Bar I, 2017, J CLIN INVEST, V127, P4403, DOI 10.1172/JCI77398; Luna-Gomes T, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00027; Luna-Gomes T, 2011, J IMMUNOL, V187, P6518, DOI 10.4049/jimmunol.1101806; Magone MT, 1998, CLIN IMMUNOL IMMUNOP, V87, P75, DOI 10.1006/clin.1997.4507; Manley BJ, 2011, PEDIATRICS, V128, pE71, DOI 10.1542/peds.2010-2405; Matsuba-Kitamura S, 2010, INT IMMUNOL, V22, P479, DOI 10.1093/intimm/dxq035; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; NAKAJIMA M, 1991, GRAEF ARCH CLIN EXP, V229, P411, DOI 10.1007/BF00166301; Nakazawa Yosuke, 2017, Open Med (Wars), V12, P231, DOI 10.1515/med-2017-0034; Ohba M, 2018, BIOCHEM BIOPH RES CO, V504, P562, DOI 10.1016/j.bbrc.2018.06.026; Ono SJ, 2005, J ALLERGY CLIN IMMUN, V115, P118, DOI 10.1016/j.jaci.2004.10.042; Peinhaupt M, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00104; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Rupp H, 2004, HERZ, V29, P673, DOI 10.1007/s00059-004-2602-4; Sampson AP, 2000, CLIN EXP ALLERGY, V30, P22; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Singh K, 2010, J ALLERGY CLIN IMMUN, V126, P778, DOI 10.1016/j.jaci.2010.06.050; SPADA CS, 1986, PROSTAGLANDINS, V31, P795, DOI 10.1016/0090-6980(86)90181-4; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Swamy BN, 2007, OPHTHAL EPIDEMIOL, V14, P311, DOI 10.1080/09286580701299411; Teixeira MM, 1997, J CLIN INVEST, V100, P1657, DOI 10.1172/JCI119690; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Tull SP, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000177; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Whelan J, 1996, J NUTR, V126, pS1086, DOI 10.1093/jn/126.suppl_4.1086S; WOODWARD DF, 1990, INVEST OPHTH VIS SCI, V31, P138; Woodward DF, 1996, J PHARMACOL EXP THER, V279, P137; YAMAGUCHI Y, 1988, J EXP MED, V167, P1737, DOI 10.1084/jem.167.5.1737	72	20	20	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3392	3403		10.1096/fj.201801805R	http://dx.doi.org/10.1096/fj.201801805R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30383446	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000459794800026
J	Baker, EW; Henderson, WM; Kinder, HA; Hutcheson, JM; Platt, SR; West, FD				Baker, Emily W.; Henderson, W. Matthew; Kinder, Holly A.; Hutcheson, Jessica M.; Platt, Simon R.; West, Franklin D.			Scaled traumatic brain injury results in unique metabolomic signatures between gray matter, white matter, and serum in a piglet model	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; SYSTEMS BIOLOGY; CEREBRAL-CORTEX; PROFILE CHANGES; DRUG DISCOVERY; AMINO-ACIDS; DAMAGE; BIOMARKERS; ISCHEMIA; LACTATE	Traumatic brain injury (TBI) is a leading cause of death and long-term disability in the United States. The heterogeneity of the disease coupled with the lack of comprehensive, standardized scales to adequately characterize multiple types of TBI remain to be major challenges facing effective therapeutic development. A systems level approach to TBI diagnosis through the use of metabolomics could lead to a better understanding of cellular changes post-TBI and potential therapeutic targets. In the current study, we utilize a GC-MS untargeted metabolomics approach to demonstrate altered metabolism in response to TBI in a translational pig model, which possesses many neuroanatomical and pathophysiologic similarities to humans. TBI was produced by controlled cortical impact (CCI) in Landrace piglets with impact velocity and depth of depression set to 2m/s;6mm, 4m/s;6mm, 4m/s;12mm, or 4m/s;15mm resulting in graded neural injury. Serum samples were collected pre-TBI, 24 hours post-TBI, and 7 days post-TBI. Partial least squares discriminant analysis (PLS-DA) revealed that each impact parameter uniquely influenced the metabolomic profile after TBI, and gray and white matter responds differently to TBI on the biochemical level with evidence of white matter displaying greater metabolic change. Furthermore, pathway analysis revealed unique metabolic signatures that were dependent on injury severity and brain tissue type. Metabolomic signatures were also detected in serum samples which potentially captures both time after injury and injury severity. These findings provide a platform for the development of a more accurate TBI classification scale based unique metabolomic signatures.	[Baker, Emily W.; Kinder, Holly A.; Hutcheson, Jessica M.; Platt, Simon R.; West, Franklin D.] Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA; [Baker, Emily W.; Kinder, Holly A.; Hutcheson, Jessica M.; West, Franklin D.] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [Henderson, W. Matthew] US EPA, Natl Exposure Res Lab, Off Res & Dev, Athens, GA USA; [Platt, Simon R.] Univ Georgia, Dept Small Anim Med & Surg, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; United States Environmental Protection Agency; University System of Georgia; University of Georgia	West, FD (corresponding author), Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA.; West, FD (corresponding author), Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA.	Westf@uga.edu		Kinder, Holly/0000-0001-8310-7265	Office for the Vice President of Research at the University of Georgia	Office for the Vice President of Research at the University of Georgia	This study was funded by the Office for the Vice President of Research at the University of Georgia. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Ahmad AS, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00172; Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Armengou A, 2003, J CEREBR BLOOD F MET, V23, P978, DOI 10.1097/01.WCB.0000080651.64357.C6; Babikian T, 2010, DEV NEUROSCI-BASEL, V32, P431, DOI 10.1159/000320667; Baker EW, 2019, J NEUROTRAUM, V36, P61, DOI 10.1089/neu.2017.5551; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Bourassa MW, 2016, NEUROSCI LETT, V625, P56, DOI 10.1016/j.neulet.2016.02.009; Bovo S, 2015, J ANIM SCI, V93, P5681, DOI 10.2527/jas.2015-9528; Callaway DW, 2009, J TRAUMA, V66, P1040, DOI 10.1097/TA.0b013e3181895e9e; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Farooqui AA, 2000, CHEM PHYS LIPIDS, V106, P1, DOI 10.1016/S0009-3084(00)00128-6; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Furlow B., 2013, RADIOL TECHNOL, V84, p91CT; Furlow Bryant, 2013, Radiol Technol, V84, p273CT; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Glenn Thomas C, 2013, Acta Neurochir Suppl, V118, P115, DOI 10.1007/978-3-7091-1434-6_20; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Hollenbeck PJ, 2005, NEURON, V47, P331, DOI 10.1016/j.neuron.2005.07.017; Irie M, 2014, METABOLOMICS, V10, P473, DOI 10.1007/s11306-013-0588-8; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Li ZS, 2015, ANAL BIOCHEM, V477, P105, DOI 10.1016/j.ab.2015.02.024; Lommen A, 2007, ANAL CHIM ACTA, V584, P43, DOI 10.1016/j.aca.2006.11.018; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Louin G, 2007, NITRIC OXIDE-BIOL CH, V17, P91, DOI 10.1016/j.niox.2007.05.006; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; Matute C, 2010, CELL CALCIUM, V47, P150, DOI 10.1016/j.ceca.2009.12.004; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Meng SZ, 2005, EXP BRAIN RES, V166, P56, DOI 10.1007/s00221-005-2340-8; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Niu WH, 2014, J CHROMATOGR A, V1374, P199, DOI 10.1016/j.chroma.2014.11.005; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Perez-Asenio FJ, 2005, NEUROBIOL DIS, V18, P375, DOI 10.1016/j.nbd.2004.10.018; Regnier MA, 2012, ANESTHESIOLOGY, V117, P1276, DOI 10.1097/ALN.0b013e318273349d; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sakuma S, 2012, J CLIN BIOCHEM NUTR, V51, P55, DOI 10.3164/jcbn.11-97; SHIMADA N, 1993, J NEUROCHEM, V60, P66, DOI 10.1111/j.1471-4159.1993.tb05823.x; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Stokum JA, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0239-6; Toczylowska B, 2006, BRAIN RES, V1104, P183, DOI 10.1016/j.brainres.2006.05.057; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Welle T, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1219-6; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; West FD, 2012, TOXICOL SCI, V129, P9, DOI 10.1093/toxsci/kfs185; Wishart DS, 2016, NAT REV DRUG DISCOV, V15, P473, DOI 10.1038/nrd.2016.32; Wolahan S. M., 2015, BRAIN NEUROTRAUMA MO; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yao CP, 2009, J NEUROTRAUM, V26, P1295, DOI [10.1089/neu.2008.0811, 10.1089/neu.2008-0811]; Yi LZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21320; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang ZQ, 2010, METHODS MOL BIOL, V662, P317, DOI 10.1007/978-1-60761-800-3_16	74	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206481	10.1371/journal.pone.0206481	http://dx.doi.org/10.1371/journal.pone.0206481			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379914	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700121
J	Shimizu, H; Hanzawa, F; Kim, D; Sun, S; Laurent, T; Umeki, M; Ikeda, S; Mochizuki, S; Oda, H				Shimizu, Hatsumi; Hanzawa, Fumiaki; Kim, Daeun; Sun, Shumin; Laurent, Thomas; Umeki, Miki; Ikeda, Saiko; Mochizuki, Satoshi; Oda, Hiroaki			Delayed first active-phase meal, a breakfast-skipping model, led to increased body weight and shifted the circadian oscillation of the hepatic clock and lipid metabolism-related genes in rats fed a high-fat diet	PLOS ONE			English	Article							BREAST-CANCER; HEART-DISEASE; HEALTH; TRANSCRIPTION; RECEPTOR; RHYTHMS; ALPHA; WORK; FOOD; TIME	The circadian clock is closely related to human health, such as metabolic syndrome and cardiovascular disease. Our previous study revealed that irregular feeding induced abnormal lipid metabolism with disruption of the hepatic circadian clock. We hypothesized that breakfast skipping induces lipid abnormalities, such as adiposity, by altering the hepatic circadian oscillation of clock and lipid metabolism-related genes. Here, we established a delayed first active-phase meal (DFAM) protocol as a breakfast-skipping model. Briefly, rats were fed a high-fat diet during zeitgeber time (ZT) 12-24 in a control group and ZT 16-4 in the DFAM group. The DFAM group showed increased body weight gain and perirenal adipose tissue weight without a change in total food intake. The circadian oscillations of hepatic clock and de novo fatty acid synthesis genes were delayed by 2-4 h because of DFAM. The peaks of serum insulin, a synchronizer for the liver clock, bile acids, and non-esterified fatty acid (NEFA) were delayed by 4-6 h because of DFAM. Moreover, DFAM delayed the surge in body temperature by 4 h and may have contributed to the increase in body weight gain and adipose tissue weight because of decreased energy expenditure. These data indicated a potential molecular mechanism by which breakfast skipping induces abnormal lipid metabolism, which is related to the altered circadian oscillation of hepatic gene expression. The results also suggested that the delayed peaks of serum NEFA, bile acids, and insulin entrain the circadian rhythm of hepatic clock and lipid metabolism-related genes.	[Shimizu, Hatsumi; Kim, Daeun; Sun, Shumin; Oda, Hiroaki] Nagoya Univ, Lab Nutr Biochem, Nagoya, Aichi, Japan; [Hanzawa, Fumiaki; Ikeda, Saiko] Nagoya Univ Arts & Sci, Dept Nutr Sci, Nisshin, Japan; [Laurent, Thomas; Oda, Hiroaki] Nagoya Univ, Inst Innovat Future Soc, Nagoya, Aichi, Japan; [Umeki, Miki; Mochizuki, Satoshi] Oita Univ, Fac Educ, Oita, Japan; [Umeki, Miki] Beppu Univ, Fac Food Sci & Nutr, Beppu, Oita, Japan	Nagoya University; Nagoya University; Oita University	Oda, H (corresponding author), Nagoya Univ, Lab Nutr Biochem, Nagoya, Aichi, Japan.; Oda, H (corresponding author), Nagoya Univ, Inst Innovat Future Soc, Nagoya, Aichi, Japan.	hirooda@agr.nagoya-u.ac.jp			Japan Society for the Promotion of Science [21658052, 2529069, 16H04922]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work is supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/e-grants/) (21658052, 2529069, 16H04922). HO received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph D, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00425, 10.3389/fnhum.2013.00283]; Affenito SG, 2007, J AM DIET ASSOC, V107, P565, DOI 10.1016/j.jada.2007.01.011; [Anonymous], 2005, DIET REF INT EN CARB; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Bi HS, 2015, PUBLIC HEALTH NUTR, V18, P3013, DOI 10.1017/S1368980015000257; Cahill LE, 2013, CIRCULATION, V128, P337, DOI 10.1161/CIRCULATIONAHA.113.001474; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cipriani S, 2010, J LIPID RES, V51, P771, DOI 10.1194/jlr.M001602; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Duez H, 2008, DIABETES VASC DIS RE, V5, P82, DOI 10.3132/dvdr.2008.0014; Esquirol Y, 2009, CHRONOBIOL INT, V26, P544, DOI 10.1080/07420520902821176; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Govindarajan K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167319; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Kang G, 2017, METABOLISM, V77, P13, DOI 10.1016/j.metabol.2017.08.007; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kapantais E, 2011, PUBLIC HEALTH NUTR, V14, P101, DOI 10.1017/S1368980010000765; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747; KNUTSSON A, 1986, LANCET, V2, P89; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lin XT, 2015, SLEEP MED, V16, P1381, DOI 10.1016/j.sleep.2015.02.543; Manoogian ENC, 2017, AGEING RES REV, V39, P59, DOI 10.1016/j.arr.2016.12.006; Marciano DP, 2014, CELL METAB, V19, P193, DOI 10.1016/j.cmet.2013.12.009; McNeely E, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5221-3; Ministry of Health Labour and Welfare, 2016, THE NATIONAL HEALTH; Moran-Ramos S, 2016, NUTR RES REV, V29, P180, DOI 10.1017/S095442241600010X; Morf J, 2013, CELL CYCLE, V12, P539, DOI 10.4161/cc.23670; Nolan CJ, 2008, TRENDS ENDOCRIN MET, V19, P285, DOI 10.1016/j.tem.2008.07.006; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Peek CB, 2012, TRENDS ENDOCRIN MET, V23, P312, DOI 10.1016/j.tem.2012.02.003; Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Salgado-Delgado RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060052; Sato R, 2000, J BIOL CHEM, V275, P12497, DOI 10.1074/jbc.275.17.12497; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563, DOI 10.1093/jnci/93.20.1563; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Smith AP, 1999, PHYSIOL BEHAV, V67, P9, DOI 10.1016/S0031-9384(99)00025-6; Stockman NKA, 2005, PREV MED, V41, P203, DOI 10.1016/j.ypmed.2004.11.001; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Sun SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201261; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wennberg M, 2015, PUBLIC HEALTH NUTR, V18, P122, DOI 10.1017/S1368980013003509; WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255; Wu T, 2011, CHRONOBIOL INT, V28, P890, DOI 10.3109/07420528.2011.622599; Yamajuku D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00439; Yamajuku D, 2009, CIRC RES, V105, P545, DOI 10.1161/CIRCRESAHA.109.199034; Yoshida C, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-78; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	62	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206669	10.1371/journal.pone.0206669	http://dx.doi.org/10.1371/journal.pone.0206669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379940	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700143
J	Acuna-Villaorduna, C; Schmidt-Castellani, LG; Marques-Rodrigues, P; White, LF; Hadad, DJ; Gaeddert, M; Ellner, JJ; Fennelly, KP; Palaci, M; Dietze, R; Jones-Lopez, EC				Acuna-Villaorduna, Carlos; Schmidt-Castellani, Luiz Guilherme; Marques-Rodrigues, Patricia; White, Laura F.; Hadad, David Jamil; Gaeddert, Mary; Ellner, Jerrold J.; Fennelly, Kevin P.; Palaci, Moises; Dietze, Reynaldo; Jones-Lopez, Edward C.			Cough-aerosol cultures of Mycobacterium tuberculosis in the prediction of outcomes after exposure. A household contact study in Brazil	PLOS ONE			English	Article							AIRBORNE TRANSMISSION; PULMONARY TUBERCULOSIS; RESISTANT TUBERCULOSIS; PROSPECTIVE COHORT; SKIN-TEST; INFECTION; VARIABILITY; DIAGNOSIS; DISEASE; BURDEN	Background Mycobacterium tuberculosis cultures of cough-generated aerosols from patients with pulmonary tuberculosis (TB) are a quantitative method to measure infectiousness and to predict secondary outcomes in exposed contacts. However, their reproducibility has not been established. Objective To evaluate the predictive value of colony-forming units (CFU) of M. tuberculosis in cough aerosols on secondary infection and disease in household contacts in Brazil. Methods Adult sputum smear+ and culture+ pulmonary TB cases underwent a standard evaluation and were categorized according to aerosol CFU. We evaluated household contacts for infection at baseline and at 8 weeks with TST and IGRA, and secondary disease. Results We enrolled 48 index TB cases; 40% had negative aerosols, 27% low aerosols (<10 CFU) and 33% high aerosols (>= 10 CFU). Of their 230 contacts, the proportion with a TST >= 10 mm at 8 weeks was 59%, 65% and 75%, respectively (p = 0.34). Contacts of high aerosol cases had greater IGRA readouts (median 4.6 IU/mL, IQR 0.02-10) when compared to those with low (0.8, 0.2-10) or no aerosol (0.1, 0-3.7; p = 0.08). IGRA readouts in TST converters of high aerosol cases (median 20 IU/mL, IQR 10-24) were larger than those from aerosol-negative (0.13, 0.04-3; p = 0.02). 8/9 (89%) culture+secondary TB cases occurred in contacts of aerosol+cases. Conclusion Aerosol CFU predicts quantitatively IGRA readouts among household contacts of smear positive TB cases. Our results strengthen the argument of using cough aerosols to guide targeted preventive treatment strategies, a necessary component of current TB elimination projections.	[Acuna-Villaorduna, Carlos; Gaeddert, Mary; Ellner, Jerrold J.; Jones-Lopez, Edward C.] Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA; [Acuna-Villaorduna, Carlos; Gaeddert, Mary; Ellner, Jerrold J.; Jones-Lopez, Edward C.] Boston Med Ctr, Boston, MA 02118 USA; [Schmidt-Castellani, Luiz Guilherme; Palaci, Moises] Univ Fed Espirito Santo, Mycobacteriol Lab, Nucleo Doencas Infecciosas, Vitoria, Brazil; [Marques-Rodrigues, Patricia; Hadad, David Jamil; Dietze, Reynaldo] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, Brazil; [White, Laura F.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Fennelly, Kevin P.] NHLBI, Pulm Clin Med Sect, Cardiovasc & Pulm Branch, Div Intramural Res,NIH, Bldg 10, Bethesda, MD 20892 USA; [Dietze, Reynaldo] Univ Nova Lisboa, Global Hlth & Trop Med, Inst Higiene & Med Trop, Lisbon, Portugal	Boston University; Boston Medical Center; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Acuna-Villaorduna, C (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA.; Acuna-Villaorduna, C (corresponding author), Boston Med Ctr, Boston, MA 02118 USA.	carlosvillaorduna@hotmail.com		Jones Lopez, Edward/0000-0001-6323-286X; Dietze, Reynaldo/0000-0002-6995-8001	Boston University Integrated Biomedical Pilot Grant Program; National Institute of Allergy and Infectious Diseases at the National Institutes of Health [UO1 AI065663-01, U19AI111276]; Nucleo de Doencas Infecciosas, Universidade Federal do Espirito Santo; Division of Intramural Research of the National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111276] Funding Source: NIH RePORTER	Boston University Integrated Biomedical Pilot Grant Program; National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nucleo de Doencas Infecciosas, Universidade Federal do Espirito Santo; Division of Intramural Research of the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Boston University Integrated Biomedical Pilot Grant Program (to ECJ-L), the National Institute of Allergy and Infectious Diseases at the National Institutes of Health award UO1 AI065663-01 (International Collaboration in Infectious Diseases Research) to JJE, TB research unit network award U19AI111276 to JJE and funds from the Nucleo de Doencas Infecciosas, Universidade Federal do Espirito Santo. Dr. Fennelly was supported by the Division of Intramural Research of the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acuna-Villaorduna C, 2017, EUROPEAN RESP J; Acuna-Villaorduna C, 2016, LANCET INFECT DIS, V16, P770, DOI 10.1016/S1473-3099(16)30075-5; Birring SS, 2008, EUR RESPIR J, V31, P1013, DOI 10.1183/09031936.00057407; Castellanos ME, 2018, INT J TUBERC LUNG D, V22, P1000, DOI 10.5588/ijtld.18.0073; Chandrasekaran P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199360; Collins LF, 2016, ANN INTERN MED, V164, P122, DOI 10.7326/M15-1522; Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834; Dheda K, 2017, LANCET RESP MED, V5, P269, DOI [10.1016/s2213-2600(16)30433-7, 10.1016/S2213-2600(16)30433-7]; do Prado TN, 2011, J BRAS PNEUMOL, V37, P93, DOI 10.1590/S1806-37132011000100014; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Escombe AR, 2007, CLIN INFECT DIS, V44, P1349, DOI 10.1086/515397; Falk A OCJ, 1969, DIAGNOSTIC STANDARDS; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Fennelly KP, 2007, CLIN INFECT DIS, V44, P1358, DOI 10.1086/516617; Fennelly KP, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00313; Fennelly KP, 2012, AM J RESP CRIT CARE, V186, P450, DOI 10.1164/rccm.201203-0444OC; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Jones-Lopez EC, 2016, CLIN INFECT DIS, V63, P10, DOI 10.1093/cid/ciw199; Jones-Lopez EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100984; Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Mandalakas AM, 2012, INT J TUBERC LUNG D, V16, P1033, DOI 10.5588/ijtld.12.0027; Ministerio da Saude. Secretaria de Vigilancia em Saude. Programa Nacional de Controle da Tuberculose, 2010, MAN REC CONTR TUB; Organization. WH, 1998, WHOTB98258; Palaci M, 2013, INT J TUBERC LUNG D, V17, P782, DOI 10.5588/ijtld.12.0500; Patterson Benjamin, 2017, Gates Open Res, V1, P11, DOI 10.12688/gatesopenres.12758.2; Raj AA, 2007, PULM PHARMACOL THER, V20, P334, DOI 10.1016/j.pupt.2006.10.002; RILEY RL, 1962, AM REV RESPIR DIS, V85, P511; Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051; Saini D, 2012, TUBERCULOSIS, V92, P160, DOI 10.1016/j.tube.2011.11.007; Saunders MJ, 2017, LANCET INFECT DIS, V17, P1190, DOI 10.1016/S1473-3099(17)30447-4; van Geuns H A, 1975, Bull Int Union Tuberc, V50, P107; Yates TA, 2016, LANCET INFECT DIS, V16, P227, DOI 10.1016/S1473-3099(15)00499-5; Yuen CM, 2015, LANCET, V386, P2334, DOI 10.1016/S0140-6736(15)00322-0; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1	35	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206384	10.1371/journal.pone.0206384	http://dx.doi.org/10.1371/journal.pone.0206384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372480	Green Published, Green Submitted, gold			2022-12-26	WOS:000448641200035
J	Huang, HH; Wang, YC; Chou, YC; Yu, MH; Chao, TK				Huang, Hsin-Hui; Wang, Yu-Chi; Chou, Yu-Ching; Yu, Mu-Hsien; Chao, Tai-Kuang			The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer	PLOS ONE			English	Article							STEM-CELL MARKERS; EXPRESSION; RESISTANCE; IDENTIFICATION; POPULATION; PREDICTOR; CA125; CD133	Aldehyde dehydrogenase 1 (ALDH1) and CD44 have been established as biomarkers for predicting the survival of many types of cancer patients. This study evaluated the expression and clinical significance of these putative cancer-cell markers in a series of tumor samples from endometrial cancer (EC) patients using tissue microarray. We examined 245 endometrial samples, including 132 (53.87%) pre-malignancy lesions and 113 (46.12%) malignant endometrial lesions from biopsies or hysterectomies. We examined the expression of CD44 and ALDH1 in these samples using immunohistochemistry staining. Correlations in the relative expression of these markers with clinicopathological parameters were also assessed. A high level of expression of ALDH1 was found in 44.25% (50/113) of the endometrial cancer samples, which was significantly correlated with a poor overall survival rate (p = 0.035). High-level CD44 expression was found in 35.4% (40/113) of the cases and was also correlated with a poor overall survival rate (p = 0.035). A simultaneous high expression of both markers was correlated with an extremely poor overall survival (p = 0.013). Our results show that tumors with higher expressions of both ALDH1 and CD44 were related to a poorer overall survival rate among EC patients. The combination of ALDH1 and CD44 could be a promising marker for developing additional targeted therapy for severe endometrial cancers.	[Huang, Hsin-Hui; Wang, Yu-Chi; Yu, Mu-Hsien] Natl Def Med Ctr, Triserv Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chao, Tai-Kuang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Pathol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Chao, TK (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Pathol, Taipei, Taiwan.	chaotai.kuang@msa.hinet.net			Tri-Service General Hospital [TSGH-C105-072, TSGH-C106-059, TSGH-C107-058, ATSGH-C107-058]	Tri-Service General Hospital	This study was supported by grants from the Tri-Service General Hospital (TSGH-C105-072, TSGH-C106-059, TSGH-C107-058, ATSGH-C107-058).	Abdalla N, 2016, WSPOLCZESNA ONKOL, V20, P463, DOI 10.5114/wo.2016.65606; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Balicki D, 2007, CELL STEM CELL, V1, P485, DOI 10.1016/j.stem.2007.10.015; Basakran NS, 2015, SAUDI MED J, V36, P273, DOI 10.15537/smj.2015.3.9622; Bednarz-Knoll N, 2015, ONCOTARGET, V6, P26789, DOI 10.18632/oncotarget.4628; BEHZAD F, 1994, BIOL REPROD, V51, P739, DOI 10.1095/biolreprod51.4.739; Black WJ, 2009, PHARMACOGENET GENOM, V19, P893, DOI 10.1097/FPC.0b013e3283329023; Burke W. M., 2014, GYNECOL ONCOL, V134, P385, DOI DOI 10.1016/J.YGYN0.2014.05.018; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Elbasateeny SS, 2016, PATHOL RES PRACT, V212, P10, DOI 10.1016/j.prp.2015.10.008; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hidalgo A, 2003, J CLIN PATHOL, V56, P144, DOI 10.1136/jcp.56.2.144; Huang RX, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1513-5; Januchowski R, 2013, BIOMED PHARMACOTHER, V67, P669, DOI 10.1016/j.biopha.2013.04.005; Jiang T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1260-7; Klaric M, 2019, APPL IMMUNOHISTO M M, V27, P606, DOI 10.1097/PAI.0000000000000673; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Lingala S, 2010, EXP MOL PATHOL, V89, P27, DOI 10.1016/j.yexmp.2010.05.005; Liu DY, 2012, J CLIN NEUROSCI, V19, P1700, DOI 10.1016/j.jocn.2012.01.036; Lugli A, 2010, BRIT J CANCER, V103, P382, DOI 10.1038/sj.bjc.6605762; Moreb J, 1996, CANCER GENE THER, V3, P24; Purdie DM, 2001, BEST PRACT RES CL OB, V15, P341, DOI 10.1053/beog.2000.0180; Rahadiani N, 2011, CANCER SCI, V102, P903, DOI 10.1111/j.1349-7006.2011.01864.x; Rao QX, 2012, ASIAN PAC J CANCER P, V13, P1325, DOI 10.7314/APJCP.2012.13.4.1325; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Su Y, 2010, CANCER EPIDEM BIOMAR, V19, P327, DOI 10.1158/1055-9965.EPI-09-0865; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Wang L, 2018, METHODS MOL BIOL, V1692, P31, DOI 10.1007/978-1-4939-7401-6_3; Wang YM, 2017, INT J GYNECOL OBSTET, V136, P58, DOI 10.1002/ijgo.12010; Wang YC, 2012, AM J PATHOL, V180, P1159, DOI 10.1016/j.ajpath.2011.11.015	33	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206685	10.1371/journal.pone.0206685	http://dx.doi.org/10.1371/journal.pone.0206685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372483	Green Published, Green Submitted, gold			2022-12-26	WOS:000448641200055
J	Hanif, Q; Farooq, M; Amin, I; Mansoor, S; Zhang, Y; Khan, QM				Hanif, Quratulain; Farooq, Muhammad; Amin, Imran; Mansoor, Shahid; Zhang, Yi; Khan, Qaiser Mahmood			In silico identification of conserved miRNAs and their selective target gene prediction in indicine (Bos indicus) cattle	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED MICRORNAS; COMPUTATIONAL IDENTIFICATION; BIOINFORMATICS ANALYSIS; HOLSTEIN CATTLE; HEAT; STRESS; BIOGENESIS; DIVERSITY; EVOLUTION; SEQUENCE	The modern cattle was domesticated from aurochs, sharing its physiological traits into two subspecies Bos taurus and Bos indicus. MicroRNAs (miRNAs) are a class of non-coding short RNAs of similar to 22nt which have a key role in the regulation of many cellular and physiological processes in the animal. The current study was aimed to predict and annotate the potential mutations in indicine miRNAs throughout the genome using de novo and homology-based in silico approaches. Genome-wide mapping was performed in available indicine assembly by the homology-based approach and 768 miRNAs were recovered out of 808 reported taurine miRNAs belonging to 521 unique mature miRNA families. While 42 precursors were dropped due to lack of secondary miRNA structure, increasing stringency or decreasing similarity between the two genomes' miRNA. Increasing tendency of miRNAs incidence was observed on chr5, chr7, chr8, chr12 and chr21 with 19 polycistronic miRNA within 1-kilobase distance throughout the indicine genome. Notably, 12 miRNAs showed copy number variation. Eighteen miRNAs showed a mutation in their mature sequences in which eight were found in their seed region. Whilst in de novo based approach, 12 novel potential miRNAs on Y chromosome in indicine cattle along with a new miRNA (bind-miR-1264) on chrX were found. The final data set is annotated and explains the impending target genes that are responsible for enhanced immunity, heat tolerance and disease tolerance regulation in indicine. The study conforms to better understanding and perceptive approach towards indicine genome.	[Hanif, Quratulain; Zhang, Yi] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Minist Agr,Key Lab Anim Genet & Breeding & Reprod, Beijing, Peoples R China; [Hanif, Quratulain; Farooq, Muhammad; Amin, Imran; Mansoor, Shahid] NIBGE, Bioinformat & Computat Biol Lab, Faisalabad, Pakistan; [Hanif, Quratulain] Pakistan Inst Engn & Appl Sci, Islamabad, Pakistan; [Khan, Qaiser Mahmood] NIBGE, Environm Toxicol Lab, Faisalabad, Pakistan	China Agricultural University; Ministry of Agriculture & Rural Affairs; Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science	Zhang, Y (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Minist Agr,Key Lab Anim Genet & Breeding & Reprod, Beijing, Peoples R China.; Khan, QM (corresponding author), NIBGE, Environm Toxicol Lab, Faisalabad, Pakistan.	yizhang@cau.edu.cn; qk_5@yahoo.com		Farooq, Muhammad/0000-0003-0704-3372; Mansoor, Shahid/0000-0001-7418-1826	National Institute for Biotechnology and Genetic Engineering (NIBGE); Program for Changjiang Scholars and Innovative Research in University [IRT1191]; ICARDA project [1198]	National Institute for Biotechnology and Genetic Engineering (NIBGE); Program for Changjiang Scholars and Innovative Research in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); ICARDA project	The current study was supported by an agricultural project, ICARDA project #1198 and initiated by National Institute for Biotechnology and Genetic Engineering (NIBGE). Yi Zhang was supported by the Program for Changjiang Scholars and Innovative Research in University (IRT1191).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; [Anonymous], 2005, PLOS COMPUT BIOL, V1, pe13; [Anonymous], 2009, PROTEIN NETWORKS PAT, P123; Bahbahani H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11729; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bitetti A, 2018, NAT STRUCT MOL BIOL, V25, P244, DOI 10.1038/s41594-018-0032-x; Braud M, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00003; Canavez FC, 2012, J HERED; Chaves-Olarte E, 2002, CELL MICROBIOL, V4, P663, DOI 10.1046/j.1462-5822.2002.00221.x; Cui M, 2014, BIOCHEM BIOPH RES CO, V444, P270, DOI 10.1016/j.bbrc.2014.01.051; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Das K, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00079; Devi Karam Jayanandi, 2018, Indian Journal of Plant Physiology, V23, P179, DOI 10.1007/s40502-018-0353-0; Elsik CG, 2015, NUCLEIC ACIDS RES; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hou L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193371; Hu Y, 2020, CONTEMP SOC SCI, V15, P360, DOI 10.1080/21582041.2018.1448941; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Hussain K, 2018, GENE, V653, P57, DOI 10.1016/j.gene.2018.02.017; Islam MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058902; Ji K, 2018, GENE; Keel BN, 2017, ANIM GENET, V48, P141, DOI 10.1111/age.12519; Khan MS, 2008, PAK VET J, V28, P95; Krishnan Remya, 2015, Syst Synth Biol, V9, P11, DOI 10.1007/s11693-014-9159-1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lan W, 2018, METHODS MOL BIOL, V1754, P205, DOI 10.1007/978-1-4939-7717-8_12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawless N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00611; Li AL, 2007, CELL RES, V17, P212, DOI 10.1038/sj.cr.7310113; Li ZX, 2014, ANIM GENET, V45, P20, DOI 10.1111/age.12096; Liu YX, 2010, GENET MOL RES, V9, P891, DOI 10.4238/vol9-2gmr769; Liu YX, 2011, AGR SCI CHINA, V10, P1336, DOI 10.1016/S1671-2927(11)60126-0; Lukaszewicz A, 2015, ANIM BIOTECHNOL, V26, P276, DOI 10.1080/10495398.2015.1014491; Mahjoub N, 2015, J VIROL, V89, P428, DOI 10.1128/JVI.02181-14; Malas T.B., 2012, OPEN BIOL J, V5, P23, DOI [10.2174/1874196701205010023, DOI 10.2174/1874196701205010023]; Manku HK, 2017, COMPUT BIOL CHEM, V70, P96, DOI 10.1016/j.compbiolchem.2017.08.005; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Naeem A, 2012, J DAIRY SCI, V95, P6397, DOI 10.3168/jds.2011-5173; Nayee N, 2018, J ANIMAL BREEDING GE; Norden GA, 2018, J ANIM SCI, V96, P253; Pande HO, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0410-3; Park SM, 2008, CYTOKINE GROWTH F R, V19, P303, DOI 10.1016/j.cytogfr.2008.04.011; Pitt D, 2018, EVOLUTIONARY APPL; Place RF, 2014, CELL STRESS CHAPERON, V19, P159, DOI 10.1007/s12192-013-0456-5; Pryce JE, 2018, J DAIRY SCI, V101, P3702, DOI 10.3168/jds.2017-13377; Qiao Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-544; Qibin L., 2008, MIREAP MICRORNA DISC; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reyes-Herrera PH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-454; Sahoo S, 2018, GENE REP, V11, P213, DOI 10.1016/j.genrep.2018.03.020; Samad AFA, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1164-8; Sartori R, 2011, REPROD DOMESTIC RUMI, VVII, P357; Sasazaki S, 2010, ANIM SCI J; Sengar GS, 2018, CELL STRESS CHAPERON, P1, DOI [10.1007/s12192-017-0806-9, DOI 10.1007/S12192-017-0806-9]; Sengar GS, 2018, CELL STRESS CHAPERON, V23, P155, DOI 10.1007/s12192-017-0833-6; Shukla V, 2017, BRIEF FUNCT GENOMICS, V16, P249, DOI 10.1093/bfgp/elw042; Silva CF, 2013, THERIOGENOLOGY, V79, P351, DOI 10.1016/j.theriogenology.2012.10.003; Singh J, 2008, INSECT MOL BIOL, V17, P427, DOI 10.1111/j.1365-2583.2008.00816.x; Syed MA, 2010, AM J RESP CRIT CARE, V181; Szweykowska-Kulinska Z, 2018, MOL PLANT, V11, P1006, DOI 10.1016/j.molp.2018.06.010; Vejnar CE, 2012, NUCLEIC ACIDS RES, V40, P11673, DOI 10.1093/nar/gks901; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang F, 2015, CURR OPIN PLANT BIOL, V27, P118, DOI 10.1016/j.pbi.2015.06.012; Wang H, 2018, REPROD DOMESTIC ANIM; Wang HY, 2015, GENE, V559, P119, DOI 10.1016/j.gene.2015.01.021; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang ZM, 2012, MOL PLANT, V5, P889, DOI 10.1093/mp/ssr094; Wu XM, 2014, CENT EUR J BIOL, V9, P841, DOI 10.2478/s11535-014-0308-z; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Yang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039015; Yin ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035765; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zheng CY, 2018, THAI J VET MED, V48, P37; Zheng Y, 2014, CELL STRESS CHAPERON, V19, P973, DOI 10.1007/s12192-014-0521-8; Zhou R, 2011, CELL MOL IMMUNOL, V8, P371, DOI 10.1038/cmi.2011.19; Zorc Minja, 2015, J Genomics, V3, P51, DOI 10.7150/jgen.11246; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	85	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206154	10.1371/journal.pone.0206154	http://dx.doi.org/10.1371/journal.pone.0206154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365525	Green Published, gold, Green Submitted			2022-12-26	WOS:000448448700028
J	Huetter, FK; Horn, PA; Siffert, W				Huetter, Franz Korbinian; Horn, Peter Alexander; Siffert, Winfried			Sex-specific association of a common GNAS polymorphism with self-reported cognitive empathy in healthy volunteers	PLOS ONE			English	Article							T393C POLYMORPHISM; OXYTOCIN RECEPTOR; NERVOUS-SYSTEM; GENE VARIANT; VASOPRESSIN; HYPERTENSION; GENOTYPE; OXTR; SCHIZOPHRENIA; DISORDER	Background In a recent study, we found associations of a common oxytocin receptor (OXTR) polymorphism with inter-individual differences in empathy, especially with emotional empathy in women. Many other studies found specific associations of oxytocin, arginine-vasopressin, serotonin and dopamine receptor gene polymorphisms with various aspects of trait empathy. As all these receptors belong to the guanine-binding protein (G protein) coupled receptor family, it is a reasonable assumption, that alterations in genes encoding G protein subunits also influence the signal transduction in empathy related circuits. However, to the best of our knowledge, these genomic variations have not yet been studied in genetic research on empathy. Methods Here, we analysed associations of a common polymorphism of the GNAS gene (C393T) in a previously characterized sample of 421 healthy blood donors (231 M, 190 F; age 18-74). The GNAS gene encodes the G protein adenylyl cyclase stimulator (G alpha s) G protein subunit, which activates cyclic adenosine monophosphate (cAMP)-dependent pathways by stimulating the adenylyl cyclase. Cognitive and emotional aspects of dispositional empathy were tested using Davis' Interpersonal Reactivity Index (IRI). Results In the complete sample, associations of C393T genotype with IRI empathy scores, including cognitive empathy (p = 0.055) and perspective taking (p = 0.057) scores did not reach a level of significance. None of the IRI scores was near to being significantly associated with C393T genotype for men alone. In females, however, genotype was significantly associated with cognitive empathy (r = -.204, p = 0.005) and perspective taking (r = -.209, p = 0.004), accounting for 4.2% and 4.4% of variability. The association of genotype with perspective taking remained significant after adjustment for multiple comparisons (p = 0.045). The A 393C-allele, which had been identified as a risk factor in several medical conditions such as hypertension, obesity and diabetes, was associated with higher cognitive empathy compared to the T allele in our sample. Conclusions The results suggest a significant association of GNAS C393T genotypes with the cognitive empathic capacity of perspective taking. This association could only be found in female participants.	[Huetter, Franz Korbinian; Siffert, Winfried] Univ Duisburg Essen, Inst Pharmakogenet, Univ Klinikum Essen, Essen, Germany; [Horn, Peter Alexander] Univ Duisburg Essen, Inst Transfus Med, Univ Klinikum Essen, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Huetter, FK (corresponding author), Univ Duisburg Essen, Inst Pharmakogenet, Univ Klinikum Essen, Essen, Germany.	franz.huetter@uk-essen.de	Huetter, Franz/AAA-6497-2022	Huetter, Franz/0000-0002-3333-4571				Abe M, 2002, HYPERTENSION, V40, P261, DOI 10.1161/01.HYP.0000028490.77489.0C; Adelstein JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027633; Bachmann HS, 2008, J ORTHOP RES, V26, P1562, DOI 10.1002/jor.20699; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Bakermans-Kranenburg MJ, 2006, DEV PSYCHOBIOL, V48, P406, DOI 10.1002/dev.20152; Bakermans-Kranenburg MJ, 2014, PSYCHIAT GENET, V24, P45, DOI 10.1097/YPG.0b013e3283643684; Banissy MJ, 2012, NEUROIMAGE, V62, P2034, DOI 10.1016/j.neuroimage.2012.05.081; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bem S.L., 1981, BEM SEX ROLE INVENTO; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bora E, 2016, SCHIZOPHR RES, V176, P500, DOI 10.1016/j.schres.2016.06.007; Bradley B, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.21659; Brune M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-38; Chang SC, 2014, PSYCHONEUROENDOCRINO, V39, P257, DOI 10.1016/j.psyneuen.2013.09.024; Choi D, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-4; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; Cuff BMP, 2016, EMOT REV, V8, P144, DOI 10.1177/1754073914558466; Cusi AM, 2011, PSYCHIAT RES, V188, P231, DOI 10.1016/j.psychres.2011.04.013; Dannlowski U, 2016, BIOL PSYCHIAT, V80, P398, DOI 10.1016/j.biopsych.2015.12.010; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Davis MH, 1980, JSAS CATALOG SELECTE, V10, P10; de Vries GJ, 2008, PROG BRAIN RES, V170, P17, DOI 10.1016/S0079-6123(08)00402-0; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Flandre P, 2005, ANTIVIR THER, V10, P479; Frey UH, 2005, CANCER EPIDEM BIOMAR, V14, P871, DOI 10.1158/1055-9965.EPI-04-0720; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gong HY, 2014, WORLD J GASTRO ONCOL, V6, P444, DOI 10.4251/wjgo.v6.i12.444; Haas BW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00801; Hahn S, 2006, EUR J ENDOCRINOL, V155, P763, DOI 10.1530/eje.1.02275; Huetter FK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160059; Jia HY, 1999, HYPERTENSION, V34, P8, DOI 10.1161/01.HYP.34.1.8; Keysers C, 2014, UNSER EMPATHISCHES G; Kim HS, 2010, P NATL ACAD SCI USA, V107, P15717, DOI 10.1073/pnas.1010830107; Klenke S, 2011, PHARMACOGENOMICS, V12, P633, DOI [10.2217/PGS.10.203, 10.2217/pgs.10.203]; Knafo A, 2008, EMOTION, V8, P737, DOI 10.1037/a0014179; Li JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131820; LitvackMiller W, 1997, GENET SOC GEN PSYCH, V123, P303; MacDonald KS, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00194; McGrath RE, 2006, PSYCHOL METHODS, V11, P386, DOI 10.1037/1082-989X.11.4.386; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Minoretti P, 2006, NEUROSCI LETT, V397, P159, DOI 10.1016/j.neulet.2005.12.028; Motomura Y, 2015, J PHYSIOL ANTHROPOL, V34, DOI 10.1186/s40101-015-0053-7; Nazarewicz J, 2015, PSYCHOPHYSIOLOGY, V52, P1529, DOI 10.1111/psyp.12516; Oterino A, 2007, CEPHALALGIA, V27, P429, DOI 10.1111/j.1468-2982.2007.01305.x; Paulus C, 2009, PSYCHOMETRISCHE EVAL, P1; Rameson LT, 2012, J COGNITIVE NEUROSCI, V24, P235, DOI 10.1162/jocn_a_00130; Raz G, 2014, SOC COGN AFFECT NEUR, V9, P30, DOI 10.1093/scan/nst052; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; Rubin LH, 2017, J NEUROSCI RES, V95, P576, DOI 10.1002/jnr.23820; Sarlo M, 2014, PHYSIOL BEHAV, V130, P127, DOI 10.1016/j.physbeh.2014.04.002; Sauer C, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00045; Sauer C, 2012, NEUROPSYCHOPHARMACOL, V37, P1474, DOI 10.1038/npp.2011.333; Seidel EM, 2013, PSYCHIAT RES, V210, P1168, DOI 10.1016/j.psychres.2013.08.027; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGY, V21, P431, DOI 10.1037/0894-4105.21.4.431; Stankova T, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-17; Uzefovsky F, 2015, HORM BEHAV, V67, P60, DOI 10.1016/j.yhbeh.2014.11.007; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009; Yamamoto M, 2004, HYPERTENS RES, V27, P919, DOI 10.1291/hypres.27.919; Yasuda K, 2004, CLIN EXP PHARMACOL P, V31, P597, DOI 10.1111/j.1440-1681.2004.04059.x; Zak PJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00211	61	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206114	10.1371/journal.pone.0206114	http://dx.doi.org/10.1371/journal.pone.0206114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3KA	30365517	Green Submitted, gold, Green Published			2022-12-26	WOS:000448448700026
J	Richaud, M; Galas, S				Richaud, Myriam; Galas, Simon			Defining the viability of tardigrades with a molecular sensor related to death	PLOS ONE			English	Article							FLOW-CYTOMETRIC ANALYSIS; CYTOCHROME-C-OXIDASE; HYPSIBIUS-DUJARDINI; RICHTERSIUS-CORONIFER; RADIATION TOLERANCE; BOVINE HEART; STAIN; DYE	The design of experimental protocols that use animal models to assess the impact of a stress on a population or to determine the life span expectancy impact can be time-consuming due to the need for direct observations of dead and living animals. These experiments are usually based on the detectable activity of animals such as food intake or mobility and can sometimes produce either under- or overestimated results. The tardigrade Hypsibius exemplaris is an emerging model for the evolutionary biology of the tardigrade phylum because of its convenient laboratory breeding and the recent introduction of new molecular tools. In this report, we describe the use of a new fluorescent dye that can specifically stain dead tardigrades. Furthermore, we also monitored the absence of a toxic side effect of the death-linked fluorescent dye on tardigrade populations. Finally, we conclude that tardigrade experiments that require survival counting of the Hypsibius exemplaris species can be greatly improved by using this technique in order to limit underestimation of alive animals.	[Richaud, Myriam; Galas, Simon] Univ Montpellier, ENSCM, CNRS, IBMM, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Galas, S (corresponding author), Univ Montpellier, ENSCM, CNRS, IBMM, Montpellier, France.	simon.galas@umontpellier.fr	Richaud, Myriam/N-3469-2019; Galas, Simon/X-1312-2019	Richaud, Myriam/0000-0002-7720-8569; Galas, Simon/0000-0002-1717-1266	CNRS Defi Origins 2018 funding program [265880 - Giga18]	CNRS Defi Origins 2018 funding program	This work was supported by CNRS Defi Origins 2018 funding program - Grant number : 265880 - Giga18 (http://www.cnrs.fr/mi/spip.php?article1345).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiero T, 2011, J ZOOL SYST EVOL RES, V49, P104, DOI 10.1111/j.1439-0469.2010.00607.x; Arakawa K, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.63; Beltran-Pardo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133658; Beltran-Pardo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072098; Boothby TC, 2017, MOL CELL, V65, P975, DOI 10.1016/j.molcel.2017.02.018; Boothby TC, 2016, P NATL ACAD SCI USA, V113, pE5364, DOI 10.1073/pnas.1613046113; Boothby TC, 2015, P NATL ACAD SCI USA, V112, P15976, DOI 10.1073/pnas.1510461112; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; Chiaraviglio L, 2014, ASSAY DRUG DEV TECHN, V12, P219, DOI 10.1089/adt.2014.577; Degma P, 2016, ACTUAL CHECKLIST TAR, P41; Degma P, 2007, ZOOTAXA, P41, DOI 10.11646/zootaxa.1579.1.2; Erdmann W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183380; Fei MJ, 2000, ACTA CRYSTALLOGR D, V56, P529, DOI 10.1107/S0907444900002213; Ferreira SR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/879263; Gabriel WN, 2007, DEV BIOL, V312, P545, DOI 10.1016/j.ydbio.2007.09.055; Gaforio JJ, 2002, CYTOMETRY, V48, P93, DOI 10.1002/cyto.10107; Gasiorek P, 2018, ZOOTAXA, V4415, P45, DOI 10.11646/zootaxa.4415.1.2; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Guidetti R, 2005, ZOOTAXA, P1, DOI 10.11646/zootaxa.845.1.1; Guidetti R, 2011, J INSECT PHYSIOL, V57, P567, DOI 10.1016/j.jinsphys.2011.03.003; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; Horikawa DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064793; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2005, INT J RADIAT BIOL, V81, P649, DOI 10.1080/09553000500368453; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; Kinchin IM., 1994, BIOL TARDIGRADES; Koutsovoulos G, 2016, P NATL ACAD SCI USA, V113, P5053, DOI 10.1073/pnas.1600338113; Lebaron P, 1998, APPL ENVIRON MICROB, V64, P2697; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; Molecular Probes, MP07020 MOL PROB; Ono F, 2012, J PHYS CONF SER, V377, DOI 10.1088/1742-6596/377/1/012053; Ramlov H, 2001, ZOOL ANZ, V240, P517, DOI 10.1078/0044-5231-00062; Rebecchi L, 2007, ISJ-INVERT SURVIV J, V4, P65; Rychtecky P, 2014, HYDROBIOLOGIA, V740, P177, DOI 10.1007/s10750-014-1952-z; Tenlen JR, 2013, DEV GENES EVOL, V223, P171, DOI 10.1007/s00427-012-0432-6; Welnicz W, 2011, J INSECT PHYSIOL, V57, P577, DOI 10.1016/j.jinsphys.2011.03.019; Wlodkowic D, 2011, METHODS MOL BIOL, V731, P285, DOI 10.1007/978-1-61779-080-5_23; Yoshida Y, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002266; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	40	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206444	10.1371/journal.pone.0206444	http://dx.doi.org/10.1371/journal.pone.0206444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365540	Green Published, Green Submitted, gold			2022-12-26	WOS:000448448700054
J	Tan, WH; Reyes, ML; Hoang, KL; Acevedo, T; Leon, F; Barbosa, JD; Gerardo, NM				Tan, Wen-Hao; Reyes, Miguel L.; Hoang, Kim L.; Acevedo, Tarik; Leon, Fredrick; Barbosa, Joshua D.; Gerardo, Nicole M.			How symbiosis and ecological context influence the variable expression of transgenerational wing induction upon fungal infection of aphids	PLOS ONE			English	Article							PEA APHID; ACYRTHOSIPHON-PISUM; PATHOGENS; STRESS; ENDOSYMBIONTS; RESISTANCE; BEHAVIOR; DEFENSE; COSTS; GENE	Aphids, like most animals, mount a diverse set of defenses against pathogens. For aphids, two of the best studied defenses are symbiont-conferred protection and transgenerational wing induction. Aphids can harbor bacterial symbionts that provide protection against pathogens, parasitoids and predators, as well as against other environmental stressors. In response to signals of danger, aphids also protect not themselves but their offspring by producing more winged than unwinged offspring as a way to ensure that their progeny may be able to escape deteriorating conditions. Such transgenerational wing induction has been studied most commonly as a response to overcrowding of host plants and presence of predators, but recent evidence suggests that pea aphids (Acyrthosiphon pisum) may also begin to produce a greater proportion of winged offspring when infected with fungal pathogens. Here, we explore this phenomenon further by asking how protective symbionts, pathogen dosage and environmental conditions influence this response. Overall, while we find some evidence that protective symbionts can modulate transgenerational wing induction in response to fungal pathogens, we observe that transgenerational wing induction in response to fungal infection is highly variable. That variability cannot be explained entirely by symbiont association, by pathogen load or by environmental stress, leaving the possibility that a complex interplay of genotypic and environmental factors may together influence this trait.	[Tan, Wen-Hao; Reyes, Miguel L.; Hoang, Kim L.; Acevedo, Tarik; Leon, Fredrick; Barbosa, Joshua D.; Gerardo, Nicole M.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Reyes, Miguel L.] Clayton State Univ, Dept Biol, Morrow, GA USA; [Acevedo, Tarik] Penn State Univ, Dept Ecosyst Sci & Management, State Coll, PA USA	Emory University; University System of Georgia; Clayton State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Gerardo, NM (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	ngerard@emory.edu	Hoang, Kim/HHN-0540-2022	Hoang, Kim/0000-0001-5269-1630	National Science Foundation [IOS-1149829]; National Institutes of Health/National Institute of General Medical Sciences Institutional Research and Academic Career Development Award [5K12-GM000680-17]; NSF Graduate Research Fellowship Program [DGE-1444932]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Institute of General Medical Sciences Institutional Research and Academic Career Development Award; NSF Graduate Research Fellowship Program(National Science Foundation (NSF))	This work was supported in part by National Science Foundation (https://www.nsf.gov/div/index.jsp? div= IOS) grant IOS-1149829 to NMG. MLR was supported by National Institutes of Health/National Institute of General Medical Sciences Institutional Research and Academic Career Development Award (https://www.nigms.nih.gov/Training/CareerDev/Pages/TWDInstRes.aspx)(5K12-GM000680-17), and KH was supported by an NSF Graduate Research Fellowship Program (https://www.nsfgrfp.org/) (DGE-1444932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 1999, P NATL ACAD SCI USA, V96, P14795, DOI 10.1073/pnas.96.26.14795; Alaux Cedric, 2010, Biol Lett, V6, P562, DOI 10.1098/rsbl.2009.0986; [Anonymous], 2017, R LANG ENV STAT COMP, V55, P275; Brisson JA, 2006, BIOESSAYS, V28, P747, DOI 10.1002/bies.20436; Caillaud MC, 2002, HEREDITY, V89, P346, DOI 10.1038/sj.hdy.6800146; Echaubard P, 2014, EVOL APPL, V7, P723, DOI 10.1111/eva.12169; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; Hatano E, 2012, ECOL ENTOMOL, V37, P75, DOI 10.1111/j.1365-2311.2011.01336.x; Henry LM, 2013, CURR BIOL, V23, P1713, DOI 10.1016/j.cub.2013.07.029; Kunert G, 2005, ECOL LETT, V8, P596, DOI 10.1111/j.1461-0248.2005.00754.x; LEES AD, 1967, J INSECT PHYSIOL, V13, P289, DOI 10.1016/0022-1910(67)90155-2; Lees AD, 1966, ADV INSECT PHYSL, V3, P207, DOI [DOI 10.1016/S0065-2806(08)60188-5, 10.1016/S0065-2806(08)60188-5]; Lefevre T, 2010, ECOL LETT, V13, P1485, DOI 10.1111/j.1461-0248.2010.01537.x; Leonardo TE, 2006, P ROY SOC B-BIOL SCI, V273, P1079, DOI 10.1098/rspb.2005.3408; LOCHMILLER RL, 1993, AUK, V110, P503, DOI 10.2307/4088414; Lukasik P, 2013, OECOLOGIA, V173, P985, DOI 10.1007/s00442-013-2660-5; McVean RIK, 2001, ECOL ENTOMOL, V26, P440, DOI 10.1046/j.1365-2311.2001.00341.x; Muller CB, 2001, ECOL ENTOMOL, V26, P330, DOI 10.1046/j.1365-2311.2001.00321.x; Nelson EH, 2007, OECOLOGIA, V151, P22, DOI 10.1007/s00442-006-0573-2; Ogawa K, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00001; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Papierok Bernard, 1997, P187, DOI 10.1016/B978-012432555-5/50012-9; Parker BJ, 2017, EVOLUTION, V71, P1222, DOI 10.1111/evo.13216; Parker BJ, 2014, EVOLUTION, V68, P2421, DOI 10.1111/evo.12418; Parker BJ, 2013, APPL ENVIRON MICROB, V79, P2455, DOI 10.1128/AEM.03193-12; Parker BJ, 2011, TRENDS ECOL EVOL, V26, P242, DOI 10.1016/j.tree.2011.02.005; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; Sandland GJ, 2003, TRENDS PARASITOL, V19, P571, DOI 10.1016/j.pt.2003.10.006; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Shankar AH, 1999, LANCET, V354, P203, DOI 10.1016/S0140-6736(98)08293-2; Tabadkani SM, 2013, PHYSIOL BEHAV, V110, P221, DOI 10.1016/j.physbeh.2012.12.004; Tariq M, 2012, AGR FOREST ENTOMOL, V14, P177, DOI 10.1111/j.1461-9563.2011.00557.x; Tetard-Jones C, 2007, AM NAT, V170, P492, DOI 10.1086/520115; Therneau T., 2015, PACKAGE SURVIVAL ANA; Tsuchida T, 2006, APPL ENTOMOL ZOOL, V41, P129, DOI 10.1303/aez.2006.129; Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x; Vellichirammal NN, 2017, P NATL ACAD SCI USA, V114, P1419, DOI 10.1073/pnas.1617640114; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642	40	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0201865	10.1371/journal.pone.0201865	http://dx.doi.org/10.1371/journal.pone.0201865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365488	Green Submitted, gold, Green Published			2022-12-26	WOS:000448448700002
J	Heymans, R; Vila, A; van Heerwaarden, CAM; Jansen, CCC; Castelijn, GAA; van der Voort, M; Biesta-Peters, EG				Heymans, Raymond; Vila, Amir; van Heerwaarden, Caroliene A. M.; Jansen, Claudia C. C.; Castelijn, Greetje A. A.; van der Voort, Menno; Biesta-Peters, Elisabeth G.			Rapid detection and differentiation of Salmonella species, Salmonella Typhimurium and Salmonella Enteritidis by multiplex quantitative PCR	PLOS ONE			English	Article							REAL-TIME PCR; ENTERICA SEROVAR TYPHIMURIUM; GLOBAL BURDEN; SPP.; ASSAY	A multiplex quantitative PCR (qPCR) was developed and evaluated for the simultaneous detection of Salmonella spp., S. enterica serovar Typhimurium and S. enterica serovar Enteritidis in various (food) matrices. Early and fast detection of these pathogens facilitates effective intervention and prevents further distribution of contaminated food products on the market. Three primer and probe sets were designed to target the invA gene, the STM4200 gene, and the SEN1392 gene to detect and differentiate Salmonella spp., S. Typhimurium, and S. Enteritidis, respectively. The multiplex qPCR targeting these three genes was optimized for efficiency and linearity. By testing 225 Salmonella isolates and 34 non-Salmonella isolates from various sources the inclusivity and exclusivity were determined. The inclusivity of the multiplex qPCR was 100% for all Salmonella isolates, including 72 S. Typhimurium isolates, and 53 S. Enteritidis isolates. The exclusivity for Salmonella spp., S. Typhimurium, and S. Enteritidis was 100%, 94.6%, and 100%, respectively. No positive results were reported for non-Salmonella isolates. The limit of detection (LOD) for the qPCR was determined for the matrices poultry, minced meat, egg, herbs/spices, powdered milk, fish, animal feed, bootsocks with chicken feces and chicken down. LOD values for qPCR and the conventional culture methods were similar, except for the matrix boot-socks and down, for which the LOD for the conventional culture methods performed better than the qPCR method. In conclusion, the multiplex qPCR assay developed allows for rapid screening of Salmonella spp., S. Typhimurium, and S. Enteritidis in various (food) matrices.	[Heymans, Raymond; Vila, Amir; van Heerwaarden, Caroliene A. M.; Jansen, Claudia C. C.; Castelijn, Greetje A. A.; van der Voort, Menno; Biesta-Peters, Elisabeth G.] Netherlands Food & Consumer Prod Safety Author, Labs Div, Lab Feed & Food Safety & Prod Safety, Directorate Enforcement, Wageningen, Netherlands; [Biesta-Peters, Elisabeth G.] Netherlands Food & Consumer Prod Safety Author, Design & Serv Div, Slaughterhouse Team, Directorate Inspect, Utrecht, Netherlands		van der Voort, M (corresponding author), Netherlands Food & Consumer Prod Safety Author, Labs Div, Lab Feed & Food Safety & Prod Safety, Directorate Enforcement, Wageningen, Netherlands.	m.vandervoort@nvwa.nl						[Anonymous], 2002, 6579 ISO, V4th; Ao TT, 2015, EMERG INFECT DIS, V21, P941, DOI 10.3201/eid2106.140999; BLAST, BLASTN SUIT; Brudno M, 2007, NUCLEIC ACIDS RES, V35, pW669, DOI 10.1093/nar/gkm279; de Freitas Neto OC, 2010, REV BRASI CIENCIA AV, V12; Deer DM, 2010, LETT APPL MICROBIOL, V50, P366, DOI 10.1111/j.1472-765X.2010.02804.x; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Hadjinicolaou AV, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-97; Hayward MR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-365; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Horton RA, 2013, RES VET SCI, V95, P45, DOI 10.1016/j.rvsc.2013.02.008; Hu QH, 2008, J CLIN MICROBIOL, V46, P1330, DOI 10.1128/JCM.01255-07; HUISINTVELD JHJ, 1994, MEAT SCI, V36, P123, DOI 10.1016/0309-1740(94)90038-8; International Organization for Standardization, 2011, ISOTR65793; International Organization for Standardization (ISO), 2005, 221742005 ISO; ISO, 2016, 1614022016 ISO; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Lee SH, 2009, J VET SCI, V10, P43, DOI 10.4142/jvs.2009.10.1.43; Liu B, 2012, FOOD CONTROL, V27, P87, DOI 10.1016/j.foodcont.2012.01.062; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Malorny B, 2004, APPL ENVIRON MICROB, V70, P7046, DOI 10.1128/AEM.70.12.7046-7052.2004; Maurischat S, 2015, INT J FOOD MICROBIOL, V193, P8, DOI 10.1016/j.ijfoodmicro.2014.10.004; Meerburg BG, 2007, J SCI FOOD AGR, V87, P2774, DOI 10.1002/jsfa.3004; Paiao FG, 2013, BRAZ J MICROBIOL, V44, P37, DOI 10.1590/S1517-83822013005000002; Park SH, 2015, J APPL MICROBIOL, V118, P152, DOI 10.1111/jam.12678; Silva DSP, 2011, INT J FOOD SCI TECH, V46, P1502, DOI 10.1111/j.1365-2621.2011.02646.x; RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F; Rajtak U, 2011, FOODBORNE PATHOG DIS, V8, P769, DOI 10.1089/fpd.2010.0768; Saeki EK, 2013, J FOOD SAFETY, V33, P25, DOI 10.1111/jfs.12019; Thai TH, 2012, INT J FOOD MICROBIOL, V156, P147, DOI 10.1016/j.ijfoodmicro.2012.03.016; VISTA, TOOLS COMP GEN; White PL, 1997, REV SCI TECH OIE, V16, P525, DOI 10.20506/rst.16.2.1046; Zhang SK, 2015, J CLIN MICROBIOL, V53, P1685, DOI 10.1128/JCM.00323-15	33	33	36	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206316	10.1371/journal.pone.0206316	http://dx.doi.org/10.1371/journal.pone.0206316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359449	Green Submitted, gold, Green Published			2022-12-26	WOS:000448438400066
J	Kimaro, L; Adinan, J; Damian, DJ; Njau, B				Kimaro, Lucina; Adinan, Juma; Damian, Damian J.; Njau, Bernard			Prevalence of occupational injuries and knowledge of availability and utilization of post exposure prophylaxis among health care workers in Singida District Council, Singida Region, Tanzania	PLOS ONE			English	Article							POSTEXPOSURE PROPHYLAXIS; HIV	Background Infection with Human Immunodeficiency Virus is a serious public health problem that threatens the lives of many people including health care workers. Health care workers are frequently exposed to occupational hazards throughout their careers. Health care workers are at risk of being infected by the virus when caring for patients in health care facilities. Utilization of HIV Post-exposure Prophylaxis (HIV PEP) is very vital once an individual is exposed. Aim The aim of this study is to determine the prevalence of occupational exposure, knowledge of, availability and utilization of post exposure prophylaxis among health care workers in Singida District Council, Tanzania. Methods A descriptive cross sectional study was conducted from April to May 2013. Health care workers actively treating patients were enrolled from 18 heath facilities in Singida District Council. Data were collected using a self-administered questionnaire, and analysed using Stata version 12. Results Out of 239 participants, slightly more than half, 124 (52%) had inadequate overall knowledge of HIV PEP. Of the 239, 121(50.6%) participants experienced occupational exposure. Two leading types of exposure were blood splash 57(47.1%) and needle stick injuries 45 (37.2%),respectively. Among the 121 exposed participants, 83(68.6%) reported the exposure incident, 91(75.2%) had an HIV test, 32 (26.4%), started HIV PEP after testing, 28 Occupational injuries and utilization of post exposure prophylaxis by healthcare workers in Tanzania (23.1%), completed HIV PEP, and 65 (53.7%) had a follow-up HIV test. About two thirds (159/239), of participants reported that HIV PEP services were available at the time the study was conducted, and 49 (20.5%), reported daily access to HIV PEP service. Conclusion The prevalence of occupational exposure among health care workers is high with low utilization of HIV PEP. The majority of healthcare workers had inadequate knowledge of HIV PEP. The findings highlight the need to improve the level of knowledge of HIV PEP and utilization of PEP among this at-high-risk-group in Singida.	[Kimaro, Lucina] Singida Dist Council, Singida, Tanzania; [Kimaro, Lucina; Adinan, Juma; Damian, Damian J.; Njau, Bernard] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Adinan, Juma; Damian, Damian J.; Njau, Bernard] Kilimanjaro Christian Med Ctr, Community Hlth Dept, Moshi, Tanzania; [Adinan, Juma] KCMC, Sch Assistant Med Officer AMO, Moshi, Tanzania	Kilimanjaro Christian Medical Centre	Damian, DJ (corresponding author), Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania.; Damian, DJ (corresponding author), Kilimanjaro Christian Med Ctr, Community Hlth Dept, Moshi, Tanzania.	d_jeremy5@yahoo.com	Njau, Bernard/AAI-2152-2020; Adinan, Juma/N-8259-2015	Adinan, Juma/0000-0002-7964-2879				Agaba Patricia A, 2012, Niger Med J, V53, P155, DOI 10.4103/0300-1652.104386; Alenyo R., 2009, East and Central African Journal of Surgery, V14, P99; Chalya PL, 2015, TANZAN J HLTH RES, V17, P1, DOI [10.4314/thrb.v17i2.3, DOI 10.4314/THRB.V17I2.3]; District C., 2012, INT J PHARM BIOL ARC, V3, P1394; Esin IA, 2011, NIGER J CLIN PRACT, V14, P464, DOI 10.4103/1119-3077.91757; Ganczak M, 2007, J HOSP INFECT, V66, P346, DOI 10.1016/j.jhin.2007.05.007; Gold J, 2005, TECHN M DEV GUID POL; Gupta A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-142; Health P, 2011, KNOWL PRACT HLTH CAR; Kabyemera R, 2015, AFRICAN EVAL J, V3, P1, DOI [10.4102/aej.v3i2.152, DOI 10.4102/AEJ.V3I2.152]; Kumakech E, 2011, INT NURS REV, V58, P454, DOI 10.1111/j.1466-7657.2011.00887.x; Mashoto KO, 2015, KNOWLEDGE OCCUPATION, P1, DOI 10.1186/s12913-015-0700-z; Mathewos B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-508; Mbaisi EM, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.10.1373; National Bureau of Statistics, 2013, 2012 POP HOUS CENS; NBS. Tanzania, 2011, TANZ HIV AIDS MAL IN; Oosthuysen J, 2010, INT DENT J, V60, P181, DOI 10.1922/IDJ_2371Oosthuysen09; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; Reda AA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014420; Sadoh WE, 2006, J NATL MED ASSOC, V98, P722; Tebeje B, 2010, ETHIOP J HEALTH SCI, V20, P55; Wicker S, 2008, INT ARCH OCC ENV HEA, V81, P347, DOI 10.1007/s00420-007-0219-7; World Health Organization (WHO), 2014, GUID POST PROPH HIV	23	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0201695	10.1371/journal.pone.0201695	http://dx.doi.org/10.1371/journal.pone.0201695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359370	Green Submitted, gold, Green Published			2022-12-26	WOS:000448438400006
J	Ohara, Y; Ozeki, Y; Tateishi, Y; Mashima, T; Arisaka, F; Tsunaka, Y; Fujiwara, Y; Nishiyama, A; Yoshida, Y; Kitadokoro, K; Kobayashi, H; Kaneko, Y; Nakagawa, I; Maekura, R; Yamamoto, S; Katahira, M; Matsumoto, S				Ohara, Yukiko; Ozeki, Yuriko; Tateishi, Yoshitaka; Mashima, Tsukasa; Arisaka, Fumio; Tsunaka, Yasuo; Fujiwara, Yoshie; Nishiyama, Akihito; Yoshida, Yutaka; Kitadokoro, Kengo; Kobayashi, Haruka; Kaneko, Yukihiro; Nakagawa, Ichiro; Maekura, Ryoji; Yamamoto, Saburo; Katahira, Masato; Matsumoto, Sohkichi			Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosis	PLOS ONE			English	Article							DNA-BINDING PROTEIN-1; MYCOBACTERIUM-TUBERCULOSIS; ANTIGENIC DETERMINANTS; IDENTIFICATION; ANTIBODIES; INFECTION; PURIFICATION; EXTRACTION; MECHANISM; DISORDER	Tuberculosis causes the highest mortality among all single infections. Asymptomatic tuberculosis, afflicting one third of the global human population, is the major source as 5-10% of asymptomatic cases develop active tuberculosis during their lifetime. Thus it is one of important issues to develop diagnostic tools for accurately detecting asymptomatic infection. Mycobacterial DNA-binding protein 1 (MDP1) is a major protein in persistent Mycobacterium tuberculosis and has potential for diagnostic use in detecting asymptomatic infection. However, a previous ELISA-based study revealed a specificity problem; IgGs against MDP1 were detected in both M. tuberculosis-infected and uninfected individuals. Although the tertiary structures of an antigen are known to influence antibody recognition, the MDP1 structural details have not yet been investigated. The N-terminal half of MDP1, homologous to bacterial histone-like protein HU, is predicted to be responsible for DNA-binding, while the C-terminal half is assumed as totally intrinsically disordered regions. To clarify the relationship between the MDP1 tertiary structure and IgG recognition, we refined the purification method, which allow us to obtain a recombinant protein with the predicted structure. Furthermore, we showed that an IgG-ELISA using MDP1 purified by our refined method is indeed useful in the detection of asymptomatic tuberculosis.	[Ohara, Yukiko; Ozeki, Yuriko; Tateishi, Yoshitaka; Nishiyama, Akihito; Kobayashi, Haruka; Matsumoto, Sohkichi] Niigata Univ, Dept Bacteriol, Sch Med, Niigata, Japan; [Ohara, Yukiko; Nakagawa, Ichiro] Kyoto Univ, Dept Microbiol, Grad Sch Med, Kyoto, Japan; [Mashima, Tsukasa; Katahira, Masato] Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto, Japan; [Arisaka, Fumio] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan; [Tsunaka, Yasuo] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa, Japan; [Fujiwara, Yoshie] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Sakyo Ku, Kyoto, Japan; [Yoshida, Yutaka] Niigata Univ, Grad Sch Med, Inst Nephrol, Dept Struct Pathol, Niigata, Japan; [Kitadokoro, Kengo] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biomol Engn, Sakyo Ku, Matsugasakigosyokaido Cho, Kyoto, Japan; [Kaneko, Yukihiro] Osaka City Univ, Dept Bacteriol & Virol, Grad Sch Med, Osaka, Japan; [Maekura, Ryoji] Toneyama Natl Hosp, Dept Resp Med, Natl Hosp Org, 5-1-1 Toneyama, Toyonaka, Osaka, Japan; [Maekura, Ryoji] Jikei Inst, Grad Sch Hlth Care Sci, Osaka, Japan; [Yamamoto, Saburo] Japan BCG Lab, Cent Lab, Kiyose, Tokyo, Japan	Niigata University; Kyoto University; Kyoto University; Nihon University; Yokohama City University; Kyoto University; Niigata University; Kyoto Institute of Technology; Osaka Metropolitan University	Ohara, Y; Matsumoto, S (corresponding author), Niigata Univ, Dept Bacteriol, Sch Med, Niigata, Japan.; Ohara, Y (corresponding author), Kyoto Univ, Dept Microbiol, Grad Sch Med, Kyoto, Japan.	ynishida@icems.kyoto-u.ac.jp; yuriozeki@med.niigata-u.ac.jp; sohkichi@med.niigata-u.ac.jp		Tsunaka, Yasuo/0000-0002-7366-7610; Matsumoto, Sohkichi/0000-0002-6106-7538; Kitadokoro, Kengo/0000-0001-5969-7939	Ministry of Education, Culture, Sports, Science and Technology [16H05187, 17K08823, 16K08774]; Japan Agency for Medical Research and Development [JP18fk0108005]; United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy; Japanese Ministry of Education, Culture, Sports Science and Technology [16H05187, 17K08823, 16K08774]; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED [JP18fk0108005]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy; Japanese Ministry of Education, Culture, Sports Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research (https://www.jsps.go.jp/j-grantsinaid/), Grant numbers 16H05187 (S.M.), 17K08823(A.N), 16K08774(Y.O); by the Japan Agency for Medical Research and Development, grant JP18fk0108005 to Prof. Sohkichi Matsumoto; and by The United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy to Sohkichi Matsumoto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Japanese Ministry of Education, Culture, Sports Science and Technology to Sohkichi Matsumoto, Yuriko Ozeki, and Akihito Nishiyama under grant number 16H05187, 16K08774, and 17K08823, respectively. And the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED under grant number JP18fk0108005, and the United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy to Sohkichi Matsumoto.	Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Aoki K, 2004, J BIOL CHEM, V279, P39798, DOI 10.1074/jbc.M402677200; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; BERZOFSKY JA, 1985, SCIENCE, V229, P932, DOI 10.1126/science.2410982; Bhowmick T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5124; Bold TD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002063; Chen TT, 2016, J INFECT DIS, V214, P300, DOI 10.1093/infdis/jiw141; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Dheda K, 2016, LANCET, V387, P1211, DOI 10.1016/S0140-6736(15)00151-8; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Enokizono Y, 2005, J BIOL CHEM, V280, P18862, DOI 10.1074/jbc.M411822200; Fletcher HA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11633; Furugen M, 2001, MICROB PATHOGENESIS, V30, P129, DOI 10.1006/mpat.2000.0416; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; Horsburgh CR, 2011, NEW ENGL J MED, V364, P1441, DOI 10.1056/NEJMcp1005750; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Jaiswal N, 2018, MAGN RESON CHEM, V56, P285, DOI 10.1002/mrc.4701; Katsube T, 2007, J BACTERIOL, V189, P8241, DOI 10.1128/JB.00550-07; Kunnath-Velayudhan S, 2011, CLIN MICROBIOL REV, V24, P792, DOI 10.1128/CMR.00014-11; Laue TM, 1992, R SOC CHEM; LEWIN A, 2008, BMC MICROBIOL, V8; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Lu XN, 2005, MOL CELL PROTEOMICS, V4, P1948, DOI 10.1074/mcp.M500138-MCP200; Matsugami A, 2006, NUCLEOS NUCLEOT NUCL, V25, P417, DOI 10.1080/15257770600684068; Matsumoto S, 2005, J IMMUNOL, V175, P441, DOI 10.4049/jimmunol.175.1.441; Matsumoto S, 1999, MICROBIOL IMMUNOL, V43, P1027, DOI 10.1111/j.1348-0421.1999.tb01232.x; Matsumoto S, 2000, FEMS MICROBIOL LETT, V182, P297, DOI 10.1016/S0378-1097(99)00606-0; Moguche AO, 2017, CELL HOST MICROBE, V21, P695, DOI 10.1016/j.chom.2017.05.012; Mukherjee A, 2008, BIOCHEMISTRY-US, V47, P8744, DOI 10.1021/bi800010s; MURRAY K, 1966, J MOL BIOL, V15, P409, DOI 10.1016/S0022-2836(66)80116-X; Niki M, 2012, J BIOL CHEM, V287, P27743, DOI 10.1074/jbc.M111.333385; Niki M, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/527395; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Osada-Oka M, 2013, MICROBIOL IMMUNOL, V57, P30, DOI 10.1111/j.1348-0421.2012.12005.x; Pandey SD, 2014, MICROBIOL-SGM, V160, P1637, DOI 10.1099/mic.0.079640-0; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Rothel James S, 2005, Expert Rev Anti Infect Ther, V3, P981, DOI 10.1586/14787210.3.6.981; Rylance J, 2010, LANCET INFECT DIS, V10, P886, DOI 10.1016/S1473-3099(10)70201-2; Savitskaya A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26463-9; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sharadamma N, 2011, FEBS J, V278, P3447, DOI 10.1111/j.1742-4658.2011.08267.x; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van Pinxteren LAH, 2000, CLIN DIAGN LAB IMMUN, V7, P155, DOI 10.1128/CDLI.7.2.155-160.2000; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Yeruva VC, 2006, CLIN VACCINE IMMUNOL, V13, P1137, DOI 10.1128/CVI.00125-06; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V; Zimmermann N, 2016, EMBO MOL MED, V8, P1325, DOI 10.15252/emmm.201606330	59	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0204160	10.1371/journal.pone.0204160	http://dx.doi.org/10.1371/journal.pone.0204160			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359374	Green Published, gold, Green Submitted			2022-12-26	WOS:000448438400007
J	Campbell, ZA; Marsh, TL; Mpolya, EA; Thumbi, SM; Palmer, GH				Campbell, Zoe A.; Marsh, Thomas L.; Mpolya, Emmanuel A.; Thumbi, Samuel M.; Palmer, Guy H.			Newcastle disease vaccine adoption by smallholder households in Tanzania: Identifying determinants and barriers	PLOS ONE			English	Article							VILLAGE CHICKENS	Background Food security is critical to achieving sustainable growth, poverty reduction, and political and economic stability. Livestock have the potential to improve the food security of smallholder households in developing countries, but livestock productivity is constrained by disease. The extent to which households adopt innovations such as vaccines impacts disease control; however, the behavioral and economic drivers underlying household decisions to adopt or forgo vaccination are not well understood. We address this gap with a study of adoption of Newcastle disease (ND) vaccines by chicken-owning households in Tanzania. Methods A cross-sectional survey was administered to 535 households owning indigenous chickens in Arusha, Singida, and Mbeya regions in Tanzania. We measured potential predictors of ND vaccine adoption including knowledge, attitudes, and practices. Logistic regression was used to identify predictors correlated with three stages of household adoption: awareness of ND vaccines, previous vaccination, and recent vaccination (within four months) consistent with veterinary guidelines. Results Eighty percent of households were aware of ND vaccines, 57% had previously vaccinated, and 26% had recently vaccinated. Knowing someone who vaccinated increased the odds of a household previously vaccinating [adjusted odds ratio (AOR): 1.32, 95% CI: 1.1-1.5]. Larger flock size was also associated with higher odds of previous vaccination (AOR: 1.03 for a one chicken increase, 95% CI: 1.01-1.05). Usage of traditional medicine decreased the odds of previously vaccination (AOR: 0.58, 95% CI: 0.36-0.95). Conclusion Our findings suggest that encouraging the flow of professional-level knowledge within the community by vaccine adopters is a strategy to increase vaccine adoption. Enhancing local chicken productivity through increased vaccine coverage would strengthen a key smallholder household resource for food and economic security.	[Campbell, Zoe A.; Marsh, Thomas L.; Mpolya, Emmanuel A.; Thumbi, Samuel M.; Palmer, Guy H.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Campbell, Zoe A.; Mpolya, Emmanuel A.; Palmer, Guy H.] NM AIST, Arusha, Tanzania; [Marsh, Thomas L.] Washington State Univ, Sch Econ Sci, Pullman, WA 99164 USA; [Thumbi, Samuel M.] Kenya Med Res Inst KEMRI, Kisian, Kenya	Washington State University; Washington State University; Kenya Medical Research Institute	Campbell, ZA (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.; Campbell, ZA (corresponding author), NM AIST, Arusha, Tanzania.	zoecampbella@gmail.com		Mpolya, Emmanuel/0000-0002-6210-9445; Campbell, Zoe/0000-0002-4759-9976	Bill & Melinda Gates Foundation, Seattle, WA through the Program for Enhancing Health and Productivity of Livestock (PEHPL) [OPP1083453]	Bill & Melinda Gates Foundation, Seattle, WA through the Program for Enhancing Health and Productivity of Livestock (PEHPL)	This research was funded by the Bill & Melinda Gates Foundation, Seattle, WA (grant #OPP1083453) through the Program for Enhancing Health and Productivity of Livestock (PEHPL). The funder's website can be found here: https://www.gatesfoundation.org/. The findings and conclusions contained are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alders RG, 2010, WORLD POULTRY SCI J, V66, P433, DOI 10.1017/S0043933910000516; Alders RG, 2009, WORLD POULTRY SCI J, V65, P181, DOI 10.1017/S0043933909000117; ALDERS RG, 1994, PREV VET MED, V21, P125, DOI 10.1016/0167-5877(94)90001-9; Bereuter D, 2017, STABILITY 21 CENTURY; Bernard H. R., 2017, RES METHODS ANTHR; Brownson R, 2009, APPL EPIDEMIOLOGY TH; Caudell MA, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0135-1; Darabighane B, 2012, J APPL ANIM RES, V40, P31, DOI 10.1080/09712119.2011.620435; de Bruyn J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188230; Dolberg F, 2003, ANIM PROD, P40; Fisher H., 2014, ACIAR IMPACT ASSESSM; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Gueye EF, 2005, WORLD POULTRY SCI J, V61, P39, DOI 10.1079/WPS200440; Leroy JL, 2007, J NUTR, V137, P2311, DOI 10.1093/jn/137.10.2311; Marsh TL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601410; Mgomezulu RA, 2009, TRIALS THERMOTOLERAN; Msami H, 2007, POULTRY SECTOR COUNT; Musa U., 2010, Nigerian Veterinary Journal, V31, P46; OIE World Organisation for Animal Health, 2016, NEWCASTLE DIS; OWOLODUN BY, 1975, BRIT VET J, V131, P580, DOI 10.1016/S0007-1935(17)35191-6; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Revenga A, 2012, FINANC DEV, V49; Rogers E.M., 1995, DIFFUSION INNOVATION; StataCorp, 2017, STATA STAT SOFTWARE; Tanzania Ministry of Agriculture, 2012, UN REP TANZ NAT SAMP, P3; Terfa ZG, 2015, FOOD SECUR, V7, P905, DOI 10.1007/s12571-015-0482-5; Waihenya RK, 2002, J ETHNOPHARMACOL, V79, P299, DOI 10.1016/S0378-8741(01)00370-1	27	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206058	10.1371/journal.pone.0206058	http://dx.doi.org/10.1371/journal.pone.0206058			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356260	Green Submitted, Green Published, gold			2022-12-26	WOS:000448434000070
J	Conkle, J; Suchdev, PS; Alexander, E; Flores-Ayala, R; Ramakrishnan, U; Martorell, R				Conkle, Joel; Suchdev, Parminder S.; Alexander, Eugene; Flores-Ayala, Rafael; Ramakrishnan, Usha; Martorell, Reynaldo			Accuracy and reliability of a low-cost, handheld 3D imaging system for child anthropometry	PLOS ONE			English	Article							GROWTH; HEALTH	The usefulness of anthropometry to define childhood malnutrition is undermined by poor measurement quality, which led to calls for new measurement approaches. We evaluated the ability of a 3D imaging system to correctly measure child stature (length or height), head circumference and arm circumference. In 2016-7 we recruited and measured children at 20 facilities in and around metro Atlanta, Georgia, USA; including at daycare, higher education, religious, and medical facilities. We selected recruitment sites to reflect a generally representative population of Atlanta and to oversample newborns and children under two years of age. Using convenience sampling, a total of 474 children 0-5 years of age who were apparently healthy and who were present at the time of data collection were included in the analysis. Two anthropometrists each took repeated manual measures and repeated 3D scans of each child. We evaluated the reliability and accuracy of 3D scan-derived measurements against manual measurements. The mean child age was 26 months, and 48% of children were female. Based on reported race and ethnicity, the sample was 42% Black, 28% White, 8% Asian, 21% multiple races, other or race not reported; and 16% Hispanic. Measurement reliability of repeated 3D scans was within 1 mm of manual measurement reliability for stature, head circumference and arm circumference. We found systematic bias when analyzing accuracy-on average 3D imaging overestimated stature and head circumference by 6 mm and 3 mm respectively, and underestimated arm circumference by 2 mm. The 3D imaging system used in this study is reliable, low-cost, portable, and can handle movement; making it ideal for use in routine nutritional assessment. However, additional research, particularly on accuracy, and further development of the scanning and processing software is needed before making policy and clinical practice recommendations on the routine use of 3D imaging for child anthropometry.	[Conkle, Joel; Suchdev, Parminder S.; Flores-Ayala, Rafael; Ramakrishnan, Usha; Martorell, Reynaldo] Emory Univ, Laney Grad Sch, Nutr & Hlth Sci Program, Atlanta, GA 30322 USA; [Suchdev, Parminder S.; Ramakrishnan, Usha; Martorell, Reynaldo] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Suchdev, Parminder S.; Flores-Ayala, Rafael] US Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Suchdev, Parminder S.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Alexander, Eugene] Body Surface Translat Inc BST, Athens, GA USA	Emory University; Emory University; Rollins School Public Health; Centers for Disease Control & Prevention - USA; Emory University	Conkle, J (corresponding author), Emory Univ, Laney Grad Sch, Nutr & Hlth Sci Program, Atlanta, GA 30322 USA.	jconkle@emory.edu	Suchdev, Parmi S/K-4851-2012	Conkle, Joel/0000-0003-2603-5052; Suchdev, Parmi/0000-0002-0350-3469	Bill and Melinda Gates Foundation [OPP1132308]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The Bill and Melinda Gates Foundation (OPP1132308 to RM) funded the study. The funder provided support in the form of salaries for authors PS, EA, UR and RM. The specific roles of these authors are articulated in the 'author contributions' section. The funder's project officer contributed to study design and interpretation of the data, and had no role in collection, management or analysis of data, and no role in preparation, review, or approval of the manuscript and the decision to submit the manuscript for publication.	[Anonymous], 1995, PHYS STAT US INT ANT; Assaf S, 2015, DHS METHODOLOGICAL R, V16; Barnes R., 2010, P 1 INT C 3D BOD SCA, P147, DOI [10.15221/10.147, DOI 10.15221/10.147]; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bleakley H, 2010, ANNU REV ECON, V2, P283, DOI 10.1146/annurev.economics.102308.124436; Conkle J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189332; Corsi DJ, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1328185; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; Gerner B, 2006, J PAEDIATR CHILD H, V42, P206, DOI 10.1111/j.1440-1754.2006.00831.x; Gibson RS, 2005, PRINCIPLES NUTR ASSE, P233; IEG-World Bank, 2010, WORLD BANKS COUNTRY; Jaeschke L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119430; JONES PRM, 1989, ENDEAVOUR, V13, P162, DOI 10.1016/S0160-9327(89)80004-3; Lipman TH, 2004, ARCH DIS CHILD, V89, P342, DOI 10.1136/adc.2003.030072; Mehta NM, 2013, JPEN-PARENTER ENTER, V37, P460, DOI 10.1177/0148607113479972; NHS Commissioning Board, 2013, CLIN COMM POL COMPL; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; Patel V, 2014, NUTR CLIN PRACT, V29, P483, DOI 10.1177/0884533614535446; Pullum T., 2008, ASSESSMENT QUALITY D; Sebo P, 2008, PREV MED, V47, P389, DOI 10.1016/j.ypmed.2008.06.012; Sebo P, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14115; Setboonsarng S, 2005, ADB INSTITUTE DISCUS; Soileau L, 2016, EUR J CLIN NUTR, V70, P475, DOI 10.1038/ejcn.2015.132; Suchdev PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1666; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; USAID, 2015, M JUL 14 15 2015; VOSS LD, 1992, BMJ-BRIT MED J, V305, P1400, DOI 10.1136/bmj.305.6866.1400; Weathers WM, 2014, CRANIOMAX TRAUM REC, V7, P1, DOI 10.1055/s-0033-1356758; Wit JM, 2017, HORM RES PAEDIAT, V88, P79, DOI 10.1159/000456007; World Bank, 2016, WORLD DEVELOPMENT IN; World Health Organisation (WHO), 2009, UNICEF WHO CHILD GRO; Yin HY, 2013, ANN HUM BIOL, V40, P309, DOI 10.3109/03014460.2013.775343	33	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205320	10.1371/journal.pone.0205320	http://dx.doi.org/10.1371/journal.pone.0205320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356325	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000050
J	Pardo-Perez, JM; Kear, BP; Mallison, H; Gomez, M; Moroni, M; Maxwell, EE				Pardo-Perez, Judith M.; Kear, Benjamin P.; Mallison, Heinrich; Gomez, Marcelo; Moroni, Manuel; Maxwell, Erin E.			Pathological survey on Temnodontosaurus from the Early Jurassic of southern Germany	PLOS ONE			English	Article							ICHTHYOSAUR; MOSASAURS; REPTILIA; PALEOPATHOLOGY; SQUAMATA; HABITAT	Paleopathologies document skeletal damage in extinct organisms and can be used to infer the causes of injury, as well as aspects of related biology, ecology and behavior. To date, few studies have been undertaken on Jurassic marine reptiles, while ichthyosaur pathologies in particular have never been systematically evaluated. Here we survey 41 specimens of the apex predator ichthyosaur Temnodontosaurus from the Early Jurassic of southern Germany in order to document the range and absolute frequency of pathologies observed in this taxon as a function of the number of specimens examined. According to our analysis, most observed pathologies in Temnodontosaurus are force-induced traumas with signs of healing, possibly inflicted during aggressive interactions with conspecifics. When the material is preserved, broken ribs are correlated in most of the cases with traumas elsewhere in the skeleton such as cranial injuries. The range of cranial pathologies in Temnodontosaurus is similar to those reported for extinct cetaceans and mosasaurs, which were interpreted as traces of aggressive encounters. Nevertheless, Temnodontosaurus differs from these other marine amniotes in the absence of pathologies in the vertebral column, consistent with the pattern previously documented in ichthyosaurs. We did not detect any instances of avascular necrosis in Temnodontosaurus from southern Germany, which may reflect a shallow diving life style. This study is intended to provide baseline data for the various types of observed pathologies in large ichthyosaurs occupying the 'apex predator' niche, and potentially clarifies aspects of species-specific behavior relative to other ichthyosaurs and marine amniotes.	[Pardo-Perez, Judith M.; Maxwell, Erin E.] Staatliches Museum Nat Kunde Stuttgart, Stuttgart, Germany; [Pardo-Perez, Judith M.] Univ Magallanes, Vicerrectoria Invest & Postgrad, Punta Arenas, Chile; [Kear, Benjamin P.] Uppsala Univ, Museum Evolut, Uppsala, Sweden; [Mallison, Heinrich] Museum Natur Kunde Berlin, Berlin, Germany; [Gomez, Marcelo; Moroni, Manuel] Univ Austral Chile, Fac Ciencias Vet, Escuela Med Vet, Valdivia, Chile	Universidad de Magallanes; Uppsala University; Universidad Austral de Chile	Pardo-Perez, JM (corresponding author), Staatliches Museum Nat Kunde Stuttgart, Stuttgart, Germany.; Pardo-Perez, JM (corresponding author), Univ Magallanes, Vicerrectoria Invest & Postgrad, Punta Arenas, Chile.	judith.pardo-perez@smns-bw.de	; Gomez, Marcelo/D-7311-2015; Pardo-Perez, Judith/T-9134-2018	Maxwell, Erin/0000-0002-6032-6251; Gomez, Marcelo/0000-0003-1610-4798; Pardo-Perez, Judith/0000-0001-9477-1110	Deutsche Forschungsgemeinschaft [MA 4693/4-1 DFG]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by the Deutsche Forschungsgemeinschaft (MA 4693/4-1 DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O., 1935, VORZEITLICHE LEBENSS, P644; Beardmore SR, 2016, PALAEOGEOGR PALAEOCL, V443, P131, DOI 10.1016/j.palaeo.2015.11.049; Bell PR, 2010, LETHAIA, V43, P278, DOI 10.1111/j.1502-3931.2009.00195.x; Bottcher VR, 1989, STUTTGARDER BEITR GE, V155, P1; CAMP C L, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V170, P139; Clarke R, 1988, REPORT INT WHALING C, P235; Dick DG, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0339; Everhart Michael J., 2008, Transactions of the Kansas Academy of Science, V111, P251, DOI 10.1660/0022-8443-111.3.251; Felix F, 2007, DIS AQUAT ORGAN, V75, P259, DOI 10.3354/dao075259; Fernandez MS, 1998, AMEGHINIANA, V35, P21; Fischer V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10825; Frobisch NB, 2013, P NATL ACAD SCI USA, V110, P1393, DOI 10.1073/pnas.1216750110; Hone DWE, 2015, PEERJ, V3, DOI 10.7717/peerj.885; Hopley PJ, 2001, J VERTEBR PALEONTOL, V21, P253, DOI 10.1671/0272-4634(2001)021[0253:PSPTFF]2.0.CO;2; Huene F.V., 1930, ANAT ANZEIGER, V70, P108; Kear BP, 2003, P ROY SOC B-BIOL SCI, V270, pS206, DOI 10.1098/rsbl.2003.0050; Kear BP, 2001, ALCHERINGA, V25, P387, DOI 10.1080/03115510108619228; Keller T., 2006, LESEBUCH QUERDENKER, P251; Kompanje E.J.O., 1999, Zoologische Mededelingen (Leiden), V73, P99; Lambert O, 2014, NATURWISSENSCHAFTEN, V101, P517, DOI 10.1007/s00114-014-1182-2; Lingham-Soliar T, 2004, LETHAIA, V37, P255, DOI 10.1080/00241160410006519; Lingham-Soliar T, 1998, LETHAIA, V31, P308; Loch C, 2011, DIS AQUAT ORGAN, V94, P225, DOI 10.3354/dao02339; Long DJ, 1996, WHITE SHARKS BIOL CA, P293; Maisch MW, 2003, J VERTEBR PALEONTOL, V23, P116, DOI 10.1671/0272-4634(2003)23[116:TCOOTI]2.0.CO;2; Martin J.E., 1995, JOURNAL OF VERTEBRAT, V15, p18A; Martin JE, 2012, PALAEONTOLOGY, V55, P995, DOI 10.1111/j.1475-4983.2012.01159.x; Martin LD., 1993, PALEOPATHOLOGY DIS F; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Massare Judy A., 2006, Paludicola, V5, P242; McGowan C, 1996, CAN J EARTH SCI, V33, P1011, DOI 10.1139/e96-077; McGowan C., 2003, HDB PALEOHERPETOLOGY, P175; Montes I. David, 2004, Rev. investig. vet. Perú, V15, P13; MOODIE R.L., 1918, STUDIES PALEOPATHOLO, P374; Moodie RL, 1918, SCIENCE, V48, P619, DOI 10.1126/science.48.1251.619-a; MOODIE ROY L., 1927, ANN MED HIST, V9, P91; Motani R, 1999, NATURE, V402, P747, DOI 10.1038/45435; Oremland MS, 2010, MAR MAMMAL SCI, V26, P1, DOI 10.1111/j.1748-7692.2009.00334.x; Pardo-Perez JM, 2017, J ZOOL, P1; Rabold J.M., 2013, DER STEINKERN, V15, P70; ROTHSCHILD B, 1987, SCIENCE, V236, P75, DOI 10.1126/science.236.4797.75; Rothschild B, 2006, NEW MEXICO MUSEUM NA, P187; Rothschild BM, 2012, NATURWISSENSCHAFTEN, V99, P443, DOI 10.1007/s00114-012-0918-0; Rothschild BM, 2005, NETH J GEOSCI, V84, P335, DOI 10.1017/S0016774600021119; Rothschild Bruce, 2015, Transactions of the Kansas Academy of Science, V118, P265; Sassoon J, 2012, PALAEONTOLOGY, V55, P743, DOI 10.1111/j.1475-4983.2012.01151.x; Schulp Anne S., 2006, Oryctos, V6, P41; SWEENEY JC, 1975, J AM VET MED ASSOC, V167, P533; Tanke Darren H., 2000, Gaia (Lisboa), V15, P167; Von Huene F, 1951, NEUES JAHRB GEOL P-A, V93, P277; von Huene F, 1931, ABTEILUNG B, V65, P305; von Huene F., 1931, ABHANDLUNGEN SENCKEN, V42, P345; Zammit M, 2011, ACTA PALAEONTOL POL, V56, P859, DOI 10.4202/app.2010.0117	53	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0204951	10.1371/journal.pone.0204951	http://dx.doi.org/10.1371/journal.pone.0204951			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356279	Green Submitted, gold, Green Published			2022-12-26	WOS:000448434000023
J	Reade, S; Williams, JM; Aggio, R; Duckworth, CA; Mahalhal, A; Hough, R; Pritchard, DM; Probert, CS				Reade, Sophie; Williams, Jonathan M.; Aggio, Raphael; Duckworth, Carrie A.; Mahalhal, Awad; Hough, Rachael; Pritchard, D. Mark; Probert, Chris S.			Potential role of fecal volatile organic compounds as biomarkers of chemically induced intestinal inflammation in mice	FASEB JOURNAL			English	Article						colitis; VOCs; inflammatory bowel disease	DIAGNOSTIC BIOMARKERS; METABOLOMICS; COLITIS	Metabolomics studies have the potential to discover biomarkers. Fecal volatile organic compounds (VOCs) have been found to differ in patients with inflammatory bowel disease and irritable bowel syndrome. Murine models of colitis offer an alternative to human studies in which diet can be controlled. We aimed to investigate fecal VOCs from mice in which acute and chronic colitis was induced. Groups of adult C57BL/6 mice underwent treatment with oral dextran sulfate sodium to induce colitis. Control mice received no treatment or had acute osmotic diarrhea induced with magnesium sulfate. Colitis was assessed clinically and by histology. Samples of feces and/or colon contents were collected and volatile compounds determined by solid phase microextraction-GC-MS. Statistics were performed using metabolomics tools. Acute colitis was associated with an increase in aldehydes and chronic colitis with one specific ketone. Osmotic diarrhea was associated with a significant reduction in VOCs, especially alcohols. We provide evidence that the identification of disease-associated VOC concentration ranges, combined with specific marker compounds, would potentially increase the likelihood of finding an inflammatory bowel disease-specific fecal VOC marker profile.Reade, S., Williams, J. M., Aggio, R., Duckworth, C. A., Mahalhal, A., Hough, R., Pritchard, D. M., Probert, C. S., Potential role of fecal volatile organic compounds as biomarkers of chemically induced intestinal inflammation in mice.	[Reade, Sophie; Aggio, Raphael; Duckworth, Carrie A.; Mahalhal, Awad; Hough, Rachael; Pritchard, D. Mark; Probert, Chris S.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Gastroenterol Res Unit, Ashton St, Liverpool L693GE, Merseyside, England; [Williams, Jonathan M.] Royal Vet Coll, Pathobiol & Populat Sci, Hatfield, Herts, England	University of Liverpool; University of London; University of London Royal Veterinary College	Probert, CS (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Gastroenterol Res Unit, Ashton St, Liverpool L693GE, Merseyside, England.	chris.probert@liverpool.ac.uk		Pritchard, David Mark/0000-0001-7971-3561; Probert, Christopher/0000-0003-4550-0239; Williams, Jonathan/0000-0002-6617-0323	Institute of Translational Medicine at the University of Liverpool	Institute of Translational Medicine at the University of Liverpool	The authors acknowledge T. Khalid and A. Mayor (University of Liverpool) for support in preparation, running, and analysis of samples, and the Institute of Translational Medicine at the University of Liverpool for funding this work. The authors declare no conflicts of interest.	Aggio R, 2011, BIOINFORMATICS, V27, P2316, DOI 10.1093/bioinformatics/btr379; Ahmed I, 2016, ALIMENT PHARM THER, V43, P596, DOI 10.1111/apt.13522; Ahmed I, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058204, 10.1371/journal.pone.0077869]; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; COOPER HS, 1993, LAB INVEST, V69, P238; Costello BD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/014001; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Probert CSJ, 2009, J GASTROINTEST LIVER, V18, P337; Reade S., 2014, J ANAL BIOANAL TECH, V5, P184, DOI [10.4172/2155-9872.1000184, DOI 10.4172/2155-9872.1000184]; Reade S., 2016, VOLATILE ORGANIC COM; Robert FSM, 1996, J DIARRHOEAL DIS RES, V14, P218; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380	16	7	7	2	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3129	3136		10.1096/fj.201800076RR	http://dx.doi.org/10.1096/fj.201800076RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30359099	Bronze, Green Submitted			2022-12-26	WOS:000459794800005
J	Maridas, DE; Rendina-Ruedy, E; Helderman, RC; DeMambro, VE; Brooks, D; Guntur, AR; Lanske, B; Bouxsein, ML; Rosen, CJ				Maridas, David E.; Rendina-Ruedy, Elizabeth; Helderman, Ron C.; DeMambro, Victoria E.; Brooks, Daniel; Guntur, Anyonya R.; Lanske, Beate; Bouxsein, Mary L.; Rosen, Clifford J.			Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton	FASEB JOURNAL			English	Article						PTH; bone; marrow; fat; adipocytes	BONE-MARROW FAT; ANOREXIA-NERVOSA; INTERMITTENT TREATMENT; CALORIC RESTRICTION; ENERGY-EXPENDITURE; ADIPOSE-TISSUE; VERTEBRAL BONE; PTH; ARCHITECTURE; TURNOVER	Intermittent administration of parathyroid hormone (PTH) stimulates bone formation in vivo and also suppresses the volume of bone marrow adipose tissue (BMAT). In contrast, a calorie-restricted (CR) diet causes bone loss and induces BMAT in both mice and humans. We used the CR model to test whether PTH would reduce BMAT in mice by both altering cell fate and inducing lipolysis of marrow adipocytes. Eight-week-old mice were placed on a control (Ctrl) diet or CR diet. At 12 wk, CR and Ctrl mice were injected daily with PTH (CR/PTH or Ctrl/PTH) or vehicle for 4 wk. Two other cohorts were CR and simultaneously injected (CR + PTH or CR + Veh) for 4 wk. CR mice had low bone mass and increased BMAT in the proximal tibias. PTH significantly increased bone mass in all cohorts despite calorie restrictions. Adipocyte density and size were markedly increased with restriction of calories. PTH reduced adipocyte numbers in CR + PTH mice, whereas adipocyte size was reduced in CR/PTH-treated mice. In contrast, osteoblast number was increased 3-8-fold with PTH treatment. In vitro, bone marrow stromal cells differentiated into adipocytes and, treated with PTH, exhibited increased production of glycerol and fatty acids. Moreover, in cocultures of bone marrow adipocyte and osteoblast progenitors, PTH stimulated the transfer of fatty acids to osteoblasts. In summary, PTH administration to CR mice increased bone mass by shifting lineage allocation toward osteogenesis and inducing lipolysis of mature marrow adipocytes. The effects of PTH on bone marrow adiposity could enhance its anabolic actions by providing both more cells and more fuel for osteoblasts during bone formation.Maridas, D. E., Rendina-Ruedy, E., Helderman, R. C., DeMambro, V. E., Brooks, D., Guntur, A. R., Lanske, B., Bouxsein, M. L., Rosen, C. J. Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton.	[Maridas, David E.; Rendina-Ruedy, Elizabeth; Helderman, Ron C.; DeMambro, Victoria E.; Guntur, Anyonya R.; Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ME USA; [Maridas, David E.; Lanske, Beate] Harvard Sch Dent Med, 188 Longwood Ave,5th Floor, Boston, MA 02115 USA; [Brooks, Daniel; Bouxsein, Mary L.] Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Boston, MA 02215 USA	Maine Medical Center; Harvard University; Harvard School of Dental Medicine; Harvard University; Beth Israel Deaconess Medical Center	Maridas, DE (corresponding author), Harvard Sch Dent Med, 188 Longwood Ave,5th Floor, Boston, MA 02115 USA.	david_maridas@hsdm.harvard.edu	Maridas, David/ABA-8941-2021	Maridas, David/0000-0001-6680-6005; Lanske, Beate/0000-0003-4638-804X	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK092759, DK112374]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [AR072123]; NIH NIGMS [P30GM106391, P20GM121301, U54GM115516]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR072123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK112374, R24DK092759, R01DK112374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121301, U54GM115516, P30GM106391] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank D.B. for performing the mCT analyses. All grants are supported by the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS). The authors thank Dr. Vicki Rosen (Harvard School of Dental Medicine) for the use of her equipment. This project was primarily supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grants DK092759 (to C.J.R.) and DK112374 (to C.J.R.). Additional support was provided by the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR072123 (to E.R.-R.). The experiments were performed using the Physiology, Molecular Phenotyping, and Histopathology Cores. These cores are supported by the following NIH NIGMS grants: Physiology and Histopathology Core are supported by Grants P30GM106391 [Centers of Biomedical Research Excellence (COBRE) in Stem Cell Biology and Regenerative Medicine; R. Friesel, Principal Investigator], P20GM121301 (COBRE in Metabolic Networks; L. Liaw, Principal Investigator) and U54GM115516 (Northern New England Clinical and Translational Research Network; C.J.R., Principal Investigator). The Molecular Phenotyping Core is supported by Grants P30GM106391 and U54GM115516. The authors declare no conflicts of interest.	Ahn H, 2014, NUTR RES, V34, P707, DOI 10.1016/j.nutres.2014.07.006; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Balani DH, 2017, J CLIN INVEST, V127, P3333, DOI 10.1172/JCI91699; Behrendt AK, 2016, J BONE MINER RES, V31, P852, DOI 10.1002/jbmr.2745; Ben-Awadh AN, 2014, ENDOCRINOLOGY, V155, P2797, DOI 10.1210/en.2014-1046; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bredella MA, 2014, BONE, V66, P199, DOI 10.1016/j.bone.2014.06.014; Bredella MA, 2009, J CLIN ENDOCR METAB, V94, P2129, DOI 10.1210/jc.2008-2532; Cawthorn WP, 2014, CELL METAB, V20, P368, DOI 10.1016/j.cmet.2014.06.003; DeMambro VE, 2008, ENDOCRINOLOGY, V149, P2051, DOI 10.1210/en.2007-1068; DeMambro VE, 2015, ENDOCRINOLOGY, V156, P4129, DOI 10.1210/en.2014-1452; Dempster DW, 2001, J BONE MINER RES, V16, P1846, DOI 10.1359/jbmr.2001.16.10.1846; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Esen E, 2015, J BONE MINER RES, V30, P1959, DOI 10.1002/jbmr.2556; Fan Y, 2017, CELL METAB, V25, P661, DOI 10.1016/j.cmet.2017.01.001; Fazeli PK, 2014, BONE, V66, P39, DOI 10.1016/j.bone.2014.05.014; Fazeli PK, 2014, J CLIN ENDOCR METAB, V99, P1322, DOI 10.1210/jc.2013-4105; Fazeli PK, 2013, J CLIN ENDOCR METAB, V98, P935, DOI 10.1210/jc.2012-3634; Fazeli PK, 2012, J BONE MINER RES, V27, P1864, DOI 10.1002/jbmr.1640; Gasparrini M, 2009, EXP GERONTOL, V44, P613, DOI 10.1016/j.exger.2009.05.009; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Iwaniec UT, 2013, BONE, V53, P145, DOI 10.1016/j.bone.2012.11.034; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Kim SW, 2012, J BONE MINER RES, V27, P2075, DOI 10.1002/jbmr.1665; Knopp E, 2005, ENDOCRINOLOGY, V146, P1983, DOI 10.1210/en.2004-0770; Kulkarni NH, 2007, J CELL BIOCHEM, V102, P1504, DOI 10.1002/jcb.21374; Larsson S, 2016, CELL SIGNAL, V28, P204, DOI 10.1016/j.cellsig.2015.12.012; Maridas DE, 2018, JOVE-J VIS EXP, DOI 10.3791/56750; Misra M, 2014, J ENDOCRINOL, V221, pR163, DOI 10.1530/JOE-14-0039; Pack AI, 2007, PHYSIOL GENOMICS, V28, P232, DOI 10.1152/physiolgenomics.00139.2006; Qiu T, 2015, J BONE MINER RES, V30, P309, DOI 10.1002/jbmr.2327; Rahman S, 2013, ENDOCRINOLOGY, V154, P2687, DOI 10.1210/en.2012-2162; Rickard DJ, 2006, BONE, V39, P1361, DOI 10.1016/j.bone.2006.06.010; Schwartz AV, 2013, J CLIN ENDOCR METAB, V98, P2294, DOI 10.1210/jc.2012-3949; Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005; SINHA TK, 1976, METABOLISM, V25, P251, DOI 10.1016/0026-0495(76)90083-4; Towell DB, 2001, BRIT J CLIN PSYCHOL, V40, P189, DOI 10.1348/014466501163634; TRZECIAK WH, 1974, EUR J BIOCHEM, V46, P201, DOI 10.1111/j.1432-1033.1974.tb03612.x; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; Wang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074255; Wein MN, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14745	44	39	40	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2885	2898		10.1096/fj.201800948RR	http://dx.doi.org/10.1096/fj.201800948RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30354669	Bronze, Green Published			2022-12-26	WOS:000457296600108
J	Tezuka, T; Ota, A; Karnan, S; Matsuura, K; Yokoo, K; Hosokawa, Y; Vigetti, D; Passi, A; Hatano, S; Umezawa, K; Watanabe, H				Tezuka, Takehiko; Ota, Akinobu; Karnan, Sivasundaram; Matsuura, Katsuhiko; Yokoo, Kazuhisa; Hosokawa, Yoshitaka; Vigetti, Davide; Passi, Alberto; Hatano, Sonoko; Umezawa, Kazuo; Watanabe, Hideto			The plant alkaloid conophylline inhibits matrix formation of fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix; fibroblast; transforming growth factor (TGF); hyaluronan; collagen; fibrosis; anti-fibrotic; conophylline; stellate cell; Vinca alkaloid	EPITHELIAL-MESENCHYMAL TRANSITION; STELLATE CELLS; HYALURONAN; DIFFERENTIATION; TRANSCRIPTION; SUPPRESSES; EXPRESSION; FIBROSIS; COLLAGEN; BIOSYNTHESIS	Conophylline is a Vinca alkaloid from leaves of the tropical plant Ervatamia microphylla and has been shown to mimic the effect of the growth and differentiation factor activin A on pancreatic progenitor cells. However, activin A stimulates fibrosis of pancreatic stellate cells, whereas conophylline inhibits it, suggesting that this compound may serve as an antifibrotic drug. Here we investigated the effects of conophylline on human foreskin fibroblasts, especially focusing on extracellular matrix (ECM) proteins. A gene microarray analysis revealed that conophylline remarkably suppressed expression of the gene for hyaluronan synthase 2 (HAS2) and of its antisense RNA, whereas the expression of collagen genes was unaffected. Of note, immunostaining experiments revealed that conophylline substantially inhibits incorporation of versican and collagens into the ECM in cells treated with transforming growth factor (TGF), which promotes collagen synthesis, but not in cells not treated with TGF. Moreover, a protein biosynthesis assay disclosed that conophylline decreases collagen biosynthesis, concomitant with a decrease in total protein biosynthesis, indicating that conophylline-mediated inhibition of fibrosis is not specific to collagen synthesis. Conophylline affected neither TGF-induced nuclear translocation of SMAD family member 2/3 (SMAD2/3) nor phosphorylation of SMAD2. However, conophylline substantially inhibited phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), suggesting that conophylline inhibits HAS2 expression via TGF-mediated activation of the ERK1/2 pathway. Taken together, our results indicate that conophylline may be a useful inhibitor of ECM formation in fibrosis.	[Tezuka, Takehiko; Matsuura, Katsuhiko] Aichi Med Univ, Sch Med, Dept Pharm, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan; [Ota, Akinobu; Karnan, Sivasundaram; Hosokawa, Yoshitaka] Aichi Med Univ, Sch Med, Dept Biochem, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan; [Yokoo, Kazuhisa] Aichi Med Univ, Sch Med, Dept Plast & Reconstruct Surg, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan; [Umezawa, Kazuo] Aichi Med Univ, Sch Med, Dept Mol Target Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan; [Tezuka, Takehiko; Hatano, Sonoko; Watanabe, Hideto] Aichi Med Univ, Sch Med, Inst Mol Sci Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan; [Vigetti, Davide; Passi, Alberto] Univ Insubria, Dept Med & Surg, Via Guicciardini 9, I-21100 Varese, Italy	Aichi Medical University; Aichi Medical University; Aichi Medical University; Aichi Medical University; Aichi Medical University; University of Insubria	Watanabe, H (corresponding author), Aichi Med Univ, Inst Mol Sci Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	wannabee@aichi-med-u.ac.jp	Ota, Akinobu/CAC-5999-2022; passi, alberto g/A-1752-2018; Ota, Akinobu/AAI-9396-2020; Ota, Akinobu/H-4510-2019	Ota, Akinobu/0000-0002-6296-2921; passi, alberto g/0000-0003-3328-3089; Watanabe, Hideto/0000-0001-5291-0696	 [25293096];  [15K19561];  [25460395]	; ; 	This work was supported in part by Grant-in-Aid (KAKENHI) for Scientific Research B, 25293096 (to H. W.), Grant-in-Aid (KAKENHI) for Young Scientists B, 15K19561 (to A. O.), and Grant-in-Aid (KAKENHI) for Scientific Research C, 25460395 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Atsumi S, 2003, CELL MOL LIFE SCI, V60, P2516, DOI 10.1007/s00018-003-3299-x; Bedi A, 2012, MOL CANCER THER, V11, P2429, DOI 10.1158/1535-7163.MCT-12-0101-T; Birbrair A, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt512; BLOM A, 1995, J BIOL CHEM, V270, P9698, DOI 10.1074/jbc.270.17.9698; Chao H, 2005, J BIOL CHEM, V280, P27513, DOI 10.1074/jbc.M411544200; Etscheid M, 2005, CELL SIGNAL, V17, P1486, DOI 10.1016/j.cellsig.2005.03.007; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Evanko SP, 2015, MATRIX BIOL, V42, P74, DOI 10.1016/j.matbio.2014.12.001; Ghatak S, 2017, J BIOL CHEM, V292, P10465, DOI 10.1074/jbc.M116.752451; HATA RI, 1980, BIOCHEMISTRY-US, V19, P169, DOI 10.1021/bi00542a026; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; Kojima I, 2006, INT J BIOCHEM CELL B, V38, P923, DOI 10.1016/j.biocel.2005.09.019; Kolosova I, 2011, J CELL PHYSIOL, V226, P1248, DOI 10.1002/jcp.22448; Kubo N, 2014, LIVER INT, V34, P1057, DOI 10.1111/liv.12328; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Li YJ, 2007, INT J CANCER, V120, P2557, DOI 10.1002/ijc.22550; Liu XY, 2014, CELL SIGNAL, V26, P2276, DOI 10.1016/j.cellsig.2014.05.018; Maeda-Sano K, 2014, BBA-MOL CELL BIOL L, V1841, P1256, DOI 10.1016/j.bbalip.2014.05.004; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Michael DR, 2011, J BIOL CHEM, V286, P19523, DOI 10.1074/jbc.M111.233916; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Murasawa Y, 2018, AM J PATHOL, V188, P432, DOI 10.1016/j.ajpath.2017.10.015; Nakade Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178436; Neary R, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0035-8; Ogata T, 2004, DIABETES, V53, P2596, DOI 10.2337/diabetes.53.10.2596; Porsch H, 2013, ONCOGENE, V32, P4355, DOI 10.1038/onc.2012.475; Renzoni EA, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-24; Saito R, 2012, ENDOCRINOLOGY, V153, P621, DOI 10.1210/en.2011-1767; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Schiller M, 2010, J BIOL CHEM, V285, P409, DOI 10.1074/jbc.M109.038620; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P614, DOI 10.1164/arrd.1983.127.5.614; Seubwai W, 2015, ONCOL RES, V23, P21, DOI 10.3727/096504015X14424348426071; Suwan K, 2009, J BIOL CHEM, V284, P8596, DOI 10.1074/jbc.M806927200; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Udabage L, 2005, CANCER RES, V65, P6139, DOI 10.1158/0008-5472.CAN-04-1622; UMEZAWA K, 1994, ANTICANCER RES, V14, P2413; Vigetti D, 2014, FASEB J, V28; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	41	5	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20214	20226		10.1074/jbc.RA118.005783	http://dx.doi.org/10.1074/jbc.RA118.005783			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30377255	hybrid, Green Published			2022-12-26	WOS:000454685900027
J	Fortuna, D; Hooper, DC; Roberts, AL; Harshyne, LA; Nagurney, M; Curtis, MT				Fortuna, Danielle; Hooper, D. Craig; Roberts, Amity L.; Harshyne, Larry A.; Nagurney, Michelle; Curtis, Mark T.			Potential role of CSF cytokine profiles in discriminating infectious from non-infectious CNS disorders	PLOS ONE			English	Article							NERVOUS-SYSTEM LYMPHOMA; CEREBROSPINAL-FLUID; AUTOIMMUNE ENCEPHALITIS; MULTIPLE-SCLEROSIS; GENE-EXPRESSION; CELL LYMPHOMA; DIAGNOSIS; CHEMOKINE; VIRUS; ALPHA	Current laboratory testing of cerebrospinal fluid (CSF) does not consistently discriminate between different central nervous system (CNS) disease states. Rapidly distinguishing CNS infections from other brain and spinal cord disorders that share a similar clinical presentation is critical. New approaches focusing on aspects of disease biology, such as immune response profiles that can have stimulus-specific attributes, may be helpful. We undertook this preliminary proof-of-concept study using multiplex ELISA to measure CSF cytokine levels in various CNS disorders (infections, autoimmune/demyelinating diseases, lymphomas, and gliomas) to determine the potential utility of cytokine patterns in differentiating CNS infections from other CNS diseases. Both agglomerative hierarchical clustering and mixture discriminant analyses revealed grouping of CNS disease types based on cytokine expression. To further investigate the ability of CSF cytokine levels to distinguish various CNS disease states, non-parametric statistical analysis was performed. Mann-Whitney test analysis demonstrated that CNS infections are characterized by significantly higher CSF IP-10/ CXCL10 levels than the pooled non-infectious CNS disorders (p = 0.0001). Within the infection group, elevated levels of MDC/CCL22 distinguished non-viral from viral infections (p = 0.0048). Each disease group of the non-infectious CNS disorders independently showed IP10/CXCL10 levels that are significantly lower than the infection group [(autoimmune /demyelinating disorders (p = 0.0005), lymphomas (p = 0.0487), gliomas (p = 0.0294), and controls (p = 0.0001)]. Additionally, of the non-infectious diseases, gliomas can be distinguished from lymphomas by higher levels of GRO/CXCL1 (p = 0.0476), IL-7 (p = 0.0119), and IL-8 (p = 0.0460). Gliomas can also be distinguished from autoimmune/demyelinating disorders by higher levels of GRO/CXCL1 (p = 0.0044), IL-7 (p = 0.0035) and IL-8 (p = 0.0176). Elevated CSF levels of PDGF-AA distinguish lymphomas from autoimmune/demyelinating cases (p = 0.0130). Interrogation of the above comparisons using receiver operator characteristic analysis demonstrated area under the curve (AUC) values (ranging from 0.8636-1.0) that signify good to excellent utility as potential diagnostic discriminators. In conclusion,our work indicates that upon formal validation, measurement of CSF cytokine levels may have clinical utility in both identifying a CNS disorder as infectious in etiology and, furthermore, in distinguishing viral from non-viral CNS infections.	[Fortuna, Danielle] Hosp Univ Penn, Dept Pathol & Lab Med, 3400 Spruce St, Philadelphia, PA 19104 USA; [Hooper, D. Craig] Thomas Jefferson Univ Hosp, Dept Neurosurg, Philadelphia, PA 19107 USA; [Hooper, D. Craig; Harshyne, Larry A.] Thomas Jefferson Univ, Dept Canc Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Roberts, Amity L.; Nagurney, Michelle; Curtis, Mark T.] Thomas Jefferson Univ Hosp, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	University of Pennsylvania; Pennsylvania Medicine; Jefferson University; Jefferson University; Jefferson University	Curtis, MT (corresponding author), Thomas Jefferson Univ Hosp, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	mark.curtis@jefferson.edu		Harshyne, Larry/0000-0002-8699-3028; Hooper, Douglas/0000-0002-8578-5104; curtis, mark/0000-0003-0198-7583				Nguyen AL, 2017, BRIT J PHARMACOL, V174, P1895, DOI 10.1111/bph.13780; Armangue T, 2014, CURR OPIN NEUROL, V27, P361, DOI 10.1097/WCO.0000000000000087; Arora S, 2011, INFECT IMMUN, V79, P1915, DOI 10.1128/IAI.01270-10; Bale JF, 2015, PEDIATR NEUROL, V53, P3, DOI 10.1016/j.pediatrneurol.2015.03.013; Bush NAO, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0585-6; Chai QQ, 2015, J VIROL, V89, P870, DOI 10.1128/JVI.02154-14; Coutinho LG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-326; Dwyer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045562; Fortuna D, 2017, J CLIN VIROL, V86, P39, DOI 10.1016/j.jcv.2016.11.007; Fraser E, 2015, CHIN CLIN ONCOL, V4, DOI 10.3978/j.issn.2304-3865.2015.02.01; Griffin DE, 2010, PROG NEUROBIOL, V91, P95, DOI 10.1016/j.pneurobio.2009.12.003; Hassan MA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005619; Herzig DS, 2014, CRIT CARE, V18, DOI 10.1186/cc13902; Hosking MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000937; John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033; Karabatsou K, 2006, J NEURO-ONCOL, V79, P171, DOI 10.1007/s11060-005-9102-0; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Kim DS, 2009, RADIOLOGY, V251, P467, DOI 10.1148/radiol.2512072071; Kim KS, 2009, EXPERT OPIN PHARMACO, V10, P1307, DOI 10.1517/14656560902953720; Kothur K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161656; Kothur K, 2016, CYTOKINE, V77, P227, DOI 10.1016/j.cyto.2015.10.001; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Lancaster E, 2016, J CLIN NEUROL, V12, P1, DOI 10.3988/jcn.2016.12.1.1; Lin WL, 2016, J MICROBIOL IMMUNOL, V49, P723, DOI 10.1016/j.jmii.2014.08.013; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Lund TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032218; Lupo P, 2008, INFECT IMMUN, V76, P1581, DOI 10.1128/IAI.01184-07; Mahadevan D, 2005, MOL CANCER THER, V4, P1867, DOI 10.1158/1535-7163.MCT-05-0146; Valverde-Villegas JM, 2018, INFECT GENET EVOL, V57, P51, DOI 10.1016/j.meegid.2017.11.002; Matsukawa A, 2000, J IMMUNOL, V164, P5362, DOI 10.4049/jimmunol.164.10.5362; Michael BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146288; Milo R, 2016, AUTOIMMUN REV, V15, P714, DOI 10.1016/j.autrev.2016.03.006; Miyauchi K, 2011, CANCER SCI, V102, P1236, DOI 10.1111/j.1349-7006.2011.01924.x; Nath A, 2013, ANN NEUROL, V74, P412, DOI 10.1002/ana.23988; Norose K, 2011, INVEST OPHTH VIS SCI, V52, P389, DOI 10.1167/iovs.10-5819; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Osuka K, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0142-2; Palomero J, 2014, BLOOD, V124, P2235, DOI 10.1182/blood-2014-04-569566; Pusterla N, 2006, AM J VET RES, V67, P1433, DOI 10.2460/ajvr.67.8.1433; Sanden E, 2016, PEDIATR BLOOD CANCER, V63, P2112, DOI 10.1002/pbc.26158; Scott BJ, 2013, JAMA NEUROL, V70, P311, DOI 10.1001/jamaneurol.2013.606; Sonnier DI, 2012, SHOCK, V37, P63, DOI 10.1097/SHK.0b013e31823cbff1; Sulik A, 2014, SCAND J IMMUNOL, V79, P68, DOI 10.1111/sji.12131; Sulzbacher I, 2000, MODERN PATHOL, V13, P632, DOI 10.1038/modpathol.3880109; Warford J, 2017, CAN J NEUROL SCI, V44, P96, DOI 10.1017/cjn.2016.310; Zhou Y, 2005, CARCINOGENESIS, V26, P2058, DOI 10.1093/carcin/bgi182	46	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205501	10.1371/journal.pone.0205501	http://dx.doi.org/10.1371/journal.pone.0205501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379898	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700051
J	Horumpende, PG; Said, SH; Mazuguni, FS; Antony, ML; Kumburu, HH; Sonda, TB; Mwanziva, CE; Mshana, SE; Mmbaga, BT; Kajeguka, DC; Chilongola, JO				Horumpende, Pius G.; Said, Sophia H.; Mazuguni, Festo S.; Antony, Magreth L.; Kumburu, Happiness H.; Sonda, Tolbert B.; Mwanziva, Charles E.; Mshana, Stephen E.; Mmbaga, Blandina T.; Kajeguka, Debora C.; Chilongola, Jaffu O.			Prevalence, determinants and knowledge of antibacterial self-medication: A cross sectional study in North-eastern Tanzania	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; UNIVERSITY-STUDENTS; PRESCRIPTION; CHILDREN; AVAILABILITY; POPULATION; PHARMACIES; MANAGEMENT; CRISIS	Self-medication is very common especially in developing countries and is documented to be associated with many health risks including antibiotic resistance. This study investigated the prevalence, determinants and knowledge of self-medication among residents of Siha District in Tanzania. A cross-sectional study was conducted among 300 residents in a rural District of Kilimanjaro region, North-eastern Tanzania from 1st to 28th April 2017. A semi-structured questionnaire was used to collect information regarding drugs used, knowledge, history and reasons for antibiotic self-medication. Log-binomial regression analysis was done using STATA 13 to examine factors associated with self-medication. A slightly majority of the respondents (58%) admitted to self-medication. Antibiotics most commonly utilized were amoxycillin (43%) and an antiprotozoal drug metronidazole (10%). The most common symptoms that led to self-medication were cough (51.17%), headache/ fever/ malaria (25.57%) and diarrhoea (21.59%). The most common reasons for self-medication were emergency illness (24.00%), health facility charges (20.33%), proximity of pharmacy to home (17.00%) and no reason (16.66%). Almost all reported that self-medication is not better than seeking medical consultation, 98% can result into harmful effects and 96% can result to drug resistance. The level of self-medication in this study is comparable with findings from other studies in developing countries. Pharmacies were commonly used as the first point of medical care. There is therefore a need for educative antibiotic legislative intervention to mitigate the adverse effects of antibiotic self-medication in Siha district in Tanzania.	[Horumpende, Pius G.; Said, Sophia H.; Kumburu, Happiness H.; Sonda, Tolbert B.; Kajeguka, Debora C.; Chilongola, Jaffu O.] Kilimanjaro Christian Med Univ Coll, Dept Microbiol Immunol & Mol Biol, Moshi, Kilimanjaro, Tanzania; [Horumpende, Pius G.; Kumburu, Happiness H.; Sonda, Tolbert B.; Mmbaga, Blandina T.; Chilongola, Jaffu O.] Kilimanjaro Clin Res Inst, Dept Microbiol Immunol & Mol Biol, Moshi, Kilimanjaro, Tanzania; [Horumpende, Pius G.; Mwanziva, Charles E.] Lugalo Gen Mil Hosp, Dept Prevent Med & Res, Dar Es Salaam, Tanzania; [Mazuguni, Festo S.] Ifakara Hlth Inst, Dept Publ Hlth & Res, Dar Es Salaam, Tanzania; [Antony, Magreth L.] Qual Assurance & Training Ctr, Dept Parasitol & Entomol, Natl Hlth Lab, Dar Es Salaam, Tanzania; [Mshana, Stephen E.] Catholic Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Mwanza, Tanzania; [Mmbaga, Blandina T.] Kilimanjaro Christian Med Ctr, Dept Paediat & Child Hlth, Moshi, Kilimanjaro, Tanzania	Ifakara Health Institute; Kilimanjaro Christian Medical Centre	Horumpende, PG (corresponding author), Kilimanjaro Christian Med Univ Coll, Dept Microbiol Immunol & Mol Biol, Moshi, Kilimanjaro, Tanzania.; Horumpende, PG (corresponding author), Kilimanjaro Clin Res Inst, Dept Microbiol Immunol & Mol Biol, Moshi, Kilimanjaro, Tanzania.; Horumpende, PG (corresponding author), Lugalo Gen Mil Hosp, Dept Prevent Med & Res, Dar Es Salaam, Tanzania.	p.horumpende@kcri.ac.tz	Mmbaga, Blandina Theophil/AAR-8707-2021; Chilongola, Jaffu/K-9552-2017; Mshana, Stephen/AAE-1900-2022; Horumpende, Pius/AAS-2712-2020; Kajeguka, Debora Charles/AAM-1007-2021	Mmbaga, Blandina Theophil/0000-0002-5550-1916; Chilongola, Jaffu/0000-0003-2997-6747; Horumpende, Pius/0000-0003-1241-6997; Kajeguka, Debora Charles/0000-0003-4341-5938; Mazuguni, Festo/0000-0002-0984-7529				Abasaeed A, 2009, J INFECT DEV COUNTR, V3, P491, DOI 10.3855/jidc.466; Al Rasheed A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3916874; Bansal D, 2014, INDIAN J PHARM SCI, V76, P211; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Casburn-Jones AC, 2004, GUT, V53, P296, DOI 10.1136/gut.2003.022103; Centre for Pharmaceutical Management, 2008, ACCREDITED DRUG DISP; Chalker JC, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0075-2; Chipwaza B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-252; Chung A, 2007, BMJ-BRIT MED J, V335, P429, DOI 10.1136/bmj.39274.647465.BE; Coles CL, 2013, CLIN INFECT DIS, V56, P1519, DOI 10.1093/cid/cit137; Colom K, 2003, FEMS MICROBIOL LETT, V223, P147, DOI 10.1016/S0378-1097(03)00306-9; da Silva MGC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-339; de Loyola AI, 2002, REV SAUDE PUBL, V36, P55, DOI 10.1590/S0034-89102002000100009; Del Mar C, 2007, BMJ-BRIT MED J, V335, P407, DOI 10.1136/bmj.39307.642963.80; Donkor ES, 2012, INT J ENV RES PUB HE, V9, P3519, DOI 10.3390/ijerph9103519; Donnan PT, 2004, BRIT MED J, V328, P1297, DOI 10.1136/bmj.328.7451.1297; Duong DV, 1997, TROP MED INT HEALTH, V2, P1133, DOI 10.1046/j.1365-3156.1997.d01-213.x; Esimone CO, 2007, PHARM WORLD SCI, V29, P655, DOI 10.1007/s11096-007-9124-0; Geissler PW, 2000, SOC SCI MED, V50, P1771, DOI 10.1016/S0277-9536(99)00428-1; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Justin-Temu M, 2010, East Afr J Public Health, V7, P282; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V310, P2385, DOI 10.1001/jama.2013.283828; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V310, P2135, DOI 10.1001/jama.2013.281452; Levson G, 2013, PEOPLES KNOWLEDGE AT; Liana JH, ACCREDITED DRUG DISP, DOI [10.1186/s40545-015-0044-4, DOI 10.1186/S40545-015-0044-4]; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Llor C, 2014, THER ADV DRUG SAF, V5, P229, DOI 10.1177/2042098614554919; LONDON N, 1994, J ANTIMICROB CHEMOTH, V34, P239, DOI 10.1093/jac/34.2.239; Lucet JC, 2011, J ANTIMICROB CHEMOTH, V66, P936, DOI 10.1093/jac/dkq541; Lyimo B, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0870-9; Mainous AG, 2009, ANN FAM MED, V7, P431, DOI 10.1370/afm.999; Marwa KJ, 2015, AIDS RES TREAT, V2015, DOI 10.1155/2015/103874; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V60, pI63, DOI 10.1093/jac/dkm161; Michael CA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00145; Ministry of Planning E and E, 2012, TANZANIA POPULATION; MSHANA SE, 2013, ANN CLIN MICROB ANTI, V12, P15660; Mukonzo JK, 2013, J MULTIDISCIP HEALTH, V6, P303, DOI 10.2147/JMDH.S49075; Mwanyika G. O., 2017, African Journal of Microbiology Research, V11, P45, DOI 10.5897/ajmr2016.8282; Nesme J, 2014, CURR BIOL, V24, P1096, DOI 10.1016/j.cub.2014.03.036; Ngigi CK, 2016, IMP J INTERDISCIP RE, V2, P2454; Nunez M., 2016, PERU MED U, V18, P205; Ocan M, FACTORS PREDICTING H; Ogunfowokan AA, 2010, J SCH NURS, V26, P131, DOI 10.1177/1059840509349723; Omolase CO, 2007, ANN IBADAN POSTGRADU, V5, P64, DOI [DOI 10.4314/AIPM.V5I2.64032, 10.4314/aipm.v5i2.64032]; Osemene KP, 2012, TROP J PHARM RES, V11, P683, DOI 10.4314/tjpr.v11i4.21; Pan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041314; Pawlowski SW, 2009, GASTROENTEROLOGY, V136, P1874, DOI 10.1053/j.gastro.2009.02.072; Rather IA, 2017, SAUDI J BIOL SCI, V24, P808, DOI 10.1016/j.sjbs.2017.01.004; Raz R, 2005, ISRAEL MED ASSOC J, V7, P722; Rutta Edmund, 2015, J Pharm Policy Pract, V8, P23, DOI 10.1186/s40545-015-0044-4; Sapkota AR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-610; Saradamma RD, 2000, SOC SCI MED, V50, P891, DOI 10.1016/S0277-9536(99)00380-9; Sarahroodi S, 2010, INT J PHARMACOL, V6, P48; Shah SJ, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-74; Singh AS, 2014, INT J EC COMMER MANA, V2; Spellberg B, 2014, CLIN INFECT DIS, V59, pS71, DOI 10.1093/cid/ciu392; Valimba Richard, 2014, J Pharm Policy Pract, V7, P11, DOI 10.1186/2052-3211-7-11; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Vandebroek I, 2004, B WORLD HEALTH ORGAN, V82, P243; Ventola C Lee, 2015, P T, V40, P277; Williams-Nguyen J, 2016, J ENVIRON QUAL, V45, P394, DOI 10.2134/jeq2015.07.0336; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Zafar Syed Nabeel, 2008, J Pak Med Assoc, V58, P214; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	65	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206623	10.1371/journal.pone.0206623	http://dx.doi.org/10.1371/journal.pone.0206623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY7VH	30379961	Green Submitted, Green Published, gold			2022-12-26	WOS:000448823700138
J	Schaller, JC; Davidowitz, G; Papaj, DR; Smith, RL; Carriere, Y; Moore, W				Schaller, Jason C.; Davidowitz, Goggy; Papaj, Daniel R.; Smith, Robert L.; Carriere, Yves; Moore, Wendy			Molecular phylogeny, ecology and multispecies aggregation behaviour of bombardier beetles in Arizona	PLOS ONE			English	Article							COLEOPTERA; ASSOCIATIONS; CARABIDAE; BIRDS	Aggregations of conspecific animals are common and have been documented in most phyla. Multispecies aggregations are less common and less well studied. Eight species of Brachinus beetles -famous for their unique, highly effective, chemical defense-regularly settle together form large diurnal multispecies aggregations in dark, moist areas in riparian habitats in the Sonoran Desert Region. Here, we document these multispecies aggregations and investigate the incidence and dynamics of aggregation behavior. Analysis of species composition of 59 field-collected aggregations revealed that 71% contained more than one species, eight species regularly co-occurred in aggregations, and no two species showed a preference to aggregate with one another. We provide the first phylogenetic analyses of participants in multispecies aggregations, and find that Brachinus species found together in aggregations are not each other's closest relatives but rather are dispersed throughout the phylogeny of the genus. Further, we find no tendency for species to aggregate with close relatives more frequently than distant relatives. Laboratory experiments on B. elongatulus showed that it chose to settle in occupied shelters over empty shelters. Experiments with B. hirsutus and B. elongatulus showed that B. hirsutus prefers to settle under shelters housing heterospecifics over conspecifics. Our findings suggest that these multispecies aggregations do not form by chance, but rather are initiated by a genus-wide aggregation cue associated with the presence of individuals already in a shelter, which is likely to be chemical and potentially tactile in nature.	[Schaller, Jason C.; Davidowitz, Goggy; Smith, Robert L.; Carriere, Yves; Moore, Wendy] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Papaj, Daniel R.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	University of Arizona; University of Arizona	Moore, W (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	wmoore@email.arizona.edu		Moore, Wendy/0000-0003-4441-6203	Division of Environmental Biology [0908187]; Division of Integrative Organismal Systems [1053318]	Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the Division of Environmental Biology, 0908187 to WM, and the Division of Integrative Organismal Systems, 1053318 to GD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANESHANSLEY DJ, 1969, SCIENCE, V165, P61, DOI 10.1126/science.165.3888.61; Arndt EM, 2015, SCIENCE, V348, P563, DOI 10.1126/science.1261166; Bertram B.C.R., 1978, P64; Brandmayr TZ, 2006, ETHOL ECOL EVOL, V18, P335, DOI 10.1080/08927014.2006.9522700; CLARK KL, 1979, BEHAV ECOL SOCIOBIOL, V5, P359, DOI 10.1007/BF00292524; Cullen DA, 2010, J INSECT PHYSIOL, V56, P937, DOI 10.1016/j.jinsphys.2010.04.023; EISNER T, 1962, EVOLUTION, V16, P316, DOI 10.2307/2406280; Erwin T. L., 1970, Quaest. ent., V6, P4; ERWIN TERRY L., 1967, COLEOPT BULL, V21, P41; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HEINRICH B, 1980, BEHAV ECOL SOCIOBIOL, V7, P179, DOI 10.1007/BF00299362; Jeannel R., 1942, FAUNE FRANCE; JULIANO S A, 1984, Coleopterists Bulletin, V38, P358; JULIANO SA, 1985, CAN J ZOOL, V63, P1683, DOI 10.1139/z85-250; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; King J.L., 1919, Annals of the Entomological Society of America, V12; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LINSLEY EG, 1961, EVOLUTION, V15, P15, DOI 10.2307/2405840; Machado G, 1998, J ARACHNOL, V26, P389; Miller M.A., 2010, P GAT COMP ENV WORKS; Palestrini C, 1998, J ZOOL, V245, P101, DOI 10.1111/j.1469-7998.1998.tb00077.x; Saska P, 2004, J ZOOL, V262, P29, DOI 10.1017/S0952836903004412; Saska P, 2008, ANN ENTOMOL SOC AM, V101, P533, DOI 10.1603/0013-8746(2008)101[533:SOACPB]2.0.CO;2; SCHILDKNECHT H, 1969, NATURWISSENSCHAFTEN, V56, P328, DOI 10.1007/BF00602176; SCHILDKNECHT H, 1961, ANGEW CHEM INT EDIT, V73, P1, DOI 10.1002/ange.19610730102; SCHILDKNECHT H, 1957, ANGEW CHEM INT EDIT, V69, P62, DOI 10.1002/ange.19570690115; SILLENTULLBERG B, 1988, AM NAT, V132, P723, DOI 10.1086/284884; Srinivasan U, 2010, J ANIM ECOL, V79, P948, DOI 10.1111/j.1365-2656.2010.01707.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sugiura S, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2017.0647; TERBORGH J, 1990, AM J PRIMATOL, V21, P87, DOI 10.1002/ajp.1350210203; Wada-Katsumata A, 2015, P NATL ACAD SCI USA, V112, P15678, DOI 10.1073/pnas.1504031112; Wautier V., 1971, Insectes Sociaux, V18, P1; Wickham H. F., 1893, Bulletin Lab Iowa, Vii, P330; Wild AL, 2008, MOL PHYLOGENET EVOL, V48, P877, DOI 10.1016/j.ympev.2008.05.023	35	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205192	10.1371/journal.pone.0205192	http://dx.doi.org/10.1371/journal.pone.0205192			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379830	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700030
J	Bittel, AM; Saldivar, IS; Dolman, NJ; Nan, XL; Gibbs, SL				Bittel, Amy M.; Saldivar, Isaac S.; Dolman, Nick J.; Nan, Xiaolin; Gibbs, Summer L.			Superresolution microscopy with novel BODIPY-based fluorophores	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; FLUORESCENCE MICROSCOPY; STORM; PROBES; DYES	Multicolor single-molecule localization microscopy (SMLM) expands our understanding of subcellular details and enables the study of biomolecular interactions through precise visualization of multiple molecules in a single sample with resolution of similar to 10-20 nm. Probe selection is vital to multicolor SMLM, as the fluorophores must not only exhibit minimal spectral crosstalk, but also be compatible with the same photochemical conditions that promote fluorophore photoswitching. While there are numerous commercially available photoswitchable fluorophores that are optimally excited in the standard Cy3 channel, they are restricted to short Stokes shifts (<30 nm), limiting the number of colors that can be resolved in a single sample. Furthermore, while imaging buffers have been thoroughly examined for commonly used fluorophore scaffolds including cyanine, rhodamine, and oxazine, optimal conditions have not been found for the BODIPY scaffold, precluding its routine use for multicolor SMLM. Herein, we screened common imaging buffer conditions including seven redox reagents with five additives, resulting in 35 overall imaging buffer conditions to identify compatible combinations for BODIPY-based fluorophores. We then demonstrated that novel, photoswitchable BODIPY-based fluorophores with varied length Stokes shifts provide additional color options for SMLM using a combination of BODIPY-based and commercially available photoswitchable fluorophores.	[Bittel, Amy M.; Saldivar, Isaac S.; Nan, Xiaolin; Gibbs, Summer L.] Oregon Hlth & Sci Univ, Biomed Engn Dept, Portland, OR 97201 USA; [Dolman, Nick J.] Thermo Fisher Sci, Pittsburg, KS USA; [Nan, Xiaolin; Gibbs, Summer L.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Nan, Xiaolin; Gibbs, Summer L.] Oregon Hlth & Sci Univ, OHSU Ctr Spatial Syst Biomed, Portland, OR 97201 USA	Oregon Health & Science University; Thermo Fisher Scientific; Oregon Health & Science University; Oregon Health & Science University	Gibbs, SL (corresponding author), Oregon Hlth & Sci Univ, Biomed Engn Dept, Portland, OR 97201 USA.; Gibbs, SL (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.; Gibbs, SL (corresponding author), Oregon Hlth & Sci Univ, OHSU Ctr Spatial Syst Biomed, Portland, OR 97201 USA.	gibbss@ohsu.edu		Nan, Xiaolin/0000-0002-0597-0255	Thermo Fisher Scientific; Damon Runyon-Rachleff Innovator Award from the Damon Runyon Cancer Research Foundation	Thermo Fisher Scientific; Damon Runyon-Rachleff Innovator Award from the Damon Runyon Cancer Research Foundation	This work was supported by a Collaborative Research Agreement from Thermo Fisher Scientific (S.L.G) and a Damon Runyon-Rachleff Innovator Award from the Damon Runyon Cancer Research Foundation (S.L.G and X.N.). The author Dr. Nick J. Dolman is an employee of Thermo Fisher Scientific and we also received funding from Thermo Fisher Scientific. Dr. Dolman's contribution to this paper include initial brainstorming on project directions as well as proof reading of the final manuscript. Therefore, we agree with the statement that "The funder provided support in the form of supplies for the project, but did not have any additional role in study design, data collection and analysis, decision to publish or preparation of the manuscript."	Adam V, 2011, CHEM BIOL, V18, P1241, DOI 10.1016/j.chembiol.2011.08.007; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bittel AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22892-8; Bittel AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29687; Carlini L, 2014, CHEMPHYSCHEM, V15, P750, DOI 10.1002/cphc.201301004; Carlini L, 2013, ACS CHEM BIOL, V8, P2643, DOI 10.1021/cb400467x; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Deschout H, 2014, NAT METHODS, V11, P253, DOI 10.1038/nmeth.2843; Edelstein AD, 2015, J BIOL METHODS, V1, P1; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Haugland R.P., 2005, HDB GUIDE FLUORESCEN; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Heilemann M, 2009, ANGEW CHEM INT EDIT, V48, P6903, DOI 10.1002/anie.200902073; Huang T, 2018, BIOPHYS J, V114, P301, DOI 10.1016/j.bpj.2017.11.013; Lampe A, 2012, BIOL CELL, V104, P229, DOI 10.1111/boc.201100011; Lehmann M, 2016, J BIOPHOTONICS, V9, P161, DOI 10.1002/jbio.201500119; Mlodzianoski MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147506; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Olivier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069004; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Prakash K, 2015, P NATL ACAD SCI USA, V112, P14635, DOI 10.1073/pnas.1516928112; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109; Stein IH, 2012, CHEMPHYSCHEM, V13, P931, DOI 10.1002/cphc.201100820; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; van de Linde S, 2010, J BIOTECHNOL, V149, P260, DOI 10.1016/j.jbiotec.2010.02.010; Vaughan JC, 2013, J AM CHEM SOC, V135, P1197, DOI 10.1021/ja3105279; Vogelsang J, 2009, P NATL ACAD SCI USA, V106, P8107, DOI 10.1073/pnas.0811875106; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Zhang ZY, 2015, NAT METHODS, V12, P935, DOI [10.1038/NMETH.3528, 10.1038/nmeth.3528]	31	7	7	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206104	10.1371/journal.pone.0206104	http://dx.doi.org/10.1371/journal.pone.0206104			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30366346	Green Published, gold, Green Submitted			2022-12-26	WOS:000448448700025
J	Kim, K; Son, YK; Lee, SM; Kim, SE; An, WS				Kim, Kitae; Son, Young Ki; Lee, Su Mi; Kim, Seong Eun; An, Won Suk			Early technical complications and long-term survival of urgent peritoneal dialysis according to break-in periods	PLOS ONE			English	Article							START; HEMODIALYSIS; INITIATION; OPTION; CAPD	Background Guidelines recommend a break-in period of 2 weeks before starting peritoneal dialysis (PD), but PD within 14 days is also an acceptable and safe alternative to hemodialysis (HD) in patients with an urgent need. However, the effect of the break-in period within 48 hours or later had not been evaluated for early technical complications, long-term maintenance, and survival in patients starting urgent PD. Methods Of 360 patients with a surgically inserted PD catheter, we evaluated 190 patients who needed urgent PD and 29 patients who received conventional PD at a single center between January 2007 and December 2014 in this retrospective observational study. Enrolled patients were divided according to break-in period of <48 hours (P1) or 2-13 days (P2) before starting urgent PD. The primary endpoint was incidence of early technical complications and secondary endpoints included long-term PD maintenance, and patient survival. Results PD was started in 103 patients (54.2%) within 48 hours and in 87 patients (45.8%) within 2 to 13 days. The incidence of early technical complication was significantly higher in P1 group (28.2%) than in P2 group (10.3%) (P = 0.002). The need for a repositioning procedure was significantly greater in P1 group (14.6%) than in P2 group (3.4%) (P = 0.009). However, we observed no significant differences between the two groups with respect to the prevalence of catheter dysfunction requiring change to HD within 6 months or incidence of peritonitis or exit-site infection. There was no significant difference in PD maintenance and patient survival according to the break-in period between P1 and P2 as well as against the control group. Conclusion Urgent PD was associated with a low incidence of early technical complications if start was avoided within 48 hours after catheter insertion, and long-term PD maintenance was independent of the break-in period.	[Kim, Kitae; Son, Young Ki; Lee, Su Mi; Kim, Seong Eun; An, Won Suk] Dong A Univ, Dept Internal Med, Busan, South Korea	Dong A University	An, WS (corresponding author), Dong A Univ, Dept Internal Med, Busan, South Korea.	anws@dau.ac.kr			Dong-A University	Dong-A University	This study was supported by research funds from Dong-A University.	Arramreddy R, 2014, AM J KIDNEY DIS, V63, P390, DOI 10.1053/j.ajkd.2013.09.018; Bae IE, 2012, J KOREAN SURG SOC, V83, P381, DOI 10.4174/jkss.2012.83.6.381; Banli O, 2005, PERITON DIALYSIS INT, V25, P556; Cullis B, 2014, PERITON DIALYSIS INT, V34, P494, DOI 10.3747/pdi.2013.00222; Dombros N., 2005, NEPHROL DIAL TRANSPL, V20, pix8, DOI DOI 10.1093/NDT/GFI1117; Figueiredo A, 2010, PERITON DIALYSIS INT, V30, P424, DOI 10.3747/pdi.2010.00087; Garcia Falcon T, 1994, Adv Perit Dial, V10, P206; Ghaffari A, 2012, AM J KIDNEY DIS, V59, P400, DOI 10.1053/j.ajkd.2011.08.034; Heaf JG, 2002, NEPHROL DIAL TRANSPL, V17, P112, DOI 10.1093/ndt/17.1.112; Jo YI, 2007, PERITON DIALYSIS INT, V27, P179; Khoshhali M, 2017, KIDNEY RES CLIN PRAC, V36, P182, DOI 10.23876/j.krcp.2017.36.2.182; Leblanc M, 2001, SEMIN DIAL; Liem YS, 2007, KIDNEY INT, V71, P153, DOI 10.1038/sj.ki.5002014; Liu YR, 2014, PERITON DIALYSIS INT, V34, P49, DOI 10.3747/pdi.2012.00293; Peppelenbosch A, 2008, CLIN KIDNEY J, V1, pIV23, DOI 10.1093/ndtplus/sfn120; Perl J, 2011, J AM SOC NEPHROL, V22, P1113, DOI 10.1681/ASN.2010111155; Povlsen JV, 2006, NEPHROL DIAL TRANSPL, V21, DOI 10.1093/ndt/gfl192; Sharma AP, 2008, NEPHROLOGY, V13, P672, DOI 10.1111/j.1440-1797.2008.01000.x; Skipper K, 1999, JSLS, V3, P63; TZAMALOUKAS AH, 1990, ADV PERIT D, V6, P64; Yang YF, 2011, PERITON DIALYSIS INT, V31, P551, DOI 10.3747/pdi.2009.00171	21	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206426	10.1371/journal.pone.0206426	http://dx.doi.org/10.1371/journal.pone.0206426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365566	Green Published, gold, Green Submitted			2022-12-26	WOS:000448448700052
J	Adu, KT; Wilson, R; Nichols, DS; Baker, AL; Bowman, JP; Britz, ML				Adu, Kayode T.; Wilson, Richard; Nichols, David S.; Baker, Anthony L.; Bowman, John P.; Britz, Margaret L.			Proteomic analysis of Lactobacillus casei GCRL163 cell-free extracts reveals a SecB homolog and other biomarkers of prolonged heat stress	PLOS ONE			English	Article							ACID TOLERANCE RESPONSE; SHOCK PROTEINS DNAK; MOLECULAR CHAPERONES; SURFACE-PROTEINS; GENOME SEQUENCE; SALT STRESS; MEMBRANE; GROWTH; GENES; TRANSLOCATION	Prolonged heat stress is one of the harsh conditions Lactobacillus casei strains encounter as non-starter lactic acid bacteria in dairy product manufacture. To understand the physiological and molecular mechanisms through which Lb. casei GCRL163 adapts to persistent elevated temperature, label-free quantitative proteomics of cell-free extracts was used to characterize the global responses of the strain cultured anaerobically in bioreactors at 30 to 45 degrees C, pH 6.5, together with GC-MS for fatty acid methyl ester analysis at different growth phases. At higher growth temperatures, repression of energy-consuming metabolic pathways, such as fatty acid, nucleotide and amino acid biosynthesis, was observed, while PTS- and ABC-type transporter systems associated with uptake of nitrogen and carbon sources were up-regulated. Alkaline shock protein Asp23_2 was only detected at 45 degrees C, expressed at high abundance, and presumptive alpha-L-fucosidase only at 40 and 45 degrees C, with highly increased abundance (log(2)-fold change of 7) at 45 degrees C. We identified a novel SecB homolog as a protein export chaperone putatively involved in posttranslational translocation systems, which was down-regulated as growth temperature increased and where the modelled 3D-structure shared architectural similarities with the Escherichia coli SecB protein. Membrane lipid analyses revealed temporal changes in fatty acid composition, cyclization of oleic acid to cyclopropane and novel cyclopentenyl moieties, and reduced synthesis of vaccenic acid, at higher temperatures. An 18kDa alpha-crystallin domain, Hsp20 family heat shock protein was more highly up-regulated in response to heat stress compared to other molecular chaperones, suggesting this protein could be a useful biomarker of prolonged heat stress in Lb. casei GCRL163.	[Adu, Kayode T.; Baker, Anthony L.; Bowman, John P.; Britz, Margaret L.] Univ Tasmania, Tasmanian Inst Agr, Hobart, Tas, Australia; [Wilson, Richard; Nichols, David S.] Univ Tasmania, Cent Sci Lab, Hobart, Tas, Australia	University of Tasmania; University of Tasmania	Adu, KT (corresponding author), Univ Tasmania, Tasmanian Inst Agr, Hobart, Tas, Australia.	kayode.adu@utas.edu.au	Bowman, John P/C-2414-2014; Britz, Margaret L/J-7632-2014; Bowman, John P./ABF-5108-2020; Wilson, Richard/H-8429-2012; Baker, Anthony/C-2433-2014	Bowman, John P/0000-0002-4528-9333; Bowman, John P./0000-0002-4528-9333; Wilson, Richard/0000-0003-0152-4394; Baker, Anthony/0000-0001-5455-2271; ADU, kayode/0000-0002-6379-8617; Nichols, David/0000-0002-8066-3132	Tasmania Graduate Research PhD Scholarship, University of Tasmania, Australia (UTAS); UTAS Faculty of Science, Engineering and Technology Dean's support funds award; NIGMS [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	Tasmania Graduate Research PhD Scholarship, University of Tasmania, Australia (UTAS); UTAS Faculty of Science, Engineering and Technology Dean's support funds award; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is funded by Tasmania Graduate Research PhD Scholarship, University of Tasmania, Australia (UTAS) and supported by UTAS Faculty of Science, Engineering and Technology Dean's support funds award.; Molecular graphics were performed with the UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, U.S.A. (supported by NIGMS P41-GM103311).	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Al-Naseri A, 2013, J PROTEOME RES, V12, P5313, DOI 10.1021/pr400661g; BANDI ZL, 1969, SEPAR SCI, V4, P83, DOI 10.1080/01496396908052238; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Bordes P, 2011, P NATL ACAD SCI USA, V108, P8438, DOI 10.1073/pnas.1101189108; Bowman JP, 2012, J PROTEOME RES, V11, P2409, DOI 10.1021/pr201137c; Broadbent JR, 2010, J BACTERIOL, V192, P2445, DOI 10.1128/JB.01618-09; Broadbent JR, 1997, SYST APPL MICROBIOL, V20, P12, DOI 10.1016/S0723-2020(97)80043-4; Chatzi KE, 2013, BIOCHEM J, V449, P25, DOI 10.1042/BJ20121227; Cohen DPA, 2006, PROTEOMICS, V6, P6485, DOI 10.1002/pmic.200600361; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; De Angelis M, 2004, PROTEOMICS, V4, P106, DOI 10.1002/pmic.200300497; De Angelis M, 2004, APPL ENVIRON MICROB, V70, P1336, DOI 10.1128/AEM.70.3.1336-1346.2004; De Angelis M, 2016, PROTEOMICS, V16, P946, DOI 10.1002/pmic.201500117; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Di Cagno R, 2006, APPL ENVIRON MICROB, V72, P4503, DOI 10.1128/AEM.01829-05; Dionisi F, 1999, LIPIDS, V34, P1107, DOI 10.1007/s11745-999-0462-8; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Ferrando V, 2015, FOOD MICROBIOL, V48, P63, DOI 10.1016/j.fm.2014.12.005; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Hahne H, 2010, J BACTERIOL, V192, P870, DOI 10.1128/JB.01106-09; Hannavy K, 1993, CURR OPIN CELL BIOL, V5, P694, DOI 10.1016/0955-0674(93)90142-D; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hochwind K, 2012, J BACTERIOL, V194, P6638, DOI 10.1128/JB.01386-12; Huang CD, 2016, NATURE, V537, P202, DOI 10.1038/nature18965; Jerga A, 2009, J BIOL CHEM, V284, P15364, DOI 10.1074/jbc.C109.002410; Jobin MP, 1998, LAIT, V78, P165, DOI 10.1051/lait:1998120; Johnson JW, 2013, ANN NY ACAD SCI, V1277, P54, DOI 10.1111/j.1749-6632.2012.06813.x; Kapila Suman, 2006, Indian J Med Sci, V60, P361; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kilstrup M, 1997, APPL ENVIRON MICROB, V63, P1826, DOI 10.1128/AEM.63.5.1826-1837.1997; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; Klotz C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02174; Kocharunchitt C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009019; Konings WN, 2002, ANTON LEEUW INT J G, V82, P3, DOI 10.1023/A:1020604203977; Konings WN, 1997, ANTON LEEUW INT J G, V71, P117, DOI 10.1023/A:1000143525601; Koponen J, 2012, J PROTEOMICS, V75, P1357, DOI 10.1016/j.jprot.2011.11.009; Kourkoutas Y, 2006, J DAIRY SCI, V89, P1439, DOI 10.3168/jds.S0022-0302(06)72212-3; Kowalska E, 2008, CELL MOL BIOL LETT, V13, P271, DOI 10.2478/s11658-007-0055-5; Kruger NJ, 1994, NEW PROTEIN TECHNIQU, V32, P9, DOI DOI 10.1385/0-89603-268-X:9; KUMAMOTO CA, 1989, P NATL ACAD SCI USA, V86, P5320, DOI 10.1073/pnas.86.14.5320; Laakso K, 2011, MICROB BIOTECHNOL, V4, P746, DOI 10.1111/j.1751-7915.2011.00275.x; Luders S, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-36; Mansilla MC, 2004, J BACTERIOL, V186, P6681, DOI 10.1128/JB.186.20.6681-6688.2004; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Muller M, 2014, MOL MICROBIOL, V93, P1259, DOI 10.1111/mmi.12733; MULLER J, 1992, MOL GEN GENET, V235, P89, DOI 10.1007/BF00286185; Muller JP, 2000, BIOCHEM J, V348, P367, DOI 10.1042/0264-6021:3480367; NAGAMACHI E, 1991, MICROBIOL IMMUNOL, V35, P1085, DOI 10.1111/j.1348-0421.1991.tb01630.x; Nahar A, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.01235-17, 10.1128/genomea.01235-17]; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Nezhad MH, 2012, FOOD SCI BIOTECHNOL, V21, P253, DOI 10.1007/s10068-012-0033-1; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliveira AS, 2009, QUIM NOVA, V32, P139, DOI 10.1590/S0100-40422009000100027; Papadimitriou K, 2016, MICROBIOL MOL BIOL R, V80, P837, DOI 10.1128/MMBR.00076-15; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS GJ, 1990, NATURE, V344, P882, DOI 10.1038/344882a0; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; RANDALL LL, 1992, SCIENCE, V257, P241, DOI 10.1126/science.1631545; Rossi F, 2016, J THEOR BIOL, V402, P21, DOI 10.1016/j.jtbi.2016.04.029; Rothman JE, 2011, CELL, V146, P851, DOI 10.1016/j.cell.2011.08.041; Russell NJ, 1995, INT J FOOD MICROBIOL, V28, P255, DOI 10.1016/0168-1605(95)00061-5; Schneewind O, 2014, BBA-MOL CELL RES, V1843, P1687, DOI 10.1016/j.bbamcr.2013.11.009; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Scott JR, 2006, ANNU REV MICROBIOL, V60, P397, DOI 10.1146/annurev.micro.60.080805.142256; Solovjev V, 2011, METAGENOMICITAPP, P61; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; Sugimoto S, 2008, J BIOSCI BIOENG, V106, P324, DOI 10.1263/jbb.106.324; SUUTARI M, 1992, J GEN MICROBIOL, V138, P445, DOI 10.1099/00221287-138-3-445; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Tripathy S, 2016, GENOMICS, V107, P33, DOI 10.1016/j.ygeno.2015.11.005; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; Ventura M, 2004, APPL ENVIRON MICROB, V70, P6197, DOI 10.1128/AEM.70.10.6197-6209.2004; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang YZ, 2016, EUR J NUTR, V55, P821, DOI 10.1007/s00394-015-0904-3; Weidmann S, 2017, INT J FOOD MICROBIOL, V247, P18, DOI 10.1016/j.ijfoodmicro.2016.06.005; Wild J, 1996, J BACTERIOL, V178, P3608, DOI 10.1128/jb.178.12.3608-3613.1996; Wilkins JC, 2001, APPL ENVIRON MICROB, V67, P3396, DOI 10.1128/AEM.67.8.3396-3405.2001; Wilson R, 2010, MOL CELL PROTEOMICS, V9, P1296, DOI 10.1074/mcp.M000014-MCP201; Wu DD, 2011, PROTEOMICS, V11, P2580, DOI 10.1002/pmic.201000392; Yan SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120417; Zhai ZY, 2014, ENVIRON MICROBIOL, V16, P1524, DOI 10.1111/1462-2920.12280; Zhang WY, 2018, J DAIRY SCI, V101, P1915, DOI 10.3168/jds.2017-13961; Zhou JH, 2005, MOL MICROBIOL, V58, P349, DOI 10.1111/j.1365-2958.2005.04842.x	88	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206317	10.1371/journal.pone.0206317	http://dx.doi.org/10.1371/journal.pone.0206317			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359441	Green Accepted, Green Published, gold			2022-12-26	WOS:000448438400067
J	Ramli, MI; Sulong, AB; Muhamad, N; Muchtar, A; Arifin, A; Foudzi, FM; Al-Furjan, MSH				Ramli, Mohd Ikram; Sulong, Abu Bakar; Muhamad, Norhamidi; Muchtar, Andanastuti; Arifin, Amir; Foudzi, Farhana Mohd; Al-Furjan, Mohannad Saleh Hammadi			Effect of sintering parameters on physical and mechanical properties of powder injection moulded stainless steel-hydroxyapatite composite	PLOS ONE			English	Article							YTTRIA-STABILIZED ZIRCONIA; RHEOLOGICAL PROPERTIES; TEMPERATURE; COATINGS; ALLOY; MICROSTRUCTURES; BIOACTIVITY; ATMOSPHERE; CORROSION; BEHAVIOR	The combination of metallic bio-inert material, stainless-steel 316L (SS316L) and a bio-active material, hydroxyapatite (HA) can produce a composite which has superior properties for orthopaedic applications. The main objective of this study is to investigate the effects of sintering temperature and holding time on the physical and mechanical properties of the sintered part. 50wt.% SS316L and 50wt.% HA were mixed with a binder system of palm stearin (PS) and polyethylene (PE) at 61 vol.% powder loading. Rheological properties show a pseudo-plastic behaviour of the feedstock, where viscosity decreases with increasing shear rate. The feedstock was injection moulded into a tensile bar shape while thermal debinding was carried out at 320 degrees C and 500 degrees C. The brown parts were sintered at 1000, 1100, 1200 and 1300 degrees C, with three different sintering times of 1, 3 and 5 hours in the furnace. It was found that the highest sintered density measured was 95.61% of the theoretical density. In addition, the highest hardness and Young's modulus measured were 150.45 HV and 52.61 GPa respectively, which are higher than those of human bone. The lowest percentage of carbon content was 0.022wt.% given by the sample sintered at 1300 degrees C for 1 hour. Therefore, SS316L/HA composite with good mechanical and physical properties was successfully produced through the PIM process.	[Ramli, Mohd Ikram; Sulong, Abu Bakar; Muhamad, Norhamidi; Muchtar, Andanastuti; Foudzi, Farhana Mohd] Univ Kebangsaan Malaysia, Dept Mech & Mat Engn, Bangi, Selangor, Malaysia; [Arifin, Amir] Sriwijaya Univ, Dept Mech Engn, Indralaya, Sumatera Selata, Indonesia; [Al-Furjan, Mohannad Saleh Hammadi] Hangzhou Dianzi Univ, Sch Mech Engn, Hangzhou, Zhejiang, Peoples R China	Universiti Kebangsaan Malaysia; Universitas Sriwijaya; Hangzhou Dianzi University	Sulong, AB (corresponding author), Univ Kebangsaan Malaysia, Dept Mech & Mat Engn, Bangi, Selangor, Malaysia.	abubakar@ukm.edu.my	Al-Furjan, M.S.H./L-9106-2019; Arifin, Amir/GNP-5021-2022; Ramli, Mohd Ikram/AAA-6405-2020; Foudzi, Farhana Mohd/U-1792-2019; , Abu Bakar Sulong UKM/AAN-8030-2021; Foudzi, Farhana Mohd/AGQ-0218-2022; Izwan, Izrul/K-6645-2019	Al-Furjan, M.S.H./0000-0001-8514-0202; Arifin, Amir/0000-0002-9794-5478; Ramli, Mohd Ikram/0000-0003-4228-0381; Foudzi, Farhana Mohd/0000-0001-8217-9689; , Abu Bakar Sulong UKM/0000-0001-8968-176X; Izwan, Izrul/0000-0002-7423-0058; Sulong, Abu Bakar/0000-0003-4637-1758	Transdisciplinary Research Grant Scheme from Ministry of Higher Education of Malaysia (MoHE) [TRGS/2/2014/UKM/02/4/1]; Universiti Kebangsaan Malaysia [DIP/2016/009]; Malaysia's Ministry of Higher Education (MOHE) [TRGS/2/2014/UKM/02/4/1]; Universiti Kebangsaan Malaysia's Research University Grant [DIP/2016/009]	Transdisciplinary Research Grant Scheme from Ministry of Higher Education of Malaysia (MoHE); Universiti Kebangsaan Malaysia; Malaysia's Ministry of Higher Education (MOHE); Universiti Kebangsaan Malaysia's Research University Grant	This work was supported by Transdisciplinary Research Grant Scheme from Ministry of Higher Education of Malaysia (MoHE). Project code: TRGS/2/2014/UKM/02/4/1. Fund received by Assoc. Prof. Ir. Dr. Abu Bakar Sulong, and Dana Impak Perdana from Universiti Kebangsaan Malaysia. Project code: DIP/2016/009. Fund received by Prof. Dr. Norhamidi Muhamad. Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Malaysia's Ministry of Higher Education (MOHE) [TRGS/2/2014/UKM/02/4/1] and Universiti Kebangsaan Malaysia's Research University Grant [DIP/2016/009].	Ahn S, 2009, POWDER TECHNOL, V193, P162, DOI 10.1016/j.powtec.2009.03.010; Arifin A, 2015, MATER DESIGN, V65, P1028, DOI 10.1016/j.matdes.2014.10.039; Arifin A, 2014, MATER DESIGN, V55, P165, DOI 10.1016/j.matdes.2013.09.045; Azem FA, 2009, J SOL-GEL SCI TECHN, V51, P190, DOI 10.1007/s10971-009-1964-8; Buscail H, 2008, MATER CHEM PHYS, V111, P491, DOI 10.1016/j.matchemphys.2008.04.054; Callister WD., 2005, FUNDAMENTALS MAT SCI; Choi DS, 1999, COMPOS STRUCT, V47, P655, DOI 10.1016/S0263-8223(00)00045-3; Cihlar J, 1996, BIOMATERIALS, V17, P1905, DOI 10.1016/0142-9612(95)00243-X; Deram V, 2003, SURF COAT TECH, V166, P153, DOI 10.1016/S0257-8972(02)00855-1; Dewidar MM, 2007, T NONFERR METAL SOC, V17, P468, DOI 10.1016/S1003-6326(07)60117-4; Thanh DTM, 2013, MAT SCI ENG C-MATER, V33, P2037, DOI 10.1016/j.msec.2013.01.018; Dorozhkin SV, 2012, ACTA BIOMATER, V8, P963, DOI 10.1016/j.actbio.2011.09.003; Emeka UB, 2017, J KEJURUTER, V29, P49, DOI 10.17576/jkukm-2017-29(1)-07; Fan X, 2009, T NONFERR METAL SOC, V19, P347, DOI 10.1016/S1003-6326(08)60276-9; Foudzi FM, 2013, CERAM INT, V39, P2665, DOI 10.1016/j.ceramint.2012.09.033; Fu G, 2004, MATER DESIGN, V25, P729, DOI 10.1016/j.matdes.2004.01.013; German RM, 1997, INJECTION MOLDING ME; Gokbayrak H, 1993, PRODUCTION OF HYDROX; Goller G, 2002, MATER LETT, V56, P142, DOI 10.1016/S0167-577X(02)00430-5; Gopi D, 2009, MAT SCI ENG C-BIO S, V29, P955, DOI 10.1016/j.msec.2008.08.020; Gulsoy HO, 2008, SCRIPTA MATER, V58, P295, DOI 10.1016/j.scriptamat.2007.10.004; Guo HB, 2004, MATER LETT, V58, P304, DOI 10.1016/S0167-577X(03)00474-9; Guo SB, 2006, J MATER PROCESS TECH, V173, P310, DOI 10.1016/j.jmatprotec.2005.12.001; Heng SY, 2013, CERAM INT, V39, P4457, DOI 10.1016/j.ceramint.2012.11.039; Huang BY, 2003, J MATER PROCESS TECH, V137, P132, DOI 10.1016/S0924-0136(02)01100-7; Javidi M, 2008, MAT SCI ENG C-BIO S, V28, P1509, DOI 10.1016/j.msec.2008.04.003; Ji CH, 2001, MAT SCI ENG A-STRUCT, V311, P74, DOI 10.1016/S0921-5093(01)00942-X; Johari N, 2012, COMPOS PART B-ENG, V43, P1671, DOI 10.1016/j.compositesb.2012.01.013; Juang HY, 1996, BIOMATERIALS, V17, P2059, DOI 10.1016/0142-9612(96)88882-X; Khakbiz M, 2005, MAT SCI ENG A-STRUCT, V407, P105, DOI 10.1016/j.msea.2005.06.057; KIJIMA T, 1979, J AM CERAM SOC, V62, P455, DOI 10.1111/j.1151-2916.1979.tb19104.x; Koseski RP, 2005, MAT SCI ENG A-STRUCT, V390, P171, DOI 10.1016/j.msea.2004.08.002; Lee S., 2012, MAT RES SOC, V1018, P177, DOI DOI 10.1557/OPL.2012.671; Li RKY, 1997, COMPOS STRUCT, V38, P483, DOI 10.1016/S0263-8223(97)00083-4; Lin KL, 2012, INT J APPL CERAM TEC, V9, P479, DOI 10.1111/j.1744-7402.2011.02654.x; Lin YJ, 2010, MATER TRANS, V51, P2251, DOI 10.2320/matertrans.M2010151; Liu ZY, 2002, MATER CHARACT, V49, P313, DOI 10.1016/S1044-5803(02)00282-6; Liu ZY, 2001, SCRIPTA MATER, V44, P1131, DOI 10.1016/S1359-6462(01)00664-9; Macedo AAM, 2013, COMPOS PART B-ENG, V44, P95, DOI 10.1016/j.compositesb.2012.07.010; Martinez-Alvarez C, 2013, J SURG RES, V183, P654, DOI 10.1016/j.jss.2013.03.009; Metal Powder Industries Federation, 2002, STAND TEST METH MET; Miao X, 2001, J MATER SCI, V36, P3323, DOI 10.1023/A:1017915226015; Muralithran G, 2000, CERAM INT, V26, P221, DOI 10.1016/S0272-8842(99)00046-2; Muthukumaran V, 2010, MATER DESIGN, V31, P2813, DOI 10.1016/j.matdes.2010.01.007; Nikpour MR, 2012, COMPOS PART B-ENG, V43, P1881, DOI 10.1016/j.compositesb.2012.01.056; Omar MA, 2008, J SOLID STATE SCI TE, V15, P93; Pramanik S., 2005, TRENDS BIOMATERIALS, V19, P46; Prokopiev O, 2006, MAT SCI ENG A-STRUCT, V431, P218, DOI 10.1016/j.msea.2006.05.158; Raza MR, 2017, SAINS MALAYS, V46, P285, DOI 10.17576/jsm-2017-4602-13; RUYS AJ, 1995, BIOMATERIALS, V16, P409, DOI 10.1016/0142-9612(95)98859-C; Salleh FM, 2017, PROCEDIA ENGINEER, V184, P334, DOI 10.1016/j.proeng.2017.04.103; Shiwaku Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132903; Sim CP, 1997, J MATER PROCESS TECH, V69, P75, DOI 10.1016/S0924-0136(96)00044-1; Song JF, 2011, MAT SCI ENG A-STRUCT, V528, P5421, DOI 10.1016/j.msea.2011.03.078; Sotomayor ME, 2010, POWDER TECHNOL, V200, P30, DOI 10.1016/j.powtec.2010.02.003; Sridhar TM, 2003, CORROS SCI, V45, P2337, DOI 10.1016/S0010-938X(03)00063-5; Sridhar TM, 2003, CORROS SCI, V45, P237, DOI 10.1016/S0010-938X(02)00091-4; Stangl R., 2001, European Cells & Materials, V2, P1; Sun MC, 2009, CORROS SCI, V51, P1069, DOI 10.1016/j.corsci.2009.03.008; Sutha S, 2013, MAT SCI ENG C-MATER, V33, P4046, DOI 10.1016/j.msec.2013.05.047; Thangamani N, 2002, CERAM INT, V28, P355, DOI 10.1016/S0272-8842(01)00102-X; Thian ES, 2002, MATER LETT, V56, P522, DOI 10.1016/S0167-577X(02)00544-X; Thian ES, 2002, BIOMATERIALS, V23, P2927, DOI 10.1016/S0142-9612(01)00422-7; Thian ES, 2001, ADV POWDER TECHNOL, V12, P361, DOI 10.1163/156855201750537901; WANG PE, 1993, J MATER SCI-MATER M, V4, P150, DOI 10.1007/BF00120384; Wen CE, 2007, ACTA BIOMATER, V3, P403, DOI 10.1016/j.actbio.2006.10.004; Wu JM, 2003, J MATER SCI-MATER M, V14, P1027, DOI 10.1023/B:JMSM.0000003998.37583.d7; Zhao SF, 2013, CLIN ORAL IMPLAN RES, V24, P34, DOI 10.1111/j.1600-0501.2011.02362.x; ZHOU JM, 1993, J MATER SCI-MATER M, V4, P83, DOI 10.1007/BF00122983; Zhu XL, 2004, CELLS TISSUES ORGANS, V178, P13, DOI 10.1159/000081089; Zou JP, 2004, J CENT SOUTH UNIV T, V11, P113, DOI 10.1007/s11771-004-0024-3	71	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206247	10.1371/journal.pone.0206247	http://dx.doi.org/10.1371/journal.pone.0206247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359433	Green Published, gold, Green Submitted			2022-12-26	WOS:000448438400057
J	Yang, E; Gardner, MR; Zhou, AS; Farzan, M; Arvin, AM; Oliver, SL				Yang, Edward; Gardner, Matthew R.; Zhou, Amber S.; Farzan, Michael; Arvin, Ann M.; Oliver, Stefan L.			HIV-1 inhibitory properties of eCD4-Igmim2 determined using an Env-mediated membrane fusion assay	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; ENVELOPE GLYCOPROTEIN; SOLUBLE CD4; CELL-LINES; V3 LOOP; GP120; NEUTRALIZATION; CORECEPTOR; 2G12	Human Immunodeficiency Virus-1 (HIV-1) entry is dependent on the envelope glycoprotein (Env) that is present on the virion and facilitates fusion between the envelope and the cellular membrane. The protein consists of two subunits, gp120 and gp41, with the former required for binding the CD4 receptor and either the CXCR4 or CCR5 coreceptor, and the latter for mediating fusion. The requirement of fusion for infection has made Env an attractive target for HIV therapy development and led to the FDA approval of enfuvirtide, a fusion inhibitor. Continued development of entry inhibitors is warranted because enfuvirtide resistant HIV-1 strains have emerged. In this study, a novel HIV-1 fusion assay was validated using neutralizing antibodies and then used to investigate the mechanism of action of eCD4-Ig(mim2), an HIV-1 inhibitor proposed to cooperatively bind the CD4 binding site and the sulfotyrosine-binding pocket of gp120. Greater reduction in fusion levels was observed with eCD4-Ig(mim2) in the fusion assay than all of the gp120 antibodies evaluated. Lab adapted isolates, HIV-1(HXB2) and HIV-1(YU2), were sensitive to eCD4-Ig(mim2) in the fusion assay, while primary isolates, HIV-1(BG505) and HIV-1(ZM651) were resistant. These results correlated with greater IC50 values for primary isolates compared to the lab adapted isolates observed in a virus neutralization assay. Analysis of gp120 models identified differences in the V1 and V2 domains that are associated with eCD4-Ig(mim2) sensitivity. This study highlights the use of a fusion assay to identify key areas for improving the potency of eCD4-Ig(mim2).	[Yang, Edward; Arvin, Ann M.; Oliver, Stefan L.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Yang, Edward; Arvin, Ann M.; Oliver, Stefan L.] Stanford Univ, Dept Microbiol, Sch Med, Stanford, CA 94305 USA; [Yang, Edward; Arvin, Ann M.; Oliver, Stefan L.] Stanford Univ, Dept Immunol, Sch Med, Stanford, CA 94305 USA; [Gardner, Matthew R.; Zhou, Amber S.; Farzan, Michael] Scripps Res Inst, Dept Infect Dis, Jupiter, FL USA	Stanford University; Stanford University; Stanford University; Scripps Research Institute	Yang, E (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.; Yang, E (corresponding author), Stanford Univ, Dept Microbiol, Sch Med, Stanford, CA 94305 USA.; Yang, E (corresponding author), Stanford Univ, Dept Immunol, Sch Med, Stanford, CA 94305 USA.	edwyang@stanford.edu	Oliver, Stefan/M-4714-2019	Gardner, Matthew/0000-0003-2872-7597; Farzan, Michael/0000-0002-2990-5319; Zhou, Amber/0000-0001-6412-2742; Oliver, Stefan/0000-0002-4614-7310	Center for Innovation in Global Health at Stanford University School of Medicine; NIH [SIG 1S10RR02678001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI126623, R37AI091476] Funding Source: NIH RePORTER	Center for Innovation in Global Health at Stanford University School of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Seed Grant from the Center for Innovation in Global Health at Stanford University School of Medicine. EY, SLO and AMA were supported by the grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge John Mulholland, Kitty Lee, Cedric Espenel, and John Perrino of the Stanford Cell Sciences Imaging Facility (NIH Grant SIG 1S10RR02678001) for their technical assistance. We would also like to acknowledge Edward Berger (NIH) for providing reagents.	Brauer F, 2013, ANTIMICROB AGENTS CH, V57, P679, DOI 10.1128/AAC.01152-12; BRODER CC, 1995, P NATL ACAD SCI USA, V92, P9004, DOI 10.1073/pnas.92.19.9004; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; CHANDA PK, 1990, VIROLOGY, V175, P535, DOI 10.1016/0042-6822(90)90438-W; CHESEBRO B, 1988, J VIROL, V62, P3779, DOI 10.1128/JVI.62.10.3779-3788.1988; CHESEBRO B, 1990, J VIROL, V64, P215, DOI 10.1128/JVI.64.1.215-221.1990; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Etemad-Moghadam B, 1999, J VIROL, V73, P8873, DOI 10.1128/JVI.73.10.8873-8879.1999; Finnegan CM, 2001, J VIROL, V75, P11096, DOI 10.1128/JVI.75.22.11096-11105.2001; Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264; GORNY MK, 1989, P NATL ACAD SCI USA, V86, P1624, DOI 10.1073/pnas.86.5.1624; GORNY MK, 1994, J VIROL, V68, P8312, DOI 10.1128/JVI.68.12.8312-8320.1994; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Hung CS, 1999, J VIROL, V73, P8216, DOI 10.1128/JVI.73.10.8216-8226.1999; Ishikawa H, 2012, PROTEIN ENG DES SEL, V25, P813, DOI 10.1093/protein/gzs051; Israel ZR, 1997, AIDS, V11, P128; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kong L, 2015, PROTEINS, V83, P590, DOI 10.1002/prot.24747; Kwon YD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085940; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEWIS N, 1990, J VIROL, V64, P1690, DOI 10.1128/JVI.64.4.1690-1697.1990; Liang JG, 2013, J FOOD DRUG ANAL, V21, pS52, DOI 10.1016/j.jfda.2013.09.034; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Martin M. A., 2013, FIELDS VIROLOGY, V2, P1502; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nicholas KB., 1997, GENEDOC TOOL EDITING; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2012, P NATL ACAD SCI USA, V109, P7829, DOI 10.1073/pnas.1109728109; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Salzwedel K, 2000, J VIROL, V74, P326, DOI 10.1128/JVI.74.1.326-333.2000; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; SODROSKI J, 1986, NATURE, V322, P470, DOI 10.1038/322470a0; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Sullivan N, 1998, J VIROL, V72, P6332, DOI 10.1128/JVI.72.8.6332-6338.1998; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; van Gils MJ, 2011, J VIROL, V85, P6986, DOI 10.1128/JVI.00268-11; VUJCIC LK, 1995, AIDS RES HUM RETROV, V11, P783, DOI 10.1089/aid.1995.11.783; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Welch BD, 2007, P NATL ACAD SCI USA, V104, P16828, DOI 10.1073/pnas.0708109104; West AP, 2009, J VIROL, V83, P98, DOI 10.1128/JVI.01564-08; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xing Y, 2015, P NATL ACAD SCI USA, V112, P6056, DOI 10.1073/pnas.1501176112; Yang E, 2016, J VIROL, V90, P7567, DOI 10.1128/JVI.00792-16; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; ZOLLAPAZNER S, 1995, J VIROL, V69, P3807, DOI 10.1128/JVI.69.6.3807-3815.1995; Zwick MB, 2001, J VIROL, V75, P12198, DOI 10.1128/JVI.75.24.12198-12208.2001	60	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206365	10.1371/journal.pone.0206365	http://dx.doi.org/10.1371/journal.pone.0206365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359435	Green Submitted, Green Published, gold			2022-12-26	WOS:000448438400071
J	Cohen, BP; Bernstein, JL; Morrison, KA; Spector, JA; Bonassar, LJ				Cohen, Benjamin P.; Bernstein, Jaime L.; Morrison, Kerry A.; Spector, Jason A.; Bonassar, Lawrence J.			Tissue engineering the human auricle by auricular chondrocyte-mesenchymal stem cell co-implantation	PLOS ONE			English	Article							ARTICULAR CHONDROCYTES; IMPLANTATION MACI; CARTILAGE REPAIR; COLLAGEN GELS; IN-VITRO; COCULTURE; SHAPE; REDIFFERENTIATION; CHONDROGENESIS; CONSTRUCTS	Children suffering from microtia have few options for auricular reconstruction. Tissue engineering approaches attempt to replicate the complex anatomy and structure of the ear with autologous cartilage but have been limited by access to clinically accessible cell sources. Here we present a full-scale, patient-based human ear generated by implantation of human auricular chondrocytes and human mesenchymal stem cells in a 1:1 ratio. Additional disc construct surrogates were generated with 1:0, 1:1, and 0:1 combinations of auricular chondrocytes and mesenchymal stem cells. After 3 months in vivo, monocellular auricular chondrocyte discs and 1:1 disc and ear constructs displayed bundled collagen fibers in a perichondrial layer, rich proteoglycan deposition, and elastin fiber network formation similar to native human auricular cartilage, with the protein composition and mechanical stiffness of native tissue. Full ear constructs with a 1:1 cell combination maintained gross ear structure and developed a cartilaginous appearance following implantation. These studies demonstrate the successful engineering of a patient-specific human auricle using exclusively human cell sources without extensive in vitro tissue culture prior to implantation, a critical step towards the clinical application of tissue engineering for auricular reconstruction.	[Cohen, Benjamin P.; Bonassar, Lawrence J.] Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY 14850 USA; [Bernstein, Jaime L.; Morrison, Kerry A.; Spector, Jason A.] Weill Cornell Med Coll, Div Plast Surg, New York, NY USA; [Bonassar, Lawrence J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Bonassar, LJ (corresponding author), Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY 14850 USA.; Bonassar, LJ (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	lb244@cornell.edu		Cohen, Benjamin/0000-0001-5165-6788	National Institutes of Health [5T35EB006732]; Empire State Development's Division of Science, Technology and Innovation; Empire State Stem Cell Fund through New York State Department of Health [C30293GG]; 3D BioCorp; Stem Cell Pathology unit for Scanscope services (NYSTEM) [C029155]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Development's Division of Science, Technology and Innovation; Empire State Stem Cell Fund through New York State Department of Health; 3D BioCorp; Stem Cell Pathology unit for Scanscope services (NYSTEM)	Funding provided by the National Institutes of Health Grant 5T35EB006732 (BPC, JAS, LJB), Empire State Development's Division of Science, Technology and Innovation (JAS, LJB), Empire State Stem Cell Fund through New York State Department of Health Contract #C30293GG (BPC), and 3D BioCorp (LJB) and the Stem Cell Pathology unit for Scanscope services (NYSTEM grant C029155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Katherine Hudson and Mary Clare McCorry for advisement on use of stem cells, Drs. Charles Thorne and John Sherman for assistance acquiring human auricular cartilage samples, the Cornell Statistical Consulting Unit (CSCU) for consultation on statistical analyses, and the Stem Cell Pathology unit for Scanscope services (NYSTEM grant C029155).	Ballyns JJ, 2008, TISSUE ENG PT A, V14, P1195, DOI 10.1089/ten.tea.2007.0186; Basad E, 2015, KNEE SURG SPORT TR A, V23, P3729, DOI 10.1007/s00167-014-3295-8; BAUGE AC, 2015, REVIEW; Bichara DA, 2012, TISSUE ENG PART B-RE, V18, P51, DOI [10.1089/ten.teb.2011.0326, 10.1089/ten.TEB.2011.0326]; bin Ishak MF, 2015, INT J PEDIATR OTORHI, V79, P1634, DOI 10.1016/j.ijporl.2015.06.034; Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI [10.1089/ten.tea.2009.0442, 10.1089/ten.TEA.2009.0442]; Brittberg M, 2010, AM J SPORT MED, V38, P1259, DOI 10.1177/0363546509346395; Cai Z, 2015, AESTHET PLAST SURG, V39, P431, DOI 10.1007/s00266-015-0481-0; Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S; Cohen BP, 2016, TISSUE ENG PT A, V22, P461, DOI [10.1089/ten.TEA.2015.0323, 10.1089/ten.tea.2015.0323]; Cross VL, 2010, BIOMATERIALS, V31, P8596, DOI 10.1016/j.biomaterials.2010.07.072; Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Enea D, 2012, KNEE SURG SPORT TR A, V20, P862, DOI 10.1007/s00167-011-1639-1; Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502; Grunert P, 2015, ACTA BIOMATER, V26, P215, DOI 10.1016/j.actbio.2015.06.006; Hendriks J, 2007, J TISSUE ENG REGEN M, V1, P170, DOI 10.1002/term.19; HTTPS, TEA; Ibusuki S, 2007, TISSUE ENG, V13, P1995, DOI 10.1089/ten.2006.0153; INSTITUTE OF, 2011, PRESS, V118; Kamil SH, 2004, LARYNGOSCOPE, V114, P867, DOI 10.1097/00005537-200405000-00015; Kang N, 2012, BIOMATERIALS, V33, P4535, DOI 10.1016/j.biomaterials.2012.03.019; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Lee WYW, 2017, J ORTHOP TRANSL, V9, P76, DOI 10.1016/j.jot.2017.03.005; Liao HT, 2015, PLAST RECONSTR SURG, V135, p313E, DOI 10.1097/PRS.0000000000001105; Luquetti DV, 2012, AM J MED GENET A, V158A, P124, DOI 10.1002/ajmg.a.34352; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Makris EA, 2014, P NATL ACAD SCI USA, V111, pE4832, DOI 10.1073/pnas.1414271111; Markway BD, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4272; McCorry MC, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0301-8; MCCORRY MC, 2016, CONNECT TISSUE RES T, V1, P13; Meretoja VV, 2012, BIOMATERIALS, V33, P6362, DOI 10.1016/j.biomaterials.2012.05.042; MIDDENDORF JM, 2017, J ORTHOP RES, V1, P9; MITHIEUX BSM, 2006, ADV PROTEIN CHEM, V70, P437; Morrison KA, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/9/1/015004; NEUMAN RE, 1950, J BIOL CHEM, V186, P549; NEUMAN RE, 1950, J BIOL CHEM, V184, P299; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PLEUMEEKERS MM, 2015, PRS, V136, P762; Puetzer JL, 2013, ACTA BIOMATER, V9, P7787, DOI 10.1016/j.actbio.2013.05.002; Reiffel AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056506; Rodriguez A, 1999, PLAST RECONSTR SURG, V103, P1111, DOI 10.1097/00006534-199904040-00001; Saadeh PB, 1999, ANN PLAS SURG, V42, P509, DOI 10.1097/00000637-199905000-00008; Schrobback K, 2012, CELL TISSUE RES, V347, P649, DOI 10.1007/s00441-011-1193-7; Shepherd DET, 1999, ANN RHEUM DIS, V58, P27, DOI 10.1136/ard.58.1.27; Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5; Tseng A, 2014, CARTILAGE, V5, P241, DOI 10.1177/1947603514546740; van Osch GJVM, 2004, BIORHEOLOGY, V41, P411; Yamamoto Y, 2004, SPINE, V29, P1508, DOI 10.1097/01.BRS.0000131416.90906.20; Zhang L, 2014, BIOMATERIALS, V35, P4878, DOI 10.1016/j.biomaterials.2014.02.043; ZHOU G, 2018, EBIOMEDICINE ELSEVIE; Zhou LB, 2011, TISSUE ENG PT A, V17, P1573, DOI 10.1089/ten.tea.2010.0627	54	22	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0202356	10.1371/journal.pone.0202356	http://dx.doi.org/10.1371/journal.pone.0202356			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356228	Green Published, Green Submitted, gold			2022-12-26	WOS:000448434000004
J	Kearney, A; Rosala-Hallas, A; Bacon, N; Daykin, A; Shaw, ARG; Lane, AJ; Blazeby, JM; Clarke, M; Williamson, PR; Gamble, C				Kearney, Anna; Rosala-Hallas, Anna; Bacon, Naomi; Daykin, Anne; Shaw, Alison R. G.; Lane, Athene J.; Blazeby, Jane M.; Clarke, Mike; Williamson, Paula R.; Gamble, Cerrol			Reducing attrition within clinical trials: The communication of retention and withdrawal within patient information leaflets	PLOS ONE			English	Article							INFORMED-CONSENT; MISSING DATA; RECRUITMENT; CANCER; PARTICIPATION; RANDOMIZATION; INTERVENTIONS; PREVENTION; STRATEGIES; ATTITUDES	Background The recruitment and retention of patients are significant methodological challenges for trials. Whilst research has focussed on recruitment, the failure to retain recruited patients and collect outcome data can lead to additional problems and potentially biased results. Research to identify effective retention strategies has focussed on influencing patient behaviour through incentives, reminders and alleviating patient burden, but has not sought to improve patient understanding of the importance of retention. Our aim is to assess how withdrawal, retention and the value of outcome data collection is described within the Patient Information Leaflets (PIL) used during consent. Methods Fifty adult or parent PIL from a cohort of trials starting between 2009-2012 and funded by the NIHR Health Technology Assessment programme were obtained from protocols, websites or by contacting trialists. A checklist of PIL content based on Health Research Authority (HRA) and ICH GCP Guidelines was supplemented with retention specific questions. Corresponding protocols were also evaluated to cross reference trial specific procedures with information communicated to patients. Results PIL frequently reiterated the patient's right to withdraw at any time (n = 49, 98%), without having to give a reason and without penalty (n = 45, 90%). However, few informed patients they may be asked to give a withdrawal reason where willing (n = 6, 12%). Statements about the value of retention were infrequent (n = 8, 16%). Consent documents failed to include key content that might mitigate withdrawals, such as the need for treatment equipoise (n = 3, 6%). Nearly half the trials in the cohort (n = 23, 46%) wanted to continue to collect outcome data if patients withdraw. However, in 70% of PIL using prospective consent, withdrawal was described in generic terms leaving patients unaware of the difference between stopping treatment and all trial involvement. Nineteen (38%) trials offered withdrawing patients the option to delete existing data. Conclusions Withdrawal and retention is poorly described within PIL and addressing this might positively impact levels of patient attrition, reducing missing data. Consent information is unbalanced, focussing on patient's rights to withdraw without accompanying information that promotes robust consent and sustained participation. With many citing altruistic reasons for participation it is essential that PIL include more information on retention and clarify withdrawal terminology so patients are aware of how they can make a valuable contribution to clinical studies. There is a need to determine how retention can be described to patients to avoid concerns of coercion. Future research is needed to explore whether the absence of information about retention at the time of consent is impacting attrition.	[Kearney, Anna; Williamson, Paula R.; Gamble, Cerrol] Univ Liverpool, Clin Trial Res Ctr, North West Hub Trials Methodol Res, Biostat, Liverpool, Merseyside, England; [Rosala-Hallas, Anna; Bacon, Naomi] Univ Liverpool, Clin Trial Res Ctr, Biostat, Liverpool, Merseyside, England; [Daykin, Anne; Shaw, Alison R. G.; Lane, Athene J.; Blazeby, Jane M.] Univ Bristol, ConDuCT Hub Trials Methodol Res 2, Bristol, Avon, England; [Clarke, Mike] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland	University of Liverpool; University of Liverpool; University of Bristol; Queens University Belfast	Kearney, A (corresponding author), Univ Liverpool, Clin Trial Res Ctr, North West Hub Trials Methodol Res, Biostat, Liverpool, Merseyside, England.	a.kearney@liv.ac.uk	Williamson, Paula R/B-6425-2016; Gamble, Carrol/AAE-9895-2019; kearney, anna/AGU-8774-2022; Kearney, Anna/ABD-5316-2020	Williamson, Paula R/0000-0001-9802-6636; Gamble, Carrol/0000-0002-3021-1955; Blazeby, Jane/0000-0002-3354-3330; Kearney, Anna/0000-0003-1404-3370; Heawood (nee Shaw), Alison/0000-0002-5907-4608	Medical Research Council [MR/K024310/1]; MRC [MR/K024310/1, G0901530, MR/K025643/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Methodology Research Programme (Grant MR/K024310/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration USDoHaHSFaD, 2008, GUID SPONS CLIN INV; Agency EM, 2010, GUID MISS DAT CONF C; Akl EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2809; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Authority HR, 2017, HRA GUID APPL PROP A; Bell ML, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-118; Bidad N, 2014, RES ETHICS, V10, P47; Bower P, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-399; Brueton VC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003821; Busby-Grant J, 2009, J MED ETHICS, V35, P768, DOI 10.1136/jme.2008.028035; Cameron P, 2013, CURR ONCOL, V20, pE193, DOI 10.3747/co.20.1323; Cuzick J, 2015, ANN ONCOL, V26, P2363, DOI 10.1093/annonc/mdv392; Eakin EG, 2007, HEALTH EDUC RES, V22, P361, DOI [10.1093/her/cyl095, 10.1093/het/cyl095]; Eborall HC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-7; Falagas ME, 2009, AM J SURG, V198, P420, DOI 10.1016/j.amjsurg.2009.02.010; Fallowfield LJ, 1998, EUR J CANCER, V34, P1554, DOI 10.1016/S0959-8049(98)00193-2; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Fortun P, 2008, QJM-INT J MED, V101, P625, DOI 10.1093/qjmed/hcn067; Furimsky I, 2008, CONTEMP CLIN TRIALS, V29, P862, DOI 10.1016/j.cct.2008.07.005; Griffin JM, 2006, CONTEMP CLIN TRIALS, V27, P441, DOI 10.1016/j.cct.2006.04.006; Henney S, 2014, J LARYNGOL OTOL, V128, P249, DOI 10.1017/S0022215114000449; Hussain JA, 2017, J CLIN EPIDEMIOL, V88, P81, DOI 10.1016/j.jclinepi.2017.05.009; ICH, 2016, ICH GUID GOOD CLIN P; Jenkins V, 2010, BRIT J CANCER, V103, P1801, DOI 10.1038/sj.bjc.6606004; KEARNEY A, 2017, TRIALS, V18; Kirkby HM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000509; Knapp P, 2009, J MED ETHICS, V35, P573, DOI 10.1136/jme.2008.026708; KNAPP P, 2011, BMC MED, V9; Lamberti MJ, 2012, DRUG INF J, V46, P573, DOI 10.1177/0092861512453040; Loftin WA, 2005, DIABETES EDUCATOR, V31, P251, DOI 10.1177/0145721705275517; Lorell BH, 2015, CLIN TRIALS, V12, P692, DOI 10.1177/1740774515594362; Loue S, 2008, J IMMIGR MINOR HEALT, V10, P145, DOI 10.1007/s10903-007-9063-9; Man MS, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0820-0; Mandava A, 2012, J MED ETHICS, V38, P356, DOI 10.1136/medethics-2011-100178; Matsui K, 2005, J MED ETHICS, V31, P385, DOI 10.1136/jme.2004.009530; Moorcraft SY, 2016, TRIALS, V17, DOI 10.1186/s13063-015-1105-3; O'Neill RT, 2012, CLIN PHARMACOL THER, V91, P550, DOI 10.1038/clpt.2011.340; Reinert C, 2014, EUR J CANCER, V50, P150, DOI 10.1016/j.ejca.2013.09.006; Robinson EJ, 2005, HEALTH TECHNOL ASSES, V9, pIII; Robinson KA, 2007, J CLIN EPIDEMIOL, V60, P757, DOI 10.1016/j.jclinepi.2006.11.023; Shilling V, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15150; Smith CT, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-32; Toerien M, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-52; Treweek S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002360; Walters SJ, 2017, BMJ OPEN, V7; Wittes J, 2009, J BIOPHARM STAT, V19, P957, DOI 10.1080/10543400903239825	46	15	15	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0204886	10.1371/journal.pone.0204886	http://dx.doi.org/10.1371/journal.pone.0204886			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY7VH	30379822	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700022
J	Sarri, CA; Papadopoulos, GE; Papa, A; Tsakris, A; Pervanidou, D; Baka, A; Politis, C; Billinis, C; Hadjichristodoulou, C; Mamuris, Z				Sarri, Constantina A.; Papadopoulos, Georgios E.; Papa, Anna; Tsakris, Athanasios; Pervanidou, Danai; Baka, Agoritsa; Politis, Constantina; Billinis, Charalambos; Hadjichristodoulou, Christos; Mamuris, Zissis		MALWEST Project	Amino acid signatures in the HLA class II peptide-binding region associated with protection/susceptibility to the severe West Nile Virus disease	PLOS ONE			English	Article							MHC CLASS-II; KINETIC STABILITY; T-CELLS; SEQUENCE; ALLELES; DQ	The MHC class II region in humans is highly polymorphic. Each MHC molecule is formed by an a and a beta chain, produced by different genes, creating an antigen-binding groove. In the groove there are several pockets into which antigens anchor and fit. The affinity of this fitting determines the recognition specificity of a given peptide. Here, based on our previous results about the association of MHC class II with the WNV disease, we examined the role of the binding pockets of HLA-DPA1, -DQA1 and-DRB1 in the severe form of the disease. In HLA-DQA1, variants in all pockets 1, 6 and 9 were found to be associated with either protection and/or susceptibility to neuroinvasion caused by WNV. Similarly, pockets 7, 9 and 10 in HLA-DRB1 were associated with severe disease. Protein modeling of these molecules revealed structural and functional differences among alleles with opposite roles concerning the development of the disease. Different amino acids in positions alpha 52 and alpha 66 (HLA-DQA1) significantly influenced the peptide binding while DYWLR/EFA combination (HLA-DRB1) was associated with neuronal damage. Further studies could help us understand the selectivity of pocket variants in order to create suitable peptides for an effective response.	[Sarri, Constantina A.; Papadopoulos, Georgios E.; Mamuris, Zissis] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Papa, Anna] Aristotle Univ Thessaloniki, Microbiol Lab 1, Thessaloniki, Greece; [Tsakris, Athanasios] Univ Athens, Med Sch, Athens, Greece; [Pervanidou, Danai; Baka, Agoritsa] HCDCP, Athens, Greece; [Politis, Constantina] HCDCP, Hellen coordinating Hemovigilance Ctr, Athens, Greece; [Billinis, Charalambos] Univ Thessaly, Fac Vet Med, Kardhitsa, Greece; [Hadjichristodoulou, Christos] Univ Thessaly, Fac Med, Larisa, Greece	University of Thessaly; Aristotle University of Thessaloniki; National & Kapodistrian University of Athens; University of Thessaly; University of Thessaly	Mamuris, Z (corresponding author), Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece.	zmamur@bio.uth.gr	Mamuris, Zissis/AAN-2576-2021	Papadopoulos, Georgios/0000-0002-2742-8467; Hadjichristodoulou, Christos/0000-0002-4769-8376	"Integrated surveillance and control programme for West Nile virus and malaria in Greece" (MALWEST) through the Operational Programme "Human Resources Development" of National Strategic Reference Framework (NSRF) 2007-2013	"Integrated surveillance and control programme for West Nile virus and malaria in Greece" (MALWEST) through the Operational Programme "Human Resources Development" of National Strategic Reference Framework (NSRF) 2007-2013	This work was funded by "Integrated surveillance and control programme for West Nile virus and malaria in Greece" (MALWEST) through the Operational Programme "Human Resources Development" of National Strategic Reference Framework (NSRF) 2007-2013. The URL of the funder's web site is: http://www.malwest.gr/en-us/nsrf.aspx. No grant for any co-author was received. Apart from funding, help with sample and data collection was also provided.	Ball DW, 2011, THE BASICS OF GENERA; Baumgartner C, 2010, J IMMUNOLOGY BALTIM, P184; BODMER J, 1984, IMMUNOL TODAY, V5, P251, DOI 10.1016/0167-5699(84)90129-4; Bondinas GP, 2007, IMMUNOGENETICS, V59, P539, DOI 10.1007/s00251-007-0224-8; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Eisenlohr LC, 2013, MOL IMMUNOL, V55, P169, DOI 10.1016/j.molimm.2012.10.020; Flesch BK, 2014, J CLIN ENDOCR METAB, V99, pE177, DOI 10.1210/jc.2013-2852; Brochado MJF, 2016, DATA BRIEF, V8, P364, DOI 10.1016/j.dib.2016.05.077; Gil JM, 2017, INT J DERMATOL, V56, P557, DOI 10.1111/ijd.13577; Hall FC, 2002, EUR J IMMUNOL, V32, P662, DOI 10.1002/1521-4141(200203)32:3<662::AID-IMMU662>3.0.CO;2-5; Hamzeh AR, 2015, TISSUE ANTIGENS, V86, P21, DOI 10.1111/tan.12598; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; KO HS, 1979, J EXP MED, V150, P246, DOI 10.1084/jem.150.2.246; Krini M, 2012, PEDIATR RES, V72, P625, DOI 10.1038/pr.2012.133; KWOK WW, 1993, J IMMUNOL, V150, P2263; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Mohan JF, 2012, NAT REV IMMUNOL, V12, P721, DOI 10.1038/nri3294; Nelson C A, 1999, Rev Immunogenet, V1, P47; O'Leary DR, 2004, VECTOR-BORNE ZOONOT, V4, P61, DOI 10.1089/153036604773083004; Oliveira-Cortez A, 2016, EUR J CLIN MICROBIOL, V35, P1567, DOI 10.1007/s10096-016-2713-x; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Perasaari J, 2013, TISSUE ANTIGENS, V81, P435, DOI 10.1111/tan.12116; Perez-Rodriguez M, 2017, HELICOBACTER, V22, DOI 10.1111/hel.12326; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Robinson J, 2000, TISSUE ANTIGENS, V55, P280, DOI 10.1034/j.1399-0039.2000.550314.x; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Sarri CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165952; Sparchez M, 2014, CLIN LAB, V60, P449, DOI 10.7754/Clin.Lab.2013.130341; Steele NZR, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002272; Suri A, 2006, EUR J IMMUNOL, V36, P544, DOI 10.1002/eji.200526235; Weinstock C, 2011, TISSUE ANTIGENS, V77, P317, DOI 10.1111/j.1399-0039.2011.01634.x; Wissemann WT, 2013, AM J HUM GENET, V93, P984, DOI 10.1016/j.ajhg.2013.10.009; YU DTY, 1980, J EXP MED, V152, pS89; Zavala-Ruiz Z, 2004, P NATL ACAD SCI USA, V101, P13279, DOI 10.1073/pnas.0403371101	40	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205557	10.1371/journal.pone.0205557	http://dx.doi.org/10.1371/journal.pone.0205557			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379846	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700054
J	Shafiei, SB; Hussein, AA; Guru, KA				Shafiei, Somayeh B.; Hussein, Ahmed Aly; Guru, Khurshid A.			Dynamic changes of brain functional states during surgical skill acquisition	PLOS ONE			English	Article							ROBOT-ASSISTED SURGERY; FUNDAMENTAL SKILLS; MENTAL WORKLOAD; VALIDATION; PERFORMANCE; ASYMMETRY; TASK	There is lack of a standardized measure of technical proficiency and skill acquisition for robot-assisted surgery (RAS). Learning surgical skills, in addition to the interaction with the machine and the new surgical environment adds to the complexity of the learning process. Moreover, evaluation of surgeon performance in operating room is required to optimize patient safety. In this study, we investigated the dynamic changes of RAS trainee's brain functional states by practice. We also developed brain functional state measurements to find the relationship between RAS skill acquisition (especially human-machine interaction skills) and reconfiguration of brain functional states. This relationship may help in providing trainees with helpful, structured feedback regarding skills requiring improvement and will help in tailoring training activities.	[Shafiei, Somayeh B.] Univ Buffalo SUNY, Dept Mech & Aerosp Engn, Buffalo, NY USA; [Shafiei, Somayeh B.; Hussein, Ahmed Aly; Guru, Khurshid A.] Roswell Pk Canc Inst, ATLAS, Buffalo, NY 14263 USA; [Shafiei, Somayeh B.; Hussein, Ahmed Aly; Guru, Khurshid A.] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Hussein, Ahmed Aly] Cairo Univ, Dept Urol, Cairo, Egypt	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Egyptian Knowledge Bank (EKB); Cairo University	Guru, KA (corresponding author), Roswell Pk Canc Inst, ATLAS, Buffalo, NY 14263 USA.; Guru, KA (corresponding author), Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA.	Khurshid.Guru@RoswellPark.org	Shafiei, Somayeh/U-7707-2019		Roswell Park Alliance Foundation	Roswell Park Alliance Foundation	Roswell Park Alliance Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Roswell Park Alliance Foundation.	Aghajani H, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00359; Babiloni C, 2008, J PHYSIOL-LONDON, V586, P131, DOI 10.1113/jphysiol.2007.141630; Bazzi M, 2016, MULTISCALE MODEL SIM, V14, P1, DOI 10.1137/15M1009615; Berka C, 2004, INT J HUM-COMPUT INT, V17, P151, DOI 10.1207/s15327590ijhc1702_3; Berka C, 2007, AVIAT SPACE ENVIR MD, V78, pB231; Bocci T, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-14; Carswell C Melody, 2005, Surg Innov, V12, P80, DOI 10.1177/155335060501200112; Carswell CM, 2010, APPL ERGON, V42, P138, DOI 10.1016/j.apergo.2010.06.003; Chowriappa AJ, 2013, J SURG RES, V185, P561, DOI 10.1016/j.jss.2013.06.054; Guru KA, 2015, UROLOGY, V86, P751, DOI 10.1016/j.urology.2015.07.028; HART S G, 1988, P139; Haufler AJ, 2000, BIOL PSYCHOL, V53, P131, DOI 10.1016/S0301-0511(00)00047-8; Hussein AA, 2017, J UROLOGY, V197, P1237, DOI 10.1016/j.juro.2016.11.100; Hussein AA, 2016, BJU INT, V118, P429, DOI 10.1111/bju.13445; Jamal W, 2015, PHYSICA A, V434, P273, DOI 10.1016/j.physa.2015.03.087; Jemmer P., 2009, HYPNOTHERAPY J, V2, P24, DOI DOI 10.1016/J.SCHRES.2011.04.016; Judkins TN, 2009, SURG ENDOSC, V23, P590, DOI 10.1007/s00464-008-9933-9; Jutla I.S., 2011, MATLAB; Kim MK, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/573734; Lallee S, 2013, INT ROB SYST ROS 201; Lallee S, 2010, INT ROB SYST IROS 20; Lallee S, 2011, INT ROB SYST IROS 20; Lin Henry C, 2006, Comput Aided Surg, V11, P220, DOI 10.1080/10929080600989189; Nisky I, 2013, ROB AUT ICRA 2013 IE; Quiroga RQ, 2013, PRINCIPLES OF NEURAL CODING, P1, DOI 10.1201/b14756; Raza SJ, 2014, J SURG EDUC, V71, P316, DOI 10.1016/j.jsurg.2013.10.006; Reznick RK, 2006, NEW ENGL J MED, V355, P2664, DOI 10.1056/NEJMra054785; Rubio S, 2004, APPL PSYCHOL-INT REV, V53, P61, DOI 10.1111/j.1464-0597.2004.00161.x; SALAZAR W, 1990, RES Q EXERCISE SPORT, V61, P351, DOI 10.1080/02701367.1990.10607499; Schaal S, 2003, PHILOS T R SOC B, V358, P537, DOI 10.1098/rstb.2002.1258; Shafiei SB, 2014, ASME 2014 INT DES EN; Shafiei SB, 2017, ASME 2017 INT DES EN; Shafiei SB, 2015, ASME 2015 INT DES EN; Shafiei SB, 2018, IEEE ACCESS; Shafiei SB, 2016, 2016 IEEE 38 ANN INT; Shafiei SB, 2018, INVESTIGATION BRAIN; Shafiei S, 2017, J UROLOGY, V197, pE890, DOI 10.1016/j.juro.2017.02.2374; Shafiei S, 2017, J UROLOGY, V197, pE810, DOI 10.1016/j.juro.2017.02.1887; Shafiei S, 2017, J UROLOGY, V197, pE695, DOI 10.1016/j.juro.2017.02.1614; Shafiei SB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22025-1; Shafiei SB, 2017, CURR OPIN UROL, V27, P342, DOI 10.1097/MOU.0000000000000408; Sosnik R, 2004, EXP BRAIN RES, V156, P422, DOI 10.1007/s00221-003-1799-4; Stegemann AP, 2013, UROLOGY, V81, P767, DOI 10.1016/j.urology.2012.12.033; Stikic M, 2014, BRAIN-COMPUT INTERFA, V1, P99, DOI 10.1080/2326263X.2014.912883; Teleoperation AVDR, 2013, UNC MAN AN ARM JOINT; TOMARKEN AJ, 1990, J PERS SOC PSYCHOL, V59, P791, DOI 10.1037/0022-3514.59.4.791; Verner L, 2003, ST HEAL T, V94, P373; Volpe A, 2015, EUR UROL, V68, P292, DOI 10.1016/j.eururo.2014.10.025; Williams A.M., 2004, SKILL ACQUISITION SP; Wu CX, 2007, IEEE T INTELL TRANSP, V8, P528, DOI 10.1109/TITS.2007.903443	50	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0204836	10.1371/journal.pone.0204836	http://dx.doi.org/10.1371/journal.pone.0204836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY7VH	30379871	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700021
J	Wyse, AP; dos Santos, AJB; Azevedo, JD; de Lima, JS; de Faria, JR				Wyse, Ana Paula; Boness dos Santos, Antonio Jose; Azevedo, Juarez dos Santos; de Lima, Josenildo Silva; de Faria, Jairo Rocha			Modeling the spreading and interaction between wild and transgenic mosquitoes with a random dispersal	PLOS ONE			English	Article							MATHEMATICAL-MODEL; CONTROL STRATEGIES; ENDEMIC MALARIA; FITNESS; IMPACT; TRANSFORMATION; MANIPULATION	Due to recent advances in genetic manipulation, transgenic mosquitoes may be a viable alternative to reduce some diseases. Feasibility conditions are obtained by simulating and analyzing mathematical models that describe the behavior of wild and transgenic populations living in the same geographic area. In this paper, we present a reaction-diffusion model in which the reaction term is a nonlinear function that describes the interaction between wild and transgenic mosquitoes, considering the zygosity, and the diffusive term that represents a nonuniform spatial spreading characterized by a random diffusion parameter. The resulting nonlinear system of partial differential equations is numerically solved using the sequential operator splitting technique, combining the finite element method and Runge-Kutta method. This scheme is numerically implemented considering uncertainty in the diffusion parameters of the model. Several scenarios simulating spatial release strategies of transgenic mosquitoes are analyzed, demonstrating an intrinsic association between the transgene frequency in the total population and the strategy adopted.	[Wyse, Ana Paula; Boness dos Santos, Antonio Jose; de Faria, Jairo Rocha] Univ Fed Paraiba, Informat Ctr, Dept Sci Comp, Joao Pessoa, Paraiba, Brazil; [Azevedo, Juarez dos Santos] Univ Fed Reconcavo Bahia, Exact & Technol Sci Ctr, Cruz Das Almas, BA, Brazil; [de Lima, Josenildo Silva] Univ Fed Paraiba, Informat Ctr, Grad Program Math & Computat Modeling, Joao Pessoa, Paraiba, Brazil	Universidade Federal da Paraiba; Universidade Federal do Reconcavo da Bahia; Universidade Federal da Paraiba	Wyse, AP (corresponding author), Univ Fed Paraiba, Informat Ctr, Dept Sci Comp, Joao Pessoa, Paraiba, Brazil.	anawyse@ci.ufpb.br		Azevedo, Juarez/0000-0002-3641-7604; Wyse, Ana/0000-0001-7002-4110; de Lima, Josenildo/0000-0003-2229-0806	National Council for Scientific and Technological Development - Brazil [441489/2014-1]; Universidade Federal da Paraiba	National Council for Scientific and Technological Development - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal da Paraiba	This work was partly supported by National Council for Scientific and Technological Development - Brazil, www.cnpq.br, grants 441489/2014-1 awarded to J. S. A. and by Universidade Federal da Paraiba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5; Amenya DA, 2010, INSECT MOL BIOL, V19, P263, DOI 10.1111/j.1365-2583.2009.00986.x; BAILEY SF, 1965, HILGARDIA, V37, P73, DOI 10.3733/hilg.v37n03p073; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Bowman C, 2005, B MATH BIOL, V67, P1107, DOI 10.1016/j.bulm.2005.01.002; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Collins FH., 1996, SCI MED, V3, P52; Couto PRL, 2008, ECOL MODEL, V214, P65, DOI 10.1016/j.ecolmodel.2008.01.012; CURTIS CF, 1976, MOSQ NEWS, V36, P492; Diaz H, 2011, J THEOR BIOL, V276, P57, DOI 10.1016/j.jtbi.2011.01.053; Dufourd C, 2013, COMPUT MATH APPL, V66, P1695, DOI 10.1016/j.camwa.2013.03.024; Dyck V.A., 2006, STERILE INSECT TECHN; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Geiser J, 2009, CH CRC NUMER ANAL SC, P1; Gunathilaka N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-285; Hartl DL, 1998, GENETICS PRINCIPLES; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Jia L, 2012, MATH BIOSCI, V240, P35, DOI 10.1016/j.mbs.2012.05.012; Kar Indranil, 1996, Indian Journal of Malariology, V33, P191; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Ladics T, 2016, COMPUT MATH APPL, V71, P57, DOI 10.1016/j.camwa.2015.10.015; Li CY, 2008, J HERED, V99, P275, DOI 10.1093/jhered/esn004; Li J, 2004, MATH BIOSCI, V189, P39, DOI 10.1016/j.mbs.2004.01.001; Li Jia, 2015, J Biol Dyn, V9, P1, DOI 10.1080/17513758.2014.977971; Li Jia, 2011, Journal of Biological Dynamics, V5, P474, DOI 10.1080/17513758.2010.523122; Li Jia, 2008, Journal of Biological Dynamics, V2, P241, DOI 10.1080/17513750701779633; Lutambi AM, 2013, MATH BIOSCI, V241, P198, DOI 10.1016/j.mbs.2012.11.013; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; Mattah PAD, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1941-3; McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Moreira LA, 2004, GENETICS, V166, P1337, DOI 10.1534/genetics.166.3.1337; Moreira LA, 2002, INT J PARASITOL, V32, P1599, DOI 10.1016/S0020-7519(02)00188-1; Ngwa GA, 2000, MATH COMPUT MODEL, V32, P747, DOI 10.1016/S0895-7177(00)00169-2; Ngwa GA, 2004, DISCRETE CONT DYN-B, V4, P1173, DOI 10.3934/dcdsb.2004.4.1173; Noble C, 2018, ELIFE, V7, DOI 10.7554/eLife.33423; Oyewole I. O., 2009, African Journal of Environmental Science and Technology, V3, P447; Rafikov M, 2009, J THEOR BIOL, V258, P418, DOI 10.1016/j.jtbi.2008.08.006; Rafikov M, 2010, J NONLINEAR SYST APP, V1, P27; REISEN WK, 1979, ANN TROP MED PARASIT, V73, P251, DOI 10.1080/00034983.1979.11687255; REISEN WK, 1975, MOSQ NEWS, V35, P473; Serebrovskii A.S., 1940, ZOOL ZH, V19, P618; Service MW, 1989, DEM VECT BORN DIS, P59; SULEMAN M, 1990, J MED ENTOMOL, V27, P819, DOI 10.1093/jmedent/27.5.819; Taha TR, 2005, J SUPERCOMPUT, V32, P5, DOI 10.1007/s11227-005-0183-5; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Thomas S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1321-7; Unckless RL, 2015, GENETICS, V201, P425, DOI 10.1534/genetics.115.177592; Vanderplank F. L., 1947, Transactions of the Royal Entomological Society of London, V98, P1; WHO, 2014, GLOB BRIEF VECT BORN; World Health Organization, 2017, DEPRESSION; Wyse APP, 2007, ECOL MODEL, V206, P322, DOI 10.1016/j.ecolmodel.2007.03.038; Wyse APP, 2016, P SER BRAZ SOC COMP; Wyse APP, 2017, P SER BRAZ SOC COMP; Wyse APP, 2007, THESIS	58	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205879	10.1371/journal.pone.0205879	http://dx.doi.org/10.1371/journal.pone.0205879			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379965	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700077
J	Kumar, N; Qureshi, Q; Jhala, YV; Gosler, AG; Sergio, F				Kumar, Nishant; Qureshi, Qamar; Jhala, Yadvendradev, V; Gosler, Andrew G.; Sergio, Fabrizio			Offspring defense by an urban raptor responds to human subsidies and ritual animal-feeding practices	PLOS ONE			English	Article							AVIAN NEST DEFENSE; BEHAVIORAL-RESPONSES; HUMAN DISTURBANCE; PERSONALITY; LANDSCAPES; WILDLIFE; ECOLOGY; TRAITS; AREAS; CITY	There is a growing interest in the behavioural and life history mechanisms that allow animal species to cope with rapidly expanding urban habitats, which impose frequent proximity to humans. A particular case of behavioral bottleneck (i.e. conflicting interests) faced by animals in urban environments is how they will modulate the defence of their offspring against the potential danger represented by humans, an aspect that has received scarce research attention. We examined the nest defense against humans by a dense breeding population of a raptor, the Black Kite Milvus migrans, within the megacity of Delhi (India). Here, kites live on a diet dominated by human waste and meat offered through religiously motivated bird feeding practices. Nest defense levels increased with the number of offspring, and with the progression of the breeding season. Defense also intensified close to ritual-feeding areas and with increasing human waste in the streets, suggesting synergistic effects of food availability, parental investment, personality-boldness and habituation to humans, with consequent attenuation of fear. Thus, the behavioural response to a perceived threat reflected the spatial mosaic of activity of humans in the city streets, their cultural practices of ritual-feeding, and their waste-management. For synurbic species, at the higher-end spectrum of adaptation to an urban life, human cultural practices and attitudes may well be the most defining dimensions of their urban niche. Our results suggest that, after initial urban colonization, animals may continue to adapt to the typically complex, heterogeneous environments of cities through fine-grained behavioural adjustments to human practices and activities.	[Kumar, Nishant; Gosler, Andrew G.] Univ Oxford, Edward Grey Inst Field Ornithol, Dept Zool, Oxford, England; [Kumar, Nishant; Qureshi, Qamar; Jhala, Yadvendradev, V] Wildlife Inst India, Dehra Dun, Uttarakhand, India; [Gosler, Andrew G.] Sch Anthropol & Museum Ethnog, Inst Human Sci, Oxford, England; [Sergio, Fabrizio] CSIC, Dept Conservat Biol, Estn Biol Donana, C Americo Vespucio 26, Seville, Spain	University of Oxford; Wildlife Institute of India; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Kumar, N (corresponding author), Univ Oxford, Edward Grey Inst Field Ornithol, Dept Zool, Oxford, England.; Kumar, N (corresponding author), Wildlife Inst India, Dehra Dun, Uttarakhand, India.	nishant.kumar@zoo.ox.ac.uk	Jhala, Yadvendradev/AAL-9711-2020; Gosler, Andrew/HCH-4278-2022	Kumar, Nishant/0000-0002-3505-6800	Raptor Research and Conservation Foundation (Mumbai); Govt. of India, Ministry of Environment, Forest and Climate Change; Spanish Ministry of Economy and Competitiveness [CGL2015-69445-P]; Publication Fee Assistance; Felix Scholarship Trust; Somerville College; AHRC [AH/L007584/1, AH/N004701/1] Funding Source: UKRI	Raptor Research and Conservation Foundation (Mumbai); Govt. of India, Ministry of Environment, Forest and Climate Change; Spanish Ministry of Economy and Competitiveness(Spanish Government); Publication Fee Assistance; Felix Scholarship Trust; Somerville College; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	The project was funded through multiple grants (2013-2016) by the Raptor Research and Conservation Foundation (Mumbai) http://raptors.net.in/to NK and by the Govt. of India, Ministry of Environment, Forest and Climate Change to YVJ, and NK). N. Kumar's D. Phil (2014-18) at the University of Oxford was funded by the Felix Scholarship Trust and Somerville College (https://www.some.ox.ac.uk: Discretionary Grant 2017). Funding for travelling and fieldwork by F. Sergio was afforded by Project CGL2015-69445-P of the Spanish Ministry of Economy and Competitiveness.; We are grateful to Ben Sheldon, Chris Perrins, Tommaso Pizzari, Ujjwal Kumar, and the Director, Dean and research coordinator of the Wildlife Institute of India for materials, encouragement and advice on various aspects of the project. We thank Drs. A. Margalida, W. Cresswell and two anonymous reviewers for helping us to improve a first draft of the manuscript. Delhi Police, and the Forest Departments of Delhi and Uttar Pradesh, Delhi Transport Corporation, Civic bodies of the Government of NCT of Delhi helped with legal permits, and the Director of the National Zoological Park of New Delhi gave access to study kites in the Park. Miranda House College and University of Delhi allowed access to their campus for nest monitoring. We express our most heartfelt gratitude to all the volunteers of the "Black Kite Project Group" from the University of Delhi (Sri Venkateswara and Deshbandhu Colleges), especially U. Gupta, H. Malhotra, A. Singh, P. Kumar, H. Singh, U. Nair and M. Singh, who provided essential field help, enthusiasm and cooperation in the environmental education of locally assembling crowds of curious people. Special thanks to our field assistants Laxmi Narayan, Prince Kumar and Poonam, who were the backbone of the field team. Finally, thanks to all the landowners, managers and government officials who patiently cooperated with our constant requests of access. We are thankful to the Publication Fee Assistance for financial support towards the publication of this manuscript.	Agresti A., 2010, ANAL ORDINAL CATEGOR, DOI [DOI 10.1002/9780470594001, 10.1002/9780470594001]; Alberti M., 2008, ADV URBAN ECOLOGY IN; Bagchi S, 2006, J ZOOL, V268, P217, DOI 10.1111/j.1469-7998.2005.00030.x; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Chamberlain DE, 2009, IBIS, V151, P1, DOI 10.1111/j.1474-919X.2008.00899.x; Christensen, 2015, COMPREHENSIVE R ARCH; Clucas B, 2012, AUK, V129, P8, DOI 10.1525/auk.2011.11121; Crawley MJ, 2013, R BOOK, P557; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Evans J, 2010, ETHOLOGY, V116, P588, DOI 10.1111/j.1439-0310.2010.01771.x; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Evans KL, 2010, BIOL REV, V85, P643, DOI 10.1111/j.1469-185X.2010.00121.x; Forman RTT, 2014, URBAN ECOLOGY: SCIENCE OF CITIES, P1; Francis RA, 2012, APPL GEOGR, V32, P514, DOI 10.1016/j.apgeog.2011.06.013; Gangoso L, 2013, CONSERV LETT, V6, P172, DOI 10.1111/j.1755-263X.2012.00289.x; Grimm NB, 2000, BIOSCIENCE, V50, P571, DOI 10.1641/0006-3568(2000)050[0571:IATLTO]2.0.CO;2; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hahs AK, 2015, FUNCT ECOL, V29, P863, DOI 10.1111/1365-2435.12488; HAKKARAINEN H, 1994, ANIM BEHAV, V48, P843, DOI 10.1006/anbe.1994.1308; HEDEKER D, 1994, BIOMETRICS, V50, P933, DOI 10.2307/2533433; Karanth KK, 2013, ENVIRON MANAGE, V52, P1320, DOI 10.1007/s00267-013-0162-1; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; KNIGHT RL, 1986, AUK, V103, P318, DOI 10.1093/auk/103.2.318; KNIGHT RL, 1987, CONDOR, V89, P175, DOI 10.2307/1368772; Kumar N, 2013, THESIS; Kumar N, 2018, URBAN ECOSYST, V21, P339, DOI 10.1007/s11252-017-0716-8; Kumar N, 2014, BIRD STUDY, V61, P1, DOI 10.1080/00063657.2013.876972; Kunca T, 2016, PEERJ, V4, DOI 10.7717/peerj.2070; Lepczyk CA, 2017, BIOSCIENCE, V67, P799, DOI 10.1093/biosci/bix079; Lepczyk CA, 2012, STUD AVIAN BIOL, V45, P267; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; McDonnell MJ, 2015, ANNU REV ECOL EVOL S, V46, P261, DOI 10.1146/annurev-ecolsys-112414-054258; Miranda AC, 2013, GLOBAL CHANGE BIOL, V19, P2634, DOI 10.1111/gcb.12258; MONTGOMERIE RD, 1988, Q REV BIOL, V63, P167, DOI 10.1086/415838; Moroni E, 2017, IBIS, V159, P854, DOI 10.1111/ibi.12513; Naoroji, 2007, BIRDS PREY INDIAN SU; Newton I., 1979, POPULATION ECOLOGY R; Pickett Steward T. A., 2016, Ecosystem Health and Sustainability, V2, pe01229, DOI 10.1002/ehs2.1229; Pinault D, 2008, COMP ISLAMIC STUDIES, P108; R Core Team, 2020, R LANG ENV STAT COMP; REDONDO T, 1989, BEHAVIOUR, V111, P161, DOI 10.1163/156853989X00646; Saberwal V., 2001, PEOPLE PARKS WILDLIF; Sergio F, 2001, AUK, V118, P1047, DOI 10.1642/0004-8038(2001)118[1047:NDAPCI]2.0.CO;2; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Smart J, 2010, BIOL CONSERV, V143, P1278, DOI 10.1016/j.biocon.2010.03.002; Sprau P, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00092; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; Taneja AV, 2015, COMP STUD SOUTH ASIA, V35, P204, DOI 10.1215/1089201x-3138988; Vincze E, 2016, BEHAV ECOL, V27, P1304, DOI 10.1093/beheco/arw047; Zuur A. F., 2011, MIXED EFFECTS MODELS	51	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0204549	10.1371/journal.pone.0204549	http://dx.doi.org/10.1371/journal.pone.0204549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372432	Green Published, gold, Green Submitted			2022-12-26	WOS:000448641200005
J	Theopold, J; Schleifenbaum, S; Muller, M; Werner, M; Hammer, N; Josten, C; Hepp, P				Theopold, Jan; Schleifenbaum, Stefan; Mueller, Mirijam; Werner, Michael; Hammer, Niels; Josten, Christoph; Hepp, Pierre			Biomechanical evaluation of hybrid double plate osteosynthesis using a locking plate and an inverted third tubular plate for the treatment of proximal humeral fractures	PLOS ONE			English	Article							ANGULAR STABLE PLATE; MEDIAL SUPPORT; INTERNAL-FIXATION; IN-VITRO; SCREWS; AUGMENTATION; REDUCTION; GRAFT; HEAD	Background Treating proximal humerus fractures can be challenging because of large metaphyseal defects that conceal anatomical landmarks. In such cases, medial cortical support with, for example, calcar screws, is mandatory. Nevertheless, varus dislocations and implant failures in patients with impaired bone quality persist. Thus, the need for effective treatment of these patients exists. Hybrid double plate osteosynthesis was introduced as an alternative, yielding similar results as calcar screws. However, a biomechanical comparison of the stability of these two techniques is pending. Methods Cadaveric humeral specimens were treated with plate osteosynthesis and calcar screws (group 1, n = 9) or hybrid double plate osteosynthesis (group 2, n = 9) using a proximal humerus fracture model with a two-part fracture. Displacement, stiffness, failure mode, and ultimate load were examined biomechanically in a cyclic compressive-loading scenario. Results Although the hybrid double plate osteosynthesis (group 2) tended to confer higher stiffnesses than the medial support screws at higher cycles (group 1), this trend was below the level of significance. The displacement revealed non-significantly lower values for group 1 as compared with group 2 for cycles 50 and 2000, but at 5000 cycles, group 2 offered non-significantly lower displacement values than group 1. The ultimate load tended to be non-significantly higher in the hybrid double plate osteosynthesis group (group 2: 1342 +/- 369 N, group 1: 855 +/- 408 N). Both groups yielded similar failure rates, with the majority of failures in group 2 being gap closures (n = 8), whereas those in group 1 being plate dislocations (n = 4). Conclusions The use of an additive plate osteosynthesis in the region of the bicipital groove may be a potential alternative to the previously-established method of using calcar screws. The biomechanical data obtained in this study suggests that hybrid double plate osteosynthesis is as rigid and robust as calcar screws.	[Theopold, Jan; Schleifenbaum, Stefan; Mueller, Mirijam; Josten, Christoph; Hepp, Pierre] Univ Leipzig, Dept Orthoped Trauma & Plast Surg, Leipzig, Germany; [Schleifenbaum, Stefan] ZESBO Zentrum Erforsch Stuetz & Bewegungsorgane, Leipzig, Germany; [Werner, Michael] Fraunhofer Inst Machine Tools & Forming Technol, Dresden, Germany; [Hammer, Niels] Univ Otago, Dept Anat, Dunedin, New Zealand	Leipzig University; Fraunhofer Gesellschaft; University of Otago	Theopold, J (corresponding author), Univ Leipzig, Dept Orthoped Trauma & Plast Surg, Leipzig, Germany.	jan.theopold@medizin.uni-leipzig.de	Theopold, Jan/AAA-1575-2021	Theopold, Jan/0000-0003-2884-8030; Werner, Michael/0000-0002-7864-9446; Schleifenbaum, Stefan/0000-0002-9075-3756	German Research Foundation (DFG); Leipzig University within the program of Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University within the program of Open Access Publishing	The authors acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JH, 2011, J BONE JOINT SURG BR, V93B, P937, DOI 10.1302/0301-620X.93B7.26125; Bai L, 2014, J ORTHOP TRAUMA, V28, P452, DOI 10.1097/BOT.0000000000000057; Burke NG, 2014, J ORTHOP SURG-HONG K, V22, P190, DOI 10.1177/230949901402200215; Choi S, 2014, INJURY, V45, P1280, DOI 10.1016/j.injury.2014.04.029; Court-Brown CM, 2008, J TRAUMA, V64, P1517, DOI 10.1097/TA.0b013e3181469840; Erhardt JB, 2012, J ORTHOP TRAUMA, V26, pE188, DOI 10.1097/BOT.0b013e31823db922; Gardner MJ, 2008, J ORTHOP TRAUMA, V22, P195, DOI 10.1097/BOT.0b013e31815b3922; Gardner MJ, 2007, J ORTHOP TRAUMA, V21, P185, DOI 10.1097/BOT.0b013e3180333094; He Y, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0573-4; He Y, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001775; Hersche O, 1996, SWISS SURG S, V2, P24; Hessmann MH, 2008, BIOMED TECH, V53, P130, DOI 10.1515/BMT.2008.018; Kathrein S, 2013, CLIN BIOMECH, V28, P273, DOI 10.1016/j.clinbiomech.2012.12.013; Katthagen JC, 2015, ORTHOP TRAUMATOL-SUR, V101, P431, DOI 10.1016/j.otsr.2015.01.018; Katthagen JC, 2016, INJURY, V47, P617, DOI 10.1016/j.injury.2016.01.004; Katthagen JC, 2014, CLIN BIOMECH, V29, P735, DOI 10.1016/j.clinbiomech.2014.06.008; Krappinger D, 2011, INJURY, V42, P1283, DOI 10.1016/j.injury.2011.01.017; Lescheid J, 2010, J TRAUMA, V69, P1235, DOI 10.1097/TA.0b013e3181beed96; Lill H, 2003, ARCH ORTHOP TRAUM SU, V123, P74, DOI 10.1007/s00402-002-0465-9; Lill H, 2002, ROFO-FORTSCHR RONTG, V174, P1544, DOI 10.1055/s-2002-35944; Osterhoff G, 2011, J SHOULDER ELB SURG, V20, P740, DOI 10.1016/j.jse.2010.10.040; Panchal K, 2016, INT ORTHOP, V40, P569, DOI 10.1007/s00264-015-2950-0; Roderer G, 2013, INJURY, V44, P1327, DOI 10.1016/j.injury.2013.05.008; Schliemann B, 2015, INJURY, V46, P1207, DOI 10.1016/j.injury.2015.04.020; Steinke H, 2012, MED ENG PHYS, V34, P1221, DOI 10.1016/j.medengphy.2011.12.009; Sudkamp N, 2009, J BONE JOINT SURG AM, V91A, P1320, DOI 10.2106/JBJS.H.00006; Theopold J, 2016, BMC SURG, V16, DOI [10.1186/s12893-016-0128-3, DOI 10.1186/S12893-016-0128-3]; Voigt C, 2011, J ORTHOP TRAUMA, V25, P399, DOI 10.1097/BOT.0b013e31820beb80; Wanner G A, 1998, Langenbecks Arch Chir Suppl Kongressbd, V115, P1211; Wanner GA, 2003, J TRAUMA, V54, P536, DOI 10.1097/01.TA.0000052365.96538.42; Zettl R, 2011, INT ORTHOP, V35, P1245, DOI 10.1007/s00264-011-1220-z; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103297; Zhang YK, 2016, INJURY, V47, P1191, DOI 10.1016/j.injury.2016.02.028	33	11	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206349	10.1371/journal.pone.0206349	http://dx.doi.org/10.1371/journal.pone.0206349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372476	Green Published, gold, Green Submitted			2022-12-26	WOS:000448641200031
J	Veras, AAD; Merlin, B; de Sa, PHCG				de Oliveira Veras, Adonney Allan; Merlin, Bruno; Caracciolo Gomes de Sa, Pablo Henrique			ImproveAssembly - Tool for identifying new gene products and improving genome assembly	PLOS ONE			English	Article								The availability of biological information in public databases has increased exponentially. To ensure the accuracy of this information, researchers have adopted several methods and refinements to avoid the dissemination of incorrect information; for example, several automated tools are available for annotation processes. However, manual curation ensures and enriches biological information. Additionally, the genomic finishing process is complex, resulting in increased deposition of drafts genomes. This introduces bias in other omics analyses because incomplete genomic content is used. This is also observed for complete genomes. For example, genomes generated by reference assembly may not include new products in the new sequence or errors or bias can occur during the assembly process. Thus, we developed ImproveAssembly, a tool capable of identifying new products missing from genomic sequences, which can be used for complete and draft genomes. The identified products can improve the annotation of complete genomes and drafts while significantly reducing the bias when the information is used in other omics analyses.	[de Oliveira Veras, Adonney Allan; Merlin, Bruno] Fed Univ Para, Fac Comp Engn, Campus Tucurui CAMTUC UFPA, Belem, Para, Brazil; [Caracciolo Gomes de Sa, Pablo Henrique] Fed Rural Univ Amazonia, Campus Tome Acu UFRA, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal Rural da Amazonia (UFRA)	Veras, AAD (corresponding author), Fed Univ Para, Fac Comp Engn, Campus Tucurui CAMTUC UFPA, Belem, Para, Brazil.	allanverasve@gmail.com	Veras, Adonney Allan de Oliveira/AAK-6488-2020	Veras, Adonney Allan de Oliveira/0000-0002-7227-0590; Henrique Caracciolo Gomes de Sa, Pablo/0000-0003-0398-209X; Merlin, Bruno/0000-0001-7327-9960	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Federal University of Para (UFPA) [PRO2154-2018]; Federal Rural University of Amazonia (UFRA) [092017-767]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Federal University of Para (UFPA); Federal Rural University of Amazonia (UFRA)	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). AAOV was supported by PRO2154-2018 from Federal University of Para (UFPA) and PHCGS was supported by 092017-767 from Federal Rural University of Amazonia (UFRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Dunne M, 2017, BMC GENOMICS, V18; Grau JH, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy029; Klassen JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-14; Kremer FS, 2017, GENET MOL BIOL, V40, P553, DOI [10.1590/1678-4685-GMB-2016-0230, 10.1590/1678-4685-gmb-2016-0230]; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mardis E, 2002, GENOME RES, V12, P669, DOI 10.1101/gr.032102; Nagarajan N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-242; Pantoja Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178154; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Steward CA, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0441-1; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206000	10.1371/journal.pone.0206000	http://dx.doi.org/10.1371/journal.pone.0206000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365512	gold, Green Published, Green Submitted			2022-12-26	WOS:000448448700021
J	Park, S; Lee, Y; Kwon, YM; Lee, YT; Kim, KH; Ko, EJ; Jung, JH; Song, M; Graham, B; Prausnitz, MR; Kang, SM				Park, Soojin; Lee, Youri; Kwon, Young-Man; Lee, Young-Tae; Kim, Ki-Hye; Ko, Eun-Ju; Jung, Jae Hwan; Song, Manki; Graham, Barney; Prausnitz, Mark R.; Kang, Sang-Moo			Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge	PLOS ONE			English	Article							T-CELLS; PARTICLE VACCINE; RSV VACCINE; G-GLYCOPROTEIN; INFECTION; IMMUNIZATION; DELIVERY; MODEL; MICE; SKIN	Intramuscular (IM) vaccination with formalin-inactivated respiratory syncytial virus (FI-RSV) failed in clinical trials due to vaccine-enhanced respiratory disease. To test the efficacy of skin vaccination against respiratory syncytial virus (RSV), we investigated the immunogenicity, efficacy, and inflammatory disease after microneedle (MN) patch delivery of FI-RSV vaccine (FI-RSV MN) to the mouse skin with or without an adjuvant of monophosphoryl lipid A (MPL). Compared to IM vaccination, MN patch delivery of FI-RSV was more effective in clearing lung viral loads and preventing weight loss, and in diminishing inflammation, infiltrating immune cells, and T helper type 2 (Th2) CD4 T cell responses after RSV challenge. With MPL adjuvant, MN patch delivery of FI-RSV significantly increased the immunogenicity and efficacy as well as preventing RSV disease as evidenced by lung viral clearance and avoiding pulmonary histopathology. Improved efficacy and prevention of disease by FI-RSV MN with MPL were correlated with no sign of airway resistance, lower levels of Th2 cytokines and infiltrating innate inflammatory cells, and higher levels of Th1 T cell responses into the lung. This study suggests that MN patch delivery of RSV vaccines to the skin with MPL adjuvant would be a promising vaccination method.	[Park, Soojin; Lee, Youri; Kwon, Young-Man; Lee, Young-Tae; Kim, Ki-Hye; Ko, Eun-Ju; Kang, Sang-Moo] Georgia State Univ, Ctr Inflammat Immun & Infect, Inst Biomed Sci, Atlanta, GA 30303 USA; [Jung, Jae Hwan; Prausnitz, Mark R.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Song, Manki] Int Vaccine Inst, Seoul, South Korea; [Graham, Barney] Natl Inst Infect Dis, Vaccine Res Ctr, NIH, Bethesda, MD USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia Institute of Technology; International Vaccine Institute; National Institutes of Health (NIH) - USA	Kang, SM (corresponding author), Georgia State Univ, Ctr Inflammat Immun & Infect, Inst Biomed Sci, Atlanta, GA 30303 USA.	skang24@gsu.edu	Graham, Barney S./AAC-5898-2019	Graham, Barney S./0000-0001-8112-0853; Prausnitz, Mark/0000-0002-9076-8448	National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI105170, AI093772]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093772, R01AI105170, ZIAAI005129] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health/National Institute of Allergy and Infectious Diseases grants AI105170 and AI093772 to SMK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zahrani S, 2012, EXPERT OPIN DRUG DEL, V9, P541, DOI 10.1517/17425247.2012.676038; Blanco JCG, 2014, VACCINE, V32, P1495, DOI 10.1016/j.vaccine.2013.11.032; Boukhvalova MS, 2006, VACCINE, V24, P5027, DOI 10.1016/j.vaccine.2006.03.064; Castilow EM, 2008, J IMMUNOL, V180, P2376, DOI 10.4049/jimmunol.180.4.2376; CONNORS M, 1992, J VIROL, V66, P7444, DOI 10.1128/JVI.66.12.7444-7451.1992; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fernando GJP, 2018, VACCINE, V36, P3779, DOI 10.1016/j.vaccine.2018.05.053; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Gershwin LJ, 1998, VACCINE, V16, P1225, DOI 10.1016/S0264-410X(98)80123-0; Gill HS, 2007, PHARM RES, V24, P1369, DOI 10.1007/s11095-007-9286-4; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Hwang HS, 2014, ANTIVIR RES, V110, P115, DOI 10.1016/j.antiviral.2014.07.016; Johnson TR, 2004, J VIROL, V78, P8753, DOI 10.1128/JVI.78.16.8753-8760.2004; KAKUK TJ, 1993, J INFECT DIS, V167, P553, DOI 10.1093/infdis/167.3.553; Kamphuis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036812; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Killikelly AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34108; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032226; Kim YC, 2010, AAPS PHARMSCITECH, V11, P1193, DOI 10.1208/s12249-010-9471-3; Kim YC, 2011, PHARM RES-DORDR, V28, P135, DOI 10.1007/s11095-010-0134-6; Kim YC, 2010, J CONTROL RELEASE, V142, P187, DOI 10.1016/j.jconrel.2009.10.013; Lee YT, 2015, VIROLOGY, V485, P36, DOI 10.1016/j.virol.2015.07.001; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Marshall S, 2016, HUM VACC IMMUNOTHER, V12, P2975, DOI 10.1080/21645515.2016.1171440; Martinez FD, 2003, PEDIATR INFECT DIS J, V22, pS76, DOI 10.1097/00006454-200302001-00011; Meyerholz DK, 2009, TOXICOL PATHOL, V37, P249, DOI 10.1177/0192623308329342; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; O'Hagan DT, 2017, CURR OPIN IMMUNOL, V47, P93, DOI 10.1016/j.coi.2017.07.010; Olson MR, 2007, J IMMUNOL, V179, P5415, DOI 10.4049/jimmunol.179.8.5415; Park S, 2015, IMMUN INFLAMM DIS, V3, P386, DOI 10.1002/iid3.76; Prausnitz MR, 2017, ANNU REV CHEM BIOMOL, V8, P177, DOI 10.1146/annurev-chembioeng-060816-101514; Prince GA, 2001, J GEN VIROL, V82, P2881, DOI 10.1099/0022-1317-82-12-2881; Quan FS, 2013, CLIN VACCINE IMMUNOL, V20, P1433, DOI 10.1128/CVI.00251-13; Quan FS, 2011, J INFECT DIS, V204, P987, DOI 10.1093/infdis/jir474; Quan FS, 2010, J CONTROL RELEASE, V147, P326, DOI 10.1016/j.jconrel.2010.07.125; Quan FS, 2010, J VIROL, V84, P7760, DOI 10.1128/JVI.01849-09; Quan FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007152; Rima B, 2017, J GEN VIROL, V98, P2912, DOI 10.1099/jgv.0.000959; Rouphael NG, 2017, LANCET, V390, P649, DOI 10.1016/S0140-6736(17)30575-5; Shin CI, 2017, THER DELIV, V8, P447, DOI 10.4155/tde-2017-0032; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Varga SM, 2000, J IMMUNOL, V165, P6487, DOI 10.4049/jimmunol.165.11.6487; Vrdoljak A, 2016, J CONTROL RELEASE, V225, P192, DOI 10.1016/j.jconrel.2016.01.019; Wang BZ, 2014, J CONTROL RELEASE, V178, P1, DOI 10.1016/j.jconrel.2014.01.002; Weiss KA, 2011, J IMMUNOL, V187, P3145, DOI 10.4049/jimmunol.1100764	47	12	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0205071	10.1371/journal.pone.0205071	http://dx.doi.org/10.1371/journal.pone.0205071			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365561	Green Published, gold, Green Submitted			2022-12-26	WOS:000448448700005
J	Beani, L; Cappa, F; Manfredini, F; Zaccaroni, M				Beani, Laura; Cappa, Federico; Manfredini, Fabio; Zaccaroni, Marco			Preference of Polistes dominula wasps for trumpet creepers when infected by Xenos vesparum: A novel example of co-evolved traits between host and parasite	PLOS ONE			English	Article							STREPSIPTERA; NECTAR; MANIPULATION; PREVALENCE; INSECTA	The parasitic insect Xenos vesparum induces noticeable behavioral and physiological changes-e.g. castration-in its female host, the paper wasp Polistes dominula: parasitized putative workers avoid any colony task and desert the colony to survive in the nearby vegetation, like future queens and males do. In this long-term observational study, we describe the spectacular attraction of parasitized workers towards trumpet creeper bushes (Campsis radicans) in early-summer. Two thirds of all wasps that we sampled on these bushes were parasitized, whereas the parasite prevalence was much lower in our study area and most wasps sampled on other nearby flowering bushes were non-parasitized. First, we describe the occurrence and consistency of this phenomenon across different sites and years. Second, we evaluate the spatial behavior of parasitized wasps on C. radicans bushes, which includes site-fidelity, exploitation and defense of rich extra-floral nectaries on buds and calices. Third, we record two critical steps of the lifecycle of X. vesparum on C. radicans: the parasite's mating and a summer release of parasitic larvae, that can infect larval stages of the host if transported to the host's nest. In a nutshell, C. radicans bushes provide many benefits both to the parasite X. vesparum and to its host: they facilitate the parasite's mating and bivoltine lifecycle, a phenomenon never described before for this parasite, while, at the same time, they provide the wasp host with shelter inside trumpet flowers and extrafloral gland secretions, thus likely enhancing host survival and making it a suitable vector for the infection.	[Beani, Laura; Cappa, Federico; Zaccaroni, Marco] Univ Firenze, Dipartimento Biol, Florence, Italy; [Manfredini, Fabio] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England	University of Florence; University of London; Royal Holloway University London	Zaccaroni, M (corresponding author), Univ Firenze, Dipartimento Biol, Florence, Italy.	marco.zaccaroni@unifi.it	Cappa, Federico/AAF-8489-2020; Manfredini, Fabio/AAA-3012-2019	Manfredini, Fabio/0000-0002-9134-3994; zaccaroni, marco/0000-0002-3588-6476	University of Florence, Department of Biology	University of Florence, Department of Biology	Financial support was provided by the University of Florence, Department of Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beani L, 2005, J MORPHOL, V265, P291, DOI 10.1002/jmor.10359; Beani Laura, 2007, Redia, V90, P161; Beani L, 2006, ANN ZOOL FENN, V43, P564; Beani L, 2011, ANIM BEHAV, V82, P1305, DOI 10.1016/j.anbehav.2011.09.012; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Cappa F, 2014, PARASITOLOGY, V141, P1080, DOI 10.1017/S003118201400047X; Cook JL, 2014, COMP PARASITOL, V81, P134, DOI 10.1654/4723.1; Dapporto L, 2007, PARASITOLOGY, V134, P545, DOI 10.1017/S0031182006001739; ELIAS TS, 1975, SCIENCE, V189, P289, DOI 10.1126/science.189.4199.289; ELIAS TS, 1976, AM J BOT, V63, P1349, DOI 10.2307/2441843; GALETTO L, 1995, PLANT SYST EVOL, V196, P99, DOI 10.1007/BF00985338; Geffre AC, 2017, P R SOC B; Giusti F, 2007, ARTHROPOD STRUCT DEV, V36, P183, DOI 10.1016/j.asd.2007.01.001; Hamilton WH, 1999, E COMMUNICATION; Hashem FA, 2006, PLANTA MED, V72, P1016; Hughes DP, 2005, BEHAV PROCESS, V68, P263, DOI 10.1016/j.beproc.2004.09.006; Hughes DP, 2004, ETHOL ECOL EVOL, V16, P363, DOI 10.1080/08927014.2004.9522627; Hughes DP, 2004, BEHAV ECOL, V15, P1037, DOI 10.1093/beheco/arh111; Hughes DP, 2003, INSECT SOC, V50, P62, DOI 10.1007/s000400300010; Jandt JM, 2015, BEHAV ECOL, V26, P1274, DOI 10.1093/beheco/arv082; KATHIRITHAMBY J, 1989, SYST ENTOMOL, V14, P41, DOI 10.1111/j.1365-3113.1989.tb00265.x; Kathirithamby J, 2009, ANNU REV ENTOMOL, V54, P227, DOI 10.1146/annurev.ento.54.110807.090525; Kolodziejska-Degorska I, 2006, ACTA SOC BOT POL, V75, P79; Lefevre T, 2008, TRENDS PARASITOL, V24, P435, DOI 10.1016/j.pt.2008.06.006; MANFREDINI F, 2010, ETHOL ECOL EVOL, V22, P1; Manfredini F, 2010, MICROBES INFECT, V12, P727, DOI 10.1016/j.micinf.2010.05.001; Manfredini F, 2010, J INSECT PHYSIOL, V56, P253, DOI 10.1016/j.jinsphys.2009.10.009; Mavundza EJ, 2010, ANTIOXIDANT ACTIVITY; Ness JH, 2003, OECOLOGIA, V134, P210, DOI 10.1007/s00442-002-1110-6; Poulin R, 2015, TRENDS PARASITOL, V31, P563, DOI 10.1016/j.pt.2015.07.002; Schmid-Hempel P., 1998, Parasites in social insects.; Turillazzi S., 1996, NATURAL HIST EVOLUTI; Vannini L, 2008, PARASITOLOGY, V135, P705, DOI 10.1017/S0031182008004320	33	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205201	10.1371/journal.pone.0205201	http://dx.doi.org/10.1371/journal.pone.0205201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356249	gold, Green Published, Green Submitted			2022-12-26	WOS:000448434000040
J	Burgmaier, M; Milzi, A; Dettori, R; Burgmaier, K; Marx, N; Reith, S				Burgmaier, Mathias; Milzi, Andrea; Dettori, Rosalia; Burgmaier, Kathrin; Marx, Nikolaus; Reith, Sebastian			Co-localization of plaque macrophages with calcification is associated with a more vulnerable plaque phenotype and a greater calcification burden in coronary target segments as determined by OCT	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SPOTTY CALCIFICATION; CAP RUPTURE; MICROCALCIFICATIONS; INFLAMMATION; HYPOTHESIS; MECHANISM; VESICLES; DISEASE	Background The presence of plaque macrophages and microcalcifications are acknowledged features of plaque vulnerability. Experimental data suggest that microcalcifications promote inflammation and macrophages foster microcalcifications. However, co-localization of plaque macrophages and calcification (ColocCaMa) in coronary segments and its impact on plaque phenotype and lesion vulnerability is unexplored. Methods Plaque morphology including ColocCaMa of calcified coronary target segments in patients with stable coronary artery disease (n = 116) was analyzed using optical coherence tomography (OCT) prior to coronary intervention. Therefore we considered macrophages colocalized with calcification if their distance in an OCT frame was <100 mu m and OCT-defined microcalcifications with a calcium arc <22.5 degrees. Results ColocCaMa was present in 29/116(25.0%) coronary segments. Calcium burden was greater (calcium volume index:1731 +/- 1421 degrees*mm vs. 963 +/- 984 degrees*mm, p = 0.002) and calcifications were more superficial (minimal thickness of the fibrous cap overlying the calcification 35 +/- 37 mu m vs. 64 +/- 72 mu m, p = 0.005) in the presence of ColocCaMa. Segments with ColocCaMa demonstrated a higher incidence of newly suggested features of plaque vulnerability, with a 3.5-fold higher number of OCT-defined microcalcifications (0.7 +/- 1.0 vs. 0.2 +/- 0.6, p = 0.022) and a 6.7-fold higher incidence of plaque inflammation (macrophage volume index:148.7 +/- 248.3 degrees*mm vs. 22.2 +/- 57.4 degrees*mm, p<0.001). Clinically, intima-media thickness (IMT) in carotid arteries was increased in patients with ColocCaMa (1.02 +/- 0.30mm vs. 0.85 +/- 0.18, p = 0.021). In a multivariate model, IMT (OR1.76 for 100 mu m, 95%Cl 1.16-2.65, p = 0.007), HDL-cholesterol (OR0.36 for 10mg/d1, 95%CI 0.16-0.84, p = 0.017), calcium volume index (OR1.07 for 100 degrees *mm, 95%CI 1.00-1.14, p = 0.049), macrophage volume index (OR5.77 for 100 degrees*mm, 95%CI 12.04-16.3, p = 0.001) and minimal luminal area (OR3.41, 95%Cl 1.49-7.78, p = 0.004) were independent predictors of ColocCaMa. Conclusion Plaque macrophages co-localize with calcifications in coronary target segments and this is associated with high-risk morphological features including microcalcifications and macrophage infiltration as well as with greater calcification burden. Our data may add to the understanding of the relationship between plaque macrophages, vascular calcification and their clinical impact.	[Burgmaier, Mathias; Milzi, Andrea; Dettori, Rosalia; Marx, Nikolaus; Reith, Sebastian] Rhein Westfal TH Aachen, Univ Hosp, Dept Cardiol, Aachen, Germany; [Burgmaier, Kathrin] Univ Hosp Cologne, Dept Pediat, Cologne, Germany	RWTH Aachen University; RWTH Aachen University Hospital; University of Cologne	Reith, S (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Dept Cardiol, Aachen, Germany.	sreith@ukaachen.de	Milzi, Andrea/H-2461-2018	Milzi, Andrea/0000-0001-7580-8029				Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Basalyga DM, 2004, CIRCULATION, V110, P3480, DOI 10.1161/01.CIR.0000148367.08413.E9; Burgmaier M, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0117-8; Cardoso L, 2014, J BIOMECH, V47, P870, DOI 10.1016/j.jbiomech.2014.01.010; Chatrou MLL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142335; Derlin T, 2011, J NUCL MED, V52, P1020, DOI 10.2967/jnumed.111.087452; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; Habara M, 2018, INT J CARDIOL, DOI [10.1016/j.cellbi.2007.02.009, DOI 10.1016/J.CELLBI.2007.02.009]; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Ikeda K, 2012, BIOCHEM BIOPH RES CO, V425, P39, DOI 10.1016/j.bbrc.2012.07.045; Kato K, 2012, CIRC-CARDIOVASC IMAG, V5, P433, DOI 10.1161/CIRCIMAGING.112.973701; Kelly-Arnold A, 2013, P NATL ACAD SCI USA, V110, P10741, DOI 10.1073/pnas.1308814110; Kitabata H, 2010, AM J CARDIOL, V105, P1673, DOI 10.1016/j.amjcard.2010.01.346; Kolodgie FD, 2001, CURR OPIN CARDIOL, V16, P285, DOI 10.1097/00001573-200109000-00006; Kortelainen ML, 2014, CARDIOVASC PATHOL, V23, P193, DOI 10.1016/j.carpath.2014.03.001; Krishnamoorthy P, 2017, EUROINTERVENTION, V13, P312, DOI 10.4244/EIJ-D-16-00139; Kume T, 2011, EUROINTERVENTION, V6, P768, DOI 10.4244/EIJV6I6A130; Libby P, 2014, CIRC RES, V114, P1867, DOI 10.1161/CIRCRESAHA.114.302699; Liu HM, 2007, CELL BIOL INT, V31, P900, DOI 10.1016/j.cellbi.2007.02.009; Maldonado N, 2013, J BIOMECH, V46, P396, DOI 10.1016/j.jbiomech.2012.10.040; Maldonado N, 2012, AM J PHYSIOL-HEART C, V303, pH619, DOI 10.1152/ajpheart.00036.2012; Milzi A, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0635-2; Mizukoshi M, 2013, AM J CARDIOL, V112, P34, DOI 10.1016/j.amjcard.2013.02.048; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2; New SEP, 2013, ARTERIOSCL THROM VAS, V33, P1753, DOI 10.1161/ATVBAHA.112.300128; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; Phipps JE, 2015, JACC-CARDIOVASC IMAG, V8, P63, DOI 10.1016/j.jcmg.2014.07.027; Sakaguchi M, 2016, HEART VESSELS, V31, P1915, DOI 10.1007/s00380-016-0820-3; Sinclair H, 2015, JACC-CARDIOVASC IMAG, V8, P198, DOI 10.1016/j.jcmg.2014.12.005; Tearney GJ, 2003, CIRCULATION, V107, P113, DOI 10.1161/01.CIR.0000044384.41037.43; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Vengrenyuk Y, 2006, P NATL ACAD SCI USA, V103, P14678, DOI 10.1073/pnas.0606310103; [No title captured]	34	21	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205984	10.1371/journal.pone.0205984	http://dx.doi.org/10.1371/journal.pone.0205984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356326	Green Published, Green Submitted, gold			2022-12-26	WOS:000448434000066
J	Nociti, V; Santoro, M; Quaranta, D; Losavio, FA; De Fino, C; Giordano, R; Palomba, N; Rossini, PM; Guerini, FR; Clerici, M; Caputo, D; Mirabella, M				Nociti, Viviana; Santoro, Massimo; Quaranta, Davide; Losavio, Francesco Antonio; De Fino, Chiara; Giordano, Rocco; Palomba, Nicole; Rossini, Paolo Maria; Guerini, Franca Rosa; Clerici, Mario; Caputo, Domenico; Mirabella, Massimiliano			BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression	PLOS ONE			English	Article							ACTIVITY-DEPENDENT SECRETION; NEUROTROPHIC FACTOR; VAL66MET POLYMORPHISM; DNA; CELLS; GENE	Introduction Brain-Derived Neurotrophic Factor (BDNF) and its most common polymorphism Val66Met are known to have a role in Multiple Sclerosis (MS) pathogenesis. Evidence is accumulating that there is an involvement of DNA methylation in the regulation of BDNF expression. The aim of this study was to assess in blood samples of MS patients the correlation between the methylation status of the CpG site near BDNF-Val66Met polymorphism and the severity of the disease. Methods We recruited 209 MS patients that were genotyped for the BDNF Val66Met polymorphism. For each patient we quantitatively measured the methylation level of cytosine included in the exonic CpG site that can be created or abolished by the Val66Met BDNF polymorphism. Furthermore, we analyzed the clinical history of each patient and determined the time elapsed since the onset of the disease and an EDSS score of 6.0. Results The genetic analysis identified 122 (58.4%) subjects carrying the Val/Val genotype, 81 (38.8%) with Val/Met genotype, and 6 (2.8%) carrying the Met/Met genotype. When the endpoint of an EDSS score of 6 was taken into account by means of a survival analysis, 52 failures (i.e., reaching an EDSS score of 6) were reported. When the sample was stratified according to the percentage of the BDNF methylation, subjects falling below the median (median methylation = 81%) were at higher risk of failure (IRD = 0.016; 95%CI= 0.0050-0.0279; p = 0.004). Conclusions In patients with a high disease progression the hypomethylation of the BDNF gene could increase the secretion of the protective neurotrophin, so epigenetic modifications could be the organism response to limit a brain functional reserve loss. Our study suggests that the percentage of methylation of the BDNF gene could be used as a prognostic factor for disease progression toward a high disability in MS patient.	[Nociti, Viviana; Quaranta, Davide; Losavio, Francesco Antonio; De Fino, Chiara; Giordano, Rocco; Palomba, Nicole; Rossini, Paolo Maria; Mirabella, Massimiliano] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Inst Neurol, Rome, Italy; [Santoro, Massimo; Guerini, Franca Rosa; Caputo, Domenico] IRCCS Fdn Don Carlo Gnocchi, Milan, Italy; [Clerici, Mario] Univ Milan, Dept Physiopathol & Transplantat, Milan, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Fondazione Don Carlo Gnocchi Onlus; University of Milan	Mirabella, M (corresponding author), Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Inst Neurol, Rome, Italy.	massimiliano.mirabella@unicatt.it	Palomba, Nicole Piera/ABH-4725-2020; Nociti, Viviana/Z-2441-2019; Quaranta, Davide/K-5730-2016; Nociti, Viviana/T-5022-2019; MIRABELLA, Massimiliano/AAC-4016-2020; Guerini, Franca R./G-8055-2012; Rossini, Paolo Maria/D-4994-2013	MIRABELLA, Massimiliano/0000-0002-7783-114X; Guerini, Franca R./0000-0001-9461-5927; Palomba, Nicole Piera/0000-0001-6240-9272; Losavio, Francesco Antonio/0000-0001-7796-8392; Rossini, Paolo Maria/0000-0003-2665-534X; Giordano, Rocco/0000-0003-1331-129X				Acosta CMR, 2013, CNS NEUROL DISORD-DR, V12, P1242; Aharoni R, 2009, DRUG NEWS PERSPECT, V22, P301, DOI 10.1358/dnp.2009.22.6.1395253; Azoulay D, 2008, J NEUROIMMUNOL, V195, P186, DOI 10.1016/j.jneuroim.2008.01.010; Batoulis H, 2010, ANN ANAT, V192, P179, DOI 10.1016/j.aanat.2010.06.006; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Cottrell S, 2007, J UROLOGY, V177, P1753, DOI 10.1016/j.juro.2007.01.010; D'Addario C, 2013, BIOL PSYCHIAT, V73, pE6, DOI 10.1016/j.biopsych.2012.07.009; Dincheva I, 2012, NEUROSCIENTIST, V18, P439, DOI 10.1177/1073858411431646; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Gold R, 2012, LANCET NEUROL, V11, P9, DOI 10.1016/S1474-4422(11)70268-X; Hall D, 2003, AM J HUM GENET, V73, P370, DOI 10.1086/377003; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lee DH, 2012, ACTA NEUROPATHOL, V123, P247, DOI 10.1007/s00401-011-0890-3; Liguori M, 2009, BRAIN RES, V1256, P123, DOI 10.1016/j.brainres.2008.11.047; Makar TK, 2009, J NEUROIMMUNOL, V210, P40, DOI 10.1016/j.jneuroim.2009.02.017; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Naegele M, 2014, HAND CLINIC, V122, P59, DOI 10.1016/B978-0-444-52001-2.00003-0; Namaka Michael, 2008, Consult Pharm, V23, P886, DOI 10.4140/TCP.n.2008.886; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Ramasamy Deepa P, 2011, Pathophysiology, V18, P53, DOI 10.1016/j.pathophys.2010.04.006; Rao JS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.55; Santoro M, 2016, EUR J NEUROL, V23, P630, DOI 10.1111/ene.12913; Sarchielli P, 2002, J NEUROIMMUNOL, V132, P180, DOI 10.1016/S0165-5728(02)00319-3; Tomassini V, 2018, MULT SCLER, V2; Ursini G, 2016, EPIGENETICS-US, V11, P11, DOI 10.1080/15592294.2015.1117736; Van't Veer A, 2009, J NEUROSCI RES, V87, P69, DOI 10.1002/jnr.21841; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Zivadinov R, 2007, HUM MOL GENET, V16, P2659, DOI 10.1093/hmg/ddm189	32	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206140	10.1371/journal.pone.0206140	http://dx.doi.org/10.1371/journal.pone.0206140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352103	gold, Green Published, Green Submitted			2022-12-26	WOS:000448076200030
J	Di Leo, L; Vegliante, R; Ciccarone, F; Salvatori, I; Scimeca, M; Bonanno, E; Sagnotta, A; Grazi, GL; Aquilano, K; Ciriolo, MR				Di Leo, Luca; Vegliante, Rolando; Ciccarone, Fabio; Salvatori, Illari; Scimeca, Manuel; Bonanno, Elena; Sagnotta, Andrea; Grazi, Gian Luca; Aquilano, Katia; Ciriolo, Maria Rosa			Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-alpha/p300-mediated acetylation of p53	ONCOGENE			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; HEPATOCELLULAR-CARCINOMA; TRIACYLGLYCEROL HYDROLYSIS; ENERGY-METABOLISM; LIPID-METABOLISM; FATTY-ACIDS; CANCER; LIPOLYSIS; OMEGA-3-FATTY-ACIDS; PHOSPHORYLATION	Metabolic reprogramming is a typical feature of cancer cells aimed at sustaining high-energetic demand and proliferation rate. Here, we report clear-cut evidence for decreased expression of the adipose triglyceride lipase (ATGL), the first and rate-limiting enzyme of triglyceride hydrolysis, in both human and mouse-induced hepatocellular carcinoma (HCC). We identified metabolic rewiring as major outcome of ATGL overexpression in HCC-derived cell lines. Indeed, ATGL slackened both glucose uptake/utilization and cell proliferation in parallel with increased oxidative metabolism of fatty acids and enhanced mitochondria capacity. We ascribed these ATGL-downstream events to the activity of the tumor-suppressor p53, whose protein levels-but not transcript-were upregulated upon ATGL overexpression. The role of p53 was further assessed by abrogation of the ATGL-mediated effects upon p53 silencing or in p53-null hepatocarcinoma Hep3B cells. Furthermore, we provided insights on the molecular mechanisms governed by ATGL in HCC cells, identifying a new PPAR-alpha/p300 axis responsible for p53 acetylation/accumulation. Finally, we highlighted that ATGL levels confer different susceptibility of HCC cells to common therapeutic drugs, with ATGL overexpressing cells being more resistant to glycolysis inhibitors (e.g., 2-deoxyglucose and 3-bromopyruvate), compared to genotoxic compounds. Collectively, our data provide evidence for a previously uncovered tumor-suppressor function of ATGL in HCC, with the outlined molecular mechanisms shedding light on new potential targets for anticancer therapy.	[Di Leo, Luca; Vegliante, Rolando; Ciccarone, Fabio; Aquilano, Katia; Ciriolo, Maria Rosa] Univ Roma Tor Vergata, Dept Biol, Via Ric Sci 1, I-00133 Rome, Italy; [Salvatori, Illari] IRCCS Fdn Santa Lucia, Santa Lucia Fdn, I-00143 Rome, Italy; [Scimeca, Manuel; Bonanno, Elena] Univ Roma Tor Vergata, Dept Expt Med & Surg, Via Montpellier 1, I-00133 Rome, Italy; [Scimeca, Manuel; Ciriolo, Maria Rosa] IRCCS San Raffaele Pisana, Via Pisana 235, I-00163 Rome, Italy; [Sagnotta, Andrea] Santa Maria di Terni Hosp, Digest Surg & Liver Unit, I-05100 Terni, Italy; [Sagnotta, Andrea] Sapienza Univ Rome, Fac Med & Psychol, St Andrea Hosp, Surg & Med Dept Translat Med, Via Grottarossa 1035-39, I-00189 Rome, Italy; [Grazi, Gian Luca] IRCCS, Regina Elena Natl Canc Inst, Dept Clin & Expt Oncol, Hepatopancreatobiliary Surg Unit, Via Elio Chianesi 53, I-00144 Rome, Italy; [Vegliante, Rolando] Inst Hematol & Immunol 1, INSERM U1109HOP CIVIL, Microenvironm Niche Tumorigenesis & Targeted Ther, Pl Hop, F-67091 Strasbourg, France	University of Rome Tor Vergata; IRCCS Santa Lucia; University of Rome Tor Vergata; IRCCS San Raffaele Pisana; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Ciriolo, MR (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci 1, I-00133 Rome, Italy.; Ciriolo, MR (corresponding author), IRCCS San Raffaele Pisana, Via Pisana 235, I-00163 Rome, Italy.	ciriolo@bio.uniroma2.it	AQUILANO, KATIA/K-8888-2016; CICCARONE, FABIO/K-4225-2016; Salvatori, Illari/AAB-6129-2022; Ciccarone, Fabio/AAR-9128-2021	AQUILANO, KATIA/0000-0002-5905-9870; Salvatori, Illari/0000-0001-9700-1269; Ciccarone, Fabio/0000-0002-2425-2240; Sagnotta, Andrea/0000-0002-0606-0317; Di Leo, Luca/0000-0002-2419-2196	Italian Association for Cancer Research (AIRC) [IG 15403]	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Association for Cancer Research (AIRC, IG 15403). The authors would like to thank Dr. Serena Castelli for her valid help during the revision process. This manuscript is dedicated to Prof. Maria Teresa Carri.	Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; Al-Zoughbi W, 2016, ONCOTARGET, V7, P33832, DOI 10.18632/oncotarget.9418; Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Aquilano K, 2016, ONCOTARGET, V7, P23019, DOI 10.18632/oncotarget.8552; Barascu A, 2006, INT J BIOCHEM CELL B, V38, P196, DOI 10.1016/j.biocel.2005.08.015; Barbato DL, 2014, BBA-REV CANCER, V1845, P317, DOI 10.1016/j.bbcan.2014.02.003; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Boidot R, 2012, CANCER RES, V72, P939, DOI 10.1158/0008-5472.CAN-11-2474; Bruix J, 2017, J HEPATOL; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Cardaci S, 2012, CANCER RES, V72, P4526, DOI 10.1158/0008-5472.CAN-12-1741; Cardaci S, 2012, J BIOENERG BIOMEMBR, V44, P17, DOI 10.1007/s10863-012-9422-7; Ciccarone F, 2017, SEMIN CANCER BIOL, V47, P50, DOI 10.1016/j.semcancer.2017.06.008; Cui W, 2010, AM J TRANSL RES, V2, P95; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; DeWaal D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02733-4; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; Duncan RE, 2010, J LIPID RES, V51, P309, DOI 10.1194/jlr.M000729; Gerber M, 2012, BRIT J NUTR, V107, pS228, DOI 10.1017/S0007114512001614; Grace SA, 2017, ANTICANCER RES, V37, P699, DOI 10.21873/anticanres.11366; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Ito K, 2004, CANCER RES, V64, P1071, DOI 10.1158/0008-5472.CAN-03-1670; Jha P, 2014, HEPATOLOGY, V59, P858, DOI 10.1002/hep.26732; Khan SA, 2015, DIABETES, V64, P418, DOI 10.2337/db14-0325; Kitamura K, 2011, J HEPATOL, V55, P846, DOI 10.1016/j.jhep.2011.01.038; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Kurahara H, 2018, ANN SURG ONCOL, V25, P1432, DOI 10.1245/s10434-018-6357-1; Labuschagne CF, 2018, BIOCH BIOPHYS ACTA; Lee James T, 2013, Genes Cancer, V4, P112, DOI 10.1177/1947601913484496; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Liu Y, 2012, J BIOL CHEM, V287, P41469, DOI 10.1074/jbc.M112.367847; Mashek DG, 2015, HEPATOLOGY, V62, P964, DOI 10.1002/hep.27839; McDonnell E, 2016, CELL REP, V17, P1463, DOI 10.1016/j.celrep.2016.10.012; Meex RCR, 2015, AM J PHYSIOL-ENDOC M, V308, pE960, DOI 10.1152/ajpendo.00598.2014; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Ou JJ, 2014, CELL REP, V9, P1798, DOI 10.1016/j.celrep.2014.11.016; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Puzio-Kuter Anna M, 2011, Genes Cancer, V2, P385, DOI 10.1177/1947601911409738; Reed SM, 2015, CANCERS, V7, P30, DOI 10.3390/cancers7010030; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sapiro JM, 2009, J LIPID RES, V50, P1621, DOI 10.1194/jlr.M800614-JLR200; Sathyanarayan A, 2017, CELL REP, V19, P1, DOI 10.1016/j.celrep.2017.03.026; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; So WW, 2015, NUTRIENTS, V7, P6956, DOI 10.3390/nu7085319; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; Tomin T, 2018, J PROTEOME RES, V17, P1415, DOI 10.1021/acs.jproteome.7b00782; Vegliante R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0345-z; Vegliante R, 2016, CARCINOGENESIS, V37, P233, DOI 10.1093/carcin/bgw003; Waller LP, 2015, WORLD J HEPATOL, V7, P2648, DOI 10.4254/wjh.v7.i26.2648; Won KY, 2012, HUM PATHOL, V43, P221, DOI 10.1016/j.humpath.2011.04.021; Wu JW, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006716; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Xu SB, 2013, CELL RES, V23, P423, DOI 10.1038/cr.2012.162; Zagani R, 2015, ONCOTARGET, V6, P28282, DOI 10.18632/oncotarget.5061; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhang X, 2017, ELIFE, V6; Zheng SS, 2017, CANCER RES, V77, P4342, DOI 10.1158/0008-5472.CAN-17-0424; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	64	28	28	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2019	38	11					1860	1875		10.1038/s41388-018-0545-0	http://dx.doi.org/10.1038/s41388-018-0545-0			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HO7XX	30367149	hybrid, Green Published			2022-12-26	WOS:000461164400006
J	De, R; Sarkar, S; Mazumder, S; Debsharma, S; Siddiqui, AA; Saha, SJ; Banerjee, C; Nag, S; Saha, D; Pramanik, S; Bandyopadhyay, U				De, Rudranil; Sarkar, Souvik; Mazumder, Somnath; Debsharma, Subhashis; Siddiqui, Asim Azhar; Saha, Shubhra Jyoti; Banerjee, Chinmoy; Nag, Shiladitya; Saha, Debanjan; Pramanik, Saikat; Bandyopadhyay, Uday			Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-kappa B signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; mitochondria; apoptosis; NF-B; gene silencing	KAPPA-B; GASTRIC-CANCER; FISSION; CD74; EXPRESSION; APOPTOSIS; ACID; MICROENVIRONMENT; STRESS	The indispensable role of macrophage migration inhibitory factor (MIF) in cancer cell proliferation is unambiguous, although which specific roles the cytokine plays to block apoptosis by preserving cell growth is still obscure. Using different cancer cell lines (AGS, HepG2, HCT116, and HeLa), here we report that the silencing of MIF severely deregulated mitochondrial structural dynamics by shifting the balance toward excess fission, besides inducing apoptosis with increasing sub-G(0) cells. Furthermore, enhanced mitochondrial Bax translocation along with cytochrome c release, down-regulation of Bcl-xL, and Bcl-2 as well as up-regulation of Bad, Bax, and p53 indicated the activation of a mitochondrial pathway of apoptosis upon MIF silencing. The data also indicate a concerted down-regulation of Opa1 and Mfn1 along with a significant elevation of Drp1, cumulatively causing mitochondrial fragmentation upon MIF silencing. Up-regulation of Drp1 was found to be further coupled with fissogenic serine 616 phosphorylation and serine 637 dephosphorylation, thus ensuring enhanced mitochondrial translocation. Interestingly, MIF silencing was found to be associated with decreased NF-B activation. In fact, NF-B knockdown in turn increased mitochondrial fission and cell death. In addition, the silencing of CD74, the cognate receptor of MIF, remarkably increased mitochondrial fragmentation in addition to preventing cell proliferation, inducing mitochondrial depolarization, and increasing apoptotic cell death. This indicates the active operation of a MIF-regulated CD74-NF-B signaling axis for maintaining mitochondrial stability and cell growth. Thus, we propose that MIF, through CD74, constitutively activates NF-B to control mitochondrial dynamics and stability for promoting carcinogenesis via averting apoptosis.	[De, Rudranil; Sarkar, Souvik; Mazumder, Somnath; Debsharma, Subhashis; Siddiqui, Asim Azhar; Saha, Shubhra Jyoti; Banerjee, Chinmoy; Nag, Shiladitya; Saha, Debanjan; Pramanik, Saikat; Bandyopadhyay, Uday] Indian Inst Chem Biol, CSIR, Div Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bandyopadhyay, U (corresponding author), Indian Inst Chem Biol, CSIR, Div Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	ubandyo_1964@yahoo.com		De, Rudranil/0000-0001-5846-3479; SAHA, SHUBHRA JYOTI/0000-0001-6536-6060	Council of Scientific and Industrial Research, New Delhi [BSC 0206]; J.C. Bose Fellowship from the Department of Science and Technology, Ministry of Science and Technology (DST) [SB/S2/JCB-54/2014]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); J.C. Bose Fellowship from the Department of Science and Technology, Ministry of Science and Technology (DST)	This work was supported by a fellowship (to R.D.) and Research Grants BEnD and BSC 0206 from the Council of Scientific and Industrial Research, New Delhi. This work also was supported by J.C. Bose Fellowship SB/S2/JCB-54/2014 from the Department of Science and Technology, Ministry of Science and Technology (DST). The authors declare that they have no conflicts of interest with the contents of this article.	Alavi MV, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-32; Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Andas A Reenaa Joys, 2015, Asian Pac J Cancer Prev, V16, P4311; Baumann R, 2003, FASEB J, V17, P2221, DOI 10.1096/fj.03-0110com; Berkova Z, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0080-y; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chen HC, 2017, CELL METAB, V26, P39, DOI 10.1016/j.cmet.2017.05.016; Cheng SP, 2015, ENDOCR-RELAT CANCER, V22, P179, DOI 10.1530/ERC-14-0269; Dai XY, 2016, ONCOTARGET, V7, P10841, DOI 10.18632/oncotarget.7460; de Arriba G, 2013, TOXICOL LETT, V218, P30, DOI 10.1016/j.toxlet.2013.01.007; De R, 2017, FREE RADICAL BIO MED, V113, P424, DOI 10.1016/j.freeradbiomed.2017.10.009; Fan S, 2015, ONCOTARGET, V6, P14885, DOI 10.18632/oncotarget.3659; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Galloway CA, 2013, ANTIOXID REDOX SIGN, V19, P415, DOI 10.1089/ars.2012.4779; He LJ, 2015, WORLD J GASTROENTERO, V21, P9916, DOI 10.3748/wjg.v21.i34.9916; Herst PM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00296; Hira E, 2005, CANCER, V103, P588, DOI 10.1002/cncr.20818; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jezierska-Drutel A, 2013, ADV CANCER RES, V119, P107, DOI 10.1016/B978-0-12-407190-2.00003-4; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kasama T, 2010, ARTHRITIS, DOI 10.1155/2010/106202; Kaufman JL, 2013, BRIT J HAEMATOL, V163, P478, DOI 10.1111/bjh.12565; Kindt N, 2014, J CANCER RES CLIN, V140, P937, DOI 10.1007/s00432-014-1648-9; Kotiadis VN, 2014, BBA-GEN SUBJECTS, V1840, P1254, DOI 10.1016/j.bbagen.2013.10.041; Laforge M, 2016, CELL DEATH DIFFER, V23, P89, DOI 10.1038/cdd.2015.42; Lantner F, 2007, BLOOD, V110, P4303, DOI 10.1182/blood-2007-04-087486; Li N, 2012, ONCOL REP, V28, P2016, DOI 10.3892/or.2012.2062; Li XJ, 2013, WORLD J GASTROENTERO, V19, P8619, DOI 10.3748/wjg.v19.i46.8619; Martin P, 2015, LEUKEMIA LYMPHOMA, V56, P3065, DOI 10.3109/10428194.2015.1028052; Morris KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098656; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pagliari LJ, 2000, MOL CELL BIOL, V20, P8855, DOI 10.1128/MCB.20.23.8855-8865.2000; Panngom K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.168; Parsons MJ, 2010, ESSAYS BIOCHEM, V47, P99, DOI [10.1042/BSE0470099, 10.1042/bse0470099]; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Sarkar S, 2015, J AGR FOOD CHEM, V63, P4988, DOI 10.1021/acs.jafc.5b00921; Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022; Shimwell NJ, 2012, BRIT J CANCER, V107, P1595, DOI 10.1038/bjc.2012.405; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Subbannayya T, 2016, J CELL COMMUN SIGNAL, V10, P165, DOI 10.1007/s12079-016-0326-x; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Waterborg J H, 1984, Methods Mol Biol, V1, P1, DOI 10.1385/0-89603-062-8:1; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wilson JM, 2005, GASTROENTEROLOGY, V129, P1485, DOI 10.1053/j.gastro.2005.07.061; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494; Zheng C, 2011, CELL RES, V21, P183, DOI 10.1038/cr.2010.171; Zhu GQ, 2014, NEOPLASIA, V16, P168, DOI 10.1593/neo.132034	52	18	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19740	19760		10.1074/jbc.RA118.003935	http://dx.doi.org/10.1074/jbc.RA118.003935			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30366984	hybrid, Green Published			2022-12-26	WOS:000454294900020
J	Baumgart, JK; Moes, M; Skovereng, K; Ettema, G; Sandbakk, O				Baumgart, Julia Kathrin; Moes, Maaike; Skovereng, Knut; Ettema, Gertjan; Sandbakk, Oyvind			Examination of gas exchange and blood lactate thresholds in Paralympic athletes during upper-body poling	PLOS ONE			English	Article							ANAEROBIC THRESHOLD; VENTILATORY THRESHOLDS; WHEELCHAIR EXERCISE; MODEL SELECTION; ARM CRANKING; INDIVIDUALS; RELIABILITY; PARAPLEGIA; PERFORMANCE; PARAMETERS	Objectives The primary aim was to compare physiological and perceptual outcome parameters identified at common gas exchange and blood lactate (BLa) thresholds in Paralympic athletes while upper-body poling. The secondary aim was to compare the fit of the breakpoint models used to identify thresholds in the gas exchange thresholds data versus continuous linear and curvilinear (no-breakpoint) models. Methods Fifteen elite Para ice hockey players performed seven to eight 5-min stages at increasing workload until exhaustion during upper-body poling. Two regression lines were fitted to the oxygen uptake (VO2)-carbon dioxide (VCO2) and minute ventilation (VE)NO2 data to determine the ventilatory threshold (VT), and to the VCO2-VE and VENCO2 data to determine the respiratory compensation threshold (RCT). The first lactate threshold (LT1) was determined by the first rise in BLa (+0.4mmol.L-1 and +1.0mmol.L-1) and a breakpoint in the log-log transformed VO2-BLa data, and the second lactate threshold (LT2) by a fixed rise in BLa above 4mmol.L-1 and by employing the modified D-max method. Paired-samples t-tests were used to compare the outcome parameters within and between the different threshold methods. The fit of the two regression lines (breakpoint model) used to identify thresholds in the gas exchange data was compared to that of a single regression line, an exponential and a 3rd order polynomial curve (no-breakpoint models) by Akaike weights. Results All outcome parameters identified with the VT (i.e., breakpoints in the VO2-VCO2 or VE/VO2 data) were significantly higher than the ones identified with a fixed rise in BLa (+0.4 or +1.0mmol.L-1) at the LT1 (e.g. BLa: 5.1 +/- 2.2 or 4.9 +/- 1.8 vs 1.9 +/- 0.6 or 2.3 +/- 0.5mmol-L-1, p<0.001), but were not significantly different from the log-log transformed VO2 -BLa data (4.3 +/- 1.6mmol.L-1 ,p>0.06). The outcome parameters identified with breakpoints in the VCO2-VE data to determine the RCT (e.g. BLa: 5.5 +/- 1.4mmol.L-1) were not different from the ones identified with the modified D-max method at the LT2 (5.5 +/- 1.1mmol.L-1) (all p>0.53), but were higher compared to parameters identified with VENCO2 method (4.9 +/- 1.5mmol.L-1) and a fixed BLa value of 4mmol.L-1 (all p<0.03). Although we were able to determine the VT and RCT via different gas exchange threshold methods with good fit in all 15 participants (mean R-2 >0.931), the continuous no-breakpoint models had the highest probability (>68%) of being the best models for the VO2-VCO2 and the VCO2-VE data. Conclusions In Paralympic athletes who exercise in the upper-body poling mode, the outcome parameters identified at the VT and the ones identified with fixed methods at the LT1 showed large differences, demonstrating that these cannot be used interchangeably to estimate the aerobic threshold. In addition, the close location of the VT, RCT and LT2 does not allow us to distinguish the aerobic and anaerobic threshold, indicating the presence of only one threshold in athletes with a disability exercising in an upper-body mode. Furthermore, the better fit of continuous no-breakpoint models indicates no presence of clear breakpoints in the gas exchange data for most participants. This makes us question if breakpoints in the gas exchange data really exist in an upper-body exercise mode in athletes with disabilities.	[Baumgart, Julia Kathrin; Skovereng, Knut; Ettema, Gertjan; Sandbakk, Oyvind] Norwegian Univ Sci & Technol, Ctr Elite Sports Res, Fac Med & Hlth Sci, Dept Neurosci & Movement Sci, Trondheim, Norway; [Moes, Maaike] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Human Movement Sci, Maastricht, Netherlands	Norwegian University of Science & Technology (NTNU); Maastricht University	Baumgart, JK (corresponding author), Norwegian Univ Sci & Technol, Ctr Elite Sports Res, Fac Med & Hlth Sci, Dept Neurosci & Movement Sci, Trondheim, Norway.	jk.baumgart@gmail.com	Ettema, Gertjan/C-2104-2018	Baumgart, Julia Kathrin/0000-0001-5628-6050	Faculty of Medicine at NTNU; Central Norway Regional Health Authority	Faculty of Medicine at NTNU; Central Norway Regional Health Authority	The laboratory equipment was provided by NeXt Move, Norwegian University of Science and Technology (NTNU). NeXt Move is funded by the Faculty of Medicine at NTNU and Central Norway Regional Health Authority. The funder had no role in study design, how the data collection and analysis was performed, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DEFINITION BREAK POI; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; BEAVER WL, 1985, J APPL PHYSIOL, V59, P1936, DOI 10.1152/jappl.1985.59.6.1936; Beneke R, 2001, BRIT J SPORT MED, V35, P192, DOI 10.1136/bjsm.35.3.192; Bernardi M, 2010, MED SCI SPORT EXER, V42, P1200, DOI 10.1249/MSS.0b013e3181c67d82; Bhambhani Y, 2002, SPORTS MED, V32, P23, DOI 10.2165/00007256-200232010-00002; BHAMBHANI YN, 1993, ARCH PHYS MED REHAB, V74, P305; Binder RK, 2008, EUR J CARDIOV PREV R, V15, P726, DOI 10.1097/HJR.0b013e328304fed4; Bishop D, 1998, MED SCI SPORT EXER, V30, P1270, DOI 10.1097/00005768-199808000-00014; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; BROOKS GA, 1985, MED SCI SPORT EXER, V17, P22; Buckley JD, 2003, J SCI MED SPORT, V6, P408, DOI 10.1016/S1440-2440(03)80267-0; Burnham K P, 2003, MODEL SELECT MULTIMO; Chicharro JL, 1997, J SPORT MED PHYS FIT, V37, P117; COUTTS KD, 1995, PARAPLEGIA, V33, P419, DOI 10.1038/sc.1995.93; DAVIS JA, 1976, J APPL PHYSIOL, V41, P544, DOI 10.1152/jappl.1976.41.4.544; Dekerle J, 2002, PERCEPT MOTOR SKILL, V95, P1035, DOI 10.2466/PMS.95.8.1035-1046; Faude O, 2009, SPORTS MED, V39, P469, DOI 10.2165/00007256-200939060-00003; Gaskill SE, 2001, MED SCI SPORT EXER, V33, P1841, DOI 10.1097/00005768-200111000-00007; Hegge AM, 2015, EUR J APPL PHYSL; Hopker JG, 2011, ANAESTHESIA, V66, P111, DOI 10.1111/j.1365-2044.2010.06604.x; Inbar O, 2012, ISRN PHYSL, V2013; KEYSER RE, 1989, ARCH PHYS MED REHAB, V70, P687; Leicht CA, 2014, EUR J APPL PHYSIOL, V114, P1635, DOI 10.1007/s00421-014-2886-x; Leicht C, 2008, J SPINAL CORD MED, V31, P60, DOI 10.1080/10790268.2008.11753982; Leicht CA, 2013, EUR J APPL PHYSIOL, V113, P337, DOI 10.1007/s00421-012-2441-6; LIN KH, 1993, ARCH PHYS MED REHAB, V74, P515, DOI 10.1016/0003-9993(93)90116-R; MAFFULLI N, 1994, J SPORT MED PHYS FIT, V34, P242; Myers J, 1997, CHEST, V111, P787, DOI 10.1378/chest.111.3.787; Orr JL, 2013, ANAESTHESIA, V68, P497, DOI 10.1111/anae.12195; Peronnet F, 2006, RESP PHYSIOL NEUROBI, V150, P4, DOI 10.1016/j.resp.2005.04.005; Pires FO, 2011, J STRENGTH COND RES, V25, P225, DOI 10.1519/JSC.0b013e3181b2b895; Plichta SB, 2013, MUNROS STAT METHODS, V6rd; POWERS SK, 1984, EUR J APPL PHYSIOL O, V52, P173, DOI 10.1007/BF00433388; REINHARD U, 1979, RESPIRATION, V38, P36, DOI 10.1159/000194056; Ribeiro J, 2015, J SPORT MED PHYS FIT, V55, P701; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Schneider DA, 1999, EUR J APPL PHYSIOL O, V80, P292, DOI 10.1007/s004210050595; Seiler S., 2009, SPORTSCIENCE, V13, P32; STEGMANN H, 1982, INT J SPORTS MED, V3, P105, DOI 10.1055/s-2008-1026072; Vinet A, 1997, EUR J APPL PHYSIOL O, V76, P455, DOI 10.1007/s004210050275; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; WASSERMAN K, 1984, AM REV RESPIR DIS, V129, pS35, DOI 10.1164/arrd.1984.129.2P2.S35; WASSERMAN K, 1987, CIRCULATION, V76, P29; Wasserman K, 1986, Adv Cardiol, V35, P1; Yasuda N, 2008, SCAND J MED SCI SPOR, V18, P205, DOI 10.1111/j.1600-0838.2007.00637.x	47	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205588	10.1371/journal.pone.0205588	http://dx.doi.org/10.1371/journal.pone.0205588			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379853	Green Submitted, Green Published, gold			2022-12-26	WOS:000448823700056
J	Cardoso, CS; von Keyserlingk, MAG; Hotzel, MJ; Robbins, J; Weary, DM				Cardoso, Clarissa S.; von Keyserlingk, Marina A. G.; Hotzel, Maria Jose; Robbins, Jesse; Weary, Daniel M.			Hot and bothered: Public attitudes towards heat stress and outdoor access for dairy cows	PLOS ONE			English	Article							FARM-ANIMAL WELFARE; CATTLE; PERCEPTIONS; RELIABILITY; MANAGEMENT; BEHAVIOR; PASTURE	On many dairy farms cows are kept indoors. Providing outdoor access is often considered desirable, but housing can protect animals from aversive climatic conditions. For example, by providing shade and fans, indoor housing can protect cows from heat stress they might otherwise experience on open pasture. This study tested how public attitudes to cattle rearing varied when participants were experimentally assigned to different scenarios using a 2 x 2 factorial design varying pasture versus indoor housing with or without heat stress. Participants (n = 581) were randomly assigned to a single scenario, and attitudes in response to the scenario were measured using a Likert scale (1 = "strongly disagree" to 5 = "strongly agree"). We also asked open-ended questions allowing participants to explain their responses. Participants responded most positively to the scenario that provided both pasture access and protection from heat stress (Likert 4.1 +/- 0.08), and least positively to scenario with indoor housing and heat stress (Likert 2.2 +/- 0.08). However, when the different animal welfare attributes were in conflict (i.e. naturalness as provided by pasture, and biological functioning/affective state as associated with protection from heat stress), participants placed priority on the latter: they were more supportive of the scenario providing indoor housing that protected cows from heat stress (Likert 3.5 +/- 0.08), than they were of a pasture rearing system that exposed cows to heat stress (Likert 2.4 +/- 0.08). Open-ended responses indicated that participants viewed the lack of protection from heat stress as a failure in the farmer's duty of care towards the cow. We conclude that participants valued both access to pasture and protection from heat stress for dairy cows, but prioritized protecting animal from heat stress when these features were in conflict.	[Cardoso, Clarissa S.; von Keyserlingk, Marina A. G.; Robbins, Jesse; Weary, Daniel M.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC, Canada; [Cardoso, Clarissa S.; Hotzel, Maria Jose] Univ Fed Santa Catarina, Lab Etol Aplicada & Bem Estar Anim, Dept Zootecnia & Dev Rural, Florianopolis, SC, Brazil	University of British Columbia; Universidade Federal de Santa Catarina (UFSC)	Weary, DM (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC, Canada.	dan.weary@ubc.ca	Hötzel, Maria José/H-6975-2014; Cardoso, Clarissa Silva/J-7473-2018; Weary, Daniel M/A-8868-2010	Hötzel, Maria José/0000-0003-1034-3202; Cardoso, Clarissa Silva/0000-0002-4668-4052; Weary, Daniel M/0000-0002-0917-3982				Andrews Travis M., 2017, WASHINGTON POST; Bergstra TJ, 2017, AGR HUM VALUES, V34, P393, DOI 10.1007/s10460-016-9721-4; Bishop-Williams KE, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0607-2; Bohannon J, 2016, SCIENCE, V352, P1263, DOI 10.1126/science.352.6291.1263; Boogaard BK, 2008, LIVEST SCI, V117, P24, DOI 10.1016/j.livsci.2007.11.004; Boogaard B. K., 2010, International Journal of Sociology of Agriculture and Food, V17, P24; Bureau UC, 2010, PROF GEN POP HOUS CH; Bureau UC, 2016, AM FACTFINDER RES; Bureau UC, 2010, CENS URB RUR CLASS U; Bureau UC, 2017, ED ATT US 2017; Busby D, 1996, BEEF RES REP; Calle A, 2009, BOIS FOR TROP, P79; Carter JS, 2014, ABC RURAL; Charlton GL, 2017, APPL ANIM BEHAV SCI, V192, P2, DOI 10.1016/j.applanim.2017.05.015; Clark B, 2016, J AGR ENVIRON ETHIC, V29, P455, DOI 10.1007/s10806-016-9615-x; Costa JHC, 2013, J DAIRY SCI, V96, P307, DOI 10.3168/jds.2012-5906; Minayo MCD, 2012, CIENC SAUDE COLETIVA, V17, P621, DOI 10.1590/S1413-81232012000300007; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Fishbein, 2000, EUR REV SOC PSYCHOL, V11, P1, DOI [https://doi.org/10.1080/14792779943000116, DOI 10.1080/14792779943000116, 10.1080/14792779943000116]; Fraser D, 1993, FOOD ANIMAL WELL-BEING, P37; Fraser D, 1997, ANIM WELFARE, V6, P187; Gibson K., 2015, ANIMAL ABUSE ALLEGED; Kowalski BC, 2014, OWNER VOWS CURB ANIM; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Meijer SS, 2015, J ENVIRON PSYCHOL, V43, P1, DOI 10.1016/j.jenvp.2015.05.008; Moeller Jr RB, 2011, HEAT STRESS CATTLE; Osgood C., 2017, THOUSANDS COWS DIE C; Peer E, 2017, J EXP SOC PSYCHOL, V70, P153, DOI 10.1016/j.jesp.2017.01.006; Pettersson IC, 2016, BRIT FOOD J, V118, P1979, DOI 10.1108/BFJ-02-2016-0065; Poisky L, 2017, J DAIRY SCI, V100, P8645, DOI 10.3168/jds.2017-12651; Prickett RW, 2010, ANIM WELFARE, V19, P335; Robbins J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193864; Roman S, 2017, TRENDS FOOD SCI TECH, V67, P44, DOI 10.1016/j.tifs.2017.06.010; Rouse SV, 2015, COMPUT HUM BEHAV, V43, P304, DOI 10.1016/j.chb.2014.11.004; Rozin P, 2004, APPETITE, V43, P147, DOI 10.1016/j.appet.2004.03.005; Rozin P, 2009, JUDGM DECIS MAK, V4, P475; Schneider SA, 2009, DRAKE J AGRIC LAW; Schuppli CA, 2014, J ANIM SCI, V92, P5185, DOI 10.2527/jas.2014-7725; Schutz KE, 2010, J DAIRY SCI, V93, P125, DOI 10.3168/jds.2009-2416; Tuyttens FAM, 2010, LIVEST SCI, V131, P108, DOI 10.1016/j.livsci.2010.03.008; Van Noordwijk M, 2008, ADV AGROFOR, V5, P429; Ventura BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154733	42	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205352	10.1371/journal.pone.0205352	http://dx.doi.org/10.1371/journal.pone.0205352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY7VH	30379867	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700042
J	Hodel, NC; Hamad, A; Praehauser, C; Mwangoka, G; Kasella, IM; Reither, K; Abdulla, S; Hatz, CFR; Mayr, M				Hodel, Nikolai C.; Hamad, Ali; Praehauser, Claudia; Mwangoka, Grace; Kasella, Irene Mndala; Reither, Klaus; Abdulla, Salim; Hatz, Christoph F. R.; Mayr, Michael			The epidemiology of chronic kidney disease and the association with non-communicable and communicable disorders in a population of sub-Saharan Africa	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; PUBLIC-HEALTH PROBLEM; GLOBAL BURDEN; PREVALENCE; PROTEINURIA; ALBUMINURIA; PROJECTIONS; EQUATION; KINSHASA; OBESITY	In sub-Saharan Africa (SSA), epidemiological data for chronic kidney disease (CKD) are scarce. We conducted a prospective cross-sectional study including 952 patients in an outpatient clinic in Tanzania to explore CKD prevalence estimates and the association with cardiovascular and infectious disorders. According to KDIGO, we measured albumin-to-creatinine ratio and calculated eGFR using CKD-EPI formula. Factors associated with CKD were calculated by logistic regression. Venn diagrams were modelled to visualize interaction between associated factors and CKD. Overall, the estimated CKD prevalence was 13.6% (95% CI 11-16%). Ninety-eight patients (11.2%) (95% CI 9-14%) were categorized as moderate, 12 (1.4%) (95% CI 0-4%) as high, and 9 (1%) (95% CI 0-3%) as very high risk according to KDIGO. History of tuberculosis (OR 3.75, 95% CI 1.66-8.18; p = 0.001) and schistosomiasis (OR 2.49, 95% CI 1.13-5.18; p = 0.02) were associated with CKD. A trend was seen for increasing systolic blood pressure (OR 1.02 per 1 mmHg, 95% CI 1.00-1.03; p = 0.01). Increasing BMI (OR 0.92 per 1kg/m(2), 95% CI 0.88-0.96; p = <0.001) and haemoglobin (OR 0.82 per 1g/dL, 95% CI 0.72-0.94; p = 0.004) were associated with risk reduction. Diabetes was associated with albuminuria (OR 2.81, 95% CI 1.26-6.00; p = 0.009). In 85% of all CKD cases at least one of the four most common factors (hypertension, diabetes, anaemia, and history of tuberculosis or schistosomiasis) was associated with CKD. A singular associated factor was found in 61%, two in 14%, and >= 3 in 10% of all CKD cases. We observed a high prevalence estimate for CKD and found that both classical cardiovascular and neglected infectious diseases might be associated with CKD in a semi-rural population of SSA. Our finding provides further evidence for the hypothesis that the "double burden" of non-communicable and endemic infectious diseases might affect kidney health in SSA.	[Hodel, Nikolai C.; Praehauser, Claudia; Mayr, Michael] Univ Hosp Basel, Med Outpatient Dept, Basel, Switzerland; [Hodel, Nikolai C.; Reither, Klaus; Hatz, Christoph F. R.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Hamad, Ali; Mwangoka, Grace; Reither, Klaus; Abdulla, Salim] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Kasella, Irene Mndala] Bagamoyo Dist Hosp, Bagamoyo, Tanzania; [Reither, Klaus; Hatz, Christoph F. R.] Univ Basel, Basel, Switzerland	University of Basel; University of Basel; Swiss Tropical & Public Health Institute; Ifakara Health Institute; University of Basel	Mayr, M (corresponding author), Univ Hosp Basel, Med Outpatient Dept, Basel, Switzerland.	michal.mayr@usb.ch		Reither, Klaus/0000-0001-6195-8237; Hodel, Nikolai Carl/0000-0001-9598-2729	University Hospital Basel (VFWAWF-Pool - section medicine); Freiwillige Akademische Gesellschaft Basel (FAG)	University Hospital Basel (VFWAWF-Pool - section medicine); Freiwillige Akademische Gesellschaft Basel (FAG)	The study was supported by a project fund from the University Hospital Basel (VFWAWF-Pool - section medicine) and the "Freiwillige Akademische Gesellschaft Basel (FAG)". The sponsors did not influence study design, or collection, analysis and interpretation of data, writing of the report or the decision to submit the report for publication. Parts of the results of our study were presented as abstract and poster at the Swiss Society of Nephrology (SGN) at December 2017 in Fribourg/Switzerland.	Amato DK, 2005, KIDNEY INT, V68, pS11, DOI 10.1111/j.1523-1755.2005.09702.x; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; [Anonymous], 2016, GLOBAL REPORT DIABET; Arogundade FA, 2008, AM J KIDNEY DIS, V51, P515, DOI 10.1053/j.ajkd.2007.12.006; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; BOESKEN WH, 1983, KLIN WOCHENSCHR, V61, P917, DOI 10.1007/BF01537532; Bottomley MJ, 2011, NEPHRON CLIN PRACT, V117, pC348, DOI 10.1159/000321515; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Bukabau JB, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-24; BxToolBox, 2017, AR PROP VENN DIAGR P; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; de Jong PE, 2006, J AM SOC NEPHROL, V17, P2120, DOI 10.1681/ASN.2006010097; De Zeeuw D, 2005, KIDNEY INT, V68, pS25, DOI 10.1111/j.1523-1755.2005.09805.x; Earley A, 2012, ANN INTERN MED, V156, P785, DOI 10.7326/0003-4819-156-11-201203200-00391; Eastwood JB, 2010, NEPHROL DIAL TRANSPL, V25, P2178, DOI 10.1093/ndt/gfp765; Fink HA, 2012, ANN INTERN MED, V156, P570, DOI [10.7326/0003-4819-156-8-201204170-00008, 10.7326/0003-4819-156-8-201204170-00004]; Garcia-Garcia G, 2015, BRAZ J MED BIOL RES, V48, P377, DOI [10.1590/1414-431X20144519, 10.4103/0971-4065.150078]; Glaz J, 1999, J STAT PLAN INFER, V82, P251, DOI 10.1016/S0378-3758(99)00047-6; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; HEMMINGSEN L, 1977, ACTA MED SCAND, V201, P359; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Kalyesubula R, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0521-x; Kayange NM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003472; Kaze FF, 2016, J CLIN HYPERTENS, V18, P408, DOI 10.1111/jch.12781; Kaze FF, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0102-9; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Marshall SJ, 2004, B WORLD HEALTH ORGAN, V82, P556; Masimango MI, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-146; Mazigo HD, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-274; Ministry of Health, 2016, UN REP TANZ STRAT AC; Ministry of Heath and Social Welfare, 2013, 1 NAT TUB PREV SURV; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nahas ME, 2005, KIDNEY INT, V68, P2918, DOI 10.1111/j.1523-1755.2005.00774.x; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Peck R, 2016, TROP MED INT HEALTH, V21, P393, DOI 10.1111/tmi.12651; Polkinghorne Kevan R, 2014, Clin Biochem Rev, V35, P67; R Core Team, 2013, R LANG ENV STAT COMP; REUBEN DB, 1982, NEW ENGL J MED, V306, P1031, DOI 10.1056/NEJM198204293061706; Rollinson D, 2013, ACTA TROP, V128, P423, DOI 10.1016/j.actatropica.2012.04.013; Romanowski K, 2016, KIDNEY INT, V90, P34, DOI 10.1016/j.kint.2016.01.034; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Stanifer JW, 2016, NEPHROL DIAL TRANSPL, V31, P868, DOI 10.1093/ndt/gfv466; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124506; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; Sumaili EK, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-18; Sumaili EK, 2009, NEPHROL DIAL TRANSPL, V24, P117, DOI 10.1093/ndt/gfn469; Sumaili EK, 2008, NEPHRON CLIN PRACT, V110, pC220, DOI 10.1159/000167869; Tolentino K, 2007, AM J TROP MED HYG, V77, P44, DOI 10.4269/ajtmh.2007.77.44; White SL, 2011, AM J KIDNEY DIS, V58, P19, DOI 10.1053/j.ajkd.2010.12.026; WHO, 2009, WEEKL EP REC SCH NUM; WHO Scientific Group on Nutritional Anaemias & World Health Organization, 1968, WHO TECH REP SER, V405, P5; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wools-Kaloustian K, 2007, NEPHROL DIAL TRANSPL, V22, P2208, DOI 10.1093/ndt/gfm223; Zacharias JM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-290; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	68	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205326	10.1371/journal.pone.0205326	http://dx.doi.org/10.1371/journal.pone.0205326			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379902	Green Published, Green Accepted, gold			2022-12-26	WOS:000448823700039
J	Vicens, J; Bueno-Guerra, N; Gutierrez-Roig, M; Gracia-Lazaro, C; Gomez-Gardenes, J; Perello, J; Sanchez, A; Moreno, Y; Duch, J				Vicens, Julian; Bueno-Guerra, Nereida; Gutierrez-Roig, Mario; Gracia-Lazaro, Carlos; Gomez-Gardenes, Jesus; Perello, Josep; Sanchez, Angel; Moreno, Yamir; Duch, Jordi			Resource heterogeneity leads to unjust effort distribution in climate change mitigation	PLOS ONE			English	Article							RISK; JUSTICE; IMPACT; POOR; RICH	Climate change mitigation is a shared global challenge that involves collective action of a set of individuals with different tendencies to cooperation. However, we lack an understanding of the effect of resource inequality when diverse actors interact together towards a common goal. Here, we report the results of a collective-risk dilemma experiment in which groups of individuals were initially given either equal or unequal endowments. We found that the effort distribution was highly inequitable, with participants with fewer resources contributing significantly more to the public goods than the richer -sometimes twice as much. An unsupervised learning algorithm classified the subjects according to their individual behavior, finding the poorest participants within two "generous clusters" and the richest into a "greedy cluster". Our results suggest that policies would benefit from educating about fairness and reinforcing climate justice actions addressed to vulnerable people instead of focusing on understanding generic or global climate consequences.	[Vicens, Julian; Duch, Jordi] Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain; [Vicens, Julian; Gutierrez-Roig, Mario; Perello, Josep] Univ Barcelona, Dept Fis Mat Condensada, Barcelona, Spain; [Vicens, Julian; Perello, Josep] Univ Barcelona, Inst Complex Syst UBICS, Barcelona, Spain; [Bueno-Guerra, Nereida] Comillas Pontifical Univ, Dept Psychol, Madrid, Spain; [Gutierrez-Roig, Mario] Univ Warwick, Warwick Business Sch, Behav Sci Grp, Coventry, W Midlands, England; [Gracia-Lazaro, Carlos; Gomez-Gardenes, Jesus; Sanchez, Angel; Moreno, Yamir] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Zaragoza, Spain; [Gracia-Lazaro, Carlos; Sanchez, Angel; Moreno, Yamir] UMICCS, UV UZ UC3M, Leganes, Spain; [Gomez-Gardenes, Jesus] Univ Zaragoza, Dept Condensed Matter Phys, Zaragoza, Spain; [Sanchez, Angel] Univ Carlos III Madrid, Unidad Matemat Modelizac & Ciencia Computac, GISC, Leganes, Spain; [Sanchez, Angel] Univ Carlos III Madrid, Inst BS Financial Big Data UC3M, Getafe, Spain; [Moreno, Yamir] Univ Zaragoza, Dept Theoret Phys, Zaragoza, Spain; [Moreno, Yamir] ISI Fdn, Turin, Italy; [Duch, Jordi] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL 60208 USA	Universitat Rovira i Virgili; University of Barcelona; University of Barcelona; Comillas Pontifical University; University of Warwick; University of Zaragoza; University of Zaragoza; Universidad Carlos III de Madrid; Universidad Carlos III de Madrid; University of Zaragoza; Northwestern University	Duch, J (corresponding author), Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain.; Duch, J (corresponding author), Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL 60208 USA.	jordi.duch@urv.cat	Gutiérrez-Roig, Mario/ADM-6446-2022; Bueno, Nereida/K-2743-2015; Perelló, Josep/C-5893-2011; Moreno, Yamir/A-1076-2009; Gomez-Gardeñes, Jesus/B-5818-2009; Gracia-Lázaro, Carlos/K-9334-2014; Duch, Jordi/A-7000-2008; Gomez-Gardenes, Jesus/M-9825-2019; Vicens, Julian/K-8608-2015; Sanchez, Angel/A-9229-2008	Gutiérrez-Roig, Mario/0000-0002-8488-1954; Bueno, Nereida/0000-0003-1442-7905; Perelló, Josep/0000-0001-8533-6539; Moreno, Yamir/0000-0002-0895-1893; Gomez-Gardeñes, Jesus/0000-0001-5204-1937; Gracia-Lázaro, Carlos/0000-0002-9769-8796; Duch, Jordi/0000-0003-2639-6333; Gomez-Gardenes, Jesus/0000-0001-5204-1937; Vicens, Julian/0000-0003-0643-0469; Sanchez, Angel/0000-0003-1874-2881	Generalitat de Catalunya (ES) [2013 DI 49, 2014 SGR 608]; Horizon 2020 [640772, 662725]; Ministerio de Economia y Competitividad (ES) [FIS2013-47532-C3-2-P, FIS2016-78904-C3-2-P, FIS2013-47532-C3-1-P, FIS2016-78904-C3-1-P, FIS2015-71582-C2, FIS2014-55867-P, FIS2015-64349-P]	Generalitat de Catalunya (ES)(Generalitat de Catalunya); Horizon 2020; Ministerio de Economia y Competitividad (ES)	This work was supported by Generalitat de Catalunya (ES) 2013 DI 49 to Dr. Julian Vicens and Dr. Jordi Duch, Generalitat de Catalunya (ES) 2014 SGR 608 to Dr. Mario Guiterrez-Roig and Dr. Josep Perello, Ministerio de Economia y Competitividad (ES) FIS2013-47532-C3-2-P to Dr. Mario Guiterrez-Roig and Dr. Josep Perello, Ministerio de Economia y Competitividad (ES) FIS2016-78904-C3-2-P to Dr. Julian Vicens and Dr. Josep Perello, Ministerio de Economia y Competitividad (ES) FIS2013-47532-C3-1-P to Dr. Jordi Duch, Ministerio de Economia y Competitividad (ES) FIS2016-78904-C3-1-P to Dr. Jordi Duch, Ministerio de Economia y Competitividad (ES) FIS2015-71582-C2 to Dr. Jesu s Gomez-Gardenes, Ministerio de Economia y Competitividad (ES) FIS2014-55867-P to Dr. Jesus Gomez-Gardenes and Dr. Yamir Moreno, Ministerio de Economia y Competitividad (ES) FIS2015-64349-P to Dr. Angel Sanchez, Horizon 2020 640772 to Dr. Julian Vicens, Dr. Carlos Gracia-Lazaro, and Dr. Yamir Moreno, Horizon 2020 662725 to Dr. Angel Sanchez and Dr. Yamir Moreno. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the participation of 324 anonymous volunteers who made this research possible. We are indebted to the Citizen Science Office promoted by the Direction of Creativity and Innovation from the Institute of Culture of the Barcelona City Council for their help and support for setting up the experiment at the DAU Barcelona Festival at Fabra i Coats. We specially want to thank I Bonhoure, O Marin from Outliers, N Fernandez, and P Lorente for all the logistics to make the experiment possible and to O Comas (director of the DAU) for giving us this opportunity. We are grateful to Zhen Wang and Marko Jusup for useful discussions and for sharing some preliminary results of a related study.	Abou Chakra M, 2014, J THEOR BIOL, V341, P123, DOI 10.1016/j.jtbi.2013.10.004; Abou Chakra M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002652; Azar C, 1996, ECOL ECON, V19, P169, DOI 10.1016/0921-8009(96)00065-1; Baayen R.H., 2008, PROCESSING, V2, P353; Barrett S, 2012, P NATL ACAD SCI USA, V109, P17372, DOI 10.1073/pnas.1208417109; Buchan NR, 2009, P NATL ACAD SCI USA, V106, P4138, DOI 10.1073/pnas.0809522106; Buckley E, 2006, J PUBLIC ECON, V90, P935, DOI 10.1016/j.jpubeco.2005.06.002; Bulkeley H, 2014, GLOBAL ENVIRON CHANG, V25, P31, DOI 10.1016/j.gloenvcha.2014.01.009; Burton-Chellew MN, 2013, CLIMATIC CHANGE, V120, P815, DOI 10.1007/s10584-013-0856-7; Bynum A, 2016, J THEOR POLIT, V28, P138, DOI 10.1177/0951629815586880; Chan K. S., 1999, Experimental Economics, V2, P5; Cherry TL, 2005, J ECON BEHAV ORGAN, V57, P357, DOI 10.1016/j.jebo.2003.11.010; Dannenberg A, 2015, ENVIRON RESOUR ECON, V61, P365, DOI 10.1007/s10640-014-9796-6; Dennig F, 2015, P NATL ACAD SCI USA, V112, P15827, DOI 10.1073/pnas.1513967112; Dutta PK, 2009, J ECON BEHAV ORGAN, V71, P187, DOI 10.1016/j.jebo.2009.01.013; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Freytag A, 2014, EUR J POLIT ECON, V33, P71, DOI 10.1016/j.ejpoleco.2013.11.005; Gosnell G, 2017, CLIMATIC CHANGE, V142, P575, DOI 10.1007/s10584-017-1975-3; Hagel K, 2017, PALGR COMMUN, V3, DOI 10.1057/palcomms.2017.27; Hagel K, 2016, SCI REP-UK, V6, DOI 10.1038/srep19269; Hilbe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066490; Jacquet J, 2013, NAT CLIM CHANGE, V3, P1025, DOI 10.1038/NCLIMATE2024; Mendelsohn R, 2006, ENVIRON DEV ECON, V11, P159, DOI 10.1017/S1355770X05002755; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; Milinski M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10915; Milinski M, 2011, CLIMATIC CHANGE, V109, P807, DOI 10.1007/s10584-011-0319-y; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Olivier J.G.J., 2016, TRENDS GLOBAL CO2 EM; OLSON M., 1971, LOGIC COLLECTIVE ACT; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Poncela-Casasnovas J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600451; Raupach MR, 2014, NAT CLIM CHANGE, V4, P873, DOI 10.1038/NCLIMATE2384; Rhodes CJ, 2016, SCI PROGRESS-UK, V99, P97, DOI 10.3184/003685016X14528569315192; Ruttan LM, 2006, CURR ANTHROPOL, V47, P843, DOI 10.1086/507185; Santos FC, 2012, MATH MOD METH APPL S, V22, DOI 10.1142/S0218202511400045; Smead R, 2014, NAT CLIM CHANGE, V4, P840, DOI 10.1038/NCLIMATE2367; Tavoni A, 2011, P NATL ACAD SCI USA, V108, P11825, DOI 10.1073/pnas.1102493108; Vasconcelos VV, 2014, P NATL ACAD SCI USA, V111, P2212, DOI 10.1073/pnas.1323479111; Vicens J., 2018, ARXIV PREPRINT ARXIV; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wolch JR, 2014, LANDSCAPE URBAN PLAN, V125, P234, DOI 10.1016/j.landurbplan.2014.01.017	43	13	13	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0204369	10.1371/journal.pone.0204369	http://dx.doi.org/10.1371/journal.pone.0204369			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY7VH	30379845	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000448823700012
J	Falero-Perez, J; Song, YS; Zhao, Y; Teixeira, L; Sorenson, CM; Sheibani, N				Falero-Perez, Juliana; Song, Yong-Seok; Zhao, Yun; Teixeira, Leandro; Sorenson, Christine M.; Sheibani, Nader			Cyp1b1 expression impacts the angiogenic and inflammatory properties of liver sinusoidal endothelial cells	PLOS ONE			English	Article							GROWTH-FACTOR; MOUSE-LIVER; HEPCIDIN EXPRESSION; IRON OVERLOAD; IN-VIVO; BMP6; PERMEABILITY; PHENOTYPE; PROMOTES; DEFENESTRATION	Cytochrome P450 1B1 (CYP1B1) is a member of the cytochrome p450 family of enzymes that catalyze mono-oxygenase reactions. Although constitutive Cyp1b1 expression is limited in hepatocytes, its expression and function in liver sinusoidal endothelial cells (LSEC) remains unknown. Here we determined the impact of Cyp1b1 expression on LSEC properties prepared from Cyp1b1+/+ and Cyp1b1-/-mice. LSEC expressed PECAM-1, VE-cadherin, and B4 lectin similar to EC from other mouse tissues. Cyp1b1+/+ LSEC constitutively expressed significant levels of Cyp1b1, while Cyp1b1-/-LSEC lacked Cyp1b1 expression. LSEC also expressed VEGFR3, PROX-1, and LYVE-1, VEGFR1 and VEGFR2, as well as other cell adhesion molecules including ICAM-1, ICAM-2, VCAM-1, and thrombospondin-1 (TSP1) receptors, CD36 and CD47. However, the expression of PV-1 and stabilin (fenestration markers), and endoglin were limited in these cells. The Cyp1b1-/-LSEC showed limited fenestration, and decreased levels of VEGF and BMP6. Cyp1b1-/-LSEC also showed a decrease in the levels of VE-cadherin and ZO-1 impacting adherens and gap junction formation. Cyp1b1-/-LSEC were significantly more apoptotic, proliferated at a faster rate, and were less adherent and more migratory. These changes were attributed, in part, to decreased amounts of TSP1 and increased AKT and ERK activation. The expressions of integrins were also altered by the lack of Cyp1b1, but the ability of these cells to undergo capillary morphogenesis was minimally affected. Furthermore, Cyp1b1-/-LSEC expressed lower levels of inflammatory mediators MCP-1 and TNF-alpha. Thus, Cyp1b1 expression has a significant impact on LSEC angiogenic and inflammatory functions.	[Falero-Perez, Juliana; Song, Yong-Seok; Zhao, Yun; Sheibani, Nader] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Teixeira, Leandro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Sorenson, Christine M.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomed Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sheibani, N (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA.; Sheibani, N (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53706 USA.; Sheibani, N (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomed Engn, Madison, WI 53706 USA.	nsheibanikar@wisc.edu	Sheibani, Nader/AAG-2379-2020; Teixeira, Leandro/AAU-6094-2021	Sheibani, Nader/0000-0003-2723-9217; Teixeira, Leandro/0000-0001-9960-678X	Research to Prevent Blindness [P30 EY016665, P30 CA014520, EPA 83573701, EY022883, EY026078]; RRF/Daniel M. Albert Chair; RPB Stein Innovation Award; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY016665, R01EY026078] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); RRF/Daniel M. Albert Chair; RPB Stein Innovation Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by an unrestricted award from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences, Retina Research Foundation, P30 EY016665, P30 CA014520, EPA 83573701, EY022883, and EY026078 to NS. CMS is supported by the RRF/Daniel M. Albert Chair. NS is a recipient of RPB Stein Innovation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arias I M, 1990, Prog Liver Dis, V9, P11; Arii S, 2000, J Hepatobiliary Pancreat Surg, V7, P40, DOI 10.1007/s005340050152; Benedicto A, 2017, ONCOL LETT, V14, P3883, DOI 10.3892/ol.2017.6700; BREIER G, 1992, DEVELOPMENT, V114, P521; Cabral F, 2018, JOVE-J VIS EXP, DOI 10.3791/56993; Cheluvappa R, 2010, INT J INFECT DIS, V14, pE857, DOI 10.1016/j.ijid.2010.02.2263; Chen J, 2002, AM J PHYSIOL-CELL PH, V282, pC1053, DOI 10.1152/ajpcell.00292.2001; Cogger VC, 2010, J STRUCT BIOL, V171, P382, DOI 10.1016/j.jsb.2010.06.001; DELEEUW AM, 1990, J ELECTRON MICR TECH, V14, P218; DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004; Dingle AM, 2018, ANGIOGENESIS, V21, P581, DOI 10.1007/s10456-018-9610-0; Elvevold Kjetil H, 2004, Comp Hepatol, V3, P4, DOI 10.1186/1476-5926-3-4; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Feng Q, 2012, AM J PHYSIOL-GASTR L, V302, pG1397, DOI 10.1152/ajpgi.00020.2012; Ford AJ, 2015, ACTA BIOMATER, V24, P220, DOI 10.1016/j.actbio.2015.06.028; FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; HENRIKSEN JH, 1984, LIVER, V4, P221; HORN T, 1987, HEPATOLOGY, V7, P77, DOI 10.1002/hep.1840070117; Hu CT, 2015, ONCOTARGET, V6, P22410, DOI 10.18632/oncotarget.4198; Kafarnik C, 2009, VET PATHOL, V46, P464, DOI 10.1354/vp.08-VP-0183-K-FL; Kautz L, 2011, HAEMATOL-HEMATOL J, V96, P199, DOI 10.3324/haematol.2010.031963; Kim Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015456; Knolle PA, 2003, SWISS MED WKLY, V133, P501; Koudelkova P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142134; Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429; Latour C, 2017, BLOOD, V130, P2339, DOI 10.1182/blood-2017-07-795658; Li F, 2014, J PROTEOME RES, V13, P2679, DOI 10.1021/pr500145n; Luo XY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0567-0; Maguire M, 2017, MOL CELL ENDOCRINOL, V454, P50, DOI 10.1016/j.mce.2017.05.037; MAK KM, 1984, HEPATOLOGY, V4, P386, DOI 10.1002/hep.1840040306; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Moghimi SM, 2001, PHARM RES-DORDR, V18, P1, DOI 10.1023/A:1011054123304; Morita M, 1998, CELL STRUCT FUNCT, V23, P341, DOI 10.1247/csf.23.341; O'Reilly JN, 2010, J ELECTRON MICROSC, V59, P65, DOI 10.1093/jmicro/dfp039; PALADE GE, 1979, ACTA PHYSIOL SCAND, P11; Palenski TL, 2013, AM J PHYSIOL-CELL PH, V305, pC1170, DOI 10.1152/ajpcell.00139.2013; Palenski TL, 2013, MICROVASC RES, V89, P57, DOI 10.1016/j.mvr.2013.06.007; Palenski TL, 2013, LAB INVEST, V93, P646, DOI 10.1038/labinvest.2013.55; Park S, 2013, J CELL SCI, V126, P1392, DOI 10.1242/jcs.117275; Park S, 2010, AM J PHYSIOL-CELL PH, V299, pC1468, DOI 10.1152/ajpcell.00246.2010; Pietrangelo A, 2016, LIVER INT, V36, P116, DOI 10.1111/liv.13020; Piscaglia F, 1999, BIOCHEM PHARMACOL, V58, P157, DOI 10.1016/S0006-2952(99)00066-0; Roberts WG, 1997, CANCER RES, V57, P765; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Rosenthal RA, 1990, GROWTH FACTORS, V4, DOI 10.3109/08977199009011010; Sorensen KK, 2015, COMPR PHYSIOL, V5, P1751, DOI 10.1002/cphy.c140078; Su XJ, 2003, MOL VIS, V9, P171; Sugiyama Y, 2010, DEV DYNAM, V239, P386, DOI 10.1002/dvdy.22162; Sullivan David R, 2004, Clin Biochem Rev, V25, P19; Tang YX, 2010, AM J PHYSIOL-CELL PH, V298, pC665, DOI 10.1152/ajpcell.00153.2009; Tang YX, 2009, BLOOD, V113, P744, DOI 10.1182/blood-2008-03-145219; Venkatraman L, 2013, LIVER INT, V33, P1386, DOI 10.1111/liv.12231; Victoria C, 2009, LIVER BIOL PATHOBIOL; Walter TJ, 2014, AM J PHYSIOL-GASTR L, V306, pG849, DOI 10.1152/ajpgi.00426.2013; Wang YJ, 2006, MICROVASC RES, V71, P143, DOI 10.1016/j.mvr.2006.02.004; WISSE E, 1970, J ULTRA MOL STRUCT R, V31, P125, DOI 10.1016/S0022-5320(70)90150-4; WISSE E, 1972, J ULTRA MOL STRUCT R, V38, P528, DOI 10.1016/0022-5320(72)90089-5; Wu JQ, 2003, J CELL BIOCHEM, V90, P121, DOI 10.1002/jcb.10600; Zhao Y, 2013, MOL CELL BIOL; Zhao Yun, 2015, J Ophthalmic Vis Res, V10, P60, DOI 10.4103/2008-322X.156116; Zhu MY, 2018, BIOL PHARM BULL, V41, P440, DOI 10.1248/bpb.b17-00661	63	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206756	10.1371/journal.pone.0206756	http://dx.doi.org/10.1371/journal.pone.0206756			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372497	Green Published, Green Submitted, gold			2022-12-26	WOS:000448641200056
J	Takami, M; Tsuchida, A; Takamori, A; Aoki, S; Ito, M; Kigawa, M; Kawakami, C; Hirahara, F; Hamazakim, K; Inaderam, H; Ito, S				Takami, Mio; Tsuchida, Akiko; Takamori, Ayako; Aoki, Shigeru; Ito, Mika; Kigawa, Mika; Kawakami, Chihiro; Hirahara, Fumiki; Hamazakim, Kei; Inaderam, Hidekuni; Ito, Shuichi		Japan Environm Childrens Study JEC	Effects of physical activity during pregnancy on preterm delivery and mode of delivery: The Japan Environment and Children's Study, birth cohort study	PLOS ONE			English	Article							EXERCISE; OUTCOMES	Background The aim of this study was to examine how physical activity (PA) before and during pregnancy influences pregnancy outcomes, particularly preterm delivery and mode of delivery. Methods This study was based on the Japan Environment and Children's Study. A total of 92,796 pregnant women who gave birth to live singleton babies were included. Information on mean PA per week during pregnancy was extracted from the responses to questionnaires completed by women during the second and third trimesters of pregnancy. Information on PA before pregnancy was obtained from questionnaires answered based on recall at participation. The level of PA was stratified into the following quartiles for categorical analysis: Very low, Low, Medium, and High. Pregnancy outcomes, gestational age at delivery (whether preterm delivery or not), and mode of delivery (spontaneous, instrumental, or caesarean delivery) were compared between the different groups adjusted for multiple covariates. Results With respect to PA during pregnancy, the risk of preterm delivery and instrumental delivery increased significantly in the Very low group compared to that in the Medium group (odds ratios [OR] 1.16, 95% confidence interval [CI], 1.05-1.29; OR 1.12, 95% CI, 1.03-1.22, respectively). Moreover, the risks of caesarean delivery in the Low group and instrumental delivery in the High group were significantly higher than the risks in the Medium group (OR 1.07, 95% CI, 1.00-1.15; OR 1.12, 95% CI, 1.02-1.22, respectively). In contrast, with respect to PA before pregnancy, there were no statistically significant differences when the other groups were compared to the Medium group. Conclusions Pre-pregnancy PA has no negative effects on preterm birth and caesarean delivery. In contrast, both may be affected by PA during pregnancy because a low level of PA appears to slightly increase the risk of preterm delivery and operative delivery (caesarean and instrumental).	[Takami, Mio; Aoki, Shigeru] Yokohama City Univ, Perinatal Ctr Matern & Neonate, Med Ctr, Yokohama, Kanagawa, Japan; [Takami, Mio; Aoki, Shigeru; Kawakami, Chihiro; Hirahara, Fumiki; Ito, Shuichi] Yokohama City Univ, Kanagawa Reg Ctr JECS, Grad Sch Med, Kanagawa, Japan; [Tsuchida, Akiko; Takamori, Ayako; Kigawa, Mika; Hamazakim, Kei; Inaderam, Hidekuni] Univ Toyama, Fac Med, Dept Publ Hlth, Toyama, Japan; [Tsuchida, Akiko; Ito, Mika; Hamazakim, Kei; Inaderam, Hidekuni] Univ Toyama, Toyama Reg Ctr JECS, Toyama, Japan; [Takamori, Ayako] Saga Univ Hosp, Clin Res Ctr, Saga, Japan; [Ito, Mika] Univ Toyama, Fac Med, Dept Obstet & Gynecol, Toyama, Japan; [Kigawa, Mika] Kanagawa Univ Human Serv, Fac Hlth & Welf, Kanagawa, Japan; [Hirahara, Fumiki] Yokohama City Univ Med, Dept Obstet & Gynecol, Kanagawa, Japan; [Ito, Shuichi] Yokohama City Univ, Grad Sch Med, Dept Pediat, Kanagawa, Japan	Yokohama City University; Yokohama City University; University of Toyama; University of Toyama; Saga University; University of Toyama; Yokohama City University; Yokohama City University	Takami, M (corresponding author), Yokohama City Univ, Perinatal Ctr Matern & Neonate, Med Ctr, Yokohama, Kanagawa, Japan.; Takami, M (corresponding author), Yokohama City Univ, Kanagawa Reg Ctr JECS, Grad Sch Med, Kanagawa, Japan.	tkmmio@yokohama-cu.ac.jp	Ito, Shuichi/AAD-1962-2022; Kigawa, Mika/O-2502-2018	Kigawa, Mika/0000-0002-8131-5682; Takamori, Ayako/0000-0001-6350-5282; Tsuchida, Akiko/0000-0003-1209-3104; Saito, Hirohisa/0000-0002-6630-8337; Nakayama, Takeo/0000-0002-7918-6252	Ministry of the Environment, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan [16H05243]	Ministry of the Environment, Japan(Ministry of the Environment, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The Japan Environment and Children's Study was funded by the Ministry of the Environment, Japan. This study is partly supported by Grants for Scientific Research (16H05243) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; [Anonymous], 2008, AM J OBSTET GYNECOL, V67, P114, DOI 10.1111/j.1753-4887.2008.00136.x; Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533; ARTAL R, 2003, PUBMED, V1, P28; Barakat R, 2014, J PHYS ACT HEALTH, V11, P1012, DOI 10.1123/jpah.2012-0344; Barakat R, 2012, J MATERN-FETAL NEO M, V25, P2372, DOI 10.3109/14767058.2012.696165; BERKOWITZ GS, 1983, J REPROD MED, V9, P1; BO K, 2009, OBSTET GYNECOL, V5, P23; BOVBJERG ML, 2009, PUBMED, V9, P15; Comm Obstet Practice, 2015, OBSTET GYNECOL, V126, pe135, DOI 10.1097/AOG.0000000000001214; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; DEOLIVERIA M, 2012, OBSTET GYNECOL, V7, P25; DIMASCIO D, 2016, AM J OBSTET GYNECOL, V10, P30; DOI, PUBMED; DOI, 2013, PUBMED, V5, P17; DOI, 2009, PUBMED, V1, P22; DOMENJOZ I, AM J OBSTET GYNECOL, pE1; Donahue SMA, 2010, MATERN CHILD HLTH J, V14, P235, DOI 10.1007/s10995-009-0441-x; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; KLEBANOFF MA, AM J OBSTET GYNECOL, P1450; KO PC, 2010, INT UROGYNECOL J, V8, P26; Kramer MS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000180.pub2; LEDERMAN RP, 1995, BEHAVIORAL MEDICINE, V1, P1; LIDDLE SD, 2015, DFS, P1, DOI DOI 10.1002/14651858.CD001139.PUB4; Lof M, 2008, ACTA OBSTET GYN SCAN, V87, P524, DOI 10.1080/00016340802012288; Luke B, 1997, PRETERM LABOR, P127; MELZER K, 2009, AM J OBSTET GYNECOL, V12, P22; Melzer K, 2010, PUBMED, V202, DOI 10.1016/j.ajog.2009.10.876; MISRA DP, 1998, AM J EPIDEMIOL, V4, P29; Mozurkewich EL, 2000, OBSTET GYNECOL, V95, P623, DOI 10.1016/S0029-7844(99)00598-0; Muktabhant B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub2; Murase N., 2002, J EPIDEMIOL, V49, P1; Murase N, 2002, J HLTH WELF STAT, V49, P1; Nascimento SL, 2012, CURR OPIN OBSTET GYN, V24, P387, DOI 10.1097/GCO.0b013e328359f131; Owe KM, 2009, SCAND J MED SCI SPOR, V19, P637, DOI 10.1111/j.1600-0838.2008.00840.x; PETERSEN AM, 2005, MED SCI SPORTS EXERC, V11, P2; PHYSICAL A, 2009, NUTR REV, V1, P31; Poyatos-Leon R, 2015, ACTA OBSTET GYN SCAN, V94, P1039, DOI 10.1111/aogs.12675; Price BB, 2012, MED SCI SPORT EXER, V44, P2263, DOI 10.1249/MSS.0b013e318267ad67; Robledo-Colonia AF, 2012, J PHYSIOTHER, V58, P9, DOI 10.1016/S1836-9553(12)70067-X; Sanabria-Martinez G, 2016, AM J HEALTH PROMOT, V30, P214, DOI 10.1177/0890117116639569; STAFNE SN, 2011, OBSTET GYNECOL, V12, P21; WIEBE HW, 2015, OBSTET GYNECOL, V5, P2	44	18	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206160	10.1371/journal.pone.0206160	http://dx.doi.org/10.1371/journal.pone.0206160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372455	Green Published, Green Submitted, gold			2022-12-26	WOS:000448641200025
J	Trimble, AC; Blevins, CA; Beard, LA; Deforno, AR; Davis, EG				Trimble, Amanda C.; Blevins, Christopher A.; Beard, Laurie A.; Deforno, Ashley R.; Davis, Elizabeth G.			Seroprevalence, frequency of leptospiuria, and associated risk factors in horses in Kansas, Missouri, and Nebraska from 2016-2017	PLOS ONE			English	Article							EQUINE RECURRENT UVEITIS; CHAIN-REACTION ASSAY; PATHOGENIC LEPTOSPIRES; PCR; DOGS; TRANSMISSION; SWITZERLAND; DIAGNOSIS; SAMPLES; SPP.	Leptospirosis is a worldwide veterinary and public health concern, and well recognized infectious disease of horses. Seroprevalence rates vary with geography, but many studies have confirmed a high exposure rate. The correlation between seropositivity and shedding status has not been made in horses, however. The aims of this study were to use seminested PCR on urine from apparently healthy horses to determine period prevalence of leptospiral shedding and to correlate these findings with MAT results to establish associations with client based survey data regarding horse management and environment. Serum and free-catch urine were collected from 204 healthy horses between May 2016-December 2017. Serum was used to determine GGT, creatinine concentrations, and six serovar MAT. Urine samples were submitted for PCR testing of leptospiral 23S rRNA. Client consent and survey data were collected for all subjects. Potential risk factors included drinking water source, exposure to livestock and dogs, geographical location, season, and precipitation. Two horses were positive on urine PCR for leptospirosis (shedding prevalence 1%), yet only one had a high reciprocal MAT titer of >= 800. Both horses were negative on urine PCR one month later without treatment. Approximately 77% of horses (157/204) were seroreactive (MAT reciprocal titer >= 100) with titers to serogroup Australis detected more frequently than others (47.5%; (97/204)). Apparently healthy horses infrequently shed Leptospira spp. in urine, yet seroreactivity in clinically normal horses is high (77%), confirming high exposure rates to Leptospira spp. in the Central Midwest.	[Trimble, Amanda C.; Blevins, Christopher A.; Beard, Laurie A.; Deforno, Ashley R.; Davis, Elizabeth G.] Kansas State Univ, Dept Clin Sci, Coll Vet Med, Manhattan, KS 66506 USA	Kansas State University	Trimble, AC; Davis, EG (corresponding author), Kansas State Univ, Dept Clin Sci, Coll Vet Med, Manhattan, KS 66506 USA.	trimblea87@gmail.com; edavis@vet.k-state.edu	Trimble, Amanda/GPS-4796-2022		Zoetis Inc; Department of Clinical Sciences at the Kansas State University Veterinary Health Center; Dr. John G. and Mildred L. Gish Research Fund for Large Animal Research at Kansas State University	Zoetis Inc; Department of Clinical Sciences at the Kansas State University Veterinary Health Center; Dr. John G. and Mildred L. Gish Research Fund for Large Animal Research at Kansas State University	Funds for this work were provided generously by Zoetis Inc (EGD), the Department of Clinical Sciences at the Kansas State University Veterinary Health Center (ACT), and by the Dr. John G. and Mildred L. Gish Research Fund for Large Animal Research at Kansas State University (ACT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barwick RS, 1998, PREV VET MED, V36, P153, DOI 10.1016/S0167-5877(98)00069-5; Baverud V, 2009, ACTA VET SCAND, V51, DOI [10.1186/1751-0147-51-15, 10.1186/1751-0147-51-51]; Blatti S, 2011, SCHWEIZ ARCH TIERH, V153, P449, DOI 10.1024/0036-7281/a000247; Delaude A, 2017, PREV VET MED, V141, P48, DOI 10.1016/j.prevetmed.2017.04.008; Delph KM, 2018, EQUINE VET EDUC, V30, P132, DOI 10.1111/eve.12686; Divers T.J., 2009, CURRENT THERAPY EQUI, V6, P145; Divers TJ, 2006, 24 ANN ACVIM FORUM; Erol E, 2015, EQUINE VET J, V47, P171, DOI 10.1111/evj.12281; Fang F, 2015, ZOONOSES PUBLIC HLTH, V62, P258, DOI 10.1111/zph.12146; Fink JM, 2015, J VET DIAGNOSTIC INV, V27, P159, DOI [10.1177/1040638715571360, DOI 10.1177/1040638715571360]; Frellstedt L, 2009, EQUINE VET EDUC, V21, P546, DOI 10.2746/095777309X467853; Gerding JC, 2016, EQUINE VET J, V48, P290, DOI 10.1111/evj.12451; Hamond C, 2014, VET RES COMMUN, V38, P81, DOI 10.1007/s11259-013-9582-x; Hamond C, 2013, EPIDEMIOL INFECT, V141, P33, DOI 10.1017/S0950268812000416; Hamond C, 2012, TROP ANIM HEALTH PRO, V44, P1927, DOI 10.1007/s11250-012-0158-5; Harkin KR, 2016, JAVMA-J AM VET MED A, V249, P399, DOI 10.2460/javma.249.4.399; Harkin KR, 2003, J AM VET MED ASSOC, V222, P1230, DOI 10.2460/javma.2003.222.1230; Harkin KR, 2003, J AM VET MED ASSOC, V222, P1224, DOI 10.2460/javma.2003.222.1224; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Llewellyn JR, 2016, BERL MUNCH TIERARZTL, V129, P251, DOI 10.2376/0005-9366-129-15061; Niedermaier G, 2006, DEUT TIERARZTL WOCH, V113, P418; OIE, 2012, MANUAL DIAGNOSTIC TE; Rohrbach BW, 2005, VET OPHTHALMOL, V8, P171, DOI 10.1111/j.1463-5224.2005.00367.x; Rojas P, 2010, EUR J CLIN MICROBIOL, V29, P1305, DOI 10.1007/s10096-010-0991-2; Scarcelli E, 2003, BRAZ J MICROBIOL, V34, P143, DOI 10.1590/S1517-83822003000200010; Verma A, 2013, VET MICROBIOL, V167, P61, DOI 10.1016/j.vetmic.2013.04.012; Wangdi C, 2013, AUST VET J, V91, P190, DOI 10.1111/avj.12038; Woo THS, 1997, J CLIN MICROBIOL, V35, P3140, DOI 10.1128/JCM.35.12.3140-3146.1997; Ye CL, 2014, CLIN VACCINE IMMUNOL, V21, P478, DOI 10.1128/CVI.00649-13; Zoetis LLC, 2015, B850RUS12011	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206639	10.1371/journal.pone.0206639	http://dx.doi.org/10.1371/journal.pone.0206639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372498	Green Submitted, gold, Green Published			2022-12-26	WOS:000448641200051
J	Balachiranjeevi, CH; Naik, B; Kumar, VA; Harika, G; Swamy, HKM; Sk, H; Kumar, TD; Anila, M; Kale, RR; Yugender, A; Pranathi, K; Koushik, MBVN; Suneetha, K; Bhadana, VP; Hariprasad, AS; Laha, GS; Rekha, G; Balachandran, SM; Madhav, MS; Senguttuvel, P; Fiyaz, AR; Viraktamath, BC; Giri, A; Swamy, BPM; Ali, J; Sundaram, RM				Balachiranjeevi, C. H.; Naik, Bhaskar; Kumar, Abhilash, V; Harika, G.; Swamy, Mahadev H. K.; Sk, Hajira; Kumar, Dilip T.; Anila, M.; Kale, R. R.; Yugender, A.; Pranathi, K.; Koushik, M. B. V. N.; Suneetha, K.; Bhadana, V. P.; Hariprasad, A. S.; Laha, G. S.; Rekha, G.; Balachandran, S. M.; Madhav, M. S.; Senguttuvel, P.; Fiyaz, A. R.; Viraktamath, B. C.; Giri, A.; Swamy, B. P. M.; Ali, Jauhar; Sundaram, R. M.			Marker-assisted pyramiding of two major, broad-spectrum bacterial blight resistance genes, Xa21 and Xa33 into an elite maintainer line of rice, DRR17B	PLOS ONE			English	Article							ORYZAE PV.-ORYZAE; XANTHOMONAS-ORYZAE; BASMATI RICE; WILD-RICE; IDENTIFICATION; IMPROVEMENT; VARIETY; DISEASE; QUALITY; HYBRID	Bacterial blight (BB) disease reduces the yield of rice varieties and hybrids considerably in many tropical rice growing countries like India. The present study highlights the development of durable BB resistance into the background of an elite maintainer of rice, DRR17B, by incorporating two major dominant genes, Xa21 and Xa33 through marker-assisted backcross breeding (MABB). Through two sets of back-crosses, the two BB resistance genes were transferred separately to DRR17B. In this process, at each stage of backcrossing, foreground selection was carried out for the target resistance genes and for non-fertility restorer alleles concerning the major fertility restorer genes Rf3 and Rf4, using gene-specific PCR-based markers, while background selection was done using a set of 61 and 64 parental polymorphic SSR markers respectively. Backcross derived lines possessing either Xa21 or Xa33 along with maximum genome recovery of DRR17B were identified at BC3F1 generation and selfed to develop BC(3)F(2)s. Plants harboring Xa21 or Xa33 in homozygous condition were identified among BC(3)F(2)s and were intercrossed with each other to combine both the genes. The intercross F-1 plants (ICF1) were selfed and the intercross F-2(ICF2) plants possessing both Xa21 and Xa33 in homozygous condition were identified with the help of markers. They were then advanced further by selfing until ICF4 generation. Selected ICF4 lines were evaluated for their resistance against BB with eight virulent isolates and for key agro-morphological traits. Six promising two-gene pyramiding lines of DRR17B with high level of BB resistance and agro-morphological attributes similar or superior to DRR17B with complete maintenance ability have been identified. These lines with elevated level of durable resistance may be handy tool for BB resistance breeding.	[Balachiranjeevi, C. H.; Swamy, B. P. M.; Ali, Jauhar] Int Rice Res Inst, Manila, Philippines; [Naik, Bhaskar; Harika, G.; Sk, Hajira; Kumar, Dilip T.; Anila, M.; Kale, R. R.; Yugender, A.; Pranathi, K.; Koushik, M. B. V. N.; Suneetha, K.; Hariprasad, A. S.; Laha, G. S.; Rekha, G.; Balachandran, S. M.; Madhav, M. S.; Senguttuvel, P.; Fiyaz, A. R.; Viraktamath, B. C.; Sundaram, R. M.] Indian Council Agr Res, Indian Inst Rice Res, Biotechnol, Crop Improvement, Hyderabad, India; [Kumar, Abhilash, V] Int Crops Res Inst Semi Arid Trop, Int Rice Res Inst South Asia Hub, Dept Plant Breeding, Patancheru, Andhra Pradesh, India; [Swamy, Mahadev H. K.] ICAR Sugarcane Breeding Inst, Div Crop Improvement, Coimbatore, Tamil Nadu, India; [Bhadana, V. P.] ICAR Indian Inst Agr Biotechnol, IINRG, PDU Campus, Ranchi, Jharkhand, India; [Giri, A.] Jawaharlal Nehru Technol Univ, Ctr Biotechnol, Inst PG Studies & Res, Mahaveer Marg, Hyderabad, India	CGIAR; International Rice Research Institute (IRRI); Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Rice Research; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Indian Council of Agricultural Research (ICAR); ICAR - Sugarcane Breeding Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Agricultural Biotechnology; ICAR - Indian Institute of Natural Resins & Gums; Jawaharlal Nehru Technological University - Hyderabad	Ali, J (corresponding author), Int Rice Res Inst, Manila, Philippines.; Sundaram, RM (corresponding author), Indian Council Agr Res, Indian Inst Rice Res, Biotechnol, Crop Improvement, Hyderabad, India.	J.Ali@irri.org; rms_28@rediffmail.com	Fiyaz, Abdul/AAH-7793-2021; Ali, Jauhar Ali or A. Jauhar/E-4432-2012; P, senguttuvel/AAW-2569-2020	Fiyaz, Abdul/0000-0001-6261-7071; Ali, Jauhar Ali or A. Jauhar/0000-0002-3177-2607; Arra, Yugander/0000-0001-6778-4258	Department of Biotechnology (DBT), Government of India [BT/PR11705/AGR/02/646/2008]; Bill and Melinda Gates Foundation [OPP1130530]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The authors acknowledge the Department of Biotechnology (DBT), Government of India for providing the salary to the first author 'BC' and funding for the development of the breeding materials (Grant number: BT/PR11705/AGR/02/646/2008). The Green Super Rice Project at ICAR-Indian Institute of Rice Research, Hyderabad for providing the funds to conduct the field and glasshouse experiment to screen the material for BB resistance and evaluation for agro-morphological traits (funded by the Bill and Melinda Gates Foundation, Grant number: OPP1130530).	Ahmed L, 2017, SPRIGER, V15, P100, DOI [10.1007/978-3-319-69185-5, DOI 10.1007/978-3-319-69185-5]; Ali AJ, 2006, FIELD CROP RES, V97, P66, DOI 10.1016/j.fcr.2005.08.016; [Anonymous], 2003, STAT 8 AN SOFTW STAT; Balachiranjeevi CH, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0348-8; BALAJI SP, 2012, EUPHYTICA, V187, P421, DOI DOI 10.1007/S10681-012-0737-6; Basavaraj SH, 2010, MOL BREEDING, V26, P293, DOI 10.1007/s11032-010-9407-3; Bhaskar Naik S., 2015, INT J CURRENT RES, V7, P18943; Devadath S., 1989, BACTERIAL BLIGHT RIC, P89; Ellur RK, 2016, PLANT SCI, V242, P330, DOI 10.1016/j.plantsci.2015.08.020; Gizachew H. G., 2015, TRENDS BIOSCI, V8, P2136; Gnanamanickam SS, 1999, CURR SCI INDIA, V77, P1435; Gomez K.A., 1984, STAT PROCEDURE AGR R, V2nd ed.; Haile G. G., 2015, Trends in Biosciences, V8, P1069; Hajira S, 2014, PROGR RES, V9, P1224; Hari Prasad AS, 2014, P REG EXP CONS BANGK, P85; Hari Y, 2013, PLANT BREEDING, V132, P586, DOI 10.1111/pbr.12056; Hari Y, 2011, PLANT BREEDING, V130, P608, DOI 10.1111/j.1439-0523.2011.01881.x; Hutin M, 2015, PLANT J, V84, P694, DOI 10.1111/tpj.13042; Indian Institute of Rice Research (IIRR). Production Oriented Survey (POS), 2008, PROD OR SURV POS ANN, DOI [10.1007/978-1-4020-9500-9_1, DOI 10.1007/978-1-4020-9500-9_1]; IRRI, 2014, PBTOOLS PLANT BREEDI; Joseph M, 2004, MOL BREEDING, V13, P377, DOI 10.1023/B:MOLB.0000034093.63593.4c; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Khanna A, 2015, THEOR APPL GENET, V128, P1243, DOI 10.1007/s00122-015-2502-4; Khush G. S., 1989, BACTERIAL BLIGHT RIC, P207; Khush GS, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P1, DOI 10.1007/978-1-4020-9500-9_1; Kim SM, 2015, THEOR APPL GENET, V128, P1933, DOI 10.1007/s00122-015-2557-2; Kumar PN, 2012, PHYTOPATHOLOGY, V102, P222, DOI 10.1094/PHYTO-03-11-0075; Kumar VA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01195; Laha GS, 2009, DRR TECHNICAL B, V41; Lore JS, 2011, J PHYTOPATHOL, V159, P479, DOI 10.1111/j.1439-0434.2011.01789.x; MEW TW, 1987, ANNU REV PHYTOPATHOL, V25, P359, DOI 10.1146/annurev.py.25.090187.002043; MEW TW, 1992, PLANT DIS, V76, P1029, DOI 10.1094/PD-76-1029; Nayak D., 2008, Journal of Agricultural and Biological Science, V3, P12; Pradhan SK, 2015, RICE, V8, DOI 10.1186/s12284-015-0051-8; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; RONALD PC, 1992, MOL GEN GENET, V236, P113, DOI 10.1007/BF00279649; Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1; Shanthi L. M., 2005, ORYZA, V42, P169; SHANTI LM, 2010, INT J PLANT PATHOL, V1, P58; Shanti ML, 2001, PLANT DIS, V85, P506, DOI 10.1094/PDIS.2001.85.5.506; Singh A, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls029; Srinivasan B, 2005, CURR SCI INDIA, V88, P1229; Sundaram RM, 2008, EUPHYTICA, V160, P411, DOI 10.1007/s10681-007-9564-6; Sundaram RM, 2014, RICE, V7, DOI 10.1186/s12284-014-0012-7; Sundaram Raman M., 2009, Biotechnology Journal, V4, P400, DOI 10.1002/biot.200800310; Yugander A, 2017, EUR J PLANT PATHOL, V149, P171, DOI 10.1007/s10658-017-1176-y; Yugander A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198260; Zheng K., 1995, RICE GENET NEWSLETT, V12, P255; Zhuang J. Y., 2000, RICE GENET NEWSL, V17, P56	49	14	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0201271	10.1371/journal.pone.0201271	http://dx.doi.org/10.1371/journal.pone.0201271			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359375	Green Published, Green Submitted, gold			2022-12-26	WOS:000448438400004
J	Li, JQ; Zhang, HY; Zhang, Y; Liu, HT				Li, Jing-Qiang; Zhang, Hong-Yan; Zhang, Yan; Liu, Hai-Tao			Systematic assessment of intrinsic factors influencing visual attention performances in air traffic control via clustering algorithm and statistical inference	PLOS ONE			English	Article							HUMAN ERROR; MENTAL WORKLOAD; DEPENDENCE; AVIATION; TIME; R/S	The intrinsic factors (IF) influencing visual attention performance (VAP) might cause potential human errors, such as "error/mistake", "forgetting" and "omission". It is a key issue to develop a systematic assessment of IF in order to distinguish the levels of VAP. Motivated by the Stimulus-Response (S-R) model, we take an interactive cancellation test-Neuron Type Test (NTT)-to explore the IF and present the corresponding systematic assessment. The main contributions of this work include three elements: a) modeling the IF on account of attention span, attention stability, distribution-shift of attention with measurable parameters by combining the psychological and statistical concepts; b) proposing quantitative analysis methods for assessing the IF via its computational representation-intrinsic qualities (IQ)-in the sense of computational model; and c) clustering the IQ of air traffic control (ATC) students in the feature space of interest. The response sequences of participants collected with the NTT system are characterized by three parameters: Hurst exponent, normalized number of decisions (NNoD) and error rate of decisions (ERD). The K-means clustering is applied to partition the feature space constructed from practical data of VAP. For the distinguishable clusters, the statistical inference is utilized to refine the assessment of IF. Our comprehensive analysis shows that the IQ can be classified into four levels, i.e., excellent, good, moderate and unqualified, which has a potential application in selecting air traffic controllers subject to reducing the risk of the inadequacy of attention performances in aviation safety management.	[Li, Jing-Qiang] Civil Aviat Univ China, Res Inst Civil Aviat Safety, Tianjin 300300, Peoples R China; [Li, Jing-Qiang] Civil Aviat Univ China, Natl Key Lab Air Traff Operat Safety Technol, Tianjin 300300, Peoples R China; [Zhang, Hong-Yan; Zhang, Yan] Civil Aviat Univ China, Sinoeuropean Inst Aviat Engn, Tianjin 300300, Peoples R China; [Liu, Hai-Tao] Civil Aviat Univ China, Coll Elect Informat & Automat, Tianjin 300300, Peoples R China; [Zhang, Hong-Yan] Hainan Normal Univ, Sch Informat Sci & Technol, Dept Comp Sci, Haikou 571158, Hainan, Peoples R China	Civil Aviation University of China; Civil Aviation University of China; Civil Aviation University of China; Civil Aviation University of China; Hainan Normal University	Li, JQ (corresponding author), Civil Aviat Univ China, Res Inst Civil Aviat Safety, Tianjin 300300, Peoples R China.; Li, JQ (corresponding author), Civil Aviat Univ China, Natl Key Lab Air Traff Operat Safety Technol, Tianjin 300300, Peoples R China.; Zhang, HY (corresponding author), Civil Aviat Univ China, Sinoeuropean Inst Aviat Engn, Tianjin 300300, Peoples R China.; Zhang, HY (corresponding author), Hainan Normal Univ, Sch Informat Sci & Technol, Dept Comp Sci, Haikou 571158, Hainan, Peoples R China.	jingqiang_li@foxmail.com; hongyan.rd@foxmail.com		Zhang, Hong-Yan/0000-0002-4400-9133	Humanity and Social Science Youth Foundation of Ministry of Education of China [15YJC190008]; Civil Aviation Safety Capacity Building Foundation of Civil Aviation Administration of China [OAS20150337]; Fundamental Research Funds for the Central Universities of China [3122017014]; National Natural Science Foundation of China [61201085, 61502127, 61562023]	Humanity and Social Science Youth Foundation of Ministry of Education of China; Civil Aviation Safety Capacity Building Foundation of Civil Aviation Administration of China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Humanity and Social Science Youth Foundation of Ministry of Education of China under grant number 15YJC190008 to JQL, see https://xm.sinoss.net/indexAction! to_index.action; the Civil Aviation Safety Capacity Building Foundation of Civil Aviation Administration of China under grant number OAS20150337, see http://www.caac.gov.cn/dev/cws/; the Fundamental Research Funds for the Central Universities of China under grant number 3122017014 to JQL, see http://www.moe.gov.cn/jyb_xxgk/moe_1777/moe_1779/201610/t20161028_286795.html; the National Natural Science Foundation of China under grant numbers 61201085, 61502127 and 61562023 to HYZ, see http://www.nsfc.gov.cn/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, AIRPLANE CRASH LANDS; [Anonymous], 2016, FINDINGS AIRPORT NEA; [Anonymous], 2016, CONTROLLERS PUNISHED; [Anonymous], 2017, TECH REP; Averty P, 2004, AVIAT SPACE ENVIR MD, V75, P333; Bao S-R, 2014, IEEE INT S BIOEL BIO, P1; Bishop C. M, 2006, PATTERN RECOGNITION; Borji A, 2013, IEEE T PATTERN ANAL, V35, P185, DOI 10.1109/TPAMI.2012.89; Chiang I. W. Y., 2003, DATABASE MARKETING C, V11, P149, DOI [DOI 10.1057/PALGRAVE.DBM.3240215, 10.1057/palgrave.dbm.3240215]; Christopher ABA, 2013, 4 C COMP COMM NETW T, P1; Cokorilo O, 2014, J RISK RES, V17, P1325, DOI 10.1080/13669877.2013.879493; Deco G, 2002, VISION RES, V42, P2925, DOI 10.1016/S0042-6989(02)00358-9; Dismukes K, 2001, P 11 INT S AVIATION; Endsley MR, 1997, AIR TRAFFIC CONTROL, V6, P25; Friedman Jerome, 2009, ELEMENTS STAT LEARNI, V2nd; Frintrop S, 2010, ACM T APPL PERCEPT, V7, DOI 10.1145/1658349.1658355; Gariel M, 2011, IEEE T INTELL TRANSP, V12, P1511, DOI 10.1109/TITS.2011.2160628; Graham R. L., 1972, Information Processing Letters, V1, P132, DOI 10.1016/0020-0190(72)90045-2; Heinke D, 2014, CONNECTIONIST MODELS, V1, P273; Hilburn B., 404 EEC, V4; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Isaac A, 2002, RELIAB ENG SYST SAFE, V75, P257, DOI 10.1016/S0951-8320(01)00099-0; Isaac A, 2003, TECHNICAL REV HUMAN, P30; Isaac A. R., 2017, AIR TRAFFIC CONTROL; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kulis B, 2009, J MACH LEARN RES, V10, P341; Li J-Q, 2017, CHINA SAFETY SCI J, V27, P13; Li J-Q, 2017, SCI TECHNOLOGY ENG, V17, P68; Lim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033767; Loft S, 2007, HUM FACTORS, V49, P376, DOI 10.1518/001872007X197017; Luo XL, 2014, CHINA SAFETY SCI J, V14, P26; MANDELBR.BB, 1969, WATER RESOUR RES, V5, P967, DOI 10.1029/WR005i005p00967; Mathot S, 2011, PHILOS T R SOC B, V366, P516, DOI 10.1098/rstb.2010.0187; Monechi B, 2013, AIR TRANSP SYST C; Nolan M., 2010, FUNDAMENTALS AIR TRA; OHARE D, 1994, ERGONOMICS, V37, P1855, DOI 10.1080/00140139408964954; Portnoy L., 2001, P ACM CSS WORKSH DAT, P5; Puranik TG, 2017, AIAA INFORM SYSTEMS; Robinson LJ, 2012, ACTA PSYCHOL, V141, P243, DOI 10.1016/j.actpsy.2012.05.012; Scarborough A, 2005, TECH REP; Shappell S, 2009, INT J AVIAT PSYCHOL, V19, P252, DOI 10.1080/10508410902983904; Shorrock ST, 2002, APPL ERGON, V33, P319, DOI 10.1016/S0003-6870(02)00010-8; Staugaard CF, 2016, NEUROPSYCHOLOGIA, V92, P69, DOI 10.1016/j.neuropsychologia.2016.06.020; Sun Ruishan, 2013, Journal of Beijing University of Aeronautics and Astronautics, V39, P897; Tsotsos J. K., 2011, COMPUTATIONAL PERSPE, DOI DOI 10.7551/MITPRESS/9780262015417.001.0001; van Zomeren AH, 1992, HDB NEUROPSYCHOLOGIC, P241; Visalakshi NK, 2009, INT J SOFT COMPUT, V4, P168; Vitali S, 2012, STAT REGULARITIES AT, P27; Wang YD, 2015, 2015 INTERNATIONAL SYMPOSIUM ON BIOELECTRONICS AND BIOINFORMATICS (ISBB), P164, DOI 10.1109/ISBB.2015.7344949; Weron R, 2002, PHYSICA A, V312, P285, DOI 10.1016/S0378-4371(02)00961-5; Wickens C. D., 2007, APPL ATTENTION THEOR; Wiegmann DA, 2001, INT J AVIAT PSYCHOL, V11, P341, DOI 10.1207/S15327108IJAP1104_2; Zhang HY, 2017, PHYSICA A, V469, P859, DOI 10.1016/j.physa.2016.11.054; Zhou CC, 2012, J SAFETY SCI TECHNOL, V8, P99	56	1	1	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0205334	10.1371/journal.pone.0205334	http://dx.doi.org/10.1371/journal.pone.0205334			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3GT	30359377	gold, Green Published, Green Submitted			2022-12-26	WOS:000448438400014
J	Rupniak, NMJ; Perdona, E; Griffante, C; Cavallini, P; Sava, A; Ricca, DJ; Thor, KB; Burgard, EC; Corsi, M				Rupniak, Nadia M. J.; Perdona, Elisabetta; Griffante, Cristiana; Cavallini, Palmina; Sava, Anna; Ricca, Daniel J.; Thor, Karl B.; Burgard, Edward C.; Corsi, Mauro			Affinity, potency, efficacy, and selectivity of neurokinin A analogs at human recombinant NK2 and NK1 receptors	PLOS ONE			English	Article							HUMAN URINARY-BLADDER; HAMSTER OVARY CELLS; TACHYKININ RECEPTORS; BINDING-SITES; SUBSTANCE-P; IN-VITRO; COLON; STIMULATION; ACTIVATION; RESPONSES	A series of peptide NK2 receptor agonists was evaluated for affinity, potency, efficacy, and selectivity at human recombinant NK2 and NK1 receptors expressed in CHO cells to identify compounds with the greatest separation between NK2 and NK1 receptor agonist activity. Binding studies were performed using displacement of [I-12(5)]-NKA binding to NK2 receptors and displacement of [H-3]-Septide binding to NK1 receptors expressed in CHO cells. Functional studies examining the increase in intracellular calcium levels and cyclic AMP stimulation were performed using the same cell lines. A correlation was demonstrated between binding affinities (Ki) and potency to increase intracellular calcium (EC50) for NK2 and NK1 receptors. Ranking compounds by their relative affinity (Ki) or potency (EC50) at NK2 or NK1 receptors indicated that the most selective NK2 agonists tested were [Lys(5),MeLeu(9),Nle(10)]-NKA(4-10) (NK1/NK2 Ki ratio = 674; NK1/NK2 EC50 ratio = 105) and [Arg(5),MeLeu(9),Nle(10)]-NKA(4-10) (NK1/NK2 Ki ratio = 561; NK1/NK2 EC50 ratio = 70). The endogenous peptide, NKA, lacked selectivity with an NK1/NK2 Ki ratio = 20 and NK1/NK2 EC50 ratio = 1. Of the compounds selected for evaluation in cyclic AMP stimulation assays, [beta-Ala(8)]-NKA(4-10) had the greatest selectivity for activation of NK2 over NK1 receptors (NK1/NK2 EC50 ratio = 244), followed by [Lys(5),MeLeu(9),Nle(10)]-NKA(4-10) (ratio = 74), and NKA exhibited marginal selectivity (ratio = 2.8).	[Rupniak, Nadia M. J.; Ricca, Daniel J.; Thor, Karl B.; Burgard, Edward C.] Dignify Therapeut, Res Triangle Pk, NC 27709 USA; [Perdona, Elisabetta; Griffante, Cristiana; Cavallini, Palmina; Sava, Anna; Corsi, Mauro] Aptuit Evotec Co, Drug Design & Discovery, Verona, Italy		Rupniak, NMJ (corresponding author), Dignify Therapeut, Res Triangle Pk, NC 27709 USA.	nrupniak@dignifytherapeutics.com			National Institute on Aging of the National Institutes of Health [R43AG055169]	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NMJR, KBT, DJR and ECB are partners of Dignify Therapeutics LLC. MC, CG, PC, AS and EP are employees of Aptuit. Research reported in this publication was supported in part by the National Institute on Aging of the National Institutes of Health under award number R43AG055169. The funder provided support in the form of salaries for KBT, DJR and ECB and research funding, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Burcher E, 2008, J PHARMACOL EXP THER, V324, P170, DOI 10.1124/jpet.107.130385; Carini F, 2001, BRIT J PHARMACOL, V133, P1107, DOI 10.1038/sj.bjp.0704164; CHASSAING G, 1991, NEUROPEPTIDES, V19, P91, DOI 10.1016/0143-4179(91)90137-8; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Comis A, 1999, J PEPT RES, V53, P337, DOI 10.1034/j.1399-3011.1999.00038.x; Croci T, 1998, BRIT J PHARMACOL, V124, P1321, DOI 10.1038/sj.bjp.0701960; Hastrup H, 1996, FEBS LETT, V399, P264, DOI 10.1016/S0014-5793(96)01337-3; Jensen DD, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3447; Kaczynska K, 2016, CLIN EXP PHARMACOL P, V43, P818, DOI 10.1111/1440-1681.12594; Kullmann FA, 2017, N-S ARCH PHARMACOL, V390, P163, DOI 10.1007/s00210-016-1317-4; MAGGI CA, 1986, J PHARMACOL EXP THER, V238, P259; Maudsley S, 1998, BRIT J PHARMACOL, V124, P675, DOI 10.1038/sj.bjp.0701889; Mule F, 2000, NEUROGASTROENT MOTIL, V12, P459; Mussap CJ, 1996, J PHARMACOL EXP THER, V279, P423; NAKAJIMA Y, 1992, J BIOL CHEM, V267, P2437; Palea S, 1996, J PHARMACOL EXP THER, V277, P700; Parlani M, 1996, EUR J PHARMACOL, V318, P419, DOI 10.1016/S0014-2999(96)00799-6; REGOLI D, 1990, PHARMACOL RES, V22, P1, DOI 10.1016/1043-6618(90)90738-Y; ROVERO P, 1989, NEUROPEPTIDES, V13, P263, DOI 10.1016/0143-4179(89)90080-2; ROVERO P, 1989, PEPTIDES, V10, P593, DOI 10.1016/0196-9781(89)90148-4; Rupniak NMJ, 2018, N-S ARCH PHARMACOL, V391, P907, DOI 10.1007/s00210-018-1520-6; Rupniak NMJ, 2018, J PHARMACOL EXP THER, V366, P136, DOI 10.1124/jpet.118.248765; Rupniak NMJ, 2018, N-S ARCH PHARMACOL, V391, P299, DOI 10.1007/s00210-017-1458-0; Sagan S, 1996, J PHARMACOL EXP THER, V276, P1039; TAKEDA Y, 1992, J NEUROCHEM, V59, P740, DOI 10.1111/j.1471-4159.1992.tb09430.x; Torrens Y, 2000, BIOCHEM BIOPH RES CO, V270, P668, DOI 10.1006/bbrc.2000.2477; Tramontana R, 1998, N-S ARCH PHARMACOL, V358, P293, DOI 10.1007/PL00005256; Warner FJ, 2003, CLIN EXP PHARMACOL P, V30, P632, DOI 10.1046/j.1440-1681.2003.03887.x; Warner FJ, 2002, BIOCHEM PHARMACOL, V63, P2181, DOI 10.1016/S0006-2952(02)01014-6; ZENG XP, 1995, J UROLOGY, V153, P1688, DOI 10.1016/S0022-5347(01)67505-0	31	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0205894	10.1371/journal.pone.0205894	http://dx.doi.org/10.1371/journal.pone.0205894			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359406	Green Submitted, gold, Green Published			2022-12-26	WOS:000448438400031
J	Senaras, C; Niazi, MKK; Lozanski, G; Gurcan, MN				Senaras, Cagier; Niazi, M. Khalid Khan; Lozanski, Gerard; Gurcan, Metin N.			Deep Focus: Detection of out-of-focus regions in whole slide digital images using deep learning	PLOS ONE			English	Article							NEURAL-NETWORK ARCHITECTURE; SELECTION	The development of whole slide scanners has revolutionized the field of digital pathology. Unfortunately, whole slide scanners often produce images with out-of-focus/blurry areas that limit the amount of tissue available for a pathologist to make accurate diagnosis/prognosis. Moreover, these artifacts hamper the performance of computerized image analysis systems. These areas are typically identified by visual inspection, which leads to a subjective evaluation causing high intra- and inter-observer variability. Moreover, this process is both tedious, and time-consuming. The aim of this study is to develop a deep learning based software called, DeepFocus, which can automatically detect and segment blurry areas in digital whole slide images to address these problems. DeepFocus is built on TensorFlow, an open source library that exploits data flow graphs for efficient numerical computation. DeepFocus was trained by using 16 different H&E and IHC-stained slides that were systematically scanned on nine different focal planes, generating 216,000 samples with varying amounts of blurriness. When trained and tested on two independent datasets, DeepFocus resulted in an average accuracy of 93.2% (+/- 9.6%), which is a 23.8% improvement over an existing method. DeepFocus has the potential to be integrated with whole slide scanners to automatically re-scan problematic areas, hence improving the overall image quality for pathologists and image analysis algorithms.	[Senaras, Cagier; Niazi, M. Khalid Khan; Gurcan, Metin N.] Wake Forest Sch Med, Ctr Biomed Informat, Winston Salem, NC 27101 USA; [Lozanski, Gerard] Ohio State Univ Wexner Med, Dept Pathol, Columbus, OH USA	Wake Forest University; University System of Ohio; Ohio State University	Senaras, C (corresponding author), Wake Forest Sch Med, Ctr Biomed Informat, Winston Salem, NC 27101 USA.	caglarsenaras@gmail.com	Senaras, Caglar/I-5377-2019	Senaras, Caglar/0000-0003-4211-4367; Gurcan, Metin/0000-0002-2421-8229	National Cancer Institute [R01CA134451, U24CA199374, U01CA198945]; NATIONAL CANCER INSTITUTE [U01CA198945, R01CA134451, U24CA199374] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The project described was supported in part by Awards Number R01CA134451 (PIs: Gurcan, Lozanski), U24CA199374 (PI: Gurcan), and U01CA198945 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 2016, TENSORFLOW LARGE SCA; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bengio Yoshua, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P437, DOI 10.1007/978-3-642-35289-8_26; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Fakoor R., 2013, P INT C MACHINE LEAR, V28, P3937; Gurcan MN, 2002, ACAD RADIOL, V9, P420, DOI 10.1016/S1076-6332(03)80187-3; Gurcan MN, 2001, MED PHYS, V28, P1937, DOI 10.1118/1.1395036; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hashimoto Noriaki, 2012, J Pathol Inform, V3, P9, DOI 10.4103/2153-3539.93891; Huang J., 2017, NVIDIA BLOG; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Irshad Humayun, 2014, IEEE Rev Biomed Eng, V7, P97, DOI 10.1109/RBME.2013.2295804; Jimenez A, 2016, SPIE PHOTONICS EUROP; Lahrmann B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061441; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Litjens G, 2016, SCI REP-UK, V6, DOI 10.1038/srep26286; Lopez XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082710; Mishkin Dmytro, 2015, ICLR; Nair V., 2010, P 27 INT C INT C MAC, P807; Niazi MKK, 2017, SPIE MED IMAGING; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PENROSE LS, 1946, J ROY STAT SOC A STA, V109, P53, DOI 10.2307/2981392; Senaras C., 2017, P SPIE INT SOC OPTIC, V10140; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Stathonikos N, 2013, J PATHOLOGY INFORN, V4; Sutskever I., 2013, P 30 INT C MACH LEAR, V28, P1139, DOI DOI 10.1007/S00287-015-0911-Z; Tenenbaum JM, 1970, DTIC DOCUMENT; Walkowski S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S14; Xu J, 2016, NEUROCOMPUTING, V191, P214, DOI 10.1016/j.neucom.2016.01.034; Zerbe N, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S16	30	45	48	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0205387	10.1371/journal.pone.0205387	http://dx.doi.org/10.1371/journal.pone.0205387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359393	Green Published, gold, Green Submitted			2022-12-26	WOS:000448438400017
J	Antonellis, P; Galle, S; De Clercq, D; Malcolm, P				Antonellis, Prokopios; Galle, Samuel; De Clercq, Dirk; Malcolm, Philippe			Altering gait variability with an ankle exoskeleton	PLOS ONE			English	Article							LOCAL DYNAMIC STABILITY; METABOLIC COST; KINEMATIC VARIABILITY; ATTRACTOR DIVERGENCE; WALKING SPEED; OLDER-ADULTS; FALL-PRONE; PREDICTORS; ASSISTANCE; ENERGETICS	Exoskeletons can influence human gait. A healthy gait is characterized by a certain amount of variability compared to a non-healthy gait that has more inherent variability; however which exoskeleton assistance parameters are necessary to avoid increasing gait variability or to potentially lower gait variability below that of unassisted walking are unknown. This study investigated the interaction effects of exoskeleton timing and power on gait variability. Ten healthy participants walked on a treadmill with bilateral ankle-foot exoskeletons under ten conditions with different timing (varied from 36% to 54% of the stride) and power (varied from 0.2 to 0.5 W-kg(-1)) combinations. We used the largest Lyapunov exponent (LyE) and maximum Floquet multiplier (FM) to evaluate the stride-to-stride fluctuations of the kinematic time series. We found the lowest LyE at the ankle and a significant reduction versus powered-off with exoskeleton power (summed for both legs) of 0.45 W-kg(-1) and actuation timing at 48% of the stride cycle. At the knee, a significant positive effect of power and a negative interaction effect of power and timing were found for LyE. We found significant positive interaction effects of the square of timing and power for LyE at the knee and hip joints. In contrast, the FM at the ankle increased with increasing power and later timing. We found a significant negative effect of power and a positive interaction effect of power and timing for FM at the knee and no significant effects of any of the exoskeleton parameters for FM at the hip. The ability of the exoskeleton to reduce the LyE at the ankle joint offers new possibilities in terms of altering gait variability, which could have applications for using exoskeletons as rehabilitation devices. Further efforts could examine if it is possible to simultaneously reduce the LyE and FM at one or more lower limb joints.	[Antonellis, Prokopios; Malcolm, Philippe] Univ Nebraska, Dept Biomech, Omaha, NE 68182 USA; [Antonellis, Prokopios; Malcolm, Philippe] Univ Nebraska, Ctr Res Human Movement Variabil, Omaha, NE 68182 USA; [Galle, Samuel; De Clercq, Dirk] Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium	University of Nebraska System; University of Nebraska System; Ghent University	Antonellis, P; Malcolm, P (corresponding author), Univ Nebraska, Dept Biomech, Omaha, NE 68182 USA.; Antonellis, P; Malcolm, P (corresponding author), Univ Nebraska, Ctr Res Human Movement Variabil, Omaha, NE 68182 USA.	pantonellis@unomaha.edu; pmalcolm@unomaha.edu		Antonellis, Prokopios/0000-0002-8927-1274; Malcolm, Philippe/0000-0003-4110-4167	Center for Research in Human Movement Variability of the University of Nebraska Omaha; National Institutes of Health [P20 GM109090]; Special Research Fund of Ghent University [BOF10/DOC/288]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109090] Funding Source: NIH RePORTER	Center for Research in Human Movement Variability of the University of Nebraska Omaha; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Special Research Fund of Ghent University(Ghent University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	P.A. and P.M. were supported by the Center for Research in Human Movement Variability of the University of Nebraska Omaha and the National Institutes of Health (P20 GM109090). S.G. was supported by funds from the Special Research Fund of Ghent University (BOF10/DOC/288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel H.D.I., 1996, ANAL OBSERVED CHAOTI; Arellano CJ, 2009, J EXP BIOL, V212, P1965, DOI 10.1242/jeb.026153; Arellano CJ, 2009, MED SCI SPORT EXER, V41, P620, DOI 10.1249/MSS.0b013e31818a0ea4; Awad LN, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai9084; Bhounsule PA, 2014, INT J ROBOT RES, V33, P1305, DOI 10.1177/0278364914527485; Bruijn SM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0999; Bruijn SM, 2012, MED ENG PHYS, V34, P428, DOI 10.1016/j.medengphy.2011.07.024; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Collins SH, 2005, IEEE INT CONF ROBOT, P1983; Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; Derrick TR., 2004, INNOVATIVE ANAL HUMA, P189; Ding Y, 2018, SCI ROBOT, V3, DOI 10.1126/scirobotics.aar5438; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Dingwell JB, 2007, J BIOMECH ENG-T ASME, V129, P586, DOI 10.1115/1.2746383; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; Felt W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135342; Galle S, 2017, GAIT POSTURE, V52, P183, DOI 10.1016/j.gaitpost.2016.11.040; Galle S, 2013, GAIT POSTURE, V38, P495, DOI 10.1016/j.gaitpost.2013.01.029; Galle S, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0235-0; Galle S, 2014, EUR J APPL PHYSIOL, V114, P2341, DOI 10.1007/s00421-014-2955-1; Grabowski AM, 2009, J APPL PHYSIOL, V107, P670, DOI 10.1152/japplphysiol.91609.2008; Granata KP, 2008, J ELECTROMYOGR KINES, V18, P172, DOI 10.1016/j.jelekin.2007.06.008; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; HURMUZLU Y, 1994, J BIOMECH ENG-T ASME, V116, P30, DOI 10.1115/1.2895701; Kim MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143961; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; Kurz MJ, 2010, NONLIN DYNAM PSYCHOL, V14, P151; Kurz MJ, 2005, BIOL CYBERN, V93, P213, DOI 10.1007/s00422-005-0579-6; Lamoth CC, 2010, MED ENG PHYS, V32, P1009, DOI 10.1016/j.medengphy.2010.07.001; Lee SJ, 2008, J APPL PHYSIOL, V104, P747, DOI 10.1152/japplphysiol.01380.2006; Liew BXW, 2016, J BIOMECH, V49, P3275, DOI 10.1016/j.jbiomech.2016.08.012; Lockhart T, 2008, ERGONOMICS, V51, P1860, DOI 10.1080/00140130802567079; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Malcolm P, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0014-8; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; Mombaur KD, 2005, ROBOTICA, V23, P21, DOI 10.1017/S026357470400058X; Mooney LM, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0111-3; Mooney LM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-80; Myers SA, 2009, J VASC SURG, V49, P924, DOI 10.1016/j.jvs.2008.11.020; Newell KM, 2003, J EXP PSYCHOL HUMAN, V29, P379, DOI 10.1037/0096-1523.29.2.379; Norris JA, 2007, 6 INT C MULT SYST A, V5, P1619, DOI [10.1115/DETC2007-35657, DOI 10.1115/DETC2007-35657]; Norris JA, 2007, GAIT POSTURE, V25, P620, DOI 10.1016/j.gaitpost.2006.07.002; O'Connor CM, 2007, GAIT POSTURE, V25, P469, DOI 10.1016/j.gaitpost.2006.05.016; Ojeda LV, 2015, MED ENG PHYS, V37, P929, DOI 10.1016/j.medengphy.2015.06.010; Panizzolo FA, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0150-9; Parvataneni L, 2009, CLIN BIOMECH, V24, P95, DOI 10.1016/j.clinbiomech.2008.07.002; Pavol MJ, 2001, J GERONTOL A-BIOL, V56, pM428, DOI 10.1093/gerona/56.7.M428; Quinlivan BT, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aah4416; Russell S, 2005, J BIOMECH ENG-T ASME, V127, P114, DOI 10.1115/1.1835358; Sawicki GS, 2008, J EXP BIOL, V211, P1402, DOI 10.1242/jeb.009241; Sawicki GS, 2009, J EXP BIOL, V212, P21, DOI 10.1242/jeb.017269; Segal AD, 2010, J BIOMECH, V43, P2798, DOI 10.1016/j.jbiomech.2010.05.038; Sosnoff JJ, 2006, NEUROSCI LETT, V392, P165, DOI 10.1016/j.neulet.2005.09.010; Stergiou N, 2004, CLIN BIOMECH, V19, P957, DOI 10.1016/j.clinbiomech.2004.06.008; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Takahashi KZ, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0015-7; Terrier P, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-12; Toebes MJP, 2012, GAIT POSTURE, V36, P527, DOI 10.1016/j.gaitpost.2012.05.016; van Schooten KS, 2011, GAIT POSTURE, V33, P656, DOI 10.1016/j.gaitpost.2011.02.017; Veneman JF, 2007, IEEE T NEUR SYS REH, V15, P379, DOI 10.1109/TNSRE.2007.903919; Wisse M, 2005, IEEE T ROBOT, V21, P393, DOI 10.1109/TRO.2004.838030; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Wurdeman SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100125; Wurdeman SR, 2013, ANN BIOMED ENG, V41, P806, DOI 10.1007/s10439-012-0705-2; Yakhdani HRF, 2010, CLIN BIOMECH, V25, P230, DOI 10.1016/j.clinbiomech.2009.12.003; Yentes JM, 2017, ANN AM THORAC SOC, V14, P858, DOI 10.1513/AnnalsATS.201607-547OC; Zhang JJ, 2017, SCIENCE, V356, P1280, DOI 10.1126/science.aal5054	68	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205088	10.1371/journal.pone.0205088	http://dx.doi.org/10.1371/journal.pone.0205088			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3FL	30356309	Green Submitted, Green Published, gold			2022-12-26	WOS:000448434000028
J	Bernard, P; Dore, I; Romain, AJ; Hains-Monfette, G; Kingsbury, C; Sabiston, C				Bernard, Paquito; Dore, Isabelle; Romain, Ahmed-Jerome; Hains-Monfette, Gabriel; Kingsbury, Celia; Sabiston, Catherine			Dose response association of objective physical activity with mental health in a representative national sample of adults: A cross-sectional study	PLOS ONE			English	Article							UNITED-STATES; ACTICAL ACCELEROMETER; TIME; METAANALYSIS; PEOPLE; DEPRESSION; DISORDERS; DOMAIN	Although higher physical activity (PA) levels are associated with better mental health, previous findings about the shape of the dose-response relationship between PA and mental health are inconsistent. Furthermore, this association may differ according to sedentary levels. We investigated the cross-sectional dose-response associations between objectively measured PA and mental health in a representative national sample of adults. We also examined whether sedentary time modified the PA-mental health associations. Based on 2007-2013 Canadian Health Measures Survey data, PA and sedentary time were measured using accelerometry among 8150 participants, aged 20 to 79 years. Generalized additive models with a smooth function were fitted to examine associations between minutes per day of moderate and vigorous PA (MVPA), light PA (LPA), daily steps (combined or not with sedentary time) and self-rated mental health. A significant curvilinear relationship between average daily minutes of MVPA and mental health was observed, with increasing benefits up to 50 minutes/day. For LPA, a more complex shape (monotonic and curvilinear) was found. For daily steps, inverted U-shaped curve suggested increasing benefits until a plateau between 5 000 and 16 000 steps. The MVPA-LPA combination was significantly associated with mental health but with a complex pattern (p < 0.0005E-06). The tested PA-sedentary time combinations showed that increasing sedentary time decreased the positive PA-mental health associations. Non-linear dose-response patterns between the PA modalities and self-reported mental health were observed. Optimal doses of daily minutes of MVPA, LPA, MVPA combined with LPA and daily steps are independently associated with better mental health in adults. The results also suggest that PA-mental health associations could be hampered by daily sedentary time.	[Bernard, Paquito; Hains-Monfette, Gabriel; Kingsbury, Celia] Univ Quebec Montreal, Dept Phys Act Sci, Montreal, PQ, Canada; [Bernard, Paquito; Hains-Monfette, Gabriel; Kingsbury, Celia] Univ Inst Mental Hlth Montreal, Res Ctr, Montreal, PQ, Canada; [Dore, Isabelle; Romain, Ahmed-Jerome] Ctr Hosp Univ Montreal CRCHUM, Res Ctr, Montreal, PQ, Canada; [Dore, Isabelle; Sabiston, Catherine] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada	University of Quebec; University of Quebec Montreal; Universite de Montreal; Universite de Montreal; University of Toronto	Bernard, P (corresponding author), Univ Quebec Montreal, Dept Phys Act Sci, Montreal, PQ, Canada.; Bernard, P (corresponding author), Univ Inst Mental Hlth Montreal, Res Ctr, Montreal, PQ, Canada.	bernard.paquito@uqam.ca	Romain, Ahmed Jerome/AAP-5893-2020; Dore, Isabelle/W-2671-2019; Sabiston, Catherine/AAT-4924-2020; Bernard, Paquito/ABP-8515-2022	Romain, Ahmed Jerome/0000-0003-1690-1375; Sabiston, Catherine/0000-0002-8419-6666; Bernard, Paquito/0000-0003-2180-9135; Hains-Monfette, Gabriel/0000-0002-0805-3938	Universite du Quebec a Montreal, Institut Universitaire de Sante Mentale de Montreal; Fonds de recherche du Quebec - Sante; Fonds de recherche du Quebec-Sante (FRQS); Quebec Inter-university Center for Social Statictics; Canada Chairs Program	Universite du Quebec a Montreal, Institut Universitaire de Sante Mentale de Montreal; Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Fonds de recherche du Quebec-Sante (FRQS); Quebec Inter-university Center for Social Statictics; Canada Chairs Program(Canada Research Chairs)	PB is supported by Universite du Quebec a Montreal, Institut Universitaire de Sante Mentale de Montreal and by a salary award from the Fonds de recherche du Quebec - Sante. ID and AJ are supported by Postdoctoral fellowship from the Fonds de recherche du Quebec-Sante (FRQS). GHM is supported by the Quebec Inter-university Center for Social Statictics. CMS is supported by the Canada Chairs Program. The authors thank The Quebec Population Health Research Network (QPHRN) for its contribution to the financing of this open-access publication.	4World Health Organization and Calouste Gulbenkian Foundation, 2014, SOC DET MENT HLTH; Abu-Omar K, 2004, SOZ PRAVENTIV MED, V49, P301, DOI 10.1007/s00038-004-3109-8; Ahmad F, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-398; Amagasa S, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0519-6; Asztalos M, 2015, J PHYS ACT HEALTH, V12, P1112, DOI 10.1123/jpah.2013-0513; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Bergeron E, 2005, CAN J PSYCHIAT, V50, P629, DOI 10.1177/070674370505001009; Bernard P, 2015, AGING MENT HEALTH, V19, P485, DOI 10.1080/13607863.2014.948806; Bernard P, 2013, NICOTINE TOB RES, V15, P1635, DOI 10.1093/ntr/ntt042; Cerin E., 2009, MENTAL HLTH PHYS ACT, V2, P55, DOI [10.1016/j.mhpa.2009.09.004, DOI 10.1016/J.MHPA.2009.09.004]; Chevance G, 2016, PRESSE MED, V45, P313, DOI 10.1016/j.lpm.2016.01.004; Colley RC, 2011, J SPORT SCI, V29, P783, DOI 10.1080/02640414.2011.557744; Colley Rachel C, 2011, Health Rep, V22, P7; Day Brent, 2007, Health Rep, V18 Suppl, P37; Eijsvogels TMH, 2015, JAMA-J AM MED ASSOC, V314, P1915, DOI 10.1001/jama.2015.10858; Esliger DW, 2007, MED SCI SPORT EXER, V39, P1200, DOI 10.1249/mss.0b013e3804ec4e9; Ewald B, 2014, J PHYS ACT HEALTH, V11, P509, DOI 10.1123/jpah.2012-0091; Faulkner GE., 2005, EXERCISE HLTH MENTAL; Galper DI, 2006, MED SCI SPORT EXER, V38, P173, DOI 10.1249/01.mss.0000180883.32116.28; Gibson AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185143; Gimour H, 2007, PHYSICALLY ACTIVE CA; Hamer M, 2009, BRIT J SPORT MED, V43, P1111, DOI 10.1136/bjsm.2008.046243; Hamer M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004580; Hamer M, 2010, AM J PREV MED, V38, P375, DOI 10.1016/j.amepre.2009.12.030; Holtermann A, 2012, BRIT J SPORT MED, V46, P291, DOI 10.1136/bjsm.2010.079582; Hupin D, 2015, JAMA INTERN MED, V175, P1862, DOI 10.1001/jamainternmed.2015.4744; James P, 2016, AM J HEALTH BEHAV, V40, P123, DOI 10.5993/AJHB.40.1.14; Katapally TR, 2014, J SPORT SCI MED, V13, P379; Kim YS, 2012, PREV MED, V55, P458, DOI 10.1016/j.ypmed.2012.08.021; Kirk MA, 2011, AM J PREV MED, V40, P476, DOI 10.1016/j.amepre.2010.12.015; Knowles G, 2017, SOC PSYCH PSYCH EPID, V52, P803, DOI 10.1007/s00127-017-1399-4; Ku PW, 2016, SOC INDIC RES, V127, P1349, DOI 10.1007/s11205-015-1005-7; Kwak L, 2016, J SCI MED SPORT, V19, P482, DOI 10.1016/j.jsams.2015.05.008; Levinson D, 2014, J PUBLIC HEALTH RES, V3, P122, DOI 10.4081/jphr.2014.287; Lumley T., 2010, COMPLEX SURVEYS GUID, DOI [10.1002/9780470580066, DOI 10.1002/9780470580066]; Mammen G, 2013, AM J PREV MED, V45, P649, DOI 10.1016/j.amepre.2013.08.001; Marques A, 2016, PREV MED, V91, P18, DOI 10.1016/j.ypmed.2016.07.021; Mason P, 2016, MENT HEALTH PHYS ACT, V11, P19, DOI 10.1016/j.mhpa.2016.07.001; Mummery K, 2004, AUST NZ J PUBL HEAL, V28, P188, DOI 10.1111/j.1467-842X.2004.tb00934.x; Nam JY, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1439-3; O'Donoghue G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2841-3; Pedersen BK, 2015, SCAND J MED SCI SPOR, V25, P1, DOI 10.1111/sms.12581; Pereira SMP, 2014, JAMA PSYCHIAT, V71, P1373, DOI 10.1001/jamapsychiatry.2014.1240; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Puig-Ribera A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1447-5; Ranasinghe CD, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-116; Rhodes J.S., 2013, ROUTLEDGE HDB PHYS A, P88; Rosenbaum S, 2014, J CLIN PSYCHIAT, V75, P964, DOI 10.4088/JCP.13r08765; Smith A, 2016, INT J SPORT POLICY P, V8, P593, DOI 10.1080/19406940.2016.1230554; Steeves JA, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0235-z; STEPHENS T, 1988, PREV MED, V17, P35, DOI 10.1016/0091-7435(88)90070-9; Stubbs B, 2016, SCHIZOPHR RES, V176, P431, DOI 10.1016/j.schres.2016.05.017; Tremblay MS, 2007, CAN J PUBLIC HEALTH, V98, P453, DOI 10.1007/BF03405437; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; United Nations, 2015, 2030 AG SUST DEV; Vallance JK, 2011, PREV MED, V53, P284, DOI 10.1016/j.ypmed.2011.07.013; Warburton DER, 2016, CAN J CARDIOL, V32, P495, DOI 10.1016/j.cjca.2016.01.024; White RL, 2017, AM J PREV MED, V52, P653, DOI 10.1016/j.amepre.2016.12.008; Whitelaw S, 2012, CRIT PUBLIC HEALTH, V22, P427, DOI 10.1080/09581596.2012.682147; WHO, 2008, MHGAP MENTAL HLTH GA; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; World Health Organization, 2013, MENT HLTH ACT PLAN 2; World Health Organization, 2001, WORLD HLTH REP; World Health Organization, 2013, INV MENT HLTH EV ACT	65	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e.0204682	10.1371/journal.pone.0204682	http://dx.doi.org/10.1371/journal.pone.0204682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3FL	30356252	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000448434000015
J	Kohles, JE; Page, RA; Dechmann, DKN; O'Mara, T				Kohles, Jenna E.; Page, Rachel A.; Dechmann, Dina K. N.; O'Mara, Teague			Rapid behavioral changes during early development in Peters' tent-making bat (Uroderma bilobatum)	PLOS ONE			English	Article							FRUIT-BAT; CHIROPTERA; GROWTH; PHYLLOSTOMIDAE; PTEROPODIDAE; PIPISTRELLUS; INFORMATION; MORPHOLOGY; PATTERNS; FLIGHT	Bats transition from flightless, milk-sustained infants to volant, foraging juveniles in the span of a few weeks to a few months. This rapid development is accompanied by fast growth and weight gain, but behavioral development remains poorly understood. We addressed development of maternal support and pup independence for Peters' tent-making bat (Uroderma bilobatum) in light of population level reproductive patterns. Uroderma bilobatum exhibited seasonal bimodal polyoestry at our study site. Births occurred over one month within a reproductive bout, resulting in variable levels of behavioral development for pups in the same maternity group. Pups reached adult forearm length more quickly than adult mass, facilitating the ontogeny of flight. Maternal support consisted of nursing and thermoregulation, transporting pups between night and day roosts, and milk provisioning between foraging bouts. We did not observe provisioning with solid food. Pups interacted only with their own mother. Between 25 to 40 days into a reproductive bout they matured by suckling progressively less and fledging over multiple nights in a two-stage process assisted by mothers. We describe several parturition events as well as a novel form of stereotyped tactile stimulation involving forearm pulses by mothers against suckling pups that may serve to promote weaning. Rapid behavioral changes in both pups and mothers accompany pup morphological development through maturation.	[Kohles, Jenna E.; Page, Rachel A.; Dechmann, Dina K. N.; O'Mara, Teague] Smithsonian Trop Res Inst, Panama City, Panama; [Kohles, Jenna E.; Dechmann, Dina K. N.; O'Mara, Teague] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Kohles, Jenna E.; Dechmann, Dina K. N.; O'Mara, Teague] Univ Konstanz, Dept Biol, Constance, Germany; [O'Mara, Teague] Univ Konstanz, Zukunftskolleg, Constance, Germany	Smithsonian Institution; Smithsonian Tropical Research Institute; Max Planck Society; University of Konstanz; University of Konstanz	Kohles, JE (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.; Kohles, JE (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.; Kohles, JE (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	jkohles@orn.mpg.de	Page, Rachel/AAE-4816-2021; Kohles, Jenna/ADY-0497-2022; Page, Rachel A/GQQ-2818-2022; O'Mara, M. Teague/J-6090-2012	Kohles, Jenna/0000-0002-9087-4849; Page, Rachel A/0000-0001-7072-0669; Dechmann, Dina/0000-0003-0043-8267; O'Mara, M. Teague/0000-0002-6951-1648	Smithsonian Tropical Research Institute; Clemson University Calhoun Honors College; Fulbright Scholar Program; German Academic Exchange Service; University of Konstanz Zukunftskolleg; Max Planck Society	Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Clemson University Calhoun Honors College; Fulbright Scholar Program; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); University of Konstanz Zukunftskolleg; Max Planck Society(Max Planck Society)	This study was funded by the Smithsonian Tropical Research Institute (JEK, RAP, MTO) https://stri.si.edu/; Clemson University Calhoun Honors College (JEK) https://www.clemson.edu/cuhonors/; the Fulbright Scholar Program (JEK) https://www.cies.org/; the German Academic Exchange Service (JEK) https://www.daad.org/en/; the University of Konstanz Zukunftskolleg (MTO) https://www.uni-konstanz.de/zukunftskolleg/; and the Max Planck Society (JEK, DKND, MTO) https://www.mpg.de/en.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Baker R. J., 1987, MAMMALIAN SPECIES, V279, P1, DOI DOI 10.2307/3503922; Barclay RMR, 2003, BAT ECOLOGY, P209; Barclay RMR, 1995, SYM ZOOL S, P245; Blake H, 1885, SCI P ROYAL DUBLIN S, V4, P449; Bowlby J., 1969, ATTACHMENT, V1st; BRADBURY J W, 1974, Zeitschrift fuer Tierpsychologie, V36, P137; BROWN PE, 1983, BEHAV ECOL SOCIOBIOL, V13, P287, DOI 10.1007/BF00299676; Chaverri G, 2006, J ZOOL, V270, P650, DOI 10.1111/j.1469-7998.2006.00171.x; Duverge PL, 2000, ECOGRAPHY, V23, P32, DOI 10.1034/j.1600-0587.2000.230104.x; Fenton M.B., 1985, COMMUNICATION CHIROP; FLEMING TH, 1972, ECOLOGY, V53, P555, DOI 10.2307/1934771; Gaisler J., 1989, P117; Handley C.O., 1991, SMITHSON CONTRIB ZOO, V511, P1, DOI DOI 10.5479/SI.00810282.511; Hayssen V, 1996, J MAMMAL, V77, P476, DOI 10.2307/1382823; Hofer M.A., 1978, Perspectives in Ethology, V3, P135; Hofer MA, 1996, PSYCHOSOM MED, V58, P570, DOI 10.1097/00006842-199611000-00005; HUGHES P, 1993, J ZOOL, V230, P541, DOI 10.1111/j.1469-7998.1993.tb02705.x; HUGHES PM, 1995, J ZOOL, V236, P291, DOI 10.1111/j.1469-7998.1995.tb04494.x; JANZEN DH, 1967, EVOLUTION, V21, P620, DOI 10.1111/j.1558-5646.1967.tb03416.x; Jones KE, 2001, EVOL ECOL RES, V3, P465; JONES TS, 1945, NATURE, V156, P365, DOI 10.1038/156365b0; Kleiman D.G., 1979, Texas Tech University Museum Special Publications, P387; KLEIMAN DG, 1969, J ZOOL, V157, P187, DOI 10.1111/j.1469-7998.1969.tb01697.x; KORINE C, 1994, J ZOOL, V232, P163, DOI 10.1111/j.1469-7998.1994.tb01566.x; Kunz T.H., 1987, P395; Kunz TH, 1995, SYM ZOOL S, P123; KUNZ TH, 1974, ECOLOGY, V55, P693, DOI 10.2307/1934408; KUNZ TH, 1994, J ZOOL, V232, P691, DOI 10.1111/j.1469-7998.1994.tb04622.x; Kunz Thomas H., 2000, P415, DOI 10.1016/B978-012195670-7/50011-4; Kurta A., 1987, Symposia of the Zoological Society of London, P79; LEIGH SR, 1994, AM J PHYS ANTHROPOL, V94, P499, DOI 10.1002/ajpa.1330940406; LEWIS SE, 1992, J MAMMAL, V73, P541, DOI 10.2307/1382020; McLean JA, 1997, ANIM BEHAV, V54, P1193, DOI 10.1006/anbe.1997.0498; NELSON JE, 1965, ANIM BEHAV, V13, P544, DOI 10.1016/0003-3472(65)90118-1; Norberg UM., 1987, RECENT ADV STUDY BAT, P14; O'Mara MT, 2015, FOLIA PRIMATOL, V86, P96, DOI 10.1159/000368275; O'Mara MT, 2012, AM J PHYS ANTHROPOL, V147, P11, DOI 10.1002/ajpa.21600; O'Mara MT, 2017, CLIN RESPIR  J, P1; OFARRELL MJ, 1973, ECOLOGY, V54, P18, DOI 10.2307/1934371; ORR ROBERT T., 1954, PROC CALIFORNIA ACAD SCI, V28, P165; POWERS LV, 1991, J COMP PHYSIOL A, V168, P675; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Ramakers JJC, 2016, ANIM BEHAV, V116, P83, DOI 10.1016/j.anbehav.2016.03.021; SEAY B, 1962, J CHILD PSYCHOL PSYC, V3, P123, DOI 10.1111/j.1469-7610.1962.tb02047.x; Shen HP, 2000, J MAMMAL, V81, P726, DOI 10.1644/1545-1542(2000)081<0726:MYIIAM>2.3.CO;2; Stern AA, 1998, J MAMMAL, V79, P755, DOI 10.2307/1383086; O'Mara MT, 2014, BEHAV ECOL, V25, P1233, DOI 10.1093/beheco/aru120; Thies W, 2006, J MAMMAL, V87, P331, DOI 10.1644/05-MAMM-A-161R1.1; TIMM RM, 1991, B AM MUS NAT HIST, P251; TRIVERS RL, 1974, AM ZOOL, V14, P249; Tuttle M.D., 1982, P105; Wimsatt W. A., 1960, Journal of Mammalogy, V41, P183, DOI 10.2307/1376353; WINCHELL JM, 1993, CAN J ZOOL, V71, P2244, DOI 10.1139/z93-315	54	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205351	10.1371/journal.pone.0205351	http://dx.doi.org/10.1371/journal.pone.0205351			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3FL	30356286	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000054
J	Lakhani, HV; Khanal, T; Gabi, A; Yousef, G; Alam, MB; Sharma, D; Aljoudi, H; Puri, N; Thompson, E; Shapiro, JI; Sodhi, K				Lakhani, Hari Vishal; Khanal, Tilak; Gabi, Alaa; Yousef, George; Alam, Mian Bilal; Sharma, Dana; Aljoudi, Haytham; Puri, Nitin; Thompson, Ellen; Shapiro, Joseph, I; Sodhi, Komal			Developing a panel of biomarkers and miRNA in patients with myocardial infarction for early intervention strategies of heart failure in West Virginian population	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; CARDIAC FIBROBLASTS; METABOLIC SYNDROME; IL-10 LEVELS; TNF-ALPHA; EXPRESSION; MICRORNAS; METALLOPROTEINASE; INTERLEUKIN-10; TRANSCRIPTION	Background Myocardial infarction is the most common cause of heart failure. MI has been intricately linked to ventricular remodeling, subsequently leading to the reduction in the cardiac ejection fraction causing HF. The cumulative line of evidence suggests an important role of several biomarkers in modulating the cardiac vasculature, further contributing towards the progression of post-MI complications. Studies have demonstrated, yet not fully established, that an important biomarker, IL-10, has a causal relationship with MI and associated cardiac dysfunction. Hypothesis This study aims to establish the role of IL-10 as a prognostic marker for the cardiovascular outcomes and to develop a panel of biomarkers and circulating miRNAs that could potentially result in the early detection of HF resulting from MI, allowing for early intervention strategies. Methods and results Blood was withdrawn and echocardiography assessment was performed on a total of 43 patients that were enrolled, within 24 hours of the incidence of MI. Patients were divided in three main groups, based on the ejection fraction measurement from echocardiography: control (n = 14), MI with normal EF (MI+NEF, n =13) and MI with low EF (MI+LEF, n = 16). Our results showed that TGF beta-1, TNF-alpha, IL-6 and MMP-9 were upregulated significantly in MI+NEF group and more so in MI+LEF group, as compared to control group (p<0.01). The circulating levels of miR-34a, miR-208b and miR-126 were positively correlated and showed elevated levels in the MI+NEF group, even higher in MI+LEF group, while levels of miR-24 and miR-29a were reduced in MI+NEF, and much lower in MI+LEF, as compared to the control group (p<0.01). Our results also demonstrated a direct correlation of IL-10 with the ejection fraction in patients with MI: IL-10 was elevated in MI+NEF group, however, the levels were significantly low in MI+LEF group suggesting an important role of IL-10 in predicting heart failure. Importantly, our study confirmed the correlation of IL-10 with EF by our followup echocardiography assessment that was performed 2 months after the incidence of MI. Conclusion Our results support the clinical application of these serum biomarkers to develop a panel for appropriate prognosis and management of adverse cardiac remodeling and development of heart failure post-myocardial infarction.	[Lakhani, Hari Vishal; Khanal, Tilak; Sharma, Dana; Shapiro, Joseph, I] Marshall Univ, Dept Internal Med, Joan C Edwards Sch Med, Huntington, WV USA; [Gabi, Alaa; Yousef, George; Alam, Mian Bilal; Aljoudi, Haytham; Thompson, Ellen] Marshall Univ, Dept Internal Med, Joan C Edwards Sch Med, Div Cardiol, Huntington, WV USA; [Puri, Nitin; Sodhi, Komal] Marshall Univ, Joan C Edwards Sch Med, Dept Biomed Sci, Huntington, WV 25755 USA; [Sodhi, Komal] Marshall Univ, Joan C Edwards Sch Med, Dept Surg, Huntington, WV 25755 USA	Marshall University; Marshall University; Marshall University; Marshall University	Sodhi, K (corresponding author), Marshall Univ, Joan C Edwards Sch Med, Dept Biomed Sci, Huntington, WV 25755 USA.; Sodhi, K (corresponding author), Marshall Univ, Joan C Edwards Sch Med, Dept Surg, Huntington, WV 25755 USA.	Sodhi@marshall.edu		Thompson, Ellen/0000-0002-4029-5398	National Institutes of Health [HL109015, HL105649, HL071556]; Brickstreet Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL071556, R01HL109015, R01HL105649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brickstreet Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants to JIS (HL109015, HL105649 and HL071556), and by the Brickstreet Foundation (J.I.S.). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Chan D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-34; CHUA CC, 1991, CONNECT TISSUE RES, V26, P271, DOI 10.3109/03008209109152444; Dolci A, 2008, AM J CLIN PATHOL, V130, P688, DOI 10.1309/AJCPB66LRIIVMQDR; EGHBALI M, 1991, CIRC RES, V69, P483, DOI 10.1161/01.RES.69.2.483; ESKDALE J, 1995, IMMUNOGENETICS, V42, P444; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Feng JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006121; Fiedler J, 2013, ARTERIOSCL THROM VAS, V33, P201, DOI 10.1161/ATVBAHA.112.300137; Fiedler J, 2011, CIRCULATION, V124, P720, DOI 10.1161/CIRCULATIONAHA.111.039008; Flachskampf FA, 2011, EUR HEART J, V32, P272, DOI 10.1093/eurheartj/ehq446; Frangogiannis NG, 2006, CURR MED CHEM, V13, P1877, DOI 10.2174/092986706777585086; Gerber Y, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002460; Goguet-Rubio P, 2017, INT J MED SCI, V14, P543, DOI 10.7150/ijms.18988; Hasdai D, 2003, AM HEART J, V145, P73, DOI 10.1067/mhj.2003.53; Kaur K, 2006, AM J PHYSIOL-HEART C, V291, pH106, DOI 10.1152/ajpheart.01327.2005; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Kwok CS, 2017, EUR HEART J-ACUTE CA, V6, P191, DOI 10.1177/2048872615623038; LACRAZ S, 1995, J CLIN INVEST, V96, P2304, DOI 10.1172/JCI118286; Lv P, 2014, INT J MOL SCI, V15, P5774, DOI 10.3390/ijms15045774; Matsumoto-Ida M, 2006, AM J PHYSIOL-HEART C, V290, pH709, DOI 10.1152/ajpheart.00186.2005; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1007/BF03206601; McMurray JJV, 2010, NEW ENGL J MED, V362, P228, DOI 10.1056/NEJMcp0909392; McMurray JJV, 2009, CIRCULATION, V120, P2188, DOI 10.1161/CIRCULATIONAHA.109.849117; Minicucci MF, 2011, CLIN CARDIOL, V34, P410, DOI 10.1002/clc.20922; Misra R, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2456518; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Ritschel Vibeke N, 2014, Results Immunol, V4, P8, DOI 10.1016/j.rinim.2013.11.002; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268; Sabel MS, 2001, AM J CLIN ONCOL-CANC, V24, P425, DOI 10.1097/00000421-200108000-00027; Sassi Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01737-4; Song S, 1997, BLOOD, V89, P4461, DOI 10.1182/blood.V89.12.4461; Srikanthan Krithika, 2017, J Clin Exp Cardiolog, V8, DOI 10.4172/2155-9880.1000507; Srikanthan K, 2016, INT J MED SCI, V13, P25, DOI 10.7150/ijms.13800; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Tao H, 2016, INT J BIOL MACROMOL, V88, P414, DOI 10.1016/j.ijbiomac.2016.04.010; Tao ZY, 2004, LIFE SCI, V74, P1561, DOI 10.1016/j.lfs.2003.09.042; Tian Ming, 2015, Chronic Dis Transl Med, V1, P18, DOI 10.1016/j.cdtm.2015.02.002; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Torabi A, 2008, EUR HEART J, V29, P859, DOI 10.1093/eurheartj/ehn096; Tsuji M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177988; Vegter EL, 2016, EUR J HEART FAIL, V18, P457, DOI 10.1002/ejhf.495; Velagaleti RS, 2008, CIRCULATION, V118, P2057, DOI 10.1161/CIRCULATIONAHA.108.784215; Velazquez EJ, 2004, EUR HEART J, V25, P1911, DOI 10.1016/j.ehj.2004.08.006; Wagner DR, 2006, J CARD FAIL, V12, P66, DOI 10.1016/j.cardfail.2005.08.002; Wang J, 2012, J CELL MOL MED, V16, P2150, DOI 10.1111/j.1582-4934.2012.01523.x; Wang YT, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-72; Wei XJ, 2015, BRAZ J MED BIOL RES, V48, P983, DOI 10.1590/1414-431X20154590; Weir RAP, 2006, AM J CARDIOL, V97, p13F, DOI 10.1016/j.amjcard.2006.03.005; Yilmaz MI, 2014, CLIN J AM SOC NEPHRO, V9, P1207, DOI 10.2215/CJN.08660813; Zhang YQ, 2012, J BIOL CHEM, V287, P14851, DOI 10.1074/jbc.M111.314922; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V92, P157, DOI 10.1590/S0066-782X2009000200013	54	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205329	10.1371/journal.pone.0205329	http://dx.doi.org/10.1371/journal.pone.0205329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356307	gold, Green Published, Green Submitted			2022-12-26	WOS:000448434000053
J	Skalski, JR; Richins, SM; Townsend, RL				Skalski, John R.; Richins, Shelby M.; Townsend, Richard L.			A statistical test and sample size recommendations for comparing community composition following PCA	PLOS ONE			English	Article							MULTIVARIATE-ANALYSIS; VARIANCE; ECOLOGY; MODELS	Many investigations of anthropogenic and natural impacts in ecological systems attempt to detect differences in ecological variables or community composition. Frequently, ordination procedures such as principal components analysis (PCA) or canonical correspondence analysis (CCA) are used to simplify such complex data sets into a set of primary factors that express the variation across the original variables. Scatterplots of the first and second principal components are then used to visually inspect for differences in community composition between treatment groups. We present a multidimensional extension of analysis of variance based on an analysis of distance (ANODIS) that can be used to formally test for differences in community composition using 1, 2, or more dimensions of a PCA or CCA of the original sample observations. The statistical tests of significance are based on F-statistics adapted for the analysis of this multidimensional data. Because the analysis is parametric, power and sample size calculations useful in the design of field studies can be readily computed. The use of ANODIS is illustrated using bivariate PCA scatterplots from three published studies. Statistical power calculations using the noncentral F-distribution are illustrated.	[Skalski, John R.; Richins, Shelby M.; Townsend, Richard L.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Skalski, JR (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	skalski@uw.edu			Bonneville Power Administration, US Department of Energy [1991-051-00, 76910]	Bonneville Power Administration, US Department of Energy	This research was supported by the Bonneville Power Administration, US Department of Energy, Project 1991-051-00, Contract No. 76910 to University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2000, ECOL APPL, V10, P1341, DOI 10.1890/1051-0761(2000)010[1341:REDASM]2.0.CO;2; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Annala M, 2014, ECOL APPL, V24, P1887, DOI 10.1890/13-2267.1; BOX GEP, 1955, J ROY STAT SOC B, V17, P1; BROWN MB, 1974, TECHNOMETRICS, V16, P129, DOI 10.2307/1267501; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clavero M, 2011, BIODIVERS CONSERV, V20, P41, DOI 10.1007/s10531-010-9945-3; CLINCH JJ, 1982, J EDUC STATIST, V7, P207, DOI DOI 10.3102/10769986007003207; Cushman S, 2000, MULTIVARIATE STAT WI; Day RH, 1995, USE OIL AFFECTED HAB, P726; Gilfillan ES, 1995, AM SOC TEST MATER, V1219, P398, DOI 10.1520/STP19871S; Glass G.V., 1972, REV ED RES, V42, P288; HARWELL MR, 1992, J EDUC STAT, V17, P315, DOI 10.2307/1165127; Highsmith S, 1996, IMPACT EXXON VALDEZ, P212; Hogg R.V., 1995, INTRO MATH STAT; JAMES FC, 1990, ANNU REV ECOL SYST, V21, P129, DOI 10.1146/annurev.es.21.110190.001021; Jongman RHG, 1995, DATA ANAL COMMUNITY; Kendall M, 1977, ADV THEORY STAT; Kirk ER, 1982, EXPT DESIGN PROCEDUR; KRZANOWSKI WJ, 1982, J STAT COMPUT SIM, V15, P141, DOI 10.1080/00949658208810577; Louys J, 2011, GLOBAL ECOL BIOGEOGR, V20, P717, DOI 10.1111/j.1466-8238.2010.00643.x; Magoba RN, 2010, J INSECT CONSERV, V14, P627, DOI 10.1007/s10841-010-9291-5; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Morrison D. F., 1990, MULTIVARIATE STAT ME; Myers JL, 2003, RES DESIGN STAT ANAL; Peres-Neto PR, 2003, ECOLOGY, V84, P2347, DOI 10.1890/00-0634; Saccenti E, 2016, J PROTEOME RES, V15, P2379, DOI 10.1021/acs.jproteome.5b01029; Salminen R., 1998, FOREGS GEOCHEMICAL M; SEBER GAF, 1984, MULTIVARIATE OBSERVA; Sheskin D. J., 2000, HDB PARAMETRIC NONPA; Stekoll R, 1996, COASTAL HABITAT INJU, P177; Thompson B., 1984, CANONICAL CORRELATIO; Timm NH, 2002, APPL MULTIVARIATE AN, DOI 10.1007/b98963; Towns DR, 2009, OIKOS, V118, P420, DOI 10.1111/j.1600-0706.2008.17186.x; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zhang XK, 2015, SOIL BIOL BIOCHEM, V80, P118, DOI 10.1016/j.soilbio.2014.10.003	40	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206033	10.1371/journal.pone.0206033	http://dx.doi.org/10.1371/journal.pone.0206033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356253	Green Submitted, gold, Green Published			2022-12-26	WOS:000448434000069
J	Stelcer, E; Kulcenty, K; Suchorska, WM				Stelcer, Ewelina; Kulcenty, Katarzyna; Suchorska, Wiktoria Maria			Chondrocytes differentiated from human induced pluripotent stem cells: Response to ionizing radiation	PLOS ONE			English	Article							DNA-REPAIR; HOMOLOGOUS RECOMBINATION; GENOMIC INSTABILITY; STABILITY; THERAPY; DAMAGE	Purpose Data on the response of chondrocytes differentiated from hiPSCs (hiPSC-DCHs) to ionizing radiation (IR) are lacking. The aim of present study was to assess DNA damage response (DDR) mechanisms of IR-treated hiPSC-DCHs. Methods and materials The following IR-response characteristics in irradiated hiPSC-DCHs were assessed: 1) the kinetics of DNA DSB formation; 2) activation of major DNA repair mechanisms; 3) cell cycle changes and 4) reactive oxygen species (ROS), level of key markers of apoptosis and senescence. Results DNA DSBs were observed in 30% of the hiPSC-DCHs overall, and in 60% after high-dose (> 2 Gy) IR. Nevertheless, these cells displayed efficient DNA repair mechanisms, which reduced the DSBs over time until it reached 30% by activating key genes involved in homologous recombination and non-homologous end joining mechanisms. As similar to mature chondrocytes, irradiated hiPSC-DCH cells revealed accumulation of cells in G2 phase. Overall, the hiPSC-DCH cells were characterized by low levels of ROS, cPARP and high levels of senescence. Conclusions The chondrocyte-like cells derived from hiPSC demonstrated features characteristic of both mature chondrocytes and "parental" hiPSCs. The main difference between hiPSC-derived chondrocytes and hiPSCs and mature chondrocytes appears to be the more efficient DDR mechanism of hiPSC-DCHs. The unique properties of these cells suggest that they could potentially be used safely in regenerative medicine if these preliminary findings are confirmed in future studies.	[Stelcer, Ewelina; Kulcenty, Katarzyna; Suchorska, Wiktoria Maria] Greater Poland Canc Ctr, Radiobiol Lab, Poznan, Poland; [Stelcer, Ewelina] Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland; [Stelcer, Ewelina; Kulcenty, Katarzyna; Suchorska, Wiktoria Maria] Poznan Univ Med Sci, Dept Electroradiol, Poznan, Poland	Wielkopolskie Centrum Onkologii; Medical University of Warsaw; Poznan University of Medical Sciences	Stelcer, E; Suchorska, WM (corresponding author), Greater Poland Canc Ctr, Radiobiol Lab, Poznan, Poland.; Stelcer, E (corresponding author), Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland.; Stelcer, E; Suchorska, WM (corresponding author), Poznan Univ Med Sci, Dept Electroradiol, Poznan, Poland.	ewelina.stelcer@wco.pl; wiktoria.suchorska@wco.pl	Suchorska, Wiktoria/CAG-0479-2022	Suchorska, Wiktoria/0000-0003-4742-2465	National Science Centre [2012/07/E/NZ3/01819, UMO-2016/23/N/NZ7/01892]; Greater Poland Cancer Centre [13/2017(156)]	National Science Centre(National Science Centre, Poland); Greater Poland Cancer Centre	The present study was supported by the National Science Centre (grant no. 2012/07/E/NZ3/01819 (WMS) and UMO-2016/23/N/NZ7/01892 (ES)) and by the Greater Poland Cancer Centre (grant no. 13/2017(156) (EW)).	Barczak W, 2016, BIOTECHNOL LETT, V38, P1665, DOI 10.1007/s10529-016-2163-7; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Blasco MA, 2011, EMBO J, V30, P991, DOI 10.1038/emboj.2011.50; Garitaonandia I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118307; Gonc U, 2016, ACTA ORTHOP TRAUMATO, V50, P572, DOI 10.1016/j.aott.2016.08.004; Hamdi DH, 2016, INT J RADIAT ONCOL, V95, P139, DOI 10.1016/j.ijrobp.2016.02.014; Hiura H, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-32; Hong EH, 2014, IUBMB LIFE, V66, P128, DOI 10.1002/iub.1248; Hong EH, 2010, J BIOL CHEM, V285, P1283, DOI 10.1074/jbc.M109.058628; HUG EB, 1995, INT J RADIAT ONCOL, V31, P467, DOI 10.1016/0360-3016(94)00390-7; Kang XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131128; Lach MS, 2017, STEM CELL RES, V20, P34, DOI 10.1016/j.scr.2017.02.004; Latella L, 2004, MOL CELL BIOL, V24, P6350, DOI 10.1128/MCB.24.14.6350-6361.2004; Liu K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173047; Luo L, 2014, SCI REP-UK, V4, DOI 10.1038/srep03779; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Margulies BS, 2006, CALCIFIED TISSUE INT, V78, P302, DOI 10.1007/s00223-005-0135-3; Martins-Taylor K, 2012, STEM CELLS, V30, P22, DOI 10.1002/stem.705; MATSUMOTO T, 1994, BONE, V15, P97, DOI 10.1016/8756-3282(94)90898-2; Mujoo K, 2017, STEM CELL REP, V9, P1660, DOI 10.1016/j.stemcr.2017.10.002; Rocha CRR, 2013, MUTAT RES-REV MUTAT, V752, P25, DOI 10.1016/j.mrrev.2012.09.001; Schneider L, 2012, CELL DEATH DIFFER, V19, P582, DOI 10.1038/cdd.2011.129; Suchorska WM, 2017, STEM CELL REV REP, V13, P299, DOI 10.1007/s12015-016-9708-y; Suchorska WM, 2016, EXP THER MED, V11, P695, DOI 10.3892/etm.2016.2993; Vandana S, 2011, APPL RADIAT ISOTOPES, V69, P130, DOI 10.1016/j.apradiso.2010.08.018; Venkatesh P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010058; Vitale I, 2017, MOL CELL, V66, P306, DOI 10.1016/j.molcel.2017.04.006; Yoshihara M, 2017, STEM CELL REV REP, V13, P7, DOI 10.1007/s12015-016-9680-6; Zhou LB, 2015, INT J CLIN EXP PATHO, V8, P73	30	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0205691	10.1371/journal.pone.0205691	http://dx.doi.org/10.1371/journal.pone.0205691			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352062	Green Published, Green Submitted, gold			2022-12-26	WOS:000448076200014
J	Wang, C; Gu, YY; Zhang, EB; Zhang, K; Qin, N; Dai, JC; Zhu, M; Liu, J; Xie, KP; Jiang, Y; Guo, XJ; Liu, MX; Jin, GF; Ma, HX; Jiang, T; Yin, R; Xia, YK; Liu, L; Wang, SY; Shen, B; Huo, R; Xu, L; Sha, JH; Qu, B; Shen, HB; Hu, ZB				Wang, Cheng; Gu, Yayun; Zhang, Erbao; Zhang, Kai; Qin, Na; Dai, Juncheng; Zhu, Meng; Liu, Jia; Xie, Kaipeng; Jiang, Yue; Guo, Xuejiang; Liu, Mingxi; Jin, Guangfu; Ma, Hongxia; Jiang, Tao; Yin, Rong; Xia, Yankai; Liu, Li; Wang, Shouyu; Shen, Bin; Huo, Ran; Xu, Lin; Sha, Jiahao; Qu, Bin; Shen, Hongbing; Hu, Zhibin			A cancer-testis non-coding RNA LIN28B-AS1 activates driver gene LIN28B by interacting with IGF2BP1 in lung adenocarcinoma	ONCOGENE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; COPY NUMBER ANALYSIS; INHIBITOR; REGULATOR; HALLMARKS; PACKAGE; PROTEIN; GROWTH	Our previous work found cancer-testis (CT) genes as a new source of epi-driver candidates of cancer. LIN28B was a CT gene, but the "driver" ability and the activation mechanism in lung adenocarcinoma (LUAD) remain unclear. We observed that LIN28B expression was restricted in testis. It was re-activated in LUAD patients without known genomic alterations in oncogenes and was related to poorer survival. In vitro and In vivo experiments confirmed that the activation of LIN28B could promote the proliferation and metastasis of LUAD cells and can influence cell cycle, DNA damage repair, and genome instability. In addition to the known let-7-LIN28B regulation loop, our results further revealed a let-7-independent Cis-regulator of LIN28B: LIN28B-ASI. LIN28B-ASI is a CT long non-coding RNA (CT-lncRNA). It altered the messenger RNA stability of LIN28B by directly interacting with another CT protein IGF2BP1 but not with LIN28B and constituted a novel regulation network. In sum, we identify that LIN28B is an "epi-driver" of LUAD and clarify a new lncRNA-activated mechanism of LIN28B, which provide new candidate targets for precise anticancer therapy in the future.	[Wang, Cheng; Gu, Yayun; Zhang, Erbao; Zhang, Kai; Qin, Na; Dai, Juncheng; Zhu, Meng; Liu, Jia; Xie, Kaipeng; Jiang, Yue; Guo, Xuejiang; Liu, Mingxi; Jin, Guangfu; Ma, Hongxia; Jiang, Tao; Shen, Bin; Huo, Ran; Sha, Jiahao; Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China; [Wang, Cheng; Gu, Yayun; Zhang, Erbao; Zhang, Kai; Qin, Na; Dai, Juncheng; Zhu, Meng; Liu, Jia; Xie, Kaipeng; Jiang, Yue; Jin, Guangfu; Ma, Hongxia; Jiang, Tao; Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Ctr Global Hlth, Nanjing 211166, Jiangsu, Peoples R China; [Wang, Cheng; Gu, Yayun; Zhang, Erbao; Zhang, Kai; Qin, Na; Dai, Juncheng; Zhu, Meng; Liu, Jia; Xie, Kaipeng; Jiang, Yue; Jin, Guangfu; Ma, Hongxia; Jiang, Tao; Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, Jiangsu Collaborat Innovat Ctr Canc Personalized, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing 211166, Jiangsu, Peoples R China; [Wang, Cheng] Nanjing Med Univ, Sch Biomed Engn & Informat, Dept Bioinformat, Nanjing 211166, Jiangsu, Peoples R China; [Yin, Rong; Xu, Lin] Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Collaborat Innovat Ctr Canc Personalized, Jiangsu Key Lab Mol & Translat Canc Res, Nanjing 210009, Jiangsu, Peoples R China; [Xia, Yankai; Wang, Shouyu] Nanjing Med Univ, Jiangsu Collaborat Innovat Ctr Canc Personalized, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Dept Mol Cell Biol & Toxicol,Sch Publ Hlth, Nanjing 211166, Jiangsu, Peoples R China; [Liu, Li] Nanjing Med Univ, Digest Endoscopy Ctr, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China; [Qu, Bin] Saarland Univ, Sch Med, CIPMM, Dept Biophys, Saarbrucken, Germany	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Saarland University	Shen, HB; Hu, ZB (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China.; Shen, HB; Hu, ZB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Ctr Global Hlth, Nanjing 211166, Jiangsu, Peoples R China.; Shen, HB; Hu, ZB (corresponding author), Nanjing Med Univ, Jiangsu Collaborat Innovat Ctr Canc Personalized, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing 211166, Jiangsu, Peoples R China.	hbshen@njmu.edu.cn; zhibin_hu@njmu.edu.cn	Shen, Bin/ABD-5084-2021; Guo, Xuejiang/J-9600-2014	Shen, Bin/0000-0002-8946-8448; Ma, Hongxia/0000-0002-9821-6955; zhang, erbao/0000-0002-5752-7976; Guo, Xuejiang/0000-0002-0475-5705; Qin, Na/0000-0001-6878-9464; Xu, Lin/0000-0002-2153-4840; Shen, Hongbing/0000-0002-2581-5906; Liu, Mingxi/0000-0001-6499-7899	Science Fund for Creative Research Groups of the National Natural Science Foundation of China [81521004]; State Key Program of National Natural Science of China [31530047]; National Key Research and Development Program of China [2017YFC0907905]; Young Scientists Fund of the National Natural Science Foundation of China [81703295, 81702266]; National Key Basic Research Program Grant [2015CB943003]; Ten Thousand Talent Program; Natural Science Foundation of Jiangsu Province [BK20160046]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); Top-notch Academic Programs Project of Jiangsu Higher Education Institutions [PPZY2015A067]; Jiangsu Specially-Appointed Professor project	Science Fund for Creative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Young Scientists Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program Grant(National Basic Research Program of China); Ten Thousand Talent Program; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); Top-notch Academic Programs Project of Jiangsu Higher Education Institutions; Jiangsu Specially-Appointed Professor project	We thank the TCGA project for use of the multiomics data of LUAD samples, and the Genotype-Tissue Expression (GTEx) project for use of the expression abundance of multiple normal tissues. This work was supported by Science Fund for Creative Research Groups of the National Natural Science Foundation of China (81521004), the State Key Program of National Natural Science of China (31530047), National Key Research and Development Program of China (2017YFC0907905), the Young Scientists Fund of the National Natural Science Foundation of China (81703295, 81702266), the National Key Basic Research Program Grant (2015CB943003), the Ten Thousand Talent Program, Jiangsu Specially-Appointed Professor project, Natural Science Foundation of Jiangsu Province (BK20160046), the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine), and Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (PPZY2015A067).	Alajez NM, 2012, ONCOTARGET, V3, P1641; Ali PSS, 2012, FEBS LETT, V586, P3986, DOI 10.1016/j.febslet.2012.09.034; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Araujo AN, 2014, J CLIN ENDOCR METAB, V99, pE1104, DOI 10.1210/jc.2013-2993; Battistelli C, 2017, ONCOGENE, V36, P942, DOI 10.1038/onc.2016.260; Beachy SH, 2012, BLOOD, V120, P1048, DOI 10.1182/blood-2012-01-401760; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Busch B, 2016, NUCLEIC ACIDS RES, V44, P3845, DOI 10.1093/nar/gkw099; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cuddihy AR, 2003, INT REV CYTOL, V222, P99; Darbre PD, 2014, J APPL TOXICOL, V34, P925, DOI 10.1002/jat.3027; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drilon A, 2013, CANCER DISCOV, V3, P630, DOI 10.1158/2159-8290.CD-13-0035; Enright AJ, 2004, GENOME BIOL, V5; Fuentes-Mattei E, 2014, JNCI-J NATL CANCER I, P106; Gong XQ, 2017, CANCER CELL, V32, P761, DOI 10.1016/j.ccell.2017.11.006; Hu XW, 2014, CANCER CELL, V26, P344, DOI 10.1016/j.ccr.2014.07.009; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kalb R, 2006, GENOME DYN, V1, P218, DOI 10.1159/000092510; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khanam Tasneem, 2006, RNA Biol, V3, P170; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; Nguyen LH, 2014, CANCER CELL, V26, P248, DOI 10.1016/j.ccr.2014.06.018; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pineda CT, 2015, CELL, V160, P715, DOI 10.1016/j.cell.2015.01.034; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roos M, 2016, ACS CHEM BIOL, V11, P2773, DOI 10.1021/acschembio.6b00232; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10499; Watkins J, 2015, CANCER DISCOV, V5, P488, DOI 10.1158/2159-8290.CD-14-1092; Yamada K, 2013, MOL CELL, V49, P922, DOI 10.1016/j.molcel.2012.12.023; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang M, 2013, J PROTEOME RES, V12, P5260, DOI 10.1021/pr400476a	45	46	46	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2019	38	10					1611	1624		10.1038/s41388-018-0548-x	http://dx.doi.org/10.1038/s41388-018-0548-x			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN8DD	30353165				2022-12-26	WOS:000460423800003
J	Darris, C; Revert, F; Revert-Ros, F; Gozalbo-Rovira, R; Feigley, A; Fidler, A; Lopez-Pascual, E; Saus, J; Hudson, BG				Darris, Carl; Revert, Fernando; Revert-Ros, Francisco; Gozalbo-Rovira, Roberto; Feigley, Andrew; Fidler, Aaron; Lopez-Pascual, Ernesto; Saus, Juan; Hudson, Billy G.			Unicellular ancestry and mechanisms of diversification of Goodpasture antigen-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						evolution; basement membrane; extracellular matrix; extracellular matrix protein; genomics	CERAMIDE TRANSFER PROTEIN; NONVESICULAR TRAFFICKING; EXTRACELLULAR-MATRIX; GENE DUPLICATION; STRUCTURAL BASIS; SPLICED VARIANT; COLLAGEN-IV; PHOSPHORYLATES; EXPRESSION; DROSOPHILA	The emergence of the basement membrane (BM), a specialized form of extracellular matrix, was essential in the unicellular transition to multicellularity. However, the mechanism is unknown. Goodpasture antigen-binding protein (GPBP), a BM protein, was uniquely poised to play diverse roles in this transition owing to its multiple isoforms (GPBP-1, -2, and -3) with varied intracellular and extracellular functions (ceramide trafficker and protein kinase). We sought to determine the evolutionary origin of GPBP isoforms. Our findings reveal the presence of GPBP in unicellular protists, with GPBP-2 as the most ancient isoform. In vertebrates, GPBP-1 assumed extracellular function that is further enhanced by membrane-bound GPBP-3 in mammalians, whereas GPBP-2 retained intracellular function. Moreover, GPBP-2 possesses a dual intracellular/extracellular function in cnidarians, an early nonbilaterian group. We conclude that GPBP functioning both inside and outside the cell was of fundamental importance for the evolutionary transition to animal multicellularity and tissue evolution.	[Darris, Carl; Feigley, Andrew; Fidler, Aaron; Hudson, Billy G.] Vanderbilt Univ, Div Nephrol & Hypertens, Dept Med, Nashville, TN 37232 USA; [Darris, Carl; Feigley, Andrew; Fidler, Aaron; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Revert, Fernando; Revert-Ros, Francisco; Gozalbo-Rovira, Roberto; Lopez-Pascual, Ernesto; Saus, Juan] Univ Valencia, Fibrostatin SL, Sci Pk, Valencia 46980, Spain; [Saus, Juan] Univ Valencia, Fac Med & Dent, Dept Biochem & Mol Biol, Valencia 46010, Spain; [Feigley, Andrew; Fidler, Aaron; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Aspirnaut Program, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; University of Valencia; University of Valencia; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Darris, C (corresponding author), Vanderbilt Univ, Med Ctr, Div Nephrol, S-3223 MCN,1161 21st Ave South, Nashville, TN 37232 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA.	carl.darris@vanderbilt.edu; billy.hudson@vanderbilt.edu	Revert-Ros, Francisco/AAB-7055-2019; REVERT, FERNANDO/ABF-8171-2021; Rovira, Roberto Gozalbo/A-8852-2016; Fidler, Aaron L./C-4031-2014	REVERT, FERNANDO/0000-0002-7304-5846; Rovira, Roberto Gozalbo/0000-0003-3427-3800; Fidler, Aaron L./0000-0002-2519-8864; Saus, Juan/0000-0003-2082-1597; Hudson, Billy/0000-0002-5420-4100; Darris, Carl/0000-0002-1320-7612; Revert-Ros, Francisco/0000-0002-6162-3370	NIDDK, National Institutes of Health [R01DK 28381-46S1, R01DK18381]; University of Valencia; El Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion [RTC-2014-2415-1]; Conselleria de Educacio of Generalitat Valenciana [PROMETEOII/2014/048]; Aspirnaut Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R25DK096999, R01DK018381] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Valencia; El Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion; Conselleria de Educacio of Generalitat Valenciana; Aspirnaut Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health, Grants R01DK 28381-46S1 and R01DK18381; Atraccio de Talent from the University of Valencia; El Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Grant RTC-2014-2415-1; and Conselleria de Educacio of Generalitat Valenciana Grant PROMETEOII/2014/048; and The Aspirnaut Program (to Julie K. Hudson and B. G. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson DP, 2016, ELIFE, V5, DOI 10.7554/eLife.10147; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Brown KL, 2017, PROTEIN SCI, V26, P2151, DOI 10.1002/pro.3283; CURRAN J, 1988, EMBO J, V7, P245, DOI 10.1002/j.1460-2075.1988.tb02806.x; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Fidler AL, 2018, J CELL SCI, V131, DOI 10.1242/jcs.203950; Fidler AL, 2017, ELIFE, V6, DOI 10.7554/eLife.24176; Granero F, 2005, FEBS J, V272, P5291, DOI 10.1111/j.1742-4658.2005.04925.x; Granero-Molto F, 2008, J BIOL CHEM, V283, P20495, DOI 10.1074/jbc.M801806200; Gubbiotti MA, 2017, MATRIX BIOL, V57-58, P285, DOI 10.1016/j.matbio.2016.09.003; Hammesfahr B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-77; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2014, BBA-MOL CELL BIOL L, V1841, P704, DOI 10.1016/j.bbalip.2013.06.006; Hatje Klas, 2011, BMC Res Notes, V4, P265, DOI 10.1186/1756-0500-4-265; Horne-Badovinac S, 2014, INTEGR COMP BIOL, V54, P667, DOI 10.1093/icb/icu067; Hughes AL, 2005, P NATL ACAD SCI USA, V102, P8791, DOI 10.1073/pnas.0503922102; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Iozzo RV, 2018, MATRIX BIOL, V71-72, P1, DOI 10.1016/j.matbio.2018.03.023; Irimia M, 2012, GENOME RES, V22, P2356, DOI 10.1101/gr.139725.112; Jayadev R, 2017, CURR BIOL, V27, pR207, DOI 10.1016/j.cub.2017.02.006; Jones-Paris CR, 2017, MATRIX BIOL, V57-58, P347, DOI 10.1016/j.matbio.2016.09.005; Keeley DP, 2019, MATRIX BIOL, V75-76, P58, DOI 10.1016/j.matbio.2018.05.009; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lopez-Jimenez AJ, 2017, J BIOL CHEM, V292, P16970, DOI 10.1074/jbc.M117.798603; Mencarelli C, 2012, J BIOL CHEM, V287, P14897, DOI 10.1074/jbc.M111.299545; Morrissey MA, 2015, J CELL SCI, V128, P1661, DOI 10.1242/jcs.168021; Muhlhausen S, 2015, BIOINFORMATICS, V31, P1302, DOI 10.1093/bioinformatics/btu798; Odronitz Florian, 2008, BMC Genomics, V9, P422, DOI 10.1186/1471-2164-9-422; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Pozzi A, 2017, MATRIX BIOL, V57-58, P1, DOI 10.1016/j.matbio.2016.12.009; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ramos-Lewis W, 2019, MATRIX BIOL, V75-76, P72, DOI 10.1016/j.matbio.2018.04.004; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; Revert F, 2008, J BIOL CHEM, V283, P30246, DOI 10.1074/jbc.M805026200; Revert F, 2007, AM J PATHOL, V171, P1419, DOI 10.2353/ajpath.2007.070205; Revert Fernando, 2018, Oncotarget, V9, P11020, DOI 10.18632/oncotarget.24280; Revert-Ros F, 2011, J BIOL CHEM, V286, P35030, DOI 10.1074/jbc.M111.249458; Richter DJ, 2018, ELIFE, V7, DOI 10.7554/eLife.34226; Richter DJ, 2013, ANNU REV GENET, V47, P509, DOI 10.1146/annurev-genet-111212-133456; Rokas A, 2008, ANNU REV GENET, V42, P235, DOI 10.1146/annurev.genet.42.110807.091513; Roth C, 2007, J EXP ZOOL PART B, V308B, P58, DOI 10.1002/jez.b.21124; Sebe-Pedros A, 2013, ELIFE, V2, DOI 10.7554/eLife.01287; Sekiguchi R, 2018, CURR TOP DEV BIOL, V130, P143, DOI 10.1016/bs.ctdb.2018.02.005; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; Sugiki T, 2018, J BIOL CHEM, V293, P11206, DOI 10.1074/jbc.RA118.002465; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tucker RP, 2011, INVERTEBR BIOL, V130, P11, DOI 10.1111/j.1744-7410.2010.00219.x; VRACKO R, 1974, AM J PATHOL, V77, P314; Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW385, DOI 10.1093/nar/gkl252; Yurchenco PD, 2015, CURR TOP MEMBR, V76, P1, DOI 10.1016/bs.ctm.2015.05.001; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	56	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					759	769		10.1074/jbc.RA118.006225	http://dx.doi.org/10.1074/jbc.RA118.006225			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30377252	Green Published, hybrid			2022-12-26	WOS:000458670200002
J	Ricarte, FR; Le Henaff, C; Kolupaeva, VG; Gardella, TJ; Partridge, NC				Ricarte, Florante R.; Le Henaff, Carole; Kolupaeva, Victoria G.; Gardella, Thomas J.; Partridge, Nicola C.			Parathyroid hormone(1-34) and its analogs differentially modulate osteoblastic Rankl expression via PKA/SIK2/SIK3 and PP1/PP2A-CRTC3 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						osteoblast; parathyroid hormone; osteoporosis; protein kinase A (PKA); phosphoprotein phosphatase; abaloparatide; age-related diseases; parathyroid hormone-related protein; Rankl; salt-inducible kinases	PROTEIN PHOSPHATASE 2A; KAPPA-B LIGAND; INCREASED BONE MASS; RECEPTOR ACTIVATOR; GENE-EXPRESSION; POSTMENOPAUSAL WOMEN; C-ALPHA; PTH; PHOSPHORYLATION; BINDING	Osteoporosis can result from the loss of sex hormones and/or aging. Abaloparatide (ABL), an analog of parathyroid hormone-related protein (PTHrP(1-36)), is the second osteoanabolic therapy approved by the United States Food and Drug Administration after teriparatide (PTH(1-34)). All three peptides bind PTH/PTHrP receptor type 1 (PTHR1), but the effects of PTHrP(1-36) or ABL in the osteoblast remain unclear. We show that, in primary calvarial osteoblasts, PTH(1-34) promotes a more robust cAMP response than PTHrP(1-36) and ABL and causes a greater activation of protein kinase A (PKA) and cAMP response element-binding protein (CREB). All three peptides similarly inhibited sclerostin (Sost). Interestingly, the three peptides differentially modulated two other PKA target genes, c-Fos and receptor activator of NF-B ligand (Rankl), and the latter both in vitro and in vivo. Knockdown of salt-inducible kinases (SIKs) 2 and 3 and CREB-regulated transcription coactivator 3 (CRTC3), indicated that all three are part of the pathway that regulates osteoblastic Rankl expression. We also show that the peptides differentially regulate the nuclear localization of CRTC2 and CRTC3, and that this correlates with PKA activation. Moreover, inhibition of protein phosphatases 1 and 2A (PP1/PP2A) activity revealed that they play a major role in both PTH-induced Rankl expression and the effects of PTH(1-34) on CRTC3 localization. In summary, in the osteoblast, the effects of PTH(1-34), PTHrP(1-36), and ABL on Rankl are mediated by differential stimulation of cAMP/PKA signaling and by their downstream effects on SIK2 and -3, PP1/PP2A, and CRTC3.	[Ricarte, Florante R.; Partridge, Nicola C.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Le Henaff, Carole; Kolupaeva, Victoria G.; Partridge, Nicola C.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, 345 East 24th St,902A, New York, NY 10010 USA; [Gardella, Thomas J.] Harvard Med Sch, Endocrine Unit, Massachusetts Gen Hosp, Boston, MA 02114 USA	New York University; New York University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Partridge, NC (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, 345 East 24th St,902A, New York, NY 10010 USA.	ncp234@nyu.edu		Partridge, Nicola/0000-0002-5406-4814	National Institutes of Health [DK47420, DK4742051, T32 GM066704]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047420, R56DK047420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK47420, DK4742051, and T32 GM066704. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggen JB, 2000, CHEM BIOL, V7, pR13, DOI 10.1016/S1074-5521(00)00069-7; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Cheloha RW, 2015, NAT REV ENDOCRINOL, V11, P712, DOI 10.1038/nrendo.2015.139; Dean T, 2006, MOL ENDOCRINOL, V20, P931, DOI 10.1210/me.2005-0349; Dean T, 2008, MOL ENDOCRINOL, V22, P156, DOI 10.1210/me.2007-0274; Doyle N, 2018, OSTEOPOROSIS INT, V29, P685, DOI 10.1007/s00198-017-4323-6; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Feschenko MS, 2002, J PHARMACOL EXP THER, V302, P111, DOI 10.1124/jpet.302.1.111; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Galli C, 2009, J BIOL CHEM, V284, P12654, DOI 10.1074/jbc.M806628200; Gardella TJ, 2015, PHARMACOL REV, V67, P310, DOI 10.1124/pr.114.009464; Harvey N, 2010, NAT REV RHEUMATOL, V6, P99, DOI 10.1038/nrrheum.2009.260; Hattersley G, 2016, ENDOCRINOLOGY, V157, P141, DOI 10.1210/en.2015-1726; Henriksson E, 2015, J CELL SCI, V128, P472, DOI 10.1242/jcs.153932; Henriksson E, 2012, BIOCHEM J, V444, P503, DOI 10.1042/BJ20111932; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Huang JC, 2004, J BONE MINER RES, V19, P235, DOI 10.1359/JBMR.0301226; Itoh Y, 2015, J BIOL CHEM, V290, P17879, DOI 10.1074/jbc.M115.640821; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kim JH, 2017, P NATL ACAD SCI USA, V114, P11739, DOI 10.1073/pnas.1712616114; Kim S, 2007, MOL ENDOCRINOL, V21, P197, DOI 10.1210/me.2006-0315; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Kraenzlin ME, 2011, NAT REV ENDOCRINOL, V7, P647, DOI 10.1038/nrendo.2011.108; Lee CW, 2014, J BIOL CHEM, V289, P21108, DOI 10.1074/jbc.M113.540229; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Lombardi MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185426; MACKINTOSH C, 1988, FEBS LETT, V234, P189, DOI 10.1016/0014-5793(88)81331-0; Martowicz ML, 2011, J CELL BIOCHEM, V112, P2030, DOI 10.1002/jcb.23123; Miller PD, 2016, JAMA-J AM MED ASSOC, V316, P722, DOI 10.1001/jama.2016.11136; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Obri A, 2014, J CELL BIOL, V205, P771, DOI 10.1083/jcb.201403138; Okamura H, 2013, FEBS LETT, V587, P48, DOI 10.1016/j.febslet.2012.10.041; Okamura H, 2011, BONE, V49, P368, DOI 10.1016/j.bone.2011.06.004; Onal M, 2016, J BONE MINER RES, V31, P416, DOI 10.1002/jbmr.2698; Patel K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5535; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715; Rosen CJ, 2001, J CLIN ENDOCR METAB, V86, P957, DOI 10.1210/jc.86.3.957; Saini V, 2013, J BIOL CHEM, V288, P20122, DOI 10.1074/jbc.M112.441360; Sasagawa S, 2012, DEVELOPMENT, V139, P1153, DOI 10.1242/dev.072652; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shimizu E, 2014, J BIOL CHEM, V289, P21340, DOI 10.1074/jbc.M114.550699; Shimizu E, 2010, J BIOL CHEM, V285, P9616, DOI 10.1074/jbc.M109.094862; St John HC, 2015, BONE, V72, P81, DOI 10.1016/j.bone.2014.11.010; Tseng W, 2010, J BIOL CHEM, V285, P29925, DOI 10.1074/jbc.M110.117366; Tyson DR, 1999, ENDOCRINOLOGY, V140, P1255, DOI 10.1210/en.140.3.1255; URENA P, 1993, ENDOCRINOLOGY, V133, P617, DOI 10.1210/en.133.2.617; Usui H, 1998, FEBS LETT, V430, P312, DOI 10.1016/S0014-5793(98)00684-X; Varela A, 2017, BONE, V95, P143, DOI 10.1016/j.bone.2016.11.027; Wein MN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13176; Wein Marc N, 2015, J Bone Miner Res, V30, P400, DOI 10.1002/jbmr.2381; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; Xiong JH, 2012, J BONE MINER RES, V27, P499, DOI 10.1002/jbmr.1547; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang D, 2007, BONE, V40, P1453, DOI 10.1016/j.bone.2007.02.001; Yang DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001540	60	35	37	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20200	20213		10.1074/jbc.RA118.004751	http://dx.doi.org/10.1074/jbc.RA118.004751			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30377251	Green Published, hybrid			2022-12-26	WOS:000454685900026
J	Lin, YB; Deepak, RNVK; Zheng, JZ; Fan, H; Zheng, L				Lin, Yibin; Deepak, R. N. V. Krishna; Zheng, Jonathan Zixiang; Fan, Hao; Zheng, Lei			A dual substrate-accessing mechanism of a major facilitator superfamily protein facilitates lysophospholipid flipping across the cell membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lysophospholipid; transporter; homology modeling; structural model; substrate specificity; protein-lipid interaction; phospholipid turnover; structure-function; lipid transport; lipid flipping; LplT; major facilitator superfamily; structure-function study; transport mechanism	MULTIPLE SEQUENCE ALIGNMENT; TRANSPORT MECHANISM; CRYSTAL-STRUCTURE; LYSOPHOSPHATIDYLCHOLINE; PREDICTION; MFSD2A; SYSTEM	Lysophospholipid transporter (LplT) is a member of the major facilitator superfamily present in many Gram-negative bacteria. LplT catalyzes flipping of lysophospholipids (LPLs) across the bacterial inner membrane, playing an important role in bacterial membrane homeostasis. We previously reported that LplT promotes both uptake of exogenous LPLs and intramembranous LPL flipping across the bilayer. To gain mechanistic insight into this dual LPL-flipping activity, here we implemented a combination of computational approaches and LPL transport analyses to study LPL binding of and translocation by LplT. Our results suggest that LplT translocates LPLs through an elongated cavity exhibiting an extremely asymmetric polarity. We found that two D(E)N motifs form a head group-binding site, in which the carboxylate group of Asp-30 is important for LPL head group recognition. Substitutions of residues in the head group-binding site disrupted both LPL uptake and flipping activities. However, alteration of hydrophobic residues on the interface between the N- and C-terminal domains impaired LPL flipping specifically, resulting in LPLs accumulation in the membrane, but LPL uptake remained active. These results suggest a dual substrate-accessing mechanism, in which LplT recruits LPLs to its substrate-binding site via two routes, either from its extracellular entry or through a membrane-embedded groove between transmembrane helices, and then moves them toward the inner membrane leaflet. This LPL-flipping mechanism is likely conserved in many bacterial species, and our findings illustrate how LplT adjusts the major facilitator superfamily translocation pathway to perform its versatile lipid homeostatic functions.	[Lin, Yibin; Zheng, Jonathan Zixiang; Zheng, Lei] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, McGovern Med Sch, Ctr Membrane Biol, Houston, TX 77030 USA; [Deepak, R. N. V. Krishna; Fan, Hao] ASTAR, Bioinformat Inst BII, Singapore 138671, Singapore; [Fan, Hao] Natl Univ Singapore, DBS, Singapore 117558, Singapore; [Fan, Hao] DUKE NUS Med Sch, Ctr Computat Biol, Singapore 169857, Singapore	University of Texas System; University of Texas Health Science Center Houston; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; National University of Singapore	Fan, H (corresponding author), ASTAR, Bioinformat Inst BII, Singapore 138671, Singapore.; Fan, H (corresponding author), Natl Univ Singapore, DBS, Singapore 117558, Singapore.; Fan, H (corresponding author), DUKE NUS Med Sch, Ctr Computat Biol, Singapore 169857, Singapore.; Zheng, L (corresponding author), Univ Texas Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA.	fanh@bii.a-star.edu.sg; lei.zheng@uth.tmc.edu	Krishna Deepak, Rama Nagesh Venkata/AAX-7774-2020; Lin, B.Y./AAA-7774-2020	Zheng, Lei/0000-0001-7789-5234; KRISHNA DEEPAK, RAMA NAGESH VENKATA/0000-0001-6629-8450	National Institutes of Health [R01GM097290, R01GM098572]; American Heart Association [18TPA34230046]; Biomedical Research Council of A*STAR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097290, R01GM098572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Biomedical Research Council of A*STAR(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM097290 and R01GM098572 and American Heart Association Grant 18TPA34230046 (to L. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Biomedical Research Council of A*STAR. To whom correspondence may be addressed. Tel.: 65-64788500; E-mail: fanh@bii.a-star.edu.sg.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fuller N, 2001, BIOPHYS J, V81, P243, DOI 10.1016/S0006-3495(01)75695-0; Gelis-Jeanvoine S, 2015, MOL MICROBIOL, V95, P692, DOI 10.1111/mmi.12897; Harvat EM, 2005, J BIOL CHEM, V280, P12028, DOI 10.1074/jbc.M414368200; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JACKOWSKI S, 1986, J BIOL CHEM, V261, P1328; Jiang DH, 2013, P NATL ACAD SCI USA, V110, P14664, DOI 10.1073/pnas.1308127110; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lin YB, 2018, J BIOL CHEM, V293, P3386, DOI 10.1074/jbc.RA117.001231; Lin YB, 2016, J BIOL CHEM, V291, P2136, DOI 10.1074/jbc.M115.700419; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Quek DQY, 2016, J BIOL CHEM, V291, P9383, DOI 10.1074/jbc.M116.721035; Quistgaard EM, 2016, NAT REV MOL CELL BIO, V17, P123, DOI 10.1038/nrm.2015.25; Riederer M, 2010, J LIPID RES, V51, P2957, DOI 10.1194/jlr.M006536; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Stamm M, 2014, NUCLEIC ACIDS RES, V42, pW246, DOI 10.1093/nar/gku291; Wu MS, 2013, P NATL ACAD SCI USA, V110, P11367, DOI 10.1073/pnas.1302515110; Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhao Z, 2014, NEURON, V82, P728, DOI 10.1016/j.neuron.2014.05.012; Zheng L, 2017, BBA-MOL CELL BIOL L, V1862, P1404, DOI 10.1016/j.bbalip.2016.11.015	41	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19919	19931		10.1074/jbc.RA118.005548	http://dx.doi.org/10.1074/jbc.RA118.005548			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30373772	hybrid, Green Published			2022-12-26	WOS:000454294900035
J	Yien, YY; Shi, JH; Chen, CY; Cheung, JTM; Grillo, AS; Shrestha, R; Li, LT; Zhang, XD; Kafina, MD; Kingsley, PD; King, MJ; Ablain, J; Li, HJ; Zon, LI; Palis, J; Burke, MD; Bauer, DE; Orkin, SH; Koehler, CM; Phillips, JD; Kaplan, J; Ward, DM; Lodish, HF; Paw, BH				Yien, Yvette Y.; Shi, Jiahai; Chen, Caiyong; Cheung, Jesmine T. M.; Grillo, Anthony S.; Shrestha, Rishna; Li, Liangtao; Zhang, Xuedi; Kafina, Martin D.; Kingsley, Paul D.; King, Matthew J.; Ablain, Julien; Li, Hojun; Zon, Leonard I.; Palis, James; Burke, Martin D.; Bauer, Daniel E.; Orkin, Stuart H.; Koehler, Carla M.; Phillips, John D.; Kaplan, Jerry; Ward, Diane M.; Lodish, Harvey F.; Paw, Barry H.			FAM210B is an erythropoietin target and regulates erythroid heme synthesis by controlling mitochondrial iron import and ferrochelatase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; iron metabolism; cell metabolism; erythrocyte; erythropoiesis; red blood cell	TRANSFERRIN RECEPTOR; 5-AMINOLEVULINATE SYNTHASE; FUNCTIONAL DISSECTION; GENE; IDENTIFICATION; PROTEIN; RED; BIOSYNTHESIS; TRANSPORTER; ANEMIA	Erythropoietin (EPO) signaling is critical to many processes essential to terminal erythropoiesis. Despite the centrality of iron metabolism to erythropoiesis, the mechanisms by which EPO regulates iron status are not well-understood. To this end, here we profiled gene expression in EPO-treated 32D pro-B cells and developing fetal liver erythroid cells to identify additional iron regulatory genes. We determined that FAM210B, a mitochondrial inner-membrane protein, is essential for hemoglobinization, proliferation, and enucleation during terminal erythroid maturation. Fam210b deficiency led to defects in mitochondrial iron uptake, heme synthesis, and iron-sulfur cluster formation. These defects were corrected with a lipid-soluble, small-molecule iron transporter, hinokitiol, in Fam210b-deficient murine erythroid cells and zebrafish morphants. Genetic complementation experiments revealed that FAM210B is not a mitochondrial iron transporter but is required for adequate mitochondrial iron import to sustain heme synthesis and iron-sulfur cluster formation during erythroid differentiation. FAM210B was also required for maximal ferrochelatase activity in differentiating erythroid cells. We propose that FAM210B functions as an adaptor protein that facilitates the formation of an oligomeric mitochondrial iron transport complex, required for the increase in iron acquisition for heme synthesis during terminal erythropoiesis. Collectively, our results reveal a critical mechanism by which EPO signaling regulates terminal erythropoiesis and iron metabolism.	[Yien, Yvette Y.; Zhang, Xuedi] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Yien, Yvette Y.; Chen, Caiyong; Kafina, Martin D.; King, Matthew J.; Paw, Barry H.] Harvard Med Sch, Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Shi, Jiahai; Li, Hojun; Lodish, Harvey F.] MIT, Whitehead Inst, Cambridge, MA 02139 USA; [Shi, Jiahai; Li, Hojun; Lodish, Harvey F.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Cheung, Jesmine T. M.; Koehler, Carla M.] UCLA, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Grillo, Anthony S.; Burke, Martin D.] Univ Illinois, Dept Chem & Biochem, Urbana, IL 61801 USA; [Shrestha, Rishna; Li, Liangtao; Kaplan, Jerry; Ward, Diane M.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA; [Kingsley, Paul D.; Palis, James] Univ Rochester, Med Ctr, Dept Pediat, Ctr Pediat Biomed Res, Rochester, NY 14642 USA; [Ablain, Julien; Zon, Leonard I.; Bauer, Daniel E.; Orkin, Stuart H.; Paw, Barry H.] Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Zon, Leonard I.; Bauer, Daniel E.; Orkin, Stuart H.; Paw, Barry H.] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Phillips, John D.; Paw, Barry H.] Univ Utah, Sch Med, Div Hematol & Hematol Malignancy, Salt Lake City, UT 84112 USA; [Shi, Jiahai] City Univ Hong Kong, Hong Kong, Peoples R China; [Chen, Caiyong] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Kafina, Martin D.] St Georges Univ, Sch Med, Dept Med, St Georges, Grenada; [King, Matthew J.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Delaware; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles; University of Illinois System; University of Illinois Urbana-Champaign; Utah System of Higher Education; University of Utah; University of Rochester; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Utah System of Higher Education; University of Utah; City University of Hong Kong; Zhejiang University; University of Texas System; University of Texas Health San Antonio	Yien, YY (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	yyien@udel.edu		Palis, James/0000-0001-7324-1049; Ablain, Julien/0000-0002-4509-3568; Koehler, Carla/0000-0001-8685-2412	National Institutes of Health [U54 DK110858, P30 DK34854]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116364, P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK020503, U54DK110805, R37DK030534, R01DK070838, K01DK106156, R01DK030534, K08DK093705, U54DK083909, U54DK110858, R03DK118307, F32DK098866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061721, R01GM073981, R35GM118185] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD017870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Iman Schultz for assistance on bioinformatics analysis, Johannes Wittig for assistance with model figure preparation, and Nicholas Huston for assistance with initial morpholino injections. We thank Mahnaz Paktinat for training on the use of the BD FACSCanto cell sorter. We also thank Bingbing Yuan for help with processing and analyzing the microarray data. The DS19 MEL clones were obtained from Arthur Skoultchi (Albert Einstein College of Medicine). We thank Eva Buys and her crew for the zebrafish animal husbandry. We also thank Harry Dailey and Amy Medlock for their critical feedback on the manuscript and Stashauna Carter for technical assistance. Fluorescence confocal microscopy was performed at the Harvard Digestive Disease Center Imaging Facility (Boston Children's Hospital, supported by National Institutes of Health Grant P30 DK34854) with assistance from Ramiro Massol. HPLC analyses of porphyrins were performed at the University of Utah Center for Iron and Heme Disorders supported by National Institutes of Health Grant U54 DK110858.	Amigo JD, 2011, MOL CELL BIOL, V31, P1344, DOI 10.1128/MCB.01010-10; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Chami N, 2016, AM J HUM GENET, V99, P8, DOI 10.1016/j.ajhg.2016.05.007; Chen CY, 2013, CELL METAB, V17, P343, DOI 10.1016/j.cmet.2013.01.013; Chen CY, 2012, BBA-MOL CELL RES, V1823, P1459, DOI 10.1016/j.bbamcr.2012.01.003; Chen W, 2010, BLOOD, V116, P628, DOI 10.1182/blood-2009-12-259614; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Cheng AW, 2014, BLOOD, V124, P598, DOI 10.1182/blood-2013-12-542209; Christenson ET, 2018, J BIOL CHEM, V293, P3819, DOI 10.1074/jbc.M117.817478; Chung J, 2017, ELIFE, V6, DOI 10.7554/eLife.24767; Chung J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5903; Chung J, 2014, J BIOL CHEM, V289, P7835, DOI 10.1074/jbc.M114.547778; Cioffi AG, 2015, J AM CHEM SOC, V137, P10096, DOI 10.1021/jacs.5b05765; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; DAILEY HA, 1983, J BIOL CHEM, V258, P1453; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Froschauer EM, 2013, BIOCHEM J, V455, P57, DOI 10.1042/BJ20130144; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gammella E, 2015, AM J PHYSIOL-REG I, V308, pR330, DOI 10.1152/ajpregu.00410.2014; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Ganis JJ, 2012, DEV BIOL, V366, P185, DOI 10.1016/j.ydbio.2012.03.021; Girvan HM, 2013, J BIOL CHEM, V288, P13194, DOI 10.1074/jbc.R112.422642; Grillo AS, 2017, SCIENCE, V356, P608, DOI 10.1126/science.aah3862; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Hattangadi SM, 2010, BLOOD, V115, P4853, DOI 10.1182/blood-2009-07-235093; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Kardon JR, 2015, CELL, V161, P858, DOI 10.1016/j.cell.2015.04.017; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; Kondo A, 2016, INT J HEMATOL, V103, P387, DOI 10.1007/s12185-016-1968-4; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lim JE, 2005, NAT GENET, V37, P1270, DOI 10.1038/ng1659; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Martinkova M, 2013, J BIOL CHEM, V288, P27702, DOI 10.1074/jbc.R113.473249; Matak P, 2016, P NATL ACAD SCI USA, V113, P3428, DOI 10.1073/pnas.1519473113; Medlock AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135896; Metzendorf C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-68; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Nai A, 2016, BLOOD, V127, P2327, DOI 10.1182/blood-2015-11-681494; Napier I, 2005, BLOOD, V105, P1867, DOI 10.1182/blood-2004-10-3856; Ning B, 2011, J BIOL CHEM, V286, P37196, DOI 10.1074/jbc.M111.258129; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; PROULX KL, 1993, PROTEIN SCI, V2, P1092, DOI 10.1002/pro.5560020703; Ramsey AJ, 1996, J BIOL CHEM, V271, P24395, DOI 10.1074/jbc.271.40.24395; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reischauer S, 2016, NATURE, V535, P294, DOI 10.1038/nature18614; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; ROSSI E, 1988, CLIN CHEM, V34, P2481; Roy CN, 1999, J BIOL CHEM, V274, P9022, DOI 10.1074/jbc.274.13.9022; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Sun SJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.273; Surinya KH, 1997, J BIOL CHEM, V272, P26585, DOI 10.1074/jbc.272.42.26585; Troadec MB, 2011, BLOOD, V117, P5494, DOI 10.1182/blood-2010-11-319483; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; Visconte V, 2015, LEUKEMIA, V29, P188, DOI 10.1038/leu.2014.170; Wang YM, 2011, EXP HEMATOL, V39, P784, DOI 10.1016/j.exphem.2011.05.003; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Wolff NA, 2014, FASEB J, V28, P2134, DOI 10.1096/fj.13-240564; Wong P, 2011, BLOOD, V118, pE128, DOI 10.1182/blood-2011-03-341404; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Yien YY, 2014, J CLIN INVEST, V124, P4294, DOI 10.1172/JCI76979; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	81	18	19	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19797	19811		10.1074/jbc.RA118.002742	http://dx.doi.org/10.1074/jbc.RA118.002742			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30366982	Green Published, hybrid			2022-12-26	WOS:000454294900024
J	Takahashi, A; Mulati, M; Saito, M; Numata, H; Kobayashi, Y; Ochi, H; Sato, S; Kaldis, P; Okawa, A; Inose, H				Takahashi, Akira; Mulati, Mieradili; Saito, Masanori; Numata, Hoashi; Kobayashi, Yutaka; Ochi, Hiroki; Sato, Shingo; Kaldis, Philipp; Okawa, Atsushi; Inose, Hiroyuki			Loss of cyclin-dependent kinase 1 impairs bone formation, but does not affect the bone-anabolic effects of parathyroid hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; cell cycle; osteoblast; osteoporosis; parathyroid hormone; cyclin-dependent kinase (CDK); bone loss; bony union; osteoblastogenesis	OSTEOBLAST PROLIFERATION; CDK1; PTH; PHOSPHORYLATION; DIFFERENTIATION; PROGRESSION; APOPTOSIS; NONUNION; ROLES	Bone mass is maintained by a balance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption. Although recent genetic studies have uncovered various mechanisms that regulate osteoblast differentiation, the molecular basis of osteoblast proliferation remains unclear. Here, using an osteoblast-specific loss-of-function mouse model, we demonstrate that cyclin-dependent kinase 1 (Cdk1) regulates osteoblast proliferation and differentiation. Quantitative RT-PCR analyses revealed that Cdk1 is highly expressed in bone and is down-regulated upon osteoblast differentiation. We also noted that Cdk1 is dispensable for the bone-anabolic effects of parathyroid hormone (PTH). Cdk1 deletion in osteoblasts led to osteoporosis in adult mice due to low bone formation, but did not affect osteoclast formation in vivo. Cdk1 overexpression in osteoblasts promoted proliferation, and conversely, Cdk1 knockdown inhibited osteoblast proliferation and promoted differentiation. Of note, we provide direct evidence that PTH's bone-anabolic effects occur without enhancing osteoblast proliferation in vivo. Furthermore, we found that Cdk1 expression in osteoblasts is essential for bone fracture repair. These findings may help reduce the risk of nonunion after bone fracture and identify patients at higher risk for nonresponse to PTH treatment. Collectively, our results indicate that Cdk1 is essential for osteoblast proliferation and that it functions as a molecular switch that shifts osteoblast proliferation to maturation. We therefore conclude that Cdk1 plays an important role in bone formation.	[Takahashi, Akira; Mulati, Mieradili; Saito, Masanori; Numata, Hoashi; Kobayashi, Yutaka; Okawa, Atsushi; Inose, Hiroyuki] Tokyo Med & Dent Univ, Grad Sch, Dept Orthoped, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan; [Ochi, Hiroki; Sato, Shingo] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan; [Kaldis, Philipp] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Kaldis, Philipp] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Inose, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Orthoped, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	inose.orth@tmd.ac.jp	Saito, Masanori/GRR-1714-2022; Kaldis, Philipp/G-2714-2010	Kaldis, Philipp/0000-0002-7247-7591; Saito, Masanori/0000-0002-4139-4013; Sato, Shingo/0000-0002-6227-5910; INOSE, HIROYUKI/0000-0003-4195-2545	Japan Society for the Promotion of Science (JSPS) [15H05681]; Agency for Science, Technology and Research (A*STAR), Japan Agency for Medical Research and Development (AMED); Nakatomi Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agency for Science, Technology and Research (A*STAR), Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Nakatomi Foundation	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant 15H05681, Agency for Science, Technology and Research (A*STAR), Japan Agency for Medical Research and Development (AMED), and the Nakatomi Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Almeida Maria, 2012, Bonekey Rep, V1; Augustine M, 2013, CURR OSTEOPOROS REP, V11, P400, DOI 10.1007/s11914-013-0171-2; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; Eastaugh-Waring SJ, 2009, CLIN ORTHOP RELAT R, V467, P1986, DOI 10.1007/s11999-009-0775-0; Elraiyah Tarig, 2016, Bone Rep, V4, P17, DOI 10.1016/j.bonr.2015.11.001; Inose H, 2018, SPINE, V43, pE29, DOI 10.1097/BRS.0000000000001995; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 2009, BONE, V44, P275, DOI 10.1016/j.bone.2008.10.037; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Karuppaiah K, 2016, DEVELOPMENT, V143, P1811, DOI 10.1242/dev.131722; Krege JH, 2014, OSTEOPOROSIS INT, V25, P2159, DOI 10.1007/s00198-014-2646-0; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Lindsay R, 2007, J BONE MINER RES, V22, P495, DOI 10.1359/JBMR.070104; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; Morley P, 2001, CURR PHARM DESIGN, V7, P671, DOI 10.2174/1381612013397780; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Onishi T, 1997, J BONE MINER RES, V12, P1596, DOI 10.1359/jbmr.1997.12.10.1596; Pettway GJ, 2008, BONE, V42, P806, DOI 10.1016/j.bone.2007.11.017; Qin L, 2005, J BIOL CHEM, V280, P3104, DOI 10.1074/jbc.M409846200; Rajgopal A, 2007, J CELL BIOCHEM, V100, P1509, DOI 10.1002/jcb.21137; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Saito M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20622; Satyanarayana A, 2008, DEVELOPMENT, V135, P3389, DOI 10.1242/dev.024919; Shirakawa J, 2016, CALCIFIED TISSUE INT, V98, P306, DOI 10.1007/s00223-015-0083-5; Suryadinata R, 2010, BIOSCIENCE REP, V30, P243, DOI 10.1042/BSR20090171; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Vassilev LT, 2006, CELL CYCLE, V5, P2555, DOI 10.4161/cc.5.22.3463; Wang YH, 2007, AM J PHYSIOL-ENDOC M, V292, pE594, DOI 10.1152/ajpendo.00216.2006; Zhang WW, 2011, J CELL BIOCHEM, V112, P942, DOI 10.1002/jcb.23010; Zura R, 2017, BONE, V95, P26, DOI 10.1016/j.bone.2016.11.006	37	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19387	19399		10.1074/jbc.RA118.004834	http://dx.doi.org/10.1074/jbc.RA118.004834			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30366983	Green Published, hybrid			2022-12-26	WOS:000453537300020
J	Fordham, BG; Aze, T; Haller, C; Zehady, AK; Pearson, PN; Ogg, JG; Wade, BS				Fordham, Barry G.; Aze, Tracy; Haller, Christian; Zehady, Abdullah Khan; Pearson, Paul N.; Ogg, James G.; Wade, Bridget S.			Future-proofing the Cenozoic macroperforate planktonic foraminifera phylogeny of Aze & others (2011)	PLOS ONE			English	Article							FOSSIL; DIVERSITY; EVOLUTION; RECLASSIFICATION; CLADOGENESIS; SPECIATION	The unique macroevolutionary dataset of Aze & others has been transferred onto the TimeScale Creator visualisation platform while, as much as practicable, preserving the original unrevised content of its morphospecies and lineage evolutionary trees. This is a "Corrected Version" (not a revision), which can serve as an on-going historical case example because it is now updatable with future time scales. Both macroevolutionary and biostratigraphic communities are now equipped with an enduring phylogenetic database of Cenozoic macroperforate planktonic foraminiferal morphospecies and lineages for which both graphics and content can be visualised together. Key to maintaining the currency of the trees has been specification of time scales for sources of stratigraphic ranges; these scales then locate the range dates within the calibration series. Some ranges or their sources have undergone mostly minor corrections or amendments. Links between lineage and morphospecies trees have been introduced to improve consistency and transparency in timing within the trees. Also, Aze & others' dual employment of morphospecies and lineage concepts is further elaborated here, given misunderstandings that have ensued. Features displayed on the trees include options for line styles for additional categories for range extensions or degrees of support for ancestor-descendant proposals; these have been applied to a small number of instances as an encouragement to capture more nuanced data in the future. In addition to labeling of eco- and morpho-groups on both trees, genus labels can be attached to the morphospecies tree to warn of polyphyletic morphogenera, and the lineage codes have been decoded to ease their recognition. However, it is the mouse-over pop-ups that provide the greatest opportunity to embed supporting information in the trees. They include details for stratigraphic ranges and their recalibration steps, positions relative to the standard planktonic-foraminiferal zonation, and applications as datums, as well as mutual listings between morphospecies and lineages which ease the tracing of their interrelated contents. The elaboration of the original dataset has been captured in a relational database, which can be considered a resource in itself, and, through queries and programming, serves to generate the TimeScale Creator datapacks.	[Fordham, Barry G.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Aze, Tracy] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Haller, Christian] Univ S Florida, Coll Marine Sci, St Petersburg, FL USA; [Zehady, Abdullah Khan; Ogg, James G.] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Pearson, Paul N.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff, S Glam, Wales; [Wade, Bridget S.] UCL, Dept Earth Sci, London, England	Australian National University; University of Leeds; State University System of Florida; University of South Florida; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cardiff University; University of London; University College London	Fordham, BG (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia.	barry.fordham@anu.edu.au	Fordham, Barry/H-2284-2011; Wade, Bridget S/F-4987-2014	Fordham, Barry/0000-0003-4825-1987; Wade, Bridget S/0000-0002-7245-8614; Ogg, James/0000-0001-5716-3511; Aze, Tracy/0000-0002-4201-7105	UK Natural Environment Research Council [NE/N001621/1, NE/N002598/1]; NERC; ANU; NERC [NE/N002598/1, NE/N001621/1] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ANU(Australian National University); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Paul Pearson and Bridget Wade received support from UK Natural Environment Research Council Grants NE/N001621/1 and NE/N002598/1, respectively. Publication of this article was covered by the latter NERC grant. The funders did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The other authors of the 2011 paper on which this study is based were Thomas H. G. Ezard (University of Southampton), Andy Purvis (Natural History Museum and Imperial College London), Helen K. Coxall (Stockholm University), and Duncan R. M. Stewart (Fort Halstead, UK). The TimeScale Creator teams, past and present, at the Department of Computer Science, Purdue University developed and continually improved the platform to provide the capability we have applied; in particular for the evolutionary-tree and underlying range functions, Gangi Palem (now Google), Nag Varun Chunduru (now Amazon Lab126), Aaron Ault, Adam Lugowski (now Patent Research Foundation), and Jason Bobick. The manuscript benefitted from comments by John A. Webb (La Trobe University), and was greatly improved as a result of reviews from Brian T. Huber (Smithsonian Institution) and a meticulous anonymous reviewer, both coordinated by Lukas Jonkers (PLOS ONE). Duncan Bolt and especially Oscar Branson (both Australian National University: ANU) generously shared their Illustrator skills. Lesley Wyborn (National Computational Infrastructure Australia) and Julia Martin (Australian Research Data Commons) advised expertly on data deposition, and Elke Dawson and Genevieve Turner (both ANU) guided our data onto the Australian National University Data Commons. Stephen M. Eggins (ANU) has generously provided valuable intellectual input, institutional resources, and funding for this study and its research program.	[Anonymous], 1999, SMITHSONIAN CONTRIBU; Arenillas I, 2017, HIST BIOL, V29, P25, DOI 10.1080/08912963.2015.1119133; Aubry MP, 2009, STRATIGRAPHY, V6, P100; Aze T, 2013, P NATL ACAD SCI USA, V110, pE2946, DOI 10.1073/pnas.1307562110; Aze T, 2011, BIOL REV, V86, P900, DOI 10.1111/j.1469-185X.2011.00178.x; BANDY O L, 1972, Micropaleontology (New York), V18, P294, DOI 10.2307/1485010; BANDY ORVILLE L., 1967, CONTRIB CUSHMAN FOUND FORAMINIFERAL RES, V18, P152; BE AWH, 1968, SCIENCE, V161, P881, DOI 10.1126/science.161.3844.881; BELLIER JP, 1992, CR ACAD SCI II, V314, P637; Berggren W.A., 2006, SPECIAL PUBLICATION, P257; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; Berggren W.A., 2006, SPECIAL PUBLICATION, V41, P377; Berggren WA, 2005, J FORAMIN RES, V35, P279, DOI 10.2113/35.4.279; Berggren WA, 1997, MICROPALEONTOLOGY, V43, P1, DOI 10.2307/1485988; Blow W.H., 1979, CAINOZOIC GLOBIGERIN; Bolli H.M., 1985, P155; Bolli H.M., 1985, PLANKTON STRATIGRAPH; CAIN AJ, 1953, EVOLUTION, V7, P76, DOI 10.2307/2405573; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; CIFELLI R, 1969, SYST ZOOL, V18, P154, DOI 10.2307/2412601; Cohen K.M., 2018, ICS INT CHRONOSTRATI; Coxall Helen K., 2006, Cushman Foundation for Foraminiferal Research Special Publication, V41, P213; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; DHONDT SL, 1991, J FORAMIN RES, V21, P168, DOI 10.2113/gsjfr.21.2.168; Etienne RS, 2012, P ROY SOC B-BIOL SCI, V279, P1300, DOI 10.1098/rspb.2011.1439; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Ezard THG, 2009, PALEOBIOLOGY, V35, P460, DOI 10.1666/0094-8373-35.3.460; Fleisher RS, 1974, INITIAL REPORTS DEEP, V23; Fordham BG, 2018, FUTURE PROOFING CENO, DOI [10.25911/5b8df50c1f2bd, DOI 10.25911/5B8DF50C1F2BD]; Fordham BG, 1979, CHRONOCLADOGENY CORR; Fordham BG, 2018, RELATIONAL DATABASE, P5528, DOI [10.25911/5b8df4bfb5ac9, DOI 10.25911/5B8DF4BFB5AC9]; Fordham BG, 1986, MIOCENE PLEISTOCENE, V6; Fordham BG, 2016, INT GEOL C CAP TOWN, V35; Fordham BG, 2018, CENOZOIC MACROPERFOR, P5529, DOI [10.25911/5b8df4ddb9497, DOI 10.25911/5B8DF4DDB9497]; Gee H, 2001, PAL ASS NEWSL, V47, P33; George T. N., 1956, SPECIES CONCEPT PALE, P123; Gingerich PD, 1976, PAPERS PALEONTOLOGY, V15; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Haller C, 2013, THIRD GEOLOGICAL PRO; Harland W.B., 1990, GEOLOGIC TIME SCALE; HARLAND WB, 1982, GEOLOGIC TIME SCALE; Hayward BW, 2018, WORLD FORAMINIFERA D, DOI [10.14284/170, DOI 10.14284/170]; Huber BT, 2016, MICROPALEONTOLOGY, V62, P429; Huber BT, FORAMINIFERAL DATABA; HUXLEY T. H., 1862, Q J GEOL SOC LOND, V18, pxl, DOI [DOI 10.1144/GSL.JGS.1862.018.01-02.07, 10.1144/gsl.jgs.1862.018.01-02.07]; Kennett J.P., 1983, NEOGENE PLANKTONIC F; Kucera M, 2007, DEV MARINE GEOL, V1, P213, DOI 10.1016/S1572-5480(07)01011-1; LAZARUS D, 1994, MATH GEOL, V26, P817, DOI 10.1007/BF02083119; LAZARUS DB, 1984, J PALEONTOL, V58, P163; Lazarus DB, NEPTUNE DEEP SEA MIC; LI QY, 1991, PALAEOGEOGR PALAEOCL, V83, P87, DOI 10.1016/0031-0182(91)90077-5; Mayden R.L., 1997, Systematics Association Special Volume Series, V54, P381; McGowran B., 2005, MICROFOSSILS GEOLOGI; McGOWRAN BRIAN, 1968, MICROPALEONTOL, V14, P179, DOI 10.2307/1484733; Morard R, 2016, SYST BIOL, V65, P925, DOI 10.1093/sysbio/syw031; Norell MA, 1992, EXTINCTION PHYLOGENY, P90; Ogg J, 2006, EPISODES, V29, P65; Ogg J.G., 2008, CONCISE GEOLOGIC TIM; Ogg JG, 2016, CONCISE GEOLOGIC TIME SCALE 2016, P1; Ogg JG, 2018, TIMESCALE CREATOR JA; Ogg JG, 2012, MANUALS TIMESCALE CR; Ogg JG, 2005, TIMESCALE CREATOR; Olsson Richard K., 2006, Cushman Foundation for Foraminiferal Research Special Publication, V41, P111; OLSSON RK, 1992, J FORAMIN RES, V22, P195, DOI 10.2113/gsjfr.22.3.195; Pearson P.N., 2006, ATLAS EOCENE PLANKTO, V41; Pearson PN, 2014, PALAEONTOLOGY, V57, P243, DOI 10.1111/pala.12064; Pearson PN, 2014, PALEOBIOLOGY, V40, P130, DOI 10.1666/13004; PEARSON PN, 1993, MICROPALEONTOLOGY, V39, P193, DOI 10.2307/1485898; PEARSON PN, 1992, PALEOBIOLOGY, V18, P115, DOI 10.1017/S0094837300013920; Pearson PN, 1998, NATURE DEBATES  1119; Schiebel R., 2017, PLANKTIC FORAMINIFER, DOI DOI 10.1007/978-3-662-50297-6; SCOTT GH, 1985, PALAEONTOLOGY, V28, P777; Soldan DM, 2011, J FORAMIN RES, V41, P260, DOI 10.2113/gsjfr.41.3.260; Spencer-Cervato C., 1999, PALAEONTOL ELECTRON, V2, P270; Spezzaferri S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128108; Srinivasan M.S., 1976, P329; STAINFORTH R M, 1975, University of Kansas Paleontological Contributions Article, P1; STANLEY SM, 1988, PALEOBIOLOGY, V14, P235, DOI 10.1017/S0094837300011970; STEINECK PL, 1971, TEX J SCI, V23, P167; STEINECK PL, 1978, J PALEONTOL, V52, P618; Stewart DRM, 2003, EVOLUTION NEOGENE GL; Strotz LC, 2013, P NATL ACAD SCI USA, V110, pE2947, DOI 10.1073/pnas.1308351110; Strotz LC, 2013, P NATL ACAD SCI USA, V110, P2904, DOI 10.1073/pnas.1208302110; Toumarkine M., 1985, P87; Wade B. S., 2018, ATLAS OLIGOCENE PLAN, V46; Wade BS, 2011, EARTH-SCI REV, V104, P111, DOI 10.1016/j.earscirev.2010.09.003; Wagner PJ, 2000, SYST BIOL, V49, P65, DOI 10.1080/10635150050207393; Wheeler Q, 2000, SPECIES CONCEPTS PHY; Young J, PFORAMS MIKROTAX	91	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0204625	10.1371/journal.pone.0204625	http://dx.doi.org/10.1371/journal.pone.0204625			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379910	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000448823700017
J	Gao, F; Wang, MZ; Liu, XJ; Wang, ZR				Gao, Fei; Wang, Meizhen; Liu, Xuejun; Wang, Ziran			A multi-objective scheduling optimization algorithm of a camera network for directional road network coverage	PLOS ONE			English	Article							BARRIER COVERAGE	Effective video monitoring systems require optimization of camera and road network coverage, to exploit fully the hardware and software solutions in smart city traffic applications. Monitoring requirements have grown increasingly diverse as scenes are becoming increasingly complex, thereby transforming the camera and road network coverage optimization issue into a nonlinear, high-dimension, and multi-objective problem. Previous research on this topic however, has focused on a single, specific optimization objective, which may result in invalid optimization results in actual applications. To extend this research, we propose a multi-objective scheduling optimization algorithm for a camera network that addresses the problem of directional road network coverage. In this solution, we incorporate an expanding parameter of main optical axes into particle swarm optimization algorithm. Our new strategy divides the range of main optical axes of all the cameras to control the scheduling number, achieving collaborative optimization of multiple objectives. In a simulated camera and road network, an experiment was designed for evaluating the effectiveness of the proposed method, comparing the distribution of optimization results with the global and local optimal solutions of the true value. A second experiment compared the distribution, performance and running time of the optimization results with different values of expanding parameter of main optical axes. A third experiment compared the performance of the optimization solutions with different values of camera parameters. The results showed that the proposed method can adapt to user application preference, and is effective and robust to schedule and allocate monitoring resources in different scenarios.	[Gao, Fei; Wang, Meizhen; Liu, Xuejun] Nanjing Normal Univ, Key Lab Virtual Geog Environm, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Gao, Fei; Wang, Meizhen; Liu, Xuejun] State Key Lab Cultivat Base Geog Environm Evolut, Nanjing, Jiangsu, Peoples R China; [Gao, Fei; Wang, Meizhen; Liu, Xuejun] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing, Jiangsu, Peoples R China; [Wang, Ziran] Nanjing Normal Univ, Taizhou Coll, Taizhou, Peoples R China; [Wang, Meizhen] Nanjing Normal Univ, Sch Geog Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Normal University; Taizhou University; Nanjing Normal University	Wang, MZ (corresponding author), Nanjing Normal Univ, Key Lab Virtual Geog Environm, Minist Educ, Nanjing, Jiangsu, Peoples R China.; Wang, MZ (corresponding author), State Key Lab Cultivat Base Geog Environm Evolut, Nanjing, Jiangsu, Peoples R China.	wangmeizhen@njnu.edu.cn	WANG, Meizhen/ABD-9709-2021	WANG, Meizhen/0000-0002-4135-5073; Gao, Fei/0000-0002-2739-5634	National Natural Science Foundation of China [41771420]; National Key Research and Development Program [2016YFE0131600]; Priority Academic Program Development of Jiangsu Higher Education Institutions [164320H116]; Project of Natural Science Research in Colleges and Universities in Jiangsu Province [18KJB170007]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX17_1067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program; Priority Academic Program Development of Jiangsu Higher Education Institutions; Project of Natural Science Research in Colleges and Universities in Jiangsu Province; Postgraduate Research & Practice Innovation Program of Jiangsu Province	This work was supported by National Natural Science Foundation of China (Granted No. 41771420, http://www.nsfc.gov.cn); National Key Research and Development Program (Granted No. 2016YFE0131600, http://www.most.gov.cn); Priority Academic Program Development of Jiangsu Higher Education Institutions (Granted No. 164320H116, http://www.jstd.gov.cn); Project of Natural Science Research in Colleges and Universities in Jiangsu Province (Granted No. 18KJB170007, http://www.jstd.gov.cn); Postgraduate Research & Practice Innovation Program of Jiangsu Province (Granted No. KYCX17_1067, http://www.jstd.gov.cn).	Bader J, 2011, EVOL COMPUT, V19, P45, DOI 10.1162/EVCO_a_00009; Becker E., 2009, P 2 INT C PERVS TECH, V8, P1, DOI [10.1145/1579114.1579150, DOI 10.1145/1579114.1579150]; Cheng CF, 2012, IEEE SENS J, V12, P1726, DOI 10.1109/JSEN.2011.2177966; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM; Deb K, 2014, IEEE T EVOLUT COMPUT, V18, P577, DOI 10.1109/TEVC.2013.2281535; Gupta Ankit, 2012, INT C INT ADV SYST, DOI [10.1109/ICIAS.2012.6306216, DOI 10.1109/ICIAS.2012.6306216]; Huang C.-F, 2003, P 2 ACM INT C WIR SE, P115, DOI [DOI 10.1145/941350.941367, 10.1145/941350.941367]; Huband S, 2003, IEEE C EVOL COMPUTAT, P2284; Jian Zhao, 2012, CAMERA PLANNING FUSI; JU Y, 2016, SCI REP UK, V6, P15660; Lee H. W., 2009, 2009 Conference on Lasers & Electro-Optics Europe & 11th European Quantum Electronics Conference (CLEO/EQEC), DOI 10.1109/CLEOE-EQEC.2009.5196281; Ma HD, 2009, IEEE INFOCOM SER, P2791, DOI 10.1109/INFCOM.2009.5062233; Mark Fleischer, 2002, LECT NOTES COMPUTER, V2632, P519, DOI [10.1007/3-540-36970-8_37, DOI 10.1007/3-540-36970-8_37]; Raquel CR, 2005, GECCO 2005: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOLS 1 AND 2, P257; Shi Ruifeng, 2006, STUDIES MUTIOBJECTIV; Sung TW, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/165498; Tao D, 2015, IEEE SENS J, V15, P876, DOI 10.1109/JSEN.2014.2310180; Tao D, 2012, COMPUT COMMUN, V35, P895, DOI 10.1016/j.comcom.2012.01.022; Tian Y, 2018, IEEE T EVOLUT COMPUT, V22, P609, DOI 10.1109/TEVC.2017.2749619; [王文峰 WANG WenFeng], 2007, [计算机科学, Computer Science], V34, P143; While L, 2006, IEEE T EVOLUT COMPUT, V10, P29, DOI 10.1109/TEVC.2005.851275; Wu YB, 2012, INT CON DISTR COMP S, P556, DOI 10.1109/ICDCS.2012.9; [肖甫 Xiao Fu], 2009, [计算机研究与发展, Journal of Computer Research and Development], V46, P2126; Xu YC, 2011, EURASIP J IMAGE VIDE, DOI 10.1155/2011/458283; Zhang XY, 2015, IEEE T EVOLUT COMPUT, V19, P761, DOI 10.1109/TEVC.2014.2378512; Zhao L, 2014, INT J DISTRIB SENS N, DOI 10.1155/2014/596983	27	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206038	10.1371/journal.pone.0206038	http://dx.doi.org/10.1371/journal.pone.0206038			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379925	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700085
J	de Aguilar, JR; Castillo, F; Moreno, A; Penafiel, N; Browne, L; Walter, ST; Karubian, J; Bonaccorso, E				Rivero de Aguilar, Juan; Castillo, Fernando; Moreno, Andrea; Penafiel, Nicolas; Browne, Luke; Walter, Scott T.; Karubian, Jordan; Bonaccorso, Elisa			Patterns of avian haemosporidian infections vary with time, but not habitat, in a fragmented Neotropical landscape	PLOS ONE			English	Article							BLOOD PARASITES; PASSERINE BIRDS; DISEASE RISK; MALARIA; PREVALENCE; FOREST; DIVERSITY; HOST; VECTOR; WILD	Habitat loss has the potential to alter vertebrate host populations and their interactions with parasites. Theory predicts a decrease in parasite diversity due to the loss of hosts in such contexts. However, habitat loss could also increase parasite infections as a result of the arrival of new parasites or by decreasing host immune defenses. We investigated the effect of habitat loss and other habitat characteristics on avian haemosporidian infections in a community of birds within a fragmented landscape in northwest Ecuador. We estimated Plasmodium and Haemoproteus parasite infections in 504 individual birds belonging to 8 families and 18 species. We found differences in infection status among bird species, but no relationship between forest fragment characteristics and infection status was observed. We also found a temporal effect, with birds at the end of the five-month study (which ran from the end of the rainy season thru the dry season), being less infected by Plasmodium parasites than individuals sampled at the beginning. Moreover, we found a positive relationship between forest area and Culicoides abundance. Taken as a whole, these findings indicate little effect of fragment characteristics per se on infection, although additional sampling or higher infection rates would have offered more power to detect potential relationships.	[Rivero de Aguilar, Juan; Penafiel, Nicolas; Bonaccorso, Elisa] Univ Tecnol Indoamer, Ctr Invest Biodiversidad & Cambio Climat, Quito, Pichincha, Ecuador; [Castillo, Fernando; Moreno, Andrea; Browne, Luke; Karubian, Jordan] Fdn Conservac Andes Trop, Quito, Pichincha, Ecuador; [Browne, Luke; Karubian, Jordan] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Walter, Scott T.] Texas State Univ, Dept Biol, San Marcos, TX USA; [Bonaccorso, Elisa] Univ San Francisco Quito, Inst BIOSFERA, Quito, Pichincha, Ecuador; [Bonaccorso, Elisa] Univ San Francisco Quito, Colegio Ciencias Biol & Ambientales, Quito, Pichincha, Ecuador; [Rivero de Aguilar, Juan] Univ Chile, IEB, Santiago, Region Metropol, Chile	Tulane University; Texas State University System; Texas State University San Marcos; Universidad de Chile	de Aguilar, JR (corresponding author), Univ Tecnol Indoamer, Ctr Invest Biodiversidad & Cambio Climat, Quito, Pichincha, Ecuador.; de Aguilar, JR (corresponding author), Univ Chile, IEB, Santiago, Region Metropol, Chile.	juanrdac@gmail.com	de Aguilar, Juan Rivero/AAL-3311-2021	RIVERO DE AGUILAR, JUAN/0000-0002-4746-5759	Conservation Food and Health Foundation; Conservation, Research and Education Opportunities International; Disney Conservation Fund; National Science Foundation [1548548, 1501514]; Ornithological Council; Tulane University; United States Fish and Wildlife Service; Universidad Tecnologica Indoamerica (convocatoria a proyectos 2014); Universidad San Francisco de Quito [HUBI 5433]	Conservation Food and Health Foundation; Conservation, Research and Education Opportunities International; Disney Conservation Fund; National Science Foundation(National Science Foundation (NSF)); Ornithological Council; Tulane University; United States Fish and Wildlife Service(US Fish & Wildlife Service); Universidad Tecnologica Indoamerica (convocatoria a proyectos 2014); Universidad San Francisco de Quito	This work received financial support from Conservation Food and Health Foundation; Conservation, Research and Education Opportunities International; Disney Conservation Fund; National Science Foundation (EAGER #1548548, DDIG #1501514); Ornithological Council; Tulane University; the United States Fish and Wildlife Service; Universidad Tecnologica Indoamerica (convocatoria a proyectos 2014) and Universidad San Francisco de Quito (proyecto HUBI 5433).	Anciaes M, 2000, J APPL ECOL, V37, P1013, DOI 10.1046/j.1365-2664.2000.00554.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Barton K., 2015, MULTIMODEL INFERENCE; BASTO NATALIA, 2006, Caldasia, V28, P371; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BEAUDOIN R L, 1971, Journal of Wildlife Diseases, V7, P5; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Bonneaud C, 2009, J TROP ECOL, V25, P439, DOI 10.1017/S0266467409006178; Borkent A., 2007, AQUATIC BIODIVERSITY, V4, P1; Brown JH, 2014, J BIOGEOGR, V41, P8, DOI 10.1111/jbi.12228; Browne L, 2016, BOT J LINN SOC, V182, P451, DOI 10.1111/boj.12384; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carrasco L, 2013, ORNITOL NEOTROP, V24, P321; Chasar A, 2009, MOL ECOL, V18, P4121, DOI 10.1111/j.1365-294X.2009.04346.x; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Cornet S, 2013, ECOL LETT; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, GENEIOUS V5 4; Duraes R, 2013, BIOL CONSERV, V166, P203, DOI 10.1016/j.biocon.2013.07.007; Fecchio A, 2017, PARASITOLOGY, V144, P1117, DOI 10.1017/S003118201700035X; Ferraguti M, 2018, J ANIM ECOL, V87, P727, DOI 10.1111/1365-2656.12805; Ferreira FC, 2017, PLOS ONE, P12; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Froeschke G, 2013, INT J PARASITOL, V43, P1109, DOI 10.1016/j.ijpara.2013.07.003; Gangoso L, 2018, INT J PARASITOL; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hall T., 2011, GERF B BIOSCI, V2, P60; Harbach R. E., 2013, MOSQUITO TAXONOMIC I; Harrigan RJ, 2014, EVOL APPL, V7, P799, DOI 10.1111/eva.12176; Hernandez-Lara C, 2017, LANDSCAPE URBAN PLAN, V157, P151, DOI 10.1016/j.landurbplan.2016.05.025; International BirdLife, 2015, IMP BIRD AR FACTSH M; Johnstone CP, 2012, J COMP PHYSIOL B, V182, P861, DOI 10.1007/s00360-012-0656-9; Jovani R, 2006, TRENDS PARASITOL, V22, P214, DOI 10.1016/j.pt.2006.02.011; Kamiya T, 2014, ECOGRAPHY, V37, P689, DOI 10.1111/j.1600-0587.2013.00571.x; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Knowles SCL, 2011, MOL ECOL, V20, P1062, DOI 10.1111/j.1365-294X.2010.04909.x; Kurosawa R, 2003, CONSERV BIOL, V17, P695, DOI 10.1046/j.1523-1739.2003.01118.x; Lacorte GA, 2013, PLOS ONE, P8; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; Laurance SGW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076227; Lebarbenchon C, 2008, MOL ECOL, V17, P475, DOI 10.1111/j.1365-294X.2007.03375.x; Loiseau C, 2010, J PARASITOL, V96, P21, DOI 10.1645/GE-2123.1; Martinez-Abrain A, 2004, ARDEOLA, V51, P225; Martinez-de la Puente J, 2010, BIOL LETTERS, V6, P663, DOI 10.1098/rsbl.2010.0046; Marzal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021905; Matta NE, 2017, BIOL COLLECTION GERP; Mbora DNM, 2009, J ANIM ECOL, V78, P210, DOI 10.1111/j.1365-2656.2008.01481.x; McCallum H, 2002, P ROY SOC B-BIOL SCI, V269, P2041, DOI 10.1098/rspb.2002.2079; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; Miller MA, 2015, XSEDE 15 P 2015 XSED, V39, P1, DOI [DOI 10.1145/2792745.2792784, 10.1145/2792745.2792784]; Moens MAJ, 2016, INT J PARASITOL, V46, P41, DOI 10.1016/j.ijpara.2015.08.001; Njabo KY, 2011, MOL ECOL, V20, P1049, DOI 10.1111/j.1365-294X.2010.04904.x; Ogrzewalska M, 2011, ECOHEALTH, V8, P320, DOI 10.1007/s10393-011-0726-6; Olanga EA, 2010, MALARIA J, P9; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Perez-Ramirez E, 2014, VIRUSES-BASEL, V6, P752, DOI 10.3390/v6020752; Perez-Tris J, 2005, TRENDS PARASITOL, V21, P209, DOI 10.1016/j.pt.2005.03.001; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; Perkins SL, 2014, J PARASITOL, V100, P11, DOI 10.1645/13-362.1; QGIS Development Team, 2015, QGIS GEOGR INF SYST; R Development Core Team RFFSC, 2008, R LANG ENV STAT COMP, P2673; Reiter ME, 2007, J MED ENTOMOL, V44, P861, DOI 10.1603/0022-2585(2007)44[861:LFITSD]2.0.CO;2; Remsen J.V.J., 2021, CLASSIFICATION BIRD; Ribeiro SF, 2005, PARASITOLOGY, V130, P261, DOI 10.1017/S0031182004006596; Ridgely RS, 2006, AVES; Ridgely RS, 2006, AYES DE ECUADOR; Roche B, 2011, CR BIOL, V334, P385, DOI 10.1016/j.crvi.2011.02.008; Sebaio F, 2012, REV BRAS PARASITOL V, V21, P7, DOI 10.1590/S1984-29612012000100003; Sehgal RNM, 2010, J EXP BIOL, V213, P955, DOI 10.1242/jeb.037663; Sehgal RNM, 2015, INT J PARASITOL-PAR, V4, P421, DOI 10.1016/j.ijppaw.2015.09.001; Svensson LME, 2009, PARASITOLOGY, V136, P1121, DOI 10.1017/S0031182009990497; Valkiunas G., 2005, AVIAN MALARIA PARASI; Valkiunas G, 2017, DATABASE HAEMOSPORID; van Rooyen J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-139; Vaz VC, 2007, PARASITOLOGY, V134, P1785, DOI 10.1017/S003118200700323X; Venables W. N., 2002, ISSUES ACCURACY SCAL, P868, DOI DOI 10.1198/TECH.2003.S33; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Whitcomb R.F., 1981, Ecological Studies, V41, P125; Young H, 2013, ECOL LETT, V16, P656, DOI 10.1111/ele.12094; Zuur A, 2009, MIXED EFFECTS MODELS; Zwickl D. J, 2006, GENETIC ALGORITHM AP	83	13	13	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206493	10.1371/journal.pone.0206493	http://dx.doi.org/10.1371/journal.pone.0206493			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379912	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700123
J	Wilhelmson, S; Mansson, F; Lindman, JL; Biai, A; Esbjornsson, J; Norrgren, H; Jansson, M; Medstrand, P				Wilhelmson, Sten; Mansson, Fredrik; Lindman, Jacob Lopatko; Biai, Ansu; Esbjornsson, Joakim; Norrgren, Hans; Jansson, Marianne; Medstrand, Patrik		SWEGUB CORE Grp	Prevalence of HIV-1 pretreatment drug resistance among treatment naive pregnant women in Bissau, Guinea Bissau	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; EPIDEMIOLOGY; SURVEILLANCE; TRANSMISSION; INDIVIDUALS; DIVERSITY; INFECTION; SUBTYPES	Background With increased access to antiretroviral treatment (ART) in sub-Saharan Africa emergence of HIV-1 pretreatment drug resistance constitutes a serious risk. This may lead to rapid virological failure in subjects initiating ART, and mother-to-child transmission despite prophylaxis. Methods Treatment-naive pregnant women from four antenatal care clinics in Bissau, Guinea-Bissau, were enrolled from October 2016 to November 2017. Genotypic resistance testing and phylogenetic subtype analysis was performed on 48 specimens. Results Forty eight women met the survey inclusion criteria. All specimens were successfully amplified and genotyped. Specimens from five women were associated with HIV-1 drug resistance mutations. Four carried mutations exclusively linked to non-nucleoside reverse transcriptase inhibitors (NNRTIs) (K103N, K103N/S) and one carried mutations to both NNRTIs (G190S, K101E) and nucleoside reverse transcriptase inhibitors (NRTIs) (M184V). These results corresponded to 10.4% (95% CI: 4.5-22.2%), 2.1% (95% CI: 0.4-10.9%) and 0% (95% CI: 0.0-7.4%) drug resistance mutations to NNRTIs, NRTIs and protease inhibitors, respectively. HIV-1 circulating recombinant form 02AG was most commonly found, followed by HIV-1 sub-subtype A3. Subtype/CRF was not associated with drug resistance mutations. Conclusion Our study reports a 10.4% prevalence of pretreatment drug resistance to NNRTIs in HIV-1-infected pregnant women in the capital Bissau, Guinea Bissau. Since NNRTIs are part of first-line ART in the country, baseline resistance screenings or adjustment of national treatment guidelines should be considered as antiretroviral treatment programs are scaled up.	[Wilhelmson, Sten; Mansson, Fredrik; Medstrand, Patrik] Lund Univ, Dept Translat Med, Malmo, Sweden; [Lindman, Jacob Lopatko; Norrgren, Hans] Lund Univ, Dept Clin Sci Lund, Lund, Sweden; [Biai, Ansu] Natl Publ Hlth Lab, Bissau, Guinea Bissau; [Esbjornsson, Joakim; Jansson, Marianne] Lund Univ, Dept Lab Med, Lund, Sweden	Lund University; Lund University; Lund University	Medstrand, P (corresponding author), Lund Univ, Dept Translat Med, Malmo, Sweden.	patrik.medstrand@med.lu.se		Esbjornsson, Joakim/0000-0002-3822-4953; Mansson, Fredrik/0000-0002-2802-0420; Jansson, Marianne/0000-0001-6536-8146; Lindman, Jacob/0000-0002-2034-464X	Doctors against AIDS Research Foundation, Sweden; Swedish Research Council, Sweden	Doctors against AIDS Research Foundation, Sweden; Swedish Research Council, Sweden(Swedish Research Council)	This work was supported by Doctors against AIDS Research Foundation, Sweden, and the Swedish Research Council, Sweden (No grant numbers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165333; Bennett DE, 2008, ANTIVIR THER, P42, DOI [10.1128/JCM.06689-11, DOI 10.1128/JCM.06689-11]; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bonney E Y, 2013, Ghana Med J, V47, P82; de Pina-Araujo IIM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096201; Esbjornsson J, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew010; Esbjornsson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017025; Frentz D, 2012, AIDS REV, V14, P17; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gregson J, 2016, LANCET INFECT DIS, V16, P565, DOI 10.1016/S1473-3099(15)00536-8; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Haidara A, 2010, HIV MED, V11, P404, DOI 10.1111/j.1468-1293.2009.00806.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Health GBMo, 2016, GEN DIR PREV PROM HL; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hu DJ, 2001, AIDS, V15, P683, DOI 10.1097/00002030-200104130-00003; Imade GE, 2014, AIDS RES HUM RETROV, V30, P127, DOI [10.1089/aid.2013.0074, 10.1089/AID.2013.0074]; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jespersen S, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0273-9; Kasang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023091; Los Alamos National Database, 2017, HIV SEQ DAT; Maiga AI, 2013, AIDS RES HUM RETROV, V29, P182, DOI [10.1089/AID.2012.0118, 10.1089/aid.2012.0118]; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Meloni ST, 2004, J VIROL, V78, P12438, DOI 10.1128/JVI.78.22.12438-12445.2004; Morrison CS, 2010, AIDS, V24, P573, DOI 10.1097/QAD.0b013e32833433df; Murillo W, 2010, HIV MED, V11, P95, DOI 10.1111/j.1468-1293.2009.00747.x; Myatt M, 2008, ANTIVIR THER, V13, P37; Neilson JR, 1999, J VIROL, V73, P4393, DOI 10.1128/JVI.73.5.4393-4403.1999; Oliveira V, 2012, AIDS RES HUM RETROV, V28, P510, DOI [10.1089/aid.2011.0174, 10.1089/AID.2011.0174]; Palm AA, 2014, J INFECT DIS, V209, P721, DOI 10.1093/infdis/jit416; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; Renjifo B, 2001, J HUMAN VIROL, V4, P16; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Somda A, 2012, CLIN INFECT DIS, V54, pS317, DOI 10.1093/cid/cir988; Stanford University HIV Drug resistance Database, 2018, HIVDB PROGR GEN RES, DOI [10.1371/journal.pone.0004724, DOI 10.1371/JOURNAL.PONE.0004724]; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Tilghman MW, 2014, HIV MED, V15, P339, DOI 10.1111/hiv.12122; UNAIDS, 2016, COUNTR FACTSH GUIN B; Wainberg MA, 2010, VIRUSES-BASEL, V2, P2493, DOI 10.3390/v2112493; Wallis CL, 2017, J INFECT DIS, V216, pS851, DOI 10.1093/infdis/jix409; WHO, 2018, GLOB ACT PLAN HIV DR; Winand R, 2015, AIDS, V29, P2045, DOI 10.1097/QAD.0000000000000811; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11; World Bank, 2018, GUIN BISS 2018; World Health Organization, 2018, GLOB REP EARL WARN I; World Health Organization, 2017, GUID PUBL HLTH RRESP; World Health Organization, 2018, WHAT ART REG START 1; ZHOU ZY, 2011, PLOS ONE, V6, P15660	51	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206406	10.1371/journal.pone.0206406	http://dx.doi.org/10.1371/journal.pone.0206406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379960	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700110
J	Zhou, W; Ma, TT; Chen, LK; Wu, LH; Luo, YM				Zhou, Wei; Ma, Tingting; Chen, Like; Wu, Longhua; Luo, Yongming			Application of catastrophe theory in comprehensive ecological security assessment of plastic greenhouse soil contaminated by phthalate esters	PLOS ONE			English	Article							BUTTERFLY CATASTROPHE; FILM GREENHOUSES; RISK-ASSESSMENT; HEALTH-RISK; VEGETABLES; COMMUNITY; CHINA; DIVERSITY; SYSTEMS; EXAMPLE	Large amount of phthalate esters (PAEs) used as plasticizers in polyvinyl chloride (PVC) products has caused ubiquitous contamination to the environment and potential ecology security risk all around the world, especially in places plastic films were indispensably utilized due to the widely proposing of facility agriculture in China. A case of PAEs contamination in four suburb areas of Nanjing was analyzed and discussed in this study. A new frame work has been put forward based on multi-criteria evaluation model and mathematical method of catastrophe theory, using farming work, laboratory determination and relevant environmental standards to measure the ecology security risk of PAEs in study areas. The factors were selected based on the availability of the data and the local conditions. The assessment model involves the contamination status of PAEs in soil and vegetables, the contamination effects of PAEs to human and soil organisms and the contamination source of PAEs from plastic films and other products in the four study facility agriculture areas. An evaluation system of the model was composed of thirteen mesosphere indicators and twenty-five underlying indicators including total PAEs concentration in soils, single PAE concentration in soils, total PAEs concentrations in roots, leafy, solanaceous and stem vegetables, PAE human risks, soil microbial counts, microorganism diversity indices, atmospheric deposition of PAEs, whether sewage wastewater irrigation, planting mode of the facility agriculture areas and climate condition of study areas. The modified evaluation system was used in the assessment of ecology security of the same place based on the data of 2012, and the results suggested that the ecology security indicators were reliable and were agree well with the practical situation of the study areas. The results could provide guidance for the application of health risk assessment of soil environment for the strong objectivity of catastrophe theory compared with other evaluation methods.	[Zhou, Wei] Hubei Univ Arts & Sci, Sch Civil Engn & Architecture, Xiangyang, Peoples R China; [Ma, Tingting] Hubei Univ Arts & Sci, Inst Hanjiang, Xiangyang, Peoples R China; [Ma, Tingting; Wu, Longhua; Luo, Yongming] Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing, Jiangsu, Peoples R China; [Chen, Like] Shanghai Res Inst Chem Ind, Shanghai, Peoples R China; [Luo, Yongming] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Zone Environm Proc, Yantai, Peoples R China	Hubei University of Arts & Science; Hubei University of Arts & Science; Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS	Ma, TT (corresponding author), Hubei Univ Arts & Sci, Inst Hanjiang, Xiangyang, Peoples R China.; Ma, TT (corresponding author), Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing, Jiangsu, Peoples R China.	ttma@issas.ac.cn			National Natural Science Foundation of China [41877127, 41401581]; Natural Science Fund of Hubei Province [2018CFC873, 2017CFC878]; Key Laboratory of Original Agro-Environmental Pollution Prevention and Control, Ministry of Agriculture / Tianjin Key Laboratory of Agro-environment and Safe-product; Highway Science and Technology Project of The Highway Administration Bureau of the Traffic and Transportation Department of Hubei Province in 2018; Key Laboratory of Soil Environment and Pollution Remediation, Institute of Soil Science, Chinese Academy of Sciences [SEPR2017-02]; Training Fund Program for Scientific Research of Hubei University of Arts and Science [2017 KYPY002]; Startup Scientific Research Funds for Doctors of Hubei University of Arts and Science [2020170320]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Hubei Province; Key Laboratory of Original Agro-Environmental Pollution Prevention and Control, Ministry of Agriculture / Tianjin Key Laboratory of Agro-environment and Safe-product; Highway Science and Technology Project of The Highway Administration Bureau of the Traffic and Transportation Department of Hubei Province in 2018; Key Laboratory of Soil Environment and Pollution Remediation, Institute of Soil Science, Chinese Academy of Sciences; Training Fund Program for Scientific Research of Hubei University of Arts and Science; Startup Scientific Research Funds for Doctors of Hubei University of Arts and Science	We gratefully acknowledge funding from the National Natural Science Foundation of China (41877127 and 41401581), the Natural Science Fund of Hubei Province (2018CFC873 and 2017CFC878), Key Laboratory of Original Agro-Environmental Pollution Prevention and Control, Ministry of Agriculture / Tianjin Key Laboratory of Agro-environment and Safe-product, the Highway Science and Technology Project of The Highway Administration Bureau of the Traffic and Transportation Department of Hubei Province in 2018, the Key Laboratory of Soil Environment and Pollution Remediation, the Institute of Soil Science, Chinese Academy of Sciences (SEPR2017-02), the Training Fund Program for Scientific Research of Hubei University of Arts and Science (2017 KYPY002) and the Startup Scientific Research Funds for Doctors of Hubei University of Arts and Science (2020170320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dhabaan FAM, 2017, SAUDI J BIOL SCI, V24, P901, DOI 10.1016/j.sjbs.2016.01.043; Babu-Rajendran R, 2018, J CHROMATOGR B, V1079, P15, DOI 10.1016/j.jchromb.2018.01.039; Bai LY, 2014, J MT SCI-ENGL, V11, P1231, DOI 10.1007/s11629-014-3056-7; Boerlijst MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062033; Chen Y, 2016, J TAIWAN INST CHEM E, V60, P430, DOI 10.1016/j.jtice.2015.10.048; Dan J, 2016, PLOS ONE, V11, DOI [10.1371/004101.0000.0158482, DOI 10.1371/004101.0000.0158482]; Jorgensen S.E., 2002, INTEGRATION ECOSYSTE; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; KOZAK JJ, 1974, P NATL ACAD SCI USA, V71, P1977, DOI 10.1073/pnas.71.5.1977; [李绍飞 LI Shaofei], 2007, [水利学报, Journal of Hydraulic Engineering], V38, P1312; Li XY, 2008, J ENVIRON SCI-CHINA, V20, P619, DOI 10.1016/S1001-0742(08)62103-8; LOEHLE C, 1989, ECOL MODEL, V49, P125, DOI 10.1016/0304-3800(89)90047-1; Luo K, 2014, THESIS; Ma TT, 2015, ENVIRON SCI POLLUT R, V22, P12018, DOI 10.1007/s11356-015-4401-2; Ma TT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173957; Ma TT, 2016, EUR J SOIL BIOL, V76, P53, DOI 10.1016/j.ejsobi.2016.07.004; Ma TT, 2016, ENVIRON SCI POLLUT R, V23, P15101, DOI 10.1007/s11356-016-6644-y; Ma TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151128; Ma TT, 2013, FRONT ENV SCI ENG, V7, P31, DOI 10.1007/s11783-012-0463-2; Ma TT, 2012, EUR J SOIL BIOL, V50, P76, DOI 10.1016/j.ejsobi.2011.12.001; McKee RH, 2004, REPROD TOXICOL, V18, P1, DOI 10.1016/j.reprotox.2003.09.002; Ni JN, 2015, ADV INTELL SYST, V362, P903, DOI 10.1007/978-3-662-47241-5_76; Niche Hui Q., 2008, FACTOR INTERACTION B; OUIMET C, 1988, ECOL MODEL, V42, P265, DOI 10.1016/0304-3800(88)90061-0; Su SL, 2012, STOCH ENV RES RISK A, V26, P321, DOI 10.1007/s00477-011-0551-z; Su SL, 2011, STOCH ENV RES RISK A, V25, P737, DOI 10.1007/s00477-011-0457-9; Tainaka K, 1996, ECOL MODEL, V86, P125, DOI 10.1016/0304-3800(95)00038-0; Tan WB, 2018, J HAZARD MATER, V359, P9, DOI 10.1016/j.jhazmat.2018.07.026; Wang J, 2015, SCI TOTAL ENVIRON, V523, P129, DOI 10.1016/j.scitotenv.2015.02.101; Wang J, 2013, ENVIRON POLLUT, V180, P265, DOI 10.1016/j.envpol.2013.05.036; Wang LX, 2007, CHINESE J ANAL CHEM, V35, P1559; Wang LJ, 2018, CHEMOSPHERE, V191, P467, DOI 10.1016/j.chemosphere.2017.10.066; Wang WJ, 2011, ECOL MODEL, V222, P307, DOI 10.1016/j.ecolmodel.2010.09.007; Wang XJ, 2014, MITIG ADAPT STRAT GL, V19, P463, DOI 10.1007/s11027-012-9443-x; Washington-Allen RA, 2010, ENVIRON MONIT ASSESS, V160, P101, DOI 10.1007/s10661-008-0661-3; Woodstock AER, 1974, SPRINGER LECT NOTES, V373; Wu WQ, 2014, ECOL MODEL, V288, P55, DOI 10.1016/j.ecolmodel.2014.05.017; Zhang H, 2017, SCI TOTAL ENVIRON, P1505, DOI [10.1016/j.scitotenv.2017.10.163/, DOI 10.1016/J.SCITOTENV.2017.10.163/]	38	6	6	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205680	10.1371/journal.pone.0205680	http://dx.doi.org/10.1371/journal.pone.0205680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379869	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700063
J	Grati, F; Fabi, G; Scarcella, G; Guicciardi, S; Penna, P; Scanu, M; Leoni, S; Riminucci, F; Frittelloni, C; Gagliardini, L; Bolognini, L				Grati, Fabio; Fabi, Gianna; Scarcella, Giuseppe; Guicciardi, Stefano; Penna, Pierluigi; Scanu, Martina; Leoni, Simone; Riminucci, Francesco; Frittelloni, Cristina; Gagliardini, Laura; Bolognini, Luca			Artificial spawning substrates and participatory research to foster cuttlefish stock recovery: A pilot study in the Adriatic Sea	PLOS ONE			English	Article							SEPIA-OFFICINALIS EGGS; CEPHALOPODA; PREDATION; L.	This two-year study evaluates the effects of new management strategies directed at helping the recovery of Adriatic cuttlefish populations. The ability of three specially developed artificial spawning devices-seagrass collectors (SC; deployed on artificial reefs), longline collectors (LC; deployed at mussel farms), and trap collectors (TC; delivered to 19 professional and 54 recreational trap fishermen together with a dedicated logbook)-to attract egg deposition was tested. All devices were provided with a polyethylene floating rope 8 mm in diameter that served as a collector for egg deposition. Total rope length was 1,440 m in SC (2,880 segments of 0.5 m), 250 m in LC (500 segments of 0.5 m), and 250 m in TC (10 m per trap). Although the sites where SC and LC were deployed were sheltered from the action of destructive fishing gears, heavy winter storms destroyed the SC after a year. Most recreational fishermen and none of the professional fishermen provided detailed information on percent egg coverage on their collectors. The collectors attached to the three devices proved highly suitable for cuttlefish spawning, collecting more than 500,000 eggs on 2,440 m of rope. The analysis of egg diameter distribution suggested three laying events during the spawning season. The logbook data showed that egg number peaked in June. The present approach, combining habitat reconstruction and participatory research, has the potential to contribute to the recovery of cuttlefish stocks in the framework of a broader management plan.	[Grati, Fabio; Fabi, Gianna; Scarcella, Giuseppe; Guicciardi, Stefano; Penna, Pierluigi; Scanu, Martina; Bolognini, Luca] CNR, Ist Risorse Biol & Biotecnol Marine IRBIM, Ancona, Italy; [Leoni, Simone] CNR, Ist Sci Marine ISMAR, Venice, Italy; [Riminucci, Francesco] CNR, Ist Sci Marine ISMAR, Bologna, Italy; [Frittelloni, Cristina] Agenzia Serv Settore Agroalimentare Marche, Osimo Stn, Italy; [Gagliardini, Laura] PF Caccia & Pesca, Ancona, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per le Risorse Biologiche Biotecnologie Marine (IRBIM-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Grati, F (corresponding author), CNR, Ist Risorse Biol & Biotecnol Marine IRBIM, Ancona, Italy.	fabio.grati@cnr.it	Scarcella, Giuseppe/AAW-3850-2020; Penna, Pierluigi/AAE-4307-2021; Bolognini, Luca/A-3591-2014; Grati, Fabio/AAT-4760-2020	Penna, Pierluigi/0000-0003-1806-1576; Bolognini, Luca/0000-0001-6319-6723; Scarcella, Giuseppe/0000-0001-6540-1997; Riminucci, Francesco/0000-0002-2667-7357; GRATI, FABIO/0000-0002-1793-303X; Scanu, Martina/0000-0002-3212-7378; Guicciardi, Stefano/0000-0003-3539-2828	project "Protection, improvement and integrated management of the sea environment and of cross-border natural resources -ECOSEA"; EU Adriatic IPA Cross-border Cooperation 2007-2013 [2degreesord./0236/0]	project "Protection, improvement and integrated management of the sea environment and of cross-border natural resources -ECOSEA"; EU Adriatic IPA Cross-border Cooperation 2007-2013	This work was supported by the project "Protection, improvement and integrated management of the sea environment and of cross-border natural resources -ECOSEA", funded by EU Adriatic IPA Cross-border Cooperation 2007-2013 (2 degrees ord./0236/0). The authors would also like to thank Dr. Carlo Froglia for the fruitful discussion on the early draft of the manuscript.	[Anonymous], 2001, BIOL MAR MEDITERR; Arkley K, 1996, SR467 SEA FISH IND S; Barile NB, 2013, VET ITAL, V49, P367, DOI 10.12834/VetIt.1015.19; Bastardie F, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1696; Belcari P, 2002, B MAR SCI, V71, P187; Bettoso N, 2016, MEDITERR MAR SCI, V17, P152; Blanc A, 1998, FISH RES, V38, P225, DOI 10.1016/S0165-7836(98)00164-7; Boletzky S. v., 1983, P31; Boletzky S. V., 1988, RAPP COMM INT MER ME, V31, P257; Bombace G, 2000, ARTIFICIAL REEFS IN EUROPEAN SEAS, P31; Cesini D, 2004, NAT HAZARD EARTH SYS, V4, P323, DOI 10.5194/nhess-4-323-2004; Cingolani N, 96018 EU; CONNELLY NA, 1995, T AM FISH SOC, V124, P413, DOI 10.1577/1548-8659(1995)124<0413:UOADTE>2.3.CO;2; Davison AC, 2009, CAMBRIDGE SERIES STA; Domingues PM, 2002, AQUACULT INT, V10, P207, DOI 10.1023/A:1022148802078; Fabi G, 2006, CAMPO SPERIMENTALE M, P20; FAO, 2016, NON TRADITIONAL REF; Grati F, ARTIFICIAL EGGS COLL; Grati F, LONGLINE EGGS COLLEC; Grati F, SEAGRASS EGGS COLLEC; Grati F, TRAP EGGS COLLECTOR; Guerra A, 2006, VIE MILIEU, V56, P97; Guerra A, 2011, VIE MILIEU, V61, P45; Manfrin Piccinetti G., 1984, FAO FISH REP, V290, P135; Mannini A., 2015, Biologia Marina Mediterranea, V22, P1; Martins CPP, 2018, ESTUAR COAST SHELF S, V200, P437, DOI 10.1016/j.ecss.2017.11.016; Melli V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090542; Papatheochari T., 2015, PROGR ENG PRACTICES, P348, DOI 10.4018/978-1-4666-8333-4.ch011; Pomeroy RS, 2007, PRACTICAL HDB; Relini Giulio, 1999, Biologia Marina Mediterranea, V6, P1; Roper C.F., 2006, CHAMBERED NAUTILUSES, V1; Scarcella G., 2017, STOCK ASSESSMENT FOR; Silvestri R, 2016, ATT SEST C SCI NAT A, P166	33	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2018	13	10							e0205877	10.1371/journal.pone.0205877	http://dx.doi.org/10.1371/journal.pone.0205877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7AD	30376578	Green Published, gold, Green Submitted			2022-12-26	WOS:000448752400004
J	Richter, A; Gandara, AM; Silva, F; Brante, A				Richter, Alexandra; Gandara, Alberto M.; Silva, Francisco; Brante, Antonio			The alien slipper limpet Crepipatella dilatata (Lamarck, 1819) in northern Spain: A multidisciplinary approach to its taxonomic identification and invasive biology	PLOS ONE			English	Article							NUCELLA-LAPILLUS GASTROPODA; SEX-CHANGE; PHENOTYPIC PLASTICITY; CREPIDULA-FORNICATA; HATCHING SIZE; CALYPTRAEIDAE; SUCCESS; CAENOGASTROPODA; CONSEQUENCES; PERSPECTIVES	The slipper limpet Crepipatella dilatata, native to Chile and Argentina, was introduced in Spain in 2005. The species was thought to inhabit the region of Rias Bajas, yet recently, putative C. dilatata populations have been documented on the coast of north-central Spain and in the Ebro Delta of the Spanish Mediterranean. Here we undertook a multidisciplinary approach to study the invasion biology of this species. Specifically, two geographically distant populations, one being a successfully established population from O Grove and the other a declining population from Gijon, were studied over the course of four years. Analyses of morphological and developmental traits as well as genetic information confirmed the presence of C. dilatata in these sites. The results revealed polymorphism in anatomical traits and shell shape. Shell shape polymorphism was unevenly distributed among sites and among sexes. Males were monomorphic, while females were polymorphic. Of the female morphotypes encountered, one was absent in the declining population from Gijon. Size at first female maturation and female size were greater in the declining population than in the established population. Reproductive success varied seasonally but not spatially among populations. In the established population, gregariousness was significantly greater; the size when sex changes was found to be plastic and socially controlled. The sex ratio of the declining population was female biased while in the established population the sex ratio changed during the study period from being balanced to being female biased. This change in sex ratio was probably due to higher male mortality. Molecular analyses pointed to the localities of Corral Bay in southern Chile and Puerto Madryn in southern Argentina as potential population sources. The intercontinental import of fresh mussels cultivated in Chilean farms is a likely source of this mussel in Spain. Comparison with available data of native populations of C. dilatata strongly indicate that ecophenotypic plasticity, socially controlled sex change, high gregariousness, increased nurse egg supply to viable larvae during the encapsulated developmental period, later maturation and larger female sizes altogether enhance establishment success of this non-indigenous species. Human-mediated factors like the intraregional mussel trade and transplantation are also likely secondary dispersal mechanisms favouring the spread of this organism.	[Richter, Alexandra] Univ Oviedo, Fac Biol, Dept Biol Organisms & Syst, Oviedo, Spain; [Gandara, Alberto M.] Grigore Antipa Natl Museum Nat Hist, Bucharest, Romania; [Gandara, Alberto M.] Univ Bucharest, Dept Mol Biol, Bucharest, Romania; [Silva, Francisco; Brante, Antonio] Univ Catolica Santisima Concepcion, Dept Ecol, Concepcion, Chile; [Silva, Francisco; Brante, Antonio] Univ Catolica Santisima Concepcion, CIBAS, Concepcion, Chile	University of Oviedo; University of Bucharest; Universidad Catolica de la Santisima Concepcion; Universidad Catolica de la Santisima Concepcion	Richter, A (corresponding author), Univ Oviedo, Fac Biol, Dept Biol Organisms & Syst, Oviedo, Spain.	xandrusrichter@gmail.com	Richter, Alexandra/AAD-3833-2019	Richter, Alexandra/0000-0003-0612-041X; Brante, Antonio/0000-0002-2699-9700	University of Oviedo [UNOV-13-EMERG-05]; Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT [1130868, 1170598]	University of Oviedo; Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This research was funded by the University of Oviedo UNOV-13-EMERG-05 to AR, www.uniovi.es; Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT 1130868 and FONDECYT 1170598, both to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldea Cristián, 2005, Gayana (Concepc.), V69, P364; Aneiros F, 2015, CONT SHELF RES, V110, P16, DOI 10.1016/j.csr.2015.09.018; Arias A., 2012, SERIE TECNICA GEIB, V5, P99; Arias A., 2012, CIENCIES, V2, P85; Arias A, 2013, ESTUAR COAST SHELF S, V131, P117, DOI 10.1016/j.ecss.2013.08.017; Banon Rafael, 2008, Aquatic Invasions, V3, P331, DOI 10.3391/ai.2008.3.3.8; Bishop JDD, 2013, BIOL INVASIONS, V15, P253, DOI 10.1007/s10530-012-0286-x; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blanchard Michel, 1997, Scientia Marina, V61, P109; Brante A, 2016, SCI REP-UK, V6, DOI 10.1038/srep29439; Brante A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067050; Brante A, 2012, MAR ECOL PROG SER, V458, P123, DOI 10.3354/meps09739; Byers JE, 2012, BIOL INVASIONS, V14, P2587, DOI 10.1007/s10530-012-0254-5; Carlton James T., 1992, Journal of Shellfish Research, V11, P489; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Chaparro OR, 1998, J EXP MAR BIOL ECOL, V223, P77, DOI 10.1016/S0022-0981(97)00151-2; CHAPARRO OR, 1990, MAR ECOL PROG SER, V65, P183, DOI 10.3354/meps065183; Chaparro OR, 1999, J EXP MAR BIOL ECOL, V232, P261, DOI 10.1016/S0022-0981(98)00115-4; CHARNOV EL, 1989, NATURE, V338, P148, DOI 10.1038/338148a0; Cinar ME, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.445.8464; Cledon M, 2015, MAR ECOL, DOI [10.1111/maec.1239, DOI 10.1111/MAEC.1239]; Coe WR, 1938, BIOL BULL-US, V75, P274, DOI 10.2307/1537735; Collin R, 2005, ZOOL J LINN SOC-LOND, V144, P75, DOI 10.1111/j.1096-3642.2005.00162.x; Collin R, 2003, BIOL J LINN SOC, V78, P541, DOI 10.1046/j.0024-4066.2002.00166.x; Collin R, 2006, EVOLUTION, V60, P735, DOI 10.1111/j.0014-3820.2006.tb01152.x; Collin R, 2010, AQUAT INVASIONS, V5, P197, DOI 10.3391/ai.2010.5.2.11; Collin Rachel, 2009, Aquatic Invasions, V4, P377, DOI 10.3391/ai.2009.4.2.13; Crespo D, 2015, BIOL INVASIONS, V17, P2087, DOI 10.1007/s10530-015-0862-y; CROTHERS J H, 1985, Field Studies, V6, P291; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Ding C, 2004, P 21 INT C MACHINE L; Dupont L, 2006, MOL ECOL, V15, P3009, DOI 10.1111/j.1365-294X.2006.02988.x; Dybdahl MF, 2005, ECOLOGY, V86, P1592, DOI 10.1890/04-0898; Fernandez-Gonzalez A, 2013, DT AEHE, V1301, P2; Fey F, 2010, C03210 IM WAG; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Galante-Oliveira S, 2012, J MOLLUS STUD, V78, P147, DOI 10.1093/mollus/eyr042; GALLARDO CS, 1979, STUD NEOTROP FAUNA E, V14, P215, DOI 10.1080/01650527909360557; GALLARDO CS, 1977, MAR BIOL, V39, P241, DOI 10.1007/BF00390998; Gallardo CS, 1976, MEDIO AMBIENTE, V2, P44; Gascoigne J, 2009, POPUL ECOL, V51, P355, DOI 10.1007/s10144-009-0146-4; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Gollasch Stephan, 2006, Aquatic Invasions, V1, P245, DOI 10.3391/ai.2006.1.4.8; Gonazalez-Laxe F, 2014, DISTRIBUCION CONSUMO, V3, P102; Goulletquer P, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P276; Grahame JW, 2006, EVOLUTION, V60, P268; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; HOAGLAND KE, 1986, AM MALACOL BULL, V4, P173; HOAGLAND KE, 1978, MALACOLOGIA, V17, P365; HOAGLAND KE, 1977, MALACOLOGIA, V16, P353; Hoch JM, 2012, MAR BIOL, V159, P897, DOI 10.1007/s00227-011-1867-4; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; HUANG Z G, 1983, Malacological Review, V16, P97; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Izquierdo Andres, 2007, Rapport du Congress de la CIESM, V38, P506; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Katsanevakis S, 2014, AQUAT INVASIONS, V9, P391, DOI 10.3391/ai.2014.9.4.01; Legendre P., 2014, IMODEL2 MODEL 2 REGR; LINDBERG DR, 1981, INT J INVER REP DEV, V3, P347; Lloyd MJ, 2007, BIOL BULL-US, V213, P316, DOI 10.2307/25066649; Lopez E, 2017, HELGOLAND MAR RES, V71, DOI 10.1186/s10152-017-0499-6; Lopez Soriano Joaquin, 2014, Spira, V5, P149; Marchini A, 2015, MAR POLLUT BULL, V101, P267, DOI 10.1016/j.marpolbul.2015.09.054; Marincovich L. Jr., 1973, Natural Hist Mus Los Angeles Co Sci Bull, VNo. 16, P1; Martel C, 2004, MAR ECOL PROG SER, V273, P163, DOI 10.3354/meps273163; McNeill G, 2010, AQUAT INVASIONS, V5, pS21, DOI 10.3391/ai.2010.5.S1.006; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moran AL, 1999, AM ZOOL, V39, P304; Munday PL, 2006, TRENDS ECOL EVOL, V21, P89, DOI 10.1016/j.tree.2005.10.020; Nunes AL, 2014, AQUAT INVASIONS, V9, P133, DOI 10.3391/ai.2014.9.2.02; Nunez JJ, 2012, INVERTEBR BIOL, V131, P301, DOI 10.1111/ivb.12003; Ojaveer H, 2014, MANAG BIOL INVASION, V5, P81, DOI 10.3391/mbi.2014.5.2.01; Pechenik JA, 2010, J EXP MAR BIOL ECOL, V384, P91, DOI 10.1016/j.jembe.2009.12.011; PELLEGRINI O., 1949, BOLL ZOOL, V16, P49; Penchaszadeh PE, 2002, VELIGER, V45, P172; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quintas P, 2013, B R SOC HIST NAT SEC, V106, P113; Ramon M., 2005, Boletin Instituto Espanol de Oceanografia, V21, P361; Ramon M, 2003, DESARROLLO CULTIVO M; Raschka S., 2014, DISQUES; Reid DG, 1999, J MOLLUS STUD, V65, P355, DOI 10.1093/mollus/65.3.355; Richter A, 2004, J MAR BIOL ASSOC UK, V84, P383, DOI 10.1017/S0025315404009324h; Richter A., 2012, EEI 2012 4O CONGRESO, P167; Roa R, 1999, FISH B-NOAA, V97, P570; Rolan E, 2004, J MOLLUS STUD, V70, P179, DOI 10.1093/mollus/70.2.179; Rolan E., 2007, Noticiario de la Sociedad Espanola de Malacologia, V47, P37; Rolan Emilio, 2005, Noticiario de la Sociedad Espanola de Malacologia, V44, P60; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Samadi S, 2000, EVOLUTION, V54, P492, DOI 10.1111/j.0014-3820.2000.tb00052.x; Secretaria de Estado de Comercio del Ministerio de Economia y Competitividad, 2015, DAT DAT; Simon-Bouhet B, 2006, MOL ECOL, V15, P1699, DOI 10.1111/j.1365-294X.2006.02881.x; Smith L. David, 2009, V204, P177; Sokal RR, BIOMETRY PRINCIPLES; Son MH, 2000, J MOLLUS STUD, V66, P489, DOI 10.1093/mollus/66.4.489; SOONG K, 1991, MAR BIOL, V111, P81, DOI 10.1007/BF01986349; StatSoft Inc, 2007, STATISTICA DAT ANAL; Strebel H., 1904, ABT SYSTEMATIK GEOGR, V21, P12; Streftaris N, 2005, OCEANOGR MAR BIOL, V43, P419; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarifeno E, 2012, GAYANA, V76, P167, DOI 10.4067/S0717-65382012000300010; Thresher RE, 2004, BIOL INVASIONS, V6, P295, DOI 10.1023/B:BINV.0000034598.28718.2e; Troschel F.H., 1856, GEBISS SCHNECKEN BEG, V1; Veliz D, 2003, MAR BIOL, V143, P131, DOI 10.1007/s00227-003-1042-7; Veliz D, 2012, MOLLUSCAN RES, V32, P145; Villouta E, 1984, REV CHIL HIST NAT, V57, P111; Warner RR, 1996, J EXP MAR BIOL ECOL, V204, P155, DOI 10.1016/0022-0981(96)02582-8; Wasson K, 2001, BIOL CONSERV, V102, P143, DOI 10.1016/S0006-3207(01)00098-2; Wijsman JWM, 2006, RISK ANAL MUSSEL TRA, P1; Wilson EE, 2009, P NATL ACAD SCI USA, V106, P12809, DOI 10.1073/pnas.0902979106; Zaixso Héctor E, 2004, Rev. biol. mar. oceanogr., V39, P61; Zelaya DG, 2012, J MOLLUS STUD, V78, P330, DOI 10.1093/mollus/eys020; Zenetos A, 2012, MEDITERR MAR SCI, V13, P328, DOI 10.12681/mms.327; Zorita I, 2009, INFORM DIRECCION BIO	113	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2018	13	10							e0205739	10.1371/journal.pone.0205739	http://dx.doi.org/10.1371/journal.pone.0205739			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7AD	30376564	Green Published, gold, Green Submitted			2022-12-26	WOS:000448752400003
J	Chimutengwende-Gordon, M; Dowling, R; Pendegrass, C; Blunn, G				Chimutengwende-Gordon, Mukai; Dowling, Robert; Pendegrass, Catherine; Blunn, Gordon			Determining the porous structure for optimal soft-tissue ingrowth: An in vivo histological study	PLOS ONE			English	Article							TITANIUM IMPLANTS; FIBROUS TISSUE; PORE-SIZE; PROSTHESES; ATTACHMENT; AMPUTEES; BARRIER	The success of osseointegrated transcutaneous prostheses depends on a soft-tissue seal forming at the skin-implant interface in order to prevent infection. Current designs include a flange with drilled holes or a subdermal barrier with a porous coating in an attempt to promote soft-tissue attachment. However, the soft-tissue seal is not reliably achieved despite these designs and infection remains a significant problem. This study investigated soft-tissue integration into fully porous titanium alloy structures with interconnected pores. The study aimed to determine the effect of altering pore and strut size combinations on soft-tissue ingrowth into porous titanium alloy structures in vivo. It was hypothesized that implants with a more open porous structure with larger pore sizes would increase soft-tissue ingrowth more than less open porous structures. Porous titanium alloy cylinders were inserted into sheep paparaspinal muscles (n = 6) and left in situ for four weeks. A histological assessment of soft-tissue ingrowth was performed. Percentage soft-tissue pore fill, cell nuclei density and blood vessel density were quantified. The results showed that larger pore sizes were supportive of soft-tissue ingrowth. A structure with a pore size of 700 mu m and a strut size of 300 mu m supported revascularisation to the greatest degree. A flange with this structure may be used in future studies of osseointegrated transcutaneous prostheses in order to enhance the soft-tissue seal.	[Chimutengwende-Gordon, Mukai; Dowling, Robert; Pendegrass, Catherine; Blunn, Gordon] Univ Coll London, Royal Natl Orthopaed Hosp Trust, Inst Orthopaed & Musculoskeletal Sci, John Scales Ctr Biomed Engn, Brockley Hill, Stanmore, Middx, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Chimutengwende-Gordon, M (corresponding author), Univ Coll London, Royal Natl Orthopaed Hosp Trust, Inst Orthopaed & Musculoskeletal Sci, John Scales Ctr Biomed Engn, Brockley Hill, Stanmore, Middx, England.	mukai.cg@mac.com			Stanmore Implants Worldwide; MRC [G1001942] Funding Source: UKRI	Stanmore Implants Worldwide; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Stanmore Implants Worldwide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776; BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263; BOBYN JD, 1982, J BIOMED MATER RES, V16, P571, DOI 10.1002/jbm.820160505; BRANEMARK PI, 1982, SCAND J PLAST RECONS, V16, P17, DOI 10.3109/02844318209006565; Branemark R, 2001, J REHABIL RES DEV, V38, P175; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Cheung S, 2007, J BIOMED MATER RES B, V82B, P440, DOI 10.1002/jbm.b.30749; Gupta A, 2006, J BONE JOINT SURG BR, V88B, P1367, DOI 10.1302/0301-620X.88B10.17756; Hacking SA, 2000, J BIOMED MATER RES, V52, P631; Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013; Heinl P, 2007, ADV ENG MATER, V9, P360, DOI 10.1002/adem.200700025; HOWE DF, 1974, J BIOMED MATER RES, V8, P399, DOI 10.1002/jbm.820080608; Jeyapalina S, 2012, J ORTHOP RES, V30, P1304, DOI 10.1002/jor.22081; Kang NV, 2010, J HAND SURG-AM, V35A, P1130, DOI 10.1016/j.jhsa.2010.03.037; LABERGE M, 1990, J BIOMED MATER RES, V24, P959, DOI 10.1002/jbm.820240712; Lee VSP, 1997, P I MECH ENG H, V211, P167, DOI 10.1243/0954411971534287; LEVY SW, 1995, CUTIS, V55, P297; Limbless Statistics United National Institute for Prosthetics & Orthotics Development, ANN REP 2010 2011; NELSON RJ, 1983, J THORAC CARDIOV SUR, V86, P800; Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006; Pendegrass CJ, 2006, J ANAT, V209, P59, DOI 10.1111/j.1469-7580.2006.00595.x; Pendegrass CJ, 2006, BIOMATERIALS, V27, P4183, DOI 10.1016/j.biomaterials.2006.03.041; Ponader S, 2010, J BIOMED MATER RES A, V92A, P56, DOI 10.1002/jbm.a.32337; Schultz P, 2007, EUR ARCH OTO-RHINO-L, V264, P433, DOI 10.1007/s00405-006-0195-7; Taylor D F, 1972, J Biomed Mater Res, V6, P467, DOI 10.1002/jbm.820060112; Vrana NE, 2007, PUBLIC LIB SCI, V6, P1	26	13	13	7	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206228	10.1371/journal.pone.0206228	http://dx.doi.org/10.1371/journal.pone.0206228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372471	Green Published, gold, Green Submitted			2022-12-26	WOS:000448641200029
J	Muluye, AB; Kebamo, S; Teklie, T; Alemkere, G				Muluye, Abrham Belachew; Kebamo, Selamu; Teklie, Tesfa; Alemkere, Getachew			Poor treatment outcomes and its determinants among tuberculosis patients in selected health facilities in East Wollega, Western Ethiopia	PLOS ONE			English	Article								Background Although it is a preventable and treatable disease, tuberculosis remains a major medical and public health problem throughout the world. The control and elimination of tuberculosis is currently challenged by the development and spread of antituberculosis drug resistance. The resistance is often correlated to the absence of properly implemented control measures that lead to poor treatment outcomes. Therefore, the aim of the current study was to assess poor treatment outcomes and its determinants among tuberculosis patients in selected health facilities in East Wollega zone, Western Ethiopia. Method A five-year retrospective cross-sectional study design was employed. Data were collected from patients' medical record from January to March 2017. Data were entered and analyzed using SPSS version 20. Descriptive statistics were used to generate and summarize frequencies. Univariate and multivariate logistic regression analysis were used to associate the potential determinants of poor treatment outcomes. Results From 995 patients with documented treatment outcomes, 58.9% were males with a mean age of 31.9 +/- 16.3 years and 58% lived in rural areas. Majorities of cases (95.7%) were newly treated ones. Nearly half of the cases had extrapulmonary tuberculosis and 6.8% were coinfected with HIV. Nearly three-quarter of patients had completed their treatment while 17.2%, 2.9%, 4.8%, 0.4% patients were cured, defaulted, died, and failed, respectively. The overall treatment success rate was 91.9%. Being treated in Anger Gute health center (adjusted odds ratio (AOR): 2.27; 95% confidence interval (CI): 1.18-4.38); male (AOR: 1.81; 95% CI: 1.06-3.10); lived in rural areas (AOR: 1.73; 95% CI: 1.02-2.91); previously treated (AOR: 2.72; 95% CI: 1.16-6.39) and unknown HIV status (AOR: 4.56; 95% CI: 1.98-10.50) were determinants of poor treatment outcomes. Conclusion The current treatment success rate was exceeded the recommended target. However, special attention and strict follow up is required for tuberculosis patients with high risk of unsuccessful treatment outcomes including male, rural resident, previously treated and unknown in HIV status patients throughout their treatment periods.	[Muluye, Abrham Belachew; Kebamo, Selamu; Teklie, Tesfa; Alemkere, Getachew] Wollega Univ, Dept Pharm, Coll Hlth Sci, Nekemte, Ethiopia		Muluye, AB (corresponding author), Wollega Univ, Dept Pharm, Coll Hlth Sci, Nekemte, Ethiopia.	abrhambel@gmail.com	Kolech, Getachew/W-3922-2019	Kolech, Getachew/0000-0002-8728-7600; Muluye, Abrham Belachew/0000-0003-0901-812X				Abebe T, 2015, GULHANE TIP DERG, V57, P397; Addis Z., 2013, INT J BIOMEDICAL ADV, V4, P167, DOI [10.7439/ijbar.v4i3.300, DOI 10.7439/IJBAR.V4I3.300]; Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Ayele B, 2015, MYCOBACT DIS, V5, P194, DOI [10.4172/2161-1066.1000194, DOI 10.4172/2161-1066.1000194]; Belayneh M, 2015, BRAZ J INFECT DIS, V19, P47, DOI 10.1016/j.bjid.2014.09.002; Biadglegne F., 2013, INT J MED MED SCI, V5, P85, DOI DOI 10.5897/IJMMS12.142; Biruk MYB, 2016, ADV PUBLIC HEAL, V2016, P1, DOI 10. 1155/2016/850462932.; Chetty S, 2017, BIOORG MED CHEM LETT, V27, P370, DOI 10.1016/j.bmcl.2016.11.084; Dale D, 2017, J TUBERC THER, V2, P110; Delogu G, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.070; Deshmukh R D, 2018, Indian J Tuberc, V65, P41, DOI 10.1016/j.ijtb.2017.05.003; Endris Mengistu, 2014, Tuberc Res Treat, V2014, P726193, DOI 10.1155/2014/726193; Esmail H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0437; European center for disease prevention and control (ECDC), 2010, PROGR TUB EL; Fanning A, 1999, CAN MED ASSOC J, V160, P837; Gawad Jineetkumar, 2018, Indian J Tuberc, V65, P15, DOI 10.1016/j.ijtb.2017.08.011; Gebreegziabher S., 2016, J TUBERC RES, V4, P23, DOI DOI 10.4236/JTR.2016.41004; Getahun B, 2013, BRAZ J INFECT DIS, V17, P521, DOI 10.1016/j.bjid.2012.12.010; Hamusse SD, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25382; Jemal M, 2015, MYCOBACT DIS, V5, P190, DOI [10.4172/2161-1068.1000190, DOI 10.4172/2161-1068.1000190]; Lim VKE, 2013, IEJSME, V7, P51; Melese Addisu, 2016, Tuberc Res Treat, V2016, P1354356, DOI 10.1155/2016/1354356; Moges B, 2013, ADV RES J IMMUNOL VI, V1, P31; Nachega JB, 2003, CLIN INFECT DIS, V36, pS24, DOI 10.1086/344657; Petersen E, 2017, INT J INFECT DIS, V56, P1, DOI 10.1016/j.ijid.2017.02.012; Sharma SK, 2004, INDIAN J MED RES, V120, P354; Sinshaw Y, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2238-7; Tadesse S., 2014, Health, V6, P306, DOI 10.4236/health.2014.65044; Tefera F, 2016, ETHIOP J HEALTH SCI, V26, P65, DOI 10.4314/ejhs.v26i1.11; Tesfahuneygn Gebrehiwet, 2015, BMC Res Notes, V8, P503, DOI 10.1186/s13104-015-1452-x; Tousif S, 2015, J CELL SCI R, V6, DOI [10.4172/2217-7013.1000223, DOI 10.4172/2217-7013.1000223]; Veiga AC, 2013, EUR C EPIDEMIOL, V201, P4; WHO, 2016, TREATM GUID DRUG RES; WHO, END TUB STRAT GLOB S; WHO, 2017, GLOB TUB REP; Wondale Biniam, 2017, BMC Res Notes, V10, P680, DOI 10.1186/s13104-017-3020-z; World Health Organization (WHO), 1994, FRAM EFF TUB CONTR; Zenebe T, 2016, BRAZ J INFECT DIS, V20, P635, DOI 10.1016/j.bjid.2016.07.012	38	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206227	10.1371/journal.pone.0206227	http://dx.doi.org/10.1371/journal.pone.0206227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365530	Green Submitted, Green Published, gold			2022-12-26	WOS:000448448700031
J	Jiang, HW; Newman, M; Lardelli, M				Jiang, Haowei; Newman, Morgan; Lardelli, Michael			The zebrafish orthologue of familial Alzheimer's disease gene PRESENILIN 2 is required for normal adult melanotic skin pigmentation	PLOS ONE			English	Article							GAMMA-SECRETASE; DEVELOPMENTAL GENETICS; PATTERN-FORMATION; MUTATIONS; MELANOSOMES; TYROSINASE; EXPRESSION; PHENOTYPES; EPITHELIUM; ORGANELLES	Alzheimer's disease is the most common form of age-related dementia. At least 15 mutations in the human gene PRESENILIN 2 (PSEN2) have been found to cause familial Alzheimer's disease (fAD). Zebrafish possess an orthologous gene, psen2, and present opportunities for investigation of PRESENILIN function related to Alzheimer's disease. The most prevalent and best characterized fAD mutation in PSEN2 is N1411. The equivalent codon in zebrafish psen2 is N140. We used genome editing technology in zebrafish to target generation of mutations to the N140 codon. We isolated two mutations: psen2(N140fs), (hereafter "N140fs"), causing truncation of the coding sequence, and psen2(T141)(_ L142delinsMISLISV), (hereafter "TI4I_L142delinsMISLISII), that deletes the two codons immediately downstream of N140 and replaces them with seven codons coding for amino acid residues MISLISV. Thus, like almost every fAD mutation in the PRESENILIN genes, this latter mutation does not truncate the gene's open reading frame. Both mutations are homozygous viable although N140fs transcripts are subject to nonsense-mediated decay and lack any possibility of coding for an active y-secretase enzyme. N140fs homozygous larvae initially show grossly normal melanotic skin pigmentation but subsequently lose this as they grow while retaining pigmentation in the retinal pigmented epithelium. T141_L142delinsMISLISV homozygotes retain faint skin melanotic pigmentation as adults, most likely indicating that the protein encoded by this allele retains weak y-secretase activity. Null mutations in the human PRESENILIN genes do not cause Alzheimer's disease so these two mutations may be useful for future investigation of the differential effects of null and fAD-like PRESENILIN mutations on brain aging.	[Jiang, Haowei; Newman, Morgan; Lardelli, Michael] Univ Adelaide, Sch Biol Sci, Alzheimers Dis Genet Lab, North Terrace, Adelaide, SA, Australia	University of Adelaide	Jiang, HW (corresponding author), Univ Adelaide, Sch Biol Sci, Alzheimers Dis Genet Lab, North Terrace, Adelaide, SA, Australia.	haowei.jiang@adelaide.edu.au	, Morgan/Y-5204-2019	Newman, Morgan/0000-0002-4930-4529	National Health and Medical Research Council of Australia [GNT1061006, GNT1126422]; School of Biological Sciences of the University of Adelaide; Adelaide Scholarship International from University of Adelaide	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); School of Biological Sciences of the University of Adelaide; Adelaide Scholarship International from University of Adelaide	This research was supported by grants from the National Health and Medical Research Council of Australia, GNT1061006 and GNT1126422, and by funds from the School of Biological Sciences of the University of Adelaide. HJ is supported by an Adelaide Scholarship International from the University of Adelaide.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alzheimer's Disease International, 2014, WORLD ALZH REP 2014; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Babon JJ, 2003, MOL BIOTECHNOL, V23, P73, DOI 10.1385/MB:23:1:73; Bassett A, 2014, METHODS, V69, P128, DOI 10.1016/j.ymeth.2014.02.019; Bassett AR, 2014, J GENET GENOMICS, V41, P7, DOI 10.1016/j.jgg.2013.12.004; Bibikova M, 2002, GENETICS, V161, P1169; Bissig C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091438; Campion D, 1999, AM J HUM GENET, V65, P664, DOI 10.1086/302553; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; De Gasperi R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-38; delMarmol V, 1996, FEBS LETT, V381, P165, DOI 10.1016/0014-5793(96)00109-3; Detrich H. W., 2009, ESSENTIAL ZEBRAFISH; Driever W, 1996, DEVELOPMENT, V123, P37; Fowler Douglas M, 2006, PLoS Biol, V4, pe6; Fraering PC, 2007, CURR GENOMICS, V8, P531, DOI 10.2174/138920207783769521; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Groth C, 2002, DEV GENES EVOL, V212, P486, DOI 10.1007/s00427-002-0269-5; Guerrini R, 2014, NEUROTHERAPEUTICS, V11, P269, DOI 10.1007/s13311-014-0267-0; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Higdon CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067801; Hin N, 2018, BIORXIV; Hurt JA, 2013, GENOME RES, V23, P1636, DOI 10.1101/gr.157354.113; Irion U, 2016, CURR TOP DEV BIOL, V117, P141, DOI 10.1016/bs.ctdb.2015.12.012; Jayadev S, 2010, BRAIN, V133, P1143, DOI 10.1093/brain/awq033; Jayne T, 2016, J ALZHEIMERS DIS, V52, P781, DOI 10.3233/JAD-151186; Jumpertz T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030484; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kummer MP, 2009, J BIOL CHEM, V284, P2296, DOI 10.1074/jbc.M808904200; Leimer U, 1999, BIOCHEMISTRY-US, V38, P13602, DOI 10.1021/bi991453n; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lopes VS, 2007, MOL BIOL CELL, V18, P3914, DOI 10.1091/mbc.E07-03-0268; Love S, 2016, BRAIN PATHOL, V26, P607, DOI 10.1111/bpa.12401; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Moussavi Nik Seyyed Hani, 2012, J Alzheimers Dis, V28, P515, DOI 10.3233/JAD-2011-110533; Moussavi Nik SH, 2015, HUM MOL GENET, V26; Navarro RE, 2008, ZEBRAFISH, V5, P309, DOI 10.1089/zeb.2008.0549; Nik SHM, 2011, EXP CELL RES, V317, P1503, DOI 10.1016/j.yexcr.2011.04.004; Nishikawa A, 2004, BIOCHEM BIOPH RES CO, V318, P435, DOI 10.1016/j.bbrc.2004.04.048; Nornes S, 2009, EXP CELL RES, V315, P2791, DOI 10.1016/j.yexcr.2009.06.023; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Pottier C, 2012, MOL PSYCHIATR, V17, P875, DOI 10.1038/mp.2012.15; Quigley IK, 2002, MICROSC RES TECHNIQ, V58, P442, DOI 10.1002/jemt.10162; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Rochin L, 2013, P NATL ACAD SCI USA, V110, P10658, DOI 10.1073/pnas.1220748110; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Salminen A, 2017, J NEUROCHEM, V140, P536, DOI 10.1111/jnc.13932; Sannerud R, 2016, CELL, V166, P193, DOI 10.1016/j.cell.2016.05.020; Sato N, 1999, J NEUROCHEM, V72, P2498, DOI 10.1046/j.1471-4159.1999.0722498.x; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Schraermeyer U, 1999, EXP EYE RES, V68, P237, DOI 10.1006/exer.1998.0596; Tief K, 1996, EUR J BIOCHEM, V241, P12, DOI 10.1111/j.1432-1033.1996.0012t.x; Toda Toshihiko, 2011, J Biomed Biotechnol, V2011, P617974, DOI 10.1155/2011/617974; Tomita T, 1998, J BIOL CHEM, V273, P21153, DOI 10.1074/jbc.273.33.21153; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Wasmeier C, 2008, J CELL SCI, V121, P3995, DOI 10.1242/jcs.040667; Watt B, 2013, PIGM CELL MELANOMA R, V26, P300, DOI 10.1111/pcmr.12067; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	66	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206155	10.1371/journal.pone.0206155	http://dx.doi.org/10.1371/journal.pone.0206155			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359395	Green Submitted, Green Published, gold			2022-12-26	WOS:000448438400048
J	Cantarero-Prieto, D; Pascual-Saez, M; Blazquez-Fernandez, C				Cantarero-Prieto, David; Pascual-Saez, Marta; Blazquez-Fernandez, Carla			Social isolation and multiple chronic diseases after age 50: A European macro-regional analysis	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; RISK-FACTORS; NONCOMMUNICABLE DISEASES; SOCIOECONOMIC-STATUS; PHYSICAL HEALTH; OLDER MEN; LONELINESS; DETERMINANTS; MULTIMORBIDITY; COUNTRIES	Background Different studies have found that socioeconomic determinants influence the prevalence of chronic diseases in older people. However, there has been relatively little research on the incidence of how social isolation may affect them. We suggest that social isolation is a serious concern for people living with chronic illnesses. Method In this paper, we examine whether there is an increase in the propensity of being diagnosed with chronic illnesses because of a decrease in social relations for elderly Europeans. We have used a panel data for Waves 1-6 (2004-2015) of Survey on Health, Ageing and Retirement in Europe (SHARE) and logistic regressions. Besides, we have studied three geographic macro-areas (Nordic, Continental and Southern). Being diagnosed with three or more chronic diseases is considered as a dependent variable, and as social control variables we have used three isolation proxies (living alone, providing help to family, friends or neighbours and participation-club activities). Other socio-demographic variables are included (gender, age, educational level, job situation, area of location and quality of life). Results Our results for the full sample indicate that people who participate in social activities have fewer probability of suffering from chronic diseases (OR = 0.70, 95% CI 0.54, 0.92). For people who live alone the reverse effect is observed (OR = 1.20, 95% CI 1.04, 1.39). Differences are shown by macro-areas, e.g. providing help (OR = 0.58, 95% CI 0.34, 0.97) isolation proxy is significant for the Nordic macro-area. Club-participation activities and living alone are significant for Continental and Southern macro-areas, respectively (OR = 0.65, 95% CI 0.55, 0.82; OR = 1.46, 95% CI 1.21, 1.77). Conclusions Social isolation increases the risk of being diagnosed with chronic illnesses. That is, people with greater social participation have lower risk of suffering from multiple chronic diseases. This risk linked to isolation, together with the traditional one associated with lifestyles, should be considered in the development of new public policies.	[Cantarero-Prieto, David; Pascual-Saez, Marta; Blazquez-Fernandez, Carla] Univ Cantabria IDIVAL, Dept Econ, Grp Hlth Econ & Hlth Serv Management, Santander, Spain	Universidad de Cantabria	Cantarero-Prieto, D (corresponding author), Univ Cantabria IDIVAL, Dept Econ, Grp Hlth Econ & Hlth Serv Management, Santander, Spain.	david.cantarero@unican.es		Blazquez-Fernandez, Carla/0000-0002-0204-7174; Cantarero-Prieto, David/0000-0001-8082-0639	European Commission [QLK6-CT-2001-00360, SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812, 211909, 227822, 261982]; German Ministry of Education and Research; U.S. National Institute on Aging [U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064, HHSN271201300071C]; Max Planck Society for the Advancement of Science; NATIONAL INSTITUTE ON AGING [P01AG005842] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Max Planck Society for the Advancement of Science(Max Planck Society); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This paper uses data from SHARE Waves 1, 2, 3 (SHARELIFE), 4, 5 and 6 (DOIs: 10.6103/SHARE.w1.611, 10.6103/SHARE. w2.611, 10.6103/SHARE. w3.611, 10.6103/SHARE. w4.611, 10.6103/SHARE. w5.611, 10.6103/SHARE. w6.611), see Borsch-Supan et al. (2013) for methodological details. The SHARE data collection has been primarily funded by the European Commission through FP5 (QLK6-CT-2001-00360), FP6 (SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812) and FP7 (SHARE-PREP: No211909, SHARE-LEAP: No227822, SHARE M4: No261982). Additional funding from the German Ministry of Education and Research, the Max Planck Society for the Advancement of Science, the U.S. National Institute on Aging (U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064, HHSN271201300071C) and from various national funding sources is gratefully acknowledged (see www.share-project.org).	Ahnquist J, 2012, SOC SCI MED, V74, P930, DOI 10.1016/j.socscimed.2011.11.026; Rico-Uribe LA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190033; Rico-Uribe LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145264; Allen L, 2017, LANCET GLOB HEALTH, V5, pE277, DOI 10.1016/s2214-109x(17)30058-x; Barreto PD, 2017, AM J PREV MED, V52, P373, DOI 10.1016/j.amepre.2016.08.028; Becchetti L, 2017, HEALTH POLICY, V121, P955, DOI 10.1016/j.healthpol.2017.07.008; Diem G, 2016, GLOB HEALTH PROMOT, V23, P5, DOI 10.1177/1757975914567513; Elovainio M, 2017, LANCET PUBLIC HEALTH, V2, pE260, DOI 10.1016/S2468-2667(17)30075-0; Esping-Andersen G., 1990, INT J SOCIOLOGY, V20, P92, DOI DOI 10.1080/15579336.1990.11770001; Fernandez-Ballesteros R, 2002, J SOC ISSUES, V58, P645, DOI 10.1111/1540-4560.00282; Fokkema T, 2012, J PSYCHOL, V146, P201, DOI 10.1080/00223980.2011.631612; Gerst-Emerson K, 2015, AM J PUBLIC HEALTH, V105, P1013, DOI 10.2105/AJPH.2014.302427; Granados JAT, 2017, HEALTH ECON, V26, pE219, DOI 10.1002/hec.3495; Grenade L, 2008, AUST HEALTH REV, V32, P468, DOI 10.1071/AH080468; Hakulinen C, 2018, HEART; Hakulinen C, 2016, J EPIDEMIOL COMMUN H, V70, P710, DOI [10.1136/jech-2015-206165, 10.1136/jech-2015]; Holt-Lunstad J., 2018, ANNU REV PSYCHOL, P69; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Islam SMS, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0081-9; Junius-Walker U, 2010, EUR J GEN PRACT, V16, P51, DOI 10.3109/13814780903580307; Lago S, 2018, J PUBLIC HEALTH-HEID, V26, P1, DOI 10.1007/s10389-017-0850-z; Lamu AN, 2018, HEALTH ECON, V27, P209, DOI 10.1002/hec.3536; Landeiro F, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013778; Linardakis M, 2015, J PUBLIC HEALTH-HEID, V23, P257, DOI 10.1007/s10389-015-0683-6; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mendis S, 2014, GLOBAL STATUS REPORT; Olaya B, 2017, EXP GERONTOL, V99, P120, DOI 10.1016/j.exger.2017.10.001; Ryan AK, 2007, J AGING HEALTH, V19, P907, DOI 10.1177/0898264307308340; Shankar A, 2017, HEALTH PSYCHOL, V36, P179, DOI 10.1037/hea0000437; Smith KJ, 2019, AGEING SOC, V39, P1709, DOI 10.1017/S0144686X18000132; Srakar A, 2016, ORGANIZACIJA, V49, P127, DOI 10.1515/orga-2016-0009; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; Sundstrom G, 2009, EUR J AGEING, V6, P267, DOI 10.1007/s10433-009-0134-8; World Health Organization, 1986, FIRST INTERNATIONAL; Zebhauser A, 2014, INT J GERIATR PSYCH, V29, P245, DOI 10.1002/gps.3998	37	23	23	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205062	10.1371/journal.pone.0205062	http://dx.doi.org/10.1371/journal.pone.0205062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3FL	30356322	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000027
J	Chen, ZQ; Chen, ZB				Chen, Zhiqiang; Chen, Zhibiao			Effects of ecological restoration measures on the distribution of Dicranopteris dichotoma at the microscale in the red soil hilly region of China	PLOS ONE			English	Article							HABITAT SUITABILITY; DISTRIBUTION MODELS; CLIMATE-CHANGE; PLANT; IMPACT; MICROTOPOGRAPHY; DISTURBANCE; VEGETATION; DIVERSITY; RESPONSES	Little is known about the evaluation of ecological restoration measures using species distribution models (SDMs) at the microscale. This study investigated the effect of arbor-bush- herb mixed plantation (ABHMP) on the potential distribution of D. dichotoma using SDMs in the typical microtopographies of the red soil hilly region of China. We examined D. dichotoma growth, microtopography, and environment-related factors at the microscale. The percentages of microtopographies and D. dichotoma physiology factors increased in the order from the valley to the ridge in the D. dichotoma patches. The valley had milder temperatures, higher humidity, and more fertile soil than the ridge in the gullies. Microclimate factors were the most critical environmental factors affecting the distribution of D. dichotoma, followed by soil factors, whereas the microtopography factors had only a marginal effect. The predicted potential distribution of D. dichotoma under the ABHMP scenario was nearly 3-fold higher than the current distribution, and the suitable area was located mostly in the level trenches and the valley. ABHMP had a strong effect on the potential distribution of D. dichotoma, and SDMs proved to be a valuable tool for assessing ecological restoration measures at the microscale.	[Chen, Zhiqiang; Chen, Zhibiao] Fujian Normal Univ, Minist Sci & Technol & Fujian Prov, State Key Lab Subtrop Mt Ecol, Fuzhou, Fujian, Peoples R China; [Chen, Zhiqiang; Chen, Zhibiao] Fujian Normal Univ, Inst Geog, Fuzhou, Fujian, Peoples R China; [Chen, Zhiqiang; Chen, Zhibiao] Fujian Normal Univ, Sch Geog Sci, Fuzhou, Fujian, Peoples R China	Fujian Normal University; Fujian Normal University; Fujian Normal University	Chen, ZQ (corresponding author), Fujian Normal Univ, Minist Sci & Technol & Fujian Prov, State Key Lab Subtrop Mt Ecol, Fuzhou, Fujian, Peoples R China.; Chen, ZQ (corresponding author), Fujian Normal Univ, Inst Geog, Fuzhou, Fujian, Peoples R China.; Chen, ZQ (corresponding author), Fujian Normal Univ, Sch Geog Sci, Fuzhou, Fujian, Peoples R China.	soiltuqiang061@163.com	Chen, Zhiqiang/AAO-2064-2021		National Natural Science Foundation of China [41371512]; Natural Science Foundation of Fujian Province [2017J01462]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This research was supported by grants from National Natural Science Foundation of China (No. 41371512, http://www.nsfc.gov.cn/) and Natural Science Foundation of Fujian Province (No. 2017J01462, http://www.fjkjt.gov.cn/).Zhiqiang Chen received the funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa JM, 2017, J APPL ECOLOGY, V54; Bertelsmeier C, 2013, BIOL CONSERV, V167, P107, DOI 10.1016/j.biocon.2013.07.038; Bouska KL, 2015, HYDROBIOLOGIA, V747, P159, DOI 10.1007/s10750-014-2134-8; Burke IC, 1998, BIOGEOCHEMISTRY, V42, P121, DOI 10.1023/A:1005987807596; Chefaoui RM, 2016, ESTUAR COAST, V39, P123, DOI 10.1007/s12237-015-9966-y; Chen J, 1991, CHINESE J ECOL, V19, P18; Chen YH, 2013, SCI CHINA LIFE SCI, V56, P476, DOI 10.1007/s11427-013-4475-3; Chen ZQ, 2016, PLANT SOIL, V398, P367, DOI 10.1007/s11104-015-2670-7; Coro G, 2016, ECOL MODEL, V323, P61, DOI 10.1016/j.ecolmodel.2015.12.008; Crego RD, 2014, J ARID ENVIRON, V102, P68, DOI 10.1016/j.jaridenv.2013.11.008; [邓恢 Deng Hui], 2004, [福建林学院学报, Journal of Fujian College of Forestry], V24, P262; Domisch S, 2013, ECOL MODEL, V257, P1, DOI 10.1016/j.ecolmodel.2013.02.019; Gallardo B, 2013, BIOL CONSERV, V160, P225, DOI 10.1016/j.biocon.2013.02.001; Gentili R, 2015, ECOL COMPLEX, V21, P87, DOI 10.1016/j.ecocom.2014.11.006; Guo QH, 2010, ECOGRAPHY, V33, P637, DOI 10.1111/j.1600-0587.2010.06416.x; [韩润燕 Han Runyan], 2014, [草业科学, Pratacultural Science], V31, P1825; Han X, 2014, PLANT SOIL, V382, P175, DOI 10.1007/s11104-014-2154-1; Heubes J, 2013, J ARID ENVIRON, V96, P48, DOI 10.1016/j.jaridenv.2013.04.008; Jarnevich CS, 2015, ECOL INFORM, V29, P6, DOI 10.1016/j.ecoinf.2015.06.007; Kandel K, 2015, BIOL CONSERV, V181, P150, DOI 10.1016/j.biocon.2014.10.007; Kazakov NV, 2010, EURASIAN SOIL SCI+, V43, P216, DOI 10.1134/S1064229310020122; Kooch Y., 2012, Journal of Forestry Research, V23, P81, DOI 10.1007/s11676-012-0236-6; Li CB, 2009, PROCESS BASED SOIL E, P113; [李小飞 Li Xiaofei], 2013, [水土保持通报, Bulletin of Soil and Water Conservation], V33, P33; Lin X.X., 2004, FUJIAN SOIL WATER CO, V16, P60; Liu G, 1996, STANDARD METHODS OBS, V24, P266; Ma H, 2013, ENVIRON MONIT ASSESS, V185, P8639, DOI 10.1007/s10661-013-3200-9; Maes D, 2014, J INSECT CONSERV, V18, P939, DOI 10.1007/s10841-014-9702-0; MartinezTuranzas GA, 1997, PLANT SOIL, V191, P163, DOI 10.1023/A:1004286605052; MARTINS J, 2016, FOR ECOSYST, V3, pNIL23, DOI DOI 10.1186/s40663-016-0073-8; Mikolajczak A, 2015, ECOL INFORM, V30, P196, DOI 10.1016/j.ecoinf.2015.09.005; Moser K, 2007, WETLANDS, V27, P1081, DOI 10.1672/0277-5212(2007)27[1081:COMAII]2.0.CO;2; Mostafavi H, 2014, LIMNOLOGICA, V46, P1, DOI 10.1016/j.limno.2013.12.001; Pradervand JN, 2014, PROG PHYS GEOG, V38, P79, DOI 10.1177/0309133313512667; Questad EJ, 2014, ECOL APPL, V24, P385, DOI 10.1890/13-0775.1; Ru Hai-li, 2016, Yingyong Shengtai Xuebao, V27, P25; Rull V, 2009, J BIOGEOGRAPHY; Shida Y, 2011, PLANT ECOL, V212, P1819, DOI 10.1007/s11258-011-9951-x; Teixeira TSM, 2014, J NAT CONSERV, V22, P384, DOI 10.1016/j.jnc.2014.04.001; Tokuchi N, 1999, ECOL RES, V14, P361, DOI 10.1046/j.1440-1703.1999.00309.x; Virkkala R, 2010, ACTA OECOL, V36, P269, DOI 10.1016/j.actao.2010.01.006; Weiss A., 2001, ESR INT USER C; Yao J, 2006, LANDSCAPE ECOL, V21, P1217, DOI 10.1007/s10980-006-0025-8; Yoshida N, 1999, PLANT ECOL, V140, P89, DOI 10.1023/A:1009740016420; Zou AP, 2009, SCI SOIL WATER CONSE, V7, P93, DOI [10.3969/j.issn.1672-3007.2009.02.016, DOI 10.3969/J.ISSN.1672-3007.2009.02.016]	45	1	1	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0204743	10.1371/journal.pone.0204743	http://dx.doi.org/10.1371/journal.pone.0204743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356244	Green Submitted, Green Published, gold			2022-12-26	WOS:000448434000017
J	Dydak, K; Junka, A; Szymczyk, P; Chodaczek, G; Toporkiewicz, M; Fijalkowski, K; Dudek, B; Bartoszewicz, M				Dydak, Karolina; Junka, Adam; Szymczyk, Patrycja; Chodaczek, Grzegorz; Toporkiewicz, Monika; Fijalkowski, Karol; Dudek, Bartlomiej; Bartoszewicz, Marzenna			Development and biological evaluation of Ti6Al7Nb scaffold implants coated with gentamycin-saturated bacterial cellulose biomaterial	PLOS ONE			English	Article							TI-6AL-7NB ALLOY; NANOCELLULOSE; CYTOTOXICITY; INFECTIONS; BIOFILM; ABILITY	Herein we present an innovative method of coating the surface of Titanium-Aluminium-Niobium bone scaffold implants with bacterial cellulose (BC) polymer saturated with antibiotic. Customized Ti6Al7Nb scaffolds manufactured using Selective Laser Melting were immersed in a suspension of Komagataeibacter xylinus bacteria which displays an ability to produce a 3-dimensional structure of bio-cellulose polymer. The process of complete implant coating with BC took on average 7 days. Subsequently, the BC matrix was cleansed by means of alkaline lysis and saturated with gentamycin. Scanning electron microscopy revealed that BC adheres and penetrates into the implant scaffold structure. The viability and development of the cellular layer on BC micro-structure were visualized by means of confocal microscopy. The BC-coated implants displayed a significantly lower cytotoxicity against osteoblast and fibroblast cell cultures in vitro in comparison to non-coated implants. It was also noted that gentamycin released from BC-coated implants inhibited the growth of Staphylococcus aureus cultures in vitro, confirming the suitability of such implant modification for preventing hostile microbial colonization. As demonstrated using digital microscopy, the procedure used for implant coating and BC chemical cleansing did not flaw the biomaterial structure. The results presented herein are of high translational value with regard to future use of customized, BC-coated and antibiotic-saturated implants designed for use in orthopedic applications to speed up recovery and to reduce the risk of musculoskeletal infections.	[Dydak, Karolina; Junka, Adam; Bartoszewicz, Marzenna] Wroclaw Med Univ, Dept Pharmaceut Microbiol & Parasitol, Wroclaw, Poland; [Szymczyk, Patrycja] Wroclaw Univ Sci & Technol, Fac Mech Engn, Ctr Adv Mfg Technol CAMT FPC, Wroclaw, Poland; [Chodaczek, Grzegorz; Toporkiewicz, Monika] Polish Ctr Technol Dev PORT, Lab Confocal Microscopy, Wroclaw, Poland; [Fijalkowski, Karol] West Pomeranian Univ Technol, Fac Biotechnol & Anim Husb, Dept Immunol Microbiol & Physiol Chem, Szczecin, Poland; [Dudek, Bartlomiej] Polish Ctr Technol Dev PORT, Lab Microbiol, Wroclaw, Poland	Wroclaw Medical University; Wroclaw University of Science & Technology; West Pomeranian University of Technology	Fijalkowski, K (corresponding author), West Pomeranian Univ Technol, Fac Biotechnol & Anim Husb, Dept Immunol Microbiol & Physiol Chem, Szczecin, Poland.	karol.fijalkowski@zut.edu.pl	Chodaczek, Grzegorz/AFL-9576-2022; Chodaczek, Grzegorz/AAH-1681-2022; Fijałkowski, Karol/AAA-6660-2020; Chodaczek, Grzegorz/G-4073-2014; Dydak, Karolina/ABB-9960-2021	Fijałkowski, Karol/0000-0002-4915-6298; Dydak, Karolina/0000-0001-9698-5710; Junka, Adam/0000-0002-7559-8903; BARTOSZEWICZ, MARZENNA/0000-0002-6542-2525; Szymczyk-Ziolkowska, Patrycja/0000-0001-7742-7182; Dudek, Bartlomiej/0000-0002-6181-3772	Medical University of Wroclaw [ST-904]; Wroclaw University of Science and Technology [0402/0057/17]	Medical University of Wroclaw; Wroclaw University of Science and Technology	This work was supported by Medical University of Wroclaw statutory grant ST-904 and Wroclaw University of Science and Technology statutory grant 0402/0057/17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MCIM, 2012, SAINS MALAYS, V41, P561; Ashida M, 2014, PROCEDIA ENGINEER, V81, P1523, DOI 10.1016/j.proeng.2014.10.184; Babiak I, 1998, CHIR NARZ RUCH, V63, P238; Bielawski J., 2007, ZAPALENIE KOSCI, P163; Chlebus E, 2011, MATER CHARACT, V62, P488, DOI 10.1016/j.matchar.2011.03.006; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035; Dale H, 2009, ACTA ORTHOP, V80, P639, DOI 10.3109/17453670903506658; Duewelhenke N, 2007, ANTIMICROB AGENTS CH, V51, P54, DOI 10.1128/AAC.00729-05; Elias CN, 2008, J MECH BEHAV BIOMED, V1, P234, DOI 10.1016/j.jmbbm.2007.12.002; Fijalkowski K, 2017, ELECTROMAGN BIOL MED, V36, P192, DOI 10.1080/15368378.2016.1243554; Fux Christoph A, 2003, Expert Rev Anti Infect Ther, V1, P667, DOI 10.1586/14787210.1.4.667; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; Johnson CT, 2015, ANN BIOMED ENG, V43, P515, DOI 10.1007/s10439-014-1205-3; Juncu G, 2016, INT J PHARMACEUT, V510, P485, DOI 10.1016/j.ijpharm.2015.11.053; Junka A, 2017, CARBOHYD POLYM, V157, P371, DOI 10.1016/j.carbpol.2016.10.007; Junka AF, 2016, ACTA BIOENG BIOMECH, V18, P115, DOI 10.5277/ABB-00333-2015-01; Knaepler H, 2012, INT J SURG, V10, pS15, DOI 10.1016/j.ijsu.2012.05.020; Lin N, 2014, EUR POLYM J, V59, P302, DOI 10.1016/j.eurpolymj.2014.07.025; Ludwicka K, 2016, BACTERIAL NANOCELLULOSE: FROM BIOTECHNOLOGY TO BIO-ECONOMY, P145, DOI 10.1016/B978-0-444-63458-0.00009-3; Lyczkowska E, 2014, ARCH CIV MECH ENG, V14, P586, DOI 10.1016/j.acme.2014.03.001; Moniri M, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7090257; Barud HGO, 2015, CARBOHYD POLYM, V128, P41, DOI 10.1016/j.carbpol.2015.04.007; Pawlak A, 2015, RAPID PROTOTYPING J, V21, P393, DOI 10.1108/RPJ-10-2013-0101; Pertile R, 2012, BIOTECHNOL PROGR, V28, P526, DOI 10.1002/btpr.1501; Pokrowiecki R, 2014, POSTEP MIKROBIOL, V53, P123; Pourmollaabbassi Babak, 2016, Adv Biomed Res, V5, P156; Shi Q, 2012, BIOMATERIALS, V33, P6644, DOI 10.1016/j.biomaterials.2012.05.071; Szymczyk P, 2018, MATERIALS, V11, DOI 10.3390/ma11060971; Szymczyk P, 2013, ACTA BIOENG BIOMECH, V15, P69, DOI 10.5277/abb130109; Trampuz A, 2006, INJURY, V37, P59, DOI 10.1016/j.injury.2006.04.010; Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004; Zimmermann KA, 2011, MAT SCI ENG C-MATER, V31, P43, DOI 10.1016/j.msec.2009.10.007; Zywicka A, 2018, BIOMACROMOLECULES, V19, P1528, DOI 10.1021/acs.biomac.8b00183; Zywicka A, 2016, APPL BIOCHEM BIOTECH, V180, P805, DOI 10.1007/s12010-016-2134-4	35	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205205	10.1371/journal.pone.0205205	http://dx.doi.org/10.1371/journal.pone.0205205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356274	Green Submitted, Green Published, gold			2022-12-26	WOS:000448434000041
J	Kenward, RE; Arraut, EM; Robertson, PA; Walls, SS; Casey, NM; Aebischer, NJ				Kenward, Robert E.; Arraut, Eduardo M.; Robertson, Peter A.; Walls, Sean S.; Casey, Nicholas M.; Aebischer, Nicholas J.			Resource-Area-Dependence Analysis: Inferring animal resource needs from home- range and mapping data	PLOS ONE			English	Article							HABITAT USE; STATISTICAL TECHNIQUES; HUNTING BEHAVIOR; SCIURUS-VULGARIS; RED SQUIRRELS; AVAILABILITY; SIZE; SELECTION; COVER; DENSITY	An animal's home-range can be expected to encompass the resources it requires for surviving or reproducing. Thus, animals inhabiting a heterogeneous landscape, where resource patches vary in size, shape and distribution, will naturally have home-ranges of varied sizes, so that each home-range encompasses a minimum required amount of a resource. Homerange size can be estimated from telemetry data, and often key resources, or proxies for them such as the areas of important habitat types, can be mapped. We propose a new method, Resource-Area-Dependence Analysis (RADA), which uses a sample of tracked animals and a categorical map to i) infer in which map categories important resources are accessible, ii) within which home range cores they are found, and iii) estimate the mean minimum areas of these map categories required for such resource provision. We provide three examples of applying RADA to datasets of radio-tracked animals from southern England: 15 red squirrels Sciurus vulgaris, 17 gray squirrels S. carolinensis and 114 common buzzards Buteo buteo. The analyses showed that each red squirrel required a mean (95% CL) of 0.48 ha (0.24-0.97) of pine wood within the outermost home-range, each gray squirrel needed 0.34 ha (0.11-1.12) ha of mature deciduous woodland and 0.035-0.046 ha of wheat, also within the outermost home-range, while each buzzard required 0.54 ha (0.35-0.82) of rough ground close to the home-range center and 14 ha (11-17) of meadow within an intermediate core, with 52% of them also relying on 0.41 ha (0.29-0.59) of suburban land near the homerange center. RADA thus provides a useful tool to infer key animal resource requirements during studies of animal movement and habitat use.	[Kenward, Robert E.] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Arraut, Eduardo M.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford, Oxon, England; [Arraut, Eduardo M.] Aeronaut Inst Technol, Dept Water Resources & Environm, Sao Jose Dos Campos, SP, Brazil; [Arraut, Eduardo M.] Natl Inst Space Res, Remote Sensing Div, Sao Jose Dos Campos, SP, Brazil; [Arraut, Eduardo M.] Univ Estadual Campinas, Dept Plant Biol, Sao Paulo, SP, Brazil; [Robertson, Peter A.] Newcastle Univ, Ctr Wildlife Management, Sch Biol, Newcastle Upon Tyne, Tyne & Wear, England; [Walls, Sean S.] Biotrack Ltd, Wareham, Dorset, England; [Casey, Nicholas M.] Anatrack Ltd, Wareham, Dorset, England; [Aebischer, Nicholas J.] Game & Wildlife Conservat Trust, Fordingbridge, Hants, England; [Arraut, Eduardo M.] Aeronaut Inst Technol, Dept Water Resources & Environm, Sao Jose Dos Campos, Brazil	UK Centre for Ecology & Hydrology (UKCEH); University of Oxford; Comando-Geral de Tecnologia Aeroespacial (CTA); Instituto Tecnologico de Aeronautica (ITA); Instituto Nacional de Pesquisas Espaciais (INPE); Universidade Estadual de Campinas; Newcastle University - UK; Comando-Geral de Tecnologia Aeroespacial (CTA); Instituto Tecnologico de Aeronautica (ITA)	Arraut, EM (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford, Oxon, England.; Arraut, EM (corresponding author), Aeronaut Inst Technol, Dept Water Resources & Environm, Sao Jose Dos Campos, SP, Brazil.; Arraut, EM (corresponding author), Natl Inst Space Res, Remote Sensing Div, Sao Jose Dos Campos, SP, Brazil.; Arraut, EM (corresponding author), Univ Estadual Campinas, Dept Plant Biol, Sao Paulo, SP, Brazil.; Arraut, EM (corresponding author), Aeronaut Inst Technol, Dept Water Resources & Environm, Sao Jose Dos Campos, Brazil.	emarraut@ita.br	Arraut, Eduardo Moraes/AAJ-5007-2021; Aebischer, Nicholas J/AAU-9285-2021; Arraut, Eduardo M/E-7733-2011	Arraut, Eduardo Moraes/0000-0001-5323-4431; Arraut, Eduardo M/0000-0001-5323-4431; Kenward, Robert/0000-0002-2769-1345; Walls, Sean/0000-0002-8410-4784	British Petroleum PLC; Game and Wildlife Conservation Trust; Newcastle University; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq); Instituto Nacional de Ciencia e Tecnologia para Mudancas Climaticas (INCT-MC); Oxford University; Biotrack Ltd; Anatrack Ltd	British Petroleum PLC; Game and Wildlife Conservation Trust; Newcastle University; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia para Mudancas Climaticas (INCT-MC); Oxford University; Biotrack Ltd; Anatrack Ltd	Funding was provided by British Petroleum PLC (www.bp.com) via several contracts to the Natural Environment Research Council (www.nerc.ac.uk), as well as by Biotrack Ltd (www.biotrack.co.uk), Anatrack Ltd (www.anatrack.com), the Game and Wildlife Conservation Trust (www.gwct.org.uk), Newcastle University (www.newcastle.ac.uk), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq), Instituto Nacional de Ciencia e Tecnologia para Mudancas Climaticas (INCT-MC) and Oxford University (www.oxford.ac.uk).The funders provided support in the form of salaries for authors [REK, EMA, SSW, NJA, PAR, NMC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aarts G, 2013, J ANIM ECOL, V82, P1135, DOI 10.1111/1365-2656.12061; AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; ALLDREDGE JR, 1992, J WILDLIFE MANAGE, V56, P1, DOI 10.2307/3808785; ALLDREDGE JR, 1986, J WILDLIFE MANAGE, V50, P157, DOI 10.2307/3801507; Arraut EM, 2010, J ZOOL, V280, P247, DOI 10.1111/j.1469-7998.2009.00655.x; Arthur SM, 1996, ECOLOGY, V77, P215, DOI 10.2307/2265671; Benhamou S, 2012, ECOL MODEL, V227, P112, DOI 10.1016/j.ecolmodel.2011.12.015; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; BYERS CR, 1984, J WILDLIFE MANAGE, V48, P1050, DOI 10.2307/3801467; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Camara G, 1996, COMPUT GRAPH, V20, P395, DOI 10.1016/0097-8493(96)00008-8; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cox DR, 1974, THEORETICAL STAT; Furtado LFD, 2015, ACTA AMAZON, V45, P195, DOI 10.1590/1809-4392201401439; Development Team QGIS, 2015, QGIS GEOGR INF SYST; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Erickson, 2002, J ANIM ECOL, V63, P745, DOI [10.2307/5247, DOI 10.2307/5247]; Ferguson SH, 1999, ECOL LETT, V2, P311, DOI 10.1046/j.1461-0248.1999.00090.x; Ferreira-Ferreira J, 2015, WETL ECOL MANAG, V23, P41, DOI 10.1007/s11273-014-9359-1; Fischer M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199617; Fleming CH, 2015, ECOLOGY, V96, P1182, DOI 10.1890/14-2010.1; FULLER RM, 1994, PHOTOGRAMM ENG REM S, V60, P553; FULLER RM, 1994, INT J REMOTE SENS, V15, P1357, DOI 10.1080/01431169408954170; Gautestad AO, 2012, J R SOC INTERFACE, V9, P2332, DOI 10.1098/rsif.2012.0059; GEFFEN E, 1992, OECOLOGIA, V91, P75, DOI 10.1007/BF00317244; Gomez C, 2016, ISPRS J PHOTOGRAMM, V116, P55, DOI 10.1016/j.isprsjprs.2016.03.008; Goss-Custard JD, 2008, DEVON IBIS LOND 1859, V125, P155; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Gurnell J, 1987, NATURAL HIST SQUIRRE; Hansen MC, 2008, REMOTE SENS ENVIRON, V112, P2495, DOI 10.1016/j.rse.2007.11.012; HEISEY DM, 1985, ECOLOGY, V66, P1744, DOI 10.2307/2937370; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; Hjermann DO, 2000, ECOLOGY, V81, P1462, DOI 10.1890/0012-9658(2000)081[1462:AHSIAW]2.0.CO;2; Hodder KH, 2001, COMMON BUZZARD LOWLA; Hooten MB, 2010, J AGR BIOL ENVIR ST, V15, P523, DOI 10.1007/s13253-010-0038-2; Hulbert IAR, 1996, J APPL ECOL, V33, P315, DOI [10.2307/2404753, 10.2307/2404786]; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Johnson DS, 2013, J ANIM ECOL, V82, P1155, DOI 10.1111/1365-2656.12087; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kenward R.E., 1985, P319; Kenward RE, 1998, J ZOOL, V244, P7, DOI 10.1111/j.1469-7998.1998.tb00002.x; KENWARD RE, 1986, J ZOOL, V210, P473; KENWARD RE, 1982, J ANIM ECOL, V51, P69, DOI 10.2307/4311; Kenward RE, 2001, ECOLOGY, V82, P1905, DOI 10.2307/2680056; Kenward RE, 2001, J ANIM ECOL, V70, P1, DOI 10.1046/j.1365-2656.2001.00464.x; Kenward RE., 2000, MANUAL WILDLIFE RADI; Kenward RE, 2014, RANGES 9 SOFTWARE AN; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; KODRICBROWN A, 1978, ECOLOGY, V59, P285, DOI 10.2307/1936374; Krebs JR., 1997, BEHAV ECOLOGY EVOLUT; Li XC, 2015, REMOTE SENS ENVIRON, V166, P78, DOI 10.1016/j.rse.2015.06.007; LITVAITIS JA, 1986, J WILDLIFE MANAGE, V50, P110, DOI 10.2307/3801498; Loarie SR, 2013, ANIM BEHAV, V85, P899, DOI 10.1016/j.anbehav.2013.01.018; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Macdonald DW, 2015, J ZOOL, V295, P75, DOI 10.1111/jzo.12202; MACDONALD PDM, 1979, J FISH RES BOARD CAN, V36, P987, DOI 10.1139/f79-137; Marzluff JM, 1997, CONDOR, V99, P567, DOI 10.2307/1370470; Mitchell MS, 2008, ECOL MODEL, V216, P409, DOI 10.1016/j.ecolmodel.2008.05.001; Mitchell MS, 2004, ECOL MODEL, V177, P209, DOI 10.1016/j.ecolmodel.2004.01.015; Moorcroft PR, 2012, J MAMMAL, V93, P903, DOI 10.1644/11-MAMM-S-254.1; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; NEU CW, 1974, J WILDLIFE MANAGE, V38, P541, DOI 10.2307/3800887; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; Potts JR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0231; Powell R, 1997, ECOLOGY BEHAV N AMER; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; QUADE D, 1979, J AM STAT ASSOC, V74, P680, DOI 10.2307/2286991; Rachlow JL, 1999, AFR J ECOL, V37, P295, DOI 10.1046/j.1365-2028.1999.00175.x; Rhodes JR, 2005, ECOLOGY, V86, P1199, DOI 10.1890/04-0912; Robertson PA, 1998, J APPL ECOL, V35, P928; Said S, 2009, OIKOS, V118, P1299, DOI 10.1111/j.1600-0706.2009.17346.x; Silva TSF, 2010, REMOTE SENS ENVIRON, V114, P1998, DOI 10.1016/j.rse.2010.04.007; STENGER JUDITH, 1958, AUK, V75, P335; THIRGOOD SJ, 1995, J ZOOL, V235, P645, DOI 10.1111/j.1469-7998.1995.tb01775.x; Tufto J, 1996, J ANIM ECOL, V65, P715, DOI 10.2307/5670; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; WALLS SS, 1995, IBIS, V137, P177, DOI 10.1111/j.1474-919X.1995.tb03237.x; Walter W.D., 2011, MODERN TELEMETRY, P249; Walter WD, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0039-4; WAUTERS L, 1992, ANIM BEHAV, V43, P297, DOI 10.1016/S0003-3472(05)80225-8; White G.C., 1990, ANAL WILDLIFE RADIO; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; Zhang CY, 2012, PHOTOGRAMM ENG REM S, V78, P1079, DOI 10.14358/PERS.78.10.1079	85	7	7	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206354	10.1371/journal.pone.0206354	http://dx.doi.org/10.1371/journal.pone.0206354			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356319	Green Published, Green Accepted, gold			2022-12-26	WOS:000448434000095
J	Farr, K; Ravindran, R; Strnad, L; Chang, E; Chaisson, LH; Yoon, C; Worodria, W; Andama, A; Ayakaka, I; Nalwanga, PB; Byanyima, P; Kalema, N; Kaswabuli, S; Katagira, W; Aman, KD; Musisi, E; Tumwine, NW; Sanyu, I; Ssebunya, R; Davis, JL; Huang, L; Khan, IH; Cattamanchi, A				Farr, Katherine; Ravindran, Resmi; Strnad, Luke; Chang, Emily; Chaisson, Lelia H.; Yoon, Christina; Worodria, William; Andama, Alfred; Ayakaka, Irene; Nalwanga, Priscilla Bbosa; Byanyima, Patrick; Kalema, Nelson; Kaswabuli, Sylvia; Katagira, Winceslaus; Aman, Kyomugisha Denise; Musisi, Emmanuel; Tumwine, Nuwagaba Wallen; Sanyu, Ingvar; Ssebunya, Robert; Davis, J. Lucian; Huang, Laurence; Khan, Imran H.; Cattamanchi, Adithya			Diagnostic performance of blood inflammatory markers for tuberculosis screening in people living with HIV	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ISONIAZID PREVENTIVE THERAPY; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; ACTIVE TUBERCULOSIS; SOUTH-AFRICA; ACCURACY; MICROSCOPY	Background Approaches to screening for active tuberculosis (TB) among people living with HIV are inadequate, leading to missed diagnoses and poor implementation of preventive therapy. Methods Consecutive HIV-infected adults hospitalized at Mulago Hospital (Kampala, Uganda) between June 2011 and July 2013 with a cough > 2 weeks were enrolled. Patients underwent extensive evaluation for pulmonary TB. Concentrations of 43 cytokines/chemokines were measured at the same time point as C-reactive protein (CRP) in banked plasma samples using commercially-available multiplex kits. Advanced classification algorithms were used to rank cytokines/chemokines for their ability to identify TB, and to model the specificity of the top-ranked cytokines/chemokines individually and in combination with sensitivity constrained to >= 90% as recommended for TB screening. Results The median plasma level of 5 biomarkers (IL-6, INF-gamma, MIG, CRP, IL-18) was significantly different between patients with and without TB. With sensitivity constrained to 90%, all had low specificity with IL-6 showing the highest specificity (44%; 95% CI 37.4-49.5). Biomarker panels were found to be more valuable than any biomarker alone. A panel combining IFN-gamma and IL-6 had the highest specificity (50%; 95% CI 46.7-53.3). Sensitivity remained high (>85%) for all panels among sputum smear-negative TB patients. Conclusion Direct measurement of unstimulated plasma cytokines/chemokines in peripheral blood is a promising approach to TB screening. Cytokine/chemokine panels retained high sensitivity for smear-negative TB and achieved improved specificity compared to individual cytokines/chemokines. These markers should be further evaluated in outpatient settings where most TB screening occurs and where other illnesses associated with systematic inflammation are less common.	[Farr, Katherine; Chang, Emily; Yoon, Christina; Huang, Laurence; Cattamanchi, Adithya] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Farr, Katherine; Chang, Emily; Yoon, Christina; Huang, Laurence; Cattamanchi, Adithya] Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA; [Farr, Katherine; Cattamanchi, Adithya] Univ Calif San Francisco, Curry Int TB Ctr, San Francisco, CA 94143 USA; [Ravindran, Resmi; Khan, Imran H.] Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Strnad, Luke] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97201 USA; [Strnad, Luke] Portland State Univ, Oregon Hlth & Sci Univ, Sch Publ Hlth, Epidemiol Programs, Portland, OR 97207 USA; Univ Calif San Francisco, Dept Med, Div HIV Infect Dis & Global Med, San Francisco, CA USA; [Chaisson, Lelia H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Worodria, William] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda; [Worodria, William] Mulago Hosp, Dept Med, Div Resp Med, Kampala, Uganda; [Andama, Alfred] Makerere Univ, Mulago Hosp, Dept Med, Kampala, Uganda; [Andama, Alfred; Ayakaka, Irene; Nalwanga, Priscilla Bbosa; Byanyima, Patrick; Kaswabuli, Sylvia; Katagira, Winceslaus; Aman, Kyomugisha Denise; Musisi, Emmanuel; Tumwine, Nuwagaba Wallen; Sanyu, Ingvar; Ssebunya, Robert] Infect Dis Res Collaborat, Kampala, Uganda; [Ayakaka, Irene] Univ Liverpool Liverpool Sch Trop Med, Int Multidisciplinary Programme Address Lung Hlth, Liverpool, Merseyside, England; [Kalema, Nelson] Makerere Univ, Makerere Coll Hlth Sci, Infect Dis Inst, Dept Res, Kampala, Uganda; [Musisi, Emmanuel] Makerere Univ, Coll Nat Sci, Dept Biochem, Kampala, Uganda; [Davis, J. Lucian] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Davis, J. Lucian] Yale Sch Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; Oregon Health & Science University; Oregon Health & Science University; Portland State University; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Mulago National Referral Hospital; Makerere University; Mulago National Referral Hospital; Liverpool School of Tropical Medicine; Makerere University; Makerere University; Yale University; Yale University	Khan, IH (corresponding author), Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA.	ihkhan@ucdavis.edu	Khan, Imran Ali/GVT-0232-2022; Kalema, Nelson/AAZ-5730-2020; Khan, imran/GQQ-2176-2022; Huang, Laurence/AAZ-7120-2021; Davis, J. Lucian/AAC-8376-2019; Huang, Laurence/AAE-1590-2019	Khan, Imran Ali/0000-0002-8774-2896; Kalema, Nelson/0000-0002-7118-704X; Huang, Laurence/0000-0003-3888-2195; Davis, J. Lucian/0000-0002-8629-9992; Katagira, Winceslaus/0000-0003-4622-191X; Adams, Katherine/0000-0002-1818-1730	National Institutes of Health [K23AI080147, 5T32AI007641-12, 5T32AI102623]; National Institutes of Health/National Heart, Lung, and Blood Institute [K24HL087713, R01HL090335]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [P30-AI027763]; FOGARTY INTERNATIONAL CENTER [D43TW009607, D43TW009343] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713, R01HL128156, R01HL090335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI114363, T32AI102623, T32AI007641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	LS was supported by a training grant from the National Institutes of Health (5T32AI007641-12, https://www.nih.gov/). LHC was supported by a training grant from the National Institutes of Health (5T32AI102623, https://www.nih.gov/). JLD was supported by a grant from the National Institutes of Health (K23AI080147, https://www.nih.gov/). Patient enrollment and specimen collection was supported by grants from National Institutes of Health/National Heart, Lung, and Blood Institute to LH (K24HL087713 and R01HL090335, https://www.nhlbi.nih.gov/), and this sub-study was supported by a Pilot Award to AC from the National Institutes of Health/National Institute of Allergy and Infectious Diseases-funded UCSF Center for AIDS Research (P30-AI027763, http://cfar.ucsf.edu/).	[Anonymous], 2011, GUID INT TUB CAS FIN; Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Batz H-G, 2011, LAB FREE TUBERCULOSI; Biraro IA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146098; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; Cattamanchi A, 2011, AM J RESP CRIT CARE, V183, P547, DOI 10.1164/rccm.201008-1207OC; Chen T, 2016, TUBERCULOSIS, V97, P108, DOI 10.1016/j.tube.2015.12.007; Chung W, 2015, INT J TUBERC LUNG D, V19, P1476, DOI 10.5588/ijtld.15.0325; Dawson R, 2010, INT J TUBERC LUNG D, V14, P52; Day JH, 2006, INT J TUBERC LUNG D, V10, P523; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; Drain PK, 2014, INT J TUBERC LUNG D, V18, P20, DOI 10.5588/ijtld.13.0519; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; HASTIE T, 2009, SPRINGER SERIES STAT; Hong JY, 2012, INT J INFECT DIS, V16, pE855, DOI 10.1016/j.ijid.2012.07.013; Hubbard A, 2013, J TRAUMA ACUTE CARE, V75, pS53, DOI 10.1097/TA.0b013e3182914553; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Kufa T, 2012, JAIDS-J ACQ IMM DEF, V60, pE22, DOI 10.1097/QAI.0b013e318251ae0b; Langendam MW, 2013, SYSTEMATIC REV SENSI; Lawn SD, 2013, INT J TUBERC LUNG D, V17, P636, DOI 10.5588/ijtld.12.0811; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Lemaire JF, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-40; Mihret A, 2013, J INFECTION, V66, P357, DOI 10.1016/j.jinf.2012.11.005; Polley EC, 2010, U CALIFORNIA BERKELE; Rangaka MX, 2012, CLIN INFECT DIS, V55, P1698, DOI 10.1093/cid/cis775; Ravindran R, 2013, CLIN VACCINE IMMUNOL, V20, P1283, DOI 10.1128/CVI.00213-13; Rose S, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-1-4419-9782-1; Strobl C, 2007, COMPUT STAT DATA AN, V52, P483, DOI 10.1016/j.csda.2006.12.030; Swindells S, 2013, INT J TUBERC LUNG D, V17, P532, DOI 10.5588/ijtld.12.0737; Tebruegge M, 2015, AM J RESP CRIT CARE, V192, P485, DOI 10.1164/rccm.201501-0059OC; Telisinghe L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087262; United Nations Joint Programme on HIV/ AIDS, 2016, GLOB AIDS UPD 2016; Wilson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015248; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, 2008, INT CAS FIND ICF IS; Yoon C, 2017, INT J TUBERC LUNG D, V21, P1013, DOI 10.5588/ijtld.17.0078; Yoon C, 2017, LANCET INFECT DIS, V17, P1285, DOI 10.1016/S1473-3099(17)30488-7; Yoon C, 2014, JAIDS-J ACQ IMM DEF, V65, P551, DOI 10.1097/QAI.0000000000000085; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044944	41	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206119	10.1371/journal.pone.0206119	http://dx.doi.org/10.1371/journal.pone.0206119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352099	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000448076200027
J	Tang, Y; Joo, D; Liu, GN; Tu, HL; You, J; Jin, JP; Zhao, XQ; Hung, MC; Lin, X				Tang, Yong; Joo, Donghyun; Liu, Guangna; Tu, Hailin; You, Jeffrey; Jin, Jianping; Zhao, Xueqiang; Hung, Mien-Chie; Lin, Xin			Linear ubiquitination of cFLIP induced by LUBAC contributes to TNF-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; ubiquitylation (ubiquitination); tumor necrosis factor (TNF); caspase; cell death; cFLIP; linear ubiquitination; LUBAC; RNF31	NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; C-FLIP; EMBRYONIC LETHALITY; MEDIATED APOPTOSIS; CELL-DEATH; RECEPTOR; SHARPIN; ACTIVATION; PROTEIN	The linear ubiquitin chain assembly complex (LUBAC) regulates NF-B activation by modifying proteins with linear (M1-linked) ubiquitination chains. Although LUBAC also regulates the apoptosis pathway, the precise mechanism by which LUBAC regulates apoptosis remains not fully defined. Here, we report that LUBAC-mediated M1-linked ubiquitination of cellular FLICE-like inhibitory protein (cFLIP), an anti-apoptotic molecule, contributes to tumor necrosis factor (TNF) -induced apoptosis. We found that deficiency of RNF31, the catalytic subunit of the LUBAC complex, promoted cFLIP degradation in a proteasome-dependent manner. Moreover, we observed RNF31 directly interact with cFLIP, and LUBAC further conjugated M1-linked ubiquitination chains at Lys-351 and Lys-353 of cFLIP to stabilize cFLIP, thereby protecting cells from TNF-induced apoptosis. Together, our study identifies a new substrate of LUBAC and reveals a new molecular mechanism through which LUBAC regulates TNF-induced apoptosis via M1-linked ubiquitination.	[Tang, Yong; Liu, Guangna; Tu, Hailin; Zhao, Xueqiang; Lin, Xin] Tsinghua Univ, Sch Med, Inst Immunol, Beijing 100084, Peoples R China; [Joo, Donghyun; You, Jeffrey; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Jin, Jianping] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Tsinghua University; University of Texas System; UTMD Anderson Cancer Center; Zhejiang University	Lin, X (corresponding author), Tsinghua Univ, Sch Med, Inst Immunol, Beijing 100084, Peoples R China.	linxin307@tsinghua.edu.cn	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Liu, Guangna/0000-0003-4148-4534	National Natural Science Foundation of China [81570211, 81630058]; National Institutes of Health [R01A111672211]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Grants 81570211 and 81630058 from National Natural Science Foundation of China (to X. L.) and Grant R01A111672211 from the National Institutes of Health (to M.-C. H.).The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksentijevich I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00399; Bachmann F, 2001, J INVEST DERMATOL, V117, P59, DOI 10.1046/j.0022-202x.2001.01380.x; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Boisson B, 2015, J EXP MED, V212, P939, DOI 10.1084/jem.20141130; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fujita H, 2018, CELL REP, V23, P1192, DOI 10.1016/j.celrep.2018.03.112; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goto E, 2017, BIOCHEM BIOPH RES CO, V485, P152, DOI [10.1016/J.bbrc.2017.02.040, 10.1016/j.bbrc.2017.02.040]; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Iwai K, 2014, NAT REV MOL CELL BIO, V15, P503, DOI 10.1038/nrm3836; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kumari S, 2014, ELIFE, V3, DOI 10.7554/eLife.03422; Lee EW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1981; Liang YH, 2011, J INVEST DERMATOL, V131, P141, DOI 10.1038/jid.2010.259; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Panayotova-Dimitrova D, 2013, CELL REP, V5, P397, DOI 10.1016/j.celrep.2013.09.035; Park Y, 2016, NAT IMMUNOL, V17, P286, DOI 10.1038/ni.3352; Peltzer N, 2018, NATURE, V557, P112, DOI 10.1038/s41586-018-0064-8; Peltzer N, 2014, CELL REP, V9, P153, DOI 10.1016/j.celrep.2014.08.066; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Rickard JA, 2014, ELIFE, V3, DOI 10.7554/eLife.03464; Rieser E, 2013, TRENDS BIOCHEM SCI, V38, P94, DOI 10.1016/j.tibs.2012.11.007; Rodgers MA, 2014, J EXP MED, V211, P1331, DOI 10.1084/jem.20132486; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sohn D, 2006, MOL CELL BIOL, V26, P1967, DOI 10.1128/MCB.26.5.1967-1978.2006; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tang Y, 2018, J IMMUNOL, V200, P4117, DOI 10.4049/jimmunol.1800172; Teh CE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13353; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Weinlich R, 2013, CELL REP, V5, P340, DOI 10.1016/j.celrep.2013.08.045; Wilkie-Grantham RP, 2013, J BIOL CHEM, V288, P12777, DOI 10.1074/jbc.M112.431320; Yang YK, 2016, J BIOL CHEM, V291, P25921, DOI 10.1074/jbc.M116.754028; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	49	25	25	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20062	20072		10.1074/jbc.RA118.005449	http://dx.doi.org/10.1074/jbc.RA118.005449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30361438	Green Published, hybrid			2022-12-26	WOS:000454685900016
J	Abu-El-Haija, M; Hornung, L; Denson, LA; Husami, A; Lin, TK; Matlock, K; Nathan, JD; Palermo, JJ; Thompson, T; Valencia, CA; Wang, XJ; Woo, J; Zhang, KJ; Elder, D				Abu-El-Haija, Maisam; Hornung, Lindsey; Denson, Lee A.; Husami, Ammar; Lin, Tom K.; Matlock, Kristal; Nathan, Jaimie D.; Palermo, Joseph J.; Thompson, Tyler; Valencia, C. Alexander; Wang, Xinjian; Woo, Jessica; Zhang, Keijan; Elder, Deborah			Prevalence of abnormal glucose metabolism in pediatric acute, acute recurrent and chronic pancreatitis	PLOS ONE			English	Article							DIABETES-MELLITUS; CYSTIC-FIBROSIS; RISK; ASSOCIATION; MANAGEMENT; STANDARDS; SECONDARY; CHILDREN; DISEASE; CANCER	Type 3C Diabetes, or diseases of the exocrine pancreas has been reported to occur in approximately 30% of adult patient with pancreatitis. The incidence of glucose abnormalities or risk factors that may predict the development of abnormal glucose in the pediatric pancreatitis population is not known. We performed a retrospective chart review from 1998-2016 for patients who carry the diagnosis of acute pancreatitis (AP), acute recurrent pancreatitis (ARP), and chronic pancreatitis (CP). We extracted glucose values, HbA1c%, and data from oral glucose tolerance and mixed meal testing with timing in relation to pancreatic exacerbations. Patient characteristic data such as age, gender, body proportions, family history of pancreatitis, exocrine function and genetic mutations were also assessed. Abnormal glucose was based on definitions put forth by the American Diabetes Society for pre-diabetes and diabetes. Fifty-two patients had AP and met criteria. Of those, 15 (29%) had glucose testing on or after the first attack, 21 (40%) were tested on or after the second attack (in ARP patients) and 16 (31%) were tested after a diagnosis of CP. Of the patients tested for glucose abnormalities, 25% (13/52) had abnormal glucose testing (testing indicating preDM or DM as defined by ADA guidelines. A significantly higher proportion of the abnormal glucose testing was seen in patients (85%, 11/13) with a BMI at or greater than the 85th percentile compared to the normal glucose patients (28%, 11/39) (p = 0.0007). A significantly higher proportion of the abnormal glucose patients (77%, 10/13) had SAP during the prior AP episode to testing compared to the 10% (4/39) of the normal glucose patients (p<0.0001). Older age at DM testing was associated with a higher prevalence of abnormal glucose testing (p = 0.04). In our patient population, a higher proportion of glucose abnormalities were after the second episode of pancreatitis, however 62% (8/13) with abnormalities was their first time tested. We identified obesity and having severe acute pancreatitis (SAP) during the prior AP episode to testing could be associated with abnormal glucose. We propose that systematic screening for abnormal glucose after the first episode of acute pancreatitis in order to better establish the timing of diabetes progression.	[Abu-El-Haija, Maisam; Denson, Lee A.; Lin, Tom K.; Palermo, Joseph J.; Thompson, Tyler] Cincinnati Childrens Hosp Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Abu-El-Haija, Maisam; Denson, Lee A.; Lin, Tom K.; Matlock, Kristal; Palermo, Joseph J.; Woo, Jessica; Elder, Deborah] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA; [Hornung, Lindsey; Woo, Jessica] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Husami, Ammar; Valencia, C. Alexander; Wang, Xinjian; Zhang, Keijan] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Matlock, Kristal; Elder, Deborah] Cincinnati Childrens Hosp Med Ctr, Div Pediat Endocrinol, Cincinnati, OH 45229 USA; [Nathan, Jaimie D.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Gen & Thorac Surg, Cincinnati, OH 45229 USA; [Valencia, C. Alexander] PerkinElmer Genom, Pittsburgh, PA USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Abu-El-Haija, M (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA.; Abu-El-Haija, M (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA.	Maisam.Haija@cchmc.org	Woo, Jessica/M-4984-2015; Elder, Deborah/ABC-9636-2021; Husami, Ammar/K-7777-2012	Woo, Jessica/0000-0003-3644-8432; Husami, Ammar/0000-0002-4287-2857; Matlock, Kristal/0000-0002-3794-7076; Nathan, Jaimie/0000-0002-5867-3326	National Institutes of Health NIDDK [R43 DK105640-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392, U01DK108334] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health NIDDK, R43 DK105640-01 (M.A.H.).	Abu-El-Haija M, 2017, J PEDIATR GASTR NUTR, V64, P984, DOI 10.1097/MPG.0000000000001583; Abu-El-Haija M, 2014, J PEDIATR GASTR NUTR, V58, P689, DOI 10.1097/MPG.0000000000000360; Andersen DK, 2017, DIABETES, V66, P1103, DOI 10.2337/db16-1477; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Bai HX, 2011, J PEDIATR GASTR NUTR, V52, P262, DOI 10.1097/MPG.0b013e3182061d75; Briani G, 1988, J Diabet Complications, V2, P50, DOI 10.1016/0891-6632(88)90030-X; Compain P, 2013, CHEMBIOCHEM, V14, P2050, DOI 10.1002/cbic.201300312; Das SLM, 2014, GUT, V63, P818, DOI 10.1136/gutjnl-2013-305062; Dolan LM, 2005, J PEDIATR-US, V146, P751, DOI 10.1016/j.jpeds.2005.01.045; Hart PA, 2016, LANCET GASTROENTEROL, V1, P226, DOI 10.1016/S2468-1253(16)30106-6; Hart PA, 2013, PANCREAS, V42, P1207, DOI 10.1097/MPA.0b013e3182a7c963; Liao KF, 2012, J GASTROEN HEPATOL, V27, P709, DOI 10.1111/j.1440-1746.2011.06938.x; Lopes-Pacheco M, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00275; Lopez MJ, 2002, J PEDIATR-US, V140, P622, DOI 10.1067/mpd.2002.123880; Morinville VD, 2012, J PEDIATR GASTR NUTR, V55, P261, DOI 10.1097/MPG.0b013e31824f1516; Morinville VD, 2010, PANCREAS, V39, P5, DOI 10.1097/MPA.0b013e3181baac47; Park AJ, 2010, J PEDIATR GASTR NUTR, V51, P167, DOI 10.1097/MPG.0b013e3181cea545; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schwarzenberg SJ, 2015, J PEDIATR-US, V166, P890, DOI 10.1016/j.jpeds.2014.11.019; Shen HN, 2015, AM J GASTROENTEROL, V110, P1698, DOI 10.1038/ajg.2015.356; Solomon GM, 2015, PEDIATR PULM, V50, pS3, DOI 10.1002/ppul.23240; Soo DHE, 2017, DIGEST LIVER DIS, V49, P1146, DOI 10.1016/j.dld.2017.05.021; TIENGO A, 1983, DIABETES CARE, V6, P570, DOI 10.2337/diacare.6.6.570; Wang GJ, 2009, WORLD J GASTROENTERO, V15, P1427, DOI 10.3748/wjg.15.1427; WISE JE, 1992, DIABETES CARE, V15, P826, DOI 10.2337/diacare.15.7.826; Yadav D, 2010, NAT REV GASTRO HEPAT, V7, P131, DOI 10.1038/nrgastro.2010.6; ZIEGLER O, 1994, DIABETES METAB, V20, P540	28	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0204979	10.1371/journal.pone.0204979	http://dx.doi.org/10.1371/journal.pone.0204979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379828	Green Submitted, gold, Green Published			2022-12-26	WOS:000448823700025
J	Baje, L; Smart, JJ; Chin, A; White, WT; Simpfendorfer, CA				Baje, Leontine; Smart, Jonathan J.; Chin, Andrew; White, William T.; Simpfendorfer, Colin A.			Age, growth and maturity of the Australian sharpnose shark Rhizoprionodon taylori from the Gulf of Papua	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; REPRODUCTIVE-BIOLOGY; VALIDATED AGE; FISH GROWTH; CARCHARHINIFORMES; CONSERVATION; SPHYRNIDAE; PARAMETERS; PRECISION; MORTALITY	Coastal sharks with small body sizes may be among the most productive species of chondrichthyans. The Australian sharpnose shark (Rhizoprionodon taylori) is one of the most productive members of this group based on work in northern and eastern Australia. However, life history information throughout the remainder of its range is lacking. To address this knowledge gap, the age, growth and maturity of R. taylori caught in the Gulf of Papua prawn trawl fishery in Papua New Guinea, were studied. One hundred and eighty six individuals, comprising 131 females (31-66 cm TL) and 55 males (31-53 cm TL) were aged using vertebral analysis and growth was modelled using a multi-model approach. The lack of small individuals close to the size at birth made fitting of growth curves more difficult, two methods (fixed length at birth and additional zero aged individuals) accounting for this were trialled. The von Bertalanffy growth model provided the best fit to the data when used with a fixed length-at-birth (L-0 = 26 cm TL). Males (L-infinity = 46 cm TL, k= 3.69 yr(-1), L-50 = 41.7 cm TL and A(50) = 0.5 years) grew at a faster rate and matured at smaller sizes and younger ages than females (L-infinity = 58 cm TL, k= 1.98 yr(-1), L-50 = 47.0 cm TL and A(50) = 0.93 years). However, none of the methods to account for the lack of small individuals fully accounted for this phenomenon, and hence the results remain uncertain. Despite this, the results reaffirm the rapid growth of this species and suggest that the Gulf of Papua population may grow at a faster rate than Australian populations. Rhizoprionodon taylori is possibly well placed to withstand current fishing pressure despite being a common bycatch species in the Gulf of Papua prawn trawl fishery. However, further research needs to be undertaken to estimate other key life history parameters to fully assess the population status of this exploited shark species and its vulnerability to fishing in the Gulf of Papua.	[Baje, Leontine] Natl Fisheries Author, Port Moresby, Papua N Guinea; [Baje, Leontine; Smart, Jonathan J.; Chin, Andrew; Simpfendorfer, Colin A.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia; [Baje, Leontine; Smart, Jonathan J.; Chin, Andrew; Simpfendorfer, Colin A.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Smart, Jonathan J.] SARDI Aquat Sci, Adelaide, SA, Australia; [White, William T.] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [White, William T.] CSIRO Australian Natl Fish Collect, Natl Res Collect Australia, Hobart, Tas, Australia	James Cook University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Baje, L (corresponding author), Natl Fisheries Author, Port Moresby, Papua N Guinea.; Baje, L (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia.; Baje, L (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.	leontine.baje@my.jcu.edu.au	Smart, jonathan/W-2971-2019; Simpfendorfer, Colin A/G-9681-2011; Chin, Andrew/C-2254-2008; White, William T/B-9748-2009	Smart, jonathan/0000-0003-2070-3208; Simpfendorfer, Colin A/0000-0002-0295-2238; Chin, Andrew/0000-0003-1813-4042; White, William T/0000-0001-9705-2453	National Fisheries Authority of Papua New Guinea; Australian Centre for International Agricultural Research (ACIAR) [FIS/2012/102]; CSIRO Oceans and Atmosphere; ACIAR John Allwright Fellowship; Schlumberger Foundation; CSIRO Oceans Atmosphere; John Allwright Fellowship Award; Schlumberger Foundation Faculty for the Fellowship program	National Fisheries Authority of Papua New Guinea; Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); CSIRO Oceans and Atmosphere; ACIAR John Allwright Fellowship(Australian Ctr Intl Agr Res); Schlumberger Foundation(Schlumberger); CSIRO Oceans Atmosphere; John Allwright Fellowship Award; Schlumberger Foundation Faculty for the Fellowship program(Schlumberger)	This work was funded by the National Fisheries Authority of Papua New Guinea, the Australian Centre for International Agricultural Research (ACIAR; project FIS/2012/102) and CSIRO Oceans and Atmosphere. The lead author was supported by the ACIAR John Allwright Fellowship and the Schlumberger Foundation.; This research was funded by National Fisheries Authority of Papua New Guinea, the Australian Centre for International Agricultural Research (ACIAR; project FIS/2012/102) and CSIRO Oceans & Atmosphere. The authors would like to thank Drs Chris Barlow, Ann Fleming and Jes Sammut for their support. In addition, the authors also thank Ludwig Kumoru, Leban Gisawa, Luanah Yaman, Brian Kumasi, Thomas Usu and Benthly Sabub of the NFA. Special thanks is also accorded to Fishery Observers, Baera Nawia, Siwen Ohuesaho, Ronald Wala, Sarea Tova and Ian Tony; and to Dr Ralph Mana at the University of PNG for providing laboratory space for processing specimens. The lead author was funded by the John Allwright Fellowship Award administered by ACIAR and the Schlumberger Foundation Faculty for the Fellowship program.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Barton K., 2016, MUMIN MULTIMODEL INF; Baty F, 2015, J STAT SOFTW, V66, P1; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; BEAMISH RJ, 1981, CAN J FISH AQUAT SCI, V38, P982, DOI 10.1139/f81-132; Bishop SDH, 2006, MAR FRESHWATER RES, V57, P143, DOI 10.1071/MF05077; BOWKER AH, 1948, J AM STAT ASSOC, V43, P572, DOI 10.2307/2280710; BRANSTETTER S, 1990, NOAA Technical Report NMFS, P17; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; CHANG WYB, 1982, CAN J FISH AQUAT SCI, V39, P1208, DOI 10.1139/f82-158; Cortes E, 2004, CRC MAR BIOL SER, P449; Cortes E, 2012, CRC MAR BIOL SER, P453; D'Alberto BM, 2017, MAR FRESHWATER RES, V68, P1118, DOI 10.1071/MF16165; Evans CR, 1997, MAR FRESHWATER RES, V48, P219, DOI 10.1071/MF94222; Goldman KJ, 2012, CRC MAR BIOL SER, P423; Gutteridge AN, 2013, MAR FRESHWATER RES, V64, P54, DOI 10.1071/MF12140; Haddon M., 2001, MODELING QUANTITATIV; Harry AV, 2011, J FISH BIOL, V78, P2026, DOI 10.1111/j.1095-8649.2011.02992.x; Harry AV, 2013, MAR FRESHWATER RES, V64, P277, DOI 10.1071/MF12142; Harry AV, 2011, MAR FRESHWATER RES, V62, P710, DOI 10.1071/MF10155; Harry AV, 2010, FISH RES, V106, P393, DOI 10.1016/j.fishres.2010.09.010; Heupel MR, 2010, CONSERV BIOL, V24, P1212, DOI 10.1111/j.1523-1739.2010.01491.x; Heupel MR, 2014, MAR ECOL PROG SER, V495, P291, DOI 10.3354/meps10597; Kare, 1995, SPC FFA WORKSH MAN S, P653; Katsanevakis S, 2008, FISH FISH, V9, P178, DOI 10.1111/j.1467-2979.2008.00279.x; KIMURA DK, 1980, FISH B-NOAA, V77, P765; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Loefer JK, 2003, FISH B-NOAA, V101, P75; Lombardi-Carlson LA, 2003, MAR FRESHWATER RES, V54, P875, DOI 10.1071/MF03023; MATSUOKA T, 1991, NIPPON SUISAN GAKK, V57, P1321; McAuley RB, 2006, ENVIRON BIOL FISH, V77, P385, DOI 10.1007/s10641-006-9126-0; Munroe SEM, 2015, J FISH BIOL, V86, P1567, DOI 10.1111/jfb.12660; Natanson LJ, 2007, ENVIRON BIOL FISH, V80, P293, DOI 10.1007/s10641-007-9220-y; Ogle D.H., 2021, R PACKAGE; Pardo SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33745; Pardo SA, 2013, METHODS ECOL EVOL, V4, P353, DOI 10.1111/2041-210x.12020; R Core Team, 2013, R LANG ENV STAT COMP; Siegfried KI, 2006, ENVIRON BIOL FISH, V77, P301, DOI 10.1007/s10641-006-9112-6; SIMPFENDORFER CA, 1993, ENVIRON BIOL FISH, V36, P233, DOI 10.1007/BF00001718; SIMPFENDORFER CA, 1992, AUST J MAR FRESH RES, V43, P67, DOI 10.1071/MF9920067; Simpfendorfer CA, 2002, MAR FRESHWATER RES, V53, P567, DOI 10.1071/MF01131; Simpfendorfer CA, 1998, MAR FRESHWATER RES, V49, P757, DOI 10.1071/MF97044; Simpfendorfer CA, 1999, FISH B-NOAA, V97, P978; Simpfendorfer CA, 2017, CURR BIOL, V27, pR97, DOI 10.1016/j.cub.2016.12.017; Smart JJ, 2017, CORAL REEFS, V36, P577, DOI 10.1007/s00338-016-1533-x; Smart JJ, 2016, FISH FISH, V17, P955, DOI 10.1111/faf.12154; Smart JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153116; Smart JJ, 2013, AQUAT CONSERV, V23, P124, DOI 10.1002/aqc.2274; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; STEVENS JD, 1991, AUST J MAR FRESH RES, V42, P151; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Taylor SM, 2016, J FISH BIOL, V89, P2399, DOI 10.1111/jfb.13126; Thorson JT, 2009, FISH RES, V98, P75, DOI 10.1016/j.fishres.2009.03.016; Walker Terence I., 2005, P81; Waltrick D, 2012, REV FISH BIOL FISHER, V22, P849, DOI 10.1007/s11160-012-9267-5; White WT, 2007, J FISH BIOL, V71, P1512, DOI 10.1111/j.1095-8649.2007.01623.x; White WT, 2010, J FISH BIOL, V76, P2090, DOI 10.1111/j.1095-8649.2010.02654.x; White WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140075; Wilson KL, 2018, METHODS ECOL EVOL, V9, P822, DOI 10.1111/2041-210X.12931; Yamaguchi A, 2000, ENVIRON BIOL FISH, V57, P221, DOI 10.1023/A:1007558324902; Zhu LX, 2009, CHIN J OCEANOL LIMN, V27, P457, DOI 10.1007/s00343-009-9236-6	64	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206581	10.1371/journal.pone.0206581	http://dx.doi.org/10.1371/journal.pone.0206581			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379918	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000448823700132
J	Barron, ME; Thies, AB; Espinoza, JA; Barott, KL; Hamdoun, A; Tresguerres, M				Barron, Megan E.; Thies, Angus B.; Espinoza, Jose A.; Barott, Katie L.; Hamdoun, Amro; Tresguerres, Martin			A vesicular Na+/Ca2+ exchanger in coral calcifying cells	PLOS ONE			English	Article							SODIUM-CALCIUM EXCHANGER; SCLERACTINIAN CORALS; SECRETORY VESICLES; PROTEINS; LOCALIZATION; TRANSPORTERS; EVOLUTION; CALCIFICATION; MECHANISMS; EXPRESSION	The calcium carbonate skeletons of corals provide the underlying structure of coral reefs; however, the cellular mechanisms responsible for coral calcification remain poorly understood. In osteoblasts from vertebrate animals, a Na+/Ca2+ exchanger (NCX) present in the plasma membrane transports Ca2+ to the site of bone formation. The aims of this study were to establish whether NCX exists in corals and its localization within coral cells, which are essential first steps to investigate its potential involvement in calcification. Data mining identified genes encoding for NCX proteins in multiple coral species, a subset of which were more closely related to NCXs from vertebrates (NCXA). We cloned NCXA from Acropora yongei (AyNCX(A)), which, unexpectedly, contained a peptide signal that targets proteins to vesicles from the secretory pathway. AyNCX(A) subcellular localization was confirmed by heterologous expression of fluorescently tagged AyNCX(A) protein in sea urchin embryos, which localized together with known markers of intracellular vesicles. Finally, immunolabeling of coral tissues with specific antibodies revealed AyNCX(A) was present throughout coral tissue. AyNCX(A) was especially abundant in calcifying cells, where it exhibited a subcellular localization pattern consistent with intracellular vesicles. Altogether, our results demonstrate AyNCX(A) is present in vesicles in coral calcifying cells, where potential functions include intracellular Ca2+ homeostasis and Ca2+ transport to the growing skeleton as part of an intracellular calcification mechanism.	[Barron, Megan E.; Thies, Angus B.; Espinoza, Jose A.; Hamdoun, Amro; Tresguerres, Martin] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Barott, Katie L.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Pennsylvania	Tresguerres, M (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	mtresguerres@ucsd.edu	Hamdoun, Amro/AAE-1905-2021	Barott, Katie/0000-0001-7371-4870; Tresguerres, Martin/0000-0002-7090-9266; Thies, Angus/0000-0002-3235-2436; Hamdoun, Amro/0000-0003-2568-048X	National Science Foundation [EF-1220641, OCE-1538495]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation grants EF-1220641 https://www.nsf.gov/awardsearch/showAward?AWD_ID=1220641 and OCE-1538495 https://www.nsf.gov/awardsearch/showAward?AWD_ID=1538495&HistoricalAwards=false to M.T.	Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; Barott KL, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1769; Barott KL, 2015, AM J PHYSIOL-REG I, V309, pR235, DOI 10.1152/ajpregu.00052.2015; Bertucci A, 2011, MAR BIOTECHNOL, V13, P992, DOI 10.1007/s10126-011-9363-x; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Campanale JP, 2012, DEVELOPMENT, V139, P783, DOI 10.1242/dev.076752; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clode PL, 2002, TISSUE CELL, V34, P187, DOI 10.1016/S0040-8166(02)00031-9; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; Drake JL, 2014, P NATL ACAD SCI USA, V111, P12728, DOI [10.1073/pnas.1301419110/-/DCSupplemental/st01.docx, DOI 10.1073/PNAS.1301419110/-/DCSUPPLEMENTAL/ST01.DOCX]; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Euw Von S, 2017, AM ASS ADVANCEMENT S, V356, P933, DOI [10.1126/science.aam6371, DOI 10.1126/SCIENCE.AAM6371]; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Gagnon AC, 2012, EARTH PLANET SC LETT, V329, P150, DOI 10.1016/j.epsl.2012.03.005; Giladi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01102-x; Gokirmak T, 2014, MOL REPROD DEV, V81, P778, DOI 10.1002/mrd.22357; Gokirmak T, 2012, J BIOL CHEM, V287, P43876, DOI 10.1074/jbc.M112.424879; Gokirmak T, 2016, AM J PHYSIOL-CELL PH, V310, pC911, DOI 10.1152/ajpcell.00029.2016; HAYES RL, 1977, BIOL BULL, V152, P26, DOI 10.2307/1540724; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; ISA Y, 1986, MAR BIOL, V93, P91, DOI 10.1007/BF00428658; IWATA T, 1995, CELL CALCIUM, V17, P263, DOI 10.1016/0143-4160(95)90072-1; Johnston I.S., 1980, International Review of Cytology, V67, P171; KRIEGERBRAUER H, 1982, BIOCHIM BIOPHYS ACTA, V691, P61, DOI 10.1016/0005-2736(82)90214-0; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lepage T, 2004, METHOD CELL BIOL, V74, P677; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Marshall AT, 1996, SCIENCE, V271, P637, DOI 10.1126/science.271.5249.637; Mass T, 2017, P NATL ACAD SCI USA, V114, pE7670, DOI 10.1073/pnas.1707890114; Mass T, 2013, CURR BIOL, V23, P1126, DOI 10.1016/j.cub.2013.05.007; Massa T, 2014, P NATL ACAD SCI USA, V111, P12728, DOI 10.1073/pnas.1408621111; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; On C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-127; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; PHILIPSON KD, 1988, BIOCHIM BIOPHYS ACTA, V945, P298, DOI 10.1016/0005-2736(88)90492-0; Plaisance L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025026; Quednau BD, 2004, PFLUG ARCH EUR J PHY, V447, P543, DOI 10.1007/s00424-003-1065-4; Ren XY, 2013, J MOL CELL CARDIOL, V57, P68, DOI 10.1016/j.yjmcc.2013.01.010; Romano SL, 2000, B MAR SCI, V67, P1043; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sosnoski DA, 2008, J CELL BIOCHEM, V103, P1101, DOI 10.1002/jcb.21483; SPURGEON JPG, 1992, MAR POLLUT BULL, V24, P529, DOI 10.1016/0025-326X(92)90704-A; Stains JP, 1998, J BONE MINER RES, V13, P1862, DOI 10.1359/jbmr.1998.13.12.1862; Stains JP, 2002, J CELL BIOCHEM, V84, P625, DOI 10.1002/jcb.10050; Stolarski J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-316; Tambutte E, 2012, P ROY SOC B-BIOL SCI, V279, P19, DOI 10.1098/rspb.2011.0733; Thirion S, 1999, P NATL ACAD SCI USA, V96, P3206, DOI 10.1073/pnas.96.6.3206; TRESGUERRES M, 2017, ACID BASE BALANCE NI, P193, DOI DOI 10.1007/978-3-319-39617-0_7; Troadec JD, 1998, BIOL CELL, V90, P339; VANDERMEULEN JH, 1975, MAR BIOL, V31, P69, DOI 10.1007/BF00390649; Zoccola D, 1999, GENE, V227, P157, DOI 10.1016/S0378-1119(98)00602-7; Zoccola D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09983; Zutz A, 2009, BBA-BIOENERGETICS, V1787, P681, DOI 10.1016/j.bbabio.2009.02.009	63	19	19	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205367	10.1371/journal.pone.0205367	http://dx.doi.org/10.1371/journal.pone.0205367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379874	Green Submitted, Green Published, gold			2022-12-26	WOS:000448823700043
J	Moolhuijzen, PM; See, PT; Oliver, RP; Moffat, CS				Moolhuijzen, Paula M.; See, Pao Theen; Oliver, Richard P.; Moffat, Caroline S.			Genomic distribution of a novel Pyrenophora tritici-repentis ToxA insertion element	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TAN SPOT; STAGONOSPORA-NODORUM; SELECTIVE TOXIN; GENE ONTOLOGY; CAUSAL AGENT; WHEAT; PURIFICATION; RESISTANCE; PATHOGENS	The ToxA effector is a major virulence gene of Pyrenophora tritici-repentis (Ptr), a necro-trophic fungus and the causal agent of tan spot disease of wheat. ToxA and co-located genes are believed to be the result of a recent horizontally transferred highly conserved 14kb region a major pathogenic event for Ptr. Since this event, monitoring isolates for pathogenic changes has become important to help understand the underlying mechanisms in play. Here we examined ToxA in 100 Ptr isolates from Australia, Europe, North and South America and the Middle East, and uncovered in isolates from Denmark, Germany and New Zealand a new variation, a novel 166 bp insertion element (PtrHp1) which can form a perfectly matched 59 bp inverted repeat hairpin structure located downstream of the ToxA coding sequence in the 3' UTR exon. A wider examination revealed PtrHp1 elements to be distributed throughout the genome. Analysis of genomes from Australia and North America had 50-112 perfect copies that often overlap other genes. The hairpin element appears to be unique to Ptr and the lack of ancient origins in other species suggests that PtrHp1 emerged after Ptr speciation. Furthermore, the ToxA UTR insertion site is identical for different isolates, which suggests a single insertion event occurred after the ToxA horizontal transfer. In vitro and in planta-detached leaf assays found that the PtrHp1 element insertion had no effect on ToxA expression. However, variation in the expression of ToxA was detected between the Ptr isolates from different demographic locations, which appears to be unrelated to the presence of the element. We envision that this discovery may contribute towards future understanding of the possible role of hairpin elements in Ptr.	[Moolhuijzen, Paula M.; See, Pao Theen; Oliver, Richard P.; Moffat, Caroline S.] Curtin Univ, Dept Environm & Agr, Ctr Crop Dis & Management, Bentley, WA, Australia	Curtin University	Moolhuijzen, PM (corresponding author), Curtin Univ, Dept Environm & Agr, Ctr Crop Dis & Management, Bentley, WA, Australia.	paula.moolhuijzen@curtin.eu.au	Moffat, Caroline S/I-1058-2014	Moffat, Caroline S/0000-0002-6360-1933; See, Pao Theen/0000-0001-6554-4146; Moolhuijzen, Paula/0000-0002-3502-7612	Grains Research and Development Corporation (GRDC) [CUR00023]; National Collaborative Research Infrastructure Strategy (NCRIS)	Grains Research and Development Corporation (GRDC)(Grains R&D Corp); National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science)	This project was generously supported by the Grains Research and Development Corporation (GRDC) https://grdc.com.au/and Curtin University https://www.curtin.edu.au/, project code CUR00023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Lise Jorgensen (Aarhus University, Denmark), Michael Hess (Technische Universitat Munchen, Germany), Eirian Jones and Sean Weith (Lincoln University, New Zealand), Pawan Singh (CIMMYT, Mexico), Timothy Friesen and Danielle Holmes (United States Department of Agriculture, North Dakota, USA), Jozsef Bakonyi (Plant Protection Institute, Centre for Agricultural Research, Hungarian Academy of Sciences, Hungary), Hassan Momeni (Iranian Research Institute of Plant Protection, Iran) and Bruce McDonald (Institute of Integrative Biology, Zurich, Switzerland) for non-Australian Ptr DNA and isolates. We wish to also acknowledge Kalai Marathamuthu (Centre for Crop Disease Management, Curtin University, Australia) for her technical assistance in the exploratory stage of this work. This work used computational resources provided by the Australian Government through the Pawsey Supercomputing Centre under the National Computational Merit Allocation Scheme (NCMAS). This research also used the Nectar Research Cloud and the Pawsey Nimbus cloud services, a collaborative Australian research platform supported by the National Collaborative Research Infrastructure Strategy (NCRIS). The Australian Genome Research Facility performed Miseq and Illumina sequencing.	Adhikari TB, 2009, MOL PLANT MICROBE IN, V22, P1056, DOI 10.1094/MPMI-22-9-1056; Andrews S., 2016, FASTQC 2011; Antoni EA, 2010, AUSTRALAS PLANT PATH, V39, P63, DOI 10.1071/AP09056; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Ciuffetti LM, 1997, PLANT CELL, V9, P135, DOI 10.1105/tpc.9.2.135; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellwood SR, 2012, FUNGAL GENET BIOL, V49, P825, DOI 10.1016/j.fgb.2012.07.003; Ellwood SR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r109; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Friesen TL, 2006, NAT GENET, V38, P953, DOI 10.1038/ng1839; Friesen TL, 2005, PHYTOPATHOLOGY, V95, P1144, DOI 10.1094/PHYTO-95-1144; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; Hesketh J., 2001, 3 UTRS REGULATION EL; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Maclean DE, 2017, CAN J PLANT PATHOL, V39, P433, DOI 10.1080/07060661.2017.1387178; Mair W, 2016, PEST MANAG SCI, V72, P1449, DOI 10.1002/ps.4301; Manning VA, 2013, G3-GENES GENOM GENET, V3, P41, DOI 10.1534/g3.112.004044; Manning VA, 2009, MOL PLANT MICROBE IN, V22, P665, DOI 10.1094/MPMI-22-6-0665; McDonald MC, 2018, MOL PLANT PATHOL, V19, P432, DOI 10.1111/mpp.12535; Meile L, 2018, NEW PHYTOL, V219, P1048, DOI 10.1111/nph.15180; Moffat CS, 2015, AUSTRALAS PLANT PATH, V44, P161, DOI 10.1007/s13313-014-0335-2; Moffat C.S., 2019, INTEGRATED DIS MANAG, P95; Moffat CS, 2014, MOL PLANT PATHOL, V15, P918, DOI 10.1111/mpp.12154; Momeni H, 2014, J PLANT PATHOL, V96, P287; Moolhuijzen P, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4680-3; Oliver R, 2012, NEW PHYTOL, V196, P1015, DOI 10.1111/j.1469-8137.2012.04330.x; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Ortiz R, 2007, EUPHYTICA, V157, P365, DOI 10.1007/s10681-007-9375-9; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ren GX, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01276; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Richards JK, 2018, G3-GENES GENOM GENET, V8, P393, DOI 10.1534/g3.117.300462; Rybak K, 2017, MOL PLANT PATHOL, V18, P420, DOI 10.1111/mpp.12511; See PT, 2018, PLANT PATHOL, V67, P1066, DOI 10.1111/ppa.12835; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sperschneider J, 2016, NEW PHYTOL, V210, P743, DOI 10.1111/nph.13794; Steinbiss S, 2009, BIOINFORMATICS, V25, P533, DOI 10.1093/bioinformatics/btn657; Stukenbrock EH, 2007, MOL PLANT PATHOL, V8, P321, DOI 10.1111/J.1364-3703.2007.00396.X; Syme RA, 2013, G3-GENES GENOM GENET, V3, P959, DOI 10.1534/g3.112.004994; Tan KC, 2012, MOL PLANT MICROBE IN, V25, P515, DOI 10.1094/MPMI-10-11-0273; Tan KC, 2010, FUNCT PLANT BIOL, V37, P907, DOI 10.1071/FP10067; TOMAS A, 1990, MOL PLANT MICROBE IN, V3, P221, DOI 10.1094/MPMI-3-221; TUORI RP, 1995, MOL PLANT MICROBE IN, V8, P41, DOI 10.1094/MPMI-8-0041; Moreno MV, 2015, TROP PLANT PATHOL, V40, P141, DOI 10.1007/s40858-015-0011-2; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	55	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206586	10.1371/journal.pone.0206586	http://dx.doi.org/10.1371/journal.pone.0206586			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379913	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700133
J	Olivares, A; Hernandez-Reyes, A; Felix, R; Forero, A; Mata-Rocha, M; Hernandez-Sanchez, J; Santos, I; Aguirre-Alvarado, C; Oviedo, N				Olivares, Aleida; Hernandez-Reyes, Adriana; Felix, Ricardo; Forero, Angela; Mata-Rocha, Minerva; Hernandez-Sanchez, Javier; Santos, Isis; Aguirre-Alvarado, Charmina; Oviedo, Norma			Regulation of CATSPER1 expression by the testis-determining gene SRY	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN; POSTNATAL-DEVELOPMENT; SEX DETERMINATION; MOUSE TESTIS; CHANNEL; TRANSCRIPTS; SPERMATOZOA; MOTILITY; FETAL	CATSPER1 gene encodes a pore-forming and pH-sensing subunit of the CatSper Ca2+- permeable channel, a protein in the flagellum essential for sperm hyperactivation. Previous studies have shown that the murine Catsperl gene promoter is regulated by different Sox proteins. Likewise, it is acknowledged that the human CATSPER1 gene promoter sequence is enriched in potential interaction sites for the sex-determining region Y gene (SRY), which suggest a novel regulatory transcriptional mechanism for CatSperl channel expression. Therefore, in this work, we sought to determine whether the human CATSPER1 gene expression is regulated by the SRY transcription factor. To this end, a series of deletions and mutations were introduced in the wild- type CATSPER1 gene promoter to eliminate the SRY sites, and the different constructs were tested for their ability to activate transcription in human embryonic kidney and murine spermatogonial germ cell lines (HEK-293 and GC1-spg, respectively) using luciferase assays. In addition, by using a strategy that combines electrophoretic mobility shift assays (EMSA) and chromatin immunoprecipitation (ChIP) we investigated whether the CATSPER1 gene expression is regulated by the SRY transcription factor both in vitro and in vivo. Our results show that the transcriptional factor SRY specifically binds to different sites in the promoter sequence and has the ability to control CAT-SPER1 gene transcription.	[Olivares, Aleida; Santos, Isis] Hosp Gineco Obstet 4 Luis Castelazo Ayala, Unidad Invest Med Med Reprod, IMSS, Ciudad De Mexico, Mexico; [Hernandez-Reyes, Adriana; Aguirre-Alvarado, Charmina; Oviedo, Norma] Ctr Med Nacl La Raza, Unidad Invest Med Inmunol & Infectol, IMSS, Ciudad De Mexico, Mexico; [Felix, Ricardo; Forero, Angela] Inst Politecn Nacl, Cinvestav, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Ciudad De Mexico, Mexico; [Mata-Rocha, Minerva] Inst Nacl Med Genom INMEGEN, Dept Farmacogenom, Ciudad De Mexico, Mexico; [Hernandez-Sanchez, Javier] IPN, Cinvestav, Dept Genet & Biol Mol, Ciudad De Mexico, Mexico	Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Nacional de Medicina Genomica; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Oviedo, N (corresponding author), Ctr Med Nacl La Raza, Unidad Invest Med Inmunol & Infectol, IMSS, Ciudad De Mexico, Mexico.	naoviedoa@yahoo.com.mx	Felix, Ricardo/A-6989-2008; Oviedo, Norma/F-2293-2015	Felix, Ricardo/0000-0002-5383-7176; Oviedo, Norma/0000-0002-2359-5751; Olivares, Aleida/0000-0001-7212-0480; MATA, MINERVA/0000-0003-0949-461X; aguirre, charmina/0000-0003-1495-0245	Instituto Mexicano del Seguro Social [FIS/IMSS/PROT/G15/1410, FIS/IMSS/PROT/G12/1150]	Instituto Mexicano del Seguro Social	This work was supported by the Instituto Mexicano del Seguro Social (Grant number: FIS/IMSS/PROT/G15/1410 to NO; and FIS/IMSS/PROT/G12/1150 to AO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Avenarius MR, 2009, AM J HUM GENET, V84, P505, DOI 10.1016/j.ajhg.2009.03.004; Avidan N, 2003, EUR J HUM GENET, V11, P497, DOI 10.1038/sj.ejhg.5200991; Carlson AE, 2005, J BIOL CHEM, V280, P32238, DOI 10.1074/jbc.M501430200; Chung JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1153; Dewing P, 2006, CURR BIOL, V16, P415, DOI 10.1016/j.cub.2006.01.017; DiTacchio L, 2012, J BIOL CHEM, V287, P23657, DOI 10.1074/jbc.M111.320101; Ely D, 2010, STEROIDS, V75, P747, DOI 10.1016/j.steroids.2009.10.015; Jin JL, 2005, BIOL REPROD, V73, P1235, DOI 10.1095/biolreprod.105.045468; Kim CW, 2010, MOL REPROD DEV, V77, P650, DOI 10.1002/mrd.21216; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; LAHR G, 1995, MOL BRAIN RES, V33, P179; Li HG, 2007, MOL HUM REPROD, V13, P299, DOI 10.1093/molehr/gam009; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; Lobley Anna, 2003, Reprod Biol Endocrinol, V1, P53, DOI 10.1186/1477-7827-1-53; Mata-Rocha M, 2014, FEBS LETT, V588, P3352, DOI 10.1016/j.febslet.2014.07.024; Mata-Rocha M, 2013, MOL HUM REPROD, V19, P336, DOI 10.1093/molehr/gat003; Modi D, 2005, REPRODUCTION, V130, P603, DOI 10.1530/rep.1.00413; Nikpoor P, 2004, HUM REPROD, V19, P124, DOI 10.1093/humrep/deh043; Nishikawa K, 2004, MOL MICROBIOL, V54, P546, DOI 10.1111/j.1365-2958.2004.04291.x; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Salas-Cortes L, 1999, INT J DEV BIOL, V43, P135; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Tamburrino L, 2014, HUM REPROD, V29, P418, DOI 10.1093/humrep/det454; Tanaka SS, 2014, CELL MOL LIFE SCI, V71, P4781, DOI 10.1007/s00018-014-1703-3; Wang HK, 2009, BIOL REPROD, V81, P539, DOI 10.1095/biolreprod.109.077107	29	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205744	10.1371/journal.pone.0205744	http://dx.doi.org/10.1371/journal.pone.0205744			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379860	Green Submitted, Green Published, gold			2022-12-26	WOS:000448823700069
J	Passos, LF; Garcia, G; Young, RJ				Passos, Luiza F.; Garcia, Gerardo; Young, Robert J.			Comparing the bacterial communities of wild and captive golden mantella frogs: Implications for amphibian conservation	PLOS ONE			English	Article							SYMBIOTIC BACTERIA; SKIN MICROBIOTA; REINTRODUCTION; AURANTIACA; DYNAMICS	Bacterial communities are frequently found in symbiotic associations with most animal species. The characteristically moist amphibian skin provides a good environment for the growth of some species of bacteria; among these a few can act as a first line defense mechanism against infections. Amphibians in the wild have relatively high exposure to bacteria through environmental transmission and through interactions with different conspecifics, whilst in captivity animals interact with fewer individuals, as well as experiencing a less complex environment through which to obtain their bacterial community. Here we compared the skin microbiota of captive and wild Mantella aurantiaca to investigate whether the captive environment was affecting individuals' skin associated bacteria. This could have survivor-ship implications if captive animals had a different skin microbial community in comparison to wild counterparts and they were to be used in a reintroduction program. The microbial community were characterized through 16S rRNA amplicon sequencing methodology. Analyses showed that captive individuals had significantly lower diversity of bacterial species and lower relative abundant microbiota when compared to wild populations; this could result in captive frogs released back to the wild probably has greater susceptibility to infections due to inadequate skin microbiota.	[Passos, Luiza F.; Young, Robert J.] Univ Salford Manchester, Sch Environm & Life Sci, Salford, Lancs, England; [Passos, Luiza F.; Garcia, Gerardo] Chester Zoo, Cedar House, Chester, Cheshire, England		Young, RJ (corresponding author), Univ Salford Manchester, Sch Environm & Life Sci, Salford, Lancs, England.	r.j.young@salford.ac.uk	Young, Robert/B-7356-2013	Young, Robert/0000-0002-8407-2348	CAPES [6060-13-7]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	LFP was in receipt of a CAPES postgraduate scholarship Proc. 6060-13-7.	Antwis RE, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou042; Antwis RE, 2015, APPL ENVIRON MICROB, V81, P3706, DOI 10.1128/AEM.00010-15; Antwis RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085563; Assis AB, 2016, J CHEM ECOL, V42, P139, DOI DOI 10.1007/S10886-016-0665-3; Bates KA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02967-w; Becker MH, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2881; Becker MH, 2014, BIOL CONSERV, V176, P199, DOI 10.1016/j.biocon.2014.05.029; Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Bletz MC, 2017, ISME J, V11, P1521, DOI 10.1038/ismej.2017.41; Bletz MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08633; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cramp RL, 2014, CONSERV PHYSIOL, V2, P1; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Edmonds D, 2015, SALAMANDRA, V51, P315; Flechas SV, 2017, PEERJ, V5, DOI 10.7717/peerj.3594; Griffiths RA, 2008, CONSERV BIOL, V22, P852, DOI 10.1111/j.1523-1739.2008.00967.x; Harding G, 2016, CONSERV BIOL, V30, P340, DOI 10.1111/cobi.12612; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Johnson K., 2008, AMPHIBIAN ARK SPECIE; Kueneman JG, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1553; Kueneman JG, 2014, MOL ECOL, V23, P1238, DOI 10.1111/mec.12510; Kung D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087101; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Loudon AH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00333; Loudon AH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00441; Loudon AH, 2014, ISME J, V8, P830, DOI 10.1038/ismej.2013.200; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McKenzie VJ, 2012, ISME J, V6, P588, DOI 10.1038/ismej.2011.129; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Moran NA, 2006, P NATL ACAD SCI USA, V103, P12803, DOI 10.1073/pnas.0605772103; Passos LF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181972; Passos LF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181931; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Piovia-Scott J, 2017, MICROB ECOL, V74, P217, DOI 10.1007/s00248-016-0916-4; Poole VA, 2012, AMPHIBIAN HUSBANDRY, P238; R Studio Team, 2016, RSTUDIO INT DEV ENV; Randrianavelona R, 2010, AFR J HERPETOL, V59, P65, DOI 10.1080/04416651.2010.481761; Rebollar EA, 2016, ISME J, V10, P1682, DOI 10.1038/ismej.2015.234; Sabino-Pinto J, 2016, MICROB ECOL, V72, P460, DOI 10.1007/s00248-016-0797-6; Shade A, 2014, MBIO, V5, DOI 10.1128/mBio.01371-14; Vences M, 2004, IUCN 2009 IUCN RED L; Vences M, 2015, AMPHIBIA-REPTILIA, V36, P5, DOI 10.1163/15685381-00002970; Walke JB, 2014, ISME J, V8, P2207, DOI 10.1038/ismej.2014.77; Walke JB, 2011, BIOTROPICA, V43, P396, DOI 10.1111/j.1744-7429.2011.00787.x; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Woodhams DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096375	47	5	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205652	10.1371/journal.pone.0205652	http://dx.doi.org/10.1371/journal.pone.0205652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379861	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000448823700060
J	Sanchez-Moran, M; Hernandez, JA; Dunabeitia, JA; Estevez, A; Barcena, L; Gonzalez-Lahera, A; Bajo, MT; Fuentes, LJ; Aransay, AM; Carreiras, M				Sanchez-Moran, Mirian; Andres Hernandez, Juan; Andoni Dunabeitia, Jon; Estevez, Adelina; Barcena, Laura; Gonzalez-Lahera, Aintzane; Teresa Bajo, Maria; Fuentes, Luis J.; Aransay, Ana M.; Carreiras, Manuel			Genetic association study of dyslexia and ADHD candidate genes in a Spanish cohort: Implications of comorbid samples	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PHONOLOGICAL PROCESSING ABILITIES; DEFICIT HYPERACTIVITY DISORDER; DEVELOPMENTAL DYSLEXIA; READING-DISABILITY; EXECUTIVE FUNCTION; KIAA0319; COMT; DCDC2; POLYMORPHISM	Dyslexia and attention deficit hyperactivity disorder (ADHD) are two complex neuro-behaviorally disorders that co-occur more often than expected, so that reading disability has been linked to inattention symptoms. We examined 4 SNPs located on genes previously associated to dyslexia (KIAA0319, DCDC2, DYX1C1 and FOXP2) and 3 SNPs within genes related to ADHD (COMT, MAOA and DBH) in a cohort of Spanish children (N = 2078) that met the criteria of having one, both or none of these disorders (dyslexia and ADHD). We used a case-control approach comparing different groups of samples based on each individual diagnosis. In addition, we also performed a quantitative trait analysis with psychometric measures on the general population (N = 3357). The results indicated that the significance values for some markers change depending on the phenotypic groups compared and/or when considering pair-wise marker interactions. Furthermore, our quantitative trait study showed significant genetic associations with specific cognitive processes. These outcomes advocate the importance of establishing rigorous and homogeneous criteria for the diagnosis of cognitive disorders, as well as the relevance of considering cognitive endophenotypes.	[Sanchez-Moran, Mirian; Andoni Dunabeitia, Jon; Carreiras, Manuel] BCBL Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Gipuzkoa, Spain; [Sanchez-Moran, Mirian; Barcena, Laura; Gonzalez-Lahera, Aintzane; Aransay, Ana M.] CIC bioGUNE, Derio, Bizkaia, Spain; [Andres Hernandez, Juan; Estevez, Adelina] Univ La Laguna, Tenerife, Spain; [Gonzalez-Lahera, Aintzane; Aransay, Ana M.] Inst Salud Carlos III, CIBERehd, Madrid, Spain; [Teresa Bajo, Maria] Univ Granada, Res Ctr Brain Mind & Behav, Granada, Spain; [Fuentes, Luis J.] Univ Murcia, Murcia, Spain; [Carreiras, Manuel] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Carreiras, Manuel] Univ Basque Country, UPV EHU, Leioa, Bizkaia, Spain	CIC bioGUNE; Universidad de la Laguna; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; University of Granada; University of Murcia; Basque Foundation for Science; University of Basque Country	Carreiras, M (corresponding author), BCBL Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Gipuzkoa, Spain.; Carreiras, M (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao, Spain.; Carreiras, M (corresponding author), Univ Basque Country, UPV EHU, Leioa, Bizkaia, Spain.	m.carreiras@bcbl.eu	Aransay, Ana M./F-8086-2011; Bajo, Teresa/N-3154-2019; Bajo, Teresa/D-9927-2011; Duñabeitia, Jon Andoni/C-8503-2014; Hernández-Cabrera, Juan/H-8309-2015; Bárcena, Laura/AAC-1290-2021; Hernandez, Jose A./B-6823-2008; Carreiras, Manuel/D-5267-2009	Aransay, Ana M./0000-0002-8271-612X; Bajo, Teresa/0000-0003-2996-8261; Bajo, Teresa/0000-0003-2996-8261; Duñabeitia, Jon Andoni/0000-0002-3312-8559; Hernández-Cabrera, Juan/0000-0001-6731-5670; Hernandez, Jose A./0000-0001-7211-5147; Carreiras, Manuel/0000-0001-6726-7613	CONSOLIDER-Ingenio-2010_COEDUCA [CSD2008-00048]; Basque Department of Industry, Tourism and Trade (Etortek Program); Innovation Technology Department of Bizkaia; CIBERehd Network; Ayuda Centro de Excelencia Severo Ochoa from the MINECO [SEV-2015-0490]; European Research Council [ERC-2011-ADG-295362];  [PSI2015-67353-R]	CONSOLIDER-Ingenio-2010_COEDUCA; Basque Department of Industry, Tourism and Trade (Etortek Program); Innovation Technology Department of Bizkaia; CIBERehd Network; Ayuda Centro de Excelencia Severo Ochoa from the MINECO; European Research Council(European Research Council (ERC)European Commission); 	The work of MSM and MC was supported by CONSOLIDER-Ingenio-2010_COEDUCA (CSD2008-00048). AMA, LB and AG-L's work was supported by the Basque Department of Industry, Tourism and Trade (Etortek Program), Innovation Technology Department of Bizkaia and CIBERehd Network. MC was also supported by grants (PSI2015-67353-R), and Ayuda Centro de Excelencia Severo Ochoa SEV-2015-0490 from the MINECO, and by grant (ERC-2011-ADG-295362) from the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutagava-Martins GC, 2016, J PSYCHIATR NEUROSCI, V41, P405, DOI 10.1503/jpn.150270; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bates TC, 2010, MOL PSYCHIATR, V15, P1190, DOI 10.1038/mp.2009.120; Becker J, 2014, EUR J HUM GENET, V22, P675, DOI 10.1038/ejhg.2013.199; Bellini G, 2005, J MOL NEUROSCI, V27, P311, DOI 10.1385/JMN:27:3:311; Biederman J, 2008, AM J MED GENET B, V147B, P1511, DOI 10.1002/ajmg.b.30874; Bishop D., 2015, P ROY SOC LOND B BIO, P282; Boada R, 2012, TOP LANG DISORD, V32, P264, DOI 10.1097/TLD.0b013e31826203ac; Carravieri A, 2018, ENVIRON POLLUT, V237, P824, DOI 10.1016/j.envpol.2017.11.004; Carrion-Castillo A, 2013, DYSLEXIA, V19, P214, DOI 10.1002/dys.1464; COOK EH, 1995, AM J HUM GENET, V56, P993; Cope NA, 2005, MOL PSYCHIATR, V10, P237, DOI 10.1038/sj.mp.4001596; Couto JM, 2009, BIOL PSYCHIAT, V66, P368, DOI 10.1016/j.biopsych.2009.02.016; Czamara D, 2011, BEHAV GENET, V41, P110, DOI 10.1007/s10519-010-9413-6; Deffenbacher KE, 2004, HUM GENET, V115, P128, DOI 10.1007/s00439-004-1126-6; Degen C, 2016, DEMENT GERIATR COGN, V41, P27, DOI 10.1159/000439585; Fan J, 2003, P NATL ACAD SCI USA, V100, P7406, DOI 10.1073/pnas.0732088100; Field LL, 2013, GENES BRAIN BEHAV, V12, P56, DOI 10.1111/gbb.12003; Fisher SE, 2002, NAT REV NEUROSCI, V3, P767, DOI 10.1038/nrn936; Flint J, 2007, PSYCHOL MED, V37, P163, DOI 10.1017/S0033291706008750; Fossella J, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-14; Francks C, 2004, AM J HUM GENET, V75, P1046, DOI 10.1086/426404; Greven CU, 2011, J CAN ACAD CHILD ADO, V20, P6; Grigorenko EL, 2007, DEV PSYCHOPATHOL, V19, P1089, DOI 10.1017/S0954579407000557; Gurvich C, 2015, BEHAV BRAIN RES, V281, P96, DOI 10.1016/j.bbr.2014.11.045; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Harold D, 2006, MOL PSYCHIATR, V11, P1085, DOI 10.1038/sj.mp.4001904; Hawi Z, 2000, AM J MED GENET, V96, P282, DOI 10.1002/1096-8628(20000612)96:3<282::AID-AJMG9>3.0.CO;2-R; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Jin J, 2016, GENES BRAIN BEHAV, V15, P271, DOI 10.1111/gbb.12270; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Landi N, 2013, DEVELOPMENTAL SCI, V16, P13, DOI 10.1111/j.1467-7687.2012.01180.x; Lim CKP, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-16; Lim CKP, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-23; Lind PA, 2010, EUR J HUM GENET, V18, P668, DOI 10.1038/ejhg.2009.237; Loo SK, 2004, MOL PSYCHIATR, V9, P485, DOI 10.1038/sj.mp.4001450; Ludwig KU, 2008, J NEURAL TRANSM, V115, P1587, DOI 10.1007/s00702-008-0124-6; Mascheretti S, 2013, GENES BRAIN BEHAV, V12, P47, DOI 10.1111/gbb.12000; Mascheretti S, 2017, J CHILD PSYCHOL PSYC, V58, P75, DOI 10.1111/jcpp.12612; McGrath LM, 2011, J CHILD PSYCHOL PSYC, V52, P547, DOI 10.1111/j.1469-7610.2010.02346.x; Miller DI, 2014, TRENDS COGN SCI, V18, P37, DOI 10.1016/j.tics.2013.10.011; Neuhoff N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034909; Newbury DF, 2011, BEHAV GENET, V41, P90, DOI 10.1007/s10519-010-9424-3; Paracchini S, 2008, AM J PSYCHIAT, V165, P1576, DOI 10.1176/appi.ajp.2008.07121872; Paracchini S, 2007, ANNU REV GENOM HUM G, V8, P57, DOI 10.1146/annurev.genom.8.080706.092312; Peter B, 2011, J NEURODEV DISORD, V3, P39, DOI 10.1007/s11689-010-9065-0; Plourde V, 2015, J CHILD PSYCHOL PSYC, V56, P1074, DOI 10.1111/jcpp.12394; Powers NR, 2013, AM J HUM GENET, V93, P19, DOI 10.1016/j.ajhg.2013.05.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roeske D, 2011, MOL PSYCHIATR, V16, P97, DOI 10.1038/mp.2009.102; Scerri TS, 2011, BIOL PSYCHIAT, V70, P237, DOI 10.1016/j.biopsych.2011.02.005; Schneider KK, 2015, COGN AFFECT BEHAV NE, V15, P104, DOI 10.3758/s13415-014-0320-9; Schulte-Korne G, 1998, NEUROREPORT; Shao SS, 2016, MOL NEUROBIOL, V53, P3967, DOI 10.1007/s12035-015-9334-8; Sheikhi AR, 2013, AM J MED GENET B, V162B, P44, DOI 10.1002/ajmg.b.32119; Stergiakouli E, 2010, NEUROPSYCH DIS TREAT, V6, P551, DOI 10.2147/NDT.S11322; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; Thapar A, 2005, HUM MOL GENET, V14, pR275, DOI 10.1093/hmg/ddi263; Tong J, 2015, WORLD J BIOL PSYCHIA, V16, P610, DOI 10.3109/15622975.2015.1036771; Trezzi V, 2017, J HUM GENET, V62, P949, DOI 10.1038/jhg.2017.80; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; Venkatesh SK, 2014, PSYCHIAT GENET, V24, P10, DOI 10.1097/YPG.0000000000000009; Wadsworth SJ, 2015, TWIN RES HUM GENET, V18, P755, DOI 10.1017/thg.2015.66; Wadsworth SJ, 2016, TWIN RES HUM GENET, P1, DOI [10.1017/thg.2015.91, DOI 10.1017/THG.2015.91]; WAGNER RK, 1994, DEV PSYCHOL, V30, P73, DOI 10.1037/0012-1649.30.1.73; Wagner RK, 1997, DEV PSYCHOL, V33, P468, DOI 10.1037/0012-1649.33.3.468; WAGNER RK, 1986, J LEARN DISABIL, V19, P623, DOI 10.1177/002221948601901009; Wigg KG, 2008, GENES BRAIN BEHAV, V7, P877, DOI 10.1111/j.1601-183X.2008.00425.x; Wigg KG, 2005, SCI STUD READ, V9, P261, DOI 10.1207/s1532799xssr0903_5; Wilcke A, 2009, ANN DYSLEXIA, V59, P1, DOI 10.1007/s11881-008-0020-7; Willcutt EG, 2005, DEV NEUROPSYCHOL, V27, P35, DOI 10.1207/s15326942dn2701_3; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Willcutt EG, 2007, AM J MED GENET B, V144B, P709, DOI 10.1002/ajmg.b.30310; Willcutt EG, 2010, CORTEX, V46, P1345, DOI 10.1016/j.cortex.2010.06.009; Willcutt Erik G., 2008, V24, P195, DOI 10.1159/000118526; Zhang YP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153603	76	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206431	10.1371/journal.pone.0206431	http://dx.doi.org/10.1371/journal.pone.0206431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379906	gold, Green Published			2022-12-26	WOS:000448823700114
J	Sediqi, H; Wray, A; Jones, C; Jones, M				Sediqi, Hamid; Wray, Alex; Jones, Christopher; Jones, Mark			Application of Spectral Phasor analysis to sodium microenvironments in myoblast progenitor cells	PLOS ONE			English	Article							INTRACELLULAR PH; FUZZY SPACE; NA+; FLUORESCENCE; DIFFERENTIATION; CONTRACTION; MICROSCOPY; EXCITATION; EXCHANGE; CALCIUM	Sodium ions (Na+) are key regulators of molecular events in many cellular processes, yet the dynamics of this ion remain poorly defined. Developing approaches to identify and characterise Na+ microenvironments will enable more detailed elucidation of the mechanisms of signal transduction. Here we report the application of Spectral Phasor analysis to the Na+ fluorophore, CoroNa Green, to identify and spatially map spectral emissions that report Na+ microenvironments. We use differentiating stem cells where Na+ fluxes were reported as an antecedent. Myoblast stem cells were induced to differentiate by serum starvation and then fixed at intervals between 0 and 40-minutes of differentiation prior to addition of CoroNa Green. The fluorescent intensity was insufficient to identify discrete Na+ microenvironments. However, using Spectral Phasor analysis we identified spectral shifts in CoroNa Green fluorescence which is related to the Na+ microenvironment. Further, spectral-heterogeneity appears to be contingent on the distance of Na+ from the nucleus in the early stages of differentiation. Spectral Phasor analysis of CoroNa Green in fixed stem cells demonstrates for the first time that CoroNa Green has unique spectral emissions depending on the nature of the Na+ environment in differentiating stem cells. Applying Spectral Phasor analysis to CoroNa Green in live stem cells is likely to further elucidate the role of Na+ microenvironments in the differentiation process.	[Sediqi, Hamid; Wray, Alex; Jones, Christopher; Jones, Mark] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia	Western Sydney University	Sediqi, H (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia.	17525754@student.westernsydney.edu.au		Sediqi, Hamid/0000-0003-0803-2245	University of Western Sydney	University of Western Sydney	All funding from University of Western Sydney.	Andrews LM, 2013, BIOMED OPT EXPRESS, V4, P171, DOI 10.1364/BOE.4.000171; Aronsen JM, 2013, J MOL CELL CARDIOL, V61, P11, DOI 10.1016/j.yjmcc.2013.06.003; Blackburn GM, 2006, NUCLEIC ACIDS IN CHEMISTRY AND BIOLOGY, THIRD EDITION, P1, DOI 10.1039/9781847555380; Cutrale F, 2013, METHODS APPL FLUORES, V1, DOI 10.1088/2050-6120/1/3/035001; Despa S, 2000, ANAL BIOCHEM, V281, P159, DOI 10.1006/abio.2000.4560; Fereidouni F, 2012, OPT EXPRESS, V20, P12729, DOI 10.1364/OE.20.012729; Galva C, 2012, J CELL SCI, V125, P6137, DOI 10.1242/jcs.114959; Garini Y, 2006, CYTOM PART A, V69A, P735, DOI 10.1002/cyto.a.20311; Garner MH, 2002, J MEMBRANE BIOL, V187, P97, DOI 10.1007/s00232-001-0155-5; Gohara DW, 2016, J BIOL CHEM, V291, P20840, DOI 10.1074/jbc.R116.737833; Gratton E, GLOBALS SOFTWARE SPE; Iamshanova O, 2016, EUR BIOPHYS J BIOPHY, V45, P765, DOI 10.1007/s00249-016-1173-7; Kettani A, 1998, J MOL BIOL, V282, P619, DOI 10.1006/jmbi.1998.2030; KOCH KS, 1979, CELL, V18, P153, DOI 10.1016/0092-8674(79)90364-7; LADOUX A, 1988, EUR J BIOCHEM, V175, P455, DOI 10.1111/j.1432-1033.1988.tb14216.x; LEBLANC N, 1990, SCIENCE, V248, P372, DOI 10.1126/science.2158146; LEDERER WJ, 1990, SCIENCE, V248, P283, DOI 10.1126/science.2326638; Malacrida L, 2016, BBA-BIOMEMBRANES, V1858, P2625, DOI 10.1016/j.bbamem.2016.07.017; Meier SD, 2006, J NEUROSCI METH, V155, P251, DOI 10.1016/j.jneumeth.2006.01.009; MINTA A, 1989, J BIOL CHEM, V264, P19449; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Schreiner AE, 2012, CURRENT MICROSCOPY C, P119; Sena F, 2017, PLANT PHYSIOL BIOCH, V119, P224, DOI 10.1016/j.plaphy.2017.08.017; Stuart, 2005, INFRARED SPECTROSCOP, P76; Tseng AS, 2010, J NEUROSCI, V30, P13192, DOI 10.1523/JNEUROSCI.3315-10.2010; Tyler WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003511; Verdonck F, 2004, CELL CALCIUM, V35, P603, DOI 10.1016/j.ceca.2004.01.014; Wang HY, 1997, J BIOL CHEM, V272, P26545, DOI 10.1074/jbc.272.42.26545; YAFFE D, 1977, DIFFERENTIATION, V7, P159, DOI 10.1111/j.1432-0436.1977.tb01507.x; Yannone SM, 2012, CURR OPIN BIOTECH, V23, P89, DOI 10.1016/j.copbio.2011.11.005	31	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0204611	10.1371/journal.pone.0204611	http://dx.doi.org/10.1371/journal.pone.0204611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379959	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700016
J	Shaw, B; Fountain, MT; Wijnen, H				Shaw, Bethan; Fountain, Michelle T.; Wijnen, Herman			Recording and reproducing the diurnal oviposition rhythms of wild populations of the soft- and stone- fruit pest Drosophila suzukii	PLOS ONE			English	Article							SPOTTED-WING DROSOPHILA; EGG-LAYING RHYTHM; DIPTERA DROSOPHILIDAE; BEHAVIORAL RHYTHMS; MELANOGASTER; TEMPERATURE; RESISTANCE; INVASION; BIOLOGY; CLOCK	Drosophila suzukii is a horticultural pest on a global scale which causes both yield and economic losses on a range of soft- and stone-fruit. Tackling this pest is problematic but exploiting behavioral rhythms could increase the impact of control. To do this, a better understanding of behavioral patterns is needed. Within this study we aimed to investigate rhythms in reproductive behavior of wild D. suzukii under natural conditions in the field. Environmental parameters were also recorded to decipher how they influence these rhythms. Assays were then performed on laboratory cultures, housed under artificial conditions mimicking the temperature and light cycles, to see if these patterns were reproducible and rhythmic. We were able to promote field like oviposition patterns within the laboratory using realistic temperature and light cycles regardless of variations in other factors including substrate, humidity, and lighting type. Locomotion activity was also recorded under these mimicked conditions to identify how this behavior interacts with oviposition rhythms. Both our field and laboratory assays show that oviposition behavior is likely under the control of the circadian clock and primarily occurs during the day. However, consistent with prior reports we observed that these patterns become crepuscular when day-time temperature peaks exceeded 30 degrees C. This was also found within locomotion rhythms. With an increased understanding of how these behaviors are influenced by environmental conditions, we highlight the importance of using realistic temperature and light cycles when investigating behavioral patterns. From an increased understanding of D. suzukii behavior we increase our ability to target the pest in the field.	[Shaw, Bethan; Fountain, Michelle T.] NIAB EMR, East Malling, Kent, England; [Shaw, Bethan; Wijnen, Herman] Univ Southampton, Southampton, Hants, England	University of Southampton	Shaw, B (corresponding author), NIAB EMR, East Malling, Kent, England.; Shaw, B; Wijnen, H (corresponding author), Univ Southampton, Southampton, Hants, England.	bethan.shaw@emr.ac.uk; h.wijnen@soton.ac.uk	Wijnen, Herman/N-8391-2019; Fountain, Michelle/GPS-8312-2022	Wijnen, Herman/0000-0002-8710-5176; Shaw, Bethan/0000-0003-0226-7529	University of Southampton; Agricultural and Horticultural Development Board [14992/03]; NIAB EMR; UK Spotted Wing Drosophila Working Group; AHDB	University of Southampton; Agricultural and Horticultural Development Board; NIAB EMR; UK Spotted Wing Drosophila Working Group; AHDB	This work was funded by the University of Southampton and the Agricultural and Horticultural Development Board (grant reference: 14992/03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thank you to G.H. Dean, Norton Folgate and Driscoll's for fruit donations for this research. Thanks to the NIAB EMR, University of Southampton staff and the UK Spotted Wing Drosophila Working Group for support with this work. Thank you to the AHDB and the University of Southampton for funding this work.	Abram PK, 2016, BIOL REV, DOI [10.1101/056051, DOI 10.1101/056051]; Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Bollinger T, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13984; Cha DH, 2014, PEST MANAG SCI, V70, P324, DOI 10.1002/ps.3568; Chang DC, 2006, BEHAV PROCESS, V71, P211, DOI 10.1016/j.beproc.2005.12.008; Cini A, 2012, B INSECTOL, V65, P149; Dalton DT, 2011, PEST MANAG SCI, V67, P1368, DOI 10.1002/ps.2280; De J, 2013, P NATL ACAD SCI USA, V110, P8984, DOI 10.1073/pnas.1220960110; Dillon ME, 2009, J THERM BIOL, V34, P109, DOI 10.1016/j.jtherbio.2008.11.007; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Enriquez T, 2017, PEERJ, V5, DOI 10.7717/peerj.3112; Evans RK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171718; Ferguson CTJ, 2015, J EXP BIOL, V218, P3855, DOI 10.1242/jeb.125468; Gerdeman B, 2012, ENT SOC AM ANN M; Hamby KA, 2016, J PEST SCI, V89, P605, DOI 10.1007/s10340-016-0756-5; Hamby KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068472; Horvath B, 2018, EVOLUTION, V72, P318, DOI 10.1111/evo.13411; Kannan NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050379; Kannan NN, 2012, J INSECT PHYSIOL, V58, P245, DOI 10.1016/j.jinsphys.2011.11.012; Lee JC, 2011, PEST MANAG SCI, V67, P1349, DOI 10.1002/ps.2271; Lin QC, 2014, FLA ENTOMOL, V97, P1424, DOI 10.1653/024.097.0417; Manjunatha T, 2008, J GENET, V87, P495, DOI 10.1007/s12041-008-0072-9; Menegazzi P, 2013, J BIOL RHYTHM, V28, P3, DOI 10.1177/0748730412471303; Menegazzi P, 2012, J BIOL RHYTHM, V27, P433, DOI 10.1177/0748730412463181; Miyatake T, 2011, APPL ENTOMOL ZOOL, V46, P3, DOI 10.1007/s13355-010-0017-7; Overgaard J, 2011, J THERM BIOL, V36, P409, DOI 10.1016/j.jtherbio.2011.07.005; Paranjpe Dhanashree A., 2005, Journal of Circadian Rhythms, V3, P1; Pfeiffenberger Cory, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5518; Revadi S, 2015, INSECTS, V6, P183, DOI 10.3390/insects6010183; Ryan GD, 2016, J ECON ENTOMOL, V109, P746, DOI 10.1093/jee/tow006; Shearer PW, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0070-3; Stephens AR, 2015, ENVIRON ENTOMOL, V44, P1619, DOI 10.1093/ee/nvv134; Tochen S, 2016, J APPL ENTOMOL, V140, P47, DOI 10.1111/jen.12247; Tochen S, 2014, ENVIRON ENTOMOL, V43, P501, DOI 10.1603/EN13200; Toxopeus J, 2016, J INSECT PHYSIOL, V89, P37, DOI 10.1016/j.jinsphys.2016.03.006; Van Timmeren S, 2017, ENVIRON ENTOMOL, V46, P1106, DOI 10.1093/ee/nvx131; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Wallingford AK, 2016, ENVIRON ENTOMOL, V45, P1081, DOI 10.1093/ee/nvw088; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Zerulla FN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187682	41	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0199406	10.1371/journal.pone.0199406	http://dx.doi.org/10.1371/journal.pone.0199406			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379809	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000448823700004
J	Zarghani, SN; Hill, JM; Glasa, M; Marais, A; Wetzel, T; Faure, C; Vigne, E; Velt, A; Lemaire, O; Boursiquot, JM; Okic, A; Ruiz-Garcia, AB; Olmos, A; Lacombe, T; Candresse, T				Zarghani, Shaheen Nourinejhad; Hill, Jean Michel; Glasa, Miroslav; Marais, Armelle; Wetzel, Thierry; Faure, Chantal; Vigne, Emmanuelle; Velt, Amandine; Lemaire, Olivier; Boursiquot, Jean Michel; Okic, Arnela; Belen Ruiz-Garcia, Ana; Olmos, Antonio; Lacombe, Thierry; Candresse, Thierry			Grapevine virus T diversity as revealed by full-length genome sequences assembled from high-throughput sequence data	PLOS ONE			English	Article							PITTING-ASSOCIATED-VIRUS; PLANT-VIRUSES; VARIANTS; VARIABILITY; FOVEAVIRUS; ALIGNMENT; GENETICS; PRIMERS; DISEASE; GENUS	RNASeq or double-stranded RNA based approaches allowed the reconstruction of a total of 9 full-length or near full-length genomes of the recently discovered grapevine virus T (GVT). In addition, datamining of publicly available grapevine RNASeq transcriptome data allowed the reconstruction of a further 14 GVT genomes from five grapevine sources. Together with four GVT sequences available in Genbank, these novel sequences were used to analyse GVT diversity. GVT shows a very limited amount of indels variation but a high level of nucleotide and aminoacid polymorphism. This level is comparable to that shown in the closely related grapevine rupestris stem pitting-associated virus (GRSPaV). Further analyses showed that GVT mostly evolves under conservative selection pressure and that recombination has contributed to its evolutionary history. Phylogenetic analyses allow to identify at least seven clearly separated groups of GVT isolates. Analysis of the only reported PCR GVT-specific detection primer pair indicates that it is likely to fail to amplify some GVT isolates. Taken together these results point at the distinctiveness of GVT but also at the many points it shares with GRSPaV. They constitute the first pan-genomic analysis of the diversity of this novel virus.	[Zarghani, Shaheen Nourinejhad; Wetzel, Thierry] Inst Plant Protect, DLR Rheinpfalz, Neustadt An Der Weinstra, Germany; [Zarghani, Shaheen Nourinejhad] Univ Tehran, Coll Abouraihan, Dept Plant Protect, Tehran, Iran; [Hill, Jean Michel; Vigne, Emmanuelle; Velt, Amandine; Lemaire, Olivier] Univ Strasbourg, INRA, SVQV UMR A 1131, Colmar, France; [Glasa, Miroslav] Slovak Acad Sci, Biomed Res Ctr, Inst Virol, Bratislava, Slovakia; [Marais, Armelle; Faure, Chantal; Candresse, Thierry] Univ Bordeaux, INRA, UMR BFP 1332, Equipe Virol, Villenave Dornon, France; [Boursiquot, Jean Michel; Lacombe, Thierry] Montpellier SupAgro, INRA, UMR AGAP 1334, Montpellier, France; [Boursiquot, Jean Michel; Lacombe, Thierry] INRA, Ctr Ressources Biol Vigne, Marseillan Plage, France; [Okic, Arnela] Univ Sarajevo, Fac Agr & Food Sci, Sarajevo, Bosnia & Herceg; [Belen Ruiz-Garcia, Ana; Olmos, Antonio] Inst Valenciano Invest Agr, Valencia, Spain	Helmholtz Association; German Aerospace Centre (DLR); University of Tehran; INRAE; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Slovak Academy of Sciences; INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE; Institut Agro; Montpellier SupAgro; INRAE; University of Sarajevo; Instituto Valenciano de Investigaciones Agrarias (IVIA)	Candresse, T (corresponding author), Univ Bordeaux, INRA, UMR BFP 1332, Equipe Virol, Villenave Dornon, France.	thierry.candresse@inra.fr	Lemaire, Olivier/V-2287-2019; Olmos, Antonio/C-1570-2013; Okic, Arnela/ABF-6488-2020; Glasa, Miroslav/AAC-3814-2019; Ruiz-Garcia, Ana Belen/ABB-1915-2021	Olmos, Antonio/0000-0001-8406-7963; Okic, Arnela/0000-0003-4609-4527; Glasa, Miroslav/0000-0002-8495-7971; Ruiz-Garcia, Ana Belen/0000-0001-5704-2138; hily, jean-michel/0000-0001-9141-9701; Candresse, Thierry/0000-0001-9757-1835; Marais, Armelle/0000-0003-2482-1543; Nourinejhad Zarghani, Shaheen/0000-0003-3226-6914; Velt, Amandine/0000-0003-2368-839X; VIGNE, Emmanuelle/0000-0002-3287-0786; LEMAIRE, Olivier/0000-0002-6042-4361	Conseil Interprofessionnel du Vin de Bordeaux (CIVB); Slovak Research and Development Agency [APVV-15-0232]; Georg Foster Grant (Alexander von Humbold Stiftung) [3.4 - IRN/1186607]; COST (European Cooperation in Science and Technology) [FA1407]	Conseil Interprofessionnel du Vin de Bordeaux (CIVB); Slovak Research and Development Agency(Slovak Research and Development Agency); Georg Foster Grant (Alexander von Humbold Stiftung); COST (European Cooperation in Science and Technology)(European Cooperation in Science and Technology (COST))	Work in the NRA partner laboratory was partially supported by grant InViCeB to TC from the Conseil Interprofessionnel du Vin de Bordeaux (CIVB). MG acknowledges support from the Slovak Research and Development Agency (grant APVV-15-0232). SNZ was supported by a Georg Foster Grant (Ref 3.4 - IRN/1186607, Alexander von Humbold Stiftung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors wish to thank Sebastien Theil (UMR 1332 BFP, INRA Villenave d'Ornon, France) for preliminary analysis of some of the high-throughput sequence data, Laurianne Renaud and Camille Rustenhotz for providing a curated list of RNAseq transcriptome data available in GenBank, Sandrine Dedet (Centre de Ressources-Biologiques Vigne INRA-Unite Experimentale Domaine de Vassal, Marseillan-Plage, France) for the preparation of some grapevine samples and Dr. Miroslav Glasa (Institute of Virology, Slovak Academy of Sciences, Bratislava, Slovak Republic) for making available GVT sequence information prior to publication. The GetPlaGe sequencing platform facility (https://get.genotoul.fr/la-plateforme/get-plage/) is gratefully acknowledged. This study is based upon work carried out in the frame of COST Action FA1407 (DIVAS), supported by COST (European Cooperation in Science and Technology).	Adams M. J., 2012, VIRUS TAXONOMY, P920, DOI DOI 10.1016/B978-0-12-384684-6.00078-1; Alabi OJ, 2010, J GEN VIROL, V91, P265, DOI 10.1099/vir.0.014423-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Candresse T, 2013, PHYTOPATHOLOGY, V103, P293, DOI 10.1094/PHYTO-10-12-0275-R; Glasa M, 2018, VIRUS GENES, V54, P737, DOI 10.1007/s11262-018-1587-7; Glasa M, 2017, PLANT PATHOLOGY J, V33, P34, DOI 10.5423/PPJ.OA.07.2016.0158; Hily JM, 2018, ARCH VIROL, V163, P3105, DOI 10.1007/s00705-018-3945-0; Hu GJ, 2015, ARCH VIROL, V160, P2641, DOI 10.1007/s00705-015-2544-6; Jo Y, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00995-17; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mann K, 2013, VIRUS GENES, V47, P93, DOI 10.1007/s11262-013-0908-0; Marais A, 2018, METHODS MOL BIOL, V1746, P45, DOI 10.1007/978-1-4939-7683-6_4; Martelli G.P., 2017, GRAPEVINE VIRUSES MO, P31, DOI DOI 10.1007/978-3-319-57706-7_2; Martelli GP, 1998, ARCH VIROL, V143, P1245, DOI 10.1007/s007050050372; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Massart S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00045; Massart S, 2014, VIRUS RES, V188, P90, DOI 10.1016/j.virusres.2014.03.029; Meng B, 1999, ARCH VIROL, V144, P2071, DOI 10.1007/s007050050623; Meng B., 2017, GRAPEVINE VIRUSES MO, P257, DOI DOI 10.1007/978-3-319-57706-7; Meng BaoZhong, 2003, Current Topics in Virology. Volume 3, P125; Meng BZ, 1999, EUR J PLANT PATHOL, V105, P191, DOI 10.1023/A:1008771713839; Mostert I, 2018, ARCH VIROL, V163, P2491, DOI 10.1007/s00705-018-3883-x; Nakaune R, 2008, J GEN PLANT PATHOL, V74, P156, DOI 10.1007/s10327-008-0079-3; Nolasco G, 2006, ARCH VIROL, V151, P83, DOI 10.1007/s00705-005-0611-0; Nolasco G, 2000, EUR J PLANT PATHOL, V106, P311, DOI 10.1023/A:1008748924494; Ruiz-Garcia AB, 2018, PLANT DIS, V102, P1675, DOI [10.1094/pdis-01-18-0105-pdn, 10.1094/PDIS-01-18-0161-PDN]; Terlizzi F, 2011, ANN APPL BIOL, V159, P478, DOI 10.1111/j.1744-7348.2011.00512.x; Terlizzi F, 2010, PLANT PATHOL, V59, P48, DOI 10.1111/j.1365-3059.2009.02156.x; Teycheney PY, 2005, J GEN VIROL, V86, P3179, DOI 10.1099/vir.0.81197-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voncina D, 2018, ARCH VIROL, V163, P2239, DOI 10.1007/s00705-018-3850-6; Weaver S, 2018, MOL BIOL EVOL, V35, P773, DOI 10.1093/molbev/msx335; Zhang YP, 1998, PHYTOPATHOLOGY, V88, P1231, DOI 10.1094/PHYTO.1998.88.11.1231	34	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2018	13	10							e0206010	10.1371/journal.pone.0206010	http://dx.doi.org/10.1371/journal.pone.0206010			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7AD	30376573	Green Submitted, Green Published, gold			2022-12-26	WOS:000448752400005
J	Gurari, N; Drogos, JM; Dewald, JPA				Gurari, Netta; Drogos, Justin M.; Dewald, Julius P. A.			Ability of individuals with chronic hemiparetic stroke to locate their forearms during single-arm and between-arms tasks	PLOS ONE			English	Article							LIMB POSITION SENSE; FUSIMOTOR STIMULATION; MUSCLE-SPINDLES; BODY SHAPE; ASYMMETRIES; MOVEMENT; ERROR; REPRESENTATION; THIXOTROPY; FREQUENCY	Background According to between-arms assessments, more than 50% of individuals with stroke have an impaired position sense. Our previous work, which employed a clinical assessment and slightly differing tasks, indicates that individuals who have a deficit on a between-forearms position-localization task do not necessarily have a deficit on a single-forearm position-localization task. Objective Our goal here was to, using robotics tools, determine whether individuals with stroke who have a deficit when matching forearm positions within an arm also have a deficit when mirroring forearm positions between arms, independent of the arm that leads the task. Methods Eighteen participants with chronic hemiparetic stroke and nine controls completed a single-arm position-matching experiment and between-arms position-mirroring experiment. For each experiment, the reference forearm (left/right) passively rotated about the elbow joint to a reference target location (flexion/extension), and then the participant actively rotated their same/opposite forearm to match/mirror the reference forearm's position. Participants with stroke were classified as having a position-matching/-mirroring deficit based on a quantitative threshold that was derived from the controls' data. Results On our single-arm task, one participant with stroke was classified as having a position-matching deficit with a mean magnitude of error greater than 10.7 degrees when referencing their paretic arm. Position-matching ability did not significantly differ for the controls and the remaining seventeen participants with stroke. On our between-arms task, seven participants with stroke were classified as having a position-mirroring deficit with a mean magnitude of error greater than 10.1 degrees. Position-mirroring accuracy was worse for these participants with stroke, when referencing their paretic arm, than the controls. Concluding remark Findings underscore the need for assessing within-arm position-matching deficits, in addition to between-arms position-mirroring deficits when referencing each arm, to comprehensively evaluate an individual's ability to locate their forearm(s).	[Gurari, Netta; Drogos, Justin M.; Dewald, Julius P. A.] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Dewald, Julius P. A.] Northwestern Univ, Dept Phys Med & Rehabil, Evanston, IL USA; [Dewald, Julius P. A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Dewald, Julius P. A.] Univ Twente, Fac Engn Technol, Dept Biomech Engn, Enschede, Netherlands	Northwestern University; Northwestern University; Northwestern University; University of Twente	Gurari, N (corresponding author), Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.	netta.gurari@northwestern.edu	Dewald, Julius/AAD-2806-2019	Drogos, Justin/0000-0002-5683-1749	 [NIH R01HD039343]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD039343] Funding Source: NIH RePORTER	; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grant NIH R01HD039343 (PI: JPA Dewald) (https://www.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Neurologic Physical Therapy, 2011, STROKEEDGE DOCUMENTS; Adamovich SV, 1999, EXP BRAIN RES, V125, P200, DOI 10.1007/s002210050674; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Bastian H.C., 1887, BRAIN, V10, P1, DOI [10.1093/brain/10.1.1, DOI 10.1093/BRAIN/10.1.1]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BROWN MC, 1969, J PHYSIOL-LONDON, V205, P677, DOI 10.1113/jphysiol.1969.sp008990; Carey LM, 2011, J REHABIL MED, V43, P257, DOI 10.2340/16501977-0662; Carey LM, 1996, ARCH PHYS MED REHAB, V77, P1271, DOI 10.1016/S0003-9993(96)90192-6; CARSON RG, 1990, NEUROPSYCHOLOGIA, V28, P99, DOI 10.1016/0028-3932(90)90090-B; Chapman CD, 2001, BRAIN COGNITION, V46, P62, DOI 10.1016/S0278-2626(01)80035-X; COLLEY A, 1984, CORTEX, V20, P47, DOI 10.1016/S0010-9452(84)80022-2; Connell LA, 2008, CLIN REHABIL, V22, P758, DOI 10.1177/0269215508090674; Corkin S, T AM NEUROLOGICAL AS, V98, P118; dos Santos CM, 2012, REV BRAS MED ESPORTE, V18, P38, DOI 10.1590/S1517-86922012000100008; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; EKLUND G, 1972, J NEUROL NEUROSUR PS, V35, P606, DOI 10.1136/jnnp.35.5.606; FISH DR, 1985, PHYS THER, V65, P1666, DOI 10.1093/ptj/65.11.1666; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; GANDEVIA SC, 1992, TRENDS NEUROSCI, V15, P62, DOI 10.1016/0166-2236(92)90028-7; Goble DJ, 2007, EXP BRAIN RES, V180, P693, DOI 10.1007/s00221-007-0890-7; Goble DJ, 2010, PHYS THER, V90, P1176, DOI 10.2522/ptj.20090399; Goble DJ, 2009, EXP BRAIN RES, V197, P403, DOI 10.1007/s00221-009-1922-2; Goble DJ, 2006, EXP BRAIN RES, V168, P307, DOI 10.1007/s00221-005-0280-y; Goble DJ, 2005, HUM MOVEMENT SCI, V24, P155, DOI 10.1016/j.humov.2005.05.004; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; Gurari N, 2018, EXP BRAIN RES, V236, P765, DOI 10.1007/s00221-018-5173-y; Gurari N, 2017, CLIN NEUROPHYSIOL, V128, P18, DOI 10.1016/j.clinph.2016.10.009; Gurari N, 2014, J NEUROSCI METH, V235, P169, DOI 10.1016/j.jneumeth.2014.07.001; Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556; HENRY FM, 1974, J MOTOR BEHAV, V6, P149, DOI 10.1080/00222895.1974.10734991; Hillier S, 2015, NEUROREHAB NEURAL RE, V29, P933, DOI 10.1177/1545968315573055; Hirayama K, 1999, J NEUROL SCI, V167, P45, DOI 10.1016/S0022-510X(99)00136-7; HOLM S, 1979, SCAND J STAT, V6, P65; Imanaka K, 1995, BRAIN COGNITION, V29, P232, DOI 10.1006/brcg.1995.1280; JONES B, 1972, PERCEPT PSYCHOPHYS, V12, P95, DOI 10.3758/BF03212850; Kim JS, 1996, STROKE, V27, P677, DOI 10.1161/01.STR.27.4.677; Kuznetsova A., 2015, R PACKAGE VERSION PA; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lincoln NB, 1998, PHYSIOTHERAPY, V84, P358, DOI [10.1016/S0031-9406(05)61454-X, DOI 10.1016/S0031-9406(05)61454-X]; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Lonn J, 2000, ARCH PHYS MED REHAB, V81, P592, DOI 10.1016/s0003-9993(00)90040-6; MARTENIUK RG, 1973, J MOTOR BEHAV, V5, P249, DOI 10.1080/00222895.1973.10734972; MCCLOSKEY DI, 1978, PHYSIOL REV, V58, P763, DOI 10.1152/physrev.1978.58.4.763; MCCLOSKEY DI, 1973, BRAIN, V96, P269, DOI 10.1093/brain/96.2.269; MORGAN DL, 1984, J PHYSIOL-LONDON, V356, P465, DOI 10.1113/jphysiol.1984.sp015477; Niessen MH, 2008, ARCH PHYS MED REHAB, V89, P333, DOI 10.1016/j.apmr.2007.08.157; NISHIZAWA S, 1987, CORTEX, V23, P485, DOI 10.1016/S0010-9452(87)80009-6; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Paillard J, 1968, NEUROPSYCHOLOGY SPAT, P37; Pinheiro J, 2012, R PACKAGE VERSION, V3, P1; PROSKE U, 1993, PROG NEUROBIOL, V41, P705, DOI 10.1016/0301-0082(93)90032-N; Proske U, 2014, EXP BRAIN RES, V232, P3397, DOI 10.1007/s00221-014-4088-5; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; ROY EA, 1978, CORTEX, V14, P250, DOI 10.1016/S0010-9452(78)80051-3; SCHUTZ RW, 1973, J MOTOR BEHAV, V5, P141, DOI 10.1080/00222895.1973.10734959; Simo L, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-77; Sukal TM, 2007, EXP BRAIN RES, V183, P215, DOI 10.1007/s00221-007-1029-6; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; Walsh LD, 2004, J PHYSIOL-LONDON, V558, P705, DOI 10.1113/jphysiol.2004.062703; Wilson ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011851; Winter JA, 2005, J PHYSIOL-LONDON, V568, P1035, DOI 10.1113/jphysiol.2005.092619; WORRINGHAM CJ, 1985, EXP BRAIN RES, V61, P38; Zia S, 2002, CLIN ANAT, V15, P23, DOI 10.1002/ca.1087	66	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206518	10.1371/journal.pone.0206518	http://dx.doi.org/10.1371/journal.pone.0206518			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY5SG	30372499	Green Published, Green Submitted, gold			2022-12-26	WOS:000448641200042
J	Mihara, H; Uchida, K; Koizumi, S; Moriyama, Y				Mihara, Hiroshi; Uchida, Kunitoshi; Koizumi, Schuichi; Moriyama, Yoshinori			Involvement of VNUT-exocytosis in transient receptor potential vanilloid 4-dependent ATP release from gastrointestinal epithelium	PLOS ONE			English	Article							VESICULAR NUCLEOTIDE TRANSPORTER; THERAPEUTIC TARGET; CALCIUM INFLUX; TRPV4; CLODRONATE; CHANNEL; MOUSE; MODULATION; ACTIVATION; SENSATION	Adenosine triphosphate (ATP) modulates mechanosensitive vagal afferent nerves in the gastrointestinal tract. ATP is stored in secretory vesicles via the ATP transporter VNUT. Recently, the bisphosphate clodronate was reported to inhibit VNUT and was suggested to be a safe potent therapeutic option for chronic pain. Transient receptor potential vanilloid 4 (TRPV4) is activated by mechanical stimuli and some epoxyeicosatrienoic acids and becomes sensitized under inflammatory conditions. We have previously reported that TRPV4 and VNUT are expressed in mouse esophageal keratinocytes and that TRPV4 activation induces ATP release in gastric epithelial cells. Here we show the expression of TRPV4 and VNUT in normal human gastrointestinal cell derived cell lines (GES-1 and CCD 841) and in tissues from normal and VNUT-KO mice. TRPV4 agonists (GSK101 or 8,9-EET) induced an increase in cytosolic Ca2+ and/or current responses in mouse primary colonic epithelial cells and CCD 841 cells, but not in cells isolated from TRPV4-KO mice. TRPV4 agonists (GSK101 or 5.6-EET) also induced ATP release in GES-1 and CCD 841 cells, which could be blocked by the VNUT inhibitor, clodronate. Thus, VNUT inhibition with clodronate could represent a novel therapeutic option for visceral pain.	[Mihara, Hiroshi] Univ Toyama, Ctr Med Educ & Career Dev, Grad Sch Med & Pharmaceut Sci, Toyama, Japan; [Mihara, Hiroshi] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Gastroenterol, Toyama, Japan; [Uchida, Kunitoshi] Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Fukuoka, Fukuoka, Japan; [Koizumi, Schuichi] Univ Yamanashi, Dept Neuropharmacol, Yamanashi, Japan; [Moriyama, Yoshinori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Membrane Biochem, Okayama, Japan	University of Toyama; University of Toyama; Fukuoka Dental College (FDC); University of Yamanashi; Okayama University	Mihara, H (corresponding author), Univ Toyama, Ctr Med Educ & Career Dev, Grad Sch Med & Pharmaceut Sci, Toyama, Japan.; Mihara, H (corresponding author), Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Gastroenterol, Toyama, Japan.	m164-tym@umin.net	Mihara, Hiroshi/AAE-3961-2021; Koizumi, Schuichi/E-8568-2010	Koizumi, Schuichi/0000-0001-6184-3106	JSPS KAKENHI [JP26870214]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP26870214 to H.M.	Abitbol V, 2007, CLIN GASTROENTEROL H, V5, P1184, DOI 10.1016/j.cgh.2007.05.016; Alpizar YA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01201-3; Burnstock G, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00661; Burnstock G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-69; Cenac N, 2008, GASTROENTEROLOGY, V135, P937, DOI 10.1053/j.gastro.2008.05.024; Cenac N, 2015, GASTROENTEROLOGY, V149, P433, DOI 10.1053/j.gastro.2015.04.011; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; Darby WG, 2016, INT J BIOCHEM CELL B, V78, P217, DOI 10.1016/j.biocel.2016.07.012; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; Grace MS, 2017, PHARMACOL THERAPEUT, V177, P9, DOI 10.1016/j.pharmthera.2017.02.019; Kato Y, 2017, P NATL ACAD SCI USA, V114, pE6297, DOI 10.1073/pnas.1704847114; Kidane D, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.42; Kitahata Y, 2016, ONCOTARGET, V7, P48860, DOI 10.18632/oncotarget.10379; Mcilwrath SL, 2009, NEUROGASTROENT MOTIL, V21, P890, DOI 10.1111/j.1365-2982.2009.01292.x; Mihara H, 2017, HELICOBACTER, V22, DOI 10.1111/hel.12361; Mihara H, 2016, WORLD J GASTROENTERO, V22, P5512, DOI 10.3748/wjg.v22.i24.5512; Mihara H, 2011, J PHYSIOL-LONDON, V589, P3471, DOI 10.1113/jphysiol.2011.207829; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Moreno SG, 2018, METHODS MOL BIOL, V1784, P259, DOI 10.1007/978-1-4939-7837-3_23; Moriyama Y, 2018, TRENDS PHARMACOL SCI, V39, P13, DOI 10.1016/j.tips.2017.10.007; Moriyama Y, 2017, PURINERG SIGNAL, V13, P387, DOI 10.1007/s11302-017-9568-1; Nardi A, 2016, CLIN CASES MINER BON, V13, P33, DOI 10.11138/ccmbm/2016.13.1.033; Ochoa-Cortes F, 2014, INFLAMM BOWEL DIS, V20, P1259, DOI 10.1097/MIB.0000000000000047; Page AJ, 2002, J NEUROPHYSIOL, V87, P2095, DOI 10.1152/jn.00785.2001; Sakamoto S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06689; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Shinozaki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04329; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Vergnolle N, 2014, BIOCHEM PHARMACOL, V89, P157, DOI 10.1016/j.bcp.2014.01.005; Vincent F, 2009, BIOCHEM BIOPH RES CO, V389, P490, DOI 10.1016/j.bbrc.2009.09.007; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Wynn G, 2004, AM J PHYSIOL-GASTR L, V287, pG647, DOI 10.1152/ajpgi.00020.2004; Xu XP, 2009, CHANNELS, V3, P156, DOI 10.4161/chan.3.3.8555; Yamawaki H, 2014, AM J PHYSIOL-GASTR L, V307, pG33, DOI 10.1152/ajpgi.00105.2013	34	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206276	10.1371/journal.pone.0206276	http://dx.doi.org/10.1371/journal.pone.0206276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365528	Green Submitted, Green Published, gold			2022-12-26	WOS:000448448700036
J	Beazley, L; Wang, ZL; Kenchington, E; Yashayaev, I; Rapp, HT; Xavier, JR; Murillo, FJ; Fenton, D; Fuller, S				Beazley, Lindsay; Wang, Zeliang; Kenchington, Ellen; Yashayaev, Igor; Rapp, Hans Tore; Xavier, Joana R.; Murillo, Francisco Javier; Fenton, Derek; Fuller, Susanna			Predicted distribution of the glass sponge Vazella pourtalesi on the Scotian Shelf and its persistence in the face of climatic variability	PLOS ONE			English	Article							HEXACTINELLID SPONGE; PHERONEMA-CARPENTERI; SURFICIAL SEDIMENTS; VARIABLE IMPORTANCE; ATLANTIC-OCEAN; NORTH-ATLANTIC; SEA; GROUNDS; CIRCULATION; SLOPE	Emerald Basin on the Scotian Shelf off Nova Scotia, Canada, is home to a globally unique aggregation of the glass sponge Vazella pourtalesi, first documented in the region in 1889. In 2009, Fisheries and Oceans Canada (DFO) implemented two Sponge Conservation Areas to protect these sponge grounds from bottom fishing activities. Together, the two conservation areas encompass 259 km(2). In order to ascertain the degree to which the sponge grounds remain unprotected, we modelled the presence probability and predicted range distribution of V. pourtalesi on the Scotian Shelf using random forest modelling on presence-absence records. With a high degree of accuracy the random forest model predicted the highest probability of occurrence of V. pourtalesi in the inner basins on the central Scotian Shelf, with lower probabilities at the shelf break and in the Fundian and Northeast Channels. Bottom temperature was the most important determinant of its distribution in the model. Although the two DFO Sponge Conservation Areas protect some of the more significant concentrations of V. pourtalesi, much of its predicted distribution remains unprotected (over 99%). Examination of the hydrographic conditions in Emerald Basin revealed that the V. pourtalesi sponge grounds are associated with a warmer and more saline water mass compared to the surrounding shelf. Reconstruction of historical bottom temperature and salinity in Emerald Basin revealed strong multi-decadal variability, with average bottom temperatures varying by 8 degrees C. We show that this species has persisted in the face of this climatic variability, possibly indicating how it will respond to future climate change.	[Beazley, Lindsay; Wang, Zeliang; Kenchington, Ellen; Yashayaev, Igor; Murillo, Francisco Javier; Fenton, Derek] Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada; [Rapp, Hans Tore; Xavier, Joana R.] Univ Bergen, Dept Biol Sci, Bergen, Norway; [Rapp, Hans Tore; Xavier, Joana R.] Univ Bergen, KG Jebsen Ctr Deep Sea Res, Bergen, Norway; [Xavier, Joana R.] Univ Porto, CIIMAR Interdisciplinary Ctr Marine & Environm Re, Ave Gen Norton Matos, Matosinhos, Portugal; [Fuller, Susanna] Oceans North, Halifax, NS, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; University of Bergen; University of Bergen; Universidade do Porto	Beazley, L (corresponding author), Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada.	lindsay.beazley@dfo-mpo.gc.ca	Murillo, Francisco Javier/C-7182-2019; Xavier, Joana/J-8387-2012	Yashayaev, Igor/0000-0002-6976-7803; Beazley, Lindsay/0000-0001-9983-8732; Xavier, Joana/0000-0003-1386-4492	Fisheries and Oceans Canada's (DFO) Strategic Program for Ecosystem-Based Research and Advice (SPERA) project "Evaluation of the Effectiveness of Two Sponge Conservation Areas in the Maritimes Region: Identifying Patterns of Dispersal, Connectivity, and Re; H2020 EU Framework Programme for Research and Innovation Project SponGES (Deep-sea Sponge Grounds Ecosystems of the North Atlantic: an integrated approach towards their preservation and sustainable exploitation) [679849]	Fisheries and Oceans Canada's (DFO) Strategic Program for Ecosystem-Based Research and Advice (SPERA) project "Evaluation of the Effectiveness of Two Sponge Conservation Areas in the Maritimes Region: Identifying Patterns of Dispersal, Connectivity, and Re; H2020 EU Framework Programme for Research and Innovation Project SponGES (Deep-sea Sponge Grounds Ecosystems of the North Atlantic: an integrated approach towards their preservation and sustainable exploitation)	This research was funded through Fisheries and Oceans Canada's (DFO) Strategic Program for Ecosystem-Based Research and Advice (SPERA) project "Evaluation of the Effectiveness of Two Sponge Conservation Areas in the Maritimes Region: Identifying Patterns of Dispersal, Connectivity, and Recovery Potential of the Russian Hat Sponge Vazella pourtalesi"led by L.I.B. and the H2020 EU Framework Programme for Research and Innovation Project SponGES (Deep-sea Sponge Grounds Ecosystems of the North Atlantic: an integrated approach towards their preservation and sustainable exploitation) (Grant Agreement no. 679849). The funders supported the collection of data used in this manuscript. Oceans North provided support in the form of salaries for S.D. Fuller, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; AUSTER PJ, 2003, ENVIRON BIOL FISHES, V68; AZETSUSCOTT K, 1995, CONT SHELF RES, V15, P281, DOI 10.1016/0278-4343(93)E0003-Q; Barthel D, 1996, MAR ECOL-P S Z N I, V17, P603, DOI 10.1111/j.1439-0485.1996.tb00420.x; Basher Z, 2016, PEERJ, V4, DOI 10.7717/peerj.1713; Beazley L., 2017, Canadian Technical Report of Fisheries and Aquatic Sciences, V3212, P1; Beazley L., 2016, Canadian Technical Report of Fisheries and Aquatic Sciences, V3172, pI; Beazley L, 2017, GEOMARINE LETT, V3212; Beazley L, 2016, CAN REP FISH AQUAT S, V3175; Beazley L, 2015, DEEP-SEA RES PT I, V98, P102, DOI 10.1016/j.dsr.2014.11.016; Beazley LI, 2013, ICES J MAR SCI, V70, P1471, DOI 10.1093/icesjms/fst124; Bennecke S, 2017, DEEP-SEA RES PT II, V137, P420, DOI 10.1016/j.dsr2.2016.06.005; BETT BJ, 1992, OPHELIA, V36, P217, DOI 10.1080/00785326.1992.10430372; Bo M, 2012, HYDROBIOLOGIA, V687, P163, DOI 10.1007/s10750-011-0964-1; Breeze H., 2004, THESIS, V04; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brodeur RD, 2001, CONT SHELF RES, V21, P207, DOI 10.1016/S0278-4343(00)00083-2; Cathalot C, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00037; Chen C, 2004, A MODERN APPROACH TO; CHEN C, 2004, BERKELEY; Cook SE, 2008, MAR ENVIRON RES, V66, pS80, DOI 10.1016/j.marenvres.2008.09.002; Cuff A, 2015, CONT SHELF RES, V110, P149, DOI 10.1016/j.csr.2015.10.004; DFO, 2010, SPONGE DISTRIBUTION; DFO, 2017, CANADIAN TECHNICAL R; Doherty P, 2007, MARINE BENTHIC SEASC, V2774; Drinkwater K, 1982, DFO CAN SCI ADVIS SE, V1093; DRINKWATER KF, 1998, NAFO SCR DOC 98 37, V98, P37; Evans JS, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P139, DOI 10.1007/978-1-4419-7390-0_8; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fichefet T, 1997, J GEOPHYS RES-OCEANS, V102, P12609, DOI 10.1029/97JC00480; Freese JL, 2003, MAR FISH REV, V65, P38; Freese L, 1999, MAR ECOL PROG SER, V182, P119, DOI 10.3354/meps182119; Fuller SD., 2011, THESIS; Fuller SD, 1998, DG, V2; Gehling JG, 1996, J PALEONTOL, V70, P185, DOI 10.1017/S0022336000023283; Gregory DN, 1988, PLOS ONE, V106, DOI DOI 10.1371/J0URNAL; GREGORY DN, 1988, CAN TECH REP HYDROGR, V106, P197; Guijarro J., 2016, Canadian Technical Report of Fisheries and Aquatic Sciences, V3171, P1; Hanberry B.B., 2013, WEB ECOL, V13, P19, DOI DOI 10.5194/we-13-13-2013; Hanz U, 2017, CAN TECH REP FISH AQ, V12, DOI 10.1371/journal.pone.0189720; Herrick KA, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-42; Hogg MM, 2010, CAMBRIDGE, V32; Honeyman D, 1889, PROC TRANS NS INST N, V7, P205; Howell KL, 2016, DEEP-SEA RES PT I, V115, P309, DOI 10.1016/j.dsr.2016.07.005; Murillo FJ, 2012, MAR BIOL RES, V8, P842, DOI 10.1080/17451000.2012.682583; JH, COMMUNITY STRUCTURE; Johnson D, 2018, MAR POLICY, V87, P111, DOI 10.1016/j.marpol.2017.09.034; Kenchington E, 2013, MAR ECOL PROG SER, V477, P217, DOI 10.3354/meps10127; Kenchington E, 2016, VULNERABLE MARINE EC; KENCHINGTON E, 2016, CAN SCI ADVIS SEC RE, V93, P1; Kenchington E, 2010, FISHERIES AND OCEANS; Kenchington E, 2014, SPONGES, V9, DOI 10.1371/journal.pone.0109365; KING LH, 1970, MARINE SCIENCE PAPER, V16, P1; Klitgaard AB, 2004, PROG OCEANOGR, V61, P57, DOI 10.1016/j.pocean.2004.06.002; KLITGAARD AB, 1995, SARSIA, V80, P1; KLITGAARD AB, 1997, THE RESPONSES OF MAR, V30, P129; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Knudby A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082306; Kuhn M, 2013, DFO CAN SCI ADVIS SE; Kunzmann K, 1996, PLOS ONE, V210, P1; Kunzmann Kathrin, 1996, Berichte zur Polarforschung, V210, P1; Leys SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027787; Liaw A, 2002, APPLIED PREDICTIVE M, V2, P18; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Loder J., 1998, SEA VOLUME 11 GLOBAL, V5, P105; Loder J. W., 1998, CAN TECH REP FISH AQ, P105; MADEC G, 1998, OPA 8 1 OCEAN GEN CI, V11, P1; Madec G, 1998, OFFSHORE SITE INVEST, P11; MALDONADO M, MARINE ANIMAL FOREST; Maldonado M, 2015, SPONGES, P1, DOI 10.1007/978-3-319-17001-5_24-1; Marliave JB, 2009, MAR BIOL, V156, P2247, DOI 10.1007/s00227-009-1252-8; Massaro AJ, 2012, J EXP MAR BIOL ECOL, V416, P55, DOI 10.1016/j.jembe.2012.02.008; McCarthy GD, 2015, NATURE, V521, P508, DOI 10.1038/nature14491; Metaxas A, 2005, J MAR BIOL ASSOC UK, V85, P1381, DOI 10.1017/S0025315405012567; Murillo F. J., 2016, DFO CAN SCI ADVIS SE, V3172, P189; Murillo F. J., 2016, SPRINGER, V3172, P189; Murillo FJ, 2016, MAR CHEM, V3170; PETRIE B, 1993, J GEOPHYS RES-OCEANS, V98, P20079, DOI 10.1029/93JC02191; PETRIE B, 1977, ATMOSPHERE, V15, P117; Petrie BD., 1983, DFO CAN SCI ADVIS SE, V88, P9478; Pile AJ, 2006, DEEP-SEA RES PT I, V53, P1148, DOI 10.1016/j.dsr.2006.03.008; PIPER DJW, 1991, CONT SHELF RES, V11, P1013, DOI 10.1016/0278-4343(91)90089-O; POCKLINGTON R, 1991, CONT SHELF RES, V11, P1069, DOI 10.1016/0278-4343(91)90091-J; R Core Team, 2016, VIENNA; Reiswig Henry M., 1996, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V66, P135; RICE AL, 1990, PROG OCEANOGR, V24, P179, DOI 10.1016/0079-6611(90)90029-2; Roberts EM, 2018, DEEP-SEA RES PT I, V138, P98, DOI 10.1016/j.dsr.2018.06.007; Ross LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140061; Ross LK, 2015, CAN TECH REP FISH AQ, V10, DOI 10.1371/journal.pone.0140061; SMITH PC, 1978, J FISH RES BOARD CAN, V35, P1067, DOI 10.1139/f78-170; Sperling EA, 2010, GEOBIOLOGY, V8, P24, DOI 10.1111/j.1472-4669.2009.00225.x; SPONGES PDF, 2013, SPONGES, V69, P21; SPONGES PDF, 2001, SPONGES, P24; SPONGES PDF, SPONGES; Strobl C, 2008, ENVIRONMENTAL SYSTEM, V9, P307; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Tabachnick K. R., 2002, SYSTEMA PORIFERA GUI, P1441, DOI DOI 10.1007/978-1-4615-0747-5_; TABACHNICK KR, 1994, SPONGES IN TIME AND SPACE, P225; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Townsend D. W., 2015, J GEOPHYS RES, V73, P93; Townsend DW, 2015, J MAR RES, V73, P93, DOI 10.1357/002224015815848811; van Haren H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189720; van Soest RWM, 2007, J MAR BIOL ASSOC UK, V87, P1345, DOI 10.1017/S0025315407059048; Van Soest RWM, 2017, ZOOTAXA, V4217, P1, DOI 10.11646/zootaxa.4217.1.1; Wang ZL, 2016, J GEOPHYS RES-OCEANS, V121, P5338, DOI 10.1002/2016JC011721; Wu YS, 2012, PROG OCEANOGR, V106, P28, DOI 10.1016/j.pocean.2012.06.005; Xavier JR, 2015, J MAR BIOL ASSOC UK, V95, P1389, DOI 10.1017/S0025315415000685; Yahel G, 2007, LIMNOL OCEANOGR, V52, P428, DOI 10.4319/lo.2007.52.1.0428; Zhang LP, 2013, J GEOPHYS RES-OCEANS, V118, P5772, DOI 10.1002/jgrc.20390	110	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205505	10.1371/journal.pone.0205505	http://dx.doi.org/10.1371/journal.pone.0205505			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356324	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000059
J	Koshkin, R; Shtyrov, Y; Myachykov, A; Ossadtchi, A				Koshkin, Roman; Shtyrov, Yury; Myachykov, Andriy; Ossadtchi, Alex			Testing the efforts model of simultaneous interpreting: An ERP study	PLOS ONE			English	Article							SELECTIVE-ATTENTION; INDIVIDUAL-DIFFERENCES; WORKING-MEMORY; LANGUAGE; MECHANISMS; FREQUENCY; BRAIN; POTENTIALS; MODULATION; LOAD	We utilized the event-related potential (ERP) technique to study neural activity associated with different levels of working memory (WM) load during simultaneous interpretation (SI) of continuous prose. The amplitude of N1 and P1 components elicited by task-irrelevant tone probes was significantly modulated as a function of WM load but not the direction of interpretation. Furthermore, the latency of the P1 increased significantly with WM load. The WM load effect on N1 latency, however, did not reach significance. Larger negativity under lower WM loads suggests that more attention is available to process the source message, providing the first electrophysiological evidence in support of the Efforts Model of SI. Relationships between the direction of interpretation and median WM load are also discussed.	[Koshkin, Roman; Shtyrov, Yury; Myachykov, Andriy; Ossadtchi, Alex] NRU Higher Sch Econ, Moscow, Russia; [Shtyrov, Yury] Aarhus Univ, Ctr Functionally Integrat Neurosci, Dept Clin Med, Aarhus, Denmark; [Myachykov, Andriy] Northumbria Univ, Dept Psychol, Newcastle Upon Tyne, Tyne & Wear, England	HSE University (National Research University Higher School of Economics); Aarhus University; Northumbria University	Koshkin, R (corresponding author), NRU Higher Sch Econ, Moscow, Russia.	roman.koshkin@gmail.com	Myachykov, Andriy/ABA-7129-2020; Ossadtchi, Alex/M-9067-2013; Shtyrov, Yury/ABI-2266-2020	Ossadtchi, Alex/0000-0001-8827-9429; Shtyrov, Yury/0000-0001-7203-4902; Koshkin, Roman/0000-0002-8739-4545	Center for Bioelectric Interfaces of the Institute for Cognitive Neuroscience of the National Research University Higher School of Economics, RF Government [14.641.31.0003]	Center for Bioelectric Interfaces of the Institute for Cognitive Neuroscience of the National Research University Higher School of Economics, RF Government	This work was supported by the Center for Bioelectric Interfaces of the Institute for Cognitive Neuroscience of the National Research University Higher School of Economics, RF Government grant, ag. No. 14.641.31.0003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salman S, 2002, META, V47, P607, DOI 10.7202/008040ar; [Anonymous], 1994, BRIDGING GAP EMPIRIC, DOI DOI 10.1075/BTL.3.13CHE; Ardila A, 2003, J COMMUN DISORD, V36, P233, DOI 10.1016/S0021-9924(03)00022-4; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Baddeley A, 1992, SCIENCE; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bajo MT, 2000, TRANSLATION CONTEXT, DOI [10.1075/btl.39.15baj, DOI 10.1075/BTL.39.15BAJ]; Bartlomiejczyk Magdalena, 2006, INTERPRETING, V8, P149; Bird S., 2009, NATURAL LANGUAGE PRO; Bledowski D, 2007, NEUROIMAGE, V36, P441, DOI [10.1016/j, DOI 10.1016/J]; Burgess C, 1998, BEHAV RES METH INS C, V30, P272, DOI 10.3758/BF03200655; Camayd-Freixas E, 2011, P 52 C TRANSL ASS, P13; Chernov Ghelly, 2004, INFERENCE ANTICIPATI, DOI [10.1075/btl.57, DOI 10.1075/BTL.57]; Chincotta Dino, 1998, INTERPRETING, V3, P1, DOI [10.1075/intp.3.1.01chi, DOI 10.1075/INTP.3.1.01CHI]; Coch D, 2005, J COGNITIVE NEUROSCI, V17, P605, DOI 10.1162/0898929053467631; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cowan Nelson, 2001, INTERPRETING, V5, P117, DOI [10.1075/intp.5.2.05cow, DOI 10.1075/INTP.5.2.05C0W]; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DOBBS AR, 1985, J EXP PSYCHOL HUMAN, V11, P81; Elmer S, 2016, FRONT HUM NEUROSCI, V10, P1, DOI [10.3389/fnhum.2016.00001, DOI 10.3389/FNHUM.2016.00001]; Elmer S, 2014, CORTEX, V54, P179, DOI 10.1016/j.cortex.2014.02.014; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Feher B, 2011, 13 C HUNG NEUG NEUR, DOI [10.3389/conf.fnins.2011.84.00117, DOI 10.3389/CONF.FNINS.2011.84.00117]; GARDNER MK, 1987, MEM COGNITION, V15, P24, DOI 10.3758/BF03197709; GERNSBACHER MA, 1984, J EXP PSYCHOL GEN, V113, P256, DOI 10.1037/0096-3445.113.2.256; Gerver D, 1974, ACTA PSYCHOL AMST, V159-167; Gerver David., 1975, META, V20, P119, DOI DOI 10.7202/002885AR; Gile D, 1988, PARTAGE LATTENTION D, P4; Gile D, 1999, TESTING EFFORT MODEL, P153; Gile D, 2008, FORUM-REV INT INTERP, V6, P59, DOI 10.1075/forum.6.2.04gil; Gile Daniel, 2009, BASIC CONCEPTS MODEL, DOI [10.1075/btl.8, DOI 10.1075/BTL.8]; Giuliano RJ, 2014, J COGNITIVE NEUROSCI, V26, P2682, DOI 10.1162/jocn_a_00684; GOLDMANE.F, 1972, J PSYCHOLINGUIST RES, V1, P127, DOI 10.1007/BF01068102; Gurin I, 2009, THESIS; Handy TC, 2005, EVENT RELATED POTENT; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; HINK RF, 1976, PERCEPT PSYCHOPHYS, V20, P236, DOI 10.3758/BF03199449; Kade O., 1971, BABEL, V17, P12, DOI [DOI 10.1075/BABEL.17.2.04CAR, 10.1075/babel.17.2.04car]; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kim, 2005, META TRANSL J, V50, DOI [10.7202/019846ar, DOI 10.7202/019846AR]; LAMBERT S, 1992, META, V37, P263, DOI 10.7202/003378ar; Li CS, 2010, J SPEC TRANSL, P19; Liu Minhua, 2004, INTERPRETING, V6, P19, DOI DOI 10.1075/INTP.6.1.04LIU; Miller J, 2009, PSYCHOPHYSIOLOGY, V46, P300, DOI 10.1111/j.1469-8986.2008.00761.x; Mizuno A, 2005, META, V50, P739, DOI 10.7202/011015ar; Mullen TR, 2015, IEEE T BIO-MED ENG, V62, P2553, DOI 10.1109/TBME.2015.2481482; NAATANEN R, 1982, PSYCHOL BULL, V92, P605; Nicodemus B, 2013, BILING-LANG COGN, V16, P624, DOI 10.1017/S1366728912000521; OLERON P, 1965, J Psychol Norm Pathol (Paris), V62, P73; Padilla P., 1995, TOPICS INTERPRETING, P61; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Pellegrino F, 2011, LANGUAGE, V87, P539; Pratt N, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00057; Proverbio AM, 2004, NEUROPSYCHOLOGIA, V42, P1636, DOI 10.1016/j.neuropsychologia.2004.04.013; Pym A, 2009, BENJAMIN TRANSL LIB, V80, P83; Rinne JO, 2000, NEUROSCI LETT, V294, P85, DOI 10.1016/S0304-3940(00)01540-8; RUBENSTEIN H, 1971, J VERB LEARN VERB BE, V10, P645, DOI 10.1016/S0022-5371(71)80071-3; Sabri M, 2014, NEUROPSYCHOLOGIA, V61, P269, DOI 10.1016/j.neuropsychologia.2014.06.009; SCARBOROUGH DL, 1977, J EXP PSYCHOL HUMAN, V3, P1, DOI 10.1037/0096-1523.3.1.1; Schoonen R, 2003, LANG LEARN, V53, P165, DOI 10.1111/1467-9922.00213; Setton Robin, 1999, SIMULTANEOUS INTERPR; Signorelli T., 2013, MEMORY LANGUAGE BILI, P95; Simon SS, 2016, FRONT HUM NEUROSCI, V10, P1, DOI [10.3389/fnhum.2016.00001, DOI 10.3389/FNHUM.2016.00001]; Sorqvist P, 2014, PSYCH J, V3, P42, DOI 10.1002/pchj.47; TEDER W, 1993, PSYCHOPHYSIOLOGY, V30, P71; Thorn ASC, 2001, PSYCHON B REV, V8, P357, DOI 10.3758/BF03196173; WHALEY CP, 1978, J VERB LEARN VERB BE, V17, P143, DOI 10.1016/S0022-5371(78)90110-X; WOLDORFF MG, 1991, ELECTROEN CLIN NEURO, V79, P170, DOI 10.1016/0013-4694(91)90136-R; WOODS DL, 1984, J EXP PSYCHOL HUMAN, V10, P761, DOI 10.1037/0096-1523.10.6.761; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773	71	5	5	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206129	10.1371/journal.pone.0206129	http://dx.doi.org/10.1371/journal.pone.0206129			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3FL	30356337	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000448434000075
J	Matenge, TG; Mash, B				Matenge, Tjedza G.; Mash, Bob			Barriers to accessing cervical cancer screening among HIV positive women in Kgatleng district, Botswana: A qualitative study	PLOS ONE			English	Article							HEALTH; ATTITUDES	Background Low and middle-income countries have a greater share of the cervical cancer burden, but lower screening coverage, compared to high-income countries. Moreover, screening uptake and disease outcomes are generally worse in rural areas as well as in the HIV positive population. Efforts directed at increasing the screening rates are important in order to decrease cancer-related morbidity and mortality. This study aimed to explore the barriers to women with HIV accessing cervical cancer screening in Kgatleng district, Botswana. Methods A phenomenological qualitative study utilising semi-structured interviews with fourteen HIV positive women, selected by purposive sampling. The interviews were transcribed verbatim and the 5-steps of the framework method, assisted by Atlas-ti software, was used for qualitative data analysis. Results Contextual factors included distance, public transport issues and work commitments. Health system factors highlighted unavailability of results, inconsistent appointment systems, long queues and equipment shortages and poor patient-centred communication skills, particularly skills in explanation and planning. Patient factors identified were lack of knowledge of cervical cancer, benefits of screening, effectiveness of treatment, as well as personal fears and misconceptions. Conclusion Cervical cancer screening was poorly accessed due to a weak primary care system, insufficient health promotion and information as well as poor communication skills. These issues could be partly addressed by considering alternative technology and one-stop models of testing and treating.	[Matenge, Tjedza G.; Mash, Bob] Stellenbosch Univ, Div Family Med & Primary Care, Cape Town, South Africa	Stellenbosch University	Mash, B (corresponding author), Stellenbosch Univ, Div Family Med & Primary Care, Cape Town, South Africa.	rm@sun.ac.za		Mash, Robert/0000-0001-7373-0774; Matenge, Tjedza/0000-0003-2739-1657				Adjorlolo-Johnson G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-242; [Anonymous], 2008, PRIM HLTH CAR NOW MO; Bukirwa A, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0243-9; Cain J, 2007, INT J GYNECOL OBSTET, V97, P232, DOI 10.1016/j.ijgo.2007.03.004; Catarino R, 2015, WORLD J CLIN ONCOL, V6, P281, DOI 10.5306/wjco.v6.i6.281; Cunningham MS, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005828; Daley E, 2011, J COMMUN HEALTH, V36, P121, DOI 10.1007/s10900-010-9289-7; Fallala MS, 2015, AFR J PRIM HEALTH CA, V7, DOI 10.4102/phcfm.v7i1.742; Fylan F, 1998, BRIT J GEN PRACT, V48, P1509; Ibekwe C, 2011, ARCH CLIN MICROBIOL, V2, DOI 10:3823/222; Idowu A, 2016, J CANCER EPIDEMIOL, V2016, DOI 10.1155/2016/6469240; Kawonga M, 2008, REPROD HEALTH MATTER, V16, P32, DOI 10.1016/S0968-8080(08)32403-3; Kringos DS, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-65; Lim JNW, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12444; Mabuza LH, 2014, AFR J PRIM HEALTH CA, V6, DOI 10.4102/phcfm.v6i1.640; Markovic M, 2005, SOC SCI MED, V61, P2528, DOI 10.1016/j.socscimed.2005.05.001; McFarland D M, 2003, Int Nurs Rev, V50, P167, DOI 10.1046/j.1466-7657.2003.00195.x; Ministry of Health, 2012, BOTSW NAT HIV AIDS T; Mosavel M, 2009, J CANCER EDUC, V24, P114, DOI 10.1080/08858190902854590; Ndejjo R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149696; Ogedegbe G, 2005, J NATL MED ASSOC, V97, P162; Perng P, 2013, INT J GYNECOL OBSTET, V123, P221, DOI 10.1016/j.ijgo.2013.05.026; Reid S, 2014, AFR J PRIM HEALTH CA, V6, P1, DOI DOI 10.4102/PHCFM.V6I1.632; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; United Nations International Children's Emergency Fund, BOTSW COUNTR PROF; Victoria K, 2011, PATIENT PREFER ADHER, V5, P125, DOI [10.2147/PPA.S17317, DOI 10.2147/PPA.S17317]; Walling A, 2005, AM FAM PHYSICIAN, V72, P1347	27	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205425	10.1371/journal.pone.0205425	http://dx.doi.org/10.1371/journal.pone.0205425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356248	gold, Green Published, Green Submitted			2022-12-26	WOS:000448434000057
J	Nam, HS; Choi, CW; Kim, SJ; Kang, DH; Kim, HW; Park, SB; Ryu, DG; Choi, JS				Nam, Hyeong Seok; Choi, Cheol Woong; Kim, Su Jin; Kang, Dae Hwan; Kim, Hyung Wook; Park, Su Bum; Ryu, Dae Gon; Choi, Jung Sik			Preprocedural prediction of non-curative endoscopic submucosal dissection for early gastric cancer	PLOS ONE			English	Article							CONVENTIONAL ENDOSCOPY; RESECTION; CARCINOMA; DIAGNOSIS; INVASION; PATTERNS; OUTCOMES; STRATEGY; STOMACH; DEPTH	Background and aim Endoscopic submucosal dissection (ESD) has been accepted as the treatment of choice for early gastric cancer (EGC) without lymph node metastasis. However, additional surgical gastrectomy should be considered after non-curative endoscopic resection. We aimed to evaluate the predictive factors associated with non-curative endoscopic resection. Methods Between November 2008 and June 2015, a retrospective study was conducted in a single, tertiary, referral hospital. A total of 596 EGC lesions resected by ESD were analyzed. Noncurative endoscopic resection was defined as the occurrence of lesions associated with piecemeal resection, positive resection margins, lymphovascular invasion, or lesions that did not meet the expanded indications for ESD. Results The rate of non-curative endoscopic resection was 16.1%. The mean follow-up period was 35.3 +/- 25.0 months. Associated predictive factors for non-curative endoscopic resection were female sex (OR, 2.470; p= 0.004), lesion size >= 20 mm (OR 3.714; p < 0.001), longer procedure time (OR 2.449, p = 0.002), ulceration (OR 3.538, p = 0.002), nodularity (OR 2.967, p<0.001), depression (OR 1.806, p = 0.038), undifferentiated carcinoma (OR 2.825, p = 0.031) and lesion located in the mid or upper third of stomach (OR 7.135 and OR 4.155, p<0.001, respectively). As the number of risk factors increased, the risk of non-curative ESD also increased. Conclusions Prior to selection of ESD, the risks associated with non-curative ESD should be considered so that appropriate treatment modalities may be selected.	[Nam, Hyeong Seok; Choi, Cheol Woong; Kim, Su Jin; Kang, Dae Hwan; Kim, Hyung Wook; Park, Su Bum; Ryu, Dae Gon] Pusan Natl Univ, Dept Internal Med, Sch Med, Yangsan Hosp, Yangsan, South Korea; [Nam, Hyeong Seok; Choi, Cheol Woong; Kim, Su Jin; Kang, Dae Hwan; Kim, Hyung Wook; Park, Su Bum; Ryu, Dae Gon] Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, Yangsan, South Korea; [Choi, Jung Sik] Inje Univ, Busan Paik Hosp, Dept Internal Med, Coll Med, Pusan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Inje University	Choi, CW (corresponding author), Pusan Natl Univ, Dept Internal Med, Sch Med, Yangsan Hosp, Yangsan, South Korea.; Choi, CW (corresponding author), Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, Yangsan, South Korea.	luckyace@hanmail.net		Choi, Cheol Woong/0000-0001-8867-3039				Ahn JY, 2011, GASTROINTEST ENDOSC, V74, P485, DOI 10.1016/j.gie.2011.04.038; Akashi Y, 2011, MED MOL MORPHOL, V44, P39, DOI 10.1007/s00795-010-0503-6; Choi J, 2010, ENDOSCOPY, V42, P705, DOI 10.1055/s-0030-1255617; Choi J, 2011, GASTROINTEST ENDOSC, V73, P917, DOI 10.1016/j.gie.2010.11.053; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI [DOI 10.1007/PL00011681, DOI 10.1007/S101209800016]]; Kang DH, 2017, SURG ENDOSC, V31, P4673, DOI 10.1007/s00464-017-5534-9; Kim EH, 2017, GASTROINTEST ENDOSC, V85, P976, DOI 10.1016/j.gie.2016.10.018; Kim H, 2015, GUT LIVER, V9, P720, DOI 10.5009/gnl14203; Mihara M, 1999, HELICOBACTER, V4, P40, DOI 10.1046/j.1523-5378.1999.09016.x; Min BH, 2015, ENDOSCOPY, V47, P784, DOI 10.1055/s-0034-1392249; Ono H, 2006, EUR J GASTROEN HEPAT, V18, P863, DOI 10.1097/00042737-200608000-00009; Park S, 2008, GUT LIVER, V2, P199, DOI 10.5009/gnl.2008.2.3.199; Satodate H, 2003, GASTROINTEST ENDOSC, V58, P288, DOI 10.1067/mge.2003.361; Suh M, 2013, CANCER RES TREAT, V45, P86, DOI 10.4143/crt.2013.45.2.86; Tsujii Y, 2015, GASTROINTEST ENDOSC, V82, P452, DOI 10.1016/j.gie.2015.01.022	18	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206179	10.1371/journal.pone.0206179	http://dx.doi.org/10.1371/journal.pone.0206179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356294	Green Submitted, Green Published, gold			2022-12-26	WOS:000448434000079
J	Svolgaard, O; Andersen, KW; Bauer, C; Madsen, KH; Blinkenberg, M; Selleberg, F; Siebner, HR				Svolgaard, Olivia; Andersen, Kasper Winther; Bauer, Christian; Madsen, Kristoffer Hougaard; Blinkenberg, Morten; Selleberg, Finn; Siebner, Hartwig Roman			Cerebellar and premotor activity during a non-fatiguing grip task reflects motor fatigue in relapsing-remitting multiple sclerosis	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; BRAIN ACTIVITY; COGNITIVE FUNCTIONS; BASAL GANGLIA; SCALE; CORTEX; FMRI; MOVEMENT; SYSTEM; FORCE	Fatigue is a common and highly disabling symptom of multiple sclerosis. Patients experience an effort-independent general subjective feeling of fatigue as well as excessive fatigability when engaging in physical or mental activity. Previous research using functional magnetic resonance imaging (fMRI) has revealed heterogeneous findings, but some evidence implicates the motor system. To identify brain correlates of fatigue, 44 mildly impaired patients with relapsing-remitting multiple sclerosis and 25 age- and gender-matched healthy controls underwent functional magnetic resonance imaging at 3 Tesla, while they performed alternating blocks of rest and a non-fatiguing precision grip task. We investigated neural correlates of fatigue using the motor subscore of Fatigue Scale for Motor and Cognitive Functions (FSMCMOTOR) using the bilateral motor cerebellum, putamen, and dorsal premotor cortex as regions of interest. Patients and healthy controls performed the grip force task equally well without being fatigued. In patients, task-related activity in lobule VI of right motor cerebellum changed in proportion with individual FSMCMOTOR scores. In right dorsal premotor cortex, linear increases in activity across consecutive task blocks scaled with individual FSMCMOTOR scores in healthy controls, but not in patients. In premotor and dorsomedial prefrontal areas, patients were impaired at upscaling task-related activity the more they were affected by motor fatigue. The results support the notion that increased sensorimotor processing in the cerebellum contributes to the experience of motor fatigue and fatigability in multiple sclerosis. Additionally, downscaling of motivational input or sensorimotor processing in prefrontal and premotor areas may constitute an additional pathophysiological factor.	[Svolgaard, Olivia; Andersen, Kasper Winther; Bauer, Christian; Madsen, Kristoffer Hougaard; Siebner, Hartwig Roman] Copenhagen Univ Hosp Hvidovre, Danish Res Ctr Magnet Resonance, Ctr Funct & Diagnost Imaging & Res, Hvidovre, Denmark; [Bauer, Christian] Metropolitan Univ Coll, Copenhagen, Denmark; [Madsen, Kristoffer Hougaard] Tech Univ Denmark, Dept Appl Math & Comp Sci, Lyngby, Denmark; [Blinkenberg, Morten; Selleberg, Finn] Copenhagen Univ Hosp, Danish Multiple Sclerosis Ctr, Rigshosp, Copenhagen, Denmark; [Siebner, Hartwig Roman] Copenhagen Univ Hosp Bispebjerg, Dept Neurol, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Svolgaard, O; Siebner, HR (corresponding author), Copenhagen Univ Hosp Hvidovre, Danish Res Ctr Magnet Resonance, Ctr Funct & Diagnost Imaging & Res, Hvidovre, Denmark.; Siebner, HR (corresponding author), Copenhagen Univ Hosp Bispebjerg, Dept Neurol, Copenhagen, Denmark.	oliviamrs@dranr.dk; h.siebner@drcmr.dk	Madsen, Kristoffer Hougaard/M-9547-2014	Madsen, Kristoffer Hougaard/0000-0001-8606-7641	Lundbeckfonden [R59-A5399]; Danish Multiple Sclerosis Society [R308-A19386, R367-A25015, R399-A27956, R431-A29804]; RegionH Research Foundation for Health Research; Consultant Torben Fogs and Erik Triers foundation; Biogen Idec [GDRC-002-2014]; Jascha Foundation [5588]	Lundbeckfonden(Lundbeckfonden); Danish Multiple Sclerosis Society; RegionH Research Foundation for Health Research; Consultant Torben Fogs and Erik Triers foundation; Biogen Idec(Biogen); Jascha Foundation	This study was supported by Lundbeckfonden, https://www.lundbeckfonden.com/, grant number: R59-A5399; Danish Multiple Sclerosis Society, https://www.scleroseforeningen.dk/, grant number: R308-A19386, R367-A25015, R399-A27956, R431-A29804; The RegionH Research Foundation for Health Research, https://www.regionh.dk/til-fagfolk/forskning-oginnovation/Finansiering/Soeg-regionens-midler/Sider/Forskningsprojekter.aspx, grant number: no number; Consultant Torben Fogs and Erik Triers foundation, URLs: no website, grant number: no number; Biogen Idec, https://www.biogen.com/en_us/biogen-foundation. html, grant number: GDRC-002-2014; Jascha Foundation, URLs: https://jaschafonden.dk/, grant number: 5588. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett P, 2005, MULT SCLER J, V11, P328, DOI 10.1191/1352458505ms1162oa; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Bonzano L, 2017, BEHAV BRAIN RES, V325, P63, DOI 10.1016/j.bbr.2017.02.008; Bonzano L, 2013, NEUROIMAGE, V65, P257, DOI 10.1016/j.neuroimage.2012.10.012; Boussaoud D, 2001, NEUROIMAGE, V14, pS40, DOI 10.1006/nimg.2001.0816; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Coombes SA, 2012, CEREB CORTEX, V22, P616, DOI 10.1093/cercor/bhr141; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Dobryakova E, 2018, MULT SCLER J, V24, P1174, DOI 10.1177/1352458517717087; Dogonowski AM, 2014, NEUROIMAGE-CLIN, V4, P130, DOI 10.1016/j.nicl.2013.11.005; Enoka RM, 2016, MED SCI SPORT EXER, V48, P2228, DOI 10.1249/MSS.0000000000000929; Filippi M, 2002, NEUROIMAGE, V15, P559, DOI 10.1006/nimg.2001.1011; Filippi M, 2013, EXPERT REV NEUROTHER, V13, P27, DOI 10.1586/14737175.2013.865871; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fox Robert J, 2015, Neurodegener Dis Manag, V5, P3, DOI 10.2217/nmt.15.55; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Hanakawa T, 2006, EXP BRAIN RES, V172, P275, DOI 10.1007/s00221-005-0336-z; Hoshi E, 2007, CURR OPIN NEUROBIOL, V17, P234, DOI 10.1016/j.conb.2007.02.003; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Keren-Happuch E, 2014, HUM BRAIN MAPP, V35, P593, DOI 10.1002/hbm.22194; Khan F, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00177; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Krupp LB, 2010, EXPERT REV NEUROTHER, V10, P1437, DOI [10.1586/ern.10.99, 10.1586/ERN.10.99]; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kuhtz-Buschbeck JP, 2008, NEUROIMAGE, V40, P1469, DOI 10.1016/j.neuroimage.2008.01.037; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lamers I, 2014, ARCH PHYS MED REHAB, V95, P1184, DOI 10.1016/j.apmr.2014.02.023; Lopez-Gongora M, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0296-2; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Matelli M, 2001, NEUROIMAGE, V14, pS27, DOI 10.1006/nimg.2001.0835; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Mills RJ, 2010, J NEUROL NEUROSUR PS, V81, P1049, DOI 10.1136/jnnp.2008.151340; Minden SL, 2014, NEUROLOGY, V82, P174, DOI 10.1212/WNL.0000000000000013; Minden SL, 2006, MULT SCLER J, V12, P24, DOI 10.1191/135248506ms1262oa; Mumford JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126255; Oervik MS, 2017, MULT SCLER RELAT DIS, V17, P130, DOI 10.1016/j.msard.2017.07.017; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pardini M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02001; Penhune VB, 2012, BEHAV BRAIN RES, V226, P579, DOI 10.1016/j.bbr.2011.09.044; Penner IK, 2009, MULT SCLER J, V15, P1509, DOI 10.1177/1352458509348519; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Popa LS, 2016, CEREBELLUM, V15, P93, DOI 10.1007/s12311-015-0685-5; Popp RFJ, 2017, SLEEP MED REV, V32, P95, DOI 10.1016/j.smrv.2016.03.004; Possa MF, 2010, NEUROL SCI, V31, P219, DOI 10.1007/s10072-010-0374-6; Righart R, 2017, ANN NEUROL, V82, P519, DOI 10.1002/ana.25020; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rocca MA, 2007, HUM BRAIN MAPP, V28, P373, DOI 10.1002/hbm.20279; Rocca MA, 2016, MULT SCLER J, V22, P1144, DOI 10.1177/1352458515614407; Rocca MA, 2009, J NEUROL, V256, P470, DOI 10.1007/s00415-009-0116-y; Roelcke U, 1997, NEUROLOGY, V48, P1566, DOI 10.1212/WNL.48.6.1566; Sarica A, 2015, INT J MOL SCI, V16, P12185, DOI 10.3390/ijms160612185; Simpson S, 2016, ACTA NEUROL SCAND, V134, P403, DOI 10.1111/ane.12554; Specogna I, 2012, RADIOL MED, V117, P1398, DOI 10.1007/s11547-012-0845-3; Spiteri S, 2019, MULT SCLER J, V25, P256, DOI 10.1177/1352458517743090; Stephan KE, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00550; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Eimeren T, 2006, NEUROIMAGE, V29, P286, DOI 10.1016/j.neuroimage.2005.07.014; van Nuenen BFL, 2012, J NEUROSCI, V32, P5272, DOI 10.1523/JNEUROSCI.5673-11.2012; Weier K, 2015, CEREBELLUM, V14, P364, DOI 10.1007/s12311-014-0634-8; Weygandt M, 2016, P NATL ACAD SCI USA, V113, P13444, DOI 10.1073/pnas.1605829113	65	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0201162	10.1371/journal.pone.0201162	http://dx.doi.org/10.1371/journal.pone.0201162			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356315	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000002
J	Gondwe, A; Ashorn, P; Ashorn, U; Dewey, KG; Maleta, K; Nkhoma, M; Mbotwa, J; Jorgensen, JM				Gondwe, Austrida; Ashorn, Per; Ashorn, Ulla; Dewey, Kathryn G.; Maleta, Kenneth; Nkhoma, Minyanga; Mbotwa, John; Jorgensen, Josh M.			Pre-pregnancy body mass index (BMI) and maternal gestational weight gain are positively associated with birth outcomes in rural Malawi	PLOS ONE			English	Article							INFANT OUTCOMES; PREGNANCY; NUTRITION; WOMEN	Background Whereas poor maternal nutritional status before and during pregnancy is widely associated with adverse birth outcomes, studies quantifying this association in low income countries are scarce. We examined whether maternal pre-pregnancy body mass index (BMI) and weight gain during pregnancy are associated with birth outcomes in rural Malawi. Methods We analyzed the associations between pre-pregnancy BMI and average weekly gestational weight gain (WWG) and birth outcomes [duration of gestation, birth weight, length-for-age zscore (LAZ), and head circumference-for-age z-score (HCZ)]. We also determined whether women with low or high pre-pregnancy BMI or women with inadequate or excessive WWG were at increased risk of adverse birth outcomes. Results The analyses included 1287 women with a mean BMI of 21.8 kg/m(2) , of whom 5.9% were underweight (< 18.5 kg/m(2)), 10.9% were overweight (>= 25 kg/m(2)), 71.8% had low WWG [below the lower limit of the Institute of Medicine (IOM) recommendation], and 5.2% had high WWG (above IOM recommendation). In adjusted models, pre-pregnancy BMI was not associated with duration of pregnancy (p = 0.926), but was positively associated with birth weight and HCZ (<0.001 and p = 0.003, respectively). WWG was positively associated with duration of gestation (p = 0.031), birth weight (p<0.001), LAZ (p<0.001), and HCZ (p<0.001). Compared to normal weight women, underweight women were at increased risk of having stunted infants (p = 0.029). Women with low WWG were at increased risk of having infants with low birth weight (p = 0.006) and small head circumference (p = 0.024) compared to those with normal weight gain. Those with high BMI or high WWG were not at increased risk of adverse birth outcomes. Conclusions WWG is an important predictor of birth outcomes in rural Malawi. The high prevalence of inadequate WWG compared to low pre-pregnancy BMI highlights the need to investigate causes of inadequate weight gain in this region.	[Gondwe, Austrida; Ashorn, Per; Ashorn, Ulla; Nkhoma, Minyanga] Univ Tampere, Fac Med & Life Sci, Ctr Child Hlth Res, Tampere, Finland; [Ashorn, Per] Tampere Univ Hosp, Dept Paediat, Tampere, Finland; [Dewey, Kathryn G.; Jorgensen, Josh M.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Maleta, Kenneth; Mbotwa, John] Univ Malawi, Coll Med, Sch Publ Hlth & Family Med, Blantyre, Malawi	Tampere University; Tampere University; Tampere University Hospital; University of California System; University of California Davis; University of Malawi	Gondwe, A (corresponding author), Univ Tampere, Fac Med & Life Sci, Ctr Child Hlth Res, Tampere, Finland.	augondwe@yahoo.co.uk	Maleta, Ken M/J-2821-2016	Maleta, Ken M/0000-0002-2536-3938; Mbotwa, John/0000-0002-9704-8419; Gondwe, Austrida/0000-0003-1921-2225; Ashorn, Per/0000-0003-2311-2593	Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development (USAID) under the Food and Nutrition Technical Assistance III Project (FANTA) [AID-OAA-A-12-00005]; Bill & Melinda Gates Foundation; Academy of Finland [252075]; Medical Research Fund of Tampere University Hospital [9 M004]	Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development (USAID) under the Food and Nutrition Technical Assistance III Project (FANTA)(United States Agency for International Development (USAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Academy of Finland(Academy of Finland); Medical Research Fund of Tampere University Hospital	This publication is based on research funded in part by the Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development (USAID) under terms of Cooperative Agreement No. AID-OAA-A-12-00005, through the Food and Nutrition Technical Assistance III Project (FANTA), managed by FHI 360, with additional funding from a grant to the University of California, Davis by the Bill & Melinda Gates Foundation. For data management and statistical analysis, the team received additional support in grants from the Academy of Finland (grant 252075) and the Medical Research Fund of Tampere University Hospital (grant 9 M004). The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the United States Government, USAID, the Bill & Melinda Gates Foundation, or the other funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, B WORLD HEALTH ORGAN, P73; [Anonymous], 1990, SUBC NUTR STAT WEIGH; Arimond M, 2013, MATERN CHILD NUTR; Ashorn P, 2015, AM J CLIN NUTR, V101, P387, DOI 10.3945/ajcn.114.088617; Ayensu J, 2016, NUTR FOOD SCI, V46, P542, DOI 10.1108/NFS-11-2015-0146; Baugh N, 2016, J PREGNANCY, V2016, DOI 10.1155/2016/5871313; Cheung WY, 2013, J CANCER SURVIV, V7, P343, DOI 10.1007/s11764-013-0281-y; Choi SK, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-6; Crane JMG, 2009, J OBSTET GYNAECOL CA, V31, P28, DOI 10.1016/S1701-2163(16)34050-6; El Rafei R, 2016, PAEDIATR PERINAT EP, V30, P38, DOI 10.1111/ppe.12249; Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635; Guelinckx L, 2008, INT ASS STUDY OBES, V9; Han Z, 2011, INT J EPIDEMIOL, V40, P65, DOI 10.1093/ije/dyq195; Haugen M, 2014, BMC PREGNANCY CHILDB, V14, P201, DOI DOI 10.1186/1471-2393-14-201; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Kanade A, 2008, J AM COLL NUTR; Lartey A, 2008, P NUTR SOC, V67, P105, DOI 10.1017/S0029665108006083; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Mahumud Rashidul Alam, 2017, J Prev Med Public Health, V50, P18, DOI 10.3961/jpmph.16.087; National Statistical Office (NSO) [Malawi] and ICF, 2017, MALAWI DEMOGRAPHIC H; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Ota E, 2011, B WORLD HEALTH ORGAN, V89, P127, DOI 10.2471/BLT.10.077982; Pan Y, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011227; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x; Sananpanichkul P, 2015, SE ASIAN J TRP MED P, V46; Stotland NE, 2006, OBSTET GYNECOL, V108, P635, DOI 10.1097/01.AOG.0000228960.16678.bd; Wen TY, 2015, INT J CLIN EXP MED, V8, P2881; World Health Organisation, 2004, WHO TECHN REP SER; Xiao L, 2016, ASS MATERNAL PREPREG; Xiao LL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41073; Xie YJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010935; 2005, MALAWI DEMOGRAPHIC H	32	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206035	10.1371/journal.pone.0206035	http://dx.doi.org/10.1371/journal.pone.0206035			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352100	Green Published, gold, Green Submitted			2022-12-26	WOS:000448076200023
J	Ou, JF; Si, YN; Goh, K; Yasui, N; Guo, YC; Song, JJ; Wang, LZ; Jaskula-Sztul, R; Fan, JD; Zhou, LF; Liu, RH; Liu, XG				Ou, Jianfa; Si, Yingnan; Goh, KahYong; Yasui, Norio; Guo, Yichen; Song, Jiajia; Wang, Lizhong; Jaskula-Sztul, Renata; Fan, Jinda; Zhou, Lufang; Liu, Runhua; Liu, Xiaoguang			Bioprocess development of antibody-drug conjugate production for cancer treatment	PLOS ONE			English	Article							SITE-SPECIFIC CONJUGATION; TRASTUZUMAB EMTANSINE; CYTOTOXIC DRUG; BREAST-CANCER; IMPROVES; INTERNALIZATION; OPTIMIZATION; EFFICACY; DELIVERY; POTENT	Antibody-drug conjugate (ADC) is a class of targeted cancer therapies that combine the advantages of monoclonal antibody (mAb)'s specific targeting and chemotherapy's potent cytotoxicity. The therapeutic effect of ADC is significantly affected by its bioproduction process. This study aims to develop an effective ADC production process using anti-HER2 mAb-drug as a model therapeutic. First, a high titer (>2 g/L) of mAb was produced by Chinese hamster ovary cells from fed-batch cell culture. Both live-cell confocal microscopy imaging and flow cytometry analysis demonstrated that the produced mAb and ADC had strong and specific binding to HER2(+) cell line BT474. Second, various conjugation conditions of mAb and drug, including linker selection, ratio of drug and mAb, and conjugation approaches, were investigated to improve the production yield and product quality. Finally, the ADC structure and biological quality were evaluated by SDS-PAGE and anti-breast cancer toxicity study, respectively. The ADC with integral molecular structure and high cytotoxicity (IC50 of 1.95 nM) was produced using the optimized production process. The robust bioproduction process could guide the development of ADC-based biopharmaceuticals.	[Ou, Jianfa; Si, Yingnan; Goh, KahYong; Guo, Yichen; Song, Jiajia; Zhou, Lufang; Liu, Xiaoguang] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Yasui, Norio; Fan, Jinda] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL USA; [Wang, Lizhong; Liu, Runhua] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Jaskula-Sztul, Renata] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Liu, XG (corresponding author), Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.	mliu@uab.edu	Wang, Lizhong/J-4268-2019; Liu, Runhua/K-2388-2019	Wang, Lizhong/0000-0003-1980-4730; Liu, Runhua/0000-0002-0892-6946; Zhou, Lufang/0000-0002-1321-8442; Song, Jiajia/0000-0001-6753-518X	National Institute of Health [R21 HL 127599A1]; University of Alabama at Birmingham (UAB); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121206, R21HL127599] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham (UAB); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health, Grant Number R21 HL 127599A1, 2016, by LZ, and the start-up fund from the University of Alabama at Birmingham (UAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adem YT, 2014, BIOCONJUGATE CHEM, V25, P656, DOI 10.1021/bc400439x; Badescu G, 2014, BIOCONJUGATE CHEM, V25, P1124, DOI 10.1021/bc500148x; Behrens CR, 2015, MOL PHARMACEUT, V12, P3986, DOI 10.1021/acs.molpharmaceut.5b00432; Boeggeman E, 2009, BIOCONJUGATE CHEM, V20, P1228, DOI 10.1021/bc900103p; Bouchard H, 2014, BIOORG MED CHEM LETT, V24, P5357, DOI 10.1016/j.bmcl.2014.10.021; Bryant P, 2015, MOL PHARMACEUT, V12, P1872, DOI 10.1021/acs.molpharmaceut.5b00116; Bunn PA, 2016, J THORAC ONCOL, V11, P453, DOI 10.1016/j.jtho.2016.01.012; Debaene F, 2014, ANAL CHEM, V86, P10674, DOI 10.1021/ac502593n; Diamantis N, 2016, BRIT J CANCER, V114, P362, DOI 10.1038/bjc.2015.435; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Drake PM, 2015, CURR OPIN CHEM BIOL, V28, P174, DOI 10.1016/j.cbpa.2015.08.005; Fishkin N, 2015, MOL PHARMACEUT, V12, P1745, DOI 10.1021/mp500843r; Hofer T, 2009, BIOCHEMISTRY-US, V48, P12047, DOI 10.1021/bi901744t; Hughes B, 2010, ANTIBODY DRUG CONJUG; Jeger S, 2010, ANGEW CHEM INT EDIT, V49, P9995, DOI 10.1002/anie.201004243; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Junutula JR, 2008, J IMMUNOL METHODS, V332, P41, DOI 10.1016/j.jim.2007.12.011; Junutula JR, 2010, CLIN CANCER RES, V16, P4769, DOI 10.1158/1078-0432.CCR-10-0987; Kellogg BA, 2011, BIOCONJUGATE CHEM, V22, P717, DOI 10.1021/bc100480a; Larson RA, 2005, CANCER, V104, P1442, DOI 10.1002/cncr.21326; Liu CN, 1996, P NATL ACAD SCI USA, V93, P8618, DOI 10.1073/pnas.93.16.8618; LoRusso PM, 2011, CLIN CANCER RES, V17, P6437, DOI 10.1158/1078-0432.CCR-11-0762; Lyon RP, 2015, NAT BIOTECHNOL, V33, P733, DOI 10.1038/nbt.3212; Marcoux J, 2015, PROTEIN SCI, V24, P1210, DOI 10.1002/pro.2666; Nanna AR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01257-1; Nejadmoghaddam MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13682-9; Nunes JPM, 2015, CHEM COMMUN, V51, P10624, DOI 10.1039/c5cc03557k; Oflazoglu E, 2008, BRIT J HAEMATOL, V142, P69, DOI 10.1111/j.1365-2141.2008.07146.x; Pabst M, 2017, J CONTROL RELEASE, V253, P160, DOI 10.1016/j.jconrel.2017.02.027; Panowski S, 2014, MABS-AUSTIN, V6, P34, DOI 10.4161/mabs.27022; Perez HL, 2014, DRUG DISCOV TODAY, V19, P869, DOI 10.1016/j.drudis.2013.11.004; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Schumacher FF, 2014, ORG BIOMOL CHEM, V12, P7261, DOI 10.1039/c4ob01550a; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Sommerfeld S, 2005, CHEM ENG PROCESS, V44, P1123, DOI 10.1016/j.cep.2005.03.006; Stump B, 2013, METHODS MOL BIOL, V1045, P235, DOI 10.1007/978-1-62703-541-5_14; Sun MMC, 2005, BIOCONJUGATE CHEM, V16, P1282, DOI 10.1021/bc050201y; Trail PA, 2018, PHARMACOL THERAPEUT, V181, P126, DOI 10.1016/j.pharmthera.2017.07.013; Tsuchikama K, 2018, PROTEIN CELL, V9, P33, DOI 10.1007/s13238-016-0323-0; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Xu NN, 2017, BIOCHEM ENG J, V124, P122, DOI 10.1016/j.bej.2017.05.007; Xu S, 2015, PHARM RES-DORDR, V32, P3577, DOI 10.1007/s11095-015-1729-8; Yang JD, 2007, BIOTECHNOL BIOENG, V98, P141, DOI 10.1002/bit.21413; Younes A, 2012, NAT REV DRUG DISCOV, V11, P19, DOI 10.1038/nrd3629; Zemskov EA, 2007, J CELL SCI, V120, P3188, DOI 10.1242/jcs.010397; Zhang H, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.15	46	14	15	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206246	10.1371/journal.pone.0206246	http://dx.doi.org/10.1371/journal.pone.0206246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352095	Green Published, gold, Green Submitted			2022-12-26	WOS:000448076200043
J	Wang, WX; Zhang, JH; Liu, X; Li, D; Li, Y; Tian, YQ; Tan, HR				Wang, Wenxi; Zhang, Jihui; Liu, Xiang; Li, Dong; Li, Yue; Tian, Yuqing; Tan, Huarong			Identification of a butenolide signaling system that regulates nikkomycin biosynthesis in Streptomyces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular genetics; receptor; transcription regulation; antibiotics; signal transduction; secondary metabolism; butenolide signaling molecules; gene cluster; nikkomycin; Streptomyces	ANTIBIOTIC PRODUCTION; SECONDARY METABOLISM; MORPHOLOGICAL-DIFFERENTIATION; AUTOREGULATOR-RECEPTOR; LANKAMYCIN PRODUCTION; MOLECULAR REGULATION; A-FACTOR; COELICOLOR; GENE; ADPA	Butenolides are an emerging family of signaling molecules in Streptomyces. They control complex physiological traits, such as morphological differentiation and antibiotic production. However, how butenolides regulate these processes is poorly investigated because of obstacles in obtaining these signaling molecules. This study reports the identification of a butenolide-type signaling system for nikkomycin biosynthesis in Streptomyces ansochromogenes with distinct features. We identified a gene cluster, sab, consisting of three genes, sabAPD, for butenolide biosynthesis and two regulator genes, sabR1 and sabR2, and characterized three butenolides (SAB1, -2, and -3) by heterologous expression of sabAPD. sabA disruption abolished nikkomycin production, which could be restored by the addition of SABs or by deletion of sabR1 in sabA. Electrophoretic mobility-shift assays and transcriptional analyses indicated that SabR1 indirectly represses the transcription of nikkomycin biosynthetic genes, but directly represses sabA and sabR1. In the presence of SABs, the SabR1 transcriptional regulator dissociated from its target genes, verifying that SabR1 is the cognate receptor of SABs. Genome-wide scanning with the conserved SabR1-binding sequence revealed another SabR1 target gene, cprC, whose transcription was strongly repressed by SabR1. Intriguingly, CprC positively regulated the pleiotropic regulatory gene adpA by binding to its promoter and, in turn, activated nikkomycin biosynthesis. This is the first report that butenolide-type signaling molecules and their cognate receptor SabR1 can regulate adpA via a newly identified activator, CprC, to control nikkomycin production. These findings pave the way for further studies seeking to unravel the regulatory mechanism and functions of the butenolide signaling system in Streptomyces.	[Wang, Wenxi; Zhang, Jihui; Liu, Xiang; Li, Dong; Li, Yue; Tian, Yuqing; Tan, Huarong] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China; [Wang, Wenxi; Liu, Xiang; Li, Dong; Tian, Yuqing; Tan, Huarong] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, JH; Tan, HR (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing 100101, Peoples R China.	zhang.jihui@im.ac.cn; tanhr@im.ac.cn		Zhang, Jihui/0000-0001-5029-0833; Wang, Wenxi/0000-0001-6152-0403	Ministry of Science and Technology of China [2015CB150600]; National Natural Science Foundation of China [31571281,31771378, 31470206]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2015CB150600 and National Natural Science Foundation of China Grants 31571281,31771378, and 31470206. The authors declare that they have no conflicts of interest with the contents of this article.	Arakawa K, 2007, MICROBIOL-SGM, V153, P1817, DOI 10.1099/mic.0.2006/002170-0; Arakawa K, 2012, CHEMBIOCHEM, V13, P1447, DOI 10.1002/cbic.201200149; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; BRAUN D, 1995, FEMS MICROBIOL LETT, V126, P37, DOI 10.1111/j.1574-6968.1995.tb07387.x; Corre C, 2008, P NATL ACAD SCI USA, V105, P17510, DOI 10.1073/pnas.0805530105; Gomez-Escribano JP, 2011, MICROB BIOTECHNOL, V4, P207, DOI 10.1111/j.1751-7915.2010.00219.x; He XH, 2010, MICROBIOL-SGM, V156, P828, DOI 10.1099/mic.0.033605-0; Higo A, 2012, DNA RES, V19, P259, DOI 10.1093/dnares/dss010; Horinouchi S, 2007, P JPN ACAD B-PHYS, V83, P277, DOI [10.2183/pjab.83.277, 10.2183/pjab/83.277]; Kato JY, 2007, P NATL ACAD SCI USA, V104, P2378, DOI 10.1073/pnas.0607472104; Kitani S, 2011, P NATL ACAD SCI USA, V108, P16410, DOI 10.1073/pnas.1113908108; Li JJ, 2018, CELL CHEM BIOL, V25, P143, DOI 10.1016/j.chembiol.2017.10.012; Li Y, 2017, SCI CHINA LIFE SCI, V60, P935, DOI 10.1007/s11427-017-9115-x; Li Y, 2016, J BIOL CHEM, V291, P5406, DOI 10.1074/jbc.M115.695874; Liu G, 2005, MOL MICROBIOL, V55, P1855, DOI 10.1111/j.1365-2958.2005.04512.x; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Lu C, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0359-5; Myronovskyi M, 2011, APPL ENVIRON MICROB, V77, P5370, DOI 10.1128/AEM.00434-11; Niu GQ, 2016, FEMS MICROBIOL REV, V40, P554, DOI 10.1093/femsre/fuw012; Onaka H, 1998, MOL MICROBIOL, V28, P743, DOI 10.1046/j.1365-2958.1998.00832.x; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Pan YY, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-164; Pan YY, 2009, MOL MICROBIOL, V72, P710, DOI 10.1111/j.1365-2958.2009.06681.x; Sidda JD, 2016, ORG BIOMOL CHEM, V14, P6390, DOI 10.1039/c6ob00840b; Sultan SP, 2016, APPL MICROBIOL BIOT, V100, P9581, DOI 10.1007/s00253-016-7781-4; Suzuki T, 2010, BIOSCI BIOTECH BIOCH, V74, P819, DOI 10.1271/bbb.90927; Takano E, 2001, MOL MICROBIOL, V41, P1015, DOI 10.1046/j.1365-2958.2001.02562.x; Nguyen TB, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02791-17; Wang WS, 2014, P NATL ACAD SCI USA, V111, P5688, DOI 10.1073/pnas.1324253111; Xu GM, 2010, J BIOL CHEM, V285, P27440, DOI 10.1074/jbc.M110.143081; Xu JJ, 2017, J BIOL CHEM, V292, P19708, DOI 10.1074/jbc.M117.809145; Zhong XY, 2013, SCI CHINA LIFE SCI, V56, P609, DOI 10.1007/s11427-013-4506-0; Zhu JY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02577; Zhu JY, 2016, MOL MICROBIOL, V102, P562, DOI 10.1111/mmi.13479; Zou ZZ, 2014, MOL MICROBIOL, V94, P490, DOI 10.1111/mmi.12752	36	11	13	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20029	20040		10.1074/jbc.RA118.005667	http://dx.doi.org/10.1074/jbc.RA118.005667			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30355730	Green Published, hybrid			2022-12-26	WOS:000454685900013
J	Briquet, S; Ourimi, A; Pionneau, C; Bernardes, J; Carbone, A; Chardonnet, S; Vaquero, C				Briquet, Sylvie; Ourimi, Asma; Pionneau, Cedric; Bernardes, Juliana; Carbone, Alessandra; Chardonnet, Solenne; Vaquero, Catherine			Identification of Plasmodium falciparum nuclear proteins by mass spectrometry and proposed protein annotation	PLOS ONE			English	Article							PRECURSOR ION-EXCLUSION; TRANSCRIPTION FACTOR; TRANSLATION; PFMYB1; GENES; CYCLE; VIEW	The nuclear proteome of Plasmodium falciparum results from the continual shuttle of proteins between the cell cytoplasm-nucleus and vice versa. Using shotgun proteomics tools, we explored the nuclear proteins of mixed populations of Plasmodium falciparum extracted from infected erythrocytes. We combined GeLC-MS/MS and 2D-LC-MS/MS with a peptide ion exclusion procedure in order to increase the detection of low abundant proteins such as those involved in gene expression. We have identified 446 nuclear proteins covering all expected nuclear protein families involved in gene regulation. All structural ribosomal (40S and 60S) proteins were identified which is consistent with the nuclear localization of ribosomal biogenesis. Proteins involved in the translation machinery were also found suggesting that translational events might occur in the nucleus in P. falciparum as previously hypothesized in eukaryotes. These data were compared to the protein list established by PlasmoDB and submitted to Plasmobase a recently reported Plasmodium annotation website to propose new functional putative annotation of several unknown proteins found in the nuclear extracts.	[Briquet, Sylvie; Ourimi, Asma; Vaquero, Catherine] Sorbonne Univ, CIMI Paris, Ctr Immunol & Malad Infect, CNRS,INSERM, Paris, France; [Pionneau, Cedric; Chardonnet, Solenne] Sorbonne Univ, Plateforme Post Genom Pitie Salpetriere, UMS Omique, INSERM, Paris, France; [Bernardes, Juliana; Carbone, Alessandra] Sorbonne Univ, CNRS, IBPS, Lab Biol Computat & Quantitat LCQB, 4 Pl Jussieu, Paris, France; [Carbone, Alessandra] Inst Univ France, Paris, France; [Ourimi, Asma] Modern Amer Sch, Amman, Jordan	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut Universitaire de France	Vaquero, C (corresponding author), Sorbonne Univ, CIMI Paris, Ctr Immunol & Malad Infect, CNRS,INSERM, Paris, France.	Catherine.vaquero@upmc.fr		Vaquero, Catherine/0000-0001-9224-822X; Carbone, Alessandra/0000-0003-2098-5743; PIONNEAU, Cedric/0000-0001-6270-7421	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Only INSERM funding allowed the project.	[Anonymous], 1989, Eur J Biochem, V186, P1; Antwi-Baffour S, 2017, PROTEOME SCI, V15, DOI 10.1186/s12953-017-0113-5; Bernardes J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1887-8; Bernardes J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005038; Bischoff E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-34; Boschet C, 2004, MOL BIOCHEM PARASIT, V138, P159, DOI 10.1016/j.molbiopara.2004.07.011; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Breci L, 2005, PROTEOMICS, V5, P2018, DOI 10.1002/pmic.200401103; Cruz AK, 2009, CURRENT DRUG TARGETS; Dahlberg JE, 2003, RNA, V9, P1, DOI 10.1261/rna.2121703; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Foth BJ, MOL CELL PROTEOMICS; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; Gissot M, 2005, J MOL BIOL, V346, P29, DOI 10.1016/j.jmb.2004.11.045; Jackson KE, 2011, TRENDS PARASITOL, V27, P467, DOI 10.1016/j.pt.2011.05.005; Khosh-Naucke M, INT J MED MICROBIOL; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; MCCUTCHAN TF, 1995, PARASITOL TODAY, V11, P134, DOI 10.1016/0169-4758(95)80132-4; Oehring SC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r108; Osta M, 2002, MOL BIOCHEM PARASIT, V121, P87, DOI 10.1016/S0166-6851(02)00029-4; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Sims PFG, 2006, EXPERT REV PROTEOMIC, V3, P87, DOI 10.1586/14789450.3.1.87; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; Trinkle-Mulcahy L, 2007, SCIENCE, V318, P1402, DOI 10.1126/science.1142033; Vembar SS, 2016, WIRES RNA, V7, P772, DOI 10.1002/wrna.1365; Wang N, 2008, ANAL CHEM, V80, P4696, DOI 10.1021/ac800260w; Xia D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r116; Yoshihama M, 2002, GENOME RES, V12, P379, DOI 10.1101/gr.214202; Yusupova G, 2014, ANNU REV BIOCHEM, V83, P467, DOI 10.1146/annurev-biochem-060713-035445; Zhang ZQ, 2012, J AM SOC MASS SPECTR, V23, P1400, DOI 10.1007/s13361-012-0401-3	34	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205596	10.1371/journal.pone.0205596	http://dx.doi.org/10.1371/journal.pone.0205596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379851	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700057
J	Schreur, V; Altay, L; Van Aster, F; Groenewoud, JMM; Fauser, S; Klevering, BJ; Hoyng, CB; de Jong, EK				Schreur, Vivian; Altay, Lebriz; Van Aster, Freekje; Groenewoud, Joannes M. M.; Fauser, Sascha; Klevering, B. Jeroen; Hoyng, Carel B.; de Jong, Eiko K.			Hyperreflective foci on optical coherence tomography associate with treatment outcome for anti-VEGF in patients with diabetic macular edema	PLOS ONE			English	Article							VISUAL-ACUITY; RANIBIZUMAB; BEVACIZUMAB; AFLIBERCEPT; RETINA; RETINOPATHY; PATTERNS; DOTS	Purpose To investigate the relationship between baseline number of hyperreflective foci (HF) on spectral domain optical coherence tomography (SD-OCT) in patients with diabetic macular edema (DME), as well as the dynamics of HF during treatment with anti-vascular endothelial growth factor (VEGF), and treatment response. Methods We evaluated patients diagnosed with DME scheduled for treatment with intravitreal bevacizumab. Eyes were classified as adequate or insufficient treatment responders based on log-MAR visual acuity improvement and central retinal thickness (CRT) decrease after three consecutive injections. Associations between number of HF at baseline and treatment response, the change in HF over the course of treatment, and the distribution of HF within the retinal layers were evaluated. Results In 54 eyes of 41 patients, mean number of HF and CRT decreased after intravitreal treatment with bevacizumab (p = 0.002 and p<0.001 respectively). Decrease in CRT after 3 months was independently associated with a higher number of HF at baseline (estimated effect -2.61, 95% CI [-4.42--0.31], p = 0.006). Eyes with adequate treatment response presented with more HF at baseline (OR 1.106, 95% CI [1.012-1.210], p = 0.030) than eyes with insufficient treatment response. Most HF were located within the inner retinal layers, and decrease of HF was mostly due to a decrease of inner retinal HF. Conclusions In patients with DME treated with anti-VEGF, higher baseline numbers of HF have predictive value for treatment response in terms of visual acuity improvement and CRT decrease after 3 months. In addition, HF were responsive to anti-VEGF therapy.	[Schreur, Vivian; Van Aster, Freekje; Klevering, B. Jeroen; Hoyng, Carel B.; de Jong, Eiko K.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Ophthalmol, Med Ctr, Nijmegen, Netherlands; [Altay, Lebriz; Fauser, Sascha] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany; [Groenewoud, Joannes M. M.] Radboud Univ Nijmegen, Dept Hlth Evidence, Med Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; University of Cologne; Radboud University Nijmegen	de Jong, EK (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Ophthalmol, Med Ctr, Nijmegen, Netherlands.	Eiko.de.long@radboudumc.nl	Groenewoud, Hans JMM/R-3588-2017	Groenewoud, Hans JMM/0000-0002-4974-150X	Deutsche Forschungsgemeinschaft (DFG) [FOR2240]; Stichting Blindenhulp	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Stichting Blindenhulp	This work was supported by Deutsche Forschungsgemeinschaft (DFG), FOR2240, http://www.dfg.de/en/index.jsp; Stichting Blindenhulp, http://www.blindenhulp.nl/.Both funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Bolz M, 2009, OPHTHALMOLOGY, V116, P914, DOI 10.1016/j.ophtha.2008.12.039; Bressler SB, 2012, ARCH OPHTHALMOL-CHIC, V130, P1153, DOI 10.1001/archophthalmol.2012.1107; Byeon SH, 2012, RETINA-J RET VIT DIS, V32, P1087, DOI 10.1097/IAE.0b013e3182349686; Coscas G, 2013, OPHTHALMOLOGICA, V229, P32, DOI 10.1159/000342159; Cunha-Vaz J, 2014, OPHTHALMOLOGY, V121, P1892, DOI 10.1016/j.ophtha.2014.04.019; Davoudi S, 2016, RETINA-J RET VIT DIS, V36, P1622, DOI 10.1097/IAE.0000000000001022; De Benedetto U, 2015, RETINA-J RET VIT DIS, V35, P449, DOI 10.1097/IAE.0000000000000336; Domalpally A, 2015, OPHTHALMOLOGY, V122, P779, DOI 10.1016/j.ophtha.2014.10.028; Forstreuter F, 2002, J NEUROIMMUNOL, V132, P93, DOI 10.1016/S0165-5728(02)00315-6; Framme C, 2012, INVEST OPHTH VIS SCI, V53, P5814, DOI 10.1167/iovs.12-9950; Framme C, 2010, INVEST OPHTH VIS SCI, V51, P5965, DOI 10.1167/iovs.10-5779; Gonzalez VH, 2016, AM J OPHTHALMOL, V172, P72, DOI 10.1016/j.ajo.2016.09.012; Heier JS, 2016, JAMA OPHTHALMOL, V134, P95, DOI 10.1001/jamaophthalmol.2015.4110; Holekamp NM, 2018, AM J OPHTHALMOL, V191, P83, DOI 10.1016/j.ajo.2018.04.010; Hwang HS, 2017, INVEST OPHTH VIS SCI, V58, P5958, DOI 10.1167/iovs.17-22725; Kang JW, 2016, RETINA-J RET VIT DIS, V36, P1630, DOI 10.1097/IAE.0000000000000995; Maggio E, 2018, AM J OPHTHALMOL; Murakami T, 2015, JPN J OPHTHALMOL, V59, P236, DOI 10.1007/s10384-015-0382-4; Ota M, 2010, OPHTHALMOLOGY, V117, P1996, DOI 10.1016/j.ophtha.2010.06.019; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Ross EL, 2016, JAMA OPHTHALMOL, V134, P888, DOI 10.1001/jamaophthalmol.2016.1669; Scanlon PH, 2008, J MED SCREEN, V15, P1, DOI 10.1258/jms.2008.008015; Uji A, 2012, AM J OPHTHALMOL, V153, P710, DOI 10.1016/j.ajo.2011.08.041; Vujosevic S, 2016, ACTA OPHTHALMOL; Vujosevic S, 2016, RETINA-J RET VIT DIS, V36, P1298, DOI 10.1097/IAE.0000000000000912; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Zeng HY, 2008, ARCH OPHTHALMOL-CHIC, V126, P227, DOI 10.1001/archophthalmol.2007.65	29	43	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206482	10.1371/journal.pone.0206482	http://dx.doi.org/10.1371/journal.pone.0206482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379920	Green Submitted, gold, Green Published			2022-12-26	WOS:000448823700122
J	Rusilowicz, MJ; Dickinson, M; Charlton, AJ; O'Keefe, S; Wilson, J				Rusilowicz, Martin J.; Dickinson, Michael; Charlton, Adrian J.; O'Keefe, Simon; Wilson, Julie			MetaboClust: Using interactive time-series cluster analysis to relate metabolomic data with perturbed pathways	PLOS ONE			English	Article							MASS-SPECTROMETRY DATA; ARABIDOPSIS; SYSTEMS; CELLS	Motivation Modern analytical techniques such as LC-MS, GC-MS and NMR are increasingly being used to study the underlying dynamics of biological systems by tracking changes in metabolite levels over time. Such techniques are capable of providing information on large numbers of metabolites simultaneously, a feature that is exploited in non-targeted studies. However, since the dynamics of specific metabolites are unlikely to be known a priori this presents an initial subjective challenge as to where the focus of the investigation should be. Whilst a number of feed-forward software tools are available for manipulation of metabolomic data, no tool centralizes on clustering and focus is typically directed by a workflow that is chosen in advance. Results We present an interactive approach to time-course analyses and a complementary implementation in a software package, MetaboClust. This is presented through the analysis of two LC-MS time-course case studies on plants (Medicago truncatula and Alopecurus myosuroides). We demonstrate a dynamic, user-centric workflow to clustering with intrinsic visual feedback at all stages of analysis. The software is used to apply data correction, generate the time-profiles, perform exploratory statistical analysis and assign tentative metabolite identifications. Clustering is used to group metabolites in an unbiased manner, allowing pathway analysis to score metabolic pathways, based on their overlap with clusters showing interesting trends.	[Rusilowicz, Martin J.; O'Keefe, Simon] Univ York, Dept Comp Sci, York, N Yorkshire, England; [Rusilowicz, Martin J.; O'Keefe, Simon] Univ York, York Ctr Complex Syst Anal, York, N Yorkshire, England; [Dickinson, Michael; Charlton, Adrian J.] Fera Sci Ltd, York, N Yorkshire, England; [Wilson, Julie] Univ York, Dept Math, York, N Yorkshire, England; [Wilson, Julie] Univ York, Dept Chem, York, N Yorkshire, England; [Rusilowicz, Martin J.] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England	University of York - UK; University of York - UK; Food & Environment Research Agency; University of York - UK; University of York - UK; University of Manchester	Rusilowicz, MJ (corresponding author), Univ York, Dept Comp Sci, York, N Yorkshire, England.; Rusilowicz, MJ (corresponding author), Univ York, York Ctr Complex Syst Anal, York, N Yorkshire, England.; Rusilowicz, MJ (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England.	martin.rusilowicz@manchester.ac.uk		O'Keefe, Simon/0000-0001-5957-2474	Department of Environment, Food and Rural Affairs (Defra), UK; European Union's Seventh Framework Programme for research, technological development and demonstration [FP7-KBBE-2011-5 -289562 ABSTRESS]; EPSRC [EP/F001096/1]	Department of Environment, Food and Rural Affairs (Defra), UK(Department for Environment, Food & Rural Affairs (DEFRA)); European Union's Seventh Framework Programme for research, technological development and demonstration; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Department of Environment, Food and Rural Affairs (Defra), UK and the European Union's Seventh Framework Programme for research, technological development and demonstration [grant agreement FP7-KBBE-2011-5 -289562 ABSTRESS]. MJR was supported by the EPSRC [grant number EP/F001096/1. AJC and MD are employed by Fera Science Ltd, where data collection was performed. Funders provided support in the form of salaries and financial support for data collection, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Ang JE, 2012, CHRONOBIOL INT, V29, P868, DOI 10.3109/07420528.2012.699122; Angelini C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-415; Arthur D, SOC IND APPL MATH, P1027; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Bonferroni C. E., 1936, TEORIA STAT CLASSI C; Chauvel B, 2001, CROP PROT, V20, P127, DOI 10.1016/S0261-2194(00)00065-X; Clouse S, 2001, CURR BIOL, V11, pR904, DOI 10.1016/S0960-9822(01)00549-8; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Cooke EJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-399; Cummins I., 2010, OUTLOOKS PEST MANAG, V21, P73; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; De Livera AM, 2015, ANAL CHEM, V87, P3606, DOI 10.1021/ac502439y; Fukushima A, 2014, PLANT PHYSIOL, V165, P948, DOI 10.1104/pp.114.240986; Glunde K, 2002, MAGNET RESON MED, V48, P819, DOI 10.1002/mrm.10295; Hofherr SE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017076, 10.1371/journal.pone.0023376]; Jacob L, 2015, BIOSTATISTICS, V28; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kamleh MA, 2012, ANAL CHEM, V84, P2670, DOI 10.1021/ac202733q; Kim JK, 2007, J EXP BOT, V58, P415, DOI 10.1093/jxb/erl216; Kind T., 2010, MASS SPECTROMETRY AD; Kol S, 2010, APPL ENVIRON MICROB, V76, P2574, DOI 10.1128/AEM.01992-09; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Matsuda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007490; Nakabayashi R, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29518; Ni Y, 2007, FEBS LETT, V581, P707, DOI 10.1016/j.febslet.2007.01.036; Nueda MJ, 2007, BIOINFORMATICS, V23, P1792, DOI 10.1093/bioinformatics/btm251; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rusilowicz M, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0972-2; Sato S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-51; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Stein CK, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0478-3; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Tran NQ, 2017, TURKIYE KLIN J BIOST, V9, P35, DOI [10.1073/pnas.0504609102, DOI 10.1073/PNAS.0504609102]; Tzin V, 2015, PLANT PHYSIOL, V169; Urbanczyk-Wochniak E, 2007, BIOINFORMATICS, V23, P1418, DOI 10.1093/bioinformatics/btm040; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Wehrens R, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1015-8; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Yurkovich JT, 2017, J BIOL CHEM, V292, P19556, DOI 10.1074/jbc.M117.804914; Zhang JW, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2412-y; Zweifel P.F., 1989, PHYS TODAY, V42, P72, DOI [10.1063/1.2811091, DOI 10.1063/1.2811091]	50	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0205968	10.1371/journal.pone.0205968	http://dx.doi.org/10.1371/journal.pone.0205968			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372459	gold, Green Accepted, Green Published			2022-12-26	WOS:000448641200019
J	Wang, MY; Alves, J; Tucker, M; Yang, WK; Ruckstuhl, KE				Wang, Muyang; Alves, Joana; Tucker, Meghan; Yang, Weikang; Ruckstuhl, Kathreen E.			Effects of intrinsic and extrinsic factors on ruminating, grazing, and bedding time in bighorn sheep (Ovis canadensis)	PLOS ONE			English	Article							SEXUAL SEGREGATION; BODY-SIZE; FORAGING TIME; VIGILANCE; BEHAVIOR; AGE; RAMS	Rumination is the repeated process of regurgitation of a food bolus, followed by chewing, swallowing, and regurgitation, which enhance nutrient assimilation. Time spent in lateral recumbency (i.e., bedded, lying) has often been used as a proxy for time spent ruminating due to difficulties of observing detailed rumination behavior in the field. The actual proportion of time spent ruminating, or other activities, will in turn be affected by the age and sex of an individual but also with changes in food quality. We studied the effects of intrinsic and extrinsic factors on time spent ruminating, bedding, proportion of bedding time spent ruminating, and grazing of individually marked bighorn sheep (Ovis canadensis). Our results show that bighorn sheep spent more time ruminating and less time grazing in summer and autumn. Overall, females spent less time ruminating, and more time grazing than males. Bighorn sheep decreased their time spent ruminating with increasing acid detergent fiber (ADF) content in the forage. Age influenced the time spent grazing, bedded and proportion of bedded time spent ruminating. Older sheep not only increased their bedding time but also their time spent bedded without ruminating compared to younger individuals. The proportion of time spent grazing was also affected by age, with a decrease in the proportion of time spent grazing with increasing age. Our results suggest that these four behaviors are plastic and variable. We thus conclude that bedding time does not reflect time spent ruminating but that the latter is affected by both intrinsic and extrinsic factors.	[Wang, Muyang; Yang, Weikang] Xinjiang Inst Ecol & Geog, CAS Key Lab Biogeog & Bioresources Arid Land, Urumqi, Peoples R China; [Alves, Joana] Univ Coimbra, Dept Life Sci, CFE, Coimbra, Portugal; [Tucker, Meghan; Ruckstuhl, Kathreen E.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Universidade de Coimbra; University of Calgary	Wang, MY (corresponding author), Xinjiang Inst Ecol & Geog, CAS Key Lab Biogeog & Bioresources Arid Land, Urumqi, Peoples R China.	xiacj@ms.xjb.ac.cn	Alves, Joana/A-1605-2015; Alves, Joana/GXF-4738-2022	Alves, Joana/0000-0003-2858-7803; Wang, Muyang/0000-0002-5593-632X; Ruckstuhl, Kathreen/0000-0002-2949-242X	Natural Sciences and Engineering Research Council of Canada [316189-201-2RGPIN]; Portuguese Foundation for Science and Technology [SFRH/BPD/123087/2016]; National Natural Science Foundation of China [31661143019]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors would like to thank the Natural Sciences and Engineering Research Council of Canada (Discovery Grant 316189-201-2RGPIN to KER), the Portuguese Foundation for Science and Technology (SFRH/BPD/123087/2016 to JA), and the National Natural Science Foundation of China (31661143019) for their support in making this collaboration possible.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; BAE DH, 1979, J ANIM SCI, V49, P1292, DOI 10.2527/jas1979.4951292x; Beauchamp G, 2001, BEHAV ECOL SOCIOBIOL, V51, P47, DOI 10.1007/s002650100413; Blanchard P, 2005, J ZOOL, V265, P107, DOI 10.1017/S0952836904006077; BOWYER RT, 1984, J MAMMAL, V65, P410, DOI 10.2307/1381087; Brown NA, 2010, AGR ECOSYST ENVIRON, V135, P226, DOI 10.1016/j.agee.2009.10.001; Devendra C, 1995, LIVEST PROD SCI, V43, P179; du Toit JT, 2005, OECOLOGIA, V143, P317, DOI 10.1007/s00442-004-1789-7; Festa-Bianchet M, 2007, ECOSCIENCE, V14, P318, DOI 10.2980/1195-6860(2007)14[318:AREIBS]2.0.CO;2; FESTABIANCHET M, 1988, OECOLOGIA, V75, P580, DOI 10.1007/BF00776423; Geist V., 1968, Zeitschrift fuer Tierpsychologie, V25, P199; Geist V., 1971, MOUNTAIN SHEEP STUDY; GROSS JE, 1995, J ARID ENVIRON, V30, P423, DOI 10.1006/jare.1995.0037; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; ILLIUS AW, 1987, J ANIM ECOL, V56, P989, DOI 10.2307/4961; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Li ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066261; Loudon A, 1984, S ZOOL SOC LONDON, P33; McDougall PL, 2018, ANIM BEHAV, V135, P177, DOI 10.1016/j.anbehav.2017.11.009; Meldrum GE, 2009, ANIM BEHAV, V77, P919, DOI 10.1016/j.anbehav.2008.12.023; Mooring MS, 2004, J WILDLIFE MANAGE, V68, P519, DOI 10.2193/0022-541X(2004)068[0519:VPRATA]2.0.CO;2; Moquin P, 2010, ANIM BEHAV, V79, P1047, DOI 10.1016/j.anbehav.2010.01.020; Mysterud A, 1998, OECOLOGIA, V113, P442, DOI 10.1007/s004420050396; Pan J, 2003, ANIM FEED SCI TECH, V106, P69, DOI 10.1016/S0377-8401(03)00039-7; Pelletier F, 2005, BEHAV ECOL, V16, P280, DOI 10.1093/beheco/arh162; Pelletier F, 2004, BEHAV ECOL SOCIOBIOL, V56, P546, DOI 10.1007/s00265-004-0820-7; PENNING PD, 1993, APPL ANIM BEHAV SCI, V37, P101, DOI 10.1016/0168-1591(93)90103-V; Perez-Barberia FJ, 2004, P ROY SOC B-BIOL SCI, V271, P1081, DOI 10.1098/rspb.2004.2714; Perez-Barberia FJ, 1998, BIOL J LINN SOC, V63, P233, DOI 10.1111/j.1095-8312.1998.tb01516.x; Ruckstuhl KE, 1999, BEHAVIOUR, V136, P805, DOI 10.1163/156853999501577; Ruckstuhl KE, 1998, ANIM BEHAV, V56, P99, DOI 10.1006/anbe.1998.0745; Ruckstuhl KE, 2000, BEHAVIOUR, V137, P361, DOI 10.1163/156853900502123; Ruckstuhl KE, 2003, BEHAV ECOL SOCIOBIOL, V54, P167, DOI 10.1007/s00265-003-0615-2; Ruckstuhl KE, 2006, SEXUAL SEGREGATION V, P245; Sayre R.W, 1994, P 9 BIENN S NO WILD, V9, P104; Treves A, 2000, ANIM BEHAV, V60, P711, DOI 10.1006/anbe.2000.1528; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Xia CJ, 2014, BEHAV PROCESS, V103, P5, DOI 10.1016/j.beproc.2013.10.009; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	40	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206664	10.1371/journal.pone.0206664	http://dx.doi.org/10.1371/journal.pone.0206664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372495	Green Published, Green Submitted, gold			2022-12-26	WOS:000448641200054
J	Avery, M; Nassil, J; Reynolds, J				Avery, Michael; Nassil, Jonathan; Reynolds, John			Inferring neural circuit properties from optogenetic stimulation	PLOS ONE			English	Article							NMDA RECEPTORS; VISUAL-CORTEX; GAIN-CONTROL; MACAQUE V1; AREA V4; ATTENTION; NEURONS; NORMALIZATION; INHIBITION; MODULATION	Optogenetics has become an important tool for perturbing neural circuitry with unparalleled temporal precision and cell-type specificity. However, direct activation of a specific subpopulation of neurons can rapidly modulate the activity of other neurons within the network and may lead to unexpected and complex downstream effects. Here, we have developed a biologically-constrained computational model that exploits these non-intuitive network responses in order to gain insight into underlying properties of the network. We apply this model to data recorded during optogenetic stimulation in the primary visual cortex of the alert macaque. In these experiments, we found that optogenetic depolarization of excitatory neurons often suppressed neuronal responses, consistent with engagement of normalization circuitry. Our model suggests that the suppression seen in these responses may be mediated by slow excitatory and inhibitory conductance channels. Furthermore, the model predicted that the response of the network to optogenetic perturbation depends critically on the relationship between inherent temporal properties of the network and the temporal properties of the opsin. Consistent with model predictions, stimulation of the C1V1(TT) opsin, an opsin with a fast time constant (tau = 45 ms), caused faster and stronger suppressive effects after laser offset, as compared to stimulation of the slower C1V1(T) opsin (tau = 60ms). This work illustrates how the non-intuitive network responses that result from optogenetic stimulation can be exploited to gain insight regarding network properties that underlie fundamental neuronal computations, such as normalization. This novel hybrid opto-theoretical approach can thus enhance the power of optogenetics to dissect complex neural circuits.	[Avery, Michael; Nassil, Jonathan; Reynolds, John] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Nassil, Jonathan] Inscopix, Palo Alto, CA USA	Salk Institute	Avery, M (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mikeavery@salk.edu			National Eye Institute [R01-EY021827, R21-EY020673, P30-EY-019005]; Gatsby Charitable Foundation; Salk Institute Excellerators Fellowship Program and NARSAD Young Investigator Grant; Brain and Behavior Research Foundation; Swartz Foundation; Inscopix	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Gatsby Charitable Foundation; Salk Institute Excellerators Fellowship Program and NARSAD Young Investigator Grant; Brain and Behavior Research Foundation; Swartz Foundation; Inscopix	This research was supported by grants from the National Eye Institute (R01-EY021827, R21-EY020673, P30-EY-019005), The Gatsby Charitable Foundation (to JR.), The Salk Institute Excellerators Fellowship Program and NARSAD Young Investigator Grant, Brain and Behavior Research Foundation (to JN.), and the Swartz Foundation (to MA.) The funder "Inscopix" provided support in the form of salaries for authors JN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Abilez OJ, 2011, BIOPHYS J, V101, P1326, DOI 10.1016/j.bpj.2011.08.004; Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Buchanan KA, 2012, NEURON, V75, P451, DOI 10.1016/j.neuron.2012.06.017; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Herrero JL, 2013, NEURON, V78, P729, DOI 10.1016/j.neuron.2013.03.029; Jazayeri M, 2016, NEURON, V90, P8, DOI 10.1016/j.neuron.2016.03.024; Jazayeri M, 2012, NAT NEUROSCI, V15, P1368, DOI 10.1038/nn.3210; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Mann EO, 2009, J NEUROSCI, V29, P7513, DOI 10.1523/JNEUROSCI.6162-08.2009; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Nassi JJ, 2015, NEURON, V86, P1504, DOI 10.1016/j.neuron.2015.05.040; Nassi JJ, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00105; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Palmer LM, 2012, SCIENCE, V335, P989, DOI 10.1126/science.1217276; Pinto L, 2013, NAT NEUROSCI, V16, P1857, DOI 10.1038/nn.3552; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Sato TK, 2014, NAT NEUROSCI, V17, P30, DOI 10.1038/nn.3585; Self MW, 2012, P NATL ACAD SCI USA, V109, P11031, DOI 10.1073/pnas.1119527109; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stange A, 2013, NAT NEUROSCI, V16, P1840, DOI 10.1038/nn.3548; Sundberg KA, 2012, J NEUROSCI, V32, P16040, DOI 10.1523/JNEUROSCI.0489-12.2012; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Urban-Ciecko J, 2016, NAT REV NEUROSCI, V17, P401, DOI 10.1038/nrn.2016.53; Urban-Ciecko J, 2015, CURR BIOL, V25, P722, DOI 10.1016/j.cub.2015.01.035; Zhu YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7802	34	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0205386	10.1371/journal.pone.0205386	http://dx.doi.org/10.1371/journal.pone.0205386			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365490	Green Published, gold, Green Submitted			2022-12-26	WOS:000448448700009
J	Choi, JS; Lee, SH; Leem, AY; Song, JH; Kim, SY; Chung, KS; Jung, JY; Kang, YA; Kim, YS; Chang, J; Park, MS				Choi, Ji Soo; Lee, Sang Hoon; Leem, Ah Young; Song, Joo Han; Kim, Song Yee; Chung, Kyung Soo; Jung, Ji Ye; Kang, Young Ae; Kim, Young Sam; Chang, Joon; Park, Moo Suk			Pneumocystis jirovecii pneumonia (PCP) PCR-negative conversion predicts prognosis of HIV-negative patients with PCP and acute respiratory failure	PLOS ONE			English	Article							CHAIN-REACTION ASSAY; CARINII-PNEUMONIA; IMMUNOCOMPROMISED PATIENTS; UNITED-STATES; INFECTION; DIAGNOSIS; AIDS; FEATURES; OUTCOMES	Background Pneumocystis jirovecii pneumonia (PCP) is often fatal in human immunodeficiency (HIV)-negative patients and typically presents with respiratory insufficiency. Predicting treatment failure is challenging. This study aimed to identify prognostic factors and examine PCP polymerase chain reaction (PCR)-negative conversion in non-HIV PCP patients with respiratory failure. Method We retrospectively enrolled 81 non-HIV patients diagnosed with and treated for PCP with respiratory failure in the intensive care unit at a tertiary hospital over a 3-year period. PCP was diagnosed via nested PCR-mediated detection of Pneumocystis jirovecii in induced sputum samples, endotracheal aspirates, and bronchoalveolar lavage fluids. PCP PCR was performed weekly to check for negative conversion. Results The overall survival rate was 35.8%. Seventy-four patients (91.3%) required mechanical ventilation, and 6 (7.4%) required high-flow nasal oxygen treatment. The PCP PCR-negative conversion rate was 70.5% (survivors, 97%; non-survivors, 63.5%); the median time to conversion was 10 (7.0-14.0) days. On univariate analysis, the APACHE II score (p < 0.001), renal failure requiring renal replacement therapy (p = 0.04), PCP PCR-negative conversion (p = 0.003), and the PaO2/FiO(2) ratio (first 24 hours) (p< 0.001) significantly correlated with mortality. On multivariate analysis, PCP PCR-negative conversion (hazard ratio, 0.433; 95% confidence interval, 0.203-0.928; p = 0.031) and the PaO2/FiO(2) ratio (first 24 hours) (hazard ratio, 0.988; 95% confidence interval, 0.983-0.993; p < 0.001) independently predicted prognosis. Conclusions Determination of PCP PCR-negative conversion and PaO2/FiO(2) ratios may help physicians predict treatment failure and mortality in non-HIV PCP patients with respiratory failure.	[Choi, Ji Soo; Lee, Sang Hoon; Leem, Ah Young; Song, Joo Han; Kim, Song Yee; Chung, Kyung Soo; Jung, Ji Ye; Kang, Young Ae; Kim, Young Sam; Chang, Joon; Park, Moo Suk] Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med,Div Pulmonol, Seoul, South Korea	Yonsei University; Yonsei University Health System	Park, MS (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med,Div Pulmonol, Seoul, South Korea.	pms70@yuhs.ac	Jung, Ji Ye/AAB-4993-2021	Kim, Song Yee/0000-0001-8627-486X; Lee, Sang Hoon/0000-0002-7706-5318; Kang, Young Ae/0000-0002-7783-5271; Leem, Ah Young/0000-0001-5165-3704; Jung, Ji Ye/0000-0003-1589-4142; Park, Moo Suk/0000-0003-0820-7615; Choi, Ji Soo/0000-0003-2716-6775; Kim, Young Sam/0000-0001-9656-8482; Chang, Joon/0000-0003-4542-6841; Chung, Kyung Soo/0000-0003-1604-8730				Boonsarngsuk V, 2009, INT J INFECT DIS, V13, P59, DOI 10.1016/j.ijid.2008.03.027; Chen MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139144; Church DL, 2015, CAN J INFECT DIS MED, V26, P263, DOI 10.1155/2015/138787; Curtis JR, 2000, AM J RESP CRIT CARE, V162, P393, DOI 10.1164/ajrccm.162.2.9909014; Enomoto T, 2010, RESPIROLOGY, V15, P126, DOI 10.1111/j.1440-1843.2009.01660.x; Festic E, 2005, CHEST, V128, P573, DOI 10.1378/chest.128.2.573; GERRARD JG, 1995, MED J AUSTRALIA, V162, P233, DOI 10.5694/j.1326-5377.1995.tb139873.x; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Kelley CF, 2009, CHEST, V136, P190, DOI 10.1378/chest.08-2859; Kim SJ, 2014, J INFECTION, V69, P88, DOI 10.1016/j.jinf.2014.02.015; Ko Y, 2014, J CRIT CARE, V29, P356, DOI 10.1016/j.jcrc.2013.12.005; Liu Y, 2017, ONCOTARGET, V8, P59729, DOI 10.18632/oncotarget.19927; Maschmeyer G, 2016, J ANTIMICROB CHEMOTH, V71, P2405, DOI 10.1093/jac/dkw158; Monnet X, 2008, CRIT CARE, V12, DOI 10.1186/cc6806; Morris A, 2012, CLIN MICROBIOL REV, V25, P297, DOI 10.1128/CMR.00013-12; Mu XD, 2011, CHINESE MED J-PEKING, V124, P2683, DOI 10.3760/cma.j.issn.0366-6999.2011.17.021; Riebold D, 2014, TROP MED INT HEALTH, V19, P643, DOI 10.1111/tmi.12299; Robert-Gangneux F, 2014, J CLIN MICROBIOL, V52, P3370, DOI 10.1128/JCM.01480-14; Roblot F, 2002, EUR J CLIN MICROBIOL, V21, P523, DOI 10.1007/s10096-002-0758-5; Roembke F, 2014, CLIN RESPIR J, V8, P86, DOI 10.1111/crj.12042; Roux A, 2014, EMERG INFECT DIS, V20, P1490, DOI 10.3201/eid2009.131668; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; VARTHALITIS I, 1993, CANCER, V71, P481, DOI 10.1002/1097-0142(19930115)71:2&lt;481::AID-CNCR2820710232&gt;3.0.CO;2-S; Vogel MN, 2012, EUR J RADIOL, V81, P1315, DOI 10.1016/j.ejrad.2011.02.052	24	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206231	10.1371/journal.pone.0206231	http://dx.doi.org/10.1371/journal.pone.0206231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359436	Green Published, Green Submitted, gold			2022-12-26	WOS:000448438400055
J	Almeida, F; Bonitch-Gongora, J; Padial, P; de la Fuente, B; Morales-Artacho, AJ; Feriche, B				Almeida, Filipa; Bonitch-Gongora, Juan; Padial, Paulino; de la Fuente, Blanca; Morales-Artacho, Antonio J.; Feriche, Belen			Effect of acute exposure to moderate altitude on kinematic variables of the ippon-seoi-nage and its relationship with the countermovement jump in elite judokas	PLOS ONE			English	Article							PERFORMANCE; EXERCISE; INTENSITY; VELOCITY; HYPOXIA	This study aimed to assess the effect of acute exposure to moderate altitude on kinematic variables of the ippon-seoi-nage and on the mechanical outputs of the countermovement jump (CMJ). Thirteen elite male judokas from the Spanish Judo Training Centre in Valencia (age: 21.54 +/- 2.15 years) participated in the study. All of them performed an incremental CMJ test and an ippon-seoi-nage technique test before (N) and after the ascent to a moderate altitude of 2320 m above the sea level (H). A linear velocity transducer was attached to the bar to assess the mechanical outputs of each loaded CMJ at different percentages of their own body weight (25, 50, 75 and 100%). A wearable sensor was used to assess the kinematic variables (times, accelerations and angular velocities) transferred to a dummy during the technique test. The kinematic variables showed great individual reliability (CV = 8.46% in N; CV = 8.37% in H), which contrasted with low reliability observed when the whole group was considered. The smallest important CV ratio (>1.15) showed that H caused changes in the reliability of the kinematic variables, with some variables becoming more reliable and others losing the reliability they had in N. H also caused small increments in peak velocity across all loads tested in the CMJ (+3.67%; P<0.05). In contrast, no changes in the kinematic variables were verified. In addition, there was no association between leg extension capability and the acceleration (r= -0.16 +/- 0.19 in N; r= -0.24 +/- 0.19 in H) or angular velocity (r= -0.19 +/- 0.24 in N; r= -0.30 +/- 0.26 in H) of the ippon-seoi-nage, nor was acute exposure to H found to affect this association (P>0.05). Differences between individual and within-groups CV confirm the individual adaptations that each judoka makes during this technique. Additionally, the CV ratio shows a change in the space-time pattern of the technique in H. Therefore, it would be necessary to include an adaptation period to adapt the technique after the ascent in altitude. Further studies are needed to confirm the relationship and transference from the velocity gains in CMJ during altitude training.	[Almeida, Filipa; Bonitch-Gongora, Juan; Padial, Paulino; Morales-Artacho, Antonio J.; Feriche, Belen] Univ Granada, Dept Phys Educ & Sport, Granada, Spain; [de la Fuente, Blanca] Spanish Sport Council, High Performance Ctr Sierra Nevada, Granada, Spain	University of Granada	Feriche, B (corresponding author), Univ Granada, Dept Phys Educ & Sport, Granada, Spain.	mbelen@ugr.es	Bonitch-Góngora, Juan/AAG-5406-2020; Bonitch-Góngora, Juan/P-8233-2019; De la Fuente Caynzos, Blanca/ABF-9921-2021; Almeida, Filipa/P-8230-2019; Feriche, Belén/K-2783-2012	Bonitch-Góngora, Juan/0000-0003-0083-0138; Almeida, Filipa/0000-0003-1881-4566; Feriche, Belén/0000-0002-3933-6041	Spanish Ministry of Economy and Competitiveness (MINECO/FEDER) [DEP2015-64350-P]; FPI [BES-2016-078035]	Spanish Ministry of Economy and Competitiveness (MINECO/FEDER); FPI(Spanish Government)	This study was funded by the Spanish Ministry of Economy and Competitiveness (DEP2015-64350-P MINECO/FEDER), (http://www.mineco.gob.es/portal/site/mineco/menuitem.aa5c961c0709f0fe3e85b782026041a0/?vgnextoid=7c9f2f207c415310VgnVCM1000001d04140aRCRD) and by a FPI pre-doctoral grant (BES-2016-078035) awarded to one of the authors (FA), (http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.dbc68b34d11ccbd5d52ffeb801432ea0/?vgnextoid=62b349aaa8dc4510VgnVCM1000001d04140aRCRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 21 ANN C EUR COLL SP; [Anonymous], 2006, ARCH MED DEPORT; Aruga S, 2003, TOKAI J SPORTS MED S, V15, P7; BALSOM PD, 1994, ACTA PHYSIOL SCAND, V152, P279, DOI 10.1111/j.1748-1716.1994.tb09807.x; Billaut F, 2012, SPORTS MED, V42, P751, DOI 10.2165/11634050-000000000-00000; Blais L, 2004, SCI MOT, V1, P49; Blais L, 2007, J SPORT SCI, V25, P1211, DOI 10.1080/02640410600982204; Bonitch-Dominguez J, 2010, J SPORT SCI, V28, P1527, DOI 10.1080/02640414.2010.512641; Conceicao F, 2016, J SPORT SCI, V34, P1099, DOI 10.1080/02640414.2015.1090010; Daigo T., 2005, KODOKAN JUDO THROWIN; Delliaux S, 2006, MUSCLE NERVE, V34, P754, DOI 10.1002/mus.20633; Feriche B, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0078-z; Feriche B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114072; Fulton SK, 2009, J SPORT SCI, V27, P535, DOI 10.1080/02640410802641418; Garcia JMG, 2007, RICYDE-REV INT CIENC, V3, P11, DOI 10.5232/ricyde2007.009.02; Garcia-Ramos A, 2018, J STRENGTH COND RES, V32, P475, DOI 10.1519/JSC.0000000000001592; Haff GG, 2015, J STRENGTH COND RES, V29, P386, DOI 10.1519/JSC.0000000000000705; Hahn AG, 2001, SPORTS MED, V31, P533, DOI 10.2165/00007256-200131070-00008; Hamlin MJ, 2015, INT J SPORT PHYSIOL, V10, P881, DOI 10.1123/ijspp.2014-0261; Hollings SC, 2012, EUR J SPORT SCI, V12, P201, DOI 10.1080/17461391.2011.552640; Hopkins W.G., 2000, SPORTSCIENCE, P1; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Imamura RT, 2006, J SPORT SCI MED, V5, P122; Ishii T, 2018, SPORT BIOMECH, V17, P238, DOI 10.1080/14763141.2017.1284256; Levine BD, 2008, SCAND J MED SCI SPOR, V18, P76, DOI 10.1111/j.1600-0838.2008.00835.x; Loturco I, 2016, INT J SPORT PHYSIOL, V11, P697, DOI 10.1123/ijspp.2015-0316; Marcon G., 2010, J QUANTITATIVE ANAL, V6, P1; Melo Sebastião Iberes Lopes, 2013, Rev. bras. cineantropom. desempenho hum., V15, P578, DOI 10.5007/1980-0037.2013v15n5p578; Millet GP, 2012, J APPL PHYSIOL, V112, P1783, DOI 10.1152/japplphysiol.00067.2012; Morales-Artacho AJ, 2018, J STRENGTH COND RES, V32, P930, DOI 10.1519/JSC.0000000000001925; Scott BR, 2015, J STRENGTH COND RES, V29, P807, DOI 10.1519/JSC.0000000000000680	31	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206297	10.1371/journal.pone.0206297	http://dx.doi.org/10.1371/journal.pone.0206297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356263	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000089
J	Panahi, HA; Bolhassani, A; Javadi, G; Noormohammadi, Z				Panahi, Heidar Ali; Bolhassani, Azam; Javadi, Gholamreza; Noormohammadi, Zahra			A comprehensive in silico analysis for identification of therapeutic epitopes in HPV16, 18, 31 and 45 oncoproteins	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; HLA CLASS-I; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOTOXIC T-LYMPHOCYTES; PAN-SPECIFIC PREDICTION; VIRUS-LIKE PARTICLES; DOCK WEB SERVER; IMMUNE-RESPONSES; PEPTIDE BINDING; CELL EPITOPE	Human papillomaviruses (HPVs) are a group of circular double-stranded DNA viruses, showing severe tropism to mucosal tissues. A subset of HPVs, especially HPV16 and 18, are the primary etiological cause for several epithelial cell malignancies, causing about 5.2% of all cancers worldwide. Due to the high prevalence and mortality, HPV-associated cancers have remained as a significant health problem in human society, making an urgent need to develop an effective therapeutic vaccine against them. Achieving this goal is primarily dependent on the identification of efficient tumor-associated epitopes, inducing a robust cell-mediated immune response. Previous information has shown that E5, E6, and E7 early proteins are responsible for the induction and maintenance of HPV-associated cancers. Therefore, the prediction of major histocompatibility complex (MHC) class I T cell epitopes of HPV16, 18, 31 and 45 oncoproteins was targeted in this study. For this purpose, a two-step plan was designed to identify the most probable CD8+ T cell epitopes. In the first step, MHC-I and II binding, MHC-I processing, MHC-I population coverage and MHC-I immunogenicity prediction analyses, and in the second step, MHC-I and II protein-peptide docking, epitope conservation, and cross-reactivity with host antigens' analyses were carried out successively by different tools. Finally, we introduced five probable CD8+ T cell epitopes for each oncoprotein of the HPV genotypes (60 epitopes in total), which obtained better scores by an integrated approach. These predicted epitopes are valuable candidates for in vitro or in vivo therapeutic vaccine studies against the HPV-associated cancers. Additionally, this two-step plan that each step includes several analyses to find appropriate epitopes provides a rational basis for DNA- or peptide-based vaccine development.	[Panahi, Heidar Ali; Javadi, Gholamreza; Noormohammadi, Zahra] Islamic Azad Univ, Sch Basic Sci, Dept Biol, Sci & Res Branch, Tehran, Iran; [Bolhassani, Azam] Pasteur Inst Iran, Dept Hepatitis & AIDS, Tehran, Iran	Islamic Azad University; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Bolhassani, A (corresponding author), Pasteur Inst Iran, Dept Hepatitis & AIDS, Tehran, Iran.	azam.bolhassani@yahoo.com	Noormohammadi, Zahra/AAS-6661-2021; Bolhassani, Azam/HDN-7200-2022	Noormohammadi, Zahra/0000-0003-3890-9001; Bolhassani, Azam/0000-0001-7363-7406				Abbas AK, 2014, CELLULAR AND MOLECUL; Abu-Haraz A.H., 2017, ADV TECH BIOL MED, V5, P1764, DOI [10.4172/2379-1764.1000203, DOI 10.4172/2379-1764.1000203]; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Andreatta M, 2015, IMMUNOGENETICS, V67, P641, DOI 10.1007/s00251-015-0873-y; [Anonymous], 2018, IMM EP DAT AN RES IE; Ashrafi GH, 2006, INT J CANCER, V119, P2105, DOI 10.1002/ijc.22089; Bernard HU, 2010, VIROLOGY, P401; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Blaszczyk M, 2016, METHODS, V93, P72, DOI 10.1016/j.ymeth.2015.07.004; BMI (Biomedical Informatics)-Heidelberg, 2012, INFORMATION ON SYFPE; Bruni L, 2017, HUMAN PAPILLOMAVIRUS, P1; Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266; Cassetti MC, 2004, VACCINE, V22, P520, DOI 10.1016/j.vaccine.2003.07.003; Chandy AG, 2007, VACCINE, V25, P6037, DOI 10.1016/j.vaccine.2007.05.041; Cheng WF, 2002, J BIOMED SCI, V9, P675, DOI 10.1159/000067285; Da Silva DA, 2003, VACCINE, V21, P3219, DOI 10.1016/S0264-410X(03)00237-8; Mora-Garcia MD, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-55; de Sanjose S, 2017, BEST PRACTICE RES CL; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; DiMaio D, 2013, VIROLOGY, V445, P99, DOI 10.1016/j.virol.2013.05.006; Doorbar J, 2015, REV MED VIROL, V25, P2, DOI 10.1002/rmv.1822; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Eiben GL, 2002, CANCER RES, V62, P5792; Einstein MH, 2007, GYNECOL ONCOL, V106, P453, DOI 10.1016/j.ygyno.2007.04.038; FELTKAMP MCW, 1995, EUR J IMMUNOL, V25, P2638, DOI 10.1002/eji.1830250935; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Ferrara A, 2003, J CANCER RES CLIN ON, V129; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Gomez-Gutierrez JG, 2007, CANCER IMMUNOL IMMUN, V56, P997, DOI 10.1007/s00262-006-0247-2; Gonzalez SL, 2001, J VIROL, V75, P7583, DOI 10.1128/JVI.75.16.7583-7591.2001; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Guan P, 2012, INT J CANC, V131; Hara M, 2005, INT J ONCOL, V27, P1371; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Jurtz V, 2017, J IMMUNOL, V199, P3360, DOI 10.4049/jimmunol.1700893; Jurtz VI, BIORXIV 2017 149518; Karosiene E, 2012, IMMUNOGENETICS, V64, P177, DOI 10.1007/s00251-011-0579-8; KAST WM, 1994, J IMMUNOL, V152, P3904; Kather A, 2003, INT J CANCER, V104, P345, DOI 10.1002/ijc.10940; Kaufmann AM, 2007, INT J CANCER, V121, P2794, DOI 10.1002/ijc.23022; Kawana Kei, 2012, Open Virol J, V6, P264, DOI 10.2174/1874357901206010264; Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005; Kim SW, 2006, YONSEI MED J, V47, P1, DOI 10.3349/ymj.2006.47.1.1; Kim Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-394; Kumar A, 2015, BIOLOGICALS, V43, P344, DOI 10.1016/j.biologicals.2015.07.002; Kumar Sushil, 2015, Med J Armed Forces India, V71, P171, DOI 10.1016/j.mjafi.2015.02.006; Kurcinski M, 2015, NUCLEIC ACIDS RES, V43, pW419, DOI 10.1093/nar/gkv456; Lafuente EM, 2009, CURR PHARM DESIGN, V15, P3209, DOI 10.2174/138161209789105162; Li J, 2017, VACCINE; Lin CT, 2006, J BIOMED SCI, V13, P481, DOI 10.1007/s11373-006-9086-6; Lissabet JB, 2016, VACUNAS, V17, P18; Liu DW, 2007, J VIROL, V81, P2869, DOI 10.1128/JVI.02256-06; Liu DW, 2000, J VIROL, V74, P2888, DOI 10.1128/JVI.74.6.2888-2894.2000; Liu TY, 2012, CURR TOP MED CHEM, V12, P1581, DOI 10.2174/156802612802652402; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Manuri PR, 2007, VACCINE, V25, P3302, DOI 10.1016/j.vaccine.2007.01.010; Marchetti B, 2002, ONCOGENE, V21, P7808, DOI 10.1038/sj.onc.1205885; Martel C, 2012, LANCET ONCOLOGY, V13; Matijevic M, 2011, CELL IMMUNOL, V270, P62, DOI 10.1016/j.cellimm.2011.04.005; McBride AA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006211; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Melief CJM, 2015, J CLIN INVEST, V125, P3401, DOI 10.1172/JCI80009; Mizuuchi M, 2012, EXP MOL PATHOL, V92, P185, DOI 10.1016/j.yexmp.2011.10.002; Morishima S, 2007, INT J CANCER, V120, P594, DOI 10.1002/ijc.22312; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Nakagawa M, 2004, CLIN DIAGN LAB IMMUN, V11, P889, DOI 10.1128/CDLI.11.5.889-896.2004; Nakagawa M, 2007, J VIROL, V81, P1412, DOI 10.1128/JVI.01768-06; Nezafat N, 2014, J THEOR BIOL, V349, P121, DOI 10.1016/j.jtbi.2014.01.018; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; O'Brien PM, 2002, VIRUS RES, V88, P103, DOI 10.1016/S0168-1702(02)00123-5; Oerke S, 2005, INT J CANCER, V114, P766, DOI 10.1002/ijc.20794; Ossendorp F, 2013, SEMIN IMMUNOL; Paris R, 2012, VACCINE, V30, P832, DOI 10.1016/j.vaccine.2011.11.002; PARKER KC, 1994, J IMMUNOL, V152, P163; Peng S, 2008, GENE THER, V15, P1156, DOI 10.1038/gt.2008.53; Peng SW, 2007, CLIN CANCER RES, V13, P2479, DOI 10.1158/1078-0432.CCR-06-2916; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Quakkelaar ED, 2012, ADV IMMUNOL, V114, P77, DOI 10.1016/B978-0-12-396548-6.00004-4; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rasmussen M, 2016, J IMMUNOL, V197, P1517, DOI 10.4049/jimmunol.1600582; Reche PA, 2002, HUM IMMUNOL, V63, P701, DOI 10.1016/S0198-8859(02)00432-9; Reche Pedro A., 2007, V409, P185, DOI 10.1007/978-1-60327-118-9_13; Reinis M, 2010, INT J ONCOL, V36, P545, DOI 10.3892/ijo_00000528; RESSING ME, 1995, J IMMUNOL, V154, P5934; Ribeiro SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011072; Riemer AB, 2010, J BIOL CHEM, V285, P29608, DOI 10.1074/jbc.M110.126722; Roman A, 2013, VIROLOGY, V445, P138, DOI 10.1016/j.virol.2013.04.013; Rosa DS, 2010, ARCH IMMUNOL THER EX, V58, P121, DOI 10.1007/s00005-010-0067-0; Rudolf MP, 2001, CLIN CANCER RES, V7, p788S; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schiffman M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.86; Schiller JT, 2008, VACCINE, V26, pK53, DOI 10.1016/j.vaccine.2008.06.002; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Shi JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144475; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Singh SP, 2016, HUM IMMUNOL, V77, P295, DOI 10.1016/j.humimm.2015.11.012; Sirskyj D, 2011, IMMUNOL CELL BIOL, V89, P81, DOI 10.1038/icb.2010.65; Srivastava PN, 2016, INT J PEPT RES THER, V22, P119, DOI 10.1007/s10989-015-9492-6; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Stanley M, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0268; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Tsang KY, 2017, VACCINE, V35, P2605, DOI 10.1016/j.vaccine.2017.03.025; Tsurui R, 2007, J PHARMACOL SCI, V105, P299, DOI 10.1254/jphs.CR0070056; Vambutas A, 2005, VACCINE, V23, P5271, DOI 10.1016/j.vaccine.2005.04.049; van der Burg SH, 2011, CURR OPIN IMMUNOL, V23, P252, DOI 10.1016/j.coi.2010.12.010; van Hall T, 2012, ADV IMMUNOL, V114, P51, DOI 10.1016/B978-0-12-396548-6.00003-2; Vici P, 2016, EXPERT REV VACCINES, V15, P1327, DOI 10.1080/14760584.2016.1176533; Vici P, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-29; Vignat J, 2017, INT J CANC; Villada IB, 2000, EUR J IMMUNOL, V30, P2281, DOI 10.1002/1521-4141(2000)30:8<2281::AID-IMMU2281>3.0.CO;2-N; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wang JW, 2013, VIROLOGY, V445, P175, DOI 10.1016/j.virol.2013.04.017; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Warrino DE, 2005, HUM IMMUNOL, V66, P762, DOI 10.1016/j.humimm.2005.04.006; Bosch FX, 2013, VACCINE, V31, pH1, DOI [10.1016/j.vaccine.2013.10.003, 10.1016/j.vaccine.2013.07.026]; Yoon H, 1998, VIRUS RES, V54, P23, DOI 10.1016/S0168-1702(98)00008-2; Zehbe I, 2007, J IMMUNOTHER, V30, P523, DOI 10.1097/CJI.0b013e31803240fa; Zhang H, 2009, BIOINFORMATICS, V25, P1293, DOI 10.1093/bioinformatics/btp137	131	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205933	10.1371/journal.pone.0205933	http://dx.doi.org/10.1371/journal.pone.0205933			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356257	Green Published, Green Submitted, gold			2022-12-26	WOS:000448434000065
J	Nowicki, M; Boggess, SL; Saxton, AM; Hadziabdic, D; Xiang, QYJ; Molnar, T; Huff, ML; Stator, ME; Zhao, YC; Trigiano, RN				Nowicki, Marcin; Boggess, Sarah L.; Saxton, Arnold M.; Hadziabdic, Denita; Xiang, Qiu-Yun Jenny; Molnar, Thomas; Huff, Matthew L.; Stator, Margaret E.; Zhao, Yichen; Trigiano, Robert N.			Haplotyping of Cornus florida and C. kousa chloroplasts: Insights into species-level differences and patterns of plastic DNA variation in cultivars	PLOS ONE			English	Article							SEQUENCES; ALIGNMENT; TORTOISE; HARE; PHYLOGENY; DIVERSITY; UTILITY; GENES; MICROSATELLITES; ANTHOCYANINS	Chloroplast DNA is a part of plant non-nuclear genome, and is of particular interest for lineage studies. Moreover, the non-coding regions of cpDNA display higher mutation rates than the conserved coding cpDNA, which has been employed for phylogenetic and population research. We analyzed the cpDNA of 332 gDNA samples from collections of Corn us florida and C. kousa (commercial cultivars, breeding selections, and wild kousa accessions from Asia), using the chlorotyping system developed on North America-native, wild accessions of C. florida. Our results indicated significant differences in chlorotype frequencies between the two species. Corn us florida samples were represented by all major chlorotypes previously described, whereas all C. kousa samples analyzed had only one of the chlorotype patterns shown by C. florida. The chlorotyping analytic panel was then expanded by sequencing the targeted three non-coding cpDNA regions. Results indicated a major difference in the maternally-inherited cpDNA between the two closely related Big-Bracted Corn us species. Chlorotype diversity and differences in the proportion of informative sites in the cpDNA regions of focus emphasized the importance of proper loci choice for cpDNA-based comparative studies between the closely related dogwood species. Phylogenetic analyses of the retrieved sequences for the other species of Corpus provided information on the relative utility of the cpDNA regions studied and helped delineate the groups (Big-Bracted, Cornelian Cherries, Blue/White-Fruited) within the genus. Genealogical relationships based on the cpDNA sequences and the inferred chlorotype networks indicated the need for continued analyses across further non-coding cpDNA regions to improve the phylogenetic resolution of dogwoods.	[Nowicki, Marcin; Boggess, Sarah L.; Hadziabdic, Denita; Huff, Matthew L.; Stator, Margaret E.; Trigiano, Robert N.] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Saxton, Arnold M.] Univ Tennessee, Dept Anim Sci, Knoxville, TN 37901 USA; [Xiang, Qiu-Yun Jenny] North Carolina State Univ Raleigh, Dept Plant & Microbial Biol, Raleigh, NC USA; [Molnar, Thomas] Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ USA; [Zhao, Yichen] Guizhou Univ, Guizhou Key Lab Agrobioengn, Huaxi, Guizhou, Peoples R China	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of North Carolina; North Carolina State University; Rutgers State University New Brunswick; Guizhou University	Nowicki, M (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	mnowicki@utk.edu	Nowicki, Marcin/B-4212-2011; Molnar, Thomas/AAC-1429-2021; Xiang, Jenny/ADU-6318-2022	Nowicki, Marcin/0000-0002-2655-5464; Xiang, Jenny/0000-0002-9016-0678; Staton, Margaret/0000-0003-2971-9353; Hadziabdic, Denita/0000-0003-1991-2563; Molnar, Thomas/0000-0001-6099-4244; Saxton, Arnold/0000-0003-3345-5127	ARSUSDA [58-6062-6]	ARSUSDA(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was funded fully by the ARSUSDA grant (58-6062-6) to the Trigiano lab for dogwood research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Besnard G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-80; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Bushnell B, 2014, LBNL REPORT LBNL 706; Call AB, 2012, PHYLOGEOGRAPHY SPECI; Call A, 2016, J SYST EVOL, V54, P136, DOI 10.1111/jse.12171; Choi Kyung, 2006, [Korean Journal of Plant Reources., 한국자원식물학회지], V19, P509; Coart E, 2006, MOL ECOL, V15, P2171, DOI 10.1111/j.1365-294X.2006.02924.x; Dong WP, 2013, GENOME BIOL EVOL, V5, P989, DOI 10.1093/gbe/evt063; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Du YP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06210-2; EYDE RH, 1987, SYST BOT, V12, P505, DOI 10.2307/2418886; Fan CZ, 2007, GENETICA, V130, P19, DOI 10.1007/s10709-006-0016-3; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hadziabdic D, 2010, GENETICA, V138, P1047, DOI 10.1007/s10709-010-9490-8; Hadziabdic D, 2012, TREE GENET GENOMES, V8, P855, DOI 10.1007/s11295-012-0471-1; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JANSEN RK, 1998, MOL SYSTEMATICS PLAN, V2, P87; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Katoh K, 2017, BRIEF BIOINFORM, DOI [DOI 10.1093/BIB/BBX108, 10.1093/bib/bbx108]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keir KR, 2011, AM J BOT, V98, P1327, DOI 10.3732/ajb.1000466; Keir KR, 2008, BEAUTIFUL LACKING DI; Korotkova N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112998; Landan Giddy, 2008, Pac Symp Biocomput, P15; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JH, 2010, J SYST EVOL, V48, P426, DOI 10.1111/j.1759-6831.2010.00098.x; Maddison WP, 2019, MESQUITE MODULAR SYS; Mantooth K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180345; Mattera R, 2016, THESIS; McPherson H, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-8; Melotto-Passarin DM, 2011, GENET MOL RES, V10, P2024, DOI 10.4238/vol10-3gmr1019; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Ngondya IB, 2013, FOR SCI TECHNOL, V9, P1, DOI 10.1080/21580103.2013.773654; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; Panda S, 2003, PLANT BREEDING, V122, P92, DOI 10.1046/j.1439-0523.2003.00768.x; Ranney Thomas G., 1995, Journal of Arboriculture, V21, P11; Romeiro-Brito M, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1500074; Sarkinen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082266; Santamour F Jr, 1985, J ARBORICULTURE US, V1, P29; Seeram NP, 2002, J AGR FOOD CHEM, V50, P2519, DOI 10.1021/jf0115903; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shaw J, 2014, AM J BOT, V101, P1987, DOI 10.3732/ajb.1400398; Shearer K, 2013, HORTSCIENCE, V48, P825, DOI 10.21273/HORTSCI.48.7.825; Small RL, 1998, AM J BOT, V85, P1301, DOI 10.2307/2446640; Smith K, 2013, ANR1077; Song J, 2006, J KOREAN FORESTRY SO; Song L, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0089-y; Song Y, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00662; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swangpol S, 2007, J BIOCHEM MOL BIOL, V40, P577; The R Core Team, 2017, R LANG ENV STAT COMP; USDA-NASS. Census of horticultural specialties, 2012, TABL 21 DEC FLOW TRE; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Vareed SK, 2006, LIFE SCI, V78, P777, DOI 10.1016/j.lfs.2005.05.094; Wadl PA, 2014, HORTSCIENCE, V49, P1230, DOI 10.21273/HORTSCI.49.9.1230; Wadl PA, 2008, MOL ECOL RESOUR, V8, P780, DOI 10.1111/j.1755-0998.2007.02062.x; Wadl PA, 2011, MOL BREEDING, V27, P409, DOI 10.1007/s11032-011-9551-4; Wadl PA, 2010, J AM SOC HORTIC SCI, V135, P279, DOI 10.21273/JASHS.135.3.279; Wadl PA, 2008, J AM SOC HORTIC SCI, V133, P783, DOI 10.21273/JASHS.133.6.783; Wang XW, 2009, EUPHYTICA, V165, P165, DOI 10.1007/s10681-008-9802-6; Windham M. T., 2005, Journal of Environmental Horticulture, V23, P190; Witte WT, 2000, DOGWOODS AM GARDENS; Wu TD, 2016, METHODS MOL BIOL, V1418, P283, DOI 10.1007/978-1-4939-3578-9_15; Xiang QY, 1998, AM J BOT, V85, P285, DOI 10.2307/2446317; Xiang QYJ, 2006, TAXON, V55, P9, DOI 10.2307/25065525; Xinwang W, 2008, APPL MICROSATELLITES; Yu Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171361	76	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0205407	10.1371/journal.pone.0205407	http://dx.doi.org/10.1371/journal.pone.0205407			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352068	gold, Green Submitted, Green Published			2022-12-26	WOS:000448076200008
J	Xia, P; Liu, YN; Chen, JR; Coates, S; Liu, DX; Cheng, ZK				Xia, Peng; Liu, Yuening; Chen, Jingrui; Coates, Shelby; Liu, David X.; Cheng, Zhaokang			Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; cardiovascular disease; cyclin-dependent kinase (CDK); cell cycle; cell death; mitochondria; anthracycline; Bim; cardiotoxicity; chemotherapy	HYPOXIA-INDUCED APOPTOSIS; CELL-DEATH; SELICICLIB CYC202; R-ROSCOVITINE; ACTIVATION; PHOSPHORYLATION; CARDIOTOXICITY; GROWTH; CDK2; BIM	With the rapid increase in cancer survival because of improved diagnosis and therapy in the past decades, cancer treatment-related cardiotoxicity is becoming an urgent healthcare concern. The anthracycline doxorubicin (DOX), one of the most effective chemotherapeutic agents to date, causes cardiomyopathy by inducing cardiomyocyte apoptosis. We demonstrated previously that overexpression of the cyclin-dependent kinase (CDK) inhibitor p21 promotes resistance against DOX-induced cardiomyocyte apoptosis. Here we show that DOX exposure provokes cardiac CDK2 activation and cardiomyocyte cell cycle S phase reentry, resulting in enhanced cellular sensitivity to DOX. Genetic or pharmacological inhibition of CDK2 markedly suppressed DOX-induced cardiomyocyte apoptosis. Conversely, CDK2 overexpression augmented DOX-induced apoptosis. We also found that DOX-induced CDK2 activation in the mouse heart is associated with up-regulation of the pro-apoptotic BCL2 family member BCL2-like 11 (Bim), a BH3-only protein essential for triggering Bax/Bak-dependent mitochondrial outer membrane permeabilization. Further experiments revealed that DOX induces cardiomyocyte apoptosis through CDK2-dependent expression of Bim. Inhibition of CDK2 with roscovitine robustly repressed DOX-induced mitochondrial depolarization. In a cardiotoxicity model of chronic DOX exposure (5 mg/kg weekly for 4 weeks), roscovitine administration significantly attenuated DOX-induced contractile dysfunction and ventricular remodeling. These findings identify CDK2 as a key determinant of DOX-induced cardiotoxicity. CDK2 activation is necessary for DOX-induced Bim expression and mitochondrial damage. Our results suggest that pharmacological inhibition of CDK2 may be a cardioprotective strategy for preventing anthracycline-induced heart damage.	[Xia, Peng; Liu, Yuening; Chen, Jingrui; Liu, David X.; Cheng, Zhaokang] Washington State Univ, Dept Pharmaceut Sci, 205 E Spokane Falls Blvd, Spokane, WA 99210 USA; [Coates, Shelby] Pacific Lutheran Univ, Dept Biol, Tacoma, WA 98477 USA	Washington State University; Pacific Lutheran University	Cheng, ZK (corresponding author), Washington State Univ, Dept Pharmaceut Sci, 205 E Spokane Falls Blvd, Spokane, WA 99210 USA.	zhaokang.cheng@wsu.edu	Liu, Yuening/GYQ-7182-2022	Liu, Yuening/0000-0002-6891-0006; Cheng, Zhaokang/0000-0002-9646-4824	National Institutes of Health [R00HL119605]; Washington State University College of Pharmacy; NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL119605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington State University College of Pharmacy; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health Grant R00HL119605 (to Z.C.) and the Washington State University College of Pharmacy. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Adachi S, 2001, CIRC RES, V88, P408, DOI 10.1161/01.res.88.4.408; Appleyard MVCL, 2009, INT J CANCER, V124, P465, DOI 10.1002/ijc.23938; Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026; Bourke E, 2010, ONCOGENE, V29, P616, DOI 10.1038/onc.2009.340; Chaudhry HW, 2004, J BIOL CHEM, V279, P35858, DOI 10.1074/jbc.M404975200; Chen ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29090; Cheng Z, 2014, J MOL CELL CARDIOL, V67, P1, DOI 10.1016/j.yjmcc.2013.12.002; Ellenrieder C, 2001, DNA CELL BIOL, V20, P413, DOI 10.1089/104454901750361479; Flores O, 2010, ENDOCRINOLOGY, V151, P896, DOI 10.1210/en.2009-1116; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Harvey KJ, 2000, J CELL BIOL, V148, P59, DOI 10.1083/jcb.148.1.59; Hauck L, 2002, CIRC RES, V91, P782, DOI 10.1161/01.RES.0000041030.98642.41; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Jabbour-Leung NA, 2016, MOL CANCER THER, V15, P593, DOI 10.1158/1535-7163.MCT-15-0519; Jay SM, 2013, CIRCULATION, V128, P152, DOI 10.1161/CIRCULATIONAHA.113.002203; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Lambert LA, 2008, CANCER RES, V68, P7966, DOI 10.1158/0008-5472.CAN-08-1333; Lenneman CG, 2016, CIRC RES, V118, P1008, DOI 10.1161/CIRCRESAHA.115.303633; Li DL, 2016, CIRCULATION, V133, P1668, DOI 10.1161/CIRCULATIONAHA.115.017443; Liao HS, 2001, CIRC RES, V88, P443; Liem DA, 2008, J MOL CELL CARDIOL, V45, P610, DOI 10.1016/j.yjmcc.2008.07.003; Ling YH, 1996, MOL PHARMACOL, V49, P832; Liu WJ, 2014, DEV BIOL, V392, P108, DOI 10.1016/j.ydbio.2014.04.018; Luke JJ, 2012, CLIN CANCER RES, V18, P2638, DOI 10.1158/1078-0432.CCR-11-3203; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Pang BX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2921; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; Rathos MJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-29; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Sarkar S, 2004, J BIOL CHEM, V279, P52630, DOI 10.1074/jbc.M402037200; Sarosiek KA, 2013, MOL CELL, V51, P751, DOI 10.1016/j.molcel.2013.08.048; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shapiro SD, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007668; Teitz T, 2018, J EXP MED, V215, P1187, DOI 10.1084/jem.20172246; Vella S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166233; Xia P, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9583268; Zhang J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.167; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	43	29	30	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19672	19685		10.1074/jbc.RA118.004673	http://dx.doi.org/10.1074/jbc.RA118.004673			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30361442	Green Published, hybrid			2022-12-26	WOS:000454294900015
J	De Vreese, LP; Mantesso, U; De Bastiani, E; Marangoni, A; Weger, E; Gomiero, T				De Vreese, Luc Pieter; Mantesso, Ulrico; De Bastiani, Elisa; Marangoni, Annachiara; Weger, Elisabeth; Gomiero, Tiziano			Anticholinergic burden in adult and elderly people with intellectual disabilities: Results from an Italian multicenter cross-sectional study	PLOS ONE			English	Article							OLDER-ADULTS; COGNITIVE IMPAIRMENT; NEGATIVE OUTCOMES; FUNCTIONAL STATUS; MEDICATION USE; DRUG-USE; RISK; POLYPHARMACY; ASSOCIATION; SYMPTOMS	Background Adults and older people with intellectual disabilities (ID) frequently receive anti-cholinergic drugs in chronic use, but no studies in Italy to date have investigated cumulative anticholinergic exposure and factors associated with high anticholinergic burden in this frail population. Aim To probe the cumulative exposure to anticholinergics and the demographic, social and clinical factors associated with high exposure. Methods The 2012 updated version of the Anticholinergic Burden Score (ACB) was calculated for a multicentre sample of 276 adult and older people over 40 years with ID and associations with factors assessed. Results Overall, antipsychotics, antiepileptics, anxiolytics, and antidepressants were the most frequent classes contributing to the total ACB score. People living in residential care were more likely exposed to high anticholinergic burden (an ACB score of 3+): both community housing (odds ratio [OR] 4.63, 95%CI 1.08-19.95) and nursing home facility ([OR] 9.99, 95%CI 2.32-43.04). There was also a significant association between an ACB score of 3+ and reporting mental health conditions ([OR] 25.56, 95% CI 8.08-80.89) or a neurological disease ([OR] 4.14, 95%CI 1.32-12.94). Neither demographic characteristics (age and gender) nor other clinical conditions (somatic comorbidity, levels and typology of ID) were associated with higher anticholinergic load. A high burden of anticholinergic was significantly more frequent in laxative users (22.6% ACB3+ vs. 5.1% ACB 0) (p = 0.003) Conclusions Psychotropics drugs were the highest contributors to the anticholinergic burden in adult and old age ID, especially in those people living in institutional settings with mental health and/or neurological conditions. High anticholinergic load has shown to be associated with the use of laxatives.	[De Vreese, Luc Pieter] Luigi Boni Fdn, Geriatr Ctr, Suzzara, Italy; [De Vreese, Luc Pieter; Mantesso, Ulrico; De Bastiani, Elisa; Marangoni, Annachiara; Weger, Elisabeth; Gomiero, Tiziano] ANFFAS Trentino Onlus, Project DAD Alzheimer Dementia, Trento, Italy		Gomiero, T (corresponding author), ANFFAS Trentino Onlus, Project DAD Alzheimer Dementia, Trento, Italy.	t.gomiero@virgilio.it	Gomiero, Tiziano/H-7011-2019	Gomiero, Tiziano/0000-0002-2931-9571	ANFFAS Trentino Onlus	ANFFAS Trentino Onlus	The project DAD (Down Alzheimer Disease) was entirely financed by ANFFAS Trentino Onlus, a large Italian no profit parental association of persons with Intellectual Disabilities. The Association had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailabouni N, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013800; Aylward EH, 1997, J INTELL DISABIL RES, V41, P152, DOI 10.1111/j.1365-2788.1997.tb00692.x; Baffy Noemi, 2017, Curr Treat Options Gastroenterol, V15, P363, DOI 10.1007/s11938-017-0142-2; Bertelli M, 2015, J INTELLECT DISABIL, V3, P138; Beuscart JB, 2017, CLIN INTERV AGING, V12, P1379, DOI 10.2147/CIA.S135481; Boccardi V, 2017, J NUTR HEALTH AGING, V21, P389, DOI 10.1007/s12603-016-0787-x; Boustani M., 2008, AGING HLTH, V4, P311, DOI [10.2217/1745509x.4.3.311, DOI 10.2217/1745509X.4.3.311, 10.2217/1745509XA3.311, 10.2217/1745509X.4.3.311]; British Psychological Society, 2015, DEM PEOPL INT DIS GU; Brown J, 2011, GOODMAN GILMANS PHAR; Campbell NL, 2010, NEUROLOGY, V75, P152, DOI 10.1212/WNL.0b013e3181e7f2ab; Collamati A, 2016, AGING CLIN EXP RES, V28, P25, DOI 10.1007/s40520-015-0359-7; de Kuijper G, 2014, J INTELL DISABIL RES, V58, P71, DOI 10.1111/j.1365-2788.2012.01631.x; de Kuijper GM, 2017, J INTELL DISABIL RES, V61, P899, DOI 10.1111/jir.12385; De Vreese L. P., 2007, PSICOGERIATRIA, V3, P19; De Vreese LP, 2016, PSICOGERIATRIA, P33; Eady N, 2015, DRUG AGING, V32, P95, DOI 10.1007/s40266-014-0236-7; Egberts A, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.310; Gomiero T, 2017, CURR ALZHEIMER RES, V14, P709, DOI 10.2174/1567205014666170117094757; Gray Shelly L, 2016, Ther Adv Drug Saf, V7, P217; Haasum Y, 2012, ANN PHARMACOTHER, V46, P339, DOI 10.1345/aph.1Q597; Hassler F, 2015, J NEURAL TRANSM, V122, P93, DOI 10.1007/s00702-014-1219-x; Hermans H, 2014, RES DEV DISABIL, V35, P776, DOI 10.1016/j.ridd.2014.01.022; Indiana University Center for Aging Research, 2012, ANT COGN BURD SCAL; Jahromi SR, 2011, SEIZURE-EUR J EPILEP, V20, P343, DOI 10.1016/j.seizure.2010.12.011; Jaidi Y, 2018, AM J GERIAT PSYCHIAT, V26, P280, DOI 10.1016/j.jagp.2017.08.005; Landi F, 2007, CLIN PHARMACOL THER, V81, P235, DOI 10.1038/sj.clpt.6100035; Landi F, 2014, J AM MED DIR ASSOC, V15, P825, DOI 10.1016/j.jamda.2014.08.002; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; McCarron M, 2017, J INTELL DISABIL RES, V61, P843, DOI 10.1111/jir.12390; McCarron M, 2014, AJIDD-AM J INTELLECT, V119, P253, DOI 10.1352/1944-7558-119.3.253; Morad M, 2007, RES DEV DISABIL, V28, P580, DOI 10.1016/j.ridd.2006.08.002; Moran JA, 2013, MAYO CLIN PROC, V88, P831, DOI 10.1016/j.mayocp.2013.04.024; O'Dwyer M, 2018, THER ADV DRUG SAF, V9, P535, DOI 10.1177/2042098618782785; O'Dwyer M, 2016, BRIT J PSYCHIAT, V209, P504, DOI 10.1192/bjp.bp.115.173971; O'Dwyer M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010505; O'Mahony D, 2015, AGE AGEING, V44, P213, DOI 10.1093/ageing/afu145; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Pasina L, 2013, DRUG AGING, V30, P103, DOI 10.1007/s40266-012-0044-x; Pfistermeister B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171353; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Risacher SL, 2016, JAMA NEUROL, V73, P721, DOI 10.1001/jamaneurol.2016.0580; Ruxton K, 2015, BRIT J CLIN PHARMACO, V80, P209, DOI 10.1111/bcp.12617; Salahudeen MS, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0029-9; Scheifes A, 2016, RES DEV DISABIL, V49-50, P13, DOI 10.1016/j.ridd.2015.11.017; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Sheehan R, 2017, LANCET PSYCHIAT, V4, P238, DOI 10.1016/S2215-0366(16)30191-2; Sheehan R, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4326; Silverman W, 2004, AM J MENT RETARD, V109, P111, DOI 10.1352/0895-8017(2004)109<111:DIAWMR>2.0.CO;2; Solmi M, 2017, THER CLIN RISK MANAG, V13, P757, DOI 10.2147/TCRM.S117321; Tamura BK, 2012, CLIN GERIATR MED, V28, P217, DOI 10.1016/j.cger.2012.01.005; Tible OP, 2017, THER ADV NEUROL DISO, V10, P297, DOI 10.1177/1756285617712979; Tyrer Peter, 2014, BMJ, V349, pg4323, DOI 10.1136/bmj.g4323; Wiseman FK, 2015, NAT REV NEUROSCI, V16, P564, DOI 10.1038/nrn3983; World Health Organization, 2015, WORLD REP AG HLTH 20; Zaal RJ, 2016, RES DEV DISABIL, V55, P132, DOI 10.1016/j.ridd.2016.03.014	55	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205897	10.1371/journal.pone.0205897	http://dx.doi.org/10.1371/journal.pone.0205897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY7VH	30379948	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700081
J	Haddix, SG; Lee, YI; Kornegay, JN; Thompson, WJ				Haddix, Seth G.; Lee, Young Il; Kornegay, Joe N.; Thompson, Wesley J.			Cycles of myofiber degeneration and regeneration lead to remodeling of the neuromuscular junction in two mammalian models of Duchenne muscular dystrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; MDX MICE; ANIMAL-MODEL; CELLS; TRANSMISSION; DEFICIENCY; SARCOLEMMA; DIAPHRAGM; PATHOLOGY; MYOPATHY	Mice lacking the sarcolemmal protein dystrophin, designated mdx, have been widely used as a model of Duchenne muscular dystrophy. Dystrophic mdx mice as they mature develop notable morphological abnormalities to their neuromuscular junctions, the peripheral cholinergic synapses responsible for activating muscle fibers. Most obviously the acetylcholine receptor aggregates are fragmented into small non-continuous, islands. This contrasts with wild type mice whose acetylcholine receptor aggregates are continuous and pretzel-shaped in appearance. We show here that these abnormalities in mdx mice are also present in a canine model of Duchenne muscular dystrophy and provide additional evidence to support the hypothesis that NMJ remodeling occurs due to myofiber degeneration and regeneration. Using a method to investigate synaptic AChR replacement, we show that neuromuscular junction remodeling in mdx animals is caused by muscle fiber degeneration and regeneration at the synaptic site and is mimicked by deliberate myofiber injury in wild type mice. Importantly, the innervating motor axon plays a crucial role in directing the remodeling of the neuromuscular junction in dystrophy, as has been recorded in aging and deliberate muscle fiber injury in wild type mice. The remodeling occurs repetitively through the life of the animal and the changes in junctions become greater with age.	[Haddix, Seth G.; Lee, Young Il; Kornegay, Joe N.; Thompson, Wesley J.] Texas A&M Univ, Texas A&M Inst Neurosci, College Stn, TX 77843 USA; [Lee, Young Il; Thompson, Wesley J.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Kornegay, Joe N.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Haddix, SG (corresponding author), Texas A&M Univ, Texas A&M Inst Neurosci, College Stn, TX 77843 USA.	seth.haddix@tamu.edu		Kornegay, Joe/0000-0002-5594-1882; Lee, Young il/0000-0003-4993-9038; Haddix, Seth/0000-0003-0342-6413	National Institute of Health [R01 NS020480, 1S10RR028951-01]; Texas AM University; Texas AAMP;M University Open Access to Knowledge (OAK) Fund; Texas AAMP;M University Open Access to Knowledge Fund (OAKFund); Office of the Vice President for Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020480] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas AM University; Texas AAMP;M University Open Access to Knowledge (OAK) Fund; Texas AAMP;M University Open Access to Knowledge Fund (OAKFund); Office of the Vice President for Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: National Institute of Health, R01 NS020480, WJT, https://projectreporter.nih.gov/project_info_description.cfm?aid=9544333&icde=41787423& ddparam=& ddvalue=& Texas AM University, start-up funds, WJT; Texas AM University, Heep Fellowship, SGH, https://tlac.tamu.edu/student-services/financial-assistance/; National Institute of Health, 1S10RR028951-01, WJT, https://projectreporter.nih.gov/project_info_description.cfm?aid=7840152&icde=41787514&ddparam=&ddvalue=&ddsub=&cr=40&csb=default&cs=ASC&pball=.Texas A&M University Open Access to Knowledge (OAK) Fund, SGH, https://library.tamu.edu/services/scholarly_communication/Open_Access/oakfund.html.The open access publishing fees for this article have been covered by the Texas A&M University Open Access to Knowledge Fund (OAKFund), supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BENOIT PW, 1970, J ANAT, V107, P547; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Carlson CG, 2001, PFLUG ARCH EUR J PHY, V442, P369; CARPENTER S, 1989, J NEUROPATH EXP NEUR, V48, P154, DOI 10.1097/00005072-198903000-00003; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; DANGAIN J, 1984, MUSCLE NERVE, V7, P700, DOI 10.1002/mus.880070903; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fletcher S, 2007, MOL THER, V15, P1587, DOI 10.1038/sj.mt.6300245; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; KARPATI G, 1988, MUSCLE NERVE, V11, P795, DOI 10.1002/mus.880110802; Kong J, 2012, NEUROREPORT, V23, P82, DOI 10.1097/WNR.0b013e32834e7e54; Kong JM, 1999, BRAIN RES, V839, P298, DOI 10.1016/S0006-8993(99)01737-0; Kornegay JN, 2012, MAMM GENOME, V23, P85, DOI 10.1007/s00335-011-9382-y; Lee YI, 2016, P NATL ACAD SCI USA, V113, pE479, DOI 10.1073/pnas.1519156113; Li Y, 2011, J NEUROSCI, V31, P14910, DOI 10.1523/JNEUROSCI.3590-11.2011; Li Y, 2011, J NEUROSCI, V31, P13191, DOI 10.1523/JNEUROSCI.2953-11.2011; LORING RH, 1980, P NATL ACAD SCI-BIOL, V77, P2293, DOI 10.1073/pnas.77.4.2293; Love FM, 1998, J NEUROSCI, V18, P9376; Lovering RM, 2004, AM J PHYSIOL-CELL PH, V286, pC230, DOI 10.1152/ajpcell.00199.2003; LYONS PR, 1991, J NEUROCYTOL, V20, P969, DOI 10.1007/BF01187915; Marques MJ, 2007, ANAT REC, V290, P181, DOI 10.1002/ar.20421; MCGEACHIE JK, 1993, J NEUROL SCI, V119, P169, DOI 10.1016/0022-510X(93)90130-Q; Minatel E, 2003, MUSCLE NERVE, V28, P561, DOI 10.1002/mus.10416; NAGEL A, 1990, MUSCLE NERVE, V13, P742, DOI 10.1002/mus.880130813; Nguyen F, 2002, J COMP PATHOL, V126, P100, DOI 10.1053/jcpa.2001.0526; Pagel CN, 1999, J NEUROL SCI, V164, P103, DOI 10.1016/S0022-510X(99)00061-1; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; PELLEGRINO C, 1963, J CELL BIOL, V17, P327, DOI 10.1083/jcb.17.2.327; Personius KE, 2006, NEUROMUSCULAR DISORD, V16, P168, DOI 10.1016/j.nmd.2006.01.002; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Pratt SJP, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00252; PURVES D, 1974, J PHYSIOL-LONDON, V239, P125, DOI 10.1113/jphysiol.1974.sp010559; Ramaswamy KS, 2011, J PHYSIOL-LONDON, V589, P1195, DOI 10.1113/jphysiol.2010.201921; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; SLATER CR, 1990, PROG BRAIN RES, V84, P73; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Strack S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020524; TANABE Y, 1986, ACTA NEUROPATHOL, V69, P91, DOI 10.1007/BF00687043; THESLEFF S, 1975, J PHYSIOL-LONDON, V244, P313, DOI 10.1113/jphysiol.1975.sp010800; Trontelj J, 1985, MUSCLE NERVE, V8, P383; VALENTINE BA, 1992, AM J MED GENET, V42, P352, DOI 10.1002/ajmg.1320420320; VALENTINE BA, 1988, J NEUROL SCI, V88, P69, DOI 10.1016/0022-510X(88)90206-7; van der Pijl EM, 2016, EUR J NEUROSCI, V43, P1623, DOI 10.1111/ejn.13249; Wada KI, 2008, ANAT REC, V291, P122, DOI 10.1002/ar.20626; Willadt S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24849; Xu RF, 1997, J NEUROSCI, V17, P8194; Zuo Y, 2004, J NEUROSCI, V24, P10999, DOI 10.1523/JNEUROSCI.3934-04.2004	58	29	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205926	10.1371/journal.pone.0205926	http://dx.doi.org/10.1371/journal.pone.0205926			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379896	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700084
J	Minoudi, S; Papapetridis, I; Karaiskou, N; Chatzinikos, E; Triantaphyllidis, C; Abatzopoulos, TJ; Triantafyllidis, A				Minoudi, Styliani; Papapetridis, Ioannis; Karaiskou, Nikoleta; Chatzinikos, Evangelos; Triantaphyllidis, Costas; Abatzopoulos, Theodore J.; Triantafyllidis, Alexandros			Genetic analyses of brown hare (Lepus europaeus) support limited migration and translocation of Greek populations	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; MULTIPLE REFUGIA; PHYLOGEOGRAPHY; DIVERSITY; COLONIZATION; INSIGHTS; SURVIVAL; CLIMATE; RANGES; PALLAS	Numerous studies have shown that the phylogeography of many species, including European brown hare, has been affected by the climatic oscillations of the Pleistocene. During this period the Balkans acted as a major refugium offering habitable conditions for many species. However, few studies have focused on the specific role of the Greek peninsula in the phylogeographic history of species in this southernmost margin of Balkans. We, therefore analyzed a 528 bp fragment of the D-loop region of mitochondrial DNA in 154 wild brown hare individuals from unsampled areas from both mainland and island Greece and compared it to 310 available brown hare sequences (including 110 Greek samples). Newly identified haplotypes show characteristic distribution in specific Greek areas reinforcing the theory that Greece can be considered as a subrefuge within Balkans for a number of species, with several "refugia within refugia" spots, holding significant genetic diversity. No haplotypes from wild Greek individuals clustered with the Central and Western Europe group revealing a minimal contribution of this area to the colonization of central Europe. One hundred and ten reared brown hares were also analyzed to elucidate the impact of introductions on local populations. Most of these samples presented close genetic affinity with haplotypes from Central and Western Europe indicating that farms in Greece use breeders from those areas. Therefore, despite human translocation of individuals, the genetic structure of brown hare has mostly been influenced by paleoclimatic conditions and minimally by human actions.	[Minoudi, Styliani; Papapetridis, Ioannis; Karaiskou, Nikoleta; Triantaphyllidis, Costas; Abatzopoulos, Theodore J.; Triantafyllidis, Alexandros] Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki, Greece; [Chatzinikos, Evangelos] 4th Hunting Federat Sterea Hellas, Fokionos 8 & Ermou, Athens, Greece	Aristotle University of Thessaloniki	Triantafyllidis, A (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki, Greece.	atriant@bio.auth.gr	Minoudi, Styliani/AAU-2519-2021	Minoudi, Styliani/0000-0003-2991-8483	4th Hunting Federation of Sterea Hellas	4th Hunting Federation of Sterea Hellas	This work was supported by the 4th Hunting Federation of Sterea Hellas.	Abellan P, 2014, BIOL J LINN SOC, V113, P13, DOI 10.1111/bij.12309; Alexandri P, 2012, J BIOGEOGR, V39, P713, DOI 10.1111/j.1365-2699.2011.02636.x; Antoniou A, 2013, GENETICA, V141, P23, DOI 10.1007/s10709-013-9703-z; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Bilgin R, 2011, INT J MOL SCI, V12, P4080, DOI 10.3390/ijms12064080; Centeno-Cuadros A, 2009, MOL ECOL, V18, P3652, DOI 10.1111/j.1365-294X.2009.04297.x; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dermitzakis M.D., 1991, Accademia Nazionale dei Lincei Atti Convegni Lincei (Rome), V85, P263; Dermitzakis MD, 1981, ANN GEOL PAYS HELL, V30, P245; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Fickel J, 2008, EUR J WILDLIFE RES, V54, P495, DOI 10.1007/s10344-008-0175-x; Flux J.E.C., 1983, Acta Zoologica Fennica, P7; Flux JEC, 1990, HARES PIKAS STATUS S, P61; Geraga M, 2000, PALAEOGEOGR PALAEOCL, V156, P1, DOI 10.1016/S0031-0182(99)00123-6; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hillis David M., 1996, P321; Hulbert IAR, 1996, J APPL ECOL, V33, P315, DOI [10.2307/2404753, 10.2307/2404786]; Karaiskou N, 2014, J HERED, V105, P334, DOI 10.1093/jhered/esu007; Kasapidis P, 2005, MOL PHYLOGENET EVOL, V34, P55, DOI 10.1016/j.ympev.2004.09.007; Kotlik P, 2006, P NATL ACAD SCI USA, V103, P14860, DOI 10.1073/pnas.0603237103; Krystufek B, 2009, HEREDITY, V103, P129, DOI 10.1038/hdy.2009.41; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lykousis V, 2009, CONT SHELF RES, V29, P2037, DOI 10.1016/j.csr.2008.11.005; Mamuris Z, 2001, BIOL CONSERV, V101, P187, DOI 10.1016/S0006-3207(01)00065-9; Mcdevitt AD, 2012, BIOL J LINN SOC, V106, P57, DOI 10.1111/j.1095-8312.2012.01840.x; Misiorowska M, 2012, ACTA THERIOL, V57, P305, DOI 10.1007/s13364-012-0081-1; Munwes I, 2010, MOL ECOL, V19, P2675, DOI 10.1111/j.1365-294X.2010.04712.x; Niedzialkowska M, 2017, MAMM BIOL, V84, P35, DOI 10.1016/j.mambio.2017.01.004; Parducci L, 2012, SCIENCE, V335, P1083, DOI 10.1126/science.1216043; Patricelli D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-14; PEREZSUAREZ G, 1994, BIOCHEM GENET, V32, P423, DOI 10.1007/BF00566063; Pierpaoli M, 1999, MOL ECOL, V8, P1805, DOI 10.1046/j.1365-294x.1999.00766.x; Pironon S, 2017, BIOL REV, V92, P1877, DOI 10.1111/brv.12313; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Randi E, 2007, Phylogeography of Southern European Refugia, P101, DOI 10.1007/1-4020-4904-8_3; Ricklefs RE, 1999, J ANIM ECOL, V68, P1142, DOI 10.1046/j.1365-2656.1999.00358.x; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Schmitt T, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-22; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Sotiropoulos K, 2007, MOL PHYLOGENET EVOL, V45, P211, DOI 10.1016/j.ympev.2007.03.012; Stamatis C, 2009, J BIOGEOGR, V36, P515, DOI 10.1111/j.1365-2699.2008.02013.x; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thulin CG, 1997, MOL ECOL, V6, P463, DOI 10.1046/j.1365-294X.1997.t01-1-00199.x; Tzedakis PC, 2002, SCIENCE, V297, P2044, DOI 10.1126/science.1073083; Ursenbacher S, 2008, MOL PHYLOGENET EVOL, V46, P1116, DOI 10.1016/j.ympev.2007.11.002; Van Andel T. H., 1982, J FIELD ARCHAEOLOGY, V9, P445; Weiss S, 2007, PHYLOGEOGRAPHY SO EU; Wielstra B, 2010, MOL PHYLOGENET EVOL, V56, P888, DOI 10.1016/j.ympev.2010.04.030; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yannic G, 2012, BIOL J LINN SOC, V105, P864, DOI 10.1111/j.1095-8312.2011.01824.x	60	2	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206327	10.1371/journal.pone.0206327	http://dx.doi.org/10.1371/journal.pone.0206327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379887	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700101
J	Montague, TG; Almansoori, A; Gleason, EJ; Copeland, DS; Foley, K; Kraves, S; Saavedra, EA				Montague, Tessa G.; Almansoori, Alia; Gleason, Emily J.; Copeland, D. Scott; Foley, Kevin; Kraves, Sebastian; Saavedra, Ezequiel Alvarez			Gene expression studies using a miniaturized thermal cycler system on board the International Space Station	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; HEAT-SHOCK PROTEINS; GENOMIC DNA; MICROGRAVITY; SPACEFLIGHT; RADIATION; CELLS	The distance and duration of human spaceflight missions is set to markedly increase over the coming decade as we prepare to send astronauts to Mars. However, the health impact of long-term exposure to cosmic radiation and microgravity is not fully understood. In order to identify the molecular mechanisms underpinning the effects of space travel on human health, we must develop the capacity to monitor changes in gene expression and DNA integrity in space. Here, we report successful implementation of three molecular biology procedures on board the International Space Station (ISS) using a miniaturized thermal cycler system and C. elegans as a model organism: first, DNA extraction-the initial step for any type of DNA analysis; second, reverse transcription of RNA to generate complementary DNA (cDNA); and third, the subsequent semi-quantitative PCR amplification of cDNA to analyze gene expression changes in space. These molecular procedures represent a significant expansion of the budding molecular biology capabilities of the ISS and will permit more complex analyses of space-induced genetic changes during spaceflight missions aboard the ISS and beyond.	[Montague, Tessa G.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Almansoori, Alia] Al Mawakeb Sch Al Barsha, Dubai, U Arab Emirates; [Gleason, Emily J.; Kraves, Sebastian; Saavedra, Ezequiel Alvarez] MiniPCR, Cambridge, MA 02140 USA; [Copeland, D. Scott; Foley, Kevin] Boeing, Houston, TX USA	Harvard University; Boeing	Saavedra, EA (corresponding author), MiniPCR, Cambridge, MA 02140 USA.	zeke@minipcr.com		Montague, Tessa/0000-0002-5918-6327				Andersen EC, 2007, DEVELOPMENT, V134, P2991, DOI 10.1242/dev.009373; BACKUP P, 1994, AM J PHYSIOL, V266, pE567, DOI 10.1152/ajpendo.1994.266.4.E567; Barrila J, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.39; Berezovska OP, 1998, ADV SPACE RES, V21, P1059, DOI 10.1016/S0273-1177(98)00028-3; BIKLE DD, 1994, AM J PHYSIOL-ENDOC M, V267, pE822, DOI 10.1152/ajpendo.1994.267.6.E822; Boguraev AS, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0033-9; Carmeliet G, 1999, FASEB J, V13, pS129, DOI 10.1096/fasebj.13.9001.s129; Crucian B, 2015, NPJ MICROGRAVITY, V1, DOI 10.1038/npjmgrav.2015.13; Cubano LA, 2001, J LEUKOCYTE BIOL, V69, P755; Cucinotta FA, 2014, LIFE SCI SPACE RES, V2, P54, DOI 10.1016/j.lssr.2014.06.003; Cucinotta FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074988; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Ethiraj P, 2018, J CELL BIOCHEM, V119, P5696, DOI 10.1002/jcb.26750; Gaiser AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025485; McIntyre ABR, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.35; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Michurina T V, 1996, Adv Space Res, V17, P295, DOI 10.1016/0273-1177(95)00650-4; Moreno-Villanueva M, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0019-7; MOREY ER, 1978, SCIENCE, V201, P1138, DOI 10.1126/science.150643; Parra M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183480; Pomerantz A, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy033; Sambandam Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep25143; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Semov A, 2002, FASEB J, V16, P899, DOI 10.1096/fj.01-1002fje; Szewczyk NJ, 2008, ADV SPACE RES, V42, P1072, DOI 10.1016/j.asr.2008.03.017; Terada M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150801; Thiel CS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05580-x; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; WESTERLIND KC, 1995, J BONE MINER RES, V10, P843; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Zerath E, 1991, Physiologist, V34, pS194; Zupanska AK, 2013, AM J BOT, V100, P235, DOI 10.3732/ajb.1200343	32	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205852	10.1371/journal.pone.0205852	http://dx.doi.org/10.1371/journal.pone.0205852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379894	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700075
J	Vidula, MK; McCarthy, CP; Butala, NM; Kennedy, KF; Wasfy, JH; Yeh, RW; Secemsky, EA				Vidula, Mahesh K.; McCarthy, Cian P.; Butala, Neel M.; Kennedy, Kevin F.; Wasfy, Jason H.; Yeh, Robert W.; Secemsky, Eric A.			Causes and predictors of early readmission after percutaneous coronary intervention among patients discharged on oral anticoagulant therapy	PLOS ONE			English	Article							DUAL ANTIPLATELET THERAPY; ATRIAL-FIBRILLATION; 30-DAY READMISSION; HOSPITAL READMISSIONS; RISK; VALIDATION; SCORE; MANAGEMENT; EVENTS; IMPACT	Patients discharged on oral anticoagulant (OAC) therapy after percutaneous coronary intervention (PCI) represent a complex population and are at higher risk of early readmission. The reasons and predictors of early readmission in this group have not been well characterized. We identified patients in an integrated health care system who underwent PCI between 2009 and 2014 and were readmitted within 30 days within this health care system. Of the 9,357 patients surviving to discharge after the index PCI, 692 were readmitted within 30 days (7.4%). At the time of readmission, 143 had been discharged from the index PCI hospitalization on OACs (96.5% on warfarin) and 549 had not been discharged on OACs, with readmission rates of 12.9% and 6.7%, respectively (p<0.01). The most common reason for readmission among all patients was chest pain syndromes (21.7% on OACs, 34.4% not on OACs). However, bleeding represented the next most frequent cause of readmission among patients on OACs (14.0% on OACs vs 6.0% not on OACs, p<0.01). Among patients on OAC therapy, peripheral arterial disease (odds ratio [OR] 1.66, 95% confidence interval [CI] 1.07-2.57, p = 0.02) and nonelective PCI (OR 1.91, 95% CI 1.17-3.12, p<0.01) were found to be independent predictors of 30-day readmission. During rehospitalization, compared to patients not on OACs, patients on OACs suffered a higher unadjusted rate of mortality (6.3% vs 1.8%, p<0.01) and a longer length of stay (6.4 +/- 7.1 days vs 4.9 +/- 6.8 days, p = 0.02). In conclusion, patients discharged on OAC therapy after PC I are commonly readmitted, with bleeding representing a major reason. These readmissions are associated with high mortality and longer lengths of stay. Interventions targeted towards optimizing discharge planning for these complex patients are needed to potentially reduce readmissions.	[Vidula, Mahesh K.] Hosp Univ Penn, Dept Med, Div Cardiovasc Med, Philadelphia, PA 19104 USA; [McCarthy, Cian P.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Butala, Neel M.; Wasfy, Jason H.] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; [Kennedy, Kevin F.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64110 USA; [Yeh, Robert W.; Secemsky, Eric A.] Beth Israel Deaconess Med Ctr, Dept Med, Smith Ctr Outcomes Res Cardiol, Boston, MA 02215 USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Harvard University; Beth Israel Deaconess Medical Center	Secemsky, EA (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Smith Ctr Outcomes Res Cardiol, Boston, MA 02215 USA.	ericsecemsky@gmail.com	Yeh, Robert/AAJ-3463-2020		National Institutes of Health career development award [KL2 TR001100]; Abbott Vascular; Abiomed; AstraZeneca; Boston Scientific	National Institutes of Health career development award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Vascular(Abbott Laboratories); Abiomed; AstraZeneca(AstraZeneca); Boston Scientific(Boston Scientific)	The authors declare the following commercial affiliations: Jason Wasfy (National Institutes of Health career development award (KL2 TR001100)) and Robert Yeh (Abbott Vascular, Consulting/Advisory Board and Research grant; Abiomed, Research grant; Asahi Intecc, Consulting/Advisory Board; AstraZeneca, Research grant; Boston Scientific, Research grant, Consulting/Advisory Board; Medtronic, Consulting/Advisory Board; Teleflex, Consulting/Advisory Board). The funder provided support in the form of salaries for authors [JHW and RWY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], BPCI ADVANCED; Baber U, 2016, J AM COLL CARDIOL, V67, P2224, DOI 10.1016/j.jacc.2016.02.064; Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454; Centers for Medicare & Medicaid Services, READM RED PROGR HRRP; Costa F, 2017, LANCET, V389, P1025, DOI 10.1016/S0140-6736(17)30397-5; Deitelzweig S, 2016, CURR MED RES OPIN, V32, P573, DOI 10.1185/03007995.2015.1131676; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Khawaja FJ, 2012, ARCH INTERN MED, V172, P112, DOI 10.1001/archinternmed.2011.569; Ko DT, 2010, CIRC-CARDIOVASC INTE, V3, P140, DOI 10.1161/CIRCINTERVENTIONS.109.928721; Kwok CS, 2017, INT J CARDIOL, V227, P370, DOI 10.1016/j.ijcard.2016.11.050; McNeely C, 2016, AM HEART J, V179, P195, DOI 10.1016/j.ahj.2016.07.002; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mercaldi CJ, 2011, STROKE, V42, P112, DOI 10.1161/STROKEAHA.110.592907; Minges KE, 2017, CATHETER CARDIO INTE, V89, P955, DOI 10.1002/ccd.26701; Oudot A, 2006, HEART, V92, P1077, DOI 10.1136/hrt.2005.074070; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Rao SV, 2013, JACC-CARDIOVASC INTE, V6, P897, DOI 10.1016/j.jcin.2013.04.016; Ricciardi MJ, 2012, AM J CARDIOL, V110, P1389, DOI 10.1016/j.amjcard.2012.07.002; Rubboli A, 2009, J INTERV CARDIOL, V22, P390, DOI 10.1111/j.1540-8183.2009.00468.x; Secemsky EA, 2017, JAMA CARDIOL, V2, P478, DOI 10.1001/jamacardio.2017.0063; Secemsky EA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004310; Tanguturi VK, 2016, CIRC-CARDIOVASC QUAL, V9, P600, DOI 10.1161/CIRCOUTCOMES.116.003086; Wasfy JH, 2017, ANN INTERN MED, V166, P324, DOI 10.7326/M16-0185; Wasfy JH, 2014, CIRC-CARDIOVASC INTE, V7, P97, DOI 10.1161/CIRCINTERVENTIONS.113.000988; Wasfy JH, 2013, CIRC-CARDIOVASC QUAL, V6, P429, DOI 10.1161/CIRCOUTCOMES.111.000093; Wittkowsky AK, 2013, J THROMB THROMBOLYS, V35, P304, DOI 10.1007/s11239-013-0879-y; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205457	10.1371/journal.pone.0205457	http://dx.doi.org/10.1371/journal.pone.0205457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379868	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700047
J	Morita, I; Sakuma, S; Shimomura, J; Hayashi, N; Toda, S				Morita, Ichizo; Sakuma, Shigemitsu; Shimomura, Junko; Hayashi, Noriko; Toda, Sueko			Brain activity in response to the touch of a hand on the center of the back	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; FALSE DISCOVERY RATE; PREFRONTAL CORTEX; GENTLE TOUCH; EXECUTIVE FUNCTIONS; TACTILE AFFERENTS; HEALING TOUCH; SKIN; TOPOGRAPHY; EFFICACY	The aim of this study was to validate the possibility of using functional Near-Infrared Spectroscopy (fNIRS) to measure changes in cerebral blood flow in response to a hand being placed on a participant's back, and to identify the areas of enhanced activity in the brain. Nineteen female adult volunteers participated in the study. An experienced school nurse touched the center of the participant's back between the shoulder blades with the palm of her hand. Cerebral blood volume dynamics were measured with a 52-channel fNIRS system. Significantly higher oxygenated hemoglobin (oxy-Hb) concentration levels were recorded by channels 11, 14, 21, 22, 24, 32, 35, 45, 46, and 49 during the touching period than during the resting period. These channels indicated enhanced activity in the supramarginal gyrus, the middle frontal gyrus, the superior temporal gyrus, and the inferior frontal gyrus. The ability to detect changes in cerebral blood flow using this method indicates the possibility of measuring changes in cerebral blood flow using fNIRS when a person is touched on the back. fNIRS has been shown to be useful for studying the effects of touch.	[Morita, Ichizo] Japanese Red Cross Toyota Coll Nursing, Toyota, Aichi, Japan; [Sakuma, Shigemitsu] Aichi Gakuin Univ, Sch Dent, Dept Fixed Prosthodont, Nagoya, Aichi, Japan; [Shimomura, Junko] Aichi Gakuin Univ, Fac Psychol & Phys Sci, Dept Hlth Sci, Nisshin, Aichi, Japan; [Hayashi, Noriko] Tokai Gakuen Univ, Nagoya, Aichi, Japan; [Toda, Sueko] Nagoya Univ Arts & Sci, Nisshin, Aichi, Japan	Aichi Gakuin University; Aichi Gakuin University	Morita, I (corresponding author), Japanese Red Cross Toyota Coll Nursing, Toyota, Aichi, Japan.	i-morita@rctoyota.ac.jp	Sakuma, Shigemitsu/AAP-4624-2020		Research Grant of 2016 Aichi Gakuin University Institute for Psychological and Physical Science	Research Grant of 2016 Aichi Gakuin University Institute for Psychological and Physical Science	This study poses no potential conflicts of interest. It was funded by the Research Grant of 2016 Aichi Gakuin University Institute for Psychological and Physical Science (JS).	Abdallah B, 2013, INFANT BEHAV DEV, V36, P662, DOI 10.1016/j.infbeh.2013.06.009; Ackerley R, 2014, J NEUROSCI, V34, P2879, DOI 10.1523/JNEUROSCI.2847-13.2014; Asadollahi Malihe, 2016, J Caring Sci, V5, P187; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett RH, 2014, SOC COGN AFFECT NEUR, V9, P470, DOI 10.1093/scan/nst008; Brady K, 2014, JOGNN-J OBST GYN NEO, V43, P488, DOI 10.1111/1552-6909.12469; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; Funane T, 2014, NEUROIMAGE, V85, P150, DOI 10.1016/j.neuroimage.2013.02.026; Goshiki T, 2008, PSYCHOLOGIA, V51, P28, DOI 10.2117/psysoc.2008.28; Hartley AA, 2000, MICROSC RES TECHNIQ, V51, P45, DOI 10.1002/1097-0029(20001001)51:1<45::AID-JEMT5>3.3.CO;2-F; Hoshi Y, 2003, PSYCHOPHYSIOLOGY, V40, P511, DOI 10.1111/1469-8986.00053; Inamoto K, 2015, NEUROSCI LETT, V588, P67, DOI 10.1016/j.neulet.2014.12.034; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; Kida T, 2013, NEUROSCI RES, V76, P76, DOI 10.1016/j.neures.2013.03.006; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Koizumi H, 1999, J BIOMED OPT, V4, P403, DOI 10.1117/1.429959; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lu DF, 2013, GERIATR NURS, V34, P314, DOI 10.1016/j.gerinurse.2013.05.003; MacIntyre B, 2008, ALTERN THER HEALTH M, V14, P24; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Naseer Noman, 2015, Front Hum Neurosci, V9, P3, DOI 10.3389/fnhum.2015.00003; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Pawling R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173457; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Robbins TW, 1996, PHILOS T ROY SOC B, V351, P1463, DOI 10.1098/rstb.1996.0131; Sakatani K, 1998, STROKE, V29, P1299, DOI 10.1161/01.STR.29.7.1299; Sakuma S, 2014, NEUROSCI LETT, V575, P74, DOI 10.1016/j.neulet.2014.05.040; Silani G, 2013, J NEUROSCI, V33, P15466, DOI 10.1523/JNEUROSCI.1488-13.2013; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; Watanabe E, 1996, NEUROSCI LETT, V205, P41, DOI 10.1016/0304-3940(96)12376-4; Weze C, 2005, PUBLIC HEALTH, V119, P3, DOI 10.1016/j.puhe.2004.03.003; Weze C, 2004, AM J PUBLIC HEALTH, V94, P50, DOI 10.2105/AJPH.94.1.50	36	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206451	10.1371/journal.pone.0206451	http://dx.doi.org/10.1371/journal.pone.0206451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY5SG	30372462	gold, Green Submitted, Green Published			2022-12-26	WOS:000448641200039
J	Sasaki, K; Ugajin, A; Harano, K				Sasaki, Ken; Ugajin, Atsushi; Harano, Ken-ichi			Caste-specific development of the dopaminergic system during metamorphosis in female honey bees	PLOS ONE			English	Article							DEPENDENT SEX DETERMINATION; APIS-MELLIFERA L; MUSHROOM BODIES; DROSOPHILA-MELANOGASTER; REPRODUCTIVE WORKERS; GENE-EXPRESSION; BRAIN; MECHANISMS; BEHAVIOR; QUEENS	Caste-specific differences in the dopaminergic systems of social insects assist in maintaining caste-specific behavior. To determine how caste differences in the honey bee occur during metamorphosis, a number of comparative analyses between castes were performed including comprehensive quantification of: levels of dopamine and its metabolite in the brain, the gene expression levels of enzymes involved in dopamine biosynthesis and conversion as well as expression levels of dopamine receptors and a dopamine transporter. Dopamine levels standardized to the protein contents of a whole brain at the day of eclosion in queens were 3.6-fold higher than those in workers. Dopamine levels increased until eclosion (7 days) in queens, whereas those in workers increased until 5-6 days before eclosion and then maintained until eclosion (10 days). These caste-specific dopamine dynamics in the brain were supported by the higher expression of genes (Amddc and Amth) encoding enzymes involved in dopamine synthesis in queens. The distribution of cells expressing Amddc in the brain revealed that soma clusters of dopaminergic cells were similar between castes at 7-8 days after pupation, suggesting the upregulation of Amddc expression in some cells in queens rather than addition of cell clusters. In contrast, genes encoding dopamine receptors were downregulated in queens or showed similar expression levels between castes. The expression of genes encoding dopamine transporters did not differ between castes. These results reveal the developmental process of caste-specific dopaminergic systems during metamorphosis in the honey bee, suggesting caste-specific behavior and division of reproduction in this highly eusocial species.	[Sasaki, Ken; Ugajin, Atsushi; Harano, Ken-ichi] Tamagawa Univ, Grad Sch Agr, Machida, Tokyo, Japan; [Ugajin, Atsushi] JT Biohist Res Hall, Murasaki Cho, Takatsuki, Osaka, Japan		Sasaki, K (corresponding author), Tamagawa Univ, Grad Sch Agr, Machida, Tokyo, Japan.	sasakik@agr.tamagawa.ac.jp		Sasaki, Ken/0000-0003-3515-2170; Ugajin, Atsushi/0000-0003-1834-3565	Japan Society for the Promotion of Science (JSPS) KAKENHI [26440181, 17K07491, 17K08154, 14J12036]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI grant numbers 26440181 (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-26440181/) and 17K07491 (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-17K07491/) to KS, 17K08154 (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-17K08154/) to KH and 14J12036 (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-14J12036/) (Grant-in-Aid for JSPS Research Fellow) to AU.	ARNOLD G, 1988, INT J INSECT MORPHOL, V17, P185, DOI 10.1016/0020-7322(88)90036-0; Beggs KT, 2005, INSECT BIOCHEM MOLEC, V35, P873, DOI 10.1016/j.ibmb.2005.03.005; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; Boulay R, 2001, PHYSIOL ENTOMOL, V26, P294, DOI 10.1046/j.0307-6962.2001.00250.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brakefield PM, 1996, TRENDS ECOL EVOL, V11, P275, DOI 10.1016/0169-5347(96)30025-6; BRANDES C, 1990, COMP BIOCHEM PHYS C, V97, P53, DOI 10.1016/0742-8413(90)90171-5; Brent CS, 2016, J COMP PHYSIOL B, V186, P169, DOI 10.1007/s00360-015-0953-1; Burrows M., 1996, NEUROBIOLOGY INSECT; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calcagno B, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.139; Corona M, 2016, CURR OPIN INSECT SCI, V13, P55, DOI 10.1016/j.cois.2015.12.003; Dodson JJ, 2013, BIOL REV, V88, P602, DOI 10.1111/brv.12019; Dombroski TCD, 2003, APIDOLOGIE, V34, P281, DOI 10.1051/apido:2003024; Evans P.D., 1980, Advances in Insect Physiology, V15, P317, DOI 10.1016/S0065-2806(08)60143-5; Farkhary S, 2017, J INSECT BEHAV, V30, P717, DOI 10.1007/s10905-017-9650-0; Farris SM, 1999, J COMP NEUROL, V414, P97, DOI 10.1002/(SICI)1096-9861(19991108)414:1&lt;97::AID-CNE8&gt;3.0.CO;2-Q; Ford CP, 2014, NEUROSCIENCE, V282, P13, DOI 10.1016/j.neuroscience.2014.01.025; Geddes LH, 2013, LEARN MEMORY, V20, P399, DOI 10.1101/lm.030825.113; Groh C, 2008, ARTHROPOD STRUCT DEV, V37, P459, DOI 10.1016/j.asd.2008.04.001; Harano K, 2008, PHYSIOL ENTOMOL, V33, P395, DOI 10.1111/j.1365-3032.2008.00644.x; HARRIS JW, 1995, COMP BIOCHEM PHYS C, V111, P271, DOI 10.1016/0742-8413(95)00048-S; Hartfelder K., 2005, P651; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; JAY S. CAMERON, 1962, BEE WORLD, V43, P119; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Kamhi JF, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00074; Kokay IC, 1997, J COMP PHYSIOL A, V181, P415, DOI 10.1007/s003590050125; Kurshan PT, 2003, J COMP NEUROL, V466, P91, DOI 10.1002/cne.10864; Laidlaw HH., 1997, QUEEN REARING BEE BR; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Matsuyama S, 2015, GEN COMP ENDOCR, V211, P1, DOI 10.1016/j.ygcen.2014.11.005; Nall A, 2014, BEHAV NEUROSCI, V128, P264, DOI 10.1037/a0036209; Neckameyer WS, 1998, LEARN MEMORY, V5, P157; O'Donnell S, 2011, P NATL ACAD SCI USA, V108, P7107, DOI 10.1073/pnas.1017566108; Okada Y, 2015, J EXP BIOL, V218, P1091, DOI 10.1242/jeb.118414; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Perry CJ, 2013, ANNU REV ENTOMOL, V58, P543, DOI 10.1146/annurev-ento-120811-153631; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pieau C, 2004, J ENDOCRINOL, V181, P367, DOI 10.1677/joe.0.1810367; Pinto LZ, 2003, INT J DEV BIOL, V47, P385; Rahman S, 2000, J NEUROCHEM, V74, P684, DOI 10.1046/j.1471-4159.2000.740684.x; Ramsey M, 2009, SEMIN CELL DEV BIOL, V20, P283, DOI 10.1016/j.semcdb.2008.10.004; Sasaki K, 2001, J INSECT PHYSIOL, V47, P1205, DOI 10.1016/S0022-1910(01)00105-6; Sasaki K, 2012, GEN COMP ENDOCR, V178, P46, DOI 10.1016/j.ygcen.2012.04.006; Sasaki K, 2009, NATURWISSENSCHAFTEN, V96, P625, DOI 10.1007/s00114-009-0510-4; SCHAFER S, 1989, J COMP NEUROL, V280, P43, DOI 10.1002/cne.902800105; Schapiro AM, 1976, EVOL BIOL, V9, P259; SCHURMANN FW, 1989, CELL TISSUE RES, V256, P399, DOI 10.1007/BF00218898; Shen ZG, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-26; Snodgrass R.E., 1956, ANATOMY HONEY BEE; TAYLOR DJ, 1992, J COMP PHYSIOL A, V170, P715, DOI 10.1007/BF00198982; Tedjakumala SR, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00047; Ugajin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032902; Vergoz V, 2012, INSECT MOL BIOL, V21, P21, DOI 10.1111/j.1365-2583.2011.01106.x; Verlinden H, 2009, GEN COMP ENDOCR, V162, P79, DOI 10.1016/j.ygcen.2008.11.016; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Wicker-Thomas C, 2008, J INSECT PHYSIOL, V54, P1423, DOI 10.1016/j.jinsphys.2008.08.005	59	8	8	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206624	10.1371/journal.pone.0206624	http://dx.doi.org/10.1371/journal.pone.0206624			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372493	Green Submitted, Green Published, gold			2022-12-26	WOS:000448641200048
J	Chen, YY; Fang, WH; Wang, CC; Kao, TW; Chang, YW; Yang, HF; Wu, CJ; Sun, YS; Chen, WL				Chen, Yuan-Yuei; Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Yang, Hui-Fang; Wu, Chen-Jung; Sun, Yu-Shan; Chen, Wei-Liang			Detrimental association between betel nut chewing and colorectal polyps in adult populations	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; METABOLIC SYNDROME; ORAL-CANCER; ARECA; RISK; OBESITY; COLON; INTERLEUKIN-6; EPIDEMIOLOGY; INFLAMMATION	Adverse systemic effect caused by betel nut had been reported for decades. Our aim was to determine whether betel nut had detrimental impact on the development of colorectal polyps in general population. Participants who attended health examinations at the Tri-Service General Hospital (TSGH) from 2010 to 2016 were included in the study. The habit of betel nut chewing was obtained from a self-reported questionnaire. Colorectal polyps were diagnosed by colonoscopies operated by experienced physicians. A logistic regression model was used for the association between betel nut chewing with the presence of colorectal polyps. After adjustment for pertinent information such as age, gender, biochemistry data and personal history, the odd ratios (ORs) of colorectal polyps among betel nut chewers was 1.49 (95%CI: 1.14-1.94). Besides, betel nut chewers in the higher percentage body fat (PBF) group had higher risk for developing colorectal polyps with ORs of 2.07 (95%CI:1.23-3.47). Subjects with habit of betel nut chewing were associated with an increased risk of colorectal polyps in Taiwanese general population. Screening for betel nut chewing history and encouraging cessation might offer improved quality of life. A further research for this association was warranted.	[Chen, Yuan-Yuei] Triserv Gen Hosp, Dept Internal Med, Songshan Branch, Taipei, Taiwan; [Chen, Yuan-Yuei; Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Yang, Hui-Fang; Wu, Chen-Jung; Sun, Yu-Shan; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chen, Yuan-Yuei; Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Yang, Hui-Fang; Wu, Chen-Jung; Sun, Yu-Shan; Chen, Wei-Liang] Triserv Gen Hosp, Div Family Med, Dept Family & Community Med, Taipei, Taiwan; [Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Yang, Hui-Fang; Sun, Yu-Shan; Chen, Wei-Liang] Triserv Gen Hosp, Hlth Management Ctr, Natl Def Med Ctr, Dept Family & Community Med, Taipei, Taiwan; [Kao, Tung-Wei; Chang, Yaw-Wen; Yang, Hui-Fang; Wu, Chen-Jung; Sun, Yu-Shan; Chen, Wei-Liang] Triserv Gen Hosp, Div Geriatr Med, Dept Family & Community Med, Taipei, Taiwan; [Kao, Tung-Wei] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Wu, Chen-Jung] Taoyuan Armed Forces Gen Hosp, Div Family Med, Dept Community Med, Taoyuan, Taiwan	Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; National Taiwan University	Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Triserv Gen Hosp, Div Family Med, Dept Family & Community Med, Taipei, Taiwan.	weiliang0508@gmail.com	Chang, Yaw-Wen/AAF-2630-2020	Chang, Yaw-Wen/0000-0002-8436-0518; Yang, Hui-Fang/0000-0001-6400-0462				An W, 2012, EUR J CANCER PREV, V21, P126, DOI 10.1097/CEJ.0b013e32834c9b55; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Benjamin Amos L., 2001, Papua New Guinea Medical Journal, V44, P101; Boucher BJ, 2002, ADDICT BIOL, V7, P103, DOI 10.1080/13556210120091464; Boucher BJ, 2001, INT J CANCER, V91, P592, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1085>3.0.CO;2-K; Burnett-Hartman AN, 2011, NUTR CANCER, V63, P583, DOI 10.1080/01635581.2011.553021; Chiang CJ, 2016, J FORMOS MED ASSOC, V115, P1076, DOI 10.1016/j.jfma.2015.10.011; Chu NS, 2002, ADDICT BIOL, V7, P111, DOI 10.1080/13556210120091473; Chung FM, 2006, DIABETES CARE, V29, P1714, DOI 10.2337/dc06-0628; Cowey S, 2006, AM J PATHOL, V169, P1505, DOI 10.2353/ajpath.2006.051090; Dasgupta R, 2010, MOL CELL ENDOCRINOL, V319, P1, DOI 10.1016/j.mce.2010.01.005; Endo H, 2011, GUT, V60, P1363, DOI 10.1136/gut.2010.235754; Fu ZM, 2012, AM J EPIDEMIOL, V176, P766, DOI 10.1093/aje/kws157; Giorgino F, 2005, ACTA PHYSIOL SCAND, V183, P13, DOI 10.1111/j.1365-201X.2004.01385.x; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Giri S, 2006, CHEM RES TOXICOL, V19, P818, DOI 10.1021/tx0600402; Grahn Sarah W, 2008, Clin Colon Rectal Surg, V21, P247, DOI 10.1055/s-0028-1089939; Gunter MJ, 2006, J NUTR BIOCHEM, V17, P145, DOI 10.1016/j.jnutbio.2005.06.011; Gupta PC, 2002, ADDICT BIOL, V7, P77, DOI 10.1080/13556210020091437; Harima S, 2013, HEPATO-GASTROENTEROL, V60, P733, DOI 10.5754/hge12895; Health, PREV COL CANC; Hsiao TJ, 2007, ANN EPIDEMIOL, V17, P479, DOI 10.1016/j.annepidem.2006.12.007; Hsu HF, 2010, TOXICOL APPL PHARM, V245, P370, DOI 10.1016/j.taap.2010.04.008; Huang XF, 2009, OBES REV, V10, P610, DOI 10.1111/j.1467-789X.2009.00607.x; Hursting SD, 2012, ARTERIOSCL THROM VAS, V32, P1766, DOI 10.1161/ATVBAHA.111.241927; Javed F, 2010, SCAND J PUBLIC HEALT, V38, P838, DOI 10.1177/1403494810379291; Jeng JH, 2003, CARCINOGENESIS, V24, P1301, DOI 10.1093/carcin/bgg083; Jinjuvadia R, 2013, J CLIN GASTROENTEROL, V47, P33, DOI 10.1097/MCG.0b013e3182688c15; Lan TY, 2007, AM J EPIDEMIOL, V165, P677, DOI 10.1093/aje/kwk056; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Leu CM, 2003, ONCOGENE, V22, P7809, DOI 10.1038/sj.onc.1207084; Lin WY, 2008, AM J CLIN NUTR, V87, P1204, DOI 10.1093/ajcn/87.5.1204; LING PR, 1994, METABOLISM, V43, P279, DOI 10.1016/0026-0495(94)90093-0; Marsland AL, 2010, METABOLISM, V59, P1801, DOI 10.1016/j.metabol.2010.05.015; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Park YB, 2002, LIFE SCI, V70, P1849, DOI 10.1016/S0024-3205(02)01485-6; Riondino S, 2014, WORLD J GASTROENTERO, V20, P5177, DOI 10.3748/wjg.v20.i18.5177; Sergi G, 2017, AGING CLIN EXP RES, V29, P591, DOI 10.1007/s40520-016-0622-6; Shafique K, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-67; Shrubsole MJ, 2008, AM J EPIDEMIOL, V167, P1050, DOI 10.1093/aje/kwm400; Trabulo D, 2015, WORLD J GASTROENTERO, V21, P5320, DOI 10.3748/wjg.v21.i17.5320; Tripkovic I, 2004, ARCH MED RES, V35, P215, DOI 10.1016/j.arcmed.2003.12.003; Wang FW, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/985205; Wollina U, 2002, HAUTARZT, V53, P795, DOI 10.1007/s00105-002-0413-1	44	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206383	10.1371/journal.pone.0206383	http://dx.doi.org/10.1371/journal.pone.0206383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359431	gold, Green Published, Green Submitted			2022-12-26	WOS:000448438400073
J	Kaur, A; Itell, HL; Ehlinger, EP; Varner, V; Gantt, S; Permar, SR				Kaur, Amitinder; Itell, Hannah L.; Ehlinger, E. Peek; Varner, Valerie; Gantt, Soren; Permar, Sallie R.			Natural history of postnatal rhesus cytomegalovirus shedding by dams and acquisition by infant rhesus monkeys	PLOS ONE			English	Article							T-LYMPHOCYTE RESPONSES; NONHUMAN PRIMATE MODEL; BREAST-MILK; PRETERM INFANTS; YOUNG-CHILDREN; DAY-CARE; INFECTION; VIRUS; TRANSMISSION; CMV	Background Human infants frequently acquire human cytomegalovirus (HCMV) through breastfeeding, resulting in persistent high-level viral shedding in saliva and urine and infectivity to others, including pregnant women. Thus, vaccination to interrupt postnatal HCMV transmission is an attractive strategy to prevent HCMV spread and congenital infection. Rhesus CMV (RhCMV) in nonhuman primates is a valuable model for the study of immune strategies to prevent CMV transmission. Although rhesus monkeys typically acquire RhCMV before 1 year of age, the timing and mode of natural infant RhCMV transmission remain unknown. Methods We followed 5 RhCMV-seropositive dams and their infants from birth until weaning, approximately 6 months later. RhCMV DNA levels in plasma, breast milk, saliva, and urine were measured every 2 weeks by quantitative PCR. RhCMV-specific T cell responses in peripheral blood and breast milk were measured by interferon gamma ELISpot assays. Serum IgG antibody levels were measured by ELISA. Results Four of five postpartum RhCMV-seropositive mothers had intermittent, low-level RhCMV shedding in breast milk, whereas all had high-magnitude RhCMV shedding in saliva and urine. The kinetics of maternal blood RhCMV-specific T cell responses and viral shedding in urine and saliva did not strongly associate, though dams with consistently high systemic RhCMV-specific T cell responses tended to have undetectable RhCMV shedding in breast milk. All RhCMV-exposed infants had intermittent, low-level RhCMV shedding in saliva during the lactation period, with minimal systemic RhCMV-specific T cell responses. Conclusions Despite exposure to RhCMV shedding in breast milk and other maternal fluids, postnatal mother-to-child RhCMV transmission appears to be less efficient than that of HCMV. A greater understanding of the determinants of RhCMV transmission and its usefulness as a model of HCMV mucosal acquisition may provide insight into strategies to prevent HCMV infections in humans.	[Kaur, Amitinder] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; [Itell, Hannah L.] Univ Washington, Mol & Cellular Biol PhD Program, Seattle, WA 98195 USA; [Ehlinger, E. Peek] Alaska Family Med Residency, Anchorage, AK USA; [Varner, Valerie] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA; [Gantt, Soren] Univ British Columbia, BC Childrens Hosp Res Inst, Vancouver, BC, Canada; [Permar, Sallie R.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27708 USA	Tulane University; University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of British Columbia; Duke University	Kaur, A (corresponding author), Tulane Natl Primate Res Ctr, Covington, LA 70433 USA.; Permar, SR (corresponding author), Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27708 USA.	akaur@tulane.edu; Sallie.permar@duke.edu		Itell, Hannah/0000-0001-8296-8645; Gantt, Soren/0000-0001-5743-3606; Permar, Sallie/0000-0003-1438-4554	DP2 grant - National Institutes of Health Office [4DP2-HD075699]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	DP2 grant - National Institutes of Health Office; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a DP2 grant awarded by the the National Institutes of Health Office of the Director to Dr. Sallie Permar (grant number: 4DP2-HD075699; https://projectreporter.nih.gov/project_info_description.cfm?aid=8844114&icde=0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2011, J VIROL, V85, P2878, DOI 10.1128/JVI.00883-10; Adland E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01016; ADLER SP, 1985, J INFECT DIS, V152, P760, DOI 10.1093/infdis/152.4.760; Antoine P, 2014, J INFECT DIS, V210, P1090, DOI 10.1093/infdis/jiu215; ASHER DM, 1974, P SOC EXP BIOL MED, V145, P794; Assaf BT, 2012, J VIROL, V86, P6354, DOI 10.1128/JVI.00607-12; Barry PA, 2006, ILAR J, V47, P49, DOI 10.1093/ilar.47.1.49; Barry PA, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P1051; BASKIN GB, 1988, VET PATHOL, V25, P456, DOI 10.1177/030098588802500609; Bialas KM, 2015, P NATL ACAD SCI USA, V112, P13645, DOI 10.1073/pnas.1511526112; CHOI YC, 1978, J INFECT DIS, V138, P197, DOI 10.1093/infdis/138.2.197; DWORSKY M, 1983, PEDIATRICS, V72, P295; Ehlinger EP, 2011, J INFECT DIS, V204, P1672, DOI 10.1093/infdis/jir632; Gantt S, 2016, J INFECT DIS, V214, P36, DOI 10.1093/infdis/jiw076; Hamprecht K, 2003, J CLIN VIROL, V28, P303, DOI 10.1016/S1386-6532(03)00074-X; Hamprecht K, 2001, LANCET, V357, P513, DOI 10.1016/S0140-6736(00)04043-5; Hamprecht K, 2008, J CLIN VIROL, V41, P198, DOI 10.1016/j.jcv.2007.12.005; Hansen SG, 2003, J VIROL, V77, P6620, DOI 10.1128/JVI.77.12.6620-6636.2003; Huff JL, 2003, J GEN VIROL, V84, P83, DOI 10.1099/vir.0.18808-0; HUTTO C, 1985, PEDIATR INFECT DIS J, V4, P149, DOI 10.1097/00006454-198503000-00008; Itell HL, 2017, CURR OPIN VIROL, V25, P126, DOI 10.1016/j.coviro.2017.08.005; Jim WT, 2009, PEDIATR INFECT DIS J, V28, P891, DOI 10.1097/INF.0b013e3181a55c52; JONES LA, 1985, J INFECT DIS, V151, P953, DOI 10.1093/infdis/151.5.953; Jones-Engel L, 2006, EMERG INFECT DIS, V12, P900, DOI 10.3201/eid1206.060030; Kanai K, 2011, J GEN VIROL, V92, P1005, DOI 10.1099/vir.0.027789-0; Kaur A, 1996, J VIROL, V70, P7725, DOI 10.1128/JVI.70.11.7725-7733.1996; Kaur A, 2003, J VIROL, V77, P5749, DOI 10.1128/JVI.77.10.5749-5758.2003; Kaur A, 2002, J VIROL, V76, P3646, DOI 10.1128/JVI.76.8.3646-3658.2002; Krause PR, 2013, VACCINE, V32, P4, DOI 10.1016/j.vaccine.2013.09.042; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Pilar RGM, 2015, J MED VIROL, V87, P845, DOI 10.1002/jmv.24101; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mayer BT, 2017, J VIROL, V91, DOI 10.1128/JVI.00380-17; Mayer BT, 2016, J INFECT DIS, V214, P1735, DOI 10.1093/infdis/jiw442; Moylan DC, 2017, J INFECT DIS, V216, P1176, DOI 10.1093/infdis/jix457; Murata H, 2009, PEDIATR INT, V51, P530, DOI 10.1111/j.1442-200X.2009.02814.x; Nelson CS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94002; Oxford KL, 2011, J VIROL, V85, P5105, DOI 10.1128/JVI.02631-10; Park AH, 2010, ARCH OTOLARYNGOL, V136, P48, DOI 10.1001/archoto.2009.210; PASS RF, 1987, NEW ENGL J MED, V316, P1366, DOI 10.1056/NEJM198705283162203; PASS RF, 1984, PEDIATRICS, V74, P121; PASS RF, 1986, NEW ENGL J MED, V314, P1414, DOI 10.1056/NEJM198605293142204; Pass RF., 1990, SEMIN PEDIATR INFECT, V1, P245; Powers C, 2008, MED MICROBIOL IMMUN, V197, P109, DOI 10.1007/s00430-007-0073-y; PREECE PM, 1984, ARCH DIS CHILD, V59, P1120, DOI 10.1136/adc.59.12.1120; Rivailler P, 2006, J VIROL, V80, P4179, DOI 10.1128/JVI.80.8.4179-4182.2006; Roxby AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087855; Schleiss MR, 2010, FUTURE VIROL, V5, P207, DOI 10.2217/FVL.10.8; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; SWACK NS, 1982, J MED PRIMATOL, V11, P169; TABER LH, 1985, J INFECT DIS, V151, P948, DOI 10.1093/infdis/151.5.948; Vochem M, 1998, PEDIATR INFECT DIS J, V17, P53, DOI 10.1097/00006454-199801000-00012; VOGEL P, 1994, LAB ANIM SCI, V44, P25; Wang ZC, 2006, J VIROL, V80, P2771, DOI 10.1128/JVI.80.6.2771-2783.2006; Yasuda A, 2003, PEDIATRICS, V111, P1333, DOI 10.1542/peds.111.6.1333	55	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206330	10.1371/journal.pone.0206330	http://dx.doi.org/10.1371/journal.pone.0206330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356332	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000094
J	Piil, JF; Lundbye-Jensen, J; Christiansen, L; Ioannou, L; Tsoutsoubi, L; Dallas, CN; Mantzios, K; Flouris, AD; Nybo, L				Piil, Jacob F.; Lundbye-Jensen, Jesper; Christiansen, Lasse; Ioannou, Leonidas; Tsoutsoubi, Lydia; Dallas, Constantinos N.; Mantzios, Konstantinos; Flouris, Andreas D.; Nybo, Lars			High prevalence of hypohydration in occupations with heat stress-Perspectives for performance in combined cognitive and motor tasks	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; PROLONGED EXERCISE; HYDRATION STATUS; PASSIVE HYPERTHERMIA; DEHYDRATION; WORKERS; MOOD; IMPACT; METABOLISM; INCREASES	Purpose To evaluate the prevalence of dehydration in occupational settings and contextualize findings to effects on performance in cognitively dominated tasks, simple and complex motor tasks during moderate and high heat stress. Methods The study included an occupational part with hydration assessed in five industries across Europe with urine samples collected from 139 workers and analyzed for urine specific gravity. In addition, laboratory experiments included eight male participants completing mildintensity exercise once with full fluid replacement to maintain euhydration, and once with restricted water intake until the dehydration level corresponded to 2% bodyweight deficit. Following familiarization, euhydration and dehydration sessions were completed on separate days in random order (cross-over design) with assessment of simple motor (target pinch), complex motor (visuo-motor tracking), cognitive (math addition) and combined motor-cognitive (math and pinch) performance at baseline, at 1 degrees C (MOD) and 2 degrees C (HYPER) delta increase in body core temperature. Results The field studies revealed that 70% of all workers had urine specific gravity values >= 1.020 corresponding to the urine specific gravity (1.020 +/- 0.001) at the end of the laboratory dehydration session. At this hydration level, HYPER was associated with reductions in simple motor task performance by 4 +/- 1%, math task by 4 +/- 1%, math and pinch by 9 +/- 3% and visuomotor tracking by 16 +/- 4% (all P<0.05 compared to baseline), whereas no significant changes were observed when the heat stress was MOD (P>0.05). In the euhydration session, HYPER reduced complex (tracking) motor performance by 10 +/- 3% and simple pinch by 3 +/- 1% (both P<0.05, compared to baseline), while performance in the two cognitively dominated tasks were unaffected when dehydration was prevented (P>0.05). Conclusion Dehydration at levels commonly observed across a range of occupational settings with environmental heat stress aggravates the impact of hyperthermia on performance in tasks relying on combinations of cognitive function and motor response accuracy.	[Piil, Jacob F.; Lundbye-Jensen, Jesper; Christiansen, Lasse; Nybo, Lars] Univ Copenhagen, Dept Nutr Exercise & Sports, Sect Integrat Physiol, Copenhagen, Denmark; [Ioannou, Leonidas; Tsoutsoubi, Lydia; Dallas, Constantinos N.; Mantzios, Konstantinos; Flouris, Andreas D.] Univ Thessaly, Dept Exercise Sci, FAME Lab, Karies, Trikala, Greece	University of Copenhagen; University of Thessaly	Piil, JF (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sports, Sect Integrat Physiol, Copenhagen, Denmark.	jpp@nexs.ku.dk	Flouris, Andreas/GXG-4893-2022; Lundbye-Jensen, Jesper/ABH-4025-2020; Piil, Jacob Feder/L-6210-2016; Christiansen, Lasse/D-2658-2015; Nybo, Lars/P-6153-2014	Lundbye-Jensen, Jesper/0000-0003-3144-861X; Piil, Jacob Feder/0000-0001-8583-1150; Christiansen, Lasse/0000-0002-9316-1529; Nybo, Lars/0000-0002-9090-1958; Tsoutsoubi, Lydia/0000-0002-5093-1458; Ioannou, Leonidas/0000-0001-5460-8167	European Union's Horizon 2020 research and innovation program [668786]	European Union's Horizon 2020 research and innovation program	The study has received funding from the European Union's Horizon 2020 research and innovation program under the grant agreement No 668786 to LN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam GE, 2008, PHYSIOL BEHAV, V93, P748, DOI 10.1016/j.physbeh.2007.11.028; Armstrong LE, 2012, J NUTR, V142, P382, DOI 10.3945/jn.111.142000; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bates GP, 2010, ANN OCCUP HYG, V54, P137, DOI 10.1093/annhyg/mep076; Benton D, 2011, NUTRIENTS, V3, P555, DOI 10.3390/nu3050555; Biggs C, 2011, ANN OCCUP HYG, V55, P6, DOI 10.1093/annhyg/meq068; Brearley M, 2015, J OCCUP ENVIRON HYG, V12, P156, DOI 10.1080/15459624.2014.957831; Castro-Sepulveda M, 2016, J HUM KINET, V50, P79, DOI 10.1515/hukin-2015-0145; Cheuvront SN, 2014, COMPR PHYSIOL, V4, P257, DOI 10.1002/cphy.c130017; Cheuvront SN, 2010, J APPL PHYSIOL, V109, P1989, DOI 10.1152/japplphysiol.00367.2010; Convertino VA, MED SCI SPORTS EXERC, V28; CRAIG FN, 1966, J APPL PHYSIOL, V21, P670, DOI 10.1152/jappl.1966.21.2.670; Ely BR, 2013, EUR J APPL PHYSIOL, V113, P1027, DOI 10.1007/s00421-012-2506-6; Farshad A, 2014, IRAN J PUBLIC HEALTH, V43, P492; Ganio MS, 2011, BRIT J NUTR, V106, P1535, DOI 10.1017/S0007114511002005; Gaoua N, 2018, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02290; Gaoua N, 2011, INT J HYPERTHER, V27, P1, DOI 10.3109/02656736.2010.519371; Garcia-Trabanino R, 2015, ENVIRON RES, V142, P746, DOI 10.1016/j.envres.2015.07.007; Gonzalez-Alonso J, 1998, INT J SPORTS MED, V19, pS111, DOI 10.1055/s-2007-971972; GONZALEZALONSO J, 1995, J APPL PHYSIOL, V79, P1487, DOI 10.1152/jappl.1995.79.5.1487; GonzalezAlonso J, 1997, J APPL PHYSIOL, V82, P1229, DOI 10.1152/jappl.1997.82.4.1229; GOPINATHAN PM, 1988, ARCH ENVIRON HEALTH, V43, P15, DOI 10.1080/00039896.1988.9934367; Grandjean AC, 2007, J AM COLL NUTR, V26, p549S, DOI 10.1080/07315724.2007.10719657; Hancock PA, 2003, INT J HYPERTHER, V19, P355, DOI 10.1080/0265673021000054630; HANCOCK PA, 1982, AVIAT SPACE ENVIR MD, V53, P778; Hocking C, 2001, COMP BIOCHEM PHYS A, V128, P719, DOI 10.1016/S1095-6433(01)00278-1; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kantak SS, 2012, BEHAV BRAIN RES, V228, P219, DOI 10.1016/j.bbr.2011.11.028; Kempton MJ, 2011, HUM BRAIN MAPP, V32, P71, DOI 10.1002/hbm.20999; Lieberman HR, 2007, J AM COLL NUTR, V26, p555S, DOI 10.1080/07315724.2007.10719658; Lindseth PD, 2013, MIL MED, V178, P792, DOI 10.7205/MILMED-D-13-00013; Liu K, 2013, BEHAV BRAIN RES, V243, P220, DOI 10.1016/j.bbr.2013.01.013; Lutz EA, 2014, J OCCUP ENVIRON MED, V56, P388, DOI 10.1097/JOM.0000000000000107; Masento NA, 2014, BRIT J NUTR, V111, P1841, DOI 10.1017/S0007114513004455; Maughan RJ, 2003, EUR J CLIN NUTR, V57, pS19, DOI 10.1038/sj.ejcn.1601897; Montazer S, 2013, INT J OCCUP MED ENV, V26, P762, DOI 10.2478/s13382-013-0143-x; Morley J, 2012, EUR J APPL PHYSIOL, V112, P1733, DOI 10.1007/s00421-011-2144-4; Nielsen B., 1981, SCAND J MED SCI SPOR, V3, P2; Nybo L, 2002, J APPL PHYSIOL, V93, P58, DOI 10.1152/japplphysiol.00049.2002; Nybo L, 2001, J APPL PHYSIOL, V91, P1055, DOI 10.1152/jappl.2001.91.3.1055; Nybo L, 2001, J APPL PHYSIOL, V90, P1057, DOI 10.1152/jappl.2001.90.3.1057; Nybo L, 2014, COMPR PHYSIOL, V4, P657, DOI 10.1002/cphy.c130012; Osterberg KL, 2009, J ATHL TRAINING, V44, P53, DOI 10.4085/1062-6050-44.1.53; Periard JD, 2014, MUSCLE NERVE, V50, P822, DOI 10.1002/mus.24228; Piil Jacob F, 2017, Temperature (Austin), V4, P420, DOI 10.1080/23328940.2017.1368877; Racinais S, 2015, SPORTS MED, V45, P925, DOI 10.1007/s40279-015-0343-6; Racinais S, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.19; Sahu S, 2013, IND HEALTH, V51, P424, DOI 10.2486/indhealth.2013-0006; Sawka MN, 2000, AM J CLIN NUTR, V72, p564S, DOI 10.1093/ajcn/72.2.564S; Spector JT, 2018, APPL ERGON, V67, P1, DOI 10.1016/j.apergo.2017.09.002; Taylor L, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00372; Tomporowski PD, 2007, INT J SPORTS MED, V28, P891, DOI 10.1055/s-2007-965004; Trangmar SJ, 2017, EXERC SPORT SCI REV, V45, P146, DOI 10.1249/JES.0000000000000109; Trangmar SJ, 2015, AM J PHYSIOL-HEART C, V309, pH1598, DOI 10.1152/ajpheart.00525.2015; Trangmar SJ, 2014, J PHYSIOL-LONDON, V592, P3143, DOI 10.1113/jphysiol.2014.272104; van den Heuvel AMJ, 2017, EUR J APPL PHYSIOL, V117, P1025, DOI 10.1007/s00421-017-3592-2; Wasterlund DS, 2004, APPL ERGON, V35, P29, DOI 10.1016/j.apergo.2003.09.002; Watson P, 2015, PHYSIOL BEHAV, V147, P313, DOI 10.1016/j.physbeh.2015.04.028	58	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205321	10.1371/journal.pone.0205321	http://dx.doi.org/10.1371/journal.pone.0205321			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356308	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000051
J	Zabeck, H; Dienemann, H; Hoffmann, H; Pfannschmidt, J; Warth, A; Schnabel, PA; Muley, T; Meister, M; Sultmann, H; Frohlich, H; Kuner, R; Lasitschka, F				Zabeck, Heike; Dienemann, Hendrik; Hoffmann, Hans; Pfannschmidt, Joachim; Warth, Arne; Schnabel, Philipp A.; Muley, Thomas; Meister, Michael; Sueltmann, Holger; Froehlich, Holger; Kuner, Ruprecht; Lasitschka, Felix			Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma	PLOS ONE			English	Article							RESPIRATORY SOCIETY CLASSIFICATION; INTERNATIONAL-ASSOCIATION; GENE-EXPRESSION; INDEPENDENT PREDICTOR; SURVIVAL; MICRODISSECTION; RECURRENCE; ANGIOGENIN	Background The current classification of human lung adenocarcinoma defines five different histological growth patterns within the group of conventional invasive adenocarcinomas. The five growth patterns are characterised by their typical architecture, but also by variable tumor biological behaviour. Aims The aim of this study was to identify specific gene signatures of the five adenocarcinoma growth patterns defined by the joint IASLC/ATS/ERS working group. Methods Total RNA from microdissected adenocarcinoma tissue samples of ten lepidic, ten acinar, ten solid, nine papillary, and nine micropapillary tumor portions was isolated and prepared for gene expression analysis. Differential expression of genes was determined using the R package "LIMMA". The overall significance of each signature was assessed via global test. Gene ontology statistics were analysed using GOstat. For immunohistochemical validation, tissue specimens from 20 tumors with solid and 20 tumors with lepidic growth pattern were used. Results Microarray analyses between the growth patterns resulted in numerous differentially expressed genes between the solid architecture and other patterns. The comparison of transcriptomic activity in the solid and lepidic patterns revealed 705 up- and 110 downregulated non-redundant genes. The pattern-specific protein expression of Inositol-1,4,5-trisphosphate-kinase-A (ITPKA) and angiogenin by immunohistochemistry confirmed the RNA levels. The strongest differences in protein expression between the two patterns were shown for ITPKA (p = 0.02) and angiogenin (p = 0.113). Conclusions In this study growth pattern-specific gene signatures in pulmonary adenocarcinoma were identified and distinct transcriptomic differences between lung adenocarcinoma growth patterns were defined. The study provides valuable new information about pulmonary adenocarcinoma and allows a better assessment of the five adenocarcinoma subgroups.	[Zabeck, Heike; Dienemann, Hendrik; Hoffmann, Hans; Pfannschmidt, Joachim] Univ Hosp Heidelberg, Thoraxklin, Dept Thorac Surg, Heidelberg, Germany; [Hoffmann, Hans; Warth, Arne; Muley, Thomas; Meister, Michael; Sueltmann, Holger; Kuner, Ruprecht] German Ctr Lung Res DZL, Translat Lung Res Ctr Heidelberg, Heidelberg, Germany; [Warth, Arne; Schnabel, Philipp A.; Lasitschka, Felix] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany; [Muley, Thomas; Meister, Michael] Heidelberg Univ, Translat Res Unit STF, Thoraxklin, Heidelberg, Germany; [Sueltmann, Holger; Kuner, Ruprecht] German Canc Res Ctr, Canc Genome Res B063, Heidelberg, Germany; [Sueltmann, Holger; Kuner, Ruprecht] German Canc Consortium DKTK, Heidelberg, Germany; [Froehlich, Holger] Univ Bonn, Algorithm Bioinformat, Bonn Aachen Int Ctr IT, Inst Comp Sci, Bonn, Germany; [Pfannschmidt, Joachim] HELIOS Hosp Emil von Behring, Lung Clin Heckeshorn, Dept Thorac Surg, Berlin, Germany; [Schnabel, Philipp A.] Saarland Univ, Inst Pathol, Homburg, Germany; [Kuner, Ruprecht] Johannes Gutenberg Univ Mainz, Univ Med Ctr, TRON Translat Oncol, Mainz, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Bonn; Universitatsklinikum des Saarlandes; Johannes Gutenberg University of Mainz	Zabeck, H (corresponding author), Univ Hosp Heidelberg, Thoraxklin, Dept Thorac Surg, Heidelberg, Germany.	heike.zabeck@med.uni-heidelberg.de	Muley, Thomas/AAY-9200-2020; Pfannschmidt, Joachim/AAF-4225-2020; Fröhlich, Holger/H-1976-2017; Sultmann, Holger/E-4534-2013	Pfannschmidt, Joachim/0000-0002-6779-1826; Fröhlich, Holger/0000-0002-5328-1243; Sultmann, Holger/0000-0002-5257-8600	"Stiftung fur Krebs- und Scharlachforschung Mannheim"; German Federal Ministry of Education and Research: German Center for Lung Research [82DZL00404]	"Stiftung fur Krebs- und Scharlachforschung Mannheim"; German Federal Ministry of Education and Research: German Center for Lung Research	This study was supported by the "Stiftung fur Krebs- und Scharlachforschung Mannheim" and by the German Federal Ministry of Education and Research: German Center for Lung Research (82DZL00404). The funders had no role in study design, data collection and Analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Burgemeister R, 2005, J HISTOCHEM CYTOCHEM, V53, P409, DOI 10.1369/jhc.4B6421.2005; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Hergenhahn M, 2003, PATHOL RES PRACT, V199, P419, DOI 10.1078/0344-0338-00440; Hung JJ, 2013, ANN SURG, V258, P1079, DOI 10.1097/SLA.0b013e31828920c0; Izumchenko E, 2014, CANCER RES, V74, P3995, DOI 10.1158/0008-5472.CAN-14-0110; Jacobsen B, 2013, J THORAC ONCOL, V8, P152, DOI 10.1097/JTO.0b013e318279d503; Kadota K, 2013, CANCER-AM CANCER SOC, V119, P931, DOI 10.1002/cncr.27863; Mazieres J, 2013, LUNG CANCER, V82, P231, DOI 10.1016/j.lungcan.2013.07.016; Pirker R, 2012, LANCET ONCOL, V13, P33, DOI 10.1016/S1470-2045(11)70318-7; Russell PA, 2011, J THORAC ONCOL, V6, P1496, DOI 10.1097/JTO.0b013e318221f701; Sadagopan S, 2012, ONCOGENE, V31, P4835, DOI 10.1038/onc.2011.648; Schroder D, 2013, BIOCHEM BIOPH RES CO, V439, P228, DOI 10.1016/j.bbrc.2013.08.053; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Solis LM, 2012, CANCER-AM CANCER SOC, V118, P2889, DOI 10.1002/cncr.26584; Travis WD, 2013, ARCH PATHOL LAB MED, V137, P685, DOI 10.5858/arpa.2012-0264-RA; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Walker WL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-494; Warth A, 2012, J CLIN ONCOL, V30, P1438, DOI 10.1200/JCO.2011.37.2185; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Windhorst S, 2011, INT J CANCER, V129, P1300, DOI 10.1002/ijc.25782; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Yuan Y, 2009, LUNG CANCER, V66, P28, DOI 10.1016/j.lungcan.2008.12.027; Zwiener I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085150	31	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206132	10.1371/journal.pone.0206132	http://dx.doi.org/10.1371/journal.pone.0206132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352093	gold, Green Published			2022-12-26	WOS:000448076200029
J	Jia, YF; Gu, DS; Wan, J; Yu, BQ; Zhang, XL; Chiorean, EG; Wang, YS; Xie, JW				Jia, Yanfei; Gu, Dongsheng; Wan, Jun; Yu, Beiqin; Zhang, Xiaoli; Chiorean, E. Gabriela; Wang, Yunshan; Xie, Jingwu			The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer	ONCOGENE			English	Article							STEM-CELLS; HEDGEHOG PATHWAY; PROMOTES; INHIBITION; IDENTIFICATION; CHEMOTHERAPY; ACTIVATION; GROWTH; EXPRESSION; TRIAL	Pancreatic cancer, mostly pancreatic ductal adenocarcinomas (PDAC), is one of the most lethal cancers, with a dismal median survival around 8 months. PDAC is notoriously resistant to chemotherapy. Thus far, numerous attempts using novel targeted therapies and immunotherapies yielded limited clinical benefits for pancreatic cancer patients. It is hoped that delineating the molecular mechanisms underlying drug resistance in pancreatic cancer may provide novel therapeutic options. Using acquired gemcitabine resistant pancreatic cell lines, we revealed an important role of the GLI-SOX2 signaling axis for regulation of gemcitabine sensitivity in vitro and in animal models. Down-regulation of GLI transcriptional factors (GLI1 or GLI2), but not SMO signaling inhibition, reduces tumor sphere formation, a characteristics of tumor initiating cell (TIC). Down-regulation of GLI transcription factors also decreased expression of TIC marker CD24. Similarly, high SOX2 expression is associated with gemcitabine resistance whereas down-regulation of SOX2 sensitizes pancreatic cancer cells to gemcitabine treatment. We further revealed that elevated SOX2 expression is associated with an increase in GLI1 or GLI2 expression. Our ChIP assay revealed that GLI proteins are associated with a putative Gli binding site within the SOX2 promoter, suggesting a more direct regulation of SOX2 by GLI transcription factors. The relevance of our findings to human disease was revealed in human cancer specimens. We found that high SOX2 protein expression is associated with frequent tumor relapse and poor survival in stage II PDAC patients (all of them underwent gemcitabine treatment), indicating that reduced SOX2 expression or down-regulation of GLI transcription factors may be effective in sensitizing pancreatic cancer cells to gemcitabine treatment.	[Jia, Yanfei; Wang, Yunshan] Shandong Univ, Cent Lab, Jinan Cent Hosp, Jinan, Shandong, Peoples R China; [Jia, Yanfei; Gu, Dongsheng; Yu, Beiqin; Zhang, Xiaoli; Xie, Jingwu] Indiana Univ Sch Med, Dept Pediat, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Wan, Jun] Indiana Univ, Simon Canc Ctr, Dept Mol & Med Genet, Indianapolis, IN 46202 USA; [Yu, Beiqin] Shanghai Jiao Tong Univ, Shanghai Key Lab Gastr Neoplasms, Shanghai Inst Digest Surg, Ruijin Hosp,Sch Med, Shanghai 200025, Peoples R China; [Chiorean, E. Gabriela] Univ Washington, Div Med Oncol, 825 Eastlake Ave E,G4-833, Seattle, WA 98109 USA; [Chiorean, E. Gabriela] Fred Hutchinson Canc Res Ctr, 825 Eastlake Ave E,G4-833, Seattle, WA 98109 USA	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Shanghai Jiao Tong University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Wang, YS (corresponding author), Shandong Univ, Cent Lab, Jinan Cent Hosp, Jinan, Shandong, Peoples R China.; Xie, JW (corresponding author), Indiana Univ Sch Med, Dept Pediat, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.	w_yunshan@126.com; jinxie@iu.edu	Liu, Bingya/GMW-5655-2022; Xie, J/AAR-7259-2020; Wan, Jun/AAN-1337-2020; Xin, Xiaofei/N-4518-2018	Wan, Jun/0000-0001-9286-6562; Xin, Xiaofei/0000-0002-7618-0808; xie, jingwu/0000-0002-3674-332X	Department of Pediatrics; Well Center for Pediatric Research; Jeff Gordon Research Laboratory; AGA; Healthcare Initiatives, Inc.; CTSI Indiana; Walther Cancer Foundation; Riley Foundation for Children; National Natural Science Foundation of China [31671468, 81602593]; Shandong Provincial Natural Science Foundation of China [ZR2015HM018];  [NIH-R01-155086]; NATIONAL CANCER INSTITUTE [R01CA155086] Funding Source: NIH RePORTER	Department of Pediatrics; Well Center for Pediatric Research; Jeff Gordon Research Laboratory; AGA; Healthcare Initiatives, Inc.; CTSI Indiana; Walther Cancer Foundation; Riley Foundation for Children; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank you Professor Keping Xie and Dr. Zizheng Dong for help with cell line generation, and generous support from the Department of Pediatrics, The Well Center for Pediatric Research, Jeff Gordon Research Laboratory, AGA, Healthcare Initiatives, Inc., and CTSI Indiana. The bioinformatics data analysis was performed in collaboration with the Collaborative Core for Cancer Bioinformatics (C3B) shared by Indiana University Simon Cancer Center and Purdue University Center for Cancer Research with support from the Walther Cancer Foundation. This work was supported by the following grants and foundations: NIH-R01-155086; Riley Foundation for Children; National Natural Science Foundation of China (No. 31671468 and 81602593), Shandong Provincial Natural Science Foundation of China (ZR2015HM018).	Abel EV, 2013, GASTROENTEROLOGY, V144, P1241, DOI 10.1053/j.gastro.2013.01.072; Athar M, 2004, CANCER RES, V64, P7545, DOI 10.1158/0008-5472.CAN-04-1393; Boehme KA, 2016, INT J ONCOL, V48, P801, DOI 10.3892/ijo.2015.3293; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Cao X, 2012, ONCOGENE, V31, P104, DOI 10.1038/onc.2011.219; Catenacci DVT, 2015, J CLIN ONCOL, V33, P4284, DOI 10.1200/JCO.2015.62.8719; Chen T, 2012, CELL RES, V22, P248, DOI 10.1038/cr.2011.109; Chen WJ, 2013, HEPATO-GASTROENTEROL, V60, P949, DOI 10.5754/hge12881; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Fan QP, 2014, CANCER RES, V74, P471, DOI 10.1158/0008-5472.CAN-13-2134-T; Frenzel A, 2009, APOPTOSIS, V14, P584, DOI 10.1007/s10495-008-0300-z; Fukamachi H, 2011, CANCER SCI, V102, P1313, DOI 10.1111/j.1349-7006.2011.01947.x; Goldman J, 2015, CLIN CANCER RES, V21, P1002, DOI 10.1158/1078-0432.CCR-14-1234; Gu DS, 2013, MOL CANCER THER, V12, P1038, DOI 10.1158/1535-7163.MCT-12-1030; GUDJONSSON B, 1987, CANCER, V60, P2284, DOI 10.1002/1097-0142(19871101)60:9<2284::AID-CNCR2820600930>3.0.CO;2-V; He J, 2006, J BIOL CHEM, V281, P35598, DOI 10.1074/jbc.C600200200; Hong SP, 2009, INT J CANCER, V125, P2323, DOI 10.1002/ijc.24573; Huang SH, 2006, CARCINOGENESIS, V27, P1334, DOI 10.1093/carcin/bgi378; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Jeon HM, 2011, CANCER RES, V71, P3410, DOI 10.1158/0008-5472.CAN-10-3340; Jiang J, 2012, ONCOGENE, V31, P671, DOI 10.1038/onc.2011.282; Julian LM, 2017, CURR OPIN GENET DEV, V46, P24, DOI 10.1016/j.gde.2017.06.005; Justilien V, 2015, CLIN CANCER RES, V21, P505, DOI 10.1158/1078-0432.CCR-14-0507; Kim EJ, 2014, CLIN CANCER RES, V20, P5937, DOI 10.1158/1078-0432.CCR-14-1269; Kim J, 2013, CANCER CELL, V23, P23, DOI 10.1016/j.ccr.2012.11.017; Lauressergues E, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.214; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu Hailan, 2011, Chin J Cancer, V30, P13; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; Ma XL, 2006, INT J CANCER, V118, P139, DOI 10.1002/ijc.21295; Mondesire WH, 2004, CLIN CANCER RES, V10, P7031, DOI 10.1158/1078-0432.CCR-04-0361; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; O'Neil BH, 2015, ANN ONCOL, V26, P2505, DOI 10.1093/annonc/mdv477; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Peter Marcus E, 2004, Biochem J, V382, pe1; Piva M, 2014, EMBO MOL MED, V6, P66, DOI 10.1002/emmm.201303411; Platzbecker U, 2017, J CLIN ONCOL, V35, P605, DOI 10.1200/JCO.2016.67.1982; Rahib L, 2016, JAMA ONCOL, V2, P1209, DOI 10.1001/jamaoncol.2016.0585; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rassouli FB, 2016, TUMOR BIOL, V37, P7, DOI 10.1007/s13277-015-4155-y; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schniewind B, 2004, INT J CANCER, V109, P182, DOI 10.1002/ijc.11679; Shimokawa T, 2008, J BIOL CHEM, V283, P14345, DOI 10.1074/jbc.M800299200; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stacy AE, 2013, MOL PHARMACOL, V84, P655, DOI 10.1124/mol.113.088609; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Takebe N, 2015, NAT REV CLIN ONCOL, V12, P445, DOI 10.1038/nrclinonc.2015.61; Tesei A, 2002, CLIN CANCER RES, V8, P233; Vogelzang NJ, 2012, J CLIN ONCOL, V30, P88, DOI 10.1200/JCO.2011.40.1919; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang T, 2011, BRIT J CANCER, V105, P658, DOI 10.1038/bjc.2011.287; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Yang DG, 2013, ACTA HAEMATOL-BASEL, V130, P260, DOI 10.1159/000351603; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392; Yu BQ, 2017, ONCOTARGET, V8, P27412, DOI 10.18632/oncotarget.16174; Zhang LN, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0145-7; Zhang ZL, 2016, CANCER LETT, V382, P53, DOI 10.1016/j.canlet.2016.08.023; Zhao D, 2013, CANCER CELL, V23, P464, DOI 10.1016/j.ccr.2013.02.005; Zhao HQ, 2017, J CELL MOL MED, V21, P2055, DOI 10.1111/jcmm.13126	60	31	33	0	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2019	38	10					1764	1777		10.1038/s41388-018-0553-0	http://dx.doi.org/10.1038/s41388-018-0553-0			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN8DD	30382189	hybrid, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000460423800014
J	Pulugulla, SH; Workman, R; Rutter, NW; Yang, ZY; Adamik, J; Lupish, B; Macar, DA; el Abdouni, S; Esposito, EX; Galson, DL; Camacho, CJ; Madura, JD; Auron, PE				Pulugulla, Sree H.; Workman, Riley; Rutter, Nathan W.; Yang, Zhiyong; Adamik, Juraj; Lupish, Brian; Macar, David A.; el Abdouni, Samir; Esposito, Emilio Xavier; Galson, Deborah L.; Camacho, Carlos J.; Madura, Jeffry D.; Auron, Philip E.			A combined computational and experimental approach reveals the structure of a C/EBP-Spi1 interaction required for IL1B gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interleukin 1 (IL-1); ETS transcription factor family; CCAAT-enhancer-binding protein (C; EBP); gene transcription; protein-protein interaction; molecular docking; molecular dynamics; inflammation; cytokine	CONSERVED ETS DOMAIN; PROTEIN-PROTEIN; INTERLEUKIN-1-BETA GENE; FACTORS NF-IL6; FORCE-FIELD; DNA-BINDING; FACTOR PU.1; WEB SERVER; ACTIVATION; EXPRESSION	We previously reported that transcription of the human IL1B gene, encoding the proinflammatory cytokine interleukin 1, depends on long-distance chromatin looping that is stabilized by a mutual interaction between the DNA-binding domains (DBDs) of two transcription factors: Spi1 proto-oncogene at the promoter and CCAAT enhancer-binding protein (C/EBP) at a far-upstream enhancer. We have also reported that the C-terminal tail sequence beyond the C/EBP leucine zipper is critical for its association with Spi1 via an exposed residue (Arg-232) located within a pocket at one end of the Spi1 DNA-recognition helix. Here, combining in vitro interaction studies with computational docking and molecular dynamics of existing X-ray structures for the Spi1 and C/EBP DBDs, along with the C/EBP C-terminal tail sequence, we found that the tail sequence is intimately associated with Arg-232 of Spi1. The Arg-232 pocket was computationally screened for small-molecule binding aimed at IL1B transcription inhibition, yielding l-arginine, a known anti-inflammatory amino acid, revealing a potential for disrupting the C/EBP-Spi1 interaction. As evaluated by ChIP, cultured lipopolysaccharide (LPS)-activated THP-1 cells incubated with l-arginine had significantly decreased IL1B transcription and reduced C/EBP's association with Spi1 on the IL1B promoter. No significant change was observed in direct binding of either Spi1 or C/EBP to cognate DNA and in transcription of the C/EBP-dependent IL6 gene in the same cells. These results support the notion that disordered sequences extending from a leucine zipper can mediate protein-protein interactions and can serve as druggable targets for regulating gene promoter activity.	[Pulugulla, Sree H.; Lupish, Brian; Macar, David A.; Madura, Jeffry D.; Auron, Philip E.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Workman, Riley; Rutter, Nathan W.; Madura, Jeffry D.] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA; [Yang, Zhiyong] Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Adamik, Juraj; Galson, Deborah L.] Univ Pittsburgh, Dept Med, Hillman Canc Ctr, UPMC, 930 Scaife Hall, Pittsburgh, PA 15213 USA; [el Abdouni, Samir; Camacho, Carlos J.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Esposito, Emilio Xavier] ExeResearch, E Lansing, MI 48823 USA; [Galson, Deborah L.; Auron, Philip E.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Yang, Zhiyong] Janssen Res & Dev, Cardiovasc & Metab, Boston, MA 02115 USA	Duquesne University; Duquesne University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Auron, PE (corresponding author), Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA.	auronp@duq.edu	Galson, Deborah L./E-9370-2010; Pulugulla, Sree/AAV-5319-2021	Galson, Deborah L./0000-0002-2045-8807; Esposito, Emilio Xavier/0000-0002-6193-0485; Pulugulla, Sree/0000-0002-6474-1129	National Science Foundation [CHE1126465, CHE1726824]; Gaussian, Inc. (Wallimabrd, CT); NATIONAL CANCER INSTITUTE [R01CA068544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA032519] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Gaussian, Inc. (Wallimabrd, CT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Emily Cribas, Christopher Osburi, Scott Boesch, and Megan Bean for contributions to this work. Duquesne University Center Pr Computational Science and Jeffrey Evanseck are acknowledged for computational facilities. Duquesne University Center Jiff Computational Science is supported by National Science Foundation Grants CHE1126465 and CHE1726824 (to Jeffrey Evanseck) and by funds from Gaussian, Inc. (Wallimabrd, CT).	Adamik J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070622; Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Edelsbrunner H, 1992, WEIGHTED ALPHA SHAPE, DOI DOI 10.5555/871114; Edelsbrunner H., 1995, P 28 HAW INT C SYST; Everett BM, 2018, J AM COLL CARDIOL, V71, P2392, DOI 10.1016/j.jacc.2018.03.002; Fritz JH, 2013, INFECT IMMUN, V81, P3500, DOI 10.1128/IAI.00789-13; GALSON DL, 1993, MOL CELL BIOL, V13, P2929, DOI 10.1128/MCB.13.5.2929; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; GRAY JG, 1993, MOL CELL BIOL, V13, P6678, DOI 10.1128/MCB.13.11.6678; HAGEMEIER C, 1993, P NATL ACAD SCI USA, V90, P1580, DOI 10.1073/pnas.90.4.1580; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janin J, 2007, ACTA CRYSTALLOGR D, V63, P1, DOI 10.1107/S090744490603575X; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; KOMINATO Y, 1995, MOL CELL BIOL, V15, P58; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Lam SY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001027; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Linton B, 1999, CURR OPIN CHEM BIOL, V3, P307, DOI 10.1016/S1367-5931(99)80047-7; Listman JA, 2005, J BIOL CHEM, V280, P41421, DOI 10.1074/jbc.M509143200; Meraro D, 1999, J IMMUNOL, V163, P6468; Morris SM, 2016, J NUTR, V146, P2579, DOI 10.3945/jn.115.226621; Munde M, 2014, NUCLEIC ACIDS RES, V42, P1379, DOI 10.1093/nar/gkt955; NAGULAPALLI S, 1995, J IMMUNOL, V155, P4330; Perkel JM, 1998, J IMMUNOL, V160, P241; Petosa C, 2006, MOL CELL, V21, P565, DOI 10.1016/j.molcel.2006.01.006; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Pugh BF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149339; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; SAPSE AM, 1984, INT J QUANTUM CHEM, V26, P91, DOI 10.1002/qua.560260107; Shimokawa T, 2005, BLOOD, V106, P2534, DOI 10.1182/blood-2004-06-2413; Shimokawa T, 2013, BBA-GENE REGUL MECH, V1829, P1207, DOI 10.1016/j.bbagrm.2013.09.004; Shimokawa T, 2010, BIOCHEM J, V430, P129, DOI 10.1042/BJ20091742; SHIRAKAWA F, 1993, MOL CELL BIOL, V13, P1332, DOI 10.1128/MCB.13.3.1332; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; TSUKADA J, 1994, MOL CELL BIOL, V14, P7285, DOI 10.1128/MCB.14.11.7285; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Turkistany SA, 2011, ARCH IMMUNOL THER EX, V59, P431, DOI 10.1007/s00005-011-0147-9; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wara-Aswapati N, 1999, MOL CELL BIOL, V19, P6803; Wojciechowski M, 2004, J PHYS CHEM B, V108, P18368, DOI 10.1021/jp046748b; Yang ZY, 2000, J BIOL CHEM, V275, P21272, DOI 10.1074/jbc.M000145200; ZHANG YH, 1994, P NATL ACAD SCI USA, V91, P2225, DOI 10.1073/pnas.91.6.2225	52	3	3	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					19942	19956		10.1074/jbc.RA118.005627	http://dx.doi.org/10.1074/jbc.RA118.005627			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30355733	hybrid, Green Published			2022-12-26	WOS:000454685900001
J	Gong, QM; Stump, MR; Zhou, ZF				Gong, Qiuming; Stump, Matthew R.; Zhou, Zhengfeng			Regulation of Kv11.1 potassium channel C-terminal isoform expression by the RNA-binding proteins HuR and HuD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						potassium channel; ELAV-like protein 1 (HuR (human antigen R)); polyadenylation; RNA binding protein; RNA interference (RNAi); alternative polyadenylation; hERG; KCNH2; Kv11; 1; Hu proteins	MESSENGER-RNA; K+ CHANNEL; CARDIAC-ARRHYTHMIA; UP-REGULATION; POLYADENYLATION; HERG; RECTIFIER; LONG; IDENTIFICATION; MECHANISM	The potassium voltage-gated channel subfamily H member 2 (KCNH2) gene encodes the Kv11.1 potassium channel, which conducts the rapidly activating delayed rectifier current in the heart. KCNH2 pre-mRNA undergoes alternative polyadenylation and forms a functional, full-length Kv11.1a isoform if exon 15 is polyadenylated or a nonfunctional, C-terminally truncated Kv11.1a-USO isoform if intron 9 is polyadenylated. The molecular mechanisms that regulate Kv11.1 isoform expression are poorly understood. In this study, using HEK293 cells and reporter gene expression, pulldown assays, and RNase protection assays, we identified the RNA-binding proteins Hu antigen R (HuR) and Hu antigen D (HuD) as regulators of Kv11.1 isoform expression. We show that HuR and HuD inhibit activity at the intron 9 polyadenylation site. When co-expressed with the KCNH2 gene, HuR and HuD increased levels of the Kv11.1a isoform and decreased the Kv11.1a-USO isoform in the RNase protection assays and immunoblot analyses. In patch clamp experiments, HuR and HuD significantly increased the Kv11.1 current. siRNA-mediated knockdown of HuR protein decreased levels of the Kv11.1a isoform and increased those of the Kv11.1a-USO isoform. Our findings suggest that the relative expression levels of Kv11.1 C-terminal isoforms are regulated by the RNA-binding HuR and HuD proteins.	[Gong, Qiuming; Zhou, Zhengfeng] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97239 USA; [Stump, Matthew R.] George Fox Univ, Dept Biol, Newberg, OR 97132 USA	Oregon Health & Science University	Zhou, ZF (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhouzh@ohsu.edu		Zhou, Zhengfeng/0000-0002-2629-425X; Stump, Matthew/0000-0001-9259-5491	National Institutes of Health [R01 HL068854]; American Heart Association [15GRNT23020018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health Grant R01 HL068854 and American Heart Association Grant 15GRNT23020018. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmohsen K, 2009, EMBO J, V28, P1271, DOI 10.1038/emboj.2009.67; Alvarez Maria Fernanda, 2017, F1000Res, V6, P390, DOI 10.12688/f1000research.11078.1; Anderson KD, 2000, J NEUROCHEM, V75, P1103, DOI 10.1046/j.1471-4159.2000.0751103.x; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Barker A, 2012, J BIOCHEM, V151, P423, DOI 10.1093/jb/mvs010; Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; Dickson AM, 2012, J BIOL CHEM, V287, P36229, DOI 10.1074/jbc.M112.371203; Gong QM, 2018, GENE, V641, P220, DOI 10.1016/j.gene.2017.10.063; Gong QM, 2014, J MOL CELL CARDIOL, V76, P26, DOI 10.1016/j.yjmcc.2014.08.007; Gong QM, 2014, CIRC-CARDIOVASC GENE, V7, P482, DOI 10.1161/CIRCGENETICS.114.000586; Gong QM, 2010, J BIOL CHEM, V285, P32233, DOI 10.1074/jbc.M109.095695; Govindaraju Suman, 2013, World J Biol Chem, V4, P111, DOI 10.4331/wjbc.v4.i4.111; Gu L, 2017, ANTIOXID REDOX SIGN, V27, P1013, DOI 10.1089/ars.2016.6880; Guasti L, 2008, MOL CELL BIOL, V28, P5043, DOI 10.1128/MCB.00304-08; Hall-Pogar T, 2007, RNA, V13, P1103, DOI 10.1261/rna.577707; Ince-Dunn G, 2012, NEURON, V75, P1067, DOI 10.1016/j.neuron.2012.07.009; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; La Rosa P, 2016, ELIFE, V5, DOI 10.7554/eLife.20750; Larsen AP, 2010, PFLUG ARCH EUR J PHY, V460, P803, DOI 10.1007/s00424-010-0855-8; LeesMiller JP, 1997, CIRC RES, V81, P719; London B, 1997, CIRC RES, V81, P870; Mansfield KD, 2012, NUCLEIC ACIDS RES, V40, P2734, DOI 10.1093/nar/gkr1114; Masuda K, 2009, AGING-US, V1, P681, DOI 10.18632/aging.100073; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SCHWARTZ PJ, 1978, CIRCULATION, V57, P1074, DOI 10.1161/01.CIR.57.6.1074; Stump MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042552; Tian B, 2013, TRENDS BIOCHEM SCI, V38, P312, DOI 10.1016/j.tibs.2013.03.005; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Wang WG, 2001, MOL CELL BIOL, V21, P5889, DOI 10.1128/MCB.21.17.5889-5898.2001; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhu H, 2007, J BIOL CHEM, V282, P2203, DOI 10.1074/jbc.M609349200	35	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19624	19632		10.1074/jbc.RA118.003720	http://dx.doi.org/10.1074/jbc.RA118.003720			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30377250	Green Published, hybrid			2022-12-26	WOS:000454294900011
J	Huang, PCJ; Low, PY; Wang, I; Hsu, STD; Angata, T				Huang, Po-Chun Jimmy; Low, Penk-Yeir; Wang, Iren; Hsu, Shang-Te Danny; Angata, Takashi			Soluble Siglec-14 glycan-recognition protein is generated by alternative splicing and suppresses myeloid inflammatory responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomarker; alternative splicing; G-quadruplex; inflammation; sialic acid; toll-like receptor (TLR); Siglec; soluble receptor; transmembrane signaling	G-QUADRUPLEXES; SMALL-MOLECULE; RECEPTOR; DNA; IDENTIFICATION; CLONING; MECHANISMS; EXPRESSION; BIOMARKER; PROMOTER	Human sialic acid-binding immunoglobulin-like lectin 14 (Siglec-14) is a glycan-recognition protein that is expressed on myeloid cells, recognizes bacterial pathogens, and elicits pro-inflammatory responses. Although Siglec-14 is a transmembrane protein, a soluble form of Siglec-14 is also present in human blood. However, the mechanism that generates soluble Siglec-14 and what role this protein form may play remain unknown. Here, investigating the generation and function of soluble Siglec-14, we found that soluble Siglec-14 is derived from an alternatively spliced mRNA that retains intron 5, containing a termination codon and thus preventing the translation of exon 6, which encodes Siglec-14's transmembrane domain. We also note that the translated segment in intron 5 encodes a unique C-terminal 7-amino acid extension, which allowed the specific antibody-mediated detection of this isoform in human blood. Moreover, soluble Siglec-14 dose-dependently suppressed pro-inflammatory responses of myeloid cells that expressed membrane-bound Siglec-14, likely by interfering with the interaction between membrane-bound Siglec-14 and Toll-like receptor 2 on the cell surface. We also found that intron 5 contains a G-rich segment that assumes an RNA tertiary structure called a G-quadruplex, which may regulate the efficiency of intron 5 splicing. Taken together, we propose that soluble Siglec-14 suppresses pro-inflammatory responses triggered by membrane-bound Siglec-14.	[Huang, Po-Chun Jimmy; Low, Penk-Yeir; Wang, Iren; Hsu, Shang-Te Danny; Angata, Takashi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Huang, Po-Chun Jimmy; Hsu, Shang-Te Danny; Angata, Takashi] Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan; [Wang, Iren] United BioPharma, Hsinchu 30351, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Angata, T (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan.	angata@gate.sinica.edu.tw	Hsu, Shang-Te Danny/L-2826-2014; Hsu, Shang-Te Danny/B-2324-2009	Hsu, Shang-Te Danny/0000-0002-7231-0185	Ministry of Science and Technology, Republic of China [MOST 104-2321-B-001-070, 105-2321-B-001-051, 1062321- B-001-032]; Institute of Biological Chemistry, Academia Sinica	Ministry of Science and Technology, Republic of China; Institute of Biological Chemistry, Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Ministry of Science and Technology, Republic of China, Grants MOST 104-2321-B-001-070, 105-2321-B-001-051, and 1062321- B-001-032 (to T.A.) and intramural funding from the Institute of Biological Chemistry, Academia Sinica (to S.T.D.H. and T.A.). The authors declare that they have no conflicts of interest with the contents of this article.	Ali SR, 2014, J EXP MED, V211, P1231, DOI 10.1084/jem.20131853; Angata T, 2006, FASEB J, V20, P1964, DOI 10.1096/fj.06-5800com; Angata T, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12069; Angata T, 2015, TRENDS PHARMACOL SCI, V36, P645, DOI 10.1016/j.tips.2015.06.008; Angata T, 2014, GLYCOBIOLOGY, V24, P785, DOI 10.1093/glycob/cwu043; Angata T, 2013, CELL MOL LIFE SCI, V70, P3199, DOI 10.1007/s00018-013-1311-7; Biedermann B, 2007, LEUKEMIA RES, V31, P211, DOI 10.1016/j.leukres.2006.05.026; Bugaut A, 2010, ORG BIOMOL CHEM, V8, P2771, DOI 10.1039/c002418j; Chang LY, 2017, J PROTEOME RES, V16, P3929, DOI 10.1021/acs.jproteome.7b00625; Chen G. W., 2014, XINJIANG RECLAIM SCI, V1, P3, DOI DOI 10.7554/ELIFE.04066; Connolly NP, 2002, BRIT J HAEMATOL, V119, P221, DOI 10.1046/j.1365-2141.2002.03808.x; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dash J, 2008, J AM CHEM SOC, V130, P15950, DOI 10.1021/ja8046552; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Forster K, 2018, AM J RESP CRIT CARE, V197, P1076, DOI 10.1164/rccm.201706-1218LE; Furtig B, 2003, CHEMBIOCHEM, V4, P936, DOI 10.1002/cbic.200300700; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Higgins RD, 2018, J PEDIATR-US, V197, P300, DOI 10.1016/j.jpeds.2018.01.043; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Ishikawa J, 2016, BONE, V83, P210, DOI 10.1016/j.bone.2015.11.012; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitzig F, 2002, BIOCHEM BIOPH RES CO, V296, P355, DOI 10.1016/S0006-291X(02)00885-9; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Lugade AA, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00010; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Matsubara K, 2015, J NEUROSCI, V35, P2452, DOI 10.1523/JNEUROSCI.4088-14.2015; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Pepin M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37953; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Ryan RM, 2008, CLIN REV ALLERG IMMU, V34, P174, DOI 10.1007/s12016-007-8031-4; Shimojima C, 2016, J IMMUNOL, V196, P4164, DOI 10.4049/jimmunol.1501457; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; STEIS RG, 1988, BLOOD, V71, P1304; Takei Y, 1997, CYTOGENET CELL GENET, V78, P295, DOI 10.1159/000134676; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Waller ZAE, 2009, J AM CHEM SOC, V131, P12628, DOI 10.1021/ja901892u; Wang ZF, 2016, NUCLEIC ACIDS RES, V44, P3958, DOI 10.1093/nar/gkw145; Wang ZF, 2014, NUCLEIC ACIDS RES, V42, P4723, DOI 10.1093/nar/gku083; Weldon C, 2018, NUCLEIC ACIDS RES, V46, P886, DOI 10.1093/nar/gkx1122; Weldon C, 2017, NAT CHEM BIOL, V13, P18, DOI [10.1038/nchembio.2228, 10.1038/NCHEMBIO.2228]; Yamanaka M, 2009, GLYCOBIOLOGY, V19, P841, DOI 10.1093/glycob/cwp052; Yasui K, 2011, BRIT J HAEMATOL, V153, P794, DOI 10.1111/j.1365-2141.2010.08488.x; Ye W, 2014, RESPIROLOGY, V19, P501, DOI 10.1111/resp.12270; Yonchuk JG, 2015, AM J RESP CRIT CARE, V192, P785, DOI 10.1164/rccm.201501-0137PP; Zearfoss NR, 2013, RNA, V19, P948, DOI 10.1261/rna.036780.112; Zearfoss NR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001269; Zhao LX, 2010, P NATL ACAD SCI USA, V107, P19061, DOI 10.1073/pnas.1007487107	53	8	9	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19645	19658		10.1074/jbc.RA118.005676	http://dx.doi.org/10.1074/jbc.RA118.005676			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30377253	Green Published, hybrid			2022-12-26	WOS:000454294900013
J	Goshu, M; Godefay, H; Bihonegn, F; Ayalew, F; Haileselassie, D; Kebede, A; Temam, G; Gidey, G				Goshu, Miruts; Godefay, Hagos; Bihonegn, Fantaw; Ayalew, Firew; Haileselassie, Daniel; Kebede, Abebe; Temam, Girma; Gidey, Gebreamlak			Assessing the competence of midwives to provide care during labor, childbirth and the immediate postpartum period - A cross sectional study in Tigray region, Ethiopia	PLOS ONE			English	Article							LOW-RESOURCE SETTINGS; MIXED-METHODS; ADDIS-ABABA; EDUCATION; WORLD; PERFORMANCE; MIDWIFERY; PROGRAM	Background The availability of a skilled birth attendant is widely recognized as a critical factor in reducing maternal and newborn mortality. Competence of maternal healthcare providers directly affects quality of care and health outcomes. This study assessed competence of midwives and associated factors in provision of care during labor, and the immediate postpartum period at public health facilities in Tigray, Ethiopia. Methods A cross-sectional study design was employed to collect data through direct observation of the performance of 144 midwives selected from 57 health facilities. Data were collected from January to February 2015 by 12 experienced midwives who were trained on basic emergency obstetric care and had previous experience with data collection. Using a standardized competence checklist, adapted from International confederation of midwives, data collectors interviewed and directly observed the performance of midwives from admission of laboring mothers to six hours after delivery. Multivariable linear regression was used to identify predicators associated with overall clinical competence of midwives. Result The mean competence score of midwives was found to be 51%. In multivariable linear regression, male midwifery professionals (p = 0.022), availability of up to date job aids in work place (p = 0.04) and being recognized for improved performance (p = 0.005) were significantly associated with competence of midwives in the provision of care during labor, childbirth and immediate postpartum period. Conclusion Competence of midwives was found to be low to provide safe and quality maternity care in the region. Male gender, availability of complete job aids and receiving recognition/awards for better performance were predicted competence. This requires attention and investment from Tigray regional health bureau and health development partners working on maternal and child health. Competence based in-service training, on-the-job mentoring, availing up to dated standard job aids, recognition of high performing midwives are recommended to improve the quality of maternity care in public health facilities of the region. Moreover, affirmative actions including on-the-job training and supervision are needed to improve the competence of female midwives.	[Goshu, Miruts; Bihonegn, Fantaw; Haileselassie, Daniel; Kebede, Abebe] Jhpiego, Mekelle, Ethiopia; [Godefay, Hagos] Tigray Reg Hlth Bur, Mekelle, Ethiopia; [Ayalew, Firew; Temam, Girma] Jhpiego, Addis Ababa, Ethiopia; [Gidey, Gebreamlak] Aksum Univ, Coll Hlth Sci, Dept Midwifery, Aksum, Ethiopia	Jhpiego; Jhpiego	Goshu, M (corresponding author), Jhpiego, Mekelle, Ethiopia.	Miruts.Goshu@jhpiego.org		Abebe, Gebreamlak Gidey/0000-0003-0152-8643	USAID; Government of Ethiopia [AID-663-A-12-00008]; Government of United States [AID-663-A-12-00008]	USAID(United States Agency for International Development (USAID)); Government of Ethiopia; Government of United States	The study was made possible through the Strengthening Human Resources for Health Project, which is a five year (2012-2017) bilateral cooperative agreement between the Governments of Ethiopia and the United States under the Cooperative Agreement AID-663-A-12-00008. The authors thank USAID for funding the study.	[Anonymous], 2016, ETH DEM HLTH SURV KE; Austin A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0493-4; Ayiasi RM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-65; Chaturvedi S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-174; Chopra M, 2009, LANCET, V374, P1023, DOI 10.1016/S0140-6736(09)61122-3; Dreesch N, 2005, APPROACH ESTIMATING, DOI [10.1093/heapol/czi036, DOI 10.1093/HEAPOL/CZI036]; Fauveau V, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-21; Federal Ministry of Health Ethiopia, HUM RES HLTH HRH STR; Fort Alfredo L, 2004, Hum Resour Health, V2, P8, DOI 10.1186/1478-4491-2-8; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Godefay H, 2015, J GLOB HEALTH, V5, P1; Harries AD, 2005, LANCET, V366, P1606, DOI 10.1016/S0140-6736(05)67659-3; Harvey SA, 2007, B WORLD HEALTH ORGAN, V85, P783, DOI 10.2471/BLT.06.038455; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Hulton L, 2000, FRAMEWORK EVALUATION; International Confederation of Midwives (ICM) Council, ESS COMP BAS MIDW PR; Jennings L, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-75; Karamagi CAS, 2004, AFRI HLTH SCI, V4, P31; Kibwana Sharon, 2016, Educ Health (Abingdon), V29, P3, DOI 10.4103/1357-6283.178931; Kim YM, 2007, PATIENT EDUC COUNS, V66, P235, DOI 10.1016/j.pec.2006.12.007; Leon FR, 2005, STUD FAMILY PLANN, V36, P117, DOI 10.1111/j.1728-4465.2005.00049.x; Leshabari S, 2007, TESTING PMTCT INFANT; Min, 2011, HLTH MEDICAL TECHNOL; Mirkuzie AH, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-354; Mumtaz Z, 2015, BJOG-INT J OBSTET GY, V122, P249, DOI 10.1111/1471-0528.13112; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Rowe LA, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-5; The Federal Democratic Republic of Ethiopia Ministry of Health 2015, 2015, HLTH SECT TRANSF PLA; World Health Organization, 2010, GLOB STRAT WOM CHILD; Yigzaw T, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0410-6; Zainullah P, 2014, MIDWIFERY, V30, P1056, DOI 10.1016/j.midw.2013.10.026	31	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206414	10.1371/journal.pone.0206414	http://dx.doi.org/10.1371/journal.pone.0206414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379970	gold, Green Submitted, Green Published			2022-12-26	WOS:000448823700112
J	Seneque, E; Morisset, S; Lesimple, C; Hausberger, M				Seneque, Emilie; Morisset, Stephane; Lesimple, Clemence; Hausberger, Martine			Testing optimal methods to compare horse postures using geometric morphometrics	PLOS ONE			English	Article							EQUINE BACK; WALKING; KINEMATICS; RESPONSES; BEHAVIOR; COMFORT; SADDLE; SHEEP; SHAPE; PAIN	The study of animal behavior, especially regarding welfare, needs the development of tools to identify, quantify and compare animal postures with interobserver reliability. While most studies subjectively describe animal postures, or quantify only limited parts of the body, the usage of geometric morphometrics has allowed for the description of horses' and pigs' upper body outline and the comparison of postures from different populations thanks to robust statistical analysis. We have attempted here to optimize the geometric morphometrics (GM) method already used in horses by introducing the outline analysis with sliding semilandmarks (SSL), by eliminating the balance movement of the neck and by focusing only on parts of the upper line. For this purpose, photographs of 85 horses from 11 riding schools, known for differing in terms of housing and working conditions, were analyzed with previous and new GM methods and these results were compared with each other. Using SSL and eliminating the neck movement appeared to better discriminate the horse populations than the previous GM method. Study of parts of the dorsum proved efficient too. This new methodology should now be used to examine if posture could be an indicator of horse welfare state, and similar studies should be performed in other species in order to validate the same methodology.	[Seneque, Emilie; Lesimple, Clemence; Hausberger, Martine] Univ Caen Normandie, Univ Rennes, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Caen Normandie; Universite de Rennes	Seneque, E (corresponding author), Univ Caen Normandie, Univ Rennes, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	emilie.seneque@ac-lyon.fr	; Morisset, Stephane/B-9629-2019	Seneque, Emilie/0000-0003-0574-2129; /0000-0003-0664-1151; Morisset, Stephane/0000-0002-7747-113X	University of Rennes 1; Centre National de la Recherche Scientifique (CNRS); Groupement d'Interet Scientifique "Cerveau - Comportement - Societe" (GIS CCS); Caisse Centrale de la Mutualite Agricole (MSA); Rennes 2 University	University of Rennes 1; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Groupement d'Interet Scientifique "Cerveau - Comportement - Societe" (GIS CCS); Caisse Centrale de la Mutualite Agricole (MSA); Rennes 2 University	This work was funded by the University of Rennes 1, the Centre National de la Recherche Scientifique (CNRS), the Groupement d'Interet Scientifique "Cerveau - Comportement - Societe" (GIS CCS) and the Caisse Centrale de la Mutualite Agricole (MSA; Clemence Lesimple PhD grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the owners and staff of the riding schools for allowing us to work with their horses, and for their understanding, Prof JE Gombert and Rennes 2 University for their support.	Adams DC, 1999, EVOL ECOL RES, V1, P959; Beerda B, 1999, PHYSIOL BEHAV, V66, P233, DOI 10.1016/S0031-9384(98)00289-3; Boissy A, 2011, ANIM WELFARE, V20, P47; Bookstein F L, 1997, Med Image Anal, V1, P225; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Bookstein FL, 2002, NEUROIMAGE, V15, P233, DOI 10.1006/nimg.2001.0977; Boujenane I, 2008, REV MED VET-TOULOUSE, V159, P144; Chabchoub A, 2004, REV MED VET-TOULOUSE, V155, P31; Chapman RE, 1990, P MICH MORPH WORKSH; Cook WR, 2003, PFERDEHEILKUNDE, V19, P75, DOI 10.21836/PEM20030111; Cook WR, 1999, J EQUINE VET SCI, V19, P196, DOI 10.1016/S0737-0806(99)80067-7; DAVIES WG, 1978, ANIM BEHAV, V26, P381, DOI 10.1016/0003-3472(78)90056-8; Decker L, 2006, CR PALEVOL, V5, P571, DOI 10.1016/j.crpv.2005.11.011; Egenvall A, 2009, PREV VET MED, V88, P193, DOI 10.1016/j.prevetmed.2008.10.004; Faber M, 2000, AM J VET RES, V61, P399, DOI 10.2460/ajvr.2000.61.399; Finlayson K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166446; Fruehwirth B, 2004, EQUINE VET J, V36, P754, DOI 10.2746/0425164044848235; Fureix C, 2011, NATURWISSENSCHAFTEN, V98, P583, DOI 10.1007/s00114-011-0803-2; Fureix C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012434; Gillis C, 1999, VET CLIN N AM-EQUINE, V15, P97; Gomez Alvarez C B, 2006, Equine Vet J Suppl, P445; Gregoire J, 2013, ANIMAL, V7, P1163, DOI 10.1017/S1751731113000098; Guedaoura S., 2011, ANN MED VET, V155, P14; Hagen K, 2004, APPL ANIM BEHAV SCI, V85, P203, DOI 10.1016/j.applanim.2003.11.007; Haussler KK, 1999, AM J VET RES, V60, P143; Haussler KK, 2000, AAEP P, P84; Haussler KK., 2006, EQUINE VET J; Hobbs SJ, 2010, WIEN TIERARZTL MONAT, V97, P55; Huzzey JM, 2005, J DAIRY SCI, V88, P2454, DOI 10.3168/jds.S0022-0302(05)72923-4; Jeffcoat LB, 1999, VET J, V158, P113, DOI 10.1053/tvjl.1998.0334; JEFFCOTT LB, 1979, EQUINE VET J, V11, P129, DOI 10.1111/j.2042-3306.1979.tb01324.x; JEFFCOTT LB, 1980, EQUINE VET J, V12, P197, DOI 10.1111/j.2042-3306.1980.tb03427.x; Kafkafi N, 1998, BIOL CYBERN, V78, P441, DOI 10.1007/s004220050448; KILEYWORTHINGTON M, 1976, BEHAVIOUR, V56, P69, DOI 10.1163/156853976X00307; Krawczel PD, 2008, J DAIRY SCI, V91, P1903, DOI 10.3168/jds.2007-0520; Lepicard EM, 2003, PSYCHIAT RES, V118, P273, DOI 10.1016/S0165-1781(03)00069-6; Lesimple C, 2016, APPL ANIM BEHAV SCI; Lesimple C., 2016, ANIM BEHAV COGN, V3, P159, DOI [10.12966/abc.05.08.2016, DOI 10.12966/ABC.05.08.2016]; Lesimple C, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-209; Lesimple C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044604; Lesimple C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010257; Licka T, 1998, EQUINE VET J, V30, P412, DOI 10.1111/j.2042-3306.1998.tb04511.x; Martin BB, 1999, VET CLIN N AM-EQUINE, V15, P61; McGreevy P, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P196; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Peham C, 2006, J BIOMECH, V39, P2845, DOI 10.1016/j.jbiomech.2005.09.019; Peham C, 2004, HUM MOVEMENT SCI, V23, P663, DOI 10.1016/j.humov.2004.10.006; Poursaberi A, 2010, COMPUT ELECTRON AGR, V74, P110, DOI 10.1016/j.compag.2010.07.004; Reefmann N, 2009, APPL ANIM BEHAV SCI, V118, P199, DOI 10.1016/j.applanim.2009.02.013; Rhodin M, 2005, EQUINE VET J, V37, P7, DOI 10.2746/0425164054406928; Ridgway K, 1999, VET CLIN N AM-EQUINE, V15, P263; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Schilder MBH, 2004, APPL ANIM BEHAV SCI, V85, P319, DOI 10.1016/j.applanim.2003.10.004; Tallet C, 2016, APPL ANIM BEHAV SCI, V174, P32, DOI 10.1016/j.applanim.2015.10.008; von Cramon-Taubadel N, 2007, AM J PHYS ANTHROPOL, V134, P24, DOI 10.1002/ajpa.20616; von Wachenfelt H, 2009, BIOSYST ENG, V104, P534, DOI 10.1016/j.biosystemseng.2009.08.008; Wallin L, 2000, LIVEST PROD SCI, V63, P275, DOI 10.1016/S0301-6226(99)00126-8; WILSON RH, 1974, ANIM BEHAV, V22, P75, DOI 10.1016/S0003-3472(74)80055-2; Xin H, 1999, J ANIM SCI, V77, P1; Zimmerman M, 2011, VET RADIOL ULTRASOUN, V52, P661, DOI 10.1111/j.1740-8261.2011.01845.x	60	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0204208	10.1371/journal.pone.0204208	http://dx.doi.org/10.1371/journal.pone.0204208			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379841	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700010
J	Sugano, SS; Nishihama, R; Shirakawa, M; Takagi, J; Matsuda, Y; Ishida, S; Shimada, T; Hara-Nishimura, I; Osakabe, K; Kohchi, T				Sugano, Shigeo S.; Nishihama, Ryuichi; Shirakawa, Makoto; Takagi, Junpei; Matsuda, Yoriko; Ishida, Sakiko; Shimada, Tomoo; Hara-Nishimura, Ikuko; Osakabe, Keishi; Kohchi, Takayuki			Efficient CRISPR/Cas9-based genome editing and its application to conditional genetic analysis in Marchantia polymorpha	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; CHLAMYDOMONAS-REINHARDTII; TARGETED MUTAGENESIS; SMALL RNAS; LIVERWORT; NUCLEASES; SPECIFICITY; PROSPECTS; MODEL; GUIDE	Marchantia polymorpha is one of the model species of basal land plants. Although CRISPR/ Cas9-based genome editing has already been demonstrated for this plant, the efficiency was too low to apply to functional analysis. In this study, we show the establishment of CRISPR/Cas9 genome editing vectors with high efficiency for both construction and genome editing. Codon optimization of Cas9 to Arabidopsis achieved over 70% genome editing efficiency at two loci tested. Systematic assessment revealed that guide sequences of 17 nt or shorter dramatically decreased this efficiency. We also demonstrated that a combinatorial use of this system and a floxed complementation construct enabled conditional analysis of a nearly essential gene. This study reports that simple, rapid, and efficient genome editing is feasible with the series of developed vectors.	[Sugano, Shigeo S.] Ritsumeikan Univ, R GIRO, Kusatsu, Shiga, Japan; [Sugano, Shigeo S.] PRESTO, JST, Kawaguchi, Saitama, Japan; [Nishihama, Ryuichi; Shirakawa, Makoto; Matsuda, Yoriko; Ishida, Sakiko; Kohchi, Takayuki] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Takagi, Junpei; Shimada, Tomoo; Hara-Nishimura, Ikuko] Kyoto Univ, Grad Sch Sci, Kyoto, Japan; [Osakabe, Keishi] Tokushima Univ, Fac Biosci & Bioind, Tokushima, Tokushima, Japan	Ritsumeikan University; Japan Science & Technology Agency (JST); Kyoto University; Kyoto University; Tokushima University	Kohchi, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan.	tkohchi@lif.kyoto-u.ac.jp	Nishihama, Ryuichi/X-8623-2019	Nishihama, Ryuichi/0000-0002-7032-732X; Kohchi, Takayuki/0000-0002-9712-4872	JST PRESTO [11106]; Japan Society for the Promotion of Science (JSPS) [24005453];  [22000014];  [25113009];  [17H07424];  [24570048];  [60726313]	JST PRESTO(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; ; 	This work was supported by the Grant-in-Aid for Specially Promoted Research to I.H-.N. [no. 22000014], by the Grant-in-Aid for Scientific Research on Innovative Area to T.K. [no. 25113009], by the Grant-in-Aid for Scientific Research (S) to T.K. [no. 17H07424], by the Grant-in-Aid for Scientific Research (C) to R.N. [no. 24570048], by the Grant-in-Aid for Young Scientists (B) to S.S.S. [no. 60726313], by the JST PRESTO Grant to S.S.S. [no. 11106], and by a donation from Otsuka Pharmaceuticals to Tokushima University. M.S. was supported by the Research Fellowship for Young Scientists [no. 24005453] and by the Postdoctoral Fellowships for Research Abroad from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida T, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3331-9; Althoff F, 2014, TRANSGENIC RES, V23, P235, DOI 10.1007/s11248-013-9746-z; Barnes CR, 1908, BOT GAZ, V46, P401, DOI 10.1086/329782; Bowman JL, 2017, CELL, V171, P287, DOI 10.1016/j.cell.2017.09.030; Chang CR, 2016, CELL, V167, P325, DOI 10.1016/j.cell.2016.08.031; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Ferenczi A, 2017, P NATL ACAD SCI USA, V114, P13567, DOI 10.1073/pnas.1710597114; Flores-Sandoval E, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005207; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gaj T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023754; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Greiner A, 2017, PLANT CELL, V29, P2498, DOI 10.1105/tpc.17.00659; Hall Bradford, 2009, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1912s44; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Ishizaki K, 2016, PLANT CELL PHYSIOL, V57, P262, DOI 10.1093/pcp/pcv097; Ishizaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138876; Ishizaki K, 2013, PLANT CELL, V25, P4075, DOI 10.1105/tpc.113.117051; Ishizaki K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01532; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson RA, 2015, PLANT MOL BIOL, V87, P143, DOI 10.1007/s11103-014-0266-x; Kato H, 2017, PLANT CELL PHYSIOL, V58, P1642, DOI 10.1093/pcp/pcx095; Kato H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005084; Komatsu A, 2014, PLANT PHYSIOL, V166, P411, DOI 10.1104/pp.114.245100; Kopischke S, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0167-5; Kosetsu K, 2010, PLANT CELL, V22, P3778, DOI 10.1105/tpc.110.077164; Kubota A, 2013, BIOSCI BIOTECH BIOCH, V77, P167, DOI 10.1271/bbb.120700; Lin PC, 2016, PLANT CELL PHYSIOL, V57, P339, DOI 10.1093/pcp/pcw020; Lopez-Obando M, 2016, PHYSCOMITRELLA PATEN, DOI [10.1534/g3.116.033266, DOI 10.1534/G3.116.033266]; Ma HM, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.12; Ma J, 2014, CELL CYCLE, V13, P337, DOI 10.4161/cc.27508; Mikami M, 2015, PLANT MOL BIOL, V88, P561, DOI 10.1007/s11103-015-0342-x; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nishihama R, 2016, PLANT CELL PHYSIOL, V57, P271, DOI 10.1093/pcp/pcv102; Nomura T, 2016, PLANT CELL PHYSIOL, V57, P2600, DOI 10.1093/pcp/pcw173; Osakabe Y, 2015, PLANT CELL PHYSIOL, V56, P389, DOI 10.1093/pcp/pcu170; Puchta H, 2017, CURR OPIN PLANT BIOL, V36, P1, DOI 10.1016/j.pbi.2016.11.011; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Shen H, 2017, G3-GENES GENOM GENET, V7, P193, DOI 10.1534/g3.116.035204; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; Tsuboyama-Tanaka S, 2015, J PLANT RES, V128, P337, DOI 10.1007/s10265-014-0695-2; Tsuzuki M, 2016, PLANT CELL PHYSIOL, V57, P359, DOI 10.1093/pcp/pcv182; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Xu J, 2015, TRENDS PLANT SCI, V20, P56, DOI 10.1016/j.tplants.2014.10.001; Yin KQ, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.107; Zhang F, 2015, HUM GENE THER, V26, P409, DOI 10.1089/hum.2015.29002.fzh	52	78	82	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205117	10.1371/journal.pone.0205117	http://dx.doi.org/10.1371/journal.pone.0205117			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379827	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700027
J	Butt, SA; Lidegaardi, O; Skovlund, C; Hannaford, PC; Iversen, L; Fielding, S; Morch, LS				Butt, Sedrah Arif; Lidegaardi, Ojvind; Skovlund, Charlotte; Hannaford, Philip C.; Iversen, Lisa; Fielding, Shona; Morch, Lina Steinrud			Hormonal contraceptive use and risk of pancreatic cancer-A cohort study among premenopausal women	PLOS ONE			English	Article							REPRODUCTIVE FACTORS; EPIDEMIOLOGY	Importance The association between the use of hormonal contraceptive and pancreatic cancer among premenopausal women has until now been unclear. This is the first study to investigate the risk of pancreatic cancer in pre-menopausal women. Objective To determine whether hormonal contraception increases the risk of developing pancreatic cancer in pre-menopausal women. Design A nationwide prospective cohort study followed all women in Denmark in the age range of 15-49 years without previous cancer or venous thrombosis from 1995 to 2014. The Danish National Prescription Registry provided individually updated exposure information on use of hormonal contraception. The Danish Cancer Registry provided cancer diagnoses, and the Danish National Patient Register containing clinical diagnoses and surgical codes at discharge from public and private hospitals. Setting Population-based cohort study. Participants All women living in Denmark aged 15-49 years at January 1st, 1995, and those subsequently reaching age 15 years up to December 31st, 2014 were eligible for the study. Results Among 1.9 million women who were followed on average for 11.4 years, 235 pancreatic cancers occurred. Compared to never users, ever users of any type of hormonal contraception had a relative risk (RR) of pancreatic cancer of 0.90 (95% confidence interval (CI) 0.68-1.19). No overall association between duration of hormonal contraceptive use and pancreatic cancer risk was found. Neither was long-term use of hormonal contraception associated with pancreas cancer, RR 0.83 (95% CI 0.47-1.50). The risk did not vary between users of combined and progestogen-only products. All models were adjusted for age, completed or ongoing education, polycystic ovary syndrome, endometriosis and among parous women; parity, age at first birth, smoking and body mass index. Conclusions and relevance Compared to never users the risk of pancreatic cancer is not significantly higher among current and recent users of contemporary hormonal contraception and does not vary between users of combined and progestogen-only products. In conclusion, our study suggests no risk of pancreatic cancer with use of any type of hormonal contraception.	[Butt, Sedrah Arif; Lidegaardi, Ojvind; Skovlund, Charlotte; Morch, Lina Steinrud] Copenhagen Univ Hosp, Juliane Marie Ctr, Dept Gynecol, Copenhagen, Denmark; [Hannaford, Philip C.; Iversen, Lisa] Univ Aberdeen, Acad Primary Care, Inst Appl Hlth Sci, Aberdeen, Scotland; [Fielding, Shona] Univ Aberdeen, Inst Appl Hlth Sci, Med Stat Team, Aberdeen, Scotland	University of Copenhagen; University of Aberdeen; University of Aberdeen	Butt, SA (corresponding author), Copenhagen Univ Hosp, Juliane Marie Ctr, Dept Gynecol, Copenhagen, Denmark.	sedrah_butt@hotmail.com		Morch, Lina/0000-0001-6506-2569; Butt Balaganeshan, Sedrah/0000-0002-0275-7440	Novo Nordisk Foundation [11645]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Drs. Morch and Lidegaard were supported by a grant (No 11645) from the Novo Nordisk Foundation. The funder had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the paper; or in the decision to submit the paper for publication.	Duell EJ, 2005, AM J EPIDEMIOL, V161, P741, DOI 10.1093/aje/kwi104; Duell EJ, 2013, INT J CANCER, V132, P2164, DOI 10.1002/ijc.27875; Duell EJ, 2009, CANCER CAUSE CONTROL, V20, P1757, DOI 10.1007/s10552-009-9408-x; Fristrup C, 2016, CLIN EPIDEMIOL, V8, P645, DOI 10.2147/CLEP.S99471; Guan HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092738; Ilic M, 2016, WORLD J GASTROENTERO, V22, P9694, DOI 10.3748/wjg.v22.i44.9694; Kabat GC, 2017, CANCER EPIDEMIOL, V49, P1, DOI 10.1016/j.canep.2017.05.002; Kreiger N, 2001, ANN EPIDEMIOL, V11, P563, DOI 10.1016/S1047-2797(01)00219-8; Lee E, 2013, AM J EPIDEMIOL, V178, P1403, DOI 10.1093/aje/kwt154; Lucenteforte E, 2011, PANCREAS, V40, P460, DOI 10.1097/MPA.0b013e31820bf986; Lujan-Barroso L, 2016, PANCREAS, V45, P1401, DOI 10.1097/MPA.0000000000000635; Nations U, NON TRADITIONAL REF; Nielsen LH, 2008, PHARMACOEPIDEM DR S, V17, P384, DOI 10.1002/pds.1549; Prizment AE, 2007, J PANCREAS, V8, P16; Silvera SAN, 2005, PANCREAS, V30, P369, DOI 10.1097/01.mpa.0000160301.59319.ba; Skinner HG, 2003, CANC EPIDEMIOL BIOMA, V12; Soini T, 2014, OBSTET GYNECOL, V124, P292, DOI 10.1097/AOG.0000000000000356; STORM HH, 1988, INT J EPIDEMIOL, V17, P44, DOI 10.1093/ije/17.1.44; Storm HH, 1997, DAN MED BULL, V44, P535; Tang B, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000177; Teng Y, 2017, EUR J CANCER PREV, V1; Teras LR, 2005, SOURCE CANC CAUSES C, V16; Tsogzolmaa D, 2010, INT J CANCER, V124, P2442; Wahi MM, 2009, ANN EPIDEMIOL, V19, P103, DOI 10.1016/j.annepidem.2008.11.003; Yazdani S, 2015, NEUROENDOCRINOLOGY, V101, P309, DOI 10.1159/000381455; Yeo TP, 2015, SEMIN ONCOL, V42, P8, DOI 10.1053/j.seminoncol.2014.12.002	26	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2018	13	10							e0206358	10.1371/journal.pone.0206358	http://dx.doi.org/10.1371/journal.pone.0206358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7AD	30376560	Green Published, Green Submitted, gold			2022-12-26	WOS:000448752400011
J	Krishnaswamy, S; Zivanovic, N; Sharma, R; Pe'er, D; Bodenmiller, B				Krishnaswamy, Smita; Zivanovic, Nevena; Sharma, Roshan; Pe'er, Dana; Bodenmiller, Bernd			Learning time-varying information flow from single-cell epithelial to mesenchymal transition data	PLOS ONE			English	Article							MASS CYTOMETRY; PROGRESSION; STEM	Cellular regulatory networks are not static, but continuously reconfigure in response to stimuli via alterations in protein abundance and confirmation. However, typical computational approaches treat them as static interaction networks derived from a single time point. Here, we provide methods for learning the dynamic modulation of relationships between proteins from static single-cell data. We demonstrate our approach using TGF ss induced epithelial-to-mesenchymal transition (EMT) in murine breast cancer cell line, profiled with mass cytometry. We take advantage of the asynchronous rate of transition to EMT in the data and derive a pseudotime EMT trajectory. We propose methods for visualizing and quantifying time-varying edge behavior over the trajectory, and a metric of edge dynamism to predict the effect of drug perturbations on EMT.	[Krishnaswamy, Smita] Yale Univ, Dept Genet, Dept Comp Sci, New Haven, CT USA; [Zivanovic, Nevena; Bodenmiller, Bernd] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Sharma, Roshan] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY USA; [Pe'er, Dana] Mem Sloan Kettering Canc Ctr, Program Computat & Syst Biol, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA	Yale University; University of Zurich; Columbia University; Memorial Sloan Kettering Cancer Center	Pe'er, D (corresponding author), Mem Sloan Kettering Canc Ctr, Program Computat & Syst Biol, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.	peerd@mskcc.org		Pe'er, Dana/0000-0002-9259-8817	National Institutes of Health [DP1-HD084071, R01CA164729]; Cancer Center Support Grant [P30 CA008748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD084071] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA164729, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work received support from the National Institutes of Health DP1-HD084071 (D.P.), National Institutes of Health R01CA164729 (D.P.), and Cancer Center Support Grant P30 CA008748 (D.P.).	Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Botev ZI, 2010, ANN STAT, V38, P2916, DOI 10.1214/10-AOS799; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Eungdamrong NJ, 2004, BIOL CELL, V96, P355, DOI 10.1016/j.biolcel.2004.03.004; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Gray A., 2003, P JOINT STAT M; Grille SJ, 2003, CANCER RES, V63, P2172; Haberman R., 2013, APPL PARTIAL DIFFERE, VFifth; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Hardle W, 2000, WILEY SER PROB STAT, P357; Heck C, 2012, THESIS; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Klipp E, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S10; Krejci P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035826; Kroese DP, 2011, HDB MONTE CARLO METH; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li WV, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03405-7; Lin PJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1188-0; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Moustakas A, 2001, J CELL SCI, V114, P4359; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Nestorowa S, 2016, BLOOD, V128, pE20, DOI 10.1182/blood-2016-05-716480; Ocone A, 2015, BIOINFORMATICS, V31, P89, DOI 10.1093/bioinformatics/btv257; Prabhakaran S, 2016, PR MACH LEARN RES, V48; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Silverman B.W., 1986, DENSITY ESTIMATION S; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Waldmeier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048651; WAND MP, 1994, COMPUTATION STAT, V9, P97; Wand MP, 1994, KERNEL SMOOTHING; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yilmaz M, 2011, EMBO J, V30, P4489, DOI 10.1038/emboj.2011.319; Zheng SW, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178041; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	44	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0203389	10.1371/journal.pone.0203389	http://dx.doi.org/10.1371/journal.pone.0203389			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372433	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000448641200004
J	Mees, L; Fidler, J; Kreuzer, M; Fu, JM; Pardue, MT; Garcia, PS				Mees, Lukas; Fidler, Jonathan; Kreuzer, Matthias; Fu, Jieming; Pardue, Machelle T.; Garcia, Paul S.			Faster emergence behavior from ketamine/xylazine anesthesia with atipamezole versus yohimbine	PLOS ONE			English	Article							KETAMINE; RATS; XYLAZINE; DEXMEDETOMIDINE; ANTAGONISM; RECEPTORS; RECOVERY; ALPHA(1); AGENT; MICE	Recent interest in reversal of the hypnotic effects of anesthesia has mainly focused on over-coming a surge in GABA-mediated inhibitory signaling through activation of subcortical arousal circuits or antagonizing GABA receptors. Here we examine the reversal of anesthesia produced from non-GABA agents ketamine/xylazine and the effects of antagonists of adrenoreceptors. These antagonists vary in selectivity and produce temporally unique waking behavior post-anesthesia. We compared two antagonists with differential selectivity for alpha(1)- vs. alpha(2)-receptors, yohimbine (YOH, 1:40 selectivity) and atipamezole (ATI, 1:8500). Adult mice received intraperitoneal injections of either YOH (4.3 mg/kg), ATI (0.4 mg/kg), or saline after achieving sustained loss of righting following injection of ketamine/xylazine (ketamine: 65.0 mg/kg; xylazine: 9.9 mg/kg). Behaviors indicative of the post-anesthesia, re-animation sequence were carefully monitored and the timing of each behavior relative to anesthesia induction was compared. Both YOH and ATI hastened behaviors indicative of emergence, but ATI was faster than YOH to produce certain behaviors, including whisker movement (YOH: 21.9 +/- 1.5 min, ATI: 17.5 +/- 0.5 min, p = 0.004) and return of righting reflex (RORR) (YOH: 40.6 +/- 8.8 min, ATI: 26.0 +/- 1.2 min, p<0.001). Interestingly, although YOH administration hastened early behavioral markers of emergence relative to saline (whisking), the completion of the emergence sequence (time from first marker to appearance of RORR) was delayed with YOH. We attribute this effect to antagonism of alpha(1) receptors by yohimbine. Also notable was the failure of either antagonist to hasten the re-establishment of coordinated motor behavior (e.g., attempts to remove adhesive tape on the forepaw placed during anesthesia) relative to the end of emergence (RORR). In total, our work suggests that in addition to pharmacokinetic effects, re-establishment of normal waking behaviors after anesthesia involves neuronal circuits dependent on time and/or activity.	[Mees, Lukas; Fidler, Jonathan; Kreuzer, Matthias; Fu, Jieming; Pardue, Machelle T.; Garcia, Paul S.] Atlanta VA Ctr Visual & Neurocognit Rehabil, Decatur, GA 30033 USA; [Fidler, Jonathan; Kreuzer, Matthias; Garcia, Paul S.] Emory Univ, Dept Anesthesiol, Atlanta, GA 30322 USA; [Kreuzer, Matthias] Tech Univ Munich, Dept Anesthesiol & Crit Care, Munich, Germany; [Pardue, Machelle T.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Garcia, Paul S.] Columbia Univ, Dept Anesthesiol, Med Ctr, New York, NY 10027 USA	Emory University; Technical University of Munich; University System of Georgia; Georgia Institute of Technology; Columbia University	Garcia, PS (corresponding author), Atlanta VA Ctr Visual & Neurocognit Rehabil, Decatur, GA 30033 USA.; Garcia, PS (corresponding author), Emory Univ, Dept Anesthesiol, Atlanta, GA 30322 USA.; Garcia, PS (corresponding author), Columbia Univ, Dept Anesthesiol, Med Ctr, New York, NY 10027 USA.	pg32618@cumc.columbia.edu	Kreuzer, Matthias/AAX-6501-2021; Pardue, Machelle T/N-9795-2013	Garcia, Paul/0000-0001-5544-6251	United States Department of Veteran Affairs [BX00167]; Biomedical Laboratory Research and Development Service; James S. McDonnell Foundation [220023046]; Department of Veterans Affairs, Rehabilitation Research and Development Service [C9257-5]; Veterans Affairs [IK6RX003134] Funding Source: NIH RePORTER	United States Department of Veteran Affairs(US Department of Veterans Affairs); Biomedical Laboratory Research and Development Service(US Department of Veterans Affairs); James S. McDonnell Foundation; Department of Veterans Affairs, Rehabilitation Research and Development Service(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	Dr. Garcia's research efforts are supported in part by a Career Development Award #BX00167 (PI: PS Garcia, MD, PhD) from the United States Department of Veteran Affairs (https://www.research.va.gov/funding/), Biomedical Laboratory Research and Development Service (https://www.research.va.gov/services/blrd/) and the James S. McDonnell Foundation grant #220023046 (PI: PS Garci a, MD, PhD) (https://www.jsmf.org/apply/).Dr.Pardue's research efforts are supported by a Research Scientist Award C9257-5 from the Department of Veterans Affairs, Rehabilitation Research and Development Service (http://www.rehab.research.va.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkaya M, 2013, J CEREBR BLOOD F MET, V33, P330, DOI 10.1038/jcbfm.2012.185; Chander D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106291; Chemali JJ, 2012, ANESTHESIOLOGY, V116, P998, DOI 10.1097/ALN.0b013e3182518bfc; DUNDEE JW, 1970, LANCET, V1, P1370; Garcia P, 2017, ANESTHESIOLOGY, V126, P371, DOI 10.1097/ALN.0000000000001513; Greene ST, 1988, J VET PHARM THERAPEU, V4; Haapalinna A, 1997, N-S ARCH PHARMACOL, V356, P570, DOI 10.1007/PL00005092; Hadi SM, 2015, INT J PEDIATR OTORHI, V79, P671, DOI 10.1016/j.ijporl.2015.02.012; Hentschke, 2011, MEAS EFF SIZ TOOLB; Hight DF, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00146; Hudetz JA, 2009, J CARDIOTHOR VASC AN, V23, P651, DOI 10.1053/j.jvca.2008.12.021; Janssen CF, 2017, J AM ASSOC LAB ANIM, V56, P142; KOMULAINEN A, 1991, AM J VET RES, V52, P585; LEVANEN J, 1995, ANESTHESIOLOGY, V82, P1117, DOI 10.1097/00000542-199505000-00005; Li LD, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00612; Makary L, 2010, J ORAL MAXIL SURG, V68, P386, DOI 10.1016/j.joms.2009.09.107; Mashour GA, 2013, P NATL ACAD SCI USA, V110, P10357, DOI 10.1073/pnas.1301188110; Mathew SJ, 2012, CNS DRUGS, V26, P189, DOI 10.2165/11599770-000000000-00000; MAZE M, 1991, ANESTHESIOLOGY, V74, P581, DOI 10.1097/00000542-199103000-00029; McDonald J.H., 2009, HDB BIOL STAT; Melchiorre C, 1998, FARMACO, V53, P278, DOI 10.1016/S0014-827X(98)00022-6; Pertovaara A, 2005, CNS DRUG REV, V11, P273; PIERIBONE VA, 1994, J NEUROSCI, V14, P4252; Safavynia SA, 2016, ANESTHESIOLOGY, V125, P147, DOI 10.1097/ALN.0000000000001134; Saha JK, 2005, EXP BIOL MED, V230, P777, DOI 10.1177/153537020523001012; Sakamoto H, 2013, J NEUROSURG ANESTH, V25, P399, DOI 10.1097/ANA.0b013e3182978ff0; Scholz J, 1999, ANASTH INTENSIV NOTF, V34, P642, DOI 10.1055/s-1999-219; Schwartz DD, 1998, J VET PHARMACOL THER, V21, P107, DOI 10.1046/j.1365-2885.1998.00113.x; Strazielle C, 1999, NEUROSCIENCE, V94, P287, DOI 10.1016/S0306-4522(99)00321-8; Subramaniam K, 2004, ANESTH ANALG, V99, P482, DOI 10.1213/01.ANE.0000118109.12855.07; Tanibuchi Y, 2009, EUR NEUROPSYCHOPHARM, V19, P861, DOI 10.1016/j.euroneuro.2009.07.005; Taylor NE, 2013, ANESTHESIOLOGY, V118, P30, DOI 10.1097/ALN.0b013e318278c896; Turner PV, 2005, COMPARATIVE MED, V55, P175; Virtanen RS, 1989, ARCH INT PHARMACODYN; Wang Q, 2014, J NEUROPHYSIOL, V111, P1331, DOI 10.1152/jn.00792.2013; Zaretsky DV, 2015, NEUROSCI LETT, V606, P215, DOI 10.1016/j.neulet.2015.09.008	36	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0199087	10.1371/journal.pone.0199087	http://dx.doi.org/10.1371/journal.pone.0199087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372437	gold, Green Published, Green Submitted			2022-12-26	WOS:000448641200001
J	Tang, ZY; Wang, Y; Lv, L; Li, LG; Zhang, H				Tang, Zhiyuan; Wang, Yan; Lv, Liang; Li, Linge; Zhang, Hua			Mice with double knockout of H2-Eb1 and H2-Ab1 exhibit reduced susceptibility to allergic rhinitis	PLOS ONE			English	Article							EXPRESSION; CANCER	We herein examined the importance of H2-Eb1 and H2-Ab1 in the susceptibility of mice to allergic rhinitis (AR) by developing double-gene (H2-Eb1+H2-Ab1) knockout mice. The mice were randomly grouped into different sensitization and excitation treatments, then their behavioral scores; nasal mucosa HE staining; thymus tissue toluidine blue staining; levels of ovalbumin (OVA)-specific IgE, IL-2 and IL-13 in the serum; and expression of IL-2 and IL-13 in the nasal mucosa were observed. H2-Ab1 and H2-Eb1 were both successfully knocked out in the study group (KO-OVA). Compared with the control group (WT-OVA), the nasal mucosal tissue in the KO-OVA mice showed fewer histological changes, reduced numbers of eosinophilic granulocytes, fewer mast cells in the thymus tissue, reduced concentrations of OVA-specific IgE and IL-13 in the serum, and reduced expression of IL-13 in the nasal mucosa. The behavior of the mice was also improved. In addition, the IL-2 concentration in the serum and IL-2 expression in the nasal mucosa were increased. There were two important findings of this study: (1) The H2-Ab1 and H2-Eb1 double knockout model of allergic rhinitis was successfully constructed, and the Th1/Th2 cell factors were in imbalance in these mice compared to WT mice; (2) the AR susceptibility of the dual knockout mice was reduced, confirming that H2-Ab1 and H2-Eb1 contribute to allergic rhinitis, at least in mice.	[Tang, Zhiyuan; Wang, Yan; Lv, Liang; Li, Linge; Zhang, Hua] Xinjiang Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University	Zhang, H (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Urumqi, Xinjiang, Peoples R China.	hzhang1106@126.com			National Natural Science Foundation of China [81160125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from National Natural Science Foundation of China (81160125). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andiappan AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019719; [Anonymous], [No title captured]; Azouaou N, 1997, IMMUNOLOGY, V91, P414, DOI 10.1046/j.1365-2567.1997.00282.x; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bais AG, 2005, J CLIN PATHOL, V58, P1096, DOI 10.1136/jcp.2004.025072; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brown JJ, 2010, CLIN EXP DERMATOL, V35, P305, DOI 10.1111/j.1365-2230.2009.03506.x; Cui Z, 2010, J XINJIANG MED U, V33, P253; [崔忠涛 CUI Zhongtao], 2011, [临床耳鼻咽喉头颈外科杂志, Journal of Clinical Otorhinolaryngology Head and Neck Surgery], V25, P645; Dai JH, 2001, CLIN J LAB ANIMAL SC, V11, P167; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Hatanaka H, 2000, ANN ONCOL, V11, P815, DOI 10.1023/A:1008375208574; Hoyer KK, 2009, BLOOD, V113, P389, DOI 10.1182/blood-2008-04-153346; Kimzey SL, 2004, J IMMUNOL, V173, P632, DOI 10.4049/jimmunol.173.1.632; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Lazaar AL, 2004, DRUG DISCOV TODAY DI, V1, P111; Lin YG, 1996, INFECT IMMUN, V64, P1351, DOI 10.1128/IAI.64.4.1351-1356.1996; Miescher SM, 2002, MOL ASPECTS MED, V23, P413, DOI 10.1016/S0098-2997(02)00009-2; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Munthe-Kaas MC, 2007, ALLERGY, V62, P991, DOI 10.1111/j.1398-9995.2007.01377.x; Sehmi R, 1997, J CLIN INVEST, V100, P2466, DOI 10.1172/JCI119789; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Skoner DP, 2014, ALLERGY ASTHMA PROC, V35, P338, DOI 10.2500/aap.2014.35.3760; TAKAHASHI N, 1990, J PHARMACOBIO-DYNAM, V13, P414, DOI 10.1248/bpb1978.13.414; Thorsby E, 2011, TISSUE ANTIGENS, V78, P229, DOI 10.1111/j.1399-0039.2011.01770.x; Torres-Galvan MJ, 1999, ANN ALLERG ASTHMA IM, V82, P198, DOI 10.1016/S1081-1206(10)62597-5; Wang L, 2013, CLIN LAB, V59, P429, DOI 10.7754/Clin.Lab.2012.120625; XI LIN, 2008, INT J OTOLARYNGOLOGY, V32, P81; Xue J, 1998, CHINESE J OTORHINOLA, V33, P139; Zhang Y, 2014, ASIAN PAC J ALLERGY, V32, P308, DOI 10.12932/AP0478.32.4.2014; Zhang Yu, 2014, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V28, P327	31	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206122	10.1371/journal.pone.0206122	http://dx.doi.org/10.1371/journal.pone.0206122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372475	Green Submitted, gold, Green Published			2022-12-26	WOS:000448641200022
J	Boehmer, T; Vogler, AJ; Thomas, A; Sauer, S; Hergenroether, M; Straubinger, RK; Birdsell, D; Keim, P; Sahl, JW; Williamson, CHD; Riehm, JM				Boehmer, Tim; Vogler, Amy J.; Thomas, Astrid; Sauer, Sabine; Hergenroether, Markus; Straubinger, Reinhard K.; Birdsell, Dawn; Keim, Paul; Sahl, Jason W.; Williamson, Charles H. D.; Riehm, Julia M.			Phenotypic characterization and whole genome analysis of extended-spectrum beta- lactamase-producing bacteria isolated from dogs in Germany	PLOS ONE			English	Article							RESISTANT ESCHERICHIA-COLI; BLAST SCORE RATIO; MOLECULAR CHARACTERIZATION; COMPANION ANIMALS; HIGH PREVALENCE; ANTIMICROBIAL RESISTANCE; CTX-M; ENTEROBACTERIACEAE; CATS; SEQUENCE	Asymptomatic colonization with extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae has been described for humans, various mammal species, and birds. Here, antimicrobial resistant bacteria were recovered from dog feces originating in Germany, Kosovo, Afghanistan, Croatia, and Ukraine, with a subset of mostly E. coli isolates obtained from a longitudinal collection over twelve months. In vitro antimicrobial resistance testing revealed various patterns of resistance against single or all investigated beta-lactam antibiotics, with none of the 101 isolates resistant against two tested carbapenem antibiotics. Whole genome sequence analysis revealed bacteria species-specific patterns for 23 antimicrobial resistance coding DNA sequences (CDS) that were unapparent from the in vitro analysis alone. Phylogenetic analysis of single nucleotide polymorphisms (SNP) revealed clonal bacterial isolates originating from different dogs, suggesting transmission between dogs in the same community. However, individual resistant E. co/i clones were not detected over a period longer than seven days. Multi locus sequence typing (MLST) of 85 E. co/i isolates revealed 31 different sequence types (ST) with an accumulation of ST744 (n = 9), ST10 (n = 8), and ST648 (n = 6), although the world-wide hospital-associated CTX-M beta-lactamase producing ST131 was not detected. Neither the antimicrobial resistance CDSs patterns nor the phylogenetic analysis revealed an epidemiological correlation among the longitudinal isolates collected from a period longer than seven days. No genetic linkage could be associated with the geographic origin of isolates. In conclusion, healthy dogs frequently carry ESBL-producing bacteria, independent to prior treatment, which may be transmitted between individual dogs of the same community. Otherwise, these antimicrobial resistant bacteria share few commonalities, making their presence eerily unpredictable.	[Boehmer, Tim; Hergenroether, Markus; Riehm, Julia M.] Bundeswehr Med Serv Munich, Cent Inst, Garching, Bavaria, Germany; [Vogler, Amy J.; Birdsell, Dawn; Keim, Paul; Sahl, Jason W.; Williamson, Charles H. D.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ USA; [Thomas, Astrid; Straubinger, Reinhard K.] Ludwig Maximilians Univ Munchen, Fac Vet Med, Inst Infect Dis & Zoonoses, Dept Vet Sci, Munich, Germany; [Sauer, Sabine] Bundeswehr Headquarter, Munich, Germany	Northern Arizona University; University of Munich	Riehm, JM (corresponding author), Bundeswehr Med Serv Munich, Cent Inst, Garching, Bavaria, Germany.	juliariehm@gmx.de		, Jason/0000-0002-2497-0138; Keim, Paul/0000-0003-0089-5820; Straubinger, Reinhard/0000-0001-8382-7182	Cowden Endowment for Microbiology	Cowden Endowment for Microbiology	Funding of the study was supported by the Cowden Endowment for Microbiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aly SA, 2012, CAN J MICROBIOL, V58, P1288, DOI 10.1139/w2012-105; [Anonymous], 2018, AN CAR WELF VET SUPP; [Anonymous], 2017, M100S27 CLSI; Baede VO, 2015, ANTIMICROB AGENTS CH, V59, P3117, DOI 10.1128/AAC.04576-14; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brodrick HJ, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0457-6; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Carattoli A, 2005, ANTIMICROB AGENTS CH, V49, P833, DOI 10.1128/AAC.49.2.833-835.2005; Casella T, 2017, J GLOB ANTIMICROB RE, V9, P124, DOI 10.1016/j.jgar.2017.04.002; Clinical and Laboratory Standards Institute (CLSI), 2013, VET01 A4, V4; Colavecchio A, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00102-17; Dallman TJ, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000029; Dallman TJ, 2015, CLIN INFECT DIS, V61, P305, DOI 10.1093/cid/civ318; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dolejska M, 2016, J ANTIMICROB CHEMOTH, V71, P63, DOI 10.1093/jac/dkv306; Dudley MN, 2013, CLIN INFECT DIS, V56, P1301, DOI 10.1093/cid/cit017; Endimiani A, 2012, DIAGN MICR INFEC DIS, V73, P31, DOI 10.1016/j.diagmicrobio.2012.01.004; European Food Safety Authority (EFSA) and European Centers for Disease Control (ECDC), 2014, EFSA J, V13, P4036; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Federal Ministry of Justice and Consumer Protection, VER TIER HAUS TAHAV; Federal Veterinary Surgeons' Association (Bundestierarztekammer BTK), 2015, GUID PRUD US VET ANT, P3; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hordijk J, 2013, J ANTIMICROB CHEMOTH, V68, P2468, DOI 10.1093/jac/dkt219; Hordijk J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00242; Huber H, 2013, VET MICROBIOL, V162, P992, DOI 10.1016/j.vetmic.2012.10.029; Jahreis K, 2002, J BACTERIOL, V184, P5307, DOI 10.1128/JB.184.19.5307-5316.2002; Jan S, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00046; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Kang CI, 2014, INT J ANTIMICROB AG, V43, P456, DOI 10.1016/j.ijantimicag.2014.01.030; Karch H, 2012, EMBO MOL MED, V4, P841, DOI 10.1002/emmm.201201662; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Liao XP, 2013, J FOOD PROTECT, V76, P2018, DOI 10.4315/0362-028X.JFP-13-200; Ljungquist Oskar, 2016, Infection Ecology & Epidemiology, V6, P31514, DOI 10.3402/iee.v6.31514; Mahon CR, 2014, TXB DIAGNOSTIC MICRO, P268; MATSUMOTO Y, 1988, ANTIMICROB AGENTS CH, V32, P1243, DOI 10.1128/AAC.32.8.1243; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Murugan N, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00140-14; O'Keefe A, 2010, ANTIMICROB AGENTS CH, V54, P3489, DOI 10.1128/AAC.01701-09; Papp-Wallace KM, 2011, ANTIMICROB AGENTS CH, V55, P4943, DOI 10.1128/AAC.00296-11; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Peirano G, 2010, INT J ANTIMICROB AG, V35, P316, DOI 10.1016/j.ijantimicag.2009.11.003; Pietsch M, 2017, VET MICROBIOL, V200, P130, DOI 10.1016/j.vetmic.2015.11.028; Poirel L, 2013, ANTIMICROB AGENTS CH, V57, P2372, DOI 10.1128/AAC.02622-12; Randall L, 2012, RES VET SCI, V93, P23, DOI 10.1016/j.rvsc.2011.06.016; Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2; Reeves PT, 2017, GUIDELINES USE ANTIB; Roer L, 2017, J ANTIMICROB CHEMOTH, V72, P1922, DOI 10.1093/jac/dkx092; Sahl JW, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000074; Sahl JW, 2014, PEERJ, V2, DOI 10.7717/peerj.332; Schaufler K, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv155; Schmiedel J, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-187; Shaheen BW, 2011, ANTIMICROB AGENTS CH, V55, P5666, DOI 10.1128/AAC.00656-11; So JH, 2012, DIAGN MICR INFEC DIS, V73, P195, DOI 10.1016/j.diagmicrobio.2012.03.010; Stoesser N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06256-2; Sun Y, 2010, CLIN MICROBIOL INFEC, V16, P1475, DOI 10.1111/j.1469-0691.2010.03127.x; Thomson KS, 2001, ANTIMICROB AGENTS CH, V45, P3548, DOI 10.1128/AAC.45.12.3548-3554.2001; Toutain PL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02344; Tschudin-Sutter S, 2012, CLIN INFECT DIS, V55, P1505, DOI 10.1093/cid/cis770; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wang J, 2016, J ANTIMICROB CHEMOTH, V71, P3062, DOI 10.1093/jac/dkw278; Wedley AL, 2011, VET REC, V168, DOI 10.1136/vr.d1540; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zogg AL, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00062; Zogg AL, 2018, VET MICROBIOL, V216, P79, DOI 10.1016/j.vetmic.2018.02.011	72	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206252	10.1371/journal.pone.0206252	http://dx.doi.org/10.1371/journal.pone.0206252			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365516	Green Published, Green Submitted, gold			2022-12-26	WOS:000448448700035
J	Grange, J; Chatellier, M; Cheve, MT; Paumier, A; Launay-Bourillon, C; Legendre, G; Olivier, M; Ducarme, G				Grange, Josephine; Chatellier, Manon; Cheve, Marie-Therese; Paumier, Anne; Launay-Bourillon, Claudine; Legendre, Guillaume; Olivier, Marion; Ducarme, Guillaume			Predictors of failed intrauterine balloon tamponade for persistent postpartum hemorrhage after vaginal delivery	PLOS ONE			English	Article							OBSTETRICIANS CNGOF; CLINICAL-PRACTICE; FRENCH COLLEGE; MANAGEMENT; GYNECOLOGISTS; GUIDELINES; SECONDARY; COHORT	Objective To identify the predictors of intrauterine balloon tamponade (IUBT) failure for persistent postpartum hemorrhage (PPH) after vaginal delivery. Design Retrospective case-series in five maternity units in a perinatal network. Setting All women who underwent IUBT for persistent PPH after vaginal delivery from January 2011 to December 2015 in these hospitals. Methods All maternity apply the same management policy for PPH. I UBT, using a Bakri balloon, was used as a second line therapy for persistent PPH after failure of bimanual uterine massage and uterotonics to stop bleeding after vaginal delivery. Women who required another second line therapy (embolization or surgical procedures) to stop bleeding after IUBT were defined as cases, and women whom IUBT stopped bleeding were defined as control group. We determined independent predictors for failed IUBT using multiple regression and adjusting for demographics with adjusted odds ratios (aORs) and 95% confidence intervals (95% CI). Results During the study period, there were 91,880 deliveries in the five hospitals and IUBT was used in 108 women to control bleeding. The success rate was 74.1% (80/108). In 28 women, invasive procedures were required (19 embolization and 9 surgical procedures with 5 peripartum hysterectomies). Women with failed IUBT were more often obese (25.9% vs. 8.1%; p = 0.03), duration of labor was shorter (363.9 min vs. 549.7min; p = 0.04), and major PPH >= 1,500 mL) before IUBT was more frequent (64% vs. 40%; p = 0.04). Obesity was a predictive factor of failed IUBT (aOR 4.40, 95% CI 1.06-18.31). Major PPH before IUBT seemed to be another predictor of failure (aOR 1.001, 95% CI 1.000-1.002), but our result did not reach statistical significativity. Conclusion Intrauterine balloon tamponade is an effective second line therapy for persistent primary PPH after vaginal delivery. Pre-pregnancy obesity is a risk factor of IUBT failure.	[Grange, Josephine; Ducarme, Guillaume] Ctr Hosp Dept, Dept Obstet & Gynecol, La Roche Sur Yon, France; [Chatellier, Manon; Olivier, Marion] Reseau Securite Naissance Pays de la Loire, Nantes, France; [Cheve, Marie-Therese] Le Mans Gen Hosp, Dept Obstet & Gynecol, Le Mans, France; [Paumier, Anne] Atlantic Polyclin, Dept Obstet & Gynecol, St Herblain, France; [Launay-Bourillon, Claudine] Jules Verne Clin, Dept Obstet & Gynecol, Nantes, France; [Legendre, Guillaume] Angers Univ Hosp, Dept Obstet & Gynecol, Angers, France	CHD Vendee; Centre Hospitalier Le Mans; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Ducarme, G (corresponding author), Ctr Hosp Dept, Dept Obstet & Gynecol, La Roche Sur Yon, France.	g.ducarme@gmail.com	, DUCARME/I-1248-2019	, DUCARME/0000-0002-2549-353X; Legendre, Guillaume/0000-0001-6787-6531				Bagou G, 2004, J GYNECOL OBST BIO R, V33, p4S89; Committee on Practice Bulletins-Obstetrics, 2017, Obstet Gynecol, V130, pe168, DOI 10.1097/AOG.0000000000002351; Darwish AM, 2018, J MATERN-FETAL NEO M, V31, P747, DOI 10.1080/14767058.2017.1297407; DENEUXTHARAUX C, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F1541; Doumouchtsis SK, 2007, OBSTET GYNECOL SURV, V62, P540, DOI 10.1097/01.ogx.0000271137.81361.93; Einerson BD, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.10.040; Flood KM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.001; Georgiou C, 2009, BJOG-INT J OBSTET GY, V116, P748, DOI 10.1111/j.1471-0528.2009.02113.x; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; Howard TF, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.04.017; Kayem G, 2011, BJOG-INT J OBSTET GY, V118, P856, DOI 10.1111/j.1471-0528.2011.02921.x; Laas E, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.028; Lim CC, 2015, BEST PRACT RES CL OB, V29, P309, DOI 10.1016/j.bpobgyn.2014.10.008; Martin E, 2015, ACTA OBSTET GYN SCAN, V94, P399, DOI 10.1111/aogs.12591; Revert M, 2017, BJOG-INT J OBSTET GY, V124, P1255, DOI 10.1111/1471-0528.14382; Revert M, 2018, OBSTET GYNECOL, V131, P143, DOI 10.1097/AOG.0000000000002405; Sentilhes L, 2016, EUR J OBSTET GYN R B, V198, P12, DOI 10.1016/j.ejogrb.2015.12.012; Son M, 2017, AM J PERINAT, V34, P164, DOI 10.1055/s-0036-1585084; Tuncalp O, 2013, INT J GYNECOL OBSTET, V123, P254, DOI 10.1016/j.ijgo.2013.06.024; Vayssiere C, 2013, EUR J OBSTET GYN R B, V169, P10, DOI 10.1016/j.ejogrb.2013.01.026; Vintejoux E, 2015, AUST NZ J OBSTET GYN, V55, P572, DOI 10.1111/ajo.12376; Zwart JJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.003	22	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206663	10.1371/journal.pone.0206663	http://dx.doi.org/10.1371/journal.pone.0206663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365539	Green Submitted, Green Published, gold			2022-12-26	WOS:000448448700065
J	Hubbard, AH; Zhang, XK; Jastrebski, S; Lamont, SJ; Singh, A; Schmidt, CJ				Hubbard, Allen H.; Zhang, Xiaoke; Jastrebski, Sara; Lamont, Susan J.; Singh, Abhyudai; Schmidt, Carl J.			Identifying mechanisms of regulation to model carbon flux during heat stress and generate testable hypotheses	PLOS ONE			English	Article							METABOLISM; HOMOCYSTEINE; CHICKENS; IDENTIFICATION; METHIONINE; HEALTH; LIPIDS; LIVER; LINE	Understanding biological response to stimuli requires identifying mechanisms that coordinate changes across pathways. One of the promises of multi-omics studies is achieving this level of insight by simultaneously identifying different levels of regulation. However, computational approaches to integrate multiple types of data are lacking. An effective systems biology approach would be one that uses statistical methods to detect signatures of relevant network motifs and then builds metabolic circuits from these components to model shifting regulatory dynamics. For example, transcriptome and metabolome data complement one another in terms of their ability to describe shifts in physiology. Here, we extend a previously described linear-modeling based method used to identify single nucleotide polymorphisms (SNPs) associated with metabolic changes. We apply this strategy to link changes in sulfur, amino acid and lipid production under heat stress by relating ratios of compounds to potential precursors and regulators. This approach provides integration of multi-omics data to link previously described, discrete units of regulation into functional pathways and identifies novel biology relevant to the heat stress response, in addition to generating hypotheses.	[Hubbard, Allen H.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Zhang, Xiaoke] George Washington Univ, Dept Stat, Washington, DC 20052 USA; [Jastrebski, Sara; Schmidt, Carl J.] Univ Delaware, Dept Anim & Food Sci, Newark, DE USA; [Lamont, Susan J.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Singh, Abhyudai] Univ Delaware, Dept Elect Engn & Comp Sci, Newark, DE USA	Donald Danforth Plant Science Center; George Washington University; University of Delaware; Iowa State University; University of Delaware	Hubbard, AH (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.	ahubbard@danforthcenter.org		Schmidt, Carl/0000-0002-8386-4781; Zhang, Xiaoke/0000-0002-7272-1523	Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture National Institute of Food and Agriculture [2011-67003-30228]	Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture National Institute of Food and Agriculture	This project was supported by the Agriculture and Food Research Initiative Competitive Grant 2011-67003-30228 from the United States Department of Agriculture National Institute of Food and Agriculture.	Akbarian A, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0097-5; Arlauckas SP, 2016, PROG LIPID RES, V63, P28, DOI 10.1016/j.plipres.2016.03.005; Balogh G, 2013, FEBS LETT, V587, P1970, DOI 10.1016/j.febslet.2013.05.016; Council NR, 1994, NUTR REQ POULTR 9 RE; Dahlhoff C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057387; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Ezzili C, 2010, BIOORG MED CHEM LETT, V20, P5959, DOI 10.1016/j.bmcl.2010.08.048; Fulda S., 2010, INT J CELL BIOL; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Hubbard AH, 2018, BIORXIV, DOI [10.1101/340125, DOI 10.1101/340125]; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Innis SM, 2007, AM J CLIN NUTR, V85, P702, DOI 10.1093/ajcn/85.3.702; Jastrebski SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181900; Jung YS, 2015, BIOL PHARM BULL, V38, P971, DOI 10.1248/bpb.b15-00244; Kempson SA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00159; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Kpodo K, 2015, RESPONSE HEAT STRESS; Lara Lucas J, 2013, Animals (Basel), V3, P356, DOI 10.3390/ani3020356; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; Lozoya OA, 2018, MITOCHONDRIAL NICOTI, DOI DOI 10.1371/JOURNAL.PBIO.2005707; Mashaly MM, 2004, POULTRY SCI, V83, P889, DOI 10.1093/ps/83.6.889; Mujahid A, 2007, FEBS LETT, V581, P3461, DOI 10.1016/j.febslet.2007.06.051; Obeid R, 2009, FEBS LETT, V583, P1215, DOI 10.1016/j.febslet.2009.03.038; PENTTILA KE, 1990, BIOCHEM J, V269, P659, DOI 10.1042/bj2690659; Strakova J, 2011, NUTR RES, V31, P563, DOI 10.1016/j.nutres.2011.06.004; Sun L, 2015, CELL STRESS CHAPERON, V20, P939, DOI 10.1007/s12192-015-0621-0; Van Goor A, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0176-7; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0205824	10.1371/journal.pone.0205824	http://dx.doi.org/10.1371/journal.pone.0205824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365526	Green Published, Green Submitted, gold			2022-12-26	WOS:000448448700014
J	Wu, YQ; Li, JH; Qin, X; Sun, SQ; Xiao, ZB; Dong, XY; Shahid, MS; Yin, DF; Yuan, JM				Wu, Yuqin; Li, Jianhui; Qin, Xin; Sun, Shiqiang; Xiao, Zhibin; Dong, Xiaoyu; Shahid, Muhammad Suhaib; Yin, Dafei; Yuan, Jianmin			Proteome and microbiota analysis reveals alterations of liver-gut axis under different stocking density of Peking ducks	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; GROWTH-PERFORMANCE; OXIDATIVE STRESS; CARCASS YIELD; DISEASE; EXPRESSION; BROILERS; INFLAMMATION; DEFICIENCY; INDICATORS	This study aimed to determine the impact of stocking density on the liver proteome and cecal microbiota of Peking ducks. A total of 1,200 21-day-old ducks were randomly assigned to 5 stocking density groups of 5, 6, 7, 8 and 9 ducks/m(2), with 6 replicates for each group. At 40 days of age, duck serum and pectorals were collected for biochemical tests; liver and cecal contents of ducks were gathered for proteome and microbiota analysis, respectively. Serum MDA increased while pectorals T-AOC reduced linearly with enhancing stocking density. Duck lipid metabolism was altered under different stocking density as well. Serum LDL-C increased linearly with increasing stocking density. Proteome analysis revealed fatty acid biosynthesis proteins such as acyl-CoA synthetase family member 2 and fatty acid oxidation related proteins including acyl-CoA dehydrogenase long chain and acyl-coenzyme A oxidase were enriched in high stocking density group. Additionally, high stocking density increased oxidative response associated proteins such as DDRGK domain containing 1. Furthermore, increasing stocking density diminished proteins of anti-oxidant capacity including regucalcin and catalase. 16S rDNA analysis revealed that higher stocking density was accompanied with decreased microbial diversity, as well as depletion of anti-inflammatory bacterial taxa, including Bacteroidales, Butyricimonas and Alistipe. Besides, reduced bile acid metabolism-associated bacteria such as Ruminococcaceae, Clostridiales and Desulfovibrionaceae were found in the high-density group. Both proteome and 16S rDNA results showed inflammation and chronic liver disease trend in the high-density group, which suggests the involvement of the liver-gut axis in oxidative stress.	[Wu, Yuqin; Sun, Shiqiang; Xiao, Zhibin; Dong, Xiaoyu; Shahid, Muhammad Suhaib; Yin, Dafei; Yuan, Jianmin] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China; [Li, Jianhui; Qin, Xin] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu, Peoples R China	China Agricultural University; Shanxi Agricultural University	Yuan, JM (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China.	yuanjm@cau.edu.cn	s, sq/HHN-6384-2022; Yuan, Jianmin/AAD-6116-2020; Wu, Yuqin/O-1316-2019	Wu, Yuqin/0000-0002-1762-1896	National Key Research and Development Program of China [2016YFD0500509]; System for Poultry Production Technology, Beijing Agriculture Innovation Consortium [BAIC04-2017]	National Key Research and Development Program of China; System for Poultry Production Technology, Beijing Agriculture Innovation Consortium	This research was supported by the National Key Research and Development Program of China (2016YFD0500509) and the System for Poultry Production Technology, Beijing Agriculture Innovation Consortium (Project Number: BAIC04-2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Bensaad K, 2014, CELL REP, V9, P349, DOI 10.1016/j.celrep.2014.08.056; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Buijs S, 2010, APPL ANIM BEHAV SCI, V124, P97, DOI 10.1016/j.applanim.2010.02.007; Carrera G, 2003, AM J GASTROENTEROL, V98, P1142; Cengiz O, 2015, POULTRY SCI, V94, P2395, DOI 10.3382/ps/pev194; Chavez-Talavera O, 2017, GASTROENTEROLOGY, V152, P1679, DOI 10.1053/j.gastro.2017.01.055; Chen T, 2015, PLOS ONE, V10; Dai M, 2015, CELL MOL NEUROBIOL, V35, P463, DOI 10.1007/s10571-014-0140-z; Del Chierico F, 2017, HEPATOLOGY, V65, P451, DOI 10.1002/hep.28572; Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004; Dozier WA, 2006, POULTRY SCI, V85, P344, DOI 10.1093/ps/85.2.344; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Hagert C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00114; Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015; Jiang WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08096; Kakiyama G, 2013, J HEPATOL, V58, P949, DOI 10.1016/j.jhep.2013.01.003; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Kpundeh M. D., 2013, Journal of Aquaculture Research and Development, V4, P189; Leung C, 2016, NAT REV GASTRO HEPAT, V13, P412, DOI 10.1038/nrgastro.2016.85; Li JH, 2017, ANIM SCI J, V88, P900, DOI 10.1111/asj.12697; Liu HX, 2016, J HEPATOL, V64, P641, DOI 10.1016/j.jhep.2015.09.022; Liu J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14186; Lonsdale D, 2015, MED HYPOTHESES, V84, P129, DOI 10.1016/j.mehy.2014.12.004; Luo J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009098; Mancabelli L, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix153; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Menezes C, 2015, AQUACULTURE, V435, P257, DOI 10.1016/j.aquaculture.2014.09.044; Mourot J, 2000, COMP BIOCHEM PHYS B, V126, P81, DOI 10.1016/S0305-0491(00)00171-1; Naderi M, 2017, FISH PHYSIOL BIOCHEM, V43, P1373, DOI 10.1007/s10695-017-0378-8; Najafi P, 2015, INT J BIOMETEOROL, V59, P1577, DOI 10.1007/s00484-015-0964-3; Osorio F, 2014, NAT IMMUNOL, V15, P248, DOI 10.1038/ni.2808; OSUMI T, 1980, J BIOCHEM, V87, P1735, DOI 10.1093/oxfordjournals.jbchem.a132918; Pereira-Fantini PM, 2016, J GASTROEN HEPATOL, V31, P1946, DOI 10.1111/jgh.13383; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; Pillai H, 2017, MOL REPROD DEV, V84, P1133, DOI 10.1002/mrd.22873; Polansky O, 2016, APPL ENVIRON MICROB, V82, P1569, DOI 10.1128/AEM.03473-15; Pymm P, 2017, NAT STRUCT MOL BIOL, V24, P387, DOI 10.1038/nsmb.3381; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Ray K, 2013, NAT REV GASTRO HEPAT, V10, P621, DOI [10.1038/nrgastro.2013.184, 10.1038/nrgastro.2013.197]; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Sanders JG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9285; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shen LF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02159-4; Sheng LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01576-9; Simitzis PE, 2012, BRIT POULTRY SCI, V53, P721, DOI 10.1080/00071668.2012.745930; Tang J, 2017, BRIT J NUTR, V118, P641, DOI 10.1017/S0007114517002641; Tong HB, 2012, POULTRY SCI, V91, P667, DOI 10.3382/ps.2011-01597; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, P11033, DOI 10.1093/nar/gkw880; Whitson JA, 2017, FREE RADICAL BIO MED, V113, P84, DOI 10.1016/j.freeradbiomed.2017.09.019; Xi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064231; Xie M, 2014, POULTRY SCI, V93, P1644, DOI 10.3382/ps.2013-03741; Yeoman CJ, 2014, ANNU REV ANIM BIOSCI, V2, P469, DOI 10.1146/annurev-animal-022513-114149; Yu S, 2016, ANIM GENET, V47, P451, DOI 10.1111/age.12435; Zhang LS, 2015, EFFECTS STOCKING DEN; Zhang YR, 2018, ANIM SCI J, V89, P925, DOI 10.1111/asj.12997	57	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0198985	10.1371/journal.pone.0198985	http://dx.doi.org/10.1371/journal.pone.0198985			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365498	Green Published, Green Submitted, gold			2022-12-26	WOS:000448448700001
J	Bhagwandin, C; Ashbeck, EL; Whalen, M; Bandola-Simon, J; Roche, PA; Szajman, A; Truong, SM; Wertheim, BC; Klimentidis, YC; Ishido, S; Renquist, BJ; Lybarger, L				Bhagwandin, Candida; Ashbeck, Erin L.; Whalen, Michael; Bandola-Simon, Joanna; Roche, Paul A.; Szajman, Adam; Truong, Sarah Mai; Wertheim, Betsy C.; Klimentidis, Yann C.; Ishido, Satoshi; Renquist, Benjamin J.; Lybarger, Lonnie			The E3 ubiquitin ligase MARCH1 regulates glucose-tolerance and lipid storage in a sex-specific manner	PLOS ONE			English	Article							MHC CLASS-II; BETA-CELL FAILURE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; DOWN-REGULATION; T-CELLS; B-CELLS; DEPOT DIFFERENCES; LINKING OBESITY; INFLAMMATION	Type 2 diabetes is typified by insulin-resistance in adipose tissue, skeletal muscle, and liver, leading to chronic hyperglycemia. Additionally, obesity and type 2 diabetes are characterized by chronic low-grade inflammation. Membrane-associated RING-CH-1 (MARCH1) is an E3 ubiquitin ligase best known for suppression of antigen presentation by dendritic and B cells. MARCH1 was recently found to negatively regulate the cell surface levels of the insulin receptor via ubiquitination. This, in turn, impaired insulin sensitivity in mouse models. Here, we report that MARCH1-deficient (knockout; KO) female mice exhibit excessive weight gain and excessive visceral adiposity when reared on standard chow diet, without increased inflammatory cell infiltration of adipose tissue. By contrast, male MARCH1 KO mice had similar weight gain and visceral adiposity to wildtype (WT) male mice. MARCH1 KO mice of both sexes were more glucose tolerant than WT mice. The levels of insulin receptor were generally higher in insulin-responsive tissues (especially the liver) from female MARCH1 KO mice compared to males, with the potential to account in part for the differences between male and female MARCH1 KO mice. We also explored a potential role for MARCH1 in human type 2 diabetes risk through genetic association testing in publicly-available datasets, and found evidence suggestive of association. Collectively, our data indicate an additional link between immune function and diabetes, specifically implicating MARCH1 as a regulator of lipid metabolism and glucose tolerance, whose function is modified by sex-specific factors.	[Bhagwandin, Candida; Whalen, Michael; Lybarger, Lonnie] Univ Arizona, Cellular & Mol Med, Tucson, AZ 85721 USA; [Ashbeck, Erin L.; Wertheim, Betsy C.] Univ Arizona, Canc Ctr, Tucson, AZ USA; [Bandola-Simon, Joanna; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Szajman, Adam; Truong, Sarah Mai] Univ Arizona, Mol & Cellular Biol, Tucson, AZ USA; [Klimentidis, Yann C.] Univ Arizona, Dept Epidemiol & Biostat, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Ishido, Satoshi] Hyogo Coll Med, Dept Microbiol, Nishinomiya, Hyogo, Japan; [Renquist, Benjamin J.] Univ Arizona, Anim & Comparat Biomed Sci, Tucson, AZ USA	University of Arizona; University of Arizona; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Arizona; University of Arizona; Hyogo College of Medicine; University of Arizona	Lybarger, L (corresponding author), Univ Arizona, Cellular & Mol Med, Tucson, AZ 85721 USA.	lybarger@email.arizona.edu	Renquist, Benjamin/K-6051-2019; Klimentidis, Yann/B-2348-2015	Renquist, Benjamin/0000-0003-1517-8226; Klimentidis, Yann/0000-0002-6065-4044; Roche, Paul/0000-0002-8949-9172	National Institutes of Health [1R56AI080756-01A2, CA87969, CA55075, DK58845]; University of Arizona; Intramural Research Program of the National Institutes of Health; Gene and Environment Initiatives in Type 2 Diabetes through the NIH Genes, Environment and Health Initiative [GEI] [U01HG004399]; NIH GEI [U01HG004424]; Northwestern University's Center for Genetic Medicine, Northwestern University; Northwestern Memorial Hospital; eMERGE Coordinating Center [U01HG04603]; NIH, NHGRI eMERGE Network [U01HG004609]; NIH [U01HG004424]; National Human Genome Research Institute (NHGRI); National Institute of General Medical Sciences (NIGMS); Vanderbilt CTSA from NCRR/NIH [UL1RR024975]; NATIONAL CANCER INSTITUTE [ZIABC009404, P01CA087969, P01CA055075] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004424, U01HG004399, U01HG004446, U01HG004603, U01HG004609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arizona; Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gene and Environment Initiatives in Type 2 Diabetes through the NIH Genes, Environment and Health Initiative [GEI]; NIH GEI; Northwestern University's Center for Genetic Medicine, Northwestern University; Northwestern Memorial Hospital; eMERGE Coordinating Center; NIH, NHGRI eMERGE Network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Vanderbilt CTSA from NCRR/NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by National Institutes of Health grant 1R56AI080756-01A2 (to L. Lybarger), start-up funds from the University of Arizona (to L. Lybarger), and the Intramural Research Program of the National Institutes of Health (to P. Roche and J. Bandola-Simon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding support for the GWAS of Gene and Environment Initiatives in Type 2 Diabetes was provided through the NIH Genes, Environment and Health Initiative [GEI] (U01HG004399).; The human subjects participating in the GWAS derive from The Nurses' Health Study and Health Professionals' Follow-up Study and these studies are supported by National Institutes of Health grants CA87969, CA55075, and DK58845. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the Gene Environment Association Studies, GENEVA Coordinating Center (U01 HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Funding support for genotyping, which was performed at the Broad Institute of MIT and Harvard, was provided by the NIH GEI (U01HG004424). The datasets used for the analyses described in this manuscript were obtained from dbGaP at [http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gap] through dbGaP accession number [phs000091].; Samples and data used in this study were provided by the NUgene Project (www.nugene.org).Funding support for the NUgene Project was provided by the Northwestern University's Center for Genetic Medicine, Northwestern University, and Northwestern Memorial Hospital. Assistance with phenotype harmonization was provided by the eMERGE Coordinating Center (Grant number U01HG04603). This study was funded through the NIH, NHGRI eMERGE Network (U01HG004609). Funding support for genotyping, which was performed at The Broad Institute, was provided by the NIH (U01HG004424). Assistance with phenotype harmonization and genotype data cleaning was provided by the eMERGE Administrative Coordinating Center (U01HG004603) and the National Center for Biotechnology Information (NCBI). The datasets used for the analyses described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000237.; Funding support for the Vanderbilt Genome-Electronic Records (VGER) project was provided through a cooperative agreement (U01HG004603) with the National Human Genome Research Institute (NHGRI) with additional funding from the National Institute of General Medical Sciences (NIGMS). The dataset and samples used for the VGER analyses were obtained from Vanderbilt University Medical Center's BioVU, which is supported by institutional funding and by the Vanderbilt CTSA grant UL1RR024975 from NCRR/NIH. Funding support for genotyping, which was performed at The Broad Institute, was provided by the NIH (U01HG004424). Assistance with phenotype harmonization and genotype data cleaning was provided by the eMERGE Administrative Coordinating Center (U01HG004603) and the National Center for Biotechnology Information (NCBI).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Basu A, 2009, DIABETES CARE, V32, P866, DOI 10.2337/dc08-1826; Bhargava P, 2012, BIOCHEM J, V442, P253, DOI 10.1042/BJ20111708; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fried SK, 2015, OBESITY, V23, P1345, DOI 10.1002/oby.21133; Galbas T, 2012, CYTOKINE, V59, P27, DOI 10.1016/j.cyto.2012.03.015; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Ishido S, 2010, MOL CELLS, V29, P229, DOI 10.1007/s10059-010-0051-x; Jabbour M, 2009, J IMMUNOL, V183, P6500, DOI 10.4049/jimmunol.0901521; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kraakman MJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00470; Lee M, 2016, NUTR RES PRACT, V10, P115, DOI 10.4162/nrp.2016.10.1.115; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nagarajan A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12639; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Poloso NJ, 2004, J IMMUNOL, V173, P4539, DOI 10.4049/jimmunol.173.7.4539; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sim X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001363; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Thompson ACS, 2012, J LIPID RES, V53, P2797, DOI 10.1194/jlr.D031286; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; White UA, 2014, BBA-MOL BASIS DIS, V1842, P377, DOI 10.1016/j.bbadis.2013.05.006; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001	41	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0204898	10.1371/journal.pone.0204898	http://dx.doi.org/10.1371/journal.pone.0204898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356278	Green Published, Green Submitted, gold			2022-12-26	WOS:000448434000022
J	Wei, B; Kang, M; Jang, HK				Wei, Bai; Kang, Min; Jang, Hyung-Kwan			Evaluation of potassium clavulanate supplementation of Bolton broth for enrichment and detection of Campylobacter from chicken	PLOS ONE			English	Article							CEFOPERAZONE-DEOXYCHOLATE AGAR; E. COLI; SPP.; MEDIA; QUANTIFICATION; SELECTIVITY; CULTURE	Culture-based detection of Campylobacter can be affected by competing flora, temperature, incubation time, and presence of blood. The presence of extended-spectrum P-lactamase (ESBL)-producing Escherichia coli in poultry has become one of the most common factors interfering with the detection of Campylobacter. In the present study, we evaluated potassium clavulanate (ESBL inhibitor) as a supplement in Bolton broth (C-Bolton broth) for enrichment and detection of Campylobacter. First, we determined growth kinetics of Campylobacter in the presence of different concentrations of ESBL E. coli in C-Bolton broth during enrichment. The effects of other factors such as incubation time, incubation temperature, and presence of blood on Campylobacter detection in C-Bolton broth were also investigated. The growth of Campylobacter co-cultured at a low concentration (2 and 4 log(10) CFU/mL) of ESBL E. coli was similar to that of Campylobacter alone in C-Bolton broth, and Campy/obacterco-cultured at a high concentration (6 and 8 log(10) CFU/mL) of ESBL E. coli showed slower growth than the pure Campylobacter culture. The Campylobacter detection limit was 1 log(10) CFU/mL when mixed with 2, 4, or 6 log(10) CFU/mL of E. co/iand 3 log(10) CFU/mL when mixed with 8 log(10) CFU/mL of E. coli after 48 h enrichment in the broth. Campylobacter detection from chicken feces and litter samples was not affected by incubation time, or presence of blood in the broth. A modified procedure of enrichment in C-Bolton broth at 37 degrees C for 24 h without blood showed a significantly (P <= 0.05) higher detection rate and a lower false-negative rate than the ISO 10272-1:2006 method for Campylobacter detection from chicken feces and litter samples. In summary, the present study demonstrates the efficacy of Bolton broth supplemented with potassium clavulanate in the detection of Campylobacter mixed with ESBL E. coli, and an improved procedure to detect Campylobacter from chicken feces and litter samples.	[Jang, Hyung-Kwan] Chonbuk Natl Univ, Dept Vet Infect Dis & Avian Dis, Coll Vet Med, Iksan, South Korea; Chonbuk Natl Univ, Ctr Poultry Dis Control, Iksan, South Korea	Jeonbuk National University; Jeonbuk National University	Jang, HK (corresponding author), Chonbuk Natl Univ, Dept Vet Infect Dis & Avian Dis, Coll Vet Med, Iksan, South Korea.	hkjang@jbnu.ac.kr			Korea Institute of Planning and Evaluation for technology in Food, Agriculture, Forestry and Fisheries [716002-7]; Basic Science Research Program through the NRF - Ministry of Education [2017R1D1A1B03030883]; Research of Animal and Plant Quarantine Agency [Z-1543073-2015-16-01]	Korea Institute of Planning and Evaluation for technology in Food, Agriculture, Forestry and Fisheries; Basic Science Research Program through the NRF - Ministry of Education; Research of Animal and Plant Quarantine Agency	This work was supported by Korea Institute of Planning and Evaluation for technology in Food, Agriculture, Forestry and Fisheries (716002-7) to HKJ, Basic Science Research Program through the NRF funded by the Ministry of Education (2017R1D1A1B03030883) to MK, and Research of Animal and Plant Quarantine Agency (Z-1543073-2015-16-01) to HKJ, South Korea.	[Anonymous], 1027222006 ISO; [Anonymous], 1027212006 ISO; Becker HM, 2014, DIGESTION, V89, P110, DOI 10.1159/000357521; Chon JW, 2012, POULTRY SCI, V91, P2382, DOI 10.3382/ps.2011-01980; Chon JW, 2014, J FOOD SCI, V79, pM923, DOI 10.1111/1750-3841.12388; Chon JW, 2013, INT J FOOD MICROBIOL, V165, P7, DOI 10.1016/j.ijfoodmicro.2013.04.006; CORRY JEL, 1995, INT J FOOD MICROBIOL, V26, P43, DOI 10.1016/0168-1605(95)00044-K; Dame-Korevaar A, 2017, VET MICROBIOL, V203, P211, DOI 10.1016/j.vetmic.2017.03.024; deBoer E, 1996, LETT APPL MICROBIOL, V23, P64; Edson DC, 2009, J FOOD SAFETY, V29, P521, DOI 10.1111/j.1745-4565.2009.00174.x; European Food Safety Authority, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5182; Hazeleger WC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01430; Ibekwe AM, 2003, J APPL MICROBIOL, V94, P421, DOI 10.1046/j.1365-2672.2003.01848.x; Jasson V, 2009, INT J FOOD MICROBIOL, V135, P248, DOI 10.1016/j.ijfoodmicro.2009.09.007; Journet L, 2016, ECOSAL PLUS, V7, P1, DOI [10.1128/ecosalplus.ESP-0009-2015, DOI 10.1128/EC0SALPLUS.ESP-0009-2015]; Kaakoush NO, 2007, RES MICROBIOL, V158, P644, DOI 10.1016/j.resmic.2007.07.009; Kaczor AA, 2017, CURR MED CHEM, V24, P1948, DOI 10.2174/0929867323666161213102127; Keepers TR, 2014, ANTIMICROB AGENTS CH, V58, P5297, DOI 10.1128/AAC.02894-14; Khan IUH, 2013, APPL ENVIRON MICROB, V79, P7639, DOI 10.1128/AEM.02324-13; Kiess AS, 2010, POULTRY SCI, V89, P1755, DOI 10.3382/ps.2009-00587; Lee MD, 2006, AVIAN DIS, V50, P1, DOI 10.1637/7474-111605R.1; Line JE, 2006, J RAPID METH AUT MIC, V14, P110, DOI 10.1111/j.1745-4581.2006.00032.x; Line JE, 2002, POULTRY SCI, V81, P1473, DOI 10.1093/ps/81.10.1473; Linton D, 1996, RES MICROBIOL, V147, P707, DOI 10.1016/S0923-2508(97)85118-2; Liu L, 2009, J FOOD PROTECT, V72, P2428, DOI 10.4315/0362-028X-72.11.2428; Molinaro AM, 2015, NEURO-ONCOL PRACT, V2, P162, DOI 10.1093/nop/npv030; Moran L, 2011, LETT APPL MICROBIOL, V52, P614, DOI 10.1111/j.1472-765X.2011.03046.x; Murphy C, 2006, J APPL MICROBIOL, V100, P623, DOI 10.1111/j.1365-2672.2006.02903.x; Reperant E, 2016, J MICROBIOL METH, V128, P42, DOI 10.1016/j.mimet.2016.06.028; Smith S, 2015, INT J FOOD MICROBIOL, V210, P131, DOI 10.1016/j.ijfoodmicro.2015.06.014; United States Department of Agriculture/ Food Safety and Inspection Service (USDA/FSIS), ISOLATION IDENTIFICA; Vaz CSL, 2014, POULTRY SCI, V93, P2887, DOI 10.3382/ps.2014-03943; Williams LK, 2009, INT J FOOD MICROBIOL, V130, P131, DOI 10.1016/j.ijfoodmicro.2009.01.018; Wingstrand A, 2006, EMERG INFECT DIS, V12, P280	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205324	10.1371/journal.pone.0205324	http://dx.doi.org/10.1371/journal.pone.0205324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356296	Green Submitted, Green Published, gold			2022-12-26	WOS:000448434000052
J	Wei, Y; Toth, JI; Blanco, GA; Bobkov, AA; Petroski, MD				Wei, Yang; Toth, Julia I.; Blanco, Gabrielle A.; Bobkov, Andrey A.; Petroski, Matthew D.			Adapted ATPase domain communication overcomes the cytotoxicity of p97 inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; proteasome; ATPases associated with diverse cellular activities (AAA); protein degradation; protein homeostasis; protein quality control; protein unfolding	AAA-ATPASE; NUCLEOTIDE-BINDING; P97/VCP ATPASE; PAGET-DISEASE; D1 RING; MUTATIONS; MECHANISM; UBIQUITIN; CANCER; CONFORMATION	The AAA(+) ATPase p97 regulates ubiquitin-dependent protein homeostasis and has been pursued as a cancer drug target. The ATP-competitive inhibitor CB-5083 and allosteric inhibitor NMS-873 are the most advanced p97 inhibitors described to date. Previous studies have reported that their cytotoxicity can be readily overcome and involves single p97 mutations in the linker between the D1 and D2 ATPase domains and within D2. We report here that the proline 472 to leucine (P472L) mutation, in the D1-D2 linker and identified in CB-5083-resistant cells, desensitizes p97 to both inhibitor classes. This mutation does not disrupt the distinct D2-binding sites of the inhibitors. Instead, P472L changes ATPase domain communication within the p97 hexamer. P472L enhances cooperative D2 ATP binding and hydrolysis. This mechanism alters the function of the D1-D2 linker in the control of D2 activity involving the ATP-bound state of D1. Although increased D2 activity is sufficient to desensitize the P472L mutant to NMS-873, the mutant's desensitization to CB-5083 also requires D1 ATPase domain function. Our study highlights the remarkable adaptability of p97 ATPase domain communication that enables escape from mechanistically distinct classes of cytotoxic p97 inhibitors.	[Wei, Yang; Toth, Julia I.; Blanco, Gabrielle A.; Bobkov, Andrey A.; Petroski, Matthew D.] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Petroski, MD (corresponding author), Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.	petroski@sbpdiscovery.org			Padres Pedal the Cause Postdoctoral Fellowship; National Institutes of Health [R01CA180150, R01CA185300]; Sanford Burnham Prebys NCI Cancer Center Support Grant from the National Institutes of Health [P30 CA030199]; NATIONAL CANCER INSTITUTE [R01CA185300, P30CA030199, R01CA180150] Funding Source: NIH RePORTER	Padres Pedal the Cause Postdoctoral Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanford Burnham Prebys NCI Cancer Center Support Grant from the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a Padres Pedal the Cause Postdoctoral Fellowship (to Y. W.), National Institutes of Health Grants R01CA180150 and R01CA185300 (to M. D. P.), and Sanford Burnham Prebys NCI Cancer Center Support Grant P30 CA030199 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Banerjee S, 2016, SCIENCE, V351, P871, DOI 10.1126/science.aad7974; Bastola P, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.65; Blythe EE, 2017, P NATL ACAD SCI USA, V114, pE4380, DOI 10.1073/pnas.1706205114; Bodnar NO, 2018, NAT STRUCT MOL BIOL, V25, P616, DOI 10.1038/s41594-018-0085-x; Bodnar NO, 2017, CELL, V169, P722, DOI 10.1016/j.cell.2017.04.020; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Bulfer SL, 2016, ACS CHEM BIOL, V11, P2112, DOI 10.1021/acschembio.6b00350; Chapman E, 2015, MOLECULES, V20, P3027, DOI 10.3390/molecules20023027; Chou TF, 2014, J MOL BIOL, V426, P2886, DOI 10.1016/j.jmb.2014.05.022; Chou TF, 2011, J BIOL CHEM, V286, P16546, DOI 10.1074/jbc.M110.215319; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Deshaies RJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0094-0; Hanzelmann P, 2016, STRUCTURE, V24, P127, DOI 10.1016/j.str.2015.10.026; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Her NG, 2016, CELL CHEM BIOL, V23, P517, DOI 10.1016/j.chembiol.2016.03.012; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Locke M, 2014, BIOCHEM J, V459, P205, DOI 10.1042/BJ20120662; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Schuetz AK, 2016, ELIFE, V5, DOI 10.7554/eLife.20143; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Stach L, 2017, BIOCHEM J, V474, P2953, DOI 10.1042/BCJ20160783; Tang WK, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00079; Tang WK, 2013, J BIOL CHEM, V288, P36624, DOI 10.1074/jbc.M113.488924; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; van den Boom J, 2018, MOL CELL, V69, P182, DOI 10.1016/j.molcel.2017.10.028; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang Q, 2005, J BIOL CHEM, V280, P40515, DOI 10.1074/jbc.M509636200; Wang Q, 2003, J BIOL CHEM, V278, P32784, DOI 10.1074/jbc.M303869200; Wang Q, 2003, BIOCHEM BIOPH RES CO, V300, P253, DOI 10.1016/S0006-291X(02)02840-1; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00039; Zhang XY, 2015, P NATL ACAD SCI USA, V112, pE1705, DOI 10.1073/pnas.1418820112; Zhou HJ, 2015, J MED CHEM, V58, P9480, DOI 10.1021/acs.jmedchem.5b01346	45	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20169	20180		10.1074/jbc.RA118.004301	http://dx.doi.org/10.1074/jbc.RA118.004301			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30381397	Green Published, hybrid			2022-12-26	WOS:000454685900024
J	Cantrell, CL; Abbas; Jones, AMP				Cantrell, Charles L.; Abbas; Jones, A. Maxwell P.			Isolation and identification of mosquito biting deterrents from the North American mosquito repelling folk remedy plant, Matricaria discoidea DC.	PLOS ONE			English	Article							VITRO BIOASSAY SYSTEM; NATURAL-PRODUCTS; FATTY-ACIDS; REPELLENTS; DISCOVERY; DIPTERA	Matricaria discoidea DC. (Asteraceae) has documented use as an insect repellent by Blackfoot Indians and other indigenous groups of North America. This investigation was conducted to evaluate this practice and systematically identify chemical constituents responsible for any insect repelling effect by utilizing a mosquito (Aedes aegypti (Linnaeus)) biting deterrent bioactivity-directed purification approach. Hydrodistilled oil from dried aerial parts of M. discoidea was the most bioactive crude extract generated and was as. Fractionation of this extract, followed by re-evaluation for mosquito biting deterrence using the K & D (Klun and Debboun) bioassay, produced many active fractions that were subsequently evaluated by spectroscopic techniques and the most active compounds were determined to be alpha-terpineol, spathulenol, and neryl isovalerate. A & K (Ali and Khan) large cage in vitro evaluation of pure compounds isolated from M. discoidea indicated alpha-terpineol to be the most active compound providing complete protection at 25 mu g/cm(2). This is the first report on the mosquito repellency of neryl isovalerate and scientific evidence reported here validates the traditional use of M. discoidea as a biting-insect deterrent.	[Cantrell, Charles L.] ARS, Nat Prod Utilizat Res Unit, USDA, University, MS 38635 USA; [Abbas] Univ Mississippi, Natl Ctr Nat Prod Res, University, MS 38677 USA; [Jones, A. Maxwell P.] Univ Guelph, Gosling Res Inst Plant Preservat, Dept Plant Agr, Guelph, ON, Canada	United States Department of Agriculture (USDA); University of Mississippi; University of Guelph	Cantrell, CL (corresponding author), ARS, Nat Prod Utilizat Res Unit, USDA, University, MS 38635 USA.	charles.cantrell@ars.usda.gov			Deployed War-Fighter Protection (DWFP) research program grant - U.S. Department of Defense through the Armed Forces Pest Management Board [6060-32000-002-04-I]; Deployed War-Fighter Protection (DWFP) research program grant - U.S. Department of Defense through USDA/ARS [58-6066-6-043]	Deployed War-Fighter Protection (DWFP) research program grant - U.S. Department of Defense through the Armed Forces Pest Management Board; Deployed War-Fighter Protection (DWFP) research program grant - U.S. Department of Defense through USDA/ARS	This study was supported in part by a Deployed War-Fighter Protection (DWFP) research program grant funded by the U.S. Department of Defense through the Armed Forces Pest Management Board (project No. 6060-32000-002-04-I) and through USDA/ARS grant No. 58-6066-6-043.	Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Ali A, 2017, J MED ENTOMOL, V54, P1328, DOI 10.1093/jme/tjx100; Ali A, 2012, J MED ENTOMOL, V49, P1370, DOI 10.1603/ME12026; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Buono-Core GE, 2011, J CHIL CHEM SOC, V56, P549, DOI 10.4067/S0717-97072011000100006; Cantrell CL, 2016, J AGR FOOD CHEM, V64, P8352, DOI 10.1021/acs.jafc.6b01668; Cantrell CL, 2012, J NAT PROD, V75, P1231, DOI 10.1021/np300024u; Cantrell CL, 2011, J MED ENTOMOL, V48, P836, DOI 10.1603/ME10244; Cantrell CL, 2005, J AGR FOOD CHEM, V53, P5948, DOI 10.1021/jf0509308; DEPASCUAL J, 1983, PHYTOCHEMISTRY, V22, P1757, DOI 10.1016/S0031-9422(00)80265-4; FONTANA A, 1993, J CHEM ECOL, V19, P339, DOI 10.1007/BF00993700; HART J, 1992, MONTANA NATIVE PLANT; HWANG YS, 1985, J CHEM ECOL, V11, P1297, DOI 10.1007/BF01024117; Jones AMP, 2012, J AGR FOOD CHEM, V60, P3867, DOI 10.1021/jf300101w; Klun JA, 2005, J AM MOSQUITO CONTR, V21, P64, DOI 10.2987/8756-971X(2005)21[64:ANIVBS]2.0.CO;2; Linda K., 2000, EDIBLE MED PLANTS RO; Lopes D, 2013, J ESSENT OIL BEAR PL, V8, P178; Moerman DE, 1998, NATIVE AM ETHNOBOTAN, P337; SAS Institute, 2007, SAS ONL DOC VERS 9 2; Shiwakoti S, 2016, IND CROP PROD, V94, P251, DOI 10.1016/j.indcrop.2016.08.036; Tabanca N, 2016, CURR ORG CHEM, V20, P2690, DOI 10.2174/1385272820666160421151503; WEYERSTAHL P, 1992, LIEBIGS ANN CHEM, P1325	22	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206594	10.1371/journal.pone.0206594	http://dx.doi.org/10.1371/journal.pone.0206594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379955	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700135
J	Fondevilla, V; Dalla Vecchia, FM; Gaete, R; Galobart, A; Moncunill-Sole, B; Mohler, M				Fondevilla, Victor; Marco Dalla Vecchia, Fabio; Gaete, Rodrigo; Galobart, Angel; Moncunill-Sole, Blanca; Mohler, Meike			Ontogeny and taxonomy of the hadrosaur (Dinosauria, Ornithopoda) remains from Basturs Poble bonebed (late early Maastrichtian, Tremp Syncline, Spain)	PLOS ONE			English	Article							SOUTH-CENTRAL PYRENEES; GROWTH-PATTERNS; FOSSIL RECORD; LAMBEOSAURINE DINOSAUR; DYNAMICS; CHINA; AGE; DIVERSITY; MAIASAURA; TURNOVER	The lower Maastrichtian site of Basturs Poble (southern Pyrenees, Spain) is the first hadrosaur bonebed reported from Europe. It is an accumulation of disarticulated lambeosaurine skeletal elements, possibly belonging to Pararhabdodon isonensis. The sample shows high intraspecific morphological variability among many skeletal elements, suggesting the need for caution in choosing characters for phylogenetic analyses. Juvenile to adult individuals are represented in the sample, while hatchling remains are absent. Bone histology reveals that juveniles are over-represented and that the youngest individuals represented by tibia specimens were two years old. Adult individuals, with tibiae 550-600 mm long, were 14-15 years old when they died. However, individual variation in tibia length at skeletal maturity occurs within the sample, so individual maturity cannot be assumed on the basis of bone size alone. The Basturs Poble bonebed occurs within the upper part of the C31r magnetochron. Thus, lambeosaurine hadrosaurids were already present and abundant in the Ibero-Armorica Island at the end of the early Maastrichtian and P. isonensis spans the upper part of the lower Maastrichtian to the upper part of the upper Maastrichtian (upper part of C31 r-lower part of C29r).	[Fondevilla, Victor; Marco Dalla Vecchia, Fabio; Galobart, Angel; Moncunill-Sole, Blanca; Mohler, Meike] Inst Catala Paleontol Miquel Crusafont, Sabadell, Catalonia, Spain; [Fondevilla, Victor] Univ Autonoma Barcelona, Dept Geol, Bellaterra, Catalonia, Spain; [Marco Dalla Vecchia, Fabio] Museo Friulano Storia Nat, Udine, Italy; [Gaete, Rodrigo; Galobart, Angel] Museu Conca Della, Isona Lleida, Catalonia, Spain; [Moncunill-Sole, Blanca] Univ Autonoma Barcelona, Dept Biol Anim & Vegetal, Bellaterra, Catalonia, Spain; [Mohler, Meike] ICREA, Barcelona, Catalonia, Spain	Institut Catala de Paleontologia Miquel Crusafont (ICP); Autonomous University of Barcelona; Autonomous University of Barcelona; ICREA	Fondevilla, V (corresponding author), Inst Catala Paleontol Miquel Crusafont, Sabadell, Catalonia, Spain.; Fondevilla, V (corresponding author), Univ Autonoma Barcelona, Dept Geol, Bellaterra, Catalonia, Spain.	victo.fiondevilla@icp.cat	Galobart, Àngel À/H-5024-2011; Fondevilla, Víctor/F-5726-2015; Moncunill-Solé, Blanca/T-9986-2019	Galobart, Àngel À/0000-0003-1508-4561; Fondevilla, Víctor/0000-0001-9355-2389; Moncunill-Solé, Blanca/0000-0001-8042-4257; Kohler, Meike/0000-0002-6816-6651	Spanish Ministerio de Economia y Competitividad [CGL2011-30069-C02-01, CGL2016-77230-P, CGL-2015-63777]; Generalitat Catalunya [20014/100927, 2014-SGR-1207]; Ministerio de Economia y Competitividad [BES-2012-052366]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat Catalunya; Ministerio de Economia y Competitividad(Spanish Government)	This paper is a contribution to the projects CGL2011-30069-C02-01 (PI: AG), CGL2016-77230-P (PI: AG) and CGL-2015-63777 (PI: MK) funded by the Spanish Ministerio de Economia y Competitividad (www.mineco.gob.es, and the projects 20014/100927 (PI: AG) and 2014-SGR-1207 (PI: MK) funded by the Generalitat Catalunya (www.gencat.cat).V.Fondevilla acknowledges support from the Ministerio de Economia y Competitividad (FPI grant, BES-2012-052366). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertalanffy L. v., 1934, ARCH ENTWICKLUNGMECH, V131, P613, DOI DOI 10.1007/BF00650112; Blanco Alejandro, 2015, Spanish Journal of Palaeontology, V30, P147; Blanco A, 2016, CRETACEOUS RES, V57, P624, DOI 10.1016/j.cretres.2015.07.005; Blanco A, 2015, CRETACEOUS RES, V56, P447, DOI 10.1016/j.cretres.2015.04.001; Brett-Surman M.K., 2006, HORNS BEAKS CERATOPS, P135; Brinkman Donald B., 2014, P416; Brown B, 1916, B AM MUS NAT HIST, V35, P709; Brown CM, 2015, J ANAT, V226, P322, DOI 10.1111/joa.12280; Canudo JI, 2016, CRETACEOUS RES, V57, P540, DOI 10.1016/j.cretres.2015.06.013; Casanovas-Cladellas M.L., 1995, Paleontologia i Evolucio, V26-27, P121; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Company J, 2015, J IBER GEOL, V41, P71, DOI 10.5209/rev_JIGE.2015.v41.n1.48656; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; Cruzado-Caballero P, 2013, J VERTEBR PALEONTOL, V33, P1367, DOI 10.1080/02724634.2013.772061; Cruzado-Caballero P, 2010, CAN J EARTH SCI, V47, P1507, DOI 10.1139/E10-081; Dalla Vecchia Fabio M., 2006, Natura Nascosta, V32, P1; Dalla Vecchia Fabio M., 2014, P268; Dalla Vecchia Fabio M., 2014, P298; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; Diez-Canseco D, 2014, SEDIMENT GEOL, V312, P31, DOI 10.1016/j.sedgeo.2014.06.008; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Fondevilla V, 2016, SEDIMENT GEOL, V337, P55, DOI 10.1016/j.sedgeo.2016.03.006; Gaete R, 2009, THESIS; Godefroit P, 2008, ACTA PALAEONTOL POL, V53, P47, DOI 10.4202/app.2008.0103; Godefroit Pascal, 2004, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V74, P139; Godefroit Pascal, 2011, Global Geology - English Edition, V14, P160; Gomez-Gras D, 2016, CRETACEOUS RES, V57, P414, DOI 10.1016/j.cretres.2015.09.010; Homer J. R., 1994, DINOSAUR EGGS BABIES, P312; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Hubner TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029958; Husson D, 2011, EARTH PLANET SC LETT, V305, P328, DOI 10.1016/j.epsl.2011.03.008; Verdu FJ, 2017, CRETACEOUS RES, V74, P65, DOI 10.1016/j.cretres.2017.02.006; Lauters P, 2008, PALAIOS, V23, P153, DOI 10.2110/palo.2006.p06-031r; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Margerie E., 2002, CR BIOL, V325, P221, DOI DOI 10.1016/S1631-0691(02)01429-4; Martin M, 2007, 55 S VERT PAL COMP A, P40; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036745; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P413; Norman DB, 2015, ZOOL J LINN SOC-LOND, V173, P92, DOI 10.1111/zoj.12193; Oms O, 2014, RECONSTRUCTING TERRE, V7, P1; Ostrom JH., 1961, B AM MUS NAT HIST, V122, P1; Parks W.A., 1920, U TRONTO STUDIES GEO, V11, P1; Parks WA, 1923, GEOLOGICAL SERIES, V15, P1; Pereda-Suberbiola X, 2009, CR PALEVOL, V8, P559, DOI 10.1016/j.crpv.2009.05.002; Prieto-Marquez A., 2001, THESIS; Prieto-Marquez A, 2008, THESIS; Prieto-Marquez A, 2006, J VERTEBR PALEONTOL, V26, P929, DOI 10.1671/0272-4634(2006)26[929:HDFTLC]2.0.CO;2; Prieto-Marquez A, 2007, J VERTEBR PALEONTOL, V27, p131A; Prieto-Marquez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082268; Prieto-Marquez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069835; Prieto-Marquez A, 2010, AM MUS NOVIT, P1, DOI 10.1206/3694.2; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Riera V., 2010, THESIS; Riera V, 2009, PALAEOGEOGR PALAEOCL, V283, P160, DOI 10.1016/j.palaeo.2009.09.018; Rosell J., 2001, REV SOC GEOLOGICA ES, V14, P47; SANZ JL, 1995, NATURE, V376, P731, DOI 10.1038/376731a0; Selles AG, 2014, CRETACEOUS RES, V49, P45, DOI 10.1016/j.cretres.2014.02.004; Vila B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072579; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; WEISHAMPEL DB, 1993, PALAEONTOLOGY, V36, P361; Woodward HN, 2015, PALEOBIOLOGY, V41, P503, DOI 10.1017/pab.2015.19; You HL, 2003, CRETACEOUS RES, V24, P347, DOI 10.1016/S0195-6671(03)00048-X; Young CC., 1958, PALAEONTOLOGICA SI C, V16, P53	67	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206287	10.1371/journal.pone.0206287	http://dx.doi.org/10.1371/journal.pone.0206287			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379888	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700099
J	King, C; Nightingale, R; Phiri, T; Zadutsa, B; Kainja, E; Makwenda, C; Colbourn, T; Stevenson, F				King, Carina; Nightingale, Rebecca; Phiri, Tambosi; Zadutsa, Beatiwel; Kainja, Esther; Makwenda, Charles; Colbourn, Tim; Stevenson, Fiona			Non-adherence to oral antibiotics for community paediatric pneumonia treatment in Malawi - A qualitative investigation	PLOS ONE			English	Article							CHILDHOOD PNEUMONIA; ADHERENCE; CHILDREN; AMOXICILLIN; DIARRHEA; THERAPY; MALARIA	Background Pneumonia remains the leading cause of paediatric infectious mortality globally. Treatment failure, which can result from non-adherence to oral antibiotics, can lead to poor outcomes and therefore improving adherence could be a strategy to reduce pneumonia related morbidity and mortality. However, there is little published evidence from low-resource settings for the drivers of non-adherence to oral antibiotics in children. Objective We aimed to investigate reasons for adherence and non-adherence in children diagnosed and treated in the community with fast-breathing pneumonia in rural Malawi. Methods We conducted focus group discussions (FGDs) with caregivers of children known to have been diagnosed and treated with oral antibiotics for fast-breathing pneumonia in the community and key informant interviews with community healthcare workers (CHW). FGDs and interviews were conducted within communities in Chichewa, the local language. We used a framework approach to analyze the transcripts. Results We conducted 4 FGDs with caregivers and 10 interviews with CHWs. We identified four themes, which were common across caregivers and CHWs: knowledge and understanding, effort, medication perceptions and community influences. Caregivers and CHWs demonstrated good knowledge of pneumonia and types of treatment, but caregivers showed confusion around dosing and treatment durations. Effort was needed to seek care, prepare medication and understand regimens, acting as a barrier to adherence. Perceptions of how well the treatment was working influenced adherence, with both quick recovery and slow recovery leading to non-adherence. Community influences were both supportive, with transport assistance for referrals and home visits to improve adherence, and detrimental, with pressure to share treatments. Conclusion Adherence to oral antibiotic treatment for fast-breathing pneumonia was understood to be important, however considerable barriers we described within this rural low-resource setting, such as the effort preparing and administering medication, community pressures to share drugs and potential complexity of regimens.	[King, Carina; Colbourn, Tim] UCL, Inst Global Hlth, London, England; [Nightingale, Rebecca] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Phiri, Tambosi; Zadutsa, Beatiwel; Kainja, Esther; Makwenda, Charles] Parent & Child Hlth Initiat, Lilongwe, Malawi; [Stevenson, Fiona] UCL, Res Dept Primary Care & Populat Hlth, London, England	University of London; University College London; Liverpool School of Tropical Medicine; University of London; University College London	King, C (corresponding author), UCL, Inst Global Hlth, London, England.	c.king@ucl.ac.uk	Stevenson, Fiona/AAJ-2727-2021; Colbourn, Tim/AAE-6645-2019	Stevenson, Fiona/0000-0003-2139-2309; Colbourn, Tim/0000-0002-6917-6552; Nightingale, Rebecca/0000-0001-5636-8531; King, Carina/0000-0002-6885-6716	University College London Grand Challenges in Global Health [156425]	University College London Grand Challenges in Global Health	This project was supported by the University College London Grand Challenges in Global Health small grant scheme (grant code: 156425).	Ansah EK, 2001, TROP MED INT HEALTH, V6, P496, DOI 10.1046/j.1365-3156.2001.00740.x; Awasthi S, 2004, BMJ-BRIT MED J, V328, P791; Baguley D, 2012, ARCH DIS CHILD, V97, P293, DOI 10.1136/archdischild-2011-300909; Beer N, 2009, TROP MED INT HEALTH, V14, P766, DOI 10.1111/j.1365-3156.2009.02289.x; Chopra M, 2013, LANCET, V381, P1499, DOI 10.1016/S0140-6736(13)60319-0; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Grant GB, 2009, LANCET INFECT DIS, V9, P185, DOI 10.1016/S1473-3099(09)70044-1; Hazir T, 2002, LANCET, V360, P835; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; Kanyuka M, 2016, LANCET GLOB HEALTH, V4, pE201, DOI 10.1016/S2214-109X(15)00294-6; Kardas P, 2002, J ANTIMICROB CHEMOTH, V49, P897, DOI 10.1093/jac/dkf046; Kardas P, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00091; King C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136839; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; McCollum ED, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0392-x; Menendez R, 2004, THORAX, V59, P960, DOI 10.1136/thx.2003.017756; Mjaland K, 2014, PUNISHM SOC, V16, P336, DOI 10.1177/1462474514527149; MoH, 2015, MAL STAND TREATM GUI; National Statistical Office (NSO) [Malawi] and ICF, 2017, MALAWI DEMOGRAPHIC H; Nightingale R, 2016, PNEUMONIA, V8, DOI 10.1186/s41479-016-0024-8; Nsona H, 2012, AM J TROP MED HYG, V87, P54, DOI 10.4269/ajtmh.2012.11-0759; Rajesh SM, 2013, INT J PREVENTIVE MED, V4, P1162; Reyes H, 1997, J CLIN EPIDEMIOL, V50, P1297, DOI 10.1016/S0895-4356(97)00197-2; Venables R, 2015, INT J PHARM; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; World Health Organization, 2011, CAR SICK CHILD COMM	28	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206404	10.1371/journal.pone.0206404	http://dx.doi.org/10.1371/journal.pone.0206404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379968	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700109
J	Kosakowski, J; Verma, P; Sengupta, S; Higgs, PG				Kosakowski, Jakub; Verma, Prateek; Sengupta, Supratim; Higgs, Paul G.			The evolution of antibiotic production rate in a spatial model of bacterial competition	PLOS ONE			English	Article							ROCK-PAPER-SCISSORS; PROMOTES BIODIVERSITY; MICROBIAL COMMUNITIES; CYCLIC COMPETITION; GAME; DIVERSITY; POPULATIONS; DEGRADATION; DYNAMICS	We consider competition between antibiotic producing bacteria, non-producers (or cheaters), and sensitive cells in a two-dimensional lattice model. Previous work has shown that these three cell types can survive in spatial models due to the presence of spatial patterns, whereas coexistence is not possible in a well-mixed system. We extend this to consider the evolution of the antibiotic production rate, assuming that the cost of antibiotic production leads to a reduction in growth rate of the producers. We find that coexistence occurs for an intermediate range of antibiotic production rate. If production rate is too high or too low, only sensitive cells survive. When evolution of production rate is allowed, a mixture of cell types arises in which there is a dominant producer strain that produces sufficient to limit the growth of sensitive cells and which is able to withstand the presence of cheaters in its own species. The mixture includes a range of low-rate producers and non-producers, none of which could survive without the presence of the dominant producer strain. We also consider the case of evolution of antibiotic resistance within the sensitive species. In order for the resistant cells to survive, they must grow faster than both the non-producers and the producers. However, if the resistant cells grow too rapidly, the producing species is eliminated, after which the resistance mutation is no longer useful, and sensitive cells take over the system. We show that there is a range of growth rates of the resistant cells where the two species coexist, and where the production mechanism is maintained as a polymorphism in the producing species and the resistance mechanism is maintained as a polymorphism in the sensitive species.	[Kosakowski, Jakub] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Verma, Prateek; Sengupta, Supratim] Indian Inst Sci Educ & Res Kolkata, Dept Phys Sci, Mohanpur, India; [Higgs, Paul G.] McMaster Univ, Dept Phys & Astron, Hamilton, ON, Canada	McMaster University; Indian Institute of Science Education & Research (IISER) - Kolkata; McMaster University	Higgs, PG (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON, Canada.	higgsp@mcmaster.ca	Verma, Prateek/AGF-1205-2022	Higgs, Paul/0000-0001-5220-9760; Sengupta, Supratim/0000-0001-5294-0561; Verma, Prateek/0000-0003-3431-246X	Natural Sciences and Engineering Research Council of Canada [261831]; Aditi Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Aditi Foundation	This work was supported by Discovery Grant 261831 to PGH from the Natural Sciences and Engineering Research Council of Canada, by Compute Canada computing facilities, and by a travel grant from the Aditi Foundation allowing Prateek Verma to visit McMaster University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom CT, 2000, GENETICS, V155, P1505; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; Clardy J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-232; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Durrett R, 1997, J THEOR BIOL, V185, P165, DOI 10.1006/jtbi.1996.0292; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Goyal A, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.158102; Guill C, 2011, J THEOR BIOL, V276, P16, DOI 10.1016/j.jtbi.2011.01.036; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Karolyi G, 2005, J THEOR BIOL, V236, P12, DOI 10.1016/j.jtbi.2005.02.012; Kelsic ED, 2015, NATURE, V521, P516, DOI 10.1038/nature14485; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Mao-Jones J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000345; MAY RM, 1975, SIAM J APPL MATH, V29, P243, DOI 10.1137/0129022; Muller APO, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.052901; Nanjwade BK, 2010, TROP J PHARM RES, V9, P231; Pagie L, 1999, J THEOR BIOL, V196, P251, DOI 10.1006/jtbi.1998.0838; Perlin MH, 2009, P ROY SOC B-BIOL SCI, V276, P3759, DOI 10.1098/rspb.2009.0997; Reichenbach T, 2008, J THEOR BIOL, V254, P368, DOI 10.1016/j.jtbi.2008.05.014; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Scheuring I, 2012, ECOL LETT, V15, P1300, DOI 10.1111/j.1461-0248.2012.01853.x; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Szilagyi A, 2017, J THEOR BIOL, V423, P53, DOI 10.1016/j.jtbi.2017.04.025; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Wiener P, 2000, ECOL LETT, V3, P122, DOI 10.1046/j.1461-0248.2000.00129.x; Wolkowicz GSK, 2006, FIELDS I COMMUN, V48, P279; Wright GD, 2005, ADV DRUG DELIVER REV, V57, P1451, DOI 10.1016/j.addr.2005.04.002; Zeeman M.L., 1993, DYNAM STABIL SYST, V8, P189	32	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205202	10.1371/journal.pone.0205202	http://dx.doi.org/10.1371/journal.pone.0205202			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379843	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700031
J	Kusama, T; Aida, J; Tsuboya, T; Sugiyama, K; Yamamoto, T; Igarashi, A; Osaka, K				Kusama, Taro; Aida, Jun; Tsuboya, Toru; Sugiyama, Kemmyo; Yamamoto, Takafumi; Igarashi, Ayaka; Osaka, Ken			The association between socioeconomic status and reactions to radiation exposure: a cross-sectional study after the Fukushima Daiichi nuclear power station accident	PLOS ONE			English	Article							GENETICALLY-MODIFIED FOOD; HEALTH MANAGEMENT SURVEY; PSYCHOLOGICAL DISTRESS; MINORITY POPULATIONS; BEHAVIOR; PERCEPTION; ANXIETY; COHORT; RISKS; PLANT	Risk perception and individual reactions to risk are not necessarily comparable, and socioeconomic status may affect individual reactions to risk. This study aimed to investigate the association between socioeconomic status and reactions to radiation exposure risk. This cross-sectional study, based on a self-reported online survey was conducted between 3 March and 21 March 2012, one year after the accident at Fukushima Daiichi nuclear power station. We used feelings of anxiety and risk-averse behavior concerning radiation exposure as dependent variables, and equivalent income and educational attainment as independent variables. Multiple logistic regression analysis was applied to estimate adjusted odds ratios (aORs) and 95% confidence intervals (95% Cls) with adjustment for possible confounders. Among 10 000 participants, 23.0% felt anxious and 12.0% engaged in risk-averse behavior for radiation exposure. Participants with a higher socioeconomic status tended not to feel anxious but undertook risk-averse behavior. Participants in the highest quartile income category did not report feeling anxious but showed prevalent undertaking of risk-averse behavior for radiation exposure compared to the lowest income category (for anxiety, aOR, 0.77; 95% CI, 0.64-0.93, for risk-averse behavior, aOR, 1.33; 95% CI, 1.04-1.69). University or graduate-school graduates were associated with greater risk-averse behavior compared to junior high school or high school graduates (aOR, 1.49; 95% CI, 1.29-1.73). Socioeconomic status may affect reactions to radiation exposure risk. Risk communication strategies should consider the socioeconomic status of those affected.	[Kusama, Taro; Aida, Jun; Tsuboya, Toru; Sugiyama, Kemmyo; Yamamoto, Takafumi; Igarashi, Ayaka; Osaka, Ken] Tohoku Univ, Grad Sch Dent, Dept Int & Community Oral Hlth, Sendai, Miyagi, Japan	Tohoku University	Aida, J (corresponding author), Tohoku Univ, Grad Sch Dent, Dept Int & Community Oral Hlth, Sendai, Miyagi, Japan.	j-aida@umin.ac.jp	Tsuboya, Toru/ABF-1756-2020; TSUBOYA, Toru/M-3847-2016; Sugiyama, Kemmyo/AAF-4222-2019; Aida, Jun/S-9371-2019	Tsuboya, Toru/0000-0001-7741-0751; TSUBOYA, Toru/0000-0001-7741-0751; Sugiyama, Kemmyo/0000-0001-5110-2216; Aida, Jun/0000-0002-8405-9872; Yamamoto, Takafumi/0000-0002-3329-2332; Kusama, Taro/0000-0001-8683-4484				Aruga K, 2017, ENVIRON ECON POLICY, V19, P677, DOI 10.1007/s10018-016-0169-y; BETTINGHAUS EP, 1986, PREV MED, V15, P475, DOI 10.1016/0091-7435(86)90025-3; Boholm A., 1998, J RISK RES, V1, P135, DOI [10.1080/136698798377231, DOI 10.1080/136698798377231]; Bolin R.C., 1986, RACE RELIG ETHNICITY; Consumer Affairs Agency, 2016, SURV CONS AW RUM DAM; Costa-Font J, 2005, APPL ECON LETT, V12, P859, DOI 10.1080/13504850500365830; Costa-Font M, 2008, FOOD POLICY, V33, P99, DOI 10.1016/j.foodpol.2007.07.002; Croyle R., 2005, THEORY GLANCE GUIDE, DOI [10.1097/EDE.0000000000000038, DOI 10.1097/EDE.0000000000000038]; Dosman DM, 2001, RISK ANAL, V21, P307, DOI 10.1111/0272-4332.212113; Eisenman DP, 2009, AM J PUBLIC HEALTH, V99, P168, DOI 10.2105/AJPH.2007.124206; Eisenman DP, 2006, AM J PREV MED, V30, P1, DOI 10.1016/j.amepre.2005.09.001; Green MJ, 2013, SOC PSYCH PSYCH EPID, V48, P1951, DOI 10.1007/s00127-013-0720-0; Hino Y, 2016, TOHOKU J EXP MED, V239, P333, DOI 10.1620/tjem.239.333; Hirose K, 2012, J ENVIRON RADIOACTIV, V111, P13, DOI 10.1016/j.jenvrad.2011.09.003; Hutchins SS, 2009, AM J PUBLIC HEALTH, V99, pS261, DOI 10.2105/AJPH.2009.161505; Jacob P, 2009, SCI TOTAL ENVIRON, V408, P14, DOI 10.1016/j.scitotenv.2009.09.006; Kim Jihye, 2014, J Prev Med Public Health, V47, P94, DOI 10.3961/jpmph.2014.47.2.94; Linander I, 2015, EUR J PUBLIC HEALTH, V25, P231, DOI 10.1093/eurpub/cku137; Murakami M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0112791, 10.1]; Nandi A, 2014, EPIDEMIOLOGY, V25, P170, DOI 10.1097/EDE.0000000000000038; Needham BL, 2013, SOC SCI MED, V85, P1, DOI 10.1016/j.socscimed.2013.02.023; Olofsson A, 2011, RISK ANAL, V31, P1016, DOI 10.1111/j.1539-6924.2010.01566.x; Rowel R, 2009, GUIDE ENHANCE GRASSR; Rowel R, 2012, HEALTH PROMOT PRACT, V13, P124, DOI 10.1177/1524839910390312; Schmidlin TW, 1993, TORNADO ITS STRUCTUR; Singh-Manoux A, 2005, AM J EPIDEMIOL, V161, P831, DOI 10.1093/aje/kwi109; Stevens G, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-797; Stevens G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-91; Suzuki Y, 2015, B WORLD HEALTH ORGAN, V93, P598, DOI 10.2471/BLT.14.146498; Takebayashi Y, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111306; Traill WB, 2005, AGBIOFORUM; Veeman M., 2005, RISK PERCEPTIONS SOC; WAHLEN M, 1980, SCIENCE, V207, P639, DOI 10.1126/science.7352276; Wakamatsu H, 2016, MAR RESOUR ECON, V31, P27, DOI 10.1086/683686; World Health Organization, 2017, COMM RISK PUBL HLTH	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205531	10.1371/journal.pone.0205531	http://dx.doi.org/10.1371/journal.pone.0205531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY7VH	30379864	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700052
J	Osazuwa-Peters, OL; Stevens, WD; Jimenez, I				Osazuwa-Peters, Oyomoare L.; Stevens, W. D.; Jimenez, Ivan			Using museum specimens to estimate broad- scale species richness: Exploring the performance of individual-based and spatially explicit rarefaction	PLOS ONE			English	Article							PLANT RICHNESS; BIODIVERSITY; DIVERSITY; BIASES; DETERMINANTS; BIOGEOGRAPHY; SHORTFALLS; KNOWLEDGE; CURVES; MODEL	Estimates of spatial patterns of broad-scale species richness are central to major questions in ecology, evolution and conservation. Yet, they are scarce due to incomplete information on species distributions. Often the only germane data derives from museum specimens collected during non-standardized sampling. Rarefaction, a promising approach to estimate broad-scale richness with these data, estimates the expected number of species represented in subsets of n specimens drawn from Nspecimens collected in a sampling unit. One version of rarefaction, known as individual-based rarefaction, assumes that the Nspecimens collected in a sampling unit constitute a random sample of individuals in that sampling unit. Another version, known as spatially explicit rarefaction, assumes that the N specimens collected in a sampling unit are spatially aggregated. We examined the working hypothesis that, when applied to museum specimen data, spatially explicit rarefaction is less biased than individual-based rarefaction because it reduces overestimation due to spatially aggregated sampling. We derived five predictions from this working hypothesis and tested them using computer simulation experiments based on a database of 129,782 plant specimens from Nicaragua, and sampling units of 5 x 5, 50 x 50, and 100 x 100 km. One experiment was a negative control, whereby we simulated collection of randomly chosen individuals from each sampling unit. In contrast, three other experiments included spatially aggregated sampling. In all experiments we applied individual-based and spatially explicit rarefaction to estimate richness, with n = 200 and n = 500 specimens. As expected, the experiment designed as a negative control did not support the working hypothesis. The other three experiments supported the working hypothesis in analyses of larger sampling units, but not in 5 x 5 km sampling units. The predictions we derived from the working hypothesis can be used to assess which rarefaction version is best in particular systems.	[Osazuwa-Peters, Oyomoare L.; Jimenez, Ivan] Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO 63110 USA; [Osazuwa-Peters, Oyomoare L.; Stevens, W. D.; Jimenez, Ivan] Missouri Bot Garden, Sci & Conservat Div, St Louis, MO 63110 USA	Missouri Botanical Gardens; Missouri Botanical Gardens	Osazuwa-Peters, OL (corresponding author), Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO 63110 USA.; Osazuwa-Peters, OL (corresponding author), Missouri Bot Garden, Sci & Conservat Div, St Louis, MO 63110 USA.	Oyomoare.Osazuwa-peters@mobot.org		Osazuwa-Peters, Oyomoare/0000-0002-6601-657X				Bacaro G, 2012, ECOL COMPLEX, V12, P63, DOI 10.1016/j.ecocom.2012.05.007; Ballesteros-Mejia L, 2016, ECOGRAPHY, DOI [10.1111/ecoq.02438, DOI 10.1111/ECPG.02438]; Ballesteros-Mejia L, 2013, GLOBAL ECOL BIOGEOGR, V22, P586, DOI 10.1111/geb.12039; Bivand R., 2018, RGDAL BINDINGS GEOSP; Brown P., 2018, MAPMISC UTILITIES PR; Cayuela L, 2015, ECOL MONOGR, V85, P437, DOI 10.1890/14-1261.1; Champely S., 2018, R PACKAGE, V1; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chiarucci A, 2009, COMMUNITY ECOL, V10, P209, DOI 10.1556/ComEc.10.2009.2.11; Collins MD, 2009, ENVIRON ECOL STAT, V16, P89, DOI 10.1007/s10651-007-0051-y; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Crist TO, 2006, ECOL LETT, V9, P923, DOI 10.1111/j.1461-0248.2006.00941.x; Dale M.R.T., 2014, SPATIAL ANAL GUIDE E; Daru BH, 2018, NEW PHYTOL, V217, P939, DOI 10.1111/nph.14855; Distler T, 2009, ANN MO BOT GARD, V96, P470, DOI 10.3417/2008034; Engemann K, 2015, ECOL EVOL, V5, P807, DOI 10.1002/ece3.1405; Gotelli N., 2013, ENCY BIODIVERSITY, V5, P195, DOI DOI 10.1016/B978-0-12-384719-5.00424-X; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gotelli NJ, 1996, NULL MODELS ECOLOGY; Hijmans R.J., 2017, RASTER GEOGRAPHIC DA; Hortal J, 2015, ANNU REV ECOL EVOL S, V46, P523, DOI 10.1146/annurev-ecolsys-112414-054400; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Hurlbert SH, 1971, NONCONCEPT SPECIES D, DOI [10.2307/1934145, DOI 10.2307/1934145]; Jimenez I, 2009, ECOGRAPHY, V32, P433, DOI 10.1111/j.1600-0587.2008.05165.x; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; Lomolino MV, 2004, FRONTIERS OF BIOGEOGRAPHY: NEW DIRECTIONS IN THE GEOGRAPHY OF NATURE, P1; Mannion PD, 2014, TRENDS ECOL EVOL, V29, P42, DOI 10.1016/j.tree.2013.09.012; Mannion PD, 2012, GLOBAL ECOL BIOGEOGR, V21, P898, DOI 10.1111/j.1466-8238.2011.00735.x; McGill B, 2003, EVOL ECOL RES, V5, P469; McGill BJ, 2010, ECOL LETT, V13, P627, DOI 10.1111/j.1461-0248.2010.01449.x; Meyer C, 2016, ECOL LETT, V19, P992, DOI 10.1111/ele.12624; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Oliveira U, 2016, DIVERS DISTRIB, V22, P1232, DOI 10.1111/ddi.12489; Pebesma E, 2018, CLASSES METHODS SPAT; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2021, R LANGUAGE ENV STAT; Ricklefs RE, 2015, ECOL LETT, V18, P497, DOI 10.1111/ele.12431; Ripley B, 2018, CA 1998 KH PARTIAL P; Schluter D, 2016, AM NAT, V187, P1, DOI 10.1086/684193; Schmidt-Lebuhn AN, 2013, BIODIVERS CONSERV, V22, P905, DOI 10.1007/s10531-013-0457-9; Sheth SN, 2012, GLOBAL ECOL BIOGEOGR, V21, P732, DOI 10.1111/j.1466-8238.2011.00716.x; SMITH W, 1977, BIOMETRICS, V33, P283, DOI 10.2307/2529778; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Stevens WD, 2001, FLORA NICARAGUA; Ter Steege H, 2011, AM J BOT, V98, P31, DOI 10.3732/ajb.1000215; Thompson GG, 2007, AUSTRAL ECOL, V32, P564, DOI 10.1111/j.1442-9993.2007.01728.x; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Wickham H, 2017, SCALES SCALE FUNCTIO; Wilcox R., 2015, J STAT DISTRIB APPL, V2, DOI [10.1186/s40488-015-0026-8, DOI 10.1186/S40488-015-0026-8]; Xu HG, 2016, SCI REP-UK, V6, DOI 10.1038/srep21988; Zar J.H., 2010, BIOSTAT ANAL	52	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0204484	10.1371/journal.pone.0204484	http://dx.doi.org/10.1371/journal.pone.0204484			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379842	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700015
J	Fan, Q; Creamer, R; Li, YZ				Fan, Qin; Creamer, Rebecca; Li, Yanzhong			Time-course metabolic profiling in alfalfa leaves under Phoma medicaginis infection	PLOS ONE			English	Article							SPRING BLACK STEM; STRESS RESPONSES; LEAF-SPOT; SATIVA L; RESISTANCE; DEFENSE; GENES; DISCRIMINATE; ARABIDOPSIS; EXPRESSION	Information on disease process and pathogenicity mechanisms is important for understanding plant disease. Spring black stem and leaf spot caused by the necrotrophic pathogen Phoma medicaginis var. medicaginis Malbr. & Roum causes large losses to alfalfa. However, till now, little is known about alfalfa-P. medicagnis interactions and the pathogenicity mechanisms of the pathogen. Here, alfalfa inoculated with P. medicaginis was subjected to GC-MS based metabolic profiling. The metabolic response in P. medicaginis-inoculated and mock-inoculated alfalfa leaves was assessed at 2, 4, 6, 8, 12, 16, 20, 24, 26 and 28 days post inoculation. In total, 101 peaks were detected in the control and inoculated groups, from which 70 metabolites were tentatively identified. Using multivariate analysis, 16 significantly regulated compounds, including amino acids, nitrogen-containing compounds and organic acids, polyols, fatty acids, and sugars were tentatively identified (Variable importance values, VIP>1.0 and p <0.05). Among these metabolites, the levels of malate, 5-oxoproline, palmitic acid and stearic acid were increased significantly in P. medicaginis-infected alfalfa leaves compared to the controls. In contrast, the levels ofy-aminobutyric acid and 2-pyrrolidinone were significantly decreased in infected leaves compared to the controls. Further metabolic pathway analysis of the 16 significantly regulated compounds demonstrated that glycolysis, the tricarboxylic acid cycle, and beta-oxidation of fatty acids were significantly induced in the alfalfa leaves at later stages of P. medicaginis infection. The strong induction of tricarboxylic acid cycle pathways at later infection stages caused by the pathogen may induce senescence in the alfalfa leaves, leading to plant death. However, intermediate metabolites of these metabolic pathways, and inositol phosphate, glutathione, the metabolic pathways of some amino acids accumulated rapidly and strongly at early stages of infection, which may enhance the ability of alfalfa to resist necrotrophic P. medicaginis disease. Understanding metabolic pathways is essential for understanding pathogenesis.	[Fan, Qin; Li, Yanzhong] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst,Key Lab Grass, Engn Res Ctr Grassland Ind,Minist Educ,Minist Min, Lanzhou, Gansu, Peoples R China; [Fan, Qin] Gansu Univ Chinese Med, Lanzhou, Gansu, Peoples R China; [Creamer, Rebecca] New Mexico State Univ, Las Cruces, NM 88003 USA; [Li, Yanzhong] Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Peoples R China	Lanzhou University; Gansu University of Chinese Medicine; New Mexico State University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS	Li, YZ (corresponding author), Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst,Key Lab Grass, Engn Res Ctr Grassland Ind,Minist Educ,Minist Min, Lanzhou, Gansu, Peoples R China.; Li, YZ (corresponding author), Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Peoples R China.	liyzh@lzu.edu.cn	Li, Yanzhong/W-4260-2017	Li, Yanzhong/0000-0002-1319-4436	Special Fund for Agro-scientific Research in the Public Interest [201303057]	Special Fund for Agro-scientific Research in the Public Interest	This research was financially supported by Special Fund for Agro-scientific Research in the Public Interest (No. 201303057) to Yanzhong Li. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu HO, 2008, PLANT DIS, V92, P833, DOI 10.1094/PDIS-92-5-0833A; Barbetti MJ, 2007, PLANT DIS, V91, P239, DOI 10.1094/PDIS-91-3-0239; BARBETTI MJ, 1990, AUST J EXP AGR, V30, P209, DOI 10.1071/EA9900209; Herrera-Rodriguez MB, 2006, J PLANT PHYSIOL, V163, P1061, DOI 10.1016/j.jplph.2005.10.012; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; BLOUNT JW, 1992, PHYSIOL MOL PLANT P, V41, P333, DOI 10.1016/0885-5765(92)90020-V; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Castell-Miller CV, 2007, CAN J PLANT PATHOL, V29, P290; Chatnaparat T, 2016, MOL PLANT MICROBE IN, V29, P508, DOI 10.1094/MPMI-01-16-0007-R; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Djebali N, 2013, PHYTOPATHOL MEDITERR, V52, P3; Fan Qin, 2017, Acta Prataculturae Sinica, V26, P112; Fischer JA, 2001, FUNGAL GENET BIOL, V34, P21, DOI 10.1006/fgbi.2001.1287; Hamzehzarghani H, 2005, PHYSIOL MOL PLANT P, V66, P119, DOI 10.1016/j.pmpp.2005.05.005; Han Ting-Li, 2017, F1000Res, V6, P967, DOI 10.12688/f1000research.11823.1; Jasinski M, 2009, PLANT PHYSIOL BIOCH, V47, P847, DOI 10.1016/j.plaphy.2009.05.004; Kamphuis LG, 2012, MOL PLANT PATHOL, V13, P593, DOI 10.1111/j.1364-3703.2011.00767.x; Karunakaran R, 2013, APPL ENVIRON MICROB, V79, P4496, DOI 10.1128/AEM.00919-13; Li YZ, 2016, ALFALFA DIS ATLAS; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lu XS, 2013, CHINESE DAIRY CATTLE, P3; MAHER EA, 1993, PHYSIOL MOL PLANT P, V43, P329, DOI 10.1006/pmpp.1993.1062; Mandavi V, 2015, ANAL BIOCHEM, V478, P65, DOI 10.1016/j.ab.2015.02.021; Molina A, 1997, PLANT MOL BIOL, V33, P803, DOI 10.1023/A:1005712803130; Nan ZB., 2001, ANIMAL SCI ANIMAL ME, V18, P81; Navarova H, 2012, PLANT CELL, V24, P5123, DOI 10.1105/tpc.112.103564; PAIVA NL, 1994, PLANT CELL TISS ORG, V38, P213, DOI 10.1007/BF00033879; Petroff OAC, 1999, NEUROLOGY, V52, P473, DOI 10.1212/WNL.52.3.473; RENFRO BL, 1963, PHYTOPATHOLOGY, V53, P1340; Schliemann W, 2008, PHYTOCHEMISTRY, V69, P112, DOI 10.1016/j.phytochem.2007.06.032; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; Song JT, 2004, PLANT J, V40, P200, DOI 10.1111/j.1365-313X.2004.02200.x; Sun HZ, 2015, J PROTEOME RES, V14, P1287, DOI 10.1021/pr501305g; Wang YT, 2017, CHINA DAIRY, P74; Wang Yu, 2016, Acta Prataculturae Sinica, V25, P52; Wang Yu, 2015, Acta Prataculturae Sinica, V24, P155; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; [杨青川 Yang Qingchuan], 2011, [中国草地学报, Chinese Journal of Grassland], V33, P95; [张丽 Zhang Li], 2016, [草地学报, Acta Agrestia Sinica], V24, P652; [张丽 Zhang Li], 2015, [中国农业大学学报, Journal of China Agricultural University], V20, P158	41	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206641	10.1371/journal.pone.0206641	http://dx.doi.org/10.1371/journal.pone.0206641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372486	gold, Green Submitted, Green Published			2022-12-26	WOS:000448641200052
J	Wang, Q; Cai, YC; He, YP; Yang, LT; Pan, LW				Wang, Qiang; Cai, Yicun; He, Yuping; Yang, Litao; Pan, Liangwen			Collaborative ring trial of two real-time PCR assays for the detection of porcine- and chicken-derived material in meat products	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MULTIPLEX PCR; SPECIES IDENTIFICATION; LENGTH POLYMORPHISM; PORK ADULTERATION; FOOD-CHAIN; VALIDATION; BUFFALO; BOVINE; GENE	In this study, we describe an inter-laboratory collaborative ring trial validation of species-specific TaqMan real-time PCR assays for the detection of porcine- and chicken-derived materials in meat products. We comprehensively evaluated the performance of these assays in different environments and situations. This validation included the participation of thirteen laboratories across Europe and Asia. The results from the thirteen participating laboratories were analyzed to determine the specificity, accuracy, false positive rate, limit of detection (LOD), and probability of detection (POD) of the developed methods. These results indicated that the methods developed to detect porcine- and chicken-derived materials in meat products are robust and repeatable. The false positive and false negative rates were both 0%, and the LOD was determined to be five copies/reaction. The laboratory standard deviation (sigma(L)) was 0.30 for both detection methods, indicating that the developed methods are suitable for detection and identification of the porcine- and chicken-derived materials in meat products.	[Wang, Qiang; Cai, Yicun; He, Yuping; Pan, Liangwen] Shanghai Entry Exit Inspect & Quarantine Bur Chin, Tech Ctr Anim Plant & Food Inspect & Quarantine, Pudong New Area, Shanghai, Peoples R China; [Yang, Litao] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Minhang Area, Shanghai, Peoples R China	Shanghai Jiao Tong University	Pan, LW (corresponding author), Shanghai Entry Exit Inspect & Quarantine Bur Chin, Tech Ctr Anim Plant & Food Inspect & Quarantine, Pudong New Area, Shanghai, Peoples R China.	panlw888@126.com		Yang, Litao/0000-0002-4515-5722	National Key Research and Development Program of China [2017YFC1601700]; Shanghai Entry-Exit Food and Feed Safety Special Technology Service Platform Fund [17DZ2293700]; Shanghai Science and Technology Commission Standard Special Fund [16DZ0501501]; Shanghai Science and Technology Commission Joint Science and Technology Project of the Yangtze River Delta, China Postdoctoral Research Fund [2017M611628]; Shanghai Entry-Exit Inspection and Quarantine Bureau of Science and Technology Plan Projects Fund [HK008-2017]	National Key Research and Development Program of China; Shanghai Entry-Exit Food and Feed Safety Special Technology Service Platform Fund; Shanghai Science and Technology Commission Standard Special Fund; Shanghai Science and Technology Commission Joint Science and Technology Project of the Yangtze River Delta, China Postdoctoral Research Fund; Shanghai Entry-Exit Inspection and Quarantine Bureau of Science and Technology Plan Projects Fund	Financial support from the National Key Research and Development Program of China (2017YFC1601700), Shanghai Entry-Exit Food and Feed Safety Special Technology Service Platform Fund (17DZ2293700), Shanghai Science and Technology Commission Standard Special Fund (16DZ0501501), Shanghai Science and Technology Commission Joint Science and Technology Project of the Yangtze River Delta, China Postdoctoral Research Fund (2017M611628) and Shanghai Entry-Exit Inspection and Quarantine Bureau of Science and Technology Plan Projects Fund (HK008-2017) are acknowledged with thanks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ME, 2012, MEAT SCI, V91, P454, DOI 10.1016/j.meatsci.2012.02.031; Ali ME, 2015, FOOD CHEM, V177, P214, DOI 10.1016/j.foodchem.2014.12.098; Axelsson E, 2005, GENOME RES, V15, P120, DOI 10.1101/gr.3021305; Cai YC, 2017, MEAT SCI, V134, P119, DOI 10.1016/j.meatsci.2017.07.022; Calvo JH, 2002, J AGR FOOD CHEM, V50, P5262, DOI 10.1021/jf020051a; Deng YM, 2015, J CLIN VIROL, V68, P43, DOI 10.1016/j.jcv.2015.04.019; Druml B, 2015, FOOD CHEM, V178, P319, DOI 10.1016/j.foodchem.2015.01.003; Fang X, 2016, FOOD CHEM, V192, P485, DOI 10.1016/j.foodchem.2015.07.020; Floren C, 2015, FOOD CHEM, V173, P1054, DOI 10.1016/j.foodchem.2014.10.138; Grohmann L, 2009, J AGR FOOD CHEM, V57, P8913, DOI 10.1021/jf901598r; Heymann D. L., 2015, CONTROL COMMUNICABLE; Hossain MAM, 2017, J AGR FOOD CHEM, V65, P3975, DOI 10.1021/acs.jafc.7b00730; Hossain MAM, 2017, FOOD CONTROL, V73, P175, DOI 10.1016/j.foodcont.2016.08.008; Hossain MAM, 2016, J AGR FOOD CHEM, V64, P6343, DOI 10.1021/acs.jafc.6b02224; Hou B, 2015, MEAT SCI, V101, P90, DOI 10.1016/j.meatsci.2014.11.007; Hsieh YHP, 2014, J AGR FOOD CHEM, V62, P12536, DOI 10.1021/jf504032j; International Organization for Standardization, 2016, ISO 12300 HLTH INFOR, P1, DOI DOI 10.3403/30317718; International Organization for Standardization (ISO), 2005, 228662005E ISO, P1; Jonges M, 2014, J VIROL, V88, P1694, DOI 10.1128/JVI.02044-13; Kesmen Z, 2009, MEAT SCI, V82, P444, DOI 10.1016/j.meatsci.2009.02.019; Kesmen Z, 2012, J FOOD SCI, V77, pC167, DOI 10.1111/j.1750-3841.2011.02536.x; Kuswandi B, 2015, J FOOD SCI TECH MYS, V52, P7655, DOI 10.1007/s13197-015-1882-4; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Lin CL, 2006, J ANIM BREED GENET, V123, P384, DOI 10.1111/j.1439-0388.2006.00622.x; Lin CC, 2014, MEAT SCI, V96, P922, DOI 10.1016/j.meatsci.2013.09.001; Nakyinsige K, 2012, MEAT SCI, V91, P207, DOI 10.1016/j.meatsci.2012.02.015; Nau Jean-Yves, 2013, Rev Med Suisse, V9, P532; Nihad AM, 2016, AL MUTHANNA J PURE S, V3, P1; Puech C, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0382-0; Pun KM, 2009, ELECTROPHORESIS, V30, P1008, DOI 10.1002/elps.200800365; Rohman A, 2011, MEAT SCI, V88, P91, DOI 10.1016/j.meatsci.2010.12.007; Uhlig S, 2015, ACCREDIT QUAL ASSUR, V20, P75, DOI 10.1007/s00769-015-1112-9; Wang Q, 2017, EUROPEAN FOOD RES TE, V244, P767	33	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206609	10.1371/journal.pone.0206609	http://dx.doi.org/10.1371/journal.pone.0206609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372489	Green Submitted, gold, Green Published			2022-12-26	WOS:000448641200047
J	Oumer, M; Guday, E; Teklu, A; Muche, A				Oumer, Mohammed; Guday, Edengenet; Teklu, Alemayehu; Muche, Abebe			Anterior fontanelle size among term neonates on the first day of life born at University of Gondar Hospital, Northwest Ethiopia	PLOS ONE			English	Article							BIRTH	Background Anterior fontanelle is the largest, prominent and most important fontanelle, which is used for clinical evaluation. It is mainly characterized by its size and shape variation and is possibly influenced by gender, race and genetics. Understanding the variation of anterior fontanelle is used for recognition of different medical disorders and abnormal skeletal morphogenesis. Objective To determine the mean size of anterior fontanelle among term neonates on the first day of life born at University of Gondar Hospital, Gondar Town, Northwest Ethiopia, 2018. Methods Descriptive cross sectional study design was undertaken in 384 term and apparently healthy neonates, using standard methods. Descriptive analysis, student t-test, one way ANOVA and Pearson correlation coefficient were implemented. Results In this study, the mean size of anterior fontanelle in term neonates was 3.00 +/- 0.62 cm (range 1.70-5.50 cm). The mean size of anterior fontanelle was 3.10 +/- 0.66 cm for males, and 2.88 +/- 0.57 cm for females. There was statistically significant difference in anterior fontanelle size in neonates of different genders (p<0.001), mode of delivery (p<0.001) and duration of labour (p = 0.006). However, the size of anterior fontanelle was not significantly affected by the birth order, onset of labour and socio-demographic variables of the mother except occupation of the mother (p = 0.01). There was a significant positive correlation between the mean size of anterior fontanelle with birth weight (r = 0.11; p = 0.04) and head circumference (r = 0.17; p = 0.001). Conclusions At term, male neonates had significantly larger anterior fontanelle than female neonates and anterior fontanelle size has a direct relationship with birth weight and head circumference.	[Oumer, Mohammed; Guday, Edengenet; Muche, Abebe] Univ Gondar, Coll Med & Hlth Sci, Dept Human Anat, Gondar, Amhara, Ethiopia; [Teklu, Alemayehu] Univ Gondar, Coll Med & Hlth Sci, Dept Pediat, Gondar, Amhara, Ethiopia; [Teklu, Alemayehu] Univ Gondar, Coll Med & Hlth Sci, Dept Child Hlth, Gondar, Amhara, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Oumer, M (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Dept Human Anat, Gondar, Amhara, Ethiopia.	mohammedoumer58@gmail.com	Oumer, Mohammed/AAE-2467-2019	Oumer, Mohammed/0000-0002-9358-9242; Toni, Alemayehu Teklu/0000-0003-4235-0255	University of Gondar	University of Gondar	Funded by University of Gondar (http://UoG.edu.et) (MO). Sponsors or funders did not play role in study design, data collection and analysis. They want this article to be published.	Adeyemo AA., 1991, W AFR J MED, V18, P55; AISENSON MR, 1950, PEDIATRICS, V6, P223; BRANDT I, 1986, KLIN PADIATR, V198, P330, DOI 10.1055/s-2008-1033882; CHAKRABARTI K, 1989, Indian Pediatrics, V26, P41; CHANG B-F, 1990, Acta Paediatrica Sinica, V31, P307; Crelin ES, 1973, FUNCTIONAL ANATOMY N; DAVIES DP, 1975, ARCH DIS CHILD, V50, P81, DOI 10.1136/adc.50.1.81; DUC G, 1986, PEDIATRICS, V78, P904; El-Mougi M., 1988, AL AZHAR MED J, V17, P75; Esmaeili M, 2015, IRAN J CHILD NEUROL, V9, P15; FAIX RG, 1982, J PEDIATR-US, V100, P304, DOI 10.1016/S0022-3476(82)80661-6; Jackson GL, 2010, AM J PERINAT, V27, P307, DOI 10.1055/s-0029-1241738; Kiesler J, 2003, AM FAM PHYSICIAN, V67, P2547; LYALL H, 1991, SCOT MED J, V36, P20, DOI 10.1177/003693309103600111; Malas M A, 2000, J Obstet Gynaecol, V20, P601; Mathur S, 1994, Indian Pediatr, V31, P161; Meskel T, 2004, SIZE ANTERIOR FONTAN, P1; MIR NA, 1988, ANN TROP PAEDIATR, V8, P184, DOI 10.1080/02724936.1988.11748566; Moffett EA, 2014, ANAT REC, V297, P234, DOI 10.1002/ar.22830; Nelson WE., 2011, TXB PEDIAT, V19th; OGUNYE O, 1982, Nigerian Journal of Paediatrics, V9, P21; OMOTADE OO, 1995, ANN TROP PAEDIATR, V15, P89, DOI 10.1080/02724936.1995.11747754; Paladini D, 2008, ULTRASOUND OBST GYN, V32, P755, DOI 10.1002/uog.5368; Pedroso FS, 2008, J CHILD NEUROL, V23, P1419, DOI 10.1177/0883073808319318; Perera PJ, 2013, CEYLON MED J, V58, P96, DOI 10.4038/cmj.v58i3.6102; Periyasamy V, 2014, INT J HLTH SCI, V4, P107; POPICH GA, 1972, J PEDIATR-US, V80, P749, DOI 10.1016/S0022-3476(72)80125-2; Shajari Hamideh, 2011, Acta Med Iran, V49, P543; SILVER W, 1970, CLIN PEDIATR, V9, P42, DOI 10.1177/000992287000900111; SRUGO I, 1987, ISRAEL J MED SCI, V23, P1137; TAN KL, 1976, AM J DIS CHILD, V130, P386, DOI 10.1001/archpedi.1976.02120050044007; Tirpude A., 2016, NATL J CLIN ANAT, V5, P78, DOI [10.4103/2277-4025.298191, DOI 10.4103/2277-4025.298191]; Uzukwu-Edeani CV, 2013, S AFR J CHILD HEALTH, V7, P50, DOI 10.7196/SAJCH.516	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0202454	10.1371/journal.pone.0202454	http://dx.doi.org/10.1371/journal.pone.0202454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365494	Green Published, Green Submitted, gold			2022-12-26	WOS:000448448700004
J	Umeokonkwo, CD; Aniebue, PN; Onoka, CA; Agu, AP; Sufiyan, MB; Ogbonnaya, L				Umeokonkwo, Chukwuma David; Aniebue, Patricia Nonye; Onoka, Chima Ariel; Agu, Adaoha Pearl; Sufiyan, Muawiyyah Babale; Ogbonnaya, Lawrence			Patients' satisfaction with HIV and AIDS care in Anambra State, Nigeria	PLOS ONE			English	Article							HOSPITAL-CARE; GLOBAL BURDEN; RETENTION; DISEASE; MODEL	Introduction HIV and AIDS care requires frequent visits to the hospital. Patient satisfaction with care services during hospital visits is important in considering quality and outcome of care. Increasing number of patients needing treatment led to the decentralization of care to lower level hospitals without documented patient perception on the quality of services. The study determined and compared patient satisfaction with HIV and AIDS care services in public and private hospitals and identified the factors that influence it. Method This was a cross-sectional comparative study of patients receiving antiretroviral treatment in public and private hospitals in Anambra State. The sampling frame for the hospitals consisted of all registered public and private hospitals that have rendered antiretroviral services for at least one year. There were three public urban, nine public rural, eleven private urban and ten private rural hospitals that met the criteria. One hospital was selected by simple random sampling (balloting) from each group. Out of a total of 6334 eligible patients (had received ART for at least 12 months), 1270 were recruited by simple random sampling from the hospitals proportionate to size of patient in each hospital. Adapted, validated and pretested Patient Satisfaction Questionnaire (PSQ18) was interviewer-administered on consenting patients as an exit interview. A Chi-square test and logistic regression analysis were conducted at 5% level of significance. Result There were 635 participants each in public and private hospitals. Of the 408 patients who had primary education or less, 265(65.0%) accessed care in public hospitals compared to 143(35.0%) who accessed care in private hospital (p<0.001). Similarly, of the 851 patients who were currently married, 371 (43.6%) accessed their care in public compared to 480 6.4%) who accessed care in private (p<0.001). The proportion of participants who were satisfied were more in public hospitals (71.5%) compared to private hospitals (41.4%). The difference in proportion was statistically significant (chi(2) = 116.85, p <0.001). Good retention in care [AOR: 2.3, 95%CI: 1.5-3.5] was the only predictor of satisfaction in public hospitals while primary education [adjusted odds ratio (AOR); 2.3, 95%CI: 1.5-3.4], residing in rural area [AOR: 2.0, 95%CI: 1.4-2.9], and once-daily dosing [AOR: 3.2, 95%CI: 2.1-4.8] were independent predictors of patient' satisfaction among private hospital respondents. Conclusion Satisfaction was higher among patients attending public hospitals. Patient's satisfaction was strongly associated with retention in care among patients in public hospitals. However, in private hospitals, it was influenced by the patient's level of education, place of residence, and antiretroviral medication dosing frequency.	[Umeokonkwo, Chukwuma David] Fed Teaching Hosp Abakaliki, Dept Community Med, Abakaliki, Ebonyi State, Nigeria; [Umeokonkwo, Chukwuma David] Nigeria Field Epidemiol Training Program, Abuja, Nigeria; [Aniebue, Patricia Nonye; Onoka, Chima Ariel] Univ Nigeria, Dept Community Med, Enugu Campus, Enugu, Enugu State, Nigeria; [Agu, Adaoha Pearl; Ogbonnaya, Lawrence] Ebonyi State Univ, Dept Community Med, Abakaliki, Ebonyi State, Nigeria; [Sufiyan, Muawiyyah Babale] Ahmadu Bello Univ, Dept Community Med, Zaria, Kaduna State, Nigeria	University of Nigeria; Ahmadu Bello University	Umeokonkwo, CD (corresponding author), Fed Teaching Hosp Abakaliki, Dept Community Med, Abakaliki, Ebonyi State, Nigeria.; Umeokonkwo, CD (corresponding author), Nigeria Field Epidemiol Training Program, Abuja, Nigeria.	chukwumau@gmail.com	Agu, Adaoha Pearl/AAE-9628-2022; Agu, Adaoha Pearl/AFE-8029-2022; Umeokonkwo, Chukwuma David/U-7112-2019; Sufiyan, Muawiyyah Babale/GWN-2609-2022	Agu, Adaoha Pearl/0000-0001-6987-3801; Agu, Adaoha Pearl/0000-0001-6987-3801; Umeokonkwo, Chukwuma David/0000-0002-0050-2874; Sufiyan, Muawiyyah Babale/0000-0003-3630-6995				Aharony L, 1993, Med Care Rev, V50, P49, DOI 10.1177/002570879305000104; [Anonymous], 2013, GLOB UPD HIV TREATM, P7; Beyrer C, 2013, CURR OPIN HIV AIDS, V8, P306, DOI 10.1097/COH.0b013e328361f53a; Broughton EI, 2016, INT J QUAL HEALTH C, V28, P802, DOI 10.1093/intqhc/mzw116; Chow MYK, 2012, ASIA-PAC J PUBLIC HE, V24, P406, DOI 10.1177/1010539510384843; Dang BN, 2016, AIDS BEHAV, V20, P2477, DOI 10.1007/s10461-016-1340-y; Dang BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054729; Dansereau E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009700; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Devnani M, 2012, AIDS CARE, V24, P100, DOI 10.1080/09540121.2011.592816; Federal Ministry of Health, 2010, TECHN REP 2010 NAT H; Hargraves JL, 2001, MED CARE, V39, P635; Jaipaul CK, 2003, J GEN INTERN MED, V18, P23, DOI 10.1046/j.1525-1497.2003.20114.x; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Marshall GN, PATIENT SATISFACTION; Mfinanga SG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-167; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Munoz-Moreno J. A., 2007, ASSESSING SELF REPOR; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NACA, 2017, NAT HIV AIDS STRAT F; Nwabueze SA, 2013, AFRIMEDIC J, V1, P1; Olowookere Samuel Anu, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P188, DOI 10.1177/1545109711402214; Onoka CA, 2012, PATHOG GLOB HEALTH, V106, P46, DOI 10.1179/2047773211Y.0000000018; Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67; Owoaje EE, 2013, PREV MED, V1, P11, DOI [10.12691/jpm-1-3-1, DOI 10.12691/JPM-1-3-1]; Rahmqvist M, 2001, INT J QUAL HEALTH C, V13, P385, DOI 10.1093/intqhc/13.5.385; Rahmqvist M, 2010, INT J QUAL HEALTH C, V22, P86, DOI 10.1093/intqhc/mzq009; South African National AIDS Council, 2010, NAT AIDS STRAT PLAN; Sullivan LM, 2000, J GEN INTERN MED, V15, P462, DOI 10.1046/j.1525-1497.2000.03359.x; Tu D, 2013, CAN FAM PHYSICIAN, V59, P650; Ugochukwu U, 2013, J HIV HUM, V1, P58; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Vahab SA, 2016, J CLIN DIAGN RES, V10, pOC8, DOI 10.7860/JCDR/2016/19100.7557; Ware J E Jr, 1983, Eval Program Plann, V6, P247, DOI 10.1016/0149-7189(83)90005-8; Wung BA, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1512-5; Yehia BR, 2012, AIDS, V26, P1131, DOI 10.1097/QAD.0b013e3283528afa	38	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206499	10.1371/journal.pone.0206499	http://dx.doi.org/10.1371/journal.pone.0206499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3KA	30365560	Green Submitted, gold, Green Published			2022-12-26	WOS:000448448700057
J	Bhagat, HA; Compton, SA; Musso, DL; Laudeman, CP; Jackson, KMP; Yi, NY; Nierobisz, LS; Forsberg, L; Brenman, JE; Sexton, JZ				Bhagat, Hiral A.; Compton, Sarah A.; Musso, David L.; Laudeman, Christopher P.; Jackson, Kimberly M. P.; Yi, Na Young; Nierobisz, Lidia S.; Forsberg, Lawrence; Brenman, Jay E.; Sexton, Jonathan Z.			N-substituted phenylbenzamides of the niclosamide chemotype attenuate obesity related changes in high fat diet fed mice	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; HIGH-CARBOHYDRATE; ACID SYNTHESIS; LIVER-DISEASE; PATHWAY; IDENTIFICATION; REPLICATION; DERIVATIVES	Obesity and insulin resistance are primary risk factors for Non-Alcoholic Fatty Liver Disease (NAFLD). NAFLD is generally exhibited by non-progressive simple steatosis. However, a significant subset of patient's progress to nonalcoholic steatohepatitis (NASH) that is defined by the presence of steatosis, inflammation and hepatocyte injury with fibrosis. Unfortunately, there are no approved therapies for NAFLD or NASH and therefore therapeutic approaches are urgently needed. Niclosamide is an U.S. Food and Drug Administration (FDA)-approved anthelmintic drug that mediates its effect by uncoupling oxidative phosphorylation. Niclosamide and its salt forms, Niclosamide Ethanolamine (NEN), and Niclosamide Piperazine (NPP) have shown efficacy in murine models of diet induced obesity characterized by attenuation of the prominent fatty liver disease phenotype and improved glucose metabolism. While the exact mechanism(s) underlying these changes remains unclear, the ability to uncouple oxidative phosphorylation leading to increased energy expenditure and lipid metabolism or attenuation of PKA mediated glucagon signaling in the liver have been proposed. Unfortunately, niclosamide has very poor water solubility, leading to low oral bioavailability. This, in addition to mitochondrial uncoupling activity and potential genotoxicity have reduced enthusiasm for its clinical use. More recently, salt forms of niclosamide, NEN and NPP, have demonstrated improved oral bioavailability while retaining activity. This suggests that development of safer more effective niclosamide derivatives for the treatment of NAFLD and Type 2 Diabetes may be possible. Herein we explored the ability of a series of N-substituted phenylbenzamide derivatives of the niclosamide salicylanilide chemotype to attenuate hepatic steatosis using a novel phenotypic in vitro model of fatty liver and the high fat diet-fed mouse model of diet induced obesity. These studies identified novel compounds with improved pre-clinical properties that attenuate hepatic steatosis in vitro and in vivo. These compounds with improved drug properties may be useful in alleviating symptoms and protection against disease progression in patients with metabolic syndrome and NAFLD.	[Bhagat, Hiral A.; Compton, Sarah A.; Musso, David L.; Laudeman, Christopher P.; Jackson, Kimberly M. P.; Sexton, Jonathan Z.] Curl Bio LLC, Durham, NC 27707 USA; [Yi, Na Young; Nierobisz, Lidia S.] North Carolina Cent Univ, Biomfg Res Inst & Technol Enterprise, Durham, NC 27707 USA; [Forsberg, Lawrence; Brenman, Jay E.] North Carolina Cent Univ, Dept Cell Biol & Physiol, Durham, NC 27707 USA; [Sexton, Jonathan Z.] Univ Michigan, Dept Internal Med, Med Sch, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA; [Sexton, Jonathan Z.] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA	University of North Carolina; North Carolina Central University; University of North Carolina; North Carolina Central University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sexton, JZ (corresponding author), Curl Bio LLC, Durham, NC 27707 USA.; Sexton, JZ (corresponding author), Univ Michigan, Dept Internal Med, Med Sch, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA.; Sexton, JZ (corresponding author), Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA.	jzsexton@med.umich.edu		Sexton, Jonathan/0000-0002-9244-5888	National Institute of Neurological Disorders and Stroke [NS063858]; National Institute of Diabetes and Digestive and Kidney Diseases [DK088248, DK093345]; CurlBio LLC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK101229] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CurlBio LLC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Neurological Disorders and Stroke grant number NS063858 to Jonathan Sexton and Jay Brenman, The National Institute of Diabetes and Digestive and Kidney Diseases grant number DK088248 to Jonathan Sexton and Jay Brenman, and grant DK093345 to David Musso and Sarah Compton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CurlBio LLC provided support in the form of salaries for authors HAB, SAC, DLM, CPL, KMPJ and JZS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ai N, 2016, PHARM RES-DORDR, V33, P3044, DOI 10.1007/s11095-016-2027-9; Al-Hadiya Badraddin M H, 2005, Profiles Drug Subst Excip Relat Methodol, V32, P67, DOI 10.1016/S0099-5428(05)32002-8; ANDREWS P, 1982, PHARMACOL THERAPEUT, V19, P245, DOI 10.1016/0163-7258(82)90064-X; Beristain-Castillo E, 2013, MUTAGENESIS, V28, P645, DOI 10.1093/mutage/get043; Chang YW, 2006, J FOOD DRUG ANAL, V14, P329; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Chen MY, 2009, BIOCHEMISTRY-US, V48, P10267, DOI 10.1021/bi9009677; Chen W, 2010, AM J PHYSIOL-GASTR L, V299, pG293, DOI 10.1152/ajpgi.00005.2010; Chowdhury MKH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40159; De Clercq Erik, 2006, Expert Rev Anti Infect Ther, V4, P291, DOI 10.1586/14787210.4.2.291; ESPINOSAAGUIRRE JJ, 1991, MUTAT RES, V264, P139, DOI 10.1016/0165-7992(91)90131-M; Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206; Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638; Giri AK, 1996, MUTAT RES-GENET TOX, V370, P1, DOI 10.1016/S0165-1218(96)90121-4; Glickman JF, 2010, PRACTICAL GUIDE ASSA; Goldgof M, 2014, J BIOL CHEM, V289, P19341, DOI 10.1074/jbc.M114.568204; Grundlingh J, 2011, J MED TOXICOL, V7, P205, DOI 10.1007/s13181-011-0162-6; Guo JJ, 2019, EAT WEIGHT DISORD-ST, V24, P91, DOI 10.1007/s40519-017-0424-7; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Ikeda M, 1998, VIRUS RES, V56, P157, DOI 10.1016/S0168-1702(98)00063-X; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kanuri G, 2013, INT J MOL SCI, V14, P11963, DOI 10.3390/ijms140611963; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049; Lanaspa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048801; Law CJ, 2014, ASSAY DRUG DEV TECHN, V12, P375, DOI 10.1089/adt.2014.591; Liu CF, 2014, CLIN CANCER RES, V20, P3198, DOI 10.1158/1078-0432.CCR-13-3296; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Marques-Lopes I, 2001, AM J CLIN NUTR, V73, P253; Mook RA, 2017, BIOORGAN MED CHEM, V25, P1804, DOI 10.1016/j.bmc.2017.01.046; Mook RA, 2015, BIOORGAN MED CHEM, V23, P5829, DOI 10.1016/j.bmc.2015.07.001; Onyenwoke RU, 2012, MOL BIOL CELL, V23, P381, DOI 10.1091/mbc.E11-08-0699; Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978; OSTROSKYWEGMAN P, 1986, MUTAT RES, V173, P81, DOI 10.1016/0165-7992(86)90015-1; PARASCANDOLA J, 1974, MOL CELL BIOCHEM, V5, P69, DOI 10.1007/BF01874175; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z; Renner SW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176502; Sanders FWB, 2016, BIOL REV, V91, P452, DOI 10.1111/brv.12178; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; Sexton Jonathan Z, 2010, Int J High Throughput Screen, V2010, P127; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Tomita K, 2005, ALCOHOL CLIN EXP RES, V29, p240S, DOI 10.1097/01.alc.0000191126.11479.69; Tu Zhen, 2015, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V33, P101; Vedala A, 2006, J LIPID RES, V47, P2562, DOI 10.1194/jlr.M600200-JLR200; VEGA SG, 1988, MUTAT RES, V204, P269, DOI 10.1016/0165-1218(88)90099-7; Waller-Evans H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082825; Wang AM, 2009, J CELL BIOCHEM, V106, P682, DOI 10.1002/jcb.22065; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27; Weinbach E, 1969, MECH ACTION REAGENTS; Wilke MS, 2009, DIABETOLOGIA, V52, P1628, DOI 10.1007/s00125-009-1405-9; Wu CJ, 2004, ANTIMICROB AGENTS CH, V48, P2693, DOI 10.1128/AAC.48.7.2693-2696.2004; Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184; Ye TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085887	58	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0204605	10.1371/journal.pone.0204605	http://dx.doi.org/10.1371/journal.pone.0204605			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359371	gold, Green Published, Green Submitted			2022-12-26	WOS:000448438400008
J	Chen, YX; Milenkovic, M; Horsfall, W; Salahpour, A; Soderling, SH; Ramsey, AJ				Chen, Yuxiao; Milenkovic, Marija; Horsfall, Wendy; Salahpour, Ali; Soderling, Scott H.; Ramsey, Amy J.			Restoring striatal WAVE-1 improves maze exploration performance of GluN1 knockdown mice	PLOS ONE			English	Article							NMDA RECEPTOR EXPRESSION; SYNAPTIC PLASTICITY; SPATIAL MEMORY; DENDRITIC SPINES; RHO-GTPASES; Y-MAZE; HIPPOCAMPAL; BEHAVIOR; RATS; PHOSPHORYLATION	NMDA receptors are important for cognition and are implicated in neuropsychiatric disorders. GluN1 knockdown (GluN1KD) mice have reduced NMDA receptor levels, striatal spine density deficits, and cognitive impairments. However, how NMDA depletion leads to these effects is unclear. Since Rho GTPases are known to regulate spine density and cognition, we examined the levels of RhoA, Rac1, and Cdc42 signaling proteins. Striatal Rac1-pathway components are reduced in GluN1KD mice, with Rac1 and WAVE-1 deficits at 6 and 12 weeks of age. Concurrently, medium spiny neuron (MSN) spine density deficits are present in mice at these ages. To determine whether WAVE-1 deficits were causal or compensatory in relation to these phenotypes, we intercrossed GluN1KD mice with WAVE-1 overexpressing (WAVE-Tg) mice to restore WAVE-1 levels. GluN1KD-WAVE-Tg hybrids showed rescue of striatal WAVE-1 protein levels and MSN spine density, as well as selective behavioral rescue in the Y-maze and 8-arm radial maze tests. GluN1KD-WAVE-Tg mice expressed normalized WAVE-1 protein levels in the hippocampus, yet spine density of hippocampal CA1 pyramidal neurons was not significantly altered. Our data suggest a nuanced role for WAVE-1 effects on cognition and a delineation of specific cognitive domains served by the striatum. Rescue of striatal WAVE-1 and MSN spine density may be significant for goal-directed exploration and associated long-term memory in mice.	[Chen, Yuxiao; Milenkovic, Marija; Horsfall, Wendy; Salahpour, Ali; Ramsey, Amy J.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Soderling, Scott H.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	University of Toronto; Duke University	Ramsey, AJ (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada.	a.ramsey@utoronto.ca		Ramsey, Amy/0000-0002-2717-5279; Chen, Yuxiao/0000-0001-9493-7918	Natural Sciences and Engineering Research Council of Canada [RGPIN-2018-06409]; National Institutes of Health [NIH R01 MH103374]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH103374] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study is funded by the Natural Sciences and Engineering Research Council of Canada (grant number: RGPIN-2018-06409) to AJR and by the National Institutes of Health (grant number: NIH R01 MH103374) to SHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JL, 2015, NMDA RECEPTOR ANTAGO; Ben Abdallah NMB, 2011, EXP NEUROL, V227, P42, DOI 10.1016/j.expneurol.2010.09.008; Bennett M, 2009, AUST NZ J PSYCHIAT, V43, P711, DOI 10.1080/00048670903001943; Bompard G, 2004, J CELL BIOL, V166, P957, DOI 10.1083/jcb.200403127; Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Ceglia I, 2010, J NEUROCHEM, V114, P182, DOI 10.1111/j.1471-4159.2010.06743.x; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Choy KHC, 2008, HIPPOCAMPUS, V18, P655, DOI 10.1002/hipo.20425; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Dash PK, 2004, BIOCHEM BIOPH RES CO, V322, P893, DOI 10.1016/j.bbrc.2004.08.004; Dean O, 2009, BEHAV BRAIN RES, V198, P258, DOI 10.1016/j.bbr.2008.11.017; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Dzirasa K, 2009, J NEUROSCI, V29, P8215, DOI 10.1523/JNEUROSCI.1773-09.2009; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Floresco SB, 1997, J NEUROSCI, V17, P1880; Gandal MJ, 2012, GENES BRAIN BEHAV, V11, P740, DOI 10.1111/j.1601-183X.2012.00816.x; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Haditsch U, 2009, MOL CELL NEUROSCI, V41, P409, DOI 10.1016/j.mcn.2009.04.005; Hardingham GE, 2016, NAT REV NEUROSCI, V17, P1, DOI 10.1038/nrn.2015.19; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Kim IH, 2013, J NEUROSCI, V33, P6081, DOI 10.1523/JNEUROSCI.0035-13.2013; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Lu W, 2013, NEURON, V78, P433, DOI 10.1016/j.neuron.2013.02.030; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Manahan-Vaughan D, 2008, HIPPOCAMPUS, V18, P125, DOI 10.1002/hipo.20367; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; MAURICE T, 1994, BRAIN RES, V647, P44, DOI 10.1016/0006-8993(94)91397-8; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mielnik CA, 2014, GENES BRAIN BEHAV, V13, P592, DOI 10.1111/gbb.12155; Milenkovic M, 2014, GENES BRAIN BEHAV, V13, P850, DOI 10.1111/gbb.12183; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Morris RGM, 2013, EUR J NEUROSCI, V37, P700, DOI 10.1111/ejn.12086; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Ramsey AJ, 2011, P NATL ACAD SCI USA, V108, P5795, DOI 10.1073/pnas.1012621108; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Ruddy RM, 2015, SYNAPSE, V69, P52, DOI 10.1002/syn.21784; Sanders J, 2012, J NEUROSCI, V32, P12570, DOI 10.1523/JNEUROSCI.1131-12.2012; Saneyoshi T, 2012, CYTOSKELETON, V69, P545, DOI 10.1002/cm.21037; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seabold Gail K, 2010, J Vis Exp, DOI 10.3791/2081; Shu SY, 2015, MOL NEUROBIOL, V51, P827, DOI 10.1007/s12035-014-8891-6; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Sossey-Alaoui K, 2003, MAMM GENOME, V14, P314, DOI 10.1007/s00335-002-2247-7; Sung JY, 2008, P NATL ACAD SCI USA, V105, P3112, DOI 10.1073/pnas.0712180105; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Wesseling H, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-38; Yuan HJ, 2015, MOL PHARMACOL, V88, P203, DOI 10.1124/mol.115.097998	60	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0199341	10.1371/journal.pone.0199341	http://dx.doi.org/10.1371/journal.pone.0199341			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352064	Green Published, Green Submitted, gold			2022-12-26	WOS:000448076200002
J	Dexter, JP; Ward, PS; Dasgupta, T; Hosios, AM; Gunawardena, J; Vander Heiden, MG				Dexter, Joseph P.; Ward, Patrick S.; Dasgupta, Tathagata; Hosios, Aaron M.; Gunawardena, Jeremy; Vander Heiden, Matthew G.			Lack of evidence for substrate channeling or flux between wildtype and mutant isocitrate dehydrogenase to produce the oncometabolite 2-hydroxyglutarate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; glioblastoma; isotopic tracer; mathematical modeling; systems biology; tumor metabolism; isocitrate dehydrogenase; metabolic compartmentalization; oncometabolite; substrate channeling	MOLECULAR-MECHANISMS; IDH2 MUTATIONS; LEUKEMIA; NADPH; INHIBITORS; DISEASE; REVEAL; CELLS	Monoallelic point mutations in the gene encoding the cytosolic, NADP(+)-dependent enzyme isocitrate dehydrogenase 1 (IDH1) cause increased production of the oncometabolite 2-hydroxyglutarate (2-HG) in multiple cancers. Most IDH1 mutant tumors retain one wildtype (WT) IDH1 allele. Several studies have proposed that retention of this WT allele is protumorigenic by facilitating substrate channeling through a WT-mutant IDH1 heterodimer, with the WT subunit generating a local supply of -ketoglutarate and NADPH that is then consumed by the mutant subunit to produce 2-HG. Here, we confirmed that coexpression of WT and mutant IDH1 subunits leads to formation of WT-mutant hetero-oligomers and increases 2-HG production. An analysis of a recently reported crystal structure of the WT-R132H IDH1 heterodimer and of in vitro kinetic parameters for 2-HG production, however, indicated that substrate channeling between the subunits is biophysically implausible. We also found that putative carbon-substrate flux between WT and mutant IDH1 subunits is inconsistent with the results of isotope tracing experiments in cancer cells harboring an endogenous monoallelic IDH1 mutation. Finally, using a mathematical model of WT-mutant IDH1 heterodimers, we estimated that the NADPH:NADP(+) ratio is higher in the cytosol than in the mitochondria, suggesting that NADPH is unlikely to be limiting for 2-HG production in the cytosol. These findings argue against supply of either substrate being limiting for 2-HG production by a cytosolic IDH1 mutant and suggest that the retention of a WT allele in IDH1 mutant tumors is not due to a requirement for carbon or cofactor flux between WT and mutant IDH1.	[Dexter, Joseph P.; Dasgupta, Tathagata; Gunawardena, Jeremy] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Ward, Patrick S.] Univ Penn, Perelman Sch Med, Med Scientist Training Program, Philadelphia, PA 19104 USA; [Ward, Patrick S.; Hosios, Aaron M.; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hosios, Aaron M.; Vander Heiden, Matthew G.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute	Gunawardena, J (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.; Vander Heiden, MG (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	jeremy@hms.harvard.edu; mvh@mit.edu	; Ward, Patrick/H-2361-2014	Dexter, Joseph/0000-0001-8524-5792; Vander Heiden, Matthew/0000-0002-6702-4192; Ward, Patrick/0000-0001-6437-8174; Gunawardena, Jeremy/0000-0002-7280-1152	National Science Foundation (NSF) Graduate Research Fellowship [DGE1144152]; University of Pennsylvania Medical Scientist Training Program; NSF [1462629]; Stand Up To Cancer (SU2C); Massachusetts Institute of Technology (MIT) Center for Precision Cancer Medicine; Ludwig Center at MIT; NCI, National Institutes of Health; Howard Hughes Medical Institute	National Science Foundation (NSF) Graduate Research Fellowship(National Science Foundation (NSF)); University of Pennsylvania Medical Scientist Training Program; NSF(National Science Foundation (NSF)); Stand Up To Cancer (SU2C); Massachusetts Institute of Technology (MIT) Center for Precision Cancer Medicine; Ludwig Center at MIT; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by National Science Foundation (NSF) Graduate Research Fellowship DGE1144152 (to J. P. D.); the University of Pennsylvania Medical Scientist Training Program (to P. S. W.); NSF Grant 1462629 (to J. G.); and Stand Up To Cancer (SU2C), the Massachusetts Institute of Technology (MIT) Center for Precision Cancer Medicine, the Ludwig Center at MIT, the NCI, National Institutes of Health, and a faculty scholars award from the Howard Hughes Medical Institute (to M. G. V. H.). M. G. V. H. is a consultant for and member of the scientific advisory board of Agios Pharmaceuticals and Aeglea Biotherapeutics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAHAM MH, 1987, CHROMATOGRAPHIA, V23, P243, DOI 10.1007/BF02311772; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Borger DR, 2014, CLIN CANCER RES, V20, P1884, DOI 10.1158/1078-0432.CCR-13-2649; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Bralten LBC, 2011, ANN NEUROL, V69, P455, DOI 10.1002/ana.22390; Brooks E, 2014, J BIOMOL SCREEN, V19, P1193, DOI 10.1177/1087057114541148; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; Castellana M, 2014, NAT BIOTECHNOL, V32, P1011, DOI 10.1038/nbt.3018; Chen WW, 2016, CELL, V166, P1324, DOI 10.1016/j.cell.2016.07.040; Cornish-Bowden A, 2004, FUNDAMENTALS ENZYME, P169; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; de la Fuente MI, 2016, NEURO-ONCOLOGY, V18, P283, DOI 10.1093/neuonc/nov307; Dexter JP, 2013, J BIOL CHEM, V288, P5770, DOI 10.1074/jbc.M112.339226; DiNardo CD, 2018, NEW ENGL J MED, V378, P2386, DOI 10.1056/NEJMoa1716984; Fack F, 2017, EMBO MOL MED, V9, P1681, DOI 10.15252/emmm.201707729; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gelman SJ, 2018, CELL REP, V22, P512, DOI 10.1016/j.celrep.2017.12.050; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; HASINOFF BB, 1983, BIOCHEMISTRY-US, V22, P58, DOI 10.1021/bi00270a008; Intlekofer AM, 2018, NATURE, V559, P125, DOI 10.1038/s41586-018-0251-7; Jin GL, 2013, CANCER RES, V73, P496, DOI 10.1158/0008-5472.CAN-12-2852; Leonardi R, 2012, J BIOL CHEM, V287, P14615, DOI 10.1074/jbc.C112.353946; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Li SC, 2013, NEURO-ONCOLOGY, V15, P57, DOI 10.1093/neuonc/nos261; Manrai AK, 2008, BIOPHYS J, V95, P5533, DOI 10.1529/biophysj.108.140632; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Matteo DA, 2017, J BIOL CHEM, V292, P7971, DOI 10.1074/jbc.M117.776179; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pichler MM, 2011, BRIT J HAEMATOL, V152, P669, DOI 10.1111/j.1365-2141.2010.08404.x; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Popovici-Muller J, 2018, ACS MED CHEM LETT, V9, P300, DOI 10.1021/acsmedchemlett.7b00421; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; Robinson Gemma L, 2016, Cancer Res Front, V2, P311, DOI 10.17980/2016.311; Salamanca-Cardona L, 2017, CELL METAB, V26, P830, DOI 10.1016/j.cmet.2017.10.001; SAMEC Z, 1994, J PHYS CHEM-US, V98, P6352, DOI 10.1021/j100076a020; SOUTHARD MZ, 1991, PHARMACEUT RES, V8, P1489, DOI 10.1023/A:1015886131198; Stein EM, 2017, BLOOD, V130, P722, DOI 10.1182/blood-2017-04-779405; Ward PS, 2013, J BIOL CHEM, V288, P3804, DOI 10.1074/jbc.M112.435495; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xie XL, 2017, STRUCTURE, V25, P506, DOI 10.1016/j.str.2016.12.017; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang B, 2010, CELL RES, V20, P1188, DOI 10.1038/cr.2010.145; Yen K, 2017, CANCER DISCOV, V7, P478, DOI 10.1158/2159-8290.CD-16-1034; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	47	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20051	20061		10.1074/jbc.RA118.004278	http://dx.doi.org/10.1074/jbc.RA118.004278			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30381394	Green Published, hybrid			2022-12-26	WOS:000454685900015
J	Bovo, S; Ribani, A; Utzeri, VJ; Schiavo, G; Bertolini, F; Fontanesi, L				Bovo, Samuele; Ribani, Anisa; Utzeri, Valerio Joe; Schiavo, Giuseppina; Bertolini, Francesca; Fontanesi, Luca			Shotgun metagenomics of honey DNA: Evaluation of a methodological approach to describe a multi-kingdom honey bee derived environmental DNA signature	PLOS ONE			English	Article							APIS-MELLIFERA; PAENIBACILLUS-LARVAE; ERWINIA-AMYLOVORA; IDENTIFICATION; POLLUTION; PRODUCTS; GENOME; PLANT; TOOL	Honey bees are considered large-scale monitoring tools due to their environmental exploration and foraging activities. Traces of these activities can be recovered in the honey that also may reflect the hive ecological micro-conditions in which it has been produced. This study applied a next generation sequencing platform (Ion Torrent) for shotgun metagenomic analysis of honey environmental DNA (eDNA). The study tested a methodological framework to interpret DNA sequence information useful to describe the complex ecosystems of the honey bee colony superorganism, its pathosphere and the heterogeneity of the agroecological environments and environmental sources that left DNA marks in the honey. Analysis of two honeys reported sequence reads from five main organism groups (kingdoms or phyla): arthropods (that mainly included reads from Apis mellifera, several other members of the Hymenotpera, in addition to members of the Diptera, Coleoptera and Lepidoptera, as well as aphids and mites), plants (that clearly confirmed the botanical origin of the two honeys, i.e. orange tree blossom and eucalyptus tree blossom honeys), fungi and bacteria (including common hive and honey bee gut microorganisms, honey bee pathogens and plant pathogens), and viruses (which accounted for the largest number of reads in both honeys, mainly assigned to Apis mellifera filamentous virus). The shotgun metagenomic approach that was used in this study can be applied in large scale experiments that might have multiple objectives according to the multi-kingdom derived eDNA that is contained in the honey.	[Bovo, Samuele; Ribani, Anisa; Utzeri, Valerio Joe; Schiavo, Giuseppina; Fontanesi, Luca] Univ Bologna, Dept Agr & Food Sci, Bologna, Italy; [Bertolini, Francesca] Tech Univ Denmark, Dept Bio & Hlth Informat, Lyngby, Denmark	University of Bologna; Technical University of Denmark	Fontanesi, L (corresponding author), Univ Bologna, Dept Agr & Food Sci, Bologna, Italy.	luca.fontanesi@unibo.it	Bovo, Samuele/M-4179-2019; bertolini, francesca/AAX-3836-2021; Fontanesi, Luca/L-1770-2014	Bovo, Samuele/0000-0002-5712-8211; Fontanesi, Luca/0000-0001-7050-3760; Bertolini, Francesca/0000-0003-4181-3895	University of Bologna RFO	University of Bologna RFO	University of Bologna RFO 2016-2017 funded this research (www.unibo.it).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova M, 2002, ACTA HORTIC, P201, DOI 10.17660/ActaHortic.2002.590.29; Anderson KE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058425, 10.1371/journal.pone.0083125]; [Anonymous], 2007, J TRACE ELEM MED BIO, V21, P77, DOI [10.1016/j.jtemb.2007.09.015, DOI 10.1016/J.JTEMB.2007.09.015]; Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Bakonyi T, 2003, APPL ENVIRON MICROB, V69, P1504, DOI 10.1128/AEM.69.3.1504-1510.2003; Barganska Z, 2016, CRIT REV ENV SCI TEC, V46, P235, DOI 10.1080/10643389.2015.1078220; Bertolini F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121701; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; BROMENSHENK JJ, 1985, SCIENCE, V227, P632, DOI 10.1126/science.227.4687.632; CHAO A, 1984, SCAND J STAT, V11, P265; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; Cowart DA, 2018, MAR GENOM, V37, P148, DOI 10.1016/j.margen.2017.11.003; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; D'Alessandro B, 2007, WORLD J MICROB BIOT, V23, P593, DOI 10.1007/s11274-006-9261-y; de Vere N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42838; Deiner K, 2017, MOL ECOL, V26, P5872, DOI 10.1111/mec.14350; Gauthier L, 2015, VIRUSES-BASEL, V7, P3798, DOI 10.3390/v7072798; Giersch T, 2009, APIDOLOGIE, V40, P117, DOI 10.1051/apido/2008065; Gossard HA, 1916, J ECON ENTOMOL, V9, P59; Hartmann U, 2015, VIRUSES-BASEL, V7, P2654, DOI 10.3390/v7052654; Hawkins J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134735; Israili ZH, 2014, AM J THER, V21, P304, DOI 10.1097/MJT.0b013e318293b09b; JIMENEZ M, 1994, J SCI FOOD AGR, V64, P67, DOI 10.1002/jsfa.2740640111; JOHNSON KB, 1993, PHYTOPATHOLOGY, V83, P478, DOI 10.1094/Phyto-83-478; Kast C, 2017, FOOD MICROBIOL, V62, P282, DOI 10.1016/j.fm.2016.10.025; Kek SP, 2017, FOOD CONTROL, V78, P150, DOI 10.1016/j.foodcont.2017.02.025; Liu GL, 2016, FOOD SCI BIOTECHNOL, V25, P1645, DOI 10.1007/s10068-016-0253-x; Loncaric I, 2009, APIDOLOGIE, V40, P40, DOI 10.1051/apido/2008062; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Olivieri C, 2012, J FORENSIC SCI, V57, P222, DOI 10.1111/j.1556-4029.2011.01964.x; Parks DH, 2017, NAT MICROBIOL, V2, P1533, DOI 10.1038/s41564-017-0012-7; Porter TM, 2018, MOL ECOL, V27, P313, DOI 10.1111/mec.14478; Prosser SWJ, 2017, FOOD CHEM, V214, P183, DOI 10.1016/j.foodchem.2016.07.077; Quince C, 2017, NAT BIOTECHNOL, V35, P833, DOI 10.1038/nbt.3935; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Ribani A, 2018, FOOD CHEM, V246, P90, DOI 10.1016/j.foodchem.2017.11.006; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Sinacori M, 2014, FOOD MICROBIOL, V38, P284, DOI 10.1016/j.fm.2013.07.013; Smart AS, 2016, METHODS ECOL EVOL, V7, P1291, DOI 10.1111/2041-210X.12598; Smart AS, 2015, ECOL APPL, V25, P1944, DOI 10.1890/14-1751.1; Soares S, 2018, FOOD RES INT, V105, P686, DOI 10.1016/j.foodres.2017.11.081; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Tringe SG, 2005, NAT REV GENET, V6, P805, DOI 10.1038/nrg1709; Utzeri VJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27933-w; Utzeri VJ, 2018, FOOD CONTROL, V91, P294, DOI 10.1016/j.foodcont.2018.04.010; Utzeri VJ, 2018, FOOD CONTROL, V86, P342, DOI 10.1016/j.foodcont.2017.11.033; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Wolterbeek B, 2002, ENVIRON POLLUT, V120, P11, DOI 10.1016/S0269-7491(02)00124-0; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472	54	27	28	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205575	10.1371/journal.pone.0205575	http://dx.doi.org/10.1371/journal.pone.0205575			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379893	gold, Green Submitted, Green Published			2022-12-26	WOS:000448823700055
J	Kumar, NG; Contaifer, D; Baker, PRS; Ekroos, K; Jefferson, KK; Wijesinghe, DS				Kumar, Naren Gajenthra; Contaifer, Daniel, Jr.; Baker, Paul R. S.; Ekroos, Kim; Jefferson, Kimberly K.; Wijesinghe, Dayanjan S.			Untargeted lipidomic analysis to broadly characterize the effects of pathogenic and non-pathogenic staphylococci on mammalian lipids	PLOS ONE			English	Article							GENE REGULATOR AGR; AUREUS STRAIN; SHOTGUN LIPIDOMICS; GENOME SEQUENCE; CERAMIDE KINASE; HUMAN BLOOD; VIRULENCE; LIPASE; IDENTIFICATION; USA300	Modification of the host lipidome via secreted enzymes is an integral, but often overlooked aspect of bacterial pathogenesis. In the current era of prevalent antibiotic resistance, knowledge regarding critical host pathogen lipid interactions has the potential for use in developing novel antibacterial agents. While most studies to date on this matter have focused on specific lipids, or select lipid classes, this provides an incomplete picture. Modern methods of untargeted lipidomics have the capacity to overcome these gaps in knowledge and provide a comprehensive understanding of the role of lipid metabolism in the pathogenesis of infections. In an attempt to determine the role of lipid modifying enzymes produced by staphylococci, we exposed bovine heart lipids, a standardized model for the mammalian lipidome, to spent medium from staphylococcal cultures, and analyzed lipid molecular changes by MS/MS ALL shotgun lipidomics. We elucidate distinct effects of different staphylococcal isolates, including 4 clinical isolates of the pathogenic species Staphylococcus aureus, a clinical isolate of the normally commensal species S. epidermidis, and the non-pathogenic species S. carnosus. Two highly virulent strains of S. aureus had a more profound effect on mammalian lipids and modified more lipid classes than the other staphylococcal strains. Our studies demonstrate the utility of the applied untargeted lipidomics methodology to profile lipid changes induced by different bacterial secretomes. Finally, we demonstrate the promise of this lipidomics approach in assessing the specificity of bacterial enzymes for mammalian lipid classes. Our data suggests that there may be a correlation between the bacterial expression of lipid-modifying enzymes and virulence, and could facilitate the guided discovery of lipid pathways required for bacterial infections caused by S. aureus and thereby provide insights into the generation of novel antibacterial agents.	[Kumar, Naren Gajenthra; Jefferson, Kimberly K.] Virginia Commonwealth Univ, Sch Med, Dept Microbiol & Immunol, Richmond, VA USA; [Contaifer, Daniel, Jr.; Wijesinghe, Dayanjan S.] Virginia Commonwealth Univ, Sch Pharm, Dept Pharmacotherapy & Outcomes Sci, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Baker, Paul R. S.] SCIEX Ltd, Concord, ON, Canada; [Ekroos, Kim] Lipidom Consulting Ltd, Espoo, Finland; [Wijesinghe, Dayanjan S.] Virginia Commonwealth Univ, Dept Pharmacotherapy & Outcomes Sci, Med Coll Virginia Campus, Richmond, VA 23284 USA	Virginia Commonwealth University; Virginia Commonwealth University; SCIEX; Virginia Commonwealth University	Wijesinghe, DS (corresponding author), Virginia Commonwealth Univ, Sch Pharm, Dept Pharmacotherapy & Outcomes Sci, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Wijesinghe, DS (corresponding author), Virginia Commonwealth Univ, Dept Pharmacotherapy & Outcomes Sci, Med Coll Virginia Campus, Richmond, VA 23284 USA.	wijesingheds@vcu.edu	Kumar, Naren Gajenthra/AFH-3198-2022	Wijesinghe, Dayanjan/0000-0002-2124-5109; Gajenthra Kumar, Naren/0000-0001-7248-6351; Contaifer Junior, Daniel/0000-0002-3165-4192; Jefferson, Kimberly/0000-0003-1052-1988	National Institutes of Health [HD087198]; SCIEX LLC; Avanti Polar Lipids	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SCIEX LLC; Avanti Polar Lipids	Research reported in this publication was supported by research grants to Dayanjan S Wijesinghe from National Institutes of Health under grant numbers HD087198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SCIEX LLC provided support in the form of salaries for author PRSB who at the time was an employee of SCIEX LLC. Furthermore, SCIEX allowed PRSB to generate early proof of concept data using their in house instrument platform. This data was later repeated independently at VCU. In addition to this, SCIEX LLC but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. PRSB is currently an employee at Avanti Polar Lipids which provides salary support, but had no additional roles in data collection and analysis, decision to publish, or preparation of the manuscript. Lipidomics Consulting Ltd is solely owned and operated by KE and had input in data analysis and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Adams Simons, LIPASE STAPHYLOCOCCU, V242, P760; Alnaseri H, 2015, J BACTERIOL, V197, P1893, DOI 10.1128/JB.02607-14; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arsic B, 2012, INDUCTION STAPHYLOCC, V7, DOI [10.1371/journal.pone.0045952, DOI 10.1371/JOURNAL.PONE.0045952]; Arsic B., 2012, STAPHYLOCOCCUS AUREU; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Becker KA, 2017, STAPHYLOCOCCUS AUREU, DOI [10.1128/IAI.00606-17, DOI 10.1128/IAI.00606-17]; Benson MA, 2012, J BACTERIOL, V194, P4355, DOI 10.1128/JB.00706-12; BLIGH EG, 1959, CANADIAN J BIOCH PHY, V37; Blomster- Hautamaa DA, 1988, METHODS ENZYMOL, V165; Bornscheuer UT, 2002, TRENDS BIOTECHNOL, V20, P433, DOI 10.1016/S0167-7799(02)02046-2; Bose JL, 2014, INFECT IMMUN, V82, P1813, DOI 10.1128/IAI.01655-13; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Cadieux B, 2014, J BACTERIOL, V196, P4044, DOI 10.1128/JB.02044-14; Chen YE, 2018, NATURE, V553, P427, DOI 10.1038/nature25177; Cojutti P., 2014, DIAGNOSTIC MICROBIOL, V81, P53, DOI DOI 10.1016/J.DIAGMICR0BI0.2014.09.016; Cue D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123027; Diekema DJ, 2014, INFECT CONT HOSP EP, V35, P285, DOI 10.1086/675283; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ekroos K, 2010, LIPIDOMICS TOOL STUD, P273; Elke Wagner JD, 1998, MICROBIOL-UK, V144, P509; Ericson ME, 2017, CROSSM ROLE FATTY AC, V8, P1; FURUKAWA I, 1982, CLIN CHEM, V28, P110; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Han XL, 2012, MASS SPECTROM REV, V31, P134, DOI 10.1002/mas.20342; Haven N., 1966, ENZYMATIC SYNTHESIS, V125, P542; Jones RC, 2008, J BACTERIOL, V190, P5265, DOI 10.1128/JB.00383-08; Kassymov A, 2017, AIP CONF PROC, V1880, DOI 10.1063/1.5000601; Keller G, 1983, CONSTRUCTION CHARACT, V278, P270; Kelsey JA, 2006, FATTY ACIDS MONOACYL; Kolde R., 2015, PHEATMAP PRETTY HEAT; Krute CN, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00828-16; LEARY WM, 1964, J BACTERIOL, V88, P1356; Lee IT, 2010, AM J PATHOL, V176, P1671, DOI 10.2353/ajpath.2010.090714; Liebisch G, 2017, BBA-MOL CELL BIOL L, V1862, P747, DOI 10.1016/j.bbalip.2017.02.013; Liebisch G, 2015, CLIN CHEM, V61, P1542, DOI 10.1373/clinchem.2015.244830; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Liu Q, 2016, GENES-BASEL, V7, DOI 10.3390/genes7100081; LONG JP, 1992, J MED MICROBIOL, V37, P232, DOI 10.1099/00222615-37-4-232; Longshaw CM, 2000, MICROBIOL-UK, V146, P1419, DOI 10.1099/00221287-146-6-1419; Lopes DB, 2011, CIENCIA TECNOL ALIME, V31, P608, DOI 10.1590/S0101-20612011000300009; Masukawa Y, 2008, J LIPID RES, V49, P1466, DOI 10.1194/jlr.M800014-JLR200; Miro JM, 2005, CLIN INFECT DIS, V41, P507, DOI 10.1086/431979; Miskin JE, 2015, PRODUCES 33 KDA EXTR, P1745; Nehal F, 2017, J BASIC MICROB, V57, P253, DOI 10.1002/jobm.201600462; Nguyen M.K., 2017, IEEE T CONTROL NETW, P1, DOI [10.1016/j.ijmm.2016.12.001, DOI 10.1016/J.IJMM.2016.12.001]; Nygaard TK, 2013, J LEUKOCYTE BIOL, V94, P971, DOI 10.1189/jlb.0213080; Olson ME, 2013, INFECT IMMUN, V81, P1316, DOI 10.1128/IAI.01242-12; Pakshir K, 2013, J MYCOL MED, V23, P113, DOI 10.1016/j.mycmed.2013.04.007; Parsons JB, 2014, P NATL ACAD SCI USA, V111, P10532, DOI 10.1073/pnas.1408797111; Parsons JB, 2014, MOL MICROBIOL, V92, P234, DOI 10.1111/mmi.12556; Parsons JB, 2013, ANTIMICROB AGENTS CH, V57, P5729, DOI 10.1128/AAC.01038-13; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Pettus BJ, 2003, J BIOL CHEM, V278, P38206, DOI 10.1074/jbc.M304816200; Prabhakara R, 2013, INFECT IMMUN, V81, P1306, DOI 10.1128/IAI.01304-12; Richardson EJ, 2018, NAT ECOL EVOL, V2, P1468, DOI 10.1038/s41559-018-0617-0; ROLLOF J, 1987, BIOCHIM BIOPHYS ACTA, V921, P364, DOI 10.1016/0005-2760(87)90038-5; Rosenstein R, 2000, STAPHYLOCOCCAL LIPAS, V82; Sabirova JS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1956-8; Simons B, 2012, METABOLITES, V2, P195, DOI 10.3390/metabo2010195; Simons JWFA, 1996, EUR J BIOCHEM, V242, P760, DOI 10.1111/j.1432-1033.1996.0760r.x; SMELTZER MS, 1992, APPL ENVIRON MICROB, V58, P2815, DOI 10.1128/AEM.58.9.2815-2819.1992; Stehr F, 2003, J MOL CATAL B-ENZYM, V22, P347, DOI 10.1016/S1381-1177(03)00049-3; Stergiou PY, 2013, BIOTECHNOL ADV, V31, P1846, DOI 10.1016/j.biotechadv.2013.08.006; Sun F, 2010, J BACTERIOL, V192, P2111, DOI 10.1128/JB.01524-09; van Kampen MD, 2001, BBA-PROTEIN STRUCT M, V1544, P229, DOI 10.1016/S0167-4838(00)00224-7; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; White MJ, 2014, INFECT IMMUN, V82, P1559, DOI 10.1128/IAI.01168-13; Wijesinghe DS, 2014, J LIPID RES, V55, P1298, DOI 10.1194/jlr.M048207; Xiong YQ, 2002, J INFECT DIS, V186, P668, DOI 10.1086/342046; Yao JW, 2015, J BIOL CHEM, V290, P5940, DOI 10.1074/jbc.R114.636241; Zurek OW, 2014, J INNATE IMMUN, V6, P21, DOI 10.1159/000351200	75	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206606	10.1371/journal.pone.0206606	http://dx.doi.org/10.1371/journal.pone.0206606			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379915	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700137
J	Li, H; Guan, Y; Dong, YL; Zhao, L; Rong, SH; Chen, WQ; Lv, MM; Xu, H; Gao, XL; Chen, RJ; Li, LH; Xu, ZJ				Li, Hui; Guan, Ying; Dong, Yilun; Zhao, Lu; Rong, Songhao; Chen, Wenqian; Lv, Miaomiao; Xu, Hong; Gao, Xiaoling; Chen, Rongjun; Li, Lihua; Xu, Zhengjun			Isolation and evaluation of endophytic Bacillus tequilensis GYLH001 with potential application for biological control of Magnaporthe oryzae	PLOS ONE			English	Article							RICE BLAST; BIOCONTROL AGENT; IDENTIFICATION; DISEASES; GRISEA; GROWTH; WILT	Biological control is a promising measure in the control of plant disease. In the present study, we isolated 13 endophytic strains from Angelica dahurica. Among them, an endophytic strain which was named GYLH001 exhibited remarkable activity against Magnaporthe oryzae. 16S rRNA sequence analysis, biochemical and physiological proved that it is Bacillus tequilensis. The sterilized culture filtrate of GYLH001 can inhibit the growth of M. oryzae, which suggests the presence of secondary metabolites. Proved by experiment, GYLH001 can produce cellulase, protease, gelatinase, indole-3-acetic acid and 1-aminocyclopropane-1-carboxylate deaminase. In addition, the temperature experiment showed that secondary metabolites produced by GYLH001 had good thermal stability. They can remain activity even heated at 100 degrees C for 30 min. They also had good acid-resistance in heavily acidic condition. But under alkaline condition, the antifungal effect decreased significantly. By simulative field tests, the spraying of GYLH001 spore solution could prevent and treat rice blast. Through continuous separation and purification of sterilized culture filtrate and identification by mass spectrometry, the molecular weight of an active substance is 364.26. In the control of rice blast, B. tequilensis GYLH001 has potential as a biological control agent in agriculture.	[Li, Hui; Guan, Ying; Dong, Yilun; Zhao, Lu; Rong, Songhao; Chen, Wenqian; Lv, Miaomiao; Xu, Hong; Gao, Xiaoling; Chen, Rongjun; Li, Lihua; Xu, Zhengjun] Sichuan Agr Univ, Rice Res Inst, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Li, LH; Xu, ZJ (corresponding author), Sichuan Agr Univ, Rice Res Inst, Chengdu, Sichuan, Peoples R China.	lilihua1976@tom.com; mywildrice@aliyun.com	Guan, Ying/AAN-5109-2020; Gao, xiao ling/GQI-2790-2022	Guan, Ying/0000-0002-1207-2656; 	National Natural Science Foundation of China [31271802]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work in our lab was supported by the National Natural Science Foundation of China (Grant No. 31271802). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work in our lab was supported by the National Natural Science Foundation of China (Grant No. 31271802). Thank you very much.	Agrawal T, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-73; Boone D., 1984, BERGEYS MANUAL SYSTE, V38, P89; Bose A, 2014, ANN MICROBIOL, V64, P343, DOI 10.1007/s13213-013-0669-y; Boukaew S, 2014, CROP PROT, V61, P1, DOI 10.1016/j.cropro.2014.02.012; Chen Y, 2014, ENVIRON MICROBIOL, V16, P788, DOI 10.1111/1462-2920.12204; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Gatson JW, 2006, INT J SYST EVOL MICR, V56, P1475, DOI 10.1099/ijs.0.63946-0; Gopalakrishnan S, 2011, CROP PROT, V30, P1070, DOI 10.1016/j.cropro.2011.03.006; Hou K., 2018, J AGR SCI TECH, V15, P1415; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Hyakumachi M, 2014, J GEN PLANT PATHOL, V80, P287, DOI 10.1007/s10327-014-0524-4; JENSEN MA, 1993, APPL ENVIRON MICROB, V59, P945, DOI 10.1128/AEM.59.4.945-952.1993; Ji XL, 2008, FEMS MICROBIOL ECOL, V65, P565, DOI 10.1111/j.1574-6941.2008.00543.x; Karthikeyan V, 2008, CROP PROT, V27, P263, DOI 10.1016/j.cropro.2007.05.013; Krishnamurthy K, 1998, BIOL CONTROL, V13, P158, DOI 10.1006/bcon.1998.0654; Liu B, 2009, BIOL CONTROL, V49, P277, DOI 10.1016/j.biocontrol.2009.02.007; Liu CH, 2007, APPL MICROBIOL BIOT, V76, P459, DOI 10.1007/s00253-007-1010-0; Lu JL, 2009, BIOCHEM SYST ECOL, V37, P405, DOI 10.1016/j.bse.2009.04.007; Miah G, 2013, MOL BIOL REP, V40, P2369, DOI 10.1007/s11033-012-2318-0; Nagendran K, 2014, WORLD APPL SCI J, V28, P2229, DOI DOI 10.5829/IDOSI.WASJ.2013.28.12.2009; Park CH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005529; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Prabavathy VR, 2006, BIOL CONTROL, V39, P313, DOI 10.1016/j.biocontrol.2006.07.011; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; ROSSMAN AY, 1990, MYCOLOGIA, V82, P509, DOI 10.2307/3760024; Sellem I, 2017, J BASIC MICROB, V57, P393, DOI 10.1002/jobm.201600604; Shan HY, 2013, CROP PROT, V44, P29, DOI 10.1016/j.cropro.2012.10.012; Shrestha A, 2015, EUR J PLANT PATHOL, V142, P577, DOI 10.1007/s10658-015-0636-5; Sturz AV, 2000, CRIT REV PLANT SCI, V19, P1, DOI 10.1016/S0735-2689(01)80001-0; Xiang LP, 2006, ARCH PHARM RES, V29, P741; Xiong XQ, 2014, LETT APPL MICROBIOL, V58, P123, DOI 10.1111/lam.12163; Xu T, 2017, J SCI FOOD AGR, V97, P1149, DOI 10.1002/jsfa.7841; YUAN WM, 1995, APPL ENVIRON MICROB, V61, P3119, DOI 10.1128/AEM.61.8.3119-3128.1995; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104; Zhang YL, 2013, J AGR FOOD CHEM, V61, P1521, DOI 10.1021/jf305210u	35	33	34	10	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0203505	10.1371/journal.pone.0203505	http://dx.doi.org/10.1371/journal.pone.0203505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379821	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700006
J	Rooney, MF; Hill, EW; Kelly, VP; Porter, RK				Rooney, Mary F.; Hill, Emmeline W.; Kelly, Vincent P.; Porter, Richard K.			The "speed gene" effect of myostatin arises in Thoroughbred horses due to a promoter proximal SINE insertion	PLOS ONE			English	Article							RACING PERFORMANCE; MUSCLE MASS; MSTN GENE; GENOME; EXPRESSION; MUTATION; CATTLE; IDENTIFICATION; ORGANIZATION; ASSOCIATION	Thoroughbred horses are finely-tuned athletes with a high aerobic capacity relative to skeletal muscle mass, attributable to centuries of genetic selection for speed and stamina. Polymorphisms in the myostatin gene (MSTN), a pronounced inhibitor of skeletal muscle growth, have been shown to almost singularly account for gene-based race distance aptitude in racehorses. In Thoroughbreds, two MSTN polymorphisms, a single nucleotide variation in the first intron (SNP g.66493737C>T) and a non-coding transposable element within the promoter region (a 227 bp SINE insertion) are of particular interest. Until now, it has not been clear which of these variants affect skeletal muscle phenotypes or whether both can impact racing performance. In a large cohort of Thoroughbreds, we observed a complete concordance between the SNP and the SINE insertion. By means of in vitro assays in C2C12 myoblasts, we isolated the SNP variant from the SINE polymorphism and showed the latter is exclusively responsible for adversely affecting transcription initiation and gene expression thereby limiting myostatin protein production. Mapping the MSTNtranscription start site in horse skeletal muscle likewise revealed anomalous transcription initiation in the presence of the SINE insertion. Our data provides mechanistic evidence that the SINE insertion uniquely accounts for the MSTN "speed gene" effect on race distance aptitude in the Thoroughbred horse.	[Rooney, Mary F.; Kelly, Vincent P.; Porter, Richard K.] Trinity Coll Dublin, TBSI, Sch Biochem & Immunol, Dublin 2, Ireland; [Rooney, Mary F.; Hill, Emmeline W.] Univ Coll Dublin, UCD Sch Agr & Food Sci, Dublin 4, Ireland	Trinity College Dublin; University College Dublin	Rooney, MF (corresponding author), Trinity Coll Dublin, TBSI, Sch Biochem & Immunol, Dublin 2, Ireland.; Rooney, MF (corresponding author), Univ Coll Dublin, UCD Sch Agr & Food Sci, Dublin 4, Ireland.	marooney@tcd.ie	Kelly, Vincent P/I-2151-2017; Porter, Richard/HGF-0546-2022	Kelly, Vincent P/0000-0001-7067-5407; Porter, Richard/0000-0001-9854-5161	Science Foundation Ireland [11/PI/1166]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This publication has emanated from research conducted with the financial support of Science Foundation Ireland (http://www.sfi.ie/) under Grant Number 11/PI/1166 to EWH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Binns MM, 2010, ANIM GENET, V41, P154, DOI 10.1111/j.1365-2052.2010.02126.x; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Bower MA, 2011, BIOL LETTERS, V7, P316, DOI 10.1098/rsbl.2010.0800; Bower MA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1644; Bryan K, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4007-9; Cappelli K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-49; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cunningham EP, 2001, ANIM GENET, V32, P360, DOI 10.1046/j.1365-2052.2001.00785.x; DallOlio S, 2010, J BIOMEDICINE BIOTEC, V2010; Felkel S, 2018, ANIM GENET, V49, P90, DOI 10.1111/age.12635; GAFFNEY B, 1988, NATURE, V332, P722, DOI 10.1038/332722a0; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Hill E, 2016, METHOD PREDICTING AT; Hill EW, 2010, ANIM GENET, V41, P56, DOI 10.1111/j.1365-2052.2010.02104.x; Hill Emmeline W, 2012, Recent Pat DNA Gene Seq, V6, P203; Hill EW, 2012, J APPL PHYSIOL, V112, P86, DOI 10.1152/japplphysiol.00793.2011; Hill EW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-552; Hill EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008645; Hill EW, 2002, ANIM GENET, V33, P287, DOI 10.1046/j.1365-2052.2002.00870.x; Jeanplong F, 2001, MOL CELL BIOCHEM, V220, P31, DOI 10.1023/A:1010801511963; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ledwith A, 2004, EQUINE VET EDUC, V16, P62, DOI 10.1111/j.2042-3292.2004.tb00268.x; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Petersen JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003211; Petersen JL, 2014, ANIM GENET; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Reese MG, 1995, GENOME SCI TECHNOLOG, V1, P45; Rooney MF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186247; Santagostino M, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0281-1; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Solovyev VV, 2010, METHODS MOL BIOL, V674, P57, DOI 10.1007/978-1-60761-854-6_5; Stinckens A, 2008, ANIM GENET, V39, P586, DOI 10.1111/j.1365-2052.2008.01774.x; Tozaki T, 2012, ANIM GENET, V43, P42, DOI 10.1111/j.1365-2052.2011.02201.x; Tozaki T, 2010, ANIM GENET, V41, P28, DOI 10.1111/j.1365-2052.2010.02095.x; Tozaki T, 2011, J VET MED SCI, V73, P1617, DOI 10.1292/jvms.11-0295; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van den Hoven R, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0428-3; Wallner B, 2017, CURR BIOL, V27, P2029, DOI 10.1016/j.cub.2017.05.086; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43; Yu LZ, 2007, SCI CHINA SER C, V50, P642, DOI 10.1007/s11427-007-0075-4; Zhang CY, 2012, MOL BIOL REP, V39, P3081, DOI 10.1007/s11033-011-1071-0; [No title captured]	48	21	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205664	10.1371/journal.pone.0205664	http://dx.doi.org/10.1371/journal.pone.0205664			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379863	Green Submitted, Green Published, gold			2022-12-26	WOS:000448823700061
J	Dinh, QD; Finkers, R; Westphal, AH; van Dongen, WMAM; Visser, RGF; Trindade, LM				Quy-Dung Dinh; Finkers, Richard; Westphal, Adrie H.; van Dongen, Walter M. A. M.; Visser, Richard G. F.; Trindade, Luisa M.			Exploring natural genetic variation in tomato sucrose synthases on the basis of increased kinetic properties	PLOS ONE			English	Article							SOLANUM-TUBEROSUM L.; MEMBRANE ASSOCIATION; AFFINITY-CHROMATOGRAPHY; ARABIDOPSIS-THALIANA; SINK STRENGTH; FRUIT; METABOLISM; PHOSPHORYLATION; PHOTOSYNTHESIS; ACCUMULATION	Sucrose synthase (SuSy) is one key enzyme directly hydrolyzing sucrose to supply substrates for plant metabolism, and is considered to be a biomarker for plant sink strength. Improvement in plant sink strength could lead to enhanced plant growth and yield. Cultivated tomatoes are known to have a narrow genetic diversity, which hampers further breeding for novel and improved traits in new cultivars. In this study, we observed limited genetic variation in SuSy1, SuSy3 and SuSy4 in 53 accessions of cultivated tomato and landraces, but identified a wealth of genetic diversity in 32 accessions of related wild species. The variation in the deduced amino acid sequences was grouped into 23, 22, and 17 distinct haplotypes for SuSy1/3/4, respectively. Strikingly, all known substrate binding sites were highly conserved, as well as most of the phosphorylation sites except in SuSy1. Two SuSy1 and three SuSy3 protein variants were heterologously expressed to study the effect of the amino acid changes on enzyme kinetic properties, i.e. maximal sucrose hydrolyzing capacity (V-max), affinity for sucrose (K-m), and catalytic efficiency (V-max/K-m) at 25 degrees C and 16 degrees C. SuSy1-haplotype#3 containing phosphorylation site Ser-16 did not have an improvement in the kinetic properties compared to the reference SuSy1-haplotype#1 containing Arg-16. Meanwhile SuSy3-haplotype#9 from a wild accession, containing four amino acid changes S53A, S1061, E727D and K741E, showed an increase in V-max/K-m at 16 degrees C compared to the reference SuSy3-haplotype#1. This study demonstrates that SuSy kinetic properties can be enhanced by exploiting natural variation, and the potential of this enzyme to improve sucrose metabolism and eventually sink strength in planta.	[Quy-Dung Dinh; Finkers, Richard; Visser, Richard G. F.; Trindade, Luisa M.] Wageningen Univ & Res, Plant Breeding, Wageningen, Netherlands; [Quy-Dung Dinh] Wageningen Univ, Grad Sch Expt Plant Sci, Wageningen, Netherlands; [Westphal, Adrie H.; van Dongen, Walter M. A. M.] Wageningen Univ & Res, Lab Biochem, We Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Trindade, LM (corresponding author), Wageningen Univ & Res, Plant Breeding, Wageningen, Netherlands.	luisa.trindade@wur.nl	Trindade, Luisa M/F-8824-2010; Visser, Richard GF/B-3423-2012; Westphal, Adrie Herman/L-3517-2019; Finkers, Richard/G-1706-2010	Visser, Richard GF/0000-0002-0213-4016; Westphal, Adrie Herman/0000-0003-4264-6267; Finkers, Richard/0000-0002-4368-8058; Dinh, Quy Dung (Peter)/0000-0002-8481-2924	FOM/ALW (a Dutch public funding body) within the program Towards Biosolar Cells Research	FOM/ALW (a Dutch public funding body) within the program Towards Biosolar Cells Research	This work was funded by the FOM/ALW (a Dutch public funding body) within the program Towards Biosolar Cells Research (http://www.biosolarcells.nl/onderzoek/planten/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accessions Search, ACC SEARCH; Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Anguenot R, 1999, ARCH BIOCHEM BIOPHYS, V365, P163, DOI 10.1006/abbi.1999.1146; Anguenot R, 2006, PLANT PHYSIOL BIOCH, V44, P294, DOI 10.1016/j.plaphy.2006.06.009; Bai YL, 2007, ANN BOT-LONDON, V100, P1085, DOI 10.1093/aob/mcm150; Barrero-Sicilia C, 2011, PLANTA, V234, P391, DOI 10.1007/s00425-011-1408-x; Bauchet G, 2012, GENETIC DIVERSITY TO; BRUGGEMANN W, 1992, PLANTA, V186, P172, DOI 10.1007/BF00196246; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; D'Aoust MA, 1999, PLANT CELL, V11, P2407, DOI 10.1105/tpc.11.12.2407; Fiser A, 2010, METHODS MOL BIOL, V673, P73, DOI 10.1007/978-1-60761-842-3_6; Freeman AM, 2011, J BACTERIOL, V193, P4709, DOI 10.1128/JB.00070-11; Goren S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182334; Goren S, 2011, PLANTA, V233, P1011, DOI 10.1007/s00425-011-1356-5; Hardin SC, 2004, PLANT PHYSIOL, V134, P1427, DOI 10.1104/pp.103.036780; Hardin SC, 2003, PLANT J, V35, P588, DOI 10.1046/j.1365-313X.2003.01831.x; Hardin SC, 2006, PLANT PHYSIOL, V141, P1106, DOI 10.1104/pp.106.078006; Heuvelink E., 2005, Tomatoes, P85, DOI 10.1079/9780851993966.0085; Huang YC, 2016, PLANT MOL BIOL, V90, P127, DOI 10.1007/s11103-015-0401-3; Kaur S, 2009, J AGRON CROP SCI, V195, P393, DOI 10.1111/j.1439-037X.2009.00383.x; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Kortstee AJ, 2007, PLANTA, V226, P929, DOI 10.1007/s00425-007-0539-6; Lammens W, 2008, J MOL BIOL, V377, P378, DOI 10.1016/j.jmb.2007.12.074; Marcelis LFM, 1996, J EXP BOT, V47, P1281, DOI 10.1093/jxb/47.Special_Issue.1281; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; MUSZYNSKA G, 1986, BIOCHEMISTRY-US, V25, P6850, DOI 10.1021/bi00370a018; MUSZYNSKA G, 1992, J CHROMATOGR, V604, P19, DOI 10.1016/0021-9673(92)85524-W; Qin GZ, 2016, PLANT PHYSIOL, V172, P1596, DOI 10.1104/pp.16.01269; Rodriguez GR, 2011, PLANT PHYSIOL, V156, P275, DOI 10.1104/pp.110.167577; Romer U, 2004, J BIOTECHNOL, V107, P135, DOI 10.1016/j.jbiotec.2003.10.017; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauerzapfe B, 2008, ENZYME MICROB TECH, V43, P289, DOI 10.1016/j.enzmictec.2008.04.001; Shields R, 1998, PLANT PHYSIOL, V118, P1533; STOMMEL JR, 1992, PLANT PHYSIOL, V99, P324, DOI 10.1104/pp.99.1.324; Untergasser A, RNA MINIPREP USING C; Venema JH, 1999, J PLANT PHYSIOL, V155, P711, DOI 10.1016/S0176-1617(99)80087-X; Volpicella M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00266; WANG F, 1993, PLANT PHYSIOL, V101, P321, DOI 10.1104/pp.101.1.321; WANG F, 1993, PLANT PHYSIOL, V103, P1463, DOI 10.1104/pp.103.4.1463; Wu R, 2015, J BACTERIOL, V197, P2734, DOI 10.1128/JB.00110-15; Zheng Y, 2011, J BIOL CHEM, V286, P36108, DOI 10.1074/jbc.M111.275974	44	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206636	10.1371/journal.pone.0206636	http://dx.doi.org/10.1371/journal.pone.0206636			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372500	gold, Green Published, Green Submitted			2022-12-26	WOS:000448641200049
J	Park, JS; Vohra, R; Klussmann, T; Bengtsson, NE; Chamberlain, JS; Lee, D				Park, Joshua S.; Vohra, Ravneet; Klussmann, Thomas; Bengtsson, Niclas E.; Chamberlain, Jeffrey S.; Lee, Donghoon			Non-invasive tracking of disease progression in young dystrophic muscles using multi-parametric MRI at 14T	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MOUSE SKELETAL-MUSCLE; MAGNETIZATION-TRANSFER; MDX MICE; T-2 RELAXATION; DIFFUSION; T2; BIOPSY; MODEL; WATER	In this study, multi-parametric magnetic resonance imaging (MRI) was conducted to monitor skeletal muscle changes in dystrophic (mdx(4cv)) and age-matched control (C57BL/6J) mice starting at 3 weeks of age. The objective of this study was to evaluate and characterize changes in muscle tissue characteristics of hind limbs in young, dystrophic mice using MRI. Mdx(4cv) (n = 25) and age-matched C57BL/6J (n = 5) were imaged at 3, 5, 7, 9, and 11 weeks of age. Multiple MR measurements were taken from the tibialis anterior, gastrocnemius, and soleus muscles. There were significant differences between dystrophic and control groups for all three muscle types when comparing transverse relaxation times (T-2) in lower hind limb muscles. Additionally, fractional anisotropy, radial diffusivity, and eigenvalue analysis of diffusion tensor imaging also demonstrated significant differences between groups. Longitudinal relaxation times (T-1) displayed no significant differences between groups. The earliest time points in the magnetization transfer ratio measurements displayed a significant difference. Histological analysis revealed significant differences in the tibialis anterior and gastrocnemius muscles between groups with the mdx mice displaying greater variability in muscle fiber size in later time points. The multi-parametric MRI approach offers a promising alternative for future development of a noninvasive avenue for tracking both disease progression and treatment response.	[Park, Joshua S.; Vohra, Ravneet; Klussmann, Thomas; Lee, Donghoon] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Bengtsson, Niclas E.; Chamberlain, Jeffrey S.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Bengtsson, Niclas E.; Chamberlain, Jeffrey S.] Univ Washington, Senator Paul D Wellstone Muscular Dystrophy Coope, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lee, D (corresponding author), Univ Washington, Dept Radiol, Seattle, WA 98195 USA.	dhoolee@uw.edu	Vohra, Ravneet/AAD-5864-2019	Chamberlain, Jeffrey/0000-0001-5299-0059; Vohra, Ravneet/0000-0001-6258-2710	Muscular Dystrophy Association Foundation [MDA 312455]; National Institutes of Health (NIH) [R01 CA18865, R01 AR40864]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040864] Funding Source: NIH RePORTER	Muscular Dystrophy Association Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from the Muscular Dystrophy Association Foundation (MDA 312455 - DL) and National Institutes of Health (NIH) (R01 CA18865 - DL, R01 AR40864 - JSC).	Ababneh Z, 2005, MAGNET RESON MED, V54, P524, DOI 10.1002/mrm.20610; Adler J, 2011, RADIOLOGY, V259, P127, DOI 10.1148/radiol.10091648; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; COGGAN AR, 1995, J GERONTOL A-BIOL, V50, P30; COLE WC, 1993, MAGNET RESON MED, V29, P19, DOI 10.1002/mrm.1910290106; Dunn JF, 1999, MUSCLE NERVE, V22, P1367, DOI 10.1002/(SICI)1097-4598(199910)22:10<1367::AID-MUS5>3.3.CO;2-8; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Farr N, 2017, CANCER MED-US, V6, P1082, DOI 10.1002/cam4.1062; Feng S, 2014, J MAGN RESON IMAGING, V40, P779, DOI 10.1002/jmri.24417; Filosto M, 2007, NEUROLOGY, V68, P181, DOI 10.1212/01.wnl.0000252252.29532.cc; Finanger EL, 2012, PHYS MED REH CLIN N, V23, P1, DOI 10.1016/j.pmr.2011.11.004; Forbes SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106435; FULLERTON G D, 1982, Magnetic Resonance Imaging, V1, P209, DOI 10.1016/0730-725X(82)90172-2; FULLERTON GD, 1985, RADIOLOGY, V155, P727, DOI 10.1148/radiology.155.3.4001376; Galban CJ, 2004, EUR J APPL PHYSIOL, V93, P253, DOI 10.1007/s00421-004-1186-2; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; HADAR H, 1983, AM J ROENTGENOL, V141, P895, DOI 10.2214/ajr.141.5.895; HAZLEWOOD CF, 1974, BIOPHYS J, V14, P583, DOI 10.1016/S0006-3495(74)85937-0; Heemskerk AM, 2007, RADIOLOGY, V243, P413, DOI 10.1148/radiol.2432060491; Heemskerk AM, 2006, MAGN RESON MED, V56, P272, DOI 10.1002/mrm.20953; Heier CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112477; HENKELMAN RM, 1993, MAGNET RESON MED, V29, P759, DOI 10.1002/mrm.1910290607; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HUANG YM, 1994, JMRI-J MAGN RESON IM, V4, P59, DOI 10.1002/jmri.1880040113; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; Kim HK, 2010, RADIOLOGY, V255, P899, DOI 10.1148/radiol.10091547; Kleopa KA, 2006, HUM MOL GENET, V15, P1623, DOI 10.1093/hmg/ddl083; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Li WG, 2012, MAGN RESON MED, V68, P1291, DOI 10.1002/mrm.24127; LOUBOUTIN JP, 1993, NEUROMUSCULAR DISORD, V3, P463, DOI 10.1016/0960-8966(93)90098-5; Mathur S, 2011, MUSCLE NERVE, V43, P878, DOI 10.1002/mus.21986; Mathur S, 2010, ARCH PHYS MED REHAB, V91, P1051, DOI 10.1016/j.apmr.2010.03.024; MATTILA KT, 1995, MAGN RESON MED, V33, P185, DOI 10.1002/mrm.1910330207; Mavrogeni S, 2009, EUR J PAEDIATR NEURO, V13, P34, DOI 10.1016/j.ejpn.2008.02.006; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Park J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124914; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Pertl C, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-26; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Pratt Stephen J P, 2013, BMC Res Notes, V6, P262, DOI 10.1186/1756-0500-6-262; Prayson RA, 2006, AM J CLIN PATHOL, V126, P843, DOI 10.1309/78B3MOTGJYT4RUUM; Prior BM, 1999, J APPL PHYSIOL, V87, P2107, DOI 10.1152/jappl.1999.87.6.2107; Ramaswamy KS, 2011, J PHYSIOL-LONDON, V589, P1195, DOI 10.1113/jphysiol.2010.201921; Roth SM, 2000, EUR J APPL PHYSIOL, V83, P239, DOI 10.1007/s004210000287; Rottmar M, 2016, RADIOLOGY, V281, P436, DOI 10.1148/radiol.2016152330; Saab G, 1999, MAGNET RESON MED, V42, P150, DOI 10.1002/(SICI)1522-2594(199907)42:1<150::AID-MRM20>3.0.CO;2-5; SCHOFIELD JN, 1995, DEV DYNAM, V204, P178, DOI 10.1002/aja.1002040208; Stuckey DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028569; Van Donkelaar CC, 1999, J ANAT, V194, P79, DOI 10.1046/j.1469-7580.1999.19410079.x; VanDoorn A, 1996, EUR J MORPHOL, V34, P5, DOI 10.1076/ejom.34.1.5.13156; Vohra RS, 2016, MUSCLE NERVE, V53, P84, DOI 10.1002/mus.24675; Vohra RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128915; Walter G, 2005, MAGN RESON MED, V54, P1369, DOI 10.1002/mrm.20721; Willis TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070993; Xu S, 2012, J APPL PHYSIOL, V113, P808, DOI 10.1152/japplphysiol.00530.2012; YOSHIOKA H, 1994, MAGN RESON IMAGING, V12, P991, DOI 10.1016/0730-725X(94)91229-P; Zhang JY, 2008, EXP NEUROL, V212, P448, DOI 10.1016/j.expneurol.2008.04.033	58	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206323	10.1371/journal.pone.0206323	http://dx.doi.org/10.1371/journal.pone.0206323			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365532	Green Published, gold, Green Submitted			2022-12-26	WOS:000448448700043
J	Duek, L; Barkai, O; Elran, R; Adawi, I; Choder, M				Duek, Lea; Barkai, Oren; Elran, Ron; Adawi, Isra; Choder, Mordechai			Dissociation of Rpb4 from RNA polymerase II is important for yeast functionality	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SUBUNIT; TRANSCRIPTION; STRESS; DECAY; INITIATION; COMPLEX; TEMPERATURE; REVEALS	Rpb4 is an RNA polymerase II (Pol II) subunit that binds Pol II transcripts co-transcriptionally, accompanies them to the cytoplasm and modulates mRNA export, translation and decay by interacting with cytoplasmic RNA modulators. The importance of the cytoplasmic roles of Rpb4 was challenged by a study reporting that the phenotype of rpb2 Delta rpb4 Delta cells can be rescued by an Rpb2-Rpb4 fusion protein, assuming that its Rpb4 moiety cannot dissociate from Pol II and functions in the cytoplasm. Here we demonstrate that although the fusion protein supports normal transcription, it adversely affects mRNA decay, cell proliferation and adaptability-e.g., response to stress. These defects are similar, albeit milder, than the defects that characterize rpb4 Delta, cells. At least two mechanisms alleviate the deleterious effect of the fusion protein. First, a portion of this fusion protein is cleaved into free Rpb2 and Rpb4. The free Rpb4 is functional, as it binds mRNAs and polysomes, like WT Rpb4. Second, the fusion protein is also capable of binding poly(A)+ mRNAs in the cytoplasm, in an Rpb7-mediated manner, probably complementing the functions of the diminished Rpb4. Collectively, normal coupling between mRNA synthesis and decay requires wild-type configuration of Rpb4, and fusing Rpb4 to Rpb2 compromises this coupling.	[Duek, Lea; Barkai, Oren; Elran, Ron; Adawi, Isra; Choder, Mordechai] Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Microbiol, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Choder, M (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Microbiol, Haifa, Israel.	choder@technion.ac.il		Choder, Mordechai/0000-0003-0187-2110	Israel Science Foundation [1472/15]	Israel Science Foundation(Israel Science Foundation)	This research was funded by a grant #1472/15 from the Israel Science Foundation to M. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allepuz-Fuster P, 2014, NUCLEIC ACIDS RES, V42, P13674, DOI 10.1093/nar/gku1227; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Babbarwal V, 2014, J BIOL CHEM, V289, P33125, DOI 10.1074/jbc.C114.601088; Bloom ALM, 2013, MOL MICROBIOL, V89, P65, DOI 10.1111/mmi.12258; Bourbonnais Y, 2001, MOL GEN GENET, V264, P763, DOI 10.1007/s004380000365; Braun E, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/3/036602; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; CHODER M, 1993, J BACTERIOL, V175, P6358, DOI 10.1128/JB.175.19.6358-6363.1993; Choder M, 2004, TRENDS BIOCHEM SCI, V29, P674, DOI 10.1016/j.tibs.2004.10.007; CHODER M, 1993, MOL CELL BIOL, V13, P6984, DOI 10.1128/MCB.13.11.6984; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Farago M, 2003, MOL BIOL CELL, V14, P2744, DOI 10.1091/mbc.E02-11-0740; Garrido-Godino AI, 2016, BBA-GENE REGUL MECH, V1859, P731, DOI 10.1016/j.bbagrm.2016.03.008; Goler-Baron V, 2008, GENE DEV, V22, P2022, DOI 10.1101/gad.473608; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P585, DOI 10.1093/nar/gkp928; Jensen GJ, 1998, EMBO J, V17, P2353, DOI 10.1017/S1431927600024983; Kamenski T, 2004, MOL CELL, V15, P399, DOI 10.1016/j.molcel.2004.06.035; KHAZAK V, 1995, MOL BIOL CELL, V6, P759, DOI 10.1091/mbc.6.7.759; Kimura M, 2002, MOL CELL BIOL, V22, P1577, DOI 10.1128/MCB.22.5.1577-1588.2002; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Lotan R, 2007, J CELL BIOL, V178, P1133, DOI 10.1083/jcb.200701165; Meka H, 2005, NUCLEIC ACIDS RES, V33, P6435, DOI 10.1093/nar/gki945; Miyao T, 2001, J BIOL CHEM, V276, P46408, DOI 10.1074/jbc.M107012200; Moore LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111133; Orlicky SM, 2001, J BIOL CHEM, V276, P10097, DOI 10.1074/jbc.M003165200; Pillai B, 2003, J BIOL CHEM, V278, P3339, DOI 10.1074/jbc.M112180200; Rosenheck S, 1998, J BACTERIOL, V180, P6187; Runner V, 2008, MOL CELL BIOL; Schulz D, 2014, J BIOL CHEM, V289, P17446, DOI 10.1074/jbc.M114.568014; Selitrennik M, 2006, EUKARYOT CELL, V5, P2092, DOI 10.1128/EC.00288-06; Shalem O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002273; Sheffer A, 1999, MOL CELL BIOL, V19, P2672; Shi YS, 2015, GENE DEV, V29, P889, DOI 10.1101/gad.261974.115; Somekh J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107085; Stern S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100147; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Verma-Gaur J, 2008, EUKARYOT CELL, V7, P1009, DOI 10.1128/EC.00057-08; Villanyi Z, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004569	40	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206161	10.1371/journal.pone.0206161	http://dx.doi.org/10.1371/journal.pone.0206161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359412	gold, Green Submitted, Green Published			2022-12-26	WOS:000448438400050
J	Gibbon, A; Saunders, CJ; Collins, M; Gamieldien, J; September, AV				Gibbon, Andrea; Saunders, Colleen J.; Collins, Malcolm; Gamieldien, Junaid; September, Alison, V			Defining the molecular signatures of Achilles tendinopathy and anterior cruciate ligament ruptures: A whole-exome sequencing approach	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TENASCIN-C; COL5A1 GENE; TISSUE-INJURY; RISK; VARIANTS; IDENTIFICATION; FRAMEWORK; DISEASE; FUTURE	Musculoskeletal soft tissue injuries are complex phenotypes with genetics being one of many proposed risk factors. Case-control association studies using the candidate gene approach have predominately been used to identify risk loci for these injuries. However, the ability to identify all risk conferring variants using this approach alone is unlikely. Therefore, this study aimed to further define the genetic profile of these injuries using an integrated omics approach involving whole exome sequencing and a customised analyses pipeline. The exomes of ten exemplar asymptomatic controls and ten exemplar cases with Achilles tendinopathy were individually sequenced using a platform that included the coverage of the untranslated regions and miRBase miRNA genes. Approximately 200 000 variants were identified in the sequenced samples. Previous research was used to guide a targeted analysis of the genes encoding the tenascin-C (TNC) glycoprotein and the alpha 1 chain of type XXVII collagen (COL27A1) located on chromosome 9. Selection of variants within these genes were; however, not predetermined but based on a tiered filtering strategy. Four variants in TNC (rs1061494, rs1138545, rs2104772 and rs1061495) and three variants in the upstream COL27A1 gene (rs2567706, rs2241671 and rs2567705) were genotyped in larger Achilles tendinopathy and anterior cruciate ligament (ACL) rupture sample groups. The CC genotype of TNC rs1061494 (C/T) was associated with the risk of Achilles tendinopathy (p = 0.018, OR: 2.5 95% CI: 1.2-5.1). Furthermore, the AA genotype of the TNC rs2104772 (A/T) variant was significantly associated with ACL ruptures in the female subgroup (p = 0.035, OR: 2.3 95% CI: 1.1-5.5). An inferred haplotype in the TNC gene was also associated with the risk of Achilles tendinopathy. These results provide a proof of concept for the use of a customised pipeline for the exploration of a larger genomic dataset. This approach, using previous research to guide a targeted analysis of the data has generated new genetic signatures in the biology of musculoskeletal soft tissue injuries.	[Gibbon, Andrea; Collins, Malcolm; September, Alison, V] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Div Exercise Sci & Sports Med, Cape Town, South Africa; [Saunders, Colleen J.; Gamieldien, Junaid] Univ Western Cape, SA MRC Unit Bioinformat Capac Dev, South African Natl Bioinformat Inst, Cape Town, South Africa; [Saunders, Colleen J.] Univ Cape Town, Fac Hlth Sci, Dept Surg, Div Emergency Med, Cape Town, South Africa	University of Cape Town; University of the Western Cape; University of Cape Town	September, AV (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Div Exercise Sci & Sports Med, Cape Town, South Africa.	Alison.September@uct.ac.za	Collins, Malcolm/G-4046-2011; Saunders, Colleen/AAO-8072-2020	Collins, Malcolm/0000-0002-2564-0480; September, Alison V/0000-0003-0950-286X; Saunders, Colleen/0000-0001-7956-9619	National Research Foundation; Department of Science and Technology; DST/NRF Innovation postdoctoral fellowship	National Research Foundation; Department of Science and Technology(Department of Science & Technology (India)); DST/NRF Innovation postdoctoral fellowship	This work was supported by the National Research Foundation and the Department of Science and Technology and DST/NRF Innovation postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Altinisik J, 2015, AM J SPORT MED, V43, P1784, DOI 10.1177/0363546515578661; Baird AEG, 2014, ANIM GENET, V45, P542, DOI 10.1111/age.12162; Baker LA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173810; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Caso E, 2016, INJURY, V47, pS41, DOI 10.1016/S0020-1383(16)30605-2; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Gibbon A, 2017, J SPORT SCI, V35, P655, DOI 10.1080/02640414.2016.1183806; Giblin SP, 2015, CELL ADHES MIGR, V9, P48, DOI 10.4161/19336918.2014.987587; Gibson WT, 2009, BRIT J SPORT MED, V43, P314, DOI 10.1136/bjsm.2008.052191; Gonzalez, 2014, SNP BASED WHOLE GENO; Grundberg E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001279; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Kim SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170422; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kluger R, 2017, AM J SPORT MED, V45, P2955, DOI 10.1177/0363546517729810; Kluger R, 2017, J ORTHOP RES, V35, P894, DOI 10.1002/jor.23321; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Little J, 2009, EUR J CLIN INVEST, V39, P247, DOI 10.1111/j.1365-2362.2009.02125.x; Ljungqvist A, 2008, CLIN SPORT MED, V27, P231, DOI 10.1016/j.csm.2007.10.007; Lourdusamy A, 2012, HUM MOL GENET, V21, P3719, DOI 10.1093/hmg/dds186; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Mannion S, 2014, BRIT J SPORT MED, V48, P1640, DOI 10.1136/bjsports-2013-093201; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Midwood KS, 2016, J CELL SCI, V129, P4321, DOI 10.1242/jcs.190546; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Mokone GG, 2006, SCAND J MED SCI SPOR, V16, P19, DOI 10.1111/j.1600-0838.2005.00439.x; Mokone GG, 2005, AM J SPORT MED, V33, P1016, DOI 10.1177/0363546504271986; Nica AC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0362; Pace JM, 2003, MATRIX BIOL, V22, P3, DOI 10.1016/S0945-053X(03)00007-6; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Posthumus M, 2009, BRIT J SPORT MED, V43, P352, DOI 10.1136/bjsm.2008.056150; Posthumus M, 2009, AM J SPORT MED, V37, P2234, DOI 10.1177/0363546509338266; Rahim M, 2016, MED SPORT SCI, V61, P68, DOI 10.1159/000445243; Rumian AP, 2007, J ORTHOP RES, V25, P458, DOI 10.1002/jor.20218; Saunders CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19820; Saunders CJ, 2013, J ORTHOP RES, V31, P632, DOI 10.1002/jor.22278; September A, 2016, ADV EXP MED BIOL, V920, P109, DOI 10.1007/978-3-319-33943-6_9; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Sinnwell, 2015, STAT ANAL HAPLOTYPES; Tashjian RZ, 2016, J SHOULDER ELB SURG, V25, P174, DOI 10.1016/j.jse.2015.07.005; Vaser R, 2016, NAT PROTOC, V11, P1, DOI 10.1038/nprot.2015.123; Wang G, 2016, MED SPORT SCI, V61, P55, DOI 10.1159/000445241; WANG K, 2010, NUCLEIC ACIDS RES, V38; Warnes G., 2013, GENETICS POPULATION	49	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0205860	10.1371/journal.pone.0205860	http://dx.doi.org/10.1371/journal.pone.0205860			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359423	Green Published, Green Submitted, gold			2022-12-26	WOS:000448438400028
J	Huntley, NF; Patience, JF				Huntley, Nichole F.; Patience, John F.			Xylose metabolism in the pig	PLOS ONE			English	Article							D-ERYTHRULOSE REDUCTASE; DIETARY FIBER; INTESTINAL TRANSPORT; ALDEHYDE REDUCTASE; PURIFICATION; ENERGY; DEHYDROGENASE; ENZYME; LIVER; XYLULOKINASE	It is important to understand if, and to what extent, the pig can utilize xylose as an energy source if xylanase releases free xylose in the small intestine. The experimental objectives were to determine the effects of industry-relevant dietary xylose concentrations and adaptation time on xylose retention efficiency and metabolism, diet digestibility and energy value, nitrogen balance, and hindgut fermentation. Forty-eight pigs were housed in metabolism crates and randomly assigned to one of four treatments with increasing D-xylose levels (n = 12/treatment) in 2 replications of a 22-d experiment with 3 collection periods. The control diet was xylose-free (0%), to which either 2, 4, or 8% D-xylose was added. Adaptation effects were assessed during three fecal and urine collection periods: d 5-7, 12-14, and 19-21. On d 22, pigs from the 0 and 8% treatments were euthanized; cecal and colon digesta were collected. Dietary xylose did not affect the total tract digestibility of dry matter, gross energy, or crude protein (P>0.10). Digesta short chain fatty acids concentrations and molar proportions and cecal pH were not different (P>0.10). This experiment utilized a targeted metabolomics approach to characterize and quantify urine xylose and metabolite excretion. Xylose retention decreased from 60% to 47% to 41% when pigs were fed diets containing 2, 4, or 8% xylose, respectively. In the 4 and 8% treatments, xylose retention was greater in the 2nd and 3rd collection periods compared to the 1st. A comprehensive pathway for xylose metabolism was proposed and D-threitol was confirmed as the major urinary metabolite of xylose. In conclusion, pigs can metabolize xylose, but with considerably lower efficiency than glucose, and may be able to adapt with time to utilize xylose more efficiently.	[Huntley, Nichole F.; Patience, John F.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA	Iowa State University	Patience, JF (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	jfp@iastate.edu	Patience, john F./A-2935-2009	Patience, John/0000-0002-1672-5116	Elanco Animal Health [1506-1604]; Iowa Pork Producers Association	Elanco Animal Health; Iowa Pork Producers Association	Elanco Animal Health (Study #1506-1604) provided funds in support of this project (JFP). The Iowa Pork Producers Association provided support of the graduate students (Huntley) stipend; no grant number applies (JFP). The funders identified in this submission had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguita M, 2006, J ANIM SCI, V84, P2766, DOI 10.2527/jas.2005-212; Aoki S, 2001, CHEM-BIOL INTERACT, V130, P775, DOI 10.1016/S0009-2797(00)00307-0; Asano T., 1996, Nippon Eiyo Shokuryo Gakkaishi = Journal of the Japanese Society of Nutrition and Food Science, V49, P157; Bae YJ, 2011, NUTR RES PRACT, V5, P533, DOI 10.4162/nrp.2011.5.6.533; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; BIELY P, 1992, PROGR BIOTECHNOL, V7, P81; BOSRON WF, 1972, J BIOL CHEM, V247, P4480; Bunker RD, 2013, J BIOL CHEM, V288, P1643, DOI 10.1074/jbc.M112.427997; Chen H, 2015, J NUTR, V145, P51, DOI 10.3945/jn.114.201772; COUGHLAN MP, 1992, PROGR BIOTECHNOL, V7, P111; CROMLISH JA, 1983, J BIOL CHEM, V258, P3416; CSAKY TZ, 1964, BIOCHIM BIOPHYS ACTA, V82, P215, DOI 10.1016/0304-4165(64)90041-8; CZAKY TZ, 1965, P SOC EXP BIOL MED, V120, P403; El-Kabbani O, 2004, CURR MED CHEM, V11, P465, DOI 10.2174/0929867043455927; FLYNN TG, 1975, J BIOL CHEM, V250, P2933; FOWLER D, 1960, GUT, V1, P67, DOI 10.1136/gut.1.1.67; FREEMAN DE, 1993, AM J VET RES, V54, P965; Goering H., 1970, AGR HDB, V379, P1; Gutierrez NA, 2014, J ANIM SCI, V92, P4505, DOI 10.2527/jas.2013-7265; HICKMAN J, 1958, J BIOL CHEM, V232, P737; Hollmann S., 1969, INT S MET PHYS CLIN, P79; Hootman KC, 2017, P NATL ACAD SCI USA, V114, pE4233, DOI 10.1073/pnas.1620079114; Horwitz W W., 2007, OFFICIAL METHODS ANA; Huntley NF, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-017-0226-9; Jun YJ, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1261-0; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kerr BJ, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-11; Knudsen KEB, 2011, J ANIM SCI, V89, P1965, DOI 10.2527/jas.2010-3602; Knudsen KEB, 1997, ANIM FEED SCI TECH, V67, P319, DOI 10.1016/S0377-8401(97)00009-6; Knudsen KEB, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600518; Lang K., 1969, INT S MET PHYS CLINC, P151, DOI [10.1007/978-3-642-46191-0_10, DOI 10.1007/978-3-642-46191-0_10]; LEONE JL, 1973, J ASSOC OFF ANA CHEM, V56, P535; Maeda M, 1998, J BIOCHEM-TOKYO, V123, P602; Matsunaga T, 2006, DRUG METAB PHARMACOK, V21, P1, DOI 10.2133/dmpk.21.1; MENZIES IS, 1974, BIOCHEM SOC T, V2, P1042, DOI 10.1042/bst0021042; Merrifield CA, 2011, MOL BIOSYST, V7, P2577, DOI 10.1039/c1mb05023k; Mostad SB, 1997, BIOCHEM BIOPH RES CO, V233, P681, DOI 10.1006/bbrc.1997.6519; Nakagawa J, 2002, J BIOL CHEM, V277, P17883, DOI 10.1074/jbc.M110703200; Nakayama T, 1990, ENZYMOLOGY MOL BIOL, P187; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Noblet J, 2001, ANIM FEED SCI TECH, V90, P35, DOI 10.1016/S0377-8401(01)00195-X; OHASHI K, 1984, EUR J BIOCHEM, V142, P347, DOI 10.1111/j.1432-1033.1984.tb08293.x; Onkenhout W, 2002, MOL GENET METAB, V77, P80, DOI 10.1016/S1096-7192(02)00125-7; Oresanya TF, 2007, CAN J ANIM SCI, V87, P45, DOI 10.4141/A05-064; Paloheimo M, 2010, ENZYMES IN FARM ANIMAL NUTRITION, 2ND EDITION, P12, DOI 10.1079/9781845936747.0012; Patience J F, 2012, FEED EFFIC SWINE, P101, DOI DOI 10.3920/978-90-8686-756-1_5; PITKANEN E, 1977, CLIN CHIM ACTA, V80, P49, DOI 10.1016/0009-8981(77)90262-5; SCHIWARA HW, 1968, H-S Z PHYSIOL CHEM, V349, P1575, DOI 10.1515/bchm2.1968.349.2.1575; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; SCHUTTE JB, 1991, BRIT J NUTR, V66, P83, DOI 10.1079/BJN19910012; SMILEY JD, 1961, J BIOL CHEM, V236, P357; Touster O., 1969, CARBOHYD METABOL, P229; UEHARA K, 1980, J BIOCHEM, V87, P47, DOI 10.1093/oxfordjournals.jbchem.a132751; Van Soest PJ., 1979, STANDARDIZATION ANAL, P49; Verstegen MWA, 1997, J ANIM PHYSIOL AN N, V77, P180, DOI 10.1111/j.1439-0396.1997.tb00753.x; WESER E, 1968, Biochemical Medicine, V2, P53, DOI 10.1016/0006-2944(68)90007-0; WESER E, 1967, J CLIN INVEST, V46, P499, DOI 10.1172/JCI105552; WISE MB, 1954, J ANIM SCI, V13, P365, DOI 10.2527/jas1954.132365x; WYNGAARDEN JB, 1957, J CLIN INVEST, V36, P1395, DOI 10.1172/JCI103539; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Yule Marianne A., 1992, International Journal of Food Sciences and Nutrition, V43, P31, DOI 10.3109/09637489209027530; ZEPEDA S, 1990, BIOCHEM J, V266, P637, DOI 10.1042/bj2660637	62	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0205913	10.1371/journal.pone.0205913	http://dx.doi.org/10.1371/journal.pone.0205913			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359396	Green Published, gold, Green Submitted			2022-12-26	WOS:000448438400032
J	Sanches, CL; Augereau, O; Kise, K				Sanches, Charles Lima; Augereau, Olivier; Kise, Koichi			Estimation of reading subjective understanding based on eye gaze analysis	PLOS ONE			English	Article							CONFIDENCE; MOVEMENTS	The integration of ubiquitous technologies in the field of education has considerably enhanced our way of learning. Such technologies enable students to get a gradual feedback about their performance and to provide adapted learning materials. It is particularly important in the domain of foreign language learning which requires intense daily practice. One of the main inputs of adaptive learning systems is the user's understanding of a reading material. The reader's understanding can be divided into two parts: the objective understanding and the subjective understanding. The objective understanding can be measured by comprehension questions about the content of the text. The subjective understanding is the reader's perception of his own understanding. The subjective understanding plays an important role in the reader's motivation, self-esteem and confidence. However, its automatic estimation remains a challenging task. This paper is one of the first to propose a method to estimate the subjective understanding. We show that using the eye gaze to predict the subjective understanding improves the estimation by 13% as compared to using comprehension questions.	[Sanches, Charles Lima; Augereau, Olivier; Kise, Koichi] Osaka Prefecture Univ, Sakai, Osaka, Japan	Osaka Metropolitan University	Sanches, CL (corresponding author), Osaka Prefecture Univ, Sakai, Osaka, Japan.	charles-ls@hotmail.fr		Kise, Koichi/0000-0001-5779-6968	Japanese Science and Technology Agency, Core Research for Evolutionary Science and Technology [JPMJCR16E1]; JSPS KAKENHI [15K12712]; Japanese Society for the Promotion of Science, KAKENHI [16K16089]; Key Project Grant Program of Osaka Prefecture University; JST CREST [JPMJCR16E1]; JSPS KAKENHI Grant [16K16089]	Japanese Science and Technology Agency, Core Research for Evolutionary Science and Technology; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Key Project Grant Program of Osaka Prefecture University; JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is in part supported by Japanese Science and Technology Agency, Core Research for Evolutionary Science and Technology (JPMJCR16E1), https://www.jst.go.jp/kisoken/crest/en/; JSPS KAKENHI Grant Number 15K12712, https://www.jsps.go.jp/english/e-grants/; Japanese Society for the Promotion of Science, KAKENHI (16K16089), https://www.jsps.go.jp/english/e-grants/; and Key Project Grant Program of Osaka Prefecture University.; This work was supported in part by JST CREST Grant Number JPMJCR16E1, JSPS KAKENHI Grant Numbers 15K12712 and 16K16089, and Key Project Grant Program of Osaka Prefecture University.	Augereau O, 2016, INT C PATT RECOG, P1285, DOI 10.1109/ICPR.2016.7899814; Benabou R, 2002, Q J ECON, V117, P871, DOI 10.1162/003355302760193913; Beymer David, 2005, CHI 05 EXTENDED ABST, DOI [10.1145/1056808.1057055, DOI 10.1145/1056808.1057055]; Biedert Ralf, 2012, P S EYE TRACK RES AP, P201; Chen CC, 2012, COMPUT EDUC, V59, P873, DOI 10.1016/j.compedu.2012.04.003; Chougale P, 2016, INT J EMERGING TREND, V5; Christie H, 2008, STUD HIGH EDUC, V33, P567, DOI 10.1080/03075070802373040; Dengel A., 2009, INFRMATIK SPEKTRUM, V33, P272, DOI [10.1007/s00287-009-0381-2, DOI 10.1007/S00287-009-0381-2]; Gibaldi A, 2017, BEHAV RES METHODS, V49, P923, DOI 10.3758/s13428-016-0762-9; Initiative OBL, 2013, OECD GUIDELINES ON M; Jones V, 2004, P 21 ASCILITE C, V468, P474; Karolus J, 2017, PROCEEDINGS OF THE 2017 ACM SIGCHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'17), P2998, DOI 10.1145/3025453.3025601; Kise K, 2013, CHI 13 HUM FACT COMP, P217, DOI [DOI 10.1145/2468356.2468396, 10.1145/2468356.2468396]; Krashen S. D., 2004, POWER READING INSIGH; Kudo Riki, 2015, P 2015 ACM INT JOINT, P1221; Lima Sanches C, 2017, ADJ P 2017 ACM INT J; Liu TY, 2010, COMPUT EDUC, V55, P630, DOI 10.1016/j.compedu.2010.02.023; Martinez-Gomez P., 2014, P 19 INT C INTELLIGE, P95, DOI [10.1145/2557500.255 7546, DOI 10.1145/2557500.2557546, 10.1145/2557500.2557546]; Mason B., 1997, SYSTEM, V25, P91, DOI DOI 10.1016/S0346-251X(96)00063-2; MCCONKIE GW, 1988, VISION RES, V28, P1107, DOI 10.1016/0042-6989(88)90137-X; Munoz-Cristobal JA, 2015, IEEE T LEARN TECHNOL, V8, P83, DOI 10.1109/TLT.2014.2370634; Ogata H., 2003, P KEST, P1; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 2006, SCI STUD READ, V10, P241, DOI 10.1207/s1532799xssr1003_3; Sanches C. Lima, 2016, IPSJ T COMPUTER VISI, V8, P7, DOI [10.1186/s41074-016-0008-x, DOI 10.1186/S41074-016-0008-X]; Sanches CL, 2017, PROC INT CONF DOC, P28, DOI 10.1109/ICDAR.2017.377; TOEIC, 2014, 2014 REP TEST LAK WO; White SJ, 2012, READ WRIT, V25, P981, DOI 10.1007/s11145-010-9289-0; Woodford P. E., 1980, TEST ENGLISH INT COM; Yoshimura K, 2015, PROC INT CONF DOC, P251, DOI 10.1109/ICDAR.2015.7333762	30	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206213	10.1371/journal.pone.0206213	http://dx.doi.org/10.1371/journal.pone.0206213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3GT	30359411	Green Published, Green Submitted, gold			2022-12-26	WOS:000448438400053
J	Yin, ZC; Guo, WY; Xiao, HY; Liang, J; Hao, XY; Dong, NY; Leng, TR; Wang, YJ; Wang, QY; Yin, FX				Yin, Zhichao; Guo, Wenyun; Xiao, Huanyu; Liang, Jie; Hao, Xiyu; Dong, Naiyuan; Leng, Tingrui; Wang, Yingjie; Wang, Qingyu; Yin, Fengxiang			Nitrogen, phosphorus, and potassium fertilization to achieve expected yield and improve yield components of mung bean	PLOS ONE			English	Article							PLANT GROWTH; L.; CULTIVARS; REGION	Mung bean (Vigna radiata L.) is an important edible bean in the human diet worldwide. However, its growth, development, and yield may be restricted or limited by insufficient or unbalanced nitrogen (N), phosphorus (P), and potassium (K) fertilization. Despite this, there are few long-term studies of the effects of varying levels of N, P, and K combined fertilizers and the optimal fertilization for improving mung bean yield and quality. This study was conducted to optimize the fertilization strategies for high yield and to improve yield components (pods per plant, seeds per pod, and 100-seed weight) in the Bailv9 mung bean cultivar, 23 treatments were tested in 2013-2015, using a three-factor (N, P, and K fertilizers), five-level quadratic orthogonal rotation combination design. Our studies showed that, the N, P, and K fertilizers significantly influenced the pods per plant and yield, which increased and then decreased with the increasing N, P, and K fertilizers. The 100-seed weight was significantly affected by the N and P fertilization, and it was increased consistently with the increasing N fertilizer, and decreased significantly with the increasing P fertilizer. Whereas, the seeds per pod significantly decreased with the increasing N and K fertilizers, and the P fertilizer had no significant effect on it. The NP interaction had a significant effect on yield and pods per plant at high N levels, while the NK interaction had a significant but opposite effect on yield at low N levels. The optimal fertilization conditions to obtain yield >2,141.69 kg ha(-1) were 34.38-42.62 kg ha(-1) N, 17.55-21.70 kg ha(-1) P2O5, and 53.23-67.29 kg ha(-1) K2O. Moreover, the optimal N, P, and K fertilization interval to achieve pods per plant > 23.41 and the optimal N fertilization to achieve a 100-seed weight > 6.58 g intersected with the interval for yield, but the seeds per pod did not. The fertilizer ratio for the maximum yield was N:P2O5:K2O = 1:0.5:1.59. Following three years experimentation, the optimal fertilization measures were validated in 2016-2017, the results indicated that yield increased by 19.6% than that obtained using conventional fertilization. The results of this study provide a theoretical basis and technical guidance for high-yield mung bean cultivation using the optimal fertilization measures.	[Yin, Zhichao; Guo, Wenyun; Wang, Qingyu] Jilin Univ, Coll Plant Sci, Changchun, Jilin, Peoples R China; [Guo, Wenyun; Xiao, Huanyu; Liang, Jie; Hao, Xiyu; Leng, Tingrui; Wang, Yingjie; Yin, Fengxiang] Baicheng Acad Agr Sci, Baicheng, Jilin, Peoples R China; [Dong, Naiyuan] Amer Pioneer Thoroughbred Int Co, Changchun Off, Changchun, Jilin, Peoples R China	Jilin University	Wang, QY (corresponding author), Jilin Univ, Coll Plant Sci, Changchun, Jilin, Peoples R China.; Yin, FX (corresponding author), Baicheng Acad Agr Sci, Baicheng, Jilin, Peoples R China.	qywang@jlu.edu.cn; yinfx@163.com		zhichao, Yin/0000-0001-5108-5057	Agricultural Research System of China [CARS-08-G4]	Agricultural Research System of China	The Agricultural Research System of China (Item No. CARS-08-G4 to FY) supported the study design, data collection and analysis, publish decision.	Alemu I.D., 2016, INT J AGR INNO RES, V5, P232; Asaduzzaman M., 2008, American-Eurasian Journal of Scientific Research, V3, P40; BETHLENFALVAY GJ, 1982, PLANT PHYSIOL, V70, P446, DOI 10.1104/pp.70.2.446; Chandrayudu E., 2005, Journal of Applied Zoological Researches, V16, P147; Chen J, 2008, ACTA AGR BOREALI SIN, V23, P298, DOI DOI 10.7668/HBNXB.2008.S2.069; [陈剑 Chen Jian], 2012, [作物杂志, Crops], P76; Cheng XZ, 1996, MUNG BEAN; Cheng XZ, 2002, CHINAS MUNG BEANS IN; Cheng XZ, 2016, MUNG BEAN PRODUCTION; Eeswaran R, 2014, JAFFN U INT RES C, P1; Fageria NK, 2014, J PLANT NUTR, V37, P1899, DOI 10.1080/01904167.2014.911889; [郭中校 Guo Zhongxiao], 2010, [吉林农业科学, Journal of Jilin Agricultural Sciences], V35, P24; Hua JI, 2006, PROGR MODERN BIOMEDI, V10, P143; Hussain F, 2011, J ANIM PLANT SCI, V21, P622; Ikraam M, 2002, INT J AGRIC BIOL, V3, P335; Jain A. K., 2007, Legume Research, V30, P201; Jin J, 2015, ANN BOT-LONDON, V116, P975, DOI 10.1093/aob/mcu209; Khan M.A., 1999, PAKISTAN J BIOL SCI, V2, P667, DOI [10.3923/pjbs.1999.667.669, DOI 10.3923/PJBS.1999.667.669]; Liang J, 2011, J HORTICULTURE SEED, V6, P81; Naeem M., 2006, J AGR SOC SCI, V4, P227; Oad F. C., 2003, Journal of Applied Sciences, V3, P428; Patel IC, 2005, EFFECT SEED RATE ROW; Rahimi A, 2012, RES CROP, V13, P118; Rahman MM, 2008, INT J SUSTAIN CROP P, V3, P26; Robu T, 2014, SCI PAP-SER A-AGRON, V57, P310; Sadeghipour O., 2010, Journal of Applied Sciences, V10, P843; Sun GH, 2004, RIAN FED CROPS, V24, P37; Tian J, 2011, 14 NIAS INT WORKSH G, P83; Yanni YG, 2001, AUST J PLANT PHYSIOL, V28, P845, DOI 10.1071/PP01069; Zafar ZU, 2013, PAK J BOT, V45, P617; Zang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128503; [曾玲玲 Zeng Lingling], 2010, [黑龙江农业科学, Heilongjiang Agricultural Science], P48; Zhao CH, 2013, J INNER MONGOLIA AGR, P60; Zhao J, 1993, J ZHEJIANG AGR U, V19	34	14	15	8	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206285	10.1371/journal.pone.0206285	http://dx.doi.org/10.1371/journal.pone.0206285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359450	gold, Green Submitted, Green Published			2022-12-26	WOS:000448438400060
J	Barros, C; Thuiller, W; Munkemuller, T				Barros, Ceres; Thuiller, Wilfried; Munkemuller, Tamara			Drought effects on the stability of forest-grassland ecotones under gradual climate change	PLOS ONE			English	Article							TREE MORTALITY; EXTREME DROUGHT; ECOSYSTEM PRODUCTIVITY; MOUNTAIN VEGETATION; SCOTS PINE; BIODIVERSITY; CONSEQUENCES; RESISTANCE; PLANTS; MODEL	Plant communities in forest-grassland ecotones of the European Alps are already suffering from gradual climate change and will likely be exposed to more frequent and intense drought periods in the future. Yet, how gradual climate change and extreme drought will affect the stability of these plant communities is largely unknown. Here, we investigated how drought modulates the effects of gradual climate change on the long-term structural stability of these ecotone communities using a multidimensional approach. Using a spatially explicit landscape vegetation model, we simulated three drought scenarios, on top of gradual changes of climate variables, and their impacts on the dynamics of 24 plant functional groups, distinguishing between forests and grasslands, as well as different land uses. We then used ndimensional hypervolumes to define community states under the different drought scenarios, and compared them to initial conditions to assess changes in community structural stability. In general, added drought effects did not counteract the long-term consequences of gradual climate changes, although they resulted in quantitatively different effects. Importantly, drought and climate change had non-negligible consequences for taxonomic and functional structure that differed between communities and land-use regimes. For instance, forest taxonomic structure was more overall more stable than grassland's, despite the observed functional shifts towards more warm-adapted species compositions. Conversely, unmanaged grasslands were the least stable, suffering the loss of characteristic alpine species. Also, while frequent and severe drought regimes caused forests to become more variable in time, they had the opposite effect on grasslands. Our results agree with observations of drought- and climate-driven changes in mountain communities of the Alps, and we discuss their relevance for ecosystem management. Importantly, we demonstrate the utility of this multidimensional approach to study community stability for analysing cross-community and cross-disturbance responses to global change.	[Barros, Ceres; Thuiller, Wilfried; Munkemuller, Tamara] Univ Grenoble Alpes, Univ Savoie Mt Blanc, CNRS, Lab Ecol Alpine LECA, Grenoble, France; [Barros, Ceres] UBC Forest Sci Ctr, Dept Forest Resources Management, Fac Forestry, Vancouver, BC, Canada; [Barros, Ceres] Canadian Forest Serv Nat Resources Canada, Pacific Forestry Ctr, Victoria, BC, Canada	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; University of British Columbia; Natural Resources Canada; Canadian Forest Service	Barros, C (corresponding author), Univ Grenoble Alpes, Univ Savoie Mt Blanc, CNRS, Lab Ecol Alpine LECA, Grenoble, France.; Barros, C (corresponding author), UBC Forest Sci Ctr, Dept Forest Resources Management, Fac Forestry, Vancouver, BC, Canada.; Barros, C (corresponding author), Canadian Forest Serv Nat Resources Canada, Pacific Forestry Ctr, Victoria, BC, Canada.	cbarros@mail.ubc.ca	Thuiller, Wilfried/G-3283-2010; Barros, Ceres/ABA-8265-2021; Münkemüller, Tamara/AAQ-1670-2020	Thuiller, Wilfried/0000-0002-5388-5274; Barros, Ceres/0000-0003-4036-977X; 	European Research Council [ERC-2011-StG-281422-TEEMBIO]; French National Research Agency (Agence Nationale de la Recherche) [ANR-15-IDEX-02]; French National Research Agency [ANR-15-IDEX-02]	European Research Council(European Research Council (ERC)European Commission); French National Research Agency (Agence Nationale de la Recherche)(French National Research Agency (ANR)); French National Research Agency(French National Research Agency (ANR))	Research leading to these results received funding from the European Research Council (ERC-2011-StG-281422-TEEMBIO) and the French National Research Agency (Agence Nationale de la Recherche) in the framework of the Investissements d'avenir program (ANR-15-IDEX-02, CDP-Trajectories project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. J. Levine and F. Jabot for their useful comments on earlier versions of the manuscript. Research leading to these results received funding from the European Research Council (ERC-2011-StG-281422-TEEMBIO) and the French National Research Agency in the framework of the Investissements d'avenir program (ANR-15-IDEX-02, CDP-Trajectories project).	Alatalo JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21720; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; Andrello M, 2012, BIOL CONSERV, V147, P99, DOI 10.1016/j.biocon.2011.12.012; Barros C, 2017, J APPL ECOL, V54, P39, DOI 10.1111/1365-2664.12742; Barros C, 2016, ECOL LETT, V19, P729, DOI 10.1111/ele.12617; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Bigler C, 2006, ECOSYSTEMS, V9, P330, DOI 10.1007/s10021-005-0126-2; Blonder B, 2014, GLOBAL ECOL BIOGEOGR, V23, P595, DOI 10.1111/geb.12146; Bloor JMG, 2012, PERSPECT PLANT ECOL, V14, P193, DOI 10.1016/j.ppees.2011.12.001; Bottero A, 2017, J APPL ECOL, V54, P1605, DOI 10.1111/1365-2664.12847; Boulangeat I, 2014, ECOGRAPHY, V37, P1230, DOI 10.1111/ecog.00694; Boulangeat I, 2014, GLOBAL CHANGE BIOL, V20, P2368, DOI 10.1111/gcb.12466; Boulangeat I, 2012, GLOBAL CHANGE BIOL, V18, P3464, DOI 10.1111/j.1365-2486.2012.02783.x; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Copeland SM, 2016, ECOL MONOGR, V86, P295, DOI 10.1002/ecm.1218; de Bello F, 2007, COMMUNITY ECOL, V8, P163, DOI 10.1556/ComEc.8.2007.2.3; de Bruijn A, 2014, ECOL MODEL, V287, P44, DOI 10.1016/j.ecolmodel.2014.05.004; Deleglise C, 2015, AGR ECOSYST ENVIRON, V213, P94, DOI 10.1016/j.agee.2015.07.020; Domec JC, 2015, FOREST ECOL MANAG, V355, P58, DOI 10.1016/j.foreco.2015.04.012; Esterni M, 2006, DELPHINE DECOUPAGE L; Evans SE, 2011, J ECOL, V99, P1500, DOI 10.1111/j.1365-2745.2011.01864.x; Ferrier S., 2016, IPBES METHODOLOGICAL; FORD HA, 1981, EMU, V81, P202, DOI 10.1071/MU9810202; Frank D, 2015, GLOBAL CHANGE BIOL, V21, P2861, DOI 10.1111/gcb.12916; Gehrig-Fasel J, 2007, J VEG SCI, V18, P571, DOI 10.1111/j.1654-1103.2007.tb02571.x; Gomez-Aparicio L, 2005, J VEG SCI, V16, P191, DOI 10.1111/j.1654-1103.2005.tb02355.x; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Gross K, 2014, AM NAT, V183, P1, DOI 10.1086/673915; Ialongo C, 2016, BIOCHEM MEDICA, V26, P150, DOI 10.11613/BM.2016.015; Isbell F, 2015, NATURE, V526, P574, DOI 10.1038/nature15374; Jung V, 2014, J ECOL, V102, P45, DOI 10.1111/1365-2745.12177; Kane JM, 2011, PLANT ECOL, V212, P733, DOI 10.1007/s11258-010-9859-x; Lavorel S, 2012, J ECOL, V100, P128, DOI 10.1111/j.1365-2745.2011.01914.x; Lavorel S, 2011, J ECOL, V99, P135, DOI 10.1111/j.1365-2745.2010.01753.x; Legay N, 2018, PLANT SOIL, V424, P233, DOI 10.1007/s11104-017-3403-x; Levesque M, 2014, AGR FOREST METEOROL, V197, P1, DOI 10.1016/j.agrformet.2014.06.001; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Martinez ND, 2006, SFI S SCI C, P163; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Morecroft MD, 2002, GLOBAL ECOL BIOGEOGR, V11, P7, DOI 10.1046/j.1466-822X.2002.00174.x; Parc Naturel Regional du Queyras Parc National des Ecrins., 2012, PRAIR NAT ENJ LIES P; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Pillar VD, 2013, J VEG SCI, V24, P963, DOI 10.1111/jvs.12047; Puettmann KJ, 2015, FOR ECOSYST, V2, DOI 10.1186/s40663-015-0031-x; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Rigling A, 2013, GLOBAL CHANGE BIOL, V19, P229, DOI 10.1111/gcb.12038; Sanz-Elorza M, 2003, ANN BOT-LONDON, V92, P273, DOI 10.1093/aob/mcg130; Scheller RM, 2011, ECOL MODEL, V222, P144, DOI 10.1016/j.ecolmodel.2010.09.009; Seekell DA, 2013, THEOR ECOL-NETH, V6, P385, DOI 10.1007/s12080-013-0183-7; Sippel S, 2018, CURR CLIM CHANGE REP, V4, P266, DOI 10.1007/s40641-018-0103-4; Stocker T., 2013, COMPUTATIONAL GEOMET, DOI 10.1017/ CBO9781107415324; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Sturtevant BR, 2004, ECOL MODEL, V180, P153, DOI 10.1016/j.ecolmodel.2004.01.021; Tappeiner U, 2009, LAND USE LAND COVER; Tasser E, 2017, LAND USE POLICY, V60, P60, DOI 10.1016/j.landusepol.2016.10.019; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tilman D, 2012, P NATL ACAD SCI USA, V109, P10394, DOI 10.1073/pnas.1208240109; van der Molen MK, 2011, AGR FOREST METEOROL, V151, P765, DOI 10.1016/j.agrformet.2011.01.018; Vanoni M, 2016, FOREST ECOL MANAG, V382, P51, DOI 10.1016/j.foreco.2016.10.001; Wang WF, 2012, ENVIRON REV, V20, P109, DOI [10.1139/A2012-004, 10.1139/a2012-004]; Wardle DA, 2000, OIKOS, V89, P11, DOI 10.1034/j.1600-0706.2000.890102.x; Zhou SX, 2013, AGR FOREST METEOROL, V182, P204, DOI 10.1016/j.agrformet.2013.05.009; Zwicke M, 2015, ANN BOT-LONDON, V116, P1001, DOI 10.1093/aob/mcv037	65	10	11	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206138	10.1371/journal.pone.0206138	http://dx.doi.org/10.1371/journal.pone.0206138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356292	Green Published, Green Submitted, gold			2022-12-26	WOS:000448434000076
J	Boccellino, M; Di Domenico, M; Donniacuo, M; Bitti, G; Gritti, G; Ambrosio, P; Quagliuolo, L; Rinaldi, B				Boccellino, Mariarosaria; Di Domenico, Marina; Donniacuo, Maria; Bitti, Giuseppe; Gritti, Giulia; Ambrosio, Pasqualina; Quagliuolo, Lucio; Rinaldi, Barbara			AT1-receptor blockade: Protective effects of irbesartan in cardiomyocytes under hypoxic stress	PLOS ONE			English	Article							TYPE-1 RECEPTOR ANTAGONIST; MYOCARDIAL ISCHEMIA/REPERFUSION; INFLAMMATORY RESPONSE; HYPERTENSIVE PATIENTS; NATRIURETIC PEPTIDE; OXIDATIVE STRESS; HEART-DISEASE; INJURY; DYSFUNCTION; ATHEROSCLEROSIS	Hypoxia induces myocardial injury through the activation of inflammatory and oxidative processes. The pivotal role of the renin angiotensin system (RAS) in the pathogenesis of cardiovascular diseases has been firmly established in clinical trials and practice; in fact many experimental and clinical data have highlighted that its inhibition has a cardioprotective role. Activated RAS also stimulates inflammation directly inducing proinflammatory and oxidative gene expression. This study aimed to investigate the protective role of a pre-treatment (10 and 100 mu M) with irbesartan on injury induced by 24 h of hypoxia in HL-1 cardiomyocytes; in particular, we have analyzed the natriuretic peptide (BNP) expression, a biomarker able to modulate inflammatory reaction to cardiac injury and some markers involved in oxidative stress and inflammation. Our results demonstrated that a pre-treatment with 100 mu M irbesartan significantly increased SOD activity and catalase expression of 15 and 25%, respectively, compared to hypoxic cells (P<0.05). On the other hand, it was able to reduce the release of peroxynitrite and iNOS protein expression of 20 and 50% respectively (P<0.05). In addition irbesartan exerts an anti-inflammatory activity reducing Toll-like receptors (TLRs)-2 and -4 mRNA expression, TNF-alpha expression and activity (20%) and increasing the expression of the cytokine IL-17 (40%) (P<0.05 vs hypoxia). Our findings also showed that BNP induced by ischemia was significantly and in a concentration-dependent manner reduced by irbesartan. The findings of our study demonstrated that the AT1 receptor antagonist irbesartan exerts a protective role in an in vitro hypoxic condition reducing oxidative stress and inflammation.	[Boccellino, Mariarosaria; Di Domenico, Marina; Bitti, Giuseppe; Ambrosio, Pasqualina; Quagliuolo, Lucio] Univ Campania Luigi Vanvitelli, Dept Precis Med, Naples, Italy; [Di Domenico, Marina] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA; [Donniacuo, Maria; Gritti, Giulia; Rinaldi, Barbara] Univ Campania Luigi Vanvitelli, Dept Expt Med, Sect Pharmacol, Naples, Italy	Universita della Campania Vanvitelli; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Universita della Campania Vanvitelli	Di Domenico, M (corresponding author), Univ Campania Luigi Vanvitelli, Dept Precis Med, Naples, Italy.; Di Domenico, M (corresponding author), Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA.	marina.didomenico@unicampania.it		QUAGLIUOLO, Lucio/0000-0003-0651-3264; Di Domenico, Marina/0000-0002-6201-4200				Baban B, 2013, HYPERTENSION, V61, P95, DOI 10.1161/HYPERTENSIONAHA.111.00028; Babiker F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165777; Balistreri CR, 2017, J MOL CELL CARDIOL, V110, P38, DOI 10.1016/j.yjmcc.2017.06.011; Ben Mkaddem S, 2010, ONCOTARGET, V1, P741, DOI 10.18632/oncotarget.209; Bergler-Klein J, 2014, CAN J CARDIOL, V30, P1027, DOI 10.1016/j.cjca.2014.07.014; Burley DS, 2007, BASIC RES CARDIOL, V102, P529, DOI 10.1007/s00395-007-0672-1; Cadenas S, 2018, FREE RADICAL BIO MED, V117, P76, DOI 10.1016/j.freeradbiomed.2018.01.024; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; D'Angelo S, 2012, J MED FOOD, V15, P1024, DOI 10.1089/jmf.2012.0076; Deftereos S, 2014, MED CHEM, V10, P653, DOI 10.2174/1573406410666140806103651; Fallach R, 2010, J MOL CELL CARDIOL, V48, P1236, DOI 10.1016/j.yjmcc.2010.02.020; Farias JG, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090966; Fineschi V, 2015, CURR VASC PHARMACOL, V13, P3; Gao JM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1674613; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Goetze JP, 2003, FASEB J, V17, P1105, DOI 10.1096/fj.02-0796fje; Hashem SI, 2015, STEM CELLS, V33, P2343, DOI 10.1002/stem.2015; Helaleh MIH, 2001, J AOAC INT, V84, P53; Helanova K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006872; Hernandez-Resendiz S, 2018, CURR MED CHEM, V25, P1275, DOI 10.2174/0929867324666170329100619; Hirohata A, 2010, J AM COLL CARDIOL, V55, P976, DOI 10.1016/j.jacc.2009.09.062; Isailovic N, 2015, J AUTOIMMUN, V60, P1, DOI 10.1016/j.jaut.2015.04.006; Ke Y, 2009, J IMMUNOL, V182, P3183, DOI 10.4049/jimmunol.0802487; Kusunoki H, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000103; Li JB, 2015, MOL MED REP, V11, P1120, DOI 10.3892/mmr.2014.2955; Liu ZD, 2014, ATHEROSCLEROSIS, V233, P291, DOI 10.1016/j.atherosclerosis.2013.12.004; Lu ML, 2015, PHYTOTHER RES, V29, P599, DOI 10.1002/ptr.5297; Maione F, 2009, BIOCHEM PHARMACOL, V77, P878, DOI 10.1016/j.bcp.2008.11.011; Meno H, 2012, CLIN DRUG INVEST, V32, P171, DOI 10.2165/11597620-000000000-00000; Min XY, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4013685; Ong SB, 2018, PHARMACOL THERAPEUT, V186, P73, DOI 10.1016/j.pharmthera.2018.01.001; Parashar A, 2015, AM J CARDIOL, V116, P508, DOI 10.1016/j.amjcard.2015.05.007; Rinaldi B, 2011, BRIT J PHARMACOL, V163, P609, DOI 10.1111/j.1476-5381.2011.01248.x; Rohde D, 2014, EMBO MOL MED, V6, P778, DOI 10.15252/emmm.201303498; Roksnoer LCW, 2016, CLIN SCI, V130, P1209, DOI 10.1042/CS20160197; SAMET I, 2014, OXID MED CELL LONGEV, DOI DOI 10.1155/2014/134862; Shimada K, 2011, NUTR METAB CARDIOVAS, V21, P672, DOI 10.1016/j.numecd.2009.12.016; Taguchi I, 2013, HYPERTENS RES, V36, P608, DOI 10.1038/hr.2013.3; Toldo S, 2011, MOL MED, V17, P1012, DOI 10.2119/molmed.2011.00100; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Vanacore D, 2018, J CELL PHYSIOL, V233, P9345, DOI 10.1002/jcp.26427; Vilahur G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00496; Wen ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067242; Wong PCY, 2017, ADV PHYSIOL EDUC, V41, P179, DOI 10.1152/advan.00177.2016; Zhang X, 2017, BIOMED PHARMACOTHER, V91, P1042, DOI 10.1016/j.biopha.2017.05.033; Zhao P, 2009, J CELL MOL MED, V13, P1513, DOI 10.1111/j.1582-4934.2009.00798.x	46	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0202297	10.1371/journal.pone.0202297	http://dx.doi.org/10.1371/journal.pone.0202297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356256	Green Submitted, Green Published, gold			2022-12-26	WOS:000448434000003
J	Lepheana, RJ; Oguttu, JW; Qekwana, DN				Lepheana, Relebohile Juliet; Oguttu, James Wabwire; Qekwana, Daniel Nenene			Temporal patterns of anthrax outbreaks among livestock in Lesotho, 2005-2016	PLOS ONE			English	Article							ZIMBABWE	Background Although anthrax is endemic in Lesotho, limited information is available on the patterns of the disease among livestock animals. This study investigated temporal patterns of anthrax outbreaks and cases among livestock animals in Lesotho. Methods Secondary data of anthrax outbreaks reported to the Department of Livestock Services between January 2005 and December 2016 was used for this study. Proportions of anthrax outbreaks and cases, and their corresponding 95% confidence interval were calculated and compared across year, season, month and region using the Chi-square or Fisher's exact test. The autoregression model was used to evaluate annual trends of anthrax outbreaks and cases. Results A total of 38 outbreaks were reported in the Lowlands districts of Lesotho. District was significantly (p<0.0001) associated with outbreaks and cases, with the highest proportions of outbreaks (52.6%) and cases (70.2%) reported in Maseru. Significantly (p = 0.0004) higher proportions of anthrax outbreaks (78.9%) and cases (95.1%) were reported in the rainy-hot season compared to the dry-cold season. Five hundred and twenty-six (n = 526) anthrax cases were reported with significantly (p<0.0001) higher proportion of cases (70.3%) in cattle compared to other species. Higher proportion of anthrax cases (35.9%) were reported in 2008 and during the months of February (30.8%) and April (30.2%). There was no significant annual trend in anthrax outbreaks (r = 0.0282; p = 0.6213) and cases (r = 0.0873; p = 0.3512) over the study period. Conclusion The burden of anthrax in Lesotho is significantly higher in cattle. Anthrax outbreaks occur only in the lowland districts and follow a seasonal pattern. Therefore, more effort should be targeted at curbing the disease in cattle and the lowlands districts. Furthermore, there should be heightened monitoring of cases in the rainy season to ensure that resultant carcasses are disposed of appropriately to minimise future outbreaks.	[Lepheana, Relebohile Juliet; Qekwana, Daniel Nenene] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, Sect Vet Publ Hlth, Pretoria, South Africa; [Oguttu, James Wabwire] Univ South Africa, Coll Agr & Environm Sci, Dept Agr & Anim Hlth, Florida Sci Campus, Johannesburg, South Africa	University of Pretoria; University of South Africa	Qekwana, DN (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, Sect Vet Publ Hlth, Pretoria, South Africa.	nenene.qekwana@up.ac.za	Oguttu, James W/F-4670-2014	Oguttu, James W/0000-0001-6810-4437; Lepheana, Relebohile/0000-0003-1522-9767	University of Pretoria	University of Pretoria	The author acknowledges support from the Department of Livestock Services, Lesotho, for permitting access to the departmental database and the University of Pretoria for the support and resources used in this study. The authors wish to acknowledge the Department of Language Services of the University of South Africa that assisted with editing of the manuscript.	Aikembayev AM, 2010, EMERG INFECT DIS, V16, P789, DOI 10.3201/eid1605.091427; Barro AS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004689; Bellan S, 2011, THESIS; Bengis Roy G., 2012, P98; Beyer W, 2009, MOL ASPECTS MED, V30, P481, DOI 10.1016/j.mam.2009.08.004; Beyer W, 1976, PLOS NEGLECT TROP D, V6, pe1534; Bezymennyi M, 2014, APPL GEOGR, V54, P129, DOI 10.1016/j.apgeog.2014.07.016; Bureau of Statistics, 2015, LES LIV STAT REP 201; Chen WJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004637; Chikerema SM, 2013, PREV VET MED, V111, P25, DOI 10.1016/j.prevetmed.2013.04.006; Chikerema SM, 2012, TROP ANIM HEALTH PRO, V44, P63, DOI 10.1007/s11250-011-9888-z; DRAGON DC, 1995, CAN VET J, V36, P295; FAO, 2016, SEED SEC ASS LES 201; Government of Lesotho, 1969, TITL 23 LIV IND PROC; Hampson K, 2011, J APPL ECOL, V48, P1333, DOI 10.1111/j.1365-2664.2011.02030.x; Hughes-Jones M, 1999, J APPL MICROBIOL, V87, P189, DOI 10.1046/j.1365-2672.1999.00867.x; Kracalik I, 2017, VACCINE, V35, P6283, DOI 10.1016/j.vaccine.2017.09.081; Kracalik I, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002985; Kracalik IT, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005885; Lesotho Meteorological Services, 2013, CLIM LES; McAllaster L, 2003, 16 ANN NESUG C; Moeletsi ME, 2013, THEOR APPL CLIMATOL, V114, P227, DOI 10.1007/s00704-012-0829-1; Munang'andu HM, 2012, J VET SCI, V13, P293, DOI 10.4142/jvs.2012.13.3.293; Nicol J., 1942, J S AFR VET ASSOC, V13, P53; OIE World Animal Health Information System OIE World Animal Health Information System, 2016, WEEKL AN DIS SEV GLO; Smith KL, 2000, J CLIN MICROBIOL, V38, P3780, DOI 10.1128/JCM.38.10.3780-3784.2000; Sumner PD, 2004, GEOGR ANN A, V86A, P289, DOI 10.1111/j.0435-3676.2004.00232.x; Turner WC, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00245.1; World health Organization; Food and Agriculture Organization of the United Nations; World Organisation for Animal Health, 2008, ANTHR HUM AN	29	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0204758	10.1371/journal.pone.0204758	http://dx.doi.org/10.1371/journal.pone.0204758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356323	Green Submitted, gold, Green Published			2022-12-26	WOS:000448434000018
J	Flores, EM; Woeller, CF; Falsetta, ML; Susiarjo, M; Phipps, RP				Flores, E'Lissa M.; Woeller, Collynn F.; Falsetta, Megan L.; Susiarjo, Martha; Phipps, Richard P.			Thy1 (CD90) expression is regulated by DNA methylation during adipogenesis	FASEB JOURNAL			English	Article						3T3-L1; obesity; mesenchymal stem cells; 5-aza-dC; epigenetics	PPAR-GAMMA; STEM-CELLS; OBESITY; PROMOTER; MURINE; OSTEOBLASTOGENESIS; INDUCTION; GENES; BONE	The obesity epidemic is developing into the most costly health problem facing the world. Obesity, characterized by excessive adipogenesis and enlarged adipocytes, promotes morbidities, such as diabetes, cardiovascular disease, and cancer. Regulation of adipogenesis is critical to our understanding of how fat cell formation causes obesity and associated health problems. Thy1 (also called CD90), a widely used stem cell marker, blocks adipogenesis and reduces lipid accumulation. Thy1-knockout mice are prone to diet-induced obesity. Although the importance of Thy1 in adipogenesis and obesity is now evident, how its expression is regulated is not. We hypothesized that DNA methylation has a role in promoting adipogenesis and affects Thy1 expression. Using the methylation inhibitor 5-aza-2-deoxycytidine (5-aza-dC), we investigated whether DNA methylation alters Thy1 expression during adipogenesis in both mouse 3T3-L1 preadipocytes and mouse mesenchymal stem cells. Thy1 protein and mRNA levels were decreased dramatically during adipogenesis. However, 5-aza-dC treatment prevented that phenomenon. Methylation-sensitive pyrosequencing analysis showed that CpG sites at the Thy1 locus have increased methylation during adipogenesis, as well as increased methylation in adipose tissue from diet-induced obese mice. These new findings highlight the potential role of Thy1 and DNA methylation in adipogenesis and obesity.Flores, E. M., Woeller, C. F., Falsetta, M. L., Susiarjo, M., Phipps, R. P. Thy1 (CD90) expression is regulated by DNA methylation during adipogenesis.	[Flores, E'Lissa M.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Clin & Translat Sci Inst, Rochester, NY USA; [Woeller, Collynn F.; Falsetta, Megan L.; Susiarjo, Martha; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY USA; [Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Woeller, CF (corresponding author), Univ Rochester, Dept Environm Med, 601 Elmwood Ave,Box 850,Room 3-11001, Rochester, NY 14642 USA.	collynn_woeller@urmc.rochester.edu	Falsetta, Megan L./AAE-1586-2020; Woeller, Collynn/U-3877-2019	Woeller, Collynn/0000-0001-7197-5057	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences [F31ES027767, ES001247, ES0023032]; NIH National Heart, Lung, and Blood Institute [HL133761]; University of Rochester Clinical and Translational Science Award from the NIH [TL1-TR000096]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247, F31ES027767] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Rochester Clinical and Translational Science Award from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Stephen Pollock (University of Rochester Medical Center) for assisting with figure preparation for the manuscript. This project is funded by U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grants F31ES027767 (to E.F.), ES001247, and ES0023032; NIH National Heart, Lung, and Blood Institute Grant HL133761; and University of Rochester Clinical and Translational Science Award TL1-TR000096 from the NIH. The authors declare no conflicts of interest.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996; Alipour R, 2010, INT J PREVENTIVE MED, V1, P164; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bearden RN, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0639-6; Bowers RR, 2006, P NATL ACAD SCI USA, V103, P13022, DOI 10.1073/pnas.0605789103; Broholm C, 2016, EPIGENOMICS-UK, V8, P1601, DOI 10.2217/epi-2016-0077; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Chen YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25283; Chung MT, 2013, TISSUE ENG PT A, V19, P989, DOI [10.1089/ten.tea.2012.0370, 10.1089/ten.TEA.2012.0370]; Du JJ, 2016, BIOCHEM BIOPH RES CO, V475, P140, DOI 10.1016/j.bbrc.2016.05.057; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; GIGUERE V, 1985, EMBO J, V4, P2017, DOI 10.1002/j.1460-2075.1985.tb03886.x; GUNDERSEN G, 1992, GENE, V113, P207, DOI 10.1016/0378-1119(92)90397-8; Guo W, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.378; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; Hansen TC, 2017, PLAST RECONSTR SURG, V140, P316, DOI 10.1097/PRS.0000000000003542; He JT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010744; Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; Hudak Carolyn S, 2013, Front Endocrinol (Lausanne), V4, P79, DOI 10.3389/fendo.2013.00079; Jing K, 2009, BBA-MOL CELL BIOL L, V1791, P816, DOI 10.1016/j.bbalip.2009.04.010; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; John E, 2012, NUCLEIC ACIDS RES, V40, P4446, DOI 10.1093/nar/gks025; Kasaai B, 2012, J HISTOCHEM CYTOCHEM, V60, P219, DOI 10.1369/0022155411432010; Keller M, 2017, MOL METAB, V6, P86, DOI 10.1016/j.molmet.2016.11.003; Kim CY, 2012, BIOCHEM BIOPH RES CO, V426, P551, DOI 10.1016/j.bbrc.2012.08.125; KOLSTO AB, 1986, NUCLEIC ACIDS RES, V14, P9667; Kumar A, 2012, ENDOCRINOLOGY, V153, P254, DOI 10.1210/en.2011-1169; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Lehmann GM, 2010, AM J PHYSIOL-CELL PH, V299, pC672, DOI 10.1152/ajpcell.00451.2009; Li MH, 2015, BIOL CHEM, V396, P235, DOI 10.1515/hsz-2014-0241; Liang XW, 2016, J PHYSIOL-LONDON, V594, P4453, DOI 10.1113/JP272123; Lim YC, 2016, MOL METAB, V5, P1033, DOI 10.1016/j.molmet.2016.08.006; MANN V, 1986, INT J CANCER, V37, P781, DOI 10.1002/ijc.2910370521; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Neveu WA, 2015, AM J PHYSIOL-CELL PH, V309, pC616, DOI 10.1152/ajpcell.00086.2015; Noer A, 2006, MOL BIOL CELL, V17, P3543, DOI 10.1091/mbc.E06-04-0322; Onate B, 2012, FASEB J, V26, P4327, DOI 10.1096/fj.12-207217; Orbay H, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/461718; Paine A, 2018, FASEB J, V32, P3174, DOI 10.1096/fj.201701379R; Parry PV, 2012, NEUROSURGERY, V70, pN23, DOI 10.1227/01.neu.0000413227.80467.92; Perri R, 2012, J DENT RES, V91, P33, DOI 10.1177/0022034511425045; Qian SW, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-47; Robinson CM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-74; Rudnicki MA, 2015, BONE, V80, P60, DOI 10.1016/j.bone.2015.02.009; Sakamoto H, 2008, BIOCHEM BIOPH RES CO, V366, P360, DOI 10.1016/j.bbrc.2007.11.137; Sanders YY, 2008, AM J RESP CELL MOL, V39, P610, DOI 10.1165/rcmb.2007-0322OC; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; SPANOPOULOU E, 1991, MOL CELL BIOL, V11, P2216, DOI 10.1128/MCB.11.4.2216; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Volberg V, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-016-0365-4; Woeller CF, 2017, TOXICOL SCI, V157, P305, DOI 10.1093/toxsci/kfx046; Woeller CF, 2015, FASEB J, V29, P920, DOI 10.1096/fj.14-257121; Xu S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/105940; Yang XS, 2016, MOL ENDOCRINOL, V30, P677, DOI 10.1210/me.2015-1135; Yin XH, 2015, EXP CELL RES, V335, P107, DOI 10.1016/j.yexcr.2015.04.020; Zhao QH, 2013, FEBS J, V280, P5801, DOI 10.1111/febs.12500	61	8	8	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3353	3363		10.1096/fj.201801481R	http://dx.doi.org/10.1096/fj.201801481R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30376360	Green Published, Green Submitted			2022-12-26	WOS:000459794800023
J	Ko, J; Kang, HJ; Kim, DA; Ryu, ES; Yu, M; Lee, H; Lee, HK; Ryu, HM; Park, SH; Kim, YL; Kang, DH				Ko, Jiyeon; Kang, Hyun-Jung; Kim, Dal-Ah; Ryu, Eun-Sun; Yu, Mina; Lee, Huisong; Lee, Hyeon Kook; Ryu, Hye-Myung; Park, Sun-Hee; Kim, Yong-Lim; Kang, Duk-Hee			Paricalcitol attenuates TGF-1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome	FASEB JOURNAL			English	Article						EMT; peritoneal dialysis; peritoneal fibrosis; NADPH oxidase; vitamin D agonist	TO-MESENCHYMAL TRANSITION; VITAMIN-D; TGF-BETA; RENAL INFLAMMATION; ANGIOTENSIN-II; HIGH GLUCOSE; ACTIVATION; DIALYSIS; ALDOSTERONE; MEMBRANE	Phenotype transition of mesothelial cells, such as epithelial-to-mesenchymal transition (EMT), is one of the early mechanisms of peritoneal fibrosis, which is mediated by oxidative stress and inflammation. Nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome is a multiprotein oligomer that promotes the maturation of IL-1 and IL-18. Paricalcitol is reported to exert an anti-inflammatory effect; however, there are no studies as to whether paricalcitol modulates the activation of NLRP3 inflammasome. We investigated the role of NLRP3 inflammasome in peritoneal EMT with an exploration of the effect of paricalcitol on oxidative stress, NLRP3 inflammasome, and EMT of mesothelial cells. TGF-1-induced EMT in human peritoneal mesothelial cells (HPMCs) was associated with an up-regulation of NLRP3, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), and procaspase-1, with an increased production of IL-1 and IL-18, which was ameliorated by small interfering (si)NLRP3, siASC, caspase inhibitors, or neutralizing antibodies for IL-1 and IL-18. TGF-1 enhanced reactive oxygen species generation with an increase in NADPH oxidase (NOX) activity and mitochondrial NOX4 production. Paricalcitol alleviated TGF-1-induced EMT and the NLRP3 inflammasome, which was associated with a down-regulation of NOX activity by interfering with p47phox and p22phox interaction and mitochondrial NOX4 production in HPMCs. Taken together, paricalcitol ameliorated EMT of HPMCs via modulating an NOX-dependent increase in the activity of NLRP3 inflammasome. Paricalcitol could be a novel approach to protect the peritoneum from the development of EMT and peritoneal fibrosis.Ko, J., Kang, H.-J., Kim, D.-A., Ryu, E.-S., Yu, M., Lee, H., Lee, H. K., Ryu, H.-M., Park, S.-H., Kim, Y.-L., Kang, D.-H. Paricalcitol attenuates TGF-1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome.	[Ko, Jiyeon; Kang, Hyun-Jung; Kim, Dal-Ah; Ryu, Eun-Sun; Kang, Duk-Hee] Ewha Womans Univ, Sch Med, Dept Internal Med, Div Nephrol, Seoul, South Korea; [Lee, Huisong; Lee, Hyeon Kook] Ewha Womans Univ, Sch Med, Ewha Med Res Ctr, Dept Surg, Seoul, South Korea; [Yu, Mina] Seonam Hosp, Dept Internal Med, Seoul, South Korea; [Ryu, Hye-Myung; Park, Sun-Hee; Kim, Yong-Lim] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Nephrol, Daegu, South Korea	Ewha Womans University; Ewha Womans University; Kyungpook National University	Kang, DH (corresponding author), Ewha Womans Univ, Coll Med, Ewha Med Res Ctr, Div Nephrol,Dept Internal Med, 911 Mok Dong, Seoul 158710, South Korea.	dhkang@ewha.ac.kr	Park, Sun/GSD-9620-2022		Korean Health Technology Research and Development Project (Ministry of Health and Welfare, Republic of Korea) [HI12C0050, HI15C0001, HC15C1129]; National Research Foundation of Korea (NRF) - Korean government [Ministry of Science and Information and Communications Technology (MSIT)] [NRF-2015R1A2A1A15053374, NRF-2017R1A2B2005849]; Ewha Womans University	Korean Health Technology Research and Development Project (Ministry of Health and Welfare, Republic of Korea); National Research Foundation of Korea (NRF) - Korean government [Ministry of Science and Information and Communications Technology (MSIT)]; Ewha Womans University	This work was supported by the Korean Health Technology Research and Development Project (Ministry of Health and Welfare, Republic of Korea Grants HI12C0050, HI15C0001, and HC15C1129); a National Research Foundation of Korea (NRF) grant funded by the Korean government [Ministry of Science and Information and Communications Technology (MSIT); NRF-2015R1A2A1A15053374 and NRF-2017R1A2B2005849]; and the Ewha Womans University Research Grant of 2016. The authors declare no conflicts of interest.	Ari E, 2012, BRIT J RADIOL, V85, P1038, DOI 10.1259/bjr/16327485; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Bani-Hani AH, 2009, KIDNEY INT, V76, P500, DOI 10.1038/ki.2009.216; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Brown KD, 2017, INVEST OPHTH VIS SCI, V58, P3011, DOI 10.1167/iovs.16-20633; Cho YJ, 2014, INT J NEPHROL, V2014, DOI 10.1155/2014/909373; Doerner AM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-100; Gonzalez-Mateo GT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108477; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Guo JL, 2013, ARCH TOXICOL, V87, P1963, DOI 10.1007/s00204-013-1063-z; He T, 2015, MOL CELL ENDOCRINOL, V402, P13, DOI 10.1016/j.mce.2014.12.010; Hiraga R, 2013, ANTICANCER RES, V33, P4431; Jang YH, 2013, LAB INVEST, V93, P194, DOI 10.1038/labinvest.2012.166; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kang SH, 2014, NEPHRON EXP NEPHROL, V126, P1, DOI 10.1159/000357156; Kim SH, 2012, LAB INVEST, V92, P488, DOI 10.1038/labinvest.2011.194; Lee JW, 2014, BIOCHEM BIOPH RES CO, V444, P121, DOI 10.1016/j.bbrc.2014.01.005; Lee JH, 2013, AM J PHYSIOL-RENAL, V304, pF686, DOI 10.1152/ajprenal.00148.2012; Li YJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-87; Liang H, 2018, BIOMED PHARMACOTHER, V106, P879, DOI 10.1016/j.biopha.2018.07.031; Liu WC, 2016, CLIN CHIM ACTA, V453, P1, DOI 10.1016/j.cca.2015.11.029; Lopez-Cabrera M, 2014, ADV MED, V2014; Lorenz G, 2014, NEPHROL DIAL TRANSPL, V29, P41, DOI 10.1093/ndt/gft332; Margetts PJ, 2003, PERITON DIALYSIS INT, V23, P530; Noh H, 2006, KIDNEY INT, V69, P2022, DOI 10.1038/sj.ki.5001506; Panizo S, 2013, NEPHROL DIAL TRANSPL, V28, P2735, DOI 10.1093/ndt/gft268; Park JW, 2010, AM J PHYSIOL-RENAL, V298, pF301, DOI 10.1152/ajprenal.00471.2009; Patel P, 2010, KIDNEY INT, V77, P319, DOI 10.1038/ki.2009.436; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Sahin I, 2014, EUR REV MED PHARMACO, V18, P2895; Sanchez-Nino MD, 2012, AM J PHYSIOL-RENAL, V302, pF647, DOI 10.1152/ajprenal.00090.2011; Segovia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029695; Shin HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05836-6; Shin HS, 2015, LAB INVEST, V95, P1157, DOI 10.1038/labinvest.2015.91; Stavenuiter A.W., 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/468574266053304641933; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Tan XY, 2006, J AM SOC NEPHROL, V17, P3382, DOI 10.1681/ASN.2006050520; Gonzalez-Mateo GT, 2012, NEPHROL DIAL TRANSPL, V27, P478, DOI 10.1093/ndt/gfr543; Tobar N, 2010, BRIT J CANCER, V103, P1040, DOI 10.1038/sj.bjc.6605847; Wang AYM, 2011, SEMIN NEPHROL, V31, P159, DOI 10.1016/j.semnephrol.2011.01.005; Wang W, 2013, J IMMUNOL, V190, P1239, DOI 10.4049/jimmunol.1201959; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Wu J, 2016, EXP CELL RES, V341, P42, DOI 10.1016/j.yexcr.2016.01.014; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang AH, 2003, KIDNEY INT, V63, P1530, DOI 10.1046/j.1523-1755.2003.00861.x; Yu MA, 2009, J AM SOC NEPHROL, V20, P567, DOI 10.1681/ASN.2008040424; Yu M, 2015, KIDNEY RES CLIN PRAC, V34, P83, DOI 10.1016/j.krcp.2015.03.005; Zhang LL, 2016, FREE RADICAL BIO MED, V97, P531, DOI 10.1016/j.freeradbiomed.2016.07.014; 이상협, 2013, [The Journal of Korea Robotics Society, 로봇학회 논문지], V8, P8, DOI 10.7746/jkros.2013.8.1.008	50	24	24	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					3035	3050		10.1096/fj.201800292RR	http://dx.doi.org/10.1096/fj.201800292RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30354670	Bronze			2022-12-26	WOS:000457296600119
J	Moon, TM; D'Andrea, ED; Lee, CW; Soares, A; Jakoncic, J; Desbonnet, C; Garcia-Solache, M; Rice, LB; Page, R; Peti, W				Moon, Thomas M.; D'Andrea, Everton D.; Lee, Christopher W.; Soares, Alexei; Jakoncic, Jean; Desbonnet, Charlene; Garcia-Solache, Monica; Rice, Lou B.; Page, Rebecca; Peti, Wolfgang			The structures of penicillin-binding protein 4 (PBP4) and PBP5 from Enterococci provide structural insights into beta-lactam resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ANTIBIOTICS; EXPRESSION; PATHOGENS; FAECIUM	The final steps of cell-wall biosynthesis in bacteria are carried out by penicillin-binding proteins (PBPs), whose transpeptidase domains form the cross-links in peptidoglycan chains that define the bacterial cell wall. These enzymes are the targets of beta-lactam antibiotics, as their inhibition reduces the structural integrity of the cell wall. Bacterial resistance to antibiotics is a rapidly growing concern; however, the structural underpinnings of PBP-derived antibiotic resistance are poorly understood. PBP4 and PBP5 are low-affinity, class B transpeptidases that confer antibiotic resistance to Enterococcus faecalis and Enterococcus faecium, respectively. Here, we report the crystal structures of PBP4 (1.8 angstrom) and PBP5 (2.7 angstrom) in their apo and acyl-enzyme complexes with the beta-lactams benzylpenicillin, imipenem, and ceftaroline. We found that, although these three beta-lactams adopt geometries similar to those observed in other class B PBP structures, there are small, but significant, differences that likely decrease antibiotic efficacy. Further, we also discovered that the N-terminal domain extensions in this class of PBPs undergo large rigid-body rotations without impacting the structure of the catalytic transpeptidase domain. Together, our findings are defining the subtle functional and structural differences in the Enterococcus PBPs that allow them to support transpeptidase activity while also conferring bacterial resistance to antibiotics that function as substrate mimics.	[Moon, Thomas M.; D'Andrea, Everton D.; Page, Rebecca; Peti, Wolfgang] Univ Arizona, Dept Chem & Biochem, Coll Med, Tucson, AZ 85721 USA; [Lee, Christopher W.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Soares, Alexei; Jakoncic, Jean] Brookhaven Natl Lab, Photon Sci, Upton, NY 11973 USA; [Desbonnet, Charlene; Garcia-Solache, Monica; Rice, Lou B.] Brown Univ, Dept Med, Warren Alpert Sch Med, Providence, RI 02903 USA; [Desbonnet, Charlene; Garcia-Solache, Monica; Rice, Lou B.] Brown Univ, Dept Microbiol & Immunol, Warren Alpert Sch Med, Providence, RI 02903 USA	University of Arizona; Brown University; United States Department of Energy (DOE); Brookhaven National Laboratory; Brown University; Brown University	Peti, W (corresponding author), Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA.	wolfgangpeti@email.arizona.edu	D'Andréa, Éverton D/O-6796-2016; Garcia-Solache, Monica/M-4461-2019; Moon, Thomas/F-4896-2013	Garcia-Solache, Monica/0000-0003-0696-7653; Jakoncic, Jean/0000-0002-6315-0933; Moon, Thomas/0000-0003-1568-8808	National Institutes of Health [R56AI045626]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R56AI045626 (to L. B. R. and W. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Aymanns S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019822; CHAMBERS H F, 1988, Clinical Microbiology Reviews, V1, P173; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; ELIOPOULOS GM, 1982, ANTIMICROB AGENTS CH, V22, P295, DOI 10.1128/AAC.22.2.295; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fedarovich A, 2012, J MOL BIOL, V418, P316, DOI 10.1016/j.jmb.2012.02.021; Frere JM, 2014, CURR OPIN PHARMACOL, V18, P112, DOI 10.1016/j.coph.2014.09.012; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Gonzolez A, 2010, AUTOXDS; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; JAWETZ E, 1966, NEW ENGL J MED, V274, P710, DOI 10.1056/NEJM196603312741304; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; MOELLERIRC, 1971, J CLIN INVEST, V50, P2580, DOI DOI 10.1172/JCI106758; Otero LH, 2013, P NATL ACAD SCI USA, V110, P16808, DOI 10.1073/pnas.1300118110; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; Ren JS, 2016, FEBS LETT, V590, P288, DOI 10.1002/1873-3468.12054; Rice LB, 2004, ANTIMICROB AGENTS CH, V48, P3028, DOI 10.1128/AAC.48.8.3028-3032.2004; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Rice LB, 2018, MBIO, V9, DOI 10.1128/mBio.00361-18; Sauvage E, 2002, CELL MOL LIFE SCI, V59, P1223, DOI 10.1007/s00018-002-8500-0; Stein BJ, 2016, STRUCTURE, V24, P232, DOI 10.1016/j.str.2015.12.008; Teplitsky E, 2015, J STRUCT BIOL, V191, P49, DOI 10.1016/j.jsb.2015.05.006; Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1288, DOI 10.1017/ice.2016.174; WILLIAMSON R, 1983, J GEN MICROBIOL, V129, P813; WILLIAMSON R, 1985, J GEN MICROBIOL, V131, P1933; Yamada M, 2007, ANTIMICROB AGENTS CH, V51, P3902, DOI 10.1128/AAC.00743-07; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x	33	23	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18574	18584		10.1074/jbc.RA118.006052	http://dx.doi.org/10.1074/jbc.RA118.006052			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30355734	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000458467300013
J	Droghini, A; Boutin, S				Droghini, Amanda; Boutin, Stan			The calm during the storm: Snowfall events decrease the movement rates of grey wolves (Canis lupus)	PLOS ONE			English	Article							WHITE-TAILED DEER; POPULATION-DYNAMICS; WOLF PREDATION; ENERGY EXPENDITURES; WOODLAND CARIBOU; LINEAR FEATURES; WINTER WEATHER; KILL RATES; PREY; LOCOMOTION	Mammalian predators encounter unique hunting challenges during the winter as snow increases the cost of locomotion and influences predator-prey interactions. Winter precipitation may also affect predators' ability to detect and pursue prey. We investigated the effects of snowfall events on grey wolves (Canis lupus) in a boreal forest ecosystem in northeastern Alberta, Canada. We predicted that wolves would respond to snowfall events by reducing their travel speed and the time they spent travelling. Over the course of two winters, we used remote cameras to identify localized snowfall events and estimate snow depth. We used telemetry data from 17 wolves to calculate travel speed and time spent travelling versus resting. Data were categorized by time of day (night versus day) and time since snowfall events, and analyzed using linear and logistic regression mixed-effects models. We found that wolves were less likely to travel on dates of snowfall events than any date prior to or after an event. Wolves also travelled slower during snowfall events, but only when compared to their travel speed 24 hours before. Effects were most pronounced at night, when movements appeared to be consistent with hunting behavior, and activity levels resumed within 24 hours of a snowfall event. Including snow depth as a variable did not improve model fit. Collectively, our findings suggest that wolves' response is not driven by increased hunting success or by energetic considerations resulting from increased snow depth. Instead, we propose that wolves reduce their activity levels because precipitation dampens hunting success. Snowfall events may impact wolves' ability to detect prey and changes in prey behavior could also lead to decreased encounter rates. We encourage scientists to further investigate the effects of short-term weather events on movement rates and predator-prey interactions.	[Droghini, Amanda; Boutin, Stan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Droghini, A (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	droghini@ualberta.ca	Droghini, Amanda/AAK-3935-2020; Boutin, Stan/A-2619-2014	Droghini, Amanda/0000-0001-6692-2348; Boutin, Stan/0000-0001-6317-038X	Canada's Oil Sands Innovation Alliance; Northern Scientific Training Program (University of Alberta); Circumpolar Boreal Alberta Research (University of Alberta); Natural Sciences and Engineering Research Council of Canada Graduate Scholarships-Master's Program; Fonds de recherche du Quebec - Nature et technologies	Canada's Oil Sands Innovation Alliance; Northern Scientific Training Program (University of Alberta); Circumpolar Boreal Alberta Research (University of Alberta); Natural Sciences and Engineering Research Council of Canada Graduate Scholarships-Master's Program(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche du Quebec - Nature et technologies	This work was supported by: 1. Canada's Oil Sands Innovation Alliance (SB); 2. Northern Scientific Training Program (University of Alberta) (AD), URL: https://www.ualberta.ca/why-ualberta/arctic/north/grants-and-scholarships; 3. Circumpolar Boreal Alberta Research (University of Alberta) (AD), URL: https://www.ualberta.ca/why-ualberta/arctic/north/grants-and-scholarships; 4. Natural Sciences and Engineering Research Council of Canada Graduate Scholarships-Master's Program (AD), URL: http://www.nserc-crsng.gc.ca/Students-Etudiants/PG-CS/CGSM-BESCM_eng.asp; 5. Fonds de recherche du Quebec - Nature et technologies (AD) URL: http://www.frqnt.gouv.qc.ca/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SM, 2006, J BIOGEOGR, V33, P2001, DOI 10.1111/j.1365-2699.2006.01564.x; [Anonymous], 2000, NON TRADITIONAL REF; ATTENBOROUGH K, 1988, APPL ACOUST, V24, P289, DOI 10.1016/0003-682X(88)90086-2; Ballard W. B., 1987, WILDLIFE MONOGR, V98, P3; BALLARD WB, 1991, WILDLIFE MONOGR, P1; Barton K., 2016, MUMIN MULTIMODEL INT; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benaglia T, 2009, J STAT SOFTW, V32, P1; Bergman EJ, 2006, ECOL APPL, V16, P273, DOI 10.1890/04-1532; Boutin S, 2015, WILDLIFE HABITAT EFF; BOYCE MS, 1991, APPL ANIM BEHAV SCI, V29, P239, DOI 10.1016/0168-1591(91)90251-R; Brivio F, 2016, BEHAV ECOL SOCIOBIOL, V70, P1291, DOI 10.1007/s00265-016-2137-8; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cablk ME, 2008, SENSORS-BASEL, V8, P2208, DOI 10.3390/s8042208; Conover M. R., 2007, PREDATOR PREY DYNAMI; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Crete M, 2003, CAN J ZOOL, V81, P1808, DOI 10.1139/Z03-182; Dickie M, 2017, J APPL ECOL, V54, P253, DOI 10.1111/1365-2664.12732; Droghini A, 2018, CAN J ZOOL, V96, P39, DOI 10.1139/cjz-2017-0041; Environment Canada, 2015, CAN CLIM NORM 1981 2; FANCY SG, 1987, CAN J ZOOL, V65, P122, DOI 10.1139/z87-018; Formozov AN, 1961, SIGNIFICANCE SNOW CO; FULLER TK, 1989, WILDLIFE MONOGR, P1; FULLER TK, 1991, CAN J ZOOL, V69, P283, DOI 10.1139/z91-044; FULLER TK, 1980, J WILDLIFE MANAGE, V44, P583, DOI 10.2307/3808006; Garroway CJ, 2005, CAN J ZOOL, V83, P1246, DOI 10.1139/Z05-118; Gese EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082862; Government of Canada, 2018, AL PAR ENV CAN US IS; Hebblewhite M, 2005, J ANIM ECOL, V74, P226, DOI 10.1111/j.1365-2656.2004.00909.x; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; HUGGARD DJ, 1993, J WILDLIFE MANAGE, V57, P382, DOI 10.2307/3809437; JEDRZEJEWSKI W, 1992, OECOLOGIA, V90, P27, DOI 10.1007/BF00317805; Jedrzejewski W, 2002, ECOLOGY, V83, P1341, DOI 10.2307/3071948; KOLENOSKY GB, 1972, J WILDLIFE MANAGE, V36, P357, DOI 10.2307/3799065; Kuzyk GW, 2004, CAN FIELD NAT, V118, P368, DOI 10.22621/cfn.v118i3.15; Kyro EM, 2009, BOREAL ENVIRON RES, V14, P527; Latham ADM, 2013, ECOGRAPHY, V36, P1276, DOI 10.1111/j.1600-0587.2013.00035.x; Latham ADM, 2011, ECOL APPL, V21, P2854, DOI 10.1890/11-0666.1; Mech L. David, 1970, WOLF ECOLOGY BEHAV E; Messer MA, 2009, TERR ECOL SER, V3, P137, DOI 10.1016/S1936-7961(08)00208-X; Mills KJ, 2006, WILDLIFE SOC B, V34, P1463, DOI 10.2193/0091-7648(2006)34[1463:EOVSFO]2.0.CO;2; MOEN AN, 1976, ECOLOGY, V57, P192, DOI 10.2307/1936411; Murie A., 1944, FAUNA SERIES US DEP; Neilson EW, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1913; NELSON ME, 1986, J WILDLIFE MANAGE, V50, P471, DOI 10.2307/3801108; Paquet P., 1996, CUMULATIVE EFFECTS A; Paquet Paul C., 2010, P157; PARKER KL, 1984, J WILDLIFE MANAGE, V48, P474, DOI 10.2307/3801180; Peterson RO, 1977, NATL PARK SERVICE SC; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Pruitt William, 1978, BOREAL ECOLOGY; R Core Team, 2021, R LANGUAGE ENV STAT; Richard JH, 2014, CAN J ZOOL, V92, P1067, DOI 10.1139/cjz-2014-0118; Robinson BG, 2012, OIKOS, V121, P28, DOI 10.1111/j.1600-0706.2011.19408.x; Ruzicka RE, 2011, CAN FIELD NAT, V125, P132, DOI 10.22621/cfn.v125i2.1196; Shivik JA, 2002, WILDLIFE SOC B, V30, P721; Sidorovich V, 2017, MAMM BIOL, V83, P44, DOI 10.1016/j.mambio.2016.11.012; Stien A, 2010, ECOLOGY, V91, P915, DOI 10.1890/09-0056.1; TELFER ES, 1984, ECOLOGY, V65, P1828, DOI 10.2307/1937779; Thurfjell H, 2014, ACTA THERIOL, V59, P467, DOI 10.1007/s13364-014-0185-x; Togunov RR, 2017, SCI REP-UK, V7, DOI 10.1038/srep46332; Vennen LMV, 2016, FUNCT ECOL, V30, P1568, DOI 10.1111/1365-2435.12642; Wang GM, 2002, CLIMATIC CHANGE, V54, P205, DOI 10.1023/A:1015725103348; Webb NF, 2008, J WILDLIFE MANAGE, V72, P798, DOI 10.2193/2006-566; Wickham H., 2016, VEGAN COMMUNITY ECOL; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wikenros C, 2009, ACTA THERIOL, V54, P207, DOI 10.4098/j.at.0001-7051.082.2008; Zuur Alain F., 2009, P1	68	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205742	10.1371/journal.pone.0205742	http://dx.doi.org/10.1371/journal.pone.0205742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379852	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700068
J	Filipova, M; Elhelu, OK; De Paoli, SH; Fremuntova, Z; Mosko, T; Cmarko, D; Simak, J; Holada, K				Filipova, Marcela; Elhelu, Oumsalama K.; De Paoli, Silvia H.; Fremuntova, Zuzana; Mosko, Tibor; Cmarko, Dusan; Simak, Jan; Holada, Karel			An effective "three-in-one" screening assay for testing drug and nanoparticle toxicity in human endothelial cells	PLOS ONE			English	Article							CARBON NANOTUBES; SILICA NANOPARTICLES; CYTOTOXICITY; NECROSIS; DELIVERY; INACTIVATION; APOPTOSIS; RELEASE; BINDING; TOOLS	Evaluating nanoparticle (NP) toxicity in human cell systems is a fundamental requirement for future NP biomedical applications. In this study, we have designed a screening assay for assessing different types of cell death induced by NPs in human umbilical vein endothelial cell (HUVEC) culture. This assay consists of WST-8, LDH and Hoechst 33342 staining, all performed in one well, which enables an evaluation of cell viability, necrosis and apoptosis, respectively, in the same cell sample. The 96-well format and automated processing of fluorescent images enhances the assay rapidity and reproducibility. After testing the assay functionality with agents that induced different types of cell death, we investigated the endothelial toxicity of superparamagnetic iron oxide nanoparticles (SPIONs, 8 nm), silica nanoparticles (SiNPs, 7-14 nm) and carboxylated multiwall carbon nanotubes (CNTCOOHs, 60 nm). Our results indicated that all the tested NP types induced decreases in cell viability after 24 hours at a concentration of 100 mu g/ml. SPIONs caused the lowest toxicity in HUVECs. By contrast, SiNPs induced pronounced necrosis and apoptosis. A time course experiment showed the gradual toxic effect of all the tested NPs. CNTCOOHs inhibited tetrazolium derivatives at 100 mu g/ml, causing false negative results from the WST-8 and LDH assay. In summary, our data demonstrate that the presented "three-in-one" screening assay is capable of evaluating NP toxicity effectively and reliably. Due to its simultaneous utilization of two different methods to assess cell viability, this assay is also capable of revealing, if NPs interfere with tetrazolium salts.	[Filipova, Marcela; Fremuntova, Zuzana; Mosko, Tibor; Holada, Karel] Charles Univ Prague, Fac Med 1, Inst Immunol & Microbiol, Prague, Czech Republic; [Filipova, Marcela; Fremuntova, Zuzana; Mosko, Tibor; Cmarko, Dusan; Holada, Karel] Gen Univ Hosp Prague, Prague, Czech Republic; [Filipova, Marcela] Acad Sci Czech Republ, Inst Macromol Chem, Dept Biol Models, Vvi, Prague, Czech Republic; [Elhelu, Oumsalama K.; De Paoli, Silvia H.; Simak, Jan] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Cmarko, Dusan] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences; US Food & Drug Administration (FDA); Charles University Prague	Holada, K (corresponding author), Charles Univ Prague, Fac Med 1, Inst Immunol & Microbiol, Prague, Czech Republic.; Holada, K (corresponding author), Gen Univ Hosp Prague, Prague, Czech Republic.	karel.holada@lf1.cuni.cz	Filipova, Marcela/P-2793-2016; Simak, Jan/C-1153-2011	Filipova, Marcela/0000-0003-3503-7973; Simak, Jan/0000-0001-8910-7362	Ministry of Education, Youth and Sports of the Czech Republic [LH12014]; Charles University in Prague [PROGRES-Q26/LF1, GAUK 1200213]; Czech health research council [AZV NV15-32961A]; Grant Agency of the Czech Republic [P302/12/G157]; U.S. Department of Energy; U.S. Food and Drug Administration	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague; Czech health research council; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Food and Drug Administration	This study was partially supported by grant LH12014 from the Ministry of Education, Youth and Sports of the Czech Republic. MF and KH were partially supported by the following projects from Charles University in Prague: PROGRES-Q26/LF1 and GAUK 1200213 and by project from the Czech health research council: AZV NV15-32961A. DC acknowledges support from the Grant Agency of the Czech Republic, grant P302/12/G157. This project was supported in part by the appointment of OE to the Research Participation Program at the Center for Biologics Evaluation and Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpha Raj M., 2016, CALCULATING LD50 LC5; [Anonymous], [No title captured]; Bagwe RP, 2006, LANGMUIR, V22, P4357, DOI 10.1021/la052797j; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Casey A, 2007, CARBON, V45, P1425, DOI 10.1016/j.carbon.2007.03.033; Corbalan JJ, 2011, INT J NANOMED, V6, P2821, DOI 10.2147/IJN.S25071; de Oliveira LF, 2016, LANGMUIR, V32, P3217, DOI 10.1021/acs.langmuir.6b00214; Etrych T, 2011, J CONTROL RELEASE, V154, P241, DOI 10.1016/j.jconrel.2011.06.015; Fang C, 2006, EUR J PHARM SCI, V27, P27, DOI 10.1016/j.ejps.2005.08.002; Finney D.J., 1971, PROBIT ANAL; Grela Ewa, 2015, Avicenna Journal of Medical Biotechnology, V7, P159; Guadagnini R, 2015, NANOTOXICOLOGY, V9, P25, DOI 10.3109/17435390.2013.855830; Guldi DM, 2005, ACCOUNTS CHEM RES, V38, P871, DOI 10.1021/ar040238i; Halamoda-Kenzaoui B, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0281-6; Hashida Y, 2014, J CONTROL RELEASE, V173, P59, DOI 10.1016/j.jconrel.2013.10.039; Jeong SH, 2002, CHEM MATER, V14, P1859, DOI 10.1021/cm011620h; Jo HY, 2015, EXP NEUROBIOL, V24, P235, DOI 10.5607/en.2015.24.3.235; Kendig DM, 2007, TOXICOL IN VITRO, V21, P125, DOI 10.1016/j.tiv.2006.08.004; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kong B, 2011, NANOMEDICINE-UK, V6, P929, DOI [10.2217/NNM.11.77, 10.2217/nnm.11.77]; Kroll A, 2012, ARCH TOXICOL, V86, P1123, DOI 10.1007/s00204-012-0837-z; Kura AU, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-46; Laroui H, 2011, AM J PHYSIOL-GASTR L, V300, pG371, DOI 10.1152/ajpgi.00466.2010; Louis KS, 2011, METHODS MOL BIOL, V740, P7, DOI 10.1007/978-1-61779-108-6_2; Madani SY, 2011, INT J NANOMED, V6, P2963, DOI 10.2147/IJN.S16923; McKeague AL, 2003, BRIT J CANCER, V88, P125, DOI 10.1038/sj.bjc.6600675; Misra R., 2014, PHARM ANAL ACTA, V5, P279; Nichols JW, 2012, NANO TODAY, V7, P606, DOI 10.1016/j.nantod.2012.10.010; Orecna M, 2014, NANOMED-NANOTECHNOL, V10, P939, DOI 10.1016/j.nano.2014.02.001; Peng XH, 2008, INT J NANOMED, V3, P311; Potapova IA, 2009, J CELL PHYSIOL, V219, P23, DOI 10.1002/jcp.21645; Rahman SNSA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/257108; Re F, 2012, NANOMED-NANOTECHNOL, V8, pS51, DOI 10.1016/j.nano.2012.05.007; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Sanfins E, 2011, ACS NANO, V5, P4504, DOI 10.1021/nn103534d; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma A, 2012, EXPERT OPIN DRUG MET, V8, P47, DOI 10.1517/17425255.2012.637916; Shi JJ, 2017, NAT REV CANCER, V17, P20, DOI 10.1038/nrc.2016.108; Siafaka PI, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091440; Simak J, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-11; Simenc J, 2012, RADIOL ONCOL, V46, P312, DOI 10.2478/v10019-012-0036-9; Sliwka L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155772; Takhar P., 2011, APPL SCI RES, V3, P389; Thomsen LB, 2015, THER DELIV, V6, P1145, DOI 10.4155/tde.15.56; Tominaga H, 1999, ANAL COMMUN, V36, P47, DOI 10.1039/a809656b; Torchilin VP, 2006, ADV DRUG DELIVER REV, V58, P1532, DOI 10.1016/j.addr.2006.09.009; Troyano A, 2003, CELL DEATH DIFFER, V10, P889, DOI 10.1038/sj.cdd.4401249; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Watson C, 2014, ACS NANO, V8, P2118, DOI 10.1021/nn404871p; Werengowska-Ciecwierz K, 2015, ADV CONDENSED MATTER, V2015; Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c; Wu ZQ, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2563-3; Xia T, 2013, ENVIRON HEALTH PERSP, V121, P683, DOI 10.1289/ehp.1306561; Zhang Q, 2017, COLLOID SURFACE B, V149, P138, DOI 10.1016/j.colsurfb.2016.10.018; Zhivotosky B, 2001, CURRENT PROTOCOLS CE	55	8	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206557	10.1371/journal.pone.0206557	http://dx.doi.org/10.1371/journal.pone.0206557			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379903	Green Submitted, Green Published, gold			2022-12-26	WOS:000448823700130
J	Guo, G; Liu, FM; Bian, YL; Li, XH				Guo, Gang; Liu, Fengmao; Bian, Yanli; Li, Xiaohan			Bitter gourd has the highest azoxystrobinon residue after open field application on four cucurbit vegetables	PLOS ONE			English	Article							WINTER-WHEAT; FUNGICIDES; RESISTANCE; NITROGEN	The goal of this study was to select a representative cucurbit vegetable crop that contained the highest residue levels of the pesticide azoxystrobinon. To do this, we used open field application of azoxystrobinon in four cucurbit crops (cucumber, zucchini, bitter gourd, and loofah) in Beijing, Shandong, and Anhui. Liquid chromatograph-mass spectrometry/mass spectrometry (LC-MS/MS) with selected reaction monitoring was used to determine azoxystrobinon levels in each of the selected cucurbit vegetables. The azoxystrobinon limit of detection was 0.005 mg kg(-1) for all samples. Recoveries of azoxystrobinon ranged from 94.2% to 107.1% at spiked levels of 0.005-0.5 mg kg(-1) . In field trials, the half-life of azoxystrobinon in each of the four cucurbit crops was within the range of 1.4-3.1 d. Based on these results, we recommend that bitter gourd is selected as a representative cucurbit vegetable for future studies of azoxystrobinon. The obtained residual data were also assessed for their dietary risk and results indicated that there is no chronic dietary risk in any of the four, selected cucurbit vegetables. The recommended maximum residue limit (MRL) of azoxystrobinon in this subgroup was 0.2 mg/kg.	[Guo, Gang; Liu, Fengmao; Bian, Yanli; Li, Xiaohan] China Agr Univ, Coll Sci, Beijing, Peoples R China	China Agricultural University	Liu, FM (corresponding author), China Agr Univ, Coll Sci, Beijing, Peoples R China.	liufengmao@cau.edu.cn	Liu, Fengmao/AAL-8487-2021	Liu, Fengmao/0000-0002-1958-7230; bian, yanli/0000-0002-4222-0728	Special Fund for Agro-scientific Research in the Public Interest of China [201503107]	Special Fund for Agro-scientific Research in the Public Interest of China	This work was supported by Special Fund for Agro-scientific Research in the Public Interest of China (grant: 201503107) to F.L. The funders gave the suggestions to the study design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Special Fund for Agro-scientific Research in the Public Interest of China (201503107).	ANKE T, 1977, J ANTIBIOT, V30, P806, DOI 10.7164/antibiotics.30.806; [Anonymous], 2016, GB27632016; [Anonymous], 2017, EU CROP CLASSIFICATI; [Anonymous], 2012, COD COMM PEST RES 44; Bartlett DW, 2002, PEST MANAG SCI, V58, P649, DOI 10.1002/ps.520; Bonasia A, 2013, POSTHARVEST BIOL TEC, V85, P67, DOI 10.1016/j.postharvbio.2013.04.012; CCPR, 2014, COD COMM PEST RES 46; Herms S, 2002, PLANT PHYSIOL, V130, P120, DOI 10.1104/pp.004432; Hou F, 2017, J AGR FOOD CHEM, V65, P4484, DOI 10.1021/acs.jafc.7b01316; Hu D, 2017, J FOOD PROTECT, V80, P2112, DOI [10.4315/0362-028x.jfp-17-228, 10.4315/0362-028X.JFP-17-228]; JOINT FAO/WHO FOOD STANDARDS PROGRAMME CODEX COMMITTEE ON PESTICIDE RESI-DUES, 2017, JOINT FAO WHO FOOD S; JOINT FAO/WHO FOOD STANDARDS PROGRAMME CODEX COMMITTEE ON PESTICIDE RESI-DUES, 2014, JOINT FAO WHO FOOD S; JOINT FAO/WHO FOOD STANDARDS PROGRAMME CODEX COMMITTEE ON PESTICIDE RESI-DUES, 2013, JOINT FAO WHO FOOD S; JOINT FAO/WHO FOOD STANDARDS PROGRAMME CODEX COMMITTEE ON PESTICIDE RESI-DUES, 2015, JOINT FAO WHO FOOD S; Joint FAO/WHO Food Standards Programme Or- ganization WH. Codex Alimentarius Commission, 2016, JOINT FAO WHO FOOD S; Margot P., 1998, Brighton Crop Protection Conference: Pests & Diseases - 1998: Volume 2: Proceedings of an International Conference, Brighton, UK, 16-19 November 1998., P375; Rodrigues ET, 2013, ENVIRON INT, V53, P18, DOI 10.1016/j.envint.2012.12.005; Ruske RE, 2003, J AGR SCI, V140, P395, DOI 10.1017/S0021859603003228; Sauter H, 1999, ANGEW CHEM INT EDIT, V38, P1329, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1328::AID-ANIE1328>3.0.CO;2-1; Vincelli P, 2002, PLANT DIS, V86, P235, DOI 10.1094/PDIS.2002.86.3.235; Wu YX, 2001, PESTIC BIOCHEM PHYS, V71, P1, DOI 10.1006/pest.2001.2561; Zhang YJ, 2010, PESTIC BIOCHEM PHYS, V98, P151, DOI 10.1016/j.pestbp.2010.04.007	22	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0203967	10.1371/journal.pone.0203967	http://dx.doi.org/10.1371/journal.pone.0203967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379877	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700007
J	Park, SH; Yoo, W; Lee, CW; Jeong, CS; Shin, SC; Kim, HW; Park, H; Kim, KK; Kim, TD; Lee, JH				Park, Sun-Ha; Yoo, Wanki; Lee, Chang Woo; Jeong, Chang Sook; Shin, Seung Chul; Kim, Han-Woo; Park, Hyun; Kim, Kyeong Kyu; Kim, T. Doohun; Lee, Jun Hyuck			Crystal structure and functional characterization of a cold-active acetyl xylan esterase (PbAcE) from psychrophilic soil microbe Paenibacillus sp.	PLOS ONE			English	Article							CEPHALOSPORIN-C; SUBSTRATE-SPECIFICITY; BACILLUS-SUBTILIS; ENZYME; FAMILY; HYDROLASE	Cold-active acetyl xylan esterases allow for reduced bioreactor heating costs in bioenergy production. Here, we isolated and characterized a cold-active acetyl xylan esterase (PbAcE) from the psychrophilic soil microbe Paenibacillus sp. R4. The enzyme hydrolyzes glucose penta-acetate and xylan acetate, reversibly producing acetyl xylan from xylan, and it shows higher activity at 4 degrees C than at 25 degrees C. We solved the crystal structure of PbAcE at 2.1 - A resolution to investigate its active site and the reason for its low-temperature activity. Structural analysis showed that PbAcE forms a hexamer with a central substrate binding tunnel, and the inter-subunit interactions are relatively weak compared with those of its mesophilic and thermophilic homologs. PbAcE also has a shorter loop and different residue composition in the beta 4-alpha 3 and beta 5-alpha 4 regions near the substrate binding site. Flexible subunit movements and different active site loop conformations may enable the strong low-temperature activity and broad substrate specificity of PbAcE. In addition, PbAcE was found to have strong activity against antibiotic compound substrates, such as cefotaxime and 7-amino cephalosporanic acid (7-ACA). In conclusion, the PbAcE structure and our biochemical results provide the first example of a cold-active acetyl xylan esterase and a starting template for structure-based protein engineering.	[Park, Sun-Ha; Lee, Chang Woo; Jeong, Chang Sook; Shin, Seung Chul; Kim, Han-Woo; Park, Hyun; Lee, Jun Hyuck] Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea; [Yoo, Wanki; Kim, T. Doohun] Sookmyung Womans Univ, Coll Nat Sci, Dept Chem, Seoul, South Korea; [Yoo, Wanki; Kim, Kyeong Kyu] Sungkyunkwan Univ, Samsung Biomed Res Inst, Dept Mol Cell Biol, Sch Med, Suwon, South Korea; [Lee, Chang Woo; Jeong, Chang Sook; Kim, Han-Woo; Park, Hyun; Lee, Jun Hyuck] Univ Sci & Technol, Dept Polar Sci, Incheon, South Korea	Korea Polar Research Institute (KOPRI); Sookmyung Women's University; Sungkyunkwan University (SKKU)	Lee, JH (corresponding author), Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea.; Kim, TD (corresponding author), Sookmyung Womans Univ, Coll Nat Sci, Dept Chem, Seoul, South Korea.; Lee, JH (corresponding author), Univ Sci & Technol, Dept Polar Sci, Incheon, South Korea.	doohunkim@sookmyung.ac.kr; junhyucklee@kopri.re.kr	kim, doohun/AAC-4528-2019; Kim, Kyeong Kyu/ABH-1988-2020	Kim, Kyeong Kyu/0000-0003-2515-8894	Korea Polar Research Institute [PE18210]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MSIP) [NRF-2017M1A5A1013568]; Korea Polar Research Institute (KOPRI) [PN18082]	Korea Polar Research Institute(Korea Polar Research Institute of Marine Research Placement (KOPRI)); National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Korea Polar Research Institute (KOPRI)(Korea Polar Research Institute of Marine Research Placement (KOPRI))	This work was supported by the Korea Polar Research Institute [grant number PE18210]; the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (MSIP) [application study on Arctic cold-active enzymes degrading organic carbon compounds; NRF grant number NRF-2017M1A5A1013568]; and the Korea Polar Research Institute (KOPRI) [grant number PN18082].	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adesioye FA, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02695-17; Altaner C, 2003, J BIOTECHNOL, V105, P95, DOI 10.1016/S0168-1656(03)00187-1; BIELY P, 1986, BIO-TECHNOL, V4, P731, DOI 10.1038/nbt0886-731; Biely P, 2011, J BIOTECHNOL, V151, P137, DOI 10.1016/j.jbiotec.2010.10.074; Bommarius AS, 2013, CHEM SOC REV, V42, P6534, DOI 10.1039/c3cs60137d; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Degrassi G, 2000, MICROBIOL-SGM, V146, P1585, DOI 10.1099/00221287-146-7-1585; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dodd D, 2009, GCB BIOENERGY, V1, P2, DOI 10.1111/j.1757-1707.2009.01004.x; Drzewiecki K, 2010, MICROB BIOTECHNOL, V3, P84, DOI 10.1111/j.1751-7915.2009.00150.x; Ebringerova A, 2000, MACROMOL RAPID COMM, V21, P542; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FORKMANN G, 1980, BIOCHEM GENET, V18, P519, DOI 10.1007/BF00484399; Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4; GILBERT HJ, 1993, J GEN MICROBIOL, V139, P187, DOI 10.1099/00221287-139-2-187; Hedge MK, 2012, BBA-PROTEINS PROTEOM, V1824, P1024, DOI 10.1016/j.bbapap.2012.05.009; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Levisson M, 2012, PROTEINS, V80, P1545, DOI 10.1002/prot.24041; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Martinez-Martinez I, 2007, ANAL BIOCHEM, V369, P210, DOI 10.1016/j.ab.2007.06.030; Montoro-Garcia S, 2011, BIOCHEM J, V436, P321, DOI 10.1042/BJ20101859; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082; Sheldon RA, 2011, APPL MICROBIOL BIOT, V92, P467, DOI 10.1007/s00253-011-3554-2; Singh MK, 2017, PROTEIN ENG DES SEL, V30, P559, DOI 10.1093/protein/gzx049; Singh MK, 2017, PROTEINS, V85, P694, DOI 10.1002/prot.25249; Singh MK, 2016, BIOCHEM BIOPH RES CO, V476, P63, DOI 10.1016/j.bbrc.2016.05.061; Singh MK, 2016, J STRUCT BIOL, V194, P434, DOI 10.1016/j.jsb.2016.04.008; Tian QQ, 2014, APPL MICROBIOL BIOT, V98, P2081, DOI 10.1007/s00253-013-5056-x; Vaghari H, 2016, BIOTECHNOL LETT, V38, P223, DOI 10.1007/s10529-015-1977-z; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vincent F, 2003, J MOL BIOL, V330, P593, DOI 10.1016/S0022-2836(03)00632-6; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yiu HHP, 2012, J CHEM TECHNOL BIOT, V87, P583, DOI 10.1002/jctb.3735	41	14	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206260	10.1371/journal.pone.0206260	http://dx.doi.org/10.1371/journal.pone.0206260			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379876	Green Published, gold			2022-12-26	WOS:000448823700098
J	Russell, PH; Johnson, RL; Ananthan, S; Harnke, B; Carlson, NE				Russell, Pamela H.; Johnson, Rachel L.; Ananthan, Shreyas; Harnke, Benjamin; Carlson, Nichole E.			A large-scale analysis of bioinformatics code on GitHub	PLOS ONE			English	Article							SOFTWARE; BIOLOGY	In recent years, the explosion of genomic data and bioinformatic tools has been accompanied by a growing conversation around reproducibility of results and usability of software. However, the actual state of the body of bioinformatics software remains largely unknown. The purpose of this paper is to investigate the state of source code in the bioinformatics community, specifically looking at relationships between code properties, development activity, developer communities, and software impact. To investigate these issues, we curated a list of 1,720 bioinformatics repositories on GitHub through their mention in peer-reviewed bioinformatics articles. Additionally, we included 23 high-profile repositories identified by their popularity in an online bioinformatics forum. We analyzed repository metadata, source code, development activity, and team dynamics using data made available publicly through the GitHub API, as well as article metadata. We found key relationships within our dataset, including: certain scientific topics are associated with more active code development and higher community interest in the repository; most of the code in the main dataset is written in dynamically typed languages, while most of the code in the high-profile set is statically typed; developer team size is associated with community engagement and high-profile repositories have larger teams; the proportion of female contributors decreases for high-profile repositories and with seniority level in author lists; and, multiple measures of project impact are associated with the simple variable of whether the code was modified at all after paper publication. In addition to providing the first large-scale analysis of bioinformatics code to our knowledge, our work will enable future analysis through publicly available data, code, and methods. Code to generate the dataset and reproduce the analysis is provided under the MIT license at https://github.com/pamelarussell/github-bioinformatics. Data are available at https://doi.org/10.17605/OSF.IO/UWHX8.	[Russell, Pamela H.; Johnson, Rachel L.; Carlson, Nichole E.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO 80045 USA; [Ananthan, Shreyas] Natl Renewable Energy Lab, High Performance Algorithms & Complex Fluids, Golden, CO USA; [Harnke, Benjamin] Univ Colorado, Hlth Sci Lib, Anschutz Med Campus, Aurora, CO USA	Colorado School of Public Health; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Colorado System; University of Colorado Anschutz Medical Campus	Russell, PH (corresponding author), Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO 80045 USA.	pamela.russell@ucdenver.edu	Russell, Pamela/O-8504-2019	Russell, Pamela/0000-0003-2997-6392	National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards Biostatistics, Epidemiology and Research Design Program [UL1 TR001082]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards Biostatistics, Epidemiology and Research Design Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards Biostatistics, Epidemiology and Research Design Program, Grant Number UL1 TR001082, received by N.C. (http://www.ucdenver.edu/research/CCTSI/programsservices/berd/Pages/default.aspx).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, NATURE; [Anonymous], 2016, SPOTLIGHT BIOINFORMA, DOI [10.1038/nj0478, DOI 10.1038/NJ0478]; Babraham Bioinformatics, FASTQC QUALITY CONTR; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Blincoe K, 2016, INFORM SOFTWARE TECH, V70, P30, DOI 10.1016/j.infsof.2015.10.002; Blischak JD, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004668; Bonham KS, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005134; Borges H, 2016, UNDERSTANDING FACTOR; Chen TY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-24; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Crusoe MR, 2016, J OPEN RES STW, V4, DOI [10.5334/jors.35, DOI 10.5334/JORS.35]; Duck G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157989; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GitHub, GITHUB API V3 GITHUB; GitHub, GITHUB PRIV STAT US; GitHub, GITHUB TERMS SERV US; Goble C, 2014, IEEE INTERNET COMPUT, V18, P4, DOI 10.1109/MIC.2014.88; Hagen JB, 2000, NAT REV GENET, V1, P231, DOI 10.1038/35042090; Hothorn T, 2011, BRIEF BIOINFORM, V12, P288, DOI 10.1093/bib/bbq084; Hu Y, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2897-7; Jacobsen Kjetil, PYCURL HOME PAGE; Kamali Amir Hossein, 2015, Biophys Rev, V7, P343, DOI 10.1007/s12551-015-0177-3; Kochhar PS, 2013, INT CONF QUAL SOFTW, P103, DOI 10.1109/QSIC.2013.57; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leprevost FD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00199; Ma WWY, 2016, PROCEEDINGS 2016 THIRD INTERNATIONAL CONFERENCE ON TRUSTWORTHY SYSTEMS AND THEIR APPLICATIONS (TSA), P87, DOI 10.1109/TSA.2016.23; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; National Science Foundation, 2017, 18304 NSF NAT CTR SC; Nielsen MW, 2017, P NATL ACAD SCI USA, V114, P1740, DOI 10.1073/pnas.1700616114; Ortu M., 2017, J SOFTWARE ENG RES D, V5, P1, DOI [10.1186/s40411-017-0044-y, DOI 10.1186/S40411-017-0044-Y]; Parnell LD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002216; Prlic A, 2012, BIOINFORMATICS, V28, P2693, DOI 10.1093/bioinformatics/bts494; Ray B, 2014, 22ND ACM SIGSOFT INTERNATIONAL SYMPOSIUM ON THE FOUNDATIONS OF SOFTWARE ENGINEERING (FSE 2014), P155, DOI 10.1145/2635868.2635922; Sandve GK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003285; Searls DB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000809; Seemann T, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-15; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sheoran J., 2014, P 11 WORK C MIN SOFT, P336, DOI [10.1145/2597073.2597114, DOI 10.1145/2597073.2597114]; StackOverflow, 2018, STACK OV DEV SURV 20; Vasilescu B, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P3789, DOI 10.1145/2702123.2702549; Wilson G., 2014, F1000RES, P3, DOI [10.12688/f1000research.3-3.v2, DOI 10.12688/F1000RESEARCH.3-3.V2]; Wilson G, 2006, COMPUT SCI ENG, V8, P66, DOI 10.1109/MCSE.2006.122; Wilson G, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001745; Yang A, 2017, COMPUT STRUCT BIOTEC, V15, P379, DOI 10.1016/j.csbj.2017.07.002	45	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205898	10.1371/journal.pone.0205898	http://dx.doi.org/10.1371/journal.pone.0205898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379882	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700082
J	Schenk, L; Rauma, M; Fransson, MN; Johanson, G				Schenk, Linda; Rauma, Matias; Fransson, Martin N.; Johanson, Gunnar			Percutaneous absorption of thirty-eight organic solvents in vitro using pig skin	PLOS ONE			English	Article							DERMAL ABSORPTION; FLOW-THROUGH; AQUEOUS-SOLUTIONS; GLYCOL ETHERS; PENETRATION; PERMEATION; MODELS; PERMEABILITY; METABOLISM; PREDICTION	Percutaneous absorption is highly variable between chemicals but also within chemicals depending on exposure conditions and experimental set up. We tested a larger number of organic solvents with the same experimental set up, using skin from new-born piglets and static diffusion cells. Thirty-six common organic solvents were studied neat (and 31 of them also in water dilution): acetone, acetonitrile, n-butanol 2-butanone 2-butoxyethanol, 1-butoxy-2-propanol, n-butyl acetate, butyl acrylate, cyclohexane, cyclohexanone, 1,2-dichloroethane, dichloromethane, ethanol, 2-ethoxyethanol, ethyl acetate, ethyl acrylate, ethylbenzene, furfuryl alcohol, n-hexane, 2-hexanone, 2-isopropoxyethanol, methanol, 1-methoxy-2-propanol, methyl acrylate, 3-methyl-1-butanol, methyl tertiary butyl ether, 4-metyl-2-pentanol, methyl methacrylate, 2-propanol, 2-propen-1-ol, 2-propoxyethanol, 1-propoxy-2-propanol, styrene, trichloromethane, toluene and m-xylene. In addition, a mixture of 2-methylbutyl acetate and n-pentyl acetate was tested. For most of the solvents, little or no percutaneous absorption data have been published. Lag times, steady-state fluxes and apparent permeability coefficients were obtained from the time courses of solvent appearance in the receptor medium, as measured by gas chromatography. The use of the same methodology and kind of skin resulted in small variability within experiments, underlining the need for consistent methodology for useful results for developing predictive models. Furthermore, a comparison of the neat and diluted data shows that water dilution affects all these variables and that the direction and magnitude of the effects vary between chemicals. This comparison strongly supports that prediction of percutaneous absorption of neat and water diluted chemicals requires different models.	[Schenk, Linda; Rauma, Matias; Fransson, Martin N.; Johanson, Gunnar] Karolinska Inst, Inst Environm Med, Unit Work Environm Toxicol, Stockholm, Sweden; [Rauma, Matias] Systecon AB, Stockholm, Sweden; [Fransson, Martin N.] Pharmetheus AB, Uppsala, Sweden	Karolinska Institutet	Schenk, L (corresponding author), Karolinska Inst, Inst Environm Med, Unit Work Environm Toxicol, Stockholm, Sweden.	linda.schenk@ki.se	Schenk, Linda/I-6336-2012; Johanson, Gunnar/A-3745-2015	Schenk, Linda/0000-0003-3799-4814; Johanson, Gunnar/0000-0002-8759-9567	Swedish Council for Health, Working Life and Welfare (Forte) [2006-0332, 2009-1765]	Swedish Council for Health, Working Life and Welfare (Forte)	This work was supported by the Swedish Council for Health, Working Life and Welfare (Forte, https://forte.se/), grant numbers 2006-0332 and 2009-1765 (GJ). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba H, 2015, PHARM RES-DORDR, V32, P2360, DOI 10.1007/s11095-015-1629-y; BARBER ED, 1992, FUND APPL TOXICOL, V19, P493, DOI 10.1016/0272-0590(92)90086-W; BARBER ED, 1995, TOXICOL LETT, V80, P167, DOI 10.1016/0378-4274(95)03393-Y; Barbero AM, 2009, TOXICOL IN VITRO, V23, P1, DOI 10.1016/j.tiv.2008.10.008; BARTNIK FG, 1987, FUND APPL TOXICOL, V8, P59, DOI 10.1016/0272-0590(87)90100-X; Batterman SA, 1997, INT ARCH OCC ENV HEA, V70, P341, DOI 10.1007/s004200050228; BERODE M, 1985, INT ARCH OCC ENV HEA, V55, P331, DOI 10.1007/BF00377691; Betts CJ, 2006, CONTACT DERMATITIS, V55, P140, DOI 10.1111/j.1600-0536.2006.00898.x; Boman A, 2000, ANN OCCUP HYG, V44, P125, DOI 10.1016/S0003-4878(99)00076-9; BRONAUGH RL, 1985, J PHARM SCI, V74, P64, DOI 10.1002/jps.2600740117; Brown MB, 2012, J PHARM PHARMACOL, V64, P566, DOI 10.1111/j.2042-7158.2011.01436.x; Bunge AL, 2012, INT J PHARMACEUT, V435, P50, DOI 10.1016/j.ijpharm.2012.01.058; Cilurzo F, 2007, AAPS PHARMSCITECH, V8; CLEEK RL, 1993, PHARMACEUT RES, V10, P497, DOI 10.1023/A:1018981515480; CLOWES HM, 1994, TOXICOL IN VITRO, V8, P827, DOI 10.1016/0887-2333(94)90078-7; Dennerlein K, 2013, TOXICOL IN VITRO, V27, P708, DOI 10.1016/j.tiv.2012.11.016; DeOim T., 2003, J PHARM SCI, V92, P656, DOI [10.1002/jps.10312, DOI 10.1002/JPS.10312]; DIVINCENZO GD, 1978, TOXICOL APPL PHARM, V44, P593, DOI 10.1016/0041-008X(78)90267-3; DUGARD PH, 1984, ENVIRON HEALTH PERSP, V57, P193, DOI 10.2307/3429916; DUTKIEWICZ B, 1980, INT ARCH OCC ENV HEA, V47, P81, DOI 10.1007/BF00378331; Dutkiewicz B., 1967, BRIT J IND MED, V24, P330; Dutkiewicz T, 1968, Int Arch Arbeitsmed, V24, P253, DOI 10.1007/BF00345921; DUTKIEWICZ T, 1968, BRIT J IND MED, V25, P243; Ekins S, 2016, PHARM RES-DORDR, V33, P2594, DOI 10.1007/s11095-016-2029-7; ENGSTROM K, 1977, INT ARCH OCC ENV HEA, V39, P181, DOI 10.1007/BF00405662; Fasano WJ, 2008, REGUL TOXICOL PHARM, V51, P181, DOI 10.1016/j.yrtph.2008.04.005; Filon FL, 1999, INT ARCH OCC ENV HEA, V72, P480, DOI 10.1007/s004200050402; FISEROVABERGEROVA V, 1990, AM J IND MED, V17, P617, DOI 10.1002/ajim.4700170507; FRANZ TJ, 1975, J INVEST DERMATOL, V64, P190, DOI 10.1111/1523-1747.ep12533356; Frasch HF, 2007, CUTAN OCUL TOXICOL, V26, P147, DOI 10.1080/15569520701212274; Frasch HF, 2014, INT J PHARMACEUT, V460, P240, DOI 10.1016/j.ijpharm.2013.11.007; Godin B, 2007, ADV DRUG DELIVER REV, V59, P1152, DOI 10.1016/j.addr.2007.07.004; GUMMER CL, 1986, FOOD CHEM TOXICOL, V24, P305, DOI 10.1016/0278-6915(86)90007-4; Guth K, 2013, TOXICOL LETT, V221, pS187, DOI 10.1016/j.toxlet.2013.05.426; Hauck WW, 2007, PHARM RES-DORDR, V24, P2018, DOI 10.1007/s11095-007-9329-x; Huong SP, 2009, SKIN RES TECHNOL, V15, P253, DOI 10.1111/j.1600-0846.2009.00368.x; JACOBS RR, 1993, AM IND HYG ASSOC J, V54, P569; Jakasa I, 2004, INT ARCH OCC ENV HEA, V77, P79, DOI 10.1007/s00420-003-0456-3; JOHANSON G, 1988, SCAND J WORK ENV HEA, V14, P95, DOI 10.5271/sjweh.1941; Johanson G., 2008, ARBETE HALSA, V42; Johanson G., 1988, SCAND J WORK ENV HEA, V12, P499; Kezic S, 1997, OCCUP ENVIRON MED, V54, P38, DOI 10.1136/oem.54.1.38; Korinth G, 2007, ARCH TOXICOL, V81, P833, DOI 10.1007/s00204-007-0221-6; Korinth G, 2012, ARCH TOXICOL, V86, P423, DOI 10.1007/s00204-011-0777-z; Lian GP, 2008, J PHARM SCI-US, V97, P584, DOI 10.1002/jps.21074; Lockley DJ, 2004, ARCH TOXICOL, V78, P617, DOI 10.1007/s00204-004-0581-0; Lockley DJ, 2002, TOXICOL APPL PHARM, V180, P74, DOI 10.1006/taap.2002.9373; LODEN M, 1986, ACTA PHARMACOL TOX, V58, P382; MARZULLI FN, 1965, J INVEST DERMATOL, V44, P339, DOI 10.1038/jid.1965.59; Mayr A, 2016, FRONT ENV SCI-SWITZ, V3, DOI 10.3389/fenvs.2015.00080; Meidan VM, 2008, TOXICOL IN VITRO, V22, P1062, DOI 10.1016/j.tiv.2008.01.009; MRAZ J, 1994, INT ARCH OCC ENV HEA, V66, P203, DOI 10.1007/BF00380781; Neely BJ, 2009, J PHARM SCI-US, V98, P4069, DOI 10.1002/jps.21678; Ng SF, 2010, AAPS PHARMSCITECH, V11, P1432, DOI 10.1208/s12249-010-9522-9; Nielsen JB, 2004, AM J IND MED, V45, P275, DOI 10.1002/ajim.10340; Nielsen JB, 2009, J TOXICOL ENV HEAL A, V72, P315, DOI 10.1080/15287390802529872; OECD, 2004, VITRO METHOD OECD GU, DOI DOI 10.1787/9789264071087-EN; Patel H, 2002, CHEMOSPHERE, V48, P603, DOI 10.1016/S0045-6535(02)00114-5; Pendlington RU, 2001, FOOD CHEM TOXICOL, V39, P169, DOI 10.1016/S0278-6915(00)00120-4; POTTS RO, 1992, PHARMACEUT RES, V9, P663, DOI 10.1023/A:1015810312465; Puzyn T., 2010, RECENT ADV QSAR STUD; RIIHIMAKI V, 1979, SCAND J WORK ENV HEA, V5, P143, DOI 10.5271/sjweh.2658; Sartorelli P, 2010, MED LAV, V101, P3; Sartorelli P, 1998, ANN OCCUP HYG, V42, P267, DOI 10.1093/annhyg/42.4.267; Sartorelli P, 2007, REGUL TOXICOL PHARM, V49, P301, DOI 10.1016/j.yrtph.2007.08.008; SCHEUPLEIN RJ, 1973, J INVEST DERMATOL, V60, P286, DOI 10.1111/1523-1747.ep12723090; Schmook FP, 2001, INT J PHARM, V215, P51, DOI 10.1016/S0378-5173(00)00665-7; SUSTEN AS, 1990, J APPL TOXICOL, V10, P217, DOI 10.1002/jat.2550100313; ten Berge W, 2009, CHEMOSPHERE, V75, P1440, DOI 10.1016/j.chemosphere.2009.02.043; Traynor MJ, 2007, TOXICOL APPL PHARM, V218, P128, DOI 10.1016/j.taap.2006.09.019; Tsakovska I, 2017, TOXICOLOGY, V387, P27, DOI 10.1016/j.tox.2017.06.008; TSURUTA H, 1977, Industrial Health, V15, P131; TSURUTA H, 1982, Industrial Health, V20, P335; URSIN C, 1995, AM IND HYG ASSOC J, V56, P651, DOI 10.1202/0002-8894(1995)056<0651:POCSTL>2.0.CO;2; US EPA, 2012, EST PROGR INT SUIT M, V167; Wilkinson SC, 2002, INT ARCH OCC ENV HEA, V75, P519, DOI 10.1007/s00420-002-0367-8; WILSCHUT A, 1995, CHEMOSPHERE, V30, P1275, DOI 10.1016/0045-6535(95)00023-2	77	12	12	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205458	10.1371/journal.pone.0205458	http://dx.doi.org/10.1371/journal.pone.0205458			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379962	Green Submitted, Green Published, gold			2022-12-26	WOS:000448823700048
J	Strohmeier, H; Scholte, WF; Ager, A				Strohmeier, Hannah; Scholte, Willem F.; Ager, Alastair			Factors associated with common mental health problems of humanitarian workers in South Sudan	PLOS ONE			English	Article							AID WORKERS; COPING STRATEGIES; PTSD SYMPTOMS; BURNOUT; STRESS; SPIRITUALITY; COMORBIDITY; VALIDATION; CAREGIVERS; EXPATRIATE	Background The latest data on major attacks against civilian aid operations have identified South Sudan as the most dangerous country for aid workers globally. Exposure to other traumatic events and chronic stress is also common in this population. No research exists on the mental health of humanitarian workers in South Sudan. Objectives This study examined symptom burden and predictors of posttraumatic stress disorder (PTSD), depression, anxiety, hazardous alcohol consumption, and burnout among humanitarian workers in South Sudan. Method We conducted a cross-sectional online survey with humanitarian workers (national and international staff, consultants, United Nations volunteers). We applied validated measures useful for this setting. We applied Least Absolute Shrinkage and Selection Operator (LASSO) regression to fit models with high prediction accuracy for each outcome and used ordinary least squares (OLS) regression to obtain final coefficients and perform inference. Results A total of 277 humanitarian workers employed by 45 organizations completed the survey (a response rate in the order of 10%). We estimated prevalence of PTSD (24%), depression (39%), anxiety disorder (38%), hazardous alcohol consumption in men (35%) and women (36%), and the burnout components emotional exhaustion (24%) and depersonalization (19%). Chronic stress exposure was positively associated with PTSD (p < .001), depression (p < .001), anxiety (p < .001), emotional exhaustion (p < .01), and depersonalization (p < .001). We found no significant association between emotion focused and problem focused coping and mental health outcomes. Associations between dysfunctional coping and depression (p < .001) and anxiety (p < .01) were positive. Higher levels of spirituality were associated with lower risk of hazardous alcohol consumption (p < .001). Contrary to expectations, working directly with humanitarian aid beneficiaries was significantly associated with lower risk for emotional exhaustion (p < .01). Conclusion Our results suggest that humanitarian workers in South Sudan experience substantial levels of mental ill-health. This study points to the need for staff support strategies that effectively mitigate humanitarian workers' chronic stress exposure. The dynamics between coping and mental health among humanitarian workers require further study.	[Strohmeier, Hannah; Ager, Alastair] Queen Margaret Univ, Inst Global Hlth & Dev, Edinburgh, Midlothian, Scotland; [Strohmeier, Hannah] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Scholte, Willem F.] Antares Fdn, Amsterdam, Netherlands; [Scholte, Willem F.] Univ Amsterdam, Dept Psychiat, Amsterdam UMC, Amsterdam, Netherlands; [Ager, Alastair] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Queen Margaret University; Yale University; University of Amsterdam; Vrije Universiteit Amsterdam; Columbia University	Strohmeier, H (corresponding author), Queen Margaret Univ, Inst Global Hlth & Dev, Edinburgh, Midlothian, Scotland.; Strohmeier, H (corresponding author), Yale Univ, Dept Anthropol, New Haven, CT 06520 USA.	Hannah.strohmeier@qmu.ac.uk	Scholte, Willem/AAJ-1088-2020	Ager, Alastair/0000-0002-9474-3563	German-American Fulbright Commission; Whitney and Betty MacMillan Center for International; Program on Refugees, Forced Displacement, and Humanitarian Responses; Conflict, Resilience and Health Program	German-American Fulbright Commission; Whitney and Betty MacMillan Center for International; Program on Refugees, Forced Displacement, and Humanitarian Responses; Conflict, Resilience and Health Program	This work was supported by the German-American Fulbright Commission (https://www.fulbright.de/).The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We would like to thank all humanitarian organizations in South Sudan that supported the online survey on the mental health and well-being of humanitarian workers, especially the designated focal points within organizations who facilitated the smooth implementation of the survey. We would also like to express our gratitude to all humanitarian workers who participated in the survey for taking the time and sharing their experiences with us. We are grateful for the support provided by the The Whitney and Betty MacMillan Center for International and Area Studies at Yale, especially the Program on Refugees, Forced Displacement, and Humanitarian Responses, and the Conflict, Resilience and Health Program. We particularly acknowledge the valuable comments from Professor Catherine Panter-Brick that greatly improved this manuscript.	Adaku A, 2016, CONFL HEALTH, V10, DOI 10.1186/s13031-016-0085-6; Ager A, 2012, J TRAUMA STRESS, V25, P713, DOI 10.1002/jts.21764; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Amnesty International, 2016, OUR HEARTS HAV GON D; [Anonymous], 2016, AID WORKER SECURITY; [Anonymous], 2017, AID WORKER SECURITY; [Anonymous], 2016, HUMANITARIAN OUTCOME; [Anonymous], 2017, S SUDAN NGO FORUM; [Anonymous], 2015, SECRET AID WORKER GU; [Anonymous], 2015, GUARDIAN; Antares Foundation, 2012, MAN STRESS HUM WORKS; Babor T. F, 2001, GUIDELINES USE PRIMA; Belloni A, 2013, BERNOULLI, V19, P521, DOI 10.3150/11-BEJ410; Bertocci MA, 2017, PSYCHOL MED, V47, P1357, DOI 10.1017/S0033291716003147; Bliese P, 1996, J APPL SOCIAL PSYCHO, V26; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; Brunello N, 2001, NEUROPSYCHOBIOLOGY, V43, P150, DOI 10.1159/000054884; Burgard SA, 2014, SOC SCI MED, V106, P143, DOI 10.1016/j.socscimed.2014.01.045; Burri Andrea, 2014, BMC Res Notes, V7, P407, DOI 10.1186/1756-0500-7-407; Bush KR, 1998, ALCOHOL USE DISORDER; Cardozo BL, 2013, PSYCHOL TRAUMA-US, V5, P581, DOI 10.1037/a0030969; Cardozo BL, 2005, DISASTERS, V29, P152, DOI 10.1111/j.0361-3666.2005.00278.x; Cherewick M, 2016, GLOBAL HLTH RES POLI, V1; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Connorton E, 2012, EPIDEMIOL REV, V34, P145, DOI 10.1093/epirev/mxr026; Coolidge FL, 2000, J ANXIETY DISORD, V14, P157, DOI 10.1016/S0887-6185(99)00046-8; Cooper C, 2006, J AFFECT DISORDERS, V90, P15, DOI 10.1016/j.jad.2005.08.017; Cooper C, 2008, INT J GERIATR PSYCH, V23, P929, DOI 10.1002/gps.2007; de Beer J, 2017, LEADERSHIP DYNAMIS W; del-Pino-Casado R, 2014, J CLIN NURS, V23, P3335, DOI 10.1111/jocn.12561; Dumo D, 2017, S SUDAN SOLDIERS ACC; Eriksson C. B., 2012, TRAUMATOLOGY, V19, P41; Eriksson CB, 2001, J TRAUMA STRESS, V14, P205, DOI 10.1023/A:1007804119319; Eriksson CB, 2013, J AGGRESS MALTREAT T, V22, P660, DOI 10.1080/10926771.2013.803506; Eriksson CB, 2015, PSYCHOL RELIG SPIRIT, V7, P13, DOI 10.1037/a0037703; Eriksson CB, 2009, MENT HEALTH RELIG CU, V12, P671, DOI 10.1080/13674670903029146; Fast L, 2014, PA STUD HUM RIGHTS, P127; Flom Peter L, 2007, P NE SAS US GROUP NE; Fryrear A., 2015, SURVEY RESPONSE RATE; Ganocy SJ, 2016, J NERV MENT DIS, V204, P524, DOI 10.1097/NMD.0000000000000519; Grogan TR, 2017, COMMUN STAT-SIMUL C, V46, P7180, DOI 10.1080/03610918.2016.1230216; Hakanen JJ, 2012, J AFFECT DISORDERS, V141, P415, DOI 10.1016/j.jad.2012.02.043; Holtz TH, 2002, J TRAUMA STRESS, V15, P389, DOI 10.1023/A:1020133308188; Inter-Agency Standing Committee (IASC), 2007, AM PSYCHOL ASS, DOI [DOI 10.1037/E518422011-002, 10.1037/e518422011-002]; Jachens L, 2016, J STUD ALCOHOL DRUGS, V77, P904, DOI 10.15288/jsad.2016.77.904; James G., 2014, INTRO STAT LEARNING; Kapsou M, 2010, J HEALTH PSYCHOL, V15, P215, DOI 10.1177/1359105309346516; Kavanagh A, 2011, ACCESSIBILITY ALCOHO; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Leng CL, 2006, STAT SINICA, V16, P1273; Lopes-Cardozo B, 2012, PLOS ONE, V7; Maslach C, 2016, MASLACH BURNOUT INVE; McKay L, 2011, STRENGHTENING KEY OR; Meneses-Gaya Cd, 2009, PSYCHOL NEUROSCIENCE, V2; Miller KE, 2010, SOC SCI MED, V70, P7, DOI 10.1016/j.socscimed.2009.09.029; Muhumuza R., 2017, AID WORKERS FACE UNI; Musa SA, 2008, SOC BEHAV PERSONAL, V36, P407, DOI 10.2224/sbp.2008.36.3.407; Pantuliano Sara., 2015, LIFE HUMANITARIAN FR; PHAP, 2015, PHAP SUPP WORLD HUM; Poghosyan L, 2009, INT J NURS STUD, V46, P894, DOI 10.1016/j.ijnurstu.2009.03.004; Remes O, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.497; Renner W, 2006, SOC BEHAV PERSONAL, V34, P1101, DOI 10.2224/sbp.2006.34.9.1101; Ruffin Coral L., 1993, AUSTR PSYCHOL, V28; Schafer A, 2010, INTERVENTION, V8, P121, DOI 10.1097/WTF.0b013e32833c1f57; Schaufeli W.B., 2014, BRIDGING OCCUPATIONA, P43; Schaufeli WB, 2017, ORGAN DYN, V46, P120, DOI 10.1016/j.orgdyn.2017.04.008; Seidlitz L, 2002, J SCI STUD RELIG, V41, P439, DOI 10.1111/1468-5906.00129; Seidlitz L, 2002, J SCI STUDY RELIG, V41; Silove, 2004, MEASURING TRAUMA MEA; Sinclair M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-132; Slim H, 2015, GUIDE MORALITY AID W; Stoddard A., 2017, AID WORKER SECURITY; Stoddard A., 2011, SAFETY SECURITY NATL; Strohmeier H, 2018, ORG STAFF SUPPORT S; Strohmeier H, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.28541; Surya M, 2017, GLOB HEALTH-SCI PRAC, V5, P188, DOI 10.9745/GHSP-D-17-00017; Symes L, 2016, J WOMENS HEALTH, V25, P340, DOI 10.1089/jwh.2015.5287; UN News Center, 2017, UN AID CHIEF URG GLO; UNHCR University W, 2016, STAFF WELL BEING MEN; UNOCHA, 2018, S SUD AID WORK FREED; UNOCHA South Sudan, 2016, 2017 HUM NEEDS OV; Ventevogel P, 2007, SOC PSYCH PSYCH EPID, V42, P328, DOI 10.1007/s00127-007-0161-8; Wall I, 2015, GUARDIAN; Weathers F. W., 2013, PTSD CHECKLIST DSM 5, DOI DOI 10.1037/T02622-000; Welle Deutsche, 2016, EMBASSIES EVACUATE V; Welton-Mitchell C. E., 2013, UNHCRS MENTAL HLTH P; WHO, 2015, LIST NAT ETH COMM; Woodward A, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0124-1; Woolf N., 2016, DDOS ATTACK DISRUPTE; Yusoff N, 2010, Med J Malaysia, V65, P41; Zhang C-H, 2008, ANN STAT, V36; Zhao S, 2017, ARXIV170505543STATME	94	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205333	10.1371/journal.pone.0205333	http://dx.doi.org/10.1371/journal.pone.0205333			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY7VH	30379909	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700040
J	Nomura, R; Liang, YZ; Morita, K; Fujiwara, K; Ikeguchi, T				Nomura, Ryota; Liang, Ying-Zong; Morita, Kenji; Fujiwara, Kantaro; Ikeguchi, Tohru			Threshold-varying integrate-and-fire model reproduces distributions of spontaneous blink intervals	PLOS ONE			English	Article							STATE	Spontaneous blinking is one of the most frequent human behaviours. While attentionally guided blinking may benefit human survival, the function of spontaneous frequent blinking in cognitive processes is poorly understood. To model human spontaneous blinking, we proposed a leaky integrate-and-fire model with a variable threshold which is assumed to represent physiological fluctuations during cognitive tasks. The proposed model is capable of reproducing bimodal, normal, and widespread peak-less distributions of inter-blink intervals as well as the more common popular positively skewed distributions. For bimodal distributions, the temporal positions of the two peaks depend on the baseline and the amplitude of the fluctuating threshold function. Parameters that reproduce experimentally derived bimodal distributions suggest that relatively slow oscillations (0.11-0.25 Hz) govern blink elicitations. The results also suggest that changes in blink rates would reflect fluctuations of threshold regulated by human internal states.	[Nomura, Ryota; Ikeguchi, Tohru] Tokyo Univ Sci, Grad Sch Engn, Tokyo, Japan; [Liang, Ying-Zong] Univ Tokyo, Grad Sch Engn, Tokyo, Japan; [Nomura, Ryota; Morita, Kenji] Univ Tokyo, Grad Sch Educ, Tokyo, Japan; [Fujiwara, Kantaro] Univ Tokyo, Int Res Ctr Neurointelligence, Tokyo, Japan; [Ikeguchi, Tohru] Tokyo Univ Sci, Fac Engn, Tokyo, Japan	Tokyo University of Science; University of Tokyo; University of Tokyo; University of Tokyo; Tokyo University of Science	Nomura, R (corresponding author), Tokyo Univ Sci, Grad Sch Engn, Tokyo, Japan.; Nomura, R (corresponding author), Univ Tokyo, Grad Sch Educ, Tokyo, Japan.	nomura@hisenkei.net			Japan Society for the Promotion of Science [JP15H05876, JP15KT0112, JP15K04076, JP16K16138, JP17K00348, JP18KT0076]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding was provided by Japan Society for the Promotion of Science: grant number JP15H05876 to KM (https://kaken.nii.ac.jp/en/grant/KAKENHI-PLANNED-15H05876/); grant number JP15KT0112 to TI (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-15KT0112/); grant number JP15K04076 to RN (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-15K04076/); grant number JP16K16138 to KF (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-16K16138/); grant number JP17K00348 to TI (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-17K00348/); and grant number JP18KT0076 to RN (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-18KT0076/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blount W., 1927, Q J EXP PHYSL, V18, P16, DOI [DOI 10.1113/EXPPHYSIOL.1927.SP000426, 10.1113/expphysiol.1927.sp000426]; Bonfiglio L, 2009, NEUROSCI LETT, V449, P57, DOI 10.1016/j.neulet.2008.10.039; Burkitt AN, 2006, BIOL CYBERN, V95, P1, DOI 10.1007/s00422-006-0068-6; Chelliah V, 2015, NUCLEIC ACIDS RES, V43, pD542, DOI 10.1093/nar/gku1181; Cruz AAV, 2011, OCUL SURF, V9, P29, DOI 10.1016/S1542-0124(11)70007-6; FUKUDA K, 1983, JPN PSYCHOL RES, V25, P140, DOI 10.4992/psycholres1954.25.140; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; HALL A, 1945, BRIT J OPHTHALMOL, V29, P445, DOI 10.1136/bjo.29.9.445; Hoppe D, 2018, P NATL ACAD SCI USA, V115, P2246, DOI 10.1073/pnas.1714220115; Hoshino K, 1997, P IEEE EMBS, V18, P1784; Janert P. K, 2008, KERNEL DENSITY ESTIM; Jongkees BJ, 2016, NEUROSCI BIOBEHAV R, V71, P58, DOI 10.1016/j.neubiorev.2016.08.020; Kaminer J, 2011, J NEUROSCI, V31, P11256, DOI 10.1523/JNEUROSCI.6218-10.2011; Lindner B, 2001, PHYS REV LETT, V86, P2934, DOI 10.1103/PhysRevLett.86.2934; Liu CC, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00489; Moraitis T, 2014, NEUROPSYCHOLOGIA, V65, P279, DOI 10.1016/j.neuropsychologia.2014.09.010; Nakano T, 2013, P NATL ACAD SCI USA, V110, P702, DOI 10.1073/pnas.1214804110; Nomura R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140774; Nomura R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00447; PONDER ERIC, 1927, QUART JOUR EXP PHYSIOL, V18, P89; Rac-Lubashevsky R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02942-3; Richardson MJE, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021919; Schindler M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.048102; VanRullen R, 2013, CURR BIOL, V23, pR1110, DOI 10.1016/j.cub.2013.11.006; Yoder N., 2011, PEAKFINDER	25	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2018	13	10							e0206528	10.1371/journal.pone.0206528	http://dx.doi.org/10.1371/journal.pone.0206528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7AD	30376565	Green Published, Green Submitted, gold			2022-12-26	WOS:000448752400016
J	Pardo-Muras, M; Puig, CG; Lopez-Nogueira, A; Cavaleiro, C; Pedrol, N				Pardo-Muras, Maria; Puig, Carolina G.; Lopez-Nogueira, Antonio; Cavaleiro, Carlos; Pedrol, Nuria			On the bioherbicide potential of Ulex europaeus and Cytisus scoparius: Profiles of volatile organic compounds and their phytotoxic effects	PLOS ONE			English	Article							ESSENTIAL OILS; WEED-CONTROL; SEED-GERMINATION; PLANT VOLATILES; CANADIAN WEEDS; ALLELOPATHY; MONOTERPENES; FLOWERS; GROWTH; L.	The phytotoxic potential of the legume shrubs Ulex europaeus L. (gorse) and Cytisus scoparius (L.) Link. (Scotch broom) is studied in this work for the first time. On the basis of their richness in active principles, the previous evidence of biological activity, and the abundance of biomass in their native range and invaded areas, a question arose: can U. europaeus and C. scoparius be considered as potential sources of natural herbicides for sustainable agriculture ? By means of volatile bioassays, the flowering fresh plant material of both shrub species was shown to produce and emit volatile organic compounds (VOCs) able to inhibit the germination and/or early growth of two agricultural weeds: Amaranthus retroflexus and Digitaria sanguinalis. Novel complete VOCs profiles from the volatile extracts of the shrub species were obtained by GC and GC/MS. A total of 20 compounds were identified from U. europaeus flowering biomass, theaspirane and eugenol, among others, being described in gorse for the first instance. The chemical profile of C. scoparius yielded 28 compounds and was rich in oxygenated monoterpenes such as terpinen-4-ol, verbenol, alpha-terpineol, and verbenone, which were also identified in this species for the first time. Using dose-response bioassays with pure compounds, these VOCs were argued to be involved in the phytotoxicity observed for the plant materials, even at very low concentrations. The phytotoxic effects were predominantly irreversible, particularly for D. sanguinalis, since the seeds exposed to the VOCs produced damaged seedlings, were unable to recover germination capacity after removing the phytotoxin or, when recovered, produced unviable seedlings. Our results extend the interest of the abundant U. europaeus and C. scoparius for the obtention of natural products with bioherbicide potential, or to be used as allelopathic biomass in the development of new sustainable agricultural practices.	[Pardo-Muras, Maria; Puig, Carolina G.; Lopez-Nogueira, Antonio; Pedrol, Nuria] Univ Vigo, Dept Plant Biol & Soil Sci, Vigo, Spain; [Cavaleiro, Carlos] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Cavaleiro, Carlos] Univ Coimbra, CNC, Coimbra, Portugal	Universidade de Vigo; Universidade de Coimbra; Universidade de Coimbra	Pedrol, N (corresponding author), Univ Vigo, Dept Plant Biol & Soil Sci, Vigo, Spain.	pedrol@uvigo.es	Cavaleiro, Carlos MF/E-6147-2010; Cavaleiro, Carlos/P-4828-2019; Pedrol, Nuria/I-6228-2019; Puig, Carolina G./O-4708-2019	Cavaleiro, Carlos MF/0000-0002-5937-1127; Cavaleiro, Carlos/0000-0002-5937-1127; Pedrol, Nuria/0000-0001-6725-373X; Puig, Carolina G./0000-0002-4596-8571; Pardo-Muras, Maria/0000-0003-2853-9721	Spanish Ministry of Economy and Competitiveness [CGL2016-78660-R]; Galician Government	Spanish Ministry of Economy and Competitiveness(Spanish Government); Galician Government	This work was supported by the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/; BIOINPUT (CGL2016-78660-R)) (NP). This research has been developed in the frame of the 'Agri-Food Research and Transfer Centre of the Water Campus (CITACA) at the University of Vigo (Spain), which is economically supported by the Galician Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah ZS, 2014, J CHEM ECOL, V40, P534, DOI 10.1007/s10886-014-0450-0; Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Angelini LG, 2003, J AGR FOOD CHEM, V51, P6158, DOI 10.1021/jf0210728; [Anonymous], 2014, INDO AM J PHARM RES; Araniti F, 2013, NAT PROD RES, V27, P1651, DOI 10.1080/14786419.2012.746337; Atlan A, 2015, INT J PLANT SCI, V176, P515, DOI 10.1086/681669; Bainard LD, 2006, WEED SCI, V54, P833, DOI 10.1614/WS-06-039R.1; Baldwin IT, 2010, CURR BIOL, V20, pR392, DOI 10.1016/j.cub.2010.02.052; Barbosa LCD, 2003, PEST MANAG SCI, V59, P1043, DOI 10.1002/ps.717; Barney JN, 2005, J CHEM ECOL, V31, P247, DOI 10.1007/s10886-005-1339-8; BASANTA M, 1989, VEGETATIO, V82, P105, DOI 10.1007/BF00045024; Benvenuti S, 2017, WEED RES, V57, P342, DOI 10.1111/wre.12266; Bhowmik PC, 2003, CROP PROT, V22, P661, DOI 10.1016/S0261-2194(02)00242-9; Boissard C, 2001, ATMOS ENVIRON, V35, P917, DOI 10.1016/S1352-2310(00)00362-9; Cao XL, 1997, J GEOPHYS RES-ATMOS, V102, P18903, DOI 10.1029/97JD00421; Chiapusio G, 1997, J CHEM ECOL, V23, P2445, DOI 10.1023/B:JOEC.0000006658.27633.15; Clements DR, 2001, CAN J PLANT SCI, V81, P325, DOI 10.4141/P99-128; Rodrigues-Correa KCD, 2012, FOOD ENERGY SECUR, V1, P81, DOI 10.1002/fes3.13; Dayan FE, 2000, J CHEM ECOL, V26, P2079, DOI 10.1023/A:1005512331061; de Albuquerque MB, 2011, AGRON SUSTAIN DEV, V31, P379, DOI 10.1051/agro/2010031; de Bertoldi C, 2009, CHEMOECOLOGY, V19, P169, DOI 10.1007/s00049-009-0019-5; De Martino L, 2010, MOLECULES, V15, P6630, DOI 10.3390/molecules15096630; Dudai N, 1999, J CHEM ECOL, V25, P1079, DOI 10.1023/A:1020881825669; Fogarty G, 1999, PLANT ECOL, V144, P27, DOI 10.1023/A:1009808116068; GISD (Global Invasive Species Database), 2013, 100 WORLDS WORST INV; Griffiths DW, 1999, PHYTOCHEMISTRY, V52, P607, DOI 10.1016/S0031-9422(99)00298-8; Grove S, 2012, PLANT ECOL, V213, P1869, DOI 10.1007/s11258-012-0079-4; Havemanl R, 2017, TUEXENIA, P143, DOI 10.14471/2016.37.022; Hu Q, 2017, MOLECULES, V22, DOI 10.3390/molecules22101678; Joulain D., 1998, ATLAS SPECTRAL DATA; Kordali S, 2007, Z NATURFORSCH C, V62, P207; Kordali S, 2009, IND CROP PROD, V29, P562, DOI 10.1016/j.indcrop.2008.11.002; Koroch AR., 2007, FLAVOURS FRAGRANCES, P87, DOI [10.1007/978-3-540-49339-6_5, DOI 10.1007/978-3-540-49339-6_5]; KURIHARA T, 1980, YAKUGAKU ZASSHI, V100, P1054, DOI 10.1248/yakushi1947.100.10_1054; Larit F, 2018, PHYTOCHEM LETT, V24, P1, DOI 10.1016/j.phytol.2017.12.012; Lemaitre AB, 2014, ARTHROPOD-PLANT INTE, V8, P261, DOI 10.1007/s11829-014-9308-1; Likens ST., 1964, J AM SOC BREW CHEM, V22, P5; Lopes A.C.A., 2015, PHASEOLUS LUNATUS DI, P163; Lopez-Hortas L, 2016, CR CHIM, V19, P718, DOI 10.1016/j.crci.2015.11.027; Lores M, 2015, TALANTA, V140, P134, DOI 10.1016/j.talanta.2015.03.034; Luiza Ishii-Iwamoto E., 2012, CURR BIOACT COMPD, V8, P50, DOI [10.2174/157340712799828223, DOI 10.2174/157340712799828223]; Macias FA, 2007, PEST MANAG SCI, V63, P327, DOI 10.1002/ps.1342; Maffei ME, 2010, S AFR J BOT, V76, P612, DOI 10.1016/j.sajb.2010.03.003; Marin-Loaiza JC, 2007, REV FITOTEC MEX, V30, P327; Marinho CR, 2014, PLANT BIOLOGY, V16, P215, DOI 10.1111/plb.12000; Marsili R., 2001, FLAVOR FRAGRANCE ODO; Maximo P, 2002, J NAT PROD, V65, P175, DOI 10.1021/np010147j; Mayer A.M., 1963, GERMINATION SEEDS, V1st ed., P244; McLafferty, 2009, WILEY REGISTRY MASS; Nunez-Regueira L, 2004, BIORESOURCE TECHNOL, V91, P215, DOI 10.1016/S0960-8524(03)00169-X; de Elguea-Culebras GO, 2017, J SOIL SCI PLANT NUT, V17, P475; Pedrol N, 2006, ALLELOPATHY: A PHYSIOLOGICAL PROCESS WITH ECOLOGICAL IMPLICATIONS, P171, DOI 10.1007/1-4020-4280-9_9; Peterson DJ, 1998, CAN J PLANT SCI, V78, P497, DOI 10.4141/P97-079; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; Pinela J, 2011, FOOD CHEM TOXICOL, V49, P2983, DOI 10.1016/j.fct.2011.07.054; Puig CG, 2013, WEED SCI, V61, P154, DOI 10.1614/WS-D-12-00056.1; Rees M, 2001, J APPL ECOL, V38, P364, DOI 10.1046/j.1365-2664.2001.00598.x; Rice EL, 1984, ALLELOPATHY; Richardson R. G., 1998, Plant Protection Quarterly, V13, P46; Seybold SJ, 2018, ANNU REV ENTOMOL, V63, P407, DOI 10.1146/annurev-ento-020117-043339; Shah AN, 2016, ENVIRON SCI POLLUT R, V23, P14854, DOI 10.1007/s11356-016-6969-6; Simpson SR, 2005, PLANT BIOLOGY, V7, P541, DOI 10.1055/s-2005-865855; Singh HP, 2002, ANN APPL BIOL, V141, P111, DOI 10.1111/j.1744-7348.2002.tb00202.x; Sobrero M.C., 2004, ENSAYOS TOXICOLOGICO, P55; Souza-Alonso P, 2020, RENEW AGR FOOD SYST, V35, P26, DOI 10.1017/S1742170518000170; Souza-Alonso P, 2018, CHEM ECOL, V34, P126, DOI 10.1080/02757540.2017.1404584; Spinola V, 2016, IND CROP PROD, V90, P9, DOI 10.1016/j.indcrop.2016.06.007; Tesio F, 2010, INT J SUST DEV WORLD, V17, P377, DOI 10.1080/13504509.2010.507402; Vaid S., 2010, BIOSCAN, V5, P339; Vasilakoglou I, 2013, J ESSENT OIL RES, V25, P1, DOI 10.1080/10412905.2012.751054; VAUGHN SF, 1993, WEED SCI, V41, P114, DOI 10.1017/S0043174500057672; Verdeguer M, 2009, BIOCHEM SYST ECOL, V37, P362, DOI 10.1016/j.bse.2009.06.003; Vokou D, 2003, J CHEM ECOL, V29, P2281, DOI 10.1023/A:1026274430898; WEIDENHAMER JD, 1993, J CHEM ECOL, V19, P1799, DOI 10.1007/BF00982309; Weston LA, 2003, CRIT REV PLANT SCI, V22, P367, DOI 10.1080/713610861	75	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0205997	10.1371/journal.pone.0205997	http://dx.doi.org/10.1371/journal.pone.0205997			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372468	Green Published, Green Submitted, gold			2022-12-26	WOS:000448641200020
J	Stiles, L; Zheng, YW; Smith, PF				Stiles, Lucy; Zheng, Yiwen; Smith, Paul F.			The effects of electrical stimulation of the peripheral vestibular system on neurochemical release in the rat striatum	PLOS ONE			English	Article							D-SERINE; PARAFASCICULAR NUCLEUS; ACETYLCHOLINE-RELEASE; HIPPOCAMPAL-FORMATION; BRAIN MICRODIALYSIS; DOPAMINE RELEASE; BASAL GANGLIA; ACTIVATION; GLUTAMATE; CONNECTIONS	For over a century, it has been speculated that the vestibular system transmits information about self-motion to the striatum. There have been inconsistent reports of such a connection, and interest in the subject has been increased by the experimental use of galvanic vestibular stimulation in the treatment of Parkinson's Disease patients. Nonetheless, there are few data available on the effects of vestibular stimulation on neurochemical changes in the striatum. We used in vivo microdialysis to analyse changes in the extracellular levels of amino acids and monoamines in the rat striatum, following electrical vestibular stimulation. Stimulation caused a significant decrease in serine and threonine, compared to the no-stimulation controls (P <= 0.005 and P <= 0.01, respectively). The ratio of DOPAC:dopamine, decreased on the ipsilateral side following stimulation (P <= 0.005). There was a significant treatment x side x intensity interaction for taurine levels (P <= 0.002), due to a decrease on the contralateral side in stimulated animals, which varied as a function of current. These results show that peripheral vestibular stimulation causes some neurochemical changes in the striatum and support the view that activaton of the vestibular system exerts effects on the function of the striatum.	[Stiles, Lucy; Zheng, Yiwen; Smith, Paul F.] Univ Otago, Sch Biomed Sci, Dept Pharmacol & Toxicol, Dunedin, New Zealand; [Stiles, Lucy; Zheng, Yiwen; Smith, Paul F.] Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand; [Stiles, Lucy; Zheng, Yiwen; Smith, Paul F.] Univ Otago, Brain Res New Zealand Ctr Res Excellence, Dunedin, New Zealand; [Stiles, Lucy; Zheng, Yiwen; Smith, Paul F.] Univ Auckland, Brain Res New Zealand Ctr Res Excellence, Auckland, New Zealand; [Stiles, Lucy; Zheng, Yiwen; Smith, Paul F.] Univ Auckland, Eisdell Moore Ctr Hearing & Balance Res, Auckland, New Zealand	University of Otago; University of Otago; University of Otago; University of Auckland; University of Auckland	Smith, PF (corresponding author), Univ Otago, Sch Biomed Sci, Dept Pharmacol & Toxicol, Dunedin, New Zealand.; Smith, PF (corresponding author), Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand.; Smith, PF (corresponding author), Univ Otago, Brain Res New Zealand Ctr Res Excellence, Dunedin, New Zealand.; Smith, PF (corresponding author), Univ Auckland, Brain Res New Zealand Ctr Res Excellence, Auckland, New Zealand.; Smith, PF (corresponding author), Univ Auckland, Eisdell Moore Ctr Hearing & Balance Res, Auckland, New Zealand.	paul.smith@otago.ac.nz			University of Otago Research Committee [9076]; Maurice and Phyllis Paykel Trust [1954]; University of Otago PhD Scholarship; Jean Cathie Estate Senior Research Fellowship	University of Otago Research Committee; Maurice and Phyllis Paykel Trust; University of Otago PhD Scholarship; Jean Cathie Estate Senior Research Fellowship	This research was supported by grants from the University of Otago Research Committee (9076 to PFS*) and the Maurice and Phyllis Paykel Trust (1954 to PFS*). LS was supported by a University of Otago PhD Scholarship and YZ by a Jean Cathie Estate Senior Research Fellowship administered by the Auckland Medical Research Foundation.	Aitken P, 2017, BRAIN STRUCT FUNCT, V222, P3319, DOI 10.1007/s00429-017-1407-1; Aitken P, 2016, HIPPOCAMPUS, V26, P1509, DOI 10.1002/hipo.22651; Avila-Luna A, 2015, NEUROCHEM RES, V40, P1431, DOI 10.1007/s11064-015-1611-4; Babu GN, 2018, CLIN CHIM ACTA, V480, P214, DOI 10.1016/j.cca.2018.02.022; Beckstead R. M., 1993, NEUROANATOMY, P449; Blandini F, 1996, MOL NEUROBIOL, V12, P73, DOI 10.1007/BF02740748; Borland LM, 2005, J NEUROSCI METH, V146, P149, DOI 10.1016/j.jneumeth.2005.02.002; BOTTINI G, 1994, EXP BRAIN RES, V99, P164; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; CLARKE DJ, 1983, BRAIN RES, V289, P342, DOI 10.1016/0006-8993(83)90039-2; Dawson R, 1999, BRAIN RES BULL, V48, P319, DOI 10.1016/S0361-9230(99)00003-9; Dehorter N, 2014, BASAL GANGLIA, V3, P197, DOI 10.1016/j.baga.2013.10.001; Della-Justina HM, 2015, EXP BRAIN RES, V233, P237, DOI 10.1007/s00221-014-4107-6; El Arfani A, 2015, NEUROCHEM INT, V88, P88, DOI 10.1016/j.neuint.2015.07.005; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; FREUND TF, 1985, J NEUROSCI, V5, P603; GEYER MA, 1976, BRAIN RES, V106, P241, DOI 10.1016/0006-8993(76)91023-4; Giardino L, 1996, BRAIN RES, V736, P111, DOI 10.1016/S0006-8993(96)00692-0; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; HORII A, 1994, J NEUROPHYSIOL, V72, P605, DOI 10.1152/jn.1994.72.2.605; KELLEY AE, 1982, NEUROSCIENCE, V7, P2321, DOI 10.1016/0306-4522(82)90198-1; Khlebnikova NN, 2017, B EXP BIOL MED+, V163, P190, DOI 10.1007/s10517-017-3763-5; Kilb W, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00328; Kim DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069055; Kim N, 2017, EXP BRAIN RES, V235, P1617, DOI 10.1007/s00221-016-4864-5; Lai H, 2000, BRAIN RES, V872, P208, DOI 10.1016/S0006-8993(00)02457-4; LIEDGREN SRC, 1976, ACTA OTO-LARYNGOL, V81, P73, DOI 10.3109/00016487609107480; MATSUNAMI K, 1975, BRAIN RES, V91, P140, DOI 10.1016/0006-8993(75)90473-4; McCulloch C. E., 2008, GEN LINEAR MIXED MOD; Molchanova S, 2004, AMINO ACIDS, V27, P261, DOI 10.1007/s00726-004-0139-8; MOORE RY, 1978, ANNU REV NEUROSCI, V1, P129, DOI 10.1146/annurev.ne.01.030178.001021; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Muskens LJJ, 1913, BRAIN, V36, P352; Muskens LJJ, 1922, BRAIN, V45, P454, DOI 10.1093/brain/45.3-4.454; Pan WD, 2008, J NEUROL, V255, P1657, DOI 10.1007/s00415-008-0950-3; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pisani A, 2005, MOVEMENT DISORD, V20, P395, DOI 10.1002/mds.20394; Rancz EA, 2015, J NEUROSCI, V35, P5926, DOI 10.1523/JNEUROSCI.1869-14.2015; Saddoris MP, 2015, J NEUROSCI, V35, P11572, DOI 10.1523/JNEUROSCI.2344-15.2015; Samoudi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029308; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; SEGUNDO JP, 1956, J NEUROPHYSIOL, V19, P325, DOI 10.1152/jn.1956.19.4.325; Sergeeva OA, 2001, NEUROSCIENCE, V104, P1043, DOI 10.1016/S0306-4522(01)00130-0; SPIEGEL EA, 1965, ARCH NEUROL-CHICAGO, V12, P258, DOI 10.1001/archneur.1965.00460270034005; Stevens ER, 2003, P NATL ACAD SCI USA, V100, P6789, DOI 10.1073/pnas.1237052100; Stiles L, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13791; Stiles L, 2015, BRAIN RES, V1597, P180, DOI 10.1016/j.brainres.2014.11.063; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Timmerman W, 1997, SYNAPSE, V27, P242, DOI 10.1002/(SICI)1098-2396(199711)27:3<242::AID-SYN9>3.0.CO;2-D; VERSTEEG DHG, 1976, BRAIN RES, V113, P563, DOI 10.1016/0006-8993(76)90057-3; Vitte E, 1996, EXP BRAIN RES, V112, P523; Walker RH, 2009, SYNAPSE, V63, P136, DOI 10.1002/syn.20592; Ward RP, 1996, J COMP NEUROL, V370, P405, DOI 10.1002/(SICI)1096-9861(19960701)370:3<405::AID-CNE10>3.0.CO;2-R; WEINER DM, 1990, P NATL ACAD SCI USA, V87, P7050, DOI 10.1073/pnas.87.18.7050; WESTERINK BHC, 1988, J NEUROCHEM, V51, P683, DOI 10.1111/j.1471-4159.1988.tb01798.x; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yamamoto Y, 2005, ANN NEUROL, V58, P175, DOI 10.1002/ana.20574; Zheng YW, 2014, HIPPOCAMPUS, V24, P541, DOI 10.1002/hipo.22247	59	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0205869	10.1371/journal.pone.0205869	http://dx.doi.org/10.1371/journal.pone.0205869			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372453	gold, Green Published, Green Submitted			2022-12-26	WOS:000448641200017
J	Larmour, LI; Cousins, FL; Teague, JA; Deane, JA; Jobling, TW; Gargett, CE				Larmour, Luke, I; Cousins, Fiona L.; Teague, Julie A.; Deane, James A.; Jobling, Tom W.; Gargett, Caroline E.			A patient derived xenograft model of cervical cancer and cervical dysplasia	PLOS ONE			English	Article							TUMOR XENOGRAFTS; MOUSE MODELS; RADIOTHERAPY; METASTASIS; CARCINOMA; MICE	Aim To develop a patient derived xenograft (PDX) model of cervical cancer and cervical dysplasia using the subrenal capsule. Methods Cervical cancer (12 Squamous Cell Carcinoma, 1 Adenocarcinoma, 1 Adenosquamous Carcinoma), 7 cervical dysplasia biopsy and normal cervical tissues were transplanted beneath the renal capsule of immunocompromised NOD/SCID/gamma mice. Resulting tumours were harvested and portions serially transplanted into new recipient mice for up to three in vivo passages. Parent and xenograft tumours were examined by immunohistochemistry for p16(INK41), HPV, and CD-45. Single cell suspensions of mixed mouse and human, or human only cell populations were also transplanted. Results The overall engraftment rate for the primary cervical cancer PDX model was 71.4 +/- 12.5% (n = 14). Tumours maintained morphological, histoarchitecture and immunohistochemical features of the parent tumour, and demonstrated invasiveness into local tissues. Single cell suspensions did not produce tumour growth in this model. Mean length of time (32.4 +/- 3.5 weeks) for the transplanted tissue to generate a tumour in the animal was similar between successive transplantations. Three of four xenografted cervical dysplasia tissues generated microscopic cystic structures resembling dysplastic cervical tissue. Normal cervical tissue (4 of 5 xenografted) also developed microscopic cervical tissue grafts. Conclusion The subrenal capsule can be used for a PDX model of human cervical cancer with a good engraftment rate and the ability to model in vivo characteristics of cervical cancer. For the first time we have demonstrated that cervical dysplasia and normal cervical tissue generated microscopic tissues in a PDX model.	[Larmour, Luke, I; Cousins, Fiona L.; Deane, James A.; Gargett, Caroline E.] Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Larmour, Luke, I; Cousins, Fiona L.; Deane, James A.; Jobling, Tom W.; Gargett, Caroline E.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic, Australia; [Teague, Julie A.] Melbourne Pathol, Collingwood, Vic, Australia	Hudson Institute of Medical Research; Monash University	Larmour, LI (corresponding author), Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia.; Larmour, LI (corresponding author), Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic, Australia.	luke.larmour@monashhealth.org.au	Deane, James A/G-3592-2011; Gargett, Caroline E/Q-7911-2019; Cousins, Fiona L/K-3790-2016	Deane, James A/0000-0001-8409-0303; Gargett, Caroline E/0000-0002-3590-2077; Cousins, Fiona L/0000-0002-7064-8596; Larmour, Luke/0000-0002-7146-5978	National Health and Medical Research Council Senior Research Fellowship [1042298]; Royal Australian and New Zealand College of Obstetricians and Gynaecologists Research Foundation Mary Elizabeth Courier Scholarship; Monash University David Healy Memorial Scholarship; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Royal Australian and New Zealand College of Obstetricians and Gynaecologists Research Foundation Mary Elizabeth Courier Scholarship; Monash University David Healy Memorial Scholarship; Victorian Government's Operational Infrastructure Support Program	This work was supported by National Health and Medical Research Council Senior Research Fellowship (1042298) (C.E.G.), Royal Australian and New Zealand College of Obstetricians and Gynaecologists Research Foundation Mary Elizabeth Courier Scholarship (L.I.L.), Monash University David Healy Memorial Scholarship (L.I.L) and the Victorian Government's Operational Infrastructure Support Program. Melbourne Pathology provided support in the form of salary for author J.A.T., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section. The work performed by J.A.T was on her own time. The funding bodies had no role in any aspect of the study.	[Anonymous], 2018, ANTIHPV ANTIBODY BPV, P1; Bondarenko G, 2015, NEOPLASIA, V17, P735, DOI 10.1016/j.neo.2015.09.004; Borowsky AD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009670; Bruni L, 2015, HUMAN PAPILLOMAVIRUS, P1; Chaudary Naz, 2012, Cancers (Basel), V4, P821, DOI 10.3390/cancers4030821; Chen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039294; Dallenbach-Hellweg G, 2005, COLOR ATLAS HISTOPAT; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Diaz-Padilla I, 2013, CRIT REV ONCOL HEMAT, V85, P303, DOI 10.1016/j.critrevonc.2012.07.006; Duan P, 2012, EUR J GYNAECOL ONCOL, V33, P472; Eoh KJ, 2018, CANCER RES TREAT, V50, P956, DOI 10.4143/crt.2017.181; Hiroshima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117417; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2015, NAT REV CANCER, V15, P451, DOI 10.1038/nrc3972; Hoffmann C, 2010, GYNECOL ONCOL, V118, P76, DOI 10.1016/j.ygyno.2010.03.019; Hubbard SA, 2009, CANCER RES, V69, P8241, DOI 10.1158/0008-5472.CAN-08-4808; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Larmour LI, 2015, INT J GYNECOL CANCER, V25, P1345, DOI 10.1097/IGC.0000000000000525; Malaney P, 2014, CANCER LETT, V344, P1, DOI 10.1016/j.canlet.2013.10.010; Meehan TF, 2017, CANCER RES, V77, pE62, DOI 10.1158/0008-5472.CAN-17-0582; NEWTON M, 1975, AM J OBSTET GYNECOL, V123, P535, DOI 10.1016/0002-9378(75)90041-1; Oh DY, 2015, ONCOTARGET, V6, P36219, DOI 10.18632/oncotarget.5283; Pearson AT, 2016, ONCOTARGET, V7, P7993, DOI 10.18632/oncotarget.6919; Petrillo LA, 2012, BREAST CANCER RES TR, V135, P913, DOI 10.1007/s10549-012-2226-y; Quinn M, 2006, INT J GYNECOL OBSTET, V95, pS43, DOI 10.1016/S0020-7292(06)60030-1; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Riley RR, 2003, CANCER RES, V63, P4862; Scott Clare L, 2014, Am Soc Clin Oncol Educ Book, pe258, DOI 10.14694/EdBook_AM.2014.34.e258; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang YW, 2005, LAB INVEST, V85, P1392, DOI 10.1038/labinvest.3700335; Zhou QJ, 2014, CANCER LETT, V344, P13, DOI 10.1016/j.canlet.2013.10.015	34	12	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206539	10.1371/journal.pone.0206539	http://dx.doi.org/10.1371/journal.pone.0206539			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365542	Green Submitted, Green Published, gold			2022-12-26	WOS:000448448700061
J	Ebisch, RMF; Ketelaars, PJW; van der Sanden, WMH; Schmeink, CE; Lenselink, CH; Siebers, AG; Massuger, LFAG; Melchers, WJG; Bekkers, RLM				Ebisch, Renee M. F.; Ketelaars, Pleun J. W.; van der Sanden, Wouter M. H.; Schmeink, Channa E.; Lenselink, Charlotte H.; Siebers, Albert G.; Massuger, Leon F. A. G.; Melchers, Willem J. G.; Bekkers, Ruud L. M.			Screening for persistent high-risk HPV infections may be a valuable screening method for young women; A retrospective cohort study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; PREVALENCE; CLEARANCE; AGE	Introduction Screening of young women is often discouraged because of the high risk of unnecessary diagnostics or over-treatment. Multiple countries therefore use cytology instead of high risk human papillomavirus (hrHPV)-testing as screening method for young women because of the limited specificity of hrHPV-testing. The objective of this study was to investigate how hrHPV screening before the age of 30, can be used to reduce the future prevalence of high-grade cervical lesions in young women. Methods We retrospectively analyzed follow-up data from a cohort study on HPV prevalence in unscreened Dutch women aged 18-29 years. Women performed multiple self-collected cervico-vaginal samples for HPV detection and genotyping. At least one valid cervical pathology result was obtained from 1,018 women. Women were categorized as hrHPV negative, cleared- or persistent hrHPV infection. Anonymized follow-up data for each group was obtained. Composite outcome measures were defined as; normal, low-grade squamous intraepithelial lesion (LSIL) or high-grade squamous intraepithelial lesion (HSIL). The association between prior hrHPV status and cytology and histology outcome was analyzed. Results After exclusion, a pathology result was registered for 962 women. The prevalence of HSIL was 19.3% in women with a persistent HPV infection at a younger age. This is significantly higher (p<0,001) compared with the HSIL prevalence of 1.5% in HPV-negative women, and 3.1% (n = 8) in women who cleared the hrHPV infection in the past. Conclusion Women with a persistent hrHPV infection in their 20s, show an increased prevalence of HSIL lesions in their early 30s. Screening for persistent hrHPV infections, instead of cytology screening before the age of 30, can be used to reduce the future prevalence of cervical cancer in young women.	[Ebisch, Renee M. F.; Ketelaars, Pleun J. W.; van der Sanden, Wouter M. H.; Schmeink, Channa E.; Massuger, Leon F. A. G.; Bekkers, Ruud L. M.] Radboud Univ Nijmegen, Dept Obstet & Gynaecol, Med Ctr, Nijmegen, Netherlands; [Lenselink, Charlotte H.] Deventer Hosp, Dept Obstet & Gynaecol, Deventer, Netherlands; [Siebers, Albert G.] Radboud Univ Nijmegen, Dept Pathol, Med Ctr, Nijmegen, Netherlands; [Melchers, Willem J. G.] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, Nijmegen, Netherlands; [Ebisch, Renee M. F.; Bekkers, Ruud L. M.] Catharina Hosp, Dept Obstet & Gynaecol, Eindhoven, Netherlands	Radboud University Nijmegen; Deventer Hospital; Radboud University Nijmegen; Radboud University Nijmegen; Catharina Hospital	Ebisch, RMF (corresponding author), Radboud Univ Nijmegen, Dept Obstet & Gynaecol, Med Ctr, Nijmegen, Netherlands.; Ebisch, RMF (corresponding author), Catharina Hosp, Dept Obstet & Gynaecol, Eindhoven, Netherlands.	renee.ebisch@radboudumc.nl	Melchers, Willem/C-8819-2015; Bekkers, Ruud/AAU-5319-2020; Siebers, Albert/D-6300-2015	Melchers, Willem/0000-0002-5446-2230; Siebers, Albert/0000-0002-6085-0678				Argyri E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-53; Bekkers RLM, 2004, REV MED VIROL, V14, P95, DOI 10.1002/rmv.416; Bosgraaf RP, 2015, INT J CANCER, V136, P646, DOI 10.1002/ijc.29026; Bosgraaf RP, 2014, EXPERT REV ANTICANC, V14, P75, DOI 10.1586/14737140.2014.856273; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Bulk S, 2004, J CLIN PATHOL, V57, P388, DOI 10.1136/jcp.2003.011841; Chesson HW, 2014, SEX TRANSM DIS, V41, P660, DOI 10.1097/OLQ.0000000000000193; Cuschieri KS, 2005, J CLIN PATHOL, V58, P946, DOI 10.1136/jcp.2004.022863; Ebisch RMF, 2016, INT J CANCER, V139, P691, DOI 10.1002/ijc.30090; Erasmus MC, 2015, LANDELIJKE EVALUATIE; Giesbers H, 2016, 20160064 RIJKS VOLKS; Heinonen A, 2013, OBSTET GYNECOL, V121, P1063, DOI 10.1097/AOG.0b013e31828caa31; Lai CH, 2008, INT J CANCER, V123, P1685, DOI 10.1002/ijc.23679; Lenselink CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003743; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Melchers WJG, 1999, AM J PATHOL, V155, P1473, DOI 10.1016/S0002-9440(10)65462-4; Mollers M, 2013, VACCINE, V31, P394, DOI 10.1016/j.vaccine.2012.10.087; NHS cervical cancer screening programme, 2016, COLPOSCOPY AND PROGR; Rijkaart DC, 2012, INT J CANCER, V130, P602, DOI 10.1002/ijc.26056; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Sauer AG, 2015, CANCER EPIDEMIOL, V39, P650, DOI 10.1016/j.canep.2015.05.002; Schmeink CE, 2013, INT J CANCER, V133, P172, DOI 10.1002/ijc.27986; Snijders PJF, 2013, INT J CANCER, V132, P2223, DOI 10.1002/ijc.27790; van der Aa MA, 2008, INT J CANCER, V123, P1403, DOI 10.1002/ijc.23652; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	25	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206219	10.1371/journal.pone.0206219	http://dx.doi.org/10.1371/journal.pone.0206219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356297	Green Submitted, gold, Green Published			2022-12-26	WOS:000448434000081
J	Lien, HC; Jeng, YM; Jhuang, YL; Yuan, RH				Lien, Huang-Chun; Jeng, Yung-Ming; Jhuang, Yu-Ling; Yuan, Ray-Hwang			Increased Trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma	PLOS ONE			English	Article							BETA-CATENIN; CHROMATIN MODIFICATIONS; FAVORABLE PROGNOSIS; EARLY RECURRENCE; TUMOR-GROWTH; P53 GENE; EXPRESSION; CANCER; LIVER; OVEREXPRESSION	Introduction Trimethylation of histone H3K36 (H3K36me3), an epigenetic marker of transcription-associated histone modification and stem cell regulation, is expressed in a variety of human cancers. This study elucidated the prognostic significance of H3K36me3 in patients with resectable hepatocellular carcinoma (HCC). Methods Expression of H3K36me3 was retrospectively evaluated through immunohistochemistry in 152 surgically resected primary HCCs. Results In nontumorous liver parenchyma, H3K36Me3 was detected in bile ducts but not in hepatocytes. H3K36me3 was positive in 104 (68.4%) of the HCCs. Positivity for H3K36me3 was associated with high level of serum alpha-fetoprotein (>200 ng/mL, P = 0.0148), high tumor grade (P= 0.0017), and high tumor stage (P = 0.0008). Patients with H3K36me3-positive tumors were more likely to have lower 5-year disease-free survival and 5-year overall survival than those with H3K36me3-negative tumors (P = 0.0484 and P = 0.0213, respectively). Multivariate analysis showed that H3K36me3 positivity was an independent predictor of high tumor grade (P = 0.0475) and high tumor stage (P = 0.0114) and thus contributed to poor prognosis. Furthermore, H3K36me3 positivity was significantly correlated with the expression of biliary markers cytokeratin 19 (CK19) and hepatocyte nuclear factor 1 beta (HNF1 beta) (P < 0.0001 and P = 0.0005, respectively). Combinatorial analysis revealed that CK19 and HNF1I3 expression individually exerted additive prognostic adverse effects on HCCs with H3K36me3 positivity. Conclusions Our study indicates that H3K36me3 positivity is associated with the expression of biliary markers and is a crucial predictor of poor prognosis in resectable HCC.	[Lien, Huang-Chun; Jeng, Yung-Ming] Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan; [Lien, Huang-Chun; Jeng, Yung-Ming] Natl Taiwan Univ, Coll Med, Dept Pathol, Taipei, Taiwan; [Lien, Huang-Chun; Jeng, Yung-Ming; Jhuang, Yu-Ling] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei, Taiwan; [Yuan, Ray-Hwang] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan; [Yuan, Ray-Hwang] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Yuan, Ray-Hwang] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Yuan, RH (corresponding author), Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan.; Yuan, RH (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan.; Yuan, RH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Surg, Taipei, Taiwan.	d83409009@ntu.edu.tw		Yuan, Ray-Hwang/0000-0002-2767-633X	National Taiwan University Hospital [106-S3382]; Ministry of Science and Technology, Taiwan [106-2314-B-002-139-MY3]	National Taiwan University Hospital(National Taiwan University); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was financially supported by grant 106-S3382, National Taiwan University Hospital, and grant 106-2314-B-002-139-MY3, Ministry of Science and Technology, Taiwan, to RHY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballare C, 2012, NAT STRUCT MOL BIOL, V19, P1257, DOI 10.1038/nsmb.2434; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Carvalho S, 2013, NUCLEIC ACIDS RES, V41, P2881, DOI 10.1093/nar/gks1472; Coffinier C, 2002, DEVELOPMENT, V129, P1829; Dominguez D, 2016, CELL RES, V26, P946, DOI 10.1038/cr.2016.84; Edge SB, 2010, AJCC CANC STAGING MA; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Endo K, 2000, HUM PATHOL, V31, P558, DOI 10.1053/hp.2000.6683; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Gan L, 2018, BIOMARK RES, V6, DOI 10.1186/s40364-018-0122-2; Ho TH, 2016, MODERN PATHOL, V29, P34, DOI 10.1038/modpathol.2015.123; HSU HC, 1993, CANCER RES, V53, P4691; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; HSU HC, 1994, HEPATOLOGY, V19, P122, DOI 10.1016/0270-9139(94)90062-0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LAI YS, 1989, ARCH PATHOL LAB MED, V113, P134; Lee SM, 2014, P NATL ACAD SCI USA, V111, P9555, DOI 10.1073/pnas.1400604111; Lee W, 2014, NAT GENET, V46, P1227, DOI 10.1038/ng.3095; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li J, 2016, ONCOTARGET, V7, P50719, DOI 10.18632/oncotarget.9368; Li XW, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1983-5; Liu M, 2014, PROTEIN CELL, V5, P673, DOI 10.1007/s13238-014-0065-9; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; Pan HW, 2003, CANCER-AM CANCER SOC, V98, P119, DOI 10.1002/cncr.11487; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Roskams T, 1998, J HEPATOL, V29, P455, DOI 10.1016/S0168-8278(98)80065-2; Schafer DF, 1999, LANCET, V353, P1253, DOI 10.1016/S0140-6736(98)09148-X; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; White KK, 2009, FASEB J, V23; Yang P, 2012, MOL CELL BIOL, V32, P3121, DOI 10.1128/MCB.00204-12; Young LC, 2013, BIOCHEM CELL BIOL, V91, P369, DOI 10.1139/bcb-2012-0054; Yuan RH, 2006, J PATHOL, V209, P549, DOI 10.1002/path.2011; Yuan RH, 2014, J GASTROINTEST SURG, V18, P1784, DOI 10.1007/s11605-014-2596-z; Yuan RH, 2011, J GASTROINTEST SURG, V15, P321, DOI 10.1007/s11605-010-1373-x; Yuan RH, 2005, CLIN CANCER RES, V11, P2568, DOI 10.1158/1078-0432.CCR-04-2039; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894	38	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206261	10.1371/journal.pone.0206261	http://dx.doi.org/10.1371/journal.pone.0206261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356299	gold, Green Submitted, Green Published			2022-12-26	WOS:000448434000086
J	Manohar, P; Tamhankar, AJ; Lundborg, CS; Ramesh, N				Manohar, Prasanth; Tamhankar, Ashok J.; Lundborg, Cecilia Stalsby; Ramesh, Nachimuthu			Isolation, characterization and in vivo efficacy of Escherichia phage myPSH1131	PLOS ONE			English	Article							THERAPY; COLI; BACTERIOPHAGE; INFECTION; COCKTAILS; DIARRHEA; STRAINS	Phage therapy is the use of lytic bacteriophages to cure infections caused by bacteria. The aim of this study is to isolate and to characterize the bacteriophages against Escherichia coli isolated from clinical samples. For isolation of bacteriophages, water samples were collected from the Ganges River, and phage enrichment method was followed for phage isolation. Microbiological, genomic and lyophilization experiments were carried out to characterize the bacteriophage. Galleria mellonella was used to study the potential of phages against E. coli infection. Escherichia phage myPSH1131 belonging to Podoviridae family and found to have broad host range infectivity (n = 31) to infect Enterohemorrhagic E. coli (n = 9), Enteropathogenic E. coli (n = 6), Enterotoxigenic E. coli (n = 3), Enteroaggregative E. coli (n = 3), Uropathogenic E. coli (n = 9) and one unknown E. coll. The genome size is 76,163 base pairs (97 coding regions) and their genes show high similarity to SU10 phage. Lyophilization studies showed that the use of 1M sucrose, 2% gelatin and the combination of both 0.5M sucrose plus 1% gelatin could restore phage viability up to 20 months at 4 degrees C. For in vivo studies, it was observed that a single phage dose can reduce the E. coli infection but to achieve 100% survival rate the infected larvae should be treated with three phage doses (20 mu L, 10(3) PFU/mL) at 6 hours interval. The characterized Escherichia phage myPSH1131 was found to have broad host range activity against E. coli pathogens and in vivo studies showed that multiple doses are required for effective treatment.	[Manohar, Prasanth; Ramesh, Nachimuthu] VIT, Sch Biosci & Technol, Antibiot Resistance & Phage Therapy Lab, Vellore, Tamil Nadu, India; [Tamhankar, Ashok J.; Lundborg, Cecilia Stalsby] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth Hlth Syst & Policy HSP Med Focusing A, Stockholm, Sweden; [Tamhankar, Ashok J.] Indian Initiat Management Antibiot Resistance, Bombay, Maharashtra, India	Vellore Institute of Technology; Karolinska Institutet	Ramesh, N (corresponding author), VIT, Sch Biosci & Technol, Antibiot Resistance & Phage Therapy Lab, Vellore, Tamil Nadu, India.	drpnramesh@gmail.com	Nachimuthu/N-8689-2019; Manohar, Prasanth/S-8486-2016; Nachimuthu, Ramesh/S-8552-2016	Nachimuthu/0000-0002-8350-1809; Manohar, Prasanth/0000-0002-5546-1117; Nachimuthu, Ramesh/0000-0002-8350-1809; Stalsby Lundborg, Cecilia/0000-0001-6525-1861	Vellore Institute of Technology; Swedish Research Council [2012-02889, 2017-01327]	Vellore Institute of Technology; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Vellore Institute of Technology in the form of a VIT Seed Grant. This work was partly supported by Swedish Research Council with grants to CSL (Grant No. 2012-02889 and 2017-01327). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19032; Bisi-Johnson MA, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-9; Bourdin G, 2014, APPL ENVIRON MICROB, V80, P1469, DOI 10.1128/AEM.03357-13; Bourdin G, 2014, MICROB BIOTECHNOL, V7, P165, DOI 10.1111/1751-7915.12113; Bruttin A, 2005, ANTIMICROB AGENTS CH, V49, P2874, DOI 10.1128/AAC.49.7.2874-2878.2005; Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/FMB.13.47, 10.2217/fmb.13.47]; Dalmasso M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156773; Endersen L, 2014, ANNU REV FOOD SCI T, V5, P327, DOI 10.1146/annurev-food-030713-092415; Gill JJ, 2010, CURR PHARM BIOTECHNO, V11, P2, DOI 10.2174/138920110790725311; Hua YH, 2014, ARCH VIROL, V159, P3249, DOI 10.1007/s00705-014-2189-x; Jurczak-Kurek A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34338; Maal KB, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.14945; Malik DJ, 2017, ADV COLLOID INTERFAC, V249, P100, DOI 10.1016/j.cis.2017.05.014; Merabishvili M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104853; Merabishvili M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068797; Merril CR, 1996, P NATL ACAD SCI USA, V93, P3188, DOI 10.1073/pnas.93.8.3188; Mirzaei MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118557; Mirzaei MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116294; Nale JY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01383; Nobrega FL, 2015, TRENDS MICROBIOL, V23, P185, DOI 10.1016/j.tim.2015.01.006; Olszak T, 2015, APPL MICROBIOL BIOT, V99, P6021, DOI 10.1007/s00253-015-6492-6; Pirnay JP, 2015, PHARM RES-DORDR, V32, P2173, DOI 10.1007/s11095-014-1617-7; Puapermpoonsiri U, 2010, INT J PHARMACEUT, V389, P168, DOI 10.1016/j.ijpharm.2010.01.034; Reardon S, 2014, NATURE, V510, P15, DOI 10.1038/510015a; Sabri MB, 2014, IRAQI J MED SCI, V12; Sarker SA, 2016, ANN NY ACAD SCI, V1372, P42, DOI 10.1111/nyas.13087; Seed KD, 2009, ANTIMICROB AGENTS CH, V53, P2205, DOI 10.1128/AAC.01166-08; Sharma S, 2017, FOLIA MICROBIOL, V62, P17, DOI 10.1007/s12223-016-0471-x; Tsai CJY, 2016, VIRULENCE, V7, P214, DOI 10.1080/21505594.2015.1135289; Vahedi A, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny136	30	36	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206278	10.1371/journal.pone.0206278	http://dx.doi.org/10.1371/journal.pone.0206278			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356310	Green Published, Green Submitted, gold			2022-12-26	WOS:000448434000088
J	Pausch, P; Steinchen, W; Wieland, M; Klaus, T; Freibert, SA; Altegoer, F; Wilson, DN; Bange, G				Pausch, Patrick; Steinchen, Wieland; Wieland, Maximiliane; Klaus, Thomas; Freibert, Sven-Andreas; Altegoer, Florian; Wilson, Daniel N.; Bange, Gert			Structural basis for (p)ppGpp-mediated inhibition of the GTPase RbgA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase; X-ray crystallography; ribosome assembly; inhibition mechanism; enzyme kinetics; (p)ppGpp; alarmone; cell stress; RbgA; stringent response	BINDING PROTEIN; YLQF; BIOGENESIS; PRECURSOR; (P)PPGPP; DOMAINS; RPL10P; GROWTH; NMD3P	Efficient adaptation to environmental changes is pivotal for all bacterial cells. Almost all bacterial species depend on the conserved stringent response system to prompt timely transcriptional and metabolic responses according to stress conditions and nutrient depletion. The stringent response relies on the stress-dependent synthesis of the second messenger nucleotides and alarmones (p)ppGpp, which pleiotropically target and reprogram processes that consume cellular resources, such as ribosome biogenesis. Here we show that (p)ppGpp acts on the ribosome biogenesis GTPase A (RbgA) of Gram-positive bacteria. Using X-ray crystallography, hydrogen-deuterium exchange MS (HDX-MS) and kinetic analysis, we demonstrate that the alarmones (p)ppGpp bind to RbgA in a manner similar to that of binding by GDP and GTP and thereby act as competitive inhibitors. Our structural analysis of Staphylococcus aureus RbgA bound to ppGpp and pppGpp at 1.8 and 1.65 resolution, respectively, suggested that the alarmones (p)ppGpp prevent the active GTPase conformation of RbgA by sterically blocking the association of its G2 motif via their 3-pyrophosphate moieties. Taken together, our structural and biochemical characterization of RbgA in the context of the alarmone-mediated stringent response reveals how (p)ppGpp affects the function of RbgA and reprograms this GTPase to arrest the ribosomal large subunit.	[Pausch, Patrick; Steinchen, Wieland; Klaus, Thomas; Altegoer, Florian; Bange, Gert] Philipps Univ Marburg, Dept Chem, D-35043 Marburg, Germany; [Freibert, Sven-Andreas] Philipps Univ Marburg, Inst Cytobiol & Cytopathol, D-35043 Marburg, Germany; [Pausch, Patrick; Steinchen, Wieland; Klaus, Thomas; Freibert, Sven-Andreas; Altegoer, Florian; Bange, Gert] Synmikro Ctr Synthet Microbiol, D-35043 Marburg, Germany; [Wieland, Maximiliane; Wilson, Daniel N.] Univ Hamburg, Inst Biochem & Mol Biol, D-20146 Hamburg, Germany	Philipps University Marburg; Philipps University Marburg; University of Hamburg	Pausch, P; Bange, G (corresponding author), Philipps Univ Marburg, Dept Chem, D-35043 Marburg, Germany.; Pausch, P; Bange, G (corresponding author), Synmikro Ctr Synthet Microbiol, D-35043 Marburg, Germany.	Patrick.Pausch@synmikro.uni-marburg.de; Gert.Bange@synmikro.uni-marburg.de	Bange, Gert/AAB-3734-2021; Wilson, Daniel/AAE-8504-2019; Altegoer, Florian/AAM-1354-2020	Wilson, Daniel/0000-0003-3816-3828; Altegoer, Florian/0000-0002-6012-9047; Bange, Gert/0000-0002-7826-0932	Deutsche Forschungsgemeinschaft [SPP1879]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Program SPP1879 (to G. B. and D. N. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Achila D, 2012, J BIOL CHEM, V287, P8417, DOI 10.1074/jbc.M111.331322; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anand B, 2006, NUCLEIC ACIDS RES, V34, P2196, DOI 10.1093/nar/gkl178; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; Chen SS, 2012, MOL BIOSYST, V8, P3325, DOI 10.1039/c2mb25310k; Corrigan RM, 2016, P NATL ACAD SCI USA, V113, pE1710, DOI 10.1073/pnas.1522179113; Davis JH, 2016, CELL, V167, P1610, DOI 10.1016/j.cell.2016.11.020; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gabadinho J, 2010, J SYNCHROTRON RADIAT, V17, P700, DOI 10.1107/S0909049510020005; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Gulati M, 2013, NUCLEIC ACIDS RES, V41, P3217, DOI 10.1093/nar/gks1475; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jomaa A, 2014, NUCLEIC ACIDS RES, V42, P3419, DOI 10.1093/nar/gkt1295; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanjee U, 2012, MOL MICROBIOL, V85, P1029, DOI 10.1111/j.1365-2958.2012.08177.x; Karniel A, 2018, J MOL BIOL, V430, P1607, DOI 10.1016/j.jmb.2018.04.017; Kim DJ, 2008, PROTEINS, V72, P1363, DOI 10.1002/prot.22112; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Li NN, 2013, NUCLEIC ACIDS RES, V41, P7073, DOI 10.1093/nar/gkt423; Malyutin AG, 2017, EMBO J, V36, P854, DOI 10.15252/embj.201696012; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Matsuo Y, 2007, J BIOL CHEM, V282, P25270, DOI 10.1074/jbc.M703894200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mier P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169750; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; Patacq C, 2018, ANAL CHEM, V90, P10715, DOI 10.1021/acs.analchem.8b00829; Pausch P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8494; Schaper S, 2017, P NATL ACAD SCI USA, V114, pE4822, DOI 10.1073/pnas.1702435114; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Steinchen W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20634-4; Steinchen W, 2016, MOL MICROBIOL, V101, P531, DOI 10.1111/mmi.13412; Steinchen W, 2015, P NATL ACAD SCI USA, V112, P13348, DOI 10.1073/pnas.1505271112; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Varik V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10988-6; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043	40	23	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19699	19709		10.1074/jbc.RA118.003070	http://dx.doi.org/10.1074/jbc.RA118.003070			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30366986	Green Published, hybrid			2022-12-26	WOS:000454294900017
J	Cheng, L; Brzozowska, B; Sollazzo, A; Lundholm, L; Lisowska, H; Haghdoost, S; Wojcik, A				Cheng, Lei; Brzozowska, Beata; Sollazzo, Alice; Lundholm, Lovisa; Lisowska, Halina; Haghdoost, Siamak; Wojcik, Andrzej			Simultaneous induction of dispersed and clustered DNA lesions compromises DNA damage response in human peripheral blood lymphocytes	PLOS ONE			English	Article							AM-241 ALPHA-PARTICLES; HIGH-LET RADIATIONS; SEQUENTIAL IRRADIATION; MAMMALIAN-CELLS; MIXED BEAM; X-RAYS; BIOLOGICAL EFFECTIVENESS; RADIONUCLIDE THERAPY; FAST-NEUTRONS; COMET ASSAY	Due to its ability to induce DNA damage in a space and time controlled manner, ionising radiation is a unique tool for studying the mechanisms of DNA repair. The biological effectiveness of ionising radiation is related to the ionisation density which is defined by the linear energy transfer (LET). Alpha particles are characterised by high LET, while X-rays by low LET values. An interesting question is how cells react when exposed to a mixed beam of high and low LET radiation. In an earlier study carried out with human peripheral blood lymphocytes (PBL) we could demonstrate that alpha radiation X-rays interact in producing more chromosomal aberrations than expected based on additivity. The aim of the present investigation was to look at the mechanism of the interaction, especially with respect to the question if it is due to an augmented level of initial damage or impaired DNA repair. PBL were exposed to various doses of alpha particles, X-rays and mixed beams. DNA damage and the kinetics of damage repair was quantified by the alkaline comet assay. The levels of phosphorylated, key DNA damage response (DDR) proteins ATM, p53 and DNA-PK were measured by Western blotting and mRNA levels of 6 damage-responsive genes were measured by qPCR. Alpha particles and X-rays interact in inducing DNA damage above the level predicted by assuming additivity and that the repair of damage occurs with a delay. The activation levels of DDR proteins and mRNA levels of the studied genes were highest in cells exposed to mixed beams. The results substantiate the idea that exposure to mixed beams presents a challenge for the cellular DDR system.	[Cheng, Lei; Brzozowska, Beata; Sollazzo, Alice; Lundholm, Lovisa; Haghdoost, Siamak; Wojcik, Andrzej] Stockholm Univ, Ctr Radiat Protect Res, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Brzozowska, Beata] Univ Warsaw, Fac Phys, Biomed Phys Div, Warsaw, Poland; [Lisowska, Halina; Wojcik, Andrzej] Jan Kochanowski Univ Humanities & Sci, Inst Biol, Kielce, Poland	Stockholm University; University of Warsaw; Jan Kochanowski University	Wojcik, A (corresponding author), Stockholm Univ, Ctr Radiat Protect Res, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden.; Wojcik, A (corresponding author), Jan Kochanowski Univ Humanities & Sci, Inst Biol, Kielce, Poland.	andrzej.wojcik@su.se	Lundholm, Lovisa/A-8935-2015	Lundholm, Lovisa/0000-0003-2023-7454; Cheng, Lei/0000-0002-0984-6964; Wojcik, Andrzej/0000-0002-3951-774X; Brzozowska, Beata/0000-0003-0247-697X; Lisowska, Halina/0000-0002-5774-7514	Swedish Radiation Safety Authority; Narodowe Centrum Nauki, Poland [2016/23/D/ST7/03544]; NCN, Poland [2016/23/D/ST7/03544]	Swedish Radiation Safety Authority; Narodowe Centrum Nauki, Poland(National Science Centre, Poland); NCN, Poland	AW, AS, LC and SH were supported by the Swedish Radiation Safety Authority (www.ssm.se).BB was supported in part by a grant from Narodowe Centrum Nauki (https://www.ncn.gov.pl/), Poland (2016/23/D/ST7/03544). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support: AW, AS, LC and SH were supported by the Swedish Radiation Safety Authority. BB was supported in part by a grant from NCN, Poland (2016/23/D/ST7/03544).	Allen BJ, 2014, BIOL-TARGETS THER, V8, P255, DOI 10.2147/BTT.S29947; Andrew BA, 2004, RADIOTHER ONCOL, V73, P265, DOI 10.1016/j.radonc.2004.09.008; Andrysik Z, 2017, GENOME RES, V27, P1645, DOI 10.1101/gr.220533.117; [Anonymous], 2007, ICRP 103, P21; Antonelli F, 2015, RADIAT RES, V183, P417, DOI 10.1667/RR13855.1; BARENDSEN GW, 1960, RADIAT RES, V13, P841, DOI 10.2307/3570859; Bartlett DT, 2004, RADIAT PROT DOSIM, V109, P349, DOI 10.1093/rpd/nch311; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bennett PV, 2007, RADIAT ENVIRON BIOPH, V46, P119, DOI 10.1007/s00411-006-0091-y; BIRD RP, 1983, RADIAT RES, V93, P444, DOI 10.2307/3576024; Bodet-Milin C, 2016, SEMIN NUCL MED, V46, P135, DOI 10.1053/j.semnuclmed.2015.10.007; Brenner DJ, 2008, RADIOTHER ONCOL, V86, P165, DOI 10.1016/j.radonc.2007.12.003; BROOKS AL, 1990, INT J RADIAT BIOL, V58, P799, DOI 10.1080/09553009014552181; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; Cordier D, 2016, SEMIN NUCL MED, V46, P243, DOI 10.1053/j.semnuclmed.2016.01.009; De Kruijff RM, 2015, PHARMACEUTICALS, V8, P321, DOI 10.3390/ph8020321; Difilippo F, 2003, MED PHYS, V30, P2849, DOI 10.1118/1.1612947; Farah J, 2014, PHYS MED BIOL, V59, P2747, DOI 10.1088/0031-9155/59/11/2747; Furusawa Y, 2002, ADV SPACE RES, V30, P877, DOI 10.1016/S0273-1177(02)00409-X; Georgakilas AG, 2013, RADIAT RES, V180, P100, DOI 10.1667/RR3041.1; Goodhead DT, 1999, J RADIAT RES, V40, P1, DOI 10.1269/jrr.40.S1; Goodhead DT, 2006, RADIAT PROT DOSIM, V122, P3, DOI 10.1093/rpd/ncl498; GRIFFIN TW, 1984, INT J RADIAT ONCOL, V10, P2211, DOI 10.1016/0360-3016(84)90225-6; Hada M, 2008, J RADIAT RES, V49, P203, DOI 10.1269/jrr.07123; Hendry JH, 2009, J RADIOL PROT, V29, pA29, DOI 10.1088/0952-4746/29/2A/S03; HIGGINS PD, 1984, RADIAT RES, V99, P591, DOI 10.2307/3576333; HIGGINS PD, 1983, RADIAT RES, V95, P45, DOI 10.2307/3576070; Hoeijmakers JHJ, 2007, MECH AGEING DEV, V128, P460, DOI 10.1016/j.mad.2007.05.002; Jeggo PA, 1997, MUTAT RES-DNA REPAIR, V384, P1, DOI 10.1016/S0921-8777(97)00009-8; Jeggo PA, 1998, ADV GENET, V38; Kanai T, 1997, RADIAT RES, V147, P78, DOI 10.2307/3579446; Kerzendorfer C, 2009, DNA REPAIR, V8, P1139, DOI 10.1016/j.dnarep.2009.04.018; Kry SF, 2005, INT J RADIAT ONCOL, V62, P1204, DOI 10.1016/j.ijrobp.2004.12.091; Kry SF, 2005, INT J RADIAT ONCOL, V62, P1195, DOI 10.1016/j.ijrobp.2005.03.053; Lundholm L, 2014, INT J RADIAT BIOL, V90, P718, DOI 10.3109/09553002.2014.905725; Mavragani IV, 2017, CANCERS, V9, DOI 10.3390/cancers9070091; MCNALLY NJ, 1984, INT J RADIAT BIOL, V45, P301, DOI 10.1080/09553008414550441; MCNALLY NJ, 1988, INT J RADIAT BIOL, V53, P917, DOI 10.1080/09553008814551281; Mueller S, 2017, PHYS MED BIOL, V62, P5840, DOI 10.1088/1361-6560/aa70c5; Newhauser WD, 2015, PHYS MED BIOL, V60, pR155, DOI 10.1088/0031-9155/60/8/R155; NGO FQH, 1977, INT J RADIAT BIOL, V32, P507, DOI 10.1080/09553007714551291; NGO FQH, 1981, RADIAT RES, V87, P59, DOI 10.2307/3575541; NGO FQH, 1988, RADIAT RES, V115, P54, DOI 10.2307/3577055; Nikjoo H, 1997, INT J RADIAT BIOL, V71, P467, DOI 10.1080/095530097143798; Norain A, 2016, SEMIN NUCL MED, V46, P250, DOI 10.1053/j.semnuclmed.2015.12.005; Paganetti H, 2014, PHYS MED BIOL, V59, pR419, DOI 10.1088/0031-9155/59/22/R419; Phoenix B, 2009, APPL RADIAT ISOTOPES, V67, pS318, DOI 10.1016/j.apradiso.2009.03.097; Rodgers K, 2016, J CELL PHYSIOL, V231, P15, DOI 10.1002/jcp.25053; Sage E., 2016, FREE RADIC BIOL MED; Schrodinger Erwin., 1946, WHAT IS LIFE; Sollazzo A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020519; Sollazzo A, 2017, RADIAT RES, V188, P400, DOI 10.1667/RR14803.1; Sollazzo A, 2016, J RADIOL PROT, V36, P721, DOI 10.1088/0952-4746/36/4/721; Staaf E, 2013, MUTAT RES-GEN TOX EN, V756, P95, DOI 10.1016/j.mrgentox.2013.05.001; Staaf Elina, 2012, Genome Integr, V3, P8, DOI 10.1186/2041-9414-3-8; Staaf E, 2012, RADIAT PROT DOSIM, V151, P570, DOI 10.1093/rpd/ncs024; Staaf E, 2012, RADIAT ENVIRON BIOPH, V51, P283, DOI 10.1007/s00411-012-0417-x; STEEL GG, 1979, INT J RADIAT ONCOL, V5, P85; STREFFER C, 1987, INT J RADIAT BIOL, V51, P961, DOI 10.1080/09553008714551261; SUZUKI S, 1993, RADIAT RES, V133, P327, DOI 10.2307/3578217; Szumiel I, 2008, RADIAT RES, V169, P249, DOI 10.1667/RR1239.1; Takam R, 2011, RADIAT RES, V176, P508, DOI 10.1667/RR2606.1; Trott KR, 2017, PHYS MEDICA, V42, P221, DOI 10.1016/j.ejmp.2017.05.002; UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation), 1977, UN SCI COMM EFF AT R; Wojewodzka M, 1998, MUTAT RES-GEN TOX EN, V416, P21, DOI 10.1016/S1383-5718(98)00073-4; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Zhou GM, 2006, RADIAT RES, V166, P488, DOI 10.1667/RR0596.1	67	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0204068	10.1371/journal.pone.0204068	http://dx.doi.org/10.1371/journal.pone.0204068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379881	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700008
J	de Monteynard, LA; Matheron, S; Grabar, S; de Truchis, P; Gilquin, J; Pavie, J; Launay, O; Meynard, JL; Khuong-Josses, MA; Rey, D; Mehemet, A; Dray-Spira, R; Simon, A; Costagliola, D; Abgrall, S				de Monteynard, Laure-Amelie; Matheron, Sophie; Grabar, Sophie; de Truchis, Pierre; Gilquin, Jacques; Pavie, Juliette; Launay, Odile; Meynard, Jean-Luc; Khuong-Josses, Marie-Aude; Rey, David; Mehemet, Aba; Dray-Spira, Rosemarie; Simon, Anne; Costagliola, Dominique; Abgrall, Sophie		FHDH-ANRS CO4	Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual H IV-infected men and women in France	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV; MIGRANTS; PEOPLE; RISK; INITIATION; SURVIVAL; COHORT; DEATH	Background The influence of geographic origin on the risk of severe illness and death on cART has not been explored in European countries. Method We studied antiretroviral-naive heterosexual HIV-1-infected individuals enrolled in the FHDH-ANRS CO4 cohort in France who started cART between 2006 and 2011. Individuals originating from France (French natives), sub-Saharan Africa (SSA) and non-French West-Indies (NFW) were studied until 2012. Crude and adjusted rate ratios (aRR) of severe morbid events/deaths (AIDS-related and non-AIDS-related) were calculated using Poisson regression models stratified by sex, comparing each group of migrants to French natives. Results Among 2334 eligible men, 1379 (59.1%) originated from France, 838 (35.9%) from SSA and 117 (5.0%) from NFW. SSA male migrants had a higher aRR for non-AIDS infections, particularly bacterial infections (aRR 1.56 (95% CI 1.07-2.29), p = 0.0477), than French natives. Among 2596 eligible women, 1347 (51.9%) originated from France, 1131 (43.6%) from SSA, and 118 (4.5%) from NFW. SSA and NFW female migrants had a higher aRR for non-AIDS infections, particularly non-bacterial infections (respectively, 2.04 (1.18-3.53) and 7.87 (2.54-24.4), p = 0.0010), than French natives. We observed no other significant differences related to geographic origin as concerns the aRRs for AIDS-related infections or malignancies, or for other non-AIDS events/deaths such as cardiovascular disease, neurological/psychiatric disorders, non-AIDS malignancies and iatrogenic disorders, in either gender. Conclusion Heterosexual migrants from SSA or NFW living in France have a higher risk of non-AIDS-defining infections than their French native counterparts. Special efforts are needed to prevent infectious diseases among HIV-infected migrants.	[de Monteynard, Laure-Amelie; Grabar, Sophie; Dray-Spira, Rosemarie; Costagliola, Dominique; Abgrall, Sophie] Univ Paris 06, Sorbonne Univ, UPMC, INSERM,IPLESP UMRS 1136, Paris, France; [Matheron, Sophie] Univ Paris Diderot, Sorbonne Paris Cite, UMR 1137, Paris, France; [Matheron, Sophie] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, Paris, France; [Grabar, Sophie; Launay, Odile] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Grabar, Sophie] Grp Hosp Cochin Broca Hotel Dieu, AP HP, Unite Biostat & Epidemiol, Paris, France; [de Truchis, Pierre] Hop Univ Paris Ile France Ouest, Hop Raymond Poincare, AP HP, Dept Med Aigue Specialisee, Garches, France; [Gilquin, Jacques] Hop Hotel Dieu, AP HP, Unite Immunoinfectiol, Paris, France; [Pavie, Juliette] Hop Europeen Georges Pompidou, AP HP, Serv Immunol Clin, Paris, France; [Launay, Odile] Hop Cochin, AP HP, Paris, France; [Meynard, Jean-Luc] Hop St Antoine, AP HP, Serv Malad Infect & Trop, Paris, France; [Khuong-Josses, Marie-Aude] Ctr Hosp St Denis, Hop Delafontaine, Serv Malad Infect & Trop, St Denis, Reunion, France; [Rey, David] Hop Univ Strasbourg, Ctr Soins Infect VIH, Strasbourg, France; [Mehemet, Aba] Ctr Hosp Andree Rosemon, Serv Malad Infect & Trop, Cayenne, France; [Simon, Anne] Grp Hosp Pitie Salpetriere, AP HP, Dept Med Interne, Paris, France; [Abgrall, Sophie] Hop Antoine Beclere, AP HP, Serv Med Interne Immunol Clin, Clamart, France; [Abgrall, Sophie] Univ Paris Sud, Univ Paris Saclay, CESP INSERM U1018, UVSQ, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Abgrall, S (corresponding author), Univ Paris 06, Sorbonne Univ, UPMC, INSERM,IPLESP UMRS 1136, Paris, France.; Abgrall, S (corresponding author), Hop Antoine Beclere, AP HP, Serv Med Interne Immunol Clin, Clamart, France.; Abgrall, S (corresponding author), Univ Paris Sud, Univ Paris Saclay, CESP INSERM U1018, UVSQ, Le Kremlin Bicetre, France.	sophie.abgrall@aphp.fr	Grabar, Sophie/AAM-9857-2020; Costagliola, Dominique/H-5849-2011	Costagliola, Dominique/0000-0003-0765-0869; Dray-Spira, Rosemary/0000-0001-7646-3667	ANRS ("France REcherche Nord&Sud Sida-hiv Hepatites"); INSERM; French Ministry of Health; Sorbonne Universites UPMC Paris Univ 06	ANRS ("France REcherche Nord&Sud Sida-hiv Hepatites")(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry of Health; Sorbonne Universites UPMC Paris Univ 06	The FHDH is supported by the ANRS ("France REcherche Nord&Sud Sida-hiv Hepatites"), INSERM, and the French Ministry of Health. Laure-Amelie de Monteynard was supported by a doctoral contract from Sorbonne Universites UPMC Paris Univ 06.	Abgrall S, 2014, INT J STD AIDS, V25, P389, DOI 10.1177/0956462413506894; Abgrall S, 2016, CURR OPIN HIV AIDS, V11, P501, DOI 10.1097/COH.0000000000000301; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Ansart S, 2002, REV MAL RESPIR, V19, P693; Berry SA, 2012, JAIDS-J ACQ IMM DEF, V59, P368, DOI 10.1097/QAI.0b013e318246b862; Collin A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152970; Costagliola D, 2016, CURR OPIN HIV AIDS, V11, P451, DOI 10.1097/COH.0000000000000304; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; de Monteynard LA, 2016, AIDS, V30, P2235, DOI 10.1097/QAD.0000000000001193; del Amo J, 2017, AIDS, V31, P253, DOI 10.1097/QAD.0000000000001270; del Amo J, 2013, CLIN INFECT DIS, V56, P1800, DOI 10.1093/cid/cit111; European Centre for Disease Control and Prevention (ECDC), 2013, THEM REP MIGR MON IM; Ferry T, 2009, JAIDS-J ACQ IMM DEF, V51, P407, DOI 10.1097/QAI.0b013e3181acb65f; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Gebreselassie HM, 2017, HIV MED, V18, P564, DOI 10.1111/hiv.12491; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Hessamfar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102671; Lapadula G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124741; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; LUZ PM, 2014, BMC INFECT DIS, V14, P15660; Mary-Krause M, 2014, INT J EPIDEMIOL, V43, P1425, DOI 10.1093/ije/dyu002; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Monge S, 2015, LANCET HIV, V2, pE540, DOI 10.1016/S2352-3018(15)00203-9; Monge S, 2013, HIV MED, V14, P273, DOI 10.1111/hiv.12001; Montlahuc C, 2013, JAIDS-J ACQ IMM DEF, V64, P197, DOI 10.1097/QAI.0b013e31829cfbfa; Morlat P, 2014, AIDS, V28, P1181, DOI 10.1097/QAD.0000000000000222; Mouala C, 2008, JAIDS-J ACQ IMM DEF, V49, P55, DOI 10.1097/QAI.0b013e31817e635b; Mullaert J, 2015, VACCINE, V33, P4938, DOI 10.1016/j.vaccine.2015.07.036; O'Donnell C, 2013, LANCET, V382, P393, DOI 10.1016/S0140-6736(13)61666-9; Shepherd BE, 2013, AIDS, V27, P1321, DOI 10.1097/QAD.0b013e32835faa95; Thierry X., 2008, INED POPULAT SOC, V442, P1; van Veen KEB, 2016, J INFECTION, V72, P362, DOI 10.1016/j.jinf.2016.01.001; Yeni P, 2008, PRISE CHARGE MED PER	34	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205385	10.1371/journal.pone.0205385	http://dx.doi.org/10.1371/journal.pone.0205385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379870	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700044
J	Gyori, E; Tzou, CHJ; Weninger, WJ; Reissig, L; Schmidt-Erfurth, U; Radtke, C; Dunavoelgyi, R				Gyori, Eva; Tzou, Chieh-Han John; Weninger, Wolfgang J.; Reissig, Lukas; Schmidt-Erfurth, Ursula; Radtke, Christine; Dunavoelgyi, Roman			Axon numbers and landmarks of trigeminal donor nerves for corneal neurotization	PLOS ONE			English	Article							TO-SIDE NEURORRHAPHY; REINNERVATION; REGENERATION; ANATOMY; GRAFTS; REPAIR	Purpose Corneal anesthesia leads to chronic corneal injury. This anatomical study characterizes the donor nerve branches of the supratrochlear and supraorbital nerves used for corneal neurotization. Methods In 13 non-embalmed cadavers, the supratrochlear and supraorbital nerves were dissected and distances to anatomical landmarks measured. Cross-sections of supratrochlear and supraorbital donor nerves were harvested and histomorphometrically analyzed to assess the number of myelinated axons. Results The donor axon counts were 3146 +/- 1069.9 for the supratrochlear and 1882 +/- 903 for the supraorbital nerve distal to the supraorbital notch. The supratrochlear nerve was dissected on the medial upper eyelid 2 cm lateral to the facial midline and the branch of the supraorbital nerve 1 cm medial to the mid-pupillary line. Conclusion The supraorbital and supratrochlear branches of the trigeminal nerve are potent donor nerves for corneal neurotization in the treatment of neuropathic keratopathy and can be reliably dissected using anatomical landmarks.	[Gyori, Eva; Tzou, Chieh-Han John; Radtke, Christine] Med Univ Vienna, Dept Surg, Div Plast & Reconstruct Surg, Vienna, Austria; [Weninger, Wolfgang J.; Reissig, Lukas] Med Univ Vienna, Div Anat, Vienna, Austria; [Schmidt-Erfurth, Ursula; Dunavoelgyi, Roman] Med Univ Vienna, Dept Ophthalmol & Optometry, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Dunavoelgyi, R (corresponding author), Med Univ Vienna, Dept Ophthalmol & Optometry, Vienna, Austria.	roman.dunavoelgyi@meduniwien.ac.at	Tzou, Chieh-Han John/A-4897-2017; Radtke, Christine/B-8491-2018	Tzou, Chieh-Han John/0000-0002-3903-801X; Dunavoelgyi, Roman/0000-0002-1842-240X; Weninger, Wolfgang J/0000-0003-0575-0073; Reissig, Lukas F/0000-0001-5833-8176; Radtke, Christine/0000-0001-6877-5038; Placheta-Gyoeri, Eva/0000-0002-6234-0284	Austrian grant "Medical Research Fund of the Mayor of Vienna" [17010]	Austrian grant "Medical Research Fund of the Mayor of Vienna"	The study was funded by the Austrian grant "Medical Research Fund of the Mayor of Vienna" (project no. 17010) to RD, https://www.wien.gv.at/gesundheit/einrichtungen/med-wissfonds/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bains RD, 2015, PLAST RECONSTR SURG, V135, p397E, DOI 10.1097/PRS.0000000000000994; Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; Benkhatar H, 2018, CORNEA, V37, P647, DOI 10.1097/ICO.0000000000001549; Bonini S, 2003, EYE, V17, P989, DOI 10.1038/sj.eye.6700616; CAVANAGH HD, 1989, ACTA OPHTHALMOL, V67, P115; Dvali LT, 2008, HAND CLIN, V24, P455, DOI 10.1016/j.hcl.2008.04.006; Elbaz U, 2014, JAMA OPHTHALMOL, V132, P1288, DOI 10.1001/jamaophthalmol.2014.2316; Frey M, 2006, PLAST RECONSTR SURG, V117, P597, DOI 10.1097/01.prs.0000197136.56749.c6; Fung SSM, 2018, CORNEA, V37, P109, DOI 10.1097/ICO.0000000000001315; Giovanoli P, 2000, PLAST RECONSTR SURG, V106, P383, DOI 10.1097/00006534-200008000-00021; Hayashi A, 2008, EXP NEUROL, V211, P539, DOI 10.1016/j.expneurol.2008.02.031; Jacinto Frances, 2016, Am J Ophthalmol Case Rep, V4, P14, DOI 10.1016/j.ajoc.2016.07.001; Leyngold I, 2018, OPHTHAL PLAST RECONS, V34, P213, DOI 10.1097/IOP.0000000000000913; Leyngold I, 2018, OPHTHAL PLAST RECONS, V34, P82, DOI 10.1097/IOP.0000000000001023; Marfurt CF, 2010, EXP EYE RES, V90, P478, DOI 10.1016/j.exer.2009.12.010; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Pannucci C, 2007, RESTOR NEUROL NEUROS, V25, P45; Placheta E, 2015, PLAST RECONSTR SURG, V135, P460, DOI 10.1097/PRS.0000000000000893; Ramaesh K, 2007, SURV OPHTHALMOL, V52, P50, DOI 10.1016/j.survophthal.2006.10.004; Ray WZ, 2010, EXP NEUROL, V223, P77, DOI 10.1016/j.expneurol.2009.03.031; Riedl O, 2013, PLAST RECONSTR SURG, V131, P802, DOI 10.1097/PRS.0b013e3182818cd4; ROSENBERG ML, 1984, BRAIN, V107, P1073, DOI 10.1093/brain/107.4.1073; Sacchetti M, 2014, CLIN OPHTHALMOL, V8, P571, DOI 10.2147/OPTH.S45921; Tarasidis G, 1997, ANN OTO RHINOL LARYN, V106, P506, DOI 10.1177/000348949710600612; Terzis JK, 2009, PLAST RECONSTR SURG, V124, P1499, DOI 10.1097/PRS.0b013e3181babb93; Terzis JK, 2009, PLAST RECONSTR SURG, V123, P112, DOI 10.1097/PRS.0b013e3181904d3a; Ting DSJ, 2018, CORNEA, V37, P641, DOI 10.1097/ICO.0000000000001522; Tzou CHJ, 2011, PLAST RECONSTR SURG, V128, P861, DOI 10.1097/PRS.0b013e31821b6369; VITERBO F, 1995, PLAST RECONSTR SURG, V96, P494, DOI 10.1097/00006534-199508000-00054; Viterbo F, 2000, 5 INT MUSCL S, P151	30	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206642	10.1371/journal.pone.0206642	http://dx.doi.org/10.1371/journal.pone.0206642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379941	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700139
J	Kawai, YK; Ikenaka, Y; Ishizuka, M; Kubota, A				Kawai, Yusuke K.; Ikenaka, Yoshinori; Ishizuka, Mayumi; Kubota, Akira			The evolution of UDP-glycosyl/glucuronosyltransferase 1E (UGT1E) genes in bird lineages is linked to feeding habits but UGT2 genes is not	PLOS ONE			English	Article							DIOXIN SENSITIVITY; INFERENCE; GLUCURONOSYLTRANSFERASES; PHYLOGENY; ENZYMES; MRBAYES; CLONING	UDP-glycosyltransferase (UGT) catalyzes the transfer of glycosyl groups (e.g., glucuronic acid) to exogenous or endogenous chemicals and plays an important role in conjugation reactions. In vertebrates, UGT genes are divided into 5 families: UGT1, UGT2, UGT3, UGT5, and UGT8. Among these UGT enzymes, UGT1 and UGT2 enzymes are known to be important xenobiotic metabolizing enzymes in mammals. However, little is known about UGT1 and UGT2 genes in avian species. In this study, we therefore aimed to classify avian UGT1 and UGT2 genes based on their evolutionary relationships. We also investigated the association between UGT molecular evolution and ecological factors, specifically feeding habits, habitat, and migration. By examining the genomes of 43 avian species with differing ecology, we showed that avian UGT1 E genes are divided into 6 groups and UGT2 genes into 3 groups. Correlations between UGT gene count and ecological factors suggested that the number of UGT1 E genes is decreasing in carnivorous species. Estimates of selection pressure also support the hypothesis that diet influenced avian UGT1 E gene evolution, similar to mammalian UGT1A and UGT2B genes.	[Kawai, Yusuke K.; Kubota, Akira] Obihiro Univ Agr & Vet Med, Dept Vet Med, Obihiro, Hokkaido, Japan; [Ikenaka, Yoshinori; Ishizuka, Mayumi] Hokkaido Univ, Sch Vet Med, Lab Toxicol, Sapporo, Hokkaido, Japan; [Ikenaka, Yoshinori] North West Univ, Unit Environm Sci & Management, Water Res Grp, Potchefstroom, North West Prov, South Africa	Obihiro University of Agriculture & Veterinary Medicine; Hokkaido University; North West University - South Africa	Kawai, YK (corresponding author), Obihiro Univ Agr & Vet Med, Dept Vet Med, Obihiro, Hokkaido, Japan.	ykawai@obihiro.ac.jp	IKENAKA, Yoshinori/F-8529-2012	Ikenaka, Yoshinori/0000-0002-6633-6637; Kawai, Yusuke/0000-0002-4942-4432				Almeida D, 2016, GENOME BIOL EVOL, V8, P1115, DOI 10.1093/gbe/evw041; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chouinard S, 2008, J STEROID BIOCHEM, V109, P247, DOI 10.1016/j.jsbmb.2008.03.016; Court MH, 2008, MOL PHARMACOL, V74, P744, DOI 10.1124/mol.108.045500; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Fujisawa N, 2013, J VET MED SCI, V75, P1577, DOI 10.1292/jvms.13-0179; Guillemette C, 2010, DRUG METAB REV, V42, P24, DOI 10.3109/03602530903210682; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Huang HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009144; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hwang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30017; Jedlitschky G, 1999, BIOCHEM J, V340, P837, DOI 10.1042/0264-6021:3400837; Kakehi M, 2015, TOXICOL SCI, V147, P360, DOI 10.1093/toxsci/kfv144; Karchner SI, 2006, P NATL ACAD SCI USA, V103, P6252, DOI 10.1073/pnas.0509950103; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kondo T, 2017, TOXICOL SCI, V158, P90, DOI 10.1093/toxsci/kfx072; Lerch-Henning S, 2017, J COMP PHYSIOL B, V187, P591, DOI 10.1007/s00360-016-1055-4; Li C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-69; Locuson CW, 2007, XENOBIOTICA, V37, P155, DOI 10.1080/00498250601129109; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Meech R, 2012, PHARMACOL THERAPEUT, V134, P200, DOI 10.1016/j.pharmthera.2012.01.009; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perreault M, 2013, DRUG METAB DISPOS, V41, P1616, DOI 10.1124/dmd.113.052613; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Rainio MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033926; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowland A, 2013, INT J BIOCHEM CELL B, V45, P1121, DOI 10.1016/j.biocel.2013.02.019; Shrestha B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018046; Tanabe A.S, MRBAYES5D; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Wang YM, 2014, MOL PHARMACOL, V86, P62, DOI 10.1124/mol.113.091462; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	39	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205266	10.1371/journal.pone.0205266	http://dx.doi.org/10.1371/journal.pone.0205266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379829	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700036
J	Maaser, A; Forstner, AJ; Strohmaier, J; Hecker, J; Ludwig, KU; Sivalingam, S; Streit, F; Degenhardt, F; Witt, SH; Reinbold, CS; Koller, AC; Raff, R; Heilmann-Heimbach, S; Fischer, SB; Herms, S; Hoffmann, P; Thiele, H; Nurnberg, P; Fier, HL; Orozco-Diaz, G; Carmenate-Naranjo, D; Proenza-Barzaga, N; Auburger, GWJ; Andlauer, TFM; Cichon, S; Marcheco-Teruel, B; Mors, O; Rietschel, M; Nothen, MM				Maaser, Anna; Forstner, Andreas J.; Strohmaier, Jana; Hecker, Julian; Ludwig, Kerstin U.; Sivalingam, Sugirthan; Streit, Fabian; Degenhardt, Franziska; Witt, Stephanie H.; Reinbold, Celine S.; Koller, Anna C.; Raff, Ruth; Heilmann-Heimbach, Stefanie; Fischer, Sascha B.; Herms, Stefan; Hoffmann, Per; Thiele, Holger; Nuernberg, Peter; Fier, Heide Loehlein; Orozco-Diaz, Guillermo; Carmenate-Naranjo, Deinys; Proenza-Barzaga, Niurka; Auburger, Georg W. J.; Andlauer, Till F. M.; Cichon, Sven; Marcheco-Teruel, Beatriz; Mors, Ole; Rietschel, Marcella; Noethen, Markus M.		Psychiat Genomics Consortium	Exome sequencing in large, multiplex bipolar disorder families from Cuba	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; SCHIZOPHRENIA; IDENTIFICATION; MUTATIONS; DATABASE; CACNA1C; DBNSFP; GENES; PLINK	Bipolar disorder (BD) is a major psychiatric illness affecting around 1% of the global population. BD is characterized by recurrent manic and depressive episodes, and has an estimated heritability of around 70%. Research has identified the first BD susceptibility genes. However, the underlying pathways and regulatory networks remain largely unknown. Research suggests that the cumulative impact of common alleles with small effects explains only around 25-38% of the phenotypic variance for BD. A plausible hypothesis therefore is that rare, high penetrance variants may contribute to BD risk. The present study investigated the role of rare, nonsynonymous, and potentially functional variants via whole exome sequencing in 15 BD cases from two large, multiply affected families from Cuba. The high prevalence of BD in these pedigrees renders them promising in terms of the identification of genetic risk variants with large effect sizes. In addition, SNP array data were used to calculate polygenic risk scores for affected and unaffected family members. After correction for multiple testing, no significant increase in polygenic risk scores for common, BD-associated genetic variants was found in BD cases compared to healthy relatives. Exome sequencing identified a total of 17 rare and potentially damaging variants in 17 genes. The identified variants were shared by all investigated BD cases in the respective pedigree. The most promising variant was located in the gene SERPING1 (p.L349F), which has been reported previously as a genome-wide significant risk gene for schizophrenia. The present data suggest novel candidate genes for BD susceptibility, and may facilitate the discovery of disease-relevant pathways and regulatory networks.	[Maaser, Anna; Forstner, Andreas J.; Ludwig, Kerstin U.; Sivalingam, Sugirthan; Degenhardt, Franziska; Koller, Anna C.; Raff, Ruth; Heilmann-Heimbach, Stefanie; Herms, Stefan; Hoffmann, Per; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany; [Maaser, Anna; Forstner, Andreas J.; Ludwig, Kerstin U.; Sivalingam, Sugirthan; Degenhardt, Franziska; Koller, Anna C.; Raff, Ruth; Heilmann-Heimbach, Stefanie; Herms, Stefan; Hoffmann, Per; Cichon, Sven; Noethen, Markus M.] Univ Hosp Bonn, Bonn, Germany; [Maaser, Anna; Forstner, Andreas J.; Ludwig, Kerstin U.; Sivalingam, Sugirthan; Degenhardt, Franziska; Koller, Anna C.; Heilmann-Heimbach, Stefanie; Herms, Stefan; Hoffmann, Per; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Forstner, Andreas J.; Reinbold, Celine S.; Fischer, Sascha B.; Herms, Stefan; Hoffmann, Per; Cichon, Sven] Univ Basel, Dept Biomed, Human Genom Res Grp, Basel, Switzerland; [Forstner, Andreas J.; Reinbold, Celine S.; Fischer, Sascha B.; Herms, Stefan; Hoffmann, Per; Cichon, Sven] Univ Hosp Basel, Inst Med Genet & Pathol, Basel, Switzerland; [Forstner, Andreas J.] Univ Basel, Dept Psychiat UPK, Basel, Switzerland; [Strohmaier, Jana; Streit, Fabian; Witt, Stephanie H.; Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Hecker, Julian; Fier, Heide Loehlein] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Hoffmann, Per; Cichon, Sven] Res Ctr Julich, Inst Neurosci & Med INM 1, Julich, Germany; [Thiele, Holger; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Fier, Heide Loehlein] Univ Bonn, Inst Genom Math, Bonn, Germany; [Orozco-Diaz, Guillermo] Emergency & Crit Care Unit, Malaga, Spain; [Carmenate-Naranjo, Deinys; Marcheco-Teruel, Beatriz] Med Univ Havana, Natl Ctr Med Genet, Havana, Cuba; [Proenza-Barzaga, Niurka] Gen Hosp Bayamo, Bayamo, Cuba; [Auburger, Georg W. J.] Goethe Univ Hosp, Expt Neurol, Frankfurt, Germany; [Andlauer, Till F. M.] Max Planck Inst Psychiat, Dept Translat Res Psychiat, Munich, Germany; [Andlauer, Till F. M.] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany; [Mors, Ole] Aarhus Univ Hosp, Psychosis Res Unit, Risskov, Denmark	University of Bonn; University of Bonn; University of Bonn; University of Basel; University of Basel; University of Basel; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Harvard University; Harvard T.H. Chan School of Public Health; Helmholtz Association; Research Center Julich; University of Cologne; University of Bonn; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Max Planck Society; Technical University of Munich; Aarhus University	Forstner, AJ (corresponding author), Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany.; Forstner, AJ (corresponding author), Univ Hosp Bonn, Bonn, Germany.; Forstner, AJ (corresponding author), Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany.; Forstner, AJ (corresponding author), Univ Basel, Dept Biomed, Human Genom Res Grp, Basel, Switzerland.; Forstner, AJ (corresponding author), Univ Hosp Basel, Inst Med Genet & Pathol, Basel, Switzerland.; Forstner, AJ (corresponding author), Univ Basel, Dept Psychiat UPK, Basel, Switzerland.	forstner@uni-bonn.de	Thiele, Holger/ABE-6792-2020; Mahon, Pamela Belmonte/O-9806-2018; Ludwig, Kerstin/H-7828-2019; Herms, Stefan/J-1949-2014; Andlauer, Till/AAV-1893-2020; Greenwood, Tiffany/F-6356-2012; Hoffmann, Per/A-5149-2010	Thiele, Holger/0000-0002-0169-998X; Mahon, Pamela Belmonte/0000-0002-3947-441X; Ludwig, Kerstin/0000-0002-8541-2519; Herms, Stefan/0000-0002-2786-8200; Andlauer, Till/0000-0002-2917-5889; Greenwood, Tiffany/0000-0002-6080-6503; Hoffmann, Per/0000-0002-6573-983X; Reinbold, Celine S/0000-0002-3394-3158	German Federal Ministry of Education and Research (BMBF) through Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders) under e:Med Programme [01ZX1314A/01ZX1614A, 01ZX1314G/01ZX1614G]; BONFOR program of the Medical Faculty of the University of Bonn; DFG; German Research Foundation (DFG) [FOR2107, RI908/11-1, NO246/10-1];  [DFG-INST 217/674-1 FUGG]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH109536] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research (BMBF) through Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders) under e:Med Programme(Federal Ministry of Education & Research (BMBF)); BONFOR program of the Medical Faculty of the University of Bonn; DFG(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was supported by the German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders), under the auspices of the e:Med Programme (grant 01ZX1314A/01ZX1614A to M.M.N. and S.C., grant 01ZX1314G/01ZX1614G to M.R.). A.J.F. received support from the BONFOR program of the Medical Faculty of the University of Bonn. M.M.N. is a member of the DFG-funded Excellence-Cluster ImmunoSensation. The study was also supported by the German Research Foundation (DFG; grant FOR2107; RI908/11-1 to M.R.; NO246/10-1 to M.M.N.). Instruments at the UKB NGS core facility were supported in part by grant DFG-INST 217/674-1 FUGG. The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ament SA, 2015, P NATL ACAD SCI USA, V112, P3576, DOI 10.1073/pnas.1424958112; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Belonogova NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065395; Benazzi F, 2009, PROG NEURO-PSYCHOPH, V33, P86, DOI 10.1016/j.pnpbp.2008.10.007; Blanch Alvaro, 2002, Hum Mutat, V20, P405, DOI 10.1002/humu.9073; Canty A., 2017, PACKAGE BOOT BOOTSTR; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen DT, 2013, MOL PSYCHIATR, V18, P195, DOI 10.1038/mp.2011.157; Chen YC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003224; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Collins AL, 2013, MOL PSYCHIATR, V18, P1245, DOI 10.1038/mp.2012.176; Craddock N, 1999, J MED GENET, V36, P585, DOI 10.1136/jmg.36.8.585; Cruceanu C, 2013, GENOME, V56, P634, DOI 10.1139/gen-2013-0081; Davison AC, 1997, BOOTSTRAP METHODS TH; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fiorentino A, 2014, BIPOLAR DISORD, V16, P583, DOI 10.1111/bdi.12203; Fouche AS, 2014, ANN ALLERG ASTHMA IM, V112, P371, DOI 10.1016/j.anai.2013.05.028; Georgi B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004229; Goes FS, 2016, JAMA PSYCHIAT, V73, P590, DOI 10.1001/jamapsychiatry.2016.0251; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Johnsrud I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131637; Kataoka M, 2016, MOL PSYCHIATR, V21, P885, DOI 10.1038/mp.2016.69; Kato T, 2015, PSYCHIAT CLIN NEUROS, V69, P65, DOI 10.1111/pcn.12247; Kerner Berit, 2013, Front Psychiatry, V4, P154, DOI 10.3389/fpsyt.2013.00154; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Marcheco-Teruel B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004488; Marshall CR, 2017, NAT GENET, V49, P27, DOI 10.1038/ng.3725; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Muhleisen TW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4339; Nothen Markus M, 2010, Dialogues Clin Neurosci, V12, P85; Nurnberger JI, 2014, JAMA PSYCHIAT, V71, P657, DOI 10.1001/jamapsychiatry.2014.176; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; R Development Core Team, 2017, R LANG ENV STAT COMP; Rao AR, 2017, MOL PSYCHIATR, V22, P1009, DOI 10.1038/mp.2016.181; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shinozaki G, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0493-5; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Stahl Eli A, 2019, Nat Genet, V51, P793, DOI 10.1038/s41588-019-0397-8; Strauss KA, 2014, HUM MOL GENET, V23, P6395, DOI 10.1093/hmg/ddu335; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Whiteford HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116820; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202	58	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205895	10.1371/journal.pone.0205895	http://dx.doi.org/10.1371/journal.pone.0205895			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379966	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700080
J	Oyane, A; Nakamura, M; Sakamaki, I; Shimizu, Y; Miyata, S; Miyaji, H				Oyane, Ayako; Nakamura, Maki; Sakamaki, Ikuko; Shimizu, Yoshiki; Miyata, Saori; Miyaji, Hirofumi			Laser-assisted wet coating of calcium phosphate for surface-functionalization of PEEK	PLOS ONE			English	Article							BONE-LIKE APATITE; POLYETHER ETHER KETONE; IN-VITRO; POLY(ETHERETHERKETONE) SURFACE; PRENUCLEATION CLUSTERS; BIOMIMETIC PROCESS; TITANIUM METAL; HYDROXYAPATITE; BIOACTIVITY; COMPOSITE	Calcium phosphate (CaP) coating is an effective method for surface-functionalization of bioinert materials and for production of osteoconductive implants. Recently, we developed a laser-assisted biomimetic process (LAB process) for facile and area-specific CaP coating. In this study, the LAB process was applied to chemically stable and mechanically durable poly(etheretherketone) (PEEK), which has become widely used as an orthopedic and dental implant material. The LAB process was carried out by irradiating pulsed Nd:YAG laser light (355 nm) onto a PEEK substrate that was immersed in supersaturated CaP solution. The CaP coating applicability depended on laser fluence, i.e., CaP successfully formed on PEEK surface after the LAB process at 2 W/cm(2). Further increase in laser fluence did not result in the successful formation. At the optimal fluence of 2 W/cm(2), the laser-irradiated PEEK surface was modified and heated to induce heterogeneous CaP precipitation within 10 min in CaP solution, followed by further CaP growth over the irradiation time (tested up to 30 min). The LAB process improved the cytocompatibility of PEEK surface with osteoblastic MC3T3-E1 cells. Furthermore, the LAB-processed CaP-coated PEEK substrate formed a dense hydroxyapatite layer on its surface in the simulated body fluid, suggesting the osteoconductivity of this material. The present LAB process can be a useful new tool to produce osteoconductive PEEK-based implants.	[Oyane, Ayako; Nakamura, Maki; Sakamaki, Ikuko; Shimizu, Yoshiki] Natl Inst Adv Ind Sci & Technol, Nanomat Res Inst, Tsukuba, Ibaraki, Japan; [Miyata, Saori; Miyaji, Hirofumi] Hokkaido Univ, Fac Dent Med, Dept Periodontol & Endodontol, Sapporo, Hokkaido, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Hokkaido University	Oyane, A (corresponding author), Natl Inst Adv Ind Sci & Technol, Nanomat Res Inst, Tsukuba, Ibaraki, Japan.	a-oyane@aist.go.jp	Shimizu, Yoshiki/M-6972-2018	Shimizu, Yoshiki/0000-0002-2991-1356; Oyane, Ayako/0000-0001-6037-5558; Miyaji, Hirofumi/0000-0002-1023-7680	JSPS KAKENHI (Japan Society for the Promotion of Science) [JP17H02093, JP15H00906]	JSPS KAKENHI (Japan Society for the Promotion of Science)	This study was supported by JSPS KAKENHI grant numbers JP17H02093, JP15H00906 (funder: Japan Society for the Promotion of Science; https://www.jsps.go.jp/english/index.html; AO received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkarmo S, 2013, J BIOMED MATER RES A, V101, P465, DOI 10.1002/jbm.a.34358; Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001; BOSKEY AL, 1973, J PHYS CHEM-US, V77, P2313, DOI 10.1021/j100638a011; Chou YC, 2008, J CLIN NEUROSCI, V15, P1240, DOI 10.1016/j.jocn.2007.05.016; CHRISTOFFERSEN MR, 1990, J CRYST GROWTH, V106, P349, DOI 10.1016/0022-0248(90)90079-Z; Dey A, 2010, NAT MATER, V9, P1010, DOI [10.1038/nmat2900, 10.1038/NMAT2900]; Dorozhkin SV, 2015, CERAM INT, V41, P13913, DOI 10.1016/j.ceramint.2015.08.004; Durham JW, 2017, J BIOMED MATER RES B, V105, P560, DOI 10.1002/jbm.b.33578; Gebauer D, 2011, NANO TODAY, V6, P564, DOI 10.1016/j.nantod.2011.10.005; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013; Laurens P, 2000, APPL SURF SCI, V154, P211, DOI 10.1016/S0169-4332(99)00443-2; Lee BH, 2009, ACS APPL MATER INTER, V1, P1520, DOI 10.1021/am900183e; Lee JC, 2016, J CERAM PROCESS RES, V17, P732; Ma R, 2014, INT J MOL SCI, V15, P5426, DOI 10.3390/ijms15045426; Mahanti M, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/30/304003; MCDOWELL H, 1977, J RES NBS A PHYS CH, V81, P273, DOI 10.6028/jres.081A.017; Miyazaki T, 2017, MAT SCI ENG C-MATER, V70, P71, DOI 10.1016/j.msec.2016.08.058; Najeeb S, 2015, INT J DENT, V2015, DOI 10.1155/2015/381759; Nakamura M, 2016, J MATER CHEM B, V4, P6289, DOI 10.1039/c6tb01362g; Nathanael AJ, 2018, ACTA BIOMATER, V79, P148, DOI 10.1016/j.actbio.2018.08.025; Onuma K, 1998, CHEM MATER, V10, P3346, DOI 10.1021/cm980062c; Oyane A, 1999, J PHYS CHEM B, V103, P8230, DOI 10.1021/jp9910340; Oyane A, 2006, BIOMATERIALS, V27, P167, DOI 10.1016/j.biomaterials.2005.06.001; Oyane A, 2015, COLLOID INTERFAC SCI, V4, P5, DOI 10.1016/j.colcom.2015.03.003; Oyane A, 2014, RSC ADV, V4, P53645, DOI 10.1039/c4ra09313e; Oyane A, 2013, KEY ENG MATER, V529-530, P217, DOI 10.4028/www.scientific.net/KEM.529-530.217; Oyane A, 2012, J BIOMED MATER RES A, V100A, P2573, DOI 10.1002/jbm.a.34192; Oyane A, 2012, ACTA BIOMATER, V8, P2034, DOI 10.1016/j.actbio.2012.02.003; Panayotov IV, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5731-4; Pecheva E, 2008, CHEM ENG J, V137, P144, DOI 10.1016/j.cej.2007.07.096; Pino M, 2008, ACTA BIOMATER, V4, P1827, DOI 10.1016/j.actbio.2008.05.004; Poulsson AHC, 2014, BIOMATERIALS, V35, P3717, DOI 10.1016/j.biomaterials.2013.12.056; Riveiro A, 2012, APPL SURF SCI, V258, P9437, DOI 10.1016/j.apsusc.2012.01.154; Shimizu T, 2016, ACTA BIOMATER, V35, P305, DOI 10.1016/j.actbio.2016.02.007; Tanahashi M, 1997, J BIOMED MATER RES, V34, P305; Toita R, 2015, J MATER CHEM B, V3, P8738, DOI 10.1039/c5tb01679g; Uchida M, 2004, ADV MATER, V16, P1071, DOI 10.1002/adma.200400152; VANKEMENADE MJJM, 1987, J COLLOID INTERF SCI, V118, P564, DOI 10.1016/0021-9797(87)90490-5; Wang LX, 2014, BIOMATERIALS, V35, P6758, DOI 10.1016/j.biomaterials.2014.04.085; Wang XP, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/022001; Wu GM, 2009, SURF COAT TECH, V203, P2755, DOI 10.1016/j.surfcoat.2009.02.115; Zhao Y, 2013, BIOMATERIALS, V34, P9264, DOI 10.1016/j.biomaterials.2013.08.071; Zheng YY, 2015, MAT SCI ENG C-MATER, V55, P512, DOI 10.1016/j.msec.2015.05.070; Zheng YY, 2014, MATER LETT, V126, P147, DOI 10.1016/j.matlet.2014.04.021	45	17	18	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206524	10.1371/journal.pone.0206524	http://dx.doi.org/10.1371/journal.pone.0206524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379904	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700126
J	Berli, C; Luscher, J; Luszczynska, A; Schwarzer, R; Scholz, U				Berli, Corina; Luescher, Janina; Luszczynska, Aleksandra; Schwarzer, Ralf; Scholz, Urte			Couples' daily self-regulation: The Health Action Process Approach at the dyadic level	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PHYSICAL-ACTIVITY; BEHAVIOR-CHANGE; EFFICACY; SMOKING; INTENTIONS; ADULTS; ASSOCIATIONS; EXERCISE; LIFE	Objective Regulating health behavior change often occurs in a dyadic context of romantic relationships. Dyadic approaches to standard health behavior change models are, however, barely considered. We investigated volitional processes of the Health Action Process Approach model for two health behaviors within a dyadic context of romantic couples. Specifically, we tested whether day-to-day volitional self-regulation predicted one's own and one's partner's cigarettes smoked (Study 1) and physical activity (Study 2). Methods In two dyadic intensive longitudinal studies (Study 1: 83 dual-smoker couples intending to jointly quit smoking; Study 2: 61 overweight couples intending to become physically active), heterosexual partners independently reported on intention, self-efficacy, action planning, and action control in end-of-day diaries. In Study 1, daily number of cigarettes smoked was assessed via self-report. In Study 2, daily moderate-to-vigorous physical activity (MVPA) was assessed objectively via accelerometers. In both studies, dyadic cross-lagged intensive longitudinal analyses based on the Actor-Partner Interdependence Model were applied. Results Across both studies, individual's own volitional self-regulation positively predicted one's own health behavior (less cigarettes smoked and more MVPA). One's partner's action control and intention also positively predicted one's own health behavior. A marginal partner effect for self-efficacy was found in the context of smoking only. Conclusions Behavioral self-regulation is not only relevant for individuals themselves, but some volitional processes may spill over to their partners. This highlights the need to specify couple-level processes involved in health behavior change, and to consider a social context of self-regulation.	[Berli, Corina; Luescher, Janina; Scholz, Urte] Univ Zurich, Dept Psychol, Zurich, Switzerland; [Luszczynska, Aleksandra] Univ Colorado, Trauma Hlth & Hazards Ctr, Colorado Springs, CO 80907 USA; [Luszczynska, Aleksandra; Schwarzer, Ralf] SWPS Univ Social Sci & Humanities, Psychol Dept, Wroclaw, Poland; [Schwarzer, Ralf] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany; [Scholz, Urte] Univ Zurich, Univ Res Prior Program Dynam Hlth Aging, Zurich, Switzerland	University of Zurich; University of Colorado System; University of Colorado at Colorado Springs; SWPS University of Social Sciences & Humanities; Free University of Berlin; University of Zurich	Berli, C (corresponding author), Univ Zurich, Dept Psychol, Zurich, Switzerland.	corina.berli@psychologie.uzh.ch	Luszczynska, Aleksandra/F-3692-2014; Schwarzer, Ralf/C-4581-2014	Luszczynska, Aleksandra/0000-0002-4704-9544; Schwarzer, Ralf/0000-0002-0069-3826; Scholz, Urte/0000-0003-0184-5921	Swiss National Science Foundation [PP00P1_133632/1, CR12I1_166348/1]; National Science Center, Poland [2014/15/B/HS6/00923]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Center, Poland(National Science Centre, Poland)	The two projects (PP00P1_133632/1), Corina Berli (PP00P1_133632/1) and Janina Luscher (PP00P1_133632/1 and CR12I1_166348/1) were funded by the Swiss National Science Foundation, www.snf.ch.Aleksandra Luszczynska's contribution was supported by grant number 2014/15/B/HS6/00923 from the National Science Center, Poland, https://www.ncn.gov.pl/?language=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I, 1985, ACTION CONTROL, P11; Atkins DC, 2013, PSYCHOL ADDICT BEHAV, V27, P166, DOI 10.1037/a0029508; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bergkvist L, 2007, J MARKETING RES, V44, P175, DOI 10.1509/jmkr.44.2.175; Berli C, 2016, SOC SCI MED, V163, P89, DOI 10.1016/j.socscimed.2016.07.003; Berli C, 2015, J BEHAV MED, V38, P306, DOI 10.1007/s10865-014-9598-x; Bierbauer W, 2017, APPL PSYCHOL-HLTH WE, DOI [10.1111/aphw.12084PMID:29024515, DOI 10.1111/APHW.12084]; Bolger N, 2013, INTENSIVE LONGITUDIN; Burkert S, 2011, SOC SCI MED, V73, P783, DOI 10.1016/j.socscimed.2011.06.016; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Cobb LK, 2016, AM J EPIDEMIOL, V183, P444, DOI 10.1093/aje/kwv104; FIORE MC, 2000, TREATING TOBACCO USE; Fitzsimons GM, 2015, PSYCHOL REV, V122, P648, DOI 10.1037/a0039654; Gesundheit N, 2009, BEW SCHW GES BEW; Holt-Lunstad J, 2017, AM PSYCHOL, V72, P517, DOI 10.1037/amp0000103; Howland M, 2016, HEALTH PSYCHOL, V35, P733, DOI 10.1037/hea0000334; Jackson SE, 2015, JAMA INTERN MED, V175, P385, DOI 10.1001/jamainternmed.2014.7554; Kenny D. A., 2006, DYADIC DATA ANAL; Knoll N, 2017, HEALTH PSYCHOL, V36, P8, DOI 10.1037/hea0000423; Kreft I. G., 1998, INTRO MULTILEVEL MOD, DOI DOI 10.4135/9781849209366; Laurenceau J.-P., 2012, HDB RES METHODS STUD, P407; Luscher J, 2017, DAILY DIARY STUDY JO; Maher JP, 2016, HEALTH PSYCHOL, V35, P262, DOI 10.1037/hea0000300; Meyler D, 2007, SOC SCI MED, V64, P2297, DOI 10.1016/j.socscimed.2007.02.007; Parschau L, 2014, REHABIL PSYCHOL, V59, P42, DOI 10.1037/a0035290; Prestwich A, 2012, HEALTH PSYCHOL, V31, P486, DOI 10.1037/a0027672; Rohrbaugh MJ, 2004, J FAM PSYCHOL, V18, P184, DOI 10.1037/0893-3200.18.1.184; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Scholz U, 2008, BRIT J SOC PSYCHOL, V47, P421, DOI 10.1348/014466607X266606; Scholz U, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1321; Scholz U, 2009, HEALTH PSYCHOL, V28, P702, DOI 10.1037/a0016088; Scholz U, 2009, PSYCHOL HEALTH, V24, P545, DOI 10.1080/08870440801902519; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; Sniehotta FF, 2006, BRIT J SOC PSYCHOL, V45, P87, DOI 10.1348/014466605X62460; Sniehotta FF, 2005, PSYCHOL HEALTH, V20, P143, DOI 10.1080/08870440512331317670; Stadler G, 2012, PSYCHOSOM MED, V74, P398, DOI 10.1097/PSY.0b013e31825473b8; Sterba KR, 2011, NICOTINE TOB RES, V13, P194, DOI 10.1093/ntr/ntq236; United Nations, 2011, POP FACTS; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; Wilson SE, 2002, SOC SCI MED, V55, P1157, DOI 10.1016/S0277-9536(01)00253-2	41	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0205887	10.1371/journal.pone.0205887	http://dx.doi.org/10.1371/journal.pone.0205887			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY5SG	30372470	Green Published, gold, Green Accepted			2022-12-26	WOS:000448641200018
J	Honermann, B; Sharp, A; Sherwood, J; Kshetry, P; Jones, A; O'Hagan, R; Lazar, L; Chandra, C; Hoffmann, T; Millett, G				Honermann, Brian; Sharp, Alana; Sherwood, Jennifer; Kshetry, Pratima; Jones, Austin; O'Hagan, Richael; Lazar, Laura; Chandra, Christina; Hoffmann, Topher; Millett, Greg			Calculating indirect costs from international PEPFAR implementing partners	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV; PEOPLE	Background UNAIDS estimates global HIV investment needs in low- and middle-income countries (LMICs) at $26 billion per year in 2020. Yet international financing for HIV programs has stagnated amidst despite the increasing number of people requiring and accessing treatment. Despite increased efficiencies in HIV service delivery, evaluating programs for greater efficiencies remains necessary. While HIV budgets have been under scrutiny in recent years, indirect costs have not been quantified for any major global HIV program, but may constitute an additional avenue to identify program efficiencies. This analysis presents a method for estimating indirect costs in the President's Emergency Plan for AIDS Relief (PEPFAR). Methods Utilizing PEPFAR country operational plan (COP) funding data from 2007 to 2016 for international organizations (IOs) and universities and standard regulatory cost bases, we calculated modified total direct costs on which indirect cost rates may be applied by partner and funding agency. We then apply a series of plausible indirect cost rates (10%-36.28%) to develop a range for total indirect costs that have accrued over the period. Findings Of $37.01 billion in total COP funding between 2007 and 2016, $22.24 billion (60.08%) was identifiably allocated to lOs ($17.95B) and universities ($4.29B). After excluding funding for sub-awards ($1.92B) and other expenses ($3.89B) to which indirect rates cannot be applied, $16.44B remained in combined direct and indirect costs. From this, we estimate that between $1.85B (8.30% of total international partner funding) and $4.34B (19.51%) has been spent on indirect costs from 2007-2016, including $157-$369 million in 2016. Interpretation To our knowledge, this is the first analysis to quantify the indirect costs of major implementing partners of a global HIV funder. However, lack of transparency in the indirect cost rates of non-University international partners creates an opaque layer of programmatic costs. Given the current funding environment and evolution of HIV programming in PEPFAR countries, the findings motivate a re-examination of the current policies and the return on investment in indirect cost recovery across the PEPFAR program.	[Honermann, Brian; Sharp, Alana; Sherwood, Jennifer; Kshetry, Pratima; Jones, Austin; O'Hagan, Richael; Lazar, Laura; Chandra, Christina; Hoffmann, Topher; Millett, Greg] amfAR, Fdn AIDS Res, Washington, DC 20005 USA		Honermann, B (corresponding author), amfAR, Fdn AIDS Res, Washington, DC 20005 USA.	brian.honermann@amfar.org		Chandra, Christina/0000-0002-9471-5749; Honermann, Brian/0000-0002-4907-0603; Sherwood, Jennifer/0000-0003-2814-1684				amfAR, COUNTR REG OP PLAN D; [Anonymous], 2017, FILES RECORD AUTHORS; Barnhart S, 2016, LANCET, V387, P943, DOI 10.1016/S0140-6736(16)00570-5; Children's Investment Fund Foundation and United States President's Emergency Plan for AIDS Relief, 2014, ACC CHILDR HIV AIDS; Crane JT, 2010, J CIVILIZATION, P78; Duncombe C, 2015, TROP MED INT HEALTH, V20, P430, DOI 10.1111/tmi.12460; Github, AMFAR PPO IND MOD; Jennifer Kates BH, 2016, AIDS2016; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Kaiser J., 2017, SCIENCE; Ledford H, 2014, NATURE, V515, P326, DOI 10.1038/515326a; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Medicine JH., INDIRECT COST RATES; MSF, 2016, UNT WEB ANT PRIC RED; National Institutes of Health, RES PORTF ONL REP TO; PEPFAR, PROGR RES ACH PEPFAR; PEPFAR, PEPFAR FUND; PEPFAR, COUNTR OP PLANS; PEPFAR, 2016, SUST HIV EP CONTR; PEPFAR, 2018, PEPFAR Q DAT; Queenan Jeri Eckhard, 2013, STOP STARVING SCALE; Rouzier V, 2014, ANTIVIR THER, V19, P91, DOI 10.3851/IMP2904; Treasury USDo, 2018, NON TRADITIONAL REF; UNAIDS, 2016, FAST TRACK UPD INV N; UNAIDS, NEW HIGH QUAL ANT TH; UNAIDS K, 2017, DON GOV FUND HIV LOW; USAID, 2016, IND COST RAT GUID NO	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206425	10.1371/journal.pone.0206425	http://dx.doi.org/10.1371/journal.pone.0206425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372464	Green Published, gold, Green Submitted			2022-12-26	WOS:000448641200037
J	Suh, JK; Lee, J; Lee, JH; Shin, S; Tchoe, HJ; Kwon, JW				Suh, Jae Kyung; Lee, Jayoun; Lee, Jeong-Hoon; Shin, Sangjin; Tchoe, Ha Jin; Kwon, Jin-Won			Risk factors for developing liver cancer in people with and without liver disease	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA INCIDENCE; HEPATITIS-B-VIRUS; CLINICAL-OUTCOMES; UNITED-STATES; ASSOCIATION; POPULATION; MORTALITY; COHORT; TRENDS; RATES	Background The National Liver Cancer Surveillance Program (NLCSP) targets patients with liver diseases that lead to liver cancer in South Korea. This study aimed to investigate the risk of liver disease leading to liver cancer using nationally representative data to establish an efficient NLCSP. Methods This study used data from the National Health Insurance Service National Sample Cohort (NHIS-NSC) from 2002 to 2013. A retrospective matched cohort design was applied to compare the development of liver cancer in patients with and without liver disease. Cox- proportional hazard regression for liver cancer with competing risk of death was performed for all subjects or each group stratified according to age or income level. Results A total of 66,192 patients with liver disease and matched subjects without liver disease were included in the study. The incidences of liver cancer among patients with and without liver disease within a median 8-year follow-up period were 2.68% (n = 1,772) and 0.34% (n = 210), respectively. Cox- regression analysis for liver cancer incidence indicated that cirrhosis had the highest risk (hazard ratio [HR]: 18.13, 95% confidence interval [CI]: 15.24-21.58), followed by hepatitis B (HR: 9.32, 95% CI: 8.00-10.85). Subgroup analysis showed that the presence of liver disease was an important risk factor in younger as well as elderly people, and a higher risk of liver disease was also observed in the patients with Medicaid. Conclusions Attention should be paid to the development of liver cancer in young people under 50 years old and preventive efforts to decrease the incidence of liver cancer among Medicaid recipients is needed.	[Suh, Jae Kyung; Lee, Jayoun; Lee, Jeong-Hoon; Shin, Sangjin; Tchoe, Ha Jin; Kwon, Jin-Won] Natl Evidence Based Healthcare Collaborating Agcy, Div Healthcare Technol Assessment Res, Seoul, South Korea; [Lee, Jeong-Hoon] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kwon, Jin-Won] Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea; [Kwon, Jin-Won] Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Daegu, South Korea	National Evidence-based Healthcare Collaborating Agency (NECA); Seoul National University (SNU); Seoul National University Hospital; Kyungpook National University; Kyungpook National University	Kwon, JW (corresponding author), Natl Evidence Based Healthcare Collaborating Agcy, Div Healthcare Technol Assessment Res, Seoul, South Korea.; Kwon, JW (corresponding author), Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea.; Kwon, JW (corresponding author), Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Daegu, South Korea.	jwkwon@knu.ac.kr	Tchoe, Hajin/GSE-2969-2022		National Evidence-based Healthcare Collaborating Agency [NB16-001]; NHIS	National Evidence-based Healthcare Collaborating Agency; NHIS	This study was supported by the National Evidence-based Healthcare Collaborating Agency (NB16-001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study used the NHIS-NSC data (NHIS-2016-2-203) provided by the National Health Insurance Service (NHIS). We thank NHIS for the support. The authors declare that they have no conflict of interest.	Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11; Anyiwe K, 2016, LIVER INT, V36, P902, DOI 10.1111/liv.12982; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; El-Serag HB, 2014, HEPATOLOGY, V60, P1767, DOI 10.1002/hep.27222; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Jung KW, 2017, CANCER RES TREAT, V49, P306, DOI 10.4143/crt.2017.130; Kim BK, 2012, LIVER INT, V32, P1120, DOI 10.1111/j.1478-3231.2012.02811.x; Kim BH, 2018, CLIN MOL HEPATOL, V24, P1, DOI 10.3350/cmh.2017.0112; Kim BH, 2018, J GASTROEN HEPATOL, V33, P475, DOI 10.1111/jgh.13848; Kwak HW, 2014, J GASTROEN HEPATOL, V29, P820, DOI 10.1111/jgh.12470; Lee EY, 2011, BMC NURS, V10, DOI 10.1186/1472-6955-10-22; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Lee YS, 2018, GUT LIVER, V12, P94, DOI 10.5009/gnl17040; Li LB, 2016, J CANCER RES THER, V12, P284, DOI 10.4103/0973-1482.200763; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; McGlynn KA, 2015, CLIN LIVER DIS, V19, P223, DOI 10.1016/j.cld.2015.01.001; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Park B, 2012, CANCER RES TREAT, V44, P113, DOI 10.4143/crt.2012.44.2.113; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Petrick JL, 2016, INT J CANCER, V139, P1534, DOI 10.1002/ijc.30211; Sinn DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112184; Yang T, 2011, WORLD J SURG, V35, P2073, DOI 10.1007/s00268-011-1161-0; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; Zhao CQ, 2016, J CLIN GASTROENTEROL, V50, P120, DOI 10.1097/MCG.0000000000000446	24	22	23	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206374	10.1371/journal.pone.0206374	http://dx.doi.org/10.1371/journal.pone.0206374			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372481	Green Published, Green Submitted, gold			2022-12-26	WOS:000448641200033
J	Fridman, I; Ubel, PA; Higgins, ET				Fridman, Ilona; Ubel, Peter A.; Higgins, E. Tory			Eye-tracking evidence shows that non-fit messaging impacts attention, attitudes and choice	PLOS ONE			English	Article							AFFECTIVE-COGNITIVE CONSISTENCY; REGULATORY FIT; PERSUASIVE APPEALS; INFORMATION; MEDIATION; FOCUS; EXPERIENCES; COMPLEXITY; PREVENTION; PROMOTION	When patients have strong initial attitudes about a medical intervention, they might not be open to learning new information when choosing whether or not to receive the intervention. We aim to show that non-fit messaging (messages framed in a manner that is incongruent with recipients' motivational orientation) can increase attention to the message content, thereby de-intensifying an initial attitude bias and reducing the influence of this bias on choice. In this study, 196 students received information about the pros and cons of a vaccine, framed in either a fit or non-fit manner with their motivational orientation. The results show that when information was presented in a non-fit (vs. fit) manner, the strength of participants' initial attitude was reduced. An eye-tracking procedure indicated that participants read information more thoroughly (measured by the average length of fixation time while reading) in the non-fit condition versus fit condition. This average time of fixation mediated the effect of message framing on the strength of people's attitudes. A reduction in attitude was associated with participants' ability to recall the given information correctly and make a choice consistent with the provided information. Non-fit messaging increases individuals' willingness to process information when individuals' pre-existing attitude biases might otherwise cause them to make uninformed decisions.	[Fridman, Ilona; Higgins, E. Tory] Columbia Business Sch, Management Dept, New York, NY 10027 USA; [Ubel, Peter A.] Duke Univ, Fuqua Sch Business Sch, Sanford Sch Publ Policy, Durham, NC USA	Columbia University; Duke University	Fridman, I (corresponding author), Columbia Business Sch, Management Dept, New York, NY 10027 USA.	ilona.fridman@duke.edu						Alter AL, 2007, J EXP PSYCHOL GEN, V136, P569, DOI 10.1037/0096-3445.136.4.569; Avnet T, 2003, J EXP SOC PSYCHOL, V39, P525, DOI 10.1016/S0022-1031(03)00027-1; Cesario J, 2004, J PERS SOC PSYCHOL, V86, P388, DOI 10.1037/0022-3514.86.3.388; CHAIKEN S, 1981, J PERS SOC PSYCHOL, V41, P1, DOI 10.1037/0022-3514.41.1.1; CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752; CHAIKEN S, 1985, J PERS SOC PSYCHOL, V49, P1470, DOI 10.1037/0022-3514.49.6.1470; Collins LM, 1998, MULTIVAR BEHAV RES, V33, P295, DOI 10.1207/s15327906mbr3302_5; Eagly A.H., 1998, HDB SOCIAL PSYCHOL; Ferrer RA, 2016, J BEHAV DECIS MAKING, V29, P245, DOI 10.1002/bdm.1871; Festinger L., 1962, THEORY COGNITIVE DIS; Fridman I., 2017, REGULATORY FOCUS REG, DOI 10.1093/acrefore/9780190228613.001.0001/acrefore-9780190228613-e-257; Fridman I, 2016, PERS SOC PSYCHOL B, V42, P1025, DOI 10.1177/0146167216649931; Gliem JA, MIDWEST RES TO PRACT; Halvorson HG, 2013, FOCUS USE DIFFERENT; Hayes A., 2017, INTRO MEDIATION MODE; Hernandez J, DISFLUENCY DISRUPTS; Higgins ET, 2006, PSYCHOL REV, V113, P439, DOI 10.1037/0033-295X.113.3.439; Higgins ET, 2000, AM PSYCHOL, V55, P1217, DOI 10.1037/0003-066X.55.11.1217; Higgins ET, 1998, ADV EXP SOC PSYCHOL, V30, P1, DOI 10.1016/S0065-2601(08)60381-0; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Higgins ET, 2003, J PERS SOC PSYCHOL, V84, P1140, DOI 10.1037/0022-3514.84.6.1140; Higgins ET, 2001, EUR J SOC PSYCHOL, V31, P3, DOI 10.1002/ejsp.27; Higgins ET, 2014, DUAL PROCESS ORIE, P423; Higgins ET, MOTIVATION SELF REGU, P78; Hirsh JB, 2012, PSYCHOL SCI, V23, P578, DOI 10.1177/0956797611436349; Idson LC, 2004, PERS SOC PSYCHOL B, V30, P926, DOI 10.1177/0146167204264334; JUDD CM, 1981, EVALUATION REV, V5, P602, DOI 10.1177/0193841X8100500502; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Koenig AM, 2009, PERS SOC PSYCHOL B, V35, P1342, DOI 10.1177/0146167209339076; Kuo FY, 2009, DECIS SUPPORT SYST, V48, P81, DOI 10.1016/j.dss.2009.06.011; Lanaj K, 2012, PSYCHOL BULL, V138, P998, DOI 10.1037/a0027723; Lee AY, 2004, J PERS SOC PSYCHOL, V86, P205, DOI 10.1037/0022-3514.86.2.205; LINVILLE PW, 1982, J PERS SOC PSYCHOL, V42, P193, DOI 10.1037/0022-3514.42.2.193; Ludolph R, 2015, SOC SCI MED, V128, P142, DOI 10.1016/j.socscimed.2015.01.021; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MAHESWARAN D, 1991, J PERS SOC PSYCHOL, V61, P13, DOI 10.1037/0022-3514.61.1.13; Noar SM, 2007, PSYCHOL BULL, V133, P673, DOI 10.1037/0033-2909.133.4.673; Petty R.E., 1986, ADV EXPT SOCIAL PSYC, V19, P123, DOI [10.1016/S0065-2601(08)60214-2, DOI 10.1016/S0065-2601(08)60214-2, https://doi.org/10.1016/S0065-2601(08)60214-2]; PETTY RE, 1979, J PERS SOC PSYCHOL, V37, P1915, DOI 10.1037/0022-3514.37.10.1915; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1986, MEM COGNITION, V14, P191, DOI 10.3758/BF03197692; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Tsai CI, 2008, ORGAN BEHAV HUM DEC, V107, P97, DOI 10.1016/j.obhdp.2008.01.005; Vaughn LA, 2006, J EXP SOC PSYCHOL, V42, P654, DOI 10.1016/j.jesp.2005.09.004; Zola D, 1981, 216 CTR STUD READ	49	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0205993	10.1371/journal.pone.0205993	http://dx.doi.org/10.1371/journal.pone.0205993			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3KA	30365559	gold, Green Published, Green Submitted			2022-12-26	WOS:000448448700020
J	Kim, YE; Park, WS; Ahn, SY; Sung, DK; Chang, YS				Kim, Young Eun; Park, Won Soon; Ahn, So Yoon; Sung, Dong Kyung; Chang, Yun Sil			Intratracheal transplantation of mesenchymal stem cells attenuates hyperoxia-induced lung injury by down-regulating, but not direct inhibiting formyl peptide receptor 1 in the newborn mice	PLOS ONE			English	Article							ALVEOLAR COUNT METHOD; HOST-DEFENSE; PATHOGENESIS; REAPPRAISAL; CHEMOKINES; MITHAL; EMERY	Formyl peptide receptor 1 (FPR1) has been shown to be a key regulator of inflammation. However, its role in bronchopulmonary dysplasia (BPD) has not been delineated yet. We investigated whether FPR1 plays a pivotal role in regulating lung inflammation and injuries, and whether intratracheally transplanted mesenchymal stem cells (MSCs) attenuate hyperoxic lung inflammation and injuries by down-regulating FPR1. Newborn wild type (WT) or FPR1 knockout (FPR1(-/-)) C57/BL6 mice were randomly exposed to 80% oxygen or room air for 14 days. At postnatal day (P) 5, 2x10(5) MSCs were intratracheally transplanted. At P14, mice were sacrificed for histopathological and morphometric analyses. Hyperoxia significantly increased lung neutrophils, macrophages, and TUNEL-positive cells, while impairing alveolarization and angiogenesis, along with a significant increase in FPR1 mRNA levels in WT mice. The hyperoxia-induced lung inflammation and lung injuries were significantly attenuated, with the reduced mRNA level of FPR1, in WT mice with MSC transplantation and in FPR1(-/-) mice, irrespective of MSCs transplantation. However, only MSC transplantation, but not the FPR1 knockout, significantly attenuated the hyperoxia-induced increase in TUNEL-positive cells. Our findings indicate that FPR1 play a critical role in regulating lung inflammation and injuries in BPD, and MSCs attenuate hyperoxic lung inflammation and injuries, but not apoptosis, with down regulating, but not direct inhibiting FPR1.	[Kim, Young Eun; Chang, Yun Sil] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Kim, Young Eun; Park, Won Soon; Ahn, So Yoon; Sung, Dong Kyung; Chang, Yun Sil] Samsung Med Ctr, Stem Cell & Regenerat Med Inst, Seoul, South Korea; [Park, Won Soon; Ahn, So Yoon; Chang, Yun Sil] Samsung Med Ctr, Dept Pediat, Seoul, South Korea; [Park, Won Soon; Sung, Dong Kyung; Chang, Yun Sil] Sungkyunkwan Univ, Samsung Biomed Res Inst, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Chang, YS (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.; Chang, YS (corresponding author), Samsung Med Ctr, Stem Cell & Regenerat Med Inst, Seoul, South Korea.; Chang, YS (corresponding author), Samsung Med Ctr, Dept Pediat, Seoul, South Korea.; Chang, YS (corresponding author), Sungkyunkwan Univ, Samsung Biomed Res Inst, Sch Med, Seoul, South Korea.	yschang@skku.edu		Chang, Yun Sil/0000-0001-9201-2938	Korean Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [HI12C1821, HI14C3484]; Samsung Biomedical Research Institute; Samsung Advanced Institute for Health Sciences and Technology; Samsung Medical Center	Korean Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea; Samsung Biomedical Research Institute(Samsung); Samsung Advanced Institute for Health Sciences and Technology(Samsung); Samsung Medical Center(Samsung)	This work was supported by grants HI12C1821 and HI14C3484 from the Korean Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Young Eun Kim and Yun Sil Chang are employed by Samsung Advanced Institute for Health Sciences and Technology (SAIHST). Won Soon Park, Ahn So Yoon, Dong Kyung Sung and Yun Sil Chang are employed by Samsung Medical Center. Won Soon Park, DongKyung Sung and Yun Sil Chang are employed by Samsung Biomedical Research Institute. Samsung Biomedical Research Institute, Samsung Advanced Institute for Health Sciences and Technology and Samsung Medical Center provided support in the form of salaries for authors YEK, YSC, WSP, ASY and DKS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahn SY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25902-x; Ahn SY, 2017, J PEDIATR-US, V185, P49, DOI 10.1016/j.jpeds.2017.02.061; Ahn SY, 2013, YONSEI MED J, V54, P416, DOI 10.3349/ymj.2013.54.2.416; Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Anderson PJ, 2006, SEMIN PERINATOL, V30, P227, DOI 10.1053/j.semperi.2006.05.010; Bhandari V, 2007, J IMMUNOL, V178, P4993, DOI 10.4049/jimmunol.178.8.4993; Bhandari V, 2014, BIRTH DEFECTS RES A, V100, P189, DOI 10.1002/bdra.23220; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Cardini S, 2012, AM J RESP CELL MOL, V47, P332, DOI 10.1165/rcmb.2012-0036OC; Chang YS, 2013, PUBMED, V8, P52419; Chang YS, 2014, J PEDIATR-US, V164, P966, DOI 10.1016/j.jpeds.2013.12.011; Chang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052419; Chang YS, 2011, CELL TRANSPLANT, V20, P1843, DOI 10.3727/096368911X565038; Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189; Chao CM, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00027; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Comoli P, 2008, NEPHROL DIAL TRANSPL, V23, P1196, DOI 10.1093/ndt/gfm740; COONEY TP, 1982, THORAX, V37, P572, DOI 10.1136/thx.37.8.572; COONEY TP, 1982, THORAX, V37, P580, DOI 10.1136/thx.37.8.580; Dahlgren C, 2016, BIOCHEM PHARMACOL, V114, P22, DOI 10.1016/j.bcp.2016.04.014; Dorward DA, 2017, THORAX, V72, P928, DOI 10.1136/thoraxjnl-2017-210030; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; English K, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015560; Fillion I, 2001, J IMMUNOL, V166, P7353, DOI 10.4049/jimmunol.166.12.7353; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gauthier JF, 2007, INFECT IMMUN, V75, P5361, DOI 10.1128/IAI.02008-06; GAVINS FN, FASEB JOURNAL OFFICI, P1; Gien J, 2011, CURR OPIN PEDIATR, V23, P305, DOI 10.1097/MOP.0b013e328346577f; Grommes J, 2014, J INNATE IMMUN, V6, P111, DOI 10.1159/000353229; Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00007; Jobe AH, 2016, AM J PERINAT, V33, P1076, DOI 10.1055/s-0036-1586107; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Liu M., 2012, PUBMED, V2, P786; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Park WS, 2018, PEDIATR RES, V83, P214, DOI 10.1038/pr.2017.249; Park WS, 2016, CELL TRANSPLANT, V25, P1131, DOI 10.3727/096368915X689640; PMID, PUBMED; Snyder JM, 2005, PEDIATR RES, V57, P384, DOI 10.1203/01.PDR.0000151315.81106.D3; Sung DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135574; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Warner BB, 1998, AM J PHYSIOL-LUNG C, V275, pL110, DOI 10.1152/ajplung.1998.275.1.L110; Yang SE, 2004, CYTOTHERAPY, V6, P476, DOI 10.1080/14653240410005041; ZHANG Q, 2007, PUBMED, DOI DOI 10.1038/NATURE08780	46	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206311	10.1371/journal.pone.0206311	http://dx.doi.org/10.1371/journal.pone.0206311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356317	gold, Green Published, Green Submitted			2022-12-26	WOS:000448434000092
J	Palaniswamy, V; Ng, SK; Manickaraj, N; Ryan, M; Yelland, M; Rabago, D; Bisset, L				Palaniswamy, Vijayakumar; Ng, Shu-Kay; Manickaraj, Nagarajan; Ryan, Michael; Yelland, Michael; Rabago, David; Bisset, Leanne			Relationship between ultrasound detected tendon abnormalities, and sensory and clinical characteristics in people with chronic lateral epicondylalgia	PLOS ONE			English	Article							TENNIS ELBOW; CENTRAL SENSITIZATION; THERMAL HYPERALGESIA; GRIP STRENGTH; PAIN; TENDINOPATHY; PRESSURE; RELIABILITY; THRESHOLDS; THICKNESS	Objective To investigate the relationship between tendon structural changes determined by static ultrasound images (US) and sensory changes using quantitative sensory testing (QST), and clinical measures in lateral epicondylalgia. Materials and methods Both elbows of 66 adult participants with a clinical diagnosis of lateral epicondylalgia were investigated. Using a standardised ultrasound image rating scale, common extensor hypoechogenicity, heterogenicity, neovascularity, and bony abnormalities at the enthesis were scored, and tendon thickness (longitudinal and transverse plane) was measured by a trained assessor. Sensory measures of pressure, heat and cold pain thresholds and vibration detection threshold were recorded. Pain and function were assessed using the patientrated tennis elbow (PRTEE), pain-free grip strength, pain visual analog scale (PVAS) and quality of life (EuroQoL EQ -5D). Univariate and multivariate linear regression analyses were used to explore the association between tendon structural, sensory and clinical variables which were adjusted for age, gender and duration of symptoms. Results A negative correlation was identified between the presence of neovascularity and cold pain threshold (P = 0.015). Multiple regression analyses revealed that a combination of female gender (P = 0.044) and transverse tendon thickness (P = 0.010) were significantly associated with vibration detection threshold in affected elbows, while gender (P = 0.012) and total ultrasound scale score (P = 0.024) were significantly associated with heat pain threshold and vibration detection threshold in unaffected elbows. Heat pain threshold and gender were significantly associated with pain and disability (PRTEE; P < 0.001), and pain-free grip that no competing interests exist. strength (P < 0.001) respectively, in the affected elbows. Conclusion Generally, structural and sensory measures were weakly correlated. However, neovascularity and transverse tendon thickness may be related to sensory system changes in LE.	[Palaniswamy, Vijayakumar; Ng, Shu-Kay; Manickaraj, Nagarajan; Ryan, Michael; Yelland, Michael; Bisset, Leanne] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Ryan, Michael] Simon Fraser Univ, Burnaby, BC, Canada; [Rabago, David] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA	Griffith University; Menzies Health Institute Queensland; Simon Fraser University; University of Wisconsin System; University of Wisconsin Madison	Bisset, L (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia.	l.bisset@griffith.edu.au	Bisset, Leanne/AAS-8947-2021	Bisset, Leanne/0000-0001-8807-7093; Ng, Shu Kay/0000-0002-6865-9384	Griffith Health Institute; Australasian Faculty of Musculoskeletal Medicine; Australian Association of Musculoskeletal Medicine; Hackett-Hemwall Patterson Foundation	Griffith Health Institute; Australasian Faculty of Musculoskeletal Medicine; Australian Association of Musculoskeletal Medicine; Hackett-Hemwall Patterson Foundation	The study was funded by Griffith Health Institute, Australasian Faculty of Musculoskeletal Medicine, Australian Association of Musculoskeletal Medicine, Hackett-Hemwall Patterson Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BINDER AI, 1983, BRIT J RHEUMATOL, V22, P73; Bisset LM, 2006, ARCH PHYS MED REHAB, V87, P490, DOI 10.1016/j.apmr.2005.11.029; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Chourasia AO, 2013, J ORTHOP SPORT PHYS, V43, P368, DOI 10.2519/jospt.2013.4411; Clarke AW, 2010, AM J SPORT MED, V38, P1209, DOI 10.1177/0363546509359066; Connell D, 2001, AM J ROENTGENOL, V176, P777, DOI 10.2214/ajr.176.3.1760777; Cook JL, 2016, BRIT J SPORT MED, V50, P1187, DOI 10.1136/bjsports-2015-095422; Cook JL, 2009, BRIT J SPORT MED, V43, P409, DOI 10.1136/bjsm.2008.051193; Coombes BK, 2009, BRIT J SPORT MED, V43, P252, DOI 10.1136/bjsm.2008.052738; Coombes BK, 2015, J ORTHOP SPORT PHYS, V17, P1; Coombes BK, 2015, CLIN J PAIN, V31, P30, DOI 10.1097/AJP.0000000000000078; Coombes BK, 2012, CLIN J PAIN, V28, P595, DOI 10.1097/AJP.0b013e31823dd333; Coombes BK, 2010, LANCET, V376, P1751, DOI 10.1016/S0140-6736(10)61160-9; du Toit C, 2008, BRIT J SPORT MED, V42, P872, DOI 10.1136/bjsm.2007.043901; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Felix ER, 2009, J REHABIL RES DEV, V46, P69, DOI 10.1682/JRRD.2008.04.0058; Fernandez-Carnero J, 2009, J PAIN, V10, P1179, DOI 10.1016/j.jpain.2009.04.015; Fernandez-Carnero J, 2009, CLIN J PAIN, V25, P555, DOI 10.1097/AJP.0b013e3181a68a040; Gonzalez-Duarte A, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.466; Graven-Nielsen T, 2010, NAT REV RHEUMATOL, V6, P599, DOI 10.1038/nrrheum.2010.107; Gruchow H W, 1979, Am J Sports Med, V7, P234; Gurcay E, 2017, PAIN MED, V18, P396, DOI 10.1093/pm/pnw181; Heales LJ, 2015, MED SCI SPORT EXER, V47, P2268, DOI 10.1249/MSS.0000000000000681; Heales LJ, 2014, MED SCI SPORT EXER, V46, P2070, DOI 10.1249/MSS.0000000000000345; Ingwersen KG, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011746; Jespersen A, 2013, PAIN MED, V14, P297, DOI 10.1111/pme.12021; KELLEY JD, 1994, AM J SPORT MED, V22, P359, DOI 10.1177/036354659402200311; Khan K, 2003, CLIN SPORT MED, V22, P711, DOI 10.1016/S0278-5919(03)00035-8; Klauser AS, 2017, EUR RADIOL, V27, P3460, DOI 10.1007/s00330-016-4711-x; Kostrominova TY, 2013, AGE, V35, P2203, DOI 10.1007/s11357-013-9514-2; Krogh TP, 2013, ULTRASCHALL MED, V34, P468, DOI 10.1055/s-0033-1335951; Lautenbacher S, 2005, PAIN, V115, P410, DOI 10.1016/j.pain.2005.03.025; Lim ECW, 2012, J PAIN, V13, P676, DOI 10.1016/j.jpain.2012.04.005; Ljung BO, 2004, J ORTHOPAED RES, V22, P321, DOI 10.1016/S0736-0266(03)00183-9; Nijs J, 2010, MANUAL THER, V15, P135, DOI 10.1016/j.math.2009.12.001; Nirschl R P, 1973, Orthop Clin North Am, V4, P787; NIRSCHL RP, 1992, CLIN SPORT MED, V11, P851; Obst SJ, 2014, ULTRASOUND MED BIOL, V40, P62, DOI 10.1016/j.ultrasmedbio.2013.08.009; Ohberg L, 2001, KNEE SURG SPORT TR A, V9, P233, DOI 10.1007/s001670000189; Paungmali Aatit, 2012, Asian J Sports Med, V3, P8; Pavlakovic Goran, 2010, Curr Rheumatol Rep, V12, P455, DOI 10.1007/s11926-010-0131-0; Plinsinga ML, 2018, BRIT J SPORT MED, V52, P284, DOI 10.1136/bjsports-2016-097163; Poltawski L, 2012, SKELETAL RADIOL, V41, P83, DOI 10.1007/s00256-011-1132-4; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rio E, 2014, SPORTS MED, V44, P9, DOI 10.1007/s40279-013-0096-z; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Rompe JD, 2007, J HAND THER, V20, P3, DOI 10.1197/j.jht.2006.10.003; Ruiz-Ruiz B, 2011, J PAIN, V12, P1040, DOI 10.1016/j.jpain.2011.04.001; Sanders TL, 2015, AM J SPORT MED, V43, P1066, DOI 10.1177/0363546514568087; Scott A, 2013, BRIT J SPORT MED, V47, P536, DOI 10.1136/bjsports-2013-092329; Shiri R, 2006, AM J EPIDEMIOL, V164, P1065, DOI 10.1093/aje/kwj325; Smidt N, 2002, ARCH PHYS MED REHAB, V83, P1145, DOI 10.1053/apmr.2002.33728; Sran M, 2002, PAIN CLINIC, V13, P251; STRATFORD PW, 1989, PHYS THER, V69, P276, DOI 10.1093/ptj/69.4.276; Teggeler M, 2015, ULTRASOUND MED BIOL, V41, P1592, DOI 10.1016/j.ultrasmedbio.2015.01.018; van Wilgen CP, 2013, SCAND J MED SCI SPOR, V23, P149, DOI 10.1111/j.1600-0838.2011.01375.x; Wright A., 1992, Pain Clinic, V5, P221; Wright A, 1994, J MUSCULOSKELET PAIN, V2, P83; Zaslansky R, 1998, J NEUROL SCI, V153, P215, DOI 10.1016/S0022-510X(97)00293-1	60	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205171	10.1371/journal.pone.0205171	http://dx.doi.org/10.1371/journal.pone.0205171			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356266	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000448434000035
J	Matsubara, K; Yonemaru, J; Kobayashi, N; Ishii, T; Yamamoto, E; Mizobuchi, R; Tsunematsu, H; Yamamoto, T; Kato, H; Yano, M				Matsubara, Kazuki; Yonemaru, Jun-ichi; Kobayashi, Nobuya; Ishii, Takuro; Yamamoto, Eiji; Mizobuchi, Ritsuko; Tsunematsu, Hiroshi; Yamamoto, Toshio; Kato, Hiroshi; Yano, Masahiro			A follow-up study for biomass yield QTLs in rice	PLOS ONE			English	Article							GRAIN-YIELD; ENVIRONMENT INTERACTIONS; GENETIC DISSECTION; TRAITS; IDENTIFICATION; POWERFUL; WEIGHT	The biomass yield (plant weight) of rice fluctuates from year to year. In a previous study, we demonstrated that six quantitative trait loci (QTLs) contribute to the variation in the plant weight of recombinant inbred lines (RILs) of high-yielding Japanese rice cultivars. However, it remains unclear whether the effects of those QTLs are stable over multiple years. Therefore, we evaluated the effect of the alleles on the plant weight of RILs over multiple years, including a change of fertilization level (i.e., in different environments). Even though the biomass yields of all RILs fluctuated among environments, RILs that were selected on the basis of the genotypes of the detected QTLs had a stable rank order of plant weight that corresponded to their genotypes. This multiple-environment experiment reveals the highly significant contribution of both genotypic and environmental variances to the observed variance in plant weight. A marginally significant QTL-environment interaction was detected at only one of the six QTLs, with a subtle contribution. These results support the idea that the biomass yield of rice can be improved through QTL-based allele selection.	[Matsubara, Kazuki; Yonemaru, Jun-ichi; Kobayashi, Nobuya; Ishii, Takuro; Mizobuchi, Ritsuko; Tsunematsu, Hiroshi; Yamamoto, Toshio; Kato, Hiroshi; Yano, Masahiro] NARO Natl Agr & Food Res Org, Inst Crop Sci, Tsukuba, Ibaraki, Japan; [Yamamoto, Eiji] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Yamamoto, Eiji] Kazusa DNA Res Inst, Kisarazu, Chiba, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; National Institute of Agrobiological Sciences - Japan; Kazusa DNA Research Institute	Matsubara, K (corresponding author), NARO Natl Agr & Food Res Org, Inst Crop Sci, Tsukuba, Ibaraki, Japan.	vague@affrc.go.jp	Yamamoto, Toshio/AAX-7146-2020; Matsubara, Kazuki/S-9378-2019; Yano, Masahiro/AAC-5441-2019	Yamamoto, Toshio/0000-0002-5209-7735; Matsubara, Kazuki/0000-0002-2084-8362; Yamamoto, Eiji/0000-0002-3095-6455	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry of Japan; Ministry of Agriculture, Forestry and Fisheries of Japan	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry of Japan; Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This research was funded by grants from the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry of Japan and by the Ministry of Agriculture, Forestry and Fisheries of Japan to HK and MY.	ALLARD R. W., 1964, Crop science, V4, P503, DOI 10.2135/cropsci1964.0011183X000400050021x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardo R, 2014, CROP SCI, V54, P68, DOI 10.2135/cropsci2013.05.0315; Bernier J, 2007, CROP SCI, V47, P507, DOI 10.2135/cropsci2006.07.0495; CHURCHILL GA, 1994, GENETICS, V138, P963; Falconer DS, 1996, QUANTITATIVE GENETIC; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Goto A, 2009, JARQ-JPN AGR RES Q, V43, P13, DOI 10.6090/jarq.43.13; GRiSP (Global Rice Science Partnership), 2013, RICE ALMANAC; Hittalmani S, 2003, THEOR APPL GENET, V107, P679, DOI 10.1007/s00122-003-1269-1; Ikeda M, 2013, CURR OPIN PLANT BIOL, V16, P213, DOI 10.1016/j.pbi.2013.02.002; Kuchel H, 2007, THEOR APPL GENET, V115, P1015, DOI 10.1007/s00122-007-0628-8; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li ZK, 2003, THEOR APPL GENET, V108, P141, DOI 10.1007/s00122-003-1401-2; Liu Gui-Fu, 2006, Acta Genetica Sinica, V33, P607, DOI 10.1016/S0379-4172(06)60090-5; Mackay TFC, 2007, TRENDS GENET, V23, P311, DOI 10.1016/j.tig.2007.03.013; Marais D. L. des, 2013, Annual Review of Ecology, Evolution, and Systematics, V44, P5, DOI 10.1146/annurev-ecolsys-110512-135806; Matsubara K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151830; MCCOUCH SR, 1995, TRENDS GENET, V11, P482, DOI 10.1016/S0168-9525(00)89157-X; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Ohta H., 2010, B NATL I CROP SCI, V11, P67; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Senthilvel S, 2008, J INTEGR PLANT BIOL, V50, P1108, DOI 10.1111/j.1744-7909.2008.00713.x; Song XJ, 2015, P NATL ACAD SCI USA, V112, P76, DOI 10.1073/pnas.1421127112; Spindel JE, 2016, HEREDITY, V116, P395, DOI 10.1038/hdy.2015.113; STUBER CW, 1992, GENETICS, V132, P823; United Nations, 2015, ESAPWP241 UN; Wade LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124127; Wang S, 2012, WINDOWS QTL CARTOGRA; Wu Y, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006386; Yonemaru J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-346; Yonemaru J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032982; Zhang L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14789; Zhang ZH, 2004, PLANT SCI, V167, P1, DOI 10.1016/j.plantsci.2004.01.007	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206054	10.1371/journal.pone.0206054	http://dx.doi.org/10.1371/journal.pone.0206054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352074	Green Published, Green Submitted, gold			2022-12-26	WOS:000448076200024
J	Khan, MI; Al Johani, A; Hamid, A; Ateeq, B; Manzar, N; Adhami, VM; Lall, RK; Rath, S; Sechi, M; Siddiqui, IA; Choudhry, H; Zamzami, MA; Havighurst, TC; Huang, W; Ntambi, JM; Mukhtar, H				Khan, Mohammad Imran; Al Johani, Ahmed; Hamid, Abid; Ateeq, Bushra; Manzar, Nishat; Adhami, Vaqar Mustafa; Lall, Rahul K.; Rath, Suvasmita; Sechi, Mario; Siddiqui, Imtiaz Ahmad; Choudhry, Hani; Zamzami, Mazin A.; Havighurst, Thomas C.; Huang, Wei; Ntambi, James M.; Mukhtar, Hasan			Proproliferative function of adaptor protein GRB10 in prostate carcinoma	FASEB JOURNAL			English	Article						GRB10; PTEN; PI3K; RTKs; mTOR	INSULIN-RECEPTOR; CELL-PROLIFERATION; PTEN; INHIBITION; GROWTH; CANCER; PI3K; PHOSPHORYLATION; DISRUPTION; ACTIVATION	Growth factor receptor-binding protein 10 (GRB10) is a well-known adaptor protein and a recently identified substrate of the mammalian target of rapamycin (mTOR). Depletion of GRB10 increases insulin sensitivity and overexpression suppresses PI3K/Akt signaling. Because the major reason for the limited efficacy of PI3K/Akt-targeted therapies in prostate cancer (PCa) is loss of mTOR-regulated feedback suppression, it is therefore important to assess the functional importance and regulation of GRB10 under these conditions. On the basis of these background observations, we explored the status and functional impact of GRB10 in PCa and found maximum expression in phosphatase and tensin homolog (PTEN)-deficient PCa. In human PCa samples, GRB10 inversely correlated with PTEN and positively correlated with pAKT levels. Knockdown of GRB10 in nontumorigenic PTEN null mouse embryonic fibroblasts and tumorigenic PCa cell lines reduced Akt phosphorylation and selectively activated a panel of receptor tyrosine kinases. Similarly, overexpression of GRB10 in PTEN wild-type PCa cell lines accelerated tumorigenesis and induced Akt phosphorylation. In PTEN wild-type PCa, GRB10 overexpression promoted mediated PTEN interaction and degradation. PI3K (but not mTOR) inhibitors reduced GRB10 expression, suggesting primarily PI3K-driven regulation of GRB10. In summary, our results suggest that GRB10 acts as a major downstream effector of PI3K and has tumor-promoting effects in prostate cancer.Khan, M. I., Al Johani, A., Hamid, A., Ateeq, B., Manzar, N., Adhami, V. M., Lall, R. K., Rath, S., Sechi, M., Siddiqui, I. A., Choudhry, H., Zamzami, M. A., Havighurst, T. C., Huang, W., Ntambi, J. M., Mukhtar, H. Proproliferatve function of adaptor protein GRB10 in prostate carcinoma.	[Khan, Mohammad Imran; Choudhry, Hani; Zamzami, Mazin A.] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 21589, Saudi Arabia; [Khan, Mohammad Imran; Choudhry, Hani; Zamzami, Mazin A.] King Abdulaziz Univ, Fac Sci, Canc Metab & Epigenet Unit, Jeddah, Saudi Arabia; [Khan, Mohammad Imran; Hamid, Abid; Adhami, Vaqar Mustafa; Lall, Rahul K.; Rath, Suvasmita; Siddiqui, Imtiaz Ahmad; Mukhtar, Hasan] Univ Wisconsin, Dept Dermatol, Sch Med & Publ Hlth, Madison, WI USA; [Al Johani, Ahmed; Ntambi, James M.] Univ Wisconsin, Dept Biochem, Sch Med & Publ Hlth, 420 Henry Mall, Madison, WI 53705 USA; [Havighurst, Thomas C.] Univ Wisconsin, Dept Biostat & Med Informat, Sch Med & Publ Hlth, Madison, WI USA; [Huang, Wei] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Madison, WI USA; [Ateeq, Bushra; Manzar, Nishat] Indian Inst Technol Kanpur, Dept Biol Sci & Bioengn, Mol Oncol Lab, Kanpur, Uttar Pradesh, India; [Sechi, Mario] Univ Sassari, Dept Chem & Pharm, Sassari, Italy; [Al Johani, Ahmed] King Saud Bin Abdulaziz Univ Hlth Sci, Natl Guard Hlth Affairs, Riyadh, Saudi Arabia; [Hamid, Abid] Cent Univ Kashmir, Sch Life Sci, Dept Biotechnol, Kashmir, India	King Abdulaziz University; King Abdulaziz University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; University of Sassari; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Ministry of National Guard - Health Affairs; National Guard Health Affairs - Saudi Arabia; Central University of Kashmir	Khan, MI (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 21589, Saudi Arabia.	mad4res@gmail.com	Zamzami, Mazin A/D-9101-2017; Ateeq, Bushra/I-3967-2019; Rath, Suvasmita/N-7915-2017; Adhami, Vaqar/AAY-2837-2020; Khan, Mohammad Imran/AAH-3327-2020; Khan, Mohammad Dr/B-2030-2019; Aljohani, Ahmed/HHD-3455-2022	Ateeq, Bushra/0000-0003-4682-9773; Rath, Suvasmita/0000-0001-8738-1560; Adhami, Vaqar/0000-0002-2048-4570; Manzar, Nishat/0000-0003-3628-6832; Lall, Rahulkumar/0000-0002-0042-6103; Khan, Mohammad Imran/0000-0001-5832-5017	U.S. National Institutes of Health, National Cancer Institute [RO1CA160867]; Regione Autonoma dellaSardegna (Annualita 2010) within the frame of Leggeregionale [CRP-25920, 7/2007]; University of Wisconsin Translational Research Initiatives Pathology Laboratory - University of Wisconsin Department of Pathology and Laboratory Medicine; University of Wisconsin Carbone Cancer Center [P30CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Regione Autonoma dellaSardegna (Annualita 2010) within the frame of Leggeregionale; University of Wisconsin Translational Research Initiatives Pathology Laboratory - University of Wisconsin Department of Pathology and Laboratory Medicine; University of Wisconsin Carbone Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Prof. John Blenis (Weill Cornell Medical College, New York, NY, USA), Dr. Yonghao Yu (University of Texas Southwestern Medical Center, Dallas, TX, USA), and Prof. Illena Illert (University Medical Center Freiburg, Freiburg, Germany) for providing plasmids used in this study, and Prof. Tak W. Mak (University of Toronto, Toronto, ON, Canada) for providing PTEN MEF<SUP>WT</SUP> and PTEN MEF<SUP>-/-</SUP> cells. The authors also thank Precision Antibody (Columbia, MD, USA) for their helpful technical assistance. This work was supported by the U.S. National Institutes of Health, National Cancer Institute Grant RO1CA160867 (to H.M.), Regione Autonoma dellaSardegna (Annualita 2010) within the frame of Leggeregionale n 7/2007 (Grant CRP-25920 to M.S.), and the University of Wisconsin Translational Research Initiatives Pathology Laboratory, supported, in part, by the University of Wisconsin Department of Pathology and Laboratory Medicine and the University of Wisconsin Carbone Cancer Center (P30CA014520), for use of its facilities and services. The authors declare no conflicts of interest.	Armstrong AJ, 2013, CLIN GENITOURIN CANC, V11, P397, DOI 10.1016/j.clgc.2013.05.007; Boot A, 2016, J PATHOL, V240, P72, DOI 10.1002/path.4756; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Brisbin S, 2009, DEV CELL, V17, P459, DOI 10.1016/j.devcel.2009.08.009; Britschgi A, 2012, CANCER CELL, V22, P796, DOI 10.1016/j.ccr.2012.10.023; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Das TP, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.403; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Deng YP, 2007, J CELL BIOCHEM, V100, P557, DOI 10.1002/jcb.21030; Deng YP, 2003, J BIOL CHEM, V278, P39311, DOI 10.1074/jbc.M304599200; El Sheikh SS, 2008, NEOPLASIA, V10, P949, DOI 10.1593/neo.08582; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Halilovic E, 2010, CANCER RES, V70, P6804, DOI 10.1158/0008-5472.CAN-10-0409; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Jahn T, 2002, MOL CELL BIOL, V22, P979, DOI 10.1128/MCB.22.4.979-991.2002; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kabir NN, 2014, MOL BIOL REP, V41, P1985, DOI 10.1007/s11033-014-3046-4; Kazi JU, 2013, MOL ONCOL, V7, P402, DOI 10.1016/j.molonc.2012.11.003; Li Y, 2008, EXP MOL PATHOL, V84, P234, DOI 10.1016/j.yexmp.2008.03.013; Lim MA, 2004, FRONT BIOSCI-LANDMRK, V9, P387, DOI 10.2741/1226; LIU F, 1995, P NATL ACAD SCI USA, V92, P10287, DOI 10.1073/pnas.92.22.10287; Liu J, 2014, ONCOGENE, V33, P3878, DOI 10.1038/onc.2013.347; Liu ML, 2014, CELL METAB, V19, P967, DOI 10.1016/j.cmet.2014.03.018; Martelli AM, 2012, BBA-MOL CELL RES, V1823, P2168, DOI 10.1016/j.bbamcr.2012.08.017; Mirmohammadsadegh A, 2004, CELLS TISSUES ORGANS, V177, P119, DOI 10.1159/000079985; Mohamed AM, 2006, DEV BIOL, V290, P164, DOI 10.1016/j.ydbio.2005.11.019; Moutoussamy S, 1998, J BIOL CHEM, V273, P15906, DOI 10.1074/jbc.273.26.15906; Ni J, 2012, CANCER DISCOV, V2, P425, DOI 10.1158/2159-8290.CD-12-0003; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Okino K, 2005, ONCOL REP, V13, P1069; R Development CoreTeam, 2014, R LANG ENV STAT COMP; Ramos FJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1262, DOI 10.1152/ajpendo.00609.2005; Reid AHM, 2010, BRIT J CANCER, V102, P678, DOI 10.1038/sj.bjc.6605554; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schwartz S, 2015, CANCER CELL, V27, P109, DOI 10.1016/j.ccell.2014.11.008; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang JJ, 2012, DIABETES, V61, P3189, DOI 10.2337/db12-0249	48	7	8	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3198	3211		10.1096/fj.201800265RR	http://dx.doi.org/10.1096/fj.201800265RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30379590	Green Published, Bronze			2022-12-26	WOS:000459794800011
J	Malik, N; Dantu, SC; Shukla, S; Kombrabail, M; Ghosh, SK; Krishnamoorthy, G; Kumar, A				Malik, Nikita; Dantu, Sarath Chandra; Shukla, Shivangi; Kombrabail, Mamta; Ghosh, Santanu Kumar; Krishnamoorthy, Guruswamy; Kumar, Ashutosh			Conformational flexibility of histone variant CENP-A(Cse4) is regulated by histone H4: A mechanism to stabilize soluble Cse4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						centromere; histone; structural biology; molecular dynamics; fluorescence anisotropy; cell division; histone tails; histone variants; protein-protein interactions; kinetochore assembly; centromeric protein A; chromosome	E3 UBIQUITIN LIGASE; H3 VARIANT; MOLECULAR-DYNAMICS; STRUCTURAL DETERMINANTS; CENTROMERIC NUCLEOSOME; FOLD DOMAIN; N-TERMINUS; YEAST; PROTEIN; CORE	The histone variant CENP-A(Cse4) is a core component of the specialized nucleosome at the centromere in budding yeast and is required for genomic integrity. Accordingly, the levels of Cse4 in cells are tightly regulated, primarily by ubiquitin-mediated proteolysis. However, structural transitions in Cse4 that regulate its centromeric localization and interaction with regulatory components are poorly understood. Using time-resolved fluorescence, NMR, and molecular dynamics simulations, we show here that soluble Cse4 can exist in a closed conformation, inaccessible to various regulatory components. We further determined that binding of its obligate partner, histone H4, alters the interdomain interaction within Cse4, enabling an open state that is susceptible to proteolysis. This dynamic model allows kinetochore formation only in the presence of H4, as the Cse4 N terminus, which is required for interaction with other centromeric components, is unavailable in the absence of H4. The specific requirement of H4 binding for the conformational regulation of Cse4 suggests a structure-based regulatory mechanism for Cse4 localization. Our data suggested a novel structural transition-based mechanism where conformational flexibility of the Cse4 N terminus can control Cse4 levels in the yeast cell and prevent Cse4 from interacting with kinetochore components at ectopic locations for formation of premature kinetochore assembly.	[Malik, Nikita; Dantu, Sarath Chandra; Shukla, Shivangi; Ghosh, Santanu Kumar; Kumar, Ashutosh] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Krishnamoorthy, Guruswamy] Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India; [Kombrabail, Mamta; Krishnamoorthy, Guruswamy] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India; [Dantu, Sarath Chandra] Brunel Univ London, Dept Comp Sci, Synthet Biol Theme, Uxbridge UB8 3PH, Middx, England	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Tata Institute of Fundamental Research (TIFR); Brunel University	Kumar, A (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.; Krishnamoorthy, G (corresponding author), Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India.; Krishnamoorthy, G (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India.	gk@tifr.res.in; ashutoshk@iitb.ac.in	Dantu, Sarath/AAB-7883-2020	DANTU, SARATH CHANDRA/0000-0003-2019-5311	Council of Scientific and Industrial Research, India; Indian Institute of Technology Bombay, Government of India [BT/PR21656/BRB/10/1562/2016]; Department of Biotechnology, Government of India [BT/PR21656/BRB/10/1562/2016]	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Institute of Technology Bombay, Government of India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Council of Scientific and Industrial Research, India (to N.M.) and Indian Institute of Technology Bombay and Department of Biotechnology, Government of India Seed Grant BT/PR21656/BRB/10/1562/2016 (to A.K.).	[Anonymous], 2008, J BIOMED OPT, DOI [10.1117/1.2904580, DOI 10.1117/1.2904580]; Au WC, 2013, GENETICS, V194, P513, DOI 10.1534/genetics.113.149898; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bevington PR, 1969, DATA REDUCTION ERROR; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Blau C, 2013, COMPUT PHYS COMMUN, V184, P2856, DOI 10.1016/j.cpc.2013.07.018; Bloom K, 2006, CURR BIOL, V16, pR276, DOI 10.1016/j.cub.2006.03.054; Boeckmann L, 2013, MOL BIOL CELL, V24, P2034, DOI 10.1091/mbc.E12-12-0893; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen YH, 2000, MOL CELL BIOL, V20, P7037, DOI 10.1128/MCB.20.18.7037-7048.2000; Cheng HL, 2016, J BIOL CHEM, V291, P10372, DOI 10.1074/jbc.M115.701813; Cho US, 2011, P NATL ACAD SCI USA, V108, P9367, DOI 10.1073/pnas.1106389108; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; Dechassa ML, 2014, NUCLEIC ACIDS RES, V42, P5532, DOI 10.1093/nar/gku205; Deyter GMR, 2017, GENETICS, V205, P113, DOI 10.1534/genetics.116.194027; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Haase J, 2013, CURR BIOL, V23, P1939, DOI 10.1016/j.cub.2013.07.083; Henikoff S, 2010, COLD SH Q B, V75, P51, DOI 10.1101/sqb.2010.75.001; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Hewawasam G, 2010, MOL CELL, V40, P444, DOI 10.1016/j.molcel.2010.10.014; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Jha A, 2009, J MOL BIOL, V393, P735, DOI 10.1016/j.jmb.2009.08.053; Keith KC, 1999, MOL CELL BIOL, V19, P6130; Kumar A, 2006, J MOL BIOL, V361, P180, DOI 10.1016/j.jmb.2006.06.003; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; Malik N, 2016, J BIOMOL NMR, V66, P21, DOI 10.1007/s10858-016-0054-9; Meluh PB, 1997, GENE DEV, V11, P3401, DOI 10.1101/gad.11.24.3401; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Mishra PK, 2015, MOL BIOL CELL, V26, P2067, DOI 10.1091/mbc.E14-08-1335; Morey L, 2004, EUKARYOT CELL, V3, P1533, DOI 10.1128/EC.3.6.1533-1543.2004; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Ohkuni K, 2014, GENETICS, V196, P1041, DOI 10.1534/genetics.114.161224; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ranjitkar P, 2010, MOL CELL, V40, P455, DOI 10.1016/j.molcel.2010.09.025; Samel A, 2012, P NATL ACAD SCI USA, V109, P9029, DOI 10.1073/pnas.1120968109; Santra MK, 2003, J BIOL CHEM, V278, P21336, DOI 10.1074/jbc.M301303200; Saxena A, 2005, SPR S FLUOR, V3, P163; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Zhang WG, 2007, CELL, V129, P1047, DOI 10.1016/j.cell.2007.05.054; Zhou Z, 2011, NATURE, V472, P234, DOI 10.1038/nature09854	54	1	1	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20273	20284		10.1074/jbc.RA118.004141	http://dx.doi.org/10.1074/jbc.RA118.004141			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30381395	Green Published, hybrid			2022-12-26	WOS:000454685900032
J	Belyy, A; Santecchia, I; Renault, L; Bourigault, B; Ladant, D; Mechold, U				Belyy, Alexander; Santecchia, Ignacio; Renault, Louis; Bourigault, Blandine; Ladant, Daniel; Mechold, Undine			The extreme C terminus of the Pseudomonas aeruginosa effector ExoY is crucial for binding to its eukaryotic activator, F-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; bacterial toxin; protein-protein interaction; cyclic nucleotide; Pseudomonas aeruginosa (P; aeruginosa); confocal microscopy; protein cross-linking; type III secretion system (T3SS); ExoY	PERTUSSIS ADENYLYL-CYCLASE; STRUCTURAL BASIS; YEAST ACTIN; PROTEIN; FILAMENTS; DOMAINS; GTPASES; TOXIN; GENES	Bacterial nucleotidyl cyclase toxins are potent virulence factors that upon entry into eukaryotic cells are stimulated by endogenous cofactors to catalyze the production of large amounts of 35-cyclic nucleoside monophosphates. The activity of the effector ExoY from Pseudomonas aeruginosa is stimulated by the filamentous form of actin (F-actin). Utilizing yeast phenotype analysis, site-directed mutagenesis, functional biochemical assays, and confocal microscopy, we demonstrate that the last nine amino acids of the C terminus of ExoY are crucial for the interaction with F-actin and, consequently, for ExoY's enzymatic activity in vitro and toxicity in a yeast model. We observed that isolated C-terminal sequences of P. aeruginosa ExoY that had been fused to a carrier protein bind to F-actin and that synthetic peptides corresponding to the extreme ExoY C terminus inhibit ExoY enzymatic activity in vitro and compete with the full-length enzyme for F-actin binding. Interestingly, we noted that various P. aeruginosa isolates of the PA14 family, including highly virulent strains, harbor ExoY variants with a mutation altering the C terminus of this effector. We found that these naturally occurring ExoY variants display drastically reduced enzymatic activity and toxicity. Our findings shed light on the molecular basis of the ExoY-F-actin interaction, revealing that the extreme C terminus of ExoY is critical for binding to F-actin in target cells and that some P. aeruginosa isolates carry C-terminally mutated, low-activity ExoY variants.	[Belyy, Alexander; Ladant, Daniel; Mechold, Undine] Inst Pasteur, CNRS UMR 3528, Unite Biochim Interact Macromol, Dept Biol Struct & Chim, 25-28 Rue Dr Roux, F-75724 Paris 15, France; [Santecchia, Ignacio] Inst Pasteur, Unite Biol & Genet Paroi Bacterienne, Dept Microbiol, F-75724 Paris 15, France; [Renault, Louis; Bourigault, Blandine] Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell I2BC, CEA,CNRS, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Belyy, A; Mechold, U (corresponding author), Inst Pasteur, CNRS UMR 3528, Unite Biochim Interact Macromol, Dept Biol Struct & Chim, 25-28 Rue Dr Roux, F-75724 Paris 15, France.	alexander.belyy@pasteur.fr; undine.mechold@pasteur.fr	Mechold, Undine/GYV-3918-2022	Mechold, Undine/0000-0002-6019-0972; LADANT, Daniel/0000-0003-1955-548X; RENAULT, Louis/0000-0003-1722-074X; Belyy, Alexander/0000-0003-3106-6574	French National Research Agency [ANR 10-INSB-04-01]	French National Research Agency(French National Research Agency (ANR))	A. B. thanks Dr. Cosmin Saveanu, Dr. Ina Attree, and Dr. Yury Belyi for fruitful discussions. We thank Dorothee Raoux-Barbot for technical support, Dr. Violaine David for critical reading, Dr. Alexandre Chenal for help in peptide design, and Prof. Sabine Rospert for the anti-RPS9 serum. We acknowledge the Imagopole France-BioImaging infrastructure, which is supported by French National Research Agency Grant ANR 10-INSB-04-01 (Investments for the Future), for advice and access to the Leica TCS SP5 system.	Arnoldo A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000005; Balczon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074343; Belyy A, 2018, TOXICON, V149, P65, DOI 10.1016/j.toxicon.2017.12.046; Belyy A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13582; Berube BJ, 2016, CURR GENET, V62, P109, DOI 10.1007/s00294-015-0522-x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; FU H, 1993, P NATL ACAD SCI USA, V90, P2320, DOI 10.1073/pnas.90.6.2320; Galle M, 2012, CURR PROTEIN PEPT SC, V13, P831, DOI 10.2174/138920312804871210; Ganter MT, 2009, AM J RESP CELL MOL, V40, P108, DOI 10.1165/rcmb.2007-0454OC; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Gendrin C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002637; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goode BL, 2002, METHOD ENZYMOL, V351, P433; Guo Q, 2005, EMBO J, V24, P3190, DOI 10.1038/sj.emboj.7600800; Haghi F, 2018, MICROB PATHOGENESIS, V115, P251, DOI 10.1016/j.micpath.2017.12.052; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; He CX, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00239-17; Huber P, 2014, CELL MOL LIFE SCI, V71, P1927, DOI 10.1007/s00018-013-1451-9; Jeon J, 2017, FEBS J, V284, P3392, DOI 10.1111/febs.14199; Jiwani S, 2013, J BACTERIOL, V195, P708, DOI 10.1128/JB.01768-12; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khanppnavar B, 2018, BBA-GEN SUBJECTS, V1862, P2090, DOI 10.1016/j.bbagen.2018.05.021; Klockgether Jens, 2017, F1000Res, V6, P1261, DOI 10.12688/f1000research.10506.1; Kloth C, 2018, TOXINS, V10, DOI 10.3390/toxins10050185; KRON SJ, 1992, P NATL ACAD SCI USA, V89, P4466, DOI 10.1073/pnas.89.10.4466; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; Maresso A. W., 2006, COMPREHENSIVE SOURCE, P257, DOI [DOI 10.1016/B978-012088445-2/50019-6, 10.1016/B978-012088445-2/50019-6]; MILLER CJ, 1995, BIOCHEMISTRY-US, V34, P2694, DOI 10.1021/bi00008a037; Myeni SK, 2010, J BIOL CHEM, V285, P13357, DOI 10.1074/jbc.M109.094045; Nishimura M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10870; O'Brien DP, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004486; Sato H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103127; Sayner SL, 2004, CIRC RES, V95, P196, DOI 10.1161/01.RES.0000134922.25721.d9; Selwa E, 2014, J BIOL CHEM, V289, P21131, DOI 10.1074/jbc.M113.530410; Shen YQ, 2005, EMBO J, V24, P929, DOI 10.1038/sj.emboj.7600574; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stevens TC, 2014, AM J PHYSIOL-LUNG C, V306, pL915, DOI 10.1152/ajplung.00135.2013; Tessmer MH, 2017, J BIOL CHEM, V292, P3411, DOI 10.1074/jbc.M116.760074; Wattam AR, 2017, NUCLEIC ACIDS RES, V45, pD535, DOI 10.1093/nar/gkw1017; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Yasmin L, 2010, BIOCHEM J, V427, P217, DOI 10.1042/BJ20100043	45	9	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19785	19796		10.1074/jbc.RA118.003784	http://dx.doi.org/10.1074/jbc.RA118.003784			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30377256	hybrid, Green Published			2022-12-26	WOS:000454294900023
J	Mallette, E; Kimber, MS				Mallette, Evan; Kimber, Matthew S.			Structural and kinetic characterization of (S)-1-amino-2-propanol kinase from the aminoacetone utilization microcompartment of Mycobacterium smegmatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein structure; enzyme kinetics; bioinformatics; biodegradation; microbiology; aminoacetone utilization microcompartment; aminopropanol kinase	MICROBIAL-METABOLISM; AMINO-ALCOHOLS; PHOSPHO-LYASE; ENZYME; PROTEINS; BINDING; 1-AMINOPROPAN-2-OL; PHOSPHOTRANSFERASE; DEHYDROGENASE; ORGANELLES	Bacterial microcompartments encapsulate enzymatic pathways that generate small, volatile, aldehyde intermediates. The Rhodococcus and Mycobacterium microcompartment (RMM) operon from Mycobacterium smegmatis encodes four enzymes, including (S)-1-amino-2-propanol dehydrogenase and a likely propionaldehyde dehydrogenase. We show here that a third enzyme (and its nonmicrocompartment-associated paralog) is a moderately specific (S)-1-amino-2-propanol kinase. We determined the structure of apo-aminopropanol kinase at 1.35 , revealing that it has structural similarity to hexosamine kinases, choline kinases, and aminoglycoside phosphotransferases. We modeled substrate binding, and tested our model by characterizing key enzyme variants. Bioinformatics analysis established that this enzyme is widespread in Actinobacteria, Proteobacteria, and Firmicutes, and is very commonly associated with a candidate phospholyase. In Rhizobia, aminopropanol kinase is generally associated with aromatic degradation pathways. In the RMM (and the parallel pathway that includes the second paralog), aminopropanol kinase likely degrades aminoacetone through a propanolamine-phosphate phospho-lyase-dependent pathway. These enzymatic activities were originally described in Pseudomonas, but the proteins responsible have not been previously identified. Bacterial microcompartments typically co-encapsulate enzymes which can regenerate required co-factors, but the RMM enzymes require four biochemically distinct co-factors with no overlap. This suggests that either the RMM shell can uniquely transport multiple co-factors in stoichiometric quantities, or that all enzymes except the phospho-lyase reside outside of the shell. In summary, aminopropanol kinase is a novel enzyme found in diverse bacteria and multiple metabolic pathways; its presence in the RMM implies that this microcompartment degrades aminoacetone, using a pathway that appears to violate some established precepts as to how microcompartments function.	[Mallette, Evan; Kimber, Matthew S.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Kimber, MS (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	mkimber@uoguelph.ca	Kimber, Matthew/Q-8144-2019	Kimber, Matthew/0000-0001-9454-5586	National Science and Engineering Council of Canada [04045-2015]	National Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Science and Engineering Council of Canada Grant 04045-2015 (to M. S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Axen SD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003898; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; Chowdhury C, 2014, MICROBIOL MOL BIOL R, V78, P438, DOI 10.1128/MMBR.00009-14; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Cuetos A, 2016, CHEMBIOCHEM, V17, P2308, DOI 10.1002/cbic.201600482; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erbilgin O, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002399; Espie GS, 2011, PHOTOSYNTH RES, V109, P7, DOI 10.1007/s11120-011-9656-y; Fan CG, 2012, P NATL ACAD SCI USA, V109, P14995, DOI 10.1073/pnas.1207516109; Fan CG, 2011, J BACTERIOL, V193, P5623, DOI 10.1128/JB.05661-11; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; FAULKNER A, 1974, BIOCHEM J, V138, P263, DOI 10.1042/bj1380263; Fong DH, 2010, J BIOL CHEM, V285, P9545, DOI 10.1074/jbc.M109.038364; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huseby DL, 2013, J BACTERIOL, V195, P2864, DOI 10.1128/JB.02179-12; JONES A, 1973, BIOCHEM J, V134, P959, DOI 10.1042/bj1340959; Jorda J, 2013, PROTEIN SCI, V22, P179, DOI 10.1002/pro.2196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kataoka M, 2006, LETT APPL MICROBIOL, V43, P430, DOI 10.1111/j.1472-765X.2006.01970.x; Kerfeld CA, 2016, CURR OPIN PLANT BIOL, V31, P66, DOI 10.1016/j.pbi.2016.03.009; Mallette E, 2018, BIOCHEMISTRY-US, V57, P3780, DOI 10.1021/acs.biochem.8b00464; Mallette E, 2017, J BIOL CHEM, V292, P1197, DOI 10.1074/jbc.M116.754093; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Schiroli D, 2015, FEBS J, V282, P183, DOI 10.1111/febs.13122; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi K, 2011, BIOCHEMISTRY-US, V50, P6237, DOI 10.1021/bi200747f; Sutter M, 2017, SCIENCE, V356, P1293, DOI 10.1126/science.aan3289; Tuck LR, 2016, SCI REP-UK, V6, DOI 10.1038/srep22108; Urano N, 2011, APPL MICROBIOL BIOT, V89, P739, DOI 10.1007/s00253-010-2924-5; Wang KC, 2014, ACTA CRYSTALLOGR D, V70, P1401, DOI 10.1107/S1399004714004209; Yeates TO, 2013, J MOL MICROB BIOTECH, V23, P290, DOI 10.1159/000351347; Zarzycki J, 2015, APPL ENVIRON MICROB, V81, P8315, DOI 10.1128/AEM.02587-15	36	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19909	19918		10.1074/jbc.RA118.005485	http://dx.doi.org/10.1074/jbc.RA118.005485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30361441	Green Published, hybrid			2022-12-26	WOS:000454294900034
J	Zhao, J; Ueda, K; Riera, M; Kim, HJ; Sparrow, JR				Zhao, Jin; Ueda, Keiko; Riera, Marina; Kim, Hye Jin; Sparrow, Janet R.			Bisretinoids mediate light sensitivity resulting in photoreceptor cell degeneration in mice lacking the receptor tyrosine kinase Mer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retina; retinal degeneration; receptor tyrosine kinase; phagocytosis; photoreceptor; bisretinoid; lipofuscin; Mertk; Mertk-; -; photodegradation; retinal pigment epithelium	INHERITED RETINAL DYSTROPHY; QUANTITATIVE FUNDUS AUTOFLUORESCENCE; PIGMENT EPITHELIAL-CELLS; SHORT-WAVELENGTH AUTOFLUORESCENCE; OPTICAL COHERENCE TOMOGRAPHY; ROD-CONE DYSTROPHY; STARGARDT-DISEASE; MOUSE MODELS; IN-VIVO; RCS RAT	The receptor tyrosine kinase Mer is expressed by retinal pigment epithelial (RPE) cells and participates in photoreceptor outer-segment phagocytosis, a process enabling membrane renewal. Mutations in the gene encoding MERTK cause blinding retinitis pigmentosa in humans. Targeted Mertk disruption in mice causes defective RPE-mediated phagocytosis of the outer segments, leading to deposition of autofluorescent debris at the RPE-photoreceptor cell interface, followed by photoreceptor cell degeneration. Here, we show that retinaldehyde adducts (bisretinoid fluorophores) that form in photoreceptor outer segments occupy the unphagocytosed outer-segment debris that accumulates in Mertk(-/-) mice. Bisretinoids measured by HPLC were elevated in Mertk(-/-) mice compared with WT animals. Bisretinoids were also more abundant in albino Mertk(-/-) mice expressing leucine at position 450 of the isomerase RPE65 (Rpe65-Leu450) rather than the variant methionine (Rpe65-450Met) that yields lower bisretinoid levels. In Royal College of Surgeons rats having dysfunctional Mertk, bisretinoids were higher than in WT rats. Intensities of in vivo fundus autofluorescence were higher in Mertk(-/-) mice than in WT mice and peaked earlier in albino Mertk(-/-)/Rpe65-Leu450 mice than in albino Mertk(-/-)/Rpe65-450Met mice. Of note, the rate of photoreceptor cell degeneration was more rapid in albino Mertk(-/-) mice exposed to higher levels of intraocular light (albino versus pigmented mice) and in mice carrying Rpe65-Leu450 than in Rpe65-450Met mice, revealing a link between bisretinoid accumulation and light-mediated acceleration of photoreceptor cell degeneration. In conclusion, the light sensitivity of photoreceptor cell degeneration arising from Mertk deficiency is consistent with the known phototoxicity of bisretinoids.	[Zhao, Jin; Ueda, Keiko; Riera, Marina; Kim, Hye Jin; Sparrow, Janet R.] Columbia Univ, Med Ctr, Dept Ophthalmol, New York, NY 10032 USA; [Sparrow, Janet R.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Riera, Marina] Inst Ocular Microsurg, Dept Genet, Barcelona 08035, Spain	Columbia University; Columbia University	Sparrow, JR (corresponding author), Columbia Univ, Dept Ophthalmol, 635 W 165th St, New York, NY 10032 USA.	jrs88@columbia.edu		Zhao, Jin/0000-0002-1934-6445	National Institutes of Health [EY12951]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY012951, P30EY019007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in whole or in part by National Institutes of Health Grant EY12951 (to J. R. S.) and by unrestricted funds from Research to Prevent Blindness (to the Department of Ophthalmology, Columbia University). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aizawa S, 2010, CLIN EXP OPHTHALMOL, V38, P597, DOI 10.1111/j.1442-9071.2010.02321.x; Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; ANDERSON RE, 1970, BIOCHEMISTRY-US, V9, P3624, DOI 10.1021/bi00820a019; BATTELLE BA, 1978, EXP EYE RES, V26, P487, DOI 10.1016/0014-4835(78)90134-3; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Boyer NP, 2012, J BIOL CHEM, V287, P22276, DOI 10.1074/jbc.M111.329235; BURDEN EM, 1971, EXP EYE RES, V11, P140; Burke TR, 2014, INVEST OPHTH VIS SCI, V55, P2841, DOI 10.1167/iovs.13-13624; Chen XT, 2013, J NEUROPATH EXP NEUR, V72, P782, DOI 10.1097/NEN.0b013e31829e8375; Cukras CA, 2012, ARCH OPHTHALMOL-CHIC, V130, P171, DOI 10.1001/archophthalmol.2011.332; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; DELMELLE M, 1975, EXP EYE RES, V21, P369, DOI 10.1016/0014-4835(75)90047-0; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P2327; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Duncker T, 2013, INVEST OPHTH VIS SCI, V54, P585, DOI 10.1167/iovs.12-11176; EAGLE RC, 1980, OPHTHALMOLOGY, V87, P1189; Eldred G. E., 1991, FLUOROPHORES RCS RAT; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Flynn E, 2014, INVEST OPHTH VIS SCI, V55, P5643, DOI 10.1167/iovs.14-14136; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Greenberg JP, 2013, INVEST OPHTH VIS SCI, V54, P5684, DOI 10.1167/iovs.13-12445; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; HECKENLIVELY JR, 1991, ARCH OPHTHALMOL-CHIC, V109, P84, DOI 10.1001/archopht.1991.01080010086038; HERRON WL, 1969, INVEST OPHTH VISUAL, V8, P595; HERRON WL, 1974, INVEST OPHTH VISUAL, V13, P87; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Issa PC, 2009, BRIT J OPHTHALMOL, V93, P920, DOI 10.1136/bjo.2008.147397; Issa PC, 2012, INVEST OPHTH VIS SCI, V53, P1066, DOI 10.1167/iovs.11-8767; Jang YP, 2005, J BIOL CHEM, V280, P39732, DOI 10.1074/jbc.M504933200; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; KATZ ML, 1987, MECH AGEING DEV, V39, P81, DOI 10.1016/0047-6374(87)90088-1; Kim HJ, 2018, J LIPID RES, V59, P1620, DOI 10.1194/jlr.M084459; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2007, BIOCHEMISTRY-US, V46, P10122, DOI 10.1021/bi7009635; Kim SR, 2006, EXP EYE RES, V82, P828, DOI 10.1016/j.exer.2005.10.004; Kim SR, 2010, VISION RES, V50, P729, DOI 10.1016/j.visres.2009.09.015; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Koh S, 2018, J NEUROSCI, V38, P2923, DOI 10.1523/JNEUROSCI.1532-17.2018; LAVAIL MM, 1975, EXP EYE RES, V21, P167, DOI 10.1016/0014-4835(75)90080-9; LAVAIL MM, 1981, INVEST OPHTH VIS SCI, V21, P658; LI LX, 1988, EXP EYE RES, V47, P911, DOI 10.1016/0014-4835(88)90073-5; LOLLEY RN, 1976, EXP EYE RES, V22, P477, DOI 10.1016/0014-4835(76)90185-8; Lyubarsky AL, 2005, BIOCHEMISTRY-US, V44, P9880, DOI 10.1021/bi0505363; Maddox DM, 2011, INVEST OPHTH VIS SCI, V52, P4703, DOI 10.1167/iovs.10-7077; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Matthes M T, 1989, Prog Clin Biol Res, V314, P315; McHenry CL, 2004, INVEST OPHTH VIS SCI, V45, P1456, DOI 10.1167/iovs.03-0909; MULLEN RJ, 1976, SCIENCE, V192, P799, DOI 10.1126/science.1265483; Naash ML, 1996, INVEST OPHTH VIS SCI, V37, P775; Nagasaki T, 2003, INVEST OPHTH VIS SCI, V44, P558, DOI 10.1167/iovs.02-0705; Nusinowitz S, 2003, EXP EYE RES, V77, P627, DOI 10.1016/S0014-4835(03)00217-3; Organisciak DT, 1999, CURR EYE RES, V19, P188, DOI 10.1076/ceyr.19.2.188.5333; Paavo M, 2018, INVEST OPHTH VIS SCI, V59, P2459, DOI 10.1167/iovs.18-24213; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; PENN JS, 1986, EXP EYE RES, V43, P915, DOI 10.1016/0014-4835(86)90070-9; Popovic P, 2005, GRAEF ARCH CLIN EXP, V243, P1018, DOI 10.1007/s00417-005-1186-x; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Robson AG, 2008, BRIT J OPHTHALMOL, V92, P95, DOI 10.1136/bjo.2007.124008; Robson AG, 2003, INVEST OPHTH VIS SCI, V44, P3544, DOI 10.1167/iovs.02-1278; Salvador GA, 1998, LIPIDS, V33, P853, DOI 10.1007/s11745-998-0281-z; Schuerch K, 2017, INVEST OPHTH VIS SCI, V58, P1843, DOI 10.1167/iovs.16-21302; Secondi R, 2012, INVEST OPHTH VIS SCI, V53, P5190, DOI 10.1167/iovs.12-9672; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Sparrow J., 2007, ATLAS AUTOFLUORESCEN, P1; Sparrow JR, 2015, INVEST OPHTH VIS SCI, V56, P5029, DOI 10.1167/iovs.15-16763; Sparrow JR, 2013, INVEST OPHTH VIS SCI, V54, P2812, DOI 10.1167/iovs.12-11490; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2010, PHOTOCH PHOTOBIO SCI, V9, P1480, DOI 10.1039/c0pp00207k; Sparrow JR, 2010, METHODS MOL BIOL, V652, P315, DOI 10.1007/978-1-60327-325-1_18; Sparrow JR, 2003, J BIOL CHEM, V278, P18207, DOI 10.1074/jbc.M300457200; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Strick DJ, 2010, EXP EYE RES, V91, P786, DOI 10.1016/j.exer.2010.05.006; Tombran-Tink J, 2007, RETINAL DEGENERATION, P213; Tschernutter M, 2006, BRIT J OPHTHALMOL, V90, P718, DOI 10.1136/bjo.2005.084897; Ueda K, 2016, P NATL ACAD SCI USA, V113, P6904, DOI 10.1073/pnas.1524774113; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; von Ruckmann A, 1999, GRAEF ARCH CLIN EXP, V237, P1, DOI 10.1007/s004170050186; Wang JY, 2009, J CELL PHYSIOL, V220, P119, DOI 10.1002/jcp.21742; Wang NK, 2009, BRIT J OPHTHALMOL, V93, P1234, DOI 10.1136/bjo.2008.153577; WEITER JJ, 1986, INVEST OPHTH VIS SCI, V27, P145; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2003, INVEST OPHTH VIS SCI, V44, P2798, DOI 10.1167/iovs.02-1134; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; WING GL, 1978, INVEST OPHTH VIS SCI, V17, P601; Wu L, 2010, ADV EXP MED BIOL, V664, P533, DOI 10.1007/978-1-4419-1399-9_61; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Wu Y, 2009, J BIOL CHEM, V284, P20155, DOI 10.1074/jbc.M109.021345; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; Yamamoto K, 2011, INVEST OPHTH VIS SCI, V52, P9084, DOI 10.1167/iovs.11-8632; Yoon KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041309; Zhou YD, 2011, EXP EYE RES, V93, P636, DOI 10.1016/j.exer.2011.07.017	100	12	12	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19400	19410		10.1074/jbc.RA118.005949	http://dx.doi.org/10.1074/jbc.RA118.005949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30352873	hybrid, Green Published			2022-12-26	WOS:000453537300021
J	van Staveren, S; ten Haaf, T; Klopping, M; Hilvering, B; Tinnevelt, GH; de Ruiter, K; Piacentini, MF; Roelands, B; Meeusen, R; de Koning, JJ; Jansen, JJ; Vrisekoop, N; Koenderman, L				van Staveren, Selma; ten Haaf, Twan; Klopping, Margot; Hilvering, Bart; Tinnevelt, Gerjen H.; de Ruiter, Karin; Piacentini, Maria F.; Roelands, Bart; Meeusen, Romain; de Koning, Jos J.; Jansen, Jeroen J.; Vrisekoop, Nienke; Koenderman, Leo			Multi-dimensional flow cytometry analysis reveals increasing changes in the systemic neutrophil compartment during seven consecutive days of endurance exercise	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; MONOCLONAL-ANTIBODIES; AEROBIC EXERCISE; SUBJECT GROUPS; RESPONSES; EXPRESSION; ISCHEMIA; RECEPTOR; ADRENOCORTICOTROPIN; GUIDELINES	Endurance exercise is associated with a transient increase in neutrophil counts in the peripheral blood. Here we investigate the impact of intensified endurance exercise on the neutrophil compartment. We hypothesized that intensified endurance exercise leads to mobilization of neutrophil subsets, which are normally absent in the blood. Furthermore, we followed the potential build-up of neutrophil activation and the impact on overnight recovery of the neutrophil compartment during a seven-day cycling tour. The neutrophil compartment was studied in 28 healthy amateur cyclists participating in an eight-day strenuous cycling tour. Blood samples were taken at baseline, after 4 days and after 7 days of cycling. The neutrophil compartment was analyzed in terms of numbers and its phenotype by deep phenotyping of flow cytometry data with the multi-dimensional analysis method FLOOD. Repeated endurance exercise led to a gradual increase in total neutrophil counts over the days leading to a 1.26 fold-increase (95%CI 1.01-1.51 p = 0.0431) in the morning of day 8. Flow cytometric measurements revealed the appearance of 2 additional neutrophil subsets: CD16(brig)(ht)CD62L(dim) and CD16(dim)CD62L(bright). A complex change in neutrophil phenotypes was present characterized by decreased expression of both CD11 b and CD62L and marked increased expression of LAIR-1, VLA 4 and CBRM1/5. The changes in expression were found on all neutrophils present in the blood. Strikingly, in strong contrast to our findings during acute inflammation evoked by LPS challenge, these neutrophils did not upregulate classical degranulation markers. In fact, our FLOOD analysis revealed that the exercise induced neutrophil phenotype did not overlap with the neutrophil subsets arising upon acute inflammation. In conclusion, during multiple days of endurance exercise the neutrophil compartment does not regain homeostasis overnight. Thereby our study supports the concept of a build-up of inflammatory cues during repeated endurance exercise training, causing a prolonged change of the systemic neutrophil compartment.	[van Staveren, Selma; Klopping, Margot; Hilvering, Bart; Vrisekoop, Nienke; Koenderman, Leo] UMC Utrecht, Lab Translat Immunol, Dept Resp Med, Utrecht, Netherlands; [van Staveren, Selma; Tinnevelt, Gerjen H.] TI COAST, Amsterdam, Netherlands; [ten Haaf, Twan; de Koning, Jos J.] Vrije Univ Amsterdam, Fac Behav & Movement Sci, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands; [Tinnevelt, Gerjen H.; Jansen, Jeroen J.] Radboud Univ Nijmegen, Inst Mol & Mat, Analyt Chem, Nijmegen, Netherlands; [de Ruiter, Karin] LUMC Leiden, Dept Parasitol, Leiden, Netherlands; [Piacentini, Maria F.] Univ Rome Foro Italico, Dept Human Movement & Sport Sci, Rome, Italy; [Roelands, Bart; Meeusen, Romain] Vrije Univ Brussel, Human Physiol Res Grp, Brussels, Belgium; [Meeusen, Romain] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld, Australia; [de Koning, Jos J.] Univ Wisconsin, Dept Exercise & Sports Sci, La Crosse, WI 54601 USA	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Foro Italico University of Rome; Vrije Universiteit Brussel; James Cook University; University of Wisconsin System	Koenderman, L (corresponding author), UMC Utrecht, Lab Translat Immunol, Dept Resp Med, Utrecht, Netherlands.	l.koenderman@umcutrecht.nl	Roelands, Bart/E-2337-2011; Jansen, Jeroen/D-6120-2012; Hilvering, Bart/ABA-9709-2021	Roelands, Bart/0000-0002-2808-044X; Hilvering, Bart/0000-0002-7223-0281; de Koning, Jos J/0000-0002-5596-0282	Netherlands Organisation for Scientific Research (NWO) in the context of a private public partnership Technology Area COAST [053.21.112]; Netherlands Organization for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO) in the context of a private public partnership Technology Area COAST(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research received funding from the Netherlands Organisation for Scientific Research (NWO) in the context of a private public partnership Technology Area COAST. Website: www.ti-coast.com; grant number 053.21.112; grant recipient: Leo Koenderman. The commercial partners had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The partnership provided support in the form of salaries for authors SvS and GHT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section for authors SvS and GHT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research received funding from the Netherlands Organization for Scientific Research (NWO) in the framework of the Technology Area COAST.	ATHENS JW, 1961, J CLIN INVEST, V40, P989, DOI 10.1172/JCI104338; Bastian OW, 2016, CLIN IMMUNOL, V164, P78, DOI 10.1016/j.clim.2016.02.001; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; DALE DC, 1975, J CLIN INVEST, V56, P808, DOI 10.1172/JCI108159; De Pauw K, 2013, INT J SPORT PHYSIOL, V8, P111, DOI 10.1123/ijspp.8.2.111; de Ruiter K, 2018, CYTOM PART A, V93A, P540, DOI 10.1002/cyto.a.23354; Decroix L, 2016, INT J SPORT PHYSIOL, V11, P204, DOI 10.1123/ijspp.2015-0153; FARRELL PA, 1983, J APPL PHYSIOL, V55, P1441, DOI 10.1152/jappl.1983.55.5.1441; Faxon DP, 2002, J AM COLL CARDIOL, V40, P1199, DOI 10.1016/S0735-1097(02)02136-8; Franchimont D, 2000, GASTROENTEROLOGY, V119, P1560, DOI 10.1053/gast.2000.20235; FRENCH EB, 1971, BRIT J HAEMATOL, V21, P423, DOI 10.1111/j.1365-2141.1971.tb02702.x; Gavrieli R, 2008, MED SCI SPORT EXER, V40, P1623, DOI 10.1249/MSS.0b013e318176b963; HOOPER SL, 1993, MED SCI SPORT EXER, V25, P741; Ibbotson GC, 2001, NAT MED, V7, P465, DOI 10.1038/86539; Jansen JJ, 2016, CHEMOMETR INTELL LAB, V151, P126, DOI 10.1016/j.chemolab.2015.12.001; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; JOYCE RA, 1976, J LAB CLIN MED, V88, P614; Kamp VM, 2013, J LEUKOCYTE BIOL, V94, P513, DOI 10.1189/jlb.0213066; Kox M, 2014, P NATL ACAD SCI USA, V111, P7379, DOI 10.1073/pnas.1322174111; KRAEMER WJ, 1989, MED SCI SPORT EXER, V21, P146; Lavoy EC, 2013, BRAIN BEHAV IMMUN, V27, P54, DOI 10.1016/j.bbi.2012.09.006; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Leliefeld PHC, 2018, BLOOD ADV, V2, P1344, DOI 10.1182/bloodadvances.2017015578; LIESVELD JL, 1993, BLOOD, V81, P112; Lukens MV, 2010, J VIROL, V84, P2374, DOI 10.1128/JVI.01807-09; LUNDJOHANSEN F, 1993, J LEUKOCYTE BIOL, V54, P47, DOI 10.1002/jlb.54.1.47; Mackinnon LT, 1997, MED SCI SPORT EXER, V29, P1637, DOI 10.1097/00005768-199712000-00014; Massena S, 2015, BLOOD, V126, P2016, DOI 10.1182/blood-2015-03-631572; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1242, DOI 10.1097/00005768-200208000-00003; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; MUIR AL, 1984, J APPL PHYSIOL, V57, P711, DOI 10.1152/jappl.1984.57.3.711; Nieman DC, 2011, BRIT J SPORT MED, V45, P987, DOI 10.1136/bjsm.2010.077875; Nieman DC, 2000, IMMUNOL CELL BIOL, V78, P496, DOI 10.1046/j.1440-1711.2000.00950.x; Orr Y, 2005, BRIT J HAEMATOL, V131, P508, DOI 10.1111/j.1365-2141.2005.05794.x; Peake J, 2004, J APPL PHYSIOL, V97, P612, DOI 10.1152/japplphysiol.01331.2003; Peake JM, 2005, MED SCI SPORT EXER, V37, P737, DOI 10.1249/01.MSS.0000161804.05399.3B; Peake JM, 2017, J APPL PHYSIOL, V122, P1077, DOI 10.1152/japplphysiol.00622.2016; Pedersen BK, 1998, ACTA PHYSIOL SCAND, V162, P325, DOI 10.1046/j.1365-201X.1998.0325e.x; Pillay J, 2013, CELL MOL LIFE SCI, V70, P3813, DOI 10.1007/s00018-013-1286-4; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; Pingitore A, 2015, NUTRITION, V31, P916, DOI 10.1016/j.nut.2015.02.005; Robson PJ, 1999, INT J SPORTS MED, V20, P128, DOI 10.1055/s-2007-971106; Rusnak JM, 2001, AM J CARDIOL, V88, P482, DOI 10.1016/S0002-9149(01)01723-4; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; Silverman MN, 2004, ENDOCRINOLOGY, V145, P3580, DOI 10.1210/en.2003-1421; Simpson RJ, 2016, EXERC IMMUNOL REV, V22, P8; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; Spielmann G, 2014, BRAIN BEHAV IMMUN, V39, P142, DOI 10.1016/j.bbi.2013.05.003; Suzuki K, 2003, MED SCI SPORT EXER, V35, P348, DOI 10.1249/01.MSS.0000048861.57899.04; Suzuki K, 1996, INT J SPORTS MED, V17, P205, DOI 10.1055/s-2007-972833; Suzuki K, 1999, J APPL PHYSIOL, V87, P1360, DOI 10.1152/jappl.1999.87.4.1360; Svendsen IS, 2016, EUR J APPL PHYSIOL, V116, P867, DOI 10.1007/s00421-016-3340-z; Tajra LCF, 1999, J SURG RES, V87, P32, DOI 10.1006/jsre.1999.5724; Tak T, 2017, BLOOD, V129, P3476, DOI 10.1182/blood-2016-07-727669; Taneja R, 2008, SHOCK, V30, P618, DOI 10.1097/SHK.0b013e318173ef9c; Turton EPL, 2002, EUR J VASC ENDOVASC, V23, P309, DOI 10.1053/ejvs.2002.1599; Urhausen A, 1998, MED SCI SPORT EXER, V30, P407, DOI 10.1097/00005768-199803000-00011; Vejlens G, 1938, ACTA PATHOL MICROB S, P1; Verbrugge A, 2006, J LEUKOCYTE BIOL, V79, P828, DOI 10.1189/jlb.0705370; Wang JS, 2009, J APPL PHYSIOL, V107, P1213, DOI 10.1152/japplphysiol.00316.2009; Witard OC, 2012, MED SCI SPORT EXER, V44, P1689, DOI 10.1249/MSS.0b013e318257d2db; ZHANG ZG, 1995, BRAIN RES, V698, P79, DOI 10.1016/0006-8993(95)00830-J	63	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2018	13	10							e0206175	10.1371/journal.pone.0206175	http://dx.doi.org/10.1371/journal.pone.0206175			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7AD	30376575	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000448752400008
J	Weiss, G; Bajec, M				Weiss, Gregor; Bajec, Marko			Sense classification of shallow discourse relations with focused RNNs	PLOS ONE			English	Article								Understanding the sense of discourse relations between segments of text is essential to truly comprehend any natural language text. Several automated approaches have been suggested, but all rely on external resources, linguistic feature engineering, and their processing pipelines are built from substantially different models. In this paper, we introduce a novel system for sense classification of shallow discourse relations (FR system) based on focused recurrent neural networks (RNNs). In contrast to existing systems, FR system consists of a single end-to-end trainable model for handling all types and senses of discourse relations, requires no feature engineering or external resources, is language-independent, and can be applied at the word and even character levels. At its core, we present our novel generalization of the focused RNNs layer, the first multi-dimensional RNN-attention mechanism for constructing text/argument embeddings. The filtering/gating RNN enables downstream RNNs to focus on different aspects of the input sequence and project it into several embedding subspaces. These argument embeddings are then used to perform sense classification. FR system has been evaluated using the official datasets and methodology of CoNLL 2016 Shared Task. It does not fall a lot behind state-of-the-art performance on English, the most researched and supported language, but it outperforms existing best systems by 2.5% overall results on the Chinese blind dataset.	[Weiss, Gregor; Bajec, Marko] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia	University of Ljubljana	Weiss, G (corresponding author), Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia.	gregor.weiss@student.uni-lj.si			Slovenian Research Agency [P2-0359]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The authors acknowledge the financial support from the Slovenian Research Agency (research core funding No. P2-0359). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M., 2011, P 6 WORKSH INN US NL, P1, DOI DOI 10.1109/CIMSA.2011.6059919; [Anonymous], 2015, NIPS; Braud C., 2015, EMNLP, P2201, DOI DOI 10.18653/V1/D15-1262; Chiarcos C, 2015, P 19 C COMP NAT LANG, P42; Chollet F, 2016, KERAS, DOI DOI 10.1038/NATURE083580; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Dzmitry Bahdanau, 2016, Arxiv, DOI arXiv:1409.0473; Fraser B, 1999, J PRAGMATICS, V31, P931, DOI 10.1016/S0378-2166(98)00101-5; Ghosh S, 2012, P 13 ANN M SPEC INT, P150; Glorot Xavier, 2010, P MACHINE LEARNING R, P249; Graves A, 2005, IEEE IJCNN, P2047; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Hermann K. M., 2015, NIPS, p1693{1701; Ji Yangfeng, 2015, T ASS COMPUT LINGUIS, V3, P329, DOI DOI 10.1162/TACL_A_00142; Jin XJ, 2016, AAAI CONF ARTIF INTE, P1737; Kang X, 2016, P 20 C COMP NAT LANG, P27; Kingma DP., 2014, ADAM METHOD STOCHAST; Lin Z., 2011, P 49 ANN M ASS COMP, V1, P997; Lin Z., 2009, P 2009 C EMP METH NA, P343, DOI DOI 10.3115/1699510.1699555; Lin Z., 2012, LONG PAPERS, V1, P1006; Lin ZH, 2014, NAT LANG ENG, V20, P151, DOI 10.1017/S1351324912000307; Liu Y, 2016, AAAI CONF ARTIF INTE, P2750; Mann William C, 1988, TEXT, V8, P243, DOI DOI 10.1515/TEXT.1.1988.8.3.243; Marcu D, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P368; Meyer T., 2013, P WORKSHOP DISCOURSE, P19; Mihaylov Todor, 2016, P 20 C COMP NAT LANG, P100; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Park J., 2012, P SPECIAL INTEREST G, P108; Pennington J., 2014, P 2014 C EMPIRICAL M, P1532, DOI DOI 10.3115/V1/D14-1162; Pitler E., 2009, P ACL IJCNLP 2009 C, P13, DOI DOI 10.3115/1667583.1667589; Pitler E., 2009, P JOINT C 47 ANN M A, DOI DOI 10.3115/1690219.1690241; Prasad R, 2008, SIXTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, LREC 2008, P2961; Rutherford A., 2016, ACL, P55, DOI DOI 10.18653/V1/K16-2007; Rutherford A., 2015, HLTNAACL, P799, DOI DOI 10.3115/V1/N15-1081; Rutherford A, 2014, P EUROPEAN CHAPTER A, P645, DOI [DOI 10.3115/V1/E14-1068, 10.3115/v1/E14-1068]; Schenk N, 2016, P CONLL 16 SHAR TASK, P41, DOI DOI 10.18653/V1/K16-2005; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Sukhbaatar S, 2015, ADV NEUR IN, V28; Wachsmuth H, 2014, P 25 INT C COMP LING, P553; Wang JJ, 2016, ADV DIFFER EQU-NY, DOI 10.1186/s13662-016-0751-4; Wang Jianxiang, 2015, P 19 C COMP NAT LANG, P17; Webber B, 2012, NAT LANG ENG, V18, P437, DOI 10.1017/S1351324911000337; Weiss G, 2016, P 20 C COMP NAT LANG, V1, P50, DOI DOI 10.18653/V1/K16-2006; Xu K, 2015, PR MACH LEARN RES, V37, P2048; Xue N, 2016, P AMER CONTR CONF, P7141, DOI 10.1109/ACC.2016.7526799; Xue Nianwen, 2015, P 19 C COMP NAT LANG, P1, DOI DOI 10.18653/V1/K15-2001; Zhou Yuping, 2012, P 50 ANN M ASS COMP, V1, P69	47	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2018	13	10							e0206057	10.1371/journal.pone.0206057	http://dx.doi.org/10.1371/journal.pone.0206057			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7AD	30376557	Green Submitted, Green Published, gold			2022-12-26	WOS:000448752400007
J	Chang, E; Kim, DH; Yang, H; Lee, DH; Bae, SH; Park, CY				Chang, Eugene; Kim, Dae-Hee; Yang, Hyekyung; Lee, Da Hyun; Bae, Soo Han; Park, Cheol-Young			CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes	PLOS ONE			English	Article							LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; ENDOCANNABINOID SYSTEM; INSULIN-RESISTANCE; METABOLIC SYNDROME; OXIDATIVE STRESS; TISSUE INHIBITOR; ACTIVATION; STEATOSIS; EXPRESSION	Previous studies have shown that the CB1 receptor antagonist reverses steatohepatitis and its related features of metabolic syndrome, such as obesity and type 2 diabetes. However, the beneficial effects of CB1 receptor blockade on hepatic steatosis and inflammation have not been investigated independently of its effects on body weight and glycemic control. At 32 weeks of age, OLETF rats were administered with rimonabant (10 mg.kg(-1).day(-1)) by oral gavage for 6 weeks. No significant changes in body weight, OGTT, and serum glucose were observed in spite of rimonabant-decreased food intake. Moreover, there was a significant difference between initial and final body weight, regardless of rimonabant administration, indicating that OLETF rats were severely diabetic rats. Rimonabant administration significantly decreased serum liver enzyme levels such as ALT and AST, hepatic fat accumulation, lipid peroxidation, and cell death as demonstrated by the number of TUNEL-positive cells in severely uncontrolled diabetic OLETF rats. Significant decreases in hepatic gene expression of proinflammatory cytokines (CD11b, F4/80, MCP1, and TNF alpha), negative inflammatory mediators (SOCS1 and SOCS3), and fibrosis-related proteins (TGF beta, collagen 1, and TIMP1) were found in rimonabant-treated OLETF rats. Six-week administration of rimonabant significantly upregulated mRNA levels of CPT1 alpha and PPAR alpha related to beta-oxidation. Moreover, significant increases in Nrf2 gene expression and its downstream genes, NQO1, GSAT, HO-1, and TXNRD1 along with increased AMPK phosphorylation were noted in uncontrolled diabetic rats treated with rimonabant. The observed potent inhibitory effects of CB1 receptor blockade on hepatic fat infiltration and cellular death in severely uncontrolled diabetic rats indicate that CB1 receptor is a possible therapeutic target. Increased Nrf2 and AMPK phosphorylation may play a role in the mechanism of rimonabant action.	[Chang, Eugene] Ewha Womans Univ, Dept Nutr Sci & Food Management, Seoul, South Korea; [Kim, Dae-Hee; Yang, Hyekyung] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Med Res Inst, Sch Med, Seoul, South Korea; [Lee, Da Hyun; Bae, Soo Han] Yonsei Univ, Severance Biomed Sci Inst, Yonsei Biomed Res Inst, Coll Med, Seoul, South Korea; [Park, Cheol-Young] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Div Endocrinol & Metab, Dept Internal Med,Sch Med, Seoul, South Korea	Ewha Womans University; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center	Bae, SH (corresponding author), Yonsei Univ, Severance Biomed Sci Inst, Yonsei Biomed Res Inst, Coll Med, Seoul, South Korea.; Park, CY (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Div Endocrinol & Metab, Dept Internal Med,Sch Med, Seoul, South Korea.	soohanbae@yuhs.ac; cydoctor@chol.com	; Park, Cheol-Young/C-6690-2018	Lee, Da Hyun/0000-0002-5412-6878; Bae, Soo Han/0000-0002-8007-2906; Park, Cheol-Young/0000-0002-9415-9965	Medical Research Funds from Kangbuk Samsung Hospital	Medical Research Funds from Kangbuk Samsung Hospital(Samsung)	This research was supported by the Medical Research Funds from Kangbuk Samsung Hospital to CYP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Armstrong MJ, 2014, QJM-INT J MED, V107, P33, DOI 10.1093/qjmed/hct198; Bergstrom MA, 2011, DRUG METAB DISPOS, V39, P1823, DOI 10.1124/dmd.111.039412; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Caraceni P, 2009, BEST PRACT RES CL EN, V23, P65, DOI 10.1016/j.beem.2008.10.009; Chang E, 2015, WORLD J GASTROENTERO, V21, P7754, DOI 10.3748/wjg.v21.i25.7754; Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Dudas J, 2001, AM J CLIN PATHOL, V115, P725; Farrell GC, 2012, GUT LIVER, V6, P149, DOI 10.5009/gnl.2012.6.2.149; Flisiak R, 2002, HEPATO-GASTROENTEROL, V49, P1369; Flisiak R, 2000, CYTOKINE, V12, P677, DOI 10.1006/cyto.1999.0660; Garcia-Monzon C, 2011, J HEPATOL, V54, P142, DOI 10.1016/j.jhep.2010.06.021; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; KAWANO K, 1994, DIABETES RES CLIN PR, V24, pS317, DOI 10.1016/0168-8227(94)90269-0; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lanaspa MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3434; Li XN, 2009, DIABETES, V58, P2246, DOI 10.2337/db08-1512; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mai P, 2015, J IMMUNOL, V195, P3390, DOI 10.4049/jimmunol.1403205; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Migrenne S, 2009, AM J PHYSIOL-REG I, V296, pR929, DOI 10.1152/ajpregu.90824.2008; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Mukhopadhyay B, 2015, HEPATOLOGY, V61, P1615, DOI 10.1002/hep.27686; Muse ED, 2004, J CLIN INVEST, V114, P232, DOI 10.1172/JCI200421270; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Oliveira CPMS, 2002, J CELL MOL MED, V6, P399, DOI 10.1111/j.1582-4934.2002.tb00518.x; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Rau M, 2016, J IMMUNOL, V196, P97, DOI 10.4049/jimmunol.1501175; Sarzani R, 2009, METABOLISM, V58, P361, DOI 10.1016/j.metabol.2008.10.009; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Sugimoto H, 2010, AM J PHYSIOL-GASTR L, V298, pG283, DOI 10.1152/ajpgi.00296.2009; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Tam J, 2014, AM J PHYSIOL-ENDOC M, V306, pE457, DOI 10.1152/ajpendo.00489.2013; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Tibirica E, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-5; Tolman KG, 2007, DIABETES CARE, V30, P734, DOI 10.2337/dc06-1539; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Williamson RM, 2012, QJM-INT J MED, V105, P425, DOI 10.1093/qjmed/hcr233; Xu FY, 2016, J HISTOCHEM CYTOCHEM, V64, P157, DOI 10.1369/0022155415627681; Xu J, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-54; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100; Zhang YKJ, 2010, TOXICOL APPL PHARM, V245, P326, DOI 10.1016/j.taap.2010.03.016	59	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206152	10.1371/journal.pone.0206152	http://dx.doi.org/10.1371/journal.pone.0206152			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365523	Green Published, Green Submitted, gold			2022-12-26	WOS:000448448700027
J	Charbit-Henrion, F; Begue, B; Sierra, A; Hanein, S; Stolzenberg, MC; Li, Z; Pellegrini, S; Garcelon, N; Jeanpierre, M; Neven, B; Loge, I; Picard, C; Rosain, J; Bustamante, J; Le Lorc'h, M; Pigneur, B; Fernandes, A; Rieux-Laucat, F; Dias, JA; Ruemmele, FM; Cerf-Bensussan, N				Charbit-Henrion, Fabienne; Begue, Bernadette; Sierra, Anais; Hanein, Sylvain; Stolzenberg, Marie-Claude; Li, Zhi; Pellegrini, Sandra; Garcelon, Nicolas; Jeanpierre, Marc; Neven, Benedicte; Loge, Isabelle; Picard, Capucine; Rosain, Jeremie; Bustamante, Jacinta; Le Lorc'h, Marc; Pigneur, Benedicte; Fernandes, Alicia; Rieux-Laucat, Frederic; Dias, Jorge Amil; Ruemmele, Frank M.; Cerf-Bensussan, Nadine		GENIUS Grp	Copy number variations and founder effect underlying complete IL-10R beta deficiency in Portuguese kindreds	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTERLEUKIN-10 RECEPTOR; ONSET IBD; MUTATIONS; VARIANTS; COLITIS; ALPHA; GENE; IL10; MAP	Mutations in interleukin-10 receptor (IL-10R) genes are one cause of very early-onset inflammatory bowel disease with perianal lesions, which can be cured by hematopoietic stem cell transplantation. Using a functional test, which assesses responsiveness of peripheral monocytes to IL-10, we identified three unrelated Portuguese patients carrying two novel IL-10RB mutations. In the three patients, sequencing of genomic DNA identified the same large deletion of exon 3 which precluded protein expression. This mutation was homozygous in two patients born from consanguineous families and heterozygous in the third patient born from unrelated parents. Microsatellite analysis of the IL1ORBgenomic region revealed a common haplotype in the three Portuguese families pointing to a founder deletion inherited from a common ancestor 400 years ago. In the third patient, surface expression of IL-10R was normal but signaling in response to IL-10 was impaired. Complementary DNA sequencing and next-generation sequencing of IL10RB locus with custom-made probes revealed a 6 Kb duplication encompassing the exon approximate to 6 which leads to a frameshift mutation and a loss of the TYK2-interacting Box 2 motif. Altogether, we describe two novel copy number variations in IL10RB, one with founder effect and one preserving cell surface expression but abolishing signaling.	[Charbit-Henrion, Fabienne; Begue, Bernadette; Sierra, Anais; Hanein, Sylvain; Stolzenberg, Marie-Claude; Neven, Benedicte; Pigneur, Benedicte; Rieux-Laucat, Frederic; Ruemmele, Frank M.; Cerf-Bensussan, Nadine] INSERM, UMR1163, Paris, France; [Charbit-Henrion, Fabienne; Begue, Bernadette; Sierra, Anais; Pigneur, Benedicte; Ruemmele, Frank M.; Cerf-Bensussan, Nadine] Inst Imagine, Lab Intestinal Immun, Paris, France; [Charbit-Henrion, Fabienne; Begue, Bernadette; Sierra, Anais; Hanein, Sylvain; Stolzenberg, Marie-Claude; Garcelon, Nicolas; Jeanpierre, Marc; Neven, Benedicte; Picard, Capucine; Rosain, Jeremie; Bustamante, Jacinta; Pigneur, Benedicte; Rieux-Laucat, Frederic; Ruemmele, Frank M.; Cerf-Bensussan, Nadine] Paris Descartes Univ, Sorbonne Paris Cite, Paris, France; [Charbit-Henrion, Fabienne; Pigneur, Benedicte; Ruemmele, Frank M.] Necker Enfants Malad Hosp, AP HP, Dept Paediat Gastroenterol Hepatol & Nutr, Paris, France; [Charbit-Henrion, Fabienne; Begue, Bernadette; Sierra, Anais; Pigneur, Benedicte; Dias, Jorge Amil; Cerf-Bensussan, Nadine; GENIUS Grp] GENIUS Grp, Paris, France; [Hanein, Sylvain] Inst Imagine, Translat Genet, Paris, France; [Stolzenberg, Marie-Claude; Neven, Benedicte; Rieux-Laucat, Frederic] Inst Imagine, Immunogenet Paediat Autoimmun, Paris, France; [Li, Zhi; Pellegrini, Sandra] Inst Pasteur, Cytokine Signaling Unit, INSERM 1221, Paris, France; [Garcelon, Nicolas] Ctr Rech Cordeliers, Inst Imagine, INSERM, UMR Equipe 1138 22, Paris, France; [Jeanpierre, Marc] Cochin Hosp, AP HP, Genet Unit, Paris, France; [Neven, Benedicte] Necker Enfants Malad Hosp, AP HP, Paediat Haematol Immunol & Rheumatol Unit, Paris, France; [Loge, Isabelle] CHU Rouen, Hop Charles Nicolle, Dept Paediat, Rouen, France; [Picard, Capucine; Rosain, Jeremie; Bustamante, Jacinta] Necker Enfants Malad Hosp, AP HP, Study Ctr Primary Immunodeficiency, Paris, France; [Rosain, Jeremie; Bustamante, Jacinta] Necker Hosp Sick Children, INSERM UMR 1163, Necker Branch, Lab Human Genet Infect Dis, Paris, France; [Rosain, Jeremie; Bustamante, Jacinta] Necker Hosp Sick Children, Inst Imagine, Paris, France; [Bustamante, Jacinta] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Le Lorc'h, Marc] Necker Enfants Malad Hosp, AP HP, Histol Embryol & Cytogenet Unit, Paris, France; [Fernandes, Alicia] AP HP, CNRS UMS3633, INSERM US24, Ctr Biol Resources,Struct Federat Rech Necker, Paris, France; [Fernandes, Alicia] Inst Imagine, Paris, France; [Dias, Jorge Amil] Ctr Hosp S Joao, Dept Paediat, Porto, Portugal	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Sao Joao Hospital	Cerf-Bensussan, N (corresponding author), INSERM, UMR1163, Paris, France.; Cerf-Bensussan, N (corresponding author), Inst Imagine, Lab Intestinal Immun, Paris, France.; Cerf-Bensussan, N (corresponding author), Paris Descartes Univ, Sorbonne Paris Cite, Paris, France.; Cerf-Bensussan, N (corresponding author), GENIUS Grp, Paris, France.	nadine.cerf-bensussan@inserm.fr	Rieux-Laucat, Frédéric/A-7916-2017; Cerf-Bensussan, nadine/H-9505-2017; Dias, Jorge Amil/AAN-4687-2021; hanein, sylvain/AAG-4933-2019; Pellegrini, Sandra/Y-6351-2019; Pellegrini, Sandra -/G-5546-2015; Charbit-Henrion, Fabienne/H-9498-2017; Bustamante, Jacinta/H-7877-2017; Garcelon, Nicolas/AAB-3080-2022; Dias, Jorge/AAY-2074-2021; PIGNEUR, Benedicte/I-4742-2017	Rieux-Laucat, Frédéric/0000-0001-7858-7866; Cerf-Bensussan, nadine/0000-0003-0665-1245; hanein, sylvain/0000-0001-5817-6330; Pellegrini, Sandra/0000-0001-5837-7589; Pellegrini, Sandra -/0000-0001-5837-7589; Charbit-Henrion, Fabienne/0000-0003-4615-3953; Bustamante, Jacinta/0000-0002-3439-2482; Dias, Jorge/0000-0003-2704-4508; Rosain, Jeremie/0000-0002-2822-161X; PIGNEUR, Benedicte/0000-0002-5324-9964; Garcelon, Nicolas/0000-0002-3326-2811	INSERM; Investissement d'Avenir [ANR-10-IAHU-01]; Fondation Princesse Grace; CNRS; Institut Pasteur; Institut Imagine;  [ERC-2013-AdG-339407-IMMUNOBIOTA]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Investissement d'Avenir(French National Research Agency (ANR)); Fondation Princesse Grace; CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); Institut Imagine; 	This work was supported by Institutional grants from INSERM, by the European grant ERC-2013-AdG-339407-IMMUNOBIOTA, by the Investissement d'Avenir grant ANR-10-IAHU-01 and by the Fondation Princesse Grace. FCH was supported by fellowships from Institut Imagine and from INSERM. NCB benefits from an Interface-Assistance Publique-Hopitaux de Paris. Work by ZL and SP was supported by CNRS and institutional grants from Institut Pasteur and INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begue B, 2011, AM J GASTROENTEROL, V106, P1544, DOI 10.1038/ajg.2011.112; Carvalho CMB, 2016, NAT REV GENET, V17, P224, DOI 10.1038/nrg.2015.25; Casper J, 2018, NUCLEIC ACIDS RES, V46, pD762, DOI 10.1093/nar/gkx1020; Charbit-Henrion F, 2018, J CROHNS COLITIS, V12, P1104, DOI 10.1093/ecco-jcc/jjy068; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Engelhardt KR, 2013, J ALLERGY CLIN IMMUN, V131, P825, DOI 10.1016/j.jaci.2012.09.025; Glocker EO, 2010, LANCET, V376, P1272, DOI 10.1016/S0140-6736(10)61008-2; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Grandin V, 2017, HUM MUTAT, V38, P1355, DOI 10.1002/humu.23274; Hanein S, 2008, EUR J HUM GENET, V16, P115, DOI 10.1038/sj.ejhg.5201905; Heidet L, 2017, J AM SOC NEPHROL, V28, P2901, DOI 10.1681/ASN.2017010043; Huang ZH, 2017, INFLAMM BOWEL DIS, V23, P578, DOI 10.1097/MIB.0000000000001058; Karaca NE, 2016, CASE REP IMMUNOL, V2016, DOI 10.1155/2016/5459029; Kotlarz D, 2012, GASTROENTEROLOGY, V143, P347, DOI 10.1053/j.gastro.2012.04.045; Lee CH, 2014, J CROHNS COLITIS, V8, P1551, DOI 10.1016/j.crohns.2014.04.004; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li B, 2014, MUCOSAL IMMUNOL, V7, P869, DOI 10.1038/mi.2013.103; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Z, 2013, J IMMUNOL, V190, P2335, DOI 10.4049/jimmunol.1203118; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Mao H, 2012, GENES IMMUN, V13, P437, DOI 10.1038/gene.2012.8; Marabelli M, 2017, GENE CHROMOSOME CANC, V56, P846, DOI 10.1002/gcc.22488; Nemati S, 2017, EUR J MED GENET, V60, P643, DOI 10.1016/j.ejmg.2017.08.016; Neven B, 2013, BLOOD, V122, P3713, DOI 10.1182/blood-2013-06-508267; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pigneur B, 2013, INFLAMM BOWEL DIS, V19, P2820, DOI 10.1097/01.MIB.0000435439.22484.d3; Rosain J, 2018, J CLIN IMMUNOL, V38, P617, DOI 10.1007/s10875-018-0527-6; Shim JO, 2014, J HUM GENET, V59, P337, DOI 10.1038/jhg.2014.32; Shouval DS, 2014, ADV IMMUNOL, V122, P177, DOI 10.1016/B978-0-12-800267-4.00005-5; Wallweber HJA, 2014, NAT STRUCT MOL BIOL, V21, P443, DOI 10.1038/nsmb.2807; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	32	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0205826	10.1371/journal.pone.0205826	http://dx.doi.org/10.1371/journal.pone.0205826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365510	Green Published, Green Submitted, gold			2022-12-26	WOS:000448448700015
J	Romano-Keeler, J; Shilts, MH; Tovchigrechko, A; Wang, CL; Brucker, RM; Moore, DJ; Fonnesbeck, C; Meng, SF; Correa, H; Lovvorn, HN; Tang, YW; Hooper, L; Bordenstein, SR; Das, SR; Weitkamp, JH				Romano-Keeler, Joann; Shilts, Meghan H.; Tovchigrechko, Andrey; Wang, Chunlin; Brucker, Robert M.; Moore, Daniel J.; Fonnesbeck, Christopher; Meng, Shufang; Correa, Hernan; Lovvorn, Harold N., III; Tang, Yi-Wei; Hooper, Lora; Bordenstein, Seth R.; Das, Suman R.; Weitkamp, Jorn-Hendrik			Distinct mucosal microbial communities in infants with surgical necrotizing enterocolitis correlate with age and antibiotic exposure	PLOS ONE			English	Article							INTESTINAL INJURY; DIVERSITY; STABILITY; PATHOGENESIS; BACTERIA; DATABASE; MODELS; TLR4	Objective Necrotizing enterocolitis (NEC) is the most common surgical emergency in preterm infants, and pathogenesis associates with changes in the fecal microbiome. As fecal samples incompletely represent microbial communities in intestinal mucosa, we sought to determine the NEC tissue-specific microbiome and assess its contribution to pathogenesis. Design We amplified and sequenced the V1-V3 hypervariable region of the bacterial 16S rRNA gene extracted from intestinal tissue and corresponding fecal samples from 12 surgical patients with NEC and 14 surgical patients without NEC. Low quality and non-bacterial sequences were removed, and taxonomic assignment was made with the Ribosomal Database Project. Operational taxonomic units were clustered at 97%. We tested for differences between NEC and non-NEC samples in microbiome alpha- and beta-diversity and differential abundance of specific taxa between NEC and non-NEC samples. Additional analyses were performed to assess the contribution of other demographic and environmental confounding factors on the infant tissue and fecal microbiome. Results The fecal and tissue microbial communities were different. NEC was associated with a distinct microbiome, which was characterized by low diversity, higher abundances of Staphylococcus and Clostridium_sensu_stricto, and lower abundances of Actinomyces and Corynebacterium. Infant age and vancomycin exposure correlated with shifts in the tissue microbiome. Conclusion The observed low diversity in NEC tissues suggests that NEC is associated with a bacterial bloom and a distinct mucosal bacterial community. The exact bacterial species that constitute the bloom varied by infant and were strongly influenced by age and exposure to vancomycin.	[Romano-Keeler, Joann; Moore, Daniel J.; Meng, Shufang; Weitkamp, Jorn-Hendrik] Vanderbilt Univ, Dept Pediat, Nashville, TN 37235 USA; [Shilts, Meghan H.; Tovchigrechko, Andrey; Das, Suman R.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Tovchigrechko, Andrey] Medimmune, Res Bioinformat, Gaithersburg, MD USA; [Wang, Chunlin] Stanford Univ, Genome Technol Ctr, Palo Alto, CA 94304 USA; [Brucker, Robert M.; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Moore, Daniel J.; Correa, Hernan; Bordenstein, Seth R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Moore, Daniel J.; Correa, Hernan; Bordenstein, Seth R.; Das, Suman R.; Weitkamp, Jorn-Hendrik] Vanderbilt Univ, Med Univ, Vanderbilt Inst Infect Immunol & Inflammat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Fonnesbeck, Christopher] Vanderbilt Univ, Dept Biostat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Lovvorn, Harold N., III] Vanderbilt Univ, Dept Pediat Surg, 221 Kirkland Hall, Nashville, TN 37235 USA; [Tang, Yi-Wei] Mem Sloan Kettering Canc Ctr, Dept Lab Med, 1275 York Ave, New York, NY 10021 USA; [Hooper, Lora] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Brucker, Robert M.] Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02138 USA	Vanderbilt University; Vanderbilt University; AstraZeneca; Medimmune; Stanford University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University	Weitkamp, JH (corresponding author), Vanderbilt Univ, Dept Pediat, Nashville, TN 37235 USA.; Weitkamp, JH (corresponding author), Vanderbilt Univ, Med Univ, Vanderbilt Inst Infect Immunol & Inflammat, 221 Kirkland Hall, Nashville, TN 37235 USA.	hendrik.weitkamp@vanderbilt.edu	Moore, Daniel J/A-4924-2008; Das, Suman/ABB-7273-2020; Weitkamp, Joern-Hendrik/AAZ-8272-2020; Moore, Daniel/V-6145-2019	Moore, Daniel J/0000-0002-6889-9345; Das, Suman/0000-0003-2496-9724; Weitkamp, Joern-Hendrik/0000-0002-6654-4823; Moore, Daniel/0000-0002-6889-9345	American Academy of Pediatrics Marshall Klaus Perinatal Research Award; Eunice Kennedy Shriver National Institute Of Child Health AMP; Human Development (NICHD) [T32HD068256, K08HD061607]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K08DK090146]; National Institute of Health (NIH) Division of Loan Repayment National Institute of Diabetes and Digestive and Kidney Diseases Award; National Science Foundation [DEB-1046149]; Vanderbilt Microbiome Initiative; National Institute of Allergy and Infectious Diseases (NIAID) [U19AI095227, P30 AI110527]; Vanderbilt Digestive Disease Research Center [P30DK058404]; Vanderbilt Diabetes Center [P30DK20593]; Vanderbilt CTSA Grant from the National Center for Research Resources (NCRR/NIH) [UL1 RR024975-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095227, P30AI110527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	American Academy of Pediatrics Marshall Klaus Perinatal Research Award; Eunice Kennedy Shriver National Institute Of Child Health AMP; Human Development (NICHD); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Health (NIH) Division of Loan Repayment National Institute of Diabetes and Digestive and Kidney Diseases Award; National Science Foundation(National Science Foundation (NSF)); Vanderbilt Microbiome Initiative; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Vanderbilt Digestive Disease Research Center; Vanderbilt Diabetes Center; Vanderbilt CTSA Grant from the National Center for Research Resources (NCRR/NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Academy of Pediatrics Marshall Klaus Perinatal Research Award (to J.R.K.) and the Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD) [T32HD068256 (to J.R.K.), K08HD061607 (to J.H.W.)]; the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K08DK090146 (to D.J.M.)], the National Institute of Health (NIH) Division of Loan Repayment National Institute of Diabetes and Digestive and Kidney Diseases Award (to J.R.K.), the National Science Foundation [DEB-1046149] and The Vanderbilt Microbiome Initiative (to S.R.B.), and U19AI095227 and P30 AI110527, the National Institute of Allergy and Infectious Diseases (NIAID) (to S.R.D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NICHD, NIDDK, NIAID or the National Institutes of Health (NIH). This project was also funded by the Vanderbilt Digestive Disease Research Center [P30DK058404], Vanderbilt Diabetes Center [P30DK20593], and the Vanderbilt CTSA Grant UL1 RR024975-01 from the National Center for Research Resources (NCRR/NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boulesteix AL, 2009, BRIEF BIOINFORM, V10, P556, DOI 10.1093/bib/bbp034; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brower-Sinning R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105046; Bucher BT, 2011, J PEDIATR SURG, V46, P1029, DOI 10.1016/j.jpedsurg.2011.03.026; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claud EC, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-20; Coggins SA, 2015, CLIN PERINATOL, V42, P133, DOI 10.1016/j.clp.2014.10.012; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, BIOINFORMATICS, P2194; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gordon P, EJ NEONATOL RES, V2, P145; Grissom RJ, 2012, EFFECT SIZES RES UNI, DOI 10.4324/9780203803233; Guthrie Scott O, 2003, J Perinatol, V23, P278, DOI 10.1038/sj.jp.7210892; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hothorn T., 2013, EXACTRANKTESTS EXACT; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Kanehisa M Institute for Chemical Research KU Uji Kyoto 611-0011 Japan Sato Y Healthcare Solutions Department FKSL Hakata-ku Fukuoka 812- 0007 Japan Kawashima M Healthcare Solutions Department FKSL Hakata-ku Fukuoka 812-0007 Japan, 2017, NUCLEIC ACIDS RES, V44; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; McMurtry VE, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0075-8; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; MUSEMECHE CA, 1986, J PEDIATR SURG, V21, P536, DOI 10.1016/S0022-3468(86)80228-7; Oksanen J., 2014, VEGAN COMMUNITY ECOL; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Romano-Keeler J, 2014, GUT MICROBES, V5, P192, DOI 10.4161/gmic.28442; Roze JC, 2017, AM J CLIN NUTR, V106, P821, DOI 10.3945/ajcn.117.152967; Rozenfeld RA, 2001, AM J PHYSIOL-GASTR L, V281, pG957, DOI 10.1152/ajpgi.2001.281.4.G957; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shah RD, 2013, J R STAT SOC B, V75, P55, DOI 10.1111/j.1467-9868.2011.01034.x; Shilts MH, 2015, MICROBIAL ECOLOGY; Sim K, 2015, CLIN INFECT DIS, V60, P389, DOI 10.1093/cid/ciu822; Smith B, BMC MICROBIOL, P73; Stewart CJ, 2012, ACTA PAEDIATR, V101, P1121, DOI 10.1111/j.1651-2227.2012.02801.x; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Tang YW, 1998, J CLIN MICROBIOL, V36, P3674, DOI 10.1128/JCM.36.12.3674-3679.1998; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Weitkamp JH, 2014, GUT, V63, P1205, DOI 10.1136/gutjnl-2013-305928	53	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206366	10.1371/journal.pone.0206366	http://dx.doi.org/10.1371/journal.pone.0206366			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365522	Green Submitted, gold, Green Published			2022-12-26	WOS:000448448700046
J	Tani, H; Komeno, T; Fukuma, A; Fukushi, S; Taniguchi, S; Shimojima, M; Uda, A; Morikawa, S; Nakajima, N; Furuta, Y; Saijo, M				Tani, Hideki; Komeno, Takashi; Fukuma, Aiko; Fukushi, Shuetsu; Taniguchi, Satoshi; Shimojima, Masayuki; Uda, Akihiko; Morikawa, Shigeru; Nakajima, Nozomi; Furuta, Yousuke; Saijo, Masayuki			Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration	PLOS ONE			English	Article							T-705 FAVIPIRAVIR; RIBAVIRIN	Severe fever with thrombocytopenia syndrome (SFTS), caused by SFTS virus (SFTSV), is a viral hemorrhagic fever with a high case fatality rate. Favipiravir was reported to be effective in the treatment of SFTSV infection in vivo in type I interferon receptor knockout (IFNAR(-/-)) mice at treatment dosages of both 60 mg/kg/day and 300 mg/kg/day for a duration of 5 days. In this study, the efficacy of favipiravir at dosages of 120 mg/kg/day and 200 mg/kg/day against SFTSV infection in an IFNAR(-/-) mouse infection model was investigated. IFNAIR(-/-) mice were subcutaneously infected with SFTSV at a 1.0 x 10(6) 50% tissue culture infectious dose followed by twice daily administration of favipiravir, comprising a total dose of either 120 mg/kg/day or 200 mg/kg/day. The treatment was initiated either immediately post infection or at predesignated time points post infection. Neutralizing antibodies in the convalescent-phase mouse sera was examined by the pseudotyped VSV system. All mice treated with favipiravir at dosages of 120 mg/kg/day or 200 mg/kg/day survived when the treatment was initiated at no later than 4 days post infection. A decrease in body weight of mice was observed when the treatment was initiated at 3-4 days post infection. Furthermore, all control mice died. The body weight of mice did not decrease when treatment with favipiravir was initiated immediately post infection at dosages of 120 mg/kg/day and 200 mg/kg/day. Neutralizing antibodies were detected in the convalescent-phase mouse sera. Similar to the literature-reported peritoneal administration of favipiravir at 300 mg/kg/day, the oral administration of favipiravir at dosages of 120 mg/kg/day and 200 mg/kg/day to IFNAR(-/-) mice infected with SFTSV was effective.	[Tani, Hideki; Fukuma, Aiko; Fukushi, Shuetsu; Taniguchi, Satoshi; Shimojima, Masayuki; Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Tani, Hideki] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Virol, Toyama, Japan; [Komeno, Takashi; Nakajima, Nozomi; Furuta, Yousuke] Toyama Chem Co Ltd, Res Labs, Toyama, Japan; [Uda, Akihiko; Morikawa, Shigeru] Natl Inst Infect Dis, Dept Vet Sci, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Tani, H (corresponding author), Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan.; Tani, H (corresponding author), Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Virol, Toyama, Japan.	htani@med.u-toyama.ac.jp		MORIKAWA, SHIGERU/0000-0001-6249-6716; Saijo, Masayuki/0000-0001-5458-7298	Ministry of Health, Labour, and Welfare of Japan [H25-Shinko-Shitei-009]; AMED [JP18fk0108002, JP18fk0108072]; JSPS KAKENHI Grant [JP15K08510]	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); AMED(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially supported by Grants-in-Aid from the Ministry of Health, Labour, and Welfare of Japan (H25-Shinko-Shitei-009) (M. Sa.), AMED under Grant Number JP18fk0108002 (M. Sa.) and JP18fk0108072 (M.Sa.), and JSPS KAKENHI Grant Number JP15K08510 (H.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CQ, 2016, CLIN INFECT DIS, V63, P1288, DOI 10.1093/cid/ciw571; De Clercq E, 2015, BIOCHEM PHARMACOL, V93, P1, DOI 10.1016/j.bcp.2014.11.008; Delang L, 2018, ANTIVIR RES, V153, P85, DOI 10.1016/j.antiviral.2018.03.003; Deng BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080802; Furuta Y, 2017, P JPN ACAD B-PHYS, V93, P449, DOI 10.2183/pjab.93.027; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Gowen BB, 2017, J VIROL, V91, DOI 10.1128/JVI.01942-16; Gowen BB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002614; Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792; Lei XY, 2015, MICROBES INFECT, V17, P149, DOI 10.1016/j.micinf.2014.12.002; Liu Q, 2014, LANCET INFECT DIS, V14, P763, DOI 10.1016/S1473-3099(14)70718-2; Liu W, 2013, CLIN INFECT DIS, V57, P1292, DOI 10.1093/cid/cit530; Oestereich L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002804; Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014; Park I, 2017, INFECT CHEMOTHER, V49, P72, DOI 10.3947/ic.2017.49.1.72; Shimojima M, 2014, JPN J INFECT DIS, V67, P423, DOI 10.7883/yoken.67.423; Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967; Smither SJ, 2014, ANTIVIR RES, V104, P153, DOI 10.1016/j.antiviral.2014.01.012; Spengler JR, 2018, ANTIVIR RES, V150, P137, DOI 10.1016/j.antiviral.2017.11.019; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Tani H, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00061-15; Tani H, 2016, J VIROL, V90, P5292, DOI 10.1128/JVI.00110-16; Westover JB, 2017, VIROLOGY, V511, P175, DOI 10.1016/j.virol.2017.08.004; Yoshikawa T, 2014, J CLIN MICROBIOL, V52, P3325, DOI 10.1128/JCM.00742-14	24	26	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206416	10.1371/journal.pone.0206416	http://dx.doi.org/10.1371/journal.pone.0206416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365543	Green Submitted, Green Published, gold			2022-12-26	WOS:000448448700050
J	Zhu, WP; Zhang, H; Chen, XN; Jin, K; Ning, L				Zhu, Weiping; Zhang, Han; Chen, Xuning; Jin, Kan; Ning, Le			Numerical characterization of regenerative axons growing along a spherical multifunctional scaffold after spinal cord injury	PLOS ONE			English	Article							FUNCTIONAL RECOVERY; NERVOUS-SYSTEM; GLIAL SCAR; NEUROTROPHIC FACTORS; MOLECULAR GRADIENTS; LENTIVIRAL VECTORS; NOGO RECEPTOR; GUIDANCE; REPAIR; CELLS	Spinal cord injury (SCI) followed by extensive cell loss, inflammation, and scarring, often permanently damages neurological function. Biomaterial scaffolds are promising but currently have limited applicability in SCI because after entering the scaffold, regenerating axons tend to become trapped and rarelyre-enter the host tissue, the reasons for which remain to be completely explored. Here, we propose a mathematical model and computer simulation for characterizing regenerative axons growing along a scaffold following SCI, and how their growth may be guided. The model assumed a solid, spherical, multifunctional, biomaterial scaffold, that would bridge the rostral and caudal stumps of a completely transected spinal cord in a rat model and would guide the rostral regenerative axons toward the caudal tissue. Other assumptions include the whole scaffold being coated with extracellular matrix components, and the caudal area being additionally seeded with chemoattractants. The chemical factors on and around the scaffold were formulated to several coupled variables, and the parameter values were derived fromexisting experimental data. Special attention was given to the effects of coating strength, seeding location, and seeding density, as well as the ramp slope of the scaffold, on axonal regeneration. In numerical simulations, a slimmer scaffold provided a small slope at the entry "on-ramp" area that improved the success rate of axonal regeneration. If success rates are high, an increased number of regenerative axons traverse through the narrow channels, causing congestion and lowering the growth rate. An increase in the number of severed axons (300-12000) did not significantly affect the growth rate, but it reduced the success rate of axonal regeneration. However, an increase in the seeding densities of the complexes on the whole scaffold, and that in the seeding densities of the chemoattractants on the caudal area, improved both the success and growth rates. However, an increase in the density of thecomplexes on the whole scaffold risks an over-eutrophic surface that harms axonal regeneration.Although theoretical predictions are yet to be validated directly by experiments, this theoretical tool can advance the treatment of SCI, and is also applicable to scaffolds with other architectures.	[Zhu, Weiping; Zhang, Han; Chen, Xuning; Jin, Kan; Ning, Le] Shanghai Univ, Shanghai Inst Appl Math & Mech, Shanghai, Peoples R China	Shanghai University	Zhu, WP (corresponding author), Shanghai Univ, Shanghai Inst Appl Math & Mech, Shanghai, Peoples R China.	wpzhu@shu.edu.cn		Zhu, Weiping/0000-0002-3071-9783	National Natural Sciences Foundation of China [31370940]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Sciences Foundation of China Grant No. 31370940.	Ahn HS, 2015, ACTA BIOMATER, V13, P324, DOI 10.1016/j.actbio.2014.11.026; Atzeni F, 2006, RHEUM DIS CLIN N AM, V32, P413, DOI 10.1016/j.rdc.2006.02.003; Blesch A, 2012, EXP NEUROL, V235, P162, DOI 10.1016/j.expneurol.2011.12.037; Boehler RM, 2013, BIOMATERIALS, V34, P5431, DOI 10.1016/j.biomaterials.2013.04.009; Bregman BS, 2002, PROG BRAIN RES, V137, P257; Brittis PA, 2001, NEURON, V30, P11, DOI 10.1016/S0896-6273(01)00258-6; Bunge MB, 2008, J SPINAL CORD MED, V31, P262, DOI 10.1080/10790268.2008.11760720; Chedly J, 2017, BIOMATERIALS, V138, P91, DOI 10.1016/j.biomaterials.2017.05.024; Chen S, 1998, ANNU REV FLUID MECH, V30, P329, DOI 10.1146/annurev.fluid.30.1.329; Chen XN, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/3030454; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Feng SL, 2014, J THEOR BIOL, V363, P235, DOI 10.1016/j.jtbi.2014.08.033; Fortun J, 2009, NEUROSCI LETT, V456, P124, DOI 10.1016/j.neulet.2008.08.092; Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865; Girard C, 2005, J NEUROSCI, V25, P7924, DOI 10.1523/JNEUROSCI.4890-04.2005; Goodhill GJ, 1998, TRENDS NEUROSCI, V21, P226, DOI 10.1016/S0166-2236(97)01203-4; Goodhill GJ, 1997, EUR J NEUROSCI, V9, P1414, DOI 10.1111/j.1460-9568.1997.tb01496.x; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Han SF, 2015, BIOMATERIALS, V41, P89, DOI 10.1016/j.biomaterials.2014.11.031; Hendriks WTJ, 2007, J NEUROSCI RES, V85, P3041, DOI 10.1002/jnr.21432; Hentschel HGE, 1999, P ROY SOC B-BIOL SCI, V266, P2231, DOI 10.1098/rspb.1999.0913; Houchin-Ray T, 2007, BIOMATERIALS, V28, P2603, DOI 10.1016/j.biomaterials.2007.01.042; Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006; Nguyen H, 2016, ELIFE, V5, DOI 10.7554/eLife.12248; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Joo NY, 2012, ACTA BIOMATER, V8, P1802, DOI 10.1016/j.actbio.2012.01.026; Kanno H, 2014, J NEUROSCI, V34, P1838, DOI 10.1523/JNEUROSCI.2661-13.2014; Kim M, 2014, HISTOL HISTOPATHOL, V29, P1395, DOI 10.14670/HH-29.1395; Krottje JK, 2007, B MATH BIOL, V69, P3, DOI 10.1007/s11538-006-9142-4; Lee JH, 2014, ACTA BIOMATER, V10, P4425, DOI 10.1016/j.actbio.2014.06.023; Li GN, 2008, TISSUE ENG PART B-RE, V14, P33, DOI 10.1089/teb.2007.0181; Liu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117709; Liu SW, 2017, ACTA BIOMATER, V60, P167, DOI 10.1016/j.actbio.2017.07.024; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Mortimer D, 2009, P NATL ACAD SCI USA, V106, P10296, DOI 10.1073/pnas.0900715106; Qian YH., 1995, ANN REV COMPUT PHYS, V3, P195; Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259; Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958; Sarvestani AS, 2009, BIOTECHNOL BIOENG, V103, P424, DOI 10.1002/bit.22273; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Shi BC, 2008, COMPUT MATH APPL, V55, P1568, DOI 10.1016/j.camwa.2007.08.016; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Tang BL, 2003, NEUROCHEM INT, V42, P189, DOI 10.1016/S0197-0186(02)00094-3; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tuinstra HM, 2014, TISSUE ENG PT A, V20, P1027, DOI [10.1089/ten.tea.2013.0111, 10.1089/ten.TEA.2013.0111]; Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002; van Ooyen A, 2011, NAT REV NEUROSCI, V12, P311, DOI 10.1038/nrn3031; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wensch J, 2004, PARALLEL COMPUT, V30, P163, DOI 10.1016/j.parco.2003.04.006; Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002; Zhao RR, 2011, J NEUROSCI METH, V201, P228, DOI 10.1016/j.jneumeth.2011.08.003	54	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0205961	10.1371/journal.pone.0205961	http://dx.doi.org/10.1371/journal.pone.0205961			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365562	Green Submitted, gold, Green Published			2022-12-26	WOS:000448448700019
J	Di Giusto, B; Lavallee, JP; Yu, TY				Di Giusto, Bruno; Lavallee, Joseph P.; Yu, Tai-Yi			Towards an East Asian model of climate change awareness: A questionnaire study among university students in Taiwan	PLOS ONE			English	Article							HUMAN HEALTH; EDUCATION; ATTITUDES; KNOWLEDGE; RISK	East Asia emits more greenhouse gases into the atmosphere than any other region, yet little is known about attitudes towards climate change in this region. A cross-sectional survey investigating climate change knowledge, concern and behavior change was administered to 1118 university students at nine universities across Taiwan in June 2016. Knowledge was assessed with a 15-item quiz while concern and behavioral change were self-reported on 5-point Likert scales. The relationship of these three variables with various socio-demographic variables was investigated through Kruskal-Wallis tests and ordinal logistic regressions. Knowledge was homogeneous by region but differed sharply by socioeconomic position. Concern appears high by international standards, with 65% reporting being "somewhat concerned" and 28% being "very concerned," while climate change denial was negligible. Students expressing greater concern were more likely to be from eastern and southern Taiwan, regions more vulnerable to extreme weather events. However, these high concern levels did not translate into action, as only 38% of respondents reported "some" and 11% reported "very much" behavioral change in response to climate change. Higher levels of behavioral change were reported by students expressing greater concern and students with lower levels of climate change knowledge. In contrast with studies of Western societies, our findings suggest an East Asian model in which the conflict between economic growth and the environment is playing out in different ways, such that the crucial need is for policy leadership and not more education.	[Di Giusto, Bruno] Ming Chuan Univ Int Coll, Journalism & Mass Commun Program, Taipei, Taiwan; [Lavallee, Joseph P.] Ming Chuan Univ Int Coll, Int Business & Trade Program, Taipei, Taiwan; [Yu, Tai-Yi] Ming Chuan Univ, Dept Risk Management & Insurance, Taipei, Taiwan	Ming Chuan University	Lavallee, JP (corresponding author), Ming Chuan Univ Int Coll, Int Business & Trade Program, Taipei, Taiwan.	lavallee@mail.mcu.edu.tw	Yu, Tai-Yi/GNM-8279-2022; Di Giusto, Bruno/AAL-2166-2020; Yu, Tai-Yi/GSO-1462-2022	Di Giusto, Bruno/0000-0002-1037-276X; 	Taiwan's Ministry of Science and Technology [104-2410-H-130-020]	Taiwan's Ministry of Science and Technology	This study was supported by a grant from Taiwan's Ministry of Science and Technology (grant number 104-2410-H-130-020), https://www.most.gov.tw/.JL was the principal investigator; BDG and T-YY were listed as co-PIs for this grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, MEAN ED ATTAINMENT A; [Anonymous], STAT SUMM NO 2 ENR T; [Anonymous], 2015, REP SURV FAM INC EXP; [Anonymous], SURV FAM INC EXP GEN; [Anonymous], 2015, MAIN STAT NO 3 SUMM; [Anonymous], 2016, ED TAIW 2016 17; [Anonymous], 2015, SUMM ED ALL LEV BRIE; Barnett J, 2007, POLIT GEOGR, V26, P639, DOI 10.1016/j.polgeo.2007.03.003; Boden T, GLOBAL CO2 EMISSIONS; Brulle RJ, 2012, CLIMATIC CHANGE, V114, P169, DOI 10.1007/s10584-012-0403-y; Buhaug H, 2009, SOCIAL DIMENSIONS CL; Burck J, 2017, CLIMATE CHANGE PERFO; Burck J., 2016, CLIMATE CHANGE PERFO; Carlsson F, 2012, LAND ECON, V88, P326, DOI 10.3368/le.88.2.326; Chou KT, 2016, AIMS ENERGY, V4, P313, DOI 10.3934/energy.2016.2.313; Cordero EC, 2008, B AM METEOROL SOC, V89, P865, DOI 10.1175/2007BAMS2432.1; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Feit S., 2017, SMOKE FUMES LEGAL EV; Feldman L, CLIMATE CHANGE GENER; Hamilton LC, 2011, CLIMATIC CHANGE, V104, P231, DOI 10.1007/s10584-010-9957-8; IBM, 2011, IBM SPSS STAT WIND V; Jamelske E., 2013, J ENVIRON STUD SCI, V3, P269, DOI [10.1007/s13412-013-0144-x, DOI 10.1007/S13412-013-0144-X]; Jamelske E., 2015, J ENV SOC SCI, V5, P87, DOI 10.1007/s13412-015-0229-9; Johnson Chalmers, 1995, JAPAN WHO GOVERNS RI; Leahy M, 2013, INT ENERGY OUTLOOK 2, P55; Lee TM, 2015, NAT CLIM CHANGE, V5, P1014, DOI 10.1038/NCLIMATE2728; Liao HC, 2013, TAIWANS SEVERE ENERG; Liu JCE, 2009, ENVIRONMENT, V51, P32, DOI 10.3200/ENV.51.4.32-45; Liu SY, 2015, J ENVIRON EDUC, V46, P114, DOI 10.1080/00958964.2014.999742; McCright A.M., 2008, HOFSTRA LAW REV, V37, P1017; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Muttarak R, 2014, ECOL SOC, V19, DOI 10.5751/ES-06476-190142; Myers SS, 2009, ANNU REV ENV RESOUR, V34, P223, DOI 10.1146/annurev.environ.033108.102650; Patz JA, 2014, JAMA-J AM MED ASSOC, V312, P1565, DOI 10.1001/jama.2014.13186; Peters GP, 2007, ENVIRON SCI TECHNOL, V41, P5939, DOI 10.1021/es070108f; Ranney MA, 2016, TOP COGN SCI, V8, P49, DOI 10.1111/tops.12187; Rhodes E, 2014, GLOBAL ENVIRON CHANG, V29, P92, DOI 10.1016/j.gloenvcha.2014.09.001; Shealy T, 2019, ENVIRON EDUC RES, V25, P925, DOI 10.1080/13504622.2017.1293009; Shih YJ., 2012, ERCCT ONLINE PAPER S, V11; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Stevenson KT, 2014, CLIMATIC CHANGE, V126, P293, DOI 10.1007/s10584-014-1228-7; Stokes B., 2015, GLOBAL CLIMATE CHANG; Sun YY, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010091; Tien CK, 2013, ENERG POLICY, V61, P1252, DOI 10.1016/j.enpol.2013.06.016; Tsai WT, 2012, INT J EDUC DEV, V32, P359, DOI 10.1016/j.ijedudev.2011.06.003; Wachholz S, 2014, INT J SUST HIGHER ED, V15, P128, DOI 10.1108/IJSHE-03-2012-0025; Ziegler A, 2017, ENERG ECON, V63, P144, DOI 10.1016/j.eneco.2017.01.022	48	9	9	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206298	10.1371/journal.pone.0206298	http://dx.doi.org/10.1371/journal.pone.0206298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3GT	30359427	Green Published, Green Submitted, gold			2022-12-26	WOS:000448438400062
J	Foldi, A; Acs, E; Grigorszky, I; Ector, L; Wetzel, CE; Varbiro, G; Kiss, KT; Dobosy, P; Trabert, Z; Borsodi, AK; Duleba, M				Foldi, Angela; Acs, Eva; Grigorszky, Istvan; Ector, Luc; Wetzel, Carlos Eduardo; Varbiro, Gabor; Kiss, Keve Tiharner; Dobosy, Peter; Trabert, Zsuzsa; Borsodi, Andrea K.; Duleba, Monika			Unexpected consequences of bombing. Community level response of epiphytic diatoms to environmental stress in a saline bomb crater pond area	PLOS ONE			English	Article							SODA PANS; BENTHIC DIATOMS; WATER-QUALITY; MOLECULAR PHYLOGENY; BARCODING DIATOMS; CENTRAL-EUROPE; SHALLOW LAKE; SP. NOV.; NITZSCHIA; DNA	The spatial response of epiphytic diatom communities to environmental stress was studied in a moderately saline wetland area located in the plain of Danube-Tisza Interfluve, Hungary. The area is characterised by World War II bomb crater ponds and can be regarded as an excellent ecological model system where the dispersion of species is slightly limited by distance. To study the effect of environmental variables on the communities, canonical correspondence analysis was applied. Salinity, pH, total suspended solids, total phosphorous and depth proved to be significant environmental drivers in this analysis. The ecological status of the ponds was assessed with Ziemann's halobity index, as the trophity-depending metric cannot be applied to these habitats (due to the naturally high phosphorus content). Ponds in "good" ecological status significantly differed from those appertaining to water quality category of "not-good" ecological status considering characteristic of natural astatic soda pans (e.g. salinity, pH, ammonium, total phosphorous concentration, nitrogen:phosphorous ratio and turbidity). The differences between epiphytic diatom communities inhabiting the ponds were detected using non-parametric multidimensional scaling. The samples formed three groups according to the types of ponds ("transparent", "transitional" and "turbid") based on the width of the macrophyte belt around them. Indicator species related to the ecological status of the ponds and diatom communities contributing to the separation of groups of ponds were identified. One of the indicator species differed from species already described. Light and scanning electron microscopy features and phylogenetic analyses based on three genes (18S and 28S rRNA genes, rbcL) proved that it was a new species of Nitzschia genus, closely related to Nitzschia frustulum and Nitzschia inconspicua. Therefore, description of a new species, Nitzschia reskoi Acs, Duleba, C.E.Wetzel & Ector is proposed. We concluded that the increasing abundance of Nitzschia reskoi was a signal of the degradation of the intermittent saline wetlands.	[Foldi, Angela; Varbiro, Gabor] MTA Ctr Ecol Res, Sustainable Ecosyst Grp, Tihany, Hungary; [Foldi, Angela] Eotvos Lorand Univ, Doctoral Sch Environm Sci, Budapest, Hungary; [Acs, Eva; Grigorszky, Istvan; Kiss, Keve Tiharner; Dobosy, Peter; Trabert, Zsuzsa; Borsodi, Andrea K.; Duleba, Monika] Danube Res Inst, MTA Ctr Ecol Res, Budapest, Hungary; [Grigorszky, Istvan] Univ Debrecen, Dept Hydrobiol, Debrecen, Hungary; [Ector, Luc; Wetzel, Carlos Eduardo] LIST, Environm Res & Innovat Dept ERIN, Belvaux, Luxembourg; [Varbiro, Gabor] Danube Res Inst, MTA Ctr Ecol Res, Dept Tisza River Res, Debrecen, Hungary; [Borsodi, Andrea K.] Eotvos Lorand Univ, Dept Microbiol, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; University of Debrecen; Luxembourg Institute of Science & Technology; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Eotvos Lorand University	Duleba, M (corresponding author), Danube Res Inst, MTA Ctr Ecol Res, Budapest, Hungary.	duleba.monika@okologia.mat.hu	Borsodi, Andrea K./H-1148-2017; István, Grigorszky/Q-2245-2019; Varbiro, Gabor/AAH-5587-2021	Borsodi, Andrea K./0000-0002-3738-7937; Varbiro, Gabor/0000-0001-5907-3472	National Research, Development and Innovation Office - NKFIH [119208];  [GINOP-2.3.2-15-2016-00019]	National Research, Development and Innovation Office - NKFIH(National Research, Development & Innovation Office (NRDIO) - Hungary); 	This research was supported by the GINOP-2.3.2-15-2016-00019 and National Research, Development and Innovation Office - NKFIH, 119208 grants (https://nkfih.gov.hu/).	Acs E., 2005, Acta Botanica Hungarica, V47, P211, DOI 10.1556/ABot.47.2005.3-4.1; ACS E, 2015, HUNGARIAN CHEM J MAG, V70, P374; Acs E, 2017, PHYTOTAXA, V308, P54, DOI 10.11646/phytotaxa.308.1.4; Alakananda B, 2015, PHYCOL RES, V63, P29, DOI 10.1111/pre.12060; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antoniades D, 2008, ICONOGRAPHIA DIATOMO, V17; Asencio AD, 2013, ESTUAR COAST SHELF S, V124, P24, DOI 10.1016/j.ecss.2013.03.006; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bahls L., 2012, DIATOMS US; Blanco S, 2004, VIE MILIEU, V54, P71; Blanco S, 2013, DIATOM RES, V28, P13, DOI 10.1080/0269249X.2012.734528; BLINN DW, 1993, ECOLOGY, V74, P1246, DOI 10.2307/1940494; Bolla B, 2010, VIE MILIEU, V60, P197; Boros E, 2008, ACTA ZOOL ACAD SCI H, V54, P207; Boros E, 2013, ECOLOGY MANAGEMENT S; Boros E, 2017, LIMNOLOGICA, V62, P38, DOI 10.1016/j.limno.2016.10.003; Buczko K., 2001, Studia Botanica Hungarica, V32, P39; Buczko K, 1997, ACTA BOT HUNG, V40, P21; Carballeira R, 2017, EUR J PHYCOL, V52, P342, DOI 10.1080/09670262.2017.1309575; Caspers H., 1982, INT REV GESAMTEN HYD, DOI DOI 10.1002/iroh.19840690206; Cejudo-Figueiras C, 2010, VIE MILIEU, V60, P89; Cholnoky B., 1929, MAGYAR BOT LAPOK, V28, P100; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COMPERE P., 1967, BULL JARD BOT NAT BELG, V37, P109, DOI 10.2307/3667692; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Denys L, 1998, NOVA HEDWIGIA, V67, P247; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Hallfors G., 2004, BALT SEA ENV P 95; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hammer U.T., 1986, SALINE LAKE ECOSYSTE; Hamsher S, 2016, FOTTEA, V16, P79, DOI 10.5507/fot.2015.023; Hamsher SE, 2011, PROTIST, V162, P405, DOI 10.1016/j.protis.2010.09.005; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HECKY RE, 1973, LIMNOL OCEANOGR, V18, P53, DOI 10.4319/lo.1973.18.1.0053; Hellebust JA, 1977, BIOL DIATOMS, P169; Herbst DB, 1998, J PHYCOL, V34, P772, DOI 10.1046/j.1529-8817.1998.340772.x; Hofmann G., 1994, BIBLIOTHECA DIATOMOL, V30; Hofmann G., 1999, METHODEN BIOL WASSER, P319; Horvath Z, 2014, OIKOS, V123, P461, DOI 10.1111/j.1600-0706.2013.00575.x; Jones HM, 2005, EUR J PHYCOL, V40, P61, DOI 10.1080/09670260400024675; Khan-Bureau DA, 2017, NOVA HEDWIG BEIH, V146, P279, DOI 10.1127/1438-9134/2017/279; KOCIOLEK JP, 1992, T AM MICROSC SOC, V111, P338, DOI 10.2307/3226708; Kociolek P., 2011, DIATOMS US; KOMAROMY Z P, 1984, Annales Historico-Naturales Musei Nationalis Hungarici, V76, P73; Krammer K., 1988, BACILLARIOPHYCEAE 2, V2; Lange K, 2016, ECOL EVOL, V6, P23, DOI 10.1002/ece3.1822; Lange-Bertalot H, 1999, ICONOGRAPHIA DIATOMO, V6; Lange-Bertalot H., 2017, FRESHWATER BENTHIC D; Lange-Bertalot H, 1996, ICONOGRAPHIA DIATOMO, V2; LECOINTE C, 1993, HYDROBIOLOGIA, V269, P509, DOI 10.1007/BF00028048; LEGLER FR, 1940, BEIH BOT CENTRALBL ABT B, V60, P335; Lengyel E, 2016, HYDROBIOLOGIA, V777, P95, DOI 10.1007/s10750-016-2768-9; Levkov Z., 2009, DIATOMS EUROPE, V5; Levkov Z, 2016, DIATOMS EUROPE, V8; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Lobo EA, 2017, NOVA HEDWIG BEIH, V146, P229, DOI 10.1127/1438-9134/2017/229; Luddington IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045664; MacGillivary ML, 2011, J EUKARYOT MICROBIOL, V58, P529, DOI 10.1111/j.1550-7408.2011.00585.x; Madl-Szonyi J, 2009, HYDROGEOL J, V17, P961, DOI 10.1007/s10040-008-0421-z; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Molnar B., 2015, KISKUNSAGI NEMZETI P; Moniz MBJ, 2009, MOL ECOL RESOUR, V9, P65, DOI 10.1111/j.1755-0998.2009.02633.x; Oertli B, 2002, BIOL CONSERV, V104, P59, DOI 10.1016/S0006-3207(01)00154-9; Palffy K, 2014, EXTREMOPHILES, V18, P111, DOI 10.1007/s00792-013-0602-0; Passy SI, 2007, AQUAT BOT, V86, P171, DOI 10.1016/j.aquabot.2006.09.018; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Potapova M, 2003, FRESHWATER BIOL, V48, P1311, DOI 10.1046/j.1365-2427.2003.01080.x; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Reese BK, 2014, ECO DAS 10 S P ASLO, P69, DOI DOI 10.4319/ECODAS.2014.978-0-9845591-4-5.69; Riato L, 2017, HYDROBIOLOGIA, V797, P127, DOI 10.1007/s10750-017-3165-8; Rimet F, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2012018; Rimet F, 2011, DIATOM RES, V26, P273, DOI 10.1080/0269249X.2011.597988; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rovira L, 2015, J EUKARYOT MICROBIOL, V62, P815, DOI 10.1111/jeu.12240; RUMRICH U., 2000, ICONOGRAPHIA DIATOMO, V9, P1; Samylina OS, 2014, MICROBIOLOGY+, V83, P849, DOI 10.1134/S0026261714060162; Schagerl M, 2015, FOTTEA, V15, P245, DOI 10.5507/fot.2015.012; Simon S, 2011, HYDROGEOL J, V19, P701, DOI 10.1007/s10040-011-0711-8; Somogyi B, 2011, PHYCOLOGIA, V50, P1, DOI 10.2216/10-08.1; Somogyi B, 2009, AQUAT ECOL, V43, P735, DOI 10.1007/s10452-009-9269-0; Sondergaard M, 2005, ARCH HYDROBIOL, V162, P143, DOI 10.1127/0003-9136/2005/0162-0143; Stenger-Kovacs C, 2016, ECOL INDIC, V64, P1, DOI 10.1016/j.ecolind.2015.12.018; Stenger-Kovacs Cs, 2014, HIDROL KOZL, V94, P28; Stenger-Kovacs C, 2007, HYDROBIOLOGIA, V589, P141, DOI 10.1007/s10750-007-0729-z; Stenger-Kovacs Csilla, 2015, Studia Botanica Hungarica, V46, P3, DOI 10.17110/StudBot.2015.46.Suppl.3; Stenger-Kovacs C, 2014, INLAND WATERS, V4, P383, DOI 10.5268/IW-4.4.722; Stevenson RJ, 1991, SURFACE WATERS ACIDI; Suriyanti SNP, 2017, BANGL J PLANT TAXON, V24, P183, DOI 10.3329/bjpt.v24i2.35114; Szemes G., 1959, LEBEN SZELIDER SEES; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tapolczai K, 2016, HYDROBIOLOGIA, V776, P1, DOI 10.1007/s10750-016-2736-4; Taylor JC, 2007, 28207 WRC TT; Torok P, 2011, GRASSLANDS TYPES BIO, P1; Toth A, 2014, INT REV HYDROBIOL, V99, P255, DOI 10.1002/iroh.201301646; Trobajo Pujadas R, 2007, DIATOM MONOGRAPHS, V7; Trobajo R, 2013, DIATOM RES, V28, P37, DOI 10.1080/0269249X.2012.734531; Trobajo R, 2009, PHYCOLOGIA, V48, P443, DOI 10.2216/08-69.1; Tuchman Nancy C., 1996, P299, DOI 10.1016/B978-012668450-6/50039-4; Tuchman NC, 2006, HYDROBIOLOGIA, V561, P167, DOI 10.1007/s10750-005-1612-4; Tudesque L, 2008, DIATOM RES, V23, P483; Vad CF, 2017, BIOL CONSERV, V209, P253, DOI 10.1016/j.biocon.2017.02.025; Van Dam Herman, 1994, Netherlands Journal of Aquatic Ecology, V28, P117; Varbiro G, 2016, HYDROBIOLOGIA, V764, P91, DOI [10.1007/S10750-015-2278-1, DOI 10.1007/S10750-015-2278-1]; Vincent WF, 2009, ENCY INLAND WATERS, P55, DOI [10.1016/b978-012370626-3.00233-7, DOI 10.1016/B978-012370626-3.00233-7]; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; Williams WD, 2005, LAKES HANDBOOK, VOL 2: LAKE RESTORATION AND REHABILITATION, P200; WILLIAMS WD, 1986, MONOGRAPHIAE BIOLOGI, V61, P471; Yoshitake S., 1992, JAPANESE J WATER TRE, V28, P63; Ziemann Horst, 2001, Limnologica, V31, P257, DOI 10.1016/S0075-9511(01)80029-3; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6	115	9	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0205343	10.1371/journal.pone.0205343	http://dx.doi.org/10.1371/journal.pone.0205343			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359367	gold, Green Published, Green Accepted			2022-12-26	WOS:000448438400015
J	McDougall, C				McDougall, Carmel			Comparative De Novo transcriptome analysis of the Australian black-lip and Sydney rock oysters reveals expansion of repetitive elements in Saccostrea genomes	PLOS ONE			English	Article							GLOMERATA GOULD; TRANSPOSABLE ELEMENTS; RECENT INNOVATIONS; PACIFIC OYSTERS; GENE ONTOLOGY; MITOCHONDRIAL; GENERATION; STRATEGIES; CYTOSCAPE; ECHINATA	Ostreid oysters (the 'true oysters') represent a large and commercially important family of bivalve molluscs. Several species, such as the Pacific oyster (Magallana gigas), the American oyster (Crassostrea virginica), the European oyster (Ostrea edulis) and the Sydney rock oyster (Saccostrea glomerate), are currently farmed at a large scale. However a number of other species may also be suitable for commercial-scale aquaculture. One such species is the black-lip oyster', a large Saccostrea species of uncertain taxonomic affinity found in northern Australia. Here, phylogenetic analysis of the COI gene places this oyster within a Glade identified in a previous study of Japanese Saccostrea species, Saccostrea lineage J'. To facilitate comparisons between this oyster and the better-studied S. glomerate, de novo transcriptomes were generated from larval stages and adult tissues of both species. Patterns of orthology indicated an expansion of repetitive elements within Saccostrea genomes when compared to M. gigas and C. virginica, which may be reflected in increased evolutionary rates and/or genome sizes. The generation of high-quality transcriptomes for these two commercially relevant oysters provides a valuable resource for gene identification and comparison of molecular processes in these and other mollusc species.	[McDougall, Carmel] Griffith Univ, Australian Rivers Inst, Nathan, Qld, Australia	Griffith University	McDougall, C (corresponding author), Griffith Univ, Australian Rivers Inst, Nathan, Qld, Australia.	c.mcdougall@griffith.edu.au	McDougall, Carmel/G-3512-2010	McDougall, Carmel/0000-0002-2116-5651	Queensland Government Department of Science, Information Technology and Innovation [AQRF10916-17RD2]; Aquafarms Queensland	Queensland Government Department of Science, Information Technology and Innovation; Aquafarms Queensland	This research was financially supported by an Advance Queensland Fellowship (AQRF10916-17RD2) to CM from the Queensland Government Department of Science, Information Technology and Innovation, with Aquafarms Queensland as a financial partner. Staff at Aquafarms Queensland assisted with sample collection. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S, FASTQC QUALITY CONTR; Arkhipova IR, 2018, MOL BIOL EVOL, V35, P1332, DOI 10.1093/molbev/msy083; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; BRALEY RD, 1984, AUST J MAR FRESH RES, V35, P129; Bryson RK, 1977, AUST FISH, V36; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; COEROLI M, 1984, AQUACULTURE, V39, P45, DOI 10.1016/0044-8486(84)90258-8; Davis J., 2016, NATL IND RESPONSE PA; Dove MC, 2013, AQUAC RES, V44, P1791, DOI 10.1111/are.12012; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Ertl N.G., 2016, CLIM CHANG RESPONSES, V3, P1, DOI [10.1186/s40665-016-0019-y, DOI 10.1186/S40665-016-0019-Y]; Ertl NG, 2016, AQUAT TOXICOL, V177, P136, DOI 10.1016/j.aquatox.2016.05.012; Ertl NG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156649; Evgenev MB, 1997, P NATL ACAD SCI USA, V94, P196, DOI 10.1073/pnas.94.1.196; FAO, 2018, FAO YB FISH AQ STAT; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Ghiselli F, 2018, GENOME BIOL EVOL, V10, P1389, DOI 10.1093/gbe/evy082; GLUDE JB, 1984, AQUACULTURE, V39, P29, DOI 10.1016/0044-8486(84)90257-6; Gomez-Chiarri M, 2015, FISH SHELLFISH IMMUN, V46, P2, DOI 10.1016/j.fsi.2015.05.004; Goncalves P, 2017, MOL ECOL, V26, P5974, DOI 10.1111/mec.14333; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Green TJ, 2011, J SHELLFISH RES, V30, P47, DOI 10.2983/035.030.0108; Green TJ, 2009, FISH SHELLFISH IMMUN, V26, P799, DOI 10.1016/j.fsi.2009.03.003; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hadfield MG, 2001, AM ZOOL, V41, P1123, DOI 10.1668/0003-1569(2001)041[1123:MCAMAC]2.0.CO;2; HINEGARDNER R, 1974, COMP BIOCHEM PHYSIOL, V47, P447, DOI 10.1016/0300-9629(74)90008-5; Hook SE, 2014, MAR GENOM, V18, P109, DOI 10.1016/j.margen.2014.08.003; Hubley R., 2013, REPEATMASKER OPEN 40; Krassoi FR, 2001, THESIS; Lam K, 2006, J MOLLUS STUD, V72, P235, DOI 10.1093/mollus/eyl002; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Lemer S, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0857; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Munksgaard NC, 2017, MAR POLLUT BULL, V123, P47, DOI 10.1016/j.marpolbul.2017.09.031; Murgarella M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151561; Nell J.A., 2001, MAR FISH REV, V63, P14; Nell JA, 2005, AQUAC RES, V36, P753, DOI 10.1111/j.1365-2109.2005.01279.x; Nell JA, 2000, AQUAC RES, V31, P45, DOI 10.1046/j.1365-2109.2000.00387.x; Nowland SJ, 2018, J SHELLFISH RES, V37, P1, DOI [10.2983/035.037.0100, DOI 10.2983/035.037.0100]; O'Connor W, 2008, FISHERIES RES REPORT; Paul-Pont I, 2013, AQUACULTURE, V412, P202, DOI 10.1016/j.aquaculture.2013.07.038; RAMBAUT A, 2006, FIGTREE; Sekino M, 2016, J MOLLUS STUD, V82, P492, DOI 10.1093/mollus/eyw022; Sekino M, 2013, FISHERIES SCI, V79, P61, DOI 10.1007/s12562-012-0577-2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sotero-Caio CG, 2017, GENOME BIOL EVOL, V9, P161, DOI 10.1093/gbe/evw264; Southgate PC, 1998, AQUACULTURE, V169, P275, DOI 10.1016/S0044-8486(98)00382-2; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Ugalde SC, 2018, AQUACULTURE, V495, P179, DOI 10.1016/j.aquaculture.2018.05.019; Vera M, 2015, MAR GENOM, V24, P335, DOI 10.1016/j.margen.2015.08.006; In VV, 2016, PEPTIDES, V82, P109, DOI 10.1016/j.peptides.2016.06.007; Waterhouse RM, 2018, MOL BIOL EVOL, V35, P543, DOI 10.1093/molbev/msx319; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	60	4	4	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206417	10.1371/journal.pone.0206417	http://dx.doi.org/10.1371/journal.pone.0206417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359422	Green Published, gold, Green Submitted			2022-12-26	WOS:000448438400077
J	Oliveira, R; Hermo, L; Pshezhetsky, AV; Morales, CR				Oliveira, Regiana; Hermo, Louis; Pshezhetsky, Alexey, V; Morales, Carlos R.			Presence of aberrant epididymal tubules revealing undifferentiated epithelial cells and absence of spermatozoa in a combined neuraminidase-3 and-4 deficient adult mouse model	PLOS ONE			English	Article							EFFERENT DUCT LIGATION; HUMAN TAY-SACHS; RAT EPIDIDYMIS; BETA-HEXOSAMINIDASE; WOLFFIAN/EPIDIDYMAL DUCT; MONONUCLEAR PHAGOCYTES; TARGETED DISRUPTION; DENDRITIC CELLS; SIALIDASE NEU3; CLEAR CELLS	Mammalian neuraminidases are responsible for the removal of sialic acids from glycoproteins and glycolipids and function in a variety of biological phenomena such as lysosomal catabolism and control of cell differentiation and growth. Disruption of Neu3 and Neu4 genes has led to the generation of a mouse model revealing severe neurological disorders. In this study a morphological analysis was performed on the epididymis of 3 month-old neu3(-/-) neu4(-/-) mice as compared with wild type animals. In neu3(-/-) neu4(-/-) mice the majority of tubules of the main epididymal duct were large and lined by differentiated epithelial cells, but revealing lysosomal abnormalities in principal and basally located cells. Of particular note was the presence of aberrant epididymal tubules (ATs) juxtaposed next to the main tubules. ATs were small and of different shapes. Layers of myoid cells encased ATs, which they shared with those of the main tubules, but no interstitial space existed between the two. While some ATs were a dense mass of cells, others revealed a distinct lumen devoid of spermatozoa. The latter revealed an undifferentiated epithelium consisting of cuboidal cells and basal cells, with junctional complexes evident at the luminal front. The absence of spermatozoa from the lumen of the ATs suggests that they were not in contact with the main duct, as also implied by the undifferentiated appearance of the epithelium suggesting lack of lumicrine factors. Despite the presence of ATs, the main duct contained ample spermatozoa, as the neu3(-/-) neu4(-/-) mice were fertile. Taken together the data suggest that absence of Neu3 and Neu4 leads to defects in cell adhesion and differentiation of epithelial cells resulting in aberrant tubular offshoots that fail to remain connected with the main duct. Hence Neu3 and Neu 4 play an essential role in the guidance of epithelial cells during early embryonic formation.	[Oliveira, Regiana; Hermo, Louis; Morales, Carlos R.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Pshezhetsky, Alexey, V] Univ Montreal, Ctr Hosp Univ St Justine, Div Med Genet, Montreal, PQ, Canada	McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Morales, CR (corresponding author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada.	carlos.morales@mcgill.ca			NSERC [1153952]; Canadian Institutes of Health Research [156345]; Canadian Glycomic Network [148863]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Glycomic Network	This investigation was supported by an NSERC (1153952 grant to Carlos R. Morales), Canadian Institutes of Health Research (156345; http://www.cihr-irsc.gc.ca/) and Canadian Glycomic Network (148863 grant to Alexey V. Pshezhetsky).	ABE K, 1989, ARCH HISTOL CYTOL, V52, P299, DOI 10.1679/aohc.52.299; ABE K, 1984, ANAT REC, V209, P209, DOI 10.1002/ar.1092090208; ABE K, 1982, BIOL REPROD, V26, P501, DOI 10.1095/biolreprod26.3.501; ABOUHAILA A, 1984, ANAT REC, V209, P197, DOI 10.1002/ar.1092090207; Adamali HI, 1996, J ANDROL, V17, P208; Adamali HI, 1999, J ANDROL, V20, P803; Adamali HI, 1999, J ANDROL, V20, P779; ALCORN D, 1977, J ANAT, V123, P649; Badran HH, 2002, J ANDROL, V23, P358; Benias PC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23062-6; Bergeron JJM, 2016, ANNU REV BIOCHEM, V85, P573, DOI 10.1146/annurev-biochem-060815-014659; Breton S, 2016, ASIAN J ANDROL, V18, P3, DOI 10.4103/1008-682X.165946; BROOKS DE, 1983, AUST J BIOL SCI, V36, P205, DOI 10.1071/BI9830205; BURKETT BN, 1987, AM J ANAT, V178, P23, DOI 10.1002/aja.1001780104; COOPER TG, 1992, UROL RES, V20, P275, DOI 10.1007/BF00300258; Cooper TG, 1986, SPERM MATURATION FER, P117; Cooper TG, 2011, ASIAN J ANDROL, V13, P130, DOI 10.1038/aja.2010.97; Cornwall GA, 2014, ADV EXP MED BIOL, V759, P159, DOI 10.1007/978-1-4939-0817-2_8; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Da Silva N, 2016, CELL TISSUE RES, V363, P97, DOI 10.1007/s00441-015-2270-0; Da Silva N, 2015, ASIAN J ANDROL, V17, P591, DOI 10.4103/1008-682X.153540; Da Silva N, 2011, REPRODUCTION, V141, P653, DOI 10.1530/REP-10-0493; Dacheux J. -L., 2002, EPIDIDYMIS MOL CLIN, P151, DOI [10.1007/978-1-4615-0679-9_9, DOI 10.1007/978-1-4615-0679-9_9]; Day KJ, 2018, DEV CELL, V44, P56, DOI 10.1016/j.devcel.2017.12.014; DELONGEAS JL, 1987, EXP CELL BIOL, V55, P74; Domeniconi RF, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.138768; DYCHE WJ, 1979, J MORPHOL, V162, P175, DOI 10.1002/jmor.1051620203; FAWCETT DW, 1979, BIOL REPROD, V20, P162, DOI 10.1095/biolreprod20.2.162; Hamilton D.W., 1975, HDB PHYSIOLOGY     7, P259; HERMO L, 1992, ANAT REC, V232, P401, DOI 10.1002/ar.1092320310; HERMO L, 1988, AM J ANAT, V183, P107, DOI 10.1002/aja.1001830202; HERMO L, 1991, BIOL REPROD, V44, P1113, DOI 10.1095/biolreprod44.6.1113; HERMO L, 1984, AM J ANAT, V171, P59, DOI 10.1002/aja.1001710106; Hermo L, 1994, Int Rev Cytol, V154, P106; HERMO L, 1995, ANAT REC, V242, P515, DOI 10.1002/ar.1092420408; Hermo L., 2002, EPIDIDYMIS MOL CLIN, P81, DOI [10.1007/978-1-4615-0679-9_5, DOI 10.1007/978-1-4615-0679-9_5]; Hess Rex A, 2003, Reprod Biol Endocrinol, V1, P52, DOI 10.1186/1477-7827-1-52; Hess RA, 2011, J ANDROL, V32, P600, DOI 10.2164/jandrol.110.012872; Hinton BT, 1998, J REPROD FERTIL, P47; Hirai S, 2010, MED MOL MORPHOL, V43, P37, DOI 10.1007/s00795-009-0473-8; HOOPER SB, 1995, CLIN EXP PHARMACOL P, V22, P235, DOI 10.1111/j.1440-1681.1995.tb01988.x; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; ILIO KY, 1994, MICROSC RES TECHNIQ, V29, P432, DOI 10.1002/jemt.1070290604; Jean-Louis D, 2016, ANIM REPROD SCI, V169, P76, DOI 10.1016/j.anireprosci.2016.02.034; Joseph A, 2009, DEV BIOL, V325, P6, DOI 10.1016/j.ydbio.2008.10.012; Korah N, 2003, MOL REPROD DEV, V66, P358, DOI 10.1002/mrd.10359; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Luzio JP, 2010, BIOCHEM SOC T, V38, P1413, DOI 10.1042/BST0381413; Ma F, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380584; Mandon M, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.133967; MEIER EM, 1991, J BIOL CHEM, V266, P1879; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti EaM T, 2015, SIALOGLYCO CHEMISTRY; MOORE HDM, 1979, ANAT REC, V193, P293, DOI 10.1002/ar.1091930209; Morales CR, 2000, J ANDROL, V21, P765; Mukhejee P, 2008, J LIPID RES, V49, P929, DOI 10.1194/jlr.R800006-JLR200; Murashima A, 2015, ASIAN J ANDROL, V17, P749, DOI 10.4103/1008-682X.155540; NICANDER L, 1983, INT J ANDROL, V6, P91, DOI 10.1111/j.1365-2605.1983.tb00326.x; Odell WD, 2000, J ANDROL, V21, P339; Oliveira RL, 2016, MOL REPROD DEV, V83, P526, DOI 10.1002/mrd.22649; Orgebin-Crist M. C., 1969, Biology of Reproduction Suppl, VNo.1, P155, DOI 10.1095/biolreprod1.Supplement_1.155; OTTERBACH B, 1995, CELL, V81, P1053, DOI 10.1016/S0092-8674(05)80010-8; Pan XF, 2017, FASEB J, V31, P3467, DOI 10.1096/fj.201601299R; Pastor-Soler N, 2001, BIOL REPROD, V65, P384, DOI 10.1095/biolreprod65.2.384; Phaneuf D, 1996, HUM MOL GENET, V5, P1, DOI 10.1093/hmg/5.1.1; Pshezhetsky AV, 2013, BIOCHEMISTRY-MOSCOW+, V78, P736, DOI 10.1134/S0006297913070067; REID B. L., 1957, AUSTRALIAN JOUR ZOOL, V5, P223, DOI 10.1071/ZO9570223; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Robaire B., 1988, P999; Robaire B, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1071; Rodriguez-Walker M, 2015, BIOCHEM J, V470, P131, DOI 10.1042/BJ20141550; Sandhoff K, 1996, TRENDS CELL BIOL, V6, P98, DOI 10.1016/0962-8924(96)80999-8; Sandhoff K, 2013, BIOCHEM SOC T, V41, P1562, DOI 10.1042/BST20130083; Serre V, 1998, BIOL REPROD, V58, P497, DOI 10.1095/biolreprod58.2.497; SETCHELL BP, 1964, NATURE, V203, P317, DOI 10.1038/203317b0; Seyrantepe V, 2003, HUM MUTAT, V22, P343, DOI 10.1002/humu.10268; Seyrantepe V, 2008, HUM MOL GENET, V17, P1556, DOI 10.1093/hmg/ddn043; Smith TB, 2014, ANDROLOGY-US, V2, P755, DOI 10.1111/j.2047-2927.2014.00251.x; Smutova V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106320; SUZUKI F, 1982, AM J ANAT, V163, P309, DOI 10.1002/aja.1001630404; Taylor G, 1996, CURR OPIN STRUC BIOL, V6, P830, DOI 10.1016/S0959-440X(96)80014-5; Todeschini AR, 2007, J BIOL CHEM, V282, P8123, DOI 10.1074/jbc.M611407200; Trasler J, 1998, ENDOCRINOLOGY, V139, P3280, DOI 10.1210/en.139.7.3280; Turner TT, 2007, ASIAN J ANDROL, V9, P565, DOI 10.1111/j.1745-7262.2007.00302.x; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; WENGER DA, 1978, BIOCHEM BIOPH RES CO, V82, P589, DOI 10.1016/0006-291X(78)90915-4; XU BF, 2016, BIOL REPROD, V95; YEUNG CH, 1982, CELL TISSUE RES, V226, P407; Zanchetti G, 2007, BIOCHEM J, V408, P211, DOI 10.1042/BJ20070503	92	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206173	10.1371/journal.pone.0206173	http://dx.doi.org/10.1371/journal.pone.0206173			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359429	Green Published, gold, Green Submitted			2022-12-26	WOS:000448438400051
J	Yang, RH; Su, JH; Shang, JJ; Wu, YY; Li, Y; Bao, DP; Yao, YJ				Yang, Rui-Heng; Su, Jin-He; Shang, Jun-Jun; Wu, Ying-Ying; Li, Yan; Bao, Da-Peng; Yao, Yi-Jian			Evaluation of the ribosomal DNA internal transcribed spacer (ITS), specifically ITS1 and ITS2, for the analysis of fungal diversity by deep sequencing	PLOS ONE			English	Article							COMMUNITIES; IDENTIFICATION; PRIMERS; BARCODE; REGION; PCR	The nuclear ribosomal DNA internal transcribed spacer (ITS) has been widely used to assess the fungal composition in different environments by deep sequencing. To evaluate the ITS in the analysis of fungal diversity, comparisons of the clustering and taxonomy generated by sequencing with different portions of the whole fragment were conducted in this study. For a total of 83,120 full-length ITS sequences obtained from the UNITE database, it was found that, on average, ITS1 varied more than ITS2 within the kingdom Fungi; this variation included length and GC content variations and polymorphisms, with some polymorphisms specific to particular fungal groups. The taxonomic accuracy for ITS was higher than that for ITS1 or ITS2. The commonly used operational taxonomic unit (OTU) for evaluating fungal diversity and richness assigned several species to a single OTU even with clustering at 99.00% sequence similarity. The clustering and taxonomic capacities did not differ between ITS1 and ITS2. However, the OTU commonality between ITS1 and ITS2 was very low. To test this observation further, 219,741 pyrosequencing reads, including 39,840 full-length ITS sequences, were obtained from 10 soil samples and were clustered into OTUs. The pyrosequencing results agreed with the results of the in silico analysis. ITS1 might overestimate the fungal diversity and richness. Analyses using ITS, ITS1 and ITS2 yielded several different taxa, and the taxonomic preferences for ITS and ITS2 were similar. The results demonstrated that ITS2 alone might be a more suitable marker for revealing the operational taxonomic richness and taxonomy specifics of fungal communities when the full-length ITS is not available.	[Yang, Rui-Heng; Shang, Jun-Jun; Wu, Ying-Ying; Li, Yan; Bao, Da-Peng] Shanghai Acad Agr Sci, Inst Edible Fungi, Key Lab Agr Genet & Breeding Shanghai, Natl Engn Res Ctr Edible Fungi,Key Lab Edible Fun, Shanghai, Peoples R China; [Su, Jin-He] Jimei Univ, Comp Engn Coll, Xiamen, Peoples R China; [Yao, Yi-Jian] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China	Shanghai Academy of Agricultural Sciences; Jimei University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Bao, DP (corresponding author), Shanghai Acad Agr Sci, Inst Edible Fungi, Key Lab Agr Genet & Breeding Shanghai, Natl Engn Res Ctr Edible Fungi,Key Lab Edible Fun, Shanghai, Peoples R China.; Yao, YJ (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	baoap@hotmail.com; yaoyj@im.ac.com			National Natural Science Foundation of China [31800015, 31471925]; Youth Talent Development Plan of the Shanghai Municipal Agricultural System [20170108]; Shanghai Agriculture Applied Technology Development Program [G2016060103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Talent Development Plan of the Shanghai Municipal Agricultural System; Shanghai Agriculture Applied Technology Development Program	This study was supported by National Natural Science Foundation of China (31800015, 31471925), Youth Talent Development Plan of the Shanghai Municipal Agricultural System (20170108) and Shanghai Agriculture Applied Technology Development Program (G2016060103).	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Aguayo J, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02637-17; Alanagreh L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181491; Bazzicalupo AL, 2013, FUNGAL ECOL, V6, P102, DOI 10.1016/j.funeco.2012.09.003; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; De Filippis F, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00905-17; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hu JF, 2007, RES MICROBIOL, V158, P363, DOI 10.1016/j.resmic.2007.02.007; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Lentendu G, 2011, FUNGAL DIVERS, V49, P113, DOI 10.1007/s13225-011-0101-5; Lv XC, 2017, INT J FOOD MICROBIOL, V255, P58, DOI 10.1016/j.ijfoodmicro.2017.05.010; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; McDowell DG, 1998, NUCLEIC ACIDS RES, V26, P3340, DOI 10.1093/nar/26.14.3340; Mello A, 2011, MYCOLOGIA, V103, P1184, DOI 10.3852/11-027; Monard C, 2013, FEMS MICROBIOL ECOL, V84, P165, DOI 10.1111/1574-6941.12046; Mullineux T, 2009, FUNGAL GENET BIOL, V46, P855, DOI 10.1016/j.fgb.2009.08.001; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; Ryberg M, 2009, NEW PHYTOL, V181, P471, DOI 10.1111/j.1469-8137.2008.02667.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Taylor DL, 2017, APPL ENVIRON MICROB, V82, P7717, DOI [10.1186/1471-2180-10-189, DOI 10.1186/1471-2180-10-189]; Vetrovsky T, 2013, BIOL FERT SOILS, V49, P1027, DOI 10.1007/s00374-013-0801-y; VILGALYS R, 1990, CURR GENET, V18, P277, DOI 10.1007/BF00318394; Voriskova J, 2014, NEW PHYTOL, V201, P269, DOI 10.1111/nph.12481; Wang XC, 2015, MOL ECOL RESOUR, V15, P573, DOI 10.1111/1755-0998.12325; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Xu JP, 2016, GENOME, V59, P913, DOI 10.1139/gen-2016-0046; Yahr R, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0336; Yu L, 2012, PLANT SOIL, V357, P395, DOI 10.1007/s11104-012-1180-0; Zhang Z, 2018, PEERJ, V6, DOI 10.7717/peerj.4559; Zimmerman NB, 2012, P NATL ACAD SCI USA, V109, P13022, DOI 10.1073/pnas.1209872109	36	45	45	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206428	10.1371/journal.pone.0206428	http://dx.doi.org/10.1371/journal.pone.0206428			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359454	Green Published, Green Submitted, gold			2022-12-26	WOS:000448438400078
J	Yu, CC; Chen, CA; Fu, SL; Lin, HY; Lee, MS; Chiou, WY; Su, YC; Hung, SK				Yu, Chih-Chia; Chen, Chien-An; Fu, Shu-Ling; Lin, Hon-Yi; Lee, Moon-Sing; Chiou, Wen-Yen; Su, Yu-Chieh; Hung, Shih-Kai			Andrographolide enhances the anti-metastatic effect of radiation in Ras-transformed cells via suppression of ERK-mediated MMP-2 activity	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER CELLS; MATRIX METALLOPROTEINASES; IN-VITRO; MESENCHYMAL TRANSITION; SIGNALING PATHWAY; DOWN-REGULATION; ANGIOTENSIN-II; INVASION; INHIBITION	Background Activation of Ras oncogene in human tumors is associated with radiation-associated metastatic potential. Although ionizing radiation is one important method of cancer treatments, it has been shown to enhance matrix metalloproteinases (MMPs) activity and facilitates a more aggressive cancer phenotype. Our previous studies showed that andrographolide with lower dose rates of radiation could inhibit RAS-transformed cancer metastasis in vivo; however, the molecular mechanisms are not yet clear. In this study, we aimed to explore the anti-metastatic effect of andrographolide combined with radiation on Ras-transformed cells. Methods RAS-transformed cells were treated with andrographolide in the presence or absence of irradiation (2-4 Gy) or angiotensin II to examine cell invasion. In vivo tumorigenesis assays were also performed. The MMP-2 activity was detected by using Gelatin zymography. Signal transduction of NF-kappa B subunit, p65 and phosphor-ERK 1/2, were examined by using Western blotting analysis. Results Treatment with andrographolide inhibited migration of Ras-transformed cells. Andrographolide treatment with radiation significantly inhibited cancer metastasis in vivo. We found that andrographolide exhibited anti-migration and anti-invasive ability against cancer metastasis via inhibition of MMP2 activity rather than affected MMP-9 and EMT. In addition, combined andrographolide with radiation appeared to be more effective in reducing MMP-2 expression, and this effect was accompanied by suppression of ERK activation that inhibits cancer cell migration and invasion. Conclusions These findings suggest that andrographolide enhances the anti-metastatic effect of radiation in Ras-transformed cells via suppression of ERK-mediated MMP-2 activity.	[Yu, Chih-Chia; Lin, Hon-Yi; Lee, Moon-Sing; Chiou, Wen-Yen; Hung, Shih-Kai] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Radiat Oncol, Chiayi, Taiwan; [Chen, Chien-An] Taipei City Hosp, Dept Radiat Oncol, Zhongxing Branch, Taipei, Taiwan; [Fu, Shu-Ling] Natl Yang Ming Univ, Inst Tradit Med, Taipei, Taiwan; [Lin, Hon-Yi; Lee, Moon-Sing; Chiou, Wen-Yen; Hung, Shih-Kai] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Su, Yu-Chieh] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Kaohsiung, Taiwan; [Su, Yu-Chieh] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; Tzu Chi University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Hung, SK (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Radiat Oncol, Chiayi, Taiwan.; Hung, SK (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.	oncology158@yahoo.com.tw		Hung, Shih-Kai/0000-0002-4945-528X; Chiou, Wen-Yen/0000-0002-5541-6834	Buddhist Dalin Tzu Chi Hospital [DTCRD101(2)-I-13, DTCRD102-E-13, DTCRD105-E-11, TCMMP105-09-02, TCMMP106-02-02]	Buddhist Dalin Tzu Chi Hospital	The present study was supported by research grants from: 1). Buddhist Dalin Tzu Chi Hospital (DTCRD101(2)-I-13, DTCRD102-E-13, DTCRD105-E-11, TCMMP105-09-02 and TCMMP106-02-02).	Ahmed KM, 2008, FREE RADICAL BIO MED, V44, P1, DOI 10.1016/j.freeradbiomed.2007.09.022; Badiga AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020614; Banerjee M, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0257-0; Batkhuu J, 2002, BIOL PHARM BULL, V25, P1169, DOI 10.1248/bpb.25.1169; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Bozzuto G, 2010, ANN I SUPER SANITA, V46, P66, DOI 10.4415/ANN_10_01_09; CHAMBERS AF, 1993, CRIT REV ONCOGENESIS, V4, P95; Chao HP, 2010, PLANTA MED, V76, P1827, DOI 10.1055/s-0030-1250039; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Dai L, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6242103; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; Fu SL, 2016, EXP THER MED, V12, P3614, DOI 10.3892/etm.2016.3819; Fu SL, 2005, BIOCHEM BIOPH RES CO, V338, P830, DOI 10.1016/j.bbrc.2005.10.045; Fujita M, 2015, SEMIN CANCER BIOL, V35, P45, DOI 10.1016/j.semcancer.2015.09.003; Furukawa K, 2006, INT J ONCOL, V29, P73; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gupta AK, 2001, CANCER RES, V61, P4278; He B, 2015, MOL MED REP, V11, P2355, DOI 10.3892/mmr.2014.2994; Heo W, 2015, MOL MED REP, V11, P1800, DOI 10.3892/mmr.2014.2918; Hsieh CY, 2013, CHEM-BIOL INTERACT, V204, P105, DOI 10.1016/j.cbi.2013.05.005; Hung SK, 2010, INT J RADIAT ONCOL, V77, P1232, DOI 10.1016/j.ijrobp.2010.01.007; Jada SR, 2007, PHYTOCHEMISTRY, V68, P904, DOI 10.1016/j.phytochem.2006.11.031; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kumar A, 2000, BRIT J CANCER, V82, P960, DOI 10.1054/bjoc.1999.1025; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lin KL, 2011, CHEM-BIOL INTERACT, V194, P148, DOI 10.1016/j.cbi.2011.10.002; Lin ML, 2010, MOL CARCINOGEN, V49, P783, DOI 10.1002/mc.20652; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Liu WW, 2005, OTOLARYNG HEAD NECK, V132, P395, DOI 10.1016/j.otohns.2004.09.050; Luo WM, 2013, EXP THER MED, V6, P743, DOI 10.3892/etm.2013.1196; Moncharmont C, 2014, CRIT REV ONCOL HEMAT, V92, P133, DOI 10.1016/j.critrevonc.2014.05.006; Munshi Anupama, 2013, Genes Cancer, V4, P401, DOI 10.1177/1947601913485414; Nantajit D, 2017, RADIAT RES, V188, P66, DOI 10.1667/RR14698.1; Ponnusamy MP, 2013, CURR CANCER DRUG TAR, V13, P945, DOI 10.2174/15680096113136660100; Poudel B, 2015, ACTA BIOCH BIOPH SIN, V47, DOI 10.1093/abbs/gmv005; Pratheeshkumar P, 2011, J ENVIRON PATHOL TOX, V30, P33, DOI 10.1615/JEnvironPatholToxicolOncol.v30.i1.40; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Reabroi S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26278-8; SAMID D, 1991, RADIAT RES, V126, P244, DOI 10.2307/3577825; Satyanarayana C, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-26; Shen YC, 2002, BRIT J PHARMACOL, V135, P399, DOI 10.1038/sj.bjp.0704493; Shi MD, 2009, CHEM-BIOL INTERACT, V180, P344, DOI 10.1016/j.cbi.2009.04.011; Touyz RM, 2005, EXP PHYSIOL, V90, P449, DOI 10.1113/expphysiol.2005.030080; Tsai HR, 2004, EUR J PHARMACOL, V498, P45, DOI 10.1016/j.ejphar.2004.07.077; Wang CM, 2015, EXP BIOL MED, V240, P1564, DOI 10.1177/1535370215576312; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041586; Wang ZM, 2016, DIS ESOPHAGUS, V29, P54, DOI 10.1111/dote.12255; Wei LH, 2005, ONCOGENE, V24, P390, DOI 10.1038/sj.onc.1208192; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Xu HY, 2007, CANCER LETT, V247, P336, DOI 10.1016/j.canlet.2006.05.017; Yang M, 2015, WORLD J GASTROENTERO, V21, P11673, DOI 10.3748/wjg.v21.i41.11673; Yang W, 2017, TOXICOL APPL PHARM, V327, P1, DOI 10.1016/j.taap.2017.04.022; Yu AE, 1996, BIOCHEM CELL BIOL, V74, P823, DOI 10.1139/o96-088; Zhai ZJ, 2015, MOL MED REP, V11, P1139, DOI 10.3892/mmr.2014.2872; Zhang C, 2015, TUMOR BIOL, V36, P8359, DOI 10.1007/s13277-015-3578-9	55	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0205666	10.1371/journal.pone.0205666	http://dx.doi.org/10.1371/journal.pone.0205666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359388	gold, Green Published, Green Submitted			2022-12-26	WOS:000448438400021
J	Anderson, A				Anderson, Alistair			Online health information and public knowledge, attitudes, and behaviours regarding antibiotics in the UK: Multiple regression analysis of Wellcome Monitor and Eurobarometer Data	PLOS ONE			English	Article							GLOBAL SURVEY; SOCIAL MEDIA; COMMUNITY; INTERNET; SEEKING; POPULATION; INFECTIONS; PREVALENCE; TWITTER; ADVICE	Background Antimicrobial resistance is a global public health problem with some socially patterned drivers. The objective of the study was to investigate associations between use of and trust in the Internet as a source of health-related information and the public's knowledge, attitudes, and behaviours regarding antibiotics. Methods Two representative cross-sectional surveys (the 2015 Wellcome Monitor (n = 1524) and UK segment (n = 1330) of the 2016 Eurobarometer 85.1) covering knowledge about antibiotics and antibiotic consumption were analysed. Knowledge, attitude, and behaviour variables were analysed using regression in relation to demographic characteristics and use and trust in the Internet as a source of information. Results The key findings of the analysis are that both use of the Internet as a source of medical research information (variable from the Wellcome Monitor) and trust in the Internet as a source of information about antibiotics (variable from the Eurobarometer) were independently and positively associated with knowledge, attitude, and behaviour regarding antibiotics. Additionally, knowledge about antibiotics was positively associated with behaviour with antibiotics (Wellcome Monitor) and attitude towards finishing antibiotic prescriptions (Eurobarometer). Higher levels of education were associated with better knowledge about antibiotics in both datasets. Older age was positively associated with behaviour and attitude regarding antibiotic consumption. Conclusions The Internet is a resource for disseminating quality health information that has the potential to improve stewardship of antibiotics in the community. This study suggests that members of the UK public that use the Internet as a source of health-related information are more likely to be better informed about, and be more responsible with, antibiotics. This mode of information dissemination should be capitalised on to improve antimicrobial stewardship, and further research should examine what the most effective online information sources are in the UK and to what extent their association with behaviour is causal.	[Anderson, Alistair] Univ Bristol, Sch Geog Sci, Bristol, Avon, England	University of Bristol	Anderson, A (corresponding author), Univ Bristol, Sch Geog Sci, Bristol, Avon, England.	aa12938@bristol.ac.uk	Anderson, Alistair/AAH-6460-2019	Anderson, Alistair/0000-0003-2385-0211	Economic and Social Research Council studentship grant [ES/J50015X/1]	Economic and Social Research Council studentship grant	AA is supported by an Economic and Social Research Council studentship grant (reference ES/J50015X/1). The funder had no role in study design, data collection and analysis, decision to public, or preparation of the manuscript.	Andre M, 2010, J ANTIMICROB CHEMOTH, V65, P1292, DOI 10.1093/jac/dkq104; [Anonymous], 2015, INT J ENV RES PUB HE, V12, P7002, DOI DOI 10.3390/IJERPH120607002; Bianco A, 2013, J MED INTERNET RES, V15, P268, DOI 10.2196/jmir.2752; Chan YH, 2012, AM J INFECT CONTROL, V40, P113, DOI 10.1016/j.ajic.2011.03.017; Couper MP, 2010, MED DECIS MAKING, V30, p106S, DOI 10.1177/0272989X10377661; Dyar OJ, 2014, J ANTIMICROB CHEMOTH, V69, P2568, DOI 10.1093/jac/dku165; Finch RG, 2004, LANCET INFECT DIS, V4, P44, DOI 10.1016/S1473-3099(03)00860-0; Fredericks I, 2015, INT J CLIN PHARM-NET, V37, P1213, DOI 10.1007/s11096-015-0188-y; Gualano MR, 2015, PHARMACOEPIDEM DR S, V24, P2, DOI 10.1002/pds.3716; Hoffmann K, 2014, EUR J PUBLIC HEALTH, V24, P502, DOI 10.1093/eurpub/ckt112; Horvat OJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180799; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Ipsos MORI, 2016, WELLC TRUST MON WAV; Jamhour A, 2017, AM J INFECT CONTROL, V45, P384, DOI 10.1016/j.ajic.2016.11.026; Kardas P, 2007, INT J ANTIMICROB AG, V30, P530, DOI 10.1016/j.ijantimicag.2007.08.005; Kendra RL, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4220; Kim SS, 2011, J KOREAN ACAD NURS, V41, P742, DOI 10.4040/jkan.2011.41.6.742; Kogan LR, 2014, OPEN VET J, V4, P90; Lawrentschuk N, 2009, UROLOGY, V74, P1058, DOI 10.1016/j.urology.2009.05.091; Lopez-Jornet P, 2009, ORAL ONCOL, V45, pE95, DOI 10.1016/j.oraloncology.2009.03.017; Madle Gemma, 2004, Inform Prim Care, V12, P19; Mazinska B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172146; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V60, pI63, DOI 10.1093/jac/dkm161; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; Moreland J, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.4010; Mori Ipsos, 2016, WELLC TRUST MON TECH; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Office for National Statistics, 2019, INT ACC HOUS IND; Pan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041314; Patel A, 2015, EUR J ORTHODONT, V37, P447, DOI 10.1093/ejo/cju078; Pechere JC, 2007, INT J ANTIMICROB AG, V29, P245, DOI 10.1016/j.ijantimicag.2006.09.026; Perzel S, 2017, J DEV ORIG HLTH DIS, V8, P604, DOI 10.1017/S2040174417000332; Ream E, 2009, PATIENT EDUC COUNS, V76, P10, DOI 10.1016/j.pec.2008.11.019; Scanfeld D, 2010, AM J INFECT CONTROL, V38, P182, DOI 10.1016/j.ajic.2009.11.004; Scullard P, 2010, ARCH DIS CHILD, V95, P580, DOI 10.1136/adc.2009.168856; Seckin G, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5496; Shehadeh M, 2012, SAUDI PHARM J, V20, P125, DOI 10.1016/j.jsps.2011.11.005; Siliquini R, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-21; Trepka MJ, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e6; Vallin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152160; You JHS, 2008, INFECTION, V36, P153, DOI 10.1007/s15010-007-7214-5; Zucco R, 2018, INT J MED INFORM, V111, P131, DOI 10.1016/j.ijmedinf.2017.12.005	42	22	22	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0204878	10.1371/journal.pone.0204878	http://dx.doi.org/10.1371/journal.pone.0204878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356302	Green Published, Green Submitted, gold			2022-12-26	WOS:000448434000021
J	Driessen, MMP; Leiner, T; Sieswerda, GT; van Dijk, APJ; Post, MC; Friedberg, MK; Mertens, L; Doevendans, PA; Snijder, RJ; Hulzebos, EH; Meijboom, FJ				Driessen, Mieke M. P.; Leiner, Tim; Sieswerda, Gertjan Tj; van Dijk, Arie P. J.; Post, Marco C.; Friedberg, Mark K.; Mertens, Luc; Doevendans, Pieter A.; Snijder, Repke J.; Hulzebos, Erik H.; Meijboom, Folkert J.			RV adaptation to increased afterload in congenital heart disease and pulmonary hypertension	PLOS ONE			English	Article							RIGHT-VENTRICULAR FUNCTION; ARTERIAL-HYPERTENSION; MAGNETIC-RESONANCE; PRESSURE; ECHOCARDIOGRAPHY; HEMODYNAMICS; TRABECULAE; GUIDELINES; MANAGEMENT; STENOSIS	Background The various conditions causing a chronic increase of RV pressure greatly differ in the occurrence of RV failure, and in clinical outcome. To get a better understanding of the differences in outcome, RV remodeling, longitudinal function, and transverse function are compared between patients with pulmonary stenosis (PS), those with a systemic RV and those with pulmonary hypertension (PH). Materials and methods This cross-sectional study prospectively enrolled subjects for cardiac magnetic resonance imaging (CMR), functional echocardiography and cardiopulmonary exercise testing. The study included: controls (n = 37), patients with PS (n = 15), systemic RV (n = 19) and PH (n = 20). Statistical analysis was performed using Analysis of Variance (ANOVA) with posthoc Bonferroni. Results PS patients had smaller RV volumes with higher RV ejection fraction (61.1 +/- 9.6%; p<0.05) compared to controls (53.8 +/- 4.8%). PH and systemic RV patients exhibited dilated RVs with lower RV ejection fraction (36.9 +/- 9.6% and 46.3 +/- 10.1%; p<0.01 versus controls). PH patients had lower RV stroke volume (p = 0.02), RV ejection fractions (p<0.01) and VO2 peak/kg% (p<0.001) compared to systemic RV patients. Mean apical transverse RV free wall motion was lower and RV free wall shortening (p<0.001) was prolonged in PH patients- resulting in post-systolic shortening and intra-ventricular dyssynchrony. Apical transverse shortening and global longitudinal RV deformation showed the best correlation to RV ejection fraction (respectively r = 0.853, p<0.001 and r = 0.812, p<0.001). Conclusions RV remodeling and function differed depending on the etiology of RV pressure overload. In contrast to the RV of patients with PS or a systemic RV, in whom sufficient stroke volumes are maintained, the RV of patients with PH seems unable to compensate for its increase in afterload completely. Key mediators of RV dysfunction observed in PH patients, were: prolonged RV free wall shortening, resulting in post-systolic shortening and intra-ventricular dyssynchrony, and decreased transverse function.	[Driessen, Mieke M. P.; Sieswerda, Gertjan Tj; Doevendans, Pieter A.; Meijboom, Folkert J.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Driessen, Mieke M. P.] CN Netherlands Heart Inst, Utrecht, Netherlands; [Leiner, Tim] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [van Dijk, Arie P. J.] Radboud Univ Nijmegen, Dept Cardiol, Med Ctr Nijmegen, Nijmegen, Netherlands; [Post, Marco C.] Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands; [Friedberg, Mark K.; Mertens, Luc] Labatt Family Heart Ctr, Dept Paediat Cardiol, Toronto, ON, Canada; [Snijder, Repke J.] Antonius Hosp, Dept Pulmonol, Nieuwegein, Netherlands; [Hulzebos, Erik H.] Wilhelmina Childrens Hosp, Dept Paediat Phys Therapy & Exercise Physiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; University of Toronto; Wilhelmina Kinderziekenhuis	Leiner, T (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	t.leiner@umcutrecht.nl		Mertens, Luc/0000-0001-7308-1268; Friedberg, Mark/0000-0002-4108-5560; Doevendans, Pieter/0000-0002-6257-7169	Actelion Pharmaceuticals Ltd.; ICIN-NHI	Actelion Pharmaceuticals Ltd.; ICIN-NHI	Funding for this research was supported by unrestricted grants from Actelion Pharmaceuticals Ltd. and ICIN-NHI, which is a non-commercial scientific institution. These companies were not involved in the writing, data analysis or conclusions of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkles JS, 2011, AM J RESP CRIT CARE, V183, P268, DOI 10.1164/rccm.201004-0601OC; Badagliacca R., 2014, J HEART LUNG TRANSPL; Badagliacca R, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01419-2016; Badagliacca R, 2015, J HEART LUNG TRANSPL, V34, P381, DOI 10.1016/j.healun.2014.06.010; Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Braunwald E., 1980, HEART DISEASE TXB CA, P453; Cuypers JAAE, 2014, EUR HEART J, V35, P1666, DOI 10.1093/eurheartj/ehu102; da Costa AA, 2017, INT J CARDIOVAS IMAG, V33, P39, DOI 10.1007/s10554-016-0966-1; Driessen MMP, 2014, INT J CARDIOVAS IMAG, V30, P599, DOI 10.1007/s10554-014-0367-2; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Gerges M, 2015, CAN J CARDIOL, V31, P521, DOI 10.1016/j.cjca.2015.01.019; Giusca S, 2016, ECHOCARDIOGR-J CARD, V33, P546, DOI 10.1111/echo.13112; Haddad F, 2008, CIRCULATION, V117, P1436, DOI 10.1161/CIRCULATIONAHA.107.653576; Hopkins WE, 2005, CORONARY ARTERY DIS, V16, P19, DOI 10.1097/00019501-200502000-00004; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; JONES NL, 1985, AM REV RESPIR DIS, V131, P700; Jurcut R, 2011, J AM SOC ECHOCARDIOG, V24, P1109, DOI 10.1016/j.echo.2011.07.016; Kind T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-35; Koch B, 2009, EUR RESPIR J, V33, P389, DOI 10.1183/09031936.00074208; Lankhaar JW, 2006, AM J PHYSIOL-HEART C, V291, pH1731, DOI 10.1152/ajpheart.00336.2006; Maceira AM, 2006, EUR HEART J, V27, P2879, DOI 10.1093/eurheartj/ehl336; Marcus JT, 2008, J AM COLL CARDIOL, V51, P750, DOI 10.1016/j.jacc.2007.10.041; Mauritz GJ, 2012, CHEST, V141, P935, DOI 10.1378/chest.10-3277; Moceri P, 2016, EUR HEART J CARDIOVA; Morcos P, 2009, INT J CARDIOVAS IMAG, V25, P263, DOI 10.1007/s10554-008-9387-0; Noordegraaf AV, 2017, J AM COLL CARDIOL, V69, P236, DOI 10.1016/j.jacc.2016.10.047; Palau-Caballero G, 2017, AM J PHYSIOL-HEART C, V312, pH691, DOI 10.1152/ajpheart.00596.2016; Rajagopal S, 2014, J AM SOC ECHOCARDIOG, V27, P657, DOI 10.1016/j.echo.2014.02.001; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Spruijt OA, 2017, J CARDIOL, V69, P182, DOI 10.1016/j.jjcc.2016.02.019; TERKEURS HEDJ, 1980, CIRC RES, V46, P703, DOI 10.1161/01.RES.46.5.703; TINKER J, 1965, BRIT HEART J, V27, P151; van der Bom T, 2013, J AM COLL CARDIOL, V62, P926, DOI 10.1016/j.jacc.2013.06.026; Wang Zhijie, 2011, Pulm Circ, V1, P212, DOI 10.4103/2045-8932.83453; Zhang L, 2013, AM J PHYSIOL-HEART C, V304, pH246, DOI 10.1152/ajpheart.00129.2012	36	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205196	10.1371/journal.pone.0205196	http://dx.doi.org/10.1371/journal.pone.0205196			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356250	Green Submitted, Green Published, gold			2022-12-26	WOS:000448434000038
J	Marinero, NV; Cailly-Arnulphi, VB; Lambertucci, SA; Borghi, CE				Marinero, Nancy, V; Cailly-Arnulphi, Veronica B.; Lambertucci, Sergio A.; Borghi, Carlos E.			Pigmentation and not only sex and age of individuals affects despotism in the Andean condor	PLOS ONE			English	Article							SKIN COLORATION; COMMON CRANES; CAROTENOIDS; SIGNALS; CONSERVATION; COMPETITION; ARGENTINA; VULTURES; BEHAVIOR; OUTCOMES	Attributes such as sex, age and pigmentation of individuals could correspond to the competitive skills they use to access resources and, consequently, determine their social status when a hierarchy of dominance is established. We analysed patterns of social dominance in relation to sex, age and, for the first time, according to face pigmentation in a large scavenger bird species, the Andean condor (Vultur gryphus). This species displays extreme sexual dimorphism, with males being up to 50% heavier than females. Associated to this, strong hierarchical relationships characterize foraging, roosting and breeding. We recorded agonistic interactions within condor groups while foraging through video recordings in experimental stations. We corroborated a strong despotism by the adult males to the rest of the categories. More interestingly we found this despotism was also expressed by most pigmented birds; juvenile females being completely subordinated and, at the same time, not expressing pigmentation. Importantly, when condors of equal sex and age category fought, the more pigmented individuals were successful. Our results highlight that pigmentation, besides sex and age, is an attribute that also corresponds with social status in the Andean condor, making its hierarchical system more complex.	[Marinero, Nancy, V; Cailly-Arnulphi, Veronica B.; Borghi, Carlos E.] Univ Nacl San Juan, CIGEOBIO, CONICET, San Juan, Argentina; [Lambertucci, Sergio A.] Univ Nacl Comahue, INIBIOMA, Grp Invest Biol Conservac, Lab Ecotono,CONICET, San Carlos De Bariloche, Rio Negro, Argentina; [Borghi, Carlos E.] Univ Nacl San Juan, Fac Ciencias Exactas Fis & Nat, Dept Biol, San Juan, Argentina; [Borghi, Carlos E.] Univ Nacl San Juan, Fac Ciencias Exactas Fis & Nat, Museo Ciencias Nat, San Juan, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Juan; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Universidad Nacional de San Juan; Universidad Nacional de San Juan	Borghi, CE (corresponding author), Univ Nacl San Juan, CIGEOBIO, CONICET, San Juan, Argentina.	cborghi@unsj-cuim.edu.ar		Borghi, Carlos Eduardo/0000-0002-3726-6000; LAMBERTUCCI, SERGIO/0000-0002-2624-2185	Consejo de Investigacion en Ciencia, Tecnica y Creacion Artistica, Universidad Nacional de San Juan [018/14-CS]; Agencia Nacional de Promocion Cientifica y Tecnologica, Proyectos de Investigacion Cientifica y Tecnologica [0725/2014]; Secretaria de Extension Universitaria, Universidad Nacional de San Juan [02-2341-B-13]	Consejo de Investigacion en Ciencia, Tecnica y Creacion Artistica, Universidad Nacional de San Juan; Agencia Nacional de Promocion Cientifica y Tecnologica, Proyectos de Investigacion Cientifica y Tecnologica; Secretaria de Extension Universitaria, Universidad Nacional de San Juan	This study was funded by: Consejo de Investigacion en Ciencia, Tecnica y Creacion Artistica, Universidad Nacional de San Juan 018/14-CS to CEB; Agencia Nacional de Promocion Cientifica y Tecnologica, Proyectos de Investigacion Cientifica y Tecnologica 0725/2014 to SAL; Secretaria de Extension Universitaria, Universidad Nacional de San Juan 02-2341-B-13 to CEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2009, J ARID ENVIRON, V73, P144, DOI 10.1016/j.jaridenv.2008.09.028; Alarcon PAE, 2018, SCIENCE, V360, P612, DOI 10.1126/science.aat6039; Alarcon PAE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11855-0; Alonso JC, 1997, BEHAV ECOL SOCIOBIOL, V40, P401, DOI 10.1007/s002650050356; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Bamford AJ, 2010, ETHOLOGY, V116, P1163, DOI 10.1111/j.1439-0310.2010.01834.x; Bamford AJ, 2009, OSTRICH, V80, P135, DOI 10.2989/OSTRICH.2009.80.3.2.965; BAUTISTA LM, 1995, J ANIM ECOL, V64, P747, DOI 10.2307/5853; Bergmuller R, 2010, TRENDS ECOL EVOL, V25, P504, DOI 10.1016/j.tree.2010.06.012; BirdLife International, 2017, SPEC FACTSH VULT GRY; Blanco G, 2014, IBIS, V156, P668, DOI 10.1111/ibi.12155; Blanco G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065562; Blas J, 2013, J RAPTOR RES, V47, P174, DOI 10.3356/JRR-12-46.1; Bruinzeel LW, 2006, J ORNITHOL, V147, P457, DOI 10.1007/s10336-005-0037-1; Cailly Arnulphi VB, 2017, THESIS; Arnulphi VBC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185278; Carrete M, 2010, ANIM CONSERV, V13, P390, DOI 10.1111/j.1469-1795.2010.00352.x; Corcuera J., 2006, SITUACION AMBIENTAL, P227; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; del Hoyo J., 1994, HDB BIRDS WORLD NEW; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Donazar JA, 1999, BEHAV ECOL SOCIOBIOL, V45, P55, DOI 10.1007/s002650050539; Donazar JA, 2002, CONDOR, V104, P832, DOI 10.1650/0010-5422(2002)104[0832:SSOACR]2.0.CO;2; Duijns S, 2014, ANIM BEHAV, V92, P195, DOI 10.1016/j.anbehav.2014.04.007; GILL FB, 2007, ORNITHOLOGY; Horak P, 2001, OECOLOGIA, V126, P166, DOI 10.1007/s004420000513; Lambertucci SA, 2008, J FIELD ORNITHOL, V79, P147, DOI 10.1111/j.1557-9263.2008.00156.x; Lambertucci SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075821; Lambertucci SA, 2010, ORYX, V44, P441, DOI 10.1017/S0030605310000451; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Márquez Justo, 2005, Multequina, V14, P1; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; Negro JJ, 2006, COMP BIOCHEM PHYS A, V143, P78, DOI 10.1016/j.cbpa.2005.10.028; Newton I., 1998, POPULATION LIMITATIO; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; PARKER GA, 1986, ANIM BEHAV, V34, P1222, DOI 10.1016/S0003-3472(86)80182-8; Pepper JW, 2000, AUSTRAL ECOL, V25, P16, DOI 10.1111/j.1442-9993.2000.tb00003.x; Sirot E, 2000, BEHAV ECOL, V11, P351, DOI 10.1093/beheco/11.4.351; Speziale KL, 2008, BIOL CONSERV, V141, P1765, DOI 10.1016/j.biocon.2008.04.017; TORRELLA S., 2006, SITUACTION AMBIENTAL, P75; Vergara P, 2015, J EVOLUTION BIOL, V28, P146, DOI 10.1111/jeb.12553; WALLACE MP, 1987, AUK, V104, P290, DOI 10.1093/auk/104.2.290	42	8	8	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205197	10.1371/journal.pone.0205197	http://dx.doi.org/10.1371/journal.pone.0205197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356333	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000039
J	Tsujii, K; Akamatsu, T; Okamoto, R; Mori, K; Mitani, Y; Umeda, N				Tsujii, Koki; Akamatsu, Tomonari; Okamoto, Ryosuke; Mori, Kyoichi; Mitani, Yoko; Umeda, Naoya			Change in singing behavior of humpback whales caused by shipping noise	PLOS ONE			English	Article							MEGAPTERA-NOVAEANGLIAE; SONG; INCREASES; WEST	Reactions of singing behavior of individual humpback whales (Megaptera novaeangliae) to a specific shipping noise were examined. Two autonomous recorders separated by 3.0 km were used for the acoustic monitoring of each individual song sequence. A passenger-cargo liner was operated once per day, and other large ship noise was excluded given the remote location of the Ogasawara Islands, 1000 km south of Tokyo. In total, locations of between 26 and 27 singers were measured acoustically using time arrival difference at both stereo recorders on the ship presence and absence days, respectively. Source level of the ship (157 dB rms re 1 mu Pa) was measured separately in deep water. Fewer whales sang nearby, within 500 m, of the shipping lane. Humpback whales reduced sound production after the ship passed, when the minimum distance to the whale from the ship trajectory was 1200 m. In the Ogasawara water, humpback whales seemed to stop singing temporarily rather than modifying sound characteristics of their song such as through frequency shifting or source level elevation. This could be a cost effective adaptation because the propagation loss at 500 m from the sound source is as high as 54 dB. The focal ship was 500 m away within several minutes. Responses may differ where ship traffic is heavy, because avoiding an approaching ship may be difficult when many sound sources exist.	[Tsujii, Koki; Okamoto, Ryosuke] Ogasawara Whale Watching Assoc, Ogasawara, Tokyo, Japan; [Tsujii, Koki] Hokkaido Univ, Grad Sch Environm Sci, Hakodate, Hokkaido, Japan; [Akamatsu, Tomonari] Japan Fisheries Res & Educ Agcy, Natl Res Inst Fisheries Sci, Fukuura, Kanagawa, Japan; [Mori, Kyoichi] Teikyo Univ Sci, Uenohara, Yamanashi, Japan; [Mitani, Yoko] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Hakodate, Hokkaido, Japan; [Umeda, Naoya] Osaka Univ, Suita, Osaka, Japan	Hokkaido University; Japan Fisheries Research & Education Agency (FRA); Hokkaido University; Osaka University	Tsujii, K (corresponding author), Ogasawara Whale Watching Assoc, Ogasawara, Tokyo, Japan.; Tsujii, K (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Hakodate, Hokkaido, Japan.	tsujii@owa1989.com	Umeda, Naoya/GMW-8852-2022; Mitani, Yoko/D-5779-2012	Mitani, Yoko/0000-0002-7420-0596; Tsujii, Koki/0000-0003-2289-647X	Nippon Foundation	Nippon Foundation(Nippon Foundation)	This project was carried out as a research activity of underwater noise project of the Japan Ship Technology Research Association in the fiscal years 2015 and 2016; it had been funded by the Nippon Foundation.	Andrew R. K., 2002, Acoustics Research Letters Online, V3, P65, DOI 10.1121/1.1461915; Au W. W., 1993, SONAR DOLPHINS; Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Blair HB, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0005; Calambokidis J, 2001, MAR MAMMAL SCI, V17, P769, DOI 10.1111/j.1748-7692.2001.tb01298.x; Calambokidis J., 2008, AB133F03RP00078 US D; Castellote M, 2012, BIOL CONSERV, V147, P115, DOI 10.1016/j.biocon.2011.12.021; Cerchio S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086464; Clapham PJ, 1996, MAMMAL REV, V26, P27, DOI 10.1111/j.1365-2907.1996.tb00145.x; Codarin A, 2009, MAR POLLUT BULL, V58, P1880, DOI 10.1016/j.marpolbul.2009.07.011; Darling JD, 2006, BEHAVIOUR, V143, P1051, DOI 10.1163/156853906778607381; DARLING JD, 1993, CAN J ZOOL, V71, P325, DOI 10.1139/z93-045; Darling JD, 2001, MAR MAMMAL SCI, V17, P570, DOI 10.1111/j.1748-7692.2001.tb01005.x; Di Iorio L, 2010, BIOL LETTERS, V6, P51, DOI 10.1098/rsbl.2009.0651; Doyle LR, 2008, ENTROPY, V10, P33, DOI 10.3390/entropy-e10020033; Heiler J, 2016, ANIM BEHAV, V117, P167, DOI 10.1016/j.anbehav.2016.04.014; Herman LM, 2017, BIOL REV, V92, P1795, DOI 10.1111/brv.12309; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; ISO (International Organization for Standardization), 2014, DIS165543 ISO; Kamiirisa H, 2017, P 5 INT C ADV MOD ME, P53; Lesage V, 1999, MAR MAMMAL SCI, V15, P65, DOI 10.1111/j.1748-7692.1999.tb00782.x; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Mori Kyoichi, 1998, Journal of the School of Marine Science and Technology Tokai University, V45, P197; Munger LM, 2012, J ACOUST SOC AM, V132, P2265, DOI 10.1121/1.4747014; Nedwell JR, 2004, SUBACOUSTECH REPORT; Norris T. F., 1995, THESIS; Ou H, 2013, J ACOUST SOC AM, V133, P301, DOI 10.1121/1.4770251; Parks SE, 2016, P M AC, V27; Parks SE, 2011, BIOL LETTERS, V7, P33, DOI 10.1098/rsbl.2010.0451; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Pirotta E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042535; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Risch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029741; Rolland RM, 2012, P ROY SOC B-BIOL SCI, V279, P2363, DOI 10.1098/rspb.2011.2429; Shannon G, 2016, BIOL REV, V91, P982, DOI 10.1111/brv.12207; Sousa-Lima RS., 2008, CAN ACOUST, V36, P174, DOI DOI 10.1227/01.NEU.0000255476.06247.F1; Stanistreet JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061263; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Tyack PL, 2000, SPR HDB AUD, V12, P156; Van Parijs SM, 2009, MAR ECOL PROG SER, V395, P21, DOI 10.3354/meps08123; WATKINS WA, 1986, MAR MAMMAL SCI, V2, P251, DOI 10.1111/j.1748-7692.1986.tb00134.x; Weilgart L.S., 2007, INT J COMP PSYCHOL, V20, P159, DOI DOI 10.3354/MEPS07117; WINN HE, 1978, MAR BIOL, V47, P97, DOI 10.1007/BF00395631	46	14	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0204112	10.1371/journal.pone.0204112	http://dx.doi.org/10.1371/journal.pone.0204112			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356328	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000007
J	Huang, SS; Sun, LQ; Hu, X; Wang, YH; Zhang, YJ; Nevo, E; Peng, JH; Sun, DF				Huang, Sisi; Sun, Longqing; Hu, Xin; Wang, Yanhong; Zhang, Yujuan; Nevo, Eviatar; Peng, Junhua; Sun, Dongfa			Associations of canopy leaf traits with SNP markers in durum wheat (Triticum turgidum L. durum (Desf.))	PLOS ONE			English	Article							BOX RNA HELICASE; GENETIC DIVERSITY; ARABIDOPSIS-THALIANA; YIELD; TRANSCRIPTION; POPULATION; DISSECTION; EVOLUTION; REVEALS; ENCODES	The canopy leaves including the top three, i.e., the flag, the 2nd and 3rd from the top, are important for photosynthesis and grain yield of wheat. Molecular markers associated with traits of these leaves should be helpful for the high-yielding breeding. In this study, 1366 single nucleotide polymorphisms (SNP) markers covering the whole genome of durum wheat were used to genotype 150 cultivars collected from 46 countries and regions in the world. Leaf length, leaf width and chlorophyll content of the top three leaves were measured, respectively, in three consecutive years. Association analyses were performed on the leaf traits and SNP markers. A total of 120 SNP marker associations were detected on 13 of the 14 chromosomes. Among these markers, 83 were associated with the canopy leaf traits, 10 with 1000-grain weight, and 29 with kernel number per spike. This study is helpful for better understanding the potential and genetic basis of functional leaves, and facilitates pyramiding of the favorable alleles using marker assisted selection for ideal plant-type and high photosynthesis efficiency in durum wheat breeding.	[Huang, Sisi; Sun, Longqing; Hu, Xin; Wang, Yanhong; Zhang, Yujuan; Sun, Dongfa] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Nevo, Eviatar] Univ Haifa, Inst Evolut, Haifa, Israel; [Peng, Junhua] Guangdong Ocean Univ, Coll Agr, Zhanjiang, Guangdong, Peoples R China; [Peng, Junhua] China Natl Seed Grp Co Ltd, Life Sci & Technol Ctr, Wuhan, Hubei, Peoples R China; [Sun, Dongfa] Changjiang Univ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Hubei, Peoples R China	Huazhong Agricultural University; University of Haifa; Guangdong Ocean University	Sun, DF (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.; Peng, JH (corresponding author), Guangdong Ocean Univ, Coll Agr, Zhanjiang, Guangdong, Peoples R China.; Peng, JH (corresponding author), China Natl Seed Grp Co Ltd, Life Sci & Technol Ctr, Wuhan, Hubei, Peoples R China.; Sun, DF (corresponding author), Changjiang Univ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Hubei, Peoples R China.	junhuapeng@yahoo.com; sundongfa1@mail.hzau.edu.cn	Peng, Junhua/HHZ-2344-2022	Peng, Junhua/0000-0002-8428-3137	China National Key Project [2016YFD0100102]; China National Seed Group Co., Ltd.	China National Key Project; China National Seed Group Co., Ltd.	This work was supported by the China National Key Project Grant No. (2016YFD0100102). The China National Seed Group Co., Ltd. provided support in the form of salaries for author [JP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee AE, 2010, PLANT PHYSIOL, V152, P120, DOI 10.1104/pp.109.145078; BARANKIEWICZ J, 1980, BIOCHEM J, V186, P343, DOI 10.1042/bj1860343; Beale SI, 2005, TRENDS PLANT SCI, V10, P309, DOI 10.1016/j.tplants.2005.05.005; Benbella M, 1998, AGRON J, V90, P332, DOI 10.2134/agronj1998.00021962009000030004x; BURCH LR, 1987, PHYSIOL PLANTARUM, V69, P283, DOI 10.1111/j.1399-3054.1987.tb04288.x; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Cui SC, 2017, EARTH SCI INFORM, V10, P169, DOI 10.1007/s12145-016-0281-3; DAWID IB, 1995, CR ACAD SCI III-VIE, V318, P295; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Ghosh Mrityunjay, 2003, Indian Journal of Plant Physiology, V8, P199; Gomez-Garcia MR, 2007, FEBS J, V274, P3948, DOI 10.1111/j.1742-4658.2007.05927.x; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Green AJ, 2012, CROP SCI, V52, P2097, DOI 10.2135/cropsci2012.01.0026; Hu X., 2015, PLOS ONE, V10, P1, DOI DOI 10.1130/G36872.1; Hussain S., 2015, CANADIAN J BIOINFORM, V1, P23; Jia HY, 2013, THEOR APPL GENET, V126, P2123, DOI 10.1007/s00122-013-2123-8; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; Keller M, 1999, THEOR APPL GENET, V98, P903, DOI 10.1007/s001220051149; Khlestkina EK, 2004, PLANT BREEDING, V123, P122, DOI 10.1046/j.1439-0523.2003.00934.x; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Lakew B, 2013, EUPHYTICA, V189, P9, DOI 10.1007/s10681-012-0674-4; Li JingHong, 2009, Scientia Agricultura Sinica, V42, P3067; Li SC, 2001, PLANT MOL BIOL, V47, P761, DOI 10.1023/A:1013687412020; Li YH, 2010, NEW PHYTOL, V188, P242, DOI 10.1111/j.1469-8137.2010.03344.x; Li ZK, 1998, MOL BREEDING, V4, P419, DOI 10.1023/A:1009608128785; Liu KY, 2018, THEOR APPL GENET, V131, P839, DOI 10.1007/s00122-017-3040-z; Liu YX, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-017-0766-x; May A, 2011, BBA-GEN SUBJECTS, V1810, P178, DOI 10.1016/j.bbagen.2010.11.006; Mei HW, 2005, THEOR APPL GENET, V110, P649, DOI 10.1007/s00122-004-1890-7; Mitterbauer R, 2003, Mycotoxin Res, V19, P82, DOI 10.1007/BF02940100; Murray SC, 2009, PLANT GENOME-US, V2, P48, DOI 10.3835/plantgenome2008.10.0011; Murthy KK, 2009, J AGR SCI, V93, P7; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Oh IS, 2005, PLANT CELL, V17, P2832, DOI 10.1105/tpc.105.034819; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Pace DA, 2011, BIOCHEM J, V440, P229, DOI 10.1042/BJ20110641; Peng JHH, 2011, MOL BREEDING, V28, P281, DOI 10.1007/s11032-011-9608-4; Ren J, 2013, INT J MOL SCI, V14, P7061, DOI 10.3390/ijms14047061; Rybinski W, 2004, INT AGROPHYS, V18, P1861; Sabiel SAI, 2017, BREEDING SCI, V67, P83, DOI 10.1270/jsbbs.16074; Sharma SN, 2003, J AGR SCI-CAMBRIDGE, V141, P323, DOI 10.1017/S0021859603003642; Sicher R., 1993, PHOTOSYNTHESIS PHOTO, P351; Updegraff EP, 2009, SEX PLANT REPROD, V22, P197, DOI 10.1007/s00497-009-0104-5; Wang C, 2016, PHOTOSYNTHETICA, V55, P1; Wang YC, 2000, PLANT CELL, V12, P2129, DOI 10.1105/tpc.12.11.2129; Wanke D, 2010, PLANT BIOLOGY, V12, P15, DOI 10.1111/j.1438-8677.2010.00380.x; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; Wilkinson M. J., 2001, Proceedings of the international workshop on new technologies and cocoa breeding, Kota Kinabalu, Sabah, Malaysia, 16-17 October 2000, P12; Wu QH, 2016, EUPHYTICA, V208, P337, DOI 10.1007/s10681-015-1603-0; Xie LJ, 2008, ACTA AGR BOREALI SIN; Xu H, 1995, ACTA AGRONOMICA SINI; Xue SL, 2013, THEOR APPL GENET, V126, P1941, DOI 10.1007/s00122-013-2108-7; Yu GQ, 2011, NEW PHYTOL, V189, P593, DOI 10.1111/j.1469-8137.2010.03495.x; Yue Bing, 2006, Acta Genetica Sinica, V33, P824, DOI 10.1016/S0379-4172(06)60116-9; Zhang LL, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1894-4; Zhang X, 2013, PLANT SOIL ENVIRON, V59, P80, DOI 10.17221/613/2012-PSE	60	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206226	10.1371/journal.pone.0206226	http://dx.doi.org/10.1371/journal.pone.0206226			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352102	Green Published, Green Submitted, gold			2022-12-26	WOS:000448076200041
J	Kolbadinezhad, SM; Coimbra, J; Wilson, JM				Kolbadinezhad, Salman Malakpour; Coimbra, Joao; Wilson, Jonathan M.			Effect of dendritic organ ligation on striped eel catfish Plotosus lineatus osmoregulation	PLOS ONE			English	Article							INTESTINAL HCO3-SECRETION; ACID-BASE REGULATION; EUROPEAN SEA BASS; H+-ATPASE; ANTIGEN RETRIEVAL; NA+/K+-ATPASE; RECTAL GLAND; DICENTRARCHUS-LABRAX; CARBONIC-ANHYDRASE; FRESH-WATER	Unique amongst the teleost, Plotosidae catfish possess a dendritic organ (DO) as a purported salt secreting organ, whereas other marine teleosts rely on their gill ionocytes for active NaCl excretion. To address the role of the DO in ionregulation, ligation experiments were conducted in brackish water (BW) 3 parts per thousand and seawater (SW) 34 parts per thousand acclimated Plotosus lineatus and compared to sham operated fish. Ligation in SW resulted in an osmoregulatory impairment in blood (elevated ions and hematocrit) and muscle (dehydration). However, SW ligation did not elicit compensatory changes in gill or kidney Na+/K+-ATPase (NKA) activity and/or protein expression while a decrease in anterior intestine and increased in posterior intestine were observed but this was not reflected at the protein level. Following ligation in SW, protein levels of carbonic anhydrase (CA) and V-ATPase B subunit (VHAB) were higher in kidney but either lower (CA) or unchanged (VHAB) in other tissues. Taken together, the osmotic disturbance in ligated SW fish indicates the central role of the DO in salt secretion and the absence of a compensatory response from the gill.	[Kolbadinezhad, Salman Malakpour; Coimbra, Joao; Wilson, Jonathan M.] Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental, Matosinhos, Portugal; [Kolbadinezhad, Salman Malakpour; Coimbra, Joao; Wilson, Jonathan M.] Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal; [Wilson, Jonathan M.] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON, Canada	Universidade do Porto; Universidade do Porto; Wilfrid Laurier University	Wilson, JM (corresponding author), Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental, Matosinhos, Portugal.; Wilson, JM (corresponding author), Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal.; Wilson, JM (corresponding author), Wilfrid Laurier Univ, Dept Biol, Waterloo, ON, Canada.	jmwilson@wlu.ca	Quality, Aquaculture Seafood/AAD-7718-2019; Wilson, Jonathan Mark/AAG-6481-2019	Wilson, Jonathan Mark/0000-0003-3681-1166; MalakpourKolbadinezhad, Salman/0000-0002-7515-3584; Coimbra, Joao/0000-0001-6199-6727	NSERC discovery grant; FCT - Foundation for Science and Technology [UID/Multi/04423/2013]; European Regional Development Fund (ERDF)	NSERC discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); FCT - Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Regional Development Fund (ERDF)(European Commission)	This study was supported by an NSERC discovery grant and the Strategic Funding UID/Multi/04423/2013 through national funds provided by FCT - Foundation for Science and Technology and European Regional Development Fund (ERDF), in the framework of the programme PT2020 to JMW.	Basu N, 2002, GENE, V295, P173, DOI 10.1016/S0378-1119(02)00687-X; Biswas AK, 2006, AQUACULTURE, V252, P566, DOI 10.1016/j.aquaculture.2005.06.043; Bloch ME, 1794, NATURGESCHICHTE AUSL; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brock J, 1887, Z F WISS ZOOL, P45; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; BURGER J. WENDELL, 1962, PHYSIOL ZOOL, V35, P205; BURGER JW, 1965, PHYSIOL ZOOL, V38, P191, DOI 10.1086/physzool.38.3.30152829; Catches JS, 2006, J EXP BIOL, V209, P3440, DOI 10.1242/jeb.02384; CHAN DKO, 1967, J ENDOCRINOL, V37, P297, DOI 10.1677/joe.0.0370297; Cramp RL, 2015, COMP BIOCHEM PHYS A, V185, P107, DOI 10.1016/j.cbpa.2015.04.001; CUTLER CP, 1995, COMP BIOCHEM PHYS B, V111, P567, DOI 10.1016/0305-0491(95)00037-9; Deane EE, 2011, REV FISH BIOL FISHER, V21, P153, DOI 10.1007/s11160-010-9164-8; DERUITER AJH, 1985, BEHAVIOUR, V93, P8, DOI 10.1163/156853986X00694; Dymowska AK, 2014, AM J PHYSIOL-CELL PH, V307, pC255, DOI 10.1152/ajpcell.00398.2013; Evans David H., 1993, P315; EVANS DH, 1982, J EXP BIOL, V101, P295; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Ferreira-Martins D, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cov064; Freire Carolina A., 2007, P249; Gilmour KM, 2009, J EXP BIOL, V212, P1647, DOI 10.1242/jeb.029181; Grosell M, 2009, J EXP BIOL, V212, P1940, DOI 10.1242/jeb.026856; Grosell M, 2009, J EXP BIOL, V212, P1684, DOI 10.1242/jeb.027730; Grosell M, 2010, FISH PHYSL MULTIFUNC, V30, P135; Guffey S, 2011, AM J PHYSIOL-REG I, V301, pR1682, DOI 10.1152/ajpregu.00059.2011; Hiroi J, 2012, RESP PHYSIOL NEUROBI, V184, P257, DOI 10.1016/j.resp.2012.07.019; Hirota S, 1985, J COLL SCI, P1898; Holmes W. N., 1969, P1; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Inokuchi M, 2017, J EXP BIOL, V220, P4720, DOI 10.1242/jeb.167320; Iwama George K., 2006, P319; Jensen MK, 1998, J EXP ZOOL, V282, P290, DOI 10.1002/(SICI)1097-010X(19981015)282:3<290::AID-JEZ2>3.0.CO;2-H; Kolbadinezhad SM, 2012, J FISH BIOL, V81, P125, DOI 10.1111/j.1095-8649.2012.03317.x; Kolbadinezhad SM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00761; KOWARSKY J, 1973, COMP BIOCHEM PHYSIOL, V46, P477, DOI 10.1016/0300-9629(73)90098-4; KUFFER H, 1975, Z KLIN CHEM KLIN BIO, V13, P203; Kurita Y, 2008, AM J PHYSIOL-REG I, V294, pR1402, DOI 10.1152/ajpregu.00759.2007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANZING WJR, 1967, PAC SCI, V21, P498; Larsen LH, 2011, COMPR PHYSL, V4, P405; Liu ZJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11757; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madsen SS, 2015, COMP BIOCHEM PHYS A, V188, P107, DOI 10.1016/j.cbpa.2015.06.021; Marshall William S., 2006, P177; Marshall WS, 2002, J EXP BIOL, V205, P745; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; McDonald M.D., 2007, FISH OSMOREGULATION, P322; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Namimatsu S, 2005, J HISTOCHEM CYTOCHEM, V53, P3, DOI 10.1369/jhc.4C6466.2005; Perry SF, 1997, FISH PHYSIOL BIOCHEM, V17, P363, DOI 10.1023/A:1007746217349; Piermarini PM, 2000, J EXP BIOL, V203, P2957; Pillans RD, 2005, J COMP PHYSIOL B, V175, P37, DOI 10.1007/s00360-004-0460-2; PUCKE J, 1979, COPEIA, P356; Randall DJ, 2014, J EXP BIOL, V217, P1205, DOI 10.1242/jeb.093526; Reis-Santos P, 2008, J EXP BIOL, V211, P978, DOI 10.1242/jeb.014423; Rozen S, 2000, Methods Mol Biol, V132, P365; Santos CRA, 1997, COMP BIOCHEM PHYS B, V117, P185, DOI 10.1016/S0305-0491(96)00328-8; Shi SR, 2011, J HISTOCHEM CYTOCHEM, V59, P13, DOI 10.1369/jhc.2010.957191; Sinha AK, 2015, COMP BIOCHEM PHYS A, V181, P87, DOI 10.1016/j.cbpa.2014.11.024; Uchiyama M, 2012, J FISH BIOL, V80, P2236, DOI 10.1111/j.1095-8649.2012.03277.x; VANLENNEP EW, 1968, J ULTRA MOL STRUCT R, V25, P94, DOI 10.1016/S0022-5320(68)80063-2; VANLENNEP EW, 1967, J ULTRA MOL STRUCT R, V18, P333, DOI 10.1016/S0022-5320(67)80122-9; Whittamore JM, 2012, J COMP PHYSIOL B, V182, P1, DOI 10.1007/s00360-011-0601-3; Wilson JM, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1381; Wilson JM, 2002, COMP BIOCHEM PHYS A, V132, P365, DOI 10.1016/S1095-6433(02)00042-9; Wilson JM, 2007, MAR BIOL, V151, P1633, DOI 10.1007/s00227-006-0579-7; Wilson Jonathan Mark, 2007, P359; Wood CM, 2011, FISH PHYSL MULTIFUNC, V30, P116	68	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206206	10.1371/journal.pone.0206206	http://dx.doi.org/10.1371/journal.pone.0206206			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352080	Green Submitted, gold, Green Published			2022-12-26	WOS:000448076200039
J	Arnold, C; Feldner, A; Zappe, M; Komljenovic, D; De La Torre, C; Ruzicka, P; Hecker, M; Neuhofer, W; Korff, T				Arnold, Caroline; Feldner, Anja; Zappe, Maren; Komljenovic, Dorde; De La Torre, Carolina; Ruzicka, Philipp; Hecker, Markus; Neuhofer, Wolfgang; Korff, Thomas			Genetic ablation of NFAT5/TonEBP in smooth muscle cells impairs flow- and pressure-induced arterial remodeling in mice	FASEB JOURNAL			English	Article						hypertension; wall stress; transcriptome	TENASCIN-C; REQUIRES TONEBP/NFAT5; BLOOD-PRESSURE; IN-VITRO; HYPERTENSION; TRANSCRIPTION; GROWTH; CYCLOOXYGENASE-2; PROLIFERATION; EXPRESSION	The arterial wall adapts to alterations in blood flow and pressure by remodeling the cellular and extracellular architecture. Biomechanical stress of vascular smooth muscle cells (VSMCs) in the media is thought to precede this process and promote their activation and subsequent proliferation. However, molecular determinants orchestrating the transcriptional phenotype under these conditions have been insufficiently studied. We identified the transcription factor, nuclear factor of activated T cells 5 (NFAT5; or tonicity enhancer-binding protein) as a crucial regulatory element of mechanical stress responses of VSMCs. Here, the relevance of NFAT5 for arterial growth and thickening is investigated in mice upon inducible smooth muscle cell (SMC)-specific genetic ablation of Nfat5. In cultured mouse VSMCs, loss of Nfat5 inhibits the expression of gene sets involved in the control of the cell cycle and the interaction with the extracellular matrix and cytoskeletal dynamics. In vivo, SMC-specific knockout of Nfat5 did not affect the general vascular architecture and blood pressure levels under baseline conditions. However, proliferation of VSMCs and the thickening of the arterial wall were inhibited during both flow-induced collateral remodeling and hypertension-mediated arterial hypertrophy. Whereas originally described as a hypertonicity-responsive transcription factor, these findings identify NFAT5 as a novel molecular determinant of biomechanically induced phenotype changes of VSMCs and wall stress-induced arterial remodeling processes.Arnold, C., Feldner, A., Zappe, M., Komljenovic, D., De La Torre, C., Ruzicka, P., Hecker, M., Neuhofer, W., Korff, T. Genetic ablation of NFAT5/TonEBP in smooth muscle cells impairs flow- and pressure-induced arterial remodeling in mice.	[Arnold, Caroline; Feldner, Anja; Zappe, Maren; Ruzicka, Philipp; Hecker, Markus; Korff, Thomas] Heidelberg Univ, Univ Hosp Mannheim, Inst Physiol & Pathophysiol, Dept Cardiovasc Physiol, Heidelberg, Germany; [De La Torre, Carolina] Heidelberg Univ, Univ Hosp Mannheim, Ctr Med Res, Heidelberg, Germany; [Korff, Thomas] Heidelberg Univ, Univ Hosp Mannheim, European Ctr Angiosci, Med Fac Mannheim, Heidelberg, Germany; [Neuhofer, Wolfgang] Heidelberg Univ, Univ Hosp Mannheim, Med Clin 5, Heidelberg, Germany; [Komljenovic, Dorde] German Canc Res Ctr, Div Med Phys Radiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Korff, T (corresponding author), Heidelberg Univ, Dept Cardiovasc Physiol, Inst Physiol & Pathophysiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany.	korff@physiologie.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [KO2344/8-1, SFB TR23]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors acknowledge the excellent technical assistance of Gudrun Scheib, Maria Harlacher, Yvonne Feuchter (all from Heidelberg University), and Melanie Muller (computed tomography 3-dimensional reconstructions; German Cancer Research Center). This work was supported by Deutsche Forschungsgemeinschaft Grant KO2344/8-1, SFB TR23, Projects C5, C6, and Z1. The authors declare no conflicts of interest.	Ahn JD, 2002, CIRC RES, V90, P1325, DOI 10.1161/01.RES.0000023200.19316.D5; AlGhatrif M, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0523-z; Arnold C, 2014, EMBO MOL MED, V6, P1075, DOI 10.15252/emmm.201403864; Avendano MS, 2016, BRIT J PHARMACOL, V173, P1541, DOI 10.1111/bph.13457; Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; Chan CT, 2012, HYPERTENSION, V60, P1207, DOI 10.1161/HYPERTENSIONAHA.112.201251; Chang KW, 2006, HEPATOL RES, V36, P33, DOI 10.1016/j.hepres.2006.05.003; Chang KW, 2011, ANTICANCER RES, V31, P2037; Choi S, 2017, J CLIN INVEST, V127, P954, DOI 10.1172/JCI87880; Cowan KN, 2000, J CLIN INVEST, V105, P21, DOI 10.1172/JCI6539; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Demicheva E, 2008, CIRC RES, V103, P477, DOI 10.1161/CIRCRESAHA.108.177782; Eitenmuller I, 2006, CIRC RES, V99, P656, DOI 10.1161/01.RES.0000242560.77512.dd; Favale NO, 2009, BIOCHEM BIOPH RES CO, V381, P301, DOI 10.1016/j.bbrc.2008.12.189; Fredenburgh LE, 2008, CIRCULATION, V117, P2114, DOI 10.1161/CIRCULATIONAHA.107.716241; Ghosh S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001712; Golledge J, 2011, CARDIOVASC RES, V92, P19, DOI 10.1093/cvr/cvr183; Halterman JA, 2012, AM J PHYSIOL-CELL PH, V302, pC1, DOI 10.1152/ajpcell.00327.2011; Hamada K, 1998, J BIOL CHEM, V273, P6334, DOI 10.1074/jbc.273.11.6334; Han EJ, 2017, EBIOMEDICINE, V18, P261, DOI 10.1016/j.ebiom.2017.03.039; Heerkens EHJ, 2007, HYPERTENSION, V49, P1, DOI 10.1161/01.HYP.0000252753.63224.3b; Heil M, 2004, CIRC RES, V95, P449, DOI 10.1161/01.RES.0000141145.78900.44; Helisch A, 2003, MICROCIRCULATION, V10, P83, DOI 10.1038/sj.mn.7800173; Hodebeck M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00467; Holschermann H, 2006, CARDIOVASC RES, V71, P527, DOI 10.1016/j.cardiores.2006.05.021; Huveneers S, 2015, CIRC RES, V116, P895, DOI 10.1161/CIRCRESAHA.116.305720; Ihida-Stansbury K, 2006, AM J PHYSIOL-LUNG C, V291, pL694, DOI 10.1152/ajplung.00119.2006; Ingber DE, 2008, PROG BIOPHYS MOL BIO, V97, P163, DOI 10.1016/j.pbiomolbio.2008.02.005; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Intengan HD, 2000, HYPERTENSION, V36, P312, DOI 10.1161/01.HYP.36.3.312; Ishigaki T, 2011, J CELL PHYSIOL, V226, P2617, DOI 10.1002/jcp.22614; Jones PL, 2000, MATRIX BIOL, V19, P581, DOI 10.1016/S0945-053X(00)00106-2; Jones PL, 1996, CIRC RES, V79, P1131, DOI 10.1161/01.RES.79.6.1131; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kaunas R, 2006, CELL SIGNAL, V18, P1924, DOI 10.1016/j.cellsig.2006.02.008; Kawabe J, 2004, AM J PHYSIOL-HEART C, V286, pH1845, DOI 10.1152/ajpheart.00593.2003; Kuper C., 2015, FRONT PHYSIOL, V5, P507; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lee HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24921; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Li CH, 2007, CELL SIGNAL, V19, P881, DOI 10.1016/j.cellsig.2007.01.004; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; MACKIE EJ, 1992, AM J PATHOL, V141, P377; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Mills PA, 2000, J APPL PHYSIOL, V88, P1537, DOI 10.1152/jappl.2000.88.5.1537; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Mulvany MJ, 1996, HYPERTENSION, V28, P505; Mulvany MJ, 2002, CURR HYPERTENS REP, V4, P49, DOI 10.1007/s11906-002-0053-y; Numaguchi K, 1999, CIRC RES, V85, P5; Okumura T, 2002, HYPERTENS RES, V25, P927; Pfisterer L, 2012, CARDIOVASC RES, V96, P120, DOI 10.1093/cvr/cvs247; Sawada Y, 2007, CARDIOVASC RES, V74, P366, DOI 10.1016/j.cardiores.2007.02.028; Scherer C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000626; Schiffrin EL, 2012, HYPERTENSION, V59, P367, DOI 10.1161/HYPERTENSIONAHA.111.187021; Serr I, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aag1782; Wallner K, 1999, J AM COLL CARDIOL, V34, P871, DOI 10.1016/S0735-1097(99)00272-7; Wallner K, 1999, CIRCULATION, V99, P1284, DOI 10.1161/01.CIR.99.10.1284; Wharton J, 2000, CIRCULATION, V102, P3130; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Yamamoto K, 2005, CARDIOVASC RES, V65, P737, DOI 10.1016/j.cardiores.2004.10.034; Yoon HJ, 2011, ARTHRITIS RHEUM-US, V63, P1843, DOI 10.1002/art.30229; Young W, 2000, CIRC RES, V86, P906, DOI 10.1161/01.RES.86.8.906; Yue ZC, 2015, AM J PHYSIOL-HEART C, V308, pH157, DOI 10.1152/ajpheart.00457.2014; Zappe M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01190; Zhao HG, 2009, BIOCHEM BIOPH RES CO, V389, P599, DOI 10.1016/j.bbrc.2009.09.028	67	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3364	3377		10.1096/fj.201801594R	http://dx.doi.org/10.1096/fj.201801594R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30383452	Bronze			2022-12-26	WOS:000459794800024
J	Brehm, MA; Kenney, LL; Wiles, MV; Low, BE; Tisch, RM; Burzenski, L; Mueller, C; Greiner, DL; Shultz, LD				Brehm, Michael A.; Kenney, Laurie L.; Wiles, Michael V.; Low, Benjamin E.; Tisch, Roland M.; Burzenski, Lisa; Mueller, Christian; Greiner, Dale L.; Shultz, Leonard D.			Lack of acute xenogeneic graft-versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression	FASEB JOURNAL			English	Article						humanized; HU-PBL-SCID; GVHD; immunodeficient; humanized	NONOBESE DIABETIC MICE; COMPLEX CLASS-I; MOUSE MODELS; HUMAN CD4(+); IMMUNE-SYSTEM; IL-2; GENE; INTERLEUKIN-2; PREVENTION; INSULITIS	Immunodeficient mice engrafted with human peripheral blood mononuclear cells (PBMCs) support preclinical studies of human pathogens, allograft rejection, and human T-cell function. However, a major limitation of PBMC engraftment is development of acute xenogeneic graft-versus-host disease (GVHD) due to human T-cell recognition of murine major histocompatibility complex (MHC). To address this, we created 2 NOD-scid IL-2 receptor subunit (IL2rg)(null) (NSG) strains that lack murine MHC class I and II [NSG--2-microglobulin (B2M)(null) (IA IE)(null) and NSG-(K-b D-b)(null) (IA(null))]. We observed rapid human IgG clearance in NSG-B2M(null) (IA IE)(null) mice whereas clearance in NSG-(K-b D-b)(null) (IA(null)) mice and NSG mice was comparable. Injection of human PBMCs into both strains enabled long-term engraftment of human CD4(+) and CD8(+) T cells without acute GVHD. Engrafted human T-cell function was documented by rejection of human islet allografts. Administration of human IL-2 to NSG-(K-b D-b)(null) (IA(null)) mice via adeno-associated virus vector increased human CD45(+) cell engraftment, including an increase in human regulatory T cells. However, high IL-2 levels also induced the development of GVHD. These data document that NSG mice deficient in murine MHC support studies of human immunity in the absence of acute GVHD and enable evaluation of human antibody therapeutics targeting human T cells.Brehm, M. A., Kenney, L. L., Wiles, M. V., Low, B. E., Tisch, R. M., Burzenski, L., Mueller, C., Greiner, D. L., Shultz, L. D. Lack of acute xenogeneic graft-versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression.	[Brehm, Michael A.; Kenney, Laurie L.; Greiner, Dale L.] Univ Massachusetts, Med Sch, Diabet Ctr Excellence, Worcester, MA USA; [Mueller, Christian] Univ Massachusetts, Med Sch, Dept Pediat, Worcester, MA USA; [Mueller, Christian] Univ Massachusetts, Med Sch, Horae Gene Therapy Ctr, Worcester, MA USA; [Wiles, Michael V.; Low, Benjamin E.; Burzenski, Lisa; Shultz, Leonard D.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Tisch, Roland M.] Univ N Carolina, Dept Immunol & Microbiol, Chapel Hill, NC 27515 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory; University of North Carolina; University of North Carolina Chapel Hill	Brehm, MA (corresponding author), Univ Massachusetts, Med Sch, Program Mol Med, Diabet Ctr Excellence, 368 Plantat St,AS7-2053, Worcester, MA 01605 USA.	michael.brehm@umassmed.edu		Mueller, Christian/0000-0003-3589-8749; wiles, michael/0000-0002-3620-8386; Brehm, Michael/0000-0001-6813-3262	U.S. National Institutes of Health (NIH) Office of the Director Grant [1R24 OD018259]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [UC4 DK104218, CA034196, 1R01 AI132963, HL131471, 1DP3DK111898, DK098252, 1R01 DK1035486]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL131471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI132963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098252, DP3DK111898, U01DK104218, R01DK103546] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD018259] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Office of the Director Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in part, by U.S. National Institutes of Health (NIH) Office of the Director Grant 1R24 OD018259 and the NIH National Institute of Diabetes and Digestive and Kidney Diseases-supported Human Islet Research Network (https://hirnetwork.org) Grants UC4 DK104218 (to M.A.B., D.L.G., and L.D.S.), CA034196 (to L.D.S.), 1R01 AI132963 (to M.A.B. and L.D.S.), HL131471 (to C.M.), 1DP3DK111898 (to M.A.B.), DK098252 (to C.M.), and 1R01 DK1035486 (R.M.T. and M.A.B.). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. M.A.B. and D.L.C. are consultants for The Jackson Laboratory. The authors declare no conflicts of interest.	Abraham S, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00276; Abraham S, 2015, CLIN IMMUNOL, V156, P58, DOI 10.1016/j.clim.2014.11.004; Akkina R, 2016, AIDS RES HUM RETROV, V32, P109, DOI [10.1089/aid.2015.0258, 10.1089/AID.2015.0258]; Ali N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044219; Ashizawa T, 2017, CLIN CANCER RES, V23, P149, DOI 10.1158/1078-0432.CCR-16-0122; Bevan MJ, 2010, J IMMUNOL, V184, P4585, DOI 10.4049/jimmunol.1090023; BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488; Brehm M, 2016, TRANSL IMMUNOL MECH, V2016, P285, DOI [DOI 10.1016/B978-0-12-801577-3.00012-5, 10.1016/B978-0-12-801577-3.00012-5]; Brehm MA, 2014, J IMMUNOL METHODS, V410, P3, DOI 10.1016/j.jim.2014.02.011; Bruck F, 2013, CYTOTHERAPY, V15, P267, DOI 10.1016/j.jcyt.2012.09.003; Christianson SW, 1997, J IMMUNOL, V158, P3578; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Covassin L, 2013, CLIN EXP IMMUNOL, V174, P372, DOI 10.1111/cei.12180; Dai CH, 2016, J CLIN INVEST, V126, P1857, DOI 10.1172/JCI83657; Durost PA, 2018, HUM GENE THER, V29, P352, DOI 10.1089/hum.2017.072; Ferrara JLM, 2006, SEMIN HEMATOL, V43, P1, DOI 10.1053/j.seminhematol.2005.11.028; Gregoire-Gauthier J, 2015, BIOL BLOOD MARROW TR, V21, P821, DOI 10.1016/j.bbmt.2015.01.006; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; HARLAN DM, 1995, DIABETES, V44, P816, DOI 10.2337/diabetes.44.7.816; Hatano R, 2013, BRIT J HAEMATOL, V162, P263, DOI 10.1111/bjh.12378; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; He Y, 2013, HUM GENE THER, V24, P545, DOI 10.1089/hum.2013.065; Hilger N, 2016, CYTOM PART A, V89A, P803, DOI 10.1002/cyto.a.22930; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ito R, 2017, AM J TRANSPLANT, V17, P1216, DOI 10.1111/ajt.14116; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Johnson MC, 2013, DIABETES, V62, P3775, DOI 10.2337/db13-0669; Kenney LL, 2016, AM J TRANSPLANT, V16, P389, DOI 10.1111/ajt.13520; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Kumar BV, 2018, IMMUNITY, V48, P202, DOI 10.1016/j.immuni.2018.01.007; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P917, DOI 10.1016/j.dci.2005.03.003; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; MIYAZAKI T, 1992, P NATL ACAD SCI USA, V89, P9519, DOI 10.1073/pnas.89.20.9519; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; Pino S, 2010, METHODS MOL BIOL, V602, P105, DOI 10.1007/978-1-60761-058-8_7; PODOLIN PL, 1993, J EXP MED, V178, P793, DOI 10.1084/jem.178.3.793; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; RAULET DH, 1994, ADV IMMUNOL, V55, P381; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Sim GC, 2014, CYTOKINE GROWTH F R, V25, P377, DOI 10.1016/j.cytogfr.2014.07.018; Strowig T, 2011, P NATL ACAD SCI USA, V108, P13218, DOI 10.1073/pnas.1109769108; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Theocharides APA, 2016, HAEMATOLOGICA, V101, P5, DOI 10.3324/haematol.2014.115212; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; van den Broek T, 2018, NAT REV IMMUNOL, V18, P363, DOI 10.1038/s41577-018-0001-y; Wager EJ, 2000, J IMMUNOL, V165, P518, DOI 10.4049/jimmunol.165.1.518; Walsh NC, 2017, ANNU REV PATHOL-MECH, V12, P187, DOI 10.1146/annurev-pathol-052016-100332; Yang CX, 2015, DIABET METAB SYND OB, V8, P387, DOI 10.2147/DMSO.S87253	56	55	56	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3137	3151		10.1096/fj.201800636R	http://dx.doi.org/10.1096/fj.201800636R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30383447	Green Published			2022-12-26	WOS:000459794800006
J	Argenzio, E; Klarenbeek, J; Kedziora, KM; Nahidiazar, L; Isogai, T; Perrakis, A; Jalink, K; Moolenaar, WH; Innocenti, M				Argenzio, Elisabetta; Klarenbeek, Jeffrey; Kedziora, Katarzyna M.; Nahidiazar, Leila; Isogai, Tadamoto; Perrakis, Anastassis; Jalink, Kees; Moolenaar, Wouter H.; Innocenti, Metello			Profilin binding couples chloride intracellular channel protein CLIC4 to RhoA-mDia2 signaling and filopodium formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane trafficking; G protein-coupled receptor; Rho (Rho GTPase); profilin; actin; G-actin; formin; epidermal growth factor (EGF); cell adhesion; cell motility; filopodia; lysophosphatidic acid	ACTIN CYTOSKELETON; CRYSTAL-STRUCTURE; SOLUBLE FORM; COMPLEXES; NUCLEAR; IDENTIFICATION; ACTIVATION	Chloride intracellular channel 4 (CLIC4) is a cytosolic protein implicated in diverse actin-based processes, including integrin trafficking, cell adhesion, and tubulogenesis. CLIC4 is rapidly recruited to the plasma membrane by RhoA-activating agonists and then partly colocalizes with 1 integrins. Agonist-induced CLIC4 translocation depends on actin polymerization and requires conserved residues that make up a putative binding groove. However, the mechanism and significance of CLIC4 trafficking have been elusive. Here, we show that RhoA activation by either lysophosphatidic acid (LPA) or epidermal growth factor is necessary and sufficient for CLIC4 translocation to the plasma membrane and involves regulation by the RhoA effector mDia2, a driver of actin polymerization and filopodium formation. We found that CLIC4 binds the G-actin-binding protein profilin-1 via the same residues that are required for CLIC4 trafficking. Consistently, shRNA-induced profilin-1 silencing impaired agonist-induced CLIC4 trafficking and the formation of mDia2-dependent filopodia. Conversely, CLIC4 knockdown increased filopodium formation in an integrin-dependent manner, a phenotype rescued by wild-type CLIC4 but not by the trafficking-incompetent mutant CLIC4(C35A). Furthermore, CLIC4 accelerated LPA-induced filopodium retraction. We conclude that through profilin-1 binding, CLIC4 functions in a RhoA-mDia2-regulated signaling network to integrate cortical actin assembly and membrane protrusion. We propose that agonist-induced CLIC4 translocation provides a feedback mechanism that counteracts formin-driven filopodium formation.	[Argenzio, Elisabetta; Klarenbeek, Jeffrey; Kedziora, Katarzyna M.; Nahidiazar, Leila; Jalink, Kees; Moolenaar, Wouter H.] Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Isogai, Tadamoto; Innocenti, Metello] Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Perrakis, Anastassis] Netherlands Canc Inst, Div Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Moolenaar, WH (corresponding author), Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.; Innocenti, M (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	w.moolenaar@nki.nl; metelloinnocenti@gmail.com	Isogai, Tadamoto/K-4656-2019; Innocenti, Metello/X-2182-2019; Perrakis, Anastassis/E-8704-2013	Isogai, Tadamoto/0000-0003-0511-0156; Innocenti, Metello/0000-0002-7455-2559; Moolenaar, Wouter/0000-0001-7545-198X; Kedziora, Katarzyna/0000-0001-6524-7731; Perrakis, Anastassis/0000-0002-1151-6227	FP7 WeNMR [261572]; H2020 West-Life [675858]; National GRID Initiatives of Belgium; National GRID Initiatives of France; National GRID Initiatives of Italy; National GRID Initiatives of Germany; National GRID Initiatives of the Netherlands; National GRID Initiatives of Poland; National GRID Initiatives of Portugal; National GRID Initiatives of Spain; National GRID Initiatives of United Kingdom; National GRID Initiatives of South Africa; National GRID Initiatives of Malaysia; National GRID Initiatives of Taiwan; United States Open Science Grid	FP7 WeNMR; H2020 West-Life; National GRID Initiatives of Belgium; National GRID Initiatives of France; National GRID Initiatives of Italy; National GRID Initiatives of Germany; National GRID Initiatives of the Netherlands; National GRID Initiatives of Poland; National GRID Initiatives of Portugal; National GRID Initiatives of Spain; National GRID Initiatives of United Kingdom; National GRID Initiatives of South Africa; National GRID Initiatives of Malaysia; National GRID Initiatives of Taiwan; United States Open Science Grid	We thank Tatjana Heidebrecht for providing recombinant proteins for biophysical experiments performed by Alexander Fish at the NKI Protein Facility and Alexandre Bonvin for advice using HADDOCK. We also thank Guillaume Jacquemet and Hadrien Mary for advice on the use of FiloQuant and Filament-Detector ImageJ plugins, respectively. The FP7 WeNMR (project no. 261572) and H2020 West-Life (project no. 675858) European e-Infrastructure projects are acknowledged for the use of their web portals, which make use of the EGI infrastructure and the DIRAC4EGI service with the dedicated support of CESNET-MetaCloud, INFN-PADOVA, NCG-INGRID-PT, RAL-LCG2, TW-NCHC, IFCA-LCG2, SURFsara, and NIKHEF and the additional support of the National GRID Initiatives of Belgium, France, Italy, Germany, the Netherlands, Poland, Portugal, Spain, United Kingdom, South Africa, Malaysia, Taiwan, and the United States Open Science Grid.	Al Khamici H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115699; Alkam D, 2017, CELL MOL LIFE SCI, V74, P967, DOI 10.1007/s00018-016-2372-1; Argenzio E, 2016, J CELL SCI, V129, P4165, DOI 10.1242/jcs.189795; Argenzio E, 2014, J CELL SCI, V127, P5189, DOI 10.1242/jcs.150623; Beli P, 2008, NAT CELL BIOL, V10, P849, DOI 10.1038/ncb1745; Berryman M, 2004, J BIOL CHEM, V279, P34794, DOI 10.1074/jbc.M402835200; Berryman M, 2000, MOL BIOL CELL, V11, P1509, DOI 10.1091/mbc.11.5.1509; Cao LY, 2018, ELIFE, V7, DOI 10.7554/eLife.34176; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chou SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10412; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Ferron F, 2007, EMBO J, V26, P4597, DOI 10.1038/sj.emboj.7601874; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Galovic M, 2011, J CELL SCI, V124, P2001, DOI 10.1242/jcs.081182; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Hernandez-Fernaud JR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14206; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Innocenti M, 2018, CELL ADHES MIGR, V12, P401, DOI 10.1080/19336918.2018.1448352; Isogai T, 2016, BIOCHEM SOC T, V44, P1701, DOI 10.1042/BST20160187; Isogai T, 2016, J PROTEOME RES, V15, P4624, DOI 10.1021/acs.jproteome.6b00718; Isogai T, 2015, J CELL SCI, V128, P3796, DOI 10.1242/jcs.176768; Isogai T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09802; Isogai T, 2015, MOL CELL PROTEOMICS, V14, P1064, DOI 10.1074/mcp.M114.043885; Jacquemet G, 2017, J CELL BIOL, V216, P3387, DOI 10.1083/jcb.201704045; Jiang L, 2014, BBA-BIOMEMBRANES, V1838, P643, DOI 10.1016/j.bbamem.2013.05.025; Kedziora KM, 2016, J BIOL CHEM, V291, P4323, DOI 10.1074/jbc.M115.695940; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Lawson CD, 2018, J CELL BIOL, V217, P447, DOI 10.1083/jcb.201612069; Leyton-Puig D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16068; Leyton-Puig D, 2016, BIOL OPEN, V5, P1001, DOI 10.1242/bio.019570; Littler DR, 2008, PROTEINS, V71, P364, DOI 10.1002/prot.21704; Littler DR, 2010, FEBS LETT, V584, P2093, DOI 10.1016/j.febslet.2010.01.027; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Padmakumar VC, 2012, AM J PATHOL, V181, P74, DOI 10.1016/j.ajpath.2012.03.025; Ponsioen B, 2009, MOL BIOL CELL, V20, P4664, DOI 10.1091/mbc.E09-06-0529; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rotty JD, 2015, DEV CELL, V32, P54, DOI 10.1016/j.devcel.2014.10.026; Shibue T, 2012, CANCER DISCOV, V2, P706, DOI 10.1158/2159-8290.CD-11-0239; Shukla A, 2009, NAT CELL BIOL, V11, P777, DOI 10.1038/ncb1885; Ulmasov B, 2009, AM J PATHOL, V174, P1084, DOI 10.2353/ajpath.2009.080625; van der Kammen R, 2017, DEVELOPMENT, V144, P4588, DOI 10.1242/dev.156323; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; van Dijk M, 2012, J CHEM THEORY COMPUT, V8, P3463, DOI 10.1021/ct300102d; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280	55	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19161	19176		10.1074/jbc.RA118.002779	http://dx.doi.org/10.1074/jbc.RA118.002779			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30381396	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000453537300001
J	Carlow, DA; Tra, MC; Ziltener, HJ				Carlow, Douglas A.; Tra, Michelle C.; Ziltener, Hermann J.			A cell-extrinsic ligand acquired by activated T cells in lymph node can bridge L-selectin and P-selectin	PLOS ONE			English	Article							NEUTROPHIL ADHESION; INTEGRIN ACTIVATION; LEUKOCYTE MIGRATION; B-LYMPHOCYTE; EXPRESSION; BIOSYNTHESIS; PLATELETS; PSGL-1; REQUIREMENTS; ENDOTHELIUM	P-selectin expressed on activated endothelia and platelets supports recruitment of leukocytes expressing P-selectin ligand to sites of inflammation. While monitoring P-selectin ligand expression on activated CD8 + T cells in murine adoptive transfer models, we observed two distinct ligands on responding donor cells, the canonical cell-intrinsic P-selectin ligand PSGL-1 and a second undocumented P-selectin ligand we provisionally named PSL2. PSL2 is unusual among selectin ligands in that it is cell-extrinsic, loaded onto L-selectin expressed by activated T cells but not L-selectin on resting naive CD8 + T cells. PSL2 display is highest on activated T cells responding in peripheral lymph nodes and low on T cells responding in spleen suggesting that the original source of PSL2 is high endothelial venules, cells known to produce L-selectin ligands. PSL2 is a ligand for both P-selectin and L-selectin and can physically bridge the two selectins. The L-selectin/PSL2 complex can mediate Pselectin-dependent adherence of activated T cells to immobilized P-selectin or to activated platelets, either independently or cooperatively with PSGL-1. PSL2's capacity to bridge between L-selectin on activated T cells and P-selectin reveals an undocumented and unanticipated activity of cell-extrinsic selectin ligands in mediating selectin-selectin connectivity. The timing and circumstances of PSL2 detection on T cells, together with its capacity to support adherence to P-selectin-bearing substrates, are consistent with P-selectin engagement of both PSGL1 and the L-selectin/PSL2 complex during T cell recruitment. Engagement of PSGL-1 and L-selectin/PSL2 would likely deliver distinct signals known to be relevant in this process.	[Carlow, Douglas A.; Tra, Michelle C.; Ziltener, Hermann J.] Univ British Columbia, Fac Med, Biomed Res Ctr, Vancouver, BC, Canada; [Ziltener, Hermann J.] Univ British Columbia, Fac Med, Dept Pathol, Vancouver, BC, Canada; [Carlow, Douglas A.] Univ British Columbia, Fac Med, British Columbia Childrens Hosp Res Inst, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Carlow, DA (corresponding author), Univ British Columbia, Fac Med, Biomed Res Ctr, Vancouver, BC, Canada.; Carlow, DA (corresponding author), Univ British Columbia, Fac Med, British Columbia Childrens Hosp Res Inst, Vancouver, BC, Canada.	doug@brc.ubc.ca			Canadian Institutes of Health Research - Infection and Immunity [CIHR MOP - 111051]	Canadian Institutes of Health Research - Infection and Immunity(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant Number: CIHR MOP - 111051, Funded by: The Canadian Institutes of Health Research - Infection and Immunity, URL: http://www.cihr-irsc.gc.ca/e/13533.html.	Abbal C, 2006, BLOOD, V108, P3352, DOI 10.1182/blood-2006-04-013912; Angiari S, 2015, AUTOIMMUN REV, V14, P984, DOI 10.1016/j.autrev.2015.06.006; BERG EL, 1991, J CELL BIOL, V114, P343, DOI 10.1083/jcb.114.2.343; Bertozzi CR, 1997, J IMMUNOL METHODS, V203, P157, DOI 10.1016/S0022-1759(97)00026-4; CARLOW DA, 1992, J IMMUNOL, V148, P1595; Carlow DA, 2009, J IMMUNOL, V183, P1155, DOI 10.4049/jimmunol.0900409; Charfi C, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-84; DEBRUIJNEADMIRAAL LG, 1992, BLOOD, V80, P134; Dwir O, 2002, J BIOL CHEM, V277, P21130, DOI 10.1074/jbc.M201999200; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Evans SS, 1999, J IMMUNOL, V162, P3615; Galkina E, 2007, EUR J IMMUNOL, V37, P1243, DOI 10.1002/eji.200636481; Gauguet JM, 2004, BLOOD, V104, P4104, DOI 10.1182/blood-2004-05-1986; Giblin PA, 1997, J IMMUNOL, V159, P3498; Gossens K, 2009, J EXP MED, V206, P761, DOI 10.1084/jem.20082502; Green CE, 2004, J IMMUNOL, V172, P7780, DOI 10.4049/jimmunol.172.12.7780; HASSLEN SR, 1995, HISTOCHEM J, V27, P547; HEMMERICH S, 1994, J EXP MED, V180, P2219, DOI 10.1084/jem.180.6.2219; Hickey MJ, 2000, J IMMUNOL, V165, P7164, DOI 10.4049/jimmunol.165.12.7164; Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HOKE D, 1995, CURR BIOL, V5, P670, DOI 10.1016/S0960-9822(95)00132-1; Hu H, 2010, THROMB HAEMOSTASIS, V104, P1184, DOI 10.1160/TH10-05-0308; Jirouskova M, 2007, J THROMB HAEMOST, V5, P661, DOI 10.1111/j.1538-7836.2007.02407.x; Julita MA, 2002, J IMMUNOL, V169, P1768, DOI 10.4049/jimmunol.169.4.1768; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Khan TN, 2016, J EXP MED, V213, P951, DOI 10.1084/jem.20151855; KIKUTA A, 1994, BLOOD, V84, P3766, DOI 10.1182/blood.V84.11.3766.bloodjournal84113766; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kohlmeier JE, 2011, J EXP MED, V208, P1621, DOI 10.1084/jem.20102110; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; Lee M, 2014, NAT IMMUNOL, V15, P982, DOI 10.1038/ni.2983; Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6; Li N, 2008, J LEUKOCYTE BIOL, V83, P1069, DOI 10.1189/jlb.0907615; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; Liu ZH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15196; Liu ZH, 2010, J EXP MED, V207, P2975, DOI 10.1084/jem.20101545; Ludwig RJ, 2010, AM J PATHOL, V176, P1339, DOI 10.2353/ajpath.2010.081100; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; McEver RP, 2015, CARDIOVASC RES, V107, P331, DOI 10.1093/cvr/cvv154; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Mohammed RN, 2016, CELL REP, V14, P760, DOI 10.1016/j.celrep.2015.12.090; Morikis VA, 2017, BLOOD, V130, P2101, DOI 10.1182/blood-2017-05-783027; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; Shao BJ, 2015, P NATL ACAD SCI USA, V112, P8661, DOI 10.1073/pnas.1507712112; Snapp KR, 2001, BLOOD, V97, P3806, DOI 10.1182/blood.V97.12.3806; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Spectre G, 2012, THROMB HAEMOSTASIS, V108, P328, DOI 10.1160/TH12-02-0064; SPERTINI O, 1991, NATURE, V349, P691, DOI 10.1038/349691a0; Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478; Srinivasan S, 2011, BBA-BIOMEMBRANES, V1808, P1709, DOI 10.1016/j.bbamem.2011.02.006; Stadtmann A, 2013, J EXP MED, V210, P2171, DOI 10.1084/jem.20130664; Steeber DA, 2007, PROG INFLAMM RES SER, P27; Subramanian H, 2012, J IMMUNOL, V188, P3223, DOI 10.4049/jimmunol.1101032; Tang MLK, 1998, J IMMUNOL, V160, P5113; Tsang YTM, 1997, J IMMUNOL, V159, P4566; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; Varki A, 1997, J CLIN INVEST, V100, pS31; Veerman KM, 2012, J IMMUNOL, V188, P1638, DOI 10.4049/jimmunol.1103026; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491; Weetall M, 2001, ANAL BIOCHEM, V293, P277, DOI 10.1006/abio.2001.5140; Weitz-Schmidt G, 2011, METHODS MOL BIOL, V757, P15, DOI 10.1007/978-1-61779-166-6_2; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zhang Y., 2013, PLOS ONE, V8; Zollner O, 1997, J CELL BIOL, V136, P707, DOI 10.1083/jcb.136.3.707	70	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205685	10.1371/journal.pone.0205685	http://dx.doi.org/10.1371/journal.pone.0205685			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379850	gold, Green Submitted, Green Published			2022-12-26	WOS:000448823700064
J	Mateos, J; Fafian-Labora, J; Morente-Lopez, M; Lesende-Rodriguez, I; Monserrat, L; Odena, MA; de Oliveira, E; de Toro, J; Arufe, MC				Mateos, Jesus; Fafian-Labora, Juan; Morente-Lopez, Miriam; Lesende-Rodriguez, Ivan; Monserrat, Lorenzo; Odena, Maria A.; de Oliveira, Eliandre; de Toro, Javier; Arufe, Maria C.			Next-Generation Sequencing and Quantitative Proteomics of Hutchinson-Gilford progeria syndrome-derived cells point to a role of nucleotide metabolism in premature aging	PLOS ONE			English	Article							ADENOSYL-L-METHIONINE; S-ADENOSYLMETHIONINE; PHOSPHORIBOSYL PYROPHOSPHATE; PURINE SYNTHESIS; ACCUMULATION; DEFICIENT; MUTATIONS; REVEALS; LAMIN; TRIAL	Hutchinson-Gilford progeria syndrome (HGPS) is a very rare fatal disease characterized for accelerated aging. Although the causal agent, a point mutation in LMNA gene, was identified more than a decade ago, the molecular mechanisms underlying HGPS are still not fully understood and, currently, there is no cure for the patients, which die at a mean age of thirteen. With the aim of unraveling non-previously altered molecular pathways in the premature aging process, human cell lines from HGPS patients and from healthy parental controls were studied in parallel using Next-Generation Sequencing (RNAseq) and High-Resolution Quantitative Proteomics (iTRAQ) techniques. After selection of significant proteins and transcripts and crosschecking of the results a small set of protein/transcript pairs were chosen for validation. One of those proteins, ribose-phosphate pyrophosphokinase 1 (PRPS1), is essential for nucleotide synthesis. PRPS1 loss-of-function mutants present lower levels of purine. PRPS1 protein and transcript levels are detected as significantly decreased in HGPS cell lines vs. healthy parental controls. This modulation was orthogonally confirmed by targeted techniques in cell lines and also in an animal model of Progeria, the ZMPSTE24 knock-out mouse. In addition, functional experiments through supplementation with S-adenosyl-methionine (SAMe), a metabolite that is an alternative source of purine, were done. Results indicate that SAMe has a positive effect in the proliferative capacity and reduces senescence-associated Beta-galactosidase staining of the HPGS cell lines. Altogether, our data suggests that nucleotide and, specifically, purine-metabolism, are altered in premature aging, opening a new window for the therapeutic treatment of the disease.	[Mateos, Jesus; Fafian-Labora, Juan; Morente-Lopez, Miriam; de Toro, Javier; Arufe, Maria C.] Univ A Coruna, Fac Ciencias Salud, Dept Ciencias Biomed Med & Fisioterapia, Grp Terapia Celular & Med Regenerat,INIBIC CHUAC, La Coruna, Spain; [Lesende-Rodriguez, Ivan; Monserrat, Lorenzo] Hlth Code, Cardiol Dept, La Coruna, Spain; [Odena, Maria A.; de Oliveira, Eliandre] Prote Platform, Barcelona Sci Pk, Barcelona, Spain; [Mateos, Jesus] CSIC, Marine Res Inst, Vigo, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Arufe, MC (corresponding author), Univ A Coruna, Fac Ciencias Salud, Dept Ciencias Biomed Med & Fisioterapia, Grp Terapia Celular & Med Regenerat,INIBIC CHUAC, La Coruna, Spain.	maria.arufe@udc.es	de toro, javier/ABH-4217-2020; Odena Caballol, Maria Antonia/AAZ-4192-2021; arufe gonda, maria/N-3189-2014; de Oliveira, Eliandre/K-5052-2014; Fafian-Labora, Juan/AAB-4877-2019; del Carmen Arufe Gonda, María/L-2942-2019; Odena Caballol, Antonia/K-5235-2014; Mateos, Jesús/N-3610-2014	Odena Caballol, Maria Antonia/0000-0002-4530-7829; arufe gonda, maria/0000-0003-3725-0743; de Oliveira, Eliandre/0000-0003-4771-5719; Fafian-Labora, Juan/0000-0003-1510-8666; del Carmen Arufe Gonda, María/0000-0003-3725-0743; Odena Caballol, Antonia/0000-0002-4530-7829; Mateos, Jesús/0000-0002-1782-6779; de-Toro, Javier/0000-0001-6131-1273; Monserrat, Lorenzo/0000-0001-5776-0623				An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048; Bernadotte A, 2016, AGING-US, V8, P3, DOI 10.18632/aging.100871; Birch-Machin MA, 2016, BRIT J DERMATOL, V175, P26, DOI 10.1111/bjd.14906; BOSS GR, 1984, J BIOL CHEM, V259, P2936; BRADLEY JD, 1994, J RHEUMATOL, V21, P905; BRESSA GM, 1994, ACTA NEUROL SCAND, V89, P7, DOI 10.1111/j.1600-0404.1994.tb05403.x; Buchwalter A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00322-z; CANTONI GL, 1953, J BIOL CHEM, V204, P403; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chan CY, 2015, P NATL ACAD SCI USA, V112, P1368, DOI 10.1073/pnas.1423009112; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Danziger RS, 2008, HEART FAIL REV, V13, P293, DOI 10.1007/s10741-007-9061-y; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fridman A, 2013, BIOCHEM J, V454, P91, DOI 10.1042/BJ20130153; Gordon LB, 2012, P NATL ACAD SCI USA, V109, P16666, DOI 10.1073/pnas.1202529109; Guenantin AC, 2013, SEMIN CELL DEV BIOL; HARMAND MF, 1987, AM J MED, V83, P48, DOI 10.1016/0002-9343(87)90851-5; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Jalili M, 2018, BIOCH BIOPHYS ACTA; Kim HJ, 2007, AM J HUM GENET, V81, P552, DOI 10.1086/519529; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kubben N, 2017, NAT REV MOL CELL BIO, V18, P595, DOI 10.1038/nrm.2017.68; Li W, 2015, CELL MOL BIOL, V61, P91; Lieber CS, 1999, J HEPATOL, V30, P1155, DOI 10.1016/S0168-8278(99)80274-8; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mateos J, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0110-5; Mittal R, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/127013; Osorio FG, 2010, AGING CELL, V9, P947, DOI 10.1111/j.1474-9726.2010.00621.x; Pedley AM, 2017, TRENDS BIOCHEM SCI, V42, P141, DOI 10.1016/j.tibs.2016.09.009; Peinado JR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008094; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Reddy S, 2012, EXP CELL RES, V318, P1, DOI 10.1016/j.yexcr.2011.08.009; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Vidak S, 2016, HISTOCHEM CELL BIOL, V145, P401, DOI 10.1007/s00418-016-1411-1; Viteri G, 2010, MECH AGEING DEV, V131, P2, DOI 10.1016/j.mad.2009.11.006; Wong AHM, 2012, J BIOL CHEM, V287, P36804, DOI 10.1074/jbc.M112.398842; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760	40	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205878	10.1371/journal.pone.0205878	http://dx.doi.org/10.1371/journal.pone.0205878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379953	Green Submitted, Green Published, gold			2022-12-26	WOS:000448823700076
J	Ferezin, E; da Silva, RP; dos Santos, AF; Zerbato, C				Ferezin, Evaldo; da Silva, Rouverson Pereira; dos Santos, Adao Felipe; Zerbato, Cristiano			Development of an electrohydraulic drive system for the vibrating conveyor belt of the peanut digger-inverter	PLOS ONE			English	Article							AGRICULTURAL TRACTOR; GEAR SELECTION; TRANSMISSION; TILLAGE	Hydraulic systems are equipment widely used in stationary industrial equipment and in moving agricultural equipment and construction machines. Currently, the rotation of the vibrating conveyor belt of the peanut digger-inverter is triggered by the tractor power take-off. Considering that for the equipment to operate at its optimal, the tractor engine needs to work at low rotation, responsible for the rotation of the power take-off, this work aimed at developing an electro-hydraulic system able to transmit varying work rotations to the vibrating conveyor belt of the digger-inverter, regardless the rotation of the power take-off and the speed used in the tractor. The electro-hydraulic system uses the oil of the auxiliary hydraulic system (remote control) and electric power of the tractor battery. The rotation of the hydraulic motor that drives the vibrating conveyor axis is controlled by a proportional flow control valve while the direction of rotation is determined by an electro-hydraulic directional valve, controlled by a Vcontrol Personal Device Assistant controller installed in the tractor cab. The electrohydraulic system developed can be used to control the rotation of the vibrating conveyor belt of the peanut digger-inverter since it meets the torque and power requirements necessary to move the vibrating conveyor belt, with the respective rotation control.	[Ferezin, Evaldo] Fac Technol Sertaozinho FATEC, Sertaozinho, SP, Brazil; [da Silva, Rouverson Pereira; dos Santos, Adao Felipe; Zerbato, Cristiano] Sao Paulo State Univ, Lab Agr Machinery & Mechanizat, Dept Agr Engn, Jaboticabal, SP, Brazil	Universidade Estadual Paulista	Ferezin, E (corresponding author), Fac Technol Sertaozinho FATEC, Sertaozinho, SP, Brazil.	evaldoferezin@gmail.com	dos Santos, Adão Felipe/P-7312-2019; Zerbato, Cristiano/AAG-9129-2019; da Silva, Rouverson Pereira/ABG-7394-2021	dos Santos, Adão Felipe/0000-0003-3405-5360; da Silva, Rouverson Pereira/0000-0001-8852-2548				BRASIL. Ministerio da Agricultura Pecuaria e Abastecimento, 2009, REGR AN SEM MIN AGR; Colvin BC, 2018, J CROP IMPROV, V32, P287, DOI 10.1080/15427528.2017.1422073; Embrapa - Empresa Brasileira de Pesquisa Agropecuaria, 2013, SIST BRAS CLASS SOL; Felicio L.C., 2010, MODELAGEM DINAMICA S; Fiorese DA, 2015, REV BRAS ENG AGR AMB, V19, P903, DOI 10.1590/1807-1929/agriambi.v19n9p903-909; Frantz UG, 2014, CIENC RURAL, V44, P1219, DOI 10.1590/0103-8478cr20130175; Free D. H, 2014, TESTING IMPACT PLATE; Garcia A. P, 2013, C BRAS ENG AGR 2013, V42; INCE A, 2003, INT C CROP HARV PROC, P1103; Kichler CM, 2011, SOIL TILL RES, V113, P105, DOI 10.1016/j.still.2011.03.002; Kim DC, 2001, T ASAE, V44, P751; KIM YJ, 2011, J BIOSYST ENG, V36, P79; Kim YJ, 2013, SOIL TILL RES, V134, P90, DOI 10.1016/j.still.2013.07.013; Medeiros R S, 2010, RES C IN CIENT UN MA, P1039; MONTANHA G. K., 2011, ENERGIA AGR, V26, P39; Nahmgung M.J., 2001, THESIS; Ormond ATS, 2018, ENG AGR-JABOTICABAL, V38, P251, DOI [10.1590/1809-4430-Eng.Agric.v38n2p251-259/2018, 10.1590/1809-4430-eng.agric.v38n2p251-259/2018]; Ribas RL, 2010, CIENC RURAL, V40, P2206, DOI 10.1590/S0103-84782010005000162; Santos A. F., 2016, African Journal of Agricultural Research, V11, P4894; Silva R. P, 2008, RELATORIO PESQUISA; Silva RF, 2010, THESIS; SOUZA L. H., 2015, ENGENHARIA AGR, V23, P65; Spagnolo RT, 2012, ENG AGR-JABOTICABAL, V32, P131, DOI 10.1590/S0100-69162012000100014; VALE W.G, 2011, GLOBAL SCI TECHNOLOG, V4, P68; Veit AA, 2016, TECNO LOGICA, V20, P55, DOI [10.17058/TECNOLOGY.V2011.6472, DOI 10.17058/TECNOLOGY.V2011.6472]; Warner A. C., 2014, VARIABLE DEPTH PEA 1, P1; WILLIAMS E J, 1981, Peanut Science, V8, P134, DOI 10.3146/i0095-3679-8-2-15; Zerbato C, 2017, ENG AGR-JABOTICABAL, V37, P315, DOI [10.1590/1809-4430-eng.agric.v37n2p315-322/2017, 10.1590/1809-4430-Eng.Agric.v37n2p315-322/2017]	28	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2018	13	10							e0203300	10.1371/journal.pone.0203300	http://dx.doi.org/10.1371/journal.pone.0203300			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7AD	30376566	Green Published, gold, Green Submitted			2022-12-26	WOS:000448752400002
J	Vignero, J; Marshall, NW; Vande Velde, G; Bliznakova, K; Bosmans, H				Vignero, Janne; Marshall, Nicholas W.; Vande Velde, Greetje; Bliznakova, Kristina; Bosmans, Hilde			Translation from murine to human lung imaging using x-ray dark field radiography: A simulation study	PLOS ONE			English	Article							VISIBILITY-CONTRAST; DIAGNOSIS; ORIGIN	Recent studies on murine models have demonstrated the potential of dark field (DF) x-ray imaging for lung diseases. The alveolar microstructure causes small angle scattering, which is visualised in DF images. Whether DF imaging works for human lungs is not a priori guaranteed as human alveoli are larger and system settings for murine imaging will probably have to be adapted. This work examines the potential of translating DF imaging to human lungs. The DF contrast due to murine and human lung models was studied using numerical wave propagation simulations, where the lungs were modelled as a volume filled with spheres. Three sphere diameters were used: 39, 60 and 80 mu m for the murine model and 200, 300 and 400 mu m spheres for the human model. System settings applied for murine lung response modelling were taken from a prototype grating interferometry scanner used in murine lung experiments. The settings simulated for human lung imaging simulations combine the requirements for grating interferometry and conventional chest RX in terms of x-ray energy and pixel size. The DF signal in the simulated murine model was consistent with results from experimental DF data. The simulated linear diffusion coefficient for medium alveoli diameters was found to be (1.31 +/- 0.01).10(-11) mm(-1), 120 times larger than those of human lung tissue ((1.09 +/- 0.01).10(-13) mm(-1)). However, as the human thorax is typically a factor 15 times larger than that of murine animals, the overall DF effect in human lungs remains substantial. At the largest lung thickness and for the DF setup simulated, human lungs have an estimated DF response of around 0.31 and murine lungs of 0.23. Dark field imaging can therefore be considered a promising modality for use in human lung imaging.	[Vignero, Janne; Marshall, Nicholas W.; Bosmans, Hilde] Katholieke Univ Leuven, Dept Imaging & Pathol, Leuven, Belgium; [Marshall, Nicholas W.; Vande Velde, Greetje; Bosmans, Hilde] UZ Leuven, Dept Radiol, Leuven, Belgium; [Bliznakova, Kristina] Tech Univ Varna, Lab Comp Simulat Med, Varna, Bulgaria	KU Leuven; KU Leuven; University Hospital Leuven; Technical University Varna	Vignero, J (corresponding author), Katholieke Univ Leuven, Dept Imaging & Pathol, Leuven, Belgium.	janne.vignero@kuleuven.be	Bliznakova, Kristina/C-9684-2013; Bliznakova, Kristina/AAM-8790-2021; Vande Velde, Greetje/O-9161-2016	Bliznakova, Kristina/0000-0002-3630-5936; MARSHALL, Nicholas/0000-0001-5549-5133; Vande Velde, Greetje/0000-0002-5633-3993; Bosmans, Hilde/0000-0002-9694-510X	MaXIMA project: Three dimensional breast cancer models for x-ray imaging research; European Union's Horizon 2020 research and innovation programme [692097]; KULeuven IF [STG/15/024]	MaXIMA project: Three dimensional breast cancer models for x-ray imaging research; European Union's Horizon 2020 research and innovation programme; KULeuven IF	This work has been supported by the MaXIMA project: Three dimensional breast cancer models for x-ray imaging research. This project, lead by K. Bliznakova, has received funding from the European Union's Horizon 2020 research and innovation programme (https://ec.europa.eu/programmes/horizon2020) under grant agreement No 692097. The study was also funded by KULeuven IF (Grant STG/15/024 awarded to GVV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M, 2005, NUCL INSTRUM METH A, V548, P1, DOI 10.1016/j.nima.2005.03.059; Balashazy I, 2008, INHAL TOXICOL, V20, P611, DOI [10.1080/08958370801915291, 10.1080/08958370801915291 ]; Bartl P, 2009, IEEE NUCL SCI CONF R, P3577, DOI 10.1109/NSSMIC.2009.5401821; Bech M, 2010, PHYS MED BIOL, V55, P5529, DOI 10.1088/0031-9155/55/18/017; Bevins N, 2013, PROC SPIE, V8668, DOI 10.1117/12.2007035; Endrizzi M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4861855; Feher J, 2012, ACAD PR SER BIOM ENG, P1; Fox J, 2007, MOUSE BIOMEDICAL RES, DOI DOI 10.1016/B978-012369454-6/50094-7; FUJITA H, 1992, IEEE T MED IMAGING, V11, P34, DOI 10.1109/42.126908; Goodman Joseph W, 1996, INTRO FOURIER OPTICS, V8; Gromann LB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05101-w; Hellbach K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20985-y; Hellbach K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20193-8; Hellbach K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00475-3; Hellbach K, 2016, INVEST RADIOL, V51, P597, DOI 10.1097/RLI.0000000000000285; Hellbach K, 2015, INVEST RADIOL, V50, P430, DOI 10.1097/RLI.0000000000000147; HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013; Horn F, 2017, PHYS MED BIOL, V62, P6729, DOI 10.1088/1361-6560/aa7721; HUBBELL JH, 1982, INT J APPL RADIAT IS, V33, P1269, DOI 10.1016/0020-708X(82)90248-4; JAEGER HM, 1992, SCIENCE, V255, P1523, DOI 10.1126/science.255.5051.1523; Koenig T, 2016, PHYS MED BIOL, V61, P3427, DOI 10.1088/0031-9155/61/9/3427; Lin H-H, 2015, INT J COMPUT ASSIST, V10, P1; Lynch SK, 2011, APPL OPTICS, V50, P4310, DOI 10.1364/AO.50.004310; Malecki A, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/48001; Marshall NW, 2011, PHYS MED BIOL, V56, P4201, DOI 10.1088/0031-9155/56/14/002; Meinel FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059526; Perez SR, 2018, J MED IMAGING, V5, DOI 10.1117/1.JMI.5.1.013504; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Rigon L, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2713147; Samei E, 1998, MED PHYS, V25, P102, DOI 10.1118/1.598165; Saunders RS, 2003, MED PHYS, V30, P3006, DOI 10.1118/1.1621870; Scherer K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00489-x; Schleede S, 2012, P NATL ACAD SCI USA, V109, P17880, DOI 10.1073/pnas.1206684109; SELTZER SM, 1993, RADIAT RES, V136, P147, DOI 10.2307/3578607; Strand P., 2009, Annals of the ICRP, V39, P9; Strobl M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07243; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Wolf J, 2014, P SPIE MED IMAGING, V9033, P1; Yaroshenko A, 2014, CURR RADIOL REP, V2, P57, DOI [10.1007/s40134-014-0057-9, DOI 10.1007/s40134-014-0057-9]; Yaroshenko A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24269; Yaroshenko A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17492; Yaroshenko A, 2013, RADIOLOGY, V269, P426, DOI 10.1148/radiol.13122413; Yashiro W, 2010, OPT EXPRESS, V18, P16890, DOI 10.1364/OE.18.016890; Yashiro W, 2015, OPT EXPRESS, V23, P23462, DOI 10.1364/OE.23.023462	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206302	10.1371/journal.pone.0206302	http://dx.doi.org/10.1371/journal.pone.0206302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372458	Green Published, Green Submitted, gold			2022-12-26	WOS:000448641200030
J	Wallace, C; Zetterberg, H; Blennow, K; van Donkelaar, P				Wallace, Colin; Zetterberg, Henrik; Blennow, Kaj; van Donkelaar, Paul			No change in plasma tau and serum neurofilament light concentrations in adolescent athletes following sport-related concussion	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; STANDARDIZED ASSESSMENT; EPIDEMIOLOGY; PROTEIN; BIOMARKERS; DISEASE; PLAYERS; CHAIN; RATES	Sport-related concussion (SRC), a mild form of traumatic brain injury (TBI), is a common injury in contact sports. Health care professionals rely on subjective criteria (e.g., symptoms), as there is no objective marker for identification of athletes with SRC. Blood-based biomarkers have shown promise as diagnostic and prognostic tools following TBI and SRC. In the present study, we examined plasma tau and serum NF-L, two biomarkers for neuronal/axonal injury, concentrations at preseason and following SRC in contact sport athletes (n = 11) using ultrasensitive single molecule array (Simoa) assays. Preseason baseline samples were collected, and post-concussion samples were obtained at 6- and 14-days following injury. We found no difference between baseline, 6-day and 14-day post-concussion concentrations of tau (p = 0.14) or NF-L (p = 0.53). Further, no difference was found between preseason baseline and all post-SRC samples for tau (p = 0.22) or NF-L (p = 0.98). The total number of symptoms reported on the Standardized Assessment of Concussion-3(rd) Edition (SCAT3) and associated symptom severity scores increased from preseason to 6-days post-SRC but returned to baseline values at 14-days (p = 0.02 and p = 0.003, respectively). These results suggest that the severity of neuronal injury in this cohort of contact sport athletes with clinical uncomplicated SRC was too low to be detected by tau and NF-L measurements in blood samples obtained at 6- and 14-days post-injury.	[Wallace, Colin; van Donkelaar, Paul] Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Wallace, Colin] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Psychiat & Neurochem,Inst Neurosci & Physio, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Zetterberg, Henrik] UK Dementia Res Inst UCL, London, England	University of British Columbia; University of British Columbia; Sahlgrenska University Hospital; Sahlgrenska University Hospital; University of Gothenburg; University of London; University College London; University of London; University College London	Wallace, C (corresponding author), Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC, Canada.; Wallace, C (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.	colin.wallace@alumni.ubc.ca		Wallace, Colin/0000-0002-3720-6526	Canadian Institutes for Health Research (CIHR) [183304]; Canada Foundation for Innovation (CFI); Mitacs Canada [H14-02996]; Mitacs Accelerate Program	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Mitacs Canada; Mitacs Accelerate Program	The authors would also like to thank the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Torsten Soderberg Foundation, and Swedish State Support for Clinical Research (ALFGBG). This research was funded by grants to PvD from the Canadian Institutes for Health Research (CIHR) (funding number 183304), Canada Foundation for Innovation (CFI), and Mitacs Canada (funding number H14-02996). CW was supported by the Mitacs Accelerate Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Junn C, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0519-7; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mannix R, 2014, J NEUROTRAUM, V31, P1072, DOI 10.1089/neu.2013.3265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Vila-Ortiz GJ, 2001, CELL MOL NEUROBIOL, V21, P535, DOI 10.1023/A:1013823524302; Wilmoth K., 2017, ANN SPORTS MED RES, V4, P1115; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	40	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206466	10.1371/journal.pone.0206466	http://dx.doi.org/10.1371/journal.pone.0206466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372457	gold, Green Submitted, Green Published			2022-12-26	WOS:000448641200040
J	Bertoglio, D; Verhaeghe, J; Koster, L; Thomae, D; Van der Linden, A; Stroobants, S; Wityak, J; Dominguez, C; Mrzljak, L; Staelens, S				Bertoglio, Daniele; Verhaeghe, Jeroen; Koster, Lauren; Thomae, David; Van der Linden, Annemie; Stroobants, Sigrid; Wityak, John; Dominguez, Celia; Mrzljak, Ladislav; Staelens, Steven			MR-based spatial normalization improves [F-18]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington's disease	PLOS ONE			English	Article							PHOSPHODIESTERASE 10A; IN-VIVO; PDE10A; TRANSCRIPTION; STRIATUM; RECEPTOR; TRACER; MICE	The positron emission tomography (PET) tracer [F-18]MNI-659, selective for phosphodiesterase 10A (PDE10A), is a promising tool to assess an early biomarker for Huntington's disease (HD). In this study we investigated [F-18]MNI-659 uptake in the Q175 mouse model of HD. Given the focal striatal distribution of PDE10A as well as the striatal atrophy occurring in HD, the spatial normalization approach applied during the processing could sensibly affect the accuracy of the regional quantification. We compared the use of a magnetic resonance images (MRI) template based on individual MRI over a PET and CT templates for regional quantification and spatial normalization of [F-18]MNI-659 PET images. We performed [F-18] MNI-659 PET imaging in six months old heterozygous (HET) Q175 mice and wild-type (WT) littermates, followed by X-ray computed tomography (CT) scan. In the same week, individual T-2-weighted MRI were acquired. Spatial normalization and regional quantification of the PET/CT images was performed on MRI, [F-18]MNI-659 PET, or CT template and compared to binding potential (BP ND ) using volumes manually delineated on the individual MR images. Striatal volume was significantly reduced in HET mice (-7.7%, p<0.0001) compared to WT littermates. [F-18]MNI-659 BP ND in striatum of HET animals was significantly reduced (p<0.0001) when compared to WT littermates using all three templates. However, BP ND values were significantly higher for HET mice using the PET template compared to the MRI and CT ones (p<0.0001), with an overestimation at lower activities. On the other hand, the CT template spatial normalization introduced larger variability reducing the effect size. The PET and CT template-based approaches resulted in a lower accuracy in BP ND quantification with consequent decrease in the detectability of disease effect. This study demonstrates that for [F-18]MNI-659 brain PET imaging in mice the use of an MRI-based spatial normalization is recommended to achieve accurate quantification and fully exploit the detectability of disease effect.	[Bertoglio, Daniele; Verhaeghe, Jeroen; Koster, Lauren; Thomae, David; Stroobants, Sigrid; Staelens, Steven] Univ Antwerp, MICA, Antwerp, Belgium; [Thomae, David; Stroobants, Sigrid] Antwerp Univ Hosp, Dept Nucl Med, Edegem, Belgium; [Van der Linden, Annemie] Univ Antwerp, Bioimaging Lab, Antwerp, Belgium; [Wityak, John; Dominguez, Celia; Mrzljak, Ladislav] CHDI Fdn, Princeton, NJ USA	University of Antwerp; University of Antwerp; University of Antwerp	Staelens, S (corresponding author), Univ Antwerp, MICA, Antwerp, Belgium.	steven.staelens@uantwerpen.be	Bertoglio, Daniele/O-8711-2015; Staelens, Steven/D-8385-2017; Verhaeghe, Jeroen/I-1539-2016; Bertoglio, Daniele/AAG-3891-2019	Bertoglio, Daniele/0000-0003-4205-5432; Staelens, Steven/0000-0003-3376-0519; Verhaeghe, Jeroen/0000-0002-4493-1902; Bertoglio, Daniele/0000-0003-4205-5432; Stroobants, Sigrid/0000-0002-6450-9944; Kosten, Lauren/0000-0001-8368-9904	CHDI Foundation, Inc; Research Foundation Flanders (FWO) [11W2516N/11W2518N]	CHDI Foundation, Inc; Research Foundation Flanders (FWO)(FWO)	This work was funded by CHDI Foundation, Inc, a nonprofit biomedical research organization exclusively dedicated to developing therapeutics that will substantially improve the lives of HD-affected individuals. The funder had the following involvement with the study: study design and interpretation of the results. D. Bertoglio has a Ph.D. fellowship from the Research Foundation Flanders (FWO, 11W2516N/11W2518N).	Ahmad R, 2014, NEUROLOGY, V82, P279, DOI 10.1212/WNL.0000000000000037; Barbeau A, 1975, Can J Neurol Sci, V2, P81; Barret O, 2014, J NUCL MED, V55, P1297, DOI 10.2967/jnumed.113.122895; Beaumont V, 2016, NEURON, V92, P1220, DOI 10.1016/j.neuron.2016.10.064; BRANDT J, 1986, TRENDS NEUROSCI, V9, P118, DOI 10.1016/0166-2236(86)90039-1; Casteels C, 2006, J NUCL MED, V47, P1858; Casteels C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065286; Celen S, 2013, NEUROIMAGE, V82, P13, DOI 10.1016/j.neuroimage.2013.04.123; Desplats PA, 2006, J NEUROCHEM, V96, P743, DOI 10.1111/j.1471-4159.2005.03588.x; Giampa C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013417; Giralt A, 2013, HIPPOCAMPUS, V23, P684, DOI 10.1002/hipo.22128; Haggkvist J, 2017, J NUCL MED, V58, P617, DOI 10.2967/jnumed.116.180497; Hebb ALO, 2004, NEUROSCIENCE, V123, P967, DOI 10.1016/j.neuroscience.2003.11.009; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hu H, 2004, EUR J NEUROSCI, V20, P3351, DOI 10.1111/j.1460-9568.2004.03796.x; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Kim J. S., 2015, ADV MATER SCI ENG, V2015, P7; Labbadia J, 2013, TRENDS BIOCHEM SCI, V38, P378, DOI 10.1016/j.tibs.2013.05.003; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lerner RP, 2012, BRAIN RES BULL, V87, P571, DOI 10.1016/j.brainresbull.2012.01.012; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Ooms M, 2014, NEUROBIOL AGING, V35, P2858, DOI 10.1016/j.neurobiolaging.2014.06.010; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Rorden C, 2012, NEUROIMAGE, V61, P957, DOI 10.1016/j.neuroimage.2012.03.020; Russell DS, 2016, NEUROLOGY, V86, P748, DOI 10.1212/WNL.0000000000002391; Russell DS, 2014, JAMA NEUROL, V71, P1520, DOI 10.1001/jamaneurol.2014.1954; Sugars KL, 2004, J BIOL CHEM, V279, P4988, DOI 10.1074/jbc.M310226200; Vallez Garcia D, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0122363, 10.1371/journal.pone.0143900]; Verhaeghe J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00516; Verhaeghe J, 2015, MOL IMAGING, V14, DOI 10.2310/7290.2014.00037; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003	33	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206613	10.1371/journal.pone.0206613	http://dx.doi.org/10.1371/journal.pone.0206613			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365550	Green Published, gold, Green Submitted			2022-12-26	WOS:000448448700064
J	Xu, DL; Chen, HB; Aci, M; Pan, YC; Shangguan, Y; Ma, J; Li, L; Qian, G; Wang, QX				Xu, Delin; Chen, Hongbo; Aci, Murat; Pan, Yinchi; Shangguan, Yanni; Ma, Jie; Li, Lin; Qian, Gang; Wang, Qianxing			De Novo assembly, characterization and development of EST-SSRs from Bletilla striata transcriptomes profiled throughout the whole growing period	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; ROOT TRANSCRIPTOME; MICROSATELLITES; REPEATS; GENOMES	Bletilla striata is an endangered orchid that has been used for millennia as a medicinal herb, in cosmetics and as a horticultural plant. To construct the first nucleotide database for this species and to develop abundant EST-SSR markers for facilitating further studies, various tissues and organs of plants in the main developmental stages were harvested for mRNA isolation and subsequent RNA sequencing. A total of 106,054,784 clean reads were generated by using Illumina paired-end sequencing technology. The reads were assembled into 127,261 unigenes by the Trinity package; the unigenes had an average length of 612 bp and an N50 of 957 bp. Of these unigenes, 67,494 (51.86%) were annotated in a series of databases. Of these annotated unigenes, 41,818 and 24,615 were assigned to gene ontology categories and clusters of orthologous groups, respectively. Additionally, 20,764 (15.96%) unigenes were mapped onto 275 pathways using the KEGG database. In addition, 25,935 high-quality EST-SSR primer pairs were developed from the 15,433 unigenes by MISA mining. To validate the accuracy of the newly designed markers, 87 of 100 randomly selected primers were effectively amplified; 63 of those yielded PCR products of the expected size, and 25 yielded products with significant amounts of polymorphism among the 4 landraces. Furthermore, the transferability test of the 25 polymorphic markers was performed in 6 individuals of two closely related genus Phalaenopsis and dendrobium. Which results showed a total of 5 markers can successfully amplified among these populations. This research provides a comprehensive nucleotide database and lays a solid foundation for functional gene mining and genomic research in B. striata. The developed EST-SSR primers could facilitate phylogenetic studies and breeding.	[Xu, Delin; Chen, Hongbo; Pan, Yinchi; Shangguan, Yanni; Ma, Jie; Li, Lin; Qian, Gang; Wang, Qianxing] Zunyi Med Univ, Dept Med Cell Biol, Zunyi, Guizhou, Peoples R China; [Xu, Delin; Aci, Murat] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Xu, Delin; Aci, Murat] Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX USA	Zunyi Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Li, L; Qian, G (corresponding author), Zunyi Med Univ, Dept Med Cell Biol, Zunyi, Guizhou, Peoples R China.	lilin@zmc.edu.cn; pengjiaqiong@163.com	Li, Lin/GQI-2563-2022	Aci, Murat/0000-0001-6767-5094; lin, li/0000-0003-2916-9224; HongBo, Chen/0000-0003-1764-4462	National Natural Science Foundation of China [31560079, 31560102]; Chinese Scholarship Council [201408525081]; Scientific Project of Guizhou Province [QKH-ZY[2013]3002, QKH-LH[2014]7549]; Talents Promotion Project of Zunyi Medical University; 15851 Talent Project of Zunyi City [201424]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Scholarship Council(China Scholarship Council); Scientific Project of Guizhou Province; Talents Promotion Project of Zunyi Medical University; 15851 Talent Project of Zunyi City	The authors acknowledge the financial support of the National Natural Science Foundation of China (31560079, 31560102), the Chinese Scholarship Council (201408525081), the Scientific Project of Guizhou Province (QKH-ZY[2013]3002, QKH-LH[2014]7549), the Talents Promotion Project of Zunyi Medical University, and the 15851 Talent Project of Zunyi City (201424). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chen CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187738; Chen HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131939; Chen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131503; Chen LY, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0379-1; Di Lena P, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0777-8; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo JJ, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1488-z; Guo YQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1517-1; Hao DC, 2012, SCI CHINA LIFE SCI, V55, P452, DOI 10.1007/s11427-012-4319-6; He XR, 2017, J ETHNOPHARMACOL, V195, P20, DOI 10.1016/j.jep.2016.11.026; Hu XG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148985; Jiang FS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058004, 10.1371/journal.pone.0076025, 10.1371/journal.pone.0062946]; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Kim JE, 2014, MOL CELLS, V37, P36, DOI 10.14348/molcells.2014.2241; Kotwal S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150273; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; Li DM, 2015, GENET MOL RES, V14, P6189, DOI 10.4238/2015.June.9.5; Liu CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179219; Mohanty JN, 2017, GENE, V626, P395, DOI 10.1016/j.gene.2017.05.058; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Ren J, 2017, APPL PLANT SCI, V5, DOI 10.3732/apps.1600157; Sen S, 2018, MOL BIOL REP, V45, P453, DOI 10.1007/s11033-018-4181-0; Shi J, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1076-5; Sun AJ, 2016, BIOORG MED CHEM LETT, V26, P2375, DOI 10.1016/j.bmcl.2016.01.076; Thumilan BM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162909; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wiebrecht A, 2013, DTSCH Z AKUPUNKT, V56, P56; Wu MingKai, 2013, African Journal of Biotechnology, V12, P6691; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Yoichi W, 2017, PLANT SPEC BIOL, V32, P455, DOI 10.1111/1442-1984.12155; Zhang C, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/5820405; Zhang YS, 2015, CONSERV GENET RESOUR, V7, P483, DOI 10.1007/s12686-014-0401-7	35	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0205954	10.1371/journal.pone.0205954	http://dx.doi.org/10.1371/journal.pone.0205954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365506	Green Published, gold, Green Submitted			2022-12-26	WOS:000448448700018
J	Azimipour, M; Zawadzki, RJ; Gorczynska, I; Migacz, J; Werner, JS; Jonnal, RS				Azimipour, Mehdi; Zawadzki, Robert J.; Gorczynska, Iwona; Migacz, Justin; Werner, John S.; Jonnal, Ravi S.			Intraframe motion correction for raster-scanned adaptive optics images using strip- based cross-correlation lag biases	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY; HIGH-RESOLUTION; HIGH-SPEED; EYE-MOVEMENTS; OUTER RETINA; PHOTORECEPTORS; DISRUPTION; BANDS; LAYER	In retinal raster imaging modalities, fixational eye movements manifest as image warp, where the relative positions of the beam and retina change during the acquisition of single frames. To remove warp artifacts, strip-based registration methods-in which fast-axis strips from target images are registered to a reference frame-have been applied in adaptive optics (AO) scanning light ophthalmoscopy (SLO) and optical coherence tomography (OCT). This approach has enabled object tracking and frame averaging, and methods have been described to automatically select reference frames with minimal motion. However, inconspicuous motion artifacts may persist in reference frames and propagate themselves throughout the processes of registration, tracking, and averaging. Here we test a previously proposed method for removing movement artifacts in reference frames, using biases in stripwise cross-correlation statistics. We applied the method to synthetic retinal images with simulated eye motion artifacts as well as real AO-SLO images of the cone mosaic and volumetric AO-OCT images, both affected by eye motion. In the case of synthetic images, the method was validated by direct comparison with motion-free versions of the images. In the case of real AO images, performance was validated by comparing the correlation of uncorrected images with that of corrected images, by quantifying the effect of motion artifacts on the image power spectra, and by qualitative examination of AO-OCT B-scans and en face projections. In all cases, the proposed method reduced motion artifacts and produced more faithful images of the retina.	[Azimipour, Mehdi; Zawadzki, Robert J.; Migacz, Justin; Werner, John S.; Jonnal, Ravi S.] UC Davis Eye Ctr, Dept Ophthalmol & Vis Sci, Vis Sci & Adv Retinal Imaging Lab VSRI, Sacramento, CA 95817 USA; [Gorczynska, Iwona] Nicolaus Copernicus Univ, Dept Phys Astron & Informat, Torun, Poland	Nicolaus Copernicus University	Jonnal, RS (corresponding author), UC Davis Eye Ctr, Dept Ophthalmol & Vis Sci, Vis Sci & Adv Retinal Imaging Lab VSRI, Sacramento, CA 95817 USA.	rsjonnal@ucdavis.edu	Gorczynska, Iwona M./P-9367-2015; Zawadzki, Robert J./S-3236-2019	Gorczynska, Iwona M./0000-0002-6120-8791; Zawadzki, Robert J./0000-0002-9574-156X	National Eye Institute [R01-EY-024239, K99-EY-026068, EY-012576, R01-EY026556, T32-EY012567]; NATIONAL EYE INSTITUTE [R01EY024239, R00EY026068, R01EY026556] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was funded by the National Eye Institute (R01-EY-024239, JSW), (K99-EY-026068, RSJ), (EY-012576, JSW), (R01-EY026556, RJZ), and (T32-EY012567, RJZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfeld P., 1984, Computer-Aided Geometric Design, V1, P169, DOI 10.1016/0167-8396(84)90029-3; Bedggood P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174617; Boretsky A, 2012, LASER SURG MED, V44, P603, DOI 10.1002/lsm.22070; Burns SA, 2014, BIOMED OPT EXPRESS, V5, P961, DOI 10.1364/BOE.5.000961; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; Carroll J, 2010, VISION RES, V50, P1989, DOI 10.1016/j.visres.2010.07.009; Cherici C, 2012, J VISION, V12, DOI 10.1167/12.6.31; Chiu SJ, 2010, OPT EXPRESS, V18, P19413, DOI 10.1364/OE.18.019413; Chui TYP, 2008, INVEST OPHTH VIS SCI, V49, P4679, DOI 10.1167/iovs.08-2135; Chui TYP, 2008, J OPT SOC AM A, V25, P3021, DOI 10.1364/JOSAA.25.003021; Cooper RF, 2013, OPHTHAL PHYSL OPT, V33, P540, DOI 10.1111/opo.12070; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dubra A, 2011, BIOMED OPT EXPRESS, V2, P1864, DOI 10.1364/BOE.2.001864; Dubra A, 2010, LECT NOTES COMPUT SC, V6204, P60, DOI 10.1007/978-3-642-14366-3_6; Engbert R, 2011, P NATL ACAD SCI USA, V108, pE765, DOI 10.1073/pnas.1102730108; Gorczynska I, 2017, PROC SPIE, V10045, DOI 10.1117/12.2251704; Heisler M, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.3.036007; Hillmann D, 2016, P NATL ACAD SCI USA, V113, P13138, DOI 10.1073/pnas.1606428113; Jonnal RS, 2007, OPT EXPRESS, V15, P16141, DOI 10.1364/OE.15.016141; Jonnal RS, 2017, INVEST OPHTH VIS SCI, V58, P4559, DOI 10.1167/iovs.16-21138; Jonnal RS, 2014, INVEST OPHTH VIS SCI, V55, P7904, DOI 10.1167/iovs.14-14907; Jonnal RS, 2012, BIOMED OPT EXPRESS, V3, P104, DOI 10.1364/BOE.3.000104; Jonnal RS, 2010, OPT EXPRESS, V18, P5257, DOI 10.1364/OE.18.005257; Kocaoglu OP, 2016, BIOMED OPT EXPRESS, V7, P4554, DOI 10.1364/BOE.7.004554; Kocaoglu OP, 2014, BIOMED OPT EXPRESS, V5, P4186, DOI 10.1364/BOE.5.004186; Li KY, 2007, J OPT SOC AM A, V24, P1358, DOI 10.1364/JOSAA.24.001358; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Liu Z., 2017, P NATL ACAD SCI USA; Liu ZL, 2016, INVEST OPHTH VIS SCI, V57, pOCT533, DOI 10.1167/iovs.16-19106; Lu CD, 2017, INVEST OPHTH VIS SCI, V58, P4632, DOI 10.1167/iovs.17-22171; Lujan BJ, 2015, RETINA-J RET VIT DIS, V35, P1511, DOI 10.1097/IAE.0000000000000527; Lujan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1486, DOI 10.1167/iovs.10-5946; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Morgan JIW, 2009, INVEST OPHTH VIS SCI, V50, P1350, DOI 10.1167/iovs.08-2618; Pallikaris A, 2003, INVEST OPHTH VIS SCI, V44, P4580, DOI 10.1167/iovs.03-0094; Ratnam K, 2017, J VISION, V17, DOI 10.1167/17.1.30; Rha J, 2006, OPT EXPRESS, V14, P4552, DOI 10.1364/OE.14.004552; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Roorda A, 1999, NATURE, V15, P16; Rossi EA, 2017, P NATL ACAD SCI USA; Salmon AE, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.2.9; Scoles D, 2014, INVEST OPHTH VIS SCI, V55, P4244, DOI 10.1167/iovs.14-14542; Scoles D, 2013, BIOMED OPT EXPRESS, V4, P1710, DOI 10.1364/BOE.4.001710; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P1571, DOI 10.1167/iovs.07-0838; Stevenson S, 2006, J VIS, V6, P39, DOI DOI 10.1167/6.13.39; Stevenson SB, 2005, PROC SPIE, V5688, P145, DOI 10.1117/12.591190; Vogel CR, 2006, OPT EXPRESS, V14, P487, DOI 10.1364/OPEX.14.000487; Webb RH, 1996, REP PROG PHYS, V59, P427, DOI 10.1088/0034-4885/59/3/003; Xue B, 2007, J OPT SOC AM A, V24, P1364, DOI 10.1364/JOSAA.24.001364; YELLOTT JI, 1982, VISION RES, V22, P1205, DOI 10.1016/0042-6989(82)90086-4; Zang PX, 2016, BIOMED OPT EXPRESS, V7, P2823, DOI 10.1364/BOE.7.002823; Zawadzki RJ, 2005, OPT EXPRESS, V13, P8532, DOI 10.1364/OPEX.13.008532; Zawadzki RJ, 2011, BIOMED OPT EXPRESS, V2, P1674, DOI 10.1364/BOE.2.001674; Zhang PF, 2017, P NATL ACAD SCI USA, V114, pE2937, DOI 10.1073/pnas.1620572114	55	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206052	10.1371/journal.pone.0206052	http://dx.doi.org/10.1371/journal.pone.0206052			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359401	gold, Green Published, Green Submitted			2022-12-26	WOS:000448438400038
J	Bosmans, L; Pozo, MI; Verreth, C; Crauwels, S; Wilberts, L; Sobhy, IS; Wackers, F; Jacquemyn, H; Lievens, B				Bosmans, L.; Pozo, M., I; Verreth, C.; Crauwels, S.; Wilberts, L.; Sobhy, I. S.; Wackers, F.; Jacquemyn, H.; Lievens, B.			Habitat-specific variation in gut microbial communities and pathogen prevalence in bumblebee queens (Bombus terrestris)	PLOS ONE			English	Article							LAND-USE; DIVERSITY; BEE; PATTERNS; IDENTIFICATION; SEQUENCES; SYMBIONT; DECLINES; SERVICES; INSECTS	Gut microbial communities are critical for the health of many insect species. However, little is known about how gut microbial communities respond to anthropogenic changes and how such changes affect host-pathogen interactions. In this study, we used deep sequencing to investigate and compare the composition of gut microbial communities within the midgut and ileum (both bacteria and fungi) in Bombus terrestris queens collected from natural (forest) and urbanized habitats. Additionally, we investigated whether the variation in gut microbial communities under each habitat affected the prevalence of two important bumblebee pathogens that have recently been associated with Bombus declines (Crithidia bombi and Nosema bombi). Microbial community composition differed strongly among habitat types, both for fungi and bacteria. Fungi were almost exclusively associated with bumblebee queens from the forest habitats, and were not commonly detected in bumblebee queens from the urban sites. Further, gut bacterial communities of urban B. terrestris specimens were strongly dominated by bee-specific core bacteria like Snodgrassella (Betaproteobacteria) and Gilliamella (Gammaproteobacteria), whereas specimens from the forest sites contained a huge fraction of environmental bacteria. Pathogen infection was very low in urban populations and infection by Nosema was only observed in specimens collected from forest habitats. No significant relationship was found between pathogen prevalence and microbial gut diversity. However, there was a significant and negative relationship between prevalence of Nosema and relative abundance of the core resident Snodgrassella, supporting its role in pathogen defense. Overall, our results indicate that land-use change may lead to different microbial gut communities in bumblebees, which may have implications for bumblebee health, survival and overall fitness.	[Bosmans, L.; Verreth, C.; Crauwels, S.; Wilberts, L.; Sobhy, I. S.; Lievens, B.] Katholieke Univ Leuven, Dept Microbial & Mol Syst, Lab Proc Microbial Ecol & Bioinspirat Management, Campus De Nayer, St Katelijne Waver, Belgium; [Pozo, M., I; Jacquemyn, H.] Katholieke Univ Leuven, Biol Dept, Plant Conservat & Populat Biol, Heverlee, Belgium; [Sobhy, I. S.] Suez Canal Univ, Fac Agr, Dept Plant Protect, Ismailia, Egypt; [Wackers, F.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Wackers, F.] Biobest Grp, Westerlo, Belgium	KU Leuven; KU Leuven; Egyptian Knowledge Bank (EKB); Suez Canal University; Lancaster University	Lievens, B (corresponding author), Katholieke Univ Leuven, Dept Microbial & Mol Syst, Lab Proc Microbial Ecol & Bioinspirat Management, Campus De Nayer, St Katelijne Waver, Belgium.	bart.lievens@kuleuven.be	Jacquemyn, Hans/AAC-4875-2019; Sobhy, Islam S./R-3575-2019	Jacquemyn, Hans/0000-0001-9600-5794; Sobhy, Islam S./0000-0003-4984-1823; Bosmans, Lien/0000-0002-5119-2669; Pozo, Maria I./0000-0003-1135-1327; Wilberts, Liesbet/0000-0002-5582-8767	KU Leuven [PDM/17/132]; Research Foundation Flanders (FWO) [12A0716N]; Biobest	KU Leuven(KU Leuven); Research Foundation Flanders (FWO)(FWO); Biobest	This study was supported by KU Leuven (Postdoctoral Mandate, grant to L.B. (PDM/17/132)) and the Research Foundation Flanders (FWO) (grant to M.I.P. (12A0716N)). Biobest provided salary support to FW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of FW is articulated in the 'author contributions' section.	Anderson KE, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0489-1; Baer B, 1999, NATURE, V397, P151, DOI 10.1038/16451; Belhadj H., 2012, ADV ENVIRON BIOL, V6, P1415; Billiet A, 2017, APIDOLOGIE, V48, P41, DOI 10.1007/s13592-016-0447-5; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cariveau DP, 2014, ISME J, V8, P2369, DOI 10.1038/ismej.2014.68; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Colla SR, 2006, BIOL CONSERV, V129, P461, DOI 10.1016/j.biocon.2005.11.013; DeFries RS, 2004, FRONT ECOL ENVIRON, V2, P249, DOI 10.1890/1540-9295(2004)002[0249:LCBHNA]2.0.CO;2; Deshpande V, 2016, MYCOLOGIA, V108, P1, DOI 10.3852/14-293; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Edgar RC., 2016, BIORXIV, DOI [10.1101/074161, DOI 10.1101/074161, 10.1101/2020.05.12.088096]; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Evans JD, 2004, J ECON ENTOMOL, V97, P752, DOI 10.1603/0022-0493(2004)097[0752:BPIAIR]2.0.CO;2; GASTON KJ, 1991, CONSERV BIOL, V5, P283, DOI 10.1111/j.1523-1739.1991.tb00140.x; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Graystock P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1371; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Hammer TJ, 2017, P NATL ACAD SCI USA, V114, P9641, DOI 10.1073/pnas.1707186114; Hanning I, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0113-6; Huang WF, 2015, J APICULT RES, V54, P516, DOI 10.1080/00218839.2016.1173352; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koch H, 2012, J ANIM ECOL, V81, P1202, DOI 10.1111/j.1365-2656.2012.02004.x; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kwong WK, 2016, NAT REV MICROBIOL, V14, P374, DOI 10.1038/nrmicro.2016.43; Lebuhn G, 2013, CONSERV BIOL, V27, P113, DOI 10.1111/j.1523-1739.2012.01962.x; Li JL, 2015, CURR BIOL, V25, pR652, DOI 10.1016/j.cub.2015.06.031; Lievens B, 2015, ENVIRON MICROBIOL, V17, P278, DOI 10.1111/1462-2920.12570; Manirajan BA, 2016, ENVIRON MICROBIOL, V18, P5161, DOI 10.1111/1462-2920.13524; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; McFrederick QS, 2017, MICROB ECOL, V73, P188, DOI 10.1007/s00248-016-0838-1; Meeus I, 2018, CURR OPIN INSECT SCI, V26, P136, DOI 10.1016/j.cois.2018.02.007; Meeus I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125152; Meeus I, 2013, APIDOLOGIE, V44, P708, DOI 10.1007/s13592-013-0222-9; Mockler BK, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02335-17; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; MORAN NA, 2012, PLOS ONE, V7; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Nicholson JK, 2012, SCIENCE; Noriega JA, 2018, BASIC APPL ECOL, V26, P8, DOI 10.1016/j.baae.2017.09.006; Palmer-Young EC, 2018, BIORXIV, DOI [10.1101/336347, DOI 10.1101/336347]; Powell E, 2016, MOL ECOL, V25, P4461, DOI 10.1111/mec.13787; Pozo MI, 2014, FUNGAL ECOL, V11, P173, DOI 10.1016/j.funeco.2014.06.007; Pozo MI., 2015, NECTAR PRODUCTION CH, P1; Praet J, 2018, ENVIRON MICROBIOL, V20, P214, DOI 10.1111/1462-2920.13973; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Raymann K, 2018, CURR OPIN INSECT SCI, V26, P97, DOI 10.1016/j.cois.2018.02.012; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Tarpy DR, 2015, APPL ENVIRON MICROB, V81, P3182, DOI 10.1128/AEM.00307-15; Turenne CY, 1999, J CLIN MICROBIOL, V37, P1846, DOI 10.1128/JCM.37.6.1846-1851.1999; Vega Fernando E., 2005, P211; Weisser WW, 2004, ECOL STU AN, V173, P3; Williams I. H., 1994, Agricultural Zoology Reviews, VNo.6, P229; Wintermantel D., 2015, B TERRESTRIS; Yang LH, 2014, CURR OPIN INSECT SCI, V2, P26, DOI 10.1016/j.cois.2014.06.004	61	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0204612	10.1371/journal.pone.0204612	http://dx.doi.org/10.1371/journal.pone.0204612			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359366	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000448438400009
J	Chan, LL; Mak, JW; Ambu, S; Chong, PY				Chan, Li Li; Mak, Joon Wah; Ambu, Stephen; Chong, Pei Yee			Identification and ultrastructural characterization of Acanthamoeba bacterial endocytobionts belonging to the Alphaproteobacteria class	PLOS ONE			English	Article							FREE-LIVING AMEBAS; ENVIRONMENTAL SPECIMENS; ENDOSYMBIONTS; SPP.; AUTOPHAGY; BIOLOGY; PROTEOBACTERIA; RICKETTSIALES; ENCYSTATION; RESISTANCE	The detection and identification of two endocytobiotic bacterial strains, one affiliated to the "Candidatus Caedibacter acanthamoebae"/"Ca. Paracaedimonas acanthamoeba", and another to the endosymbiont of Acanthamoeba UWC8 and "Ca. Jidaibacter acanthamoeba" are described. For endocytobiont screening, we developed a PCR method with a set of broad-range bacterial 16S rRNA primers to substitute the commonly used but technically demanding fluorescent in situ hybridization technique. Our PCR test alone without sequencing failed to discriminate the endocytobiont-containing and endocytobiont-free Acanthamoeba sp. due to the presence of mismatched primers to host mitochondrial DNA. We highlighted the need to perform bacterial primer checking against the Acanthamoeba genome to avoid false positive detection in PCR. Although the genetic aspect of "Ca. Caedibacter acanthamoebae"/"Ca. Paracaedimonas acanthamoeba" and the endosymbiont of Acanthamoeba UWC8/"Ca. Jidaibacter acanthamoeba" are well studied, knowledge pertaining to their morphologies are quite vague. Hence, we used transmission electron microscopy to examine our endocytobionts which are affiliated to previously described intracellular bacteria of Acanthamoeba sp. We used good-quality TEM images for the localization and the fate of the current endocytobionts inside different life stages of the hosts. Furthermore, to the best of our knowledge, our TEM findings are the first to provide morphological evidence for the clearance of defective Acanthamoeba endocytobionts via an autophagic-like process.	[Chan, Li Li; Mak, Joon Wah; Ambu, Stephen] Int Med Univ, Sch Med, Pathol Div, Kuala Lumpur, Malaysia; [Mak, Joon Wah; Ambu, Stephen] Int Med Univ, Sch Postgrad Studies & Res, Kuala Lumpur, Malaysia; [Chong, Pei Yee] Int Med Univ, Sch Med, Med Sci, Kuala Lumpur, Malaysia	International Medical University Malaysia; International Medical University Malaysia; International Medical University Malaysia	Chan, LL (corresponding author), Int Med Univ, Sch Med, Pathol Div, Kuala Lumpur, Malaysia.	lili_chan@imu.edu.my	Mak, Joon Wah/C-9174-2011	Mak, Joon Wah/0000-0002-2538-0797	International Medical University [BMS I01(06)]	International Medical University	The research grant was awarded by the International Medical University under the grant number BMS I01(06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Balczun C, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040065; Barghouthi SA, 2011, INDIAN J MICROBIOL, V51, P430, DOI 10.1007/s12088-011-0122-5; Behera HS, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1729-5; Boyle KB, 2013, CURR OPIN MICROBIOL, V16, P339, DOI 10.1016/j.mib.2013.03.010; Chan LL, 2011, ACTA TROP, V117, P23, DOI 10.1016/j.actatropica.2010.09.004; Colson P, 2013, INTERVIROLOGY, V56, P376, DOI 10.1159/000354558; Corsaro D, 2010, PARASITOL RES, V107, P233, DOI 10.1007/s00436-010-1870-6; Coulon C, 2010, J CLIN MICROBIOL, V48, P2689, DOI 10.1128/JCM.00309-10; Diaz-Visurraga J, 2010, J APPL MICROBIOL, V108, P633, DOI 10.1111/j.1365-2672.2009.04447.x; Ferla MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083383; Fritsche TR, 1999, APPL ENVIRON MICROB, V65, P206; FRITSCHE TR, 1993, J CLIN MICROBIOL, V31, P1122, DOI 10.1128/JCM.31.5.1122-1126.1993; Garcia A, 2013, ENVIRON SCI TECHNOL, V47, P3132, DOI 10.1021/es400160k; Gast RJ, 1996, J EUKARYOT MICROBIOL, V43, P498, DOI 10.1111/j.1550-7408.1996.tb04510.x; GAUTOM RK, 1995, J EUKARYOT MICROBIOL, V42, P452, DOI 10.1111/j.1550-7408.1995.tb05890.x; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Guimaraes AJ, 2016, MICROBIOL RES, V193, P30, DOI 10.1016/j.micres.2016.08.001; HALL J, 1985, J PARASITOL, V71, P89, DOI 10.2307/3281982; Hammer MU, 2010, BIOCHEM J, V427, P477, DOI 10.1042/BJ20091607; Hewett MK, 2003, ACTA PROTOZOOL, V42, P325; Ho PT, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0966-3; Horn M, 1999, ENVIRON MICROBIOL, V1, P357, DOI 10.1046/j.1462-2920.1999.00045.x; Horn M, 2002, INT J SYST EVOL MICR, V52, P599, DOI 10.1099/00207713-52-2-599; Horn M, 2001, ENVIRON MICROBIOL, V3, P440, DOI 10.1046/j.1462-2920.2001.00210.x; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Kim SH, 2015, EXP PARASITOL, V159, P46, DOI 10.1016/j.exppara.2015.08.013; Lambrecht E, 2015, APPL ENVIRON MICROB, V81, P5604, DOI 10.1128/AEM.01031-15; Lamoth F, 2010, FEMS MICROBIOL REV, V34, P260, DOI 10.1111/j.1574-6976.2009.00207.x; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moon EK, 2011, KOREAN J PARASITOL, V49, P103, DOI 10.3347/kjp.2011.49.2.103; Morrow JL, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0276-4; Muller A, 2016, EUR J PROTISTOL, V56, P21, DOI 10.1016/j.ejop.2016.04.002; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Niyyati M, 2009, EXP PARASITOL, V121, P242, DOI 10.1016/j.exppara.2008.11.003; Nuprasert W, 2010, J CLIN MICROBIOL, V48, P4636, DOI 10.1128/JCM.01090-10; Randow F, 2014, CELL HOST MICROBE, V15, P404, DOI 10.1016/j.chom.2014.03.012; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Scheid P, 2015, PARASITOL RES, V114, P3959, DOI 10.1007/s00436-015-4731-5; Scheid P, 2014, PARASITOL RES, V113, P2407, DOI 10.1007/s00436-014-3932-7; Scheikl U, 2016, PARASITOL RES, V115, P3365, DOI 10.1007/s00436-016-5097-z; Schmitz-Esser S, 2008, APPL ENVIRON MICROB, V74, P5822, DOI 10.1128/AEM.01093-08; Schrallhammer M, 2018, SYST APPL MICROBIOL, V41, P213, DOI 10.1016/j.syapm.2018.01.005; Schulz F, 2016, ENVIRON MICROBIOL, V18, P2326, DOI 10.1111/1462-2920.12881; Schulz F, 2014, ISME J, V8, P1634, DOI 10.1038/ismej.2014.5; Shokri A, 2016, KOREAN J PARASITOL, V54, P447, DOI 10.3347/kjp.2016.54.4.447; Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6; Song SM, 2012, MOL BIOCHEM PARASIT, V183, P158, DOI 10.1016/j.molbiopara.2012.02.013; Stothard DR, 1998, J EUKARYOT MICROBIOL, V45, P45, DOI 10.1111/j.1550-7408.1998.tb05068.x; Szokoli F, 2016, APPL ENVIRON MICROB, V82, P7236, DOI 10.1128/AEM.02284-16; Szokoli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145743; Trabelsi H, 2012, PATHOL BIOL, V60, P399, DOI 10.1016/j.patbio.2012.03.002; Turner NA, 2000, J ANTIMICROB CHEMOTH, V46, P27, DOI 10.1093/jac/46.1.27; VISVESVARA GS, 1991, REV INFECT DIS, V13, pS369; Wang YF, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0005368, 10.1371/journal.pone.0007401]; Wang Z, 2014, FAMILY RICKETTSIALES, V2, DOI [10.1128/genomeA.00791-14, DOI 10.1128/GENOMEA.00791-14]; Wang Z, 2017, GENOME BIOL EVOL, V9, P3214, DOI 10.1093/gbe/evx246; Wang Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep07949; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zwirglmaier K, 2010, METHODS MOL BIOL, V659, P349, DOI 10.1007/978-1-60761-789-1_27	65	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0204732	10.1371/journal.pone.0204732	http://dx.doi.org/10.1371/journal.pone.0204732			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356282	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000016
J	Keidar-Friedman, D; Bariah, I; Kashkush, K				Keidar-Friedman, Danielle; Bariah, Inbar; Kashkush, Khalil			Genome-wide analyses of miniature inverted-repeat transposable elements reveals new insights into the evolution of the Triticum-Aegilops group	PLOS ONE			English	Article							LTR-RETROTRANSPOSONS; DRAFT GENOME; A-GENOME; RICE; SEQUENCE; MITES; FAMILY; INSERTION; STOWAWAY; GENES	The sequence drafts of wild emmer and bread wheat facilitated high resolution, genome-wide analysis of transposable elements (TEs), which account for up to 90% of the wheat genome. Despite extensive studies, the role of TEs in reshaping nascent polyploid genomes remains to be fully understood. In this study, we retrieved miniature inverted-repeat transposable elements (MITEs) from the recently published genome drafts of Triticum aestivum, Triticum turgidum ssp. dicoccoides, Aegilops tauschii and the available genome draft of Triticum urartu. Overall, 239,126 MITE insertions were retrieved, including 3,874 insertions of a newly identified, wheat-unique MITE family that we named "Inbar". The Stowaway super-family accounts for similar to 80% of the retrieved MITE insertions, while Thalos is the most abundant family. MITE insertions are distributed in the seven homologous chromosomes of the wild emmer and bread wheat genomes. The remarkably high level of insertions in the B sub-genome (similar to 59% of total retrieved MITE insertions in the wild emmer genome draft, and similar to 41% in the bread wheat genome draft), emphasize its highly repetitive nature. Nearly 52% of all MITE insertions were found within or close (less than 100bp) to coding genes, and similar to 400 MITE sequences were found in the bread wheat transcriptome, indicating that MITEs might have a strong impact on wheat genome expression. In addition, similar to 40% of MITE insertions were found within TE sequences, and remarkably, similar to 90% of Inbar insertions were located in retrotransposon sequences. Our data thus shed new light on the role of MITEs in the diversification of allopolyploid wheat species.	[Keidar-Friedman, Danielle; Bariah, Inbar; Kashkush, Khalil] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel	Ben Gurion University	Kashkush, K (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel.	kashkush@bgu.ac.il	KASHKUSH, KHALIL/ABT-5599-2022	KASHKUSH, KHALIL/0000-0001-7861-4959; Keidar-Friedman, Danielle/0000-0002-2028-0850	Israel Science Foundation [322/15]	Israel Science Foundation(Israel Science Foundation)	Funded by Israel Science Foundation (grant #322/15) https://www.isf.org.il/#/.	Avni R, 2017, SCIENCE, V357, P93, DOI 10.1126/science.aan0032; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; BUREAU TE, 1994, PLANT CELL, V6, P907, DOI 10.1105/tpc.6.6.907; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Casacuberta JM, 2003, GENE, V311, P1, DOI 10.1016/S0378-1119(03)00557-2; Castelletti S, 2014, G3-GENES GENOM GENET, V4, P805, DOI 10.1534/g3.114.010686; Charles M, 2008, GENETICS, V180, P1071, DOI 10.1534/genetics.108.092304; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Clavijo BJ, 2017, GENOME RES, V27, P885, DOI 10.1101/gr.217117.116; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Domb K, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1134-z; Dong HT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-135; Fattash I, 2013, GENOME, V56, P475, DOI 10.1139/gen-2012-0174; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Feldman M, 2009, J GENET GENOMICS, V36, P511, DOI 10.1016/S1673-8527(08)60142-3; Feschotte C, 2000, MOL BIOL EVOL, V17, P730, DOI 10.1093/oxfordjournals.molbev.a026351; Feschotte C, 2003, GENETICS, V163, P747; Feschotte C, 2002, MOBILE DNA-UK, P1147, DOI DOI 10.1128/9781555817954.CH50; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gonzalez J, 2009, SCIENCE, V325, P1352, DOI 10.1126/science.1179556; Janicki M, 2011, CHROMOSOME RES, V19, P787, DOI 10.1007/s10577-011-9230-7; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jiang N, 2004, CURR OPIN PLANT BIOL, V7, P115, DOI 10.1016/j.pbi.2004.01.004; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Jiang N, 2001, PLANT CELL, V13, P2553, DOI 10.1105/tpc.13.11.2553; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keidar D, 2018, PLANT CELL REP, V37, P193, DOI 10.1007/s00299-017-2213-1; Kikuchi K, 2003, NATURE, V421, P167, DOI 10.1038/nature01218; Li JT, 2014, CROP J, V2, P381, DOI 10.1016/j.cj.2014.07.001; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; Luo MC, 2017, NATURE, V551, P498, DOI 10.1038/nature24486; Mansour A, 2007, J CELL MOL BIOL, V6, P99; Vaschetto LM, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0440-8; Matzke MA, 1998, TRENDS ECOL EVOL, V13, P241, DOI 10.1016/S0169-5347(98)01390-1; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Nakazaki T, 2003, NATURE, V421, P170, DOI 10.1038/nature01219; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; Sabot F, 2005, MOL GENET GENOMICS, V274, P119, DOI 10.1007/s00438-005-0012-9; Shan XH, 2005, MOL BIOL EVOL, V22, P976, DOI 10.1093/molbev/msi082; Shen J, 2017, NATURE COMMUNICATION, V8; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; WESSLER SR, 1995, CURR OPIN GENET DEV, V5, P814, DOI 10.1016/0959-437X(95)80016-X; Wicker T, 2003, PLANT PHYSIOL, V132, P52, DOI 10.1104/pp.102.015743; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Yaakov B, 2012, PLANT MOL BIOL, V80, P419, DOI 10.1007/s11103-012-9957-3; Yaakov B, 2013, PLANT CELL REP, V32, P1615, DOI 10.1007/s00299-013-1472-8; Yaakov B, 2013, PLANT PHYSIOL, V161, P486, DOI 10.1104/pp.112.204404; Yaakov Beery, 2011, Int J Plant Genomics, V2011, P569826, DOI 10.1155/2011/569826; Yang GJ, 2003, NUCLEIC ACIDS RES, V31, P3659, DOI 10.1093/nar/gkg531; Yang GJ, 2007, P NATL ACAD SCI USA, V104, P10962, DOI 10.1073/pnas.0702080104; Yang GJ, 2009, SCIENCE, V325, P1391, DOI 10.1126/science.1175688; Zhang Q, 2000, P NATL ACAD SCI USA, V97, P1160, DOI 10.1073/pnas.97.3.1160; Zhao DY, 2016, BBA-GENE REGUL MECH, V1859, P366, DOI 10.1016/j.bbagrm.2015.12.005	60	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0204972	10.1371/journal.pone.0204972	http://dx.doi.org/10.1371/journal.pone.0204972			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356268	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000024
J	Su, R; Fan, YX; Qiao, X; Li, XK; Zhang, L; Li, C; Li, JQ				Su, Rui; Fan, Yixing; Qiao, Xian; Li, Xiaokai; Zhang, Lei; Li, Chun; Li, Jinquan			Transcriptomic analysis reveals critical genes for the hair follicle of Inner Mongolia cashmere goat from catagen to telogen	PLOS ONE			English	Article							ZINC-FINGER; RNA-SEQ; CAPRA-HIRCUS; STEM-CELLS; EXPRESSION; PATHWAY; ANAGEN; TECHNOLOGY; TRANSITION; PROFILES	There are two main types of hair follicle in Inner Mongolia Cashmere goats, the primary hair follicle (PHF) producing hair fibers and the secondary hair follicle (SHF) producing cashmere fibers. Of both fibers from cashmere-bearing goats in Aerbasi, Inner Mongolia, the timing of cyclical phases for the cashmere have been well clarified but hair fibers have been less noticeable. Herein, we evaluated transcriptome of PHF and SHF from the same three goats in Aerbasi at the catagen- and telogen phase of cashmere growth. We totally found 1977 DEGs between PHFs at the telogen and catagen phases of SHF, 1199 DEGs between telogen- and catagen SHF, 2629 DEGs between PHF at the catagen phase of SHF and catagen SHF, and 755 DEGs between PHF at the telogen phase of SHF and telogen SHF. By analyzing gene functions based on GO and KEGG database, we found that the DEGs have functions in muscle contraction and muscle filament sliding between catagen- and telogen SHF, indicating that arrector pilli muscles might play a role on the transition from catagen to telogen. Moreover, considering that the enriched GO and KEGG categories of the DEGs between PHF and SHF, we suggested that part of PHF might rest in their own anagen phase when SHF are at catagen, but PHF might enter into the telogen phase at SHF's telogen. Finally, we highly recommended the several potential genes acting as the regulators of the transition between growth phases including IL17RB and eight members of ZNF. These results provide insight into molecular mechanisms on the transition of SHF from catagen to telogen together with PHF's growth situation at SHF's catagen and telogen in Inner Mongolia Cashmere goats.	[Su, Rui; Fan, Yixing; Qiao, Xian; Li, Xiaokai; Zhang, Lei; Li, Jinquan] Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Inner Mongolia, Peoples R China; [Su, Rui; Li, Jinquan] Key Lab Anim Genet Breeding & Reprod, Inner Mongolia Autonomou, Hohhot, Peoples R China; [Su, Rui; Li, Jinquan] Minist Agr, Key Lab Mutton Sheep Genet & Breeding, Hohhot, Peoples R China; [Su, Rui; Li, Jinquan] Engn Res Ctr Goat Genet & Breeding, Inner Mongolia Autonomou, Hohhot, Peoples R China; [Li, Chun] Inner Mongolia Univ Nationalities, Coll Anim Sci, Tongliao, Inner Mongolia, Peoples R China	Inner Mongolia Agricultural University; Ministry of Agriculture & Rural Affairs; Inner Mongolia University for Nationalities	Li, JQ (corresponding author), Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Inner Mongolia, Peoples R China.; Li, JQ (corresponding author), Key Lab Anim Genet Breeding & Reprod, Inner Mongolia Autonomou, Hohhot, Peoples R China.; Li, JQ (corresponding author), Minist Agr, Key Lab Mutton Sheep Genet & Breeding, Hohhot, Peoples R China.; Li, JQ (corresponding author), Engn Res Ctr Goat Genet & Breeding, Inner Mongolia Autonomou, Hohhot, Peoples R China.	imauljq@126.com		Su, Rui/0000-0001-8386-7408	China Agriculture Research System [CARS-39-06]; National Natural Science Foundation of China [31660639, 31402052]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by China Agriculture Research System (CARS-39-06), National Natural Science Foundation of China (31660639, 31402052).	Adachi T, 2015, NAT MED, V21, P1272, DOI 10.1038/nm.3962; Alinejad V, 2017, BIOMED PHARMACOTHER, V88, P795, DOI 10.1016/j.biopha.2017.01.120; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Bai WL, 2016, ANIM BIOTECHNOL, V27, P104, DOI 10.1080/10495398.2015.1105240; Bai WL, 2016, GENETICA, P1; Bie QL, 2017, MOL IMMUNOL, V90, P50, DOI 10.1016/j.molimm.2017.07.004; Botchkarev VA, 2003, J INVEST DERM SYMP P, V8, P46, DOI 10.1046/j.1523-1747.2003.12171.x; Castela M, 2017, EXP DERMATOL, V26, P785, DOI 10.1111/exd.13287; Chen CC, 2016, J MOL BIOL, V428, P1423, DOI 10.1016/j.jmb.2015.07.009; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Fabre J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091433; Fan YX, 2015, GENET MOL RES, V14, P17904, DOI 10.4238/2015.December.22.15; Fantauzzo KA, 2008, GENE EXPR PATTERNS, V8, P51, DOI 10.1016/j.modgep.2007.10.006; FRANKEL AD, 1987, P NATL ACAD SCI USA, V84, P4841, DOI 10.1073/pnas.84.14.4841; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Geng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062704; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Ji XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156124; Jiang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111653; Jin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168015; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li JP, 2016, DNA CELL BIOL, V35, P696, DOI 10.1089/dna.2015.3161; Li YuRong, 2008, Scientia Agricultura Sinica, V41, P3920; Ma XH, 2017, J INVEST DERMATOL, V137, P1015, DOI 10.1016/j.jid.2017.01.012; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Miao XY, 2016, GENE, V582, P69, DOI 10.1016/j.gene.2016.01.047; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ogata H, 1998, BIOSYSTEMS, V47, P119, DOI 10.1016/S0303-2647(98)00017-3; Oliver CH, 2013, GENESIS, V51, P179, DOI 10.1002/dvg.22367; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Qi Yun-Xia, 2011, Yichuan, V33, P1191, DOI 10.3724/SP.J.1005.2011.01191; Reynolds JM, 2015, IMMUNITY, V42, P692, DOI 10.1016/j.immuni.2015.03.008; Torkamani Niloufar, 2014, Int J Trichology, V6, P88, DOI 10.4103/0974-7753.139077; Wang W, 2012, CLIN EXP ALLERGY, V42, P1604, DOI 10.1111/j.1365-2222.2012.04062.x; Wang XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164640; Xu T, 2013, GENE, V520, P30, DOI 10.1016/j.gene.2013.01.068; Ye G, 2016, PLOS ONE, V11; Zhou GX, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4603-3	39	17	18	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0204404	10.1371/journal.pone.0204404	http://dx.doi.org/10.1371/journal.pone.0204404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356261	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000009
J	De Oliveira, T; Ramakrishnan, M; Diamanti, MA; Ziegler, PK; Brombacher, F; Greten, FR				De Oliveira, Tiago; Ramakrishnan, Mallika; Diamanti, Michaela A.; Ziegler, Paul K.; Brombacher, Frank; Greten, Florian R.			Loss of Stat6 affects chromatin condensation in intestinal epithelial cells causing diverse outcome in murine models of inflammation-associated and sporadic colon carcinogenesis	ONCOGENE			English	Article							MACROPHAGE ACTIVATION; LINKS INFLAMMATION; INDUCED COLITIS; MOUSE MODEL; ER STRESS; CANCER; INHIBITION; RESPONSES; DNA; INTERLEUKIN-4	While great advances have been achieved regarding the genetic basis of colorectal cancer, the complex role of cell-cell communication and cytokine-induced signaling during its pathogenesis remains less understood. Signal transducer and activator of transcription 6 (Stat6) is the main transcription factor of interleukin-4 (IL-4) signaling and its participation in the development of various tumor types has been already reported. Here we aimed to examine the contribution of Stat6 in intestinal epithelial cells (IEC) in mouse models of intestinal carcinogenesis. Wild-type (WT), Stat6 knockout (Stat6(-/-)), and intestinal epithelial cell-specific IL-4R alpha knockout (Il-4r alpha P-Delta(IEC) ) mice were subjected to colitis-associated (AOM/DSS) and colitis-independent (sporadic) carcinogenesis. IEC proliferation, apoptosis and RNA expression were evaluated by immunohistochemical, immunoblot, and RT-PCR analysis. We found that Stat6( -/- )mice developed more tumors in the colitis-associated carcinogenesis model. This was accompanied by a more pronounced inflammatory response during colitis and an elevated Stat3-dependent proliferation of IEC. Increased sensitivity to DSS-induced colitis was caused by elevated cell death in response to the initial carcinogen exposure as Stat6 deficiency led to increased chromatin compaction affecting DNA damage response in IEC upon treatment with alkylating agents independently of IL-4R alpha engagement. Thus, loss of Stat6 caused more severe colitis and increased tumor load, however loss-of-initiated Stat6(-/-) IEC prevented tumor formation in the absence of overt inflammation. Our data unravel unexpected IL-4- independent functions of Stat6 in chromatin compaction in intestinal epithelial cells ultimately providing both tumor suppressive as well as tumor promoting effects in different models of intestinal tumorigenesis.	[De Oliveira, Tiago; Ramakrishnan, Mallika; Diamanti, Michaela A.; Ziegler, Paul K.; Greten, Florian R.] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, D-60596 Frankfurt, Germany; [Brombacher, Frank] Int Ctr Genet Engn & Biotechnol, Anzio Rd, ZA-7925 Cape Town, South Africa; [Brombacher, Frank] Univ Cape Town, Anzio Rd, ZA-7925 Cape Town, South Africa; [Brombacher, Frank] South African Med Res Ctr, External Unit, Anzio Rd, ZA-7925 Cape Town, South Africa; [Greten, Florian R.] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Greten, Florian R.] German Canc Res Ctr, D-69120 Heidelberg, Germany	Octapharma; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Greten, FR (corresponding author), Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, D-60596 Frankfurt, Germany.; Greten, FR (corresponding author), German Canc Consortium DKTK, D-69120 Heidelberg, Germany.; Greten, FR (corresponding author), German Canc Res Ctr, D-69120 Heidelberg, Germany.	greten@gsh.uni-frankfurt.de	Greten, Florian R/AAF-5196-2020; Ziegler, Paul/AAO-4379-2021	Greten, Florian R/0000-0002-3928-6080; Ziegler, Paul/0000-0002-7703-7747; De Oliveira, Tiago/0000-0002-2502-7897	LOEWE Center for Cell and Gene Therapy Frankfurt (CGT) [III L 4-518/17.004]; Georg-Speyer-Haus; Deutsche Forschungsgemeinschaft [Gr1916/5-1, FOR2438: Gr1916/11-1, SFB 815, 1177, 1292]	LOEWE Center for Cell and Gene Therapy Frankfurt (CGT); Georg-Speyer-Haus; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Christin Danneil, Hana Kunkel, Preeti Gupta, Kathleen Mohs, and Eva Rudolf for technical assistance as well as Petra Dinse at the Histology Core Facility at the Georg-Speyer-Haus for excellent technical support and all members of the Greten lab for insightful discussion. We also thank Birgitta Michels for help with karyotype analysis. This work was supported in part by the LOEWE Center for Cell and Gene Therapy Frankfurt (CGT, III L 4-518/17.004) and institutional funds from the Georg-Speyer-Haus, as well as grants from the Deutsche Forschungsgemeinschaft (Gr1916/5-1 and FOR2438: Gr1916/11-1; SFB 815, 1177 and 1292) to F.R.G..	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Cao H, 2016, ONCOTARGET, V7, P61183, DOI 10.18632/oncotarget.11282; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; Cosin-Roger J, 2016, MUCOSAL IMMUNOL, V9, P986, DOI 10.1038/mi.2015.123; Das S, 2010, BIOCHEMISTRY-US, V49, P2216, DOI 10.1021/bi9013038; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Diamanti MA, 2017, J EXP MED, V214, P423, DOI 10.1084/jem.20161867; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Elrod JW, 2005, INFLAMM BOWEL DIS, V11, P883, DOI 10.1097/01.MIB.0000182871.76434.57; Falk M, 2008, BBA-MOL CELL RES, V1783, P2398, DOI 10.1016/j.bbamcr.2008.07.010; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Gandhi NA, 2016, NAT REV DRUG DISCOV, V15, P35, DOI 10.1038/nrd4624; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Gooch JL, 2002, NEOPLASIA, V4, P324, DOI 10.1038/sj.neo.7900248; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Jayakumar A, 2017, NEOPLASIA, V19, P595, DOI 10.1016/j.neo.2017.04.006; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Leon-Cabrera SA, 2017, CANCER IMMUNOL RES, V5, P385, DOI 10.1158/2326-6066.CIR-16-0168; Li WX, 2008, TRENDS CELL BIOL, V18, P545, DOI 10.1016/j.tcb.2008.08.008; Liu L, 2017, GASTROENTEROLOGY, V153, P1517, DOI 10.1053/j.gastro.2017.08.045; Luzina IG, 2012, J LEUKOCYTE BIOL, V92, P753, DOI 10.1189/jlb.0412214; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; Pallangyo CK, 2015, J EXP MED, V212, P2253, DOI 10.1084/jem.20150576; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Schwitalla S, 2013, CANCER CELL, V23, P93, DOI 10.1016/j.ccr.2012.11.014; Shi S, 2008, NAT CELL BIOL, V10, P491, DOI 10.1038/ncb1713; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Takeda K, 1996, J IMMUNOL, V157, P3220; Takeda K, 1998, J IMMUNOL, V161, P4652; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Varga J, 2017, NAT CELL BIOL, V19, P1133, DOI 10.1038/ncb3611; Wali RK, 1999, CARCINOGENESIS, V20, P2355, DOI 10.1093/carcin/20.12.2355; Whetstone RD, 2016, MOL CARCINOGEN, V55, P1187, DOI 10.1002/mc.22361; Yan DY, 2016, CELL REP, V16, P2914, DOI 10.1016/j.celrep.2016.08.035; Yan SJ, 2011, FASEB J, V25, P232, DOI 10.1096/fj.10-169367; Zhang HS, 2015, J BIOL CHEM, V290, P15327, DOI 10.1074/jbc.M114.633560	56	10	10	3	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2019	38	11					1787	1801		10.1038/s41388-018-0551-2	http://dx.doi.org/10.1038/s41388-018-0551-2			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HO7XX	30353167	Green Published, hybrid			2022-12-26	WOS:000461164400001
J	Guo, H; Zeng, DF; Zhang, H; Bell, T; Yao, J; Liu, Y; Huang, SJ; Li, CJ; Lorence, E; Zhou, SH; Gong, TJ; Jiang, CY; Ahmed, M; Yao, YX; Nomie, KJ; Zhang, L; Wang, M				Guo, Hui; Zeng, Dongfeng; Zhang, Hui; Bell, Taylor; Yao, Jun; Liu, Yang; Huang, Shengjian; Li, Carrie J.; Lorence, Elizabeth; Zhou, Shouhao; Gong, Tiejun; Jiang, Changying; Ahmed, Makhdum; Yao, Yixin; Nomie, Krystle J.; Zhang, Liang; Wang, Michael			( Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma )	ONCOGENE			English	Article							IBRUTINIB RESISTANCE; FOLLICULAR LYMPHOMA; DNA-DAMAGE; OPEN-LABEL; PHASE-I; IDELALISIB; CUDC-907; HDAC; APOPTOSIS; PATHWAY	The dysregulation of PI3K signaling has been implicated as an underlying mechanism associated with resistance to Bruton's tyrosine kinase inhibition by ibrutinib in both chronic lymphocytic leukemia and mantle cell lymphoma (MCL). Ibrutinib resistance has become a major unmet clinical need, and the development of therapeutics to overcome ibrutinib resistance will greatly improve the poor outcomes of ibrutinib-exposed MCL patients. CUDC-907 inhibits both PI3K and HDAC functionality to exert synergistic or additive effects. Therefore, the activity of CUDC-907 was examined in MCL cell lines and patient primary cells, including ibrutinib-resistant MCL cells. The efficacy of CUDC-907 was further examined in an ibrutinib-resistant MCL patient-derived xenograft (PDX) mouse model. The molecular mechanisms by which CUDC-907 dually inhibits PI3K and histone deacetylation were assessed using reverse protein array, immunoblotting, and chromatin immunoprecipitation (ChIP) coupled with sequencing. We showed evidence that CUDC-907 treatment increased histone acetylation in MCL cells. We found that CUDC-907 caused decreased proliferation and increased apoptosis in MCL in vitro and in vivo MCL models. In addition, CUDC-907 was effective in inducing lethality in ibrutinib-resistant MCL cells. Lastly, CUDC-907 treatment increased histone acetylation in MCL cells. Overall, these studies suggest that CUDC-907 may be a promising therapeutic option for relapsed or resistant MCL.	[Guo, Hui; Zeng, Dongfeng; Zhang, Hui; Bell, Taylor; Liu, Yang; Huang, Shengjian; Li, Carrie J.; Lorence, Elizabeth; Jiang, Changying; Ahmed, Makhdum; Yao, Yixin; Nomie, Krystle J.; Zhang, Liang; Wang, Michael] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Zeng, Dongfeng] Third Mil Med Univ, Xinqiao Hosp, Dept Hematol, Chongqing 430000, Peoples R China; [Yao, Jun] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Zhou, Shouhao] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Gong, Tiejun] First Hosp Harbin, Inst Hematol & Oncol, Harbin 150010, Heilongjiang, Peoples R China; [Wang, Michael] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Army Medical University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wang, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA.; Wang, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA.	miwang@mdanderson.org	Jiang, Changying/AAL-3711-2020	Guo, Hui/0000-0003-3901-6336; Jiang, Changying/0000-0003-3778-4438; Yao, Yixin/0000-0002-8439-6043; dongfeng, zeng/0000-0002-0460-7593	NIH [P30 CA016672, R21 CA202104]; Gary Rogers Foundation; Kinder Foundation; Pharmacyclics, an AbbVie Company; NCI [CA016672]; NATIONAL CANCER INSTITUTE [R21CA202104, P30CA016672] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gary Rogers Foundation; Kinder Foundation; Pharmacyclics, an AbbVie Company; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the NIH-funded Cancer Center Support Grant (CCSG) P30 CA016672 and the R21 CA202104 (Michael Wang, PI). This study was also partially supported by the generous philanthropic support to the MD Anderson B Cell Lymphoma Moon Shot Project and philanthropy funds from The Gary Rogers Foundation and the Kinder Foundation. Pharmacyclics, an AbbVie Company, also provided funds for this laboratory work. The reagent CUDC-907 was provided by Curis, Inc. The laboratory research was not supported by Curis, Inc. Ibrutinib was provided by Pharmacyclics, an AbbVie Company. Cell line authentication was performed by the MD Anderson Cancer Center Characterized Cell Line Core Facility, funded by grant NCI # CA016672.	Ahn IE, 2017, BLOOD, V129, P1469, DOI 10.1182/blood-2016-06-719294; Ali D, 2017, STEM CELLS DEV, V26, P353, DOI 10.1089/scd.2016.0183; Bolden JE, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.9; Cheah CY, 2016, J CLIN ONCOL, V34, P1256, DOI 10.1200/JCO.2015.63.5904; Cheah CY, 2015, BLOOD, V125, P3357, DOI 10.1182/blood-2015-03-633156; Cheng S, 2015, LEUKEMIA, V29, P895, DOI 10.1038/leu.2014.263; Chiron D, 2014, CANCER DISCOV, V4, P1022, DOI 10.1158/2159-8290.CD-14-0098; Dreyling M, 2016, LANCET, V387, P770, DOI 10.1016/S0140-6736(15)00667-4; Dudakovic A, 2013, J BIOL CHEM, V288, P28783, DOI 10.1074/jbc.M113.489732; Ghosh K, 2018, J DERMATOL SCI, V89, P226, DOI 10.1016/j.jdermsci.2017.12.006; Giles F, 2006, CLIN CANCER RES, V12, P4628, DOI 10.1158/1078-0432.CCR-06-0511; Gopal AK, 2017, BLOOD, V129, P3037, DOI 10.1182/blood-2016-12-757740; Gopal AK, 2014, NEW ENGL J MED, V370, P1008, DOI 10.1056/NEJMoa1314583; Goy A, 2016, HEMATOL ONCOL CLIN N, V30, P1345, DOI 10.1016/j.hoc.2016.07.014; Graf SA, 2016, EXPERT OPIN PHARMACO, V17, P265, DOI 10.1517/14656566.2016.1135130; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Lee EJ, 2011, BIOCHEM BIOPH RES CO, V414, P384, DOI 10.1016/j.bbrc.2011.09.083; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Lemoine M, 2010, DISCOV MED, V10, P462; Lim HJ, 2016, ANTICANCER RES, V36, P5765, DOI 10.21873/anticanres.11160; Martin P, 2016, LANCET, V388, P535, DOI 10.1016/S0140-6736(16)30451-2; Martin P, 2016, LANCET, V387, P728, DOI 10.1016/S0140-6736(15)01040-5; Medina DJ, 2012, HAEMATOL-HEMATOL J, V97, P1255, DOI 10.3324/haematol.2011.040659; Oki Y, 2017, HAEMATOLOGICA, V102, P1923, DOI 10.3324/haematol.2017.172882; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Qian DZ, 2006, CLIN CANCER RES, V12, P634, DOI 10.1158/1078-0432.CCR-05-1132; Rahal R, 2014, NAT MED, V20, P87, DOI 10.1038/nm.3435; Rahmani M, 2009, BLOOD, V114, P4507, DOI 10.1182/blood-2008-09-177881; Salles G, 2017, HAEMATOLOGICA, V102, pE156, DOI 10.3324/haematol.2016.151738; Scuto A, 2008, BLOOD, V111, P5093, DOI 10.1182/blood-2007-10-117762; Sun KM, 2017, MOL CANCER THER, V16, P285, DOI 10.1158/1535-7163.MCT-16-0390; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang CH, 2014, FEBS LETT, V588, P4654, DOI 10.1016/j.febslet.2014.10.037; Woyach JA, 2017, J CLIN ONCOL, V35, P1437, DOI 10.1200/JCO.2016.70.2282; Yoshioka T, 2013, GYNECOL ONCOL, V129, P425, DOI 10.1016/j.ygyno.2013.02.008; Younes A, 2016, LANCET ONCOL, V17, P622, DOI 10.1016/S1470-2045(15)00584-7; Zhang L, 2017, CLIN CANCER RES, V23, P4212, DOI 10.1158/1078-0432.CCR-16-2703; Zhang XC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-168; Zhao XH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14920	39	11	11	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2019	38	11					1802	1814		10.1038/s41388-018-0550-3	http://dx.doi.org/10.1038/s41388-018-0550-3			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HO7XX	30361685				2022-12-26	WOS:000461164400002
J	Ohashi, H; Nishioka, K; Nakajima, S; Kim, S; Suzuki, R; Aizaki, H; Fukasawa, M; Kamisuki, S; Sugawara, F; Ohtani, N; Muramatsu, M; Wakita, T; Watashi, K				Ohashi, Hirofumi; Nishioka, Kazane; Nakajima, Syo; Kim, Sulyi; Suzuki, Ryosuke; Aizaki, Hideki; Fukasawa, Masayoshi; Kamisuki, Shinji; Sugawara, Fumio; Ohtani, Naoko; Muramatsu, Masamichi; Wakita, Takaji; Watashi, Koichi			The aryl hydrocarbon receptor-cytochrome P450 1A1 pathway controls lipid accumulation and enhances the permissiveness for hepatitis C virus assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aryl hydrocarbon receptor (AhR) (AHR); cytochrome P450; Hepatitis C virus (HCV); lipid droplet; hepatocyte; virus assembly; fatty acid metabolism; triglyceride; CYP1A1; hepatitis	FATTY-ACID-METABOLISM; CORE PROTEIN; HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC STEATOHEPATITIS; RISK-FACTOR; EXPRESSION; STEATOSIS; ACTIVATION; AHR; REPLICATION	Viruses hijack and modify host cell functions to maximize viral proliferation. Hepatitis C virus (HCV) reorganizes host cell metabolism to produce specialized membrane structures and to modify organelles such as double-membrane vesicles and enlarged lipid droplets (LDs), thereby enabling virus replication and assembly. However, the molecular bases of these host-HCV interactions are largely unknown. Here, using a chemical screen, we demonstrate that the benzamide derivative flutamide reduces the host capacity to produce infectious HCV. Flutamide disrupted the formation of enlarged LDs in HCV-infected cells, thereby abolishing HCV assembly. We also report that aryl hydrocarbon receptor (AhR), a known flutamide target, plays a key role in mediating LD accumulation and HCV production. This AhR function in lipid production was also observed in HCV-uninfected Huh-7 cells and primary human hepatocytes, suggesting that AhR signaling regulates lipid accumulation independently of HCV infection. We further observed that a downstream activity, that of cytochrome P450 1A1 (CYP1A1), was the primary regulator of AhR-mediated lipid production. Specifically, blockade of AhR-induced CYP1A1 up-regulation counteracted LD overproduction, and overproduction of CYP1A1, but not of CYP1B1, in AhR-inactivated cells restored lipid accumulation. Of note, HCV infection up-regulated the AhR-CYP1A1 pathway, resulting in the accumulation of enlarged LDs. In conclusion, we demonstrate that the AhR-CYP1A1 pathway has a significant role in lipid accumulation, a hallmark of HCV infection that maximizes progeny virus production. Our chemical-genetic analysis reveals a new strategy and lead compounds to control hepatic lipid accumulation as well as HCV infection.	[Ohashi, Hirofumi; Nishioka, Kazane; Nakajima, Syo; Kim, Sulyi; Suzuki, Ryosuke; Aizaki, Hideki; Muramatsu, Masamichi; Wakita, Takaji; Watashi, Koichi] Natl Inst Infect Dis, Dept Virol 2, Tokyo 1628640, Japan; [Fukasawa, Masayoshi] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo 1628640, Japan; [Ohashi, Hirofumi; Nishioka, Kazane; Nakajima, Syo; Kamisuki, Shinji; Sugawara, Fumio; Ohtani, Naoko; Watashi, Koichi] Tokyo Univ Sci, Grad Sch Sci & Technol, Noda, Chiba 2788510, Japan; [Watashi, Koichi] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Tokyo University of Science; Japan Science & Technology Agency (JST)	Watashi, K (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	kwatashi@nih.go.jp	Fukasawa, Masayoshi/ABD-7655-2020; Ohtani, Naoko/AAB-1891-2021	Fukasawa, Masayoshi/0000-0002-0702-0691; Ohtani, Naoko/0000-0001-8934-0797	Japan Society for the Promotion of Science KAKENHI [JP17H04085, JP18J14277, JP66KT0111]; JST CREST program; Japan Agency for Medical Research and Development (AMED) [JP18fk0310114j0002, JP18fk0310101j1002, JP18fk0310103j0202, JP18fm0208019j0002, JP18fk0210036j0001]; Suzuken Memorial Foundation; Fuji Foundation for Protein Research; Japan Food Chemical Research Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST CREST program(Core Research for Evolutional Science and Technology (CREST)Japan Science & Technology Agency (JST)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Suzuken Memorial Foundation; Fuji Foundation for Protein Research(Fuji Foundation for Protein Research); Japan Food Chemical Research Foundation(Japan Food Chemical Research Foundation)	This study was supported by Japan Society for the Promotion of Science KAKENHI Grants JP17H04085, JP18J14277, and JP66KT0111; the JST CREST program; Japan Agency for Medical Research and Development (AMED) Grants JP18fk0310114j0002, JP18fk0310101j1002, JP18fk0310103j0202, JP18fm0208019j0002, and JP18fk0210036j0001; the Suzuken Memorial Foundation; the Fuji Foundation for Protein Research; and the Japan Food Chemical Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Amako Y, 2011, J BIOL CHEM, V286, P11265, DOI 10.1074/jbc.M110.182097; Arnold C, 2010, PHARMACOL REP, V62, P536, DOI 10.1016/S1734-1140(10)70311-X; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Camus G, 2013, J BIOL CHEM, V288, P9915, DOI 10.1074/jbc.M112.434910; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Fujii-Kuriyama Y, 2005, BIOCHEM BIOPH RES CO, V338, P311, DOI 10.1016/j.bbrc.2005.08.162; He JH, 2013, MOL CELL BIOL, V33, P2047, DOI 10.1128/MCB.01658-12; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Ishida Y, 2015, AM J PATHOL, V185, P1275, DOI 10.1016/j.ajpath.2015.01.028; Iwamoto M, 2014, BIOCHEM BIOPH RES CO, V443, P808, DOI 10.1016/j.bbrc.2013.12.052; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Jin UH, 2012, J PHARMACOL EXP THER, V343, P333, DOI 10.1124/jpet.112.195339; Kato T, 2008, HEPATOLOGY, V48, P732, DOI 10.1002/hep.22422; Kim S, 2014, HEPATOLOGY, V60, P1838, DOI 10.1002/hep.27197; Kress S, 1998, EUR J BIOCHEM, V258, P803, DOI 10.1046/j.1432-1327.1998.2580803.x; Kurosaki M, 2010, HEPATOL RES, V40, P870, DOI 10.1111/j.1872-034X.2010.00692.x; Lahoti TS, 2014, J PHARMACOL EXP THER, V348, P236, DOI 10.1124/jpet.113.209726; Larrea E, 2007, J VIROL, V81, P3662, DOI 10.1128/JVI.02248-06; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Lee JH, 2010, GASTROENTEROLOGY, V139, P653, DOI 10.1053/j.gastro.2010.03.033; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Macedo LF, 2006, CANCER RES, V66, P7775, DOI 10.1158/0008-5472.CAN-05-3984; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Masaki T, 2014, J VIROL, V88, P7541, DOI 10.1128/JVI.03170-13; McIntosh AL, 2014, AM J PHYSIOL-GASTR L, V307, pG164, DOI 10.1152/ajpgi.00369.2013; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Nakajima S, 2016, J VIROL, V90, P9058, DOI 10.1128/JVI.00856-16; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Ohata K, 2003, CANCER-AM CANCER SOC, V97, P3036, DOI 10.1002/cncr.11427; Patel RD, 2006, TOXICOL SCI, V89, P75, DOI 10.1093/toxsci/kfi344; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shimada T, 2001, DRUG METAB DISPOS, V29, P1176; Shimba S, 2009, BIOCHEM PHARMACOL, V77, P560, DOI 10.1016/j.bcp.2008.09.040; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Vorrink SU, 2014, TOXICOL APPL PHARM, V274, P408, DOI 10.1016/j.taap.2013.12.002; Wada T, 2016, J BIOL CHEM, V291, P7004, DOI 10.1074/jbc.M115.693655; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Wells MA, 2016, PROSTAG OTH LIPID M, V125, P19, DOI 10.1016/j.prostaglandins.2016.07.002; Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	58	25	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19559	19571		10.1074/jbc.RA118.005033	http://dx.doi.org/10.1074/jbc.RA118.005033			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30381393	Green Published, hybrid			2022-12-26	WOS:000454294900006
J	Mishra, LN; Hayes, JJ				Mishra, Laxmi Narayan; Hayes, Jeffrey J.			A nucleosome-free region locally abrogates histone H1-dependent restriction of linker DNA accessibility in chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromatin structure; chromatin regulation; histone; histone acetylation; nucleosome; epigenetics; gene regulation; histone H1; linker histone; nucleosome free region	PIONEER TRANSCRIPTION FACTORS; H4 TAIL DOMAIN; SELF-ASSOCIATION; H1; ORGANIZATION; ARRAYS; MECHANISM; DYNAMICS; BINDING; FIBER	Eukaryotic genomes are packaged into linker-oligonucleosome assemblies, providing compaction of genomic DNA and contributing to gene regulation and genome integrity. To define minimal requirements for initial steps in the transition of compact, closed chromatin to a transcriptionally active, open state, we developed a model in vitro system containing a single, unique, target nucleosome in the center of a 25-nucleosome array and evaluated the accessibility of the linker DNA adjacent to this target nucleosome. We found that condensation of H1-lacking chromatin results in approximate to 60-fold reduction in linker DNA accessibility and that mimics of acetylation within all four core histone tail domains of the target nucleosome synergize to increase accessibility approximate to 3-fold. Notably, stoichiometric binding of histone H1 caused >2 orders of magnitude reduction in accessibility that was marginally diminished by histone acetylation mimics. Remarkably, a nucleosome-free region (NFR) in place of the target nucleosome completely abrogated H1-dependent restriction of linker accessibility in the immediate vicinity of the NFR. Our results suggest that linker DNA is as inaccessible as DNA within the nucleosome core in fully condensed, H1-containing chromatin. They further imply that an unrecognized function of NFRs in gene promoter regions is to locally abrogate the severe restriction of linker DNA accessibility imposed by H1s.	[Mishra, Laxmi Narayan; Hayes, Jeffrey J.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Mishra, Laxmi Narayan] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	University of Rochester; Yeshiva University; Albert Einstein College of Medicine	Hayes, JJ (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA.	Jeffrey_Hayes@urmc.rochester.edu	MISHRA, LAXMI NARAYAN/P-7740-2018	MISHRA, LAXMI NARAYAN/0000-0002-6596-9651; Hayes, Jeffrey/0000-0001-6981-1803	National Institutes of Health [R01GM052426]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM052426 (to J. J. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allahverdi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08512; Allahverdi A, 2011, NUCLEIC ACIDS RES, V39, P1680, DOI 10.1093/nar/gkq900; ALLAN J, 1982, J CELL BIOL, V93, P285, DOI 10.1083/jcb.93.2.285; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Bednar J, 2017, MOL CELL, V66, P384, DOI 10.1016/j.molcel.2017.04.012; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P273, DOI 10.1093/nar/20.2.273; Cao Kaixiang, 2013, PLoS Genet, V9, pe1003417, DOI 10.1371/journal.pgen.1003417; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Caterino TL, 2011, MOL CELL BIOL, V31, P2341, DOI 10.1128/MCB.05145-11; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; CHEN W, 1985, EMBO J, V4, P3273, DOI 10.1002/j.1460-2075.1985.tb04077.x; Chereji RV, 2018, BIOPHYS J, V114, P2279, DOI 10.1016/j.bpj.2018.03.015; Chereji RV, 2017, MOL CELL, V65, P565, DOI 10.1016/j.molcel.2016.12.009; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; CLARK DJ, 1988, EUR J BIOCHEM, V178, P225, DOI 10.1111/j.1432-1033.1988.tb14447.x; Cutter AR, 2017, BIOCHEM CELL BIOL, V95, P171, DOI 10.1139/bcb-2016-0097; DONG F, 1991, P NATL ACAD SCI USA, V88, P10596, DOI 10.1073/pnas.88.23.10596; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; GRUNSTEIN M, 1992, SCI AM, V267, P68, DOI 10.1038/scientificamerican1092-68; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; HANSEN JC, 1993, J BIOL CHEM, V268, P5840; Hashimoto H, 2010, NUCLEIC ACIDS RES, V38, P3533, DOI 10.1093/nar/gkq076; Hayes JJ, 1996, J BIOL CHEM, V271, P25817, DOI 10.1074/jbc.271.42.25817; HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405; Hill DA, 2000, BIOCHEMISTRY-US, V39, P11649, DOI 10.1021/bi001330z; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; Iwafuchi-Doi M, 2016, DEVELOPMENT, V143, P1833, DOI 10.1242/dev.133900; Izzo A, 2013, CELL REP, V3, P2142, DOI 10.1016/j.celrep.2013.05.003; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kan PY, 2007, MOL CELL BIOL, V27, P2084, DOI 10.1128/MCB.02181-06; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Maeshima K, 2016, EMBO J, V35, P1115, DOI 10.15252/embj.201592660; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Millan-Arino L, 2014, NUCLEIC ACIDS RES, V42, P4474, DOI 10.1093/nar/gku079; Mishra LN, 2016, SCI REP-UK, V6, DOI 10.1038/srep34808; Mishra LN, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0214-0; Ocampo J, 2016, NUCLEIC ACIDS RES, V44, P4625, DOI 10.1093/nar/gkw068; ONEILL TE, 1995, NUCLEIC ACIDS RES, V23, P1075, DOI 10.1093/nar/23.6.1075; Pan CY, 2016, BBA-GENE REGUL MECH, V1859, P496, DOI 10.1016/j.bbagrm.2015.12.002; Pepenella S, 2014, J BIOL CHEM, V289, P27342, DOI 10.1074/jbc.M114.595140; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; SHIMAMURA A, 1989, MOL CELL BIOL, V9, P5573, DOI 10.1128/MCB.9.12.5573; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Vitolo JM, 2004, MOL CELL BIOL, V24, P697, DOI 10.1128/MCB.24.2.697-707.2004; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; Zaret KS, 2016, CURR OPIN GENET DEV, V37, P76, DOI 10.1016/j.gde.2015.12.003; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zinchenko A, 2018, NUCLEIC ACIDS RES, V46, P635, DOI 10.1093/nar/gkx1135	68	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19191	19200		10.1074/jbc.RA118.005721	http://dx.doi.org/10.1074/jbc.RA118.005721			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30373774	Green Published, hybrid			2022-12-26	WOS:000453537300003
J	Dat, VQ; Huong, VTL; Turner, HC; Thwaites, L; van Doorn, HR; Nadjm, B				Vu Quoc Dat; Vu Thi Lan Huong; Turner, Hugo C.; Thwaites, Louise; van Doorn, H. Rogier; Nadjm, Behzad			Excess direct hospital cost of treating adult patients with ventilator associated respiratory infection (VARI) in Vietnam	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTIONS; HEALTH; PNEUMONIA; METAANALYSIS; PATTERNS; BURDEN; IMPACT	Introduction Ventilator associated respiratory infections (VARIs) are the most common hospital acquired infections in critical care worldwide. This work aims to estimate the total annual direct hospital cost of treating VARI throughout Vietnam. Methods A costing model was constructed to evaluate the excess cost of diagnostics and treatment of VARI in Vietnam. Model inputs included costs for extra lengths of stay, diagnostics, VARI incidence, utilisation of ventilators and antibiotic therapy. Results With the current VARI incidence rate of 21.7 episodes per 1000 ventilation-days, we estimated 34,428 VARI episodes in the 577 critical care units in Vietnam per year. The extra cost per VARI episode was $1,174.90 and the total annual excess cost was US$40.4 million. A 1% absolute reduction in VARI incidence density would save US$1.86 million annually. For each episode of VARI, the share of excess cost components was 45.1% for critical care unit stay and ventilation, 3.7% for diagnostics and 51.1% for extra antimicrobial treatment. Conclusions At the current annual government health expenditure of US$117 per capita, VARI represents a substantial cost to the health service in Vietnam. Enhanced infection prevention and control and antimicrobial stewardship programmes should be implemented to reduce this.	[Vu Quoc Dat] Hanoi Med Univ, Dept Infect Dis, Hanoi, Vietnam; [Vu Quoc Dat; Vu Thi Lan Huong; Turner, Hugo C.; Thwaites, Louise; van Doorn, H. Rogier; Nadjm, Behzad] Univ Oxford, Wellcome Trust Asia Programme, Clin Res Unit, Hanoi, Vietnam; [Turner, Hugo C.; Thwaites, Louise; van Doorn, H. Rogier; Nadjm, Behzad] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Clin Med, Oxford, England	Hanoi Medical University; University of Oxford; University of Oxford	Dat, VQ (corresponding author), Hanoi Med Univ, Dept Infect Dis, Hanoi, Vietnam.; Dat, VQ (corresponding author), Univ Oxford, Wellcome Trust Asia Programme, Clin Res Unit, Hanoi, Vietnam.	datvq@hmu.edu.vn	van Doorn, H. Rogier/H-3080-2019; Dat, Vu Quoc/L-8899-2017	van Doorn, H. Rogier/0000-0002-9807-1821; Dat, Vu Quoc/0000-0002-5904-5970	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Alvarez-Lerma F, 2006, CRIT CARE, V10, DOI 10.1186/cc4919; [Anonymous], 2015, JOINT CIRCULAR UNIFY; [Anonymous], 2017, DECISION CEILLING PR; [Anonymous], 2016, COMMON INDEX CODES A; Arefian H, 2016, AM J INFECT CONTROL, V44, P160, DOI 10.1016/j.ajic.2015.09.005; Dieleman J, 2017, LANCET, V389, P1981, DOI 10.1016/S0140-6736(17)30874-7; Drug Administration of Vietnam, 2018, SUMM BID WINN RES NA; Duong MC, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2290-3; General Statistics Office, 2017, STAT YB VIETN 2016; Gilbert DN, 2017, SANFORD GUIDE ANTIMI; Graves N, 2010, CLIN INFECT DIS, V50, P1017, DOI 10.1086/651110; Ha DT, 2015, INT J EMERG MED, V8, DOI 10.1186/s12245-015-0066-3; Ha N, 2012, AM J INFECT CONTROL, V40, pe146, DOI [10.1016/j.ajic.2012.04.259, DOI 10.1016/J.AJIC.2012.04.259]; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Kollef MH, 2012, INFECT CONT HOSP EP, V33, P250, DOI 10.1086/664049; Kollef MH, 2006, CHEST, V129, P1210, DOI 10.1378/chest.129.5.1210; Thu LTA, 2015, AM J INFECT CONTROL, V43, pE93, DOI 10.1016/j.ajic.2015.08.006; Ling ML, 2015, CLIN INFECT DIS, V60, P1690, DOI 10.1093/cid/civ095; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mathai AS, 2015, J INFECT PUBLIC HEAL, V8, P127, DOI 10.1016/j.jiph.2014.07.005; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Pekerti A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101118; Le P, 2014, TROP MED INT HEALTH, V19, P1321, DOI 10.1111/tmi.12370; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Stone PW, 2005, AM J INFECT CONTROL, V33, P501, DOI 10.1016/j.ajic.2005.04.246; Tarricone R, 2006, HEALTH POLICY, V77, P51, DOI 10.1016/j.healthpol.2005.07.016; The World Bank, GNI PER CAP ATL METH; Torres A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00582-2017; Vietnam Medical Services Administration, 2015, SURV REP CAP CLIN MA; Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6; Phu VD, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-017-0266-4; Phu VD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147544; Dat VQ, 2017, J CRIT CARE, V42, P109, DOI 10.1016/j.jcrc.2017.07.020; World Bank, 2018, OFF EXCH RAT LCU PER; World Health Organization, 2018, GLOBAL HLTH EXPENDIT; World Health Organization, MED PRIC MAK PEOPL S; Wyncoll D, 2012, CRIT CARE, V16, DOI 10.1186/cc11346; Zarb P, 2012, EURO SURVEILLANCE B, V17; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	40	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206760	10.1371/journal.pone.0206760	http://dx.doi.org/10.1371/journal.pone.0206760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379956	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700147
J	Wongjampa, W; Ekalaksananan, T; Chopjitt, P; Chuerduangphui, J; Kleebkaow, P; Patarapadungkit, N; Pientong, C				Wongjampa, Weerayut; Ekalaksananan, Tipaya; Chopjitt, Peechanika; Chuerduangphui, Jureeporn; Kleebkaow, Pilaiwan; Patarapadungkit, Natcha; Pientong, Chamsai			Suppression of miR-22, a tumor suppressor in cervical cancer, by human papillomavirus 16 E6 via a p53/miR-22/HDAC6 pathway	PLOS ONE			English	Article							CELL-PROLIFERATION; UP-REGULATION; HPV E6; EXPRESSION; MICRORNA-22; METASTASIS; CARCINOMA; HDAC6	MicroRNAs (miRNAs) are small non-coding RNAs that function to down-regulate gene expression involving in various cellular processes related to carcinogenesis. Recently, miR-22 was identified as a tumor-suppressing miRNA in many human cancers. However, the regulatory mechanism and the specific function of this miRNA in cervical cancer remain unclear. In the present study, we carried out gene transfection, western blot and quantitative RT-PCR to explore the regulatory mechanism and the functional role of miR-22 in cervical cancer. We verified that miR-22 was down-regulated in cervical cancer tissues and cervical cancer cell lines relative to matched non-tumor tissues and normal human cervical keratinocyte line (HCK1T). By contrast, histone deacetylase 6 (HDAC6) was inversely correlated with miR-22 in both cervical tissues and cancer cell lines. Mechanically, HDAC6 was down-regulated by miR-22 at the post-transcriptional level, via a specific target site within the 3'UTR, identified by a luciferase reporter assay. Moreover, we also showed that the correlation between miR-22 and HDAC6 expression was regulated by an E6/p53 pathway in HCK1Ts expressing HPV16 E6. For functional study, an ectopic expression of miR-22 could inhibit cell proliferation and migration, and could induce apoptosis of cervical cancer cell lines. These findings demonstrated that miR-22 was down-regulated in cervical cancer and inversely collated with its downstream target HDAC6. MiR-22 acts as tumor suppressor by inhibiting proliferation and migration, and by inducing apoptosis of cervical cancer cell lines by targeting the 3'UTR of HDAC6. This newly identified E6/p53/miR-22/HDAC6 regulatory network might be a candidate therapeutic target for cervical cancer.	[Wongjampa, Weerayut; Ekalaksananan, Tipaya; Chuerduangphui, Jureeporn; Pientong, Chamsai] Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand; [Wongjampa, Weerayut; Ekalaksananan, Tipaya; Chopjitt, Peechanika; Chuerduangphui, Jureeporn; Kleebkaow, Pilaiwan; Patarapadungkit, Natcha; Pientong, Chamsai] Khon Kaen Univ, HPV & EBV & Carcinogenesis Res Grp, Khon Kaen, Thailand; [Chopjitt, Peechanika] Kasetsart Univ Chalermphrakiat, Fac Publ Hlth, Sakon Nakhon Campus, Sakon Nakhon, Thailand; [Kleebkaow, Pilaiwan] Khon Kaen Univ, Dept Obstet & Gynecol, Fac Med, Khon Kaen, Thailand; [Patarapadungkit, Natcha] Khon Kaen Univ, Dept Pathol, Fac Med, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Pientong, C (corresponding author), Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand.; Pientong, C (corresponding author), Khon Kaen Univ, HPV & EBV & Carcinogenesis Res Grp, Khon Kaen, Thailand.	chapie@kku.ac.th	Chopjitt, Peechanika/ABD-4917-2020	Chopjitt, Peechanika/0000-0001-5010-4682; Wongjampa, Weerayut/0000-0003-2515-6872	Thailand Research Fund; Khon Kaen University [PHD/0296/2552]; Faculty of Medicine, Khon Kaen University [IN59127]; Khon Kaen University, Thailand [61004604]; Research Affairs and Graduate School, Khon Kaen University, Thailand [58443]	Thailand Research Fund(Thailand Research Fund (TRF)); Khon Kaen University; Faculty of Medicine, Khon Kaen University; Khon Kaen University, Thailand; Research Affairs and Graduate School, Khon Kaen University, Thailand	This work was supported by the Thailand Research Fund and Khon Kaen University through the Royal Golden Jubilee Ph.D. Program (grant no. PHD/0296/2552), Faculty of Medicine, Khon Kaen University (grant no. IN59127) and Khon Kaen University, Thailand (grant no. 61004604), and had received scholarship under the Post-Doctoral Training Program from Research Affairs and Graduate School, Khon Kaen University, Thailand (grant no. 58443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; CROOK T, 1991, CELL, V67, P547, DOI 10.1016/0092-8674(91)90529-8; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Guo MM, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0542-7; Guzman N, 2015, MOL CANCER RES, V13, P891, DOI 10.1158/1541-7786.MCR-14-0533; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Kim J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12315; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Li M, 2015, WORLD J GASTROENTERO, V21, P3245, DOI 10.3748/wjg.v21.i11.3245; Li Wu-Ju, 2015, Asian Pac J Cancer Prev, V16, P3159; Lin JP, 2014, ARTHRITIS RHEUMATOL, V66, P49, DOI 10.1002/art.38142; Ling B, 2012, J CANCER RES CLIN, V138, P1355, DOI 10.1007/s00432-012-1194-2; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; POLISENO L, 2010, SCI SIGNAL, V3, P29, DOI DOI 10.1126/SCISIGNAL.2000594; Saavedra K, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-13; Sun M, 2008, MOL CANCER THER, V7, P464, DOI 10.1158/1535-7163.MCT-07-2272; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; WANG XH, 2008, PLOS ONE, V3, DOI DOI 10.1371/JOURNAL.PONE.0002557; Wang XH, 2014, P NATL ACAD SCI USA, V111, P4262, DOI 10.1073/pnas.1401430111; Wang XH, 2011, INT J CANCER, V129, P1362, DOI 10.1002/ijc.25800; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Xiong J, 2012, CURR MOL MED, V12, P247, DOI 10.2174/156652412799218886; Xiong JH, 2010, FEBS J, V277, P1684, DOI 10.1111/j.1742-4658.2010.07594.x; Yamakuchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020291; Yu SJ, 2013, CLIN CANCER RES, V19, P1389, DOI 10.1158/1078-0432.CCR-12-1959; Zhang GJ, 2012, MED ONCOL, V29, P3108, DOI 10.1007/s12032-012-0233-9; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895; Zhang N, 2014, ONCOGENE, V33, P3119, DOI 10.1038/onc.2013.286; Zhang T, 2015, J INTEGR ONCOL, V4, P145, DOI [10.4172/2329-6771.1000145, DOI 10.4172/2329-6771.1000145]; Zheng ZM, 2011, BBA-GENE REGUL MECH, V1809, P668, DOI 10.1016/j.bbagrm.2011.05.005; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	33	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206644	10.1371/journal.pone.0206644	http://dx.doi.org/10.1371/journal.pone.0206644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379969	Green Submitted, Green Published, gold			2022-12-26	WOS:000448823700140
J	Hu, Y; Wong, YK; Wei, WT; Du, Y; Kankanhalli, M; Geng, WD				Hu, Yu; Wong, Yongkang; Wei, Wentao; Du, Yu; Kankanhalli, Mohan; Geng, Weidong			A novel attention-based hybrid CNN-RN N architecture for sEMG-based gesture recognition	PLOS ONE			English	Article								The surface electromyography (sEMG)-based gesture recognition with deep learning approach plays an increasingly important role in human-computer interaction. Existing deep learning architectures are mainly based on Convolutional Neural Network (CNN) architecture which captures spatial information of electromyogram signal. Motivated by the sequential nature of electromyogram signal, we propose an attention-based hybrid CNN and RNN (CNN - RNN) architecture to better capture temporal properties of electromyogram signal for gesture recognition problem. Moreover, we present a new sEMG image representation method based on a traditional feature vector which enables deep learning architectures to extract implicit correlations between different channels for sparse multi-channel electromyogram signal. Extensive experiments on five sEMG benchmark databases show that the proposed method outperforms all reported state-of-the-art methods on both sparse multichannel and high-density sEMG databases. To compare with the existing works, we set the window length to 200ms for NinaProDB1 and NinaProDB2, and 150ms for BioPatRec sub-database, CapgMyo sub-database, and csl-hdemg databases. The recognition accuracies of the aforementioned benchmark databases are 87.0%, 82.2%, 94.1%, 99.7% and 94.5%, which are 9.2%, 3.5%, 1.2%, 0.2% and 5.2% higher than the state-of-the-art performance, respectively.	[Hu, Yu; Wei, Wentao; Du, Yu; Geng, Weidong] Zhejiang Univ, Coll Comp Sci & Technol, State Key Lab CAD & CG, Hangzhou, Zhejiang, Peoples R China; [Wong, Yongkang] Natl Univ Singapore, Smart Syst Inst, Singapore, Singapore; [Kankanhalli, Mohan] Natl Univ Singapore, Sch Comp, Singapore, Singapore	Zhejiang University; National University of Singapore; National University of Singapore	Geng, WD (corresponding author), Zhejiang Univ, Coll Comp Sci & Technol, State Key Lab CAD & CG, Hangzhou, Zhejiang, Peoples R China.	gengwd@zju.edu.cn	Kankanhalli, Mohan/Q-9284-2019	Kankanhalli, Mohan/0000-0002-4846-2015; Wong, Yongkang/0000-0002-1239-4428	National Key Research and Development Program of China [2016YFB1001302]; National Natural Science Foundation of China [61379067]; National Research Foundation, Prime Ministers office, Singapore under its International Research Centre in Singapore Funding Initiative	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation, Prime Ministers office, Singapore under its International Research Centre in Singapore Funding Initiative(National Research Foundation, Singapore)	This work was supported by National Key Research and Development Program of China (No. 2016YFB1001302), the National Natural Science Foundation of China (No. 61379067), and the National Research Foundation, Prime Ministers office, Singapore under its International Research Centre in Singapore Funding Initiative.; This work was supported by grants from the National Key Research and Development Program of China (No. 2016YFB1001302), the National Natural Science Foundation of China (No. 61379067), and the National Research Foundation, Prime Ministers office, Singapore under its International Research Centre in Singapore Funding Initiative.	Amma C, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P929, DOI 10.1145/2702123.2702501; Amor ABH, 2017, INF COMM TECHN ACC I, P1; [Anonymous], 2016, 2016 IEEE GLOBAL COM; Asai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062956; Atzori M, 2016, FRONT NEUROROBOTICS, V10, DOI 10.3389/fnbot.2016.00009; Atzori M, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.53; Bahdanau D., 2015, ICLP; Baziotis C., 2017, P 11 INT WORKSH SEM, P747; Chen Tianqi, 2015, STATISTICS; Chorowski J., 2015, ARXIV150607503, DOI DOI 10.1016/0167-739X(94)90007-8; Doswald A., 2014, 13 MED C MED BIOL EN, P758; Du YC, 2010, EXPERT SYST APPL, V37, P4283, DOI 10.1016/j.eswa.2009.11.072; Du Y, 2017, PROCEEDINGS OF THE TWENTY-SIXTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1624; Du Y, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17030458; Englehart K, 2003, IEEE T BIO-MED ENG, V50, P848, DOI 10.1109/TBME.2003.813539; Farabet C, 2013, IEEE T PATTERN ANAL, V35, P1915, DOI 10.1109/TPAMI.2012.231; Geng WD, 2016, SCI REP-UK, V6, DOI 10.1038/srep36571; Goferman S, 2012, IEEE T PATTERN ANAL, V34, P1915, DOI 10.1109/TPAMI.2011.272; Hakonen M, 2015, BIOMED SIGNAL PROCES, V18, P334, DOI 10.1016/j.bspc.2015.02.009; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hioki M., 2012, ISRN REHABIL, V2012, DOI [DOI 10.5402/2012/604314, 10.5402/2012/604314]; Huang YY, 2009, 2008 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-4, P846, DOI 10.1109/ROBIO.2009.4913110; HUDGINS B, 1993, IEEE T BIO-MED ENG, V40, P82, DOI 10.1109/10.204774; Ioffe S, 2015, PR MACH LEARN RES, V37, P448; Jarrasse N, 2017, IEEE T NEUR SYS REH, V25, P68, DOI 10.1109/TNSRE.2016.2563222; Jiang WC, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P1307, DOI 10.1145/2733373.2806333; Jonghwa Kim, 2008, 13th International Conference on Intelligent User Interfaces. IUI 2008, P30; Jorgensen C, 2010, SPEECH COMMUN, V52, P354, DOI 10.1016/j.specom.2009.11.003; Kahou SE, 2015, ICMI'15: PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON MULTIMODAL INTERACTION, P467, DOI 10.1145/2818346.2830596; Karlik B, 2003, IEEE T BIO-MED ENG, V50, P1255, DOI 10.1109/TBME.2003.818469; Khushaba RN, 2017, IEEE T NEUR SYS REH, V25, P1821, DOI 10.1109/TNSRE.2017.2687520; Kiros R, 2015, P ADV NEURAL INFORM, P3294; Konrad P., 2005, PRACTICAL INTRO KINE, V1, P30; Lipton Zachary C., 2016, INT C LEARN REPR; Luong M.T., 2015, P 2015 C EMP METH NA, P1412; Lyons GM, 2003, P ANN INT IEEE EMBS, V25, P1625, DOI 10.1109/IEMBS.2003.1279682; Menon R, 2017, IEEE T NEUR SYS REH, VPP, P1; Merletti R., 2016, SURFACE ELECTROMYOGR; Milosevic B, 2017, DES AUT TEST EUROPE, P1432, DOI 10.23919/DATE.2017.7927217; Moon I, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P3453; Naik GR, 2014, IEEE ENG MED BIO, P3829, DOI 10.1109/EMBC.2014.6944458; Ordonez FJ, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010115; Ortiz-Catalan M, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-11; Oskoei MA, 2007, BIOMED SIGNAL PROCES, V2, P275, DOI 10.1016/j.bspc.2007.07.009; Patricia N, 2014, INT C PATT RECOG, P2769, DOI 10.1109/ICPR.2014.477; Phinyomark A., 2009, J COMPUT, V1, P71; Phinyomark A, 2012, EXPERT SYST APPL, V39, P7420, DOI 10.1016/j.eswa.2012.01.102; Quivira F., 2018, 2018 IEEE EMBS INT C, P166; Reaz MBI, 2006, BIOL PROCED ONLINE, V8, P11, DOI [10.1251/bpo115, 10.1251/bpo124]; Rosen J, 1999, COMPUT BIOMED RES, V32, P415, DOI 10.1006/cbmr.1999.1524; Samadani AA, 2014, IEEE ENG MED BIO, P4196, DOI 10.1109/EMBC.2014.6944549; Shinde S, 2017, IEEE INT C ELECT INS, P1, DOI [10.1109/ICEICE.2017.8191926, DOI 10.1109/ICEICE.2017.8191926, DOI 10.1109/SSCI.2017.8280908]; Sundermeyer M, 2012, 13TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2012 (INTERSPEECH 2012), VOLS 1-3, P194; van Dijk L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160817; Wang PS, 2016, COGN COMPUT, V8, P982, DOI 10.1007/s12559-016-9388-6; Wu ZX, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P461, DOI 10.1145/2733373.2806222; Xu K, 2015, PR MACH LEARN RES, V37, P2048; Yun LK, 2013, INT C MATH METH COMP, P50; Zhai XL, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00379; Zhang X, 2010, INT J CONTROL AUTOM, V8, P392, DOI 10.1007/s12555-010-0226-4	61	134	139	17	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2018	13	10							e0206049	10.1371/journal.pone.0206049	http://dx.doi.org/10.1371/journal.pone.0206049			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7AD	30376567	Green Published, gold, Green Submitted			2022-12-26	WOS:000448752400006
J	Araujo, ED; Borges, AC; Dias, NM; Ribeiro, DM				Araujo, Edcassio Dias; Borges, Alisson Carraro; Dias, Neriamara Martins; Ribeiro, Dimas Mendes			Effects of gibberellic acid on Tifton 85 bermudagrass (Cynodon spp.) in constructed wetland systems	PLOS ONE			English	Article							POLLUTANT REMOVAL EFFICIENCY; WASTE-WATER TREATMENT; GROWTH; PLANTS; SALINITY; NITROGEN; QUALITY; GENES; YIELD; GRASS	This study aimed to evaluate 1) the influence of gibberellic acid (GA(3)) in the development of Tifton 85 bermudagrass grown in constructed wetland systems (CWs) and 2) the plant's capacity to remove nutrients and sodium from synthetic municipal wastewater (SMW). The experiment was carried out in Vicosa, Minas Gerais, Brazil, and consisted of foliar applications of GA(3) set in randomized blocks design, with four replicates and 6 treatments as following: NC (control with plants); 0 mu M GA(3); N1: 5 mu M GA(3); N2: 25 mu M GA(3); N3: 50 and N4: 100 mu M GA(3) per CWs, NC* (control with no plants): 0 mu M GA(3). The study was conducted over two crop cycles in the spring 2016. The parameters used to evaluate the performance of the Tifton 85 bermudagrass were its plant height, productivity, chlorophyll measurement, number of internodes, nutrients and Na removals. Chemical analyses of the effluents were conducted. In response to the application of GA(3), the increase in height of Tifton 85 bermudagrass in the first crop cycle was higher than the increase in height in the second crop cycle. The decrease in plant growth in response to GA(3) in the second crop cycle may be linked to the age of the plant tissue and climatic conditions. The greater growth of the plants cultivated in the CWs allows a more efficient removal of pollutants, using simple management and low cost. The results suggest that applying 50 mu M of GA(3) to the development of Tifton 85 bermudagrass provides higher dry matter yield and removal of nitrogen, phosphorus, and sodium for the first crop cycle in CWs. However, in the second crop cycle, the application of GA(3) had no effect on dry matter production and nutrient removal by Tifton 85 bermudagrass in CWs.	[Araujo, Edcassio Dias; Borges, Alisson Carraro; Dias, Neriamara Martins] Univ Fed Vicosa, Dept Agr Engn, Vicosa, MG, Brazil; [Dias, Neriamara Martins] Univ Illinois, Dept Agr & Biol Engn, Urbana, IL USA; [Ribeiro, Dimas Mendes] Univ Fed Vicosa, Dept Plant Biol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; University of Illinois System; University of Illinois Urbana-Champaign; Universidade Federal de Vicosa	Borges, AC (corresponding author), Univ Fed Vicosa, Dept Agr Engn, Vicosa, MG, Brazil.	borges@ufv.br	Ribeiro, Dimas/C-4437-2016; Borges, Alisson Carraro/E-8024-2010; Borges, Alisson/AHB-7521-2022	Borges, Alisson Carraro/0000-0002-9729-6439; Borges, Alisson/0000-0002-9729-6439; Araujo, Edcassio/0000-0002-8503-4773	Minas Gerais State Agency for Research and Development - FAPEMIG [PPM-00561-17]	Minas Gerais State Agency for Research and Development - FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Minas Gerais State Agency for Research and Development - FAPEMIG - Grant PPM-00561-17 (ACB). www.fapemig.br	American Public Health Association, 2012, INDIAN J ENV SCI, V22nd ed.; [Anonymous], 2008, REV AMBIENTE AGUA TA; [Anonymous], 2008, CODE STATE REGULATIO; [Anonymous], 2003, WASTEWATER ENG TREAT; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Barros AL, 2005, THESIS; Bertin C, 2003, PLANT SOIL, V256, P67, DOI 10.1023/A:1026290508166; Cakir R, 2015, J ENVIRON MANAGE, V164, P121, DOI 10.1016/j.jenvman.2015.08.037; Choudhary A.K., 2010, WORLD ACAD SCI ENG T, V80, P67; COELHO YD, 1983, PESQUI AGROPECU BRAS, V18, P1229; Cruz CD, 2013, ACTA SCI-AGRON, V35, P271, DOI 10.4025/actasciagron.v35i3.21251; de Matos AT, 2010, REV BRAS ENG AGR AMB, V14, P1311, DOI 10.1590/S1415-43662010001200009; Dunne EJ, 2005, NUTRIENT MANAGEMENT IN AGRICULTURAL WATERSHEDS: A WETLANDS SOLUTION, P105; Fia FRL, 2016, THESIS; Hameed M, 2010, PAK J BOT, V42, P279; Hansson LA, 2005, FRESHWATER BIOL, V50, P705, DOI 10.1111/j.1365-2427.2005.01352.x; Herouvim E, 2011, ECOL ENG, V37, P931, DOI 10.1016/j.ecoleng.2011.01.018; Kadlec R.H., 2008, TREATMENT WETLANDS, DOI DOI 10.1201/9781420012514; Kaur S, 1998, PLANT GROWTH REGUL, V26, P85, DOI 10.1023/A:1006008711079; Khan NA, 2002, PLANT GROWTH REGUL, V38, P243, DOI 10.1023/A:1021523707239; Kiehl E.J., 1985, FERTILIZANTES ORGANI, V1st; Leverenz HL, 2010, ECOL ENG, V36, P1544, DOI 10.1016/j.ecoleng.2010.03.014; Liang YX, 2017, CHEMOSPHERE, V187, P52, DOI 10.1016/j.chemosphere.2017.08.087; Martins RG, 2012, COMUN SCI, V3, P306; MATOS A. T., 2015, MANUAL ANALISE RESID; Matos AT, 2010, REV BRAS ENG AGR AMB, V14, P510, DOI 10.1590/S1415-43662010000500008; Matos AT, 2017, DISPOSIC AGUAS RESID; Nopens I, 2001, DEP APPL MATH BIOMET; Parsons AJ, 2013, GRASS FORAGE SCI, V68, P577, DOI 10.1111/gfs.12035; Pereira OG, 2011, ENGENHARIA AGR VICOS, V19, P469; Pires EJP, 2012, CULTIVO VIDEIRA NIAG, P282; RIBEIRO A. C., 1999, RECOM USO CORRETIVOS, V1; Ribeiro DM, 2012, PLANT PHYSIOL, V160, P1781, DOI 10.1104/pp.112.204842; Santos SR, 2016, BRAZ J IRRIG DRAINA, V21, P40; Sarmento AP, 2012, WATER AIR SOIL POLL, V223, P1065, DOI 10.1007/s11270-011-0924-4; Shutes RBE, 2001, ENVIRON INT, V26, P441, DOI 10.1016/S0160-4120(01)00025-3; Silva FC, 2009, MANUAL ANALISES QUIM; TAIZ L., 2013, FISIOLOGIA VEGETAL, V5; Tuna AL, 2008, ENVIRON EXP BOT, V62, P1, DOI 10.1016/j.envexpbot.2007.06.007; Tuttolomondo T, 2016, ECOL ENG, V87, P295, DOI 10.1016/j.ecoleng.2015.11.036; Ucker Fernando Ernesto, 2012, Rev. Ambient. Água, V7, P87, DOI 10.4136/ambi-agua.925; United States Environmental Protection Agency (EPA), 2012, GUID WAT REUS; Van Rossum MH, 2013, PR N Z GRASSL ASSOC, V75, P145; Whitehead D, 2015, AGR ECOSYST ENVIRON, V207, P40, DOI 10.1016/j.agee.2015.03.019; Yu KW, 2007, SOIL SCI SOC AM J, V71, P1406, DOI 10.2136/sssaj2006.0155; Yu T., 1985, PHYS CHEM PADDY SOIL; Zang YX, 2016, SCI HORTIC-AMSTERDAM, V200, P13, DOI 10.1016/j.scienta.2015.12.057; Zurita F, 2009, ECOL ENG, V35, P861, DOI 10.1016/j.ecoleng.2008.12.026	48	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206378	10.1371/journal.pone.0206378	http://dx.doi.org/10.1371/journal.pone.0206378			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365537	Green Submitted, Green Published, gold			2022-12-26	WOS:000448448700048
J	Lyddon, C; Brown, JM; Leonardi, N; Plater, AJ				Lyddon, Charlotte; Brown, Jenny M.; Leonardi, Nicoletta; Plater, Andrew J.			Uncertainty in estuarine extreme water level predictions due to surge-tide interaction	PLOS ONE			English	Article							STORM-SURGE; SEA-LEVEL; SENSITIVITY-ANALYSIS; MEGHNA ESTUARY; EAST-COAST; BAY; VARIABILITY; ATLANTIC; CANADA; SOLENT	Storm surge is often the greatest threat to life and critical infrastructures during hurricanes and violent storms. Millions of people living in low-lying coastal zones and critical infrastructure within this zone rely on accurate storm surge forecast for disaster prevention and flood hazard mitigation. However, variability in residual sea level up-estuary, defined here as observed sea level minus predicted tide, can enhance total water levels; variability in the surge thus needs to be captured accurately to reduce uncertainty in site specific hazard assessment. Delft3D-FLOW is used to investigate surge variability, and the influence of storm surge timing on barotropic tide-surge propagation in a tide-dominant estuary using the Severn Estuary, south-west England, as an example. Model results show maximum surge elevation increases exponentially up-estuary and, for a range of surge timings consistently occurs on the flood tide. In the Severn Estuary, over a distance of 40 km from the most upstream tide gauge at Oldbury, the maximum surge elevation increases by 255%. Up-estuary locations experience short duration, high magnitude surge elevations and greater variability due to shallow-water effects and channel convergence. The results show that surge predictions from forecasting systems at tide gauge locations could under-predict the magnitude and duration of surge contribution to up-estuary water levels. Due to the large tidal range and dynamic nature of hyper-tidal estuaries, local forecasting systems should consider changes in surge elevation and shape with distance up-estuary from nearby tide gauge sites to minimize uncertainties in flood hazard assessment.	[Lyddon, Charlotte; Leonardi, Nicoletta; Plater, Andrew J.] Univ Liverpool, Dept Geog & Planning, Liverpool, Merseyside, England; [Lyddon, Charlotte; Brown, Jenny M.] Natl Oceanog Ctr Liverpool, Joseph Proudman Bldg, Liverpool, Merseyside, England	University of Liverpool; NERC National Oceanography Centre	Lyddon, C (corresponding author), Univ Liverpool, Dept Geog & Planning, Liverpool, Merseyside, England.; Lyddon, C (corresponding author), Natl Oceanog Ctr Liverpool, Joseph Proudman Bldg, Liverpool, Merseyside, England.	C.E.Lyddon@liverpool.ac.uk		Lyddon, Charlotte/0000-0003-4254-3049	Engineering and Physical Sciences Research Council as part of the Adaptation and Resilience of Coastal Energy Supply (ARCoES) project [EP/103590/1]; EPSRC Impact Acceleration Account; UK NERC BLUEcoast Project [NE/N015924/1]; Engineering and Physical Sciences Research Council [EP/I035390/1] Funding Source: researchfish; Natural Environment Research Council [NE/N015614/1] Funding Source: researchfish; EPSRC [EP/I035390/1] Funding Source: UKRI; NERC [NE/N015894/1, NE/N015614/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council as part of the Adaptation and Resilience of Coastal Energy Supply (ARCoES) project(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC Impact Acceleration Account(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK NERC BLUEcoast Project; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Engineering and Physical Sciences Research Council as part of the Adaptation and Resilience of Coastal Energy Supply (ARCoES) project, grant number EP/103590/1 to AJP and an EPSRC Impact Acceleration Account administered through the University of Liverpool. The research is also a contribution to UK NERC BLUEcoast Project (NE/N015924/1).	Antony C, 2013, ESTUAR COAST SHELF S, V131, P6, DOI 10.1016/j.ecss.2013.08.004; As-Salek JA, 1998, J PHYS OCEANOGR, V28, P227, DOI 10.1175/1520-0485(1998)028<0227:CTAFEO>2.0.CO;2; As-Salek JA, 2001, J PHYS OCEANOGR, V31, P3059, DOI 10.1175/1520-0485(2001)031<3059:TSIITM>2.0.CO;2; AUBREY DG, 1985, ESTUAR COAST SHELF S, V21, P185, DOI 10.1016/0272-7714(85)90096-4; Bastidas LA, 2016, NAT HAZARD EARTH SYS, V16, P2195, DOI 10.5194/nhess-16-2195-2016; Batstone C, 2013, OCEAN ENG, V71, P28, DOI 10.1016/j.oceaneng.2013.02.003; Bernier NB, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003168; Bernier NB, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003793; Bernier NB, 2015, OCEAN MODEL, V86, P114, DOI 10.1016/j.ocemod.2014.12.002; Bobanovic J, 2006, ATMOS OCEAN, V44, P151, DOI 10.3137/ao.440203; Brown JM, 2018, OCEAN COAST MANAGE, V163, P101, DOI 10.1016/j.ocecoaman.2018.06.007; Brown JM, 2016, OCEAN MODEL, V107, P48, DOI 10.1016/j.ocemod.2016.10.005; Brown JM, 2016, J ENVIRON MANAGE, V184, P400, DOI 10.1016/j.jenvman.2016.09.090; Brown JM, 2014, ESTUAR COAST, V37, P1041, DOI 10.1007/s12237-013-9745-6; Brown JM, 2012, OCEAN DYNAM, V62, P969, DOI 10.1007/s10236-012-0543-7; Brown JM, 2011, J MARINE SYST, V87, P13, DOI 10.1016/j.jmarsys.2011.02.006; Byrne D, 2017, IMPROVING SEA LEVEL; Chow V.T., 1959, OPEN CHANNEL HYDRAUL; Davies J.L., 1964, Z GEOMORPHOL, V8, P27; de Moel H, 2012, NAT HAZARD EARTH SYS, V12, P1045, DOI 10.5194/nhess-12-1045-2012; Desplanque C, 1999, GEOGR REV, V89, P23, DOI 10.2307/216138; Desplanque C, 2004, ATL GEOL, V40, P3; Dixon M. J., 1994, EXTREME SEA LEVELS U; DRONKERS J, 1986, NETH J SEA RES, V20, P117, DOI 10.1016/0077-7579(86)90036-0; Dyer KR, 1995, SEDIMENT TRANSPORT P, P423; Erikson L, 2018, J MAR SCI ENG, V6, DOI 10.3390/jmse6030076; Ferrarin C, 2013, OCEAN MODEL, V61, P38, DOI 10.1016/j.ocemod.2012.10.003; Ferreira CM, 2014, J GEOPHYS RES-OCEANS, V119, P1365, DOI [10.1002/2014JC010224, DOI 10.1002/2014JC010224.RECEIVED]; Flather RA, 2001, ENCY OCEAN SCI, P2882, DOI DOI 10.1006/RWOS.2001.0124; Flowerdew J, 2013, Q J ROY METEOR SOC, V139, P184, DOI 10.1002/qj.1950; Garzon JL, 2016, J MAR SCI ENG, P4, DOI [10.3390/jmse4020041, DOI 10.3390/JMSE4020041]; Greenberg DA, 2012, ATMOS OCEAN, V50, P261, DOI 10.1080/07055900.2012.668670; Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Hibbert A, 2015, J OPER OCEANOGR, V8, P40, DOI 10.1080/1755876X.2015.1014641; Horsburgh K, 2006, WEATHER, V61, P272, DOI DOI 10.1256/WEA.133.05; Horsburgh KJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004033; Idier D, 2012, NAT HAZARD EARTH SYS, V12, P3709, DOI 10.5194/nhess-12-3709-2012; Kates RW, 2006, P NATL ACAD SCI USA, V103, P14653, DOI 10.1073/pnas.0605726103; Kim SY, 2008, APPL OCEAN RES, V30, P311, DOI 10.1016/j.apor.2009.02.003; Knight PJ, 2015, NAT HAZARD EARTH SYS, V15, P1457, DOI 10.5194/nhess-15-1457-2015; Lesser GR, 2004, COAST ENG, V51, P883, DOI 10.1016/j.coastaleng.2004.07.014; Lewis M, 2013, ESTUAR COAST SHELF S, V123, P19, DOI 10.1016/j.ecss.2013.02.009; Lewis M, 2013, Q J ROY METEOR SOC, V139, P358, DOI 10.1002/qj.2040; Lewis M, 2011, J COASTAL RES, V27, P870, DOI 10.2112/JCOASTRES-D-10-00147.1; Liu WC, 2016, ENVIRON FLUID MECH, V16, P721, DOI 10.1007/s10652-015-9441-0; Lyddon C, 2018, ESTUAR COAST, V41, P1565, DOI 10.1007/s12237-018-0384-9; Martyr RC, 2013, J HYDRAUL ENG, V139, P492, DOI 10.1061/(ASCE)HY.1943-7900.0000699; Maskell J, 2014, J COASTAL RES, V30, P248, DOI 10.2112/JCOASTRES-D-12-00221.1; McMillan A, 2011, COASTAL FLOOD BOUNDA; PRANDLE D, 1978, GEOPHYS J ROY ASTR S, V55, P203, DOI 10.1111/j.1365-246X.1978.tb04758.x; Prime T., 2016, SCI POLICY, V59, P1, DOI DOI 10.1016/J.ENVSCI.2016.01.018; Prime T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117030; PROUDMAN J, 1955, PROC R SOC LON SER-A, V231, P8, DOI 10.1098/rspa.1955.0153; Pugh D., 1987, TIDES SURGES MEAN SE; Pye K, 2010, CONSIDERATION EXTREM, V2010; Pye K, 2014, ESTUAR COAST SHELF S, V150, P196, DOI 10.1016/j.ecss.2014.05.014; Quinn N, 2014, J GEOPHYS RES-OCEANS, V119, P4983, DOI 10.1002/2014JC010197; Quinn N, 2012, ESTUAR COAST SHELF S, V112, P162, DOI 10.1016/j.ecss.2012.07.011; Rego JL, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005285; Roberts KJ, 2015, J APPL METEOROL CLIM, V54, P1773, DOI 10.1175/JAMC-D-14-0314.1; ROSSITER JR, 1961, GEOPHYS J ROY ASTR S, V6, P29, DOI 10.1111/j.1365-246X.1961.tb02960.x; Saltelli A, 1999, J GEOPHYS RES-ATMOS, V104, P3789, DOI 10.1029/1998JD100042; Shen J, 2006, ESTUAR COAST SHELF S, V68, P1, DOI 10.1016/j.ecss.2005.12.018; Sibley A, 2015, WEATHER, V70, P62, DOI 10.1002/wea.2471; Spencer T, 2015, EARTH-SCI REV, V146, P120, DOI 10.1016/j.earscirev.2015.04.002; Steele M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005849; Tang YM, 1996, J PHYS OCEANOGR, V26, P2700, DOI 10.1175/1520-0485(1996)026<2700:ANSOSS>2.0.CO;2; UNCLES RJ, 1984, MAR POLLUT BULL, V15, P47, DOI 10.1016/0025-326X(84)90461-2; Wadey MP, 2013, NAT HAZARDS, V67, P829, DOI 10.1007/s11069-013-0610-5; Wainwright DJ, 2015, COAST ENG, V96, P92, DOI 10.1016/j.coastaleng.2014.11.009; Wolf J, 2005, PHILOS T R SOC A, V363, P1359, DOI 10.1098/rsta.2005.1572	71	18	19	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206200	10.1371/journal.pone.0206200	http://dx.doi.org/10.1371/journal.pone.0206200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365514	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000448448700029
J	Bidot, WA; Ericsson, AC; Franklin, CL				Bidot, Willie A.; Ericsson, Aaron C.; Franklin, Craig L.			Effects of water decontamination methods and bedding material on the gut microbiota	PLOS ONE			English	Article							LACTOBACILLUS-PLANTARUM PS128; DRINKING-WATER; AMMONIA LEVELS; EARLY-LIFE; CORNCOB; MICE; PH; BEHAVIOR; DISEASE; HEALTH	Rodent models are invaluable to understanding health and disease in many areas of biomedical research. Unfortunately, many models suffer from lack of phenotype reproducibility. Our laboratory has shown that differences in gut microbiota (GM) can modulate phenotypes of models of colon cancer and inflammatory bowel disease. We and others have also shown that a number of factors associated with rodent research, including vendor, cage system, and bedding can alter GM. The objective of this study was to expand these studies to examine the effect of additional bedding materials and methods of water decontamination on GM diversity and composition. To this end, Crl:CD1 (ICR) mice were housed on corn cob or compressed paper chip bedding and provided water that was decontaminated by four different methods: autoclaving with reverse osmosis, autoclaving with hydrochloric acid, autoclaving with sulfuric acid, and autoclaving alone. Feces was collected at day 0, and at day 28 (endpoint), fecal and cecal samples were collected. DNA was extracted from samples, amplified by PCR using conserved bacterial primer sets and subjected to next generation sequencing. Sequence data were analyzed using Qiime and groups were compared using principal coordinate analysis (PCoA) and permutational multivariate analysis of variance (PERMANOVA). Two factor PERMANOVA of cecal GM data revealed significant changes when comparing bedding and water decontamination methods, while no significant effects were noted in the fecal GM data. Subsequent PERMANOVA and PCoA of cecal data revealed that several combinations of bedding and water decontamination methods resulted in differing GM, highlighting the complexity by which environmental factors interact to modulate GM.	[Bidot, Willie A.; Ericsson, Aaron C.; Franklin, Craig L.] Univ Missouri, Comparat Med Program, Columbia, MO 65211 USA; [Ericsson, Aaron C.; Franklin, Craig L.] Univ Missouri, Metagen Ctr, Columbia, MO 65211 USA; [Ericsson, Aaron C.; Franklin, Craig L.] Univ Missouri, Mutant Mouse Resource & Res Ctr, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Franklin, CL (corresponding author), Univ Missouri, Comparat Med Program, Columbia, MO 65211 USA.; Franklin, CL (corresponding author), Univ Missouri, Metagen Ctr, Columbia, MO 65211 USA.; Franklin, CL (corresponding author), Univ Missouri, Mutant Mouse Resource & Res Ctr, Columbia, MO 65211 USA.	franklinc@missouri.edu	Ericsson, Aaron C./AAJ-1406-2021	Ericsson, Aaron C./0000-0002-3053-7269; Bidot, Willie/0000-0001-6701-160X	NIH HHS [U42 OD010918, K01 OD019924] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD010918, K01OD019924] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambery AG, 2014, J AM ASSOC LAB ANIM, V53, P449; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Burn CC, 2005, LAB ANIM-UK, V39, P68, DOI 10.1258/0023677052886592; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; DeZuane J., 1997, HDB DRINKING WATER Q; Dinan TG, 2015, J PSYCHIATR RES, V63, P1, DOI 10.1016/j.jpsychires.2015.02.021; Drewes JE, 2005, ENVIRON PROG, V24, P400, DOI 10.1002/ep.10110; Ericsson AC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21986-7; Ericsson AC, 2015, ONCOTARGET, V6, P33689, DOI 10.18632/oncotarget.5604; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Ferrecchia CE, 2014, J AM ASSOC LAB ANIM, V53, P146; Franklin CL, 2017, LAB ANIMAL, V46, P114, DOI 10.1038/laban.1222; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; HALL JE, 1980, LAB ANIM SCI, V30, P643; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hart ML, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00792; Hart ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143334; HERMANN LM, 1982, LAB ANIM SCI, V32, P603; Johnson BM, 2015, CLIN EXP IMMUNOL, V181, P323, DOI 10.1111/cei.12609; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Koontz JM, 2016, J AM ASSOC LAB ANIM, V55, P25; Krohn TC, 2008, SCAND J LAB ANIM SCI, V35, P231; LES EP, 1968, LAB ANIM CARE, V18, P210; Leys LJ, 2012, J AM ASSOC LAB ANIM, V51, P764; Liu WH, 2016, BEHAV BRAIN RES, V298, P202, DOI 10.1016/j.bbr.2015.10.046; Liu YW, 2016, BRAIN RES, V1631, P1, DOI 10.1016/j.brainres.2015.11.018; Livingston M, 2010, IMMUNOL CELL BIOL, V88, P99, DOI 10.1038/icb.2009.71; Ma BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047416; Markaverich B, 2002, ENVIRON HEALTH PERSP, V110, P169, DOI 10.1289/ehp.02110169; MCPHERSON C W, 1963, Lab Anim Care, V13, P737; Montonye DR, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01085; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; Ohsawa K, 2015, NUTR NEUROSCI, V18, P232, DOI 10.1179/1476830514Y.0000000122; Ottman N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173004; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ras T, 2002, LAB ANIM-UK, V36, P420, DOI 10.1258/002367702320389080; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sasada T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132435; Servick K, 2016, SCIENCE, V353, P741, DOI 10.1126/science.353.6301.741; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Smith E, 2004, CONTEMP TOP LAB ANIM, V43, P12; Sofi MH, 2015, DIABETES, V64, pE20, DOI 10.2337/db15-0554; Sofi MH, 2014, DIABETES, V63, P632, DOI 10.2337/db13-0981; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Tannock GW, 2004, APPL ENVIRON MICROB, V70, P3189, DOI 10.1128/AEM.70.6.3189-3194.2004; Villalon Landeros R., 2012, ENDOCRINOLOGY, V153, P949, DOI DOI 10.1210/EN.2011-1745; Whiteside TE, 2010, J AM ASSOC LAB ANIM, V49, P184; Wolf KJ, 2014, J HISTOCHEM CYTOCHEM, V62, P237, DOI 10.1369/0022155413519650; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhao YG, 2015, DIABETES, V64, pE19, DOI 10.2337/db15-0321	58	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0198305	10.1371/journal.pone.0198305	http://dx.doi.org/10.1371/journal.pone.0198305			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359379	gold, Green Published, Green Submitted			2022-12-26	WOS:000448438400002
J	Jeong, MJ; Kim, YC; Jeong, BH				Jeong, Min-Ju; Kim, Yong-Chan; Jeong, Byung-Hoon			Prion-like protein gene (PRND) polymorphisms associated with scrapie susceptibility in Korean native black goats	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; 1ST REPORT; CODON 146; BOVINE; BREEDS; SHEEP; RESISTANCE; VARIANTS; CATTLE; S146	The polymorphisms of the prion protein (PRNP) gene, which encodes normal prion proteins (PrP), are known to be involved in the susceptibility of prion diseases. The prion-like protein (Doppel) gene (PRND) is the paralog of the PRNP gene and is closely located downstream of the PRNP gene. In addition, the polymorphisms of PRND correlate with disease susceptibility in several animals. We analyzed the genotype and allele frequencies of PRND polymorphisms in 246 Korean native black goats and found a total of six single nucleotide polymorphisms (SNPs) with one novel SNP, c.99C>T. We observed linkage disequilibrium (LD) within and between loci. PRND c.28T>C, c.151A>G, and c.385G>C and PRND c.65C>T and c.286G>A were in perfect LD and we have reported for the first time strong LD between PRND and PRNP or prion-related protein gene (PRNT) loci. Specifically, between the PRND c.28T>C, c.151A>G and c.385G>C and the PRNP codon 143, PRND c.99C>T and the PRNP codon 102 or PRND SNPs (c.28T>C, c.151A>G and c.385G>C) and PRNT SNP (c.321T>C). Furthermore, we confirmed that the genotype distribution of the PRNP p. His143Arg was significantly different according to that of the PRND c.28T>C (P< 0.0001). Finally, using PolyPhen-2 and PROVEAN, we predicted that two non-synonymous SNPs, c.65C>T and c.286G>A, in the PRND gene can have a detrimental effect on Doppel. To the best of our knowledge, this is the first report of genetic characteristics of the PRND gene in Korean native black goats.	[Jeong, Min-Ju; Kim, Yong-Chan; Jeong, Byung-Hoon] Chonbuk Natl Univ, Korea Zoonosis Res Inst, Iksan, Jeonbuk, South Korea; [Jeong, Min-Ju; Kim, Yong-Chan; Jeong, Byung-Hoon] Chonbuk Natl Univ, Dept Bioact Mat Sci, Jeonju, Jeonbuk, South Korea	Jeonbuk National University; Jeonbuk National University	Jeong, BH (corresponding author), Chonbuk Natl Univ, Korea Zoonosis Res Inst, Iksan, Jeonbuk, South Korea.; Jeong, BH (corresponding author), Chonbuk Natl Univ, Dept Bioact Mat Sci, Jeonju, Jeonbuk, South Korea.	bhjeong@jbnu.ac.kr	Jeong, Byung-Hoon/AAA-3425-2020	Jeong, Byung-Hoon/0000-0002-4525-9994	Basic Science Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2015R1D1A1A010599]; National Research Foundation of Korea (NRF) - Ministry of Education [2017R1A6A1A03015876]	Basic Science Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2015R1D1A1A010599) and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1A6A1A03015876). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acutis PL, 2008, J APPL MICROBIOL, V104, P1782, DOI 10.1111/j.1365-2672.2007.03703.x; Acutis PL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-8; Balbus N, 2005, MAMM GENOME, V16, P884, DOI 10.1007/s00335-005-0052-9; Barillet F, 2009, J GEN VIROL, V90, P769, DOI 10.1099/vir.0.006114-0; Baylis M, 2004, CURR MOL MED, V4, P385, DOI 10.2174/1566524043360672; Beck JA, 2008, J MED GENET, V45, P813, DOI 10.1136/jmg.2008.061804; Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; Billinis C, 2002, J GEN VIROL, V83, P713, DOI 10.1099/0022-1317-83-3-713; Cinar MU, 2018, VET J, V233, P19, DOI 10.1016/j.tvjl.2017.12.019; Comincini S, 2001, MAMM GENOME, V12, P729, DOI 10.1007/s00335-001-2064-4; Corbiere F, 2013, J GEN VIROL, V94, P241, DOI 10.1099/vir.0.047225-0; Croes EA, 2004, EUR J HUM GENET, V12, P389, DOI 10.1038/sj.ejhg.5201161; Ferreira LM, 2016, REPROD FERTIL DEV; Georgiadou S, 2017, EPIDEMIOL INFECT, V145, P326, DOI 10.1017/S0950268816002272; Goldmann W, 2016, VET REC, V178, DOI 10.1136/vr.103521; Goldmann W, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-110; Hwang YH, 2017, KOREAN J FOOD SCI AN, V37, P948, DOI 10.5851/kosfa.2017.37.6.948; Jang SY, 2017, ASIAN AUSTRAL J ANIM, V30, P1405, DOI 10.5713/ajas.16.0868; Jeong BH, 2005, NEUROGENETICS, V6, P229, DOI 10.1007/s10048-005-0016-y; Jeong BH, 2005, EUR J HUM GENET, V13, P1094, DOI 10.1038/sj.ejhg.5201460; Jeong BH, 2005, J HUM GENET, V50, P311, DOI 10.1007/s10038-005-0254-8; Jeong BH, 2004, J HUM GENET, V49, P319, DOI 10.1007/s10038-004-0150-7; Jeong BH, 2014, J KOREAN MED SCI, V29, P623, DOI 10.3346/jkms.2014.29.5.623; Kim YC, 2018, VET REC, V182, P717, DOI 10.1136/vr.104123; Kim YC, 2018, J DAIRY RES, V85, P7, DOI [10.1017/s0022029917000814, 10.1017/S0022029917000814]; Kim YC, 2017, ACTA VET HUNG, V65, P291, DOI 10.1556/004.2017.028; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lacroux C, 2014, J VIROL, V88, P2406, DOI 10.1128/JVI.02872-13; Madsen-Bouterse SA, 2015, J VET DIAGN INVEST, V27, P332, DOI 10.1177/1040638715585865; Maestrale C, 2015, J VIROL, V89, P10044, DOI 10.1128/JVI.01262-15; Mesquita P, 2010, ANIM GENET, V41, P311, DOI 10.1111/j.1365-2052.2009.01992.x; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Ortiz-Pelaez A, 2015, EPIDEMIOL INFECT, V143, P1304, DOI 10.1017/S0950268814002064; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Papasavva-Stylianou P, 2017, J VIROL, V91, DOI [10.1128/JVI.01142-17, 10.1128/jvi.01142-17]; Papasavva-Stylianou P, 2011, VET J, V187, P245, DOI 10.1016/j.tvjl.2009.10.015; Peletto S, 2012, J GEN VIROL, V93, P1620, DOI 10.1099/vir.0.041400-0; Peoc'h K, 2000, NEUROSCI LETT, V286, P144, DOI 10.1016/S0304-3940(00)01100-9; Pereira RM, 2018, THERIOGENOLOGY, V115, P124, DOI 10.1016/j.theriogenology.2018.04.014; Pereira RM, 2009, ANIM REPROD SCI, V114, P157, DOI 10.1016/j.anireprosci.2008.10.003; Petraroli R, 1996, AM J HUM GENET, V58, P888; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RICCI A, 2017, EFSA J, V0015; Schroder B, 2001, HUM GENET, V109, P319, DOI 10.1007/s004390100591; Son YS, 1999, SMALL RUMINANT RES, V34, P303, DOI 10.1016/S0921-4488(99)00081-4; Uboldi C, 2005, MAMM GENOME, V16, P963, DOI 10.1007/s00335-005-0084-1; Vaccari G, 2009, VET RES, V40; White SN, 2012, GENE, V501, P49, DOI 10.1016/j.gene.2012.03.068	48	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206209	10.1371/journal.pone.0206209	http://dx.doi.org/10.1371/journal.pone.0206209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359416	Green Published, gold, Green Submitted			2022-12-26	WOS:000448438400052
J	Willett, DS; Alborn, HT; Stelinski, LL; Shapiro-Ilan, DI				Willett, Denis S.; Alborn, Hans T.; Stelinski, Lukasz L.; Shapiro-Ilan, David I.			Risk taking of educated nematodes	PLOS ONE			English	Article							ENTOMOPATHOGENIC NEMATODES; STEINERNEMA; IMMUNITY	Nematode parasites rely on successful host infection to perpetuate their species. Infection by individual nematode parasites can be risky, however; any one individual could be killed by the host's immune response. Here we use a model system to show that environmental cues and parasite past experience can be used by entomopathogenic nematodes to reduce individual risk of infection. Past parasite experience can more than double the infective virulence (number of host invaders) of a given cohort of entomopathogenic nematode parasites. This plasticity in individual parasite risk-taking and associated infection can be used to manage infection of parasitic nematodes: enhancing biological control with entomopathogenic nematodes and developing behavioral and chemical strategies to reduce infection by vertebrate and plant parasitic nematodes.	[Willett, Denis S.] Cornell Univ, Dept Entomol, Cornell AgriTech, Geneva, NY USA; [Alborn, Hans T.] ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Stelinski, Lukasz L.] Univ Florida, Ctr Citrus Res & Educ, Dept Entomol & Nematol, Lake Alfred, FL USA; [Shapiro-Ilan, David I.] ARS, USDA, SE Fruit & Tree Nut Res Lab, Byron, GA 31008 USA	Cornell University; United States Department of Agriculture (USDA); State University System of Florida; University of Florida; United States Department of Agriculture (USDA)	Alborn, HT (corresponding author), ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.; Shapiro-Ilan, DI (corresponding author), ARS, USDA, SE Fruit & Tree Nut Res Lab, Byron, GA 31008 USA.	hans.alborn@ars.usda.gov; david.shapiro@ars.usda.gov		Shapiro-Ilan, David/0000-0002-5666-4848				Ali JG, 2011, J ECOL, V99, P26, DOI 10.1111/j.1365-2745.2010.01758.x; Ali JG, 2010, J CHEM ECOL, V36, P361, DOI 10.1007/s10886-010-9773-7; Castelletto ML, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004305; Choe A, 2012, CURR BIOL, V22, P772, DOI 10.1016/j.cub.2012.03.024; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Fox J., 2019, R COMPANION APPL REG, V.; Fushing H, 2008, ANN APPL STAT, V2, P1503, DOI 10.1214/08-AOAS189; Grencis RK, 2015, ANNU REV IMMUNOL, V33, P201, DOI 10.1146/annurev-immunol-032713-120218; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaya Harry K., 1997, P281, DOI 10.1016/B978-012432555-5/50016-6; Kennedy MW, 2013, PARASITIC NEMATODES: MOLECULAR BIOLOGY, BIOCHEMISTRY AND IMMUNOLOGY, 2ND EDITION, P397, DOI 10.1079/9781845937591.0397; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Li XY, 2007, INT J PARASITOL, V37, P365, DOI 10.1016/j.ijpara.2006.08.009; Lin BR, 2016, NEW PHYTOL, V209, P1159, DOI 10.1111/nph.13701; MAULEON H, 1993, FUND APPL NEMATOL, V16, P185; Moncada DM, 2003, TRENDS PARASITOL, V19, P305, DOI 10.1016/S1471-4922(03)00122-3; Morrill A, 2016, AM NAT, V187, P225, DOI 10.1086/684508; Poulin R., 2011, EVOL ECOL; R. Core Team, 2015, R A LANGUAGE AND ENV; Rahatkhah Z, 2015, BIOCONTROL, V60, P641, DOI 10.1007/s10526-015-9678-z; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Riffkin M, 1996, IMMUNOLOGY CELL BIOL, V74; RStudio Team, 2015, INT DEV ENV R; Shapiro DI, 1999, ENVIRON ENTOMOL, V28, P907, DOI 10.1093/ee/28.5.907; Turlings TCJ, 2012, PLANT SOIL, V358, P47, DOI 10.1007/s11104-012-1295-3; WANG Y, 1994, J NEMATOL, V26, P11; Westerman PR, 1999, J INVERTEBR PATHOL, V73, P206, DOI 10.1006/jipa.1998.4801; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a; Wickham H., 2016, TIDYVERSE EASILY INS; Wickham H., 2016, READXL READ EXCEL FI; Willett DS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02193-2; Willett DS, 2015, SCI REP-UK, V5, DOI 10.1038/srep14388; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569	33	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0205804	10.1371/journal.pone.0205804	http://dx.doi.org/10.1371/journal.pone.0205804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359415	gold, Green Published, Green Submitted			2022-12-26	WOS:000448438400026
J	Hansen, SH; Overvad, K; Hansen, CP; Dahm, CC				Hansen, Sine Hammer; Overvad, Kim; Hansen, Camilla Plambeck; Dahm, Christina Catherine			Adherence to national food-based dietary guidelines and incidence of stroke: A cohort study of Danish men and women	PLOS ONE			English	Article							RISK-FACTORS; HEALTH; PREVENTION; DENMARK	Background and purpose National dietary guidelines are intended to promote primary prevention of lifestyle-related diseases, but little is known about their effectiveness in prevention of stroke. Methods We used the Danish cohort Diet, Cancer and Health (n = 57 053) to investigate whether adherence to the Danish food-based dietary guidelines was associated with risk of stroke. Adherence was assessed by the Danish Dietary Guidelines Index, score 0 [no adherence] to 6 [complete adherence]. Cox proportional hazards models were used to estimate adjusted hazard ratios and 95% confidence intervals for stroke and subtypes of stroke in men and women separately. Results Incident stroke was determined in 1357 men and 900 women during follow-up (median 12.5 years and 13.0 years, respectively). A higher Danish Dietary Guidelines Index score was inversely associated with total stroke in men but not in women. In men, a high Index score (>= 4) was also inversely associated with total ischemic stroke (hazard ratio 0.75, 95% confidence interval 0.65-0.86), large-artery atherosclerosis (hazard ratio 0.63, 95% confidence interval 0.44-0.92) and small artery occlusion (hazard ratio 0.68, 95% confidence interval 0.54-0.84) compared to a low Index score (<4). In women, inverse associations were found for total ischemic stroke (hazard ratio 0.84, 95% confidence interval 0.72-0.98) and intrace-rebral hemorrhage (hazard ratio 0.64, 95% confidence interval 0.43-0.96). Conclusions Our findings suggest that adherence to the Danish Dietary Guidelines is associated with a lower rate of stroke, and thus may be useful in primary prevention of disease.	[Hansen, Sine Hammer; Overvad, Kim; Dahm, Christina Catherine] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Hansen, Camilla Plambeck] Danish Clin Registries, Aarhus N, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital	Dahm, CC (corresponding author), Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark.	ccd@ph.au.dk	Dahm, Christina C/G-9787-2014	Dahm, Christina C/0000-0003-0481-2893; Overvad, Kim/0000-0001-6429-7921	Danish Cancer Society	Danish Cancer Society(Danish Cancer Society)	The Danish Cancer Society (https://www.cancer.dk/research/) funded the Diet, Cancer and Health study. The authors received no specific funding for this work.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 2014, NORDISK NORDIC NUTR; [Anonymous], 2016, ICD 10 VERS 2016; [Anonymous], 2016, DEATHS CAUS AG SEX C; Boehme AK, 2017, CIRC RES, V120, P472, DOI 10.1161/CIRCRESAHA.116.308398; Freedman LS, 2011, J NATL CANCER I, V103, P1086, DOI 10.1093/jnci/djr189; Hansen CP, PUBLIC HEALTH NUTR, V359, DOI [10.1016/j.ijcard.2014.07.017, DOI 10.1016/J.IJCARD.2014.07.017]; Luhdorf P, 2017, SCAND J PUBLIC HEALT, V45, P630, DOI 10.1177/1403494817716582; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Moller A., 1983, LEVNEDSMIDDELTABELLE; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; Schwingshackl L, 2015, J ACAD NUTR DIET, V115, P780, DOI 10.1016/j.jand.2014.12.009; Struijk EA, 2014, INT J CARDIOL, V176, P354, DOI 10.1016/j.ijcard.2014.07.017; Tetens I, 2013, EVIDENCE FDN DANISH; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986	17	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206242	10.1371/journal.pone.0206242	http://dx.doi.org/10.1371/journal.pone.0206242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356304	Green Submitted, gold, Green Published			2022-12-26	WOS:000448434000084
J	Glucs, ZE; Smith, DR; Tubbs, CW; Scherbinski, JJ; Welch, A; Burnett, J; Clark, M; Eng, C; Finkelstein, ME				Glucs, Zeka E.; Smith, Donald R.; Tubbs, Christopher W.; Scherbinski, Jennie Jones; Welch, Alacia; Burnett, Joseph; Clark, Michael; Eng, Curtis; Finkelstein, Myra E.			Glucocorticoid measurement in plasma, urates, and feathers from California condors (Gymnogyps californianus) in response to a human-induced stressor	PLOS ONE			English	Article							BASE-LINE; CORTICOSTERONE METABOLITES; ADRENOCORTICAL-RESPONSE; ENZYME-IMMUNOASSAY; BIRDS; FIELD; WILD; TESTOSTERONE; CONFINEMENT; STABILITY	Vertebrates respond to stressful stimuli with the secretion of glucocorticoid (GC) hormones, such as corticosterone (CORT), and measurements of these hormones in wild species can provide insight into physiological responses to environmental and human-induced stressors. California condors (Gymnogyps californianus) are a critically endangered and intensively managed avian species for which information on GC response to stress is lacking. Here we evaluated a commercially available I (125) double antibody radioimmunoassay (RIA) and an enzyme-linked immunosorbent assay (ELISA) kit for measurement of CORT and GC metabolites (GCM) in California condor plasma, urate, and feather samples. The precision and accuracy of the RIA assay outperformed the ELISA for CORT and GCM measurements, and CORT and GCM values were not comparable between the two assays for any sample type. RIA measurements of total CORT in condor plasma collected from 41 condors within 15 minutes of a handling stressor were highly variable (median = 70 ng/mL, range = 1-189 ng/mL) and significantly different between wild and captive condors (p = 0.02, two-tailed t-test, n =10 wild and 11 captive). Urate GCM levels (median = 620 ng/g dry wt., range = 0.74-7200 ng/g dry wt., n = 216) significantly increased within 2 hr of the acute handling stressor (p = 0.032, n = 11 condors, one-tailed paired t-test), while feather section CORT concentrations (median = 18 pg/mm, range = 6.3-68 ng/g, n = 37) also varied widely within and between feathers. Comparison of multiple regression linear models shows condor age as a significant predictors of plasma CORT levels, while age, sex, and plasma CORT levels predicted GCM levels in urates collected within 30 min of the start of handling. Our findings highlight the need for validation when selecting an immunoassay for use with a new species, and suggest that non-invasively collected urates and feathers hold promise for assessing condor responses to acute or chronic environmental and human-induced stressors.	[Glucs, Zeka E.; Smith, Donald R.; Finkelstein, Myra E.] Univ Calif Santa Cruz, Microbiol & Environm Toxicol Dept, Santa Cruz, CA 95064 USA; [Tubbs, Christopher W.] San Diego Zoo Global, Inst Conservat Res, Escondido, CA USA; [Scherbinski, Jennie Jones; Welch, Alacia] Pinnacles Natl Pk, Natl Pk Serv, Paicines, CA USA; [Burnett, Joseph] Ventana Wildlife Soc, Monterey, CA USA; [Clark, Michael; Eng, Curtis] Los Angeles Zoo, Los Angeles, CA USA; [Clark, Michael; Eng, Curtis] Bot Gardens, Los Angeles, CA USA; [Scherbinski, Jennie Jones] Humboldt State Univ, Arcata, CA 95521 USA; [Eng, Curtis] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA USA	University of California System; University of California Santa Cruz; United States Department of the Interior; California State University System; California State Polytechnic University, Humboldt; Western University of Health Sciences	Glucs, ZE (corresponding author), Univ Calif Santa Cruz, Microbiol & Environm Toxicol Dept, Santa Cruz, CA 95064 USA.	zkuspa@ucsc.edu			Association of Zoos and Aquariums Conservation Endowment Fund [14-1239]; Western National Parks Association [14-02]; National Science Foundation [NSF DGE 1339067]	Association of Zoos and Aquariums Conservation Endowment Fund; Western National Parks Association; National Science Foundation(National Science Foundation (NSF))	This work was supported by Association of Zoos and Aquariums Conservation Endowment Fund (Award #14-1239, https://www.aza.org/) and the Western National Parks Association (Award #14-02, http://www.wnpa.org/). These funding sources had no involvement in the research design, collection, analysis and interpretation of data, writing the report, or in the decision to submit the article for publication. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship grant number NSF DGE 1339067 (https://www.nsfgrfp.org/).Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Baos R, 2006, ENVIRON HEALTH PERSP, V114, P1497, DOI 10.1289/ehp.9099; Baugh AT, 2014, GEN COMP ENDOCR, V208, P154, DOI 10.1016/j.ygcen.2014.08.014; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Bortolotti GR, 2009, J EXP BIOL, V212, P1477, DOI 10.1242/jeb.022152; Braun EJ., 2014, OSMOREGULATORY SYSTE, DOI [10.1016/B978-0-12-407160-5.00012-9, DOI 10.1016/B978-0-12-407160-5.00012-9]; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Busch DS, 2010, BIOL CONSERV, V143, P1039, DOI 10.1016/j.biocon.2009.12.028; Cockrem JF, 2007, J ORNITHOL, V148, pS169, DOI 10.1007/s10336-007-0175-8; Fairhurst GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017663; Fanson KV, 2017, METHODS ECOL EVOL, V8, P1745, DOI 10.1111/2041-210X.12821; Finkelstein M, 2015, CAL COND GYMN CAL, DOI [10.2173/bna.610, DOI 10.2173/BNA.610]; Finkelstein ME, 2010, ENVIRON SCI TECHNOL, V44, P2639, DOI 10.1021/es903176w; Finkelstein ME, 2014, ENVIRON RES, V134, P270, DOI 10.1016/j.envres.2014.07.022; Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; HARVEY S, 1984, J EXP ZOOL, V232, P633, DOI 10.1002/jez.1402320332; Herring G, 2012, ENVIRON SCI TECHNOL, V46, P6339, DOI 10.1021/es300668c; Herring G, 2009, J WILDLIFE MANAGE, V73, P1010, DOI 10.2193/2008-398; Hirschenhauser K, 2012, J ORNITHOL, V153, P1179, DOI 10.1007/s10336-012-0848-9; Jachowski DS, 2015, WILDLIFE SOC B, V39, P738, DOI 10.1002/wsb.592; Jankowski MD, 2009, PHYSIOL BIOCHEM ZOOL, V82, P190, DOI 10.1086/596513; Keay JM, 2006, J ZOO WILDLIFE MED, V37, P234, DOI 10.1638/05-050.1; Khan MZ, 2002, GEN COMP ENDOCR, V128, P57, DOI 10.1016/S0016-6480(02)00063-1; Koren L, 2012, P ROY SOC B-BIOL SCI, V279, P1560, DOI 10.1098/rspb.2011.2062; Kouwenberg AL, 2015, J FIELD ORNITHOL, V86, P73, DOI 10.1111/jofo.12090; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Legagneux P, 2011, GEN COMP ENDOCR, V172, P440, DOI 10.1016/j.ygcen.2011.04.009; Lopez-Jimenez L, 2017, OECOLOGIA, V183, DOI [10.1007/s00442-017-3848-x, DOI 10.1007/S00442-017-3848-X]; Madliger CL, 2015, BIOL CONSERV, V192, P409, DOI 10.1016/j.biocon.2015.10.021; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Miller R, 2013, PSYCHONEUROENDOCRINO, V38, P50, DOI 10.1016/j.psyneuen.2012.04.019; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Mostl E, 2005, ANN NY ACAD SCI, V1046, P17, DOI 10.1196/annals.1343.004; Nakagawa S, 2003, POLAR BIOL, V26, P491, DOI 10.1007/s00300-003-0506-z; Nilsson PB, 2008, COMP BIOCHEM PHYS A, V149, P275, DOI 10.1016/j.cbpa.2008.01.002; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Raff H, 2002, CLIN CHEM, V48, P207; Rettenbacher S, 2004, BRIT POULTRY SCI, V45, P704, DOI 10.1080/00071660400006156; Romero LM, 2016, COMP BIOCHEM PHYS A, V202, P112, DOI 10.1016/j.cbpa.2016.05.002; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Schoech SJ, 1999, AUK, V116, P64, DOI 10.2307/4089454; Schoech SJ, 2013, FUNCT ECOL, V27, P1100, DOI 10.1111/1365-2435.12142; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Staley AM, 2007, J COMP PHYSIOL B, V177, P609, DOI 10.1007/s00360-007-0159-2; Tempel DJ, 2004, CONSERV BIOL, V18, P538, DOI 10.1111/j.1523-1739.2004.00372.x; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; United States Fish and Wildlife Service, 2013, CAL COND 5 YEAR REV; Virgolini MB, 2005, TOXICOL SCI, V87, P469, DOI 10.1093/toxsci/kfi269; Walker BG, 2005, INTEGR COMP BIOL, V45, P12, DOI 10.1093/icb/45.1.12; Warnken T, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0828-z; Washburn BE, 2002, CONDOR, V104, P558, DOI 10.1650/0010-5422(2002)104[0558:UACART]2.0.CO;2; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Wilcoxen TE, 2011, GEN COMP ENDOCR, V173, P461, DOI 10.1016/j.ygcen.2011.07.007; Wingfield JC, 2002, INTEGR COMP BIOL, V42, P600, DOI 10.1093/icb/42.3.600; WINGFIELD JC, 1999, STRESS PHYSL ANIMALS	57	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0205565	10.1371/journal.pone.0205565	http://dx.doi.org/10.1371/journal.pone.0205565			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352070	Green Published, Green Submitted, gold			2022-12-26	WOS:000448076200009
J	Goncharuk, SA; Artemieva, LE; Tabakmakher, VM; Arseniev, AS; Mineev, KS				Goncharuk, Sergey A.; Artemieva, Lilya E.; Tabakmakher, Valentin M.; Arseniev, Alexander S.; Mineev, Konstantin S.			CARD domain of rat RIP2 kinase: Refolding, solution structure, pH-dependent behavior and protein-protein interactions	PLOS ONE			English	Article							CELL-DEATH; NOD2; RELAXATION; COUPLINGS; DISEASE; N-15	RIP2, one of the RIP kinases, interacts with p75 neurotrophin receptor, regulating the neuron survival, and with NOD1 and NOD2 proteins, causing the innate immune response against gram-negative and gram-positive bacteria via its caspase recruitment domain (CARD). This makes RIP2 a prospective target for novel therapies, aimed to modulate the inflammatory diseases and neurogenesis/neurodegeneration. Several studies report the problems with the stability of human RIP2 CARD and its production in bacterial hosts, which is a prerequisite for the structural investigation with solution NMR spectroscopy. In the present work, we report the high yield production and refolding protocols and resolve the structure of rat RIP2 CARD. The structure reveals the important differences to the previously published conformation of the homologous human protein. Using solution NMR, we characterized the intramolecular mobility and pH-dependent behavior of RIP2 CARD, and found the propensity of the protein to form high-order oligomers at physiological pH while being monomeric under acidic conditions. The oligomerization of protein may be explained, based on the electrostatic properties of its surface. Analysis of the structure and sequences of homologous proteins reveals the residues which are significant for the unusual fold of RIP2 CARD domains from different species. The high-throughput protein production/refolding protocols and proposed explanation for the protein oligomerization, provide an opportunity to design the stabilized variants of RIP2 CARD, which could be used to study the structural details of RIP2/NOD1/NOD2 interaction and perform the rational drug design.	[Goncharuk, Sergey A.; Artemieva, Lilya E.; Tabakmakher, Valentin M.; Arseniev, Alexander S.; Mineev, Konstantin S.] RAS, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Goncharuk, Sergey A.; Artemieva, Lilya E.; Arseniev, Alexander S.; Mineev, Konstantin S.] Moscow Inst Phys & Technol, Inst Per, Dolgoprudnyi, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Moscow Institute of Physics & Technology	Mineev, KS (corresponding author), RAS, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.; Mineev, KS (corresponding author), Moscow Inst Phys & Technol, Inst Per, Dolgoprudnyi, Russia.	mineev@nmr.ru	Mineev, Konstantin/AAC-6662-2019; Mineev, Konstantin S/Q-3948-2018; Tabakmakher, Valentin/M-6846-2013; Artemieva, Liliya/AGQ-3096-2022	Mineev, Konstantin/0000-0002-2418-9421; Mineev, Konstantin S/0000-0002-2418-9421; Tabakmakher, Valentin/0000-0002-6588-1561; Artemieva, Liliya/0000-0002-0807-7403; Goncharuk, Sergey/0000-0002-0263-6462	Russian Science Foundation [14-14-00573]; Russian Ministry of Education and Science [RFMEFI62117X0018]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	The work is supported by the Russian Science Foundation, grant #14-14-00573. Experiments were partially carried out using the equipment provided by the IBCH core facility (CKP IBCH, supported by Russian Ministry of Education and Science, grant RFMEFI62117X0018). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Canning P, 2015, CHEM BIOL, V22, P1174, DOI 10.1016/j.chembiol.2015.07.017; Charalampopoulos I, 2012, CELL REP, V2, P1563, DOI 10.1016/j.celrep.2012.11.009; Chill JH, 2006, J BIOMOL NMR, V36, P123, DOI 10.1007/s10858-006-9071-4; Chugunov AO, 2013, J BIOL CHEM, V288, P19014, DOI 10.1074/jbc.M112.431650; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Fridh V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034375; GRZESIEK S, 1993, J BIOMOL NMR, V3, P487; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; Humphries F, 2015, CELL DEATH DIFFER, V22, P225, DOI 10.1038/cdd.2014.126; Jun JC, 2013, J LEUKOCYTE BIOL, V94, P927, DOI 10.1189/jlb.0213109; Kazimierczuk K, 2012, J MAGN RESON, V223, P1, DOI 10.1016/j.jmr.2012.08.001; Khursigara G, 2001, J NEUROSCI, V21, P5854, DOI 10.1523/JNEUROSCI.21-16-05854.2001; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koromyslova AD, 2014, J CHEM INF MODEL, V54, P1189, DOI 10.1021/ci500158y; Lin Z, 2015, ELIFE, V4, DOI 10.7554/eLife.11692; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lohr F, 2007, J BIOMOL NMR, V37, P205, DOI 10.1007/s10858-006-9128-4; Maharana J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170232; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Navas TA, 1999, J BIOL CHEM, V274, P33684, DOI 10.1074/jbc.274.47.33684; Nembrini C, 2009, J BIOL CHEM, V284, P19183, DOI 10.1074/jbc.M109.006353; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park HH, 2011, APOPTOSIS, V16, P209, DOI 10.1007/s10495-010-0571-z; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pellegrini E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177161; Pervushin K, 1998, J AM CHEM SOC, V120, P6394, DOI 10.1021/ja980742g; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; VUISTER GW, 1993, J AM CHEM SOC, V115, P5334, DOI 10.1021/ja00065a071; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206244	10.1371/journal.pone.0206244	http://dx.doi.org/10.1371/journal.pone.0206244			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352081	Green Published, Green Submitted, gold			2022-12-26	WOS:000448076200042
J	Reeves, P; Edmunds, K; Levi, C; Lin, LT; Cheng, X; Aviv, R; Kleinig, T; Butcher, K; Zhang, JF; Parsons, M; Bivard, A				Reeves, Penny; Edmunds, Kim; Levi, Christopher; Lin, Longting; Cheng, Xin; Aviv, Richard; Kleinig, Tim; Butcher, Kenneth; Zhang, Jingfen; Parsons, Mark; Bivard, Andrew			Cost-effectiveness of targeted thrombolytic therapy for stroke patients using multi-modal CT compared to usual practice	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; COMPUTED-TOMOGRAPHY PERFUSION; PLASMINOGEN-ACTIVATOR; MANAGEMENT; PENUMBRA	Introduction The use of multimodal computed tomography imaging (MMCT) in routine clinical assessment of stroke patients improves the identification of patients with large regions of salvageable brain tissue, lower risk for haemorrhagic transformation, or a large vessel occlusion requiring endovascular therapy. Aim To evaluate the cost-effectiveness of using MMCT compared to usual practice for determining eligibility for reperfusion therapy with alteplase using real world data from the International Stroke Perfusion Imaging Registry (INSPIRE). Methods We performed a cost-utility analysis. Mean costs and quality-adjusted life years (QALYs) per patient for two alternative screening protocols were calculated. Protocol 1 represented usual practice, while Protocol 2 reflected treatment targeting using multimodal imaging. Cost-effectiveness was assessed using the net-benefit framework. Results Protocol 1 had a total mean per patient cost of $2,013 USD and 0.148 QALYs. Protocol 2 had a total mean per patient cost of $1,519 USD and 0.153 QALYs. For a range of willingness-to-pay values, representing implicit thresholds of cost-effectiveness, the lower bound of the incremental net monetary benefit statistic was consistently greater than zero, indicating that MMCT is cost- effective compared to usual practice. The results were most sensitive to variation in the mean number of alteplase vials administered. Conclusion In a healthcare setting where multimodal imaging technologies are available and reimbursed, their use in screening patients presenting with acute stroke to determine eligibility for alteplase treatment is cost-effective given a range of willingness-to-pay thresholds and warrants consideration as an alternative to routine practice.	[Reeves, Penny; Edmunds, Kim] HMRI, Hlth Res Econ, Newcastle, NSW, Australia; [Reeves, Penny; Edmunds, Kim; Levi, Christopher; Lin, Longting; Parsons, Mark; Bivard, Andrew] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia; [Levi, Christopher; Lin, Longting; Parsons, Mark; Bivard, Andrew] John Hunter Hosp, Dept Neurol, Newcastle, NSW, Australia; [Cheng, Xin] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai, Peoples R China; [Aviv, Richard] Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Toronto, ON, Canada; [Aviv, Richard] Univ Toronto, Toronto, ON, Canada; [Kleinig, Tim] Royal Adelaide Hosp, Dept Neurol, Adelaide, SA, Australia; [Butcher, Kenneth] Univ Alberta, Dept Med, Div Neurol, Edmonton, AB, Canada; [Zhang, Jingfen] Baotou Cent Hosp, Dept Neurol, Baotou, Peoples R China	Hunter Medical Research Institute; University of Newcastle; John Hunter Hospital; Fudan University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Royal Adelaide Hospital; University of Alberta	Edmunds, K (corresponding author), HMRI, Hlth Res Econ, Newcastle, NSW, Australia.; Edmunds, K (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia.	kim.edmunds@hmri.org.au	Edmunds, Kim/AAA-6771-2022; Cheng, Xin/AAF-4744-2019; Butcher, Ken/AEP-3693-2022; Butcher, Ken/ABC-6632-2020	Cheng, Xin/0000-0001-7816-0547; Butcher, Ken/0000-0002-0590-7918; Butcher, Ken/0000-0002-0590-7918; Levi, Christopher/0000-0002-9474-796X; kleinig, Timothy/0000-0003-4430-3276; Edmunds, Kim/0000-0001-7379-1294	National Health and Medical Research Council [APP1013719]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding from a National Health and Medical Research Council grant was used to support the research study outcomes data collection (APP1013719), CL, https://www.nhmrc.gov.au/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Bivard A, 2014, J NEURORADIOLOGY, V41, P307, DOI 10.1016/j.neurad.2013.11.006; Bivard A, 2017, STROKE, V48, P645, DOI 10.1161/STROKEAHA.116.015143; Bivard A, 2017, CIRCULATION, V135, P440, DOI 10.1161/CIRCULATIONAHA.116.022582; Bivard A, 2016, ANN NEUROL, V80, P286, DOI 10.1002/ana.24714; Bivard A, 2015, BRAIN, V138, P1919, DOI 10.1093/brain/awv071; Bivard A, 2013, RADIOLOGY, V267, P543, DOI 10.1148/radiol.12120971; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Gray AM., 2012, APPL METHODS COST EF; Jung KT, 2010, J CLIN NEUROL, V6, P117, DOI 10.3988/jcn.2010.6.3.117; Lin LT, 2016, RADIOLOGY, V279, P876, DOI 10.1148/radiol.2015150319; Ramos-Goni JM, 2013, STATA J, V13, P474, DOI 10.1177/1536867X1301300303; Organisation for Economic Co-operation and Development (OECD), PRIC PURCH POW PAR; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Tanny SPT, 2013, STROKE, V44, P2269, DOI 10.1161/STROKEAHA.113.001295; Tung CE, 2011, STROKE, V42, P2257, DOI 10.1161/STROKEAHA.111.615682; Yassi N, 2013, STROKE, V44, P3039, DOI 10.1161/STROKEAHA.113.002396; Young KC, 2010, NEUROLOGY, V75, P1678, DOI 10.1212/WNL.0b013e3181fc2838	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206203	10.1371/journal.pone.0206203	http://dx.doi.org/10.1371/journal.pone.0206203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352076	Green Published, gold			2022-12-26	WOS:000448076200037
J	Wu, WM; Wang, SJ; Chen, HJ; Song, YH; Zhang, L; Peng, C; Jing, LL; Li, JC				Wu, Wenming; Wang, Shiji; Chen, Hongjian; Song, Youhong; Zhang, Lin; Peng, Chen; Jing, Lili; Li, Jincai			Optimal nitrogen regimes compensate for the impacts of seedlings subjected to waterlogging stress in summer maize	PLOS ONE			English	Article							ZEA-MAYS L.; GRAIN-YIELD; CHLOROPHYLL FLUORESCENCE; PHOTOSYNTHETIC RATE; LEAF SENESCENCE; USE-EFFICIENCY; GROWTH; ROOT; MECHANISMS; GENOTYPES	A field experiment was performed to explore the compensation effects of different nitrogen (N) regimes on the growth and photosynthetic capacity in different leaf layers of the summer maize hybrid of LuYu9105 under waterlogging at the seedling stage. The results showed that waterlogging significantly decreased the maximum green leaf area (gLA) by 10.015.3% and 9.3 similar to 22.5%, mainly due to the reduction in the below-ear layer leaves at the silking stage in 2014 and 2015, respectively. Waterlogging also significantly decreased the ear leaf photosynthetic rate (P-N), and F-v/F-m, F-v/F-a, Phi(PSII) and qP at the below-ear layer leaves at the mid- and late-filling stages, which was accompanied by a reduction in the duration of grain-filling (T) by 2.6 similar to 5.9%, thus resulting in a loss of grain yield by 7.0 similar to 18.5%. Interestingly, a shift in N from basal application to topdressing at the big flare stage was shown to compensate the adverse effects of waterlogging by through increased gLA and leaf photosynthetic capacity at the ear layer and the above-ear layer, as well as a greater grain-filling rate, resulting in an increase in grain yield by 9.9 similar to 27.0% and 17.8 similar to 25.8% compared to other N treatments. Therefore, this study showed that optimal nitrogen regimes during maize growth are capable of compensating for the impacts caused by waterlogging at the seedling stage.	[Wu, Wenming; Wang, Shiji; Chen, Hongjian; Zhang, Lin; Peng, Chen; Jing, Lili] Anhui Acad Agr Sci, Tobacco Res Inst, Maize Res Ctr, Hefei, Anhui, Peoples R China; [Song, Youhong; Li, Jincai] Anhui Agr Univ, Sch Agron, Hefei, Anhui, Peoples R China	Anhui Academy of Agricultural Sciences; Anhui Agricultural University	Li, JC (corresponding author), Anhui Agr Univ, Sch Agron, Hefei, Anhui, Peoples R China.	ljc6488@163.com	Song, Youhong/AAD-3654-2020		National Key Research and Development Program of China [2017YFD0301307]	National Key Research and Development Program of China	This work was supported by The National Key Research and Development Program of China (2017YFD0301307) (http://www.most.gov.cn/index.htm).	Agarwal S, 2006, CRIT REV PLANT SCI, V25, P1, DOI 10.1080/07352680500365232; Araki H, 2012, FIELD CROP RES, V137, P27, DOI 10.1016/j.fcr.2012.09.006; Ashraf M, 1999, J PLANT NUTR, V22, P1253, DOI 10.1080/01904169909365710; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Chandio AS, 2013, J IRRIG DRAIN ENG, V139, P710, DOI 10.1061/(ASCE)IR.1943-4774.0000590; Chen YL, 2016, CROP SCI, V56, P397, DOI 10.2135/cropsci2015.03.0170; de Souza TC, 2012, PLANT BREEDING, V131, P493, DOI 10.1111/j.1439-0523.2012.01973.x; Du HW, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0728-1; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Florio EL, 2014, AGR WATER MANAGE, V146, P75, DOI 10.1016/j.agwat.2014.07.022; Gambin BL, 2006, FIELD CROP RES, V95, P316, DOI 10.1016/j.fcr.2005.04.002; Grzesiak MT, 2014, ACTA PHYSIOL PLANT, V36, P3249, DOI 10.1007/s11738-014-1691-9; Irfan M, 2010, PROTOPLASMA, V241, P3, DOI 10.1007/s00709-009-0098-8; Jones RJ, 1996, CROP SCI, V36, P301, DOI 10.2135/cropsci1996.0011183X003600020015x; [梁哲军 LIANG Zhe-Jun], 2009, [生态学报, Acta Ecologica Sinica], V29, P3977; Liu SM, 2017, J IRRIG DRAIN ENG, V143, DOI [10.1061/(asce)ir.1943-4774.0001219, 10.1061/(ASCE)IR.1943-4774.0001219]; Liu WJ, 2006, BIOL PLANTARUM, V50, P597, DOI 10.1007/s10535-006-0094-1; Lone AA, 2016, MAYDICA, V61; Massignam AM, 2011, CROP PASTURE SCI, V62, P1045, DOI 10.1071/CP11165; MEYER WS, 1987, IRRIGATION SCI, V8, P257, DOI 10.1007/BF00257510; Mu XH, 2018, PLANT PHYSIOL BIOCH, V129, P27, DOI 10.1016/j.plaphy.2018.05.020; Nilsen E.T., 1996, PHYSL PLANTS STRESS, V2 Edn, P689; Ning P, 2017, FIELD CROP RES, V204, P249, DOI 10.1016/j.fcr.2017.01.022; Nyakudya IW, 2014, AGR WATER MANAGE, V141, P30, DOI 10.1016/j.agwat.2014.04.010; O'Neill PM, 2006, CROP SCI, V46, P681, DOI 10.2135/cropsci2005.06-0170; Osman KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079305; Peng YF, 2016, CROP SCI, V56, P3218, DOI 10.2135/cropsci2016.03.0183; Polesskaya OG, 2004, RUSS J PLANT PHYSL+, V51, P615, DOI 10.1023/B:RUPP.0000040746.66725.77; Przywara G, 1999, ACTA PHYSIOL PLANT, V21, P405, DOI 10.1007/s11738-999-0013-0; Ren BZ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01216; Ren BZ, 2017, AGRON J, V109, P185, DOI 10.2134/agronj2016.06.0353; Ren BZ, 2016, AGR WATER MANAGE, V177, P392, DOI 10.1016/j.agwat.2016.08.033; Ren BZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161424; Ren BZ, 2016, AGRON J, V108, P1060, DOI 10.2134/agronj2015.0547; Ren BZ, 2016, FIELD CROP RES, V188, P96, DOI 10.1016/j.fcr.2015.10.016; Ren BZ, 2014, CAN J PLANT SCI, V94, P23, DOI 10.4141/CJPS2013-175; Ren BW, 2018, J BIOMAT SCI-POLYM E, V29, P1344, DOI 10.1080/09205063.2018.1460140; Shangguan ZP, 2000, J PLANT PHYSIOL, V156, P46, DOI 10.1016/S0176-1617(00)80271-0; Shen Xue-shan, 2007, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V27, P1265; Song WJ, 2013, PLANT SOIL, V373, P981, DOI 10.1007/s11104-013-1867-x; Sun XF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174952; Thirunavukkarasu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070433; Wei SS, 2016, PLANT PHYSIOL BIOCH, V105, P118, DOI 10.1016/j.plaphy.2016.04.007; Wei SS, 2015, PLANT SCI, V233, P72, DOI 10.1016/j.plantsci.2015.01.002; Wu WM, 2013, J FOOD AGRIC ENVIRON, V11, P545; Yordanova RY, 2007, ACTA PHYSIOL PLANT, V29, P535, DOI 10.1007/s11738-007-0064-z; Zaidi PH, 2003, EUR J AGRON, V19, P383, DOI 10.1016/S1161-0301(02)00090-4; Zhu SS, 2016, APPL SOIL ECOL, V107, P324, DOI 10.1016/j.apsoil.2016.07.009; Zong YZ, 2014, J INTEGR AGR, V13, P73, DOI 10.1016/S2095-3119(13)60349-4; Zou XL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-189	50	9	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206210	10.1371/journal.pone.0206210	http://dx.doi.org/10.1371/journal.pone.0206210			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352090	Green Submitted, Green Published, gold			2022-12-26	WOS:000448076200040
J	Mellouk, A; Bobe, P				Mellouk, Amine; Bobe, Pierre			CD8(+), but not CD4(+) effector/memory T cells, express the CD44(high)CD45RB(high) phenotype with aging, which displays reduced expression levels of P2X(7) receptor and ATP-induced cellular responses	FASEB JOURNAL			English	Article						T-EM lymphocyte; T-CM lymphocyte; naive T lymphocyte; purinergic signaling	TUMOR-NECROSIS-FACTOR; P2X7 RECEPTOR; L-SELECTIN; ACTIVATION; LYMPHOCYTES; RELEASE; STIMULATION; INHIBITION; CHANNEL; PROTEIN	Previously we reported that the sensitivity of CD4(+) T cells to ATP does not depend on P2X(7) receptor (P2X(7)R) expression levels but on their activation and differentiation stages. Therefore, here we have investigated a potential relationship between the sensitivity of CD8(+) T cells to ATP and their stages of differentiation. Thus, the CD8(+) subpopulation exhibits a drastically reduced sensitivity to ATP with aging, which parallels the strong increase of an effector/memory CD8(+) subset expressing high levels of CD44 cell adhesion molecule and CD45RB transmembrane phosphatase (CD44(hi)CD45RB(hi)). Using l-selectin/CD62L, CC-chemokine receptor 7, and CD127/IL-7 receptor- markers, we showed that effector/memory CD8(+) T cells belong to a central or effector memory subset. In contrast, the CD44(hi)CD45RB(hi) effector/memory subset is absent or poorly expressed in the CD4(+) T subpopulation regardless of age. While ATP treatment can trigger channel and pore formation, CD62L shedding, phosphatidylserine exposure, and cell death in the CD44(lo)CD45RB(hi)-naive CD8(+) subset, it is unable to induce these cellular activities in the CD44(hi)CD45RB(hi) effector/memory CD8(+) subset. Importantly, both CD44(lo)CD45RB(hi)-naive and CD44(hi)CD45RB(hi) effector/memory subsets express similar low levels of P2X(7)R, demonstrating that the sensitivity of CD8(+) T cells to ATP depends on the stage of differentiation instead of P2X(7)R expression levels.Mellouk, A., Bobe, P. CD8(+), but not CD4(+) effector/memory T cells, express the CD44(high)CD45RB(high) phenotype with aging, which displays reduced expression levels of P2X(7) receptor and ATP-induced cellular responses.	[Mellouk, Amine; Bobe, Pierre] Univ Paris Saclay, Univ Paris Sud, INSERM, Unite Mixte UMR 1174, Orsay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Bobe, P (corresponding author), Univ Paris Sud, INSERM, UMR1174, Rue Adeles, F-91405 Orsay, France.	pierre.bobe@u-psud.fr		Bobe, Pierre/0000-0002-8835-6786	Agence Nationale de la Recherche [ANR-13-ISV6-0003]	Agence Nationale de la Recherche(French National Research Agency (ANR))	Rabbit polyclonal anti-P2X<INF>7</INF>R antisera were kindly provided by J. M. Kanellopoulos and K. Benihoud (both from Universite Paris-Sud). This work was funded by the Agence Nationale de la Recherche (ANR-13-ISV6-0003). The authors declare no conflicts of interest.	Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Adinolfi E, 2009, J BIOL CHEM, V284, P10120, DOI 10.1074/jbc.M805805200; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Auger R, 2005, J BIOL CHEM, V280, P28142, DOI 10.1074/jbc.M501290200; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; Bleesing JJH, 2001, CELL IMMUNOL, V213, P72, DOI 10.1006/cimm.2001.1865; Chen LF, 2006, J IMMUNOL, V176, P3115, DOI 10.4049/jimmunol.176.5.3115; Colomar A, 2003, J BIOL CHEM, V278, P30732, DOI 10.1074/jbc.M304534200; Coutinho-Silva R, 2003, IMMUNITY, V19, P403, DOI 10.1016/S1074-7613(03)00235-8; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Delarasse C, 2011, J BIOL CHEM, V286, P2596, DOI 10.1074/jbc.M110.200618; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; DIVIRGILIO F, 1989, J IMMUNOL, V143, P1955; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; FILIPPINI A, 1990, J BIOL CHEM, V265, P334; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Gu B, 1998, BLOOD, V92, P946; Hamad ARA, 2003, J IMMUNOL, V171, P2421, DOI 10.4049/jimmunol.171.5.2421; Heiss K, 2008, J IMMUNOL, V181, P3861, DOI 10.4049/jimmunol.181.6.3861; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Ho J, 2008, J IMMUNOL, V180, P2573, DOI 10.4049/jimmunol.180.4.2573; Humphreys BD, 2000, J BIOL CHEM, V275, P26792; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jobe O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005075; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Koni PA, 2013, J IMMUNOL, V190, P3189, DOI 10.4049/jimmunol.1203364; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Le Gall SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052161; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Loomis WH, 2003, J BIOL CHEM, V278, P4590, DOI 10.1074/jbc.M207868200; Ma CS, 2004, IMMUNOL CELL BIOL, V82, P67, DOI 10.1046/j.0818-9641.2003.01206.x; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Martina MN, 2015, IMMUNOL CELL BIOL, V93, P305, DOI 10.1038/icb.2014.99; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Meraldi V, 2005, VACCINE, V23, P2801, DOI 10.1016/j.vaccine.2004.10.044; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; Purvis HA, 2014, J IMMUNOL, V193, P1142, DOI 10.4049/jimmunol.1302467; Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO;2-P; Safya H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00360; Schenk U, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001270; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Sluyter R., 2014, INFLAMM CELL SIGNAL, V1, P44; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Tsukimoto M, 2006, J IMMUNOL, V177, P2842, DOI 10.4049/jimmunol.177.5.2842; Tsukimoto M, 2009, BIOCHEM BIOPH RES CO, V384, P512, DOI 10.1016/j.bbrc.2009.05.011; WILEY JS, 1992, ARCH BIOCHEM BIOPHYS, V292, P411, DOI 10.1016/0003-9861(92)90010-T; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458	53	8	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3225	3236		10.1096/fj.201800867R	http://dx.doi.org/10.1096/fj.201800867R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30383448				2022-12-26	WOS:000459794800013
J	Vrakas, CN; Herman, AB; Ray, M; Kelemen, SE; Scalia, R; Autieri, MV				Vrakas, Christine N.; Herman, Allison B.; Ray, Mitali; Kelemen, Sheri E.; Scalia, Rosario; Autieri, Michael V.			RNA stability protein ILF3 mediates cytokine-induced angiogenesis	FASEB JOURNAL			English	Article						endothelial cell; RNA-binding protein; proangiogenic factor; VEGF; IL-19	DOUBLE-STRANDED-RNA; 3' UNTRANSLATED REGION; AU-RICH ELEMENTS; MESSENGER-RNA; BINDING PROTEIN; DEPENDENT PHOSPHORYLATION; 3'-UNTRANSLATED REGION; GENE-EXPRESSION; NUCLEAR EXPORT; NF90	Interleukin enhancer-binding factor 3 (ILF3), an RNA-binding protein, is best known for its role in innate immunity by participation in cellular antiviral responses. A role for ILF3 in angiogenesis is unreported. ILF3 expression in CD31(+) capillaries of hypoxic cardiac tissue was detected by immunohistochemistry. Proangiogenic stimuli induce ILF3 mRNA and protein expression in cultured human coronary artery endothelial cells (hCAECs). Angiogenic indices, including proliferation, migration, and tube formation, are all significantly reduced in hCAECs when ILF3 is knocked down using small interfering RNA (siRNA), but are significantly increased when ILF3 is overexpressed using adenovirus. Protein and mRNA abundance of several angiogenic factors including CXCL1, VEGF, and IL-8 are decreased when ILF3 is knocked down by siRNA. These factors are increased when ILF3 is overexpressed by adenovirus. ILF3 is phosphorylated and translocates from the nucleus to the cytoplasm in response to angiogenic stimuli. Proangiogenic transcripts containing adenine and uridine-rich elements were bound to ILF3 through RNA immunoprecipitation. ILF3 stabilizes proangiogenic transcripts including VEGF, CXCL1, and IL-8 in hCAECs. Together these data suggest that in endothelial cells, the RNA stability protein, ILF3, plays a novel and central role in angiogenesis. Our working hypothesis is that ILF3 promotes angiogenesis through cytokine-inducible mRNA stabilization of proangiogenic transcripts.Vrakas, C. N., Herman, A. B., Ray, M., Kelemen, S. E., Scalia, R., Autieri, M. V. RNA stability protein ILF3 mediates cytokine-induced angiogenesis.	[Vrakas, Christine N.; Herman, Allison B.; Ray, Mitali; Kelemen, Sheri E.; Scalia, Rosario; Autieri, Michael V.] Temple Univ, Lewis Katz Sch Med, Dept Physiol, Independence Blue Cross Cardiovasc Res Ctr, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Autieri, MV (corresponding author), Temple Univ, Sch Med, Dept Physiol, Independence Blue Cross Cardiovasc Res Ctr, Room 1050,MERB 3500 N Broad St, Philadelphia, PA 19140 USA.	mautieri@temple.edu	Herman, Ali/GON-8233-2022	Herman, Ali/0000-0003-3826-3247	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL141108, HL117724]; American Heart Association [18PRE34080191, 17PRE33670798, 16PRE31220005, 13GRNT1685003]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK111042]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117724, R01HL141108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111042] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL141108 and HL117724, and American Heart Association Grant 13GRNT1685003 (to M.V.A.); and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant DK111042 (to R.S.). C.N.V., A.B.H., and M.R. were supported by American Heart Association Predoctoral Fellowships 18PRE34080191, 17PRE33670798, and 16PRE31220005, respectively. The authors declare no conflicts of interest.	Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Bekesova S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00336; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Castella S, 2015, WIRES RNA, V6, P243, DOI 10.1002/wrna.1270; Cha HJ, 2011, HEPATO-GASTROENTEROL, V58, P790; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Choi HJ, 2009, TOXICOL APPL PHARM, V240, P46, DOI 10.1016/j.taap.2009.06.023; Cuneo AA, 2010, J MOL CELL CARDIOL, V49, P647, DOI 10.1016/j.yjmcc.2010.04.016; England RN, 2013, AM J PHYSIOL-CELL PH, V305, pC255, DOI 10.1152/ajpcell.00069.2013; Epstein SE, 2004, CIRCULATION, V109, P2826, DOI 10.1161/01.CIR.0000132468.82942.F5; Fung PA, 1997, P NATL ACAD SCI USA, V94, P1064, DOI 10.1073/pnas.94.4.1064; Gauchotte G, 2017, J PATHOL, V242, P421, DOI 10.1002/path.4916; GILLIS P, 1991, J BIOL CHEM, V266, P3172; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Harashima A, 2010, GENE DEV, V24, P2640, DOI 10.1101/gad.1965010; Herman AB, 2018, CELL REP, V24, P1176, DOI 10.1016/j.celrep.2018.07.002; Herman AB, 2017, CLIN SCI, V131, P2687, DOI 10.1042/CS20171373; Jain S, 2011, ARTERIOSCL THROM VAS, V31, P167, DOI 10.1161/ATVBAHA.110.214916; Kako F, 2016, AM J PHYSIOL-CELL PH, V310, pC931, DOI 10.1152/ajpcell.00006.2016; Kim TW, 2010, BIOCHEM BIOPH RES CO, V391, P963, DOI 10.1016/j.bbrc.2009.11.174; Kohno T, 2003, CANCER RES, V63, P5091; Kurosu T, 2011, BRIT J CANCER, V104, P819, DOI 10.1038/bjc.2011.20; Kuwano M, 2001, INTERNAL MED, V40, P565, DOI 10.2169/internalmedicine.40.565; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; KUZUYA M, 1994, J CELL PHYSIOL, V161, P267, DOI 10.1002/jcp.1041610211; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Li Y, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020047; Li Y, 2014, J VIROL, V88, P7199, DOI 10.1128/JVI.00225-14; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; Nie YZ, 2005, MOL CELL BIOL, V25, P6956, DOI 10.1128/MCB.25.16.6956-6963.2005; Parrott AM, 2005, J MOL BIOL, V348, P281, DOI 10.1016/j.jmb.2005.02.047; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; Ray M, 2018, ARTERIOSCL THROM VAS, V38, P1297, DOI 10.1161/ATVBAHA.118.310929; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Richards J, 2015, J MOL CELL CARDIOL, V79, P21, DOI 10.1016/j.yjmcc.2014.11.002; Sakuma T, 2008, J NEURO-ONCOL, V88, P143, DOI 10.1007/s11060-008-9559-8; Saunders LR, 2001, J BIOL CHEM, V276, P32300, DOI 10.1074/jbc.M104207200; Shamanna RA, 2011, MOL CELL BIOL, V31, P4832, DOI 10.1128/MCB.05849-11; Sharp TE, 2017, CIRC RES, V121, P1263, DOI 10.1161/CIRCRESAHA.117.311174; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shi JX, 2014, INT IMMUNOPHARMACOL, V22, P480, DOI 10.1016/j.intimp.2014.07.031; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Song D, 2017, BIOCHEM BIOPH RES CO, V488, P211, DOI 10.1016/j.bbrc.2017.05.037; Suswam EA, 2005, INT J CANCER, V113, P911, DOI 10.1002/ijc.20675; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Szekanecz Zoltan, 2008, P83, DOI 10.1007/978-3-7643-7650-5_6; Tahergorabi Z, 2012, IRAN J BASIC MED SCI, V15, P1110; Thapar R, 2015, ACS CHEM BIOL, V10, P652, DOI 10.1021/cb500860x; Vries MHM, 2015, ANGIOGENESIS, V18, P163, DOI 10.1007/s10456-014-9454-1; Vumbaca F, 2008, MOL CELL BIOL, V28, P772, DOI 10.1128/MCB.02078-06; Wang H, 2016, TUMOR BIOL, V37, P14451, DOI 10.1007/s13277-016-5397-z	53	6	6	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3304	3316		10.1096/fj.201801315R	http://dx.doi.org/10.1096/fj.201801315R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30383449	Green Published			2022-12-26	WOS:000459794800019
J	Yao, HP; Ge, TD; Zhang, Y; Li, M; Yang, S; Li, H; Wang, F				Yao, Haipei; Ge, Tandi; Zhang, Yao; Li, Min; Yang, Shuai; Li, Hui; Wang, Fang			BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro	FASEB JOURNAL			English	Article						epithelial-mesenchymal transition; bone morphogenetic proteins; transforming growth factor-	BONE MORPHOGENETIC PROTEIN-7; INDUCED PULMONARY-FIBROSIS; MESENCHYMAL TRANSITION; TGF-BETA; EXPRESSION; INHIBITION; RECEPTORS; MODEL	The major pathogenesis of proliferative vitreoretinopathy (PVR) is that retinal pigment epithelial (RPE) cells undergo epithelial-mesenchymal transition (EMT) because of disordered growth factors, such as TGF-, in the vitreous humor. Bone morphogenetic proteins (BMPs) are pluripotent growth factors. In this study, we identified the antifibrotic activity of BMP7 in a PVR model both in vivo and in vitro. BMP7 expression was confirmed on the PVR proliferative membranes. BMP7 was down-regulated in the PVR vitreous humor and TGF--induced RPE cell EMT. In the in vivo studies, BMP7 injection attenuated PVR progression in the eyes of the rabbit model. Additionally, BMP7 treatment maintained RPE cell phenotypes and relieved TGF-2-induced EMT, migration, and gel contraction in vitro. BMP7 inhibited the TGF-2-induced up-regulation of fibronectin and -smooth muscle actin and the down-regulation of E-cadherin and zona occludens-1 by balancing the TGF-2/Smad2/3 and BMP7/Smad1/5/9 pathways. These findings provide direct evidence of the ability of BMP7 in PVR inhibition and the potential of BMP7 for use in PVR therapeutic intervention.Yao, H., Ge, T., Zhang, Y., Li, M., Yang, S., Li, H., Wang, F. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.	[Yao, Haipei; Ge, Tandi; Zhang, Yao; Li, Min; Yang, Shuai; Li, Hui; Wang, Fang] Shanghai Tenth Peoples Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Yao, Haipei; Zhang, Yao; Yang, Shuai; Wang, Fang] Tongji Univ, Tongji Eye Inst, Sch Med, Shanghai, Peoples R China	Tongji University	Li, H; Wang, F (corresponding author), Tongji Univ, Sch Med, Dept Ophthalmol, Shanghai Peoples Hosp 10, 301 Middle Yanchang Rd, Shanghai 200092, Peoples R China.	13817185959@163.com; 18917683335@163.com			National Nature Science Foundation of China [81770939, 81500727]; Shanghai Municipal Commission of Health and Family Planning [20174Y0052]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family Planning	This work was supported, in part, by the National Nature Science Foundation of China (Grants 81770939 and 81500727), and by the Shanghai Municipal Commission of Health and Family Planning (Grant 20174Y0052). The authors declare no conflicts of interest.	Agrawal RN, 2007, NAT PROTOC, V2, P67, DOI 10.1038/nprot.2007.4; Ali IHA, 2014, BRIT J PHARMACOL, V171, P3620, DOI 10.1111/bph.12724; Andrianifahanana M, 2013, FASEB J, V27, P4444, DOI 10.1096/fj.12-224907; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Pastor JC, 2016, PROG RETIN EYE RES, V51, P125, DOI 10.1016/j.preteyeres.2015.07.005; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Chiba C, 2014, EXP EYE RES, V123, P107, DOI 10.1016/j.exer.2013.07.009; Cirillo F, 2017, FASEB J, V31, P2146, DOI 10.1096/fj.201600878R; FASTENBERG DM, 1982, AM J OPHTHALMOL, V93, P565, DOI 10.1016/S0002-9394(14)77370-2; Fuchshofer R, 2007, INVEST OPHTH VIS SCI, V48, P715, DOI 10.1167/iovs.06-0226; Fuchshofer R, 2009, EXP EYE RES, V88, P1020, DOI 10.1016/j.exer.2009.01.002; Garweg JG, 2013, SURV OPHTHALMOL, V58, P321, DOI 10.1016/j.survophthal.2012.12.004; Hao ZM, 2012, MOL THER, V20, P2043, DOI 10.1038/mt.2012.148; He S, 2015, INVEST OPHTH VIS SCI, V56, P5579, DOI 10.1167/iovs.14-16258; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Ishikawa K, 2015, SCI REP-UK, V5, DOI 10.1038/srep16386; Justus CR, 2014, JOVE-J VIS EXP, DOI 10.3791/51046; Kimura K, 2014, INVEST OPHTH VIS SCI, V55, P2621, DOI 10.1167/iovs.13-13501; Kita T, 2008, P NATL ACAD SCI USA, V105, P17504, DOI 10.1073/pnas.0804054105; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Liang D, 2016, CHEM-BIOL INTERACT, V243, P72, DOI 10.1016/j.cbi.2015.11.012; Liu Y, 2008, INVEST OPHTH VIS SCI, V49, P1429, DOI 10.1167/iovs.07-0451; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng XM, 2013, CLIN SCI, V124, P243, DOI 10.1042/CS20120252; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Parapuram SK, 2003, INVEST OPHTH VIS SCI, V44, P1767, DOI 10.1167/iovs.02-0528; Peng HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014750; Shu DY, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20611; Sugimoto H, 2007, DIABETES, V56, P1825, DOI 10.2337/db06-1226; Sugimoto H, 2012, NAT MED, V18, P396, DOI 10.1038/nm.2629; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1; Wladis EJ, 2013, RETINA-J RET VIT DIS, V33, P807, DOI 10.1097/IAE.0b013e31826d350a; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Yang GX, 2013, TOXICOL LETT, V220, P103, DOI 10.1016/j.toxlet.2013.04.017; Yang S, 2015, DISCOV MED, V20, P207; Yang YL, 2011, J CELL BIOCHEM, V112, P2558, DOI 10.1002/jcb.23180; Yao HP, 2016, SCI REP-UK, V6, DOI 10.1038/srep32182; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang Y, 2013, EXP EYE RES, V109, P98, DOI 10.1016/j.exer.2013.02.010	41	23	25	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3212	3224		10.1096/fj.201800858RR	http://dx.doi.org/10.1096/fj.201800858RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30383450	Bronze			2022-12-26	WOS:000459794800012
J	Serban, AJ; Breen, IL; Bui, HQ; Levitus, M; Wachter, RM				Serban, Andrew J.; Breen, Isabella L.; Bui, Hoang Q.; Levitus, Marcia; Wachter, Rebekka M.			Assembly-disassembly is coupled to the ATPase cycle of tobacco Rubisco activase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; ribulose-1; 5-bisphosphate carboxylase; oxygenase (Rubisco); ATPases associated with diverse cellular activities (AAA); fluorescence correlation spectroscopy (FCS); protein assembly; carbon fixation; energy transduction; equilibrium constants; filament formation; site asymmetry; subunit exchange	RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE RUBISCO; HIGH-TEMPERATURE; IDENTIFICATION; SPECTROSCOPY; RECOGNITION; PROTEINS; RESIDUES; REVEALS; ENZYMES; DOMAIN	The carbon-fixing activity of enzyme ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) is regulated by Rubisco activase (Rca), a ring-forming ATPase that catalyzes inhibitor release. For higher plant Rca, the catalytic roles played by different oligomeric species have remained obscure. Here, we utilized fluorescence-correlation spectroscopy to estimate dissociation constants for the dimer-tetramer, tetramer-hexamer, hexamer-12-mer, and higher-order assembly equilibria of tobacco Rca. A comparison of oligomer composition with ATPase activity provided evidence that assemblies larger than hexamers are hydrolytically inactive. Therefore, supramolecular aggregates may serve as storage forms at low-energy charge. We observed that the tetramer accumulates only when both substrate and product nucleotides are bound. During rapid ATP turnover, about one in six active sites was occupied by ADP, and approximate to 36% of Rca was tetrameric. The steady-state catalytic rate reached a maximum between 0.5 and 2.5 m Rca. In this range, significant amounts of dimers, tetramers, and hexamers coexisted, although none could fully account for the observed activity profile. Therefore, we propose that dynamic assembly-disassembly partakes in the ATPase cycle. According to this model, the association of dimers with tetramers generates a hexamer that forms a closed ring at high ATP and magnesium levels. Upon hydrolysis and product release, the toroid breaks open and dissociates into a dimer and tetramer, which may be coupled to Rubisco remodeling. Although a variant bearing the R294V substitution assembled in much the same way, highly stabilized states could be generated by binding of a transition-state analog. A tight-binding pre-hydrolysis state appears to become more accessible in thermally labile Rcas.	[Serban, Andrew J.; Breen, Isabella L.; Bui, Hoang Q.; Levitus, Marcia; Wachter, Rebekka M.] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Serban, Andrew J.; Breen, Isabella L.; Bui, Hoang Q.; Wachter, Rebekka M.] Arizona State Univ, Ctr Bioenergy & Photosynth, Tempe, AZ 85287 USA; [Serban, Andrew J.; Breen, Isabella L.; Bui, Hoang Q.; Wachter, Rebekka M.] Arizona State Univ, Biodesign Ctr Appl Struct Discovery, Tempe, AZ 85287 USA; [Levitus, Marcia] Arizona State Univ, Biodesign Ctr Single Mol Biophys, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Levitus, M; Wachter, RM (corresponding author), Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA.; Wachter, RM (corresponding author), Arizona State Univ, Ctr Bioenergy & Photosynth, Tempe, AZ 85287 USA.; Wachter, RM (corresponding author), Arizona State Univ, Biodesign Ctr Appl Struct Discovery, Tempe, AZ 85287 USA.; Levitus, M (corresponding author), Arizona State Univ, Biodesign Ctr Single Mol Biophys, Tempe, AZ 85287 USA.	mlevitus@asu.edu; rwachter@asu.edu	Wachter, Rebekka/A-7772-2015	Wachter, Rebekka/0000-0002-4693-4488	United States Department of Energy Office of Basic Energy Sciences and Photosynthetic Systems [DE-FG02-09-ER16123]	United States Department of Energy Office of Basic Energy Sciences and Photosynthetic Systems	This work was supported by a grant from the United States Department of Energy Office of Basic Energy Sciences and Photosynthetic Systems Grant DE-FG02-09-ER16123 (to R. M. W. and M. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Bhat JY, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00020; Bracher A, 2017, ANNU REV PLANT BIOL, V68, P29, DOI 10.1146/annurev-arplant-043015-111633; Bracher A, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.2, 10.1038/nplants.2014.2]; Carmo-Silva AE, 2013, PLANT PHYSIOL, V161, P1645, DOI 10.1104/pp.112.213348; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chakraborty M, 2012, BIOPHYS J, V103, P949, DOI 10.1016/j.bpj.2012.07.034; CHATELIER RC, 1987, BIOPHYS CHEM, V28, P121, DOI 10.1016/0301-4622(87)80081-9; Gendron PO, 2008, J FLUORESC, V18, P1093, DOI 10.1007/s10895-008-0357-7; Hasse D, 2015, ACTA CRYSTALLOGR D, V71, P800, DOI 10.1107/S1399004715001182; Hayer-Hartl M, 2017, PROTEIN SCI, V26, P2324, DOI 10.1002/pro.3309; Hazra S, 2015, J BIOL CHEM, V290, P24222, DOI 10.1074/jbc.M115.651745; Henderson JN, 2013, BBA-PROTEINS PROTEOM, V1834, P87, DOI 10.1016/j.bbapap.2012.09.006; Henderson JN, 2011, J BIOL CHEM, V286, P35683, DOI 10.1074/jbc.C111.289595; Kanno DM, 2014, J PHYS CHEM B, V118, P12404, DOI 10.1021/jp507741r; Keown JR, 2014, BIOCHEM J, V464, P413, DOI 10.1042/BJ20140676; Keown JR, 2013, J BIOL CHEM, V288, P20607, DOI 10.1074/jbc.M113.466383; Kuriata AM, 2014, BIOCHEMISTRY-US, V53, P7232, DOI 10.1021/bi500968h; Li CH, 2005, J BIOL CHEM, V280, P24864, DOI 10.1074/jbc.M503547200; Li CS, 2006, ARCH BIOCHEM BIOPHYS, V450, P176, DOI 10.1016/j.abb.2006.04.002; Mueller-Cajar O, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00031; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; Olivares AO, 2016, NAT REV MICROBIOL, V14, P33, DOI 10.1038/nrmicro.2015.4; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Perdomo JA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00490; Peterson-Forbrook DS, 2017, BIOCHEMISTRY-US, V56, P4906, DOI 10.1021/acs.biochem.7b00574; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; Rodriguez-Aliaga P, 2016, NAT STRUCT MOL BIOL, V23, P974, DOI 10.1038/nsmb.3298; Scales JC, 2014, PHOTOSYNTH RES, V119, P355, DOI 10.1007/s11120-013-9964-5; Sharkey TD, 2010, J INTEGR PLANT BIOL, V52, P712, DOI 10.1111/j.1744-7909.2010.00975.x; Shivhare D, 2017, PLANT PHYSIOL, V174, P1505, DOI 10.1104/pp.17.00554; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Stotz M, 2011, NAT STRUCT MOL BIOL, V18, P1366, DOI 10.1038/nsmb.2171; Sutter M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16243; Tsai YCC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9883; vandeLoo FJ, 1996, BIOCHEMISTRY-US, V35, P8143, DOI 10.1021/bi9604901; Wachter RM, 2013, PHOTOSYNTH RES, V117, P557, DOI 10.1007/s11120-013-9827-0; Wang Q, 2018, J CHEM PHYS, V148, DOI 10.1063/1.5005930	42	7	7	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19451	19465		10.1074/jbc.RA118.005047	http://dx.doi.org/10.1074/jbc.RA118.005047			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30352875	Green Published, hybrid			2022-12-26	WOS:000453537300025
J	Wang, J; Yan, CS; Xu, CQ; Chua, BT; Li, P; Chen, FJ				Wang, Jia; Yan, Chengsong; Xu, Chenqi; Chua, Boon Tin; Li, Peng; Chen, Feng-Jung			Polybasic RKKR motif in the linker region of lipid droplet (LD)-associated protein CIDEC inhibits LD fusion activity by interacting with acidic phospholipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid metabolism; lipid droplet; adipose tissue; lipid-protein interaction; phospholipid; CIDEC; inhibitory regulation; lipid droplet fusion; lipid storage; polybasic RKKR motif	FAT STORAGE; BINDING; MEMBRANE; GROWTH; DOMAIN; REVEALS; FAMILY; ER; ACTIVATION; RESISTANT	Lipid droplets (LDs) are intracellular organelles and a central site for lipid synthesis, storage, and mobilization. The size of LDs reflects the dynamic regulation of lipid metabolism in cells. Previously, we found that cell death-inducing DFFA-like effector C (CIDEC) mediates LD fusion and growth by lipid transfer through LD-LD contact sites in adipocytes and hepatocytes. The CIDE-N domains of CIDEC molecules form homodimers, whereas the CIDE-C domain plays an important role in LD targeting and enrichment. Here, using targeted protein deletions and GFP expression coupled with fluorescence microscopy, we identified a polybasic RKKR motif in the linker region that connects the CIDE-N and CIDE-C domains of CIDEC and functions as a regulatory motif for LD fusion. We found that deletion of the linker region or mutation of the RKKR motif increases the formation of supersized LDs compared with LD formation in cells with WT CIDEC. This enhanced LD fusion activity required the interaction between CIDE-N domains. Mechanistically, we found that the RKKR motif interacts with acidic phospholipids via electrostatic attraction. Loss of this motif disrupted the protein-lipid interaction, resulting in enhanced lipid droplet fusion activity and thus formation of larger LDs. In summary, we have uncovered a CIDEC domain that regulates LD fusion activity, a finding that provides insights into the inhibitory regulation of LD fusion through CIDEC-lipid interactions.	[Wang, Jia; Li, Peng; Chen, Feng-Jung] Tsinghua Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Wang, Jia; Li, Peng; Chen, Feng-Jung] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Yan, Chengsong; Xu, Chenqi] Chinese Acad Sci, Univ Chinese Acad Sci, State Key Lab Mol Biol,Shanghai Inst Biochem & Ce, Shanghai Sci Res Ctr,Ctr Excellence Mol Cell Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Chua, Boon Tin; Chen, Feng-Jung] Fudan Univ, Inst Metab & Integrat Biol, Shanghai 200438, Peoples R China	Tsinghua University; Tsinghua University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University	Li, P; Chen, FJ (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.; Li, P; Chen, FJ (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China.; Chen, FJ (corresponding author), Fudan Univ, Inst Metab & Integrat Biol, Shanghai 200438, Peoples R China.	li-peng@mail.tsinghua.edu.cn; derrick.eo93g@gmail.com		Wang, Jia/0000-0002-8356-464X	National Basic Research Program [2018YFA0506901, 2016YFA0502002]; National Natural Science Foundation of China [31430040, 31690103, 31621063]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program Grants 2018YFA0506901 and 2016YFA0502002 (to P. L.) and National Natural Science Foundation of China Grants 31430040, 31690103, and 31621063 (to P. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar HC, 2007, J VIROL, V81, P4520, DOI 10.1128/JVI.02205-06; Barneda D, 2015, ELIFE, V4, DOI 10.7554/eLife.07485; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Boroda S, 2017, J BIOL CHEM, V292, P20481, DOI 10.1074/jbc.M117.786574; Chitraju C, 2012, J LIPID RES, V53, P2141, DOI 10.1194/jlr.M028902; Choudhary V, 2015, J CELL BIOL, V211, P261, DOI 10.1083/jcb.201505067; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Gao GG, 2017, BBA-MOL CELL BIOL L, V1862, P1197, DOI 10.1016/j.bbalip.2017.06.009; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Gross DA, 2014, CRIT REV BIOCHEM MOL, V49, P304, DOI 10.3109/10409238.2014.931337; Gross DA, 2011, P NATL ACAD SCI USA, V108, P19581, DOI 10.1073/pnas.1110817108; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Jack ER, 2008, MOL MEMBR BIOL, V25, P14, DOI 10.1080/09687680701494007; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Kaadige MR, 2006, J BIOL CHEM, V281, P28831, DOI 10.1074/jbc.M605624200; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Khandelia H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012811; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Lee SM, 2013, BIOCHEM BIOPH RES CO, V439, P564, DOI 10.1016/j.bbrc.2013.09.018; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Li LY, 2014, TRENDS BIOCHEM SCI, V39, P130, DOI 10.1016/j.tibs.2014.01.002; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Modha R, 2008, J BIOL CHEM, V283, P1492, DOI 10.1074/jbc.M706760200; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Nian ZQ, 2010, J BIOL CHEM, V285, P9604, DOI 10.1074/jbc.M109.043786; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Ohsaki Y, 2008, J CELL SCI, V121, P2415, DOI 10.1242/jcs.025452; Qian H, 2017, J CLIN INVEST, V127, P1353, DOI 10.1172/JCI85963; Rajamoorthi A, 2018, ATHEROSCLEROSIS, V275, P43, DOI 10.1016/j.atherosclerosis.2018.05.045; Rajamoorthi A, 2017, J LIPID RES, V58, P2127, DOI 10.1194/jlr.M077941; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Sengupta P, 2009, BIOPHYS J, V96, P4887, DOI 10.1016/j.bpj.2009.03.027; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Wu LZ, 2014, DEV CELL, V30, P378, DOI 10.1016/j.devcel.2014.07.005; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Xu DJ, 2018, J CELL BIOL, V217, P975, DOI 10.1083/jcb.201704184; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Xu WY, 2016, J BIOL CHEM, V291, P4282, DOI 10.1074/jbc.M115.701094; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Zanghellini J, 2010, J THEOR BIOL, V264, P952, DOI 10.1016/j.jtbi.2010.02.025; Zhang LJ, 2014, J LIPID RES, V55, P1279, DOI 10.1194/jlr.M046482; Zhang SS, 2014, MOL CELL BIOL, V34, P1827, DOI 10.1128/MCB.01723-13; Zhang WY, 2003, J BIOL CHEM, V278, P21459, DOI 10.1074/jbc.M301652200; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	56	5	5	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19330	19343		10.1074/jbc.RA118.004892	http://dx.doi.org/10.1074/jbc.RA118.004892			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30361435	hybrid, Green Published			2022-12-26	WOS:000453537300015
J	Choi, YJ; Lee, YK; Park, HC; Kim, EY; Cho, A; Han, C; Choi, SR; Kim, H; Kim, EJ; Yoon, JW; Noh, JW				Choi, Yoo Jin; Lee, Young-Ki; Park, Hayne Cho; Kim, Eun Yi; Cho, Ajin; Han, Chaehoon; Choi, Sun Ryoung; Kim, Hanmyun; Kim, Eun-Jung; Yoon, Jong-Woo; Noh, Jung-Woo			Prediction of vascular access stenosis: Blood temperature monitoring with the Twister versus static intra-access pressure ratio	PLOS ONE			English	Article							ARTERIOVENOUS-FISTULAS; HEMODIALYSIS; FLOW; THERMODILUTION; THROMBOSIS; ACCURACY	Background The Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines recommend intra-access flow (Qa) measurement as the preferred vascular access surveillance method over static intra-access pressure ratio (SIAPR). Recently, it has become possible to perform Qa measurement during hemodialysis using thermodilution method called blood temperature monitoring (BTM) with the Twister device. The aim of this study was to investigate the correlation between Qa by BTM and SIAPR and to compare the performance of two tests in prediction of vascular access stenosis. Methods The study was performed from January 2016 to November 2017 and included 97 patients with arteriovenous fistulas (AVF). Qa by BTM and SIAPR were simultaneously measured every 1 similar to 3 months with a total of 449 measurements during study period. Results In our study population, mean age was 59.9 +/- 10.0 years and 61.9% were diabetes. The mean Qa obtained by BTM was 1186 +/- 588 mL/min. There was no correlation between Qa by BTM and venous SIAPR (r = 0.061, P = 0.196). Angiography identified 36 stenotic AVFs (37.1%) among the study subjects. They included 13 cases with only inflow stenosis, 6 with only outflow stenosis, and 17 with stenosis on both sides. Receiver-operating characteristic (ROC) curve analysis showed that Qa by BTM had higher discriminative ability to diagnose vascular access stenosis compared to SIAPR (P <0.001). The Qa less than 583 mL/min showed the highest diagnostic accuracy in vascular stenosis prediction. Conclusion Intradialytic measurement of Qa by BTM showed better diagnostic power over venous SIAPR in prediction of vascular access stenosis.	[Choi, Yoo Jin; Kim, Eun Yi] Kangnam Sacred Heart Hosp, Hemodialysis Ctr, Seoul, South Korea; [Lee, Young-Ki; Park, Hayne Cho; Cho, Ajin; Han, Chaehoon; Choi, Sun Ryoung; Yoon, Jong-Woo; Noh, Jung-Woo] Hallym Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Hanmyun] Hallym Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Kim, Eun-Jung] Sahmyook Med Ctr, Dept Internal Med, Internal Med, Seoul, South Korea	Hallym University; Hallym University	Lee, YK (corresponding author), Hallym Univ, Dept Internal Med, Coll Med, Seoul, South Korea.	km2071@naver.com	SR, Choi/GRJ-6326-2022; choi, sun ryoung/AGZ-1893-2022	choi, sun ryoung/0000-0002-9668-3349; Park, Hayne Cho/0000-0002-1128-3750; Lee, Young-Ki/0000-0003-3464-6144				Allon M, 2002, KIDNEY INT, V62, P1109, DOI 10.1111/j.1523-1755.2002.kid551.x; Badr B, 2014, HEMODIAL INT, V18, P127, DOI 10.1111/hdi.12092; Besarab A, 1998, J AM SOC NEPHROL, V9, P284; BESARAB A, 1995, KIDNEY INT, V47, P1364, DOI 10.1038/ki.1995.192; Eloot S, 2010, BLOOD PURIFICAT, V30, P89, DOI 10.1159/000318586; Kim JD, 2014, SEMIN DIALYSIS, V27, P61, DOI 10.1111/sdi.12137; Lopot F, 2005, BLOOD PURIFICAT, V23, P36, DOI 10.1159/000082009; McCarley P, 2001, KIDNEY INT, V60, P1164, DOI 10.1046/j.1523-1755.2001.0600031164.x; National Kidney Foundation, 2006, AM J KIDNEY DIS S, V48, pS176; Roca-Tey R, 2012, NEFROLOGIA, V32, P172, DOI 10.3265/Nefrologia.pre2012.Jan.11132; Schneditz D, 2003, SEMIN DIALYSIS, V16, P483, DOI 10.1046/j.1525-139X.2003.16104.x; Schneditz D, 1999, NEPHROL DIAL TRANSPL, V14, P376, DOI 10.1093/ndt/14.2.376; Simts JHM, 2001, KIDNEY INT, V59, P1551, DOI 10.1046/j.1523-1755.2001.0590041551.x; Spergel LM, 2004, KIDNEY INT, V66, P1512, DOI 10.1111/j.1523-1755.2004.00946.x; Tessitore N, 2003, AM J KIDNEY DIS, V42, P331, DOI 10.1016/S0272-6386(03)00659-0; Tessitore N, 2011, CLIN J AM SOC NEPHRO, V6, P1073, DOI 10.2215/CJN.06230710; Tessitore N, 2011, CLIN J AM SOC NEPHRO, V6, P819, DOI 10.2215/CJN.06220710; Tonelli M, 2001, J AM SOC NEPHROL, V12, P1729, DOI 10.1681/ASN.V1281729; Trerotola SO, 2003, J VASC INTERV RADIOL, V14, P1387, DOI 10.1097/01.RVI.0000096760.74047.34; van Stralen KJ, 2009, KIDNEY INT, V75, P1257, DOI 10.1038/ki.2009.92; Wijnen E, 2007, KIDNEY INT, V72, P736, DOI 10.1038/sj.ki.5002376	21	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0204630	10.1371/journal.pone.0204630	http://dx.doi.org/10.1371/journal.pone.0204630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372435	Green Published, gold, Green Submitted			2022-12-26	WOS:000448641200006
J	Puts, R; Rikeit, P; Ruschke, K; Knaus, P; Schreivogel, S; Raum, K				Puts, Regina; Rikeit, Paul; Ruschke, Karen; Knaus, Petra; Schreivogel, Sophie; Raum, Kay			Functional regulation of YAP mechanosensitive transcriptional coactivator by Focused Low-Intensity Pulsed Ultrasound (FLIPUS) enhances proliferation of murine mesenchymal precursors	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; HIPPO PATHWAY; CONTACT INHIBITION; GROWTH-CONTROL; BONE REPAIR; CELL; MECHANOTRANSDUCTION; STIMULATION; YAP/TAZ; DIFFERENTIATION	Yes-associated protein (YAP) acts as a mechanotransducer in determining the cell fate of murine C2C12 mesenchymal precursors as investigated after stimulation with ultrasound. We applied Focused Low-Intensity Pulsed Ultrasound (FLIPUS) at a sound frequency of 3.6 MHz, 100 Hz pulse repetition frequency (PRF), 27.8% duty cycle (DC), and 44.5 mW/cm(2) acoustic intensity ISATA for 5 minutes and evaluated early cellular responses. FLIPUS decreased the level of phosphorylated YAP on Serine 127, leading to higher levels of active YAP in the nucleus. This in turn enhanced the expression of YAP-target genes associated with actin nucleation and stabilization, cytokinesis, and cell cycle progression. FLIPUS enhanced proliferation of C2C12 cells, whereas silencing of YAP expression abolished the beneficial effects of ultrasound. The expression of the transcription factor MyoD, defining cellular myogenic differentiation, was inhibited by mechanical stimulation. This study shows that ultrasound exposure regulates YAP functioning, which in turn improves the cell proliferative potential, critical for tissue regeneration process.	[Puts, Regina; Knaus, Petra; Raum, Kay] Charite Berlin Univ Med, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany; [Puts, Regina; Rikeit, Paul; Knaus, Petra; Schreivogel, Sophie; Raum, Kay] Charite Berlin Univ Med, Berlin Brandenburg Sch Regenerat Therapies BSRT, Berlin, Germany; [Rikeit, Paul; Ruschke, Karen; Knaus, Petra] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Schreivogel, Sophie] Charite Berlin Univ Med, Julius Wolff Inst, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Puts, R (corresponding author), Charite Berlin Univ Med, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany.; Puts, R (corresponding author), Charite Berlin Univ Med, Berlin Brandenburg Sch Regenerat Therapies BSRT, Berlin, Germany.	regina.puts@charite.de	; Raum, Kay/A-5576-2013	Puts, Regina/0000-0002-2019-328X; Gorlitz, Sophie/0000-0002-2302-8351; Raum, Kay/0000-0003-0573-1622	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [Ra1380/8-1]; DFG [FOR2165]; DFG through the Berlin-Brandenburg School for Regenerative Therapies [GSC 203]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); DFG through the Berlin-Brandenburg School for Regenerative Therapies	This work has been supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG, http://www.dfg.de/) grant Ra1380/8-1 (R.P. and K.R.); by the DFG grant FOR2165 "Regeneration in Aged Individuals" (P.R. and P.K.); by the DFG through the Berlin-Brandenburg School for Regenerative Therapies GSC 203 (fellowships to R.P. and P.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Castellani L, 2006, J BIOL CHEM, V281, P15249, DOI 10.1074/jbc.M601390200; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Gallo R, 1999, MOL BIOL CELL, V10, P3137, DOI 10.1091/mbc.10.10.3137; Hishikawa K, 2000, EUR J PHARMACOL, V392, P19, DOI 10.1016/S0014-2999(00)00115-1; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Judson RN, 2012, J CELL SCI, V125, P6009, DOI 10.1242/jcs.109546; Khanna A, 2009, BRIT MED BULL, V89, P169, DOI 10.1093/bmb/ldn040; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Kim DH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00555; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Padilla F, 2016, ADV EXP MED BIOL, V880, P385, DOI 10.1007/978-3-319-22536-4_21; Padilla F, 2014, ULTRASONICS, V54, P1125, DOI 10.1016/j.ultras.2014.01.004; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Puts R, 2016, IEEE T ULTRASON FERR, V63, P1505, DOI 10.1109/TUFFC.2016.2586972; Puts R, 2016, IEEE T ULTRASON FERR, V63, P91, DOI 10.1109/TUFFC.2015.2498042; Reddy P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073763; SUDOL M, 1994, ONCOGENE, V9, P2145; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Watanabe S, 2010, MOL BIOL CELL, V21, P3193, DOI 10.1091/mbc.E10-04-0324; Watt KI, 2010, BIOCHEM BIOPH RES CO, V393, P619, DOI 10.1016/j.bbrc.2010.02.034; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhong WL, 2013, STEM CELLS DEV, V22, P2083, DOI 10.1089/scd.2012.0685	35	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206041	10.1371/journal.pone.0206041	http://dx.doi.org/10.1371/journal.pone.0206041			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365513	Green Submitted, Green Published, gold			2022-12-26	WOS:000448448700023
J	Friesen, WJ; Johnson, B; Sierra, J; Zhuo, J; Vazirani, P; Xue, XJ; Tomizawa, Y; Baiazitov, R; Morrill, C; Ren, HY; Babu, S; Moon, YC; Branstrom, A; Mollin, A; Hedrick, J; Sheedy, J; Elfring, G; Weetall, M; Colacino, JM; Welch, EM; Peitz, SW				Friesen, Westley J.; Johnson, Briana; Sierra, Jairo; Zhuo, Jin; Vazirani, Priya; Xue, Xiaojiao; Tomizawa, Yuki; Baiazitov, Ramil; Morrill, Christie; Ren, Hongyu; Babu, Suresh; Moon, Young-Choon; Branstrom, Art; Mollin, Anna; Hedrick, Jean; Sheedy, Josephine; Elfring, Gary; Weetall, Marla; Colacino, Joseph M.; Welch, Ellen M.; Peitz, Stuart W.			The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential	PLOS ONE			English	Article							HUMAN GENETIC-DISEASES; NONSENSE MUTATION; CYSTIC-FIBROSIS; SYNTHETIC AMINOGLYCOSIDES; DESIGNER AMINOGLYCOSIDES; MOUSE MODEL; SUPPRESSION; ATALUREN; ZEBRAFISH; PTC124	Nonsense mutations, resulting in a premature stop codon in the open reading frame of mRNAs are responsible for thousands of inherited diseases. Readthrough of premature stop codons by small molecule drugs has emerged as a promising therapeutic approach to treat disorders resulting from premature termination of translation. The aminoglycoside antibiotics are a class of molecule known to promote readthrough at premature termination codons. Gentamicin consists of a mixture of major and minor aminoglycoside components. Here, we investigated the readthrough activities of the individual components and show that each of the four major gentamicin complex components representing 92-99% of the complex each had similar potency and activity to that of the complex itself. In contrast, a minor component (gentamicin X2) was found to be the most potent and active readthrough component in the gentamicin complex. The known oto- and nephrotoxicity associated with aminoglycosides preclude long-term use as readthrough agents. Thus, we evaluated the components of the gentamicin complex as well as the so-called "designer" aminoglycoside, NB124, for in vitro and in vivo safety. In cells, we observed that gentamicin X2 had a safety/ readthrough ratio (cytotoxicity/readthrough potency) superior to that of gentamicin, G418 or NB124. In rodents, we observed that gentamicin X2 showed a safety profile that was superior to G418 overall including reduced nephrotoxicity. These results support further investigation of gentamicin X2 as a therapeutic readthrough agent.	[Friesen, Westley J.; Johnson, Briana; Sierra, Jairo; Zhuo, Jin; Vazirani, Priya; Xue, Xiaojiao; Tomizawa, Yuki; Baiazitov, Ramil; Morrill, Christie; Ren, Hongyu; Babu, Suresh; Moon, Young-Choon; Branstrom, Art; Mollin, Anna; Hedrick, Jean; Sheedy, Josephine; Elfring, Gary; Weetall, Marla; Colacino, Joseph M.; Welch, Ellen M.; Peitz, Stuart W.] PTC Therapeut, South Plainfield, NJ 07080 USA		Friesen, WJ (corresponding author), PTC Therapeut, South Plainfield, NJ 07080 USA.	wfriesen@ptcbio.com			PTC Therapeutics	PTC Therapeutics	This work was fully funded by PTC Therapeutics. All authors are employees of PTC Therapeutics and therefore received support in the form of salary. The funders did not have any additional roles in study design, data analysis, publication decision, or preparation of the manuscript.	ARONOFF GR, 1983, ANTIMICROB AGENTS CH, V23, P74, DOI 10.1128/AAC.23.1.74; Baradaran-Heravi A, 2017, P NATL ACAD SCI USA, V114, P3479, DOI 10.1073/pnas.1620982114; Bidou L, 2017, RNA BIOL, V14, P378, DOI 10.1080/15476286.2017.1285480; BURKE JF, 1985, NUCLEIC ACIDS RES, V13, P6265, DOI 10.1093/nar/13.17.6265; Bushby K, 2014, MUSCLE NERVE, V50, P477, DOI 10.1002/mus.24332; Chiu LL, 2008, JARO-J ASSOC RES OTO, V9, P178, DOI 10.1007/s10162-008-0118-y; Clancy JP, 2001, AM J RESP CRIT CARE, V163, P1683, DOI 10.1164/ajrccm.163.7.2004001; Clemedson C, 1999, TOXICOL IN VITRO, V13, P657, DOI 10.1016/S0887-2333(99)00060-0; de Loubresse NG, 2014, NATURE, V513, P517, DOI 10.1038/nature13737; Deubner R, 2003, MAGN RESON CHEM, V41, P589, DOI 10.1002/mrc.1222; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; Finkel RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081302; Friesen WJ, 2017, RNA, V23, P567, DOI 10.1261/rna.060236.116; Gregory-Evans CY, 2014, J CLIN INVEST, V124, P111, DOI 10.1172/JCI70462; Guthrie OW, 2008, TOXICOLOGY, V249, P91, DOI 10.1016/j.tox.2008.04.015; Haas M, 2015, NEUROMUSCULAR DISORD, V25, P5, DOI 10.1016/j.nmd.2014.11.011; Hainrichson M, 2008, ORG BIOMOL CHEM, V6, P227, DOI 10.1039/b712690p; Howard M, 1996, NAT MED, V2, P467, DOI 10.1038/nm0496-467; Kandasamy J, 2012, J MED CHEM, V55, P10630, DOI 10.1021/jm3012992; Keeling KM, 2001, HUM MOL GENET, V10, P291, DOI 10.1093/hmg/10.3.291; Linde L, 2008, TRENDS GENET, V24, P552, DOI 10.1016/j.tig.2008.08.010; Malik Vinod, 2010, Ther Adv Neurol Disord, V3, P379, DOI 10.1177/1756285610388693; McDonald CM, 2017, LANCET, V390, P1489, DOI 10.1016/S0140-6736(17)31611-2; Miller JN, 2015, HUM MOL GENET, V24, P185, DOI 10.1093/hmg/ddu428; Moosajee M, 2016, HUM MOL GENET, V25, P3416, DOI 10.1093/hmg/ddw184; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Nagai Junya, 2004, Drug Metab Pharmacokinet, V19, P159, DOI 10.2133/dmpk.19.159; Peltz SW, 2013, ANNU REV MED, V64, P407, DOI 10.1146/annurev-med-120611-144851; Politano L, 2003, Acta Myol, V22, P15; Pranke I, 2018, ERJ OPEN RES, V4; Prokhorova I, 2017, P NATL ACAD SCI USA, V114, pE10899, DOI 10.1073/pnas.1715501114; Ralib AM, 2012, J AM SOC NEPHROL, V23, P322, DOI 10.1681/ASN.2011040325; Roy B, 2016, P NATL ACAD SCI USA, V113, P12508, DOI 10.1073/pnas.1605336113; Salvatori F, 2009, BIOTECHNOL APPL BIOC, V54, P41, DOI 10.1042/BA20080266; Shalev M, 2014, MEDCHEMCOMM, V5, P1092, DOI 10.1039/c4md00081a; Shulman E, 2014, J BIOL CHEM, V289, P2318, DOI 10.1074/jbc.M113.533588; Stypulkowska K, 2010, CHROMATOGRAPHIA, V72, P1225, DOI 10.1365/s10337-010-1763-y; SZILAGYI L, 1993, CARBOHYD RES, V247, P99, DOI 10.1016/0008-6215(93)84244-Z; Ton C, 2005, HEARING RES, V208, P79, DOI 10.1016/j.heares.2005.05.005; Tukey JW, 1977, EXPLORATORY DATA ANA; Vydrin A. F., 2003, PHARM CHEM J+, V37, P448, DOI DOI 10.1023/A:1027372416983; Wang CS, 2000, CANCER GENET CYTOGEN, V120, P58, DOI 10.1016/S0165-4608(99)00253-8; Wargo Kurt A, 2014, J Pharm Pract, V27, P573, DOI 10.1177/0897190014546836; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3; Wilschanski M, 2011, EUR RESPIR J, V38, P59, DOI 10.1183/09031936.00120910; Xue XP, 2014, AM J RESP CELL MOL, V50, P805, DOI 10.1165/rcmb.2013-0282OC; ZERBE GO, 1978, AM STAT, V32, P103, DOI 10.2307/2683354	48	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206158	10.1371/journal.pone.0206158	http://dx.doi.org/10.1371/journal.pone.0206158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359426	Green Published, Green Submitted, gold			2022-12-26	WOS:000448438400049
J	Furuichi, Y; Manabe, Y; Takagi, M; Aoki, M; Fujii, NL				Furuichi, Yasuro; Manabe, Yasuko; Takagi, Mayumi; Aoki, Miho; Fujii, Nobuharu L.			Evidence for acute contraction-induced myokine secretion by C2C12 myotubes	PLOS ONE			English	Article							EXERCISE-INDUCED INCREASE; TUMOR-NECROSIS-FACTOR; INSULIN SENSITIVITY; MUSCLE; INTERLEUKIN-6; ALPHA; MODEL; CALCINEURIN; OBESITY; HUMANS	Skeletal muscle is considered a secretory organ that produces bioactive proteins known as myokines, which are released in response to various stimuli. However, no experimental evidence exists regarding the mechanism by which acute muscle contraction regulates myokine secretion. Here, we present evidence that acute contractions induced myokine secretion from C2C12 myotubes. Changes in the cell culture medium unexpectedly triggered the release of large amounts of proteins from the myotubes, and these proteins obscured the contraction-induced myokine secretion. Once protein release was abolished, the secretion of interleukin-6 (IL-6), the best-known regulatory myokine, increased in response to a 1-hour contraction evoked by electrical stimulation. Using this experimental condition, intracellular calcium flux, rather than the contraction itself, triggered contraction-induced IL-6 secretion. This is the first report to show an evidence for acute contraction-induced myokine secretion by skeletal muscle cells.	[Furuichi, Yasuro; Manabe, Yasuko; Takagi, Mayumi; Aoki, Miho; Fujii, Nobuharu L.] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, Tokyo, Japan	Tokyo Metropolitan University	Manabe, Y; Fujii, NL (corresponding author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, Tokyo, Japan.	ymanabe@tmu.ac.jp; fujiin@tmu.ac.jp	, Nobuharu/J-2724-2014	, Nobuharu/0000-0002-0974-3033	Japan Society for the Promotion of Science [KAKENHI 15K16489, KAKENHI 24700700, KAKENHI 26242068]; Council for Science and Technology Policy [LS102]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP))	This work was supported by grants from the Japan Society for the Promotion of Science (KAKENHI 15K16489 to Y.F., KAKENHI 24700700 to Y.M., KAKENHI 26242068 to N.L.F) and by a grant-in-aid by the Funding Program for World-Leading Innovative R&D on Science and Technology (#LS102) from the Council for Science and Technology Policy to N.L.F. The funder's website can be found at https://www.jsps.go.jp/english/index. html. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Aoi W, 2013, GUT, V62, P882, DOI 10.1136/gutjnl-2011-300776; Benrick A, 2012, EXP PHYSIOL, V97, P1224, DOI 10.1113/expphysiol.2012.065508; Brandt C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/520258; Bruunsgaard H, 1997, J PHYSIOL-LONDON, V499, P833, DOI 10.1113/jphysiol.1997.sp021972; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Gogh IJAEV, 2015, SCI REP-UK, V5, DOI 10.1038/srep10944; Farmawati A, 2013, ENDOCR J, V60, P137, DOI 10.1507/endocrj.EJ12-0316; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Fiuza-Luces C, 2013, PHYSIOLOGY, V28, P330, DOI 10.1152/physiol.00019.2013; HAAHR PM, 1991, INT J SPORTS MED, V12, P223, DOI 10.1055/s-2007-1024672; Hamrick MW, 2011, EXERC SPORT SCI REV, V39, P43, DOI 10.1097/JES.0b013e318201f601; Hartwig S, 2014, BBA-PROTEINS PROTEOM, V1844, P1011, DOI 10.1016/j.bbapap.2013.08.004; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Jensen TE, 2014, MOL METAB, V3, P742, DOI 10.1016/j.molmet.2014.07.005; Keller C, 2006, CYTOKINE, V36, P141, DOI 10.1016/j.cyto.2006.10.014; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Lambernd S, 2012, DIABETOLOGIA, V55, P1128, DOI 10.1007/s00125-012-2454-z; Li SC, 2015, TRENDS PHARMACOL SCI, V36, P906, DOI 10.1016/j.tips.2015.08.014; Manabe Y, 2016, ANAL BIOCHEM, V497, P36, DOI 10.1016/j.ab.2015.10.010; Manabe Y, 2014, J PHYSIOL SCI, V64, P401, DOI 10.1007/s12576-014-0334-7; Manabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052592; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062; Ostrowski K, 1998, J PHYSIOL-LONDON, V513, P889, DOI 10.1111/j.1469-7793.1998.889ba.x; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033; Pedersen BK, 2011, BRAIN BEHAV IMMUN, V25, P811, DOI 10.1016/j.bbi.2011.02.010; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Quinn LS, 2009, AM J PHYSIOL-ENDOC M, V296, pE191, DOI 10.1152/ajpendo.90506.2008; Raschke S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/320724; Sarvas Jessica L, 2013, J Diabetes Metab, VSuppl 13, DOI 10.4172/2155-6156.S13-003; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Tamura Y, 2011, ENDOCR J, V58, P211, DOI 10.1507/endocrj.K10E-400; Tit-Oon P, 2014, INT J ONCOL, V45, P2108, DOI 10.3892/ijo.2014.2636	40	26	27	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206146	10.1371/journal.pone.0206146	http://dx.doi.org/10.1371/journal.pone.0206146			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356272	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000077
J	Lee, JY; Popp, MP; Wolfe, EJ; Nayga, RM; Popp, JS; Chen, PY; Seo, HS				Lee, Ji Yong; Popp, Michael P.; Wolfe, Elijah J.; Nayga, Rodolfo M.; Popp, Jennie S.; Chen, Pengyin; Seo, Han-Seok			Information and order of information effects on consumers' acceptance and valuation for genetically modified edamame soybean	PLOS ONE			English	Article							EXPERIMENTAL AUCTION APPROACH; NEGATIVITY BIAS; MODIFIED FOOD; BIOTECHNOLOGY; RICE	This study examines two different strategies with respect to managing the order in which information about genetically modified (GM) technology would reach and impact consumers of edamame, often referred to as the "vegetable soybean". Edamame are soybeans harvested while the beans are young and soft. We capture consumers' willingness to pay (WTP) for unlabeled edamame, non-GM edamame, and GM edamame using a non-hypothetical random nth price auction. We elicit consumers' valuation for each edamame product before and after introducing information, and test two strategies where the order of providing positive and negative information is reversed. The results suggest that negative information affects WTP to a much greater extent than positive information. Hence a strategy to proactively deal with eventual negative press about GM technology did not lead to a different result than a strategy that would react to or attempt to thwart negative information with positive information at a later date. These findings suggest that it would be difficult to introduce new GM edamame as edible products in the market as marginally negative preconceptions about GM at the time of the experiment were easier to reinforce with negative information than to combat with positive information about GM.	[Lee, Ji Yong; Popp, Michael P.; Wolfe, Elijah J.; Nayga, Rodolfo M.; Popp, Jennie S.] Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA; [Chen, Pengyin] Univ Missouri, Delta Ctr, Div Plant Sci, Portageville, MO USA; [Seo, Han-Seok] Univ Arkansas, Dept Food Sci, Fayetteville, AR 72703 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Missouri System; University of Missouri Columbia; University of Arkansas System; University of Arkansas Fayetteville	Lee, JY (corresponding author), Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA.	jyl003@uark.edu		Seo, Han-Seok/0000-0001-9845-8199				Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Bernick K., 2009, EDAMAME TAKES ROOT U; Colson GJ, 2011, J AGR RESOUR ECON, V36, P343; Corrigan JR, 2009, AM J AGR ECON, V91, P837, DOI 10.1111/j.1467-8276.2009.01267.x; Delwaide AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126060; FELDMAN NS, 1976, J PERS SOC PSYCHOL, V34, P694; Fiske S. T., 2013, SOCIAL COGNITION BRA, DOI DOI 10.1016/J.COSE.2015.12.006; Gaskell G., 2003, EUROPEANS BIOTECHNOL; Hossain F., 2003, INT J CONSUM STUD, V27, P353, DOI [10.1046/j.1470-6431.2003.00303.x, DOI 10.1046/J.1470-6431.2003.00303.X]; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; KROSNICK JA, 1990, J PERS SOC PSYCHOL, V59, P1140, DOI 10.1037/0022-3514.59.6.1140; Lee JY, 2014, CHINA AGR ECON REV, V6, P125, DOI 10.1108/CAER-07-2012-0071; Lee JY, 2011, AUST J AGR RESOUR EC, V55, P360, DOI 10.1111/j.1467-8489.2011.00553.x; Lusk JL, 2018, FOOD POLICY, V78, P81, DOI 10.1016/j.foodpol.2018.02.007; Lusk JL, 2015, BIOTECHNOL J, V10, P13, DOI 10.1002/biot.201400561; Lusk JL, 2004, EUR REV AGRIC ECON, V31, P179, DOI 10.1093/erae/31.2.179; McFadden JR, 2017, FOOD POLICY, V69, P82, DOI 10.1016/j.foodpol.2017.03.002; Mozzoni LA, 2009, INT J FOOD SCI TECH, V44, P1125, DOI 10.1111/j.1365-2621.2009.01929.x; Nalley L., 2012, Journal of Food Distribution Research, V43, P43; Norsworthy JK, 2011, WEED TECHNOL, V25, P430, DOI 10.1614/WT-D-10-00155.1; Perry ED, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600850; Riar DS, 2011, WEED SCI, V59, P299, DOI 10.1614/WS-D-10-00150.1; Rousu M, 2007, ECON INQ, V45, P409, DOI 10.1111/j.1465-7295.2007.00017.x; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Shogren JF, 2001, J ECON BEHAV ORGAN, V46, P409, DOI 10.1016/S0167-2681(01)00165-2; Thorne F, 2017, AGRIBUSINESS, V33, P43, DOI 10.1002/agr.21477; Wolte E., 2016, THESIS; Wszelaki AL, 2005, FOOD QUAL PREFER, V16, P651, DOI 10.1016/j.foodqual.2005.02.001	28	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206300	10.1371/journal.pone.0206300	http://dx.doi.org/10.1371/journal.pone.0206300			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3FL	30356270	gold, Green Submitted, Green Published			2022-12-26	WOS:000448434000090
J	Rangul, V; Sund, ER; Mork, PJ; Roe, OD; Bauman, A				Rangul, Vegar; Sund, Erik R.; Mork, Paul Jarle; Roe, Oluf Dimitri; Bauman, Adrian			The associations of sitting time and physical activity on total and site-specific cancer incidence: Results from the HUNT study, Norway	PLOS ONE			English	Article							PROSTATE-CANCER; LUNG-CANCER; SEDENTARY BEHAVIOR; RECTAL-CANCER; RISK; COLON; MORTALITY; METAANALYSIS; ADIPONECTIN; HEALTH	Background Sedentary behavior is thought to pose different risks to those attributable to physical inactivity. However, few studies have examined the association between physical activity and sitting time with cancer incidence within the same population. Methods We followed 38,154 healthy Norwegian adults in the Nord-Trondelag Health Study (HUNT) for cancer incidence from 1995-97 to 2014. Cox proportional hazards regression was used to estimate risk of site-specific and total cancer incidence by baseline sitting time and physical activity. Results During the 16-years follow-up, 4,196 (11%) persons were diagnosed with cancer. We found no evidence that people who had prolonged sitting per day or had low levels of physical activity had an increased risk of total cancer incidence, compared to those who had low sitting time and were physically active. In the multivariate model, sitting >= 8 h/day was associated with 22% (95% CI, 1.05-1.42) higher risk of prostate cancer compared to sitting <8 h/day. Further, men with low physical activity (<= 8.3 MET-h/week) had 31% (95% CI, 1.0-01.70) increased risk of colorectal cancer (CRC) and 45% (95% CI, 1.01-2.09) increased risk of lung cancer compared to participants with a high physical activity (>16.6 MET-h/week). The joint effects of physical activity and sitting time the indicated that prolonged sitting time increased the risk of CRC independent of physical activity in men. Conclusions Our findings suggest that prolonged sitting and low physical activity are positively associated with colorectal-, prostate- and lung cancer among men. Sitting time and physical activity were not associated with cancer incidence among women. The findings emphasizing the importance of reducing sitting time and increasing physical activity.	[Rangul, Vegar; Sund, Erik R.; Mork, Paul Jarle; Bauman, Adrian] Norwegian Univ Sci & Technol NTNU, Fac Med, HUNT Res Ctr, Dept Publ Hlth & Nursing, Levanger, Norway; [Rangul, Vegar] Nord Univ, Fac Hlth & Nursing, Levanger, Norway; [Roe, Oluf Dimitri] Levanger Hosp, Canc Clin, Nord Trondelag Hlth Trust, Levanger, Norway; [Roe, Oluf Dimitri] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Bauman, Adrian] Univ Sydney, Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW, Australia	Norwegian University of Science & Technology (NTNU); Nord University; Norwegian University of Science & Technology (NTNU); University of Sydney	Rangul, V (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med, HUNT Res Ctr, Dept Publ Hlth & Nursing, Levanger, Norway.; Rangul, V (corresponding author), Nord Univ, Fac Hlth & Nursing, Levanger, Norway.	vegar.rangul@ntnu.no		Rangul, Vegar/0000-0001-8863-0557				Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bluher M, 2007, DIABETES CARE, V30, P280, DOI 10.2337/dc06-1362; Boyle T, 2012, JNCI-J NATL CANCER I, V104, P1548, DOI 10.1093/jnci/djs354; Buffart LM, 2014, J SCI MED SPORT, V17, P67, DOI 10.1016/j.jsams.2013.02.015; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; CHOMISTEK AK, 1954, PUBMED; Cong YJ, 2014, BRIT J CANCER, V110, P817, DOI 10.1038/bjc.2013.709; EATON NE, 1999, PUBMED, V6, P11; Ekelund U, 2002, HUMAN KINETICS, P1302, DOI 10.1016/S0140-6736(16)30370-1; EKELUND U, 2001, LANCET, V388, P1302; Emaus A, 2011, RECENT RESULTS CANC, V186, P101, DOI 10.1007/978-3-642-04231-7_5; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; GERHARDSSON M, 1986, AM J EPIDEMIOL, V123, P775, DOI 10.1093/oxfordjournals.aje.a114306; GOODYEAR LJ, 1998, ANNUAL REVIEW OF MED, V3, P24; Hibler E, 2015, CURR COLORECT CANC R, V11, P388, DOI 10.1007/s11888-015-0296-z; Hildebrand JS, 2015, CANCER CAUSE CONTROL, V26, P1691, DOI 10.1007/s10552-015-0656-7; Hildebrand JS, 2013, CANCER EPIDEM BIOMAR, V22, P1906, DOI 10.1158/1055-9965.EPI-13-0407; HOFVIND S, 2006, TIDSSKRIFT NORSKE LA, V11, P23; HTTPS, PUBMED; HTTPS, 2016, PUBMED, V10, P13; HTTPS, 2011, PUBMED; HTTPS, 2015, PUBMED; HTTPS, 2014, PUBMED; Hulsegge G, 2016, J AM HEART ASSOC, V5, P1; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kurtze N, 2007, EUR J EPIDEMIOL, V22, P379, DOI 10.1007/s10654-007-9110-9; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Larsson SC, 2006, EUR J CANCER, V42, P2590, DOI 10.1016/j.ejca.2006.04.015; Lee CD, 2002, MED SCI SPORT EXER, V34, P735; LUND N, 2000, BRIT J CANCER, V82, P1358; Lynch BM, 2014, CANCER EPIDEM BIOMAR, V23, P882, DOI 10.1158/1055-9965.EPI-13-0808; Lynch BM, 2010, CANCER EPIDEM BIOMAR, V19, P2691, DOI 10.1158/1055-9965.EPI-10-0815; McGuire S, 2016, ADV NUTR, V7, P418, DOI 10.3945/an.116.012211; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; Nilsen TIL, 2006, INT J CANCER, V119, P2943, DOI 10.1002/ijc.22184; Orsini N, 2009, BRIT J CANCER, V101, P1932, DOI 10.1038/sj.bjc.6605404; PATEL AV, 2009, PUBMED; *RES WCRFAALFC, 2011, CONTINUOUS UPDATE PR; RIMPELA AH, 1987, SOC SCI MED, V24, P601, DOI 10.1016/0277-9536(87)90064-5; SCHMID D, 2014, JNCI J NATL CANCER I, V106; SHEN D, 2014, PLOS ONE, V9; Sun JY, 2012, ASIAN PAC J CANCER P, V13, P3143, DOI 10.7314/APJCP.2012.13.7.3143; Ukawa S, 2013, CANCER CAUSE CONTROL, V24, P1547, DOI 10.1007/s10552-013-0231-z; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e; Wekesa A, 2015, PROSTATE CANCER P D, V18, P197, DOI 10.1038/pcan.2015.9; Welch HG, 2016, NEW ENGL J MED, V375, P1438, DOI 10.1056/NEJMoa1600249; WHO, 2010, GLOBAL RECOMMENDATIO; Wolin KY, 2011, RECENT RESULTS CANC, V186, P73, DOI 10.1007/978-3-642-04231-7_4	51	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206015	10.1371/journal.pone.0206015	http://dx.doi.org/10.1371/journal.pone.0206015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352079	gold, Green Submitted, Green Published			2022-12-26	WOS:000448076200022
J	Zepecki, JP; Snyder, KM; Moreno, MM; Fajardo, E; Fiser, A; Ness, J; Sarkar, A; Toms, SA; Tapinos, N				Zepecki, J. P.; Snyder, K. M.; Moreno, M. M.; Fajardo, E.; Fiser, A.; Ness, J.; Sarkar, A.; Toms, S. A.; Tapinos, N.			Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a Lck targeted inhibitor	ONCOGENE			English	Article							SCHWANN-CELLS; KINASE LCK; INVASION; NEURONS; HETEROGENEITY; MYELINATION; ACTIVATION; PHENOTYPE	Migration of human glioma cells (hGCs) within the brain parenchyma makes glioblastoma one of the most aggressive and lethal tumors. Studies of the cellular and molecular mechanisms underlying hGC migration are hindered by the limitations of existing glioma models. Here we developed a dorsal root ganglion axon-oligodendrocyte-hGC co-culture to study in real time the migration and interaction of hGCs with their microenvironment. hGCs interact with myelinated and non-myelinated axons through the formation of pseudopodia. Isolation of pseudopodia-localized polysome-bound RNA reveals transcripts of Lck, Paxillin, Crk-II, and Rac I that undergo local translation. Inhibition of Lck phosphorylation using a small-molecule inhibitor (Lck-I), blocks the phosphorylation of Paxillin and Crk-II, the formation of pseudopodia and the migration of hGCs. In vivo intraventricular administration of the Lck-I using an orthotopic xenograft glioma model, results in statistically significant inhibition of tumor size and significant down-regulation of Nanog-targeted genes, which are associated with glioblastoma patient survival. Moreover, treatment of human glioma stem cells (hGSCs) with Lck-I, results in significant inhibition of self-renewal and tumor-sphere formation. The involvement of Lck in different levels of glioma malignant progression, such as migration, tumor growth, and regulation of cancer stemness, makes Lck a potentially important therapeutic target for human glioblastomas.	[Zepecki, J. P.; Moreno, M. M.; Toms, S. A.; Tapinos, N.] Brown Univ, Mol Neurosci & Neurooncol Lab, Providence, RI 02912 USA; [Snyder, K. M.] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Fajardo, E.; Fiser, A.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Ness, J.] Messiah Coll, Dept Biol Sci, Mechanicsburg, PA USA; [Sarkar, A.] Geisinger Med Clin, Dept Neurosurg, Danville, PA USA; [Toms, S. A.; Tapinos, N.] Brown Univ, Rhode Isl Hosp, Dept Neurosurg, Providence, RI 02903 USA	Brown University; University of Minnesota System; University of Minnesota Twin Cities; Yeshiva University; Albert Einstein College of Medicine; Geisinger Medical Center; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Tapinos, N (corresponding author), Brown Univ, Mol Neurosci & Neurooncol Lab, Providence, RI 02912 USA.; Tapinos, N (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Neurosurg, Providence, RI 02903 USA.	nikos_tapinos@brown.edu		Zepecki, John P/0000-0003-4127-4668; Toms, Steven/0000-0001-8732-0522; Snyder, Kristin M./0000-0002-6598-1837	Molecular Pathology Core of the COBRE Center for Cancer Research Development - National Institute of General Medical Sciences of the National Institutes of Health [P30GM110759]; Geisinger Clinic; Department of Neurosurgery of Brown University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI141816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110759] Funding Source: NIH RePORTER	Molecular Pathology Core of the COBRE Center for Cancer Research Development - National Institute of General Medical Sciences of the National Institutes of Health; Geisinger Clinic; Department of Neurosurgery of Brown University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Tapinos lab for critically reviewing the manuscript. We would like to thank Kara Lombardo and Ashlee Sturtevant at the Pathology Core of Rhode Island Hospital for the assistance with glioblastoma tissue sections and stainings. We also thank Oliver Tang for analysis of the TCGA dataset. All animal work was performed according to institutional guidelines and approved by the IACUC committee of Rhode Island Hospital and Geisinger Clinic. Work included in this publication was supported by the Molecular Pathology Core of the COBRE Center for Cancer Research Development, funded by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P30GM110759. This research project was also supported by institutional funds of the Geisinger Clinic to N.T., S.A.T., and A.S. and by institutional funds of the Department of Neurosurgery of Brown University to N.T. and S.A.T.	Adilakshmi T, 2011, J NEUROSCI, V31, P5106, DOI 10.1523/JNEUROSCI.5635-10.2011; Aubert M, 2008, J R SOC INTERFACE, V5, P75, DOI 10.1098/rsif.2007.1070; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; de la Iglesia N, 2009, CURR MOL MED, V9, P580; de la Roche M, 2013, SCIENCE, V342, P1247, DOI 10.1126/science.1244689; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Diemert S, 2012, J NEUROSCI METH, V203, P69, DOI 10.1016/j.jneumeth.2011.09.012; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gandin V, 2014, JOVE-J VIS EXP, DOI 10.3791/51455; Giese A, 1996, NEUROSURGERY, V38, P755, DOI 10.1227/00006123-199604000-00026; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Joy AM, 2003, J CELL SCI, V116, P4409, DOI 10.1242/jcs.00712; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Kaur H, 2012, MOL CANCER RES, V10, P293, DOI 10.1158/1541-7786.MCR-11-0457; Kim RK, 2010, BIOCHEM BIOPH RES CO, V402, P631, DOI 10.1016/j.bbrc.2010.10.072; Koul D, 2005, MOL CANCER THER, V4, P1681, DOI 10.1158/1535-7163.MCT-05-0258; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Merzak A, 1997, CANCER METAST REV, V16, P155, DOI 10.1023/A:1005760726850; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Ness JK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2928; Park JB, 2014, ONCOTARGET, V5, P9382, DOI 10.18632/oncotarget.2412; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pinto JP, 2015, NUCLEIC ACIDS RES, V43, pW72, DOI 10.1093/nar/gkv529; Rao SS, 2013, BIOMATERIALS, V34, P5181, DOI 10.1016/j.biomaterials.2013.03.069; Reyes SB, 2013, MOL BIOL CELL, V24, P474, DOI 10.1091/mbc.E12-07-0521; REYNOLDS PJ, 1992, ONCOGENE, V7, P1949; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ruffini F, 2004, AM J PATHOL, V165, P2167, DOI 10.1016/S0002-9440(10)63266-X; Singh SK, 2003, CANCER RES, V63, P5821; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soni Priyanka, 2017, Asian Pac J Cancer Prev, V18, P2215; Stachlewitz RF, 2005, J PHARMACOL EXP THER, V315, P36, DOI 10.1124/jpet.105.089169; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2015, JAMA-J AM MED ASSOC, V314, P2535, DOI 10.1001/jama.2015.16669; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang Y., 2007, SCI STKE, V2007, P14; Wick W, 2001, J NEUROSCI, V21, P3360, DOI 10.1523/JNEUROSCI.21-10-03360.2001; WINDEBANK AJ, 1985, J NEUROSCI, V5, P1563; WOOD PM, 1976, BRAIN RES, V115, P361, DOI 10.1016/0006-8993(76)90355-3; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137	56	34	35	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2019	38	10					1734	1750		10.1038/s41388-018-0546-z	http://dx.doi.org/10.1038/s41388-018-0546-z			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN8DD	30353164	Green Published, hybrid			2022-12-26	WOS:000460423800012
J	Kim, JS; Lee, H; Nirmala, FS; Jung, CH; Kim, MJ; Jang, YJ; Ha, TY; Ahn, J				Kim, Ji-Sun; Lee, Hyunjung; Nirmala, Farida Sukma; Jung, Chang Hwa; Kim, Min Jung; Jang, Young-Jin; Ha, Tae Youl; Ahn, Jiyun			Dihydrodaidzein and 6-hydroxydaidzein mediate the fermentation-induced increase of antiosteoporotic effect of soybeans in ovariectomized mice	FASEB JOURNAL			English	Article						isoflavone; osteogenesis; metabolite; bioavailability; cheonggukjang	PRODUCT CHEONGGUKJANG; ISOFLAVONE DAIDZEIN; HIP FRACTURE; DIFFERENTIATION; METABOLISM; GLUCOSE; EQUOL	The consumption of soybeans is known to have beneficial effects on osteoporosis in postmenopausal women. However, the effects of soybean fermentation on the bioavailability and the antiosteoporotic effect have not yet been elucidated. To address this question, we fed ovariectomized C57BL/6J mice with a 5% nonfermented raw soybean (RS)- or fermented soybean (FS)-supplemented diet. After 18 wk of treatment, microcomputed tomography showed that FSs significantly increased bone mineral density compared with RSs. This was because of the up-regulation of bone morphogenic protein 2 (Bmp2) and its downstream target osteopontin in bone tissues. We analyzed isoflavone metabolite profiles in the sera of RS- or FS-fed mice and observed that the levels of 19 isoflavone metabolites were significantly increased in the sera of FS-fed mice. Among these metabolites, we observed that both dihydrodaidzein (DHD) and 6-hydroxydaidzein (6-HD) increased osteogenesis via Bmp2 signaling pathway in MC3T3-E1 cells and reduced receptor activator of nuclear factor -B ligand-induced osteoclastogenesis in RAW264.7 cells through the inhibition of NF-B activation and MAPK phosphorylation. These data suggest that improved bioavailability of FSs resulted from the production of active metabolites such as DHD and 6-HD after consumption. DHD and 6-HD can be used as potential therapeutics for the amelioration of osteoporotic bone loss.Kim, J.-S., Lee, H., Nirmala, F. S., Jung, C. H., Kim, M. J., Jang, Y.-J., Ha, T. Y., Ahn, J. Dihydrodaidzein and 6-hydroxydaidzein mediate the fermentation-induced increase of anti-osteoporotic effect of soybeans in ovariectomized mice.	[Kim, Ji-Sun; Lee, Hyunjung; Nirmala, Farida Sukma; Jung, Chang Hwa; Kim, Min Jung; Jang, Young-Jin; Ha, Tae Youl; Ahn, Jiyun] Korea Food Res Inst, Res Div Food Funct, 245 Nongsaengmyeong Ro Iseo Myeon, Wanju Gun 55365, Jeollabuk Do, South Korea; [Kim, Ji-Sun] Korea Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea; [Nirmala, Farida Sukma; Jung, Chang Hwa; Ha, Tae Youl; Ahn, Jiyun] Korea Univ Sci & Technol, Dept Food Biotechnol, Wanju Gun, South Korea	Korea Food Research Institute (KFRI); Korea University	Ahn, J (corresponding author), Korea Food Res Inst, Res Div Food Funct, 245 Nongsaengmyeong Ro Iseo Myeon, Wanju Gun 55365, Jeollabuk Do, South Korea.	jyan@kfri.re.kr	Jang, Young Jin/AAT-1192-2020; Jang, Young Jin/GLU-3087-2022	Kim, Ji-Sun/0000-0002-9568-1114	Korea Food Research Institute	Korea Food Research Institute	This work was supported by the Korea Food Research Institute. The authors thank Dr. Sang Hee Lee (Korea Food Research Institute, Wanju-gun, South Korea) for providing the isoflavone profile. The authors declare no conflicts of interest.	Ahn J, 2013, EMBO MOL MED, V5, P1602, DOI 10.1002/emmm.201302647; Ahn J, 2013, FOOD CHEM TOXICOL, V51, P439, DOI 10.1016/j.fct.2012.08.048; Atherton KM, 2006, BIOCHEM PHARMACOL, V72, P624, DOI 10.1016/j.bcp.2006.05.015; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chai C, 2012, J CHROMATOGR B, V880, P42, DOI 10.1016/j.jchromb.2011.11.013; Chen L, 2013, J AGR FOOD CHEM, V61, P10714, DOI 10.1021/jf402694m; Chen YC, 2003, BIOSCI BIOTECH BIOCH, V67, P903, DOI 10.1271/bbb.67.903; Choi JH, 2016, J CLIN BIOCHEM NUTR, V59, P31, DOI 10.3164/jcbn.15-30; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Fujioka M, 2004, J NUTR, V134, P2623, DOI 10.1093/jn/134.10.2623; Genant HK, 1999, OSTEOPOROSIS INT, V10, P259, DOI 10.1007/s001980050224; Hallahan AR, 2003, NAT MED, V9, P1033, DOI 10.1038/nm904; Hirata H, 2016, TOHOKU J EXP MED, V239, P95, DOI 10.1620/tjem.239.95; Hirota A, 2004, BIOSCI BIOTECH BIOCH, V68, P1372, DOI 10.1271/bbb.68.1372; Hong H, 2010, J MED FOOD, V13, P640, DOI 10.1089/jmf.2009.1092; Hwang IS, 2014, NUTR RES, V34, P355, DOI 10.1016/j.nutres.2014.02.004; Hwang IS, 2014, MOL MED REP, V9, P166, DOI 10.3892/mmr.2013.1757; Hwang KM, 2008, J MED FOOD, V11, P717, DOI 10.1089/jmf.2007.0151; Jang CH, 2006, FOOD SCI BIOTECHNOL, V15, P643; Jeong Ji-Kang, 2014, J Carcinog, V13, P9, DOI 10.4103/1477-3163.137699; Jung Yun-Jung, 2015, Prev Nutr Food Sci, V20, P260, DOI 10.3746/pnf.2015.20.4.260; Kampkotter A, 2008, NUTR RES, V28, P620, DOI 10.1016/j.nutres.2008.06.002; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kim DJ, 2008, J MED FOOD, V11, P215, DOI 10.1089/jmf.2007.560; Kim MJ, 2013, J OBES, V2013, DOI 10.1155/2013/874981; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lauderdale DS, 1997, AM J EPIDEMIOL, V146, P502; Lee DH, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700322; Lee K. H., 2006, J KOREAN DIET ASS, V12, P289; Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, 2016, KOR HLTH STAT 2015 K; Nam YR, 2015, NUTR RES PRACT, V9, P235, DOI 10.4162/nrp.2015.9.3.235; Rafii F, 2015, METABOLITES, V5, P56, DOI 10.3390/metabo5010056; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Scotti L, 2012, CURR TOP MED CHEM, V12, P2785; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; Setchell KDR, 2009, AM J CLIN NUTR, V90, P1029, DOI 10.3945/ajcn.2009.27981; SILVERMAN SL, 1988, AM J PUBLIC HEALTH, V78, P1482, DOI 10.2105/AJPH.78.11.1482; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tousen Y, 2011, MENOPAUSE, V18, P563, DOI 10.1097/gme.0b013e3181f85aa7; Wilson SR, 2009, J BIOL CHEM, V284, P2584, DOI 10.1074/jbc.M805280200; Wu WJ, 2014, J MED FOOD, V17, P1298, DOI 10.1089/jmf.2013.3095; XU X, 1994, J NUTR, V124, P825, DOI 10.1093/jn/124.6.825; Zhang RR, 2013, BONE, V52, P145, DOI 10.1016/j.bone.2012.09.029	45	9	10	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3252	3263		10.1096/fj.201800953R	http://dx.doi.org/10.1096/fj.201800953R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30376359	Bronze			2022-12-26	WOS:000459794800015
J	Wray, R; Iscla, I; Kovacs, Z; Wang, JM; Blount, P				Wray, Robin; Iscla, Irene; Kovacs, Zoltan; Wang, Junmei; Blount, Paul			Novel compounds that specifically bind and modulate MscL: insights into channel gating mechanisms	FASEB JOURNAL			English	Article						mechanosensitive; osmoregulation; antibiotic	MECHANOSENSITIVE CHANNEL; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; S4-S5 LINKER; HELIX; DOMAINS; ACTIVATION; RESISTANCE; MUTATIONS; RESIDUES	The bacterial mechanosensitive channel of large conductance (MscL) normally functions as an emergency release valve discharging cytoplasmic solutes upon osmotic stress. Opening the large pore of MscL inappropriately is detrimental to the cell, and thus it has been speculated to be a potential antibiotic target. Although MscL is one of the best studied mechanosensitive channels, no chemical that influenced bacterial growth by modulating MscL is known. We therefore used a high-throughput screen to identify compounds that slowed growth in an MscL-dependent manner. We characterized 2 novel sulfonamide compounds identified in the screen. We demonstrated that, although both increase MscL gating, one of these compounds does not work through the folate pathway, as other antimicrobial sulfonamides; indeed, the sulfonamide portion of the compound is not needed for activity. The only mode of action appears to be MscL activation. The binding pocket is where an -helix runs along the cytoplasmic membrane and interacts with a neighboring subunit; analogous motifs have been observed in several prokaryotic and eukaryotic channels. The data not only demonstrate that MscL is a viable antibiotic target, but also give insight into the gating mechanisms of MscL, and they may have implications for developing agonists for other channels.Wray, R., Iscla, I., Kovacs, Z., Wang, J., Blount, P. Novel compounds that specifically bind and modulate MscL: insights into channel gating mechanisms.	[Wray, Robin; Iscla, Irene; Blount, Paul] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 15261 USA; [Kovacs, Zoltan] Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Wang, Junmei] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, 3501 Terrace St, Pittsburgh, PA 15213 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Blount, P (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 15261 USA.; Wang, JM (corresponding author), Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, 3501 Terrace St, Pittsburgh, PA 15213 USA.	junmei.wang@pitt.edu; paul.blount@utsouthwestern.edu	Wang, Junmei/ACQ-2446-2022	Wang, Junmei/0000-0002-9607-8229; Iscla, Irene/0000-0001-8936-430X	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) [R01 GM061028, GM121780]; NIH National Institute of Biomedical Imaging and Bioengineering [P41-EB015908]; Welch Foundation [I-1420]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121780, R01GM061028] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); NIH National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Drs. Limin Yang (University of Texas, Southwestern Medical Center) and Andriy Anishkin (University of Maryland, College Park, MD, USA) for helpful suggestions and critical reading of the manuscript. This work was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) Grants R01 GM061028 and GM121780, and NIH National Institute of Biomedical Imaging and Bioengineering Grant P41-EB015908 (to Z.K.); Welch Foundation Grant I-1420 (to P.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other funding organizations. The authors declare no conflicts of interest.	[Anonymous], 2015, GLIDE 6 8; Bartlett JL, 2006, BIOPHYS J, V91, P3684, DOI 10.1529/biophysj.106.088062; Bartlett JL, 2004, P NATL ACAD SCI USA, V101, P10161, DOI 10.1073/pnas.0402040101; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Batiza AF, 2002, P NATL ACAD SCI USA, V99, P5643, DOI 10.1073/pnas.082092599; Bavi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11984; Blount P, 1999, Methods Enzymol, V294, P458; Blount P, 1999, TRENDS MICROBIOL, V7, P420, DOI 10.1016/S0966-842X(99)01594-2; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1996, EMBO J, V15, P4798, DOI 10.1002/j.1460-2075.1996.tb00860.x; Blount P, 1997, J BIOL CHEM, V272, P32150, DOI 10.1074/jbc.272.51.32150; BLOUNT P, 1993, J BIOL CHEM, V268, P16388; Blount Paul, 2008, V11, P25; Blount Paul, 2008, V1, P71; Booth IR, 2012, J BACTERIOL, V194, P4802, DOI 10.1128/JB.00576-12; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Case D. A., 2015, AMBER 14 TOOLS MOL S; Cox CD, 2018, ANNU REV PHYSIOL, V80, P71, DOI 10.1146/annurev-physiol-021317-121351; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; Enkvetchakul D, 2007, J GEN PHYSIOL, V130, P329, DOI 10.1085/jgp.200709764; Iscla I, 2008, BIOPHYS J, V95, P2283, DOI 10.1529/biophysj.107.127423; Iscla I, 2007, BIOPHYS J, V92, P1224, DOI 10.1529/biophysj.106.090316; Iscla I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137994; Iscla I, 2015, J ANTIBIOT, V68, P453, DOI 10.1038/ja.2015.4; Iscla I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5891; Iscla I, 2012, CHANNELS, V6, P255, DOI 10.4161/chan.20756; Iscla I, 2012, BIOPHYS J, V103, P169, DOI 10.1016/j.bpj.2012.06.021; Iscla I, 2011, FASEB J, V25, P694, DOI 10.1096/fj.10-170878; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Levin G, 2004, BIOPHYS J, V86, P2862, DOI 10.1016/S0006-3495(04)74338-6; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Maurer JA, 2001, BBA-BIOMEMBRANES, V1514, P165, DOI 10.1016/S0005-2736(01)00390-X; Moe P, 2005, BIOCHEMISTRY-US, V44, P12239, DOI 10.1021/bi0509649; Moe PC, 1998, MOL MICROBIOL, V28, P583, DOI 10.1046/j.1365-2958.1998.00821.x; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Rao SS, 2016, J ANTIBIOT, V69, P879, DOI 10.1038/ja.2016.45; Schumann U, 2010, P NATL ACAD SCI USA, V107, P12664, DOI 10.1073/pnas.1001405107; SKOLD O, 1976, ANTIMICROB AGENTS CH, V9, P49, DOI 10.1128/AAC.9.1.49; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Stokes NR, 2003, P NATL ACAD SCI USA, V100, P15959, DOI 10.1073/pnas.2536607100; Sybyl X, 2013, MOL MOD SOFTW PACK V; Teng JF, 2016, P NATL ACAD SCI USA, V113, P11847, DOI 10.1073/pnas.1613523113; Teng JF, 2015, P NATL ACAD SCI USA, V112, P3386, DOI 10.1073/pnas.1502366112; Vedantam G, 1998, ANTIMICROB AGENTS CH, V42, P88, DOI 10.1128/AAC.42.1.88; Wang JM, 2012, J CHEM INF MODEL, V52, P1199, DOI 10.1021/ci300064d; Wray R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002473; Xiao L, 2017, J CHEM THEORY COMPUT, V13, P3398, DOI 10.1021/acs.jctc.7b00382; Yang F, 2017, PROTEIN CELL, V8, P169, DOI 10.1007/s13238-016-0353-7; Zhou XL, 2007, P NATL ACAD SCI USA, V104, P15555, DOI 10.1073/pnas.0704039104	53	11	11	1	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3180	3189		10.1096/fj.201801628R	http://dx.doi.org/10.1096/fj.201801628R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30359098	Bronze, Green Published			2022-12-26	WOS:000459794800009
J	Liu, AD; Yang, JK; Hu, Q; Dirsch, O; Dahmen, U; Zhang, CT; Gewirtz, DA; Fang, HS; Sun, J				Liu, Anding; Yang, Jiankun; Hu, Qi; Dirsch, Olaf; Dahmen, Uta; Zhang, Cuntai; Gewirtz, David A.; Fang, Haoshu; Sun, Jian			Young plasma attenuates age-dependent liver ischemia reperfusion injury	FASEB JOURNAL			English	Article						autophagy; hepatocyte; AMPK; ULK1; rats	ISCHEMIA/REPERFUSION INJURY; AUTOPHAGY; AMPK; PHOSPHORYLATION; REJUVENATION; ACTIVATION; PROTECTS; DECLINE; GROWTH; CELLS	Aging is often associated with a decreased autophagic activity that contributes to the high sensitivity of aged livers to ischemia reperfusion injury (IRI). Blood from young animals can positively affect aged animals. This study was designed to evaluate the effect of young plasma in a model of liver IRI in aged rats. Aged rats were treated with pooled plasma collected from young rats before ischemia. Administration of young plasma restored aging-induced suppression in hepatic autophagic activity and reduced liver IRI. Inhibition of the young-plasma-restored autophagic activity abrogated the beneficial effect of young plasma against liver IRI. Similarly, young serum restored autophagic activity and reduced cellular injury after hypoxia/reoxygenation (H/R) in primary old rat hepatocytes. Mechanistic studies showed thatadministration of young plasma increased AMPK phosphorylation and led to unc-51-like autophagy activating kinase (ULK)1 activation. Furthermore, AMPK-inhibition abrogated the young serum-induced ULK1 activation and autophagic activity and diminished the protective action of young serum against H/R injury in primary old rat hepatocytes, whereas AMPK-activation potentiated the effects of young serum. Young plasma could restore age-impaired autophagy, at least in part, via AMPK/ULK1 signaling. Restoration of age-impaired autophagic activity may be a critical contributing mechanism to young-plasma-afforded protection against liver IRI in aged rats.Liu, A., Yang, J., Hu, Q., Dirsch, O., Dahmen, U., Zhang, C., Gewirtz, D. A., Fang, H., Sun, J. Young plasma attenuates age-dependent liver ischemia reperfusion injury.	[Liu, Anding; Yang, Jiankun] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Expt Med Ctr, Wuhan, Hubei, Peoples R China; [Hu, Qi; Zhang, Cuntai] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr, Wuhan, Hubei, Peoples R China; [Dirsch, Olaf] Klinikum Chemnitz, Inst Pathol, Chemnitz, Germany; [Dahmen, Uta] Friedrich Schiller Univ Jena, Dept Gen Visceral & Vasc Surg, Expt Transplantat Surg, Jena, Germany; [Gewirtz, David A.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Massey Canc Ctr, Richmond, VA USA; [Fang, Haoshu] Anhui Med Univ, Dept Pathophysiol, Hefei, Anhui, Peoples R China; [Sun, Jian] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliopancreat Surg, 107 Yan Jiang West Rd, Guangzhou 510120, Guangdong, Peoples R China; [Sun, Jian] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chemnitz Clinic; Friedrich Schiller University of Jena; Virginia Commonwealth University; Anhui Medical University; Sun Yat Sen University; Sun Yat Sen University	Sun, J (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliopancreat Surg, 107 Yan Jiang West Rd, Guangzhou 510120, Guangdong, Peoples R China.	sjmed02@outlook.com	Liu, Anding/AAU-2477-2020		National Natural Science Fund of China (NSFC) [81300343]	National Natural Science Fund of China (NSFC)(National Natural Science Foundation of China (NSFC))	This project was supported by National Natural Science Fund of China (NSFC) Grant 81300343 (to A.L.). The authors declare no conflicts of interest.	Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Chang JT, 2017, ELIFE, V6, DOI 10.7554/eLife.18459; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Cursio R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/417590; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0; Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Iwamoto T, 2008, TRANSPLANTATION, V85, P1240, DOI 10.1097/TP.0b013e31816c7e90; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kireev RA, 2012, J SURG RES, V178, P922, DOI 10.1016/j.jss.2012.04.060; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Lai Q, 2011, J GASTROINTEST LIVER, V20, P383; Liu AD, 2018, AGING CELL, V17, DOI 10.1111/acel.12708; Liu AD, 2016, ONCOTARGET, V7, P78372, DOI 10.18632/oncotarget.13281; Liu AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep25042; Liu AD, 2014, CRIT CARE MED, V42, pE762, DOI 10.1097/CCM.0000000000000659; Liu AD, 2013, LIVER TRANSPLANT, V19, P762, DOI 10.1002/lt.23666; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338; Martinez-Lopez N, 2015, ADV EXP MED BIOL, V847, P73, DOI 10.1007/978-1-4939-2404-2_3; Middeldorp J, 2016, JAMA NEUROL, V73, P1325, DOI 10.1001/jamaneurol.2016.3185; Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11; Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001; Rautou PE, 2010, J HEPATOL, V53, P1123, DOI 10.1016/j.jhep.2010.07.006; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Salminen A, 2016, AGEING RES REV, V28, P15, DOI 10.1016/j.arr.2016.04.003; Salpeter SJ, 2013, DIABETES, V62, P3300, DOI 10.2337/db13-er09; Schneider JL, 2014, NAT REV GASTRO HEPAT, V11, P187, DOI 10.1038/nrgastro.2013.211; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Stenesen D, 2013, CELL METAB, V17, P101, DOI 10.1016/j.cmet.2012.12.006; Uddin MN, 2012, AGE, V34, P75, DOI 10.1007/s11357-011-9221-9; Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318; Wang JH, 2011, GASTROENTEROLOGY, V141, P2188, DOI 10.1053/j.gastro.2011.08.005; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Yun N, 2014, FREE RADICAL BIO MED, V68, P168, DOI 10.1016/j.freeradbiomed.2013.12.014; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhang DY, 2016, AUTOPHAGY, V12, P1447, DOI 10.1080/15548627.2016.1185576	48	12	12	3	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					3063	3073		10.1096/fj.201801234R	http://dx.doi.org/10.1096/fj.201801234R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30383439	Bronze			2022-12-26	WOS:000457296600121
J	Alexander, JAN; Chatterjee, SS; Hamilton, SM; Eltis, LD; Chambers, HF; Strynadka, NCJ				Alexander, J. Andrew N.; Chatterjee, Som S.; Hamilton, Stephanie M.; Eltis, Lindsay D.; Chambers, Henry F.; Strynadka, Natalie C. J.			Structural and kinetic analyses of penicillin-binding protein 4 (PBP4)-mediated antibiotic resistance in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; Methicillin-resistant Staphylococcus aureus (MRSA); X-ray crystallography; peptidoglycan; enzyme kinetics; Gram-positive bacteria; microbiology; -lactam antibiotics; multidrug resistance; penicillin-binding protein 4 (PBP4); resistance gene	BETA-LACTAM RESISTANCE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURE REFINEMENT; IN-VITRO; CEPHALOSPORINS; IDENTIFICATION; CEFTOBIPROLE; FEATURES; SERVER	Methicillin-resistant Staphylococcus aureus (MRSA) causes serious community-acquired and nosocomial infections worldwide. MRSA strains are resistant to a variety of antibiotics, including the classic penicillin and cephalosporin classes of -lactams, making them intractable to treatment. Although -lactam resistance in MRSA has been ascribed to the acquisition and activity of penicillin-binding protein 2a (PBP2a, encoded by mecA), it has recently been observed that resistance can also be mediated by penicillin-binding protein 4 (PBP4). Previously, we have shown that broad-spectrum -lactam resistance can arise following serial passaging of a mecA-negative COL strain of S. aureus, creating the CRB strain. This strain has two missense mutations in pbp4 and a mutation in the pbp4 promoter, both of which play an instrumental role in -lactam resistance. To better understand PBP4's role in resistance, here we have characterized its kinetics and structure with clinically relevant -lactam antibiotics. We present the first crystallographic PBP4 structures of apo and acyl-enzyme intermediate forms complexed with three late-generation -lactam antibiotics: ceftobiprole, ceftaroline, and nafcillin. In parallel, we characterized the structural and kinetic effects of the PBP4 mutations present in the CRB strain. Localized within the transpeptidase active-site cleft, the two substitutions appear to have different effects depending on the drug. With ceftobiprole, the missense mutations impaired the K-m value 150-fold, decreasing the proportion of inhibited PBP4. However, ceftaroline resistance appeared to be mediated by other factors, possibly including mutation of the pbp4 promoter. Our findings provide evidence that S. aureus CRB has at least two PBP4-mediated resistance mechanisms.	[Alexander, J. Andrew N.; Eltis, Lindsay D.; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Alexander, J. Andrew N.; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Eltis, Lindsay D.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Chatterjee, Som S.; Hamilton, Stephanie M.; Chambers, Henry F.] San Francisco Gen Hosp, Dept Med, Div Infect Dis, San Francisco, CA 94110 USA	University of British Columbia; University of British Columbia; University of British Columbia; San Francisco General Hospital Medical Center	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ncjs@mail.ubc.ca		Alexander, J. Andrew/0000-0002-8759-1389	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100291] Funding Source: NIH RePORTER	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research described in this paper was performed using beam lines 08B1-1 and 08ID-1 at the Canadian Light Source, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Argudin MA, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00091-18; Baneriee R, 2008, ANTIMICROB AGENTS CH, V52, P2089, DOI 10.1128/AAC.01403-07; Banerjee R, 2010, ANTIMICROB AGENTS CH, V54, P4900, DOI 10.1128/AAC.00594-10; Basuino L, 2018, J ANTIMICROB CHEMOTH, V73, P1177, DOI 10.1093/jac/dkx531; Becker K, 2016, J CLIN MICROBIOL, V54, P180, DOI 10.1128/JCM.02081-15; CHAMBERS HF, 1994, BIOCHEM J, V301, P139, DOI 10.1042/bj3010139; Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781, DOI 10.1128/CMR.10.4.781; Chan LC, 2016, ANTIMICROB AGENTS CH, V60, P3934, DOI 10.1128/AAC.00358-16; Chatterjee SS, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00932-17; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2009, J AM CHEM SOC, V131, P14345, DOI 10.1021/ja903773f; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dessen A, 2001, J BIOL CHEM, V276, P45106, DOI 10.1074/jbc.M107608200; DYKE KGH, 1966, LANCET, V1, P835; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Greninger AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149541; Griffiths JM, 2012, ANTIMICROB AGENTS CH, V56, P579, DOI 10.1128/AAC.05148-11; Hamilton SM, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02727-16; Hebeisen P, 2001, ANTIMICROB AGENTS CH, V45, P825, DOI 10.1128/AAC.45.3.825-836.2001; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katayama Y, 2003, J BACTERIOL, V185, P5465, DOI 10.1128/JB.185.18.5465-5472.2003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lahiri SD, 2016, J ANTIMICROB CHEMOTH, V71, P3050, DOI 10.1093/jac/dkw282; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Laudano JB, 2011, J ANTIMICROB CHEMOTH, V66, pIII11, DOI 10.1093/jac/dkr095; Loskill P, 2014, BIOPHYS J, V107, P1082, DOI 10.1016/j.bpj.2014.07.029; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Memmi G, 2008, ANTIMICROB AGENTS CH, V52, P3955, DOI 10.1128/AAC.00049-08; Morlot C, 2005, J BIOL CHEM, V280, P15984, DOI 10.1074/jbc.M408446200; Navratna V, 2010, J BACTERIOL, V192, P134, DOI 10.1128/JB.00822-09; Nicholas RA, 2003, J BIOL CHEM, V278, P52826, DOI 10.1074/jbc.M310177200; Nicola G, 2005, BIOCHEM J, V392, P55, DOI 10.1042/BJ20050449; Nicola G, 2005, BIOCHEMISTRY-US, V44, P8207, DOI 10.1021/bi0473004; Nicola G, 2010, BIOCHEMISTRY-US, V49, P8094, DOI 10.1021/bi100879m; Ourghanlian C, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02510-16, 10.1128/aac.02510-16]; Page MG, 2004, EXPERT OPIN INV DRUG, V13, P973, DOI 10.1517/13543784.13.8.973; Qiao Y, 2014, J AM CHEM SOC, V136, P14678, DOI 10.1021/ja508147s; Queenan AM, 2007, ANTIMICROB AGENTS CH, V51, P3089, DOI 10.1128/AAC.00218-07; Reed P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004891; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Schweizer ML, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-279; Sobhanifar S, 2013, CURR OPIN STRUC BIOL, V23, P695, DOI 10.1016/j.sbi.2013.07.008; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tomberg J, 2012, BIOCHEMISTRY-US, V51, P2775, DOI 10.1021/bi2017987; Welsh MA, 2017, J AM CHEM SOC, V139, P17727, DOI 10.1021/jacs.7b10170; WHO, 2017, WORLD HLTH ORG, P7, DOI DOI 10.1016/S1473-3099(09)70222-1; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Zapun A., 2017, ANTIMICROBIAL DRUG R, P177	58	27	27	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19854	19865		10.1074/jbc.RA118.004952	http://dx.doi.org/10.1074/jbc.RA118.004952			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30366985	Green Published, hybrid			2022-12-26	WOS:000454294900029
J	Fan, YT; Huang, LW; Jiang, D; Xu, XZ				Fan, Yaotian; Huang, Liwen; Jiang, Dan; Xu, Xianzhang			Research on shipborne aided navigation system based on enhanced traffic environment perception	PLOS ONE			English	Article								The traditional shipborne navigation system uses a two-dimensional electronic chart as a platform to integrate and control a variety of electronic navigation equipment information. It cannot intuitively restore the actual traffic environment or fundamentally improve the perception ability of the crew in poor visibility conditions. This paper proposes integrating three-dimensional simulations and real ship driving systems and presents research on "virtual- real" and "dynamic-static" ship navigation technology and equipment. In the proposed method, the hydrologic factors, topographic features, waterways, traffic dynamics, and ship driving information are effectively integrated, with a focus on achieving key advancements such as the integration of simulations and real ship driving as well as multi-source information fusion. A multi-angle, all-around, multi-level visual display for water traffic environments in poor visibility conditions is provided to enhance the ability of crews to perceive their traffic environments and thereby to provide auxiliary navigation for ships in complex weather conditions.	[Fan, Yaotian; Huang, Liwen] Wuhan Univ Technol, Sch Nav, Wuhan, Hubei, Peoples R China; [Fan, Yaotian; Huang, Liwen] Hubei Key Lab Inland Shipping Technol, Wuhan, Hubei, Peoples R China; [Jiang, Dan] Chongqing Jiaotong Univ, Dept Nav, Chongqing, Peoples R China; [Xu, Xianzhang] Univ Southampton, Fac Engn & Environm, Southampton, Hants, England	Wuhan University of Technology; Hubei Key Laboratory of Inland Shipping Technology; Chongqing Jiaotong University; University of Southampton	Jiang, D (corresponding author), Chongqing Jiaotong Univ, Dept Nav, Chongqing, Peoples R China.	jd_melody@126.com			National Natural Science Foundation of China [51379170]; Key Project in the National Science & Technology Pillar Program [2015BAG20B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project in the National Science & Technology Pillar Program	This work was financially supported by the National Natural Science Foundation of China (grant no. 51379170) received by LWH, grants from the Key Project in the National Science & Technology Pillar Program (grant no. 2015BAG20B05) received by LWH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, TYPICAL CASES WATER; Arsenault R, 2003, P 11 IAIN WORLD C SM; Dollner J., 2007, MULTIMEDIA CARTOGRAP, P229, DOI [10.1007/978-3-540-36651-5_16, DOI 10.1007/978-3-540-36651-5_16, DOI 10.1007/978-3-540-36651-516]; Fernandes RN, 2008, HYDROBIOLOGIA, V612, P297, DOI 10.1007/s10750-008-9495-9; Gan X., 2003, STUDY AIS RADAR INFO; Kang Ling, 2003, Journal of Huazhong University of Science and Technology, V31, P71; [李彩霞 Li Caixia], 2015, [中国航海, Journal of Navigation of China], V38, P85; LI WY, 2007, ALGORITHM STUDYING R; Liu F, 2013, NAVIGATION ENG, V2, P16; Liu J, 2013, CHINA TRAFFIC INFORM, V1, P16; Liu R., 2013, NAVIGATION INFORM FU; Liu X-zuo, 2013, Journal of System Simulation, V25, P1851; Luo SY, 2003, RES FUSION METHOD AI; Meng Hao, 2003, Journal of System Simulation, V15, P457; Porathe T, 2006, THESIS; Ray C, 2009, C TECHNOLOGIES LINFO; Tan D, 2010, J YANGTZE ACAD SCI, V1, P1; Yu HX, 2006, STUDY AIS RADAR DATA; Zhang Dan, 2012, Journal of System Simulation, V24, P180; Zheng JC, 2005, J JIMEI U NATURAL SC, V10, P28; Zou Q., 2013, STUDY AIS RADAR INFO	21	2	2	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206402	10.1371/journal.pone.0206402	http://dx.doi.org/10.1371/journal.pone.0206402			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379963	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000448823700108
J	Kotikoski, S; Huttunen, J; Huttunen, TJ; Helin, K; Frosen, J; Koivisto, T; Kurki, MI; zu Fraunberg, MV; Kunnamo, I; Jaaskelainen, JE; Lindgren, AE				Kotikoski, Satu; Huttunen, Jukka; Huttunen, Terhi J.; Helin, Katariina; Frosen, Juhana; Koivisto, Timo; Kurki, Mitja, I; von und zu Fraunberg, Mikael; Kunnamo, Iikka; Jaaskelainen, Juha E.; Lindgren, Antti E.			Secondary hypertension in patients with saccular intracranial aneurysm disease: A population based study	PLOS ONE			English	Article							SUBARACHNOID HEMORRHAGE; RISK-FACTORS; PREVALENCE; RUPTURE; MORTALITY; SURVIVORS; SLEEP	Background Secondary hypertension is a serious form of hypertension, involving 5% to 10% of all hypertension patients. Hypertension is a risk factor of the saccular intracranial aneurysm (sIA) disease and subarachnoid hemorrhage from ruptured slA (aSAH), but the impact of secondary hypertension on slA disease is poorly known. In a defined Eastern Finnish slA population we studied the prevalence of secondary hypertension and its impact on slA disease phenotype. Methods We included 2704 consecutive slA patients first admitted to Kuopio University Hospital from 1995 to 2014. Their clinical data from Kuopio Intracranial Aneurysm patient and Family Database was fused with prescription drug usage data, hospital diagnoses and causes of death, retrieved from nationwide registries. Medical records of hypertensive slA patients were reviewed to confirm or exclude secondary hypertension. Prevalence of secondary hypertension and associated diagnoses were calculated. Logistic regression was used to identify clinical characteristics of slA disease that associated with secondary hypertension. Results We identified 2029 (75%) slA patients with hypertension and 208 (10%) of them had secondary hypertension. Most frequent conditions associated with secondary hypertension were kidney and renovascular diseases (45%), sleep apnea (27%) and hypothyroidism (19%); 46 (22%) of the 208 patients had more than one such condition. In multivariate logistic regression analyses of 1561 aSAH patients, secondary hypertension significantly associated with the number of slAs (p = 0.003; OR 1.32; 95% CI 1.10-1.58) and male gender (p = 0.034; OR 1.59; 95% CI 1.04-2.43). Conclusions Secodary hypertension was relatively common (10%) among hypertensive slA patients. Secondary causes for hypertension should be taken into account in hypertensive slA patients, especially in aSAH patients with multiple intracranial aneurysms. Further research is indicated to evaluate the impact of secondary hypertension on the long-term rupture risk of unruptured slA carriers and long-term outcome after aSAH.	[Kotikoski, Satu; Huttunen, Jukka; Huttunen, Terhi J.; Helin, Katariina; Frosen, Juhana; Koivisto, Timo; Kurki, Mitja, I; von und zu Fraunberg, Mikael; Jaaskelainen, Juha E.; Lindgren, Antti E.] Univ Eastern Finland, Kuopio Univ Hosp, Neurosurg NeuroCtr, Kuopio, Finland; [Kotikoski, Satu; Huttunen, Jukka; Huttunen, Terhi J.; Helin, Katariina; Frosen, Juhana; Koivisto, Timo; Kurki, Mitja, I; von und zu Fraunberg, Mikael; Jaaskelainen, Juha E.; Lindgren, Antti E.] Univ Eastern Finland, Inst Clin Med, Sch Med, Fac Hlth Sci, Kuopio, Finland; [Kunnamo, Iikka] Finnish Med Soc Duodec, Helsinki, Finland; [Lindgren, Antti E.] UMC Utrecht, Dept Neurol & Neurosurg, Utrecht, Netherlands	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Utrecht University; Utrecht University Medical Center	Lindgren, AE (corresponding author), Univ Eastern Finland, Kuopio Univ Hosp, Neurosurg NeuroCtr, Kuopio, Finland.; Lindgren, AE (corresponding author), Univ Eastern Finland, Inst Clin Med, Sch Med, Fac Hlth Sci, Kuopio, Finland.; Lindgren, AE (corresponding author), UMC Utrecht, Dept Neurol & Neurosurg, Utrecht, Netherlands.	anti.lindgren@kuh.fi	Lindgren, Antti/J-2517-2019; Kurki, Mitja/GWM-5671-2022	Lindgren, Antti/0000-0002-1264-7667; von und zu Fraunberg, Mikael/0000-0002-8457-4639	North Savo Regional Fund of the Finnish Cultural Foundation; Saastamoinen Foundation; Maire Taponen Foundation; Juho Vainio foundation; Paivikki and Sakari Sohlberg Foundation; Finnish Academy of Sciences; Kuopio University Hospital	North Savo Regional Fund of the Finnish Cultural Foundation; Saastamoinen Foundation; Maire Taponen Foundation; Juho Vainio foundation; Paivikki and Sakari Sohlberg Foundation; Finnish Academy of Sciences(Academy of Finland); Kuopio University Hospital	The study was supported by by North Savo Regional Fund of the Finnish Cultural Foundation, the Saastamoinen Foundation, the Maire Taponen Foundation, the Juho Vainio foundation, the Paivikki and Sakari Sohlberg Foundation, Finnish Academy of Sciences, and Kuopio University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGLUND G, 1976, BRIT MED J, V2, P554, DOI 10.1136/bmj.2.6035.554; DANIELSON M, 1981, ACTA MED SCAND, V209, P451; Etminan N, 2016, NAT REV NEUROL, V12, P699, DOI 10.1038/nrneurol.2016.150; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Madariaga AG, 2014, J CLIN ENDOCR METAB, V99, P923, DOI 10.1210/jc.2013-2409; Garovic VD, 2005, CIRCULATION, V112, P1362, DOI 10.1161/CIRCULATIONAHA.104.492348; Gissler M., 2004, NOR EPIDEMIOL, V14, P113; Huttunen J, 2016, STROKE, V47, P2242, DOI 10.1161/STROKEAHA.116.014327; Huttunen J, 2015, NEUROLOGY, V84, P2229, DOI 10.1212/WNL.0000000000001643; Huttunen T, 2011, NEUROSURGERY, V68, P20, DOI 10.1227/NEU.0b013e3181ff33ca; Huttunen T, 2010, NEUROSURGERY, V66, P631, DOI 10.1227/01.NEU.0000367634.89384.4B; Karamanakos PN, 2012, WORLD NEUROSURG, V78, P631, DOI 10.1016/j.wneu.2011.08.033; Korja M, 2013, NEUROLOGY, V80, P481, DOI 10.1212/WNL.0b013e31827f0fb5; Lindgren AE, 2014, ANN MED, V46, P169, DOI 10.3109/07853890.2014.883168; Lindgren AE, 2013, DIABETES CARE, V36, P2020, DOI 10.2337/dc12-1048; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mosso L, 2003, HYPERTENSION, V42, P161, DOI 10.1161/01.HYP.0000079505.25750.11; Ohayon MM, 1997, BRIT MED J, V314, P860; Omura M, 2004, HYPERTENS RES, V27, P193, DOI 10.1291/hypres.27.193; Pedrosa RP, 2011, HYPERTENSION, V58, P811, DOI 10.1161/HYPERTENSIONAHA.111.179788; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; Remuzzi G, 1997, KIDNEY INT, V51, P2, DOI 10.1038/ki.1997.2; Rimoldi SF, 2014, EUR HEART J, V35, P1245, DOI 10.1093/eurheartj/eht534; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Ronkainen A, 1997, LANCET, V349, P380, DOI 10.1016/S0140-6736(97)80009-8; Tikkanen I, CURRENT CARE GUIDELI; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wermer MJH, 2007, STROKE, V38, P1404, DOI 10.1161/01.STR.0000260955.51401.cd	30	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206432	10.1371/journal.pone.0206432	http://dx.doi.org/10.1371/journal.pone.0206432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379949	Green Submitted, Green Published, gold			2022-12-26	WOS:000448823700115
J	Chen, S; Wang, ZZ; Tang, L; Tang, YN; Gao, YY; Li, HJ; Xiang, J; Zhang, Y				Chen, Shi; Wang, Zhi-Zhong; Tang, Liang; Tang, Yan-Ni; Gao, Yuan-Yuan; Li, Hui-Jia; Xiang, Ju; Zhang, Yan			Global vs local modularity for network community detection	PLOS ONE			English	Article							COMPLEX NETWORKS; MODEL	Community structures are ubiquitous in various complex networks, implying that the networks commonly be composed of groups of nodes with more internal links and less external links. As an important topic in network theory, community detection is of importance for understanding the structure and function of the networks. Optimizing statistical measures for community structures is one of most popular strategies for community detection in complex networks. In the paper, by using a type of self-loop rescaling strategy, we introduced a set of global modularity functions and a set of local modularity functions for community detection in networks, which are optimized by a kind of the self-consistent method. We carefully compared and analyzed the behaviors of the modularity-based methods in community detection, and confirmed the superiority of the local modularity for detecting community structures on large-size and heterogeneous networks. The local modularity can more quickly eliminate the first-type limit of modularity, and can eliminate or alleviate the second-type limit of modularity in networks, because of the use of the local information in networks. Moreover, we tested the methods in real networks. Finally, we expect the research can provide useful insight into the problem of community detection in complex networks.	[Chen, Shi; Tang, Liang; Tang, Yan-Ni; Gao, Yuan-Yuan; Xiang, Ju; Zhang, Yan] Changsha Med Univ, Neurosci Res Ctr, Changsha, Hunan, Peoples R China; [Chen, Shi; Tang, Liang; Tang, Yan-Ni; Gao, Yuan-Yuan; Xiang, Ju; Zhang, Yan] Changsha Med Univ, Dept Basic Med Sci, Changsha, Hunan, Peoples R China; [Wang, Zhi-Zhong] Hunan First Normal Univ, South City Coll, Changsha, Hunan, Peoples R China; [Chen, Shi; Zhang, Yan] Changsha Med Univ, Dept Informat Sci & Engn, Changsha, Hunan, Peoples R China; [Li, Hui-Jia] Cent Univ Finance & Econ, Sch Management Sci & Engn, Beijing, Peoples R China; [Xiang, Ju] Cent South Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China	Changsha Medical University; Changsha Medical University; Hunan First Normal University; Changsha Medical University; Central University of Finance & Economics; Central South University	Xiang, J; Zhang, Y (corresponding author), Changsha Med Univ, Neurosci Res Ctr, Changsha, Hunan, Peoples R China.; Xiang, J; Zhang, Y (corresponding author), Changsha Med Univ, Dept Basic Med Sci, Changsha, Hunan, Peoples R China.; Zhang, Y (corresponding author), Changsha Med Univ, Dept Informat Sci & Engn, Changsha, Hunan, Peoples R China.; Xiang, J (corresponding author), Cent South Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China.	xiang.ju@foxmail.com; zhangyancsmu@foxmail.com	Xiang, Ju/Q-2118-2016; Li, Hui-Jia/AAW-9398-2021	Xiang, Ju/0000-0002-3045-5706; Li, Huijia/0000-0003-1000-717X	construct program of the key discipline in Hunan province; Training Program for Excellent Innovative Youth of Changsha; National Natural Science Foundation of China [61702054, 71871233]; Hunan Provincial Natural Science Foundation of China [2018JJ3568]; Scientific Research Fund of Education Department of Hunan Province [17A024, 17C0180, 17B034]; Scientific Research Project of Hunan Provincial Health and Family Planning Commission of China [C2017013]; Beijing Natural Science Foundation [9182015]; Hunan key laboratory cultivation base of the research and development of novel pharmaceutical preparations [2016TP1029]	construct program of the key discipline in Hunan province; Training Program for Excellent Innovative Youth of Changsha; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Scientific Research Fund of Education Department of Hunan Province; Scientific Research Project of Hunan Provincial Health and Family Planning Commission of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Hunan key laboratory cultivation base of the research and development of novel pharmaceutical preparations	This work was supported by the construct program of the key discipline in Hunan province, the Training Program for Excellent Innovative Youth of Changsha, the National Natural Science Foundation of China (Grant No. 61702054 and 71871233), the Hunan Provincial Natural Science Foundation of China (Grant No. 2018JJ3568), the Scientific Research Fund of Education Department of Hunan Province (Grant No. 17A024, 17C0180 and 17B034), the Scientific Research Project of Hunan Provincial Health and Family Planning Commission of China (Grant No. C2017013), the Beijing Natural Science Foundation (Grant No. 9182015), and the Hunan key laboratory cultivation base of the research and development of novel pharmaceutical preparations (Grant No. 2016TP1029).	Aldecoa R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02216; Aldecoa R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01060; Aldecoa R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024195; Amelio A., 2017, P266; Arenas A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053039; Bagrow JP, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/05/P05001; Barber MJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026129; Berry JW, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056119; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Botta F, 2016, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2016/12/123402; Bu DB, 2003, NUCLEIC ACIDS RES, V31, P2443, DOI 10.1093/nar/gkg340; Chen M., 2015, COMPUT SCI, V4, P22; Chen MM, 2014, IEEE T COMPUT SOC SY, V1, P46, DOI 10.1109/TCSS.2014.2307458; Chen P, 2010, J INFORMETR, V4, P278, DOI 10.1016/j.joi.2010.01.001; Chen PY, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.032804; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; De Meo P, 2013, INFORM SCIENCES, V222, P648, DOI 10.1016/j.ins.2012.08.001; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Havemann F, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01023; Jiang YW, 2014, J PHYS A-MATH THEOR, V47, DOI 10.1088/1751-8113/47/16/165101; Jin D, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/05/P05031; Karrer B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016107; Lancichinetti A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066122; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Li HJ, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48005; Lu XY, 2018, INFORM SCIENCES, V424, P55, DOI 10.1016/j.ins.2017.09.063; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Muff S, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056107; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nicolini C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19250; Nicosia V, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/03/P03024; Pan Y, 2010, PHYSICA A, V389, P2849, DOI 10.1016/j.physa.2010.03.006; Piccardi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027028; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reichardt J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.218701; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Subelj L, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2011-20448-7; Traag VA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02930; Traag VA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036115; Xiang J, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30301-2; Xiang J, 2016, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2016/03/033405; Xiang J, 2016, PHYSICA A, V443, P451, DOI 10.1016/j.physa.2015.09.093; Xiang J, 2015, PHYSICA A, V432, P127, DOI 10.1016/j.physa.2015.03.006; Xiang J, 2015, CAN J PHYS, V93, P418, DOI 10.1139/cjp-2013-0652; Xiang J, 2012, PHYSICA A, V391, P4995, DOI 10.1016/j.physa.2012.05.006; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhang J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/113003; Zhang SH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S10; Zhang XS, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/38002	58	10	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0205284	10.1371/journal.pone.0205284	http://dx.doi.org/10.1371/journal.pone.0205284			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372429	Green Published, Green Submitted, gold			2022-12-26	WOS:000448641200008
J	Otsuka, K; Yamada, K; Taquahashi, Y; Arakaki, R; Ushio, A; Saito, M; Yamada, A; Tsunematsu, T; Kudo, Y; Kanno, J; Ishimaru, N				Otsuka, Kunihiro; Yamada, Koichi; Taquahashi, Yuhji; Arakaki, Rieko; Ushio, Aya; Saito, Masako; Yamada, Akiko; Tsunematsu, Takaaki; Kudo, Yasusei; Kanno, Jun; Ishimaru, Naozumi			Long-term polarization of alveolar macrophages to a profibrotic phenotype after inhalation exposure to multi-wall carbon nanotubes	PLOS ONE			English	Article							PULMONARY INFLAMMATION; OXIDATIVE STRESS; TISSUE-REPAIR; LUNG FIBROSIS; MICE; NANOPARTICLES; TOXICITY; RESPONSES; MECHANISMS; DEFICIENT	Background Nanomaterials are widely used in various fields. Although the toxicity of carbon nanotubes (CNTs) in pulmonary tissues has been demonstrated, the toxicological effect of CNTs on the immune system in the lung remains unclear. Methods and finding In this study, exposure to Taquann-treated multi-walled CNTs (T-CNTs) was performed using aerosols generated in an inhalation chamber. At 12 months after T-CNT exposure, alveolar inflammation with macrophage accumulation and hypertrophy of the alveolar walls were observed. In addition, fibrotic lesions were enhanced by T-CNT exposure. The macrophages in the bronchoalveolar lavage fluid of T-CNT-exposed mice were not largely shifted to any particular population, and were a mixed phenotype with M1 and M2 polarization. Moreover, the alveolar macrophages of T-CNT-exposed mice produced matrix metalloprotinase-12. Conclusions These results suggest that T-CNT exposure promoted chronic inflammation and fibrotic lesion formation in profibrotic macrophages for prolonged periods.	[Otsuka, Kunihiro; Yamada, Koichi; Arakaki, Rieko; Ushio, Aya; Yamada, Akiko; Kudo, Yasusei; Ishimaru, Naozumi] Tokushima Univ, Dept Oral Mol Pathol, Grad Sch Biomed Sci, Tokushima, Japan; [Taquahashi, Yuhji] Natl Inst Hlth Sci, Biol Safety Res Ctr, Div Cellular & Mol Toxicol, Kanagawa, Japan; [Saito, Masako] Tokushima Univ, Dept Immunol & Parasitol, Grad Sch Biomed Sci, Tokushima, Japan; [Tsunematsu, Takaaki] Tokushima Univ, Dept Pathol & Lab Med, Grad Sch Biomed Sci, Tokushima, Japan; [Kanno, Jun] Japan Org Occupat Hlth & Safety, Japan Bioassay Res Ctr, Kanagawa, Japan	Tokushima University; National Institute of Health Sciences - Japan; Tokushima University; Tokushima University	Ishimaru, N (corresponding author), Tokushima Univ, Dept Oral Mol Pathol, Grad Sch Biomed Sci, Tokushima, Japan.	ishimaru.n@tokushima-u.ac.jp		TAQUAHASHI, YUHJI/0000-0002-4612-0652	Health Sciences Research Grants [H26-kagaku-ippan-003, H29-kagakku-ippan-003]; JSPS KAKENHI [16H02690]	Health Sciences Research Grants; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Health Sciences Research Grants H26-kagaku-ippan-003 and H29-kagakku-ippan-003) and a JSPS KAKENHI (Grant Number 16H02690). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anghelina M, 2006, AM J PATHOL, V168, P529, DOI 10.2353/ajpath.2006.050255; Auffan M, 2009, NAT NANOTECHNOL, V4, P634, DOI 10.1038/nnano.2009.242; Barua S, 2014, NANO TODAY, V9, P223, DOI 10.1016/j.nantod.2014.04.008; Bonner James C, 2010, Proc Am Thorac Soc, V7, P138, DOI 10.1513/pats.200907-061RM; Boyles MSP, 2015, TOXICOL IN VITRO, V29, P1513, DOI 10.1016/j.tiv.2015.06.012; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Donaldson K, 2011, NANOMEDICINE-UK, V6, P143, DOI 10.2217/NNM.10.139; Dong J, 2016, ARCH TOXICOL, V90, P2231, DOI 10.1007/s00204-016-1711-1; Fenoglio I, 2012, CHEM RES TOXICOL, V25, P74, DOI 10.1021/tx200255h; Giannandrea M, 2014, DIS MODEL MECH, V7, P193, DOI 10.1242/dmm.012062; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Gwinn MR, 2006, ENVIRON HEALTH PERSP, V114, P1818, DOI 10.1289/ehp.8871; Johnston LK, 2012, AM J RESP CELL MOL, V47, P417, DOI 10.1165/rcmb.2012-0090OC; Kagan VE, 2006, TOXICOL LETT, V165, P88, DOI 10.1016/j.toxlet.2006.02.001; Kagan VE, 2010, NAT NANOTECHNOL, V5, P354, DOI [10.1038/NNANO.2010.44, 10.1038/nnano.2010.44]; Karo-Atar D, 2013, AM J RESP CELL MOL, V48, P456, DOI 10.1165/rcmb.2012-0329OC; Leucuta SE, 2010, CURR CLIN PHARMACOL, V5, P257, DOI 10.2174/157488410793352003; Li N, 2008, FREE RADICAL BIO MED, V44, P1689, DOI 10.1016/j.freeradbiomed.2008.01.028; Mangum JB, 2006, PART FIBRE TOXICOL, V3, DOI 10.1186/1743-8977-3-15; Meng J, 2015, ACS APPL MATER INTER, V7, P3180, DOI 10.1021/am507649n; Mitchell LA, 2009, NAT NANOTECHNOL, V4, P451, DOI [10.1038/nnano.2009.151, 10.1038/NNANO.2009.151]; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Orecchioni M, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-138; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Ravichandran P, 2011, J BIOL CHEM, V286, P29725, DOI 10.1074/jbc.M111.251884; Ravichandran P, 2010, APOPTOSIS, V15, P1507, DOI 10.1007/s10495-010-0532-6; Robert S, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160107; Sennello JA, 2017, AM J RESP CELL MOL, V56, P191, DOI 10.1165/rcmb.2016-0147OC; Shipkowski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128888; Shvedova AA, 2008, TOXICOL APPL PHARM, V231, P235, DOI 10.1016/j.taap.2008.04.018; Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005; Shvedova AA, 2008, AM J RESP CELL MOL, V38, P579, DOI 10.1165/rcmb.2007-0255OC; Shvedova AA, 2012, TOXICOL APPL PHARM, V261, P121, DOI 10.1016/j.taap.2012.03.023; Snyder-Talkington BN, 2016, J TOXICOL ENV HEAL A, V79, P352, DOI 10.1080/15287394.2016.1159635; Swaisgood CM, 2000, AM J PATHOL, V157, P177, DOI 10.1016/S0002-9440(10)64529-4; Taquahashi Y, 2013, J TOXICOL SCI, V38, P619, DOI 10.2131/jts.38.619; Tkach AV, 2011, ACS NANO, V5, P5755, DOI 10.1021/nn2014479; Witasp Erika, 2009, Inhal Toxicol, V21 Suppl 1, P131, DOI 10.1080/08958370902942574; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	41	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0205702	10.1371/journal.pone.0205702	http://dx.doi.org/10.1371/journal.pone.0205702			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372450	Green Published, gold			2022-12-26	WOS:000448641200012
J	Perveen, F; Arshad, N; Qureshi, R; Nowsherwan, J; Sultan, A; Nosheen, B; Rafique, H				Perveen, Fouzia; Arshad, Nasima; Qureshi, Rumana; Nowsherwan, Jahanzaib; Sultan, Aiesha; Nosheen, Bushra; Rafique, Hummera			Electrochemical, spectroscopic and theoretical monitoring of anthracyclines' interactions with DNA and ascorbic acid by adopting two routes: Cancer cell line studies	PLOS ONE			English	Article							MOLECULAR DOCKING; CARDIOTOXICITY; BINDING; DERIVATIVES	Pharmacodynamic interactions of three anthracycline antibiotics namely doxorubicin (DXH), epirubicin (EpiDXH) and daunorubicin (DNR) with DNA in the absence and presence of ascorbic acid (AA) as natural additive were monitored under physiological conditions (pH = 7.4, 4.7 and T = 309.5K). Route-1 (Anthracycline-AA-DNA) and Route-2 (Anthracycline-DNA-AA) were adopted to see the interactional behavior by cyclic voltammetry (CV) and UV-visible spectroscopy. In comparison to Route-2; voltammetric and spectral responses as well as binding constant (K-b) and Gibb's free energy change (Delta G) values revealed strongest and more favorable interaction of anthracycline-AA complex with DNA via Route-1. K-b, s(binding site sizes) and Delta G evaluated from experimental (CV, UV-Vis) and theoretical (molecular docking) findings showed enhanced binding strength of tertiary complexes as compared to binary drug-DNA complexes. The results were found comparatively better at pH 7.4. Consistency was observed in binding parameters evaluated from experimental and theoretical techniques. Diffusion coefficients (D-o) and heterogeneous electron transfer rate constant (k(s,h)) confirmed the formation of complexes via slow diffusion kinetics. Percent cell inhibition (%C-inh) of anthracyclines for non-small cell cancer cell lines (NSCCLs) H-1299 and H-157 were evaluated higher in the presence of AA which further complimented experimental and theoretical results.	[Perveen, Fouzia; Nowsherwan, Jahanzaib; Sultan, Aiesha; Nosheen, Bushra] Natl Univ Sci & Technol, Res Ctr Modeling & Simulat, Islamabad, Pakistan; [Arshad, Nasima] Allama Iqbal Open Univ, Dept Chem, Islamabad, Pakistan; [Qureshi, Rumana] Quaid I Azam Univ, Dept Chem, Islamabad, Pakistan; [Rafique, Hummera] Univ Gujrat, Dept Chem, Gujrat, Pakistan	National University of Sciences & Technology - Pakistan; Quaid I Azam University; University of Gujrat	Perveen, F (corresponding author), Natl Univ Sci & Technol, Res Ctr Modeling & Simulat, Islamabad, Pakistan.; Arshad, N (corresponding author), Allama Iqbal Open Univ, Dept Chem, Islamabad, Pakistan.	fouzia_qau81@yahoo.com; nasimaa2006@yahoo.com		Rafique, Hummera/0000-0001-8124-4696; Arshad, Nasima/0000-0002-4257-9909	HEC fellowship under NRPU research project [20-928/R D/07]; Higher Education Commission (HEC) of Pakistan [20-928/R D/07]	HEC fellowship under NRPU research project; Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan)	Funding was supported by HEC fellowship under NRPU research project #20-928/R & D/07.; The authors would like to thanks Research Center for Modeling and Simulations, NUST, Chemistry Departments of Quaid-i-Azam University and Allama Iqbal Open University for theoretical, experimental work and manuscript writing. Higher Education Commission (HEC) of Pakistan is also highly acknowledged for financing the research through Research Project # 20-928/R & D/07.	Abdullah Y. A., 2009, PAKISTAN J NUTR, V8, P1722; Afanas'ev I B, 1987, Free Radic Res Commun, V3, P141, DOI 10.3109/10715768709069779; Alejandro GMF, 2018, BIOSENSORS, V8, P1; Arshad N, 2017, J MOL STRUCT, V1139, P371, DOI 10.1016/j.molstruc.2017.03.055; Arshad N, 2017, J PHOTOCH PHOTOBIO B, V169, P134, DOI 10.1016/j.jphotobiol.2017.02.021; Athreya K, 2017, NUTR CANCER, V69, P1099, DOI 10.1080/01635581.2017.1362445; Babkina SS, 2005, ANAL CHEM, V77, P5678, DOI 10.1021/ac050727b; Bahuguna A, 2017, BANGL J PHARMACOL, V12, P115, DOI 10.3329/bjp.v12i2.30892; Banerjee T, 2008, BIOCHEM BIOPH RES CO, V374, P264, DOI 10.1016/j.bbrc.2008.07.053; Bramaramba G, 2015, SCI REPORTS, P1; Brett AMO, 2000, ELECTROANAL, V12, P969, DOI 10.1002/1521-4109(200008)12:12<969::AID-ELAN969>3.0.CO;2-O; Brunton L., 2018, GOODMAN GILMANS PHAR, V13th; Conklin Kenneth A, 2005, Integr Cancer Ther, V4, P110, DOI 10.1177/1534735405276191; Erdem A, 2001, ANAL CHIM ACTA, V437, P107, DOI 10.1016/S0003-2670(01)00942-4; Fragiorge EJ, 2007, GENET MOL BIOL, V30, P449, DOI 10.1590/S1415-47572007000300025; Gileadi E, 1981, J ELECTRO CHEM, V85, P1731; Guin PS, 2011, J SOLUTION CHEM, V40, P492, DOI 10.1007/s10953-011-9654-x; Gunderson C, 2016, J ELECTROANAL CHEM, V781, P174, DOI 10.1016/j.jelechem.2016.10.054; Hajian R, 2009, CHINESE J CHEM, V27, P1055, DOI 10.1002/cjoc.200990176; Ju HX, 2004, SENSORS-BASEL, V4, P71, DOI 10.3390/s40500071; Kessenbrock M, 2017, METHODS MOL BIOL, V1573, P141, DOI 10.1007/978-1-4939-6854-1_12; Kheirolomoom A, 2016, J CONTROL RELEASE, V243, P232, DOI 10.1016/j.jconrel.2016.10.012; Kim Sou Hyun, 2017, Lab Anim Res, V33, P165, DOI 10.5625/lar.2017.33.2.165; Li N, 2005, BIOPHYS CHEM, V116, P199, DOI 10.1016/j.bpc.2005.04.009; Lipshultz SE, 2018, CARDIOVASC RES, V114, P205, DOI 10.1093/cvr/cvx246; Liu JF, 2006, ANAL CHEM, V78, P6879, DOI 10.1021/ac0608624; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; McGowan JV, 2017, CARDIOVASC DRUG THER, V31, P63, DOI 10.1007/s10557-016-6711-0; Meinardi MT, 1999, CANCER TREAT REV, V25, P237, DOI 10.1053/ctrv.1999.0128; Mikirova N., 2013, J TRANSL MED, V11, P1; Patel S., 2009, INT J PHARM PHARM SC, V1, P38, DOI DOI 10.3923/IJCR.2014.74.80; Reinbolt RE, 2016, SUPPORT CARE CANCER, V24, P2173, DOI 10.1007/s00520-015-3008-y; Saddique FA, 2018, EUR J MED CHEM, V143, P1373, DOI 10.1016/j.ejmech.2017.10.036; Shishehbore MR, 2014, IRAN J PHARM RES, V13, P373; Swain P, 2015, J APPL ELECTROCHEM, V45, P209, DOI 10.1007/s10800-014-0759-y; Tian ZY, 2015, MOLECULES, V20, P16491, DOI 10.3390/molecules200916491; Volkova M, 2011, CURR CARDIOL REV, V7, P214, DOI 10.2174/157340311799960645; Wang C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02852; Zhang HM, 2000, J PHARMACEUT BIOMED, V22, P67, DOI 10.1016/S0731-7085(99)00254-X	39	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0205764	10.1371/journal.pone.0205764	http://dx.doi.org/10.1371/journal.pone.0205764			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372448	Green Submitted, Green Published, gold			2022-12-26	WOS:000448641200013
J	Lee, SH; Park, M; Park, KM; Gwag, HB; Park, J; Kim, J; Choi, GS; Lee, SK; Kim, GS				Lee, Seung-Hwa; Park, Myungsoo; Park, Kyoung-min; Gwag, Hye-bin; Park, Jungchan; Kim, Jeayoun; Choi, Gyu-Seong; Lee, Suk-Koo; Kim, Gaab Soo			Corrected QT interval on the electrocardiogram after liver transplantation: Surrogate marker of poor clinical outcomes?	PLOS ONE			English	Article							CIRRHOTIC CARDIOMYOPATHY; AUTONOMIC DYSFUNCTION; LONG QT; PROLONGATION; DISEASE; RISK; MORTALITY; SEVERITY; ETIOLOGY	Background Prolongation of corrected QT interval (QTc) on the electrocardiogram is associated with cardiac arrhythmia and sudden death. Changes in the QTc (corrected QT) interval before and after liver transplantation (LT) for the treatment of liver cirrhosis (LC) and its association with clinical outcomes have not been fully evaluated. Methods From January 2011 to May 2016, consecutive 516 consecutive recipients were enrolled into LT registry and the median follow-up was 31 months (IQR 12-52). Patients with an available electrocardiogram before LT and 1 month after from LT were analyzed. Patients were divided into 2 groups according to prolonged QTc interval. The patient groups were analyzed separately according whether the electrocardiogram was preoperative or postoperative. The primary outcome was all-cause death during the follow-up period. Results A total of 283 patients were enrolled in the study. In the preoperative QTc prolongation group, there was not a significant rate difference in all-cause mortality in multivariate analysis (hazard ratio [HR], 0.94; 95% confidence interval [CI], 0.53-1.66; P= 0.26). However, in the postoperative QTc prolongation group, mortality was significantly increased (HR, 1.78; 95%CI, 1.05-3.03; P= 0.03) in patients who underwent LT. Conclusion In patients who underwent LT for LC, postoperative QTc prolongation on ECG, rather than preoperative, is associated with mortality. Larger clinical trials are needed to support this finding.	[Lee, Seung-Hwa; Park, Kyoung-min; Gwag, Hye-bin] Sungkyunkwan Univ, Sch Med, Dept Med, Samsung Med Ctr,Heart Stroke & Vasc Inst, Seoul, South Korea; [Park, Myungsoo] Hallym Univ, Sch Med, Dept Med, Dongtan Sacred Heart Hosp, Seoul, South Korea; [Park, Jungchan; Kim, Jeayoun; Kim, Gaab Soo] Sungkyunkwan Univ, Sch Med, Dept Anesthesiol & Pain Med, Samsung Med Ctr, Seoul, South Korea; [Choi, Gyu-Seong; Lee, Suk-Koo] Sungkyunkwan Univ, Sch Med, Dept Surg, Samsung Med Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Hallym University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Park, KM (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Med, Samsung Med Ctr,Heart Stroke & Vasc Inst, Seoul, South Korea.	bkm1101@hanmail.net		Park, Kyoung-Min/0000-0002-8406-3142				Bal JS, 2003, LIVER INT, V23, P243, DOI 10.1034/j.1600-0676.2003.00833.x; Beinart R, 2014, J AM COLL CARDIOL, V64, P2111, DOI 10.1016/j.jacc.2014.08.039; Bernardi M, 1998, HEPATOLOGY, V27, P28, DOI 10.1002/hep.510270106; Bernardi M, 2012, EXPERT REV GASTROENT, V6, P57, DOI [10.1586/egh.11.86, 10.1586/EGH.11.86]; DAY CP, 1990, BRIT HEART J, V63, P342; Gajanana D, 2016, INT J CARDIOL, V223, P699, DOI 10.1016/j.ijcard.2016.08.056; Gibbs C, 2018, EUROPACE, V20, pF99, DOI 10.1093/europace/eux286; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kosar F, 2007, ANGIOLOGY, V58, P218, DOI 10.1177/0003319707300368; Liu HQ, 2017, LIVER TRANSPLANT, V23, P826, DOI 10.1002/lt.24768; Marafioti V, 2015, INT J CARDIOL, V188, P43, DOI 10.1016/j.ijcard.2015.04.026; Mitter SS, 2017, J AM COLL CARDIOL, V69, P1451, DOI 10.1016/j.jacc.2016.12.037; Mohamed R, 1996, HEPATOLOGY, V23, P1128; Myers RP, 2000, LIVER TRANSPLANT, V6, pS44, DOI 10.1002/lt.500060510; Raval Z, 2011, J AM COLL CARDIOL, V58, P223, DOI 10.1016/j.jacc.2011.03.026; Robbins J, 2003, AM J MED, V115, P689, DOI 10.1016/j.amjmed.2003.07.014; Roguin A, 2011, PACE, V34, P384, DOI 10.1111/j.1540-8159.2010.02973.x; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Tisdale JE, 2013, CIRC-CARDIOVASC QUAL, V6, P479, DOI 10.1161/CIRCOUTCOMES.113.000152; Torregrosa M, 2005, J HEPATOL, V42, P68, DOI 10.1016/j.jhep.2004.09.008; Trevisani F, 1999, HEPATOLOGY, V30, P1387, DOI 10.1002/hep.510300613; Tsiompanidis Elias, 2018, World J Gastrointest Pathophysiol, V9, P28, DOI 10.4291/wjgp.v9.i1.28; Viskin S, 2005, HEART RHYTHM, V2, P569, DOI 10.1016/j.hrthm.2005.02.011; Wasserstrum Y, 2016, INTERN MED J, V46, P1204, DOI 10.1111/imj.13170; Yap J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154901	25	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206463	10.1371/journal.pone.0206463	http://dx.doi.org/10.1371/journal.pone.0206463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365563	gold, Green Published, Green Submitted			2022-12-26	WOS:000448448700055
J	Jarolimova, J; Kabakyenga, J; Bennett, K; Muyindike, W; Kembabazi, A; Martin, JN; Hunt, PW; Boum, Y; Haberer, JE; Bangsberg, DR; Kaida, A; Matthews, LT				Jarolimova, Jana; Kabakyenga, Jerome; Bennett, Kara; Muyindike, Winnie; Kembabazi, Annet; Martin, Jeffrey N.; Hunt, Peter W.; Boum, Yap; Haberer, Jessica E.; Bangsberg, David R.; Kaida, Angela; Matthews, Lynn T.			Contraceptive use following unintended pregnancy among Ugandan women living with HIV	PLOS ONE			English	Article							POSITIVE WOMEN; UNMET NEED; FERTILITY DESIRES; POSTPARTUM WOMEN; INFECTION; ACCESS	Background Preventing unintended pregnancy is critical for women living with HIV (WLWH) to safely achieve their reproductive goals. Family planning services should support WLWH at risk of repeat unintended pregnancies. We examined the relationship between unintended pregnancy and subsequent contraception use among WLWH in Uganda. Study design This was a retrospective analysis of data from a longitudinal cohort of individuals initiating antiretroviral therapy (ART), restricted to women with pregnancy (confirmed via urine beta-hcg testing) between 2011-2013. The exposure of interest was intended vs unintended pregnancy, and the outcome was self-report of modern contraceptive use (hormonal methods, intrauterine device, sterilization, and/or consistent condom use) at 12 (range 6-18) months post-partum. A log-binomial model was used to estimate relative risks of modern contraceptive use post-partum based on intent of the index pregnancy, adjusted for age, socioeconomic status, education, relationship and HIV status of pregnancy partner, contraceptive use prior to pregnancy, years since HIV diagnosis, ART regimen, and CD4 cell count. Results Among 455 women, 110 women reported 110 incident pregnancies with report on intent. Women had a baseline median age of 29 years, baseline CD4 count 403 cells/mm(3), and were living with HIV for 3.8 years. Fifty pregnancies (45%) were reported as unintended and 60 (55%) as intended. Postpartum, 64% of women with unintended and 51% with intended pregnancy reported modern contraception (p = 0.24). In adjusted models, there was no association between pregnancy intent and post-partum contraception. However, contraceptive use prior to the referent pregnancy was positively associated with post-partum contraceptive use (aRR 1.97 (95% CI 1.12-3.48, p = 0.02), while higher baseline CD4 cell count was associated with lower post-partum contraceptive use (aRR 0.95, 95% CI 0.90-0.99, p = 0.02). Conclusions Almost half of incident pregnancies among WLWH in this cohort were unintended. Experiencing an unintended pregnancy was not associated with post-partum contraceptive use. Creative strategies to support contraceptive uptake for birth spacing and prevention of unintended pregnancies in the post-partum period are needed.	[Jarolimova, Jana; Haberer, Jessica E.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Kabakyenga, Jerome; Muyindike, Winnie; Kembabazi, Annet] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Bennett, Kara] Bennett Stat Consulting, Ballston Lake, NY USA; [Martin, Jeffrey N.; Hunt, Peter W.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Boum, Yap] MSF, Epictr, Yaounde, Cameroon; [Haberer, Jessica E.; Matthews, Lynn T.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Haberer, Jessica E.] Harvard Med Sch, Boston, MA USA; [Bangsberg, David R.] Oregon Hlth & Sci Univ, Portland State Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Kaida, Angela] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Matthews, Lynn T.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Mbarara University of Science & Technology; University of California System; University of California San Francisco; Doctors Without Borders; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Oregon Health & Science University; Portland State University; Simon Fraser University; Harvard University; Massachusetts General Hospital	Matthews, LT (corresponding author), Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA.; Matthews, LT (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	ltmatthews@partners.org	Muyindike, Winnie/W-2892-2019; Hunt, Peter W./P-2976-2017; Haberer, Jessica/AAH-7976-2019	Hunt, Peter W./0000-0002-4571-4870; Haberer, Jessica/0000-0001-5845-3190	National Institutes of Health [R21HD069194, R01MH054907, K23 MH095655, P30AI027763, U01CA066529]; Sullivan Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sullivan Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health R21HD069194 (A.K), R01MH054907 (D.R.B.), K23 MH095655 (L.T.M), P30AI027763 (J.N.M.), U01CA066529 (J.N.M.), and the Sullivan Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia IB, 1999, J WOMEN HEALTH GEN-B, V8, P587, DOI 10.1089/jwh.1.1999.8.587; Andia I, 2009, AM J PUBLIC HEALTH, V99, P340, DOI 10.2105/AJPH.2007.129528; Bradley SEK, 2014, STUD FAMILY PLANN, V45, P123, DOI 10.1111/j.1728-4465.2014.00381.x; Bradley SE, 2013, IMPACT CONTRACEPTIVE, P1; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Calvert C, 2013, AIDS, V27, P1631, DOI 10.1097/QAD.0b013e32835fd940; Casterline JB, 2007, DEMOGRAPHY, V44, P729, DOI 10.1353/dem.2007.0043; Cleland J, 2014, STUD FAMILY PLANN, V45, P105, DOI 10.1111/j.1728-4465.2014.00380.x; Crankshaw TL, 2016, AJAR-AFR J AIDS RES, V15, P157, DOI 10.2989/16085906.2016.1204330; Crede S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-197; Dhont N, 2009, EUR J CONTRACEP REPR, V14, P420, DOI 10.3109/13625180903340584; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fotso JC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-224; Gutin SA, 2014, AFR J REPROD HEALTH, V18, P67; Guttmacher Institute, 2017, ADD IT INV CONTR MAT; Heys J, 2009, AIDS, V23, pS37, DOI 10.1097/01.aids.0000363776.76129.fd; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Joint Working Group CIGRE/CIRED C4.107, 2011, CHRON CAR HIV NONC D, P1; Kabami J, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-81; Keogh Sarah C, 2012, Reprod Health Matters, V20, P39, DOI 10.1016/S0968-8080(12)39634-1; Kimani J, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0262-6; Kuroki LM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.049; Landes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044396; Matthews LT, 2013, AIDS, V27, pS105, DOI 10.1097/QAD.0000000000000040; Mayondi GK, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-015-2498-3; Mccoy SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105320; Moran NF, 2012, INT J GYNECOL OBSTET, V119, pS26, DOI 10.1016/j.ijgo.2012.03.011; Muyindike Winnie, 2012, Infect Dis Obstet Gynecol, V2012, P340782, DOI 10.1155/2012/340782; Nieves CI, 2015, CONTRACEPTION, V92, P152, DOI 10.1016/j.contraception.2015.04.011; Obare F, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-34; Office of the United Nations High Commissioner for Human Rights (OHCHR), 1966, INT COV EC SOC CULT; Ross JA, 2001, INT FAM PLAN PERSPEC, V27, P20, DOI 10.2307/2673801; Santelli J, 2003, PERSPECT SEX REPRO H, V35, P94, DOI 10.1111/j.1931-2393.2003.tb00111.x; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Uganda Bureau of Statistics ICF International, 2012, UG DEM HLTH SURV 201, P1; Uganda Bureau of Statistics ICF International, 2017, UG DEM HLTH SURV 201, P1; United Nations (UN), 1979, CONV EL ALL FORMS DI; Warren CE, 2013, BMC PREGNANCY CHILDB, V13, DOI [10.1186/1471-2393-13-21, 10.1186/1471-2393-13-150]; World Health Organization, 2017, CONS GUID SEX REPR H; World Health Organization. WHO, WHO FAMILY PLANNING; Zash RM, 2017, AIDS PATIENT CARE ST, V31, P14, DOI 10.1089/apc.2016.0154	41	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206325	10.1371/journal.pone.0206325	http://dx.doi.org/10.1371/journal.pone.0206325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3GT	30359430	Green Published, Green Submitted, gold			2022-12-26	WOS:000448438400068
J	Marcotti, S; Maki, K; Reilly, GC; Lacroix, D; Adachi, T				Marcotti, Stefania; Maki, Koichiro; Reilly, Gwendolen C.; Lacroix, Damien; Adachi, Taiji			Hyaluronic acid selective anchoring to the cytoskeleton: An atomic force microscopy study	PLOS ONE			English	Article							SHEAR-STRESS; CELLS; MECHANOTRANSDUCTION; ADHESION; MODULATION; PROTEIN; PROBE	The hyaluronic acid component of the glycocalyx plays a role in cell mechanotransduction by selectively transmitting mechanical signals to the cell cytoskeleton or to the cell membrane. The aim of this study was to evaluate the mechanical link between the hyaluronic acid molecule and the cell cytoskeleton by means of atomic force microscopy single molecule force spectroscopy. Hyaluronic acid molecules on live cells were targeted with probes coated with hyaluronic acid binding protein. Two different types of events were observed when the detachment of the target molecule from the probe occurred, suggesting the presence of cytoskeleton- and membrane-anchored molecules. Membrane-anchored molecules facilitated the formation of tethers when pulled. About 15% of the tested hyaluronic acid molecules were shown to be anchored to the cytoskeleton. When multiple molecules bonded to the probe, specific detachment patterns were observed, suggesting that a cytoskeletal bond needed to be broken to improve the ability to pull tethers from the cell membrane. This likely resulted in the formation of tethering structures maintaining a cytoskeletal core similar to the ones observed for cells over-expressing HA synthases. The different observed rupture events were associated with separate mechanotransductive mechanisms in an analogous manner to that previously proposed for the endothelial glycocalyx. Single cytoskeleton anchored rupture events represent HA molecules linked to the cytoskeleton and therefore transmitting mechanical stimuli into the inner cell compartments. Single membrane tethers would conversely represent the glycocalyx molecules connected to areas of the membrane where an abundance of signalling molecules reside.	[Marcotti, Stefania; Reilly, Gwendolen C.; Lacroix, Damien] Univ Sheffield, Insigne Inst Insilico Med, Sheffield, S Yorkshire, England; [Marcotti, Stefania; Lacroix, Damien] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England; [Marcotti, Stefania] Kings Coll London, Randall Ctr Cell & Mol Biophys, London, England; [Maki, Koichiro; Adachi, Taiji] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Biosyst Sci, Kyoto, Japan; [Maki, Koichiro] Univ Tokyo, Dept Mech Engn, Tokyo, Japan; [Reilly, Gwendolen C.] Univ Sheffield, Dept Mat Sci & Engn, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of London; King's College London; Kyoto University; University of Tokyo; University of Sheffield	Marcotti, S (corresponding author), Univ Sheffield, Insigne Inst Insilico Med, Sheffield, S Yorkshire, England.; Marcotti, S (corresponding author), Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England.; Marcotti, S (corresponding author), Kings Coll London, Randall Ctr Cell & Mol Biophys, London, England.	stefania.marcotti@kcl.ac.uk	Marcotti, Stefania/AAH-5637-2021; Lacroix, Damien/G-3230-2010; Adachi, Taiji/P-8981-2016	Lacroix, Damien/0000-0002-5482-6006; Adachi, Taiji/0000-0001-5280-4156; Marcotti, Stefania/0000-0002-2877-0133	European Research Council [258321]; Engineering and Physical Sciences Research Council [EP/K03877X/1]; Great Britain Sasakawa Foundation [4879]; University of Sheffield ("Mechanoreceptors in health and disease" Network Scholarship) [149716529]; EPSRC [EP/K03877X/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Great Britain Sasakawa Foundation; University of Sheffield ("Mechanoreceptors in health and disease" Network Scholarship); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors wish to acknowledge funding from the European Research Council ("Mechanobio", Grant No. 258321, https://erc.europa.eu/, DL), the Engineering and Physical Sciences Research Council ("Multisim", Grant No. EP/K03877X/1, https://epsrc.ukri.org/, DL), the Great Britain Sasakawa Foundation (Grant No. 4879, http://www.gbsf.org.uk/, SM) and the University of Sheffield ("Mechanoreceptors in health and disease" Network Scholarship, Grant No. 149716529, https://www.sheffield.ac.uk/, SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin R, 2006, BIOCHEM BIOPH RES CO, V348, P238, DOI 10.1016/j.bbrc.2006.07.050; Beck GR, 2001, CELL GROWTH DIFFER, V12, P61; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BIGNAMI A, 1993, ANAT EMBRYOL, V188, P419; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; Chu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064187; Cowman MK, 2005, BIOPHYS J, V88, P590, DOI 10.1529/biophysj.104.049361; Curry FE, 2012, ANN BIOMED ENG, V40, P828, DOI 10.1007/s10439-011-0429-8; Das T, 2015, NAT CELL BIOL, V17, P276, DOI 10.1038/ncb3115; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 2011, J HISTOCHEM CYTOCHEM, V59, P252, DOI 10.1369/0022155410397760; Dudko OK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.108101; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Fu BMM, 2013, WIRES SYST BIOL MED, V5, P381, DOI 10.1002/wsbm.1211; Gavara N, 2016, SCI REP-UK, V6, DOI 10.1038/srep21267; HASCALL VC, 1974, J BIOL CHEM, V249, P4242; Juffer P, 2014, CELL BIOCHEM BIOPHYS, V69, P411, DOI 10.1007/s12013-013-9812-4; Kodama HA., 1981, JPN J ORAL BIOL, V23, P899, DOI DOI 10.2330/JORALBIOSCI1965.23.899; Koistinen V, 2016, HISTOCHEM CELL BIOL, V145, P531, DOI 10.1007/s00418-016-1405-z; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Liu D, 2007, FEBS LETT, V581, P3563, DOI 10.1016/j.febslet.2007.06.071; Maki K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20115-8; Maki K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24878; Marcotti S, 2017, MECHANOBIOLOGY EXPLO, P43; Paluch EK, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0150-4; Pietuch A, 2013, BBA-MOL CELL RES, V1833, P712, DOI 10.1016/j.bbamcr.2012.11.006; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; Reilly GC, 2003, BIORHEOLOGY, V40, P591; Rico F, 2010, BIOPHYS J, V99, P1387, DOI 10.1016/j.bpj.2010.06.037; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; RIPELLINO JA, 1985, J HISTOCHEM CYTOCHEM, V33, P1060, DOI 10.1177/33.10.4045184; Santos A, 2009, J ORTHOP RES, V27, P1280, DOI 10.1002/jor.20888; Sariisik E, 2015, BIOPHYS J, V109, P1330, DOI 10.1016/j.bpj.2015.07.048; Schlierf M, 2005, J MOL BIOL, V354, P497, DOI 10.1016/j.jmb.2005.09.070; Sun MZ, 2005, BIOPHYS J, V89, P4320, DOI 10.1529/biophysj.104.058180; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tarbell JM, 2010, CARDIOVASC RES, V87, P320, DOI 10.1093/cvr/cvq146; TENGBLAD A, 1979, BIOCHIM BIOPHYS ACTA, V578, P281, DOI 10.1016/0005-2795(79)90158-2; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; Titushkin I, 2007, BIOPHYS J, V93, P3693, DOI 10.1529/biophysj.107.107797; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Weinbaum S, 2011, CELL MOL BIOENG, V4, P510, DOI 10.1007/s12195-011-0179-6; You LD, 2001, J BIOMECH, V34, P1375, DOI 10.1016/S0021-9290(01)00107-5; Zhang ZJ, 2015, TISSUE ENG PART B-RE, V21, P267, DOI [10.1089/ten.teb.2014.0286, 10.1089/ten.TEB.2014.0286]	48	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206056	10.1371/journal.pone.0206056	http://dx.doi.org/10.1371/journal.pone.0206056			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359403	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000448438400039
J	Roca, A; Camara, B; Oluwalana, C; Lette, K; Bottomley, C; D'Alessandro, U				Roca, Anna; Camara, Bully; Oluwalana, Claire; Lette, Kodou; Bottomley, Christian; D'Alessandro, Umberto			Long-lasting effect of oral azithromycin taken by women during labour on infant nutrition: Follow-up cohort of a randomized clinical trial in western Gambia	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; BIRTH-WEIGHT; MORTALITY; CARRIAGE; CHILDREN	Objective To assess the effect of administering an oral dose of 2g of azithromycin in Gambian women during labour on infant growth. Methods Children whose mothers had been randomized to receive either an oral dose of 2g of azithromycin or placebo during labour were visited at home at the end of infancy by trained study nurses blind to the treatment allocation. The follow-up visit of these cohorts (exposed and non-exposed to azithromycin), which was not part of the original trial design, was conducted between November 2014 and May 2015 when the infants were 11 to 13 months of age. During visits, nurses recorded anthropometrical measurements and transcribed information from the infants' welfare cards. Results Four-hundred and sixty-five (79.6%) of the 584 infants aged 11-13 months at the time of the survey were recruited. The proportion of children with an age-adjusted Z-score <-2SD for mid-upper-arm circumference (MUAC) was lower among those exposed to azithromycin [1.3% versus 6.3%, OR = 0.21 95%CI (0.06,0.72), p = 0.006] and there was weak evidence of a difference in the proportion of infants with weight-for-age (WAZ) Z-score <-2SD [7.1% versus 12.1%, OR = 0.58 95%CI (0.33,1.04), p = 0.065]. For all other malnutrition indicators the proportions were similar in the exposed and un-exposed cohort. Conclusions Our results show that azithromycin in labour may have a beneficial effect in MUAC among children who are below the curve. Larger studies with closer follow-up are warranted.	[Roca, Anna; Camara, Bully; Oluwalana, Claire; Lette, Kodou; D'Alessandro, Umberto] London Sch Hyg & Trop Med, MRC Unit, Fajara, Gambia; [Bottomley, Christian] London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Roca, A (corresponding author), London Sch Hyg & Trop Med, MRC Unit, Fajara, Gambia.	aroca@mrc.gm		Bottomley, Christian/0000-0002-5241-8412	UK Department for International Development (DFID) under the MRC/DFID Concordat agreement [MR/J010391/1]; European Union; MRC UK; UK MRC; MRC [MC_EX_MR/J010391/1, MC_UP_A900_1119] Funding Source: UKRI	UK Department for International Development (DFID) under the MRC/DFID Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The MRC Unit in The Gambia receives core funding from the MRC UK. The study was jointly funded by the UK MRC and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement (reference number MR/J010391/1) and is also part of the EDCTP2 program supported by the European Union.	Burr SE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1176; Burr SE, 2014, B WORLD HEALTH ORGAN, V92, P490, DOI 10.2471/BLT.13.133462; Coles CL, 2012, J NUTR, V142, P1088, DOI 10.3945/jn.111.156844; Gough EK, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2267; Hallamaa L, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2459; Harding-Esch EM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000861; Jasseh M, 2011, TROP MED INT HEALTH, V16, P1314, DOI 10.1111/j.1365-3156.2011.02809.x; Lazzerini M, 2016, LANCET GLOB HEALTH, V4, pE57, DOI 10.1016/S2214-109X(15)00215-6; Luntamo M, 2013, TROP MED INT HEALTH, V18, P386, DOI 10.1111/tmi.12074; Oluwalana C, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2281; Porco TC, 2009, JAMA-J AM MED ASSOC, V302, P962, DOI 10.1001/jama.2009.1266; Roca A, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.03.005; Roca A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0737-3; Salman S, 2016, ANTIMICROB AGENTS CH, V60, P1592, DOI 10.1128/AAC.02668-15; Unger HW, 2016, MATERN CHILD NUTR, V12, P699, DOI 10.1111/mcn.12215; Unger HW, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0258-3; WHO, 1995, WHOTRS854	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206348	10.1371/journal.pone.0206348	http://dx.doi.org/10.1371/journal.pone.0206348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359447	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000448438400069
J	Adamo, G; Sturabotti, G; Baccolini, V; de Soccio, P; Prencipe, GP; Bella, A; Magurano, F; Iannazzo, S; Villari, P; Marzuillo, C				Adamo, Giovanna; Sturabotti, Giulia; Baccolini, Valentina; de Soccio, Pasquale; Prencipe, Grazia Pia; Bella, Antonino; Magurano, Fabio; Iannazzo, Stefania; Villari, Paolo; Marzuillo, Carolina			Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal	PLOS ONE			English	Article							PLANNING PREVENTION ACTIVITIES; VACCINE; KNOWLEDGE	Although most countries in the WHO European Region were verified in 2017 as having interrupted endemic measles transmission, nine countries were still endemic. Among these, Italy accounted for the second highest number of measles cases reported in Europe in 2017. The elimination of measles is verified at national level by each country's National Verification Committee (NVC) through the production of an Annual Status Update (ASU). Since in Italy decentralization has led to an inhomogeneous implementation of immunization strategies among the 21 administrative Regions, the Italian NVC proposed that measles elimination should also be documented at the subnational level through regional ASUs and Synthetic Regional Reports (SRRs). The regional ASUs and the SRRs for 2014, 2015 and 2016 were produced and appraised by the NVC to evaluate the Regions' performances in each individual year as well as over the whole period. A specific analysis of vaccination coverage, including official immunization data for 2017, was performed. Moreover, the measles epidemic of 2017 was examined. Firstly, in the period 2014-2016, low immunization rates were registered in most Regions. Sixty-three per cent of southern Regions reported rates below the national mean and an overall low-quality performance. The approval of Italy's mandatory vaccination law in 2017 resulted in a marked increase in vaccination coverage; however, this increase was not homogeneous among Regions. Secondly, more than 50% of Regions did not report any supplemental immunization activity (SIA) for the period 2014-2016. Thirdly, from 2014 to 2016, fewer than one-third of Regions improved their reporting of outbreaks. Finally, over the study period, only two Regions reached the target required by the WHO for measles laboratory investigations. In countries with decentralized health policies, subnational monitoring can help identify local barriers to measles elimination. In Italy it has highlighted the need for further SIAs and a stronger surveillance system.	[Adamo, Giovanna; Sturabotti, Giulia; Baccolini, Valentina; de Soccio, Pasquale; Prencipe, Grazia Pia; Villari, Paolo; Marzuillo, Carolina] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy; [Bella, Antonino] Natl Inst Hlth, Dept Infect Dis, Rome, Italy; [Magurano, Fabio] Natl Inst Hlth, Natl Reference Lab Measles & Rubella, Rome, Italy; [Iannazzo, Stefania] Minist Hlth, Infect Dis & Int Prophylaxis Off, Rome, Italy	Sapienza University Rome; Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Villari, P (corresponding author), Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy.	paolo.villari@uniroma1.it	Adamo, Giovanna/AAB-6922-2019; Baccolini, Valentina/AAS-7670-2020; MAGURANO, FABIO/B-9975-2016; Iannazzo, Stefania/AAC-5004-2022; Bella, Antonino/AAB-9943-2019	Adamo, Giovanna/0000-0001-8983-1924; MAGURANO, FABIO/0000-0002-0394-7043; Iannazzo, Stefania/0000-0001-5431-4951; villari, paolo/0000-0002-3139-0668; MARZUILLO, CAROLINA/0000-0002-7299-5727; Baccolini, Valentina/0000-0002-7873-7817	Italian Ministry of Health within the project "Azioni a sostegno del Piano Nazionale per l'eliminazione del morbillo e della rosolia congenita"	Italian Ministry of Health within the project "Azioni a sostegno del Piano Nazionale per l'eliminazione del morbillo e della rosolia congenita"	This work was supported by the Italian Ministry of Health within the project "Azioni a sostegno del Piano Nazionale per l'eliminazione del morbillo e della rosolia congenita" (Actions to support the National Plan for measles and rubella elimination).	Adamo G, 2017, ANN IG MED PREV COMU, V29, P1, DOI 10.7416/ai.2017.2128; Adamo G, 2017, IG SANITA PUBBL, V74, P429; Adamo G, 2016, EPIDEMIOL BIOSTAT PU, V13, DOI 10.2427/12075; Alfonsi V, 2008, Ann Ig, V20, P105; Bonanni P, 2015, EPIDEMIOL PREV, V39, P146; D'Alessandro A, 2018, HUM VACC IMMUNOTHER, V14, P1573, DOI 10.1080/21645515.2018.1483809; D'Ancona Fortunato, 2006, Ig Sanita Pubbl, V62, P483; Dabbagh A, 2017, MMWR-MORBID MORTAL W, V66, P1148, DOI 10.15585/mmwr.mm6642a6; Datta SS, 2018, VACCINE, V36, P5408, DOI 10.1016/j.vaccine.2017.06.042; De Vito C, 2014, EPIDEMIOL BIOSTAT PU, V11, DOI 10.2427/9975; ECDC, 2020, EUR CTR DIS PREV CON; Ferre F, 2012, HEALTH POLICY, V106, P3, DOI 10.1016/j.healthpol.2012.03.007; Filia A, 2017, EUROSURVEILLANCE, V22, P2, DOI [10.2807/1560-7917.ES.2017.22.37.30614, 10.2807/1560-7917.es.2017.22.37.30614]; Filia A, 2013, EUROSURVEILLANCE, V18, P18; Garattini Livio, 2011, J Med Econ, V14, P527, DOI 10.3111/13696998.2011.593603; Giambi C, 2018, VACCINE, V36, P779, DOI 10.1016/j.vaccine.2017.12.074; Gualano MR, 2018, VACCINE, V36, P3368, DOI 10.1016/j.vaccine.2018.04.029; Italian Ministry of Health (MoH), 2017, PIAN NAZ PREV VACC 2; Italian Ministry of Health (MoH), 2017, DECR VACC LEGG TUTT; Italian Ministry of Health (MoH), 2017, VACC PED AD COP VACC; Italian Ministry of Health (MoH), 2011, PIAN NAZ EL MORB ROS; Magurano F, 2015, J CLIN VIROL, V64, P34, DOI 10.1016/j.jcv.2014.12.019; Massimi A, 2017, EPIDEMIOL BIOSTAT PU, V14, pe126251, DOI [10.2427/12625, DOI 10.2427/12625]; Merkur S, 2013, WHO REG EUR, V72; Morrone T, 2017, HUM VACC IMMUNOTHER, V13, P1921, DOI 10.1080/21645515.2017.1313940; Napolitano F, 2018, HUM VACC IMMUNOTHER, V14, P1558, DOI 10.1080/21645515.2018.1463943; Napolitano F, 2016, HUM VACC IMMUNOTHER, V12, P1504, DOI 10.1080/21645515.2016.1156271; Pezzotti P, 2018, VACCINE, V36, P1435, DOI 10.1016/j.vaccine.2018.01.065; Rosso A, 2016, INT J EQUITY HEALTH, V15, P1, DOI [10.1186/s12939-015-0290-8, DOI 10.1186/S12939-015-0290-8]; Rosso A, 2015, EUR J PUBLIC HEALTH, V25, P1117, DOI 10.1093/eurpub/ckv087; Rosso A, 2015, HEALTH POLICY, V119, P760, DOI 10.1016/j.healthpol.2015.03.012; Unim B, 2016, PUBLIC HEALTH, V130, P51, DOI 10.1016/j.puhe.2015.08.009; World Health Organization. Regional Office for Europe, 2013, HLTH 2020 EUR POL FR; World Health Organization (WHO), 2014, CAS INV PUBL HLTH PU; World Health Organization (WHO) Regional Office for Europe, 2018, WHO EPIBRIEF, V1, P1; World Health Organization (WHO) Regional Office for Europe, 2017, 6 M EUR REG VER COMM; World Health Organization (WHO) Regional Office for Europe, 2013, GUID MEASL RUB BREAK; World Health Organization (WHO) Regional Office for Europe, 2014, ELIM MEASL RUB FRAM	38	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205147	10.1371/journal.pone.0205147	http://dx.doi.org/10.1371/journal.pone.0205147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356247	Green Published, gold			2022-12-26	WOS:000448434000033
J	Cremonesi, P; Ceccarani, C; Curone, G; Severgnini, M; Pollera, C; Bronze, V; Riva, F; Addis, MF; Filipe, J; Amadori, M; Trevisi, E; Vigo, D; Moroni, P; Castiglioni, B				Cremonesi, Paola; Ceccarani, Camilla; Curone, Giulio; Severgnini, Marco; Pollera, Claudia; Bronze, Valerio; Riva, Federica; Addis, Maria Filippa; Filipe, Joel; Amadori, Massimo; Trevisi, Erminio; Vigo, Daniele; Moroni, Paolo; Castiglioni, Bianca			Milk microbiome diversity and bacterial group prevalence in a comparison between healthy Holstein Friesian and Rendena cows	PLOS ONE			English	Article							RAW-MILK; STAPHYLOCOCCUS-AUREUS; IMMUNE-SYSTEM; COMMUNITIES; COMPONENTS; SEQUENCES; MASTITIS	Dry and early lactation periods represent the most critical phases for udder health in cattle, especially in highly productive breeds, such as the Holstein Friesian (HF). On the other hand, some autochthonous cattle breeds, such as the Rendena (REN), have a lower prevalence of mastitis and other transition-related diseases. In this study, milk microbiota of 6 HF and 3 REN cows, all raised on the same farm under the same conditions, was compared. A special focus was placed on the transition period to define bacterial groups' prevalence with a plausible effect on mammary gland health. Four time points (dry-off, 1 d, 7-10 d and 30 d after calving) were considered. Through 16S rRNA sequencing, we characterized the microbiota composition for 117 out of the 144 milk samples initially collected, keeping only the healthy quarters, in order to focus on physiological microbiome changes and avoid shifts due to suspected diseases. Microbial populations were very different in the two breeds along all the time points, with REN milk showing a significantly lower microbial biodiversity. The taxonomic profiles of both cosmopolitan and local breeds were dominated by Firmicutes, mostly represented by the Streptococcus genus, although in very different proportions (HF 27.5%, REN 68.6%). Large differences in HF and REN cows were, also, evident from the metabolic predictive analysis from microbiome data. Finally, only HF milk displayed significant changes in the microbial composition along the transition period, while REN maintained a more stable microbiota. In conclusion, in addition to the influence on the final characteristics of dairy products obtained from milk of the two breeds, differences in the milk microbiome might, also, have an impact on their mammary gland health.	[Cremonesi, Paola; Castiglioni, Bianca] Natl Res Council CNR, Inst Agr Biol & Biotechnol, Lodi, Italy; [Ceccarani, Camilla; Severgnini, Marco] CNR, Natl Res Council, Inst Biomed Technol, Milan, Italy; [Ceccarani, Camilla] Univ Milan, San Paolo Hosp Med Sch, Dipartimento Sci Salute, Milan, Italy; [Curone, Giulio; Pollera, Claudia; Bronze, Valerio; Riva, Federica; Addis, Maria Filippa; Filipe, Joel; Vigo, Daniele; Moroni, Paolo] Univ Milan, Dipartimento Med Vet, Milan, Italy; [Amadori, Massimo] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Lab Cellular Immunol, Brescia, Italy; [Trevisi, Erminio] Univ Cattolica Sacro Cuore, Fac Sci Agr Alimentari & Ambientali, Dept Anim Sci Food & Nutr DIANA, Piacenza, Italy; [Moroni, Paolo] Cornell Univ, Qual Milk Prod Serv, Anim Hlth Diagnost Ctr, Ithaca, NY USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan; University of Milan; IZS Lombardia e Emilia; Catholic University of the Sacred Heart; Cornell University	Cremonesi, P (corresponding author), Natl Res Council CNR, Inst Agr Biol & Biotechnol, Lodi, Italy.	cremonesi@ibba.cnr.it	Pollera, Claudia/D-7160-2013; Filipe, Joel F Soares/U-7718-2017; Curone, Giulio/AAC-1887-2020; Curone, Giulio/L-4876-2017; Soares Filipe, Joel Fernando/GXZ-9744-2022; Cremonesi, Paola/AAP-8157-2020; Addis, Maria Filippa/I-5381-2019; VIGO, DANIELE/L-4868-2017; Moroni, Paolo/M-1527-2017	Pollera, Claudia/0000-0001-7537-7628; Filipe, Joel F Soares/0000-0001-8849-2051; Curone, Giulio/0000-0001-6352-0036; Curone, Giulio/0000-0001-6352-0036; Cremonesi, Paola/0000-0002-8239-5549; Addis, Maria Filippa/0000-0001-6934-7748; VIGO, DANIELE/0000-0002-6292-4992; Moroni, Paolo/0000-0002-0974-3084; Ceccarani, Camilla/0000-0003-3824-7239	Piano Sviluppo UNIMI Project, linea B of the University of Milan [G42I14000070005]; MIUR GenHome project "Technological Resort for the advancement of animal genomic research"	Piano Sviluppo UNIMI Project, linea B of the University of Milan; MIUR GenHome project "Technological Resort for the advancement of animal genomic research"	This work was supported by the Piano Sviluppo UNIMI Project, linea B of the University of Milan (G42I14000070005) and by MIUR GenHome project "Technological Resort for the advancement of animal genomic research."	Addis MF, 2016, MOL BIOSYST, V12, P2359, DOI 10.1039/c6mb00217j; Adkins P.R.F., 2017, LAB HDB BOVINE MASTI; Garrido-Cardenas JA, 2017, CURR GENET, V63, P819, DOI 10.1007/s00294-017-0693-8; Bonsaglia ECR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08790-5; Bouchard DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144831; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Espeche MC, 2012, ANAEROBE, V18, P103, DOI 10.1016/j.anaerobe.2012.01.002; Cremonesi P, 2006, J DAIRY SCI, V89, P163, DOI 10.3168/jds.S0022-0302(06)72080-X; Curone G, 2018, RES VET SCI, V116, P88, DOI 10.1016/j.rvsc.2017.11.020; Falentin H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00480; Gandini G, 2007, J DAIRY SCI, V90, P2004, DOI 10.3168/jds.2006-204; Green MJ, 2002, J DAIRY SCI, V85, P2589, DOI 10.3168/jds.S0022-0302(02)74343-9; Heikkila MP, 2003, J APPL MICROBIOL, V95, P471, DOI 10.1046/j.1365-2672.2003.02002.x; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Kuehn JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061959; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Li N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20862-8; Lima SF, 2017, J DAIRY SCI, V100, P3031, DOI 10.3168/jds.2016-11604; Lima SF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193671; Loor JJ, 2013, ANIM PROD SCI, V53, P931, DOI 10.1071/AN12344; Martin LM, 2018, J DAIRY SCI, V101, P8417, DOI 10.3168/jds.2018-14500; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Masoud W, 2012, INT J FOOD MICROBIOL, V153, P192, DOI 10.1016/j.ijfoodmicro.2011.11.014; Metzger SA, 2018, J DAIRY SCI, V101, P6346, DOI 10.3168/jds.2017-14212; Montel MC, 2014, INT J FOOD MICROBIOL, V177, P136, DOI 10.1016/j.ijfoodmicro.2014.02.019; Oikonomou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085904; Oikonomou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047671; OLIVER SP, 1988, J DAIRY SCI, V71, P2584, DOI 10.3168/jds.S0022-0302(88)79847-1; Pinedo PJ, 2010, J DAIRY SCI, V93, P2250, DOI 10.3168/jds.2009-2572; Podar M, 2007, METHOD ENZYMOL, V422, P32, DOI 10.1016/S0076-6879(06)22002-0; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; Quigley L, 2011, INT J FOOD MICROBIOL, V150, P81, DOI 10.1016/j.ijfoodmicro.2011.08.001; Rainard P, 2017, VET RES, V48, DOI 10.1186/s13567-017-0429-2; Schepers AJ, 1997, J DAIRY SCI, V80, P1833, DOI 10.3168/jds.S0022-0302(97)76118-6; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Spiljar M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01353; Suriyasathaporn W, 2000, VET RES, V31, P397, DOI 10.1051/vetres:2000128; Thaiss CA, 2014, CURR OPIN IMMUNOL, V26, P41, DOI 10.1016/j.coi.2013.10.016; Trevisi E, 2018, RES VET SCI, V116, P47, DOI 10.1016/j.rvsc.2017.12.001; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Young W, 2015, PEERJ, V3, DOI 10.7717/peerj.888; Zhang FX, 2017, J DAIRY SCI, V100, P7812, DOI 10.3168/jds.2017-13244; Zhang RY, 2015, J SCI FOOD AGR, V95, P1072, DOI 10.1002/jsfa.6800	46	44	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205054	10.1371/journal.pone.0205054	http://dx.doi.org/10.1371/journal.pone.0205054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356246	gold, Green Submitted, Green Published			2022-12-26	WOS:000448434000026
J	Huebinger, RM; Smith, AD; Zhang, Y; Monson, NL; Ireland, SJ; Barber, RC; Kubasiak, JC; Minshall, CT; Minei, JP; Wolf, SE; Allen, MS				Huebinger, Ryan M.; Smith, Ashley D.; Zhang, Yan; Monson, Nancy L.; Ireland, Sara J.; Barber, Robert C.; Kubasiak, John C.; Minshall, Christian T.; Minei, Joseph P.; Wolf, Steven E.; Allen, Michael S.			Variations of the lung microbiome and immune response in mechanically ventilated surgical patients	PLOS ONE			English	Article							PULMONARY INFECTION SCORE; BRONCHOALVEOLAR LAVAGE; PNEUMONIA SURVEILLANCE; ENDOTRACHEAL ASPIRATE; TRAUMA PATIENTS; DIAGNOSIS; CARE; GUIDELINES; MANAGEMENT; DYSBIOSIS	Mechanically ventilated surgical patients have a variety of bacterial flora that are often undetectable by traditional culture methods. The source of infection in many of these patients remains unclear. To address this clinical problem, the microbiome profile and host inflammatory response in bronchoalveolar lavage samples from the surgical intensive care unit were examined relative to clinical pathology diagnoses. The hypothesis was tested that clinical diagnosis of respiratory tract flora were similar to culture positive lavage samples in both microbiome and inflammatory profile. Bronchoalveolar lavage samples were collected in the surgical intensive care unit as standard of care for intubated individuals with a clinical pulmonary infection score of >6 or who were expected to be intubated for >48 hours. Cytokine analysis was conducted with the Bioplex Pro Human Th17 cytokine panel. The microbiome of the samples was sequenced for the 16S rRNA region using the Ion Torrent. Microbiome diversity analysis showed the culture-positive samples had the lowest levels of diversity and culture negative with the highest based upon the Shannon-Wiener index (culture positive: 0.77 +/- 0.36, respiratory tract flora: 2.06 +/- 0.73, culture negative: 3.97 +/- 0.65). Culture-negative samples were not dominated by a single bacterial genera. Lavages classified as respiratory tract flora were more similar to the culture-positive in the microbiome profile. A comparison of cytokine expression between groups showed increased levels of cytokines (IFN-g, IL-17F, IL-1 B, IL-31, TNF-a) in culture-positive and respiratory tract flora groups. Culture-positive samples exhibited a more robust immune response and reduced diversity of bacterial genera. Lower cytokine levels in culture-negative samples, despite a greater number of bacterial species, suggest a resident nonpathogenic bacterial community may be indicative of a normal pulmonary environment. Respiratory tract flora samples were most similar to the culture-positive samples and may warrant classification as culture-positive when considering clinical treatment.	[Huebinger, Ryan M.; Kubasiak, John C.; Minshall, Christian T.; Minei, Joseph P.; Wolf, Steven E.] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Smith, Ashley D.; Zhang, Yan; Allen, Michael S.] Univ North Texas, Hlth Sci Ctr, Dept Microbiol Immunol & Genet, Ft Worth, TX 76107 USA; [Monson, Nancy L.; Ireland, Sara J.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Monson, Nancy L.] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Barber, Robert C.] Univ North Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Texas System; University of North Texas Denton; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Texas System; University of North Texas Denton	Huebinger, RM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA.; Allen, MS (corresponding author), Univ North Texas, Hlth Sci Ctr, Dept Microbiol Immunol & Genet, Ft Worth, TX 76107 USA.	Ryan.Huebinger@UTSouthwestern.edu; Michael.Allen@unthsc.edu	Smith, Ashley/GZB-0298-2022; Zhang, Yan/L-1738-2015	Zhang, Yan/0000-0001-5784-4659; Allen, Michael/0000-0003-2293-8078; Wolf, Steven/0000-0003-2972-3440				Baselski V, 2013, J CLIN MICROBIOL, V51, P740, DOI 10.1128/JCM.03383-12; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; de Brito RDCM, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0324-z; Croce MA, 2006, J TRAUMA, V60, P523, DOI 10.1097/01.ta.0000204033.78125.1b; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Einarsson GG, 2016, THORAX, V71, P795, DOI 10.1136/thoraxjnl-2015-207235; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fujitani S, 2009, RESP CARE, V54, P1453; Grgurich PE, 2013, CURR OPIN INFECT DIS, V26, P140, DOI 10.1097/QCO.0b013e32835ebbd0; Grover V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109686; Hellyer TP, 2015, THORAX, V70, P41, DOI 10.1136/thoraxjnl-2014-205766; Hoggard M, 2017, INT FORUM ALLERGY RH, V7, P230, DOI 10.1002/alr.21871; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Kitsios GD, 2017, J CRIT CARE, V38, P84, DOI 10.1016/j.jcrc.2016.09.029; LaPar DJ, 2012, J AM COLL SURGEONS, V214, P478, DOI 10.1016/j.jamcollsurg.2011.12.015; Leonard KL, 2016, SURG INFECT, V17, P363, DOI 10.1089/sur.2014.076; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; May AK, 2015, CHEST, V147, P1494, DOI 10.1378/chest.14-1687; Michetti CP, 2012, J TRAUMA ACUTE CARE, V72, P1165, DOI 10.1097/TA.0b013e31824d10fa; Millo JL, 2004, INTENS CARE MED, V30, P68, DOI 10.1007/s00134-003-2060-0; Minei JP, 2006, J TRAUMA, V60, P1106, DOI 10.1097/01.ta.0000220424.34835.f1; Morris AC, 2017, THORAX, V72, P1046, DOI 10.1136/thoraxjnl-2016-209065; Morris AC, 2010, THORAX, V65, P201, DOI 10.1136/thx.2009.122291; Nair GB, 2015, INTENS CARE MED, V41, P34, DOI 10.1007/s00134-014-3564-5; O'Horo JC, 2016, AM J INFECT CONTROL, V44, P661, DOI 10.1016/j.ajic.2015.12.032; Piriyapatsom A, 2016, RESP CARE, V61, P269, DOI 10.4187/respcare.04280; Piters WAAD, 2016, ISME J, V10, P97, DOI 10.1038/ismej.2015.99; SAUAIA A, 1993, J TRAUMA, V35, P512, DOI 10.1097/00005373-199310000-00003; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scholte JBJ, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0087-y; Scholte JBJ, 2014, J CLIN MICROBIOL, V52, P3597, DOI 10.1128/JCM.01494-14; Schurink CAM, 2004, INTENS CARE MED, V30, P217, DOI 10.1007/s00134-003-2018-2; Smith AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166313; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Wu CL, 2002, CHEST, V122, P662, DOI 10.1378/chest.122.2.662; Yeh A, 2016, SHOCK, V46, P649, DOI 10.1097/SHK.0000000000000691; Zakharkina T, 2017, THORAX, V72, P803, DOI 10.1136/thoraxjnl-2016-209158; Zhang QL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152724; Zosa BM, 2017, SURG INFECT, V18, P558, DOI 10.1089/sur.2016.152	40	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205788	10.1371/journal.pone.0205788	http://dx.doi.org/10.1371/journal.pone.0205788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356313	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000060
J	Peng, LH; Jiang, DM				Peng, Lihua; Jiang, Dianming			Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; DRUG-RESISTANCE; ACTIVATION; APOPTOSIS; PROLIFERATION; PROMOTES; PI3K/AKT; METASTASIS; REVERSAL	Resveratrol shows potent anti-tumor therapeutic properties in various tumors. However, the exact effect of resveratrol on osteosarcoma cells, especially cancer stem cells, remains unclear. In this study, we examined the effect of resveratrol on osteosarcoma stem cells and explored the underlying molecular mechanisms. Resveratrol inhibited cell viability, self-renewal ability and tumorigenesis of osteosarcoma cells, whereas showed no significant inhibition effects to normal osteoblast cells. Mechanically, resveratrol treatment decreased cytokines synthesis and inhibited JAK2/STAT3 signaling, which was consistent with the decline of cancer stem cells marker, CD133. Exogenous STAT3 activation attenuated the cancer stem cell elimination effects of resveratrol treatment. Our results demonstrated that resveratrol inhibited osteosarcoma cell proliferation and tumorigenesis ability, which was correlated with cytokines inhibition related JAK2/STAT3 signaling blockage. Resveratrol may be a promising therapeutic agent for osteosarcoma management.	[Peng, Lihua; Jiang, Dianming] Chongqing Med Univ, Dept Orthoped, Affiliated Hosp 1, Chongqing, Peoples R China	Chongqing Medical University	Jiang, DM (corresponding author), Chongqing Med Univ, Dept Orthoped, Affiliated Hosp 1, Chongqing, Peoples R China.	jdm0512@163.com	peng, li/GQH-5153-2022					Ahmad SF, 2018, EUR J PHARMACOL, V829, P70, DOI 10.1016/j.ejphar.2018.04.008; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Chen BY, 2012, J NAT PROD, V75, P1810, DOI 10.1021/np300392n; Chen RJ, 2010, MOL NUTR FOOD RES, V54, P1819, DOI 10.1002/mnfr.201000067; Chen ZZ, 2016, IRAN J PUBLIC HEALTH, V45, P578; Dave B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030207; Denduluri SK, 2015, J BIOMED RES, V30, DOI [10.7555/JBR.29, DOI 10.7555/JBR.29]; Frojdo S, 2007, BIOCHEM J, V406, P511, DOI 10.1042/BJ20070236; Fu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102535; Gibbs CP, 2011, CURR ORTHOP PRACT, V22, P322, DOI 10.1097/BCO.0b013e318221aee8; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hu Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.363; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Lamoureux F, 2007, CANCER RES, V67, P7308, DOI 10.1158/0008-5472.CAN-06-4130; Lee SK, 2008, J AGR FOOD CHEM, V56, P7572, DOI 10.1021/jf801014p; Li JP, 2014, MOL MED REP, V10, P1717, DOI 10.3892/mmr.2014.2417; Liu BL, 2004, PLANTA MED, V70, P305, DOI 10.1055/s-2004-818940; Liu XJ, 2014, ONCOL REP, V32, P2760, DOI 10.3892/or.2014.3536; Liu Z, 2017, ONCOTARGET, V8, P65778, DOI 10.18632/oncotarget.19473; Misaghi A, 2018, SICOT-J, V4, DOI 10.1051/sicotj/2017028; Mitra A, 2015, ONCOTARGET, V6, P10697, DOI 10.18632/oncotarget.4037; Mitrut P, 2009, ROM J MORPHOL EMBRYO, V50, P429; Serra D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109048; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Siegel HJ, 2008, EXPERT REV ANTICANC, V8, P1257, DOI 10.1586/14737140.8.8.1257; Sims JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055509; Taniguchi T, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.114; Tian HY, 2015, INT J CLIN EXP PATHO, V8, P2755; Timmers S, 2012, AGING-US, V4, P146, DOI 10.18632/aging.100445; Tsai JH, 2013, TOXICOL APPL PHARM, V272, P746, DOI 10.1016/j.taap.2013.07.019; Tu B, 2012, CANCER LETT, V325, P80, DOI 10.1016/j.canlet.2012.06.006; Uddin N, 2015, CANCER SCI, V106, P718, DOI 10.1111/cas.12668; Wang HY, 2013, TOXICOLOGY, V303, P139, DOI 10.1016/j.tox.2012.09.017; Wang Q, 2018, CELL RES, V28, P336, DOI 10.1038/cr.2018.15; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Yang XG, 2016, CANCER RES, V76, P4124, DOI 10.1158/0008-5472.CAN-15-2973; Zhang Y, 2017, ONCOL REP, V38, P2685, DOI 10.3892/or.2017.5960; Zhao CG, 2016, TRENDS PHARMACOL SCI, V37, P47, DOI 10.1016/j.tips.2015.10.001	41	43	46	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205918	10.1371/journal.pone.0205918	http://dx.doi.org/10.1371/journal.pone.0205918			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356255	Green Submitted, Green Published, gold			2022-12-26	WOS:000448434000064
J	Wronska-Pilarek, D; Szkudlarz, P; Bocianowski, J				Wronska-Pilarek, Dorota; Szkudlarz, Piotr; Bocianowski, Jan			Systematic importance of morphological features of pollen grains of species from Erica (Ericaceae) genus	PLOS ONE			English	Article							ERICOIDEAE ERICACEAE; SOUTHERN-AFRICA; GENERIC RELATIONSHIP; CLASSIFICATION; PHILIPPIA; SYNONYMY	The Erica genus has as yet not been investigated satisfactorily in terms of palynology. Its complicated taxonomic system, large number of species, as well as its extensive but disrupted range of occurrence, all contribute to the fact that few researchers have undertaken investigations of this species. It was assumed that the research results would be representative thanks to a complex comparative analysis of all diagnostical, morphological pollen features performed on properly selected plant material, representing the most important distinguished intrageneric taxons at the present time (45 species from all five subgenera and 22 sections), both discriminated pollen dispersal units (tetrads and monads) as well as the main centres of genus occurrence and diversification (species from Europe, the Republic of South Africa (RSA) and Madagascar). The study revealed that the diagnostic features of the pollen grains studied were: pollen dispersal unit, exine ornamentation, P/E ratio, tetrad diameter (D) and length of polar axis (P). On the basis of these traits, 14 Erica species (six creating monads and eight-tetrads) were distinguished which, in the case of pollen features, constitutes a significant number. Other heaths created small groups, usually containing two or three species, but up to seven species. The present study, based on the highest number of Erica species (45) analysed so far, corroborated the view that an examination of palynological features may assist in clarifying classification systems for the large and taxonomically very difficult Erica genus, in particular, at the level of the subgenus and section, but also at species level. The results obtained indicate the need to continue palynological investigations on the Erica genus.	[Wronska-Pilarek, Dorota] Poznan Univ Life Sci, Dept Forest Bot, Poznan, Poland; [Szkudlarz, Piotr] Adam Mickiewicz Univ, Fac Biol, Dept Plant Taxon, Poznan, Poland; [Bocianowski, Jan] Poznan Univ Life Sci, Dept Math & Stat Methods, Poznan, Poland	Poznan University of Life Sciences; Adam Mickiewicz University; Poznan University of Life Sciences	Wronska-Pilarek, D (corresponding author), Poznan Univ Life Sci, Dept Forest Bot, Poznan, Poland.	pilarekd@up.poznan.pl	Bocianowski, Jan/T-7612-2019	Bocianowski, Jan/0000-0002-0102-0084; Wronska-Pilarek, Dorota/0000-0003-2431-6192; Szkudlarz, Piotr/0000-0002-4915-2721				Bentham G., 1839, PRODROMUS SISTEMATIS, P580; CAMUSSI A, 1985, GENETICS, V111, P945; COMTOIS P, 1981, Naturaliste Canadien (Quebec), V108, P245; Davis RA, 1997, THESIS; DIEZ M J, 1989, Pollen et Spores, V31, P215; Dorr Laurence J., 1999, Adansonia (Paris), V21, P75; DULFER H., 1965, ANN NATURHIST MUS WIEN, V68, P25; ERDTMAN G., 1960, SVENSK BOT TIDSKR, V54, P561; Erdtman G., 1952, POLLEN MORPHOLOGY PL, P1; FOSS P J, 1988, Pollen et Spores, V30, P151; Guthrie F, 1905, FLORA CAPENSIS, P4; Halbritter H., 2015, PALDAT PALYNOLOGICAL; Halbritter H., 2016, PALDAT PALYNOLOGICAL; HANSEN IRMGARD, 1950, BOT JAHRB, V75, P1; Hesse A., 2009, POLLEN TERMINOLOGY I; Ikuse M., 2001, POLLEN GRAINS JAPAN; Kron K. A., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P479; Kron KA, 2002, BOT REV, V68, P335, DOI 10.1663/0006-8101(2002)068[0335:PCOEMA]2.0.CO;2; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mateus J. E., 1989, Revista de Biologia (Lisboa), V14, P135; MCCLINTOCK D, 1989, BOT J LINN SOC, V101, P279, DOI 10.1111/j.1095-8339.1989.tb00162.x; OLDFIELD FRANK, 1959, POLLEN ET SPORES, V1, P19; OLIVER E G H, 1976, Bothalia, V12, P29; OLIVER E G H, 1980, Bothalia, V13, P65; Oliver E.G.H., 1991, CONTR BOLUS HERB, V13, P158; OLIVER EGH, 1987, S AFR J BOT, V53, P455, DOI 10.1016/S0254-6299(16)31379-5; OLIVER EGH, 1988, BOTHALIA, V18, P1; OLIVER EGH, 1994, BOTHALIA, V24, P121, DOI 10.4102/abc.v24i2.761; Oliver EGH, 2005, BOTHALIA, V35, P121, DOI 10.4102/abc.v35i2.388; Oliver EGH, 2002, BOTHALIA, V32, P37, DOI 10.4102/abc.v32i1.461; OLIVER EGH, 1987, BOTHALIA, V17, P163, DOI 10.4102/abc.v17i2.1025; OLIVER EGH, 1993, BOTHALIA, V23, P1; Oliver EGH, 2000, PLANT SYST EVOL, V147, P189; Oliver EGH., 2000, CONTRIBUTIONS BOLUS, P19; Paquereau MM, 1959, SOC LINN BORDEAUX, V97, P1; Payne R., 2012, INTRO GENSTAT WINDOW; Punt W., 1994, GLOSSARY POLLEN SPOR; RENCHER AC, 1992, AM STAT, V46, P217, DOI 10.2307/2685219; Sarwar Golam AKM, 2014, GRANA, V53, P221, DOI [10.1080/00173134.2014.912346, DOI 10.1080/00173134.2014.912346]; Sarwar Golam AKM, 2011, POLLEN MORPHOLOGY ER; Sarwar Golam AKM, 2007, THESIS; Seidler-Lozykowska K, 2012, IND CROP PROD, V35, P140, DOI 10.1016/j.indcrop.2011.06.026; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; STEVENS PF, 1971, BOT J LINN SOC, V64, P1, DOI 10.1111/j.1095-8339.1971.tb02133.x; Stevens PF, FAMILIES GENERA VASC, V6; Stevens PF, 2006, ANGIOSPERM PHYLOGENY, P7; VISSET L, 1975, B SOC BOT FR, V122, P203, DOI 10.1080/00378941.1975.10839329; WAHA M, 1984, PLANT SYST EVOL, V147, P189, DOI 10.1007/BF00989383; Webb DA, 1972, FLORA EUROPAEA, V3, P8; Yang B. Y., 1952, QUAR J TAIWAN MUS, V5, P1; Zhang XP, 2002, GRANA, V41, P201, DOI 10.1080/001731302321011997	51	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0204557	10.1371/journal.pone.0204557	http://dx.doi.org/10.1371/journal.pone.0204557			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356271	gold, Green Published, Green Submitted			2022-12-26	WOS:000448434000012
J	Kim, D; You, S; So, S; Lee, J; Yook, S; Jang, DP; Kim, IY; Park, E; Cho, K; Cha, WC; Shin, DW; Cho, BH; Park, HK				Kim, Dohyun; You, Sungmin; So, Soonwon; Lee, Jongshill; Yook, Sunhyun; Jang, Dong Pyo; Kim, In Young; Park, Eunkyoung; Cho, Kyeongwon; Cha, Won Chul; Shin, Dong Wook; Cho, Baek Hwan; Park, Hoon-Ki			A data-driven artificial intelligence model for remote triage in the prehospital environment	PLOS ONE			English	Article							INJURY SEVERITY SCORE; NEURAL-NETWORKS; TRAUMA; CLASSIFICATION; PREDICTION; VISUALIZATION; ALGORITHM; FUTURE; COMA	In a mass casualty incident, the factors that determine the survival rate of injured patients are diverse, but one of the key factors is the time for triage. Additionally, the main factor that determines the time of triage is the number of medical personnel. However, when relying on a small number of medical personnel, the ability to increase survivability is limited. Therefore, developing a classification model for survival prediction that can quickly and precisely triage via wearable devices without medical personnel is important. In this study, we designed a consciousness index to substitute the factor by manpower and improved the classification accuracy by applying a machine learning algorithm. First, logistic regression analysis using vital signs and a consciousness index capable of remote monitoring through wearable devices confirmed the high efficiency of the consciousness index. We then developed a classification model with high accuracy which corresponds to existing injury severity scoring systems through the machine learning algorithms. We extracted 460,865 cases which met our criteria for developing the survival prediction from the national sample project in the national trauma databank which contains 408,316 cases of blunt injury and 52,549 cases of penetrating injury. Among the dataset, 17,918 (3.9%) cases died while the other survived. The AUCs with 95% confidence intervals (Cis) for the different models with the proposed simplified consciousness score as follows: RTS (as baseline), 0.78 (95% CI = 0.775 to 0.785); logistic regression, 0.87 (95% CI = 0.862 to 0.870); random forest, 0.87 (95% CI = 0.862 to 0.872); deep neural network, 0.89 (95% CI = 0.882 to 0.890). As a result, we confirmed the possibility of remote triage using a wearable device. It is expected that the time required for triage can be effectively reduced by using the developed classification model of survival prediction.	[Kim, Dohyun] Korea Inst Sci & Technol, Convergence Res Ctr Diag Treatment & Care Dementi, Seoul, South Korea; [You, Sungmin; So, Soonwon; Lee, Jongshill; Yook, Sunhyun; Jang, Dong Pyo; Kim, In Young] Hanyang Univ, Dept Biomed Engn, Seoul, South Korea; [Park, Eunkyoung; Cho, Kyeongwon; Cho, Baek Hwan] Sungkyunkwan Univ, Smart Healthcare & Device Res Ctr, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Cha, Won Chul] Sungkyunkwan Univ, Samsung Med Ctr, Dept Emergency Med, Sch Med, Seoul, South Korea; [Cha, Won Chul; Shin, Dong Wook] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Digital Hlth, Seoul, South Korea; [Shin, Dong Wook] Sungkyunkwan Univ, Samsung Med Ctr, Dept Family Med, Sch Med, Seoul, South Korea; [Cho, Baek Hwan] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Med Device Management & Res, Seoul, South Korea; [Park, Hoon-Ki] Hanyang Univ, Dept Family Med, Coll Med, Seoul, South Korea	Korea Institute of Science & Technology (KIST); Hanyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Hanyang University	Cho, BH (corresponding author), Sungkyunkwan Univ, Smart Healthcare & Device Res Ctr, Samsung Med Ctr, Sch Med, Seoul, South Korea.; Cho, BH (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Med Device Management & Res, Seoul, South Korea.; Park, HK (corresponding author), Hanyang Univ, Dept Family Med, Coll Med, Seoul, South Korea.	beakhwan.cho@samsung.com; hoonkp@hanyang.ac.kr	Cho, Baek Hwan/ABC-8231-2021; Lee, Jongshill/AAF-6247-2021	Lee, Jongshill/0000-0002-9884-9672; Park, Eunkyoung/0000-0001-7700-0250; You, Sungmin/0000-0002-2144-9523	Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [NRF-2017M3A9E1064784, NRF-2017M3A9E1064781]	Bio & Medical Technology Development Program of the NRF - Korean government, MSIP(National Research Foundation of Korea)	This research was supported by the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (NRF-2017M3A9E1064781). This research was supported by the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP(NRF-2017M3A9E1064784).	Abadi M., 2016, TENSORFLOW LARGE SCA; Association AM, 1971, JAMA-J AM MED ASSOC, V215, P277; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Batista GEAPA, 2003, APPL ARTIF INTELL, V17, P519, DOI 10.1080/08839510390219309; Berglund E, 2013, PATIENT EDUC COUNS, V91, P105, DOI 10.1016/j.pec.2012.11.001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CHAMPION HR, 1981, CRIT CARE MED, V9, P672, DOI 10.1097/00003246-198109000-00015; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAMPION HR, 1983, WORLD J SURG, V7, P4, DOI 10.1007/BF01655906; Cho BH, 2008, IEEE T INF TECHNOL B, V12, P247, DOI 10.1109/TITB.2007.902300; Cho BH, 2008, ARTIF INTELL MED, V42, P37, DOI 10.1016/j.artmed.2007.09.005; COLLICOTT PE, 1992, J TRAUMA, V33, P749, DOI 10.1097/00005373-199211000-00026; Committee on Trauma American College of Surgeons, 2013, AM COLL SURG NTDB VE; DiRusso SM, 2002, J PEDIATR SURG, V37, P1098, DOI 10.1053/jpsu.2002.33885; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; Esfahani MS, 2014, BIOINFORMATICS, V30, P242, DOI 10.1093/bioinformatics/btt662; Ghosh E, 2018, RESUSCITATION, V122, P99, DOI 10.1016/j.resuscitation.2017.10.026; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gill M, 2007, ANN EMERG MED, V49, P403, DOI 10.1016/j.annemergmed.2006.03.031; Hagan M.T., 2014, NEURAL NETWORK DESIG; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Hunter A, 2000, COMPUT METH PROG BIO, V62, P11, DOI 10.1016/S0169-2607(99)00046-2; Iserson KV, 2007, ANN EMERG MED, V49, P275, DOI 10.1016/j.annemergmed.2006.05.019; Kingma DP., 2014, ADAM METHOD STOCHAST; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Little R. J. A., 1987, STAT ANAL MISSING DA; Miner AS, 2016, JAMA INTERN MED, V176, P619, DOI 10.1001/jamainternmed.2016.0400; Mutschler M, 2014, INJURY, V45, pS35, DOI 10.1016/j.injury.2014.08.015; Nair V., 2010, P 27 INT C INT C MAC, P807; Rickards CA, 2008, AVIAT SPACE ENVIR MD, V79, P670, DOI 10.3357/ASEM.2223.2008; Rickards CA, 2014, J APPL PHYSIOL, V116, P486, DOI 10.1152/japplphysiol.00012.2013; Rosner B, 2006, BIOMETRICS, V62, P185, DOI 10.1111/j.1541-0420.2005.00389.x; Schluter PJ, 2011, INJURY, V42, P90, DOI 10.1016/j.injury.2010.08.040; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; States JD, 1969, SAE TRANSACTIONS, V78, P2625, DOI DOI 10.4271/690810; TEASDALE G, 1974, LANCET, V2, P81; Weng SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174944	42	24	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206006	10.1371/journal.pone.0206006	http://dx.doi.org/10.1371/journal.pone.0206006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352077	gold, Green Published, Green Submitted			2022-12-26	WOS:000448076200021
J	Park, DY; Kim, HJ; Kim, CH; Lee, JY; Han, K; Choi, JH				Park, Do-Yang; Kim, Hyun Jun; Kim, Chang-Hoon; Lee, Jae Yong; Han, Kyungdo; Choi, Ji Ho			Prevalence and relationship of olfactory dysfunction and tinnitus among middle- and old-aged population in Korea	PLOS ONE			English	Article							NATIONAL-HEALTH; RISK-FACTORS; ANOSMIA	Olfactory dysfunction and tinnitus are age-related otorhinolaryngological disorders with a high prevalence in the elderly population and share several common clinical features. However, there is no study investigating the relationship between these two diseases. We studied the prevalence of olfactory dysfunction and tinnitus among Koreans and studied the relationship between these two diseases based on the Korean National Health and Nutrition Examination Survey. The subjects of this study were enrolled from the Fifth Korean National Health and Nutrition Examination Survey (2010-2012, n = 25,534). Data of subjects aged 40 years and older who underwent physical examination and completed a self-reported questionnaire and other anthropometric variables were statistically analyzed. Odds ratios were calculated to identify the relationship between olfactory dysfunction and tinnitus, using multiple logistic regression models. Older males, non-smokers, non/lower alcohol drinker groups exhibited the relationship between olfactory dysfunction and tinnitus. Metabolic syndrome and mental health problems were associated with both olfactory dysfunction and tinnitus. After adjusting for confounding factors, olfactory dysfunction was significantly associated with tinnitus (OR 1.318). There was a dose-response relationship between tinnitus severity and the odds of olfactory dysfunction (ORs for mild, moderate and severe tinnitus were, respectively, 1.134, 1.569 and 2.044). Additional molecular genetics and animal studies are needed to determine the shared pathophysiology of the two diseases.	[Park, Do-Yang; Kim, Hyun Jun] Ajou Univ, Dept Otolaryngol, Sch Med, Suwon, South Korea; [Park, Do-Yang] Yonsei Univ, Dept Med, Grad Sch, Seoul, South Korea; [Kim, Chang-Hoon] Yonsei Univ, Dept Otorhinolaryngol, Coll Med, Seoul, South Korea; [Lee, Jae Yong; Choi, Ji Ho] Soonchunhyang Univ, Bucheon Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Bucheon, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea	Ajou University; Yonsei University; Yonsei University; Yonsei University Health System; Soonchunhyang University; Catholic University of Korea	Choi, JH (corresponding author), Soonchunhyang Univ, Bucheon Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Bucheon, South Korea.	handsomemd@hanmail.net		Choi, Ji Ho/0000-0002-5194-930X; PARK, DO YANG/0000-0001-9969-3051	National Research Foundation of Korea Grant - Korean Government [NRF-2017R1C1B1007454]; Soonchunhyang University Research Fund	National Research Foundation of Korea Grant - Korean Government; Soonchunhyang University Research Fund	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2017R1C1B1007454). This study was supported by the Soonchunhyang University Research Fund (URL: http://sanhak.sch.ac.kr).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesveldt S, 2017, CHEM SENSES, V42, P513, DOI 10.1093/chemse/bjx025; Croy I, 2017, J NEUROL, V264, P631, DOI 10.1007/s00415-016-8227-8; FRANKENBURG FR, 1994, ARCH INTERN MED, V154, P2371, DOI 10.1001/archinte.154.20.2371; Hadley K, 2004, OTOLARYNG CLIN N AM, V37, P1115, DOI 10.1016/j.otc.2004.06.009; Hoffman HJ, 1998, ANN NY ACAD SCI, V855, P716, DOI 10.1111/j.1749-6632.1998.tb10650.x; Hwang SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148813; Jacobson G P, 2001, J Am Acad Audiol, V12, P493; Joo YH, 2015, AM J RHINOL ALLERGY, V29, P268, DOI 10.2500/ajra.2015.29.4194; Joo YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131247; Katotomichelakis M, 2013, AM J RHINOL ALLERGY, V27, P293, DOI 10.2500/ajra.2013.27.3903; Kazour F, 2017, NEUROSCI BIOBEHAV R, V80, P69, DOI 10.1016/j.neubiorev.2017.05.009; Kim HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127578; Kohli P, 2017, LARYNGOSCOPE, V127, P309, DOI 10.1002/lary.26316; Kohli P, 2016, CHEM SENSES, V41, P479, DOI 10.1093/chemse/bjw061; Lafreniere D, 2009, OTOLARYNG CLIN N AM, V42, P123, DOI 10.1016/j.otc.2008.09.001; Lee WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062725; LEWIS JE, 1994, CLIN OTOLARYNGOL, V19, P50, DOI 10.1111/j.1365-2273.1994.tb01147.x; Michikawa T, 2010, J EPIDEMIOL, V20, P271, DOI 10.2188/jea.JE20090121; Nondahl DM, 2010, INT J AUDIOL, V49, P580, DOI 10.3109/14992021003753508; Oh SW, 2004, OBES RES, V12, P2031, DOI 10.1038/oby.2004.254; Park B, 2014, OTOL NEUROTOL, V35, P1218, DOI 10.1097/MAO.0000000000000472; Park KH, 2014, J EPIDEMIOL, V24, P417, DOI 10.2188/jea.JE20140024; Park RJ, 2014, CLIN OTOLARYNGOL, V39, P89, DOI 10.1111/coa.12232; Pridmore S, 2012, OTOLARYNG HEAD NECK, V147, P193, DOI 10.1177/0194599812446286; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Swain SK, 2016, J FORMOS MED ASSOC, V115, P139, DOI 10.1016/j.jfma.2015.11.011; Van Toller S, 1999, CHEM SENSES, V24, P705, DOI 10.1093/chemse/24.6.705; Yuan TF, 2015, CNS NEUROL DISORD-DR, V14, P486, DOI 10.2174/1871527314666150429111356; Yuan TF, 2014, PROG NEURO-PSYCHOPH, V54, P26, DOI 10.1016/j.pnpbp.2014.05.013	30	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206328	10.1371/journal.pone.0206328	http://dx.doi.org/10.1371/journal.pone.0206328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352085	Green Submitted, Green Published, gold			2022-12-26	WOS:000448076200047
J	Liu, Y; Li, F; Yang, YT; Xu, XD; Chen, JS; Chen, TL; Chen, HJ; Zhu, YB; Lin, JY; Li, Y; Xie, XM; Sun, XL; Ke, YQ				Liu, Y.; Li, F.; Yang, Y. T.; Xu, X. D.; Chen, J. S.; Chen, T. L.; Chen, H. J.; Zhu, Y. B.; Lin, J. Y.; Li, Y.; Xie, X. M.; Sun, X. L.; Ke, Y. Q.			IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma	ONCOGENE			English	Article							FACTOR-BINDING PROTEIN-2; STEM-LIKE CELLS; HUMAN-MELANOMA CELLS; VASCULAR MIMICRY; GENE-EXPRESSION; GROWTH; CHEMORESISTANCE; IDENTIFICATION; MIGRATION; THERAPY	Vasculogenic mimicry (VM) refers to the fluid-conducting channels formed by aggressive tumor cells rather than endothelial cells (EC) with elevated expression of genes associated with vascularization. VM has been considered as one of the reasons that glioblastoma becomes resistant to anti-VEGF therapy. However, the molecular basis underlying VM formation remains unclear. Here we report that the insulin-like growth factor-binding protein 2 (IGFBP2) acts as a potent factor to enhance VM formation in glioma. Evidence showed that elevated IGFBP2 expression was positively related with VM formation in patients with glioma. Enforced expression of IGFBP2 increased network formation of glioma cells in vitro by activating CD144 and MMP2 (Matrix Metalloproteinase 2). U251 cells with stable knockdown of IGFBP2 led to decreased VM formation and tumor progression in orthotopic mouse model. Mechanistically, IGFBP2 interacts with integrin alpha 5 and beta 1 subunits and augments CD144 expression in a FAK/ERK pathway-dependent manner. Luciferase reporter and ChIP assay suggested that IGFBP2 activated the transcription factor SP1, which could bind to CD144 promoter. Thus, IGFBP2 acts as a stimulator of VM formation in glioma cells via enhancing CD144 and MMP2 expression.	[Liu, Y.; Li, F.; Yang, Y. T.; Xu, X. D.; Chen, J. S.; Chen, T. L.; Chen, H. J.; Zhu, Y. B.; Lin, J. Y.; Li, Y.; Xie, X. M.; Sun, X. L.; Ke, Y. Q.] Southern Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Liu, Y.; Li, F.; Yang, Y. T.; Xu, X. D.; Chen, J. S.; Chen, T. L.; Chen, H. J.; Zhu, Y. B.; Lin, J. Y.; Li, Y.; Xie, X. M.; Sun, X. L.; Ke, Y. Q.] Educ Minist China, Engn Technol Res Ctr, Natl Key Clin Specialty, Guangzhou, Guangdong, Peoples R China; [Liu, Y.; Li, F.; Yang, Y. T.; Xu, X. D.; Chen, J. S.; Chen, T. L.; Chen, H. J.; Zhu, Y. B.; Lin, J. Y.; Li, Y.; Xie, X. M.; Sun, X. L.; Ke, Y. Q.] Guangdong Prov Key Lab Brain Funct Repair & Regen, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Sun, XL; Ke, YQ (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China.; Sun, XL; Ke, YQ (corresponding author), Educ Minist China, Engn Technol Res Ctr, Natl Key Clin Specialty, Guangzhou, Guangdong, Peoples R China.; Sun, XL; Ke, YQ (corresponding author), Guangdong Prov Key Lab Brain Funct Repair & Regen, Guangzhou, Guangdong, Peoples R China.	zjsunxinlin@163.com; kyquan@smu.edu.cn			National Natural Science Foundation of China [81772651, 81772652]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81772651 and No. 81772652)	Biernacka KM, 2013, ENDOCR-RELAT CANCER, V20, P741, DOI 10.1530/ERC-13-0077; Braghiroli MI, 2017, EXPERT REV ANTICANC, V12, P567; Chen XL, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-72; Chiao MT, 2011, CURR NEUROVASC RES, V8, P210, DOI 10.2174/156720211796558023; Dunlap SM, 2007, P NATL ACAD SCI USA, V104, P11736, DOI 10.1073/pnas.0703145104; Dvorak HF, 2015, CANCER J, V21, P237, DOI 10.1097/PPO.0000000000000124; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Francescone R, 2012, J BIOL CHEM, V287, P24821, DOI 10.1074/jbc.M111.334540; Frommer KW, 2006, J MOL ENDOCRINOL, V37, P13, DOI 10.1677/jme.1.01955; Fuller GN, 1999, CANCER RES, V59, P4228; Gao S, 2016, CANCER RES, V76, P6543, DOI 10.1158/0008-5472.CAN-16-0438; Godard S, 2003, CANCER RES, V63, P6613; Guo P, 2005, AM J PATHOL, V166, P877, DOI 10.1016/S0002-9440(10)62308-5; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798; Hsieh D, 2010, BIOCHEM BIOPH RES CO, V397, P367, DOI 10.1016/j.bbrc.2010.05.145; Huang YF, 2014, ENDOCR-RELAT CANCER, V21, P217, DOI 10.1530/ERC-13-0274; Kirschmann DA, 2012, CLIN CANCER RES, V18, P2726, DOI 10.1158/1078-0432.CCR-11-3237; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kuhnl A, 2011, LEUKEMIA RES, V35, P1585, DOI 10.1016/j.leukres.2011.08.006; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; Lai CY, 2012, CANCER RES, V72, P5111, DOI 10.1158/0008-5472.CAN-12-0624; Liu TJ, 2013, ONCOGENE, V32, P544, DOI 10.1038/onc.2012.85; Liu X, 2015, CANCER SCI, V106, P857, DOI 10.1111/cas.12684; Liu XM, 2011, J NEURO-ONCOL, V105, P173, DOI 10.1007/s11060-011-0578-5; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Mei X, 2017, NEURO-ONCOLOGY, V42, P1; Mendes KN, 2010, INT J ONCOL, V37, P143, DOI 10.3892/ijo_00000662; Moore MG, 2003, INT J CANCER, V105, P14, DOI 10.1002/ijc.11015; Norden AD, 2009, J NEURO-ONCOL, V92, P149, DOI 10.1007/s11060-008-9745-8; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Pereira JJ, 2004, CANCER RES, V64, P977, DOI 10.1158/0008-5472.CAN-03-3056; Ping YF, 2011, CURR MOL MED, V11, P69, DOI 10.2174/156652411794474383; Renehan AG, 2000, BRIT J CANCER, V83, P1344, DOI 10.1054/bjoc.2000.1462; Russo VC, 2015, CYTOKINE GROWTH F R, V26, P329, DOI 10.1016/j.cytogfr.2014.12.001; Russo VC, 2005, ENDOCRINOLOGY, V146, P4445, DOI 10.1210/en.2005-0467; Sallinen SL, 2000, CANCER RES, V60, P6617; Schutt BS, 2004, J MOL ENDOCRINOL, V32, P859, DOI 10.1677/jme.0.0320859; Scully S, 2012, J NEUROSCI, V32, P12950, DOI 10.1523/JNEUROSCI.2017-12.2012; Seftor REB, 2001, CANCER RES, V61, P6322; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; So AI, 2008, CLIN CANCER RES, V14, P6944, DOI 10.1158/1078-0432.CCR-08-0408; Uzoh CC, 2011, BRIT J CANCER, V104, P1587, DOI 10.1038/bjc.2011.127; Velez DO, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01556-7; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Wang H, 2003, CANCER RES, V63, P4315; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Yue WY, 2005, J HISTOCHEM CYTOCHEM, V53, P997, DOI 10.1369/jhc.4A6521.2005; Zhu SM, 2017, GUT, V66, P802, DOI 10.1136/gutjnl-2016-312141	51	49	52	3	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2019	38	11					1815	1831		10.1038/s41388-018-0525-4	http://dx.doi.org/10.1038/s41388-018-0525-4			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HO7XX	30368528				2022-12-26	WOS:000461164400003
J	Selvaggio, G; Pearlstein, RA				Selvaggio, Gianluca; Pearlstein, Robert Alan			Biodynamics: A novel quasi-first principles theory on the fundamental mechanisms of cellular function/dysfunction and the pharmacological modulation thereof	PLOS ONE			English	Article							TARGET RESIDENCE TIME	Cellular function depends on heterogeneous dynamic intra-, inter-, and supramolecular structure-function relationships. However, the specific mechanisms by which cellular function is transduced from molecular systems, and by which cellular dysfunction arises from molecular dysfunction are poorly understood. We proposed previously that cellular function manifests as a molecular form of analog computing, in which specific time-dependent state transition fluxes within sets of molecular species ("molecular differential equations" (MDEs)) are sped and slowed in response to specific perturbations (inputs). In this work, we offer a theoretical treatment of the molecular mechanisms underlying cellular analog computing (which we refer to as "biodynamics"), focusing primarily on non-equilibrium (dynamic) intermolecular state transitions that serve as the principal means by which MDE systems are solved (the molecular equivalent of mathematical "integration"). Under these conditions, bound state occupancy is governed by k(on) and k(off), together with the rates of binding partner buildup and decay. Achieving constant fractional occupancy over time depends on: 1) equivalence between k(on) and the rate of binding site buildup); 2) equivalence between k(off) and the rate of binding site decay; and 3) free ligand concentration relative to k(off)/k(on) (n . K-d, where n is the fold increase in binding partner concentration needed to achieve a given fractional occupancy). Failure to satisfy these conditions results in fractional occupancy well below that corresponding to n. K-d. The implications of biodynamics for cellular function/dysfunction and drug discovery are discussed.	[Selvaggio, Gianluca; Pearlstein, Robert Alan] Novartis Inst BioMed Res, Comp Aided Drug Discovery, Global Discovery Chem, 181 Massachusetts Ave, Cambridge, MA 02139 USA	Novartis	Selvaggio, G; Pearlstein, RA (corresponding author), Novartis Inst BioMed Res, Comp Aided Drug Discovery, Global Discovery Chem, 181 Massachusetts Ave, Cambridge, MA 02139 USA.	gianluca.selvaggio@gmail.com; robert.pearlstein@novartis.com		Selvaggio, Gianluca/0000-0001-8911-7288; Pearlstein, Robert/0000-0002-4313-8136				Alon U, 2007, INTRO SYSTEMS BIOL D; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Beard D.A., 2012, BIOSIMULATION SIMULA; Benjannet S, 2004, NARC 1 PCSK9 ITS NAT, DOI [10.1074/jbc.M409699200, DOI 10.1074/JBC.M409699200]; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Dahl G, 2013, DRUG DISCOV TODAY, V18, P697, DOI 10.1016/j.drudis.2013.02.010; Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; Folmer RHA, 2018, DRUG DISCOV TODAY, V23, P12, DOI 10.1016/j.drudis.2017.07.016; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Gustafsen C, 2017, NAT COMMUN, V8, P1, DOI [10.1038/s41467-016-0009-6, DOI 10.1038/S41467-016-0009-6]; Hopper AK, 2011, PROTEOME HALF LIFE D, P764; Howe RM, 2005, IEEE CONTR SYST MAG, V25, P29, DOI 10.1109/MCS.2005.1432596; Invitrogen Corporation, 2008, FLUOR POL TECHN RES, P1; Jiang X, 2004, DEV METHOD SCREENING; Keener J., 2009, MATH PHYSL 1 CELLULA, DOI [10.1007/978-0-387-75847-3_1, DOI 10.1007/978-0-387-75847-3_1, DOI 10.1007/978-0-387-75847-3, 10.1007/978-0-387-75847-3]; Keener JP., 2008, MATH PHYSL 2009 SYST; Loriaux PM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002932; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Pearlstein RA, 2017, CURR TOP MED CHEM, V17, P2642, DOI 10.2174/1568026617666170414152311; Pearlstein RA, 2016, CURR TOP MED CHEM, V16, P1792, DOI 10.2174/1568026616666160315142156; Pearlstein RA, 2013, PROTEINS, V81, P1509, DOI 10.1002/prot.24276; Pearlstein RA, 2010, PROTEINS, V78, P2571, DOI 10.1002/prot.22767; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Tran QT, 2013, PROTEINS, V81, P291, DOI 10.1002/prot.24185; Rothman S, 2010, IS BALANCE PROTEIN S, P1; Schoop Andreas, 2015, Drug Discov Today Technol, V17, P9, DOI 10.1016/j.ddtec.2015.08.003; Schulz R, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0463-z; Stork D, 2007, BRIT J PHARMACOL, V151, P1368, DOI 10.1038/sj.bjp.0707356; ten Hoor M, 2009, CHEMED NZ, P7; Velez-Vega C, 2015, J CHEM THEORY COMPUT, V11, P5090, DOI 10.1021/acs.jctc.5b00439; Voit E.O., 2013, 1 COURSE SYSTEMS BIO; Willis WT, 2016, MED SCI SPORT EXER, V48, P990, DOI 10.1249/MSS.0000000000000884; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	33	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0202376	10.1371/journal.pone.0202376	http://dx.doi.org/10.1371/journal.pone.0202376			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383749	Green Submitted, Green Published, gold			2022-12-26	WOS:000449027600003
J	Case, MJ; Stinson, KA				Case, Michael J.; Stinson, Kristina A.			Climate change impacts on the distribution of the allergenic plant, common ragweed (Ambrosia artemisiifolia) in the eastern United States	PLOS ONE			English	Article							RANGE SHIFTS; SPECIES DISTRIBUTIONS; L.; CO2; TEMPERATURE; PROJECTIONS; PREDICTION; DOMINANCE; HABITAT; POLLEN	Climate change is affecting the growth, phenology, and distribution of species across north-eastern United States. In response to these changes, some species have been adversely impacted while others have benefited. One species that has benefited from climate change, historically and in response to experimental treatments, is common ragweed (Ambrosia artemisiifolia), a widely distributed annual weed and a leading cause of hay fever in North America. To better understand how climate change may affect the distribution of common ragweed, we built a maximum entropy (Maxent) predictive model using climate and bioclimatic data and over 700 observations across the eastern U.S. Our model performed well with an AUC score of 0.765 using four uncorrelated variables, including precipitation seasonality, mean diurnal temperature range, August precipitation, and January maximum temperature. After building and testing our model, we then projected potential future common ragweed distribution using a suite of 13 global climate models (GCMs) under two future greenhouse gas scenarios for mid and late-century. In addition to providing georeferenced hot spots of potential future expansion, we also provide a metric of confidence by evaluating the number of GCMs that agree. We show a substantial contraction of common ragweed in central Florida, southern Appalachian Mountains, and northeastern Virginia and areas of potential expansion at the northern margins of its current distribution, notably in northeastern U.S. However, the vast majority of this increase is projected to occur by mid-century and may be moderated somewhat by the 2070s, implying that common ragweed may be sensitive to climatic variability. Although other factors and modeling approaches should be explored, we offer preliminary insight into where common ragweed might be a new concern in the future. Due to the health impacts of ragweed, local weed control boards may be well advised to monitor areas of expansion and potentially increase eradication efforts.	[Case, Michael J.] Case Res LLC, Seattle, WA 98103 USA; [Case, Michael J.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Stinson, Kristina A.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Stinson, Kristina A.] Harvard Univ, Harvard Forest, Petersham, MA USA	University of Washington; University of Washington Seattle; University of Massachusetts System; University of Massachusetts Amherst; Harvard University	Case, MJ (corresponding author), Case Res LLC, Seattle, WA 98103 USA.; Case, MJ (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	mcase@u.washington.edu		Case, Michael/0000-0003-4111-2298	US Environmental Protection Agency (EPA) [SU834359010]; University of Massachusetts Department of Environmental Conservation	US Environmental Protection Agency (EPA)(United States Environmental Protection Agency); University of Massachusetts Department of Environmental Conservation	This research was funded by the US Environmental Protection Agency (EPA) Science to Achieve Results (STAR) Program (https://www.epa.gov/research-fellowships/science-achieve-results-star-graduate-fellowships) Grant #SU834359010; and the University of Massachusetts Department of Environmental Conservation. The funders provided support in the form of salaries for authors KS and MC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. MC is employed by a commercial company, however his affiliation had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Beckage B, 2008, P NATL ACAD SCI USA, V105, P4197, DOI 10.1073/pnas.0708921105; Case MJ, 2017, GLOBAL CHANGE BIOL, V23, P2005, DOI 10.1111/gcb.13570; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chun YJ, 2011, MOL ECOL, V20, P1378, DOI 10.1111/j.1365-294X.2011.05013.x; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Deen W, 1998, WEED SCI, V46, P555, DOI 10.1017/S0043174500091098; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Epstein P.R., 2004, INSIDE GREENHOUSE IM; Faison EK, 2006, ECOLOGY, V87, P2537, DOI 10.1890/0012-9658(2006)87[2537:EHOISN]2.0.CO;2; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gallien L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152867; Grimm EC, 2001, P ROYAL IRISH ACAD B, V101, P47; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Iverson LR, 2013, LANDSCAPE ECOL, V28, P879, DOI 10.1007/s10980-013-9885-x; Kunkel KE, 2013, NOAA TECHNICAL REPOR, P87; Leiblein M.C., 2013, ISRN ECOL, V2013, DOI [10.1155/2013/610126, DOI 10.1155/2013/610126]; Leiblein-Wild MC, 2016, J BIOGEOGR, V43, P544, DOI 10.1111/jbi.12646; ODonnell MS, 2012, USGS DATA SERIES, V691; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; PICKETT ST, 1973, B TORREY BOT CLUB, V100, P165, DOI 10.2307/2484628; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Rasmussen K, 2017, PEERJ, V5, DOI 10.7717/peerj.3104; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Rogers CA, 2006, ENVIRON HEALTH PERSP, V114, P865, DOI 10.1289/ehp.8549; Schuster WSF, 2008, TREE PHYSIOL, V28, P537, DOI 10.1093/treephys/28.4.537; Schwartz MW, 2012, BIOL CONSERV, V155, P149, DOI 10.1016/j.biocon.2012.06.011; Stinson KA, 2006, OECOLOGIA, V147, P155, DOI 10.1007/s00442-005-0250-x; Stinson KA, 2006, GLOBAL CHANGE BIOL, V12, P1680, DOI 10.1111/j.1365-2486.2006.01229.x; Stinson KA, 2017, AM J BOT, V104, P1313, DOI 10.3732/ajb.1700222; Storkey J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088156; Taramarcaz P, 2005, SWISS MED WKLY, V135, P538; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Vogl G, 2008, EUR PHYS J-SPEC TOP, V161, P167, DOI 10.1140/epjst/e2008-00758-y; Wayne P, 2002, ANN ALLERG ASTHMA IM, V88, P279, DOI 10.1016/S1081-1206(10)62009-1; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Ziska LH, 2007, GLOBAL CHANGE BIOL, V13, P266, DOI 10.1111/j.1365-2486.2006.01264.x; Ziska LH, 2003, J ALLERGY CLIN IMMUN, V111, P290, DOI 10.1067/mai.2003.53	44	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205677	10.1371/journal.pone.0205677	http://dx.doi.org/10.1371/journal.pone.0205677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379857	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700062
J	Chen, B; Yu, J; Gao, XE; Zheng, QG				Chen, Bo; Yu, Jie; Gao, Xiu-e; Zheng, Qing-Guo			A human body physiological feature selection algorithm based on filtering and improved clustering	PLOS ONE			English	Article								Research The body composition model is closely related to the physiological characteristics of the human body. At the same time there can be a large number of physiological characteristics, many of which may be redundant or irrelevant. In existing human physiological feature selection algorithms, it is difficult to overcome the impact that redundancy and irrelevancy may have on human body composition modeling. This suggests a role for selection algorithms, where human physiological characteristics are identified using a combination of filtering and improved clustering. To do this, a feature filtering method based on Hilbert-Schmidt dependency criteria is first of all used to eliminate irrelevant features. After this, it is possible to use improved Chameleon clustering to increase the combination of sub-clusters amongst the characteristics, thereby removing any redundant features to obtain a candidate feature set for human body composition modeling. Method We report here on the use of an algorithm to filter the characteristic parameters in INBODY770 (this paper used INBODY 770 as body composition analyzer.) measurement data, which has three commonly-used impedance bands (1 kHZ, 250 kHZ, 500 kHZ). This algorithm is able to filter out parameters that have a low correlation with body composition BFM. The algorithm is also able to draw upon improved clustering techniques to reduce the initial feature set from 29 parameters to 10 parameters for any parameters of the 250 kHZ band that remain after filtering. In addition, we also examined the impact of different sample sizes on feature selection. Result The proposed algorithm is able to remove irrelevant and redundant features and the resulting correlation between the model and the body composition (BFM which is a whole body fat evaluation can better assess the body's overall fat and muscle composition.) is 0.978, thereby providing an improved model for prediction with a relative error of less than 0.12.	[Chen, Bo] Lingnan Normal Univ, Coll Mech & Electron Engn, Zhanjiang, Peoples R China; [Yu, Jie; Zheng, Qing-Guo] Dalian Univ, Coll Informat Engn, Dalian, Peoples R China; [Gao, Xiu-e] Lingnan Normal Univ, Coll Informat Engn, Zhanjiang, Peoples R China	LingNan Normal University; Dalian University; LingNan Normal University	Yu, J (corresponding author), Dalian Univ, Coll Informat Engn, Dalian, Peoples R China.; Gao, XE (corresponding author), Lingnan Normal Univ, Coll Informat Engn, Zhanjiang, Peoples R China.	363474235@qq.com; 76140300@qq.com	Chen, Bo/AAR-1098-2021		National Natural Science Fund [31401131]; Field fund for the Ministry of equipment development [6140131010116JW61001, 61401310101]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Field fund for the Ministry of equipment development	This work was supported by National Natural Science Fund 31401131 by Xiue Gao and Field fund for the Ministry of equipment development 6140131010116JW61001 and 61401310101 by Bo Chen.	Bo Chen, 2015, 2015 8 INT C IEEE; Camps-Valls G, 2010, IEEE GEOSCI REMOTE S, V7, P587, DOI 10.1109/LGRS.2010.2041896; Cao Kai-di, 2016, AMART HLTH, P50; CHANG Fei-ba, 2015, BME CLIN MED, V19; Damodaran BB, 2017, IEEE T GEOSCI REMOTE, V55, P2385, DOI 10.1109/TGRS.2016.2642479; Dash M, 2009, ENCY DATABASE SYSTEM, P1119, DOI DOI 10.1007/978-0-387-39940-9_613; Fassini Priscila Giacomo, 2016, CLIN NUTR; Gao Peng-yi, 2012, Journal of Chinese Computer Systems, V33, P2379; Golnaz Bahramali, 2016, BIOCH BIOPHYSICAL RE; Huang Chang-hua, 2016, OCCUP HLTH, V32; Jin Jing, 2007, CHIN J OSTEOPOROS, V13; Josse Andrea R, 2013, MED SPORT SCI, V59, P94; Lin huan-dong, 2012, FUDAN U; LIU Cong-jun, 2016, INFORM TECHNOLOGY, P144; Liu shuai, 2015, APPL RES COMPUTERS, V32; Long Zhen-zhenu, 2009, Computer Engineering, V35, P189; Shaikh S, 2011, J HEALTH POPUL NUTR, V29, P236; Sultana S, 2011, DIABETOLOGIA, V54, pS350; [陶勇森 Tao Yongsen], 2017, [小型微型计算机系统, Journal of Chinese Computer Systems], V38, P1164; Wang B, 2009, PROC INT CONF DATA, P1657, DOI 10.1109/ICDE.2009.170; Wang chong, 2017, RES R TREE INDEX MET; Wang KX, 2015, IEEE T AFFECT COMPUT, V6, P69, DOI 10.1109/TAFFC.2015.2392101; [王连喜 Wang Lianxi], 2015, [计算机应用研究, Application Research of Computers], V32, P1305; Yamada M, 2014, NEURAL COMPUT, V26, P185, DOI 10.1162/NECO_a_00537; Yao Xu, 2013, CONTROL DECISION; Yu Yun-feng, 2006, JISUANJI YU XIANDAIH; Yun Jin, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P4808, DOI 10.1109/ICASSP.2014.6854515; Zhang li-xin, 2004, J FUDAN U NATURAL SC, V43, P894; Zhou Zhihong, 2007, China Mechanical Engineering, V18, P1988; [朱烨行 Zhu Yehang], 2015, [微电子学与计算机, Microelectronics & Computer], V32, P173	30	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0204816	10.1371/journal.pone.0204816	http://dx.doi.org/10.1371/journal.pone.0204816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379873	gold, Green Submitted, Green Published			2022-12-26	WOS:000448823700019
J	Hatter, JA; Kouche, YM; Melchor, SJ; Ng, K; Bouley, DM; Boothroyd, JC; Ewald, SE				Hatter, Jessica A.; Kouche, Yue Moi; Melchor, Stephanie J.; Ng, Katherine; Bouley, Donna M.; Boothroyd, John C.; Ewald, Sarah E.			Toxoplasma gondii infection triggers chronic cachexia and sustained commensal dysbiosis in mice	PLOS ONE			English	Article							ORAL INFECTION; SMALL-INTESTINE; IFN-GAMMA; GUT; INFLAMMATION; REPLICATION; TOLERANCE; RESPONSES; SYSTEM; IMPACT	Toxoplasma gondii is a protozoan parasite with a predation-mediated transmission cycle between rodents and felines. Intermediate hosts acquire Toxoplasma by eating parasite cysts which invade the small intestine, disseminate systemically and finally establish host life-long chronic infection in brain and muscles. Here we show that Toxoplasma infection can trigger a severe form of sustained cachexia: a disease of progressive lean weight loss that is a causal predictor of mortality in cancer, chronic disease and many infections. Toxoplasma cachexia is characterized by acute anorexia, systemic inflammation and loss of 20% body mass. Although mice recover from symptoms of peak sickness, they fail to regain muscle mass or visceral adipose depots. We asked whether the damage to the intestinal microenvironment observed at acute time points was sustained in chronic infection and could thereby play a role in sustaining cachexia. We found that parasites replicate in the same region of the distal jejunum/proximal ileum throughout acute infection, inducing the development of secondary lymphoid structures and severe, regional inflammation. Small intestine pathology was resolved by 5 weeks post-infection. However, changes in the commensal populations, notably an outgrowth of Clostridia spp., were sustained in chronic infection. Importantly, uninfected animals co-housed with infected mice display similar changes in commensal microflora but never display symptoms of cachexia, indicating that altered commensals are not sufficient to explain the cachexia phenotype alone. These studies indicate that Toxoplasma infection is a novel and robust model to study the immune-metabolic interactions that contribute to chronic cachexia development, pathology and potential reversal.	[Hatter, Jessica A.; Melchor, Stephanie J.; Ewald, Sarah E.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Hatter, Jessica A.; Melchor, Stephanie J.; Ewald, Sarah E.] Univ Virginia, Sch Med, Carter Immunol Ctr, Charlottesville, VA 22908 USA; [Kouche, Yue Moi; Bouley, Donna M.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Ng, Katherine; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	University of Virginia; University of Virginia; Stanford University; Stanford University	Ewald, SE (corresponding author), Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA.; Ewald, SE (corresponding author), Univ Virginia, Sch Med, Carter Immunol Ctr, Charlottesville, VA 22908 USA.	se2s@virginia.edu	Ewald, Sarah/AAM-8918-2020	Ewald, Sarah/0000-0002-5327-7578; Melchor, Stephanie/0000-0003-3922-3394; Ng, Katharine Michelle/0000-0003-3494-5697; Boothroyd, John C./0000-0001-9719-745X	NIH NIAID [R01AI73756, K22 AI116727-01]; NIH [T35 2T35OD010989-12]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI116727, T32AI007496] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by NIH NIAID R01AI73756 (JCB). NIH NIAID K22 AI116727-01 (SEE). NIH T35 2T35OD010989-12 (DMB).	[Anonymous], NATL VITAL STAT REPO; BEAMAN MH, 1994, J IMMUNOL, V153, P4583; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Bierly AL, 2008, J IMMUNOL, V181, P8485, DOI 10.4049/jimmunol.181.12.8485; Blader IJ, 2009, APMIS, V117, P458, DOI 10.1111/j.1600-0463.2009.02453.x; Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Boothroyd JC, 2009, MEM I OSWALDO CRUZ, V104, P179, DOI 10.1590/S0074-02762009000200009; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Coombes JL, 2013, P NATL ACAD SCI USA, V110, pE1913, DOI 10.1073/pnas.1220272110; DeBoer MD, 2009, EXPERT OPIN DRUG DIS, V4, P1145, DOI 10.1517/17460440903300842; Dubey JP, 2009, INT J PARASITOL, V39, P877, DOI 10.1016/j.ijpara.2009.01.005; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fleckenstein MC, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001358; Gregg B, 2013, INFECT IMMUN, V81, P1635, DOI 10.1128/IAI.01126-12; Grover HS, 2014, CELL REP, V7, P1716, DOI 10.1016/j.celrep.2014.04.031; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Hu XY, 2017, J BIOL CHEM, V292, P11009, DOI [10.1074/jbc.M116.768176, 10.1074/jbc.m116.768176]; Jin RM, 2017, J IMMUNOL, V198, P352, DOI 10.4049/jimmunol.1600914; Kasper DC, 2009, DIAGN MICR INFEC DIS, V63, P10, DOI 10.1016/j.diagmicrobio.2008.09.009; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Molloy MJ, 2013, CELL HOST MICROBE, V14, P318, DOI 10.1016/j.chom.2013.08.003; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Nolan SJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006362; Pathogen I, 1999, J EXP MED, V189, P1083; Pernas L, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001845; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Rao S, 2017, CELL, V168, P503, DOI 10.1016/j.cell.2017.01.006; Sanner H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092171; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; Schieber AMP, 2015, SCIENCE, V350, P558, DOI 10.1126/science.aac6468; Schluter D, 2003, J IMMUNOL, V170, P6172, DOI 10.4049/jimmunol.170.12.6172; Schreiner M, 2009, MEM I OSWALDO CRUZ, V104, P221, DOI 10.1590/S0074-02762009000200015; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; von Klitzing E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176144; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Zhu WH, 2018, NATURE, V553, P208, DOI 10.1038/nature25172	42	27	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0204895	10.1371/journal.pone.0204895	http://dx.doi.org/10.1371/journal.pone.0204895			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379866	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700023
J	Malambo, P; De Villiers, A; Lambert, EV; Puoane, T; Kengne, AP				Malambo, Pasmore; De Villiers, Anniza; Lambert, Estelle, V; Puoane, Thandi; Kengne, Andre P.			Associations of perceived neighbourhood safety from traffic and crime with overweight/obesity among South African adults of low-socioeconomic status	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; OBESITY; PERCEPTIONS	Background The relationship between perceived neighbourhood safety from traffic and crime with overweight/obesity can provide intervention modalities for obesity, yet no relevant study has been conducted in sub-Saharan African contexts. We investigated the association between perceived neighbourhood safety from traffic and crime with overweight/obesity among urban South African adults. Methods This cross-sectional study included 354 adults aged >= 35 years drawn from the Prospective Urban Rural Epidemiology (PURE) cohort study. The Neighborhood Walkability ScaleAfrica (NEWS-A) was used to evaluate the perceived neighbourhood safety. Adjusted odds ratios (ORs) and 95% confidence intervals (Cis) were calculated to examine the associations between perceived neighborhood safety and overweight/obesity defined "normal weight" and "overweight/obese" using the 25 Kg/m(2) cutoff criterion. Results In the overall sample, adults who agreed that "the speed of traffic on most nearby roads in their neighborhood was usually slow" were less likely to be overweight/obese (adjusted OR = 0.42; 95%CI 0.23-0.76). Those who agreed that "there was too much crime in their neighborhood to go outside for walks or play during the day" were more likely to be overweight/obese (OR = 2.41; 1.09-5.29). These associations were driven by significant associations in women, and no association in men, with significant statistical interactions. Conclusion Perceived neighborhood safety from traffic and crime was associated with overweight/obesity among South African adults. Our findings provide preliminary evidence on the need to secure safer environments for walkability. Future work should also consider perceptions of the neighbourhood related to food choice.	[Malambo, Pasmore; Puoane, Thandi] Univ Western Cape, Sch Publ Hlth, Fac Community & Hlth Sci, Cape Town, South Africa; [De Villiers, Anniza; Kengne, Andre P.] South African Med Res Council, Noncommunicable Dis Unit, Cape Town, South Africa; [Lambert, Estelle, V] Univ Cape Town, Dept Human Biol, Div Exercise Sci & Sports Med, Fac Hlth Sci, Cape Town, South Africa	University of the Western Cape; South African Medical Research Council; University of Cape Town	Malambo, P (corresponding author), Univ Western Cape, Sch Publ Hlth, Fac Community & Hlth Sci, Cape Town, South Africa.	pmalambo@hotmail.com	Kengne, Andre Pascal/ABB-3696-2020; Lambert, Estelle/ABF-1268-2020; De Villiers, Anniza/GQB-3288-2022	Lambert, Estelle/0000-0003-4315-9153; Kengne, Andre Pascal/0000-0002-5183-131X	Social Innovation in Public Health Impulse fellowship program; National Research Foundation of South Africa; University of Cape Town	Social Innovation in Public Health Impulse fellowship program; National Research Foundation of South Africa(National Research Foundation - South Africa); University of Cape Town	This study was supported financially by Social Innovation in Public Health Impulse fellowship program, National Research Foundation of South Africa and University of Cape Town. Funding was for data collection, analysis, interpretation, transport, and accommodation.	Amosun S. L., 2007, Physiotherapy Theory and Practice, V23, P325, DOI 10.1080/09593980701593755; ASSARI S, 2015, INT J PREVENTIVE MED, V6; Baldock K, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/589409; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Bracy NL, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-24; Case A, 2009, ECON HUM BIOL, V7, P271, DOI 10.1016/j.ehb.2009.07.002; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Cerin E, 2006, MED SCI SPORT EXER, V38, P1682, DOI 10.1249/01.mss.0000227639.83607.4d; Christian H, 2011, PREV MED, V53, P57, DOI 10.1016/j.ypmed.2011.05.004; Cois Annibale, 2015, BMC Obes, V2, P42, DOI 10.1186/s40608-015-0072-2; Cook I, 2010, MED SCI SPORT EXER, V42, P1261, DOI 10.1249/MSS.0b013e3181ca787c; DEBOURDEAUDHUIJ I, 2015, INT J BEHAV NUTR PHY, V0012; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Pham DQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105251; Dulin-Keita A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-440; Duncan DT, ASS NEIGHBORHOOD SAF, P8; Fish JS, 2010, AM J PUBLIC HEALTH, V100, P2296, DOI 10.2105/AJPH.2009.183293; Gama A, 2013, ASS PARENTAL PERCEPT, V23, P1027, DOI [10.1093/eurpub/cks187, DOI 10.1093/EURPUB/CKS187]; Isabel M, 2013, EUR J PUBLIC HLTH; Janmohammed A, 2017, THESIS, DOI [10.1186/1479-5868-9-32, DOI 10.1186/1479-5868-9-32]; Kavanaugh K, 2015, J SPORT HEALTH SCI, V4, P222, DOI 10.1016/j.jshs.2014.03.015; Kruger T, 2007, BUILT ENV, V34, P75; Kutty NAM, 2015, J NURS HLTH SCI, V4, P78; Lovasi GS, 2012, AM J PREV MED, V43, P378, DOI 10.1016/j.amepre.2012.06.018; Matozinhos F. P., 2016, Nutrire, V41, DOI 10.1186/s41110-016-0019-5; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Micklesfield LK, 2013, CARDIOVASC J AFR, V24, P369, DOI 10.5830/CVJA-2013-069; MICKLESFIELD LK, 2014, BMC PUBLIC HEALTH, V14, P15660; Morrison DS, 2004, J EPIDEMIOL COMMUN H, V58, P837, DOI 10.1136/jech.2003.017509; Nyunt MSZ, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0276-3; Oyeyemi AL, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0357-y; Oyeyemi AL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-294; Oyeyemi AL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-32; Powell-Wiley TM, 2013, OBESITY, V21, pE14, DOI 10.1002/oby.20012; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Putrik P, 2015, J URBAN HEALTH, V92, P1038, DOI 10.1007/s11524-015-9991-y; Richardson AS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0611-y; Sandy R, 2013, ECON HUM BIOL, V11, P18, DOI 10.1016/j.ehb.2012.02.005; Statistics South Africa, 2011, STAT REL REV CENS 20, P78; Story M, 2002, J AM DIET ASS S3, V102, P2002; Sturm R, 2013, SAMJ S AFR MED J, V103, P840, DOI [10.7196/SAMJ.7260, 10.7196/samj.7260]; Tamayo A, 2016, HEALTH PLACE, V39, P116, DOI 10.1016/j.healthplace.2016.03.007; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Timperio A, 2005, INT J OBESITY, V29, P170, DOI 10.1038/sj.ijo.0802865; van Hoving D J, 2015, SAMJ, S. Afr. med. j., V105, P831, DOI [10.7196/SAMJNEW.7766, 10.7196/SAMJnew.7766]; Western Cape Government Department of Community Safety, 2016, AN CRIM BAS 2015 16; WHO, 2000, OB PREV MAN GLOB EP; World Health Assembly, 2004, GLOB STRAT DIET PHYS; World Health Organization, 2011, NONCOMMUNICABLE DIS; Zwald ML, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140125	50	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206408	10.1371/journal.pone.0206408	http://dx.doi.org/10.1371/journal.pone.0206408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY7VH	30379921	gold, Green Published, Green Submitted			2022-12-26	WOS:000448823700111
J	Pedersen, MK; Andersen, AB; Folkvardsen, DB; Rasmussen, EM; Svensson, E; Lillebaek, T; Supply, P				Pedersen, Mathias Klok; Andersen, Aase Bengaard; Folkvardsen, Dorte Bek; Rasmussen, Erik Michael; Svensson, Erik; Lillebaek, Troels; Supply, Philip			Set-up and validation of mycobacterial interspersed repetitive unit-variable number of tandem repeat (MIRU-VNTR) analysis of Mycobacterium tuberculosis using BioNumerics software	PLOS ONE			English	Article							WORLDWIDE PROFICIENCY	The objective was to describe and validate a new and alternative software procedure for 24-locus mycobacterial interspersed repetitive unit-variable number-tandem repeat (MIRU-VNTR) typing of Mycobacterium tuberculosis (Mtb) based on the multipurpose BioNumerics software. DNA from randomly selected isolates of Mtb from two European laboratories, including external control samples for MIRU-VNTR typing, were analysed. Samples were genotyped using the commercial 24-locus VNTR typing kit from GenoScreen. The PCR amplified fragments were separated by capillary electrophoresis. For the subsequent analyses, the currently used software GeneMapper was compared with BioNumerics. The end-point was the level of concordance when comparing genotyping results obtained from BioNumerics with results obtained from GeneMapper and the ECDC proficiency study reference results. Also, the number of necessary manual standard size corrections and allele assignments in the two different software methods were compared. In total, 272 DNA samples, including the ECDC proficiency panel, were analysed. For all samples, there were 100% concordance of results. For a randomly selected set of 96 samples the numbers of manual corrections needed for size standards were 199 with GeneMapper versus zero for BioNumerics. The numbers of manual corrections for allele assignments were 122 with GeneMapper versus 16 with BioNumerics. In conclusion, we have validated the multipurpose software BioNumerics for standard 24-locus MIRU-VNTR typing and the software shows promising benefits in terms of simplification and minimization of hand-on time.	[Pedersen, Mathias Klok; Folkvardsen, Dorte Bek; Rasmussen, Erik Michael; Svensson, Erik; Lillebaek, Troels] Statens Serum Inst, Int Reference Lab Mycobacteriol, Copenhagen, Denmark; [Andersen, Aase Bengaard] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Supply, Philip] Univ Lille, Inst Pasteur Lille, CIIL, CHU Lille,CNRS,INSERM,UMR U1019 8204, Lille, France; [Supply, Philip] Genoscreen, Campus Inst Pasteur Lille, Lille, France	Statens Serum Institut; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille	Pedersen, MK (corresponding author), Statens Serum Inst, Int Reference Lab Mycobacteriol, Copenhagen, Denmark.	makp@ssi.dk	Supply, Philip/A-9580-2019; Svensson, Erik/Q-5926-2018	Supply, Philip/0000-0003-3690-3853; Svensson, Erik/0000-0003-0797-1080; Lillebaek, Troels/0000-0002-2601-2718; Andersen, Aase Bengaard/0000-0003-4779-7603				de Beer J, 2014, EURO SURVEILL, V19; de Beer JL, 2014, INT J TUBERC LUNG D, V18, P594, DOI 10.5588/ijtld.13.0531; de Beer JL, 2012, J CLIN MICROBIOL, V50, P662, DOI 10.1128/JCM.00607-11; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2016, TUB SURV MON EUR 201; Lillebaek T, 2013, J CLIN MICROBIOL, V51, P4040, DOI 10.1128/JCM.01916-13; Lindsey RL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00766; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organisation (WHO), 2016, GLOB TUB REP 2016	9	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205336	10.1371/journal.pone.0205336	http://dx.doi.org/10.1371/journal.pone.0205336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379832	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700041
J	Shimozaki, K; Nakase, J; Yoshioka, K; Takata, Y; Asai, K; Kitaoka, K; Tsuchiya, H				Shimozaki, Kengo; Nakase, Junsuke; Yoshioka, Katsuhito; Takata, Yasushi; Asai, Kazuki; Kitaoka, Katsuhiko; Tsuchiya, Hiroyuki			Incidence rates and characteristics of abnormal lumbar findings and low back pain in child and adolescent weightlifter: A prospective three-year cohort study	PLOS ONE			English	Article							INTERVERTEBRAL DISC DEGENERATION; STATES EMERGENCY-ROOMS; INJURIES; YOUTH; YOUNG; ATHLETE; GROWTH; SPINE; MRI	Purpose The purpose of this three-year cohort study was to assess the incidence rates and characteristics of abnormal lumbar findings and low back pain (LBP) in child and adolescent weightlifting athletes using magnetic resonance imaging (MRI) and medical questionnaires. This study evaluated subclinical sports injuries, which in turn may help prevent competition-specific injuries and improve performance levels. Materials and methods Between 2014 and 2016, twelve participants who had been competing in weightlifting events for at least 2 years were enrolled in this study. The mean age of the participants at the start of this study was 11.4 +/- 2.0 years, and there were 6 boys and 6 girls. Annual medical questionnaire surveys and lumbar examinations using MRI were performed during the 3-year follow-up. The incidence rates and variations of LBP and abnormal MRI findings were evaluated. Results At the start of this study, there were no positive findings of LBP, and abnormal lumbar findings on MRI were observed in only 2 participants. At the 2-year follow-up, 1 participant had LBP, and 8 of 12 participants had abnormal lumbar findings. In the final year, only 3 participants had LBP; however, abnormal lumbar findings were observed on MRI in 11 participants. Among these, lumbar spondylolysis was observed in 4 participants, lumbar disc protrusion or extrusion in 2 participants, and lumbar disc degeneration in 9 participants. Conclusion This prospective 3-year cohort study of 12 child and adolescent weightlifters revealed abnormal lumbar findings in 11 participants at a high rate on MRI examination. Children and adolescents undergoing resistance training at the competition level could potentially have irreversible changes in the lumbar vertebra without symptoms.	[Shimozaki, Kengo; Nakase, Junsuke; Yoshioka, Katsuhito; Takata, Yasushi; Asai, Kazuki; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthoped Surg, Takara Machi, Kanazawa, Ishikawa, Japan; [Kitaoka, Katsuhiko] Kijima Hosp, Dept Orthoped Surg, Matsutera Machi, Kanazawa, Ishikawa, Japan	Kanazawa University	Nakase, J (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthoped Surg, Takara Machi, Kanazawa, Ishikawa, Japan.	nakase1007@yahoo.co.jp		Nakase, Junsuke/0000-0002-9286-5276				Aasa U, 2017, BRIT J SPORT MED, V51, P211, DOI 10.1136/bjsports-2016-096037; Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; BROWN EW, 1983, PEDIATRICS, V72, P636; Byrd Ronald, 2003, Sports Biomech, V2, P133, DOI 10.1080/14763140308522812; Chan SCW, 2011, SPINE, V36, P2021, DOI 10.1097/BRS.0b013e318203aea5; Dahab KS, 2009, SPORTS HEALTH, V1, P223, DOI 10.1177/1941738109334215; Faigenbaum AD, 2010, BRIT J SPORT MED, V44, P56, DOI 10.1136/bjsm.2009.068098; Faigenbaum AD, 2003, J STRENGTH COND RES, V17, P162; Fujii K, 2004, J BONE JOINT SURG BR, V86B, P225, DOI 10.1302/0301-620X.86B2.14339; Goda Y, 2014, EUR SPINE J, V23, P1892, DOI 10.1007/s00586-013-3109-6; Granacher U, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00164; GUMBS VL, 1982, AM J SPORT MED, V10, P375, DOI 10.1177/036354658201000612; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Kjaer P, 2005, SPINE, V30, P798, DOI 10.1097/01.brs.0000157424.72598.ec; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Lutz GK, 2003, SPINE, V28, P1899, DOI 10.1097/01.BRS.0000083365.41261.CF; Malina RM, 2006, CLIN J SPORT MED, V16, P478, DOI 10.1097/01.jsm.0000248843.31874.be; Milone Michael T, 2013, Phys Sportsmed, V41, P101, DOI 10.3810/psm.2013.11.2041; Myer GD, 2009, J STRENGTH COND RES, V23, P2054, DOI 10.1519/JSC.0b013e3181b86712; Nishida K, 1999, SPINE, V24, P2419, DOI 10.1097/00007632-199912010-00002; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Quatman CE, 2009, J STRENGTH COND RES, V23, P2061, DOI 10.1519/JSC.0b013e3181b86cb9; Ryan J R, 1976, Am J Sports Med, V4, P26, DOI 10.1177/036354657600400105; Salminen JJ, 1999, SPINE, V24, P1316, DOI 10.1097/00007632-199907010-00008; Small EW, 2008, PEDIATRICS, V121, P835, DOI 10.1542/peds.2007-3790; TERTTI MO, 1991, RADIOLOGY, V180, P503, DOI 10.1148/radiology.180.2.1829844; Vadala G, 2014, SPINE, V39, P1881, DOI 10.1097/BRS.0000000000000554; VIDEMAN T, 1995, SPINE, V20, P699, DOI 10.1097/00007632-199503150-00011; Zheng CJ, 2015, THEOR BIOL MED MODEL, V12, DOI 10.1186/s12976-015-0020-3; Zwolski C, 2017, SPORTS HEALTH, V9, P436, DOI 10.1177/1941738117704153	30	12	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206125	10.1371/journal.pone.0206125	http://dx.doi.org/10.1371/journal.pone.0206125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372456	gold, Green Submitted, Green Published			2022-12-26	WOS:000448641200023
J	Vigetti, D; Caon, I; Passi, A				Vigetti, Davide; Caon, Ilaria; Passi, Alberto			A nutrient sentinel stands guard outside the cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							AUTOPHAGY; DECORIN	Nutrient sensing is a critical cell function that regulates survival and growth by adjusting metabolism. During nutrient shortage, autophagy enables the recycling of major cellular components to prevent cell death. Understanding the mechanisms that trigger and control autophagy is of fundamental importance, as this degradative pathway plays a pivotal role in many diseases. Gubbiotti et al. report the identification of a new player, the proteoglycan decorin, which functions as a nutrient sensor in the extracellular matrix and controls autophagy in the heart.	[Vigetti, Davide; Caon, Ilaria; Passi, Alberto] Univ Insubria, Dept Med & Surg, I-21100 Varese, Italy	University of Insubria	Vigetti, D (corresponding author), Univ Insubria, Dept Med & Surg, I-21100 Varese, Italy.	davide.vigetti@uninsubria.it						Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Gubbiotti MA, 2018, J BIOL CHEM, V293, P16940, DOI 10.1074/jbc.RA118.004563; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Ruan HB, 2017, GENE DEV, V31, P1655, DOI 10.1101/gad.305441.117; Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019	9	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16951	16952		10.1074/jbc.H118.006101	http://dx.doi.org/10.1074/jbc.H118.006101			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30366972	Green Published, hybrid			2022-12-26	WOS:000448515100034
J	Debieu, M; Sine, B; Passot, S; Grondin, A; Akata, E; Gangashetty, P; Vadez, V; Gantet, P; Fonceka, D; Cournac, L; Hash, CT; Kane, NA; Vigouroux, Y; Laplaze, L				Debieu, Marilyne; Sine, Bassirou; Passot, Sixtine; Grondin, Alexandre; Akata, Eyanawa; Gangashetty, Prakash; Vadez, Vincent; Gantet, Pascal; Fonceka, Daniel; Cournac, Laurent; Hash, Charles Tom; Kane, Ndjido Ardo; Vigouroux, Yves; Laplaze, Laurent			Response to early drought stress and identification of QTLs controlling biomass production under drought in pearl millet	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; L. R. BR.; NITRITE REDUCTASE; READ ALIGNMENT; ARABIDOPSIS; ASSOCIATION; SIROHEME; ROOTS; YIELD; TRAIT	Pearl millet plays a major role in food security in arid and semi-arid areas of Africa and India. However, it lags behind the other cereal crops in terms of genetic improvement. The recent sequencing of its genome opens the way to the use of modern genomic tools for breeding. Our study aimed at identifying genetic components involved in early drought stress tolerance as a first step toward the development of improved pearl millet varieties or hybrids. A panel of 188 inbred lines from West Africa was phenotyped under early drought stress and well-irrigated conditions. We found a strong impact of drought stress on yield components. This impact was variable between inbred lines. We then performed an association analysis with a total of 392,493 SNPs identified using Genotyping-by-Sequencing (GBS). Correcting for genetic relatedness, genome wide association study identified QTLs for biomass production in early drought stress conditions and for stay-green trait. In particular, genes involved in the sirohaem and wax biosynthesis pathways were found to co-locate with two of these QTLs. Our results might contribute to breed pearl millet lines with improved yield under drought stress.	[Debieu, Marilyne; Passot, Sixtine; Grondin, Alexandre; Vadez, Vincent; Gantet, Pascal; Vigouroux, Yves; Laplaze, Laurent] Univ Montpellier, IRD, DIADE, Montpellier, France; [Debieu, Marilyne; Sine, Bassirou; Grondin, Alexandre; Akata, Eyanawa; Fonceka, Daniel; Kane, Ndjido Ardo; Vigouroux, Yves; Laplaze, Laurent] Lab Mixte Int Adaptat Plantes & Microorganismes A, Dakar, Senegal; [Sine, Bassirou; Akata, Eyanawa; Fonceka, Daniel] ISRA, CERAAS, Thies, Senegal; [Akata, Eyanawa] ITRA, Lome, Togo; [Gangashetty, Prakash; Hash, Charles Tom] Int Crop Res Inst Semiarid Trop ICRISAT, Niamey, Niger; [Fonceka, Daniel] Univ Montpellier, Ctr Cooperat Int Rech Agron Dev CIRAD, AGAP, INRA,Montpellier SupAgro, Montpellier, France; [Cournac, Laurent] Univ Montpellier, Montpellier SupAgro, INRA, Eco&Sols,IRD,CIRAD, Montpellier, France; [Cournac, Laurent] Lab Mixte Int Intensificat Ecol Sols Cult Afrique, Dakar, Senegal; [Kane, Ndjido Ardo] ISRA, LNRPV, Dakar, Senegal; [Laplaze, Laurent] UCAD, ISRA, IRD, Lab Commun Microbiol, Dakar, Senegal; [Debieu, Marilyne] UM, IFREMER, IRD, UMR MARBEC,CNRS, Montpellier, France; [Passot, Sixtine] Catholic Univ Louvain, Earth & Life Inst Agron, Louvain La Neuve, Belgium	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; INRAE; Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite Catholique Louvain	Vigouroux, Y; Laplaze, L (corresponding author), Univ Montpellier, IRD, DIADE, Montpellier, France.; Vigouroux, Y; Laplaze, L (corresponding author), Lab Mixte Int Adaptat Plantes & Microorganismes A, Dakar, Senegal.; Laplaze, L (corresponding author), UCAD, ISRA, IRD, Lab Commun Microbiol, Dakar, Senegal.	yves.vigouroux@ird.fr; laurent.laplaze@ird.fr	Laplaze, Laurent/I-5435-2016; Vadez, Vincent/GLU-8981-2022; Vadez, Vincent/C-5310-2014; Sine, Bassirou/O-7453-2019; vigouroux, Yves/A-9056-2011; Cournac, Laurent/G-2564-2010; DIALLO, Sara/N-4362-2018; Kane, Ndjido Ardo/AAM-7656-2020	Laplaze, Laurent/0000-0002-6568-6504; Sine, Bassirou/0000-0002-1978-8446; vigouroux, Yves/0000-0002-8361-6040; DIALLO, Sara/0000-0003-1891-9982; Kane, Ndjido Ardo/0000-0002-1879-019X; Cournac, Laurent/0000-0003-0371-938X; Passot, Sixtine/0000-0002-6191-723X; Grondin, Alexandre/0000-0001-6726-6274	IRD; French Ministry for Research and Higher Education; NewPearl grant in the frame of the CERES initiative by the Agropolis Fondation as part of the "Investissement d'avenir" under the frame of I-SITE MUSE [AF 1301-015, ANR-l0-LABX-0001-0l, ANR-16-IDEX-0006]; Fondazione Cariplo [FC 2013-0891]	IRD; French Ministry for Research and Higher Education; NewPearl grant in the frame of the CERES initiative by the Agropolis Fondation as part of the "Investissement d'avenir" under the frame of I-SITE MUSE; Fondazione Cariplo(Fondazione Cariplo)	This work was supported by the IRD, the French Ministry for Research and Higher Education (PhD grant to SP) and the NewPearl grant in the frame of the CERES initiative by the Agropolis Fondation (No AF 1301-015 to LL, as part of the "Investissement d'avenir" ANR-l0-LABX-0001-0l) under the frame of I-SITE MUSE (ANR-16-IDEX-0006) and by the Fondazione Cariplo (No FC 2013-0891).SSSS	Bauerle WL, 2012, P NATL ACAD SCI USA, V109, P8612, DOI 10.1073/pnas.1119131109; Baxter I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000492; Bernard A, 2013, PROG LIPID RES, V52, P110, DOI 10.1016/j.plipres.2012.10.002; BIDINGER FR, 1987, AUST J AGR RES, V38, P37, DOI 10.1071/AR9870037; Boncompagni E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198394; Borrell AK, 2000, CROP SCI, V40, P1037, DOI 10.2135/cropsci2000.4041037x; Catala R, 2007, PLANT CELL, V19, P2952, DOI 10.1105/tpc.106.049981; Crane BR, 1997, BIOCHEMISTRY-US, V36, P12101, DOI 10.1021/bi971065q; Davenport S, 2015, PLANT PHYSIOL BIOCH, V97, P96, DOI 10.1016/j.plaphy.2015.09.013; Debieu M, 2017, TRENDS PLANT SCI, V22, P911, DOI 10.1016/j.tplants.2017.09.006; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Franke RB, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00004; Gangappa SN, 2010, PLANT PHYSIOL, V154, P1210, DOI 10.1104/pp.110.163717; Kholova J, 2010, J EXP BOT, V61, P1431, DOI 10.1093/jxb/erq013; Laubinger S, 2003, PLANT J, V35, P373, DOI 10.1046/j.1365-313X.2003.01813.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Mariac C, 2006, THEOR APPL GENET, V114, P49, DOI 10.1007/s00122-006-0409-9; Miura K, 2009, P NATL ACAD SCI USA, V106, P5418, DOI 10.1073/pnas.0811088106; Oumar I, 2008, THEOR APPL GENET, V117, P489, DOI 10.1007/s00122-008-0793-4; Passot S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00829; Ranathunge K, 2011, J EXP BOT, V62, P1961, DOI 10.1093/jxb/erq389; Sakakibara H, 1996, PLANT J, V10, P883, DOI 10.1046/j.1365-313X.1996.10050883.x; Serba DD, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01724; SINCLAIR TR, 1986, AUST J PLANT PHYSIOL, V13, P329, DOI 10.1071/PP9860329; Sokal R.R., 2012, BIOMETRY; Sultan B, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01262; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Thomas H, 2014, J EXP BOT, V65, P3889, DOI 10.1093/jxb/eru037; Varshney RK, 2017, NAT BIOTECHNOL, V35, P969, DOI 10.1038/nbt.3943; Velazco JG, 2017, THEOR APPL GENET, V130, P1375, DOI 10.1007/s00122-017-2894-4; Wingler A, 1999, PLANT CELL ENVIRON, V22, P361, DOI 10.1046/j.1365-3040.1999.00410.x; Xue DW, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00621; Yadav RS, 2002, THEOR APPL GENET, V104, P67, DOI 10.1007/s001220200008; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	36	22	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0201635	10.1371/journal.pone.0201635	http://dx.doi.org/10.1371/journal.pone.0201635			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359386	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000448438400005
J	Ha, A; Kim, YK; Park, YJ; Jeoung, JW; Park, KH				Ha, Ahnul; Kim, Young Kook; Park, Young Joo; Jeoung, Jin Wook; Park, Ki Ho			Intraocular pressure change during reading or writing on smartphone	PLOS ONE			English	Article							COMPUTER SCREEN; DRY EYES; SYMPTOMS; PATTERNS; POSITION; HEAD	Purpose To investigate the effect of reading or writing on a smartphone in terms of intraocular pressure (IOP) changes. Design Prospective, comparative case series. Participants Thirty-nine (39) healthy young (age < 40) volunteers. Methods The participants were requested to conduct standardized work (i.e., read a sample text on single mobile device and subsequently type it on the same device) under daylight [300 lux] and low-light[100 lux] conditions independently on consecutive days. On each day, three sets of 10P measurements (total: 7) using a rebound tonometer (iCare PRO; Tiolat, Helsinki, Finland) were performed: (1) pre-work (baseline) [2 measurements], (2) during smartphone work [5, 15, and 25 minutes], and (3) post-work [5 and 15 minutes]. Main outcome measures Changes in IOP at different check-out points. Results Under the daylight condition, the mean baseline IOP was 13.7 +/- 1.8 mmHg, and the mean IOP increased after 5 minutes of work (14.1 +/- 1.8 mmHg; +2.0 +/- 1.9%; P< 0.001). When the smartphone work lasted for 15 minutes, the IOP showed a further significant increase (15.5 +/- 1.7 mmHg; +12.9 +/- 4.4%; P< 0.001), which persisted over the course of the 25 minutes of smartphone work (15.3 +/- 1.8 mmHg; +11.1 +/- 3.9%; P < 0.001); then, after stopping work for 5 minutes, the IOP was restored (13.9 +/- 1.7 mmHg; +0.9 +/- 2.1%; P= 0.220). Under the lowlight condition, the mean lop was significantly increased immediately after 5 minutes of smartphone work (from 13.9 +/- 1.9 to 15.6 +/- 1.8 mmHg; +12.1 +/- 4.8%; P< 0.001); this IOP increase continued: 17.3 +/- 1.9 [+24.7 +/- 10.3%] at 15 minutes' work, and 17.0 +/- 1.7 mmHg [+23.1 +/- 9.5%] at 25 minutes' work (P< 0.001 at both check-out points). Five minutes after stopping the smartphone work, interestingly, the IOP significantly dropped, to a level even lower than that of the pre-work (12.8 +/- 1.9 mmHg; -8.1 +/- 3.0%; P< 0.001), and at post-work 15 minutes, the IOP returned to the baseline (13.9 +/- 1.8 mmHg; -0.3 +/- 2.6%; P= 0.360). Conclusions In healthy young subjects, reading or writing on smartphone significantly increased lOP, and the changes of IOP were faster and greater under the low-light condition. Smartphone users who are concerned about IOP fluctuation are advised to (1) take a break if they read or write on smartphone for more than 5 minutes, and (2) avoid using smartphones wherever possible in dark places.	[Ha, Ahnul; Kim, Young Kook; Park, Young Joo; Jeoung, Jin Wook; Park, Ki Ho] Seoul Natl Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Ha, Ahnul; Kim, Young Kook; Jeoung, Jin Wook; Park, Ki Ho] Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul, South Korea; [Park, Young Joo] Seoul Natl Univ, Dept Ophthalmol, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Park, KH (corresponding author), Seoul Natl Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea.; Park, KH (corresponding author), Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul, South Korea.	kihopark@snu.ac.kr	Ha, Ahnul/ABD-1589-2020	Ha, Ahnul/0000-0003-4211-7971; Kim, Young Kook/0000-0002-6037-8449				Asrani S, 2000, J GLAUCOMA, V9, P134; Bababekova Y, 2011, OPTOMETRY VISION SCI, V88, P795, DOI 10.1097/OPX.0b013e3182198792; Blehm C, 2005, SURV OPHTHALMOL, V50, P253, DOI 10.1016/j.survophthal.2005.02.008; Chu C, 2011, OPHTHAL PHYSL OPT, V31, P29, DOI 10.1111/j.1475-1313.2010.00802.x; Chu CA, 2014, OPTOMETRY VISION SCI, V91, P297, DOI 10.1097/OPX.0000000000000157; COLEMAN DJ, 1969, ARCH OPHTHALMOL-CHIC, V82, P637; GALLAR J, 1993, INVEST OPHTH VIS SCI, V34, P596; Ha A, JAMA OPHTHALMOLOGY; Kaluza G, 1996, J BEHAV MED, V19, P587, DOI 10.1007/BF01904906; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim KN, 2013, OPHTHALMOLOGY, V120, P731, DOI 10.1016/j.ophtha.2012.09.021; Kontiola A, 2004, GRAEF ARCH CLIN EXP, V242, P3, DOI 10.1007/s00417-003-0671-3; LANIGAN LP, 1989, EYE, V3, P477, DOI 10.1038/eye.1989.72; Lee S, 2015, ERGONOMICS, V58, P220, DOI 10.1080/00140139.2014.967311; Lemola S, 2015, J YOUTH ADOLESCENCE, V44, P405, DOI 10.1007/s10964-014-0176-x; Lin CJ, 2008, IND HEALTH, V46, P105, DOI 10.2486/indhealth.46.105; Malihi M, 2012, OPHTHALMOLOGY, V119, P987, DOI 10.1016/j.ophtha.2011.11.024; Munshi S, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.12962; Ni NN, 2012, J GLAUCOMA, V21, P590, DOI 10.1097/IJG.0b013e318220db03; PERKINS E S, 1957, Br J Ophthalmol, V41, P257, DOI 10.1136/bjo.41.5.257; Prata TS, 2010, SURV OPHTHALMOL, V55, P445, DOI 10.1016/j.survophthal.2009.12.002; Qudsiya SM, 2017, ANN MED PHYSL, V1, P22; SAUNDERS RA, 1981, OPHTHALMOLOGY, V88, P59; Schlote T, 2004, GRAEF ARCH CLIN EXP, V242, P306, DOI 10.1007/s00417-003-0845-z; Stern ME, 2004, EXP EYE RES, V78, P409, DOI 10.1016/j.exer.2003.09.003; Straker LM, 2008, ERGONOMICS, V51, P540, DOI 10.1080/00140130701711000; TSUBOTA K, 1993, NEW ENGL J MED, V328, P584, DOI 10.1056/NEJM199302253280817; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; Wang DD, 2012, CURR EYE RES, V37, P599, DOI 10.3109/02713683.2012.660593; Yan L, 2014, EYE, V28, P1334, DOI 10.1038/eye.2014.208	30	10	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206061	10.1371/journal.pone.0206061	http://dx.doi.org/10.1371/journal.pone.0206061			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3GT	30359418	Green Published, gold, Green Submitted			2022-12-26	WOS:000448438400040
J	Neustupa, J; Nemcova, Y				Neustupa, Jiri; Nemcova, Yvonne			Morphological allometry constrains symmetric shape variation, but not asymmetry, of Halimeda tuna (Bryopsidales, Ulvophyceae) segments	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; GEOMETRIC MORPHOMETRICS; DEVELOPMENTAL STABILITY; PHENOTYPIC PLASTICITY; DISTRIBUTION RANGE; FLORIDA-KEYS; GREEN-ALGAE; CONCH REEF; CHLOROPHYTA; POLLUTION	Green algae of the genus Halimeda have modular siphonous thalli composed of multiple repeated segments. Morphological variation among the segments has been related to various environmental factors, which often jointly affect their size and shape. The segments are bilaterally symmetric, which means that their shape variation can be decomposed into the symmetric and asymmetric components. Asymmetric variation might reflect both environmental heterogeneity and developmental instability of morphogenetic processes during the development of segments. In the present study, we examined if segment shape in H. tuna is related to their size and if an allometric relationship can also be found with respect to their asymmetry. Relative contributions of directional and fluctuating asymmetry to the segment shape variation within individual plants were investigated at two close localities in the northern Adriatic Sea. A series of equidistant semilandmarks were set along the outline of the segments, and analyzed by geometric morphometrics using two parallel methods to optimize their final position. Symmetric variation was strongly constrained by allometry, which also explained differences between populations. Smaller segments were significantly more asymmetric, but the difference in asymmetry between populations could not be explained solely by this allometric relationship. These differences between populations might have been caused by variation in local environmental factors. We conclude that members of the genus Halimeda represent an intriguing model system for studies of morphometric symmetry and asymmetry of sessile marine organisms, including effects of allometric relationships and infraspecific variation in relation to environmental factors of the benthic coastal habitats.	[Neustupa, Jiri; Nemcova, Yvonne] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic	Charles University Prague	Neustupa, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	neustupa@natur.cuni.cz	Nemcova, Yvonne/HGC-1581-2022; Neustupa, Jiri/J-1610-2015; Nemcova, Yvonne/I-6989-2015	Nemcova, Yvonne/0000-0002-5396-5717; Neustupa, Jiri/0000-0003-3610-8120; Nemcova, Yvonne/0000-0002-5396-5717	PROGRES project - Charles University Prague [Q43]	PROGRES project - Charles University Prague	JN and YN were supported by the PROGRES project no. Q43 funded by Charles University Prague. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Auffray JC, 1999, J EVOLUTION BIOL, V12, P207, DOI 10.1046/j.1420-9101.1999.00054.x; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baranov S. G., 2014, Advances in Environmental Biology, V8, P2391; Beach K, 2003, J PHYCOL, V39, P633, DOI 10.1046/j.1529-8817.2003.02147.x; Bookstein F L, 1997, Med Image Anal, V1, P225; Campbell JE, 2016, CORAL REEFS, V35, P357, DOI 10.1007/s00338-015-1377-9; Castro-Sanguino C, 2016, CORAL REEFS, V35, P597, DOI 10.1007/s00338-016-1412-5; Coneva V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00287; Cyronak T, 2016, ICES J MAR SCI, V73, P558, DOI 10.1093/icesjms/fsv075; Debat V, 2009, EVOLUTION, V63, P2864, DOI 10.1111/j.1558-5646.2009.00774.x; Dryden IL, 2016, PACKAGE SHAPES, P1; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Graham JH, 1998, BIOL J LINN SOC, V64, P1, DOI 10.1111/j.1095-8312.1998.tb01530.x; Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; Guiry MD, 2017, ALGAEBASE; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Hader DP, 1996, PHOTOCHEM PHOTOBIOL, V64, P428, DOI 10.1111/j.1751-1097.1996.tb03087.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Lezcano AH, 2015, MAR POLLUT BULL, V91, P524, DOI 10.1016/j.marpolbul.2014.09.038; Hillis-Colinvaux L., 1980, ECOLOGY TAXONOMY HAL; Kark S, 2004, BIOL J LINN SOC, V81, P313, DOI 10.1111/j.1095-8312.2004.00296.x; Kark S, 2001, EVOLUTION, V55, P2088; Kindt R., 2005, WORLD; Klingenberg CP, 2012, J EVOLUTION BIOL, V25, P115, DOI 10.1111/j.1420-9101.2011.02410.x; Klingenberg CP, 2015, SYMMETRY-BASEL, V7, P843, DOI 10.3390/sym7020843; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Kooistra WHCF, 2005, J PHYCOL, V41, P177, DOI 10.1111/j.1529-8817.2005.04095.x; Leamy LJ, 2001, EVOLUTION, V55, P2333, DOI 10.1111/j.0014-3820.2001.tb00746.x; MacLeod Norman, 2017, Zoological Systematics, V42, P4, DOI 10.11865/zs.201702; MacLeod N, 2015, PALAEOWORLD, V24, P408, DOI 10.1016/j.palwor.2015.07.004; McManus HA, 2011, J PHYCOL, V47, P123, DOI 10.1111/j.1529-8817.2010.00941.x; Mikula O, 2010, BIOL J LINN SOC, V101, P13, DOI 10.1111/j.1095-8312.2010.01490.x; Neustupa J, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-016-0855-1; Orlando-Bonaca M., 2009, VARSTVO NARAVE, V22, P63; Orlando-Bonaca M, 2008, MAR POLLUT BULL, V56, P666, DOI 10.1016/j.marpolbul.2007.12.018; Pelabon C, 2014, ANN NY ACAD SCI, V1320, P58, DOI 10.1111/nyas.12470; Perez SI, 2006, J ANAT, V208, P769, DOI 10.1111/j.1469-7580.2006.00576.x; Poja M, 2017, OCENA STANJA MORJA S; Pongparadon S, 2017, PHYCOL RES, V65, P136, DOI 10.1111/pre.12172; Rees SA, 2007, CORAL REEFS, V26, P177, DOI 10.1007/s00338-006-0166-x; Rohlf FJ, 2015, HYSTRIX, V26, P9, DOI 10.4404/hystrix-26.1-11264; Savriama Y, 2017, ARTHROPOD STRUCT DEV, V46, P419, DOI 10.1016/j.asd.2017.03.002; Savriama Y, 2016, DEV GENES EVOL, V226, P187, DOI 10.1007/s00427-016-0538-3; Savriama Y, 2015, ECOL INDIC, V54, P39, DOI 10.1016/j.ecolind.2015.02.004; Savriama Y, 2012, NEW PHYTOL, V196, P945, DOI 10.1111/j.1469-8137.2012.04312.x; Savriama Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-280; Savriama Y, 2010, NOVA HEDWIGIA, P43, DOI 10.1127/1438-9134/2010/0136-0043; Scalici M, 2017, ECOTOXICOLOGY, V26, P396, DOI 10.1007/s10646-017-1772-9; Sheets HD, 2004, MORPHOMETRICS: APPLICATIONS IN BIOLOGY AND PALEONTOLOGY, P67; Smith JE, 2004, LIMNOL OCEANOGR, V49, P1923, DOI 10.4319/lo.2004.49.6.1923; Stanton DE, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00916; TAN CGS, 1993, RAFFLES B ZOOL, V41, P119; Tucic B, 2018, J EVOLUTION BIOL, V31, P197, DOI 10.1111/jeb.13207; Verbruggen H, 2005, MOL PHYLOGENET EVOL, V37, P789, DOI 10.1016/j.ympev.2005.06.015; Verbruggen H, 2005, CRYPTOGAMIE ALGOL, V26, P259; Verbruggen H, 2005, J PHYCOL, V41, P126, DOI 10.1111/j.1529-8817.2005.04080.x; Verbruggen H, 2004, EUR J PHYCOL, V39, P213, DOI 10.1080/0967026042000202163; Verbruggen H, 2006, EUR J PHYCOL, V41, P337, DOI 10.1080/09670260600709315; Verbruggen H, 2009, GLOBAL ECOL BIOGEOGR, V18, P393, DOI 10.1111/j.1466-8238.2009.00463.x; Vesela J, 2009, FOTTEA, V9, P307, DOI 10.5507/fot.2009.030; Viscosi V, 2015, BOT J LINN SOC, V179, P335, DOI 10.1111/boj.12323; Vroom PS, 2003, CRYPTOGAMIE ALGOL, V24, P355; Vroom PS, 2003, HYDROBIOLOGIA, V501, P149, DOI 10.1023/A:1026287816324; Woodard K, 2016, SYMMETRY-BASEL, V8, DOI 10.3390/sym8120150; Yniguez AT, 2010, MAR ECOL PROG SER, V411, P17, DOI 10.3354/meps08643; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	68	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206492	10.1371/journal.pone.0206492	http://dx.doi.org/10.1371/journal.pone.0206492			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359424	gold, Green Submitted, Green Published			2022-12-26	WOS:000448438400080
J	Bolt, AM; Medina, S; Lauer, FT; Xu, H; Ali, AM; Liu, KJ; Burchiel, SW				Bolt, Alicia M.; Medina, Sebastian; Lauer, Fredine T.; Xu, Huan; Ali, Abdul-Mehdi; Liu, Ke Jian; Burchiel, Scott W.			Minimal uranium accumulation in lymphoid tissues following an oral 60-day uranyl acetate exposure in male and female C57BL/6J mice	PLOS ONE			English	Article							GASTROINTESTINAL ABSORPTION; RATS; HUMANS	High levels of uranium (U) exist in soil, water, and air in the Southwestern United States due, in part, to waste generated from more than 160,000 abandoned hard rock mines located in this region. As a result, many people living in this region are chronically exposed to U at levels that have been linked to detrimental health outcomes. In an effort to establish a relevant in vivo mouse model for future U immunotoxicity studies, we evaluated the tissue distribution of U in immune organs; blood, bone marrow, spleen, and thymus, as well as femur bones, kidneys, and liver, following a 60-d drinking water exposure to uranyl acetate (UA) in male and female C57BLJ6J mice. Following the 60-d exposure, there was low overall tissue retention of U (<0.01%) at both the 5 and the 50 ppm (mg/L) oral concentrations. In both male and female mice, there was limited U accumulation in immune organs. U only accumulated at low concentrations in the blood and bone marrow of male mice (0.6 and 16.8 ng/g, respectively). Consistent with previous reports, the predominant sites of U accumulation were the femur bones (350.1 and 399.0 ng/g, respectively) and kidneys (134.0 and 361.3 ng/g, respectively) of male and female mice. Findings from this study provide critical insights into the distribution and retention of U in lymphoid tissues following chronic drinking water exposure to U. This information will serve as a foundation for immunotoxicological assessments of U, alone and in combination with other metals.	[Bolt, Alicia M.; Medina, Sebastian; Lauer, Fredine T.; Liu, Ke Jian; Burchiel, Scott W.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [Xu, Huan] East China Univ Sci & Technol, Dept Pharmaceut Sci, Sch Pharm, Shanghai, Peoples R China; [Ali, Abdul-Mehdi] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA	University of New Mexico; East China University of Science & Technology; University of New Mexico	Bolt, AM (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA.	ambolt@salud.unm.edu	Xu, Huan/G-5291-2019	Xu, Huan/0000-0002-9009-3786	NIEHS-EPA UNM Metals Superfund Program [1P42ES025589-01A1]; UNM Clinical and Translational Science Center [UL1TR001449]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES025589] Funding Source: NIH RePORTER	NIEHS-EPA UNM Metals Superfund Program; UNM Clinical and Translational Science Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded through the NIEHS-EPA UNM Metals Superfund Program #1P42ES025589-01A1 (https://www.niehs.nih.gov/research/supported/centers/srp/index.cfm) to K.J.L. and S.W.B. and UNM Clinical and Translational Science Center Grant UL1TR001449 to S.W.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded through the NIEHS-EPA UNM Metals Superfund Program 1P42ES025589-01A1 and the UNM Clinical and Translational Science Center Grant UL1TR001449.	Agency for Toxic Substances and Disease Registry, 2013, TOX PROF UR; BALLOU JE, 1986, HEALTH PHYS, V51, P755, DOI 10.1097/00004032-198612000-00006; BHATTACHARYYA MH, 1989, RADIAT PROT DOSIM, V26, P159; Blake JM, 2015, ENVIRON SCI TECHNOL, V49, P8506, DOI 10.1021/acs.est.5b01408; deLemos JL, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-29; DIAMOND GL, 1989, FUND APPL TOXICOL, V13, P65, DOI 10.1016/0272-0590(89)90307-2; Durbin P.W., 1975, OCCUPATIONAL HLTH EX, P67; Geipel G, 2015, BIOMETALS, V28, P529, DOI 10.1007/s10534-015-9836-x; Hao YH, 2013, TOXICOLOGY, V309, P81, DOI 10.1016/j.tox.2013.04.013; HARRISON JD, 1981, RADIAT RES, V88, P47, DOI 10.2307/3575750; Hoover J, 2017, EXPOS HEALTH, V9, P113, DOI 10.1007/s12403-016-0226-6; Houpert P, 2001, HUM EXP TOXICOL, V20, P237, DOI 10.1191/096032701678227721; International Comission on Radiological Protection, 1995, AG DEP DOS MEMB PUBL, V25, pi; Juntunen R, 1991, URANIUM RADON WELLS; KATHREN RL, 1989, HEALTH PHYS, V57, P17, DOI 10.1097/00004032-198907000-00002; Konietzka R, 2015, REGUL TOXICOL PHARM, V71, P125, DOI 10.1016/j.yrtph.2014.08.012; LATOUCHE YD, 1987, HEALTH PHYS, V53, P147, DOI 10.1097/00004032-198708000-00005; LEGGETT RW, 1995, HEALTH PHYS, V68, P484, DOI 10.1097/00004032-199504000-00005; SINGH NP, 1987, HEALTH PHYS, V53, P261, DOI 10.1097/00004032-198709000-00005; SULLIVAN MF, 1986, HEALTH PHYS, V50, P223, DOI 10.1097/00004032-198602000-00006; SULLIVAN MF, 1988, HEALTH PHYS, V54, P311, DOI 10.1097/00004032-198803000-00008; Tannenbaum A, 1951, TRACER STUDIES DISTR; Tasat D.R., 2012, CELL METAB, P115; U.S. Enivironmental Protection Agency (US EPA), 2012, NAV NAT CLEAN AB UR; U.S. Enivironmental Protection Agency (US EPA), 2006, BAS INF RAD DRINK WA; World Health Organization, 2012, UNDERST ADDRESS VIOL, P1, DOI DOI 10.2307/1319341; Zychowski KE, 2018, TOXICOL SCI, V164, P101, DOI 10.1093/toxsci/kfy064	27	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205211	10.1371/journal.pone.0205211	http://dx.doi.org/10.1371/journal.pone.0205211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356336	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000043
J	Withanage, ND; Perera, S; Peiris, H; Athiththan, LV				Withanage, Niroshima Dedunu; Perera, Sunil; Peiris, Hemantha; Athiththan, Lohini Vijayendran			Serum 25-hydroxyvitamin D, serum calcium and vitamin D receptor (VDR) polymorphisms in a selected population with lumbar disc herniation-A case control study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; GENETIC POLYMORPHISMS; D DEFICIENCY; MATRIX METALLOPROTEINASE-3; RISK-FACTORS; ASSOCIATION; DISEASE; DEGENERATION; PREVALENCE; WOMEN	Background Association of Vitamin D receptor (VDR) polymorphisms with lumbar disc herniation (LDH) have been identified in several ethnic groups globally. Despite abundant sunlight, vitamin D deficiency is reported in many tropical countries. As vitamin D is a key modulator for intestinal calcium absorption, low vitamin D could contribute to low serum calcium leading to abnormalities of skeletal homeostasis. Therefore, present study was aimed to study the association of serum 25-hydroxyvitamin D (25(OH)D), serum calcium and VDR polymorphisms in a selected Sri Lankan population. Materials & methods A case control study was conducted in 119 participants (cases = 51: controls = 68). Serum 25(OH)D levels were measured using ELISA. The VDR polymorphisms (Fok I and Taq I) were detected by polymerase chain reaction followed by restriction fragment length polymorphism. Results Findings indicated a significantly low (p = 0.000) 25(OH)D levels in cases (18.7 +/- 3.7 ng/mL) compared to controls(25.5 +/- 9.8 ng/mL) while 25(OH)D in both groups were below the reference range. Mean serum calcium levels in both groups were within normal reference range and was not significantly different among groups. Statistically significant association was not observed between VDR Fok I polymorphisms among cases and controls. Although Fok I polymorphism genotypes were in Hardy-Weinberg equilibrium (HWE), Taq I genotypes in controls violated HWE. Conclusion Present study confirms that insufficient serum 25(OH)D levels in cases have major contribution to LDH. VDR Fok I polymorphisms did not have any significant association with LDH in Sri Lankan ethnicity.	[Withanage, Niroshima Dedunu] Univ Sri Jayewardenepura, Fac Med Sci, Dept Allied Hlth Sci, Nugogoda, Sri Lanka; [Perera, Sunil] Cent Hosp, Colombo 8, Sri Lanka; [Peiris, Hemantha; Athiththan, Lohini Vijayendran] Univ Sri Jayewardenepura, Fac Med Sci, Dept Biochem, Nugegoda, Sri Lanka	University Sri Jayewardenepura; University Sri Jayewardenepura	Withanage, ND (corresponding author), Univ Sri Jayewardenepura, Fac Med Sci, Dept Allied Hlth Sci, Nugogoda, Sri Lanka.	withanagend@sjp.ac.lk	Withanage, Niroshima/V-7019-2019		University of Sri Jayewardenepura Research Grant, Sri Lanka [ASP/01/RE/MED/2016/43]	University of Sri Jayewardenepura Research Grant, Sri Lanka	This work was supported by the University of Sri Jayewardenepura Research Grant (ASP/01/RE/MED/2016/43), Sri Lanka. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello L, 2016, NEUROL SCI, V37, P261, DOI 10.1007/s10072-015-2401-0; Al Faraj S, 2003, SPINE, V28, P177, DOI 10.1097/00007632-200301150-00015; Bhanushali Aparna A, 2009, Indian J Hum Genet, V15, P108, DOI 10.4103/0971-6866.60186; Bid Hemant K, 2005, Asian Pac J Cancer Prev, V6, P147; Serrano SC, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/302568; Cheung KMC, 2006, SPINE, V31, P1143, DOI 10.1097/01.brs.0000216530.41838.d3; Colombini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097027; Colombini A, 2013, J STEROID BIOCHEM, V138, P24, DOI 10.1016/j.jsbmb.2013.03.001; Eser B, 2010, GENET TEST MOL BIOMA, V14, P313, DOI 10.1089/gtmb.2009.0202; Eskola PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049995; Goswami R, 2008, INDIAN J MED RES, V127, P229; Harris SS, 1997, J BONE MINER RES, V12, P1043, DOI 10.1359/jbmr.1997.12.7.1043; Heshmat R, 2008, IRAN J PUBLIC HLTH S, V37; HOLICK MF, 1995, AM J CLIN NUTR, V61, p638S, DOI 10.1093/ajcn/61.3.638S; Holick MF, 2011, J INVEST MED, V59, P872, DOI 10.2310/JIM.0b013e318214ea2d; Jones G, 1998, ANN RHEUM DIS, V57, P94, DOI 10.1136/ard.57.2.94; Kawaguchi Y, 2002, J BONE JOINT SURG AM, V84A, P2022, DOI 10.2106/00004623-200211000-00018; Kim TH, 2013, PAIN PHYSICIAN, V16, P165; Lane NE, 1999, ARTHRITIS RHEUM-US, V42, P854, DOI 10.1002/1529-0131(199905)42:5&lt;854::AID-ANR3&gt;3.0.CO;2-I; Li YC, 2015, J GENET GENOMICS, V42, P135, DOI 10.1016/j.jgg.2015.03.006; Mayer JE, 2013, SPINE J, V13, P299, DOI 10.1016/j.spinee.2013.01.041; Noponen-Hietala N, 2003, ANN RHEUM DIS, V62, P1208, DOI 10.1136/ard.2003.008334; Oishi Y, 2003, BONE, V32, P405, DOI 10.1016/S8756-3282(03)00031-0; Phabphal K, 2009, BONE, V45, P232, DOI 10.1016/j.bone.2009.04.235; RIGGS BL, 1995, J BONE MINER RES, V10, P991; Sahu M, 2009, CLIN ENDOCRINOL, V70, P680, DOI 10.1111/j.1365-2265.2008.03360.x; SANDGREN ME, 1990, P NATL ACAD SCI USA, V87, P4312, DOI 10.1073/pnas.87.11.4312; Sansoni V, 2016, EUR SPINE J, V25, P192, DOI 10.1007/s00586-015-4176-7; Sedighi M, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-373; Toktas ZO, 2015, EUR SPINE J, V24, P2432, DOI 10.1007/s00586-015-4206-5; Uitterlinden AG, 2004, J STEROID BIOCHEM, V89-90, P187, DOI 10.1016/j.jsbmb.2004.03.083; Vanlint S, 2013, NUTRIENTS, V5, P949, DOI 10.3390/nu5030949; Videman T, 1998, SPINE, V23, P2477, DOI 10.1097/00007632-199812010-00002; Wootton Andrew M, 2005, Clin Biochem Rev, V26, P33; Yuan HY, 2010, J OCCUP HEALTH, V52, P23, DOI 10.1539/joh.L8149; Zawilla NH, 2014, J OCCUP REHABIL, V24, P370, DOI 10.1007/s10926-013-9472-7; Zolfaghari F, 2016, ASIAN SPINE J, V10, P834, DOI 10.4184/asj.2016.10.5.834	37	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205841	10.1371/journal.pone.0205841	http://dx.doi.org/10.1371/journal.pone.0205841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356314	Green Published, Green Submitted, gold			2022-12-26	WOS:000448434000063
J	Wen, Y; Zhou, XQ; Lu, MT; He, ML; Tian, Y; Liu, LX; Wang, MN; Tan, WC; Deng, YT; Yang, XS; Mayer, MP; Zou, F; Chen, XM				Wen, Ying; Zhou, Xueqiong; Lu, Meiting; He, Meiling; Tian, Ye; Liu, Lixia; Wang, Mengnan; Tan, Wenchong; Deng, Yaotang; Yang, Xushan; Mayer, Matthias P.; Zou, Fei; Chen, Xuemei			Bclaf1 promotes angiogenesis by regulating HIF-1 alpha transcription in hepatocellular carcinoma	ONCOGENE			English	Article							HYPOXIA; CANCER; APOPTOSIS; GROWTH; VEGF; BTF	The development of hepatocellular carcinomas (HCC) depends on their local microenvironment and the induction of neovascularization is a decisive step in tumor progression, since the growth of solid tumors is limited by nutrient and oxygen supply. Hypoxia is the critical factor that induces transcription of the hypoxia inducible factor-1 alpha (HIF-1 alpha) encoding gene HIF1A and HIF-1 alpha protein accumulation to promote angiogenesis. However, the basis for the transcriptional regulation of HIF1A expression in HCC is still unclear. Here, we show that Bcalf1 levels are highly correlated with HIF-1 alpha levels in HCC tissues, and that knockdown of Bcalf1 in HCC cell lines significantly reduces hypoxia-induced HIF1A expression. Furthermore, we found that Bcalf1 promotes HIF1A transcription via its bZIP domain, leading subsequently to increased transcription of the HIF-1 alpha downstream targets VEGFA, TGFB, and EPO that in turn promote HCC-associated angiogenesis and thus survival and thriving of HCC cells. Moreover, we demonstrate that HIF-alpha levels and microvessel density decrease after the shRNA-mediated Bcalf1 knockdown in xenograft tumors. Finally, we found that Bcalf1 levels increase in hypoxia in a HIF-1 alpha dependent manner. Therefore, our study identifies Bcalf1 as a novel positive regulator of HIF-1 alpha in the hypoxic microenvironment, providing new incentives for promoting Bcalf1 as a potential therapeutic target for an anti-HCC strategy.	[Wen, Ying; Zhou, Xueqiong; Lu, Meiting; He, Meiling; Tian, Ye; Liu, Lixia; Wang, Mengnan; Tan, Wenchong; Deng, Yaotang; Yang, Xushan; Zou, Fei; Chen, Xuemei] Southern Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Med, Guangdong Prov Key Lab Trop Dis Res, 1838 Guangzhou Rd North, Guangzhou 510515, Guangdong, Peoples R China; [Mayer, Matthias P.] Heidelberg Univ ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany	Southern Medical University - China; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Zou, F; Chen, XM (corresponding author), Southern Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Med, Guangdong Prov Key Lab Trop Dis Res, 1838 Guangzhou Rd North, Guangzhou 510515, Guangdong, Peoples R China.; Mayer, MP (corresponding author), Heidelberg Univ ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	m.mayer@zmbh.uni-heidelberg.de; zfei@smu.edu.cn; cxmcsz@smu.edu.cn	Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112	National Natural Science Foundation of China (NSFC) [81673216, 81741131, 81671860]; Deutsche Forschungsgemeinschaft [SFB/TRR77 C5, SFB1036 TP09]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by National Natural Science Foundation of China (NSFC): No. 81673216 to Xuemei Chen, Nos. 81741131 and 81671860 to Fei Zou; Deutsche Forschungsgemeinschaft (SFB/TRR77 C5, SFB1036 TP09) to Matthias P. Mayer. We like to thank the kind gifts of plasmid from Prof. J. Tang (China Agricultural University, China).	Azoitei N, 2014, CANCER RES, V74, P7125, DOI 10.1158/0008-5472.CAN-14-1017; Bao H, 2018, FASEB J, V32, P3912, DOI 10.1096/fj.201701073R; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; Dell'Aversana C, 2017, LEUKEMIA, V31, P2315, DOI 10.1038/leu.2017.64; Doe MR, 2012, CANCER RES, V72, P949, DOI 10.1158/0008-5472.CAN-11-2371; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Finn RS, 2009, EXPERT REV ANTICANC, V9, P503, DOI 10.1586/ERA.09.6; Fontoura BMA, 2005, IUBMB LIFE, V57, P65, DOI 10.1080/15216540500078608; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gorlach A, 2009, CURR PHARM DESIGN, V15, P3844, DOI 10.2174/138161209789649420; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ju UI, 2015, BIOCHEM BIOPH RES CO, V464, P1008, DOI 10.1016/j.bbrc.2015.07.037; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Koukourakis MI, 2000, CANCER RES, V60, P3088; Lee YY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.76; Li Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12495; Li YS, 2015, CELL REP, V12, P388, DOI 10.1016/j.celrep.2015.06.033; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; McPherson JP, 2009, CELL DEATH DIFFER, V16, P331, DOI 10.1038/cdd.2008.167; McPherson JP, 2011, ATLAS GENET CYTOGENE, V15, P994; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rankin EB, 2016, SCIENCE, V352, P175, DOI 10.1126/science.aaf4405; Sarras H, 2010, THESCIENTIFICWORLDJO, V10, P1450, DOI 10.1100/tsw.2010.132; Savage KI, 2014, MOL CELL, V54, P445, DOI 10.1016/j.molcel.2014.03.021; Shao AW, 2016, CELL DEATH DIFFER, V23, P865, DOI 10.1038/cdd.2015.150; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Thurnherr T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20065; Varia S, 2013, NUCLEUS-AUSTIN, V4, P229, DOI 10.4161/nucl.25187; Vohhodina J, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx1046; Wang D, 2016, IUBMB LIFE, V68, P748, DOI 10.1002/iub.1537; Wei H, 2014, MOL CARCINOGEN, V53, P1, DOI 10.1002/mc.21917; Wilson GK, 2014, J HEPATOL, V61, P1397, DOI 10.1016/j.jhep.2014.08.025; Yoshitomi T, 2011, ONCOL REP, V25, P1661, DOI 10.3892/or.2011.1253; Zhou XQ, 2019, HEPATOLOGY, V69, P1564, DOI 10.1002/hep.30172; Zhou XX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5581; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30; Zundel W, 2000, GENE DEV, V14, P391	44	55	58	1	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2019	38	11					1845	1859		10.1038/s41388-018-0552-1	http://dx.doi.org/10.1038/s41388-018-0552-1			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HO7XX	30367150	Green Published, hybrid			2022-12-26	WOS:000461164400005
J	Zou, X; Hou, SG; Liu, K; Yu, JH; Zhang, WB; Pang, HX; Hua, R; Mayewski, P				Zou, Xiang; Hou, Shugui; Liu, Ke; Yu, Jinhai; Zhang, Wangbin; Pang, Hongxi; Hua, Rong; Mayewski, Paul			Uranium record from a 3 m snow pit at Dome Argus, East Antarctica	PLOS ONE			English	Article							TRACE-ELEMENT; ICE CORE; POLLUTION; DUST; FIRN; VARIABILITY; CHEMISTRY; PATTERNS; POSITION; ESTUARY	Understanding the distribution and transport of Uranium is important because it can lead to both chemical and radiological toxicity. This study presents the Uranium concentrations time series from 1964 to 2009 obtained from a 3 m deep snow pit at Dome Argus, East Antarctic Plateau. The data shows that Uranium concentrations vary from 0.0067 pg g -1 to 0.12 pg g(-1), with a mean concentration of 0.044 pg g(-1). Its mean concentration is 2-3 folds lower than at West Antarctica study sites, such as the Antarctic Peninsula (mean 0.12 pg g(-1)), IC6 (Ice Core-6) (mean 0.11 pg g(-1)) and a suite of ice cores from the US ITASE traverse. Before the mid-1980s, the varieties of Uranium concentrations are relatively stable, with a very low mean concentration of 0.016 pg g -l and its main source is sea salt deposition, while a small number of anthropogenic sources are likely to be caused by Uranium mining operations in South Africa. A remarkable increase of Uranium concentrations has occurred since the mid-1980s (by a factor of similar to 9) compared with the amount before the mid-1980s. This increase coincides with the Uranium records at IC-6 and Antarctic Peninsula (DP-07-01) during the same period, and are mostly attributed to Uranium mining operations in Australia as a potential primary anthropogenic Uranium source. Our observations suggest that Uranium pollution in the atmosphere might have already become a global phenomenon.	[Zou, Xiang; Hou, Shugui; Liu, Ke; Yu, Jinhai; Zhang, Wangbin; Pang, Hongxi; Hua, Rong] Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China; [Hou, Shugui] CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China; [Mayewski, Paul] Univ Maine, Climate Change Inst, Orono, ME USA; [Mayewski, Paul] Univ Maine, Sch Earth & Climate Sci, Orono, ME USA	Nanjing University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Hou, SG (corresponding author), Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China.; Hou, SG (corresponding author), CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China.	Shugui@nju.edu.cn		Zou, Xiang/0000-0001-9917-6214; Hou, Shugui/0000-0002-0905-3542	National Natural Science Foundation of China [41830644, 41330526, 41622605]; State Oceanic Administration;  [CHINARE2012-02-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Oceanic Administration; 	This study was supported by National Natural Science Foundation of China(41830644, 41330526 and 41622605). This study was funded by State Oceanic Administration (www.soa.gov.cn) and grant number is CHINARE2012-02-02. Thanks to the support in the field from the Chinese Antarctic Expedition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Ansoborlo E, 1998, RADIAT PROT DOSIM, V79, P23, DOI 10.1093/oxfordjournals.rpd.a032399; Bai JH, 2015, J HYDROL, V520, P186, DOI 10.1016/j.jhydrol.2014.11.007; Barbante C, 2001, ENVIRON SCI TECHNOL, V35, P4026, DOI 10.1021/es0109186; ColeDai JH, 1997, GEOPHYS RES LETT, V24, P2679, DOI 10.1029/97GL02734; Craft ES, 2004, J TOXICOL ENV HEAL B, V7, P297, DOI 10.1080/10937400490452714; Dixon DA, 2013, CRYOSPHERE, V7, P515, DOI 10.5194/tc-7-515-2013; Fletcher MS, 2011, GEOLOGY, V39, P419, DOI 10.1130/G31807.1; Gongalsky KB, 2003, ENVIRON MONIT ASSESS, V89, P197, DOI 10.1023/A:1026031224658; Grygar TM, 2014, APPL GEOCHEM, V48, P1, DOI 10.1016/j.apgeochem.2014.06.021; Hong S, 2012, ENVIRON SCI TECHNOL, V46, P11550, DOI 10.1021/es303086c; Hou SG, 2007, CHINESE SCI BULL, V52, P428, DOI 10.1007/s11434-007-0041-3; Hou SG, 2009, SCI CHINA SER D, V52, P1502, DOI 10.1007/s11430-009-0039-6; Hua R, 2016, ANTARCT SCI, V28, P305, DOI 10.1017/S0954102016000092; Hur SD, 2007, ATMOS ENVIRON, V41, P8567, DOI 10.1016/j.atmosenv.2007.07.012; Laluraj CM, 2014, ATMOS ENVIRON, V90, P23, DOI 10.1016/j.atmosenv.2014.03.031; Lamy F, 2010, NAT GEOSCI, V3, P695, DOI [10.1038/NGEO959, 10.1038/ngeo959]; LI YH, 1991, GEOCHIM COSMOCHIM AC, V55, P3223, DOI 10.1016/0016-7037(91)90485-N; Liu YP, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015191; Mosley-Thompson E., 1996, CLIMATIC VARIATIONS, P263, DOI [10.1007/978-3-642-61113-1_13, DOI 10.1007/978-3-642-61113-1_13]; Navarro A, 2016, TOXICS, V4, DOI 10.3390/toxics4030016; Neff PD, 2015, J GEOPHYS RES-ATMOS, V120, P9303, DOI 10.1002/2015JD023304; NRIAGU JO, 1989, NATURE, V338, P47, DOI 10.1038/338047a0; Ohshima S, 1998, ENVIRON TOXICOL PHAR, V5, P267, DOI 10.1016/S1382-6689(98)00010-6; Oliver IW, 2007, J ENVIRON MONITOR, V9, P740, DOI 10.1039/b700719a; Osterberg EC, 2006, ENVIRON SCI TECHNOL, V40, P3355, DOI 10.1021/es052536w; Planchon FAM, 2002, EARTH PLANET SC LETT, V200, P207, DOI 10.1016/S0012-821X(02)00612-X; Potocki M, 2016, ATMOS ENVIRON, V140, P381, DOI 10.1016/j.atmosenv.2016.06.010; POURCHET M, 1983, J GEOPHYS RES-OCEANS, V88, P6013, DOI 10.1029/JC088iC10p06013; Raphael M, 2003, J CLIMATE, V16, P2915, DOI 10.1175/1520-0442(2003)016<2915:RLCITE>2.0.CO;2; Ravi S, 2011, REV GEOPHYS, V49, DOI 10.1029/2010RG000328; Rodriguez J. D., 2014, BIOMONITORING, V1, P63; Sala M, 2008, EARTH PLANET SC LETT, V271, P43, DOI 10.1016/j.epsl.2008.03.045; Schwanck F, 2016, ATMOS ENVIRON, V125, P257, DOI 10.1016/j.atmosenv.2015.11.027; Stein AF, 2015, B AM METEOROL SOC, V96, P2059, DOI 10.1175/BAMS-D-14-00110.1; Thamban M, 2013, ENVIRON MONIT ASSESS, V185, P2961, DOI 10.1007/s10661-012-2764-0; Vallelonga P, 2004, ANN GLACIOL-SER, V39, P169, DOI 10.3189/172756404781814483; Villa-Alfageme M, 2011, MAR POLLUT BULL, V62, P1521, DOI 10.1016/j.marpolbul.2011.04.003; Vintro LL, 2009, J ENVIRON RADIOACTIV, V100, P308, DOI 10.1016/j.jenvrad.2008.12.009	39	3	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206598	10.1371/journal.pone.0206598	http://dx.doi.org/10.1371/journal.pone.0206598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379958	Green Submitted, Green Published, gold			2022-12-26	WOS:000448823700136
J	Watanabe, L; Gomes, F; Vianez, J; Nunes, M; Cardoso, J; Lima, C; Schneider, H; Sampaio, I				Watanabe, Luciana; Gomes, Fatima; Vianez, Joao; Nunes, Marcie; Cardoso, Jedson; Lima, Clayton; Schneider, Horacio; Sampaio, Iracilda			De novo transcriptome based on next-generation sequencing reveals candidate genes with sex-specific expression in Arapaima gigas (Schinz, 1822), an ancient Amazonian freshwater fish	PLOS ONE			English	Article							EVOLUTION; ANNOTATION; PROVIDES; PATTERN; PIGMENTATION; DEGRADATION; PROTEINS; BLAST2GO; INSIGHTS; ONTOLOGY	Background The Arapaima (Arapaima gigas) is one of the world's largest freshwater bony fish, and is found in the rivers of the Amazon basin. This species is a potential aquaculture resource, although reproductive management in captivity is limited in particular due to the lack of external sexual dimorphism. In this study, using the 454 Roche platform (pyrosequencing) techniques, we evaluated a major portion of the transcriptome of this important Amazonian species. Results Four libraries obtained from the liver and skin tissue of juvenile specimens (representing males and females separately) were sequenced, yielding 5,453,919 high-quality reads. The de novo transcriptome assembly resulted in 175,792 contigs, with 51,057 significant blast hits. A total of 38,586 transcripts were mapped by Gene Ontology using Blast2GO. We identified 20,219 genes in the total transcriptome (9,551 in the liver and 16,818 in the skin). The gene expression analyses indicated 105 genes in the liver and 204 in the skin with differentiated expression profiles, with 95 being over-expressed in the females and 214 in the males. The log2 Fold Change and heatmap based on Reads Per Kilobase per Million mapped reads (RPKM) revealed that the gene expression in the skin is highly differentiated between male and female arapaima, while the levels of expression in the liver are similar between the sexes. Conclusion Transcriptome analysis based on pyrosequencing proved to be a reliable tool for the identification of genes with differentiated expression profiles between male and female arapaima. These results provide useful insights into the molecular pathways of sexual dimorphism in this important Amazonian species, and for comparative analyses with other teleosts.	[Watanabe, Luciana; Gomes, Fatima; Schneider, Horacio; Sampaio, Iracilda] Univ Fed Para, Inst Estudos Costeiros IECOS, Lab Genet & Biol Mol, Campus Braganca, Belem, Para, Brazil; [Vianez, Joao; Nunes, Marcie; Cardoso, Jedson; Lima, Clayton] IEC, CIT, Ananindeua, Para, Brazil	Universidade Federal do Para	Watanabe, L (corresponding author), Univ Fed Para, Inst Estudos Costeiros IECOS, Lab Genet & Biol Mol, Campus Braganca, Belem, Para, Brazil.	lwatanabe@ufpa.br			Center of Technological Innovation (CIT); Evandro Chagas Institute (IEC); National Council of Scientific and Technological Development (CNPq) [550939/2010-5]; Bionorte Project; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Center of Technological Innovation (CIT); Evandro Chagas Institute (IEC); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Bionorte Project; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was funded by the Center of Technological Innovation (CIT), Evandro Chagas Institute (IEC) and National Council of Scientific and Technological Development (CNPq) (Bionorte Project: 550939/2010-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank of the Centro de Inovacoes Tecnologicas (CIT) and Instituto Evandro Chagas (IEC) for the assistance and support for the development of this research. Bionorte Project and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for the PhD scholarship granted. I would like to thank Dr. Carlos Cordeiro for his assistance in sample collection and Dr. Cristiana Maciel for the availability of her laboratory to perform RNA extraction.	Adams J., 2008, TRANSCRIPTOME CONNEC; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Araipe J, 2013, PLOS ONE, V81; Arantes CC, 2013, ENVIRON BIOL FISH, V96, P1257, DOI 10.1007/s10641-011-9917-9; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Austin CM, 2015, GENOME BIOL EVOL, V7, P2885, DOI 10.1093/gbe/evv186; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Barsh GS, 2006, PIGMENTARY SYSTEM, P395, DOI DOI 10.1002/9780470987100.CH19; Bezerra RF, 2014, SCI WORLD J, DOI 10.1155/2014/541278; Bian C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24501; Bilandzija H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080823; Bondurand N, 2007, AM J HUM GENET, V81, P1169, DOI 10.1086/522090; Burton D, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P489; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Candolin U, 1999, P ROY SOC B-BIOL SCI, V266, P785, DOI 10.1098/rspb.1999.0706; Castello L, 2008, J FISH BIOL, V72, P1520, DOI 10.1111/j.1095-8649.2007.01778.x; Cavero BAS, 2002, GLOBAL AQUACULTURE A, V5, P56; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chu-Koo F, 2009, FISH PHYSIOL BIOCHEM, V35, P125, DOI 10.1007/s10695-008-9211-8; Clotfelter ED, 2007, BEHAV ECOL, V18, P1139, DOI 10.1093/beheco/arm090; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; delMarmol V, 1996, FEBS LETT, V381, P165, DOI 10.1016/0014-5793(96)00109-3; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du FK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-558; Elliott DG, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P471; Elliott Diane G., 2000, P271, DOI 10.1016/B978-012529650-2/50023-8; Evans ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118378; Faria MT, 2013, FISH PHYSIOL BIOCHEM, V39, P683, DOI 10.1007/s10695-012-9730-1; Farias IP, 2003, MOL ECOL NOTES, V3, P128, DOI 10.1046/j.1471-8286.2003.00375.x; Farias IP, 2015, NEOTROP ICHTHYOL, V13, P195, DOI 10.1590/1982-0224-20140010; Ferraris Jr C. J., 2003, CHECK LIST FRESHWATE, P470; FONTENELE OSMAR, 1948, REV BRASIL BIOL, V8, P445; Forconi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056006; Frank M, 1999, J NEUROCHEM, V73, P587, DOI 10.1046/j.1471-4159.1999.0730587.x; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fuller GM, 2006, ANN N Y ACAD SC, V936, P469; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hale MC, 2010, GENETICA, V138, P745, DOI 10.1007/s10709-010-9455-y; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; Hrbek T, 2005, ANIM CONSERV, V8, P297, DOI 10.1017/S1367943005002210; Hu QM, 2013, COMP BIOCHEM PHYS B, V165, P181, DOI 10.1016/j.cbpb.2013.03.007; Imbiriba Emir Palmeira, 2001, Acta Amazonica, V31, P299, DOI 10.1590/1809-43922001312316; Jain M, 2012, BRIEF FUNCT GENOMICS, V11, P63, DOI 10.1093/bfgp/elr038; Jensen LE, 1998, BIOCHEM J, V334, P489, DOI 10.1042/bj3340489; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelsh RN, 2004, PIGM CELL RES, V17, P326, DOI 10.1111/j.1600-0749.2004.00174.x; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Kumazawa Y, 2000, MOL BIOL EVOL, V17, P1869, DOI 10.1093/oxfordjournals.molbev.a026288; Kuo FT, 2009, CELL SIGNAL, V21, P1935, DOI 10.1016/j.cellsig.2009.09.001; Lamatsch DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118214; Lavoue S, 2004, MOL PHYLOGENET EVOL, V33, P171, DOI 10.1016/j.ympev.2004.04.021; Li J, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.105; Liao XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062308; Lopes K., 2009, Uakari, V5, P39; Lu JG, 2015, MAR BIOTECHNOL, V17, P613, DOI 10.1007/s10126-015-9650-z; Maan ME, 2006, BEHAV ECOL, V17, P691, DOI 10.1093/beheco/ark020; Machado JP, 2014, J HERED, V105, P237, DOI 10.1093/jhered/est087; Mastrochirico VA, 2016, CONSERV GENET RESOUR, V8, P109, DOI 10.1007/s12686-016-0521-3; Menezes RSDE, 1951, SERIE ESTUDOS TECNIC; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mo YY, 2004, CANCER RES, V64, P2793, DOI 10.1158/0008-5472.CAN-03-2410; Modig C, 2006, BIOL REPROD, V75, P717, DOI 10.1095/biolreprod.106.050757; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NESBITT JE, 1991, BIOCHIM BIOPHYS ACTA, V1089, P88, DOI 10.1016/0167-4781(91)90089-5; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Palstra AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053171; Parichy DM, 2006, HEREDITY, V97, P200, DOI 10.1038/sj.hdy.6800867; Carreiro Carlos Riedel Porto, 2011, Acta Amaz., V41, P415, DOI 10.1590/S0044-59672011000300012; Prado-Lima M., 2015, International Journal of Fisheries and Aquaculture, V7, P132; Prado-Lima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152366; Queiroz HL, 1999, ESTRATEGIAS MANEJO R, P108; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Rose E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139401; ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345; Salem M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121778; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Sawaya P, 1946, ZOOLOGY, V11, P255; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schulze Thomas T, 2016, J Genomics, V4, P29, DOI 10.7150/jgen.16885; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Sevilhano T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183545; Shen XY, 2014, MOL ECOL RESOUR, V14, P622, DOI 10.1111/1755-0998.12212; Shetty J, 2003, J BIOL CHEM, V278, P30506, DOI 10.1074/jbc.M301713200; Snell WJ, 1996, CELL, V85, P629, DOI 10.1016/S0092-8674(00)81230-1; Tao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063604; Thomas PD, 2007, CURR OPIN CHEM BIOL, V11, P4, DOI 10.1016/j.cbpa.2006.11.039; Tokuhiro K, 2015, SCI REP-UK, V5, DOI 10.1038/srep14254; UHLAR CM, 1994, GENOMICS, V19, P228, DOI 10.1006/geno.1994.1052; Wang Y, 2013, SCI CHINA LIFE SCI, V56, P975, DOI 10.1007/s11427-013-4563-4; Wooton RJ, 1990, ECOLOGY TELEOST FI 1, V1; Yu Y, 2010, GENOMICS, V96, P281, DOI 10.1016/j.ygeno.2010.08.003; Zeng QF, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.138818	96	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206379	10.1371/journal.pone.0206379	http://dx.doi.org/10.1371/journal.pone.0206379			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372461	Green Submitted, Green Published, gold			2022-12-26	WOS:000448641200034
J	Lasithiotaki, I; Tsitoura, E; Samara, KD; Trachalaki, A; Charalambous, I; Tzanakis, N; Antoniou, KM				Lasithiotaki, Ismini; Tsitoura, Eliza; Samara, Katerina D.; Trachalaki, Athina; Charalambous, Irini; Tzanakis, Nikolaos; Antoniou, Katerina M.			NLRP3/Caspase-1 inflammasome activation is decreased in alveolar macrophages in patients with lung cancer	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; PREMETASTATIC NICHE; NECROSIS-FACTOR; KAPPA-B; IL-18; EXPRESSION; APOPTOSIS; CYTOKINES; DISEASE; CARCINOGENESIS	Lung cancer (LC) remains the leading cause of cancer-related mortality. The interaction of cancer cells with their microenvironment, results in tumor escape or elimination. Alveolar macrophages (AMs) play a significant role in lung immunoregulation, however their role in LC has been outshined by the study of tumor associated macrophages. Inflammasomes are key components of innate immune responses and can exert either tumor-suppressive or oncogenic functions, while their role in lung cancer is largely unknown. We thus investigated the NLRP3 pathway in Bronchoalveolar Lavage derived alveolar macrophages and peripheral blood leukocytes from patients with primary lung cancer and healthy individuals. IL-1 beta and IL-18 secretion was significantly higher in unstimulated peripheral blood leukocytes from LC patients, while IL-1 beta secretion could be further increased upon NLRP3 stimulation. In contrast, in LC AMs, we observed a different profile of IL-1 beta secretion, characterized mainly by the impairment of IL-1 beta production in NLRP3 stimulated cells. AMs also exhibited an impaired TLR4/LPS pathway as shown by the reduced induction of IL-6 and TNF-alpha. Our results support the hypothesis of tumour induced immunosuppression in the lung microenvironment and may provide novel targets for cancer immunotherapy.	[Lasithiotaki, Ismini; Tsitoura, Eliza; Samara, Katerina D.; Trachalaki, Athina; Charalambous, Irini; Tzanakis, Nikolaos; Antoniou, Katerina M.] Univ Crete, Med Sch, Lab Cellular & Mol Pulmonol, Iraklion, Crete, Greece; [Tzanakis, Nikolaos; Antoniou, Katerina M.] Univ Hosp Heraklion, Dept Thorac Med, Interstitial Lung Dis Unit, Iraklion, Crete, Greece	University of Crete; University Hospital of Heraklion	Antoniou, KM (corresponding author), Univ Crete, Med Sch, Lab Cellular & Mol Pulmonol, Iraklion, Crete, Greece.; Antoniou, KM (corresponding author), Univ Hosp Heraklion, Dept Thorac Med, Interstitial Lung Dis Unit, Iraklion, Crete, Greece.	kantoniou@med.uoc.gr	Tsitoura, Eliza/AAE-9046-2020; Lasithiotaki, Ismini/B-4847-2017	Lasithiotaki, Ismini/0000-0001-5089-7547				Ahn MC, 1997, CANCER IMMUNOL IMMUN, V45, P37, DOI 10.1007/s002620050398; Awad F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175336; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Ben-Baruch A, 2006, SEMIN CANCER BIOL, V16, P38, DOI 10.1016/j.semcancer.2005.07.006; Berenson CS, 2016, IMMUNOL INVEST, V45, P130, DOI 10.3109/08820139.2015.1113427; Berenson CS, 2014, THORAX, V69, P811, DOI 10.1136/thoraxjnl-2013-203669; Berenson CS, 2013, J INFECT DIS, V208, P2036, DOI 10.1093/infdis/jit400; Biswas SK, 2013, SEMIN IMMUNOPATHOL, V35, P585, DOI 10.1007/s00281-013-0367-7; Chen WS, 2011, FRONT BIOSCI-LANDMRK, V16, P1172, DOI 10.2741/3782; Choulaki C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0775-2; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Conway EM, 2016, AM J RESP CRIT CARE, V193, P116, DOI 10.1164/rccm.201508-1545CI; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Economidou F, 2010, J RECEPT SIG TRANSD, V30, P154, DOI 10.3109/10799891003671147; Eifuku R, 2000, JPN J CLIN ONCOL, V30, P295, DOI 10.1093/jjco/hyd077; El-Shimy W. S., 2014, J BRONCHOL, V8, P91, DOI DOI 10.4103/1687-8426.145698; GATTI E, 1995, EUR RESPIR J, V8, P1566; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gomes M, 2014, ADV EXP MED BIOL, V816, P1, DOI 10.1007/978-3-0348-0837-8_1; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guo BC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36107; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Juarez E, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-2; Kang MJ, 2007, J IMMUNOL, V178, P1948, DOI 10.4049/jimmunol.178.3.1948; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karki R, 2017, CANC IMMUNOLOGY RES; Kataki A, 2002, J LAB CLIN MED, V140, P320, DOI 10.1067/mlc.2002.128317; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Kong H, 2015, TUMOR BIOL, V36, P7501, DOI 10.1007/s13277-015-3473-4; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Lasithiotaki I, 2016, EUR RESPIR J, V47, P910, DOI 10.1183/13993003.00564-2015; Lasithiotaki I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027800; Lentsch AB, 1996, J LEUKOCYTE BIOL, V60, P51, DOI 10.1002/jlb.60.1.51; Li L, 1997, TOXICOL APPL PHARM, V145, P331, DOI 10.1006/taap.1997.8189; Ma XW, 2015, SCI REP-UK, V4, DOI 10.1038/srep09918; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Ohri CM, 2009, EUR RESPIR J, V33, P118, DOI 10.1183/09031936.00065708; Park CC, 2001, J IMMUNOL, V167, P1644, DOI 10.4049/jimmunol.167.3.1644; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Pons AR, 2005, EUR RESPIR J, V25, P647, DOI 10.1183/09031936.05.00062304; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Pouniotis DS, 2006, CLIN EXP IMMUNOL, V143, P363, DOI 10.1111/j.1365-2249.2006.02998.x; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Sharma SK, 2015, J IMMUNOL, V194, P5529, DOI 10.4049/jimmunol.1403215; Shi HF, 2017, INT J CANCER, V140, P1370, DOI 10.1002/ijc.30538; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Sidiropoulos PI, 2008, ANN RHEUM DIS, V67, P1382, DOI 10.1136/ard.2007.078014; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tan TT, 2007, CURR OPIN IMMUNOL, V19, P209, DOI 10.1016/j.coi.2007.01.001; Terlizzi M, 2016, ONCOTARGET, V7, P58181, DOI 10.18632/oncotarget.11276; Tomechko SE, 2015, PROTEOMICS, V15, P3797, DOI 10.1002/pmic.201400496; Unver N, 2018, INT J CANCER, V142, P1405, DOI 10.1002/ijc.31152; Vogelmeier CF, 2017, EUR RESPIR J, V49, DOI [10.1183/13993003.00214-2017, 10.1016/j.arbres.2017.02.001, 10.1111/resp.13012, 10.1164/rccm.201701-0218PP]; Wang L, 2014, CANCER RES, V74, P4720, DOI 10.1158/0008-5472.CAN-14-0960; Wang X, 2008, ACTA PHARMACOL SIN, V29, P1275, DOI 10.1111/j.1745-7254.2008.00889.x; Yang IV, 2011, AM J RESP CRIT CARE, V183, P1295, DOI 10.1164/rccm.201010-1579PP; Yi H, 2012, INT J ONCOL, V41, P310, DOI 10.3892/ijo.2012.1447; Zaynagetdinov R, 2016, ONCOTARGET, V7, P5470, DOI 10.18632/oncotarget.6562; Zhao S, 2004, J CELL PHYSIOL, V199, P47, DOI 10.1002/jcp.10453; Zhu QF, 2017, J IMMUNOL, V198, P4210, DOI 10.4049/jimmunol.1700352; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	66	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0205242	10.1371/journal.pone.0205242	http://dx.doi.org/10.1371/journal.pone.0205242			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365491	Green Published, Green Submitted, gold			2022-12-26	WOS:000448448700008
J	Yau, KPS; Murphy, AB; Zhong, L; Mai-Prochnow, A				Yau, Ka Pui Sharon; Murphy, Anthony B.; Zhong, Ling; Mai-Prochnow, Anne			Cold plasma effect on the proteome of Pseudomonas aeruginosa - Role for bacterioferritin	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PLASMA; INACTIVATION; BIOFILMS; RESISTANCE; FERRITIN; LIBRARY; CELLS	Cold atmospheric-pressure plasma (CAP) is a relatively new method used for bacterial inactivation. CAP is ionized gas that can be generated by applying an electric current to air or a feeding gas. It contains reactive species and emits UV radiation, which have antibacterial activity. Previous data suggests that CAP is effective in microbial inactivation and can decontaminate and sterilize surfaces, but its exact mode of action is still under debate. This study demonstrates the effect of CAP on the whole proteome of Pseudomonas aeruginosa PAO1 biofilms, which is a dominant pathogen in cystic fibrosis and medical device-related infections. Liquid chromatography-mass spectrometry (LC-MS) was used to identify differentially regulated proteins of whole cell P. aeruginosa extracts. A total of 16 proteins were identified to be affected by plasma treatment compared to the control. Eight of the identified proteins have functions in transcription and translation and their expression changes are likely to be part of a general physiological response instead of a CAP-specific adaptation. However, CAP also affected bacterioferritin (Bfr), Isocitrate dehydrogenase (Idh), Trigger factor (Tig) and a chemotaxis protein, which may be involved in P. aeruginosa's specific response to CAP. We confirm that bacterioferritin B plays a role in the bacterial response to CAP because AbfrB mutants of both PAO1 and PA14 are more susceptible to plasma-induced cell-death than their corresponding wild-type strains. To our knowledge, this is the first study showing the effect of plasma on the whole proteome of a pathogenic microorganism. It will help our understanding of the mode of action of CAP-mediated bacterial inactivation and thus support a safe and effective routine use of CAP in clinical and industrial settings.	[Yau, Ka Pui Sharon; Murphy, Anthony B.; Mai-Prochnow, Anne] Commonwealth Sci & Ind Res Org CSIRO Mfg, Sydney, NSW, Australia; [Yau, Ka Pui Sharon] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Zhong, Ling] Univ New South Wales, Mark Wainwright Analyt Ctr, Bioanalyt Mass Spectrometry Facil, Sydney, NSW, Australia; [Yau, Ka Pui Sharon] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of New South Wales Sydney; University of New South Wales Sydney; Monash University	Mai-Prochnow, A (corresponding author), Commonwealth Sci & Ind Res Org CSIRO Mfg, Sydney, NSW, Australia.	anne.mai-prochnow@csiro.au	Murphy, Anthony B/A-7796-2008; Mai-Prochnow, Anne/D-3954-2013	Murphy, Anthony B/0000-0002-2820-2304; Mai-Prochnow, Anne/0000-0003-0136-9144	CSIRO OCE postdoctoral fellowship	CSIRO OCE postdoctoral fellowship	This work was partially funded by a CSIRO OCE postdoctoral fellowship to AM-P. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkawareek MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044289; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amato SM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00070; Bales PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067950; Bratlie MS, 2010, BMC GENOMICS, V11; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0; Fraud S, 2011, ANTIMICROB AGENTS CH, V55, P1068, DOI 10.1128/AAC.01495-10; Frein D, 2005, BIOCHEM PHARMACOL, V70, P811, DOI 10.1016/j.bcp.2005.04.012; Frieden T, 2013, CS239559B CTR DIS CO; Goeres DM, 2005, MICROBIOL-SGM, V151, P757, DOI 10.1099/mic.0.27709-0; Haber F., 1934, P R SOC LOND A, V147, P332, DOI [10.1098/rspa.1934.0221, DOI 10.1098/RSPA.1934.0221, DOI 10.1098/rspa.1934.0221]; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Itooka K, 2016, APPL MICROBIOL BIOT, V100, P9295, DOI 10.1007/s00253-016-7783-2; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jahid IK, 2014, COMPR REV FOOD SCI F, V13, P990, DOI 10.1111/1541-4337.12087; Joaquin JC, 2009, MICROBIOL-SGM, V155, P724, DOI 10.1099/mic.0.021501-0; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Kapatral V, 2000, J BACTERIOL, V182, P1333, DOI 10.1128/JB.182.5.1333-1339.2000; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Ortega-Roldan JL, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp211; Mai-Prochnow A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130373; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Penesyan A, 2015, MOLECULES, V20, P5286, DOI 10.3390/molecules20045286; Poole K, 2012, J ANTIMICROB CHEMOTH, V67, P2069, DOI 10.1093/jac/dks196; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Seneviratne CJ, 2012, PROTEOMICS, V12, P651, DOI 10.1002/pmic.201100356; Shawar RM, 1999, ANTIMICROB AGENTS CH, V43, P2877, DOI 10.1128/AAC.43.12.2877; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Smith JL, 2004, CRIT REV MICROBIOL, V30, P173, DOI 10.1080/10408410490435151; Wardman P, 1996, RADIAT RES, V145, P523, DOI 10.2307/3579270; WEINBERG ED, 1978, MICROBIOL REV, V42, P45, DOI 10.1128/MMBR.42.1.45-66.1978; Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067; Winsor GL, 2011, NUCL ACIDS RES, V39; Wu Y, 2015, APPL ENVIRON MICROB, V81, P996, DOI 10.1128/AEM.03322-14; Zelaya AJ, 2010, IEEE T PLASMA SCI, V38, P3398, DOI 10.1109/TPS.2010.2082570	39	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206530	10.1371/journal.pone.0206530	http://dx.doi.org/10.1371/journal.pone.0206530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365553	Green Published, gold, Green Submitted			2022-12-26	WOS:000448448700060
J	Allegre, J; Cartier, J; Glorian, V; Droin, N; Dumetier, B; Kayaci, C; Berthelet, J; Gemble, S; Vuillier, C; Maillet, L; Garrido, C; Dubrez, L				Allegre, Jennifer; Cartier, Jessy; Glorian, Valerie; Droin, Nathalie; Dumetier, Baptiste; Kayaci, Cemile; Berthelet, Jean; Gemble, Simon; Vuillier, Celine; Maillet, Laurent; Garrido, Carmen; Dubrez, Laurence			E2F1 binds to the peptide-binding groove within the BIR3 domain of cIAP1 and requires cIAP1 for chromatin binding	PLOS ONE			English	Article							APOPTOSIS PROTEIN-1 CIAP1; X-LINKED INHIBITOR; CELLULAR INHIBITOR; UBIQUITIN LIGASES; STRUCTURAL BASIS; IAP; XIAP; DEGRADATION; SMAC/DIABLO; C-IAP1	The cellular inhibitor of apoptosis 1 (cIAP1) is an E3-ubiquitin ligase that regulates cell signaling pathways involved in fundamental cellular processes including cell death, cell proliferation, cell differentiation and inflammation. It recruits ubiquitination substrates thanks to the presence of three baculoviral IAP repeat (BIR) domains at its N-terminal extremity. We previously demonstrated that cIAP1 promoted the ubiquitination of the E2 factor 1 (E2F1) transcription factor. Moreover, we showed that cIAP1 was required for E2F1 stabilization during the S phase of cell cycle and in response to DNA damage. Here, we report that E2F1 binds within the cIAP1 BIR3 domain. The BIR3 contains a surface hydrophobic groove that specifically anchors a conserved IAP binding motif (IBM) found in a number of intracellular proteins including Smac. The Smac N-7 peptide that includes the IBM, as well as a Smac mimetic, competed with E2F1 for interaction with cIAP1 demonstrating the importance of the BIR surface hydrophobic groove. We demonstrated that the first alpha-helix of BIR3 was required for E2F1 binding, as well as for the binding of Smac and Smac mimetics. Overexpression of cIAP1 modified the ubiquitination profile of E2F1, increasing the ratio of E2F1 conjugated with K11- and K63-linked ubiquitin chains, and decreasing the proportion of E2F1 modified by K48-linked ubiquitin chains. ChIP-seq analysis demonstrated that cIAP1 was required for the recruitment of E2F1 onto chromatin. Lastly, we identified an E2Fbinding site on the cIAP1-encoding birc2 gene promoter, suggesting a retro-control regulation loop.	[Allegre, Jennifer; Cartier, Jessy; Glorian, Valerie; Dumetier, Baptiste; Kayaci, Cemile; Berthelet, Jean; Gemble, Simon; Garrido, Carmen; Dubrez, Laurence] Inserm, LNC UMR1231, Dijon, France; [Allegre, Jennifer; Cartier, Jessy; Glorian, Valerie; Dumetier, Baptiste; Kayaci, Cemile; Berthelet, Jean; Gemble, Simon; Garrido, Carmen; Dubrez, Laurence] Univ Bourgogne Franche Comte, LNC UMR1231, Dijon, France; [Droin, Nathalie] Gustave Roussy, Inserm U1170, Villejuif, France; [Vuillier, Celine; Maillet, Laurent] Univ Nantes, INSERM, CRCINA, U1232, Nantes, France; [Cartier, Jessy] Univ Edinburgh, Univ British Heart Fdn, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Berthelet, Jean] Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; University of Edinburgh; La Trobe University; Olivia Newton-John Cancer Research Institute	Dubrez, L (corresponding author), Inserm, LNC UMR1231, Dijon, France.; Dubrez, L (corresponding author), Univ Bourgogne Franche Comte, LNC UMR1231, Dijon, France.	ldubrez@u-bourgogne.fr	Laurence, Dubrez/P-9472-2019; Dubrez, Laurence/I-4971-2016; Garrido, Carolina/GWM-5557-2022; Garrido, carmen/G-1633-2018; Droin, Nathalie M/Y-5506-2018; MAILLET, Laurent/K-7959-2015	Laurence, Dubrez/0000-0002-7030-2181; Dubrez, Laurence/0000-0002-7030-2181; Garrido, carmen/0000-0003-1368-1493; Droin, Nathalie M/0000-0002-6099-5324; MAILLET, Laurent/0000-0002-8169-060X; Berthelet, Jean/0000-0003-2562-0575; DUMETIER, Baptiste/0000-0001-9087-2344	'Comites de Cote d'Or et de l'Yonne' of the 'Ligue Contre le Cancer'; European Union; Conseil Regional de Bourgogne; French Government under the program "Investissements d'Avenir" [ANR-11-LABX-0021]; 'Ministere de l'Enseignement Superieur et de la Recherche' of France; Ligue Nationale Contre le Cancer; 'Fondation pour la Recherche Medicale' (FRM)	'Comites de Cote d'Or et de l'Yonne' of the 'Ligue Contre le Cancer'; European Union(European Commission); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); French Government under the program "Investissements d'Avenir"(French National Research Agency (ANR)); 'Ministere de l'Enseignement Superieur et de la Recherche' of France; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); 'Fondation pour la Recherche Medicale' (FRM)(Fondation pour la Recherche Medicale)	This work was supported by grants from the 'Comites de Cote d'Or et de l'Yonne' of the 'Ligue Contre le Cancer' (LD), the 'European Union' and the 'Conseil Regional de Bourgogne', a French Government grant managed by the 'French National Research Agency' under the program "Investissements d'Avenir" (reference ANR-11-LABX-0021), and fellowships from the 'Ministere de l'Enseignement Superieur et de la Recherche' of France (to JA, JB, JC, BD), 'Ligue Nationale Contre le Cancer' (VG) and the 'Fondation pour la Recherche Medicale' (FRM)(to JB).	Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Bornstein B, 2011, APOPTOSIS, V16, P869, DOI 10.1007/s10495-011-0622-0; Budhavarapu VN, 2012, CELL CYCLE, V11, P2030, DOI 10.4161/cc.20643; Budhidarmo R, 2015, SEMIN CELL DEV BIOL, V39, P80, DOI 10.1016/j.semcdb.2014.12.002; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Cao ZP, 2014, ONCOTARGET, V5, P7126, DOI 10.18632/oncotarget.2227; Cartier J, 2011, J BIOL CHEM, V286, P26406, DOI 10.1074/jbc.M110.191239; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Corn JE, 2014, NAT STRUCT MOL BIOL, V21, P297, DOI 10.1038/nsmb.2808; Didelot C, 2008, CELL DEATH DIFFER, V15, P859, DOI 10.1038/sj.cdd.4402320; Dogan T, 2008, NAT CELL BIOL, V10, P1447, DOI 10.1038/ncb1804; Dubrez L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102188; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Eckelman BP, 2008, CELL DEATH DIFFER, V15, P920, DOI 10.1038/cdd.2008.6; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Ertosun MG, 2016, CYTOKINE GROWTH F R, V31, P17, DOI 10.1016/j.cytogfr.2016.02.001; Estornes Y, 2015, SEMIN CELL DEV BIOL, V39, P106, DOI 10.1016/j.semcdb.2014.03.035; Galvan V, 2004, FEBS LETT, V558, P57, DOI 10.1016/S0014-5793(03)01488-1; Glorian V, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.222; Hashimoto Y, 2015, FEBS LETT, V589, P2241, DOI 10.1016/j.febslet.2015.06.041; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Jin HS, 2011, BIOCHEM BIOPH RES CO, V412, P454, DOI 10.1016/j.bbrc.2011.07.117; Julian LM, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00161; Kocab AJ, 2016, FEBS J, V283, P221, DOI 10.1111/febs.13554; Kulathila R, 2009, ACTA CRYSTALLOGR D, V65, P58, DOI 10.1107/S0907444908039243; Kurakin A, 2007, J MOL RECOGNIT, V20, P39, DOI 10.1002/jmr.809; Lee S, 2014, J BIOL CHEM, V289, P30680, DOI 10.1074/jbc.M114.587808; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Luque LE, 2002, BIOCHEMISTRY-US, V41, P13663, DOI 10.1021/bi0263964; Mace PD, 2010, J MOL BIOL, V400, P8, DOI 10.1016/j.jmb.2010.04.055; Maine GN, 2009, BIOCHEM J, V417, P601, DOI 10.1042/BJ20080854; Marivin A, 2014, ONCOGENE, V33, P5534, DOI 10.1038/onc.2013.499; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Munro S, 2012, ONCOGENE, V31, P4343, DOI 10.1038/onc.2011.603; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Ohta T, 2001, CANCER RES, V61, P1347; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Qi YF, 2012, J BIOL CHEM, V287, P32236, DOI 10.1074/jbc.M112.362160; Reingewertz TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024655; Silke J, 2000, CELL DEATH DIFFER, V7, P1275, DOI 10.1038/sj.cdd.4400790; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Tenev T, 2005, NAT CELL BIOL, V7, P70, DOI 10.1038/ncb1204; Verhagen AM, 2007, CELL DEATH DIFFER, V14, P348, DOI 10.1038/sj.cdd.4402001; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 1998, J BIOL CHEM, V273, P33915, DOI 10.1074/jbc.273.51.33915; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Xu L, 2007, MOL CELL, V28, P914, DOI 10.1016/j.molcel.2007.10.027; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Young SS, 1999, MAMM GENOME, V10, P44; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286; Zhuang M, 2013, MOL CELL, V49, P273, DOI 10.1016/j.molcel.2012.10.022	54	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206253	10.1371/journal.pone.0206253	http://dx.doi.org/10.1371/journal.pone.0206253			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359437	Green Published, gold, Green Submitted			2022-12-26	WOS:000448438400058
J	Chidumayo, NN				Chidumayo, Nozyechi Ngulube			System dynamics modelling approach to explore the effect of dog demography on rabies vaccination coverage in Africa	PLOS ONE			English	Article							MACHAKOS DISTRICT; PUBLIC-HEALTH; CANINE RABIES; ECOLOGY; POPULATION; MANAGEMENT; CAMPAIGN; BAMAKO; WORLD	Background Dogs are important reservoirs of rabies, a zoonotic viral encephalitis that kills thousands of people in Asia and Africa annually. Mass dog vaccination is recommended for the prevention of rabies in both humans and dogs. Mass vaccinations should be conducted annually but more frequent campaigns may be required in areas with high dog turnover rates. Consequently, a good understanding of dog demography is essential for the control of the disease. The aim of this study was to explore the effect of dog demography on rabies vaccination coverage following a mass vaccination campaign with at least 70% vaccination coverage. Methodology/Principal findings A dog population model was constructed to explore the effect of dog demography on rabies vaccination coverage decline. Important model parameters were identified through a comprehensive literature search on dog demography in Africa. A system dynamics approach was adopted to build a dog population model to simulate the effects of demographic processes on rabies vaccination coverage. Vensim PLE Plus software was used to construct the model. Multivariate sensitivity simulations using data from 22 studies and 12 African countries were performed to investigate the effect of dog turnover rates on vaccination coverage decline. In addition, an adjusted vaccination coverage to estimate the proportion of vaccinated dogs with adequate immunity at 12 months post-vaccination was calculated. The results demonstrated that the vaccination coverage and adjusted vaccination coverage remained over 30% and 20% respectively at 12 months if annual mass vaccinations achieved at least 70% coverage. Conclusions/Significance The results demonstrated that annual mass vaccination campaigns with at least 70% vaccination coverage would maintain a herd immunity of 20-45% between campaigns.	[Chidumayo, Nozyechi Ngulube] Univ Zambia, Sch Vet Med, Clin Studies Dept, Lusaka, Zambia	University of Zambia	Chidumayo, NN (corresponding author), Univ Zambia, Sch Vet Med, Clin Studies Dept, Lusaka, Zambia.	nozyechic@yahoo.com						AGHOMO HO, 1990, VET RES COMMUN, V14, P415, DOI 10.1007/BF00343220; Ahmed G, 2009, NVRI SEMINAR SERIES, P74; Aiyedun J. O., 2012, Sokoto Journal of Veterinary Sciences, V10, P22, DOI 10.4314/sokjvs.v10i1.5; [Anonymous], 2006, ELECT J BUSINESS RES; Atuman YJ, 2014, INT J VET SCI MED, V2, P41, DOI 10.1016/j.ijvsm.2014.04.001; Bahloul C, 2006, VACCINE, V24, P1063, DOI 10.1016/j.vaccine.2005.09.016; Butler JRA, 2000, VET REC, V147, P442, DOI 10.1136/vr.147.16.442; Chaves R, 2013, CHEMOSPHERE, V90, P2428, DOI 10.1016/j.chemosphere.2012.10.082; CHOMEL B, 1988, REV INFECT DIS, V10, pS697; Ciplak N, 2012, WASTE MANAGE RES, V30, P576, DOI 10.1177/0734242X12443405; Conan A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004177; Czupryna AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167092; Darkaoui S, 2016, CLIN EXP VACCINE RES, V5, P60, DOI 10.7774/cevr.2016.5.1.60; Davlin SL, 2012, VACCINE, V30, P3492, DOI 10.1016/j.vaccine.2012.03.069; DEBALOGH KKIM, 1993, ONDERSTEPOORT J VET, V60, P437; Ding ZK, 2016, WASTE MANAGE, V51, P130, DOI 10.1016/j.wasman.2016.03.001; Dlamini RX, 1999, DOG ECOLOGY SURVEY Q, P129; Garba A., 2017, J AGR ECOLOGY RES IN, V12, P1; Gibson AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004824; Gsell AS, 2012, BMC VET RES, V8, P1, DOI 10.1186/1746-6148-8-236; Hambolu Sunday Emmanuel, 2014, Glob J Health Sci, V6, P209, DOI 10.5539/gjhs.v6n2p209; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Hikufe EH, 2016, THESIS; Homer JB, 2006, AM J PUBLIC HEALTH, V96, P452, DOI 10.2105/AJPH.2005.062059; Hu RL, 2008, EPIDEMIOL INFECT, V136, P1556, DOI 10.1017/S0950268807000131; Hyeroba D, 2017, PREV VET MED, V137, P24, DOI 10.1016/j.prevetmed.2016.12.009; Jibat T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003447; Kayali U, 2003, B WORLD HEALTH ORGAN, V81, P739; Kitala P, 2001, ACTA TROP, V78, P217, DOI 10.1016/S0001-706X(01)00082-1; KITALA PM, 1993, ONDERSTEPOORT J VET, V60, P445; Knobel DL, 2017, VACCINE, V35, P3844, DOI 10.1016/j.vaccine.2017.05.095; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Laager M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006680; Laurenson K, 1997, ONDERSTEPOORT J VET, V64, P39; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; LeRoux K, 2018, B WORLD HEALTH ORGAN, V96, P360, DOI [10.2471/BLT.17.194886, 10.2471/blt.17.194886]; Mantik-Astawa I, 2012, INDONES J BIOMED SCI, V6, P26; Mauti S, 2017, PREV VET MED, V146, P44, DOI 10.1016/j.prevetmed.2017.07.009; Merial Animal Health, 2015, RABISIN DATA SHEET; Mojzisova J, 2007, ACTA PARASITOL, V52, P176, DOI 10.2478/s11686-007-0023-2; Morters MK, 2015, VET REC, V177, P150, DOI 10.1136/vr.102975; Morters MK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003160; Morters MK, 2014, J APPL ECOL, V51, P1096, DOI 10.1111/1365-2664.12279; MSD Animal Health, NOBIVAC RABIES SUMMA; Mshelbwala PP, 2018, ZOONOSES PUBLIC HLTH, V65, P168, DOI 10.1111/zph.12385; Muthiani Y, 2015, PREV VET MED, V120, P203, DOI 10.1016/j.prevetmed.2015.04.007; Nel LH, 2007, CURR TOP MICROBIOL, V315, P161; OKOLO MIO, 1986, J SMALL ANIM PRACT, V27, P471, DOI 10.1111/j.1748-5827.1986.tb03965.x; Omudu EA, 2010, J RES FORESTRY WILDL, V2, P85; Otolorin Gbeminiyi Richard, 2014, ISRN Vet Sci, V2014, P806849, DOI 10.1155/2014/806849; Poston DL Jr, 2010, WE ARE ALL POPULATIO, P3; Qudrat-Ullah H, 2005, 19TH EUROPEAN CONFER; Ratsitorahina M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-21; Ritchie-Dunham JL, 1999, SYST DYNAM REV, V15, P119, DOI 10.1002/(SICI)1099-1727(199922)15:2<119::AID-SDR163>3.0.CO;2-G; Rupprecht CE, 1996, PUBLIC HEALTH REP, V111, P400; RUPPRECHT CE, 1995, EMERG INFECT DIS, V1, P107, DOI 10.3201/eid0104.950401; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Seghaier C, 1999, AM J TROP MED HYG, V61, P879, DOI 10.4269/ajtmh.1999.61.879; Semwanga AR, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0101-8; Sharareh Nasser, 2016, PLoS Curr, V8; Tschopp R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004471; van Rijckevorsel GG, 2012, EUROSURVEILLANCE, V17, P12; Sittert SJ, 2010, J S AFR VET ASSOC, V81, P207; White J, 2007, CAN VET J, V48, P931; WHO, 2005, WHO SUMM CONCL 64 M, P47	65	9	9	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0205884	10.1371/journal.pone.0205884	http://dx.doi.org/10.1371/journal.pone.0205884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3GT	30359399	Green Submitted, Green Published, gold			2022-12-26	WOS:000448438400030
J	Lee, JH; Chang, YS; Ahn, SY; Sung, SI; Park, WS				Lee, Jang Hoon; Chang, Yun Sil; Ahn, So Yoon; Sung, Se In; Park, Won Soon			Dexamethasone does not prevent hydrocephalus after severe intraventricular hemorrhage in newborn rats	PLOS ONE			English	Article							INDUCED INTRACEREBRAL HEMATOMA; PRETERM INFANTS; POSTHEMORRHAGIC HYDROCEPHALUS; BRONCHOPULMONARY DYSPLASIA; BRAIN-DAMAGE; 1ST WEEK; INJURY; MODEL; METHYLPREDNISOLONE; TRANSPLANTATION	The aim of this study was done to determine whether dexamethasone treatment prevents posthemorrhagic hydrocephalus (PHH) development and attenuates brain damage after severe IVH in newborn rats. Severe IVH was induced by injecting; 100 mu L of blood into each lateral ventricle of postnatal day 4 (P4) Sprague-Dawley rats. Dexamethasone was injected intraperitoneally into rat pups at a dose of 0.5 mg/kg, 0.3 mg/kg, and 0.1 mg/kg on P5, P6, and P7, respectively. Serial brain magnetic resonance imaging and behavioral function tests, such as the negative geotaxis test and the rotarod test, were performed. On P32, brain tissues were obtained for histological and biochemical analyses. Dexamethasone treatment significantly improved the severe IVH-induced increase in the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling-positive cells, glial fibrillary acidic protein-positive astrocytes and ED-1 positive microglia, and the decrease in myelin basic protein. IVH reduced a survival of 71%, that showed a tendency to improve to 86% with dexamethasone treatment, although the result was not statistically significant. However, dexamethasone failed to prevent the progression to PHH and did not significantly improve impaired behavioral tests. Similarly, dexamethasone did not decrease the level of inflammatory cytokines such as interleukin (IL) -1 alpha and beta, IL-6, and tumor necrosis factor-a after severe IVH. Despite its some neuroprotective effects, dexamethasone failed to improve the progress of PHH and impaired behavioral tests after severe IVH.	[Lee, Jang Hoon] Ajou Univ, Dept Pediat, Sch Med, Suwon, South Korea; [Chang, Yun Sil; Ahn, So Yoon; Sung, Se In; Park, Won Soon] Sungkyunkwan Univ, Sch Med, Dept Pediat, Samsung Med Ctr, Seoul, South Korea; [Chang, Yun Sil; Park, Won Soon] Samsung Med Ctr, Stem Cell & Regenerat Med Inst, Seoul, South Korea; [Chang, Yun Sil; Park, Won Soon] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea	Ajou University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Park, WS (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Pediat, Samsung Med Ctr, Seoul, South Korea.; Park, WS (corresponding author), Samsung Med Ctr, Stem Cell & Regenerat Med Inst, Seoul, South Korea.; Park, WS (corresponding author), Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea.	wonspark@skku.edu		Lee, Jang Hoon/0000-0003-4765-9948	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HR14C0008]	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HR14C0008).	Ahn SY, 2013, STROKE, V44, P497, DOI 10.1161/STROKEAHA.112.679092; Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; BA A, 1995, NEUROSCI BIOBEHAV R, V19, P413, DOI 10.1016/0149-7634(94)00042-Y; Back SA, 2001, J NEUROSCI, V21, P1302; BARKS JDE, 1991, PEDIATR RES, V29, P558, DOI 10.1203/00006450-199106010-00008; Barnes PJ, 1999, NATURE, V402, pB31, DOI 10.1038/35037026; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; Bellavance MA, 2012, IMMUNOL REV, V248, P36, DOI 10.1111/j.1600-065X.2012.01129.x; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; Cherian S, 2004, BRAIN PATHOL, V14, P305; Chua CO, 2009, STROKE, V40, P3369, DOI 10.1161/STROKEAHA.109.549212; Dardzinski BJ, 2000, PEDIATR RES, V48, P248, DOI 10.1203/00006450-200008000-00021; Deshmukh M, 2018, ARCH DIS CHILD-FETAL, V103, pF173, DOI 10.1136/archdischild-2017-313840; Doyle LW, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub5; Doyle LW, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001145.pub4; Doyle LW, 2010, NEONATOLOGY, V98, P289, DOI 10.1159/000286212; Doyle LW, 2010, NEONATOLOGY, V98, P217, DOI 10.1159/000286210; Erler T, 2001, Z GEBURTSH NEONATOL, V205, P27, DOI 10.1055/s-2001-14554; Fang H, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-27; Feng Q, 2014, BRAIN RES, V1589, P37, DOI 10.1016/j.brainres.2014.09.029; Gay MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125033; Girard S, 2009, NEUROSCIENCE, V158, P673, DOI 10.1016/j.neuroscience.2008.10.032; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Herrera EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009250; Hudgins RJ, 1997, PEDIATR NEUROSURG, V26, P281, DOI 10.1159/000121207; Ildan F, 1995, SURG NEUROL, V44, P573; Kennedy C, 1998, LANCET, V352, P433; Kennedy CR, 2001, PEDIATRICS, V108, P597, DOI 10.1542/peds.108.3.597; Kim ES, 2012, PEDIATR RES, V72, P277, DOI 10.1038/pr.2012.71; Kim YE, 2016, PEDIATR RES, V80, P415, DOI 10.1038/pr.2016.88; Lang JT, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-33; LARROCHE JC, 1972, BIOL NEONATE, V20, P287; Lema PP, 2005, CAN J VET RES, V69, P253; Lema PP, 2004, J VET PHARMACOL THER, V27, P321, DOI 10.1111/j.1365-2885.2004.00597.x; McCrea HL, 2008, CLIN PERINATOL, V35, P777, DOI 10.1016/j.clp.2008.07.014; Murphy BP, 2002, ARCH DIS CHILD-FETAL, V87, pF37, DOI 10.1136/fn.87.1.F37; Nadeau S, 2003, J NEUROSCI, V23, P5536, DOI 10.1523/jneurosci.23-13-05536.2003; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; PANG D, 1986, NEUROSURGERY, V19, P547, DOI 10.1227/00006123-198610000-00009; Park WS, 2016, CELL TRANSPLANT, V25, P1131, DOI 10.3727/096368915X689640; Payne AH, 2013, JAMA PEDIATR, V167, P451, DOI 10.1001/jamapediatrics.2013.866; Peltoniemi OM, 2011, ACTA OBSTET GYN SCAN, V90, P719, DOI 10.1111/j.1600-0412.2011.01132.x; PERLMAN JM, 1986, AM J DIS CHILD, V140, P1122, DOI 10.1001/archpedi.1986.02140250048034; Savard C, 2009, COMPARATIVE MED, V59, P444; Savman K, 2002, ACTA PAEDIATR, V91, P1357; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Thorp JA, 2001, AM J OBSTET GYNECOL, V185, P859, DOI 10.1067/mob.2001.117355; Wang J, 2005, NEUROCRIT CARE, V3, P77, DOI 10.1385/NCC:3:1:077; Wang Y, 2018, CHILD NERV SYST, V34, P217, DOI 10.1007/s00381-017-3667-8; Whitelaw A, 2001, Semin Neonatol, V6, P135, DOI 10.1053/siny.2001.0047; Whitelaw A, 2002, ARCH DIS CHILD-FETAL, V86, P72, DOI 10.1136/fn.86.2.F72; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Yoo HS, 2013, PEDIATR RES, V73, P726, DOI 10.1038/pr.2013.51	54	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206306	10.1371/journal.pone.0206306	http://dx.doi.org/10.1371/journal.pone.0206306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359428	Green Published, gold, Green Submitted			2022-12-26	WOS:000448438400064
J	Arthun, M; Bogstad, B; Daewel, U; Keenlyside, NS; Sando, AB; Schrum, C; Ottersen, G				Arthun, Marius; Bogstad, Bjarte; Daewel, Ute; Keenlyside, Noel S.; Sando, Anne Britt; Schrum, Corinna; Ottersen, Geir			Climate based multi-year predictions of the Barents Sea cod stock	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; SUBPOLAR GYRE; GADUS-MORHUA; TEMPERATURE; RECRUITMENT; SHIFTS; VARIABILITY; ECOSYSTEMS; BIOMASS; OCEAN	Predicting fish stock variations on interannual to decadal time scales is one of the major issues in fisheries science and management. Although the field of marine ecological predictions is still in its infancy, it is understood that a major source of multi-year predictability resides in the ocean. Here we show the first highly skilful long-term predictions of the commercially valuable Barents Sea cod stock. The 7-year predictions are based on the propagation of ocean temperature anomalies from the subpolar North Atlantic toward the Barents Sea, and the strong co-variability between these temperature anomalies and the cod stock. Retrospective predictions for the period 1957-2017 capture well multi-year to decadal variations in cod stock biomass, with cross-validated explained variance of over 60%. For lead times longer than one year the statistical long-term predictions show more skill than operational short-term predictions used in fisheries management and lagged persistence forecasts. Our results thus demonstrate the potential for ecosystem-based fisheries management, which could enable strategic planning on longer time scales. Future predictions show a gradual decline in the cod stock towards 2024.	[Arthun, Marius; Keenlyside, Noel S.] Univ Bergen, Geophys Inst, N-5007 Bergen, Norway; [Arthun, Marius; Keenlyside, Noel S.; Sando, Anne Britt] Bjerknes Ctr Climate Res, N-5020 Bergen, Norway; [Bogstad, Bjarte; Sando, Anne Britt; Ottersen, Geir] Inst Marine Res, N-5817 Bergen, Norway; [Daewel, Ute; Schrum, Corinna] Helmholtz Zentrum Geesthacht, Ctr Mat & Coastal Res, D-21502 Geesthacht, Germany; [Ottersen, Geir] Univ Oslo, Ctr Ecol & Evolutionary Synth, Dept Biosci, N-0316 Oslo, Norway	University of Bergen; Bjerknes Centre for Climate Research; Institute of Marine Research - Norway; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; University of Oslo	Arthun, M (corresponding author), Univ Bergen, Geophys Inst, N-5007 Bergen, Norway.; Arthun, M (corresponding author), Bjerknes Ctr Climate Res, N-5020 Bergen, Norway.	marius.arthun@uib.no	Ottersen, Geir/M-9676-2019; Ottersen, Geir/AAS-3046-2020; Keenlyside, Noel S/E-8303-2013	Ottersen, Geir/0000-0002-9453-6679; Keenlyside, Noel S/0000-0002-8708-6868; Arthun, Marius/0000-0003-4500-1691; Daewel, Ute/0000-0003-2380-8427	Centre for Climate Dynamics at the Bjerknes Centre for Climate Research through the project PARADIGM; Research Council of Norway [229774, 263223]; Blue-Action project (European Union) [727852]	Centre for Climate Dynamics at the Bjerknes Centre for Climate Research through the project PARADIGM; Research Council of Norway(Research Council of Norway); Blue-Action project (European Union)	This research was funded by the Centre for Climate Dynamics at the Bjerknes Centre for Climate Research through the project PARADIGM, the Research Council of Norway projects EPOCASA (grant 229774) and PATHWAY (grant 263223), and the Blue-Action project (European Union's Horizon 2020 research and innovation program, grant 727852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Centre for Climate Dynamics at the Bjerknes Centre for Climate Research through the project PARADIGM, the Research Council of Norway projects EPOCASA (grant 229774) and PATHWAY (grant 263223), and the Blue-Action project (European Union's Horizon 2020 research and innovation program, grant 727852). We thank Keith Brander and two anonymous reviewers for constructive comments and suggestions that improved the manuscript.	Arthun M, 2012, J CLIMATE, V25, P4736, DOI 10.1175/JCLI-D-11-00466.1; Arthun M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15875; Bogstad B, 2016, CAN J FISH AQUAT SCI, V73, P246, DOI 10.1139/cjfas-2015-0093; Bogstad B, 2013, MAR BIOL RES, V9, P895, DOI 10.1080/17451000.2013.775451; Brander K, 2010, J MARINE SYST, V79, P389, DOI 10.1016/j.jmarsys.2008.12.015; BRANDER KM, 1995, ICES J MAR SCI, V52, P1, DOI 10.1016/1054-3139(95)80010-7; BREIMAN L, 1992, INT STAT REV, V60, P291, DOI 10.2307/1403680; Carmack E, 2006, PROG OCEANOGR, V71, P446, DOI 10.1016/j.pocean.2006.10.004; Dalpadado P, 2003, POLAR BIOL, V26, P233, DOI 10.1007/s00300-002-0470-z; Dalpadado P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095273; Dalpadado P, 2012, ICES J MAR SCI, V69, P1303, DOI 10.1093/icesjms/fss063; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Dippner JW, 2001, CLIMATE RES, V17, P73, DOI 10.3354/cr017073; Drinkwater KF, 2010, J MARINE SYST, V79, P374, DOI 10.1016/j.jmarsys.2008.12.014; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1327, DOI 10.1016/j.icesjms.2005.05.015; Dunstone N, 2016, NAT GEOSCI, V9, P809, DOI 10.1038/ngeo2824; Ebisuzaki W, 1997, J CLIMATE, V10, P2147, DOI 10.1175/1520-0442(1997)010<2147:AMTETS>2.0.CO;2; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Fossheim M, 2015, NAT CLIM CHANGE, V5, P673, DOI 10.1038/NCLIMATE2647; Gastineau G, 2015, J CLIMATE, V28, P1396, DOI 10.1175/JCLI-D-14-00424.1; Gonzalez-Pola C, 2018, ICES COOPERATIVE RES, V339, P110; Hatun H, 2005, SCIENCE, V309, P1841, DOI 10.1126/science.1114777; Hatun H, 2016, PROG OCEANOGR, V147, P49, DOI 10.1016/j.pocean.2016.07.009; Hatun H, 2009, PROG OCEANOGR, V80, P149, DOI 10.1016/j.pocean.2009.03.001; Haug T, 2017, FISH RES, V188, P38, DOI 10.1016/j.fishres.2016.12.002; Hjermann DO, 2007, P ROY SOC B-BIOL SCI, V274, P661, DOI 10.1098/rspb.2006.0069; Holliday NP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032675; Hollowed AB, 2014, SCIENCE, V344, P1084, DOI 10.1126/science.1251166; Howell D, 2013, MAR BIOL RES, V9, P920, DOI 10.1080/17451000.2013.775452; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Huse G, 2003, SCI MAR, V67, P325; ICES, 2018, REPORT OF THE ARCTIC; Kapsch ML, 2014, GEOPHYS RES LETT, V41, P5288, DOI 10.1002/2014GL060826; Kjesbu OS, 2014, P NATL ACAD SCI USA, V111, P3478, DOI 10.1073/pnas.1316342111; Korablev A., 2014, CLIMATOLOGICAL ATLAS; Langehaug HR, 2017, CLIM DYNAM, V48, P913, DOI 10.1007/s00382-016-3118-3; Loeng H, 2007, DEEP-SEA RES PT II, V54, P2478, DOI 10.1016/j.dsr2.2007.08.013; Muhling BA, 2018, ICES J MAR SCI, V75, P1341, DOI 10.1093/icesjms/fsy017; Myers RA, 1998, REV FISH BIOL FISHER, V8, P285, DOI 10.1023/A:1008828730759; Onarheim IH, 2015, GEOPHYS RES LETT, V42, P5364, DOI 10.1002/2015GL064359; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Ottersen G, 1998, ICES J MAR SCI, V55, P67, DOI 10.1006/jmsc.1997.0232; OTTERSEN G, 1994, ICES MAR SC, V198, P471; Oziel L, 2017, J GEOPHYS RES-OCEANS, V122, P5121, DOI 10.1002/2016JC012582; Payne MR, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00289; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Rose GA, 2000, CAN J FISH AQUAT SCI, V57, P644, DOI 10.1139/cjfas-57-3-644; Rutterford LA, 2015, NAT CLIM CHANGE, V5, P569, DOI 10.1038/nclimate2607; Skagseth O, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033785; Skern-Mauritzen M, 2016, FISH FISH, V17, P165, DOI 10.1111/faf.12111; Smedsrud LH, 2013, REV GEOPHYS, V51, P415, DOI 10.1002/rog.20017; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Sundby S, 2000, SARSIA, V85, P277, DOI 10.1080/00364827.2000.10414580; Sundby S, 2008, ICES J MAR SCI, V65, P953, DOI 10.1093/icesjms/fsn085; Svendsen E, 2007, DEEP-SEA RES PT II, V54, P2810, DOI 10.1016/j.dsr2.2007.07.033; TANDE KS, 1991, POLAR RES, V10, P389, DOI 10.1111/j.1751-8369.1991.tb00661.x; Tommasi D, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00201; Tommasi D, 2017, PROG OCEANOGR, V152, P15, DOI 10.1016/j.pocean.2016.12.011; Von Storch H., 2001, STAT ANAL CLIMATE RE; Yeager SG, 2017, CURR CLIM CHANGE REP, V3, P112, DOI 10.1007/s40641-017-0064-z; Yeager SG, 2015, GEOPHYS RES LETT, V42, P10704, DOI 10.1002/2015GL065364	61	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206319	10.1371/journal.pone.0206319	http://dx.doi.org/10.1371/journal.pone.0206319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356300	Green Submitted, Green Published, gold			2022-12-26	WOS:000448434000093
J	Tomasini-Johansson, BR; Zbyszynski, PW; Toraason, I; Peters, DM; Kwon, GS				Tomasini-Johansson, Bianca R.; Zbyszynski, Pawel W.; Toraason, Inger; Peters, Donna M.; Kwon, Glen S.			PEGylated pUR4/FUD peptide inhibitor of fibronectin fibrillogenesis decreases fibrosis in murine Unilateral Ureteral Obstruction model of kidney disease	PLOS ONE			English	Article							POLYACRYLAMIDE-GEL-ELECTROPHORESIS; RENAL INTERSTITIAL FIBROSIS; GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; PLASMA FIBRONECTIN; STREPTOCOCCUS-PYOGENES; DEPOSITION; COLLAGEN; NEPHROPATHY; ACTIVATION	Fibronectin is a blood and extracellular matrix glycoprotein that plays important roles in wound healing and fibrosis since it controls the deposition of collagen and other extracellular matrix molecules and is a substrate for infiltrating lymphocytes. Using a high-affinity fibronectin-binding peptide (FUD/pUR4) that inhibits fibronectin deposition into extracellular matrix (ECM), we tested the ability of a PEGylated FUD/pUR4 (PEG-FUD) to inhibit fibrosis in the Unilateral Ureteral Obstruction (UUO) kidney disease model. Fibronectin fibrillogenesis assays, using human fibroblasts and human proximal tubular epithelial cultures, showed that PEG-FUD can inhibit fibronectin fibrillogenesis in vitro with an IC50 similar to unconjugated FUD, in the order of 20-35 nM. In contrast, a mutated FUD (mFUD) conjugated to PEG that lacked activity did not inhibit fibronectin assembly, even at 20 mu M. The in vivo activity of PEG-FUD was tested in the murine UUO model by daily subcutaneous injection of 12.5 mg/kg for 7 days until harvest at day 10. Control treatments included saline, PEG, unconjugated FUD, and PEG-mFUD. Immunoblotting studies showed that fibronectin was enriched in the extracellular matrix fractions of extracted UUO kidneys, compared to contralateral untreated kidneys. In vivo, PEG-FUD significantly decreased fibronectin by similar to 70% in UUO kidneys as determined by both IHC and immunoblotting, respectively. In contrast, neither PEG-mFUD, PEG, nor saline had any significant effect. PEG-FUD also decreased collagens I and III and CD45-expressing cells (leukocytes) by similar to 60% and similar to 50%, as ascertained by picrosirius red staining and IHC, respectively. Immunoblotting studies also showed that the fibronectin remaining after PEG-FUD treatment was intact. Utilizing a custom-made polyclonal antibody generated against pUR4/FUD, intact PEG-FUD was detected by immunoblotting in both the ECM and lysate fractions of UUO kidneys. No adverse reaction or event was noted with any treatment. In summary, these studies suggest that PEG-FUD reached the kidneys without degradation, and decreased fibronectin incorporation into interstitial tissue. Decreased fibronectin was accompanied by a decrease in collagen and leukocyte infiltration. We propose that PEG-FUD, a specific inhibitor of fibronectin assembly, may be a candidate therapeutic for the treatment of fibrosis in kidney diseases.	[Tomasini-Johansson, Bianca R.; Zbyszynski, Pawel W.; Toraason, Inger; Kwon, Glen S.] Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA; [Peters, Donna M.] Univ Wisconsin, Sch Med & Publ Hlth, Pathol & Lab Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tomasini-Johansson, BR (corresponding author), Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA.	brtomasini@wisc.edu			National Institutes of Health [R01AI101157]; National Eye Institute [EY017006, EY0020490]; Department of Surgery, University of Wisconsin-Madison; NATIONAL EYE INSTITUTE [P30EY016665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Department of Surgery, University of Wisconsin-Madison; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Discretionary Funds from Hans Sollinger, Professor, Department of Surgery, University of Wisconsin-Madison; the National Institutes of Health, R01AI101157 (https://www.google.com/search?q=National+Institutes+of+Health&oq=National+Institutes+of+Health&aqs=chrome..69i57j0l5.6584j0j7&sourceid=chrome&ie=UTF-8) to GSK and the National Eye Institute, EY017006 and EY0020490 (https://www.google.com/search?q=national+eye+institute&oq=National+Eye+&aqs=chrome.0.0j69i57j0l4.4364j0j7&sourceid=chrome&ie=UTF-8) to DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENHOFFMANN BL, 1987, J BIOL CHEM, V262, P14361; Alonso J, 1996, KIDNEY INT, V50, P908, DOI 10.1038/ki.1996.391; Altrock E, 2015, J HEPATOL, V62, P625, DOI 10.1016/j.jhep.2014.06.010; Campbell D, 2015, J CLIN HYPERTENS, V17, P514, DOI 10.1111/jch.12560; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; Coito A J, 2000, Dev Immunol, V7, P239, DOI 10.1155/2000/98187; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Djamali A, 2016, TRANSPLANTATION, V100, P1198, DOI 10.1097/TP.0000000000001137; Djamali A, 2009, TRANSPLANTATION, V88, P1149, DOI 10.1097/TP.0b013e3181bcccea; Farris AB, 2014, AM J TRANSPLANT, V14, P897, DOI 10.1111/ajt.12641; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Filla MS, 2017, EXP EYE RES, V165, P7, DOI 10.1016/j.exer.2017.08.017; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Forbes MS, 2012, AM J PHYSIOL-RENAL, V303, pF120, DOI 10.1152/ajprenal.00110.2012; Genovese F, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-4; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hewitson TD, 2014, NEPHROLOGY, V19, P721, DOI 10.1111/nep.12321; HINES KL, 1994, P NATL ACAD SCI USA, V91, P5187, DOI 10.1073/pnas.91.11.5187; HUANG JM, 1990, ANAL BIOCHEM, V188, P114, DOI 10.1016/0003-2697(90)90537-J; Hullett DA, 2005, TRANSPL INT, V18, P1175, DOI 10.1111/j.1432-2277.2005.00187.x; Imagawa T, 2002, ARTHRITIS RHEUM, V46, P1102, DOI 10.1002/art.10188; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kawooya JK, 2003, ANAL BIOCHEM, V323, P103, DOI 10.1016/j.ab.2003.08.027; Kling J., 2013, BIOPROCESS, V11, P35; Klinkhammer BM, 2017, ADV CHRONIC KIDNEY D, V24, P117, DOI 10.1053/j.ackd.2016.11.002; KURFURST MM, 1992, ANAL BIOCHEM, V200, P244, DOI 10.1016/0003-2697(92)90460-O; Lefebvre JS, 2011, ARTHRITIS RHEUM-US, V63, P1527, DOI 10.1002/art.30308; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; Miller CG, 2014, MOL BIOL CELL, V25, P2342, DOI 10.1091/mbc.E14-03-0800; Moretti FA, 2007, J BIOL CHEM, V282, P28057, DOI 10.1074/jbc.M611315200; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Nanthakumar CB, 2015, NAT REV DRUG DISCOV, V14, P693, DOI 10.1038/nrd4592; Nishida M, 2007, BIOCHEM BIOPH RES CO, V354, P133, DOI 10.1016/j.bbrc.2006.12.165; OH E, 1981, P NATL ACAD SCI-BIOL, V78, P3218, DOI 10.1073/pnas.78.5.3218; Ortiz A, 2015, EUR J PHARMACOL, V759, P205, DOI 10.1016/j.ejphar.2015.03.026; Ozeri V, 1996, EMBO J, V15, P989, DOI 10.1002/j.1460-2075.1996.tb00435.x; Park JW, 2010, KIDNEY INT, V77, P1076, DOI 10.1038/ki.2010.69; Pu Kai-Ming T., 2013, Yale Journal of Biology and Medicine, V86, P537; Reese S, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-1; Ricard-Blum S, 2017, MATRIX BIOL J INT SO; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Samarakoon R, 2013, CELL SIGNAL, V25, P2198, DOI 10.1016/j.cellsig.2013.07.007; Saran R, 2016, AM J KIDNEY DIS, V67, pS1, DOI 10.1053/j.ajkd.2015.12.014; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selis F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040491; Shihab FS, 2000, KIDNEY INT, V58, P1174, DOI 10.1046/j.1523-1755.2000.00273.x; SHIRAKAMI A, 1986, LANCET, V1, P473; SNIDER J, 1992, J CHROMATOGR, V599, P141, DOI 10.1016/0021-9673(92)85467-8; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; Street JM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12088; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; Tomasini-Johansson B, 2017, EXP CLIN TRANSPLANT, V15, P641, DOI 10.6002/ect.2017.0262; Tomasini-Johansson B, 2009, THROMB HAEMOSTASIS, V102, P1278, DOI 10.1160/TH09-03-0141; Tomasini-Johansson BR, 2018, METHOD CELL BIOL, V143, P157, DOI 10.1016/bs.mcb.2017.10.001; Tomasini-Johansson BR, 2012, MATRIX BIOL, V31, P360, DOI 10.1016/j.matbio.2012.07.003; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Torr EE, 2015, J BIOL CHEM, V290, P6951, DOI 10.1074/jbc.M114.606186; Ucero AC, 2014, INT UROL NEPHROL, V46, P765, DOI 10.1007/s11255-013-0520-1; United States Renal Data System, 2014, 2014 ANN DAT REP EP; Valiente-Alandi I., 2018, CIRCULATION; Wright EJ, 1996, LAB INVEST, V74, P528; Yang JW, 2003, AM J PHYSIOL-RENAL, V284, pF349, DOI 10.1152/ajprenal.00154.2002; Zbyszynski PW, PHARM RES UNPUB	71	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205360	10.1371/journal.pone.0205360	http://dx.doi.org/10.1371/journal.pone.0205360			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356276	Green Published, Green Submitted, gold			2022-12-26	WOS:000448434000056
J	Spiliotopoulos, A; Ferreras, LB; Densham, RM; Caulton, SG; Maddison, BC; Morris, JR; Dixon, JE; Gough, KC; Dreveny, I				Spiliotopoulos, Anastasios; Ferreras, Lia Blokpoel; Densham, Ruth M.; Caulton, Simon G.; Maddison, Ben C.; Morris, Joanna R.; Dixon, James E.; Gough, Kevin C.; Dreveny, Ingrid			Discovery of peptide ligands targeting a specific ubiquitin-like domain-binding site in the deubiquitinase USP11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptide interaction; peptides; protease; crystal structure; ubiquitin; ubiquitin-dependent protease; phage display; DNA damage response; deubiquitylation (deubiquitination); cell-penetrating peptide (CPP); molecular recognition; USP11	DEUBIQUITYLATING ENZYMES; STRUCTURAL BASIS; INHIBITORS; STABILIZATION; RECOGNITION; SENSITIVITY; MECHANISM; RESPONSES; SELECTION; COMPLEX	Ubiquitin-specific proteases (USPs) reverse ubiquitination and regulate virtually all cellular processes. Defined noncatalytic domains in USP4 and USP15 are known to interact with E3 ligases and substrate recruitment factors. No such interactions have been reported for these domains in the paralog USP11, a key regulator of DNA double-strand break repair by homologous recombination. We hypothesized that USP11 domains adjacent to its protease domain harbor unique peptide-binding sites. Here, using a next-generation phage display (NGPD) strategy, combining phage display library screening with next-generation sequencing, we discovered unique USP11-interacting peptide motifs. Isothermal titration calorimetry disclosed that the highest affinity peptides (K-D of approximate to 10 m) exhibit exclusive selectivity for USP11 over USP4 and USP15 in vitro. Furthermore, a crystal structure of a USP11-peptide complex revealed a previously unknown binding site in USP11's noncatalytic ubiquitin-like (UBL) region. This site interacted with a helical motif and is absent in USP4 and USP15. Reporter assays using USP11-WT versus a binding pocket-deficient double mutant disclosed that this binding site modulates USP11's function in homologous recombination-mediated DNA repair. The highest affinity USP11 peptide binder fused to a cellular delivery sequence induced significant nuclear localization and cell cycle arrest in S phase, affecting the viability of different mammalian cell lines. The USP11 peptide ligands and the paralog-specific functional site in USP11 identified here provide a framework for the development of new biochemical tools and therapeutic agents. We propose that an NGPD-based strategy for identifying interacting peptides may be applied also to other cellular targets.	[Spiliotopoulos, Anastasios; Ferreras, Lia Blokpoel; Caulton, Simon G.; Dixon, James E.; Dreveny, Ingrid] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Spiliotopoulos, Anastasios; Gough, Kevin C.] Sch Vet Med & Sci, Sutton Bonington Campus,Coll Rd, Loughborough LE12 5RD, Leics, England; [Densham, Ruth M.; Morris, Joanna R.] Univ Birmingham, Birmingham Ctr Genome Biol, Birmingham B15 2TT, W Midlands, England; [Densham, Ruth M.; Morris, Joanna R.] Univ Birmingham, Inst Canc & Genom Sci, Med Sch, Birmingham B15 2TT, W Midlands, England; [Densham, Ruth M.; Morris, Joanna R.] Univ Birmingham, Inst Canc & Genom Sci, Dent Sch, Birmingham B15 2TT, W Midlands, England; [Maddison, Ben C.] Agr Dev & Advisory Serv, Sch Vet Med & Sci, Bonington Campus,Coll Rd, Loughborough LE12 5RD, Leics, England	University of Nottingham; University of Birmingham; University of Birmingham; University of Birmingham	Dreveny, I (corresponding author), Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England.; Gough, KC (corresponding author), Sch Vet Med & Sci, Sutton Bonington Campus,Coll Rd, Loughborough LE12 5RD, Leics, England.	kevin.gough@nottingham.ac.uk; ingrid.dreveny@nottingham.ac.uk	Dreveny, Ingrid/E-8939-2017; Morris, Joanna/AAK-3388-2021; Densham, Ruth/AAO-1971-2020	Dreveny, Ingrid/0000-0003-2256-642X; Densham, Ruth/0000-0003-4490-2842; Gough, Kevin/0000-0001-5211-2088; caulton, simon/0000-0001-7509-9728; Morris, Joanna/0000-0001-9762-8133	Biotechnology and Biological Sciences Research Council [BB/H012656/1]; BBSRC [BB/H012656/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council [Grant BB/H012656/1]. Crystallographic data were obtained with the support of Diamond Light Source, United Kingdom, and the European Synchrotron Radiation Facility (ESRF), Grenoble, France. We are grateful to colleagues at ESRF for providing assistance using beamline ID23-2 and at Diamond using beamline I02 and colleagues at the Advanced Data Analysis Centre, University of Nottingham, for advice on bioinformatics data analysis. We also thank the University of Birmingham Tech Hub Facility for FACS support.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Salihi MA, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120063; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Burkhart RA, 2013, MOL CANCER RES, V11, P901, DOI 10.1158/1541-7786.MCR-12-0699; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng JD, 2015, PROTEIN CELL, V6, P849, DOI 10.1007/s13238-015-0192-y; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Clerici M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6399; Deng TG, 2018, P NATL ACAD SCI USA, V115, P4678, DOI 10.1073/pnas.1714938115; Dias-Neto E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008338; Dixon JE, 2016, P NATL ACAD SCI USA, V113, pE291, DOI 10.1073/pnas.1518634113; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Elliott PR, 2011, FEBS LETT, V585, P3385, DOI 10.1016/j.febslet.2011.09.040; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FELICI F, 1991, J MOL BIOL, V222, P301, DOI 10.1016/0022-2836(91)90213-P; Gough KC, 1999, J VIROL METHODS, V79, P169, DOI 10.1016/S0166-0934(99)00014-2; Harper S, 2014, BIOCHEMISTRY-US, V53, P2966, DOI 10.1021/bi500116x; Harper S, 2011, BIOCHEMISTRY-US, V50, P7995, DOI 10.1021/bi200726e; Hayes SD, 2012, J BIOL CHEM, V287, P43007, DOI 10.1074/jbc.M112.386938; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Jacq X, 2013, CELL BIOCHEM BIOPHYS, V67, P25, DOI 10.1007/s12013-013-9635-3; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kategaya L, 2017, NATURE, V550, P534, DOI 10.1038/nature24006; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Lamberto I, 2017, CELL CHEM BIOL, V24, P1490, DOI 10.1016/j.chembiol.2017.09.003; Lee EW, 2015, CELL DEATH DIFFER, V22, P1463, DOI 10.1038/cdd.2014.234; Liang Q, 2014, NAT CHEM BIOL, V10, P298, DOI [10.1038/NCHEMBIO.1455, 10.1038/nchembio.1455]; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Long L, 2014, J BIOL CHEM, V289, P8916, DOI 10.1074/jbc.M114.551754; Maertens GN, 2010, EMBO J, V29, P2553, DOI 10.1038/emboj.2010.129; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Naqid IA, 2016, SCI REP-UK, V6, DOI 10.1038/srep31186; Naqid IA, 2016, SCI REP-UK, V6, DOI 10.1038/srep24232; Nishi R, 2014, NAT CELL BIOL, V16, P1016, DOI 10.1038/ncb3028; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Pfoh R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004950; Pozhidaeva A, 2017, CELL CHEM BIOL, V24, P1501, DOI 10.1016/j.chembiol.2017.09.004; Rebollo IR, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku940; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Schoenfeld AR, 2004, MOL CELL BIOL, V24, P7444, DOI 10.1128/MCB.24.17.7444-7455.2004; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stockum A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190513; Suire CN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193101; Ting JP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190850; Turnbull AP, 2017, NATURE, V550, P481, DOI 10.1038/nature24451; Vlasschaert C, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0511-1; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Yang L, 2017, TRANSL CANCER RES, V6, P218, DOI 10.21037/tcr.2017.01.16; Ye Y, 2009, MOL BIOSYST, V5, P1797, DOI 10.1039/b907669g; Zhang HK, 2011, P NATL ACAD SCI USA, V108, P13456, DOI 10.1073/pnas.1111218108; Zhang W, 2014, FEBS LETT, V588, P356, DOI 10.1016/j.febslet.2013.11.003; Zhang YN, 2013, NAT CHEM BIOL, V9, P51, DOI [10.1038/NCHEMBIO.1134, 10.1038/nchembio.1134]; Zhang ZM, 2015, CELL REP, V12, P1400, DOI 10.1016/j.celrep.2015.07.046; Zhu X, 2007, PROTEINS, V69, P1, DOI 10.1002/prot.21546; Zu XY, 2014, ANTIVIR RES, V104, P7, DOI 10.1016/j.antiviral.2014.01.011	61	17	17	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					424	436		10.1074/jbc.RA118.004469	http://dx.doi.org/10.1074/jbc.RA118.004469			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30373771	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000456263600004
J	Aguirre, LA; Portes, LL; Letellier, C				Aguirre, Luis A.; Portes, Leonardo L.; Letellier, Christophe			Structural, dynamical and symbolic observability: From dynamical systems to networks	PLOS ONE			English	Article							COMPLEX NETWORKS; CONTROLLABILITY	Classical definitions of observability classify a system as either being observable or not. Observability has been recognized as an important feature to study complex networks, and as for dynamical systems the focus has been on determining conditions for a network to be observable. About twenty years ago continuous measures of observability for nonlinear dynamical systems started to be used. In this paper various aspects of observability that are established for dynamical systems will be investigated in the context of networks. In particular it will be discussed in which ways simple networks can be ranked in terms of observability using continuous measures of such a property. Also it is pointed out that the analysis of the network topology is typically not sufficient for observability purposes, since both the dynamics and the coupling of such nodes play a vital role. Some of the main ideas are illustrated by means of numerical simulations.	[Aguirre, Luis A.; Portes, Leonardo L.] Univ Fed Minas Gerais, Programa Posgrad Engn Eletr, Belo Horizonte, MG, Brazil; [Portes, Leonardo L.] Univ Western Australia, Sch Math & Stat, Perth, WA, Australia; [Letellier, Christophe] Normandie Univ CORIA, Campus Univ Madrillet, Madrillet, France	Universidade Federal de Minas Gerais; University of Western Australia	Aguirre, LA (corresponding author), Univ Fed Minas Gerais, Programa Posgrad Engn Eletr, Belo Horizonte, MG, Brazil.	aguirre@ufmg.br	Aguirre, Luis A./A-2737-2008; Letellier, Christophe/AAC-1877-2019; dos Santos, Leonardo Luiz Portes/J-4285-2017	Aguirre, Luis A./0000-0002-2746-5102; Letellier, Christophe/0000-0003-3603-394X; dos Santos, Leonardo Luiz Portes/0000-0002-4310-2942	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [302079/20114]; ProReitoria de Pesquisa da Universidade Federal de Minas Gerais; CAPES	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ProReitoria de Pesquisa da Universidade Federal de Minas Gerais; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by 302079/20114, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/), ProReitoria de Pesquisa da Universidade Federal de Minas Gerais (http://www.ufmg.br/prpq/, LAA), and CAPES (http://www.capes.gov.br/, LLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LA, 2005, J PHYS A-MATH GEN, V38, P6311, DOI 10.1088/0305-4470/38/28/004; AGUIRRE LA, 1995, IEEE T EDUC, V38, P33, DOI 10.1109/13.350218; Aguirre LA, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066209; [Anonymous], 2010, NETWORKS INTRO NETWO, DOI DOI 10.1093/ACPROF:OSO/9780199206650.001.0001; Bianco-Martinez E, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.062912; Chan B., 1992, P 8 INT C UNC ART IN, P25; Chen C., 1999, LINEAR SYSTEM THEORY; Cowan NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038398; Friedland B., 1975, Transactions of the ASME. Series G, Journal of Dynamic Systems, Measurement and Control, V97, P444, DOI 10.1115/1.3426963; Frunzete M, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026205; Gates AJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24456; Haber A, 2018, IEEE T CONTROL NETW, V5, P694, DOI 10.1109/TCNS.2017.2728201; HERMANN R, 1977, IEEE T AUTOMAT CONTR, V22, P728, DOI 10.1109/TAC.1977.1101601; Kalman R. E., 1960, P 1 IFAC C AUT CONTR, P481, DOI 10.1109/TAC.1959.1104873.110; Leitold D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00160-5; Letellier C, 1998, J PHYS A-MATH GEN, V31, P7913, DOI 10.1088/0305-4470/31/39/008; Letellier C, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.066213; Letellier C, 2002, CHAOS, V12, P549, DOI 10.1063/1.1487570; Letellier C, 2009, PHYS REV E, V79; Letellier C, 2005, PHYS REV E, V72; Letellier C, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.020303; Letellier C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21967-w; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu YY, 2013, P NATL ACAD SCI USA, V110, P2460, DOI 10.1073/pnas.1215508110; Nadal I, 2018, SELECTING VARI UNPUB; ROSSLER OE, 1976, PHYS LETT A, V57, P397, DOI 10.1016/0375-9601(76)90101-8; Schiff SJ, 2012, COMPUT NEUROSCI-MIT, P1; Sedigh-Sarvestani M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002788; Sendina-Nadal I, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.042205; Su F, 2017, CHAOS, V27, DOI 10.1063/1.4975124; Sun J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.208701; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Wang L, 2017, SCI REPORTS, V7; Whalen AJ, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.011005	34	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206180	10.1371/journal.pone.0206180	http://dx.doi.org/10.1371/journal.pone.0206180			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379892	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700093
J	Bennett, MV; McLaurin, K; Ambrose, C; Lee, HC				Bennett, Mihoko, V; McLaurin, Kimmie; Ambrose, Christopher; Lee, Henry C.			Population-based trends and underlying risk factors for infant respiratory syncytial virus and bronchiolitis hospitalizations	PLOS ONE			English	Article							PROPHYLAXIS; PALIVIZUMAB; MORTALITY; CHILDREN	Objective Respiratory syncytial virus (RSV) is a common pathogen during infancy, with the potential to cause serious disease and mortality in high-risk groups. The objective of this study was to characterize trends of RSV and bronchiolitis hospitalizations in the first year in a population-based cohort and assess differences in trends according to risk status. Methods Using an observational retrospective cohort design, we examined a California populationbased dataset of vital statistics linked to hospital discharge data for up to 1 year after birth from 1997-2011. Infants were categorized by medical condition and then by gestational age. Medical conditions of interest included chronic lung disease, certain congenital heart diseases, or others known to affect risk for developing severe bronchiolitis. The primary outcome was hospitalization due to RSV; secondary outcome was hospitalization for unspecified bronchiolitis (UB) not coded as RSV. Annual person-year rates were calculated for infants <12 months of age during January to December of each year. Results Of 7,298,401 infants born during the study period, 121,230 (1.7%) had a medical condition associated with risk; these infants experienced 6853 RSV and 6568 UB hospitalizations in the first year. In infants without medical conditions, 96,694 RSV and 69,886 UB hospitalizations occurred. All-cause infant hospitalizations declined over time from 12.2 to 9.3 per 100 person-years. RSV hospitalization rates for infants with medical conditions decreased from 7.6 to 3.4 per 100 person-years, with the largest relative decline in infants with chronic lung disease (12.0 to 5.0 per 100 person-years). For infants without medical conditions, RSV hospitalizations declined from 1.4 to 0.8 per 100 person-years, with greater decreases among preterm infants with earlier gestational age. UB hospitalization rates remained relatively stable across the study years, from 6.2 to 5.4 and 1.0 to 0.8 per 100 person-years for infants with and without medical conditions. Conclusions Various interventions may have contributed to observed decreases in RSV hospitalizations from 1998-2011, which were greater in high-risk populations recommended for RSV immunoprophylaxis and not observed with UB. Further efforts to promote evidence-based practice and optimal targeting of appropriate interventions will ensure continued improvement in care for vulnerable infants.	[Bennett, Mihoko, V; Lee, Henry C.] Stanford Sch Med, Div Neonatal & Dev Med, Stanford, CA 94305 USA; [Bennett, Mihoko, V; Lee, Henry C.] Calif Perinatal Qual Care Collaborat, Stanford, CA 94305 USA; [McLaurin, Kimmie; Ambrose, Christopher] AstraZeneca, Gaithersburg, MD USA	Stanford University; AstraZeneca	Lee, HC (corresponding author), Stanford Sch Med, Div Neonatal & Dev Med, Stanford, CA 94305 USA.; Lee, HC (corresponding author), Calif Perinatal Qual Care Collaborat, Stanford, CA 94305 USA.	hclee@stanford.edu	Lee, Henry/GVS-2114-2022	Lee, Henry/0000-0001-8383-1720; Ambrose, Christopher/0000-0003-4175-7336	AstraZeneca (Gaithersburg, MD); AstraZeneca	AstraZeneca (Gaithersburg, MD)(AstraZeneca); AstraZeneca(AstraZeneca)	This study was supported by AstraZeneca (Gaithersburg, MD). HL received funding from AstraZeneca for research effort and travel expenses to present findings at a national conference. MB received research funding from AstraZeneca. AstraZeneca provided support in the form of salaries for authors KM and CA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Editorial support was provided by The Lockwood Group, which was in accordance with Good Publication Practice (GPP3) and funded by AstraZeneca.	Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Centers for Disease Control and Prevention, BREASTF RAT NAT IMM; Checchia PA, 2011, PEDIATR CRIT CARE ME, V12, P580, DOI 10.1097/PCC.0b013e3182070990; Chu PY, 2017, CARDIOL YOUNG, V27, P16, DOI 10.1017/S1047951116000470; Doucette A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152208; Farber HJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0627; Friedman D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172512; Hampp C, 2010, J PEDIATR-US, V156, P953, DOI 10.1016/j.jpeds.2009.12.016; Hasegawa K, 2013, PEDIATRICS, V132, P28, DOI 10.1542/peds.2012-3877; Herrchen B, 1997, COMPUT BIOMED RES, V30, P290, DOI 10.1006/cbmr.1997.1448; McDowell Margaret A, 2008, NCHS Data Brief, P1; Mejias A., 2005, NEOREVIEWS, V6, pe26, DOI [10.1542/neo.6-1-e26, DOI 10.1542/NEO.6-1-E26]; Michels KA, 2017, AM J CLIN NUTR, V106, P1456, DOI 10.3945/ajcn.116.144279; Pavilack M, 2018, INFECT DIS THER, V7, P121, DOI 10.1007/s40121-017-0178-6; Sangare L, 2006, J PEDIATR-US, V149, P373, DOI 10.1016/j.jpeds.2006.04.063; Tarrant M, 2010, EPIDEMIOLOGY, V21, P847, DOI 10.1097/EDE.0b013e3181f55803; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179	17	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205399	10.1371/journal.pone.0205399	http://dx.doi.org/10.1371/journal.pone.0205399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379957	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700045
J	Keers, RN; Placido, M; Bennett, K; Clayton, K; Brown, P; Ashcroft, DM				Keers, Richard N.; Placido, Madalena; Bennett, Karen; Clayton, Kristen; Brown, Petra; Ashcroft, Darren M.			What causes medication administration errors in a mental health hospital? A qualitative study with nursing staff	PLOS ONE			English	Article							ADVERSE DRUG EVENTS; CARE; NURSES; INTERVENTIONS; POLYPHARMACY; FREQUENCY	Objective Medication administration errors (MAEs) are a common risk to patient safety in mental health hospitals, but an absence of in-depth studies to understand the underlying causes of these errors limits the development of effective remedial interventions. This study aimed to investigate the causes of MAEs affecting inpatients in a mental health National Health Service (NHS) hospital in the North West of England. Methods Registered and student mental health nurses working in inpatient psychiatric units were identified using a combination of direct advertisement and incident reports and invited to participate in semi-structured interviews utilising the critical incident technique. Interviews were designed to capture the participants' experiences of inpatient MAEs. All interviews were transcribed verbatim and subject to framework analysis to illuminate the underlying active failures, error/violation-provoking conditions and latent failures according to Reason's model of accident causation. Results A total of 20 participants described 26 MAEs (including 5 near misses) during the interviews. The majority of MAEs were skill-based slips and lapses (n = 16) or mistakes (n = 5), and were caused by a variety of interconnecting error/violation-provoking conditions relating to the patient, medicines used, medicines administration task, health care team, individual nurse and working environment. Some of these local conditions had origins in wider organisational latent failures. Recurrent and influential themes included inadequate staffing levels, unbalanced staff skill mix, interruptions/distractions, concerns with how the medicines administration task was approached and problems with communication. Conclusions To our knowledge this is the first published in-depth qualitative study to investigate the underlying causes of specific MAEs in a mental health hospital. Our findings revealed that MAEs may arise due to multiple interacting error and violation provoking conditions and latent 'system' failures, which emphasises the complexity of this everyday task facing practitioners in clinical practice. Future research should focus on developing and testing interventions which address key local and wider organisational 'systems' failures to reduce error.	[Keers, Richard N.; Placido, Madalena; Ashcroft, Darren M.] Univ Manchester, MAHSC, Sch Hlth Sci, Div Pharm & Optometry,Ctr Pharmacoepidemiol & Dru, Manchester, Lancs, England; [Keers, Richard N.; Ashcroft, Darren M.] Univ Manchester, MAHSC, NIHR Greater Manchester Patient Safety Translat R, Manchester, Lancs, England; [Keers, Richard N.; Bennett, Karen; Clayton, Kristen; Brown, Petra] North Manchester Gen Hosp, Pk House Hosp, Greater Manchester Mental Hlth NHS Fdn Trust, Med Management Team, Manchester, Lancs, England; [Bennett, Karen] Univ Bolton, Sch Hlth & Human Sci, Bolton, England	University of Manchester; University of Manchester; University of Bolton	Keers, RN (corresponding author), Univ Manchester, MAHSC, Sch Hlth Sci, Div Pharm & Optometry,Ctr Pharmacoepidemiol & Dru, Manchester, Lancs, England.; Keers, RN (corresponding author), Univ Manchester, MAHSC, NIHR Greater Manchester Patient Safety Translat R, Manchester, Lancs, England.; Keers, RN (corresponding author), North Manchester Gen Hosp, Pk House Hosp, Greater Manchester Mental Hlth NHS Fdn Trust, Med Management Team, Manchester, Lancs, England.	richard.keers@manchester.ac.uk	Keers, Richard/D-9136-2012; Ashcroft, Darren/G-3244-2015	Keers, Richard/0000-0001-7854-8154; Ashcroft, Darren/0000-0002-2958-915X; Placido, Madalena/0000-0002-0981-951X	University of Manchester; NHS trust	University of Manchester; NHS trust	This work was supported internally by The University of Manchester and participating NHS trust, no specific grant or funding stream was used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abduldaeem HMK., 2016, IJPP, V24, P4; Alshehri GH, 2017, DRUG SAFETY, V40, P871, DOI 10.1007/s40264-017-0557-7; [Anonymous], 2016, 5 YEAR FORW VIEW MEN; Baldwin DS, 2007, ADV PSYCHIAT TREAT, V13, P414, DOI DOI 10.1192/APT.BP.107.004184; Barnes TRE, 2011, CNS DRUGS, V25, P383, DOI 10.2165/11587810-000000000-00000; Berdot S, 2016, INT J NURS STUD, V53, P342, DOI 10.1016/j.ijnurstu.2015.08.012; Browne G, 2013, INT J NURS PRACT, V19, P539, DOI 10.1111/ijn.12090; Cottney A, 2015, INT J MENT HEALTH NU, V24, P65, DOI 10.1111/inm.12096; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Dickens Geoff, 2008, Nurs Stand, V22, P35; Dickinson Tommy, 2008, Br J Nurs, V17, P82; Donisi V, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1114-0; Dougherty L, 2012, J ADV NURS, V68, P1302, DOI 10.1111/j.1365-2648.2011.05838.x; Duxbury JA, 2010, INT J MENT HEALTH NU, V19, P53, DOI 10.1111/j.1447-0349.2009.00638.x; Emily H., 2014, OECD HLTH POLICY STU; Fanneran T, 2015, J PSYCHIATR MENT HLT, V22, P764, DOI 10.1111/jpm.12263; FLANAGAN JC, 1954, PSYCHOL BULL, V51, P327, DOI 10.1037/h0061470; Ford R, 1998, BRIT MED J, V317, P1279, DOI 10.1136/bmj.317.7168.1279; Fornaro M, 2016, NEUROPSYCH DIS TREAT, V12, P719, DOI 10.2147/NDT.S100846; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Grimm P., 2010, WILEY INT ENCY MARKE, DOI [10.1002/9781444316568.wiem02057/abstract, DOI 10.1002/9781444316568.WIEM02057/ABSTRACT]; Harris N, 2009, MED MANAGEMENT MENTA; Haw C, 2011, J PSYCHIATR MENT HLT, V18, P308, DOI 10.1111/j.1365-2850.2010.01664.x; Haw C, 2007, INT J QUAL HEALTH C, V19, P210, DOI 10.1093/intqhc/mzm019; Haw C, 2015, J ADV NURS, V71, P281, DOI 10.1111/jan.12495; Haw CM, 2005, PSYCHIAT SERV, V56, P1610, DOI 10.1176/appi.ps.56.12.1610; Ito H, 2003, INT J QUAL HEALTH C, V15, P207, DOI 10.1093/intqhc/mzg038; Janssen EM, 2015, GEN HOSP PSYCHIAT, V37, P199, DOI 10.1016/j.genhosppsych.2015.03.004; Jheeta S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2462-2; Keers RN, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005948; Keers RN, 2014, DRUG SAFETY, V37, P317, DOI 10.1007/s40264-014-0152-0; Keers RN, 2013, DRUG SAFETY, V36, P1045, DOI 10.1007/s40264-013-0090-2; Kemppainen JK, 2000, J ADV NURS, V32, P1264, DOI 10.1046/j.1365-2648.2000.01597.x; Lane R, 2006, APPL ERGON, V37, P669, DOI 10.1016/j.apergo.2005.08.001; Lewis PJ, 2014, BRIT J CLIN PHARMACO, V78, P310, DOI 10.1111/bcp.12332; Maidment ID, 2005, PSYCHIATR BULL, V29, P298, DOI 10.1192/pb.29.8.298; McGinty EE, 2015, SCHIZOPHR RES, V165, P227, DOI 10.1016/j.schres.2015.04.010; McLeod M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128958; Mezulis AH, 2004, PSYCHOL BULL, V130, P711, DOI 10.1037/0033-2909.130.5.711; Mojtabai R, 2010, ARCH GEN PSYCHIAT, V67, P26, DOI 10.1001/archgenpsychiatry.2009.175; National Collaborating Centre for Mental Health, 2012, SERV US EXP AD MENT; National Institute for Health and Care Excellence, 2014, SAF STAFF NURS AD IN; Ozkan S, 2011, J NURS CARE QUAL, V26, P136, DOI 10.1097/NCQ.0b013e3182031006; Parameswaran SG, 2015, ADM POLICY MENT HLTH, V42, P288, DOI 10.1007/s10488-014-0569-x; Peusschers E, 2015, AUSTRALAS PSYCHIATRY, V23, P142, DOI 10.1177/1039856214568215; Pincus HA, 2016, HEALTH AFFAIR, V35, P1000, DOI 10.1377/hlthaff.2016.0027; Raban MZ, 2014, BMJ QUAL SAF, V23, P414, DOI 10.1136/bmjqs-2013-002118; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Reason J., 1997, MANAGING RISK ORG AC; Ritchie J, 1994, ANAL QUALITATIVE DAT, P172; Royal College of Nursing, 2010, GUID SAF NURS STAFF; Rutter L, 2015, SAFE STAFFING NURSIN; Rylander M, 2016, QUAL MANAG HEALTH CA, V25, P22, DOI 10.1097/QMH.0000000000000077; Sawamura K, 2005, PSYCHIAT CLIN NEUROS, V59, P379, DOI 10.1111/j.1440-1819.2005.01389.x; Simon M, 2014, EFFECTIVENESS MANAGE; Smetzer J, 2007, MEDICATION ERRORS, P513, DOI 10.21019/9781582120928.ch19; Taylor D, 2015, MAUDSLEY PRESCRIBING; THORNICROFT G, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F2969; Tully MP, 2009, DRUG SAFETY, V32, P819, DOI 10.2165/11316560-000000000-00000; Vigo D, 2016, LANCET PSYCHIAT, V3, P171, DOI 10.1016/S2215-0366(15)00505-2; World Health Organization, 2017, IMPR ACC APPR US MED	61	15	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206233	10.1371/journal.pone.0206233	http://dx.doi.org/10.1371/journal.pone.0206233			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3KA	30365509	Green Submitted, gold, Green Published			2022-12-26	WOS:000448448700033
J	Diop, F; Vial, T; Ferraris, P; Wichit, S; Bengue, M; Hamel, R; Talignani, L; Liegeois, F; Pompon, J; Yssel, H; Marti, G; Misse, D				Diop, Fode; Vial, Thomas; Ferraris, Pauline; Wichit, Sineewanlaya; Bengue, Michele; Hamel, Rodolphe; Talignani, Ldic; Liegeois, Florian; Pompon, Julien; Yssel, Hans; Marti, Guillaume; Misse, Dorothee			Zika virus infection modulates the metabolomic profile of microglial cells	PLOS ONE			English	Article							NERVOUS-SYSTEM; BRAIN; LYSOPHOSPHATIDYLCHOLINE; ACTIVATION; RECEPTOR; MACROPHAGES; MICRONESIA; ASYMMETRY; MECHANISM; ISCHEMIA	Zika virus (ZIKV) is an emerging arbovirus of the Flaviviridae family. Although infection with ZIKV generally leads to mild disease, its recent emergence in the Americas has been associated with an increase in the development of the Guillain-Barre syndrome in adults, as well as with neurological complications, in particular congenital microcephaly, in new-borns. To date, little information is available on neuroinflammation induced by ZIKV, notably in microglial cells in the context of their metabolic activity, a series of chemical transformations that are essential for their growth, reproduction, structural maintenance and environmental responses. Therefore, in the present study we investigated the metabolomic profile of ZIKV-infected microglia. Microglial cells were exposed to ZIKV at different time points and were analyzed by a Liquid Chromatography-High Resolution mass spectrometry-based metabolomic approach. The results show that ZIKV infection in microglia leads to modulation of the expression of numerous metabolites, including lysophospholipids, particulary Lysophosphatidylcholine, and phospholipids such as Phosphatidylcholine, Phosphatidylserine, Ceramide and Sphingomyelin, and carboxylicic acids as Undecanedioic and Dodecanedioic acid. Some of these metabolites are involved in neuronal differentiation, regulation of apoptosis, virion architecture and viral replication. ZIKV infection was associated with concomitant secretion of inflammatory mediators linked with central nervous system inflammation such as IL-6, TNF-alpha, IL-beta, iNOS and NO. It also resulted in the upregulation of the expression of the gene encoding CX3CR1, a chemokine receptor known to regulate functional synapse plasticity and signaling between microglial cells. These findings highlight an important role for microglia and their metabolites in the process of neuroinflammation that occurs during ZIKV pathogenesis.	[Diop, Fode; Ferraris, Pauline; Bengue, Michele; Hamel, Rodolphe; Talignani, Ldic; Liegeois, Florian; Pompon, Julien; Misse, Dorothee] Univ Montpellier, CNRS, IRD, MIVEGEC UMR 224, Montpellier, France; [Vial, Thomas; Marti, Guillaume] Univ Toulouse, IRD, PHARMADEV UMR 152, Toulouse, France; [Wichit, Sineewanlaya] Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Salaya, Nakhon Pathom, Thailand; [Yssel, Hans] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Ctr Immunol & Malad Infect,Inserm,U1135,UPMC, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Mahidol University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Misse, D (corresponding author), Univ Montpellier, CNRS, IRD, MIVEGEC UMR 224, Montpellier, France.	dorothee.misse@ird.fr	Ferraris, Pauline/F-9077-2017; Yssel, Hans/AFV-2907-2022; Pompon, Julien/AAA-4463-2021; Hamel, Rodolphe/AAG-1714-2020; Yvert, Blaise/E-9052-2016; Marti, Guillaume/B-4395-2016; Misse, Dorothee/A-7590-2012	Ferraris, Pauline/0000-0002-8796-3074; Yssel, Hans/0000-0001-7454-1836; Pompon, Julien/0000-0003-1110-9039; Hamel, Rodolphe/0000-0001-8603-7039; Yvert, Blaise/0000-0002-8850-7935; Vial, Thomas/0000-0003-3347-7342; Marti, Guillaume/0000-0002-6321-9005; Misse, Dorothee/0000-0002-6485-3841	Agence Nationale de la Recherche [ANR-14-CE14-0029, ANR-15-CE15-00029]; European Union's Horizon 2020 research and innovation programme under ZIKAlliance [734548]; Infectiopole Sud foundation	Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union's Horizon 2020 research and innovation programme under ZIKAlliance; Infectiopole Sud foundation	This work was supported by grants from the Agence Nationale de la Recherche (grants ANR-14-CE14-0029 and ANR-15-CE15-00029), the European Union's Horizon 2020 research and innovation programme under ZIKAlliance grant agreement No. 734548. Fode Diop was supported by a fellowship from the Infectiopole Sud foundation.	Alexander JJ, 1998, NEUROCHEM RES, V23, P227, DOI 10.1023/A:1022441211177; Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA; Arnoux I, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/689404; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Besnard M, 2014, EURO SURVEILL B EUR, V19; Bollinger CR, 2005, BBA-MOL CELL RES, V1746, P284, DOI 10.1016/j.bbamcr.2005.09.001; Brown GC, 2015, BRAIN RES, V1628, P288, DOI 10.1016/j.brainres.2015.08.031; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15; De Simone R, 2002, J NEUROPATH EXP NEUR, V61, P237, DOI 10.1093/jnen/61.3.237; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Freeman L, 2017, J EXP MED, V214, P1351, DOI 10.1084/jem.20150237; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Glinton KE, 2018, MOL GENET METAB, V123, P309, DOI 10.1016/j.ymgme.2017.12.009; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878; Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382; Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307; Muramatsu R, 2015, J BIOL CHEM, V290, P11515, DOI 10.1074/jbc.M114.587253; Nishiyama K, 2018, INT IMMUNOPHARMACOL, V55, P205, DOI 10.1016/j.intimp.2017.12.003; Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377; Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038; Ousman SS, 2000, GLIA, V30, P92, DOI 10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.0.CO;2-W; Pagani F, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00111, 10.3389/fncel.2015.00111]; Pasvogel AE, 2008, BIOL RES NURS, V10, P113, DOI 10.1177/1099800408323218; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112; Sapcariu SC, 2014, METHODSX, V1, P74, DOI 10.1016/j.mex.2014.07.002; Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1; Stock C, 2006, J IMMUNOL, V177, P8560, DOI 10.4049/jimmunol.177.12.8560; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; SUN GY, 1984, J NEUROCHEM, V43, P1081, DOI 10.1111/j.1471-4159.1984.tb12847.x; Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009; Tsugawa H, 2016, ANAL CHEM, V88, P7946, DOI 10.1021/acs.analchem.6b00770; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; Werneburg S, 2017, CURR OPIN NEUROBIOL, V47, P138, DOI 10.1016/j.conb.2017.10.002; Wolf B, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160231; Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004; Zhang JT, 2016, P NATL ACAD SCI USA, V113, pE1064, DOI 10.1073/pnas.1519730113; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063	50	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206093	10.1371/journal.pone.0206093	http://dx.doi.org/10.1371/journal.pone.0206093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359409	Green Published, Green Submitted, gold			2022-12-26	WOS:000448438400044
J	Li, ZH; Swann, JL; Keskinocak, P				Li, Zihao; Swann, Julie L.; Keskinocak, Pinar			Value of inventory information in allocating a limited supply of influenza vaccine during a pandemic	PLOS ONE			English	Article							A H1N1; COVERAGE; RISK	Objective To understand the value of information on vaccine inventory levels during an influenza pandemic, we propose a simulation study to compare vaccine allocation strategies using: (i) only population information (pro-rata, or population-based, PB), (ii) both population and vaccine inventory information (population and inventory-based, PIB). Methods We adapt an agent-based simulation model to predict the spread of the disease both geographically and temporally. We study PB and PIB when uptake rates vary geographically. The simulation study is done from 2015 to 2017, using population and commuting data from the state of Georgia from the United States census. Findings Compared to PB under reasonable scenarios, PIB reduces the infection attack rate from 23.4% to 22.4%, decreases the amount of leftover inventory from 827 to 152 thousand, and maintains or increases the percentage of vaccinated population. Conclusions Our results indicate the need for greater vaccine inventory visibility in public health supply chains, especially when supply is limited, and uptake rates vary geographically. Such visibility has a potential to decrease the number of infections, help identify locations with low uptake rates and to motivate public awareness efforts.	[Li, Zihao; Keskinocak, Pinar] Georgia Inst Technol, Sch Ind & Syst Engn, Atlanta, GA 30332 USA; [Swann, Julie L.] North Carolina State Univ, Dept Ind & Syst Engn, Raleigh, NC USA	University System of Georgia; Georgia Institute of Technology; University of North Carolina; North Carolina State University	Keskinocak, P (corresponding author), Georgia Inst Technol, Sch Ind & Syst Engn, Atlanta, GA 30332 USA.	pinar@isye.gatech.edu		Swann, Julie/0000-0003-2151-4396	Georgia Institute of Technology; Children's Healthcare of Atlanta; Harold R. and Mary Anne Nash Junior Faculty Endowment Fund	Georgia Institute of Technology; Children's Healthcare of Atlanta; Harold R. and Mary Anne Nash Junior Faculty Endowment Fund	The study was supported by a seed grant from Georgia Institute of Technology and the Children's Healthcare of Atlanta. This research was also supported in part by the Harold R. and Mary Anne Nash Junior Faculty Endowment Fund and the following Georgia Tech benefactors: William W. George, Andrea Laliberte, Joseph C. Mello, Richard "Rick" E. and Charlene Zalesky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, DISP UN EXP H1N1 VAC; [Anonymous], 2010, DISP EXP WAST H1N1 V; [Anonymous], 2009, H1N1 FLU ALL DISTR Q; Araz OM, 2012, HEALTH CARE MANAG SC, V15, P175, DOI 10.1007/s10729-012-9199-6; Bellan SE, 2015, LANCET INFECT DIS, V15, P703, DOI 10.1016/S1473-3099(15)70139-8; Cachon GP, 1999, MANAGE SCI, V45, P685, DOI 10.1287/mnsc.45.5.685; CDC, 2009, CDC 2009 H1N1 VACC C; Centers for Disease Control and Prevention, 2014, KEY FACTS SEAS FLU V; Conway JM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-932; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Drakopoulos K, 2014, IEEE DECIS CONTR P, P4447, DOI 10.1109/CDC.2014.7040083; Egede LE, 2003, AM J PUBLIC HEALTH, V93, P2074, DOI 10.2105/AJPH.93.12.2074; Ekici A, 2014, M&SOM-MANUF SERV OP, V16, P11, DOI 10.1287/msom.2013.0460; Evans J., 2010, HAPPY TRAILS SWINE F; Galarce EM, 2011, VACCINE, V29, P5284, DOI 10.1016/j.vaccine.2011.05.014; Glazner Judith E, 2009, Pediatrics, V124 Suppl 5, pS492, DOI 10.1542/peds.2009-1542H; Influenza A (H1N1), 2009, INFL H1N1 2009 MON V; Kansagra SM, 2012, AM J PUBLIC HEALTH, V102, P1378, DOI 10.2105/AJPH.2011.300363; Knox R, 2009, SWINE FLU VACCINE SH; Lawrence D, 1996, AUTOMOTIVE NEWS; Lu P. J., 2010, Morbidity and Mortality Weekly Report, V59, P363; Matrajt L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002964; Matrajt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013767; Mbah MLN, 2013, VACCINE, V31, P3079, DOI 10.1016/j.vaccine.2013.04.052; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Mylius SD, 2008, VACCINE, V26, P3742, DOI 10.1016/j.vaccine.2008.04.043; Oregon.gov, OR SEAS FLU VACC UPT; Rasmussen SA, 2009, AM J PUBLIC HEALTH, V99, pS248, DOI 10.2105/AJPH.2008.152900; Shear MD, 2009, ADM OFFICIALS BLAME; Shi P, 2010, EPIDEMIOL INFECT, V138, P1472, DOI 10.1017/S0950268810000300; Shi PY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-778; Stobbe M., 2010, NBCNEWS; Stroud C, 2011, 2009 H1N1 INFLUENZA; Taubenberger JK, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S305; Uscher-Pines L, 2011, AM J PUBLIC HEALTH, V101, P1252, DOI 10.2105/AJPH.2011.300133; Yarmand H, 2014, EUR J OPER RES, V233, P208, DOI 10.1016/j.ejor.2013.08.027	36	12	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206293	10.1371/journal.pone.0206293	http://dx.doi.org/10.1371/journal.pone.0206293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3GT	30359445	Green Published, gold, Green Submitted			2022-12-26	WOS:000448438400061
J	Sylvestre, TF; Cavalcante, RD; da Silva, JD; Paniago, AMM; Weber, SS; Pauletti, BA; de Carvalho, LR; dos Santos, LD; Mendes, RP				Sylvestre, Tatiane Fernanda; Cavalcante, Ricardo de Souza; da Silva, Julhiany de Fatima; Miranda Paniago, Anamaria Mello; Weber, Simone Schneider; Pauletti, Bianca Alves; de Carvalho, Lidia Raquel; dos Santos, Lucilene Delazari; Mendes, Rinaldo Poncio			Ceruloplasmin, transferrin and apolipoprotein A-II play important role in treatment's follow-up of paracoccidioidomycosis patients	PLOS ONE			English	Article							HUMAN PLASMA PROTEOME; MASS-SPECTROMETRY; IDENTIFICATION; IMMUNOSUPPRESSION; DIAGNOSIS; PROTEINS; ANTIGENS; HYPOXIA	Paracoccidioidomycosis (PCM) is a systemic disease caused by thermodymorphic fungi of the Paracoccidioides brasiliensis complex, (Paracoccidioides spp.). Patients with PCM reveal specific cellular immune impairment. Despite the effective treatment, quiescent fungi can lead to relapse, usually late, the serological diagnosis of which has been deficient. The present study was carried out with the objective of investigating a biomarker for the identification of PCM relapse and another molecule behaving as an immunological recovery biomarker; therefore, it may be used as a cure criterion. In the evolutionary analysis of the proteins identified in PCM patients, comparing those that presented with those that did not reveal relapse, 29 proteins were identified. The interactions observed between the proteins, using transferrin and haptoglobin, as the main binding protein, were strong with all the others. Patient follow-up suggests that cerulosplamin may be a marker of relapse and that transferrin and apolipoprotein A-II may contribute to the evaluation of the treatment efficacy and avoiding a premature decision.	[Sylvestre, Tatiane Fernanda; Cavalcante, Ricardo de Souza; da Silva, Julhiany de Fatima; Mendes, Rinaldo Poncio] Univ Estadual Paulista UNESP, Fac Med Botucatu, Botucatu, SP, Brazil; [Miranda Paniago, Anamaria Mello; Weber, Simone Schneider] Univ Fed Mato Grosso do Sul UFMS, Fac Med, Campo Grande, Brazil; [Weber, Simone Schneider] Univ Fed Amazonas UFAM, ICET, Itacoatiara, Brazil; [Pauletti, Bianca Alves] Lab Nacl Biociencias CNPEM, Campinas, SP, Brazil; [de Carvalho, Lidia Raquel] Univ Estadual Paulista UNESP, Inst Biociencia Botucatu, Botucatu, SP, Brazil; [dos Santos, Lucilene Delazari] UNESP, CEVAP, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Amazonas; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista	Sylvestre, TF (corresponding author), Univ Estadual Paulista UNESP, Fac Med Botucatu, Botucatu, SP, Brazil.	thaty_sylvestre@hotmail.com	Paniago, Anamaria M M/B-7747-2012; Paniago, Anamaria/AGS-6094-2022; de Souza Cavalcante, Ricardo/D-2058-2013; Sylvestre, Tatiane/AAV-4449-2021; de Fátima da Silva, Julhiany F/F-8706-2012	Paniago, Anamaria M M/0000-0002-8925-7712; Paniago, Anamaria/0000-0002-8925-7712; de Souza Cavalcante, Ricardo/0000-0001-6382-2675; de Fátima da Silva, Julhiany F/0000-0002-9675-088X; Poncio Mendes, Rinaldo/0000-0002-0661-5917; Sylvestre, Tatiane Fernanda/0000-0002-0023-964X	Coordenation for the Improvement of Higher Level Personnel - CAPES	Coordenation for the Improvement of Higher Level Personnel - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The Coordenation for the Improvement of Higher Level Personnel - CAPES was responsible for the scholarship of the doctoral student and did not provide support for this research. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Aragao AZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043521; Arantes TD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004606; Benard G, 1996, AM J TROP MED HYG, V54, P7, DOI 10.4269/ajtmh.1996.54.7; Benard G, 2001, CYTOKINE, V13, P248, DOI 10.1006/cyto.2000.0824; Boja ES, 2012, PROTEOMICS, V12, P1093, DOI 10.1002/pmic.201100387; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camargo ZP, 2003, MED MYCOL, V41, P539, DOI 10.1080/13693780310001615358; Coutinho Ziadir Francisco, 2002, Cad. Saúde Pública, V18, P1441, DOI 10.1590/S0102-311X2002000500037; Del Chierico F, 2016, EXP PARASITOL, V170, P82, DOI 10.1016/j.exppara.2016.09.007; Franco M, 1993, Curr Top Med Mycol, V5, P115; Grotto Helena Z. W., 2008, Rev. Bras. Hematol. Hemoter., V30, P390, DOI 10.1590/S1516-84842008000500012; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Longo LVG, 2013, FEMS MICROBIOL LETT, V341, P87, DOI 10.1111/1574-6968.12097; Lopez E, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-35; Mailhac A, 2017, J PROTEOMICS, V152, P150, DOI 10.1016/j.jprot.2016.10.017; Mendes Rinaldo Poncio, 2017, Open Microbiol J, V11, P224, DOI 10.2174/1874285801711010224; Mendes RP, 1994, PARACOCCIDIOIDOMYCOS, V2, P233, DOI DOI 10.1201/9781351075329-16; Otto A, 2014, INT J MED MICROBIOL, V304, P110, DOI 10.1016/j.ijmm.2013.11.007; Pieper R, 2003, PROTEOMICS, V3, P422, DOI 10.1002/pmic.200390057; Pitarch A, 2004, PROTEOMICS, V4, P3084, DOI 10.1002/pmic.200400903; Putnam FR, 1984, PLASMA PROTEINS STRU, V2, P45; Santo AH, 2008, PAN AM J PUBLIC HLTH, V23, P313, DOI [10.1590/S1020-49892008000500003, DOI 10.1590/S1020-49892008000500003]; Brandao RMSD, 2014, FUTURE MICROBIOL, V9, P871, DOI [10.2217/fmb.14.49, 10.2217/FMB.14.49]; Santos HM, 2010, J PROTEOMICS, V73, P1411, DOI 10.1016/j.jprot.2010.03.012; Shikanai-Yasuda MA, 2017, REV SOC BRAS MED TRO, V50, P715, DOI 10.1590/0037-8682-0230-2017; Singh P, 2015, WORLD J MICROB BIOT, V31, P1923, DOI 10.1007/s11274-015-1936-9; Martins LMS, 2013, FUTURE MICROBIOL, V8, P549, DOI [10.2217/FMB.13.22, 10.2217/fmb.13.22]; Sylvestre TF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002834; Teixeira MD, 2014, MED MYCOL, V52, P19, DOI 10.3109/13693786.2013.794311; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Turissini DA, 2017, FUNGAL GENET BIOL, V106, P9, DOI 10.1016/j.fgb.2017.05.007; Venturini J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0552-x; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Virginio ED, 2014, INT J MOL SCI, V15, P14505, DOI 10.3390/ijms150814505; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12	39	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206051	10.1371/journal.pone.0206051	http://dx.doi.org/10.1371/journal.pone.0206051			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359420	Green Published, gold, Green Submitted			2022-12-26	WOS:000448438400037
J	Tangena, JAA; Marcombe, S; Thammavong, P; Chonephetsarath, S; Somphong, B; Sayteng, K; Grandadam, M; Sutherland, IW; Lindsay, SW; Brey, PT				Tangena, Julie-Anne A.; Marcombe, Sebastien; Thammavong, Phoutmany; Chonephetsarath, Somsanith; Somphong, Boudsady; Sayteng, Kouxiong; Grandadam, Marc; Sutherland, Ian W.; Lindsay, Steve W.; Brey, Paul T.			Bionomics and insecticide resistance of the arboviral vector Aedes albopictus in northern Lao PDR	PLOS ONE			English	Article							CONTAINER-BREEDING MOSQUITOS; DIPTERA-CULICIDAE; CHIKUNGUNYA VIRUS; VERTICAL TRANSMISSION; SPATIAL-DISTRIBUTION; STEGOMYIA AEGYPTI; SKUSE DIPTERA; RISK-FACTORS; GLOBAL RISK; DENGUE	In the last four decades there has been a staggering increase in the geographical range of the arboviral vector Aedes albopictus (Skuse, 1894). This species is now found in every continent except Antarctica, increasing the distribution of arboviral diseases such as dengue and chikungunya. In Lao PDR dengue epidemics occur regularly, with cases of chikungunya also reported. As treatment methods for arboviral diseases is limited, the control of the vector mosquitoes are essential. There is a paucity of information on the bionomics and resistance status of this mosquito for successful vector control efforts. Here we describe the bionomics and insecticide resistance status of Ae. albopictus in Laos to identify opportunities for control. Adult Ae. albopictus were collected using human-baited double bed net (HDN) traps in forests, villages and rubber plantations and tested for alpha- and flaviviruses with RT-PCR. Surveys were also conducted to identify larval habitats. Seven adult and larval populations originating from Vientiane Capital and Luang Prabang province were tested against DDT, malathion, permethrin, deltamethrin and, temephos following WHO protocols. Aedes albopictus were found throughout the year, but were six-fold greater in the rainy season than the dry season. Adult females were active for 24 hours, with peak of behaviour at 18.00 h. The secondary forest and rubber plantation samples showed evidence of Pan-flaviviruses, while samples from the villages did not. More than half of the emerged Ae. albopictus were collected from mature rubber plantations (53.9%; 1,533/2,845). Most Ae. albopictus mosquitoes emerged from latex collection cups (19.7%; 562/2,845), small water containers (19.7%; 562/2,845) and tyres (17.4%; 495/2,845). Adult mosquitoes were susceptible to pyrethroids, apart from one population in Vientiane city. All populations were resistant to DDT (between 27-90% mortality) and all except one were resistant to malathion (20-86%). Three of the seven larval populations were resistant to temephos (42-87%), with suspected resistance found in three other populations (92-98%).This study demonstrates that rural areas in northern Laos are potential hot spots for arboviral disease transmission. Multiple-insecticide resistance was found. Aedes albopictus control efforts in villages need to expand to include secondary forests and rubber plantations, with larval source management and limited use of insecticides.	[Tangena, Julie-Anne A.; Marcombe, Sebastien; Thammavong, Phoutmany; Chonephetsarath, Somsanith; Somphong, Boudsady; Grandadam, Marc; Brey, Paul T.] Inst Pasteur Laos, Med Entomol & Vector Borne Dis Lab, Viangchan, Laos; [Sayteng, Kouxiong] Inst Pasteur Laos, Arbovirol & Emerging Viruses Lab, Viangchan, Laos; [Sutherland, Ian W.] US Naval Med Res Ctr Asia, PSA Sembawang, Singapore, Singapore; [Sutherland, Ian W.] US Navy Entomol Ctr Excellence, NAS Jacksonville, Jacksonville, FL USA; [Lindsay, Steve W.] Univ Durham, Dept Biosci, Durham, England	Durham University	Tangena, JAA (corresponding author), Inst Pasteur Laos, Med Entomol & Vector Borne Dis Lab, Viangchan, Laos.	jtangena@gmail.com	GRANDADAM, Marc/GNP-7470-2022	Tangena, Julie-Anne/0000-0002-8188-4498; Lindsay, Steve/0000-0002-3461-9050	Michelin Corporate Foundation; Agence Francaise de Developpement [CZZ 1809 AA]; Naval Medical Research Center - Asia [W911QY-14-2-0003]	Michelin Corporate Foundation; Agence Francaise de Developpement; Naval Medical Research Center - Asia	This work was supported by the YERSIN project funded by the Michelin Corporate Foundation and the Agence Francaise de Developpement; Grant number CZZ 1809 AA. This work was partially supported by the Naval Medical Research Center - Asia, contract #W911QY-14-2-0003. The opinions and assertions contained herein are those of the author(s) and are not to be construed as official or reflecting the views of the Department of the Navy, Department of Defense, or U.S. Government. Title 17 U.S.C. 105 provides that "Copyright protection under this title is not available for any work of the United States Government.'" Title 17 U.S.C. 101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person's official duties. This work was prepared as part of Sutherland's military official duties. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI DOI 10.1371/JOURNAL.PNTD.0003655; Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001; Almeida APG, 2005, J MED ENTOMOL, V42, P419, DOI 10.1603/0022-2585(2005)042[0419:BAVCOA]2.0.CO;2; [Anonymous], 2016, DENG VACC WHO POS PA; [Anonymous], 1994, TROP MED; [Anonymous], JPN J TROP MED HYG; [Anonymous], 2017, DENG SIT UPD NEW DEL; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Boyer S, 2013, J AM MOSQUITO CONTR, V29, P74, DOI 10.2987/12-6259R.1; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Castonguay-Vanier J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006203; Chen HY, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0125-x; Chuaycharoensuk T, 2011, J VECTOR ECOL, V36, P204, DOI 10.1111/j.1948-7134.2011.00158.x; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Detinova T. S., 1945, MEDITSINSKA PARAZITOLOG[IMAGE] I PARAZITARNYE BOLEZNI [MED PARASITOL AND PARASITIC DIS], V14, P45; Devi NP, 2007, J INSECT SCI, V7; Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51; Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6; Gopalakrishnan R, 2013, J VECTOR DIS, V50, P215; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Haddow AD, 2013, VIROLOGY, V440, P134, DOI 10.1016/j.virol.2012.12.008; HALSTEAD SB, 1966, B WORLD HEALTH ORGAN, V35, P3; Hasan HA., 2016, INT J ENTOMOLOGY RES, V3, P91; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04; Hiscox A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062769; Hiscox A, 2013, AM J TROP MED HYG, V88, P1070, DOI 10.4269/ajtmh.12-0623; Hiscox A, 2010, AM J TROP MED HYG, V83, P1166, DOI 10.4269/ajtmh.2010.09-0480; Horsfall WR, 1955, THEIR BIONOMICS RELA, P245; Ishak IH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24707; Issack MI, 2010, EMERG INFECT DIS, V16, P716, DOI 10.3201/eid1604.091582; Jirakanjanakit N, 2007, J ECON ENTOMOL, V100, P545, DOI 10.1603/0022-0493(2007)100[545:IRSIAS]2.0.CO;2; Julo-Reminiac J-E, 2014, FIELD ACTIONS SCI RE, V7, P3759; Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79; Lacroix R, 2009, J MED ENTOMOL, V46, P1117, DOI 10.1603/033.046.0519; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Lao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115569; LI YJ, 2014, PLOS NEGLECT TROP D, V8; Linthicum KJ, 2003, J AM MOSQUITO CONTR, V19, P301; Lutomiah JJL, 2007, J INSECT SCI, V7; Makino Yoshihiro, 1994, Tropical Medicine, V36, P131; Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Mitchell C. J., 1995, Parassitologia (Rome), V37, P109; MIYAGI I, 1992, MED VET ENTOMOL, V6, P290, DOI 10.1111/j.1365-2915.1992.tb00620.x; MNREPCD, 2016, LAO PEOPL DEM REP NA; MOUCHET J, 1972, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V10, P301; Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625; PAGES F, 2009, PLOS ONE, V4, DOI DOI 10.1371/JOURNAL.PONE.004691; Paily KP, 2013, PARASITOL RES, V112, P1299, DOI 10.1007/s00436-012-3265-3; Palaniyandi M., 2014, International Journal of Mosquito Research, V1, P35; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; Phommanivong Viengvaly, 2016, Trop Med Health, V44, P24, DOI 10.1186/s41182-016-0020-y; Ponlawat A, 2005, J MED ENTOMOL, V42, P821, DOI 10.1603/0022-2585(2005)042[0821:ISOAAA]2.0.CO;2; QIU FX, 1993, B WORLD HEALTH ORGAN, V71, P349; Ranson H., 2010, TROPIKA, V1, P1; Rattanarithikul R, 2005, SE ASIAN J TROP MED, p[37, 41, 36]; Rattanarithikul R, 2005, SE ASIAN J TROP MED, P41; Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163; Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72; Ritchie SA, 2010, AM J TROP MED HYG, V82, P1053, DOI 10.4269/ajtmh.2010.09-0603; Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4; Rohani A, 2014, J VECTOR DIS, V51, P327; Sanchez-Seco MP, 2005, J VIROL METHODS, V126, P101, DOI 10.1016/j.jviromet.2005.01.025; Sanchez-Seco MP, 2001, J VIROL METHODS, V95, P153, DOI 10.1016/S0166-0934(01)00306-8; Seng CM, 2008, J VECTOR ECOL, V33, P139, DOI 10.3376/1081-1710(2008)33[139:CUOTLF]2.0.CO;2; Sivan A, 2015, PARASITOL RES, V114, P3539, DOI 10.1007/s00436-015-4634-5; Somlor S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189879; Soulaphy C, 2013, WEST PAC SURVEILL RE, V4, P46, DOI [10.5365/WPSAR.2012.3.4.017, 10.5365/wpsar.2012.3.4.017]; SULAIMAN S, 1986, B ENTOMOL RES, V76, P553, DOI 10.1017/S0007485300015066; Sumodan P. K., 2003, Dengue Bulletin, V27, P197; Sumodan PK, 2015, SOCIOECOLOGICAL DIME, P160; Tangena JAA, 2017, J MED ENTOMOL, V54, P1589, DOI 10.1093/jme/tjx071; Tangena JAA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005802; Tangena JAA, 2016, TRENDS PARASITOL, V32, P402, DOI 10.1016/j.pt.2016.01.009; Tangena JAA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138735; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Thammapalo S, 2009, J VECTOR DIS, V6, P2; Thammapalo Suwich, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P426; Thanispong K, 2015, J AM MOSQUITO CONTR, V31, P346, DOI 10.2987/moco-31-04-346-352.1; Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004; Tsuda Yoshio, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P63; Tsuda Y, 2006, J AM MOSQUITO CONTR, V22, P222, DOI 10.2987/8756-971X(2006)22[222:DSDOAA]2.0.CO;2; Valerio L, 2010, VECTOR-BORNE ZOONOT, V10, P291, DOI 10.1089/vbz.2009.0007; Vallee J, 2009, TROP MED INT HEALTH, V14, P1134, DOI 10.1111/j.1365-3156.2009.02319.x; Vanwambeke SO, 2007, J MED ENTOMOL, V44, P133, DOI 10.1603/0022-2585(2007)44[133:LALCFI]2.0.CO;2; Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14; Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716; Vijayakumar K, 2014, J VECTOR DIS, V51, P27; Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008; Vythilingam I, 2006, J AM MOSQUITO CONTR, V22, P140, DOI 10.2987/8756-971X(2006)22[140:SCOMOA]2.0.CO;2; Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921; WHO, 2009, WHO TECH REP SER, V958, P1; WHO, 2016, MON MAN INS RES AED; Wilkinson DA, 2014, J INSECT PHYSIOL, V71, P114, DOI 10.1016/j.jinsphys.2014.10.005; Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348; World Health Organization, 2009, GUID LAB FIELD TEST; World Health Organization, 2012, HDB INT VECT MAN; World Health Organization, 2016, NOMA IS SEV DIS IT T, P1	109	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206387	10.1371/journal.pone.0206387	http://dx.doi.org/10.1371/journal.pone.0206387			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359425	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000448438400074
J	Dunn, J; Andrews, C; Nettle, D; Bateson, M				Dunn, Jonathon; Andrews, Clare; Nettle, Daniel; Bateson, Melissa			Evaluating the cyclic ratio schedule as an assay of feeding behaviour in the European starling (Sturnus vulgaris)	PLOS ONE			English	Article							ENHANCEMENT	The cyclic ratio (CR) schedule is a behavioural assay developed to study feeding in rats, in which the number of operant responses required to obtain food reward (the ratio requirement) increases and then decreases in a repeating cycle. In a recent study, we used the CR schedule with European starlings (Sturnus vulgaris) to investigate the effects of an early-life manipulation on adult feeding behaviour. As this was the first time the CR schedule had been used with any bird species, a more in-depth evaluation is warranted. Here, we performed a fuller CR experiment with the same birds as the prior study, a year later. First, we examine the individual consistency of feeding behaviour between experimental sessions and also between CR schedules comprising different ratio requirement progressions. We found that between-session consistency was poor to moderate, and that a geometric ratio progression provided greater between-session consistency than an arithmetic ratio progression. Second, we tried to replicate some of the canonical findings from rats working on CR schedules. In contrast to findings from rats, we found that defence of feeding rates did not increase when starlings were acutely food deprived. However, as in rats, we found that the post-reinforcement pause increased linearly with the upcoming ratio requirement, suggesting that starlings were able to learn the cyclic nature of the schedule. Third, we compared the results from the present study concerning the impacts of our early-life treatment with those from our earlier study. We found that the majority of our previous findings were replicated in the same individuals one year on, reinforcing our previous conclusion that the early-life manipulation had canalised our birds into two groups with different patterns of feeding rate defence.	[Dunn, Jonathon; Andrews, Clare; Nettle, Daniel; Bateson, Melissa] Newcastle Univ, Ctr Behav & Evolut, Newcastle, England; Newcastle Univ, Inst Neurosci, Newcastle, England	Newcastle University - UK; Newcastle University - UK	Dunn, J (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Newcastle, England.	jonathon.dunn@newcastel.ac.uk	Bateson, Melissa/AAE-7075-2022	Bateson, Melissa/0000-0002-0861-0191; Andrews, Clare/0000-0002-7484-4447; Dunn, Jonathon/0000-0002-9603-7320	Biotechnology and Biological Sciences Research Council [BB/J016446/1]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [AdG 666669]; BBSRC [BB/J016446/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council. Grant number BB/J016446/1 (https://bbsrc.ukri.org/research/grants/grants/AwardDetails.aspx?FundingReference=BB/J016446/1) to MB & DN and was also supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme. Grant agreement No AdG 666669, COMSTAR (https://ec.europa.eu/programmes/horizon2020/) to DN & MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Cardinal RN, 2010, BEHAV RES METHODS, V42, P1059, DOI 10.3758/BRM.42.4.1059; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Dess NK, 2007, INT J COMP PSYCHOL, V20, P317; Dunn J, 2018, EVALUATING THE CYCLI, DOI [10.5281/zenodo.1308685, DOI 10.5281/ZENODO.1308685]; Dunn J, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171918; ETTINGER RH, 1986, PHYSIOL BEHAV, V36, P801, DOI 10.1016/0031-9384(86)90435-X; ETTINGER RH, 1983, BEHAV NEUROSCI, V97, P639, DOI 10.1037/0735-7044.97.4.639; Feenders G, 2013, ANIM BEHAV, V86, P127, DOI 10.1016/j.anbehav.2013.05.002; Gamer M, 2012, IRR VARIOUS COEFFICI; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; HURSH SR, 1984, J EXP ANAL BEHAV, V42, P435, DOI 10.1901/jeab.1984.42-435; Killeen PR, 2009, J EXP PSYCHOL ANIM B, V35, P35, DOI 10.1037/a0012497; Kirkden RD, 2003, ANIM BEHAV, V65, P157, DOI 10.1006/anbe.2002.2035; Kirkden RD, 2006, APPL ANIM BEHAV SCI, V100, P29, DOI 10.1016/j.applanim.2006.04.009; Leslie JC, 2000, Q J EXP PSYCHOL-B, V53, P289, DOI 10.1080/027249900750001310; Nettle D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40794; O'Hare E, 2006, PSYCHOPHARMACOLOGY, V187, P138, DOI 10.1007/s00213-006-0412-5; O'Hare E, 2004, BEHAV NEUROSCI, V118, P173, DOI 10.1037/0735-7044.118.1.173; OHare E, 1996, BEHAV PHARMACOL, V7, P742; OHARE E, 1991, PHYSIOL BEHAV, V49, P331, DOI 10.1016/0031-9384(91)90052-P; R Core Team, 2021, R LANGUAGE ENV STAT; Staddon JER, 1980, ANAL MOTIVATIONAL PR, P103; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03	24	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206363	10.1371/journal.pone.0206363	http://dx.doi.org/10.1371/journal.pone.0206363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX8WQ	30352086	Green Published, Green Submitted, gold			2022-12-26	WOS:000448076200050
J	Ogata, Y; Mannen, K; Kotani, Y; Kimura, N; Sakurai, N; Shibata, D; Suzuki, H				Ogata, Yoshiyuki; Mannen, Kazuto; Kotani, Yasuto; Kimura, Naohiro; Sakurai, Nozomu; Shibata, Daisuke; Suzuki, Hideyuki			ConfeitoGUI: A toolkit for size-sensitive community detection from a correlation network	PLOS ONE			English	Article							DATABASE	Analysis of the large amounts of data accumulated in public databanks can facilitate a more comprehensive understanding of molecular biological processes. Community detection from molecular biological data is paramount in characterizing evolutionary and functional traits of organisms based on gene homology and co-expression, respectively. Although there are common tools to detect local communities from a large network, no toolkit exists for detecting communities that include an element of interest based on size sensitivity, i.e., functionality to obtain local communities with preferred sizes. Herein, we present the ConfeitoGUI toolkit for detecting local communities from a correlation network involving size sensitivity. We compared the toolkit with other common tools for detection in reconstructing communities of microarray experiments of mice. In the results, ConfeitoGUI was observed to be preferable for detecting communities whose sizes are similar to those of original communities compared to other common tools. By changing simple parameters representing sizes for the toolkit, a user can obtain local communities with preferred sizes, which is beneficial for further analysis of members belonging to the communities.	[Ogata, Yoshiyuki; Kotani, Yasuto; Kimura, Naohiro] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka, Japan; [Ogata, Yoshiyuki; Mannen, Kazuto; Sakurai, Nozomu; Shibata, Daisuke; Suzuki, Hideyuki] Kazusa DNA Res Inst, Dept Res & Dev, Chiba, Japan	Osaka Metropolitan University; Kazusa DNA Research Institute	Ogata, Y (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka, Japan.; Ogata, Y; Suzuki, H (corresponding author), Kazusa DNA Res Inst, Dept Res & Dev, Chiba, Japan.	ogata@plant.osakafu-u.ac.jp; hsuzuki@kazusa.or.jp		Ogata, Yoshiyuki/0000-0002-9299-5433	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [26350967, 25108727]; Kazusa DNA Research Institute Foundation; Promotion of Dissimilar Field Collaboration Research at Osaka Prefecture University [0203041700]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kazusa DNA Research Institute Foundation; Promotion of Dissimilar Field Collaboration Research at Osaka Prefecture University	This work was supported, in part, by Grants-in-aid for Scientific Research (C) (no. 26350967; https://www.jsps.go.jp/english/e-grants/; external) and Scientific Research on Innovative Areas (no. 25108727; https://www.jsps.go.jp/english/e-grants/grants01.html; external) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, by the Kazusa DNA Research Institute Foundation (internal) (HS), and by the Promotion of Dissimilar Field Collaboration Research at Osaka Prefecture University (grant no. 0203041700; http://www.iao.osakafu-u.ac.jp/urahp/?page_id=28 [in Japanese]; internal) (YO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Guo JQ, 2013, TECHNOMETRICS, V55, P390, DOI 10.1080/00401706.2013.804438; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Kale N. S, 2016, CURR PROTOC BIOINFOR, V53, DOI DOI 10.1002/0471250953.BI1413S53; Kaplan A, 2017, COMPUTATION STAT, V32, P535, DOI 10.1007/s00180-016-0663-5; Marx V, 2013, NATURE, V496, P253, DOI 10.1038/498255a; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Ogata Y, 2011, PLANT BIOTECHNOL-NAR, V28, P351, DOI 10.5511/plantbiotechnology.11.0818a; Ogata Y, 2010, BIOINFORMATICS, V26, P1267, DOI 10.1093/bioinformatics/btq121; Ogata Yoshiyuki, 2009, Genome Inform, V23, P117; Ogata Y, 2009, PLANT BIOTECHNOL-NAR, V26, P503, DOI 10.5511/plantbiotechnology.26.503; Ogata Y, 2009, J WOOD SCI, V55, P395, DOI 10.1007/s10086-009-1058-9; Sirim D, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-27; Traag VA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036115; VANRIJSBERGEN C, 1979, INFORM RETRIEVAL	23	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0206075	10.1371/journal.pone.0206075	http://dx.doi.org/10.1371/journal.pone.0206075			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX8WQ	30352084	gold, Green Published, Green Submitted			2022-12-26	WOS:000448076200025
J	de Lima, MFS; de Oliveira, LP; Cabral, NLD; Liberalino, LCP; Bagni, UV; de Lima, KC; Lyra, CD				Silva de Lima, Marcos Felipe; de Oliveira, Larissa Praca; de Araujo Cabral, Natalia Louise; Pereira Liberalino, Laura Camila; Bagni, Ursula Viana; de Lima, Kenio Costa; Lyra, Clelia de Oliveira			Estimating the height of elderly nursing home residents: Which equation to use?	PLOS ONE			English	Article							STATURE PREDICTION EQUATIONS; WHITE; BLACK; POPULATION; COUNTRIES; GROWTH	Estimating equations can be used when measuring the height of elderly persons is not possible. However, such methods are not always applicable; therefore, it is necessary to consider several aspects, such as sex, age, and ethnicity of the studied population to generate these equations. This study aimed to compare and validate methods of estimating the height of the Brazilian elderly nursing home residents. An accuracy study was conducted with 168 elderly persons. A total of 23 equations were quantitatively evaluated by plotting the differences in means, the Student's t-test for paired samples, the coefficient of determination (R-2), the root-mean-square error (RMSE), the interclass correlation coefficient (ICC), and by graphic analysis of the residuals. A significance value of p <0.05 was adopted. An equation was considered applicable when it had R-2 >0.7, the lowest RMSE among the equations evaluated, ICC >0.7, and a confidence interval of 95%, with the smallest difference between the upper and lower limits. A greater mean height was noted among younger elderly persons and elderly men compared to up to 80 years and women elderly. Quantitative analysis revealed that equation for Puerto Ricans, using knee height and age, was the most applicable for the overall population (ICC = 0.802). The same equation was applicable for the elderly Brazilian male participants (ICC = 0.838) and for those aged 60-69 years (ICC = 0.895). None of the equations used were applicable for the height estimation of elderly women or individuals aged 70 years or more.	[Silva de Lima, Marcos Felipe; de Oliveira, Larissa Praca; de Araujo Cabral, Natalia Louise; Pereira Liberalino, Laura Camila] Univ Fed Rio Grande do Norte, Postgrad Publ Hlth, Natal, RN, Brazil; [Bagni, Ursula Viana; Lyra, Clelia de Oliveira] Univ Fed Rio Grande do Norte, Dept Nutr, Natal, RN, Brazil; [de Lima, Kenio Costa] Univ Fed Rio Grande do Norte, Dept Dent, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	de Lima, MFS (corresponding author), Univ Fed Rio Grande do Norte, Postgrad Publ Hlth, Natal, RN, Brazil.	marcosfelipe@ymail.com	Lyra, Clelia/AAT-5093-2021	Silva de Lima, Marcos Felipe/0000-0002-2196-6985; Lima, Kenio Costa/0000-0002-5668-4398	Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (Rio Grande do Norte Research Support Foundation) (FAPERN): Programa de Apoio a Nucleos Emergentes (Emerging Centers Support Program) [Edict PRONEM/FAPERN/CNPq 003/2]; Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (Rio Grande do Norte Research Support Foundation) (FAPERN)	Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (Rio Grande do Norte Research Support Foundation) (FAPERN): Programa de Apoio a Nucleos Emergentes (Emerging Centers Support Program); Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (Rio Grande do Norte Research Support Foundation) (FAPERN)	This work was supported by the Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (Rio Grande do Norte Research Support Foundation) (FAPERN): Programa de Apoio a Nucleos Emergentes (Emerging Centers Support Program) - Edict PRONEM/FAPERN/CNPq 003/2 (KCdL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors alone are responsible for the views expressed in this article, which do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated. We thank Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (Rio Grande do Norte Research Support Foundation) (FAPERN) for financing this study, and we thank the undergraduate students who were part of the data collection: Laura Van Rooijen Cysneiros, Luana Alves dos Santos, Kerollainy Ferreira da Nobrega, Karla Mendonca Goncalves de Jesus, Miriam Farias da Silva, and Natalia de Carvalho Cordeiro Lira.	Amarya S, 2015, J CLIN GERONTOL GERI, V6, P78, DOI 10.1016/j.jcgg.2015.05.003; Bermudez OI, 1999, AM J CLIN NUTR, V69, P992; CHUMLEA WC, 1992, J GERONTOL, V47, pM197, DOI 10.1093/geronj/47.6.M197; Chumlea WC, 1998, J AM DIET ASSOC, V98, P137, DOI 10.1016/S0002-8223(98)00036-4; CHUMLEA WC, 1985, J AM GERIATR SOC, V33, P116, DOI 10.1111/j.1532-5415.1985.tb02276.x; DELEMARREVANDEWAAL HA, 1993, ENVIRON HEALTH PERSP, V101, P39, DOI 10.1289/ehp.93101s239; Dennis DM, 2015, AM J CRIT CARE, V24, P41, DOI 10.4037/ajcc2015761; Dreischarf M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116186; Fatmah F, 2009, INT J MED MED SCI, V1, P456; Fernihough A, 2015, ECON HUM BIOL, V16, P30, DOI 10.1016/j.ehb.2013.12.010; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Fogal AS, 2015, NUTR HOSP, V31, P829, DOI 10.3305/nh.2015.31.2.7618; Frid H, 2013, J HUM NUTR DIET, V26, P504, DOI 10.1111/jhn.12031; Graf C, 2006, AM J NURS, V106, P58, DOI 10.1097/00000446-200601000-00032; Hickson M, 2003, J HUM NUTR DIET, V16, P13, DOI 10.1046/j.1365-277X.2003.00416.x; Hwang IC, 2009, EPIDEMIOL HEALTH, V31, DOI 10.4178/epih/e2009004; KWOK T, 1991, J AM GERIATR SOC, V39, P492, DOI 10.1111/j.1532-5415.1991.tb02495.x; Lahner CR, 2016, S AFR J CLIN NUTR, V29, P122, DOI 10.1080/16070658.2016.1198616; Lera L, 2005, ANN HUM BIOL, V32, P773, DOI 10.1080/03014460500421304; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Malnutrition Advisory Group (MAG), 2011, MUST EXPL BOOKL; Neves KD, 2016, J PEDIAT-BRAZIL, V92, P241, DOI 10.1016/j.jped.2015.08.007; Palloni A, 2005, J GERONTOL A-BIOL, V60, P804, DOI 10.1093/gerona/60.6.804; Pederson D, 2000, ANTROPOMETRICA, P71; Rabito EI, 2008, NUTR HOSP, V23, P614; Roth DE, 2017, LANCET GLOB HEALTH, V5, pE1249, DOI 10.1016/S2214-109X(17)30418-7; Rothwell PM, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010009; Sampaio HAC, 2002, REV BRAS NUTR CLIN, V14, P117; Shahar S, 2003, ASIA PAC J CLIN NUTR, V12, P80; Silveira DH, 1994, J BRAS MED, V67, P176; Siqueira VD, 2012, CAD SAUDE PUBLICA, V28, P125; Wannamethee SG, 2006, ARCH INTERN MED, V166, P2546, DOI 10.1001/archinte.166.22.2546	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2018	13	10							e0205642	10.1371/journal.pone.0205642	http://dx.doi.org/10.1371/journal.pone.0205642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX8WQ	30352073	gold, Green Submitted, Green Published			2022-12-26	WOS:000448076200012
J	Hoeh, JPS; Bakken, GS; Mitchell, WA; O'Keefe, JM				Hoeh, Julia P. S.; Bakken, George S.; Mitchell, William A.; O'Keefe, Joy M.			In artificial roost comparison, bats show preference for rocket box style	PLOS ONE			English	Article							PIPISTRELLUS-PYGMAEUS; MYOTIS-LUCIFUGUS; SELECTION; MICROCLIMATE; INDIANA; CHIROPTERA; BEHAVIOR; THERMOREGULATION; TEMPERATURES; REGRESSION	Understanding microhabitat preferences of animals is critical for effective conservation, especially for temperate-zone bats, which receive fitness benefits from selecting optimal roost microhabitats. Artificial roost structures are increasingly being used in conservation efforts for at-risk bat species. To evaluate microhabitat differences in common artificial roost structures and determine if roost selection occurs based on structure type, we installed artificial roosts of three different styles (bat box, rocket box, and bark mimic) in six clusters. We compared size and measured temperature parameters (12 points/roost) while bats were excluded from one cluster. We simultaneously conducted census counts during the active season at five more clusters open to bats for 1-2 years. The rocket box style provided larger entrance area, surface area, and volume versus other roost types. Microclimate varied with roost design. More positions inside the bat box and rocket box stayed within critical temperature limits for bats (0-45 degrees C)-i.e., were usable. The bark-mimic provided less usable space than the rocket box and, often, large proportions of the roost were > 45 degrees C. The rocket box provided the widest temperature availability in a given hour (max range available 7 degrees C) and was more stable than the bark mimic. A maternity colony of Indiana bats (Myotis sodalis) selected the rocket box style; four of five available rocket boxes became primary maternity roosts, with 2-210 bats emerging per night. Future work should aim to manipulate roost size, temperature availability, and temperature stability in isolation to identify which features drive roost microhabitat selection by bats. Comparative studies of artificial roosts account for some inherent irregularity in natural systems, allowing us to study the dynamics of roost microhabitats. We recommend season-long monitoring of microhabitat in novel artificial refuges and comparative studies of artificial and natural roosts, and urge managers to consider potential positive and negative effects when substituting artificial roosts for natural habitat.	[Hoeh, Julia P. S.; O'Keefe, Joy M.] Indiana State Univ, Ctr Bat Res Outreach & Conservat, Terre Haute, IN 47809 USA; [Bakken, George S.; Mitchell, William A.] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA	Indiana State University; Indiana State University	O'Keefe, JM (corresponding author), Indiana State Univ, Ctr Bat Res Outreach & Conservat, Terre Haute, IN 47809 USA.	joyokeefe@gmail.com		Mitchell, William/0000-0002-5494-2445	Indiana Space Grant Consortium; Indiana State University; Hendricks County Parks; Indianapolis Airport Authority	Indiana Space Grant Consortium; Indiana State University; Hendricks County Parks; Indianapolis Airport Authority	The Indianapolis Airport Authority (https://www.indianapolisairport.com; Grant to JO), Indiana Space Grant Consortium (https://insgc.spacegrant.org; Grant to JH), Indiana State University (indstate.edu; Grant to JH), and Hendricks County Parks (http://hendrickscountyparks.org; Grant to JO) funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J., 2015, J AM SOC MINING RECL, V4, P1, DOI DOI 10.21000/JASMR15010001; ANTHONY ELP, 1977, ECOLOGY, V58, P775, DOI 10.2307/1936213; Bakken G.S., 1988, P303; Barclay Robert M.R., 2007, P17; Bartonicka T, 2007, ACTA CHIROPTEROL, V9, P517, DOI 10.3161/1733-5329(2007)9[517:IOTMOB]2.0.CO;2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergeson SM, 2018, FOREST ECOL MANAG, V427, P305, DOI 10.1016/j.foreco.2018.06.009; BOYD IL, 1989, J APPL ECOL, V26, P101, DOI 10.2307/2403654; Boyles JG, 2007, ACTA CHIROPTEROL, V9, P297, DOI 10.3161/1733-5329(2007)9[297:DRUBFB]2.0.CO;2; BRIGHAM RM, 1986, CAN J ZOOL, V64, P1128, DOI 10.1139/z86-169; Brittingham MC, 2000, WILDLIFE SOC B, V28, P197; Callahan EV, 1997, J MAMMAL, V78, P818, DOI 10.2307/1382939; Carter Timothy, 2001, Bat Research News, V42, P197; Clement MJ, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00180.1; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Doty AC, 2016, J THERM BIOL, V60, P162, DOI 10.1016/j.jtherbio.2016.07.015; Dourson D., 1997, BAT HOUSE RES, V5, P4; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; HAMILTON IM, 1994, CAN J ZOOL, V72, P744, DOI 10.1139/z94-100; HENSHAW RE, 1966, PHYSIOL ZOOL, V39, P223, DOI 10.1086/physzool.39.3.30152849; HOCK RJ, 1951, BIOL BULL-US, V101, P289, DOI 10.2307/1538547; Hoeh J. P. S, 2017, THESIS; Hoying KM, 1998, J ZOOL, V245, P15, DOI 10.1111/j.1469-7998.1998.tb00067.x; Huey R.B., 1991, American Naturalist, V137, P91; Humphries Murray M., 2005, P23; Kanuch P, 2007, MAMMALIA, V71, P126, DOI 10.1515/MAMM.2007.026; Kunz T.H., 1982, P1; Kunz TH, 2003, BAT ECOLOGY, P3; Kurta A., 2005, P IND BAT COAL MIN T, P29; Lacki MJ, 2009, AM MIDL NAT, V162, P318, DOI 10.1674/0003-0031-162.2.318; LICHT P, 1967, J MAMMAL, V48, P52, DOI 10.2307/1378169; Lima SL, 2013, BIOL REV, V88, P626, DOI 10.1111/brv.12021; Lourenco SI, 2004, BIOL CONSERV, V119, P237, DOI 10.1016/j.biocon.2003.11.006; Lucan RK, 2009, FOREST ECOL MANAG, V258, P1301, DOI 10.1016/j.foreco.2009.06.032; McNab B., 1980, AM NAT, V116, P160; Mering ED, 2012, WILDLIFE SOC B, V36, P765, DOI 10.1002/wsb.214; Nad'o L, 2015, BEHAV PROCESS, V120, P80, DOI 10.1016/j.beproc.2015.09.005; Neuweiler G., 2000, BIOL BATS; O'Keefe JM, 2017, FOREST ECOL MANAG, V391, P264, DOI 10.1016/j.foreco.2017.01.036; OFARRELL MJ, 1970, COMP BIOCHEM PHYSIOL, V35, P697, DOI 10.1016/0010-406X(70)90987-4; OKeefe JM, 2015, 2015 MONITORING PROG; OKeefe JM, 2016, 2016 MONITORING PROG; Pettit JL, 2015, THESIS; Pettit JL, 2017, J MAMMAL, V98, P1236, DOI 10.1093/jmammal/gyx054; R Core Team, 2021, R LANGUAGE ENV STAT; RACEY PA, 1981, J REPROD FERTIL, V61, P123; Ritzi CM, 2005, NORTHEAST NAT, V12, P217, DOI 10.1656/1092-6194(2005)012[0217:UOBBBA]2.0.CO;2; Rueegger N, 2016, ACTA CHIROPTEROL, V18, P279, DOI 10.3161/15081109ACC2016.18.1.017; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; Sedgeley JA, 2001, J APPL ECOL, V38, P425, DOI 10.1046/j.1365-2664.2001.00607.x; Smithson M, 2006, PSYCHOL METHODS, V11, P54, DOI 10.1037/1082-989X.11.1.54; Sparks DW, 2009, AIRPORTS: PERFORMANCE, RISKS, AND PROBLEMS, P51; STORER TRACY I., 1926, JOUR MAMMALOGY, V7, P85, DOI 10.2307/1373673; Vonhof MJ, 1996, CAN J ZOOL, V74, P1797, DOI 10.1139/z96-200; Whitaker JO, 2006, ENVIRON MANAGE, V38, P28, DOI 10.1007/s00267-005-0117-2; Whitaker John O. Jr, 2002, P48; Wiebe KL, 2001, AUK, V118, P412, DOI 10.1642/0004-8038(2001)118[0412:MOTCNI]2.0.CO;2; Wilcox A, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cov070; Willis C., 2006, FUNCTIONAL EVOLUTION, P38; Willis CKR, 2006, J MAMMAL, V87, P345, DOI 10.1644/05-MAMM-A-118R1.1; Willis CKR, 2007, BEHAV ECOL SOCIOBIOL, V62, P97, DOI 10.1007/s00265-007-0442-y	61	13	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205701	10.1371/journal.pone.0205701	http://dx.doi.org/10.1371/journal.pone.0205701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379849	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700066
J	Van Ancum, JM; Jonkman, NH; van Schoor, NM; Tressel, E; Meskers, CGM; Pijnappels, M; Maier, AB				Van Ancum, Jeanine M.; Jonkman, Nini H.; van Schoor, Natasja M.; Tressel, Emily; Meskers, Carel G. M.; Pijnappels, Mirjam; Maier, Andrea B.			Predictors of metabolic syndrome in community-dwelling older adults	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; WAIST CIRCUMFERENCE; MUSCLE STRENGTH; US POPULATION; SYNDROME METS; RISK-FACTORS; PREVALENCE; HEALTH; CUTOFF	Objectives The metabolic syndrome has been associated with a variety of individual variables, including demographics, lifestyle, clinical measures and physical performance. We aimed to identify independent predictors of the prevalence and incidence of metabolic syndrome in a large cohort of older adults. Methods The Longitudinal Aging Study Amsterdam is a prospective cohort including community-dwelling adults aged 55-85 years. Metabolic syndrome was defined according to criteria of the National Cholesterol Education Program Adult Treatment Panel III. The incidence of metabolic syndrome was calculated over a period of three years. Stepwise backward logistic regression analyses were used to identify predictors, including variables for demographics, lifestyle, clinical measures and physical performance, both in a cross-sectional cohort (n = 1292) and a longitudinal sub-cohort (n = 218). Results Prevalence and incidence of metabolic syndrome were 37% (n = 479) and 30% (n = 66), respectively. Cross-sectionally, heart disease (OR: 1.91, 95% CI: 1.37-2.65), peripheral artery disease (OR: 2.13, 95% CI: 1.32-3.42), diabetes (OR: 4.74, 95% CI: 2.65-8.48), cerebrovascular accident (OR: 1.92, 95% CI: 1.09-3.37), and a higher Body Mass Index (OR: 1.32, 95% CI: 1.26-1.38) were significant independent predictors of metabolic syndrome. Longitudinally, Body Mass Index (OR: 1.16, 95% CI: 1.05-1.27) was an independent predictor of metabolic syndrome. Conclusion Four age related diseases and a higher Body Mass Index were the only predictors of metabolic syndrome in the cross-sectional cohort, despite the large variety of variables included 161 in the multivariable analysis. In the longitudinal sub-cohort, a higher Body Mass Index was predictive of developing metabolic syndrome.	[Van Ancum, Jeanine M.; Jonkman, Nini H.; Tressel, Emily; Meskers, Carel G. M.; Pijnappels, Mirjam; Maier, Andrea B.] Vrije Univ Amsterdam, Dept Human Movement Sci, Amsterdam Movement Sci, AgeAmsterdam, Amsterdam, Netherlands; [van Schoor, Natasja M.] Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Meskers, Carel G. M.] Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, Amsterdam Movement Sci, Amsterdam, Netherlands; [Maier, Andrea B.] Univ Melbourne, Royal Melbourne Hosp, Dept Med & Aged Care, AgeMelbourne, Melbourne, Vic, Australia	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Royal Melbourne Hospital; University of Melbourne	Maier, AB (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, Amsterdam Movement Sci, AgeAmsterdam, Amsterdam, Netherlands.; Maier, AB (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med & Aged Care, AgeMelbourne, Melbourne, Vic, Australia.	andrea.maier@mh.org.au	Maier, Andrea/W-7060-2019; Maier, Andrea B./Q-5548-2019	Maier, Andrea/0000-0001-7206-1724; van Schoor, Natasja/0000-0002-0870-0795; Jonkman, Nini Hannah/0000-0002-2585-8973; Van Ancum, J.M./0000-0002-6939-0487; Pijnappels, Mirjam/0000-0001-8416-2602; Meskers, Carel/0000-0002-5056-5611	European Union [689238, 675003]; Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care	European Union(European Commission); Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care	This work was part of the PreventIT and PANINI research projects, funded by the European Union's Horizon 2020 research and innovation programme [689238, 675003]. The Longitudinal Aging Study Amsterdam was supported by a grant from the Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvim RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100223; Aye M, 2012, SINGAP MED J, V53, P545; Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Bassi N, 2014, AM J MED, V127, DOI 10.1016/j.amjmed.2014.06.035; Bisschop CNS, 2013, MATURITAS, V76, P139, DOI 10.1016/j.maturitas.2013.06.015; Blazer DG, 2006, J AM GERIATR SOC, V54, P502, DOI 10.1111/j.1532-5415.2005.00607.x; Brown CD, 2000, OBES RES, V8, P605, DOI 10.1038/oby.2000.79; Carriere I, 2014, J GERONTOL A-BIOL, V69, P79, DOI 10.1093/gerona/glt101; Childers DK, 2010, INT J OBESITY, V34, P1231, DOI 10.1038/ijo.2010.71; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gao X, 2007, DIABETES CARE, V30, P694, DOI 10.2337/dc06-1835; Gharipour M, 2017, ACTA BIOMED, V87, P291; Gnjidic D, 2012, J CLIN EPIDEMIOL, V65, P989, DOI 10.1016/j.jclinepi.2012.02.018; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hirose H, 2011, COMPUT BIOL MED, V41, P1051, DOI 10.1016/j.compbiomed.2011.09.005; Hoogendijk EO, 2016, EUR J EPIDEMIOL, V31, P927, DOI 10.1007/s10654-016-0192-0; Hsiao FC, 2009, SOUTH MED J, V102, P159, DOI 10.1097/SMJ.0b013e3181836b19; Ishii S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112718; Kawada T, 2011, DIABETES METAB SYND, V5, P25, DOI 10.1016/j.dsx.2010.05.012; Kawamoto R, 2016, CLIN EXP HYPERTENS, V38, P245, DOI 10.3109/10641963.2015.1081232; Kolovou GD, 2007, AM J MED SCI, V333, P362, DOI 10.1097/MAJ.0b013e318065c3a1; Laudisio A, 2014, CLIN NUTR, V33, P626, DOI 10.1016/j.clnu.2013.08.005; Lin KM, 2015, J NURS SCHOLARSHIP, V47, P487, DOI 10.1111/jnu.12163; Mahanta TG, 2017, CLIN EPIDEMIOL GLOB, V5, P52, DOI 10.1016/j.cegh.2016.12.004; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Palaniappan L, 2004, DIABETES CARE, V27, P788, DOI 10.2337/diacare.27.3.788; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Penninx BWJH, 2009, J GERONTOL A-BIOL, V64, P96, DOI 10.1093/gerona/gln005; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Roriz-Cruz M, 2007, J AM GERIATR SOC, V55, P374, DOI 10.1111/j.1532-5415.2007.01068.x; Saukkonen T, 2012, SCAND J PRIM HEALTH, V30, P29, DOI 10.3109/02813432.2012.654192; Sayer AA, 2007, QJM-INT J MED, V100, P707, DOI 10.1093/qjmed/hcm095; Stel VS, 2004, J CLIN EPIDEMIOL, V57, P252, DOI 10.1016/j.jclinepi.2003.07.008; Sumner AD, 2012, J CLIN HYPERTENS, V14, P502, DOI 10.1111/j.1751-7176.2012.00647.x; Tsai SP, 2008, DIABETES RES CLIN PR, V82, P148, DOI 10.1016/j.diabres.2008.07.016; Twisk J., 2014, INLEIDING TOEGEPASTE; Wu TT, 2016, BIOL RES NURS, V18, P549, DOI 10.1177/1099800416655882; Yang EF, 2012, METABOLISM, V61, P317, DOI 10.1016/j.metabol.2011.07.005; Yang FY, 2008, ASIA PAC J CLIN NUTR, V17, P339; Yu M, 2014, J EPIDEMIOL, V24, P361, DOI 10.2188/jea.JE20130112; Zhang WC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1424-z	41	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206424	10.1371/journal.pone.0206424	http://dx.doi.org/10.1371/journal.pone.0206424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY7VH	30379967	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700113
J	Rosales-Vega, M; Hernandez-Becerril, A; Murillo-Maldonado, JM; Zurita, M; Vazquez, M				Rosales-Vega, Marco; Hernandez-Becerril, Adriana; Manuel Murillo-Maldonado, Juan; Zurita, Mario; Vazquez, Martha			The role of the trithorax group TnaA isoforms in Hox gene expression, and in Drosophila late development	PLOS ONE			English	Article							CHROMATIN-REMODELING FACTOR; BITHORAX COMPLEX; POLYCOMB; BRAHMA; ULTRABITHORAX; PROTEINS; SEGMENTATION; MUTATIONS; INTERACTS; SUBUNIT	Regulation of developmental gene expression in eukaryotes involves several levels. One of them is the maintenance of gene expression along the life of the animal once it is started by different triggers early in development. One of the questions in the field is when in developmental time, the animal start to use the different maintenance mechanisms. The trithorax group (TrxG) of genes was first characterized as essential for maintaining homeotic gene expression. The TrxG gene tonalli interacts genetically and physically with genes and sub-units of the BRAHMA BAP chromatin remodeling complex and encodes TnaA proteins with putative E3 SUMO-ligase activity. In contrast to the phenocritic lethal phase of animals with mutations in other TrxG genes, tna mutant individuals die late in development. In this study we determined the requirements of TnaA for survival at pupal and adult stages, in different tna mutant genotypes where we corroborate the lack of TnaA proteins, and the presence of adult homeotic loss-of-function phenotypes. We also investigated whether the absence of TnaA in haltere and leg larval imaginal discs affects the presence of the homeotic proteins Ultrabithorax and Sex combs reduced respectively by using some of the characterized genotypes and more finely by generating TnaA defective clones induced at different stages of development. We found that, tna is not required for growth or survival of imaginal disc cells and that it is a fine modulator of homeotic gene expression.	[Rosales-Vega, Marco; Hernandez-Becerril, Adriana; Manuel Murillo-Maldonado, Juan; Zurita, Mario; Vazquez, Martha] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Fisiol Mol & Genet Desarrollo, Cuernavaca, Morelos, Mexico; [Manuel Murillo-Maldonado, Juan] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Queretaro, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Vazquez, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Fisiol Mol & Genet Desarrollo, Cuernavaca, Morelos, Mexico.	mvazquez@ibt.unam.mx		Murillo-Maldonado, Juan Manuel/0000-0003-2019-7106; Vazquez, Martha/0000-0003-0329-8802	Direccion General de Asuntos del Personal Academico (DGAPA), Programa UNAM-PAPIIT grant [IN208316]; CONACyT [307929, 453402]	Direccion General de Asuntos del Personal Academico (DGAPA), Programa UNAM-PAPIIT grant; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by funds from Direccion General de Asuntos del Personal Academico (DGAPA), Programa UNAM-PAPIIT grant IN208316 (http://dgapa.unam.mx/index.php/pf-papiit) to MV. MR-V and AH-B are doctoral students from Programa de Doctorado en Ciencias Bioquimicas, Universidad Nacional Autonoma de Mexico (UNAM) and have scholarships 307929 and 453402 respectively from CONACyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JA, 2002, EMBO J, V21, P5245, DOI 10.1093/emboj/cdf517; BEACHY PA, 1985, NATURE, V313, P545, DOI 10.1038/313545a0; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; Beuchle D, 2001, DEVELOPMENT, V128, P993; Blair SS, 2000, DROSOPHILA PROTOCOLS, P159; Brizuela BJ, 1997, MECH DEVELOP, V65, P209, DOI 10.1016/S0925-4773(97)00081-6; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Chopra VS, 2009, CURR BIOL, V19, P688, DOI 10.1016/j.cub.2009.02.055; CHRISTEN B, 1994, MECH DEVELOP, V48, P255, DOI 10.1016/0925-4773(94)90064-7; Copur O, 2018, GENETICS, V208, P633, DOI 10.1534/genetics.117.300421; Copur O, 2013, DEVELOPMENT, V140, P3478, DOI 10.1242/dev.097204; Crickmore MA, 2009, PLOS GENET, V5, P1; Cunningham MD, 2012, DEVELOPMENT, V139, P4172, DOI 10.1242/dev.084566; Daubresse G, 1999, DEVELOPMENT, V126, P1175; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; dos Santos G, 2015, NUCLEIC ACIDS RES, V43, pD690, DOI 10.1093/nar/gku1099; Elfring LK, 1998, GENETICS, V148, P251; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; GLICKSMAN MA, 1988, DEV BIOL, V127, P113, DOI 10.1016/0012-1606(88)90193-5; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Gutierrez L, 2004, GENESIS, V40, P58, DOI 10.1002/gene.20066; Gutierrez L, 2003, DEVELOPMENT, V130, P343, DOI 10.1242/dev.00222; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Ito K, 1997, DEVELOPMENT, V124, P761; Kassis JA, 2017, GENETICS, V206, P1699, DOI 10.1534/genetics.115.185116; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; Menendez J, 2010, P NATL ACAD SCI USA, V107, P14651, DOI 10.1073/pnas.1009376107; Monribot-Villanueva J, 2017, GENESIS, V55, DOI 10.1002/dvg.23009; Monribot-Villanueva J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062251; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Terriente-Felix A, 2009, DEV BIOL, V329, P350, DOI 10.1016/j.ydbio.2009.03.010; Treisman JE, 1997, GENE DEV, V11, P1949, DOI 10.1101/gad.11.15.1949; Vazquez M, 1999, DEVELOPMENT, V126, P733; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; WHITE RAH, 1985, NATURE, V318, P563, DOI 10.1038/318563a0; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2; Zraly CB, 2003, DEV BIOL, V253, P291, DOI 10.1016/S0012-1606(02)00011-8	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206587	10.1371/journal.pone.0206587	http://dx.doi.org/10.1371/journal.pone.0206587			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372466	Green Submitted, gold, Green Published			2022-12-26	WOS:000448641200045
J	Sundberg, JP; Shen, T; Fiehn, O; Rice, RH; Silva, KA; Kennedy, VE; Gott, NE; Dionne, LA; Bechtold, LS; Murray, SA; Kuiper, R; Pratt, H				Sundberg, John P.; Shen, Tong; Fiehn, Oliver; Rice, Robert H.; Silva, Kathleen A.; Kennedy, Victoria E.; Gott, Nicholas E.; Dionne, Louise A.; Bechtold, Lesley S.; Murray, Stephen A.; Kuiper, Raoul; Pratt, Herbert			Sebaceous gland abnormalities in fatty acyl CoA reductase 2 (Far2) null mice result in primary cicatricial alopecia	PLOS ONE			English	Article							HAIR FOLLICLE; TERMINAL DIFFERENTIATION; MOUSE MUTATION; IDENTIFICATION; MODEL	In a large scale screen for skin, hair, and nail abnormalities in null mice generated by The Jackson Laboratory's KOMP center, homozygous mutant Far2(tm2b(KOMP)Wtsi)/2J (hereafter referrred to as Far2(-/-)) mice were found to develop focal areas of alopecia as they aged. As sebocytes matured in wildtype C57BL/NJ mice they became pale with fine, uniformly sized clear lipid containing vacuoles that were released when sebocytes disintegrated in the duct. By contrast, the Far2(-/-) null mice had sebocytes that were similar within the gland but become brightly eosinophilic when the cells entered the sebaceous gland duct. As sebocytes disintegrated, their contents did not readily dissipate. Scattered throughout the dermis, and often at the dermal hypodermal fat junction, were dystrophic hair follicles or ruptured follicles with a foreign body granulomatous reaction surrounding free hair shafts (trichogranuloma). The Meibomian and clitoral glands (modified sebaceous glands) of Far2(-/-) mice showed ducts dilated to various degrees that were associated with mild changes in the sebocytes as seen in the truncal skin. Skin surface lipidomic analysis revealed a lower level of wax esters, cholesterol esters, ceramides, and diacylglycerols compared to wildtype control mice. Similar changes were described in a number of other mouse mutations that affected the sebaceous glands resulting in primary cicatricial alopecia.	[Sundberg, John P.; Silva, Kathleen A.; Kennedy, Victoria E.; Gott, Nicholas E.; Dionne, Louise A.; Bechtold, Lesley S.; Murray, Stephen A.; Pratt, Herbert] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Shen, Tong; Fiehn, Oliver] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA 95616 USA; [Fiehn, Oliver] King Abdulaziz Univ, Biochem Dept, Jeddah, Saudi Arabia; [Rice, Robert H.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Kuiper, Raoul] Karolinska Inst, Dept Lab Med, Stockholm, Sweden	Jackson Laboratory; University of California System; University of California Davis; King Abdulaziz University; University of California System; University of California Davis; Karolinska Institutet	Sundberg, JP (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	john.sundberg@jax.org	Rice, Robert/AAP-7813-2021	Rice, Robert/0000-0003-2058-4405; Kuiper, Raoul/0000-0001-5645-2389	National Institutes of Health [R21-AR063781, U24 DK097154]; Cicatricial Alopecia Research Foundation (CARF); American Hair Research Society Mentorship Grant; Basic Cancer Center Core Grant from the National Cancer Institute [CA034196]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097154] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UM1OD023222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cicatricial Alopecia Research Foundation (CARF); American Hair Research Society Mentorship Grant; Basic Cancer Center Core Grant from the National Cancer Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health (R21-AR063781 to JPS and a pilot grant from the West Coast Metabolomics Center, U24 DK097154, to OF), and the Cicatricial Alopecia Research Foundation (CARF), 2016, to HP. Dr. Kuiper was a visiting scientist to The Jackson Laboratory supported by an American Hair Research Society Mentorship Grant. The Jackson Laboratory Shared Services were supported in part by Basic Cancer Center Core Grant from the National Cancer Institute (CA034196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backer G, 2018, PHYSIOL GENOMICS, V50, P543, DOI 10.1152/physiolgenomics.00118.2017; Bechtold LS, 2000, SYSTEMATIC APPROACH TO EVALUATION OF MOUSE MUTATIONS, P121; Buchert R, 2014, AM J HUM GENET, V95, P602, DOI 10.1016/j.ajhg.2014.10.003; Cajka T, 2017, METHODS MOL BIOL, V1609, P149, DOI 10.1007/978-1-4939-6996-8_14; Camera E, 2010, J LIPID RES, V51, P3377, DOI 10.1194/jlr.D008391; CHASE HB, 1953, ANAT REC, V116, P75, DOI 10.1002/ar.1091160107; CHASE HB, 1954, PHYSIOL REV, V34, P113, DOI 10.1152/physrev.1954.34.1.113; CHASE HB, 1955, J SOC COSMET CHEM, V6, P9; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Ehrmann C, 2016, CELL MOL LIFE SCI, V73, P4623, DOI 10.1007/s00018-016-2312-0; Fluhr JW, 2003, J INVEST DERMATOL, V120, P728, DOI 10.1046/j.1523-1747.2003.12134.x; Glauert AM, 1987, DEHYDRATION EMBEDDIN; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Johnson KR, 1998, HUM MOL GENET, V7, P1033, DOI 10.1093/hmg/7.6.1033; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Kovacs SB, 2017, TRENDS CELL BIOL, V27, P673, DOI 10.1016/j.tcb.2017.05.005; Liang Y, 2011, J DERMATOL SCI, V63, P148, DOI 10.1016/j.jdermsci.2011.04.012; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Lunny DP, 2005, J INVEST DERMATOL, V124, P615, DOI 10.1111/j.0022-202X.2005.23623.x; Lyon MF, 1984, MOUSE NEWS LETT, V71, P26; Mecklenburg L, 2004, J INVEST DERMATOL, V123, P1001, DOI 10.1111/j.0022-202X.2004.23442.x; Mirmirani P, 2009, ARCH DERMATOL, V145, P1363, DOI 10.1001/archdermatol.2009.283; Morita Katsuko, 1995, Journal of Dermatology (Tokyo), V22, P385; Pappas A, 2009, DERM-ENDOCRINOL, V1, P72, DOI 10.4161/derm.1.2.7811; Porter RM, 2002, J INVEST DERMATOL, V119, P32, DOI 10.1046/j.1523-1747.2002.01806.x; Rice RH, 2011, J INVEST DERMATOL, V131, P1936, DOI 10.1038/jid.2011.133; Runkel F, 2004, GENOMICS, V84, P824, DOI 10.1016/j.ygeno.2004.07.003; Saeki N, 2000, MAMM GENOME, V11, P718, DOI 10.1007/s003350010138; Sardella C, 2018, J INVEST DERMATOL, V138, P500, DOI 10.1016/j.jid.2017.09.024; Sellheyer K, 2010, J CUTAN PATHOL, V37, P362, DOI 10.1111/j.1600-0560.2009.01434.x; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Silva K, 2012, LAB MOUSE, P779; Sundberg JP, 2018, EXP DERMATOL, V27, P302, DOI 10.1111/exd.13495; Sundberg JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180682; Sundberg JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113582; Sundberg JP, 2000, PATHOLOGY OF GENETICALLY ENGINEERED MICE, P183; Sundberg JP, 2000, AM J PATHOL, V156, P2067, DOI 10.1016/S0002-9440(10)65078-X; Sundberg JP, 2017, COMP ANATOMY HISTOLO, P511; Wu BJ, 2010, J INVEST DERMATOL, V130, P2666, DOI 10.1038/jid.2010.168; Zheng Y, 1999, NAT GENET, V23, P268, DOI 10.1038/15446	41	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0205775	10.1371/journal.pone.0205775	http://dx.doi.org/10.1371/journal.pone.0205775			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY5SG	30372477	Green Submitted, Green Published, gold			2022-12-26	WOS:000448641200015
J	Ellmann, S; Langer, V; Britzen-Laurent, N; Hildner, K; Huber, C; Tripel, P; Seyler, L; Waldner, M; Uder, M; Sturzl, M; Bauerle, T				Ellmann, Stephan; Langer, Victoria; Britzen-Laurent, Nathalie; Hildner, Kai; Huber, Carina; Tripel, Philipp; Seyler, Lisa; Waldner, Maximilian; Uder, Michael; Stuerzl, Michael; Baeuerle, Tobias			Application of machine learning algorithms for multiparametric MRI-based evaluation of murine colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BLOOD-FLOW; MODELS; COLONOSCOPY; GAMMA	Magnetic resonance imaging (MRI) allows non-invasive evaluation of inflammatory bowel disease (IBD) by assessing pathologically altered gut. Besides morphological changes, relaxation times and diffusion capacity of involved bowel segments can be obtained by MRI. The aim of this study was to assess the use of multiparametric MRI in the diagnosis of experimentally induced colitis in mice, and evaluate the diagnostic benefit of parameter combinations using machine learning. This study relied on colitis induction by Dextran Sodium Sulfate (DSS) and investigated the colon of mice in vivo as well as ex vivo. Receiver Operating Characteristics were used to calculate sensitivity, specificity, positive- and negative-predictive values (PPV and NPV) of these single values in detecting DSS-treatment as a reference condition. A Model Averaged Neural Network (avNNet) was trained on the multiparametric combination of the measured values, and its predictive capacity was compared to those of the single parameters using exact binomial tests. Within the in vivo subgroup (n = 19), the avNNet featured a sensitivity of 91.3% (95% CI: 86.6-96.0%), specificity of 92.3% (95% CI: 85.1-99.6%), PPV of 96.9% (94.0-99.9%) and NPV of 80.0% (95% CI: 69.9-90.1%), significantly outperforming all single parameters in at least 2 accuracy measures (p < 0.003) and performing significantly worse compared to none of the single values. Within the ex vivo subgroup (n = 30), the avNNet featured a sensitivity of 87.4% (95% CI: 82.6-92.2%), specificity of 82.9% (95% CI: 76.1-89.7%), PPV of 88.9% (84.3-93.5%) and NPV of 80.8% (95% CI: 73.8-87.9%), significantly outperforming all single parameters in at least 2 accuracy measures (p < 0.015), exceeded by none of the single parameters. In experimental mouse colitis, multiparametric MRI and the combination of several single measured values to an avNNet can significantly increase diagnostic accuracy compared to the single parameters alone. This pilot study will provide new avenues for the development of an MR-derived colitis score for optimized diagnosis and surveillance of inflammatory bowel disease.	[Ellmann, Stephan; Seyler, Lisa; Uder, Michael; Baeuerle, Tobias] Univ Hosp Erlangen, Inst Radiol, Maximilianspl 1, Erlangen, Germany; [Langer, Victoria; Britzen-Laurent, Nathalie; Stuerzl, Michael] Translat Res Ctr Erlangen, Div Mol & Expt Surg, Dept Surg, Erlangen, Germany; [Hildner, Kai; Huber, Carina; Waldner, Maximilian] Univ Hosp Erlangen, Dept Med 1, Kussmaul Campus Med Res, Erlangen, Germany; [Tripel, Philipp] Friedrich Alexander Univ Erlangen Nuremberg FAU, OICE, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Ellmann, S (corresponding author), Univ Hosp Erlangen, Inst Radiol, Maximilianspl 1, Erlangen, Germany.	stephan.ellmann@uk-erlangen.de	Britzen-Laurent, Nathalie/HDM-6965-2022; Stürzl, Michael/B-3019-2015; Ellmann, Stephan/P-3824-2016	Britzen-Laurent, Nathalie/0000-0002-0494-7117; Stürzl, Michael/0000-0002-9276-2824; Ellmann, Stephan/0000-0003-2737-5526; Bauerle, Tobias/0000-0002-0206-6199; Tripal, Philipp/0000-0003-0568-1725	Collaborative Research Center of the Deutsche Forschungsgemeinschaft DFG [1181, CRC 1181]; DFG [KFO257, FOR2438, BR5196/2-1]; W. Lutz Stiftung; Interdisciplinary Center for Clinical Research (IZKF) of the Clinical Center Erlangen	Collaborative Research Center of the Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); W. Lutz Stiftung; Interdisciplinary Center for Clinical Research (IZKF) of the Clinical Center Erlangen	This work was in part funded by the Collaborative Research Center 1181 of the Deutsche Forschungsgemeinschaft DFG (CRC 1181; https://www.sfb1181.forschung.fau.de/), projects Z02 (T. Bauerle) and B05 (K. Hildner), and DFG grants KFO257, FOR2438 (M. Sturzl), and BR5196/2-1 (N. Britzen-Laurent), by the W. Lutz Stiftung (M. Sturzl), and by the Interdisciplinary Center for Clinical Research (IZKF) of the Clinical Center Erlangen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, RSTUDIO OPEN SOURCE; Aoyagi T, 2010, HEPATO-GASTROENTEROL, V57, P468; Arora G, 2009, GASTROINTEST ENDOSC, V69, P654, DOI 10.1016/j.gie.2008.09.008; Baskerville TA, 2011, J CEREBR BLOOD F MET, V31, P1799, DOI 10.1038/jcbfm.2011.65; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Beltzer A, 2016, MOL IMAGING BIOL, V18, P697, DOI 10.1007/s11307-016-0937-x; Bianchi A, 2016, INFLAMM BOWEL DIS, V22, P1286, DOI 10.1097/MIB.0000000000000755; Brown JB, 2012, INFLAMM BOWEL DIS, V18, P323, DOI 10.1002/ibd.21779; Bruckner M, 2016, WORLD J GASTROENTERO, V22, P996, DOI 10.3748/wjg.v22.i3.996; Cawley GC, 2004, NEURAL NETWORKS, V17, P1467, DOI 10.1016/j.neunet.2004.07.002; Celisse A, 2008, COMPUT STAT DATA AN, V52, P2350, DOI 10.1016/j.csda.2007.10.002; Chang W, 2017, COMPREHENSIVE R ARCH; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Gee MS, 2011, J MAGN RESON IMAGING, V33, P527, DOI 10.1002/jmri.22504; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Haas K, 2016, WORLD J RADIOL, V8, P124, DOI 10.4329/wjr.v8.i2.124; Haep L, 2015, INFLAMM BOWEL DIS, V21, P2360, DOI 10.1097/MIB.0000000000000490; Horos-Free DICOM Medical Image Viewer, 2015, HOROS FREE DICOM MED; Jurjus Abdo R., 2004, Journal of Pharmacological and Toxicological Methods, V50, P81, DOI 10.1016/j.vascn.2003.12.002; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Klopfleisch R, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-123; KROEKER RM, 1985, MAGNET RESON MED, V2, P1, DOI 10.1002/mrm.1910020102; Kuhn M, 2016, CRAN PACKAGE CARET; Larsson AE, 2006, INFLAMM BOWEL DIS, V12, P478, DOI 10.1097/00054725-200606000-00006; Lemmens B, 2013, INFLAMM BOWEL DIS, V19, P1194, DOI 10.1097/MIB.0b013e318280e75f; Melgar S, 2007, BIOCHEM BIOPH RES CO, V355, P1102, DOI 10.1016/j.bbrc.2007.02.090; MOSER E, 1995, MAGN RESON IMAGING, V13, P429, DOI 10.1016/0730-725X(94)00135-P; Mudter J, 2011, INFLAMM BOWEL DIS, V17, P1343, DOI 10.1002/ibd.21476; Mustafi D, 2014, NMR BIOMED, V27, P272, DOI 10.1002/nbm.3060; Mustafi D, 2010, MAGN RESON MED, V63, P922, DOI 10.1002/mrm.22229; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Pendse DA, 2017, ABDOM RADIOL, V42, P115, DOI 10.1007/s00261-016-0863-z; RAMSAY SC, 1993, J PHYSIOL-LONDON, V471, P521, DOI 10.1113/jphysiol.1993.sp019913; Randhawa PK, 2014, KOREAN J PHYSIOL PHA, V18, P279, DOI 10.4196/kjpp.2014.18.4.279; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Sokol H, 2013, GASTROENTEROLOGY, V145, P591, DOI 10.1053/j.gastro.2013.05.047; Stock C, CRAN PACKAGE DTCOMPA; Walldorf J, 2015, EUR RADIOL, V25, P2984, DOI 10.1007/s00330-015-3714-3; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41	39	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206576	10.1371/journal.pone.0206576	http://dx.doi.org/10.1371/journal.pone.0206576			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365545	Green Published, Green Submitted, gold			2022-12-26	WOS:000448448700062
J	Fok, PW; Lanzer, P				Fok, Pak-Wing; Lanzer, Peter			Media sclerosis drives and localizes atherosclerosis in peripheral arteries	PLOS ONE			English	Article							NONDIABETIC PATIENTS; VASCULAR-DISEASE; CALCIFICATION; THICKNESS; ARTERIOSCLEROSIS; PATHOGENESIS; WALL	Media sclerosis (MS) and peripheral artery disease (PAD) may coincide, particularly in type 2 diabetics (T2D) and in patients with chronic kidney disease (CKD). In contrast to non-diabetics, in T2D PAD is more severe and more distal. Although MS is suspected to play a role, the underlying pathophysiological reasons for the differences still remain elusive today. We tested the hypothesis that MS is a promoter of atherosclerosis as it occurs in T2D with PAD by interfering with arterial remodeling using an in-silico simulation. We confirmed that MS aggravates PAD by promoting negative remodeling. We found that the effect is more pronounced in smaller distal arteries compared to larger proximal ones. Our results suggest that the degree of this divergence depends on the ratio between the thickness of the intima relative to the thickness of the media/adventitia of the individually affected arteries.	[Fok, Pak-Wing] Univ Delaware, Dept Math Sci, Newark, DE 19716 USA; [Lanzer, Peter] Standort Klinikum Bitterfeld, Mitteldeutsch Herzzentrum, Bitterfeld, Germany	University of Delaware	Lanzer, P (corresponding author), Standort Klinikum Bitterfeld, Mitteldeutsch Herzzentrum, Bitterfeld, Germany.	planzer@gzbiwo.de			Simons Collaboration Grant [282579]	Simons Collaboration Grant	Funding was provided by Simons Collaboration Grant #282579. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Hassan N, 2015, KIDNEY INT, V87, P195, DOI 10.1038/ki.2014.187; Arthurs ZM, 2010, J VASC SURG, V51, P933, DOI 10.1016/j.jvs.2009.11.034; Clark N, 2003, DIABETES CARE, V26, P3333; CRANLEY JJ, 1969, ARCH SURG-CHICAGO, V98, P77; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Espitia O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191976; Fok PW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159304; Gartner V, 2008, CLIN NEPHROL, V70, P1; Garimella PS, 2014, ADV CHRONIC KIDNEY D, V21, P460, DOI 10.1053/j.ackd.2014.07.005; GENSLER SW, 1965, ARCH SURG-CHICAGO, V91, P617; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Huang CL, 2014, PLOS ONE, V26, P9, DOI DOI 10.1371/J0URNAL.P0NE.0090201; Jude EB, 2001, DIABETES CARE, V24, P1433, DOI 10.2337/diacare.24.8.1433; Kamenskiy AV, 2014, ACTA BIOMATER, V10, P1301, DOI 10.1016/j.actbio.2013.12.027; KAMIYA A, 1980, AM J PHYSIOL, V239, pH14, DOI 10.1152/ajpheart.1980.239.1.H14; Kwak BR, 2014, EUR HEART J, V35, P3013, DOI 10.1093/eurheartj/ehu353; Lammers G, 2013, EXP PHYSIOL, V98, P710, DOI 10.1113/expphysiol.2012.068726; Lanzer P, 2001, Z KARDIOL, V90, P99, DOI 10.1007/s003920170195; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Marso SP, 2006, J AM COLL CARDIOL, V47, P921, DOI 10.1016/j.jacc.2005.09.065; Monckeberg JG, 1903, VIRCHOWS ARCH A, V171, P141; Moreno PR, 2004, J AM COLL CARDIOL, V44, P2293, DOI 10.1016/j.jacc.2004.07.060; NISKANEN L, 1994, DIABETES CARE, V17, P1252, DOI 10.2337/diacare.17.11.1252; Osika W, 2007, ARTERIOSCL THROM VAS, V27, P671, DOI 10.1161/01.ATV.0000256468.95403.6f; Potente M, 2017, NAT REV MOL CELL BIO, V18, P477, DOI 10.1038/nrm.2017.36; Smith CD, 2008, FOOT ANKLE INT, V29, P185, DOI 10.3113/FAI.2008.0185; Spiliopoulos S, 2017, EXPERT REV MED DEVIC, V14, P127, DOI 10.1080/17434440.2017.1280391; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Steenman M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22292-y; STRANDNESS DE, 1964, DIABETES, V13, P366, DOI 10.2337/diab.13.4.366; Telang A.V., 2016, INDIAN J CLIN ANATOM, V3, P287; Thiruvoipati T, 2015, WORLD J DIABETES, V6, P961, DOI 10.4239/wjd.v6.i7.961; van den Berkmortel FWPJ, 2000, ATHEROSCLEROSIS, V150, P397, DOI 10.1016/S0021-9150(99)00391-3; Wolf YG, 2006, J VASC SURG, V43, P488, DOI 10.1016/j.jvs.2005.11.026; WONG ML, 1993, ARTERIOSCLER THROMB, V13, P482, DOI 10.1161/01.ATV.13.4.482	36	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0205599	10.1371/journal.pone.0205599	http://dx.doi.org/10.1371/journal.pone.0205599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365531	Green Published, Green Submitted, gold			2022-12-26	WOS:000448448700011
J	Honorio, ICG; Coppede, JS; Delprete, PG; Costa, FHS; Telles, MPC; Braga, RS; Diniz, JAF; Correa, VSC; Franca, SC; Pereira, AMS; Bertoni, BW				Honorio, Isabela Cristina G.; Coppede, Juliana S.; Delprete, Piero G.; Costa, Frederico Henrique S.; Telles, Mariana P. C.; Braga, Ramilla S.; Diniz-Filho, Jose Alexandre F.; Correa, Valeria S. C.; Franca, Suzelei C.; Pereira, Ana Maria S.; Bertoni, Bianca Waleria			Genetic structure and chemical diversity in natural populations of Uncaria guianensis (Aubl.) JFGmel. (Rubiaceae)	PLOS ONE			English	Article							TOMENTOSA; INDIVIDUALS; ALKALOIDS; SOFTWARE; NUMBER	Uncaria guianensis is native to the Amazon and is used traditionally as an anti-inflammatory. Natural populations of the species have declined markedly in recent times because of strong anthropic pressure brought about by deforestation and indiscriminate collection. The aim of the present study was to assess the genetic and chemical diversity among eight natural populations of U. guianensis located in the Brazilian states of Acre, Amapa and Amazonas. A set of four primer combinations was employed in sequence-related amplified polymorphism (SRAP) amplifications of leaf DNA, and the fragments were analyzed in an LI-COR model 4300 DNA Analyzer. Genetic variability within the populations (81%) was substantially greater than that detected between them (19%). The highest percentage of polymorphic loci (90.21%) and the largest genetic variability were observed in the population located in Mazagao, Amapa. Genetic differentiation between populations was high (F-st = 0.188) and the studied populations formed three distinct genetic groups (K = 3). The population located in Assis Brasil, Acre, presented the highest average content of the mitraphylline (0.60 mg/g dry weight,). However, mitraphylline and isomitraphylline not detected in most individuals in the studied populations, and it is questionable whether they should be considered as chemical markers of the species. The genetic data confirm the urgent need for conservation programs for U. guianensis, and for further studies aimed at ascertaining the genetic basis and heritability of alkaloid accumulation.	[Honorio, Isabela Cristina G.] Univ Estadual Paulista Julio de Mesquite Filho, Botucatu, SP, Brazil; [Coppede, Juliana S.; Franca, Suzelei C.; Pereira, Ana Maria S.; Bertoni, Bianca Waleria] Univ Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Delprete, Piero G.] Herbier Guyane, Inst Rech Dev, Cayenne, French Guiana; [Costa, Frederico Henrique S.] Univ Fed Acre, Rio Branco, AC, Brazil; [Telles, Mariana P. C.] Pontificia Univ Catolica Goias, Escola Ciencias Agr & Biol, Goiania, Go, Brazil; [Telles, Mariana P. C.; Braga, Ramilla S.] Univ Fed Goias, Lab Genet & Biodiversidade, Goiania, Go, Brazil; [Diniz-Filho, Jose Alexandre F.] Univ Fed Goias, ICB, Dept Ecol, Goiania, Go, Brazil; [Correa, Valeria S. C.] Reserve EcoCerrado Brasil, Araxa, MG, Brazil	Universidade Estadual Paulista; Universidade de Ribeirao Preto; Institut de Recherche pour le Developpement (IRD); Universidade Federal do Acre (UFAC); Pontificia Universidade Catolica de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Pereira, AMS (corresponding author), Univ Ribeirao Preto, Ribeirao Preto, SP, Brazil.	apereira@unaerp.br	Diniz-Filho, José Alexandre Felizola/D-9405-2013; Delprete, Piero/U-4699-2019; Honório, Isabela Cristina ICGH Gomes/M-1391-2016; Braga, Ramilla/AAS-1010-2021; Franca, Suzelei C/E-4069-2013; Soares Pereira, Ana Maria/P-5646-2014	Diniz-Filho, José Alexandre Felizola/0000-0002-0967-9684; Honório, Isabela Cristina ICGH Gomes/0000-0002-5029-2238; Soares Pereira, Ana Maria/0000-0002-3478-4718	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [408296/2013-5]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The research was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; Grant no. 408296/2013-5). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Zevallos-Pollito PA, 2010, ECOL APL, V9, P19, DOI 10.21704/rea.v9i1-2.391; Auguie B, 2017, GRIDEXTRA MISCELLANE; Rossi AAB, 2009, GENETICA, V136, P57, DOI 10.1007/s10709-008-9309-z; Bertol G, 2012, PHYTOCHEM ANALYSIS, V23, P143, DOI 10.1002/pca.1335; Penaloza EMC, 2015, QUIM NOVA, V38, P378, DOI 10.5935/0100-4042.20150007; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falkiewicz B, 2001, AM J CASE REP, V2, P305; Honorio ICG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177103; Honorio ICG, 2016, CIENC RURAL, V46, P1401, DOI 10.1590/0103-8478cr20150138; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Laus G, 1997, PHYTOCHEMISTRY, V45, P855, DOI 10.1016/S0031-9422(97)00061-7; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Luna-Palencia GR, 2013, BIOTECHNOL LETT, V35, P791, DOI 10.1007/s10529-012-1128-8; NEI M, 1978, GENETICS, V89, P583; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; SILVA S.R., 2001, PLANTAS MED BRASIL A; Vilches LEO, 1997, GATO GENERO UNCARIA; Zhang Q, 2015, J ETHNOPHARMACOL, V173, P48, DOI 10.1016/j.jep.2015.06.011; Zheng YQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177508	23	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0205667	10.1371/journal.pone.0205667	http://dx.doi.org/10.1371/journal.pone.0205667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365495	Green Published, Green Submitted, gold			2022-12-26	WOS:000448448700012
J	Panday, D; Maharjan, B; Chalise, D; Shrestha, RK; Twanabasu, B				Panday, Dinesh; Maharjan, Bijesh; Chalise, Devraj; Shrestha, Ram Kumar; Twanabasu, Bikesh			Digital soil mapping in the Bara district of Nepal using kriging tool in ArcGIS	PLOS ONE			English	Article							SPATIAL VARIABILITY; ORGANIC-CARBON; CROPPING SYSTEMS; BORON DEFICIENCY; CLIMATE-CHANGE; LAND-USE; MANAGEMENT; FARMERS; LEVEL; INTERPOLATION	Digital soil mapping has been widely used to develop statistical models of the relationships between environmental variables and soil attributes. This study aimed at determining and mapping the spatial distribution of the variability in soil chemical properties of the agricultural floodplain lands of the Bara district in Nepal. The study was carried out in 23 Village Development Committees with 12,516 ha total area, in the southern part of the Bara district. A total of 109 surface soil samples (0 to 15 cm depth) were collected and analyzed for pH, organic matter (OM), nitrogen (N), phosphorus (P, expressed as P2O5), potassium (K, expressed as K2O), zinc (Zn), and boron (B) status. Descriptive statistics showed that most of the measured soil chemical variables (other than pH and P2O5) were skewed and nonnormally distributed and logarithmic transformation was then applied. A geostatistical tool, kriging, was used in ArcGIS to interpolate measured values for those variables and several digital map layers were developed based on each soil chemical property. Geostatistical interpolation identified a moderate spatial variability for pH, OM, N, P2O5, and a weak spatial variability for K2O, Zn, and B, depending upon the use of amendments, fertilizing methods, and tillage, along with the inherent characteristics of each variable. Exponential (pH, OM, N, and Zn), Spherical (K2O and B), and Gaussian (P2O5) models were fitted to the semivariograms of the soil variables. These maps allow farmers to assess existing farm soils, thus allowing them to make easier and more efficient management decisions and maintain the sustainability of productivity.	[Panday, Dinesh; Maharjan, Bijesh] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA; [Chalise, Devraj] Nepal Agr Res Council, Lalitpur, Nepal; [Shrestha, Ram Kumar] Inst Agr & Anim Sci, Lamjung Campus, Lamjung, Nepal; [Twanabasu, Bikesh] Hexa Int Pvt Ltd, Lalitpur, Nepal; [Twanabasu, Bikesh] Westfalische Wilhelms Univ Munster, Inst Geoinformat, Munster, Germany	University of Nebraska System; University of Nebraska Lincoln; Tribhuvan University; Institute of Agriculture & Animal Science (IAAS) - Nepal; University of Munster	Panday, D (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA.	dinesh.panday@unl.edu	Chalise, Devraj/P-1292-2016; Panday, Dinesh/M-1667-2017; Chalise, Devraj/O-6147-2019	Chalise, Devraj/0000-0001-5030-7260; Panday, Dinesh/0000-0001-8452-3797; Chalise, Devraj/0000-0001-5030-7260; Shrestha, Ram/0000-0003-0809-055X	National Land Use Project under the Ministry of Land Reform and Management, Nepal [NLUP/QCBS/01/069/070]; Hexa International Pvt. Ltd.; National Land Use Project, Ministry of Land Reform and Management, Government of Nepal	National Land Use Project under the Ministry of Land Reform and Management, Nepal; Hexa International Pvt. Ltd.; National Land Use Project, Ministry of Land Reform and Management, Government of Nepal	The National Land Use Project under the Ministry of Land Reform and Management, Nepal was providing financial support for Hexa International Pvt. Ltd., Lalitpur and En. Geo. Global Pvt. Ltd., Bhaktapur, Nepal for the preparation of VDC level Land Resource Maps, database and reports of twenty-three VDCs of Bara district (RFP #NLUP/QCBS/01/069/070). Author Bikesh Twanabasu was employed by Hexa International Pvt. Ltd. during the course of the study. Hexa International Pvt. Ltd provided support in the form of salary for author BT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; The authors would like to thank Hexa International Pvt. Ltd., Lalitpur and En. Geo. Global Pvt. Ltd., Bhaktapur, Nepal for providing access and assistant with the datasets. Also thanks to the National Land Use Project, Ministry of Land Reform and Management, Government of Nepal for their supports. The residents of the study area who supported and provided valuable information are deeply acknowledged.	Abdel-Motagally F. M. F., 2016, J SAUDI SOC AGR SCI; Adhakari B. R., 2013, Hydro Nepal: Journal of Water, Energy and Environment, V12, P59; Akpa SIC, 2014, SOIL SCI SOC AM J, V78, P1953, DOI 10.2136/sssaj2014.05.0202; Al-Ahmadi K, 2013, INT J ENV RES PUB HE, V10, P7207, DOI 10.3390/ijerph10127207; Al-Omran A. M., 2013, Journal of the Saudi Society of Agricultural Sciences, V12, P167, DOI 10.1016/j.jssas.2012.12.001; Andersen P, 2003, IGU INT C GEOGR MARG; Antwi M, 2016, COGENT GEOSCI, V2, DOI 10.1080/23312041.2016.1201906; Awasthi KD, 2005, ACTA AGR SCAND B-S P, V55, P192, DOI 10.1080/09064710510029079; BAJWA MI, 1994, POTASH REV, V3, P1; Balkovic J, 2013, SOIL WATER RES, V8, P13, DOI 10.17221/43/2012-SWR; Barrow C. J., 1991, LAND DEGRADATION DEV; Beaton J.D., 1985, SOIL AND FERTILIZERS; Berger KC, 1939, IND ENG CHEM, V11, P0540, DOI 10.1021/ac50138a007; Bhunia G. S., 2018, Journal of the Saudi Society of Agricultural Sciences, V17, P114, DOI 10.1016/j.jssas.2016.02.001; Bishwakarma BK, 2015, CLIM DEV, V7, P426, DOI 10.1080/17565529.2014.966045; Brady A.C, 2007, NATURE PROPERTIES SO, P976; Bremner DC, 1982, AM SOC AGRONOMY, V9; Cambardella C. A., 1999, Precision Agriculture, V1, P5, DOI 10.1023/A:1009925919134; Chaudhary RP, 2001, P WORKSH BERG TRIBH; Chen SN, 2017, GEOMAT NAT HAZ RISK, V8, P689, DOI 10.1080/19475705.2016.1255669; Chopart JJ, 2012, P INT SOC SUG TECHN, V27, P1; Chung Sun-Ok, 2014, Journal of Biosystems Engineering, V39, P377; Dembele D., 2016, DONNIS J AGR RES, V3, P22; Dinesh Khadka, 2017, Eurasian Journal of Soil Science, V6, P295, DOI 10.18393/ejss.303512; Dinesh Panday, 2012, Hydro Nepal: Journal of Water, Energy and Environment, VSpecial Iss., P91; ESRI, 2010, PRINC GEOST AN 3 201; Ghimire R, 2017, J INTEGR AGR, V16, P1, DOI 10.1016/S2095-3119(16)61337-0; Goovaerts P, 1999, GEODERMA, V89, P1, DOI 10.1016/S0016-7061(98)00078-0; Huang LB, 2000, ANN BOT-LONDON, V85, P493, DOI 10.1006/anbo.1999.1095; Jackson ML, 2005, SOIL CHEM ANAL ADV C; Jensen T.L., 2010, IPNI PLANT NUTR TODA; Johnson CJ, 2012, EXPERT KNOWLEDGE AND ITS APPLICATION IN LANDSCAPE ECOLOGY, P153, DOI 10.1007/978-1-4614-1034-8_8; Johnston K., 2001, USING ARCGIS GEOSTAT; Karki KB, 2000, P INT MBRKSHOP FOOD; Khadka YG, 2008, NEPAL J SCI TECHNOL, V9, P7; Lagacherie P, 2007, DEV SOIL SCI, V31, P1; Lark RM, 2000, EUR J SOIL SCI, V51, P717, DOI 10.1046/j.1365-2389.2000.00345.x; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Liu DW, 2006, AGR ECOSYST ENVIRON, V113, P73, DOI 10.1016/j.agee.2005.09.006; Lloyd CD, 2010, INT J CLIMATOL, V30, P390, DOI 10.1002/joc.1892; Lopez-Granados F, 2005, EUR J AGRON, V23, P279, DOI 10.1016/j.eja.2004.12.003; Mainuri ZG, 2014, INT SOIL WATER CONSE, V2, P1; Malone BP, 2017, PROGR SOIL SCI, P1, DOI 10.1007/978-3-319-44327-0; Malone BP, 2017, GEODERMA, V290, P91, DOI 10.1016/j.geoderma.2016.12.008; Martinez-Grana AM, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-6225-x; McBratney A, 2010, 19 WORLD C SOIL SCI; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; McCauley A., 2009, NUTR MANAG MODUL, V8, P1; Moore G.A., 2001, SOILGUIDE SOIL GUIDE; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; MYERS DE, 1994, GEODERMA, V62, P17, DOI 10.1016/0016-7061(94)90025-6; NARC, 2013, OBJ SOIL TEST METH T; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Omran E. E., 2012, International Journal of Geosciences, V3, P574; Pal DK, 2012, GEODERMA, V189, P28, DOI 10.1016/j.geoderma.2012.04.021; Panday D, 2018, SOIL AMENDMENTS SUST, P199; Pande KR, 2003, J PLANT NUTR SOIL SC, V166, P499, DOI 10.1002/jpln.200320315; Pandey S, 2018, J CROP IMPROV, V32, P19, DOI 10.1080/15427528.2017.1387837; Pandit K, 2006, NEPAL J SCI TECHNOL, V7, P89; Paudel B, 2014, AGR RES, V3, P165, DOI 10.1007/s40003-014-0103-0; Paudel GS, 2001, ENVIRON MANAGE, V28, P789, DOI 10.1007/s002670010262; Regmi BD, 2004, NEPAL AGR RES J, V5, P124; Rerkasem B, 1997, EUPHYTICA, V96, P257, DOI 10.1023/A:1003093532561; Reza S. K., 2010, Agropedology, V20, P38; Robertson GP, 2008, GAMMA DESIGN SOFTWAR, P165; Sanchez PA, 2009, SCIENCE, V325, P680, DOI 10.1126/science.1175084; Santos-Frances F, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080859; Santos-Frances F, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060568; Sarmadian F., 2013, ProEnvironment, V6, P556; SAS, 2015, SAS 9 4 IN DAT PROD; Saxena R, 2012, INDIAN J MED RES, V136, P776; SHERCHAN DB, 1995, P WORKSH HELD KATHM, P50; Shrestha BM, 2004, NUTR CYCL AGROECOSYS, V70, P201, DOI 10.1023/B:FRES.0000048472.25373.7e; Shrestha RK, 2006, NUTR CYCL AGROECOSYS, V75, P257, DOI 10.1007/s10705-006-9032-z; Silva RA, 2018, REV BRAS CIENC SOLO, V42, DOI 10.1590/18069657rbcs20170121; Srivastava S. P., 2005, Micronutrients in South and South East Asia: Proceedings of an International Workshop held in Kathmandu, Nepal, 8-11 September, 2004, P67; Stoorvogel JJ, 2017, LAND DEGRAD DEV, V28, P22, DOI 10.1002/ldr.2656; Thapa GB, 2002, LAND DEGRAD DEV, V13, P479, DOI 10.1002/ldr.536; TOTH SJ, 1949, SOIL SCI, V67, P439, DOI 10.1097/00010694-194906000-00003; Tripathi BP, 2000, 200014 LUML AGR RES; Tripathi R, 2015, ARAB J GEOSCI, V8, P10693, DOI 10.1007/s12517-015-2003-4; Tziachris P, 2017, ISPRS INT J GEO-INF, V6, DOI 10.3390/ijgi6090283; Varouchakis EA, 2013, ENVIRON MONIT ASSESS, V185, P1, DOI 10.1007/s10661-012-2527-y; Vasu D, 2017, SOIL TILL RES, V169, P25, DOI 10.1016/j.still.2017.01.006; Venteris ER, 2013, J ENVIRON QUAL, V43, P936; von Westarp S, 2004, CAN J SOIL SCI, V84, P323, DOI 10.4141/S03-053; WALKLEY A, 1947, SOIL SCI, V63, P251, DOI 10.1097/00010694-194704000-00001; Wang JF, 2009, SENSORS-BASEL, V9, P5224, DOI 10.3390/s90705224; Wang Jun-ping, 2006, J Zhejiang Univ Sci B, V7, P769, DOI 10.1631/jzus.2006.B0769; Wang YQ, 2013, LAND DEGRAD DEV, V24, P296, DOI 10.1002/ldr.1128; WEBSTER R, 1994, GEODERMA, V62, P1, DOI 10.1016/0016-7061(94)90024-8; Wilding L. P., 1985, Soil spatial variability, P166; Yao XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056537, 10.1371/journal.pone.0054660]; Yasrebi J., 2009, Research Journal of Biological Sciences, V4, P93; Zandi S, 2011, 19TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2011), P1153; Zhang Q, 2010, INT J GEOGR INF SCI, V24, P965, DOI 10.1080/13658810903257954; Zhao YN, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8090879; Zhu AX, 2015, EUR J SOIL SCI, V66, P535, DOI 10.1111/ejss.12244	99	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206350	10.1371/journal.pone.0206350	http://dx.doi.org/10.1371/journal.pone.0206350			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365521	Green Published, gold			2022-12-26	WOS:000448448700045
J	Pusceddu, M; Mura, A; Floris, I; Satta, A				Pusceddu, Michelins; Mura, Alessandra; Floris, Ignazio; Satta, Alberto			Feeding strategies and intraspecific competition in German yellowjacket (Vespula germanica)	PLOS ONE			English	Article							WASPS HYMENOPTERA; FORAGING BEHAVIOR; PAST EXPERIENCE; F HYMENOPTERA; VISUAL CUES; FOOD SOURCE; VESPIDAE; AUSTRALIA; FORAGERS	The German yellowjacket (Vespula germanica) is an opportunist predator and a scavenger, whose eclectic diet also includes honey, brood, dead and live honey-bees. There is no evidence in this species of coordinated attacks against bees involving other conspecifics, although intraspecific competition has been already reported between two or more individuals during feeding. Our aim was to gain further knowledge on the feeding behavior of V. germanica in order to evaluate its role in an apiary. Sight observations of predation and necrophagy behaviors were carried out at the ground level near hives. We also investigated how intraspecific competition can influence the feeding display in this species. Our results confirm the major role of the German yellowjacket as a scavenger, because its diet is based mostly on bee carrions. Intraspecific competition during feeding was sometimes observed. When these events occurred, the interference of another wasp led to the bee escaping only in three cases. Our study also revealed that intraspecific competition events increase when the resource is fresh (predation vs necrophagy), and that the number of competing wasps was significantly higher when the food consisted of pupae and drones, compared to adult bees. When competition involved two individuals (the most frequent case), the winner was frequently the first wasp to reach the resource in both predation and necrophagy events. This suggests that the energy invested in foraging or predating activity and in defence of prey is usually rewarded.	[Pusceddu, Michelins; Mura, Alessandra; Floris, Ignazio; Satta, Alberto] Univ Sassari, Sez Patol Vegetale & Entomol, Dipartimento Agr, Sassari, Italy	University of Sassari	Satta, A (corresponding author), Univ Sassari, Sez Patol Vegetale & Entomol, Dipartimento Agr, Sassari, Italy.	albsatta@uniss.it	Satta, Alberto/K-8597-2015	Satta, Alberto/0000-0003-1296-3835	Regione Autonoma della Sardegna	Regione Autonoma della Sardegna(Regione Sardegna)	Regione Autonoma della Sardegna has financed the Alessandra Mura' PhD scholarship. Project: P.O.R. Sardegna F.S.E. 2014/2020 Asse III-Istruzione e formazione-Obiettivo tematico 10 "Investire nell'istruzione e nella formazione professionale per le competenze e l'apprendimento permanente". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi O, 1975, ART ADVENTURE BEE KE; Akre R. D., 1986, EC IMPACT CONTROL SO; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Archer Michael E., 1998, Entomologist's Monthly Magazine, V134, P279; BRANCH GM, 1975, J ANIM ECOL, V44, P263, DOI 10.2307/3862; Braverman Y, 1998, MED VET ENTOMOL, V12, P192, DOI 10.1046/j.1365-2915.1998.00103.x; CLAPPERTON BK, 1989, NEW ZEAL J ZOOL, V16, P325, DOI 10.1080/03014223.1989.10422897; COELHO JR, 1995, FUNCT ECOL, V9, P171, DOI 10.2307/2390561; Crosland M., 1990, Australian Bee Journal, V71, P18; D'Adamo P, 2003, ANN ENTOMOL SOC AM, V96, P685, DOI 10.1603/0013-8746(2003)096[0685:CEAOVG]2.0.CO;2; D'Adamo P, 2000, INSECT SOC, V47, P289, DOI 10.1007/PL00001717; D'Adamo P, 2003, NEW ZEAL J ZOOL, V30, P171, DOI 10.1080/03014223.2003.9518336; D'Adamo P, 2007, INSECT SCI, V14, P383, DOI 10.1111/j.1744-7917.2007.00165.x; D'Adamo P, 2014, J INSECT BEHAV, V27, P395, DOI 10.1007/s10905-013-9434-0; D'Adamo P, 2009, ANN ENTOMOL SOC AM, V102, P1109, DOI 10.1603/008.102.0620; Duncan C.D., 1939, CONTRIBUTION BIOL N; Farji-Brener Alejandro G., 1998, Ecologia Austral, V8, P237; FREE JB, 1970, INSECT SOC, V17, P11, DOI 10.1007/BF02223769; Greene A., 1991, P263; HEROLD W., 1952, BIOL ZENTRALBL, V71, P461; Jandt JM, 2005, ETHOLOGY, V111, P641, DOI 10.1111/j.1439-0310.2005.01088.x; Kasper ML, 2008, INSECT SOC, V55, P288, DOI 10.1007/s00040-008-1004-7; Kastberger G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003141; Lozada M, 2009, ENVIRON ENTOMOL, V38, P803, DOI 10.1603/022.038.0333; Lozada M, 2006, J INSECT BEHAV, V19, P591, DOI 10.1007/s10905-006-9045-0; Lozada M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152080; Lozada M, 2011, J INSECT BEHAV, V24, P159, DOI 10.1007/s10905-010-9244-6; MOLLER H, 1989, NEW ZEAL J ZOOL, V16, P289, DOI 10.1080/03014223.1989.10422894; Monceau K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066492; Moreyra S, 2006, AUST J ZOOL, V54, P393, DOI 10.1071/ZO06029; Moreyra S, 2012, ANN ENTOMOL SOC AM, V105, P128, DOI 10.1603/AN11097; Pappas N., 1988, P85; PARRISH MD, 1983, ECOL ENTOMOL, V8, P185, DOI 10.1111/j.1365-2311.1983.tb00497.x; Pusceddu M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180278; Ramsay K, 1997, ESTUAR COAST SHELF S, V44, P213, DOI 10.1006/ecss.1996.0213; Sabrina M, 2014, INSECT SCI, V21, P759, DOI 10.1111/1744-7917.12077; Sackmann P, 2001, J ECON ENTOMOL, V94, P811, DOI 10.1603/0022-0493-94.4.811; Sackmann Paula, 2000, New Zealand Entomologist, V23, P55; SCHMIDHEMPEL P, 1988, J ANIM ECOL, V57, P509, DOI 10.2307/4921; Sokal R. R, 1981, BIOMETRY; SPRADBERY JP, 1992, AUST J ZOOL, V40, P495, DOI 10.1071/ZO9920495; Turillazzi S., 2003, SOC VESPE, P55; Vanni M. J., 2009, ENCY INLAND WATERS, P395, DOI DOI 10.1016/B978-012370626-3.00201-5; Winston M.L., 1991, BIOL HONEY BEE	44	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2018	13	10							e0206301	10.1371/journal.pone.0206301	http://dx.doi.org/10.1371/journal.pone.0206301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3KA	30365519	gold, Green Published, Green Submitted			2022-12-26	WOS:000448448700042
J	Courtial, L; Bielsa, VP; Houlbreque, F; Ferrier-Pages, C				Courtial, Lucile; Bielsa, Victor Planas; Houlbreque, Fanny; Ferrier-Pages, Christine			Effects of ultraviolet radiation and nutrient level on the physiological response and organic matter release of the scleractinian coral Pocillopora damicornis following thermal stress	PLOS ONE			English	Article							GREAT-BARRIER-REEF; B RADIATION; AVAILABILITY AFFECTS; DINITROGEN FIXATION; METABOLIC-ACTIVITY; WATER TEMPERATURE; CLIMATE-CHANGE; UV-RADIATION; GROWTH-RATE; NITROGEN	Understanding which factors enhance or mitigate the impact of high temperatures on corals is crucial to predict the severity of coral bleaching worldwide. On the one hand, global warming is usually associated with high ultraviolet radiation levels (UVR), and surface water nutrient depletion due to stratification. On the other hand, eutrophication of coastal reefs increases levels of inorganic nutrients and decreases UVR, so that the effect of different combinations of these stressors on corals is unknown. In this study, we assessed the individual and crossed effects of high temperature, UVR and nutrient level on the key performance variables of the reef building coral Pocillopora damicornis. We found that seawater warming was the major stressor, which induced bleaching and impaired coral photosynthesis and calcification in all nutrient and UVR conditions. The strength of this effect however, was nutrient dependent. Corals maintained in nutrient-depleted conditions experienced the highest decrease in net photosynthesis under thermal stress, while nutrient enrichment (3 mu M NO3- and 1 mu M PO4+) slightly limited the negative impact of temperature through enhanced protein content, photosynthesis and respiration rates. UVR exposure had only an effect on total nitrogen release rates, which significantly decreased under normal growth conditions and tended to decrease also under thermal stress. This result suggests that increased level of UVR will lead to significant changes in the nutrient biogeochemistry of surface reef waters. Overall, our results show that environmental factors have different and interactive effects on each of the coral's physiological parameters, requiring multifactorial approaches to predict the future of coral reefs.	[Courtial, Lucile] UPMC Univ Paris 6, Sorbonne Univ, IFD ED 129, Paris, France; [Courtial, Lucile; Bielsa, Victor Planas; Ferrier-Pages, Christine] Ctr Sci Monaco, 8 Quai Antoine 1er, Monaco, Monaco; [Courtial, Lucile; Houlbreque, Fanny] Univ La Reunion, IRD, UMR ENTROPIE, Lab Excellence CORAIL,CNRS, BP A5, Noumea, New Caledonia	UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD)	Ferrier-Pages, C (corresponding author), Ctr Sci Monaco, 8 Quai Antoine 1er, Monaco, Monaco.	ferrier@centrescientifique.mc		planas-bielsa, victor/0000-0003-0903-7603; Ferrier-Pages, Christine/0000-0002-0357-4486	Scientific Center of Monaco; IRD Nouvelle Caledonie	Scientific Center of Monaco; IRD Nouvelle Caledonie	The authors are grateful to the Scientific Center of Monaco and IRD Nouvelle Caledonie for funding this study.	ANDERSON SM, 1981, MAR BIOL, V62, P257, DOI 10.1007/BF00397692; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Bednarz VN, 2015, MAR ECOL PROG SER, V519, P141, DOI 10.3354/meps11091; Bednarz VN, 2012, J EXP BIOL, V215, P3672, DOI 10.1242/jeb.072884; BEHRENFELD MJ, 1995, J PHYCOL, V31, P25, DOI 10.1111/j.0022-3646.1995.00025.x; Beraud E, 2013, J EXP BIOL, V216, P2665, DOI 10.1242/jeb.085183; Brodie JE, 2012, MAR POLLUT BULL, V65, P81, DOI 10.1016/j.marpolbul.2011.12.012; BROWN BE, 1994, MAR ECOL PROG SER, V105, P219, DOI 10.3354/meps105219; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Cardenas A, 2018, ISME J, V12, P59, DOI 10.1038/ismej.2017.142; Cardini U, 2014, ECOL EVOL, V4, P1706, DOI 10.1002/ece3.1050; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Collos Y, 1996, J EXP MAR BIOL ECOL, V202, P177, DOI 10.1016/0022-0981(96)00025-1; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Courtial L, 2017, BIOL OPEN, V6, P1190, DOI 10.1242/bio.026757; Courtial L, 2017, LIMNOL OCEANOGR, V62, P1000, DOI 10.1002/lno.10481; D'Angelo C, 2014, CURR OPIN ENV SUST, V7, P82, DOI 10.1016/j.cosust.2013.11.029; D'Croz L, 2001, B MAR SCI, V69, P203; DAVIES PS, 1989, MAR BIOL, V101, P389; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DOHLER G, 1985, J PLANT PHYSIOL, V118, P391, DOI 10.1016/S0176-1617(85)80199-1; Drohan AF, 2005, B MAR SCI, V77, P257; Ezzat L, 2016, LIMNOL OCEANOGR, V61, P89, DOI 10.1002/lno.10200; Ezzat L, 2015, P ROY SOC B-BIOL SCI, V282, P142, DOI 10.1098/rspb.2015.0610; Fabricius KE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P493, DOI 10.1007/978-94-007-0114-4_28; Ferrier-Pages C, 2007, BIOL BULL-US, V213, P76, DOI 10.2307/25066620; Fine M, 2002, MAR ECOL PROG SER, V226, P249, DOI 10.3354/meps226249; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Fitt WK, 1995, BIOL BULL, V189, P298, DOI 10.2307/1542147; Furnas MJ, 1992, DISSOLVED PARTICULAT; Glynn Peter W., 2012, P103; Godinot C, 2013, LIMNOL OCEANOGR, V58, P227, DOI 10.4319/lo.2013.58.1.0227; Haapkyla J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016893; Hessen DO, 1997, FRESHWATER BIOL, V38, P513, DOI 10.1046/j.1365-2427.1997.00223.x; Hoadley KD, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2909-8; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holbrook SJ, 2008, MAR BIOL, V155, P521, DOI 10.1007/s00227-008-1051-7; Holcomb M, 2010, J EXP MAR BIOL ECOL, V386, P27, DOI 10.1016/j.jembe.2010.02.007; Hoogenboom M, 2010, CORAL REEFS, V29, P21, DOI 10.1007/s00338-009-0558-9; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Jackson MC, 2016, GLOBAL CHANGE BIOL, V22, P180, DOI 10.1111/gcb.13028; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jokiel P.L., 1978, CORAL REEF RES METHO, VVolume 78, P379; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Langdon C, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001941; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Lesser MP, 2000, MAR ECOL PROG SER, V192, P137, DOI 10.3354/meps192137; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; Levas S, 2016, CORAL REEFS, V35, P495, DOI 10.1007/s00338-015-1390-z; Lorrain A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03781-y; McCullagh P, 1989, GEN LINEAR MODELS; MEYER JL, 1985, LIMNOL OCEANOGR, V30, P157, DOI 10.4319/lo.1985.30.1.0157; Mizubayashi K, 2013, ESTUAR COAST SHELF S, V126, P34, DOI 10.1016/j.ecss.2013.04.002; Nakajima R, 2018, J EXP MAR BIOL ECOL, V504, P53, DOI 10.1016/j.jembe.2018.02.008; Naumann MS, 2010, CORAL REEFS, V29, P649, DOI 10.1007/s00338-010-0612-7; Nelson CE, 2013, ISME J, V7, P962, DOI 10.1038/ismej.2012.161; Niggl W, 2008, P 11 INT COR REEF S, P905, DOI [10.1242/jeb.072884, DOI 10.1242/JEB.072884]; OLSON RJ, 1980, LIMNOL OCEANOGR, V25, P1064, DOI 10.4319/lo.1980.25.6.1064; Pogoreutz C, 2017, GLOBAL CHANGE BIOL, V23, P3838, DOI 10.1111/gcb.13695; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Ringuet S, 2005, ESTUARIES, V28, P327, DOI 10.1007/BF02693916; Rix L, 2015, MAR ECOL PROG SER, V533, P79, DOI 10.3354/meps11383; Rogers JE, 2010, B MAR SCI, V86, P743; Rosset S, 2017, MAR POLLUT BULL, V118, P180, DOI 10.1016/j.marpolbul.2017.02.044; Rosset S, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00103; Santos HF, 2014, ISME J, V8, P2272, DOI 10.1038/ismej.2014.70; Sawall Y, 2011, CORAL REEFS, V30, P841, DOI 10.1007/s00338-011-0764-0; Schloder C, 2004, J EXP MAR BIOL ECOL, V313, P255, DOI 10.1016/j.jembe.2004.08.012; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Spalding MD, 2015, SCIENCE, V350, P769, DOI 10.1126/science.aad0349; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Tanaka Y, 2014, LIMNOL OCEANOGR, V59, P1468, DOI 10.4319/lo.2014.59.5.1468; Tanaka Y, 2014, J EXP MAR BIOL ECOL, V457, P220, DOI 10.1016/j.jembe.2014.04.019; Thurber RLV, 2014, GLOBAL CHANGE BIOL, V20, P544, DOI 10.1111/gcb.12450; Treguer P., 1975, MANUEL ANAL SELS NUT; Tremblay P, 2012, MAR ECOL PROG SER, V453, P63, DOI 10.3354/meps09640; Veal CJ, 2010, CORAL REEFS, V29, P893, DOI 10.1007/s00338-010-0647-9; Venn AA, 2006, PLANT CELL ENVIRON, V29, P2133, DOI 10.1111/j.1365-3040.2006.001587.x; Wang L, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00101; Watanabe S, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015749; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661; Wohlfahrt G, 2015, PLANT CELL ENVIRON, V38, P2500, DOI 10.1111/pce.12569; Wooldridge SA, 2013, BIOGEOSCIENCES, V10, P1647, DOI 10.5194/bg-10-1647-2013; Wooldridge SA, 2017, MAR POLLUT BULL, V114, P343, DOI 10.1016/j.marpolbul.2016.09.045; Wooldridge SA, 2009, MAR ECOL PROG SER, V396, P145, DOI 10.3354/meps08310; Zaneveld JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11833	90	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205261	10.1371/journal.pone.0205261	http://dx.doi.org/10.1371/journal.pone.0205261			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356284	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000046
J	Gabay, Y; Karni, A; Banai, K				Gabay, Yafit; Karni, Avi; Banai, Karen			Learning to decipher time-compressed speech: Robust acquisition with a slight difficulty in generalization among young adults with developmental dyslexia	PLOS ONE			English	Article							ATTENTIONAL REQUIREMENTS; ADVERSE CONDITIONS; PERCEPTION; LANGUAGE; MEMORY; CHILDREN; SKILL; DISSOCIATION; RECOGNITION; SYSTEMS	Learning to decipher acoustically distorted speech serves as a test case for the study of language-related skill acquisition in persons with developmental dyslexia (DD). Deciphering this type of input is rarely learned explicitly and does not yield conscious insights. Problems in implicit and procedural skill learning have been proposed as possible causes of DD. Here we examined the learning of time-compressed (accelerated) speech and its generalization to novel materials among young adults with DD compared to typical readers (TD). All participants completed a training session that involved judging the semantic plausibility of sentences, during which the level of time-compression was changed using an adaptive (staircase) procedure according to each participant's performance. In the test, phase learning (test on same items) and generalization (test on new items and same items spoken by a new speaker) were assessed. Both groups showed robust gains after training. Moreover, after training, the initial disadvantage of the DD group was no longer significant. After training, both groups experienced relative difficulties in deciphering learned tokens spoken by a different voice, though participants with DD were less able to generalize the gains to deciphering new tokens. Thus, DD individuals benefited from repeated experience with time-compressed speech no less than typical readers, but their evolving skill was apparently more dependent on the specific characteristics of the tokens. Atypical generalization, which indicates that perceptual learning is contingent on lower-level features of the input though does not necessarily point to impaired learning potential per se, may explain some of the contradictory findings in published studies of speech perception in DD.	[Gabay, Yafit] Univ Haifa, Dept Special Educ, Haifa, Israel; [Gabay, Yafit; Karni, Avi] Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, Dept Learning Disabil, Haifa, Israel; [Karni, Avi] Univ Haifa, Sagol Dept Neurobiol, Haifa, Israel; [Banai, Karen] Univ Haifa, Dept Commun Sci & Disorders, Haifa, Israel	University of Haifa; University of Haifa; University of Haifa; University of Haifa	Gabay, Y (corresponding author), Univ Haifa, Dept Special Educ, Haifa, Israel.; Gabay, Y (corresponding author), Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, Dept Learning Disabil, Haifa, Israel.	yagabay@edu.haifa.ac.il	Banai, Karen/J-1448-2019; Gabay, Yafit/P-8315-2019	Banai, Karen/0000-0002-2990-0470; Gabay, Yafit/0000-0002-7899-3044	National Institute of Psychobiology in Israel, Hebrew University of Jerusalem [108-14-15]; National Institute of Psychobiology in Israel	National Institute of Psychobiology in Israel, Hebrew University of Jerusalem; National Institute of Psychobiology in Israel	This research was supported by a grant from the National Institute of Psychobiology in Israel, Hebrew University of Jerusalem, to KB, 108-14-15.; This research was supported by a grant from the National Institute of Psychobiology in Israel to KB.	Adi-Japha E, 2011, RES DEV DISABIL, V32, P1011, DOI 10.1016/j.ridd.2011.01.048; Agnew JA, 2004, BRAIN LANG, V88, P21, DOI 10.1016/S0093-934X(03)00157-3; Agus TR, 2014, J SPEECH LANG HEAR R, V57, P1069, DOI 10.1044/1092-4388(2013/13-0020); Amir O., 2013, STUD MEDIA COMMUN, V1, P131, DOI 10.11114/smc.v1i1.119; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Banai K., 2009, LEARNING PERCEPTION, V1, P115, DOI [10.1556/LP.1.2009.1.9, DOI 10.1556/LP.1.2009.1.9]; Banai K, 2017, LANG COGN NEUROSCI, P1; Banai K, 2018, LANG COGN NEUROSCI, V33, P321, DOI 10.1080/23273798.2017.1408851; Banai K, 2016, J ACOUST SOC AM, V140, P1686, DOI 10.1121/1.4962499; Banai K, 2014, J ACOUST SOC AM, V136, P1908, DOI 10.1121/1.4895684; Banai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047099; Ben-Simon A, 2012, MATAL TEST BATTERY D; Breznitz Z, 2003, GENET SOC GEN PSYCH, V129, P183; Breznitz Z, 2003, BRAIN LANG, V85, P486, DOI 10.1016/S0093-934X(03)00071-3; Breznitz Z., 1997, PARSING TEST UNPUB; Breznitz Z, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2488; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Conway CM, 2010, COGNITION, V114, P356, DOI 10.1016/j.cognition.2009.10.009; Conway CM, 2008, ANN NY ACAD SCI, V1145, P113, DOI 10.1196/annals.1416.009; Daikhin L, 2017, J SPEECH LANG HEAR R, V60, P471, DOI 10.1044/2016_JSLHR-H-16-0114; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Fahle M, 2005, CURR OPIN NEUROBIOL, V15, P154, DOI 10.1016/j.conb.2005.03.010; Franceschini S, 2013, CURR BIOL, V23, P462, DOI 10.1016/j.cub.2013.01.044; FREEMAN BA, 1978, J SPEECH HEAR RES, V21, P497, DOI 10.1044/jshr.2103.487; Gabay Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176488; Gabay Y, 2015, CORTEX, V73, P131, DOI 10.1016/j.cortex.2015.08.008; Gabay Y, 2015, NEUROPSYCHOLOGY, V29, P844, DOI 10.1037/neu0000194; Gabay Y, 2015, J EXP PSYCHOL HUMAN, V41, P1124, DOI 10.1037/xhp0000073; Gabay Y, 2015, J SPEECH LANG HEAR R, V58, P934, DOI 10.1044/2015_JSLHR-L-14-0324; Gabay Y, 2012, NEUROPSYCHOLOGY, V26, P744, DOI 10.1037/a0030235; Gabay Y, 2012, NEUROPSYCHOLOGIA, V50, P2435, DOI 10.1016/j.neuropsychologia.2012.06.014; Gabay Y, 2012, J CLIN EXP NEUROPSYC, V34, P279, DOI 10.1080/13803395.2011.633499; Gori S, 2014, VISION RES, V99, P78, DOI 10.1016/j.visres.2013.11.011; Guediche S, 2016, J EXP PSYCHOL HUMAN, V42, P1048, DOI 10.1037/xhp0000196; Guediche S, 2015, CEREB CORTEX, V25, P1867, DOI 10.1093/cercor/bht428; Guediche S, 2014, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00126; Heald SLM, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00035; Hedenius M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063998; Inacio F, 2018, ANN DYSLEXIA, V68, P1, DOI 10.1007/s11881-018-0158-x; Inspector M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082042; JACOBY LL, 1984, PSYCHOL LEARN MOTIV, V18, P1, DOI 10.1016/S0079-7421(08)60358-8; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; Karni A, 1997, CURR OPIN NEUROBIOL, V7, P530, DOI 10.1016/S0959-4388(97)80033-5; Karni A., 1996, ACQUISITION PERCEPTU; Kelly Steve W, 2002, Dyslexia, V8, P43, DOI 10.1002/dys.208; Korman M, 2015, NEUROSCI LETT, V606, P173, DOI 10.1016/j.neulet.2015.08.051; Krishnan S, 2016, TRENDS COGN SCI, V20, P701, DOI 10.1016/j.tics.2016.06.012; Kujala T, 2001, P NATL ACAD SCI USA, V98, P10509, DOI 10.1073/pnas.181589198; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lum JAG, 2013, RES DEV DISABIL, V34, P3460, DOI 10.1016/j.ridd.2013.07.017; Magnan A, 2004, DYSLEXIA, V10, P131, DOI 10.1002/dys.270; Mattys SL, 2012, LANG COGNITIVE PROC, V27, P953, DOI 10.1080/01690965.2012.705006; Nicolson RI, 2007, TRENDS NEUROSCI, V30, P135, DOI 10.1016/j.tins.2007.02.003; Nicolson RI, 2011, CORTEX, V47, P117, DOI 10.1016/j.cortex.2009.08.016; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Obleser J, 2009, TRENDS COGN SCI, V13, P14, DOI 10.1016/j.tics.2008.09.005; Ofen-Noy N, 2003, COGNITIVE BRAIN RES, V17, P507, DOI 10.1016/S0926-6410(03)00166-6; Pavlidou EV, 2014, RES DEV DISABIL, V35, P1457, DOI 10.1016/j.ridd.2014.03.040; Pavlidou EV, 2010, DYSLEXIA, V16, P143, DOI 10.1002/dys.400; Perrachione TK, 2011, SCIENCE, V333, P595, DOI 10.1126/science.1207327; PISONI DB, 1993, SPEECH COMMUN, V13, P109, DOI 10.1016/0167-6393(93)90063-Q; Primor L, 2011, ANN DYSLEXIA, V61, P242, DOI 10.1007/s11881-011-0059-8; Prior A, 2006, PSYCHOPHYSIOLOGY, V43, P440, DOI 10.1111/j.1469-8986.2006.00426.x; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; REED J, 1994, J EXP PSYCHOL LEARN, V20, P585, DOI 10.1037/0278-7393.20.3.585; Rosen S, 2003, J PHONETICS, V31, P509, DOI 10.1016/S0095-4470(03)00046-9; Russeler J, 2006, J CLIN EXP NEUROPSYC, V28, P808, DOI 10.1080/13803390591001007; Samuel AG, 2009, ATTEN PERCEPT PSYCHO, V71, P1207, DOI 10.3758/APP.71.6.1207; Seitz AR, 2009, VISION RES, V49, P2604, DOI 10.1016/j.visres.2009.08.003; Shatil, 1995, ONE MINUTE TES UNPUB; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Shiran A, 2011, J NEUROLINGUIST, V24, P524, DOI 10.1016/j.jneuroling.2010.12.001; Svirsky MA, 2015, HEARING RES, V322, P163, DOI 10.1016/j.heares.2014.10.008; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Vandermosten M, 2010, P NATL ACAD SCI USA, V107, P10389, DOI 10.1073/pnas.0912858107; Verhelst W, 1993, AC SPEECH SIGN PROC; WATSON M, 1990, PERCEPT MOTOR SKILL, V71, P107; Wechsler D., 1997, WECHSLER ADULT INTEL	81	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205110	10.1371/journal.pone.0205110	http://dx.doi.org/10.1371/journal.pone.0205110			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3FL	30356320	gold, Green Published, Green Submitted			2022-12-26	WOS:000448434000030
J	Spoer, BR; Cantor, JH; Rummo, PE; Elbel, BD				Spoer, Ben R.; Cantor, Jonathan H.; Rummo, Pasquale E.; Elbel, Brian D.			Food environment does not predict self-reported SSB consumption in New York City: A cross sectional study	PLOS ONE			English	Article							SWEETENED BEVERAGE CONSUMPTION; OBESITY; ADULTS	The purpose of this research was to examine whether the local food environment, specifically the distance to the nearest sugar sweetened beverage (SSB) vendor, a measure of SSB availability and accessibility, was correlated with the likelihood of self-reported SSB consumption among a sample of fast food consumers. As part of a broader SSB behavior study in 2013-2014, respondents were surveyed outside of major chain fast food restaurants in New York City (NYC). Respondents were asked for the intersection closest to their home and how frequently they consume SSBs. Comprehensive, administrative food outlet databases were used to geo-locate the SSB vendor closest to the respondents' home intersections. We then used a logistic regression model to estimate the association between the distance to the nearest SSB vendor (overall and by type) and the likelihood of daily SSB consumption. Our results show that proximity to the nearest SSB vendor was not statistically significantly associated with the likelihood of daily SSB consumption, regardless of type of vendor. Our results are robust to alternative model specifications, including replacing the linear minimum distance measure with count of the total number of SSB vendors or presence of a SSB vendor within a buffer around respondents' home intersections. We conclude that there is not a strong relationship between proximity to nearest SSB vendor, or proximity to a specific type of SSB vendor, and frequency of self-reported SSB consumption among fast food consumers in NYC. This suggests that policymakers focus on alternative strategies to curtail SSB consumption, such as improving the within-store food environment or taxing SSBs.	[Spoer, Ben R.] NYU, Coll Global Publ Hlth, Dept Social Behav Studies, New York, NY USA; [Spoer, Ben R.; Cantor, Jonathan H.; Rummo, Pasquale E.; Elbel, Brian D.] NYU, Sch Med, Dept Populat Hlth, New York, NY 10003 USA; [Cantor, Jonathan H.; Elbel, Brian D.] NYU, Wagner Sch Publ Serv, New York, NY 10003 USA; [Cantor, Jonathan H.] RAND Corp, Dept Econ Sociol & Stat, Santa Monica, CA USA	New York University; New York University; New York University; RAND Corporation	Elbel, BD (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY 10003 USA.; Elbel, BD (corresponding author), NYU, Wagner Sch Publ Serv, New York, NY 10003 USA.	Brian.Elbel@nyumc.org		Elbel, Brian/0000-0003-1615-9430; Rummo, Pasquale/0000-0002-9285-5430; Spoer, Ben/0000-0002-0311-7963	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK097347, R01DK 099241]; National Institutes of Health/National Heart, Lung, and Blood Institute [R01 HL095935]; New York State Health Foundation [12-01682]; Robert Wood Johnson Foundation [70823]	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); New York State Health Foundation; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (R01DK097347) and (R01DK 099241, URL https://www.niddk.nih.gov/), the National Institutes of Health/National Heart, Lung, and Blood Institute (grant R01 HL095935, URL https://www.nhlbi.nih.gov/), the New York State Health Foundation (12-01682 URL: https://nyshealthfoundation.org/), and the Robert Wood Johnson Foundation (award 70823, URL https://www.rwjf.org/). All grants were awarded to BDE. These funders played no role in the study design, the data collection, analysis, or interpretation, nor the writing of the manuscript.	Caspi CE, 2012, HEALTH PLACE, V18, P1172, DOI 10.1016/j.healthplace.2012.05.006; Chokshi DA, 2013, JAMA-J AM MED ASSOC, V310, P1025, DOI 10.1001/jama.2013.110872; Cobb LK, 2015, OBESITY, V23, P1331, DOI 10.1002/oby.21118; Colchero MA, 2016, BMJ, V352; Dumanovsky Tamara, 2011, BMJ, V343, pd4464, DOI 10.1136/bmj.d4464; Falbe J, 2016, AM J PUBLIC HEALTH, V106, P1865, DOI 10.2105/AJPH.2016.303362; Gase LN, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00229; Gustafson A, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-17; Kansagra SM, 2015, AM J PUBLIC HEALTH, V105, pE61, DOI 10.2105/AJPH.2014.302497; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Mejia N, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150078; NYC DOHMH, 2002, COMM HLTH SURV; NYC DOHMH, 2014, 20132014 NYC HANES; Ruff RR, 2016, AM J HEALTH PROMOT, V30, P172, DOI 10.4278/ajhp.140326-QUAN-121; Ruff RR, 2014, J COMMUN HEALTH, V39, P1117, DOI 10.1007/s10900-014-9865-3; Sanger-Katz Margot, 2016, NY TIMES	16	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0196689	10.1371/journal.pone.0196689	http://dx.doi.org/10.1371/journal.pone.0196689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3FL	30356232	gold, Green Submitted, Green Published			2022-12-26	WOS:000448434000001
J	Dai, ZW; Locasale, JW				Dai, Ziwei; Locasale, Jason W.			Thermodynamic constraints on the regulation of metabolic fluxes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolism; metabolic regulation; computational biology; thermodynamics; enzyme kinetics; metabolic control analysis	CONTROL COEFFICIENTS; GLYCOLYSIS; NETWORKS; PATHWAY	Nutrition and metabolism are fundamental to cellular function. Metabolic activity (i.e. rates of flow, most commonly referred to as flux) is constrained by thermodynamics and regulated by the activity of enzymes. The general principles that relate biological and physical variables to metabolic control are incompletely understood. Using metabolic control analysis and computer simulations in several models of simplified metabolic pathways, we derive analytical expressions that define relationships between thermodynamics, enzyme activity, and flux control. The relationships are further analyzed in a mathematical model of glycolysis as an example of a complex biochemical pathway. We show that metabolic pathways that are very far from equilibrium are controlled by the activity of upstream enzymes. However, in general, regulation of metabolic fluxes by an enzyme has a more adaptable pattern, which relies more on distribution of free energy among reaction steps in the pathway than on the thermodynamic properties of the given enzyme. These findings show how the control of metabolic pathways is shaped by thermodynamic constraints of the given pathway.	[Dai, Ziwei; Locasale, Jason W.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Dai, ZW; Locasale, JW (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	ziwei.dai@duke.edu; jason.locasale@duke.edu	Locasale, Jason W/ABE-6505-2020; Dai, Ziwei/O-3397-2019	Locasale, Jason W/0000-0002-7766-3502; Dai, Ziwei/0000-0002-0858-638X	National Institutes of Health [R01 CA193256, R00CA168997]; American Cancer Society [TBE-TBE434120]; NATIONAL CANCER INSTITUTE [R01CA193256, R00CA168997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01 CA193256 and R00CA168997 and American Cancer Society Grant TBE-TBE434120 (to J. W. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achcar F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002352; Bakker BM, 1999, J BIOL CHEM, V274, P14551, DOI 10.1074/jbc.274.21.14551; Bakker BM, 2000, P NATL ACAD SCI USA, V97, P2087, DOI 10.1073/pnas.030539197; BASSHAM JA, 1969, BIOCHIM BIOPHYS ACTA, V189, P207, DOI 10.1016/0005-2728(69)90048-6; Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BROWN GC, 1990, EUR J BIOCHEM, V188, P321, DOI 10.1111/j.1432-1033.1990.tb15406.x; Brunk E, 2018, NAT BIOTECHNOL, V36, P272, DOI 10.1038/nbt.4072; Cascante M, 2002, NAT BIOTECHNOL, V20, P243, DOI 10.1038/nbt0302-243; Chandel NS., 2015, NAVIGATING METABOLIS; Chelliah V, 2015, NUCLEIC ACIDS RES, V43, pD542, DOI 10.1093/nar/gku1181; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; GROEN AK, 1986, BIOCHEM J, V237, P379, DOI 10.1042/bj2370379; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Heinrich R., 1996, REGULATION CELLULAR; Jang C, 2018, CELL, V173, P822, DOI 10.1016/j.cell.2018.03.055; KACSER H, 1981, GENETICS, V97, P639; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; Liberti MV, 2017, CELL METAB, V26, P648, DOI 10.1016/j.cmet.2017.08.017; Liebermeister W., 2013, ARXIV13090267; Liu XJ, 2017, TRENDS BIOCHEM SCI, V42, P274, DOI 10.1016/j.tibs.2017.01.004; Locasale Jason W, 2018, Curr Opin Syst Biol, V8, P32, DOI 10.1016/j.coisb.2017.11.005; Moreno-Sanchez R, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/597913; Nelson DL, 2016, LEHNINGER PRINCIPLES; Noor E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003483; Noor E, 2013, FEBS LETT, V587, P2772, DOI 10.1016/j.febslet.2013.07.028; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; PAGE RA, 1994, BBA-LIPID LIPID MET, V1210, P369, DOI 10.1016/0005-2760(94)90242-9; Park JO, 2016, NAT CHEM BIOL, V12, P482, DOI [10.1038/NCHEMBIO.2077, 10.1038/nchembio.2077]; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Qian H, 2005, BIOPHYS CHEM, V114, P213, DOI 10.1016/j.bpc.2004.12.001; REDER C, 1988, J THEOR BIOL, V135, P175, DOI 10.1016/S0022-5193(88)80073-0; Reid MA, 2017, NAT CELL BIOL, V19, P1298, DOI 10.1038/ncb3629; Reznik E, 2017, CELL REP, V20, P2666, DOI 10.1016/j.celrep.2017.08.066; Sauro Herbert M., 2003, OMICS A Journal of Integrative Biology, V7, P355, DOI 10.1089/153623103322637670; Shelley MD, 1996, BIOTECHNOL BIOENG, V51, P198, DOI 10.1002/(SICI)1097-0290(19960720)51:2&lt;198::AID-BIT9&gt;3.0.CO;2-E; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; VANDAM K, 1980, BIOCHIM BIOPHYS ACTA, V591, P240, DOI 10.1016/0005-2728(80)90156-5; WESTERHOFF HV, 1987, CELL BIOPHYS, V11, P239, DOI 10.1007/BF02797123; WESTERHOFF HV, 1984, BIOSCIENCE REP, V4, P1, DOI 10.1007/BF01120819; WESTERHOFF HV, 1984, EUR J BIOCHEM, V142, P425, DOI 10.1111/j.1432-1033.1984.tb08304.x; Xie JS, 2016, J BIOL CHEM, V291, P8987, DOI 10.1074/jbc.M115.704825; YASUMASU I, 1973, EXP CELL RES, V80, P361, DOI 10.1016/0014-4827(73)90308-X	46	8	8	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19725	19739		10.1074/jbc.RA118.004372	http://dx.doi.org/10.1074/jbc.RA118.004372			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30361440	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000454294900019
J	Zhou, JJ; Li, DP; Chen, SR; Luo, Y; Pan, HL				Zhou, Jing-Jing; Li, De-Pei; Chen, Shao-Rui; Luo, Yi; Pan, Hui-Lin			The 2-1-NMDA receptor coupling is essential for corticostriatal long-term potentiation and is involved in learning and memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurophysiology; neuroscience; neurotransmitter; electrophysiology; synaptic plasticity	NMDA RECEPTORS; BASAL GANGLIA; ALPHA(2)DELTA SUBUNIT; DORSOMEDIAL STRIATUM; SYNAPTIC PLASTICITY; CALCIUM-CHANNELS; DORSAL STRIATUM; UP-REGULATION; SPINAL-CORD; T-MAZE	The striatum receives extensive cortical input and plays a prominent role in motor learning and habit formation. Glutamate N-methyl-d-aspartate (NMDA) receptor (NMDAR)-mediated long-term potentiation (LTP) is a major synaptic plasticity involved in learning and memory. However, the molecular mechanism underlying NMDAR plasticity in corticostriatal LTP is unclear. Here, we show that theta-burst stimulation (TBS) consistently induced corticostriatal LTP and increased the coincident presynaptic and postsynaptic NMDAR activity of medium spiny neurons. We also found that 2-1 (previously known as a subunit of voltage-gated calcium channels; encoded by the Cacna2d1 gene) physically interacted with NMDARs in the striatum of mice and humans, indicating that this cross-talk is conserved across species. Strikingly, inhibiting 2-1 trafficking with gabapentin or disrupting the 2-1-NMDAR interaction with an 2-1 C terminus-interfering peptide abolished TBS-induced LTP. In Cacna2d1-knockout mice, TBS failed to induce corticostriatal LTP and the associated increases in presynaptic and postsynaptic NMDAR activities. Moreover, systemic gabapentin treatment, microinjection of 2-1 C terminus-interfering peptide into the dorsomedial striatum, or Cacna2d1 ablation impaired the alternation T-maze task and rotarod performance in mice. Our findings indicate that the interaction between 2-1 and NMDARs is of high physiological relevance and that a TBS-induced switch from 2-1-free to 2-1-bound NMDARs is critically involved in corticostriatal LTP and LTP-associated learning and memory. Gabapentinoids at high doses may adversely affect cognitive function by targeting 2-1-NMDAR complexes.	[Zhou, Jing-Jing; Li, De-Pei; Chen, Shao-Rui; Luo, Yi; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr Neurosci & Pain Res, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Luo, Yi] Wuhan Univ, Zhongnan Hosp, Dept Clin Lab Med, Wuhan 430071, Hubei, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Wuhan University	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org		Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [GM120844, NS101880]; N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS101880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health Grants GM120844 and NS101880 (to H.-L. P.) and by the N. G. and Helen T. Hawkins Endowment. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allison DW, 1998, J NEUROSCI, V18, P2423; Bliss TVP, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-5; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; Cassidy JS, 2014, P NATL ACAD SCI USA, V111, P8979, DOI 10.1073/pnas.1403731111; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; Charpier S, 1999, NEUROSCIENCE, V91, P1209, DOI 10.1016/S0306-4522(98)00719-2; Chen JJ, 2018, CELL REP, V22, P2307, DOI 10.1016/j.celrep.2018.02.021; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cole RL, 2005, J COMP NEUROL, V491, P246, DOI 10.1002/cne.20693; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; DeCoteau WE, 2007, J NEUROPHYSIOL, V97, P3800, DOI 10.1152/jn.00108.2007; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Felsted JA, 2017, CELL REP, V21, P2737, DOI 10.1016/j.celrep.2017.11.048; Friend DM, 2017, CELL METAB, V25, P312, DOI 10.1016/j.cmet.2016.12.001; Fuller-Bicer GA, 2009, AM J PHYSIOL-HEART C, V297, pH117, DOI 10.1152/ajpheart.00122.2009; Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; HAUBER W, 1989, J NEURAL TRANSM-GEN, V78, P29, DOI 10.1007/BF01247111; Hawes SL, 2013, J NEUROPHYSIOL, V110, P2027, DOI 10.1152/jn.00115.2013; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Jia YS, 2010, J NEUROSCI, V30, P14440, DOI 10.1523/JNEUROSCI.3310-10.2010; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052, DOI 10.1152/jn.1989.62.5.1052; Lana B, 2016, SCI REP-UK, V6, DOI 10.1038/srep24531; Larson J, 2015, BRAIN RES, V1621, P38, DOI 10.1016/j.brainres.2014.10.034; Lemay-Clermont J, 2011, BEHAV NEUROSCI, V125, P714, DOI 10.1037/a0025213; Lewis SJG, 2004, EUR J NEUROSCI, V19, P755, DOI 10.1111/j.1460-9568.2004.03108.x; Li DP, 2017, J NEUROSCI, V37, P10690, DOI 10.1523/JNEUROSCI.2141-17.2017; Li DP, 2014, J NEUROSCI, V34, P4309, DOI 10.1523/JNEUROSCI.4295-13.2014; Li LY, 2016, CELL REP, V15, P1376, DOI 10.1016/j.celrep.2016.04.039; Luo Y, 2018, STROKE, V49, P2464, DOI 10.1161/STROKEAHA.118.022330; Ma HJ, 2018, J NEUROSCI, V38, P6388, DOI 10.1523/JNEUROSCI.0447-18.2018; Ma HJ, 2018, J PHYSIOL-LONDON, V596, P4269, DOI 10.1113/JP276394; Mahon S, 2004, TRENDS NEUROSCI, V27, P460, DOI 10.1016/j.tins.2004.06.010; Moussa R, 2011, LEARN MEMORY, V18, P444, DOI 10.1101/lm.2123811; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Packard MG, 1997, BEHAV NEUROSCI, V111, P543, DOI 10.1037/0735-7044.111.3.543; Palencia CA, 2004, NEUROBIOL LEARN MEM, V82, P81, DOI 10.1016/j.nlm.2004.04.004; Park H, 2014, NEURON, V84, P1009, DOI 10.1016/j.neuron.2014.10.045; Partridge JG, 2000, J NEUROPHYSIOL, V84, P1422, DOI 10.1152/jn.2000.84.3.1422; Patel TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00349; Pennartz CMA, 2009, J NEUROSCI, V29, P12831, DOI 10.1523/JNEUROSCI.3177-09.2009; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Schumacher TB, 1998, EPILEPSIA, V39, P355, DOI 10.1111/j.1528-1157.1998.tb01387.x; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Taylor CP, 2008, NEUROSCIENCE, V155, P510, DOI 10.1016/j.neuroscience.2008.05.053; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Tovar KR, 2002, NEURON, V34, P253; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Yin HH, 2005, EUR J NEUROSCI, V22, P505, DOI 10.1111/j.1460-9568.2005.04219.x; Yin HH, 2004, LEARN MEMORY, V11, P459, DOI 10.1101/lm.81004; Zhang FX, 2018, CELL REP, V22, P1956, DOI 10.1016/j.celrep.2018.01.073; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010; Zhou JJ, 2015, NEUROPHARMACOLOGY, V99, P481, DOI 10.1016/j.neuropharm.2015.08.012	62	24	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19354	19364		10.1074/jbc.RA118.003977	http://dx.doi.org/10.1074/jbc.RA118.003977			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	HE6RA	30355732	hybrid, Green Published			2022-12-26	WOS:000453537300017
J	Abramowicz, A; Marczak, L; Wojakowska, A; Zapotoczny, S; Whiteside, TL; Widlak, P; Pietrowska, M				Abramowicz, Agata; Marczak, Lukasz; Wojakowska, Anna; Zapotoczny, Szczepan; Whiteside, Theresa L.; Widlak, Piotr; Pietrowska, Monika			Harmonization of exosome isolation from culture supernatants for optimized proteomics analysis	PLOS ONE			English	Article							PROTEIN; CARGO; RNA	Exosomes, the smallest subset of extracellular vesicles (EVs), have recently attracted much attention in the scientific community. Their involvement in intercellular communication and molecular reprogramming of different cell types created a demand for a stringent characterization of the proteome which exosomes carry and deliver to recipient cells. Mass spectrometry (MS) has been extensively used for exosome protein profiling. Unfortunately, no standards have been established for exosome isolation and their preparation for MS, leading to accumulation of artefactual data. These include the presence of high-abundance exosome-contaminating serum proteins in culture media which mask low-abundance exosome-specific components, isolation methods that fail to yield "pure" vesicles or variability in protein solubilization protocols. There is an unmet need for the development of standards for exosome generation, harvesting, and isolation from cellular supernatants and for optimization of protein extraction methods before proteomics analysis by MS. In this communication, we illustrate the existing problems in this field and provide a set of recommendations that are expected to harmonize exosome processing for MS and provide the faithful picture of the proteomes carried by exosomes. The recommended workflow for effective and specific identification of proteins in exosomes released by the low number of cells involves culturing cells in medium with a reduced concentration of exosome-depleted serum, purification of exosomes by size-exclusion chromatography, a combination of different protein extraction method and removal of serum-derived proteins from the final dataset using an appropriate sample of cell-unexposed medium as a control. Application of this method allowed detection of >250 vesicle-specific proteins in exosomes from 10 mL of culture medium.	[Abramowicz, Agata; Wojakowska, Anna; Widlak, Piotr; Pietrowska, Monika] Maria Sklodowska Curie Inst, Gliwice Branch, Oncol Ctr, Gliwice, Poland; [Marczak, Lukasz] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Zapotoczny, Szczepan] Jagiellonian Univ, Fac Chem, Krakow, Poland; [Whiteside, Theresa L.] Univ Pittsburgh, Sch Med, Dept Pathol Immunol & Otolaryngol, Pittsburgh, PA USA; [Whiteside, Theresa L.] UPMC Hillman Canc Ctr, Pittsburgh, PA USA	Maria Sklodowska-Curie National Research Institute of Oncology; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Jagiellonian University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pietrowska, M (corresponding author), Maria Sklodowska Curie Inst, Gliwice Branch, Oncol Ctr, Gliwice, Poland.	monika.pietrowska@io.gliwice.pl	Widlak, Piotr/AAL-8075-2021; Wojakowska, Anna/C-2075-2013; Zapotoczny, Szczepan/A-4987-2012; Marczak, Lukasz/C-9069-2011	Widlak, Piotr/0000-0001-5099-4726; Wojakowska, Anna/0000-0002-4541-1239; Zapotoczny, Szczepan/0000-0001-6662-7621; Marczak, Lukasz/0000-0001-8602-0077; Pietrowska, Monika/0000-0001-9317-7822; Abramowicz, Agata/0000-0002-7826-9398	National Science Centre, Poland [2013/11/B/NZ7/01512]; National Institutes of Health [R0-1 CA168628, R21 CA205644]; NATIONAL CANCER INSTITUTE [R01CA168628, R21CA205644] Funding Source: NIH RePORTER	National Science Centre, Poland(National Science Centre, Poland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Science Centre, Poland, Grant 2013/11/B/NZ7/01512. TLW was supported in part by National Institutes of Health, Grants R0-1 CA168628 and R21 CA205644. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowicz A, 2016, MOL BIOSYST, V12, P1407, DOI 10.1039/c6mb00082g; Alvarez ML, 2012, KIDNEY INT, V82, P1024, DOI 10.1038/ki.2012.256; Baranyai T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145686; Benedikter BJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15717-7; Caradec J, 2014, CLIN BIOCHEM, V47, P1286, DOI 10.1016/j.clinbiochem.2014.06.011; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Greening DW, 2017, EXPERT REV PROTEOMIC, V14, P69, DOI 10.1080/14789450.2017.1260450; Gupta A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-68; Hong CS, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.29289; Kalra H, 2013, PROTEOMICS, V13, P3354, DOI 10.1002/pmic.201300282; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Pathan M, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1321455; Pietrowska M, 2017, METHODS MOL BIOL, V1654, P291, DOI 10.1007/978-1-4939-7231-9_22; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rosa-Fernandes L, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00102; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tosar JP, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2016.1272832; Wei ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep31175; Whiteside TL, 2015, EXPERT REV MOL DIAGN, V15, P1293, DOI 10.1586/14737159.2015.1071666; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xiao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089534; Zhu L, 2017, THERANOSTICS, V7, P2732, DOI 10.7150/thno.18752	24	23	23	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205496	10.1371/journal.pone.0205496	http://dx.doi.org/10.1371/journal.pone.0205496			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379855	Green Published, gold, Green Submitted			2022-12-26	WOS:000448823700050
J	Fu, JY; Wan, YL; Huang, TY; Wu, CF; Liu, YH; Hsieh, MJ; Wu, YC; Wu, CY				Fu, Jui-Ying; Wan, Yung-Liang; Huang, Tzu-Yen; Wu, Ching-Feng; Liu, Yun-Hen; Hsieh, Ming-Ju; Wu, Yi-Cheng; Wu, Ching-Yang			Correlation between image characteristics and pathologic findings in non small cell lung cancer patients after anatomic resection	PLOS ONE			English	Article							GROUND-GLASS OPACITY; SECTION COMPUTED-TOMOGRAPHY; ONCOLOGY GROUP 0201; 1ST-LINE TREATMENT; PROGNOSTIC IMPACT; OPEN-LABEL; ADENOCARCINOMA; TRIAL; AFATINIB; CHEMOTHERAPY	Introduction Tumor characteristics in computed tomography (CT) are correlated to pathologic presentation and survival. However, most studies have been based on thin slice thickness CT while lymph node metastatic pattern has remained unclear. The aim of this study was to analyze the correlation between image characteristics under 5 mm slice thickness and pathology findings in non small lung cancer patients who have received curative resection. Materials and methods From January 2010 to May 2014, 440 patients who underwent curative resection were included and medical records were reviewed retrospectively. The tumor size and consolidation tumor ratio were simultaneously evaluated and measured by a physician, a thoracic surgeon, and a radiologist. The correlation between image and pathology characteristics and its survival impact was analyzed. Results Tumor sizes, as measured by CT and by pathologic measurement were highly coincident. (p < 0.001) GGO predominant lesions were correlated to well-differentiated adenocarcinoma, (p< 0.001), and less tumor necrosis (p<0.0001), lymphocyte infiltration (p = 0.0042) and tumor purity (p <0.0001). In addition, less risk of visceral pleura (p < 0.0001) and angio-lymphatic invasion, and fewer metastases to N1 lymph node (p = 0.004) involvement were identified. No lymph node metastasis (0/12) was identified in sub-centimeter pure GGO lesion. The consolidation tumor ratio could be used to differentiate patients' survival and excellent 5-year overall survival was identified in pure GGO lesion cases. Conclusion No lymph node metastasis was identified in sub-centimeter pure GGO lesion. The consolidation tumor ratio could be used to differentiate patients' disease status and overall survival, while excellent 5-year overall survival was identified in cases with pure GGO lesion.	[Fu, Jui-Ying; Wan, Yung-Liang; Huang, Tzu-Yen; Wu, Ching-Feng; Liu, Yun-Hen; Hsieh, Ming-Ju; Wu, Yi-Cheng; Wu, Ching-Yang] Chang Gung Univ, Taoyuan, Taiwan; [Fu, Jui-Ying] Chang Gung Mem Hosp Linkou, Dept Internal Med, Div Pulm & Crit Care, Taoyuan, Taiwan; [Wan, Yung-Liang] Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent Chang Gung Mem Hosp, Taoyuan, Taiwan; [Huang, Tzu-Yen] Chang Gung Mem Hosp Keelung, Dept Surg, Div Thorac & Cardiovasc Surg, Keelung, Taiwan; [Wu, Ching-Feng; Liu, Yun-Hen; Hsieh, Ming-Ju; Wu, Yi-Cheng; Wu, Ching-Yang] Chang Gung Mem Hosp Linkou, Dept Surg, Div Thorac & Cardiovasc Surg, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Wu, CY (corresponding author), Chang Gung Univ, Taoyuan, Taiwan.; Wu, CY (corresponding author), Chang Gung Mem Hosp Linkou, Dept Surg, Div Thorac & Cardiovasc Surg, Taoyuan, Taiwan.	wu.chingyang@gmail.com	Wu, Ching Feng/ABE-6562-2020; Fu, JY/GRR-6179-2022; Hsieh, Ming-Ju/AAY-2569-2021	Hsieh, Ming-Ju/0000-0003-2450-4257; Wu, Ching-Yang/0000-0002-3838-6717				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Asamura H, 2003, ANN THORAC SURG, V76, P1016, DOI 10.1016/S0003-4975(03)00835-X; Asamura H, 2013, J THORAC CARDIOV SUR, V146, P24, DOI 10.1016/j.jtcvs.2012.12.047; Berry MF, 2018, CLIN LUNG CANCER, V19, pE47, DOI 10.1016/j.cllc.2017.06.020; Boedeker KL, 2007, PHYS MED BIOL, V52, P4027, DOI 10.1088/0031-9155/52/14/002; Detterbeck FC, 2017, CHEST, V151, P193, DOI 10.1016/j.chest.2016.10.010; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fukui T, 2009, LUNG CANCER, V66, P309, DOI 10.1016/j.lungcan.2009.03.004; Funama Y, 2009, J COMPUT ASSIST TOMO, V33, P49, DOI 10.1097/RCT.0b013e31815e6291; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Giaccone G, 2008, ANN ONCOL, V19, P1219, DOI 10.1093/annonc/mdn048; Gomez-Caro A, 2012, EUR J CARDIO-THORAC, V42, P93, DOI 10.1093/ejcts/ezr272; Hattori A, 2017, ANN THORAC SURG, V104, P313, DOI 10.1016/j.athoracsur.2017.01.076; Hattori A, 2017, J THORAC ONCOL, V12, P954, DOI 10.1016/j.jtho.2017.02.015; Katakami N, 2013, J CLIN ONCOL, V31, P3335, DOI 10.1200/JCO.2012.45.0981; Kudo Y, 2015, LUNG CANCER, V90, P47, DOI 10.1016/j.lungcan.2015.07.007; Lv YG, 2017, EUR REV MED PHARMACO, V21, P3212; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Roshandel G, 2014, ANN GLOB HEALTH, V80, P346, DOI 10.1016/j.aogh.2014.09.012; Si MJ, 2016, EUR J RADIOL, V85, P1708, DOI 10.1016/j.ejrad.2016.07.012; Soria JC, 2015, LANCET ONCOL, V16, P897, DOI 10.1016/S1470-2045(15)00006-6; Sun FH, 2018, J THORAC CARDIOV SUR, V156, P808, DOI 10.1016/j.jtcvs.2018.02.110; Suzuki K, 2006, ANN THORAC SURG, V81, P413, DOI 10.1016/j.athoracsur.2005.07.058; Suzuki K, 2011, J THORAC ONCOL, V6, P751, DOI 10.1097/JTO.0b013e31821038ab; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Tsutani Y, 2014, CHEST, V145, P66, DOI 10.1378/chest.13-1094; Wu CY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002013; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yang JCH, 2012, LANCET ONCOL, V13, P539, DOI 10.1016/S1470-2045(12)70086-4; Yasuda I, 2009, RESPIRATION, V78, P423, DOI 10.1159/000235544; Yasufuku K, 2011, J THORAC CARDIOV SUR, V142, P1393, DOI 10.1016/j.jtcvs.2011.08.037; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	37	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206386	10.1371/journal.pone.0206386	http://dx.doi.org/10.1371/journal.pone.0206386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379929	Green Published, Green Submitted			2022-12-26	WOS:000448823700106
J	Gorresen, PM; Brinck, KW; DeLisle, MA; Montoya-Aiona, K; Pinzari, CA; Bonaccorso, FJ				Gorresen, P. Marcos; Brinck, Kevin W.; DeLisle, Megan A.; Montoya-Aiona, Kristina; Pinzari, Corinna A.; Bonaccorso, Frank J.			Multi-state occupancy models of foraging habitat use by the Hawaiian hoary bat (Lasiurus cinereus semotus)	PLOS ONE			English	Article							SPECIES OCCURRENCE DYNAMICS; IMPERFECT DETECTION; INSECTIVOROUS BAT; MYOTIS-LUCIFUGUS; EPTESICUS-FUSCUS; MULTIPLE STATES; ECHOLOCATION; POPULATIONS; FOREST; PREY	Multi-state occupancy modeling can often improve assessments of habitat use and site quality when animal activity or behavior data are available. We examine the use of the approach for evaluating foraging habitat suitability of the endangered Hawaiian hoary bat (Lasiurus cinereus semotus) from classifications of site occupancy based on flight activity levels and feeding behavior. In addition, we used data from separate visual and auditory sources, namely thermal videography and acoustic (echolocation) detectors, jointly deployed at sample sites to compare the effectiveness of each method in the context of occupancy modeling. Video-derived observations demonstrated higher and more accurate estimates of the prevalence of high bat flight activity and feeding events than acoustic sampling methods. Elevated levels of acoustic activity by Hawaiian hoary bats were found to be related primarily to beetle biomass in this study. The approach may have a variety of applications in bat research, including inference about species-resource relationships, habitat quality and the extent to which species intensively use areas for activities such as foraging.	[Gorresen, P. Marcos; Brinck, Kevin W.; DeLisle, Megan A.; Pinzari, Corinna A.] Univ Hawaii, Hawaii Cooperat Studies Unit, Hilo, HI 96720 USA; [Montoya-Aiona, Kristina; Bonaccorso, Frank J.] US Geol Survey, Pacific Isl Ecosyst Res Ctr, Hawaii Natl Pk, Volcano, HI USA	University of Hawaii System; University Hawaii Hilo; United States Department of the Interior; United States Geological Survey	Gorresen, PM (corresponding author), Univ Hawaii, Hawaii Cooperat Studies Unit, Hilo, HI 96720 USA.	mgorresen@usgs.gov		Gorresen, Paulo/0000-0002-0707-9212	Kawailoa Wind, LLC	Kawailoa Wind, LLC	Funding was provided by the Kawailoa Wind, LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kawailoa Wind, LLC, for funding and access to the study area and facilities. We are indebted to Ruth-Marie Stecker for the many hours of insect sorting. Paul Cryan, Brian Reichert and two anonymous reviewers provided valuable feedback on earlier versions of the manuscript. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P37; Arnett Edward B., 2013, P435; BELWOOD JJ, 1984, CAN J ZOOL, V62, P2113, DOI 10.1139/z84-306; BLACK HL, 1974, J MAMMAL, V55, P138, DOI 10.2307/1379263; Bogan M.A., 2003, MONITORING TRENDS BA; Bonaccorso FJ, 2015, J MAMMAL, V96, P64, DOI 10.1093/jmammal/gyu003; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carter TC, 2003, MONITORING TRENDS BA, P41; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Clare EL, 2014, MOL ECOL, V23, P3633, DOI 10.1111/mec.12519; Clare EL, 2014, MOL ECOL, V23, P3618, DOI 10.1111/mec.12542; Collen B, 2012, ZOOLOGICAL SOC LONDO; Corcoran AJ, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0441; Corcoran AJ, 2017, ANIM BEHAV, V132, P291, DOI 10.1016/j.anbehav.2017.08.018; de Oliveira LQ, 2015, J MAMMAL, V96, P1036, DOI 10.1093/jmammal/gyv108; Efford MG, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00308.1; Fukui D, 2006, J ANIM ECOL, V75, P1252, DOI 10.1111/j.1365-2656.2006.01146.x; Gonsalves L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064081; Gorresen PM, 2008, J MAMMAL, V89, P11, DOI 10.1644/07-MAMM-A-022.1; Gorresen PM, 2017, ECOL EVOL, V7, P6669, DOI 10.1002/ece3.3196; Gorresen PM, 2015, 064 U HAW HIL HAW CO; Griffin D.R., 1958, LISTENING DARK ACOUS; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; HARTLEY DJ, 1992, J ACOUST SOC AM, V91, P1133, DOI 10.1121/1.402640; Jacobs DS, 1999, CAN J ZOOL, V77, P1603, DOI 10.1139/cjz-77-10-1603; Jensen T, 2013, CAN J FISH AQUAT SCI, V70, P1429, DOI 10.1139/cjfas-2013-0011; KICK SA, 1984, J NEUROSCI, V4, P2725; Krebs CJ, 1972, ECOLOGY EXPT ANAL DI; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; KURTA A, 1989, PHYSIOL ZOOL, V62, P804, DOI 10.1086/physzool.62.3.30157928; Latif QS, 2016, J WILDLIFE MANAGE, V80, P192, DOI 10.1002/jwmg.1022; MacKenzie DI, 2011, METHODS ECOL EVOL, V2, P612, DOI 10.1111/j.2041-210X.2011.00110.x; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mcclintock BT, 2010, J WILDLIFE MANAGE, V74, P1882, DOI 10.2193/2009-321; Mykleseth K., 2017, HONOLULU STAR A 0114; Nebel S, 2010, AVIAN CONSERV ECOL, V5; Nichols JD, 2007, ECOLOGY, V88, P1395, DOI 10.1890/06-1474; NORBERG UM, 1976, J EXP BIOL, V64, P489; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Nurul-Ain E, 2017, BIOTROPICA, V49, P382, DOI 10.1111/btp.12430; O'Farrell MJ, 1999, J MAMMAL, V80, P24, DOI 10.2307/1383204; Pauli BP, 2017, J WILDLIFE MANAGE, V81, P878, DOI 10.1002/jwmg.21251; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Rodhouse TJ, 2015, DIVERS DISTRIB, V21, P1401, DOI 10.1111/ddi.12372; Rodhouse TJ, 2012, ECOL APPL, V22, P1098, DOI 10.1890/11-1662.1; RYDELL J, 1993, J MAMMAL, V74, P503, DOI 10.2307/1382411; SALCEDO HD, 1995, J EXP BIOL, V198, P2245; Todd CM, 2012, THESIS; Tomich PQ, 1986, BISHOP MUSEUM SPECIA; Valdez EW, 2013, WEST N AM NATURALIST, V73, P516, DOI 10.3398/064.073.0404; Valdez EW, 2009, SOUTHWEST NAT, V54, P195, DOI 10.1894/PS-45.1; Weller TJ, 2007, J WILDLIFE MANAGE, V71, P251, DOI 10.2193/2005-384; Weller TJ, 2012, J WILDLIFE MANAGE, V76, P619, DOI 10.1002/jwmg.260; WHITAKER JO, 1983, J MAMMAL, V64, P151, DOI 10.2307/1380766; Wilcox A, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cov070	58	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205150	10.1371/journal.pone.0205150	http://dx.doi.org/10.1371/journal.pone.0205150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379835	Green Submitted, gold, Green Published			2022-12-26	WOS:000448823700028
J	Weller, TJ; Rodhouse, TJ; Neubaum, DJ; Ormsbee, PC; Dixon, RD; Popp, DL; Williams, JA; Osborn, SD; Rogers, BW; Beard, LO; McIntire, AM; Hersey, KA; Tobin, A; Bjornlie, NL; Foote, J; Bachen, DA; Maxell, BA; Morrison, ML; Thomas, SC; Oliver, GV; Navo, KW				Weller, Theodore J.; Rodhouse, Thomas J.; Neubaum, Daniel J.; Ormsbee, Patricia C.; Dixon, Rita D.; Popp, Diana L.; Williams, Jason A.; Osborn, Scott D.; Rogers, Bruce W.; Beard, Laura O.; McIntire, Angela M.; Hersey, Kimberly A.; Tobin, Abigail; Bjornlie, Nichole L.; Foote, Jennifer; Bachen, Dan A.; Maxell, Bryce A.; Morrison, Michael L.; Thomas, Shawn C.; Oliver, George V.; Navo, Kirk W.			A review of bat hibernacula across the western United States: Implications for white-nose syndrome surveillance and management	PLOS ONE			English	Review							BIG-EARED BAT; CORYNORHINUS-TOWNSENDII; FIELD IDENTIFICATION; MYOTIS-LUCIFUGUS; ROOST SELECTION; ROCK CREVICES; WINTER; DISEASE; CAVES; DESTRUCTANS	Efforts to conserve bats in the western United States have long been impeded by a lack of information on their winter whereabouts, particularly bats in the genus Myotis. The recent arrival of white-nose syndrome in western North America has increased the urgency to characterize winter roost habitats in this region. We compiled 4,549 winter bat survey records from 2,888 unique structures across 11 western states. Myotis bats were reported from 18.5% of structures with 95% of aggregations composed of <= 10 individuals. Only 11 structures contained >= 100 Myotis individuals and 6 contained >= 500 individuals. Townsend's bigeared bat (Corynorhinus townsendii) were reported from 38% of structures, with 72% of aggregations composed of <= 10 individuals. Aggregations of >= 100 Townsend's big-eared bats were observed at 41 different caves or mines across 9 states. We used zero-inflated negative binomial regression to explore biogeographic patterns of winter roost counts. Myotis counts were greater in caves than mines, in more recent years, and in more easterly longitudes, northerly latitudes, higher elevations, and in areas with higher surface temperatures and lower precipitation. Townsend's big-eared bat counts were greater in caves, during more recent years, and in more westerly longitudes. Karst topography was associated with higher Townsend's big-eared bat counts but did not appear to influence Myotis counts. We found stable or slightly-increasing trends over time in counts for both Myotis and Townsend's big-eared bats from 82 hibernacula surveyed >= 5 winters since 1990. Highly-dispersed winter roosting of Myotis in the western USA complicates efforts to monitor population trends and impacts of disease. However, our results reveal opportunities to monitor winter population status of Townsend's big-eared bats across this region.	[Weller, Theodore J.] US Forest Serv, USDA, Pacific Southwest Res Stn, Arcata, CA 95521 USA; [Rodhouse, Thomas J.] Natl Pk Serv, Upper Columbia Basin Network, Bend, OR USA; [Neubaum, Daniel J.] Colorado Pk & Wildlife, Terr Sect, Grand Junction, CO USA; [Ormsbee, Patricia C.] US Forest Serv, USDA, Pacific Northwest Reg, Eugene, OR USA; [Dixon, Rita D.] Idaho Dept Fish & Game, Boise, ID USA; [Popp, Diana L.] Oregon State Univ, Human & Ecosyst Resiliency & Sustainabil Lab, Cascades Campus, Bend, OR USA; [Williams, Jason A.] Nevada Dept Wildlife, Ely, NV USA; [Osborn, Scott D.] Calif Dept Fish & Wildlife, Nongame Wildlife Program, Wildlife Branch, Sacramento, CA USA; [Rogers, Bruce W.] Western Cave Conservancy, Newcastle, CA USA; [Beard, Laura O.; Bjornlie, Nichole L.] Wyoming Game & Fish Dept, Nongame Program, Lander, WY USA; [McIntire, Angela M.] Arizona Game & Fish Dept, Phoenix, AZ USA; [Hersey, Kimberly A.; Oliver, George V.] Utah Div Wildlife Resources, Salt Lake City, UT USA; [Tobin, Abigail] Washington Dept Fish & Wildlife, Olympia, WA USA; [Foote, Jennifer] Natl Speleol Soc, Santa Fe, NM USA; [Bachen, Dan A.; Maxell, Bryce A.] Montana Nat Heritage Program, Helena, MT USA; [Morrison, Michael L.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Thomas, Shawn C.] Bat Conservat Int, Subterranean Program, Olympia, WA USA; [Navo, Kirk W.] Colorado Div Wildlife, Monte Vista, CO USA; [Navo, Kirk W.] Head First Biol LLC, Loveland, CO USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; United States Department of Agriculture (USDA); United States Forest Service; Oregon State University; Oregon State University Cascades; Washington Department of Fish & Wildlife (WDFW); Texas A&M University System; Texas A&M University College Station	Weller, TJ (corresponding author), US Forest Serv, USDA, Pacific Southwest Res Stn, Arcata, CA 95521 USA.	tweller@fs.fed.us		Rodhouse, Thomas/0000-0001-5953-9113				[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barbour R.W., 1969, BATS AM; Barclay RMR, 2003, BAT ECOLOGY, P209; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boyles JG, 2006, MAMMAL REV, V36, P267, DOI 10.1111/j.1365-2907.2006.00095.x; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Call RS, 2018, NORTHWEST SCI, V92, P158, DOI 10.3955/046.092.0201; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Ellison L.E., 2003, MONITORING BAT POPUL, P127; Ellison Laura E., 2010, Northwestern Naturalist, V91, P172; Falxa Greg, 2007, Northwestern Naturalist, V88, P98, DOI 10.1898/1051-1733(2007)88[98:WFOSAC]2.0.CO;2; Flory AR, 2012, J APPL ECOL, V49, P680, DOI 10.1111/j.1365-2664.2012.02129.x; Frick WF, 2015, GLOBAL ECOL BIOGEOGR, V24, P741, DOI 10.1111/geb.12290; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gelman A., 2007, DATA ANAL USING REGR; GENTER DL, 1986, GREAT BASIN NAT, V46, P241; Graening G.O., 2011, Publications of the Oklahoma Biological Survey, V11, P1; Haines DE, 1998, ENVIRON ECOL STAT, V5, P245, DOI 10.1023/A:1009673403664; Hayes John P., 2009, P112; Hayes MA, 2011, J WILDLIFE MANAGE, V75, P137, DOI 10.1002/jwmg.6; Hayman DTS, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500831; Hendricks P, 2000, CAN FIELD NAT, V114, P89; Hendricks Paul, 2012, Northwestern Naturalist, V93, P154; Hilbe J., 2011, NEGATIVE BINOMIAL RE; HUMPHREY SR, 1975, J MAMMAL, V56, P321, DOI 10.2307/1379364; HUPPERT GN, 1995, ENVIRON GEOL, V26, P121, DOI 10.1007/BF00768325; Ingersoll TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065907; Ingersoll TE, 2010, J MAMMAL, V91, P1242, DOI 10.1644/09-MAMM-A-288.1; Johnson JS, 2017, J MAMMAL, V98, P211, DOI 10.1093/jmammal/gyw175; Kalcounis-Ruppell MC, 2005, WILDLIFE SOC B, V33, P1123, DOI 10.2193/0091-7648(2005)33[1123:TRSBBA]2.0.CO;2; Klug-Baerwald BJ, 2017, J MAMMAL, V98, P752, DOI 10.1093/jmammal/gyx039; Knudsen GR, 2013, NORTHWEST SCI, V87, P292, DOI 10.3955/046.087.0401; Kuenzi AJ, 1999, GREAT BASIN NAT, V59, P213; Lacki M.J., 2007, BATS FORESTS CONSERV; Langwig KE, 2015, EMERG INFECT DIS, V21, P1023, DOI 10.3201/eid2106.150123; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Lausen CL, 2006, CAN J ZOOL, V84, P1079, DOI 10.1139/Z06-093; Lemen Cliff A., 2016, Transactions of the Nebraska Academy of Sciences, V36, P9; LOEB S. C., 2015, GEN TECHNICAL REPORT; Lorch JM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00148-16; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Maher SP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2301; McIntire A, 2012, 5 ANN WHIT NOS SYNDR, P19; Michaels D, 2016, OUTDOOR CALIFORNIA, V77, P8; Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001; Moosman P.R., 2015, NORTHEAST NAT, V22, P1; Navo K.W., 2018, COLORADO BAT CONSERV; Neubaum DJ, 2017, J FISH WILDL MANAG, V8, P272, DOI 10.3996/102015-JFWM-107; Neubaum DJ, 2006, J MAMMAL, V87, P470, DOI 10.1644/05-MAMM-A-252R1.1; O'Shea TJ, 2016, MAMMAL REV, V46, P175, DOI 10.1111/mam.12064; Ormsbee PC, 2011, 2011 WHIT NOS SYNDR, P20; Perkins J.M., 1990, Northwestern Naturalist, V71, P59, DOI 10.2307/3536594; PIERSON E.D, 1999, SPECIES CONSERVATION; Pierson Elizabeth D., 1998, P309; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Ransome R., 1990, NATURAL HIST HIBERNA; Rodhouse TJ, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1576; Rodhouse TJ, 2008, WEST N AM NATURALIST, V68, P437, DOI 10.3398/1527-0904-68.4.437; Rodriguez RM, 2004, J MAMMAL, V85, P842, DOI 10.1644/1545-1542(2004)085<0842:MDDDNR>2.0.CO;2; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sherwin RE, 2000, J MAMMAL, V81, P939, DOI 10.1644/1545-1542(2000)081<0939:RAOTSB>2.0.CO;2; Sherwin RE, 2003, WILDLIFE SOC B, V31, P62; Skaug H., 2016, R PACKAGE VERSION 0; Thogmartin WE, 2012, J MAMMAL, V93, P1086, DOI 10.1644/11-MAMM-A-355.1; Thompson S.K., 2012, SAMPLING, V2nd; Twente JW, 1960, P UT AC SCI ARTS LET, P67; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Vonhof MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128713; Wainwright James M., 2013, Northwestern Naturalist, V94, P240; WEARY DJ, 2014, USGS OPEN-FILE REP, V1156, P1, DOI DOI 10.3133/ofr20141156; Weller TJ, 2007, ACTA CHIROPTEROL, V9, P133, DOI 10.3161/1733-5329(2007)9[133:FIOTCV]2.0.CO;2; Weller TJ, 2014, J FISH WILDL MANAG, V5, P59, DOI 10.3996/022014-JFWM-012; Weller Theodore J., 2009, Endangered Species Research, V8, P129, DOI 10.3354/esr00149; Whiting JC, 2018, WEST N AM NATURALIST, V78, P165, DOI 10.3398/064.078.0207; Wilder AP, 2015, MOL ECOL, V24, P5495, DOI 10.1111/mec.13396; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zuur Alain F., 2009, P1	77	23	23	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0205647	10.1371/journal.pone.0205647	http://dx.doi.org/10.1371/journal.pone.0205647			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	30379854	Green Published, Green Submitted, gold			2022-12-26	WOS:000448823700059
J	Bittrich, S; Schroeder, M; Labudde, D				Bittrich, Sebastian; Schroeder, Michael; Labudde, Dirk			Characterizing the relation of functional and Early Folding Residues in protein structures using the example of aminoacyl-tRNA synthetases	PLOS ONE			English	Article							LEARNING VECTOR QUANTIZATION; STATE HYDROGEN-EXCHANGE; OPEN-SOURCE FRAMEWORK; TRANSITION-STATES; EXTRACTING INFORMATION; PREFERRED CONFORMATION; SEQUENCE ALIGNMENTS; SECONDARY STRUCTURE; BINDING-PROTEIN; ACID-SEQUENCE	Proteins are chains of amino acids which adopt a three-dimensional structure and are then able to catalyze chemical reactions or propagate signals in organisms. Without external influence, many proteins fold into their native structure, and a small number of Early Folding Residues (EFR) have previously been shown to initiate the formation of secondary structure elements and guide their respective assembly. Using the two diverse superfamilies of aminoacyl-tRNA synthetases (aaRS), it is shown that the position of EFR is preserved over the course of evolution even when the corresponding sequence conservation is small. Folding initiation sites are positioned in the center of secondary structure elements, independent of aaRS class. In class I, the predicted position of EFR resembles an ancient structural packing motif present in many seemingly unrelated proteins. Furthermore, it is shown that EFR and functionally relevant residues in aaRS are almost entirely disjoint sets of residues. The Start2Fold database is used to investigate whether this separation of EFR and functional residues can be observed for other proteins. EFR are found to constitute crucial connectors of protein regions which are distant at sequence level. Especially, these residues exhibit a high number of non-covalent residue-residue contacts such as hydrogen bonds and hydrophobic interactions. This tendency also manifests as energetically stable local regions, as substantiated by a knowledge-based potential. Despite profound differences regarding how EFR and functional residues are embedded in protein structures, a strict separation of structurally and functionally relevant residues cannot be observed for a more general collection of proteins.	[Bittrich, Sebastian; Labudde, Dirk] Univ Appl Sci Mittweida, Appl Comp Sci & Biosci, Mittweida, Saxony, Germany; [Bittrich, Sebastian; Schroeder, Michael] Tech Univ Dresden, Biotechnol Ctr BIOTEC, Dresden, Saxony, Germany	Technische Universitat Dresden	Bittrich, S (corresponding author), Univ Appl Sci Mittweida, Appl Comp Sci & Biosci, Mittweida, Saxony, Germany.; Bittrich, S (corresponding author), Tech Univ Dresden, Biotechnol Ctr BIOTEC, Dresden, Saxony, Germany.	sebastian.bittrich@hs-mittweida.de		Bittrich, Sebastian/0000-0003-3576-0387				Adhikari B, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1807-5; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; BALDWIN RL, 1995, J BIOMOL NMR, V5, P103; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bittrich S, 2015, DATABASES ARCHITECTU, P419; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Brodkin HR, 2015, PROTEIN SCI, V24, P762, DOI 10.1002/pro.2648; Burton M, 2005, BIOCHEM J, V392, P299, DOI 10.1042/BJ20050664; Bystrom R, 2010, J BIOL CHEM, V285, P19544, DOI 10.1074/jbc.M109.086074; Cammer S, 2010, BIOINFORMATICS, V26, P709, DOI 10.1093/bioinformatics/btq039; Carter Charles W Jr, 2017, Adv Exp Med Biol, V966, P103, DOI 10.1007/5584_2017_93; Carter CW, 2015, P NATL ACAD SCI USA; Chambers J.M., 2017, GRAPHICAL METHODS DA; CHAN HS, 1994, J CHEM PHYS, V100, P9238, DOI 10.1063/1.466677; Chu RA, 2002, BIOCHEMISTRY-US, V41, P7998, DOI 10.1021/bi025872n; Cilia E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3741; Consortium U, 2014, NUCLEIC ACIDS RES; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; Deane CM, 2007, BIOINFORMATICS, V23, pI142, DOI 10.1093/bioinformatics/btm175; DeGrado WF, 2003, PROTEIN SCI, V12, P647, DOI 10.1110/ps.0236503; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P8637, DOI 10.1073/pnas.122076099; Dyson HJ, 2017, ACCOUNTS CHEM RES, V50, P105, DOI 10.1021/acs.accounts.6b00511; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Englander SW, 2017, P NATL ACAD SCI USA, V114, P8253, DOI 10.1073/pnas.1706196114; Englander SW, 2014, P NATL ACAD SCI USA, V111, P15873, DOI 10.1073/pnas.1411798111; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Goluguri RR, 2016, J MOL BIOL, V428, P3102, DOI 10.1016/j.jmb.2016.06.015; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; Haglund E, 2012, J BIOL CHEM, V287, P2731, DOI 10.1074/jbc.M111.312447; Hammer B, 2002, NEURAL NETWORKS, V15, P1059, DOI 10.1016/S0893-6080(02)00079-5; Hecht M, 2013, J MOL BIOL, V425, P3937, DOI 10.1016/j.jmb.2013.07.028; Heinke F, 2013, NUCLEIC ACIDS RES, V41, pD320, DOI 10.1093/nar/gks1079; Hleap JS, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-20; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Hopf TA, 2017, NAT BIOTECHNOL, V35, P128, DOI 10.1038/nbt.3769; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jacobs TM, 2013, USING ANCHORING MOTI; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kastner M, 2012, NEUROCOMPUTING, V90, P85, DOI 10.1016/j.neucom.2011.11.029; Kaiser F, 2017, IEEE ACM T COMPUTATI; Kaiser F, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006101; Kaiser F, 2016, BIOINFORMATICS, V32, P792, DOI 10.1093/bioinformatics/btv637; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; Kapustina M, 2007, STRUCTURE, V15, P1272, DOI 10.1016/j.str.2007.08.010; KARPLUS M, 1994, PROTEIN SCI, V3, P650; KRAGELUND BB, 1993, J MOL BIOL, V230, P1260, DOI 10.1006/jmbi.1993.1240; Krishnan A, 2007, J PROTEOME RES, V6, P3924, DOI 10.1021/pr070162v; Larson SM, 2002, J MOL BIOL, V316, P225, DOI 10.1006/jmbi.2001.5344; LESK AM, 1981, P NATL ACAD SCI-BIOL, V78, P4304, DOI 10.1073/pnas.78.7.4304; Levy Y, 2017, BIOCHEMISTRY-US, V56, P5040, DOI 10.1021/acs.biochem.7b00666; Li RH, 1999, PROTEIN SCI, V8, P1571, DOI 10.1110/ps.8.8.1571; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Martinez-Rodriguez L, 2015, J BIOL CHEM, V290, P19710, DOI 10.1074/jbc.M115.642876; Mirny LA, 1998, P NATL ACAD SCI USA, V95, P4976, DOI 10.1073/pnas.95.9.4976; Myers JK, 2001, NAT STRUCT BIOL, V8, P552, DOI 10.1038/88626; Najmanovich RJ, 2017, CURR OPIN STRUC BIOL, V45, P85, DOI 10.1016/j.sbi.2016.11.024; Nickson AA, 2013, CURR OPIN STRUC BIOL, V23, P66, DOI 10.1016/j.sbi.2012.11.009; Nicolini C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19250; Nishimura C, 2000, NAT STRUCT BIOL, V7, P679, DOI 10.1038/77985; Nussinov R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-2; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Panchenko AR, 1996, P NATL ACAD SCI USA, V93, P2008, DOI 10.1073/pnas.93.5.2008; Pancsa R, 2016, BIOPHYS J, V110, P572, DOI 10.1016/j.bpj.2015.12.028; Pancsa R, 2016, NUCLEIC ACIDS RES, V44, pD429, DOI 10.1093/nar/gkv1185; Prlic A, 2012, BIOINFORMATICS, V28, P2693, DOI 10.1093/bioinformatics/bts494; Ptitsyn OB, 1999, J MOL BIOL, V291, P671, DOI 10.1006/jmbi.1999.2920; Raimondi D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08366-3; RODER H, 1988, NATURE, V335, P700, DOI 10.1038/335700a0; RODIN SN, 1995, ORIGINS LIFE EVOL B, V25, P565, DOI 10.1007/BF01582025; ROOMAN MJ, 1992, BIOCHEMISTRY-US, V31, P10239, DOI 10.1021/bi00157a010; ROOMAN MJ, 1992, BIOCHEMISTRY-US, V31, P10226, DOI 10.1021/bi00157a009; Rorick M, 2012, BIOSYSTEMS, V110, P22, DOI 10.1016/j.biosystems.2012.06.006; Rorick MM, 2011, GENOME BIOL EVOL, V3, P456, DOI 10.1093/gbe/evr046; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Royer L., 2008, PLOS COMPUTATIONAL B, V4, P7, DOI DOI 10.1371/J0URNAL.PCBI; Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9; Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084; Teilum K, 2000, J MOL BIOL, V301, P1307, DOI 10.1006/jmbi.2000.4003; Tseng YY, 2004, J MOL BIOL, V335, P869, DOI 10.1016/j.jmb.2003.11.007; Velankar S, 2013, NUCLEIC ACIDS RES, V41, pD483, DOI 10.1093/nar/gks1258; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weinreb V, 2009, STRUCTURE, V17, P952, DOI 10.1016/j.str.2009.05.007; Wolfenden R, 2015, P NATL ACAD SCI USA, V112, P7484, DOI 10.1073/pnas.1507565112; Wolynes PG, 1996, PROTEIN FOLDS, P3; Wong JTF, 2005, BIOESSAYS, V27, P416, DOI 10.1002/bies.20208	105	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2018	13	10							e0206369	10.1371/journal.pone.0206369	http://dx.doi.org/10.1371/journal.pone.0206369			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7AD	30376559	gold, Green Published, Green Submitted			2022-12-26	WOS:000448752400012
J	Somefun, OD; Odimegwu, C				Somefun, Oluwaseyi Dolapo; Odimegwu, Clifford			The protective role of family structure for adolescent development in sub-Saharan Africa	PLOS ONE			English	Article							EARLY SEXUAL DEBUT; REPRODUCTIVE HEALTH; YOUNG-PEOPLE; RISK-FACTORS; BEHAVIORS; PREGNANCY; IMPACT; YOUTH; MARRIAGE; ORPHANS	Several studies have focused on the risk factors associated with adolescent developmental outcomes, but the literature on the role of protective factors at the family and community level for positive adolescent development is scarce, especially in sub-Saharan Africa (SSA). We hypothesize that ensuring a supportive environment for adolescents may result in delayed sexual debut for adolescents in SSA. The relationship between family structure and positive adolescent sexual behaviour, measured as delay in sexual debut, was examined using the bioecological theory framed by a risk and resilience perspective. We used nationally representative data on female and male adolescents (aged 15-17 years) from 12 countries in SSA. We modelled logistic regressions to test for associations between family structure and delayed sexual debut while controlling for other covariates in SSA. The majority (90%) of the young adults delayed sexual debut, and this delay varied by family structure. After controlling for other covariates, adolescents living with neither parent had lower odds of delaying sexual debut although results were only significant for males. Interaction terms with community socio-economic status showed an interaction between community education and males living with neither parent. Future studies must investigate the gender differentials in the relationship between family structure and delayed sexual debut among adolescents in SSA.	[Somefun, Oluwaseyi Dolapo] Univ Witwatersrand, Fac Hlth Sci & Humanities, Sch Publ Hlth, Demog & Populat Studies Programme, Johannesburg, South Africa; Univ Witwatersrand, Fac Hlth Sci & Humanities, Sch Social Sci, Demog & Populat Studies Programme, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand	Somefun, OD (corresponding author), Univ Witwatersrand, Fac Hlth Sci & Humanities, Sch Publ Hlth, Demog & Populat Studies Programme, Johannesburg, South Africa.	seyi.somefun@gmail.com	Odimegwu, Clifford O./L-5589-2015	Odimegwu, Clifford O./0000-0002-6273-8807; Somefun, Oluwaseyi/0000-0002-3842-2685	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York [B 8606.R02]; Sida [54100029]; DELTAS Africa Initiative [107768/Z/15/Z]; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK) [107768/Z/15/Z]; UK government; AuthorAid	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York; Sida; DELTAS Africa Initiative; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK)(Wellcome Trust); UK government; AuthorAid	This research was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No-B 8606.R02), Sida (Grant No: 54100029), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) (Grant No: 107768/Z/15/Z) and the UK government. We also acknowledge AuthorAid for financial assistance in editing the manuscript, awarded to Miss Oluwaseyi Dolapo Somefun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2013, AFR HEALTH SCI, V13, P498, DOI 10.4314/ahs.v13i2.42; Agha S, 2004, J ADOLESCENT HEALTH, V34, P441, DOI [10.1016/j.jadohealth.2003.07.016, 10.1016/S1054-139X(03)00331-8]; Anderson S, 2014, APPL DEV SCI, V18, P123, DOI 10.1080/10888691.2014.924355; Babalola Stella, 2005, Afr J Reprod Health, V9, P49; Bastien S, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-25; Baumgartner JN, 2009, INT PERSPECT SEX R H, V35, P21, DOI 10.1363/ifpp.35.021.09; Becona E, 2013, PSICOTHEMA, V25; Biddlecom A, 2009, INT PERSPECT SEX R H, V35, P72, DOI 10.1363/ipsrh.35.072.09; BILLY JO, 1994, J MARRIAGE FAM, V56, P387, DOI 10.2307/353107; Braverman M. T., 2001, APPL RESILIENCE THEO; Calafat A, 2014, DRUG ALCOHOL DEPEN, V138, P185, DOI 10.1016/j.drugalcdep.2014.02.705; Caruthers AS, 2014, PREV SCI, V15, pS59, DOI 10.1007/s11121-013-0383-9; Christofides NJ, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18585; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Corcoran J., 2004, CHILD ADOLESC SOC WO, V21, P211, DOI [DOI 10.1023/B:CASW.0000028453.79719.65, 10.1023/B:CASW.0000028453.79719.65]; Crosnoe R, 2002, YOUTH SOC, V33, P515, DOI 10.1177/0044118X02033004002; Cubbin C, 2005, PERSPECT SEX REPRO H, V37, P125, DOI 10.1111/j.1931-2393.2005.tb00047.x; de Looze M, 2015, J SEX RES, V52, P257, DOI 10.1080/00224499.2013.858307; De Wet N, 2014, AJAR-AFR J AIDS RES, V13, P13, DOI 10.2989/16085906.2014.886605; Defo Barthelemy Kuate, 2012, Afr J Reprod Health, V16, P147; Erulkar AS, 2009, INT PERSPECT SEX R H, V35, P6, DOI 10.1363/ifpp.35.006.09; Fearon E, 2015, SOC SCI MED, V146, P62, DOI 10.1016/j.socscimed.2015.09.039; Fergus S, 2005, ANNU REV PUBL HEALTH, V26, P399, DOI 10.1146/annurev.publhealth.26.021304.144357; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Hardy SA, 2013, J APPL DEV PSYCHOL, V34, P131, DOI 10.1016/j.appdev.2012.12.002; Hillis Susan D, 2010, Perm J, V14, P18; KAO TSA, 2013, OPEN FAMILY STUDIES, V0005; Karim AM, 2003, INT FAM PLAN PERSPEC, V29, P14, DOI 10.2307/3180997; Kembo J, 2013, SAHARA J-J SOC ASP H, V10, P150, DOI 10.1080/17290376.2014.903620; Kim J, 2012, SEX HEALTH, V9, P459, DOI 10.1071/SH11124; Lawrence RS, 2009, IMPROVING SYSTEMS AD; Lenciauskiene I, 2008, SCAND J PUBLIC HEALT, V36, P607, DOI 10.1177/1403494807088460; Luseno W, 2015, AIDS CARE, V27, P1191, DOI 10.1080/09540121.2015.1036726; Madkour AS, 2014, J ADOLESCENT HEALTH, V55, P114, DOI 10.1016/j.jadohealth.2013.12.008; Marteleto LJ, 2016, STUD FAMILY PLANN, V47, P19, DOI 10.1111/j.1728-4465.2016.00048.x; Miller E, 2014, CONTRACEPTION, V89, P122, DOI 10.1016/j.contraception.2013.10.011; Mmari K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166032; Mmbaga EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041700; Neal S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2868-5; Odimegwu C, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0284-7; Oliveira-Campos M, 2013, ANN EPIDEMIOL, V23, P629, DOI 10.1016/j.annepidem.2013.03.009; Oljira L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-375; Palermo T, 2009, STUD FAMILY PLANN, V40, P101, DOI 10.1111/j.1728-4465.2009.00193.x; Peltzer K, 2010, ACTA PAEDIATR, V99, P1242, DOI 10.1111/j.1651-2227.2010.01874.x; Pilgrim NA, 2014, VULNERABLE CHILD YOU, V9, P193, DOI 10.1080/17450128.2013.842027; Pilgrim NA, 2012, J ADOLESCENT HEALTH, V50, P5, DOI 10.1016/j.jadohealth.2011.03.004; Richter L, 2015, SAMJ, S. Afr. med. j., V105, P304, DOI 10.7196/SAMJ.8925; Rivers SE, 2013, J COLL STUDENT DEV, V54, P172, DOI 10.1353/csd.2013.0012; Rutstein S.O., 2014, MAKING DEMOGRAPHIC H; Shai NJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-462; Telzer EH, 2014, J YOUTH ADOLESCENCE, V43, P270, DOI 10.1007/s10964-013-9941-5; Tenkorang EY, 2014, INT PERSPECT SEX R H, V40, P68, DOI 10.1363/4006814; Toska E, 2015, SEX HEALTH, V12, P59, DOI 10.1071/SH14089; Vagi KJ, 2013, J YOUTH ADOLESCENCE, V42, P633, DOI 10.1007/s10964-013-9907-7; West C, 2009, GENDER SOC, V23, P112, DOI 10.1177/0891243208326529; Zimmerman M. A., 2013, RESILIENCY THEORY ST	57	20	21	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206197	10.1371/journal.pone.0206197	http://dx.doi.org/10.1371/journal.pone.0206197			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY5SG	30372474	Green Published, gold, Green Submitted			2022-12-26	WOS:000448641200026
J	Adejoro, FA; Hassen, A; Thantsha, MS				Adejoro, Festus A.; Hassen, Abubeker; Thantsha, Mapitsi S.			Preparation of acacia tannin loaded lipid microparticles by solid-in-oil-in-water and melt dispersion methods, their characterization and evaluation of their effect on ruminal gas production In Vitro	PLOS ONE			English	Article							RUMEN FERMENTATION; CONDENSED TANNINS; AMINO-ACIDS; DIGESTIBILITY; RELEASE; DIGESTION; MICROENCAPSULATION; EMULSIONS; NITRATE; LIQUOR	Tannin extracts have wide biological activity in ruminant nutrition. The possibility of masking their bitter taste and enhancing sustained release in the rumen can be achieved through encapsulation. The objectives of this study were to prepare an encapsulated Acacia tannin extract (ATE) suitable for ruminants using the solid-in-oil-in-water (S/O/W) method, and to evaluate the microparticles in terms of morphology, encapsulation efficiency and in vitro release under varying pH. Subsequently, the effect of the microparticles on rumen in vitro gas and methane production would be evaluated. Lipid microparticles were prepared using the double emulsion process with palm oil and lard, dichloromethane, and Tween80/Span80 emulsifiers. The microparticles produced by S/O/W emulsion tended to be smaller (P= 0.06), and had greater encapsulation efficiency compared with those produced by the melt dispersion method. Scanning electron micrographs showed microparticles had stable cylindrical and spherical shapes, with mean size of 34 +/- 10.2 mu m. Maximum encapsulation efficiencies of 78.6% and 80.1% were obtained with lard and palm oil as lipid wall materials, respectively, even under high core material loading percentage of 80%. Wall material type did not affect the characteristics of microparticles. In acetate buffer, only about 20% of tannin was released from the lipid-encapsulated microparticles into buffer media after 24 hours. In contrast, about 90% of the tannin had been released into solution before eight hours in the crude extract. Lipid-encapsulated ATE reduced rumen gas and methane production in vitro (P <0.05) in both Eragrostis and total mixed ration (TMR) diet substrates, but the magnitude of reduction was lower than that obtained when unencapsulated ATE was the additive (10% vs 20% for total gas and 17% vs 24% for methane). Crude ATE and palm oil encapsulated ATE reduced the concentration of methane in sampled gas (P= 0.054) when fermenting the TMR substrate, but this effect was not observed in the Eragrostis substrate. Ammonia nitrogen concentration was greater in encapsulated ATE compared with the crude ATE (P <0.001). These results show that the lipid-encapsulated ATE produced small-sized and more uniform microparticles, with high encapsulation efficiency compared with microparticles prepared by melt dispersion. Encapsulation of ATE enhanced the sustained release of tannin in the rumen, and with the potential to improve gas production and reduce methane production.	[Adejoro, Festus A.; Hassen, Abubeker] Univ Pretoria, Dept Anim & Wildlife Sci, Pretoria, South Africa; [Thantsha, Mapitsi S.] Univ Pretoria, Dept Biochem Genet & Microbiol, Pretoria, South Africa	University of Pretoria; University of Pretoria	Hassen, A (corresponding author), Univ Pretoria, Dept Anim & Wildlife Sci, Pretoria, South Africa.	abubeker.hassen@up.ac.za	Adejoro, Festus Adeyemi Adeyemi/AAB-6260-2019; Thantsha, Mapitsi M.S./A-8546-2011; Hassen, Abubeker/AAC-1979-2020	Adejoro, Festus Adeyemi Adeyemi/0000-0002-2271-9847; Thantsha, Mapitsi M.S./0000-0002-6212-2770; Hassen, Abubeker/0000-0002-8240-3414	National research Foundation in South Africa [93401]	National research Foundation in South Africa(National Research Foundation - South Africa)	The research has received funding from National research Foundation in South Africa (93401 to AH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejoro FA, 2017, S AFR J ANIM SCI, V47, P168, DOI 10.4314/sajas.v47i2.8; Anal AK, 2007, TRENDS FOOD SCI TECH, V18, P240, DOI 10.1016/j.tifs.2007.01.004; Bainbridge M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164700; Benichou A, 2004, ADV COLLOID INTERFAC, V108, P29, DOI 10.1016/j.cis.2003.10.013; BERGER KG, 1982, J AM OIL CHEM SOC, V59, P244, DOI 10.1007/BF02582187; Borgogna M, 2010, FOOD CHEM, V122, P416, DOI 10.1016/j.foodchem.2009.07.043; BRODERICK GA, 1980, J DAIRY SCI, V63, P64, DOI 10.3168/jds.S0022-0302(80)82888-8; Calabro S, 2012, ANIM PHYSL ANIM NUTR, V96; CARRO MD, 1994, SMALL RUMINANT RES, V14, P9, DOI 10.1016/0921-4488(94)90003-5; Castellanos IJ, 2001, J PHARM PHARMACOL, V53, P167, DOI 10.1211/0022357011775361; Chanthakhoun V, 2012, ASIAN J ANIM VET ADV, V7, P54, DOI 10.3923/ajava.2012.54.60; Chime SA, 2013, J MICROENCAPSUL, V30, P335, DOI 10.3109/02652048.2012.726284; Ribeiro WLC, 2013, EXP PARASITOL, V135, P24, DOI 10.1016/j.exppara.2013.05.014; Dentinho MTP, 2014, SMALL RUMINANT RES, V119, P57, DOI 10.1016/j.smallrumres.2014.02.012; Dickinson E, 2011, FOOD BIOPHYS, V6, P1, DOI 10.1007/s11483-010-9188-6; Doreau M, 1997, BRIT J NUTR, V78, pS15, DOI 10.1079/BJN19970132; Dschaak CM, 2011, J DAIRY SCI, V94, P2508, DOI 10.3168/jds.2010-3818; Emanuele SM, 2006, RUM NUTR S FEBR 1 2, P1; Fang ZX, 2010, TRENDS FOOD SCI TECH, V21, P510, DOI 10.1016/j.tifs.2010.08.003; Hassanat F, 2013, J SCI FOOD AGR, V93, P332, DOI 10.1002/jsfa.5763; Ho KKY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174689; Huang XD, 2011, ANIM FEED SCI TECH, V166-67, P373, DOI 10.1016/j.anifeedsci.2011.04.026; Huang XD, 2010, ANIM FEED SCI TECH, V159, P81, DOI 10.1016/j.anifeedsci.2010.05.008; Huuskonen A, 2005, J DAIRY SCI, V88, P3575, DOI 10.3168/jds.S0022-0302(05)73042-3; Jayanegara A, 2012, J ANIM PHYSIOL AN N, V96, P365, DOI 10.1111/j.1439-0396.2011.01172.x; JEFFERY H, 1991, INT J PHARM, V77, P169, DOI 10.1016/0378-5173(91)90314-E; Jiao J, 2003, AAPS PHARMSCI, V5; Kamra D.N, 2012, DIETARY PHYTOCHEMICA, P351, DOI DOI 10.1007/978-94-007-3926-0_12; KHAZAAL K, 1995, ANIM SCI, V61, P527, DOI 10.1017/S1357729800014107; Krishnan S, 2005, CARBOHYD POLYM, V61, P95, DOI 10.1016/j.carbpol.2005.02.020; Makkar H, 1993, J SCI FOOD AGR, V73, P99; Mamvura CI, 2014, ASIAN AUSTRAL J ANIM, V27, P1577, DOI 10.5713/ajas.2014.14280; MENKE KH, 1979, J AGR SCI, V93, P217, DOI 10.1017/S0021859600086305; MIZUTANI K, 1988, FORENSIC SCI INT, V38, P113, DOI 10.1016/0379-0738(88)90015-1; Munin Aude, 2011, Pharmaceutics, V3, P793, DOI 10.3390/pharmaceutics3040793; Nakashima T, 2000, ADV DRUG DELIVER REV, V45, P47, DOI 10.1016/S0169-409X(00)00099-5; Naumann HD, 2014, VET PARASITOL, V199, P93, DOI 10.1016/j.vetpar.2013.09.025; Nazzaro F, 2012, CURR OPIN BIOTECH, V23, P182, DOI 10.1016/j.copbio.2011.10.001; ORSKOV ER, 1979, J AGR SCI, V92, P499, DOI 10.1017/S0021859600063048; Patra AK, 2010, J SCI FOOD AGR, V90, P2700, DOI 10.1002/jsfa.4143; PORTER LJ, 1985, PHYTOCHEMISTRY, V25, P223, DOI 10.1016/S0031-9422(00)94533-3; Putnam DE, 2005, MICROENCAPSULATION O, P207; Reithmeier H, 2001, J CONTROL RELEASE, V73, P339, DOI 10.1016/S0168-3659(01)00354-6; Richardson PH, 2004, United States of America: United States of America Patent Application, Patent No. [US6797291 B2, 6797291]; Rossi F, 2003, ANIM FEED SCI TECH, V108, P223, DOI 10.1016/S0377-8401(03)00131-7; Toorisaka E, 2003, INT J PHARM, V252, P271, DOI 10.1016/S0378-5173(02)00674-9; Veneman JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140282; Venkateswarlu V, 2004, J CONTROL RELEASE, V95, P627, DOI 10.1016/j.jconrel.2004.01.005; Wallace RJ, 2006, United United States of America Patent Application, Patent No. [WO2006040537 A1, 2006040537]; Wood TA, 2009, ANIM FEED SCI TECH, V152, P62, DOI 10.1016/j.anifeedsci.2009.03.006	50	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206241	10.1371/journal.pone.0206241	http://dx.doi.org/10.1371/journal.pone.0206241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3GT	30359451	Green Published, Green Submitted, gold			2022-12-26	WOS:000448438400056
J	Hammerschmidt, W; Kulke, L; Broering, C; Schacht, A				Hammerschmidt, Wiebke; Kulke, Louisa; Broering, Christina; Schacht, Annekathrin			Money or smiles: Independent ERP effects of associated monetary reward and happy faces	PLOS ONE			English	Article							FACIAL EXPRESSIONS; EMOTIONAL EXPRESSION; ATTENTION; ADVANTAGE; COMPONENT; N170	In comparison to neutral faces, facial expressions of emotion are known to gain attentional prioritization, mainly demonstrated by means of event-related potentials (ERPs). Recent evidence indicated that such a preferential processing can also be elicited by neutral faces when associated with increased motivational salience via reward. It remains, however, an open question whether impacts of inherent emotional salience and associated motivational salience might be integrated. To this aim, expressions and monetary outcomes were orthogonally combined. Participants (N = 42) learned to explicitly categorize happy and neutral faces as either reward- or zero-outcome-related via an associative learning paradigm. ERP components (P1, N170, EPN, and LPC) were measured throughout the experiment, and separately analyzed before (learning phase) and after (consolidation phase) reaching a pre-defined learning criterion. Happy facial expressions boosted early processing stages, as reflected in enhanced amplitudes of the N170 and EPN, both during learning and consolidation. In contrast, effects of monetary reward became evident only after successful learning and in form of enlarged amplitudes of the LPC, a component linked to higher-order evaluations. Interactions between expressions and associated outcome were absent in all ERP components of interest. The present study provides novel evidence that acquired salience impacts stimulus processing but independent of the effects driven by happy facial expressions.	[Hammerschmidt, Wiebke; Kulke, Louisa; Broering, Christina; Schacht, Annekathrin] Univ Goettingen, Inst Psychol, Affect Neurosci & Psychophysiol Lab, Gottingen, Germany; [Hammerschmidt, Wiebke; Kulke, Louisa; Schacht, Annekathrin] Primate Cognit, Leibniz Sci Campus, Gottingen, Germany	University of Gottingen	Schacht, A (corresponding author), Univ Goettingen, Inst Psychol, Affect Neurosci & Psychophysiol Lab, Gottingen, Germany.; Schacht, A (corresponding author), Primate Cognit, Leibniz Sci Campus, Gottingen, Germany.	schacht@psych.uni-goettingen.de	Kulke, Louisa/N-7842-2018	Kulke, Louisa/0000-0002-9696-8619; Schacht, Anne/0000-0001-9471-3842	German Research Foundation [SCHA1848/1-1]	German Research Foundation(German Research Foundation (DFG))	This research was funded by the German Research Foundation (http://www.dfg.de/; grant #SCHA1848/1-1 to AS).	Anderson BA, 2013, J VISION, V13, DOI 10.1167/13.3.7; Bayer M, 2017, SOC COGN AFFECT NEUR, V12, P146, DOI 10.1093/scan/nsw162; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bublatzky F, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00493; C ore Team R, 2012, R LANG ENV STAT COMP; Calvo MG, 2008, BEHAV RES METHODS, V40, P109, DOI 10.3758/BRM.40.1.109; Calvo MG, 2013, NEUROPSYCHOLOGIA, V51, P2051, DOI 10.1016/j.neuropsychologia.2013.07.010; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Della Libera C, 2006, PSYCHOL SCI, V17, P222; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Hammerschmidt W, 2018, NEUROIMAGE, V179, P557, DOI 10.1016/j.neuroimage.2018.06.055; Hammerschmidt W, 2017, NEUROIMAGE, V156, P466, DOI 10.1016/j.neuroimage.2017.04.032; Hinojosa JA, 2015, NEUROSCI BIOBEHAV R, V55, P498, DOI 10.1016/j.neubiorev.2015.06.002; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Kaltwasser L, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00168; KIRITA T, 1995, ACTA PSYCHOL, V89, P149, DOI 10.1016/0001-6918(94)00021-8; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P240, DOI 10.1111/j.1469-8986.2007.00611.x; Kulke L, 2017, BIORXIV, DOI [10.1101/240945, DOI 10.1101/240945]; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Liang F, 2008, J AM STAT ASSOC, V103, P410, DOI 10.1198/016214507000001337; Lin A, 2012, SOC COGN AFFECT NEUR, V7, P274, DOI 10.1093/scan/nsr006; Lundqvist D., 1998, KAROLINSKA DIRECTED; Marinkovic K, 1998, PSYCHOBIOLOGY, V26, P348; Morey RD, 2015, PACKAGE BAYESFACTOR; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pessoa L., 2015, BEHAV BRAIN SCI, V38, P1, DOI DOI 10.1017/S0140525X14001083; Pittig A, 2018, J BEHAV THER EXP PSY, V60, P69, DOI 10.1016/j.jbtep.2018.04.002; PIVIK RT, 1993, PSYCHOPHYSIOLOGY, V30, P547, DOI 10.1111/j.1469-8986.1993.tb02081.x; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Recio G, 2014, PSYCHOPHYSIOLOGY, V51, P789, DOI 10.1111/psyp.12220; Recio G, 2013, COGNITION EMOTION, V27, P1486, DOI 10.1080/02699931.2013.794128; Recio G, 2011, BRAIN RES, V1376, P66, DOI 10.1016/j.brainres.2010.12.041; Rellecke J, 2013, BRAIN TOPOGR, V26, P62, DOI 10.1007/s10548-012-0261-y; Rellecke J, 2012, BIOL PSYCHOL, V90, P23, DOI 10.1016/j.biopsycho.2012.02.002; Rellecke J, 2011, BRAIN COGNITION, V77, P23, DOI 10.1016/j.bandc.2011.07.001; Rolls ET, 2013, EMOTION AND DECISION; Rossi V, 2017, J COGNITIVE NEUROSCI, V29, P968, DOI 10.1162/jocn_a_01093; Sato W, 2001, NEUROREPORT, V12, P709, DOI 10.1097/00001756-200103260-00019; Schacht A, 2012, BIOL PSYCHOL, V89, P130, DOI 10.1016/j.biopsycho.2011.10.001; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Scherg M, 2003, MANUAL BESA BRAIN EL; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Sharot T, 2004, NAT NEUROSCI, V7, P1376, DOI 10.1038/nn1353; Steyer, 1997, MEHRDIMENSIONALE BEF; Tomasello M, 2014, EUR J SOC PSYCHOL, V44, P187, DOI 10.1002/ejsp.2015; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wei P, 2014, EXP BRAIN RES, V232, P1783, DOI 10.1007/s00221-014-3870-8; Yao SX, 2014, SOC COGN AFFECT NEUR, V9, P849, DOI 10.1093/scan/nst056; Zeelenberg R, 2006, PSYCHOL SCI, V17, P287, DOI 10.1111/j.1467-9280.2006.01700.x	51	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2018	13	10							e0206142	10.1371/journal.pone.0206142	http://dx.doi.org/10.1371/journal.pone.0206142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3GT	30359397	gold, Green Published, Green Submitted			2022-12-26	WOS:000448438400047
J	Araujo, J; Flanagan, S; Castro-Caldas, A; Goswami, U				Araujo, Joao; Flanagan, Sheila; Castro-Caldas, Alexandre; Goswami, Usha			The temporal modulation structure of illiterate versus literate adult speech	PLOS ONE			English	Article							FUNCTIONAL-ORGANIZATION; OLDER-PEOPLE; BRAIN; MORPHOLOGY; WRITE; TIME; READ	The temporal modulation structure of speech plays a key role in neural encoding of the speech signal. Amplitude modulations (AMs, quasi-rhythmic changes in signal energy or intensity) in speech are encoded by neuronal oscillations (rhythmic variations in neural excitability in large cell networks) that oscillate at matching temporal rates. To date, however, all neural studies have investigated adult-directed speech (ADS) as produced and perceived by highly literate adults. Whether temporal features of ADS vary with the skills of the speaker, for example literacy skills, is currently unknown. Here we analyse the temporal structure of ADS spoken by illiterate, low literate (<= 4 years of literacy) and highly literate (>= 12 years of literacy) adults. We find that illiterates produce speech differently. Spontaneous conversational speech produced by illiterate adults showed significantly less synchronised coupling between AM bands (less phase synchronisation) than conversational speech produced by low literate and highly literate adults, and contained significantly fewer syllables per second. There was also a significant relationship between years of literacy and the amount of theta-band energy in conversational speech. When asked to produce rhythmic proverbs learned in childhood, all groups could produce speech with similar AM phase synchronisation, suggesting that the differences in spontaneous conversational speech were not caused by physiological constraints. The data suggest that the temporal modulation structure of spoken language changes with the acquisition of cultural skills like literacy that are usually a product of schooling. There is a cultural effect on the temporal modulation structure of spoken language.	[Araujo, Joao; Castro-Caldas, Alexandre] Univ Catolica Portuguese, CI, Lisbon, Portugal; [Flanagan, Sheila; Goswami, Usha] Univ Cambridge, Ctr Neurosci Educ, Dept Psychol, Cambridge, England	Universidade Catolica Portuguesa; University of Cambridge	Araujo, J (corresponding author), Univ Catolica Portuguese, CI, Lisbon, Portugal.	jpfapsi@gmail.com	Castro-Caldas, Alexandre/M-4156-2013	Castro-Caldas, Alexandre/0000-0002-9148-3719; Goswami, Usha/0000-0001-7858-2336	Medical Research Council [G0902375]; Universidade Catolica Portuguesa (Centro de Investigacao Interdisciplinar em Saude); MRC [G0902375] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Universidade Catolica Portuguesa (Centro de Investigacao Interdisciplinar em Saude); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by funding from the Medical Research Council (G0902375) to UG and by Universidade Catolica Portuguesa (Centro de Investigacao Interdisciplinar em Saude).	Barreto H, 2008, WECHSLER ADULT INTEL; Bouchard KE, 2013, NATURE, V495, P327, DOI 10.1038/nature11911; Brady M, 2006, J NEUROLINGUIST, V19, P291, DOI 10.1016/j.jneuroling.2005.12.001; Carreiras M, 2009, NATURE, V461, P983, DOI 10.1038/nature08461; Castro-Caldas A, 1999, EUR J NEUROL, V6, P23, DOI 10.1046/j.1468-1331.1999.610023.x; Castro-Caldas A, 1998, BRAIN, V121, P1053, DOI 10.1093/brain/121.6.1053; Castro-Caldas A, 2009, J NEUROPSYCHOL, V3, P17, DOI 10.1348/174866408X289953; Davidson B, 2003, APHASIOLOGY, V17, P243, DOI 10.1080/729255457; Dehaene S, 2015, NAT REV NEUROSCI, V16, P234, DOI 10.1038/nrn3924; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Ferro J., 1986, THESIS; Flanagan S, 2018, J ACOUST SOC AM, V143, P1366, DOI 10.1121/1.5026239; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frith U, 1998, LITERALLY CHANGING T, P1011; Ghitza O, 2009, PHONETICA, V66, P113, DOI 10.1159/000208934; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Gross J, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001752; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Leong V., 2013, HEARING RES, V308, P141; Leong V., 2017, OPEN MIND, V1, P78, DOI [10.1162/OPMI_a_00008, DOI 10.1162/OPMI_A_00008]; Leong V, 2017, DEVELOPMENTAL SCI, V20, DOI 10.1111/desc.12457; Leong V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144411; Leong V, 2014, J ACOUST SOC AM, V136, P366, DOI 10.1121/1.4883366; Liberman I, 1973, J EXP CHILD PSYCHOL, P1; Lima CF, PORLEX BASE LEXICAL; Loureiro CD, 2004, BRAIN LANG, V89, P499, DOI 10.1016/j.bandl.2003.12.008; Madureira S, 1994, REVISTA PORTUGUESA D, V3, P9; Molinaro N, 2016, HUM BRAIN MAPP; MORAIS J, 1979, COGNITION, V7, P323, DOI 10.1016/0010-0277(79)90020-9; MORAIS J, 1986, COGNITION, V24, P45, DOI 10.1016/0010-0277(86)90004-1; Mota NB, 2018, PREPRINT; Mota NB, 2016, MIND BRAIN EDUC, P1; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Poeppel D, 2014, CURR OPIN NEUROBIOL, V28, P142, DOI 10.1016/j.conb.2014.07.005; Power AJ, 2016, BRAIN LANG, V160, P1, DOI 10.1016/j.bandl.2016.06.006; Power AJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00216; Reis A, 1997, J INT NEUROPSYCH SOC, V3, P444, DOI 10.1017/S135561779700444X; van den Bunt MR, 2017, J SPEECH LANG HEAR R, V60, P654, DOI 10.1044/2016_JSLHR-L-16-0201; Ventura P, 2007, J PSYCHOLINGUIST RES, V36, P341, DOI 10.1007/s10936-006-9048-1; Wechsler D., 1997, WECHSLER ADULT INTEL; Zhang R. - G., 2012, US CHINA FOREIGN LAN, V10, P1005; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	42	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205224	10.1371/journal.pone.0205224	http://dx.doi.org/10.1371/journal.pone.0205224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3FL	30356281	gold, Green Published			2022-12-26	WOS:000448434000044
J	Bae, EY; Kim, HJ; Lee, HJ; Jang, J; Lee, SM; Jung, Y; Yoon, N; Kim, TK; Kim, K; Yang, BM				Bae, Eun-Young; Kim, Hui Jeong; Lee, Hye-Jae; Jang, Junho; Lee, Seung Min; Jung, Yunkyung; Yoon, Nari; Kim, Tae Kyung; Kim, Kookhee; Yang, Bong-Min			Role of economic evidence in coverage decision-making in South Korea	PLOS ONE			English	Article							DRUG REIMBURSEMENT DECISIONS; 4 EUROPEAN COUNTRIES; COST-EFFECTIVENESS; AUSTRALIA; HEALTH; CANADA; NICE; RECOMMENDATIONS	Objectives The South Korean government required the submission of economic evidence when it implemented the Positive-List System in December 2006. This study investigates the key factors that influenced actual public insurance reimbursement decisions, including the role of economic evidence, after 10 years of decision practice under compulsory health technology assessment (HTA) for new drugs. Method Logistic regression analysis was used to estimate the impact of the variables involved, including cost-effectiveness ratio as a key variable, on reimbursement decisions. The latter were defined as "yes" or "no" at a submitted price and indication. Only cases (n = 91) that present a cost-effectiveness ratio, and that have been reviewed based on this ratio from January 2007 to December 2016, were included in the analysis. Results Cases with higher cost-effectiveness ratios were less likely to be accepted. In addition, drugs that were used to treat severe diseases and drugs with no substitute were more likely to be recommended. The probability of acceptance declined along with the level of uncertainty in the submitted evidence. The acceptance rate for severe-disease drugs has increased since 2013, when the government introduced several policies that lowered the existing barriers to positive reimbursement. However, such an increase was not statistically significant. Conclusions Cost-effectiveness is one of the most influential factors in drug-reimbursement decisions. However, inclusion of other explanatory variables, in addition to the cost-effectiveness ratio, predicted the results of decisions more accurately.	[Bae, Eun-Young] Gyeongsang Natl Univ, Sch Pharm, Jinju, South Korea; [Bae, Eun-Young] Gyeongsang Natl Univ, Inst Pharm, Jinju, South Korea; [Kim, Hui Jeong; Jang, Junho; Lee, Seung Min; Jung, Yunkyung; Yoon, Nari; Kim, Tae Kyung; Kim, Kookhee] Hlth Insurance Review & Assessment Serv, Pharmaceut Benefit Dept, Wonju, South Korea; [Lee, Hye-Jae] Natl Hlth Insurance Serv, Hlth Insurance Policy Res Inst, Wonju, South Korea; [Yang, Bong-Min] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea	Gyeongsang National University; Gyeongsang National University; National Health Insurance Service; Seoul National University (SNU)	Bae, EY (corresponding author), Gyeongsang Natl Univ, Sch Pharm, Jinju, South Korea.; Bae, EY (corresponding author), Gyeongsang Natl Univ, Inst Pharm, Jinju, South Korea.	eybae@gnu.ac.kr						Bae E-Y, 2013, STUDY PERFORMANCE PO; Bae EY, 2016, HEALTH POLICY, V120, P612, DOI 10.1016/j.healthpol.2016.03.013; Birkett DJ, 2001, HEALTH AFFAIR, V20, P104, DOI 10.1377/hlthaff.20.3.104; Chim L, 2010, PHARMACOECONOMICS, V28, P463, DOI 10.2165/11533000-000000000-00000; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Dakin H, 2014, HEALTH ECON, DOI [10.1002/hec.3086, DOI 10.1002/HEC.3086]; Dakin HA, 2006, HEALTH POLICY, V77, P352, DOI 10.1016/j.healthpol.2005.08.008; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; Drummond M., 2004, AUST ECON REV, V37, P3, DOI [10.1111/j.1467-8462.2004.00304.x, DOI 10.1111/J.1467-8462.2004.00304.X]; Drummond M, 2013, J HEALTH POLIT POLIC, V38, P1081, DOI 10.1215/03616878-2373148; Franken M, 2015, HEALTH POLICY, V119, P195, DOI 10.1016/j.healthpol.2014.10.007; Franken M, 2013, PHARMACOECONOMICS, V31, P781, DOI 10.1007/s40273-013-0074-1; Harris AH, 2008, MED DECIS MAKING, V28, P713, DOI 10.1177/0272989X08315247; HIRA, 2017, PHARM BEN LIST; Mauskopf J, 2013, HEALTH POLICY, V110, P49, DOI 10.1016/j.healthpol.2013.01.017; McMahon M, 2006, HEALTH POLICY, V77, P339, DOI 10.1016/j.healthpol.2005.08.006; Nicod E, 2017, VALUE HEALTH, V20, P919, DOI 10.1016/j.jval.2017.03.005; Park SE, 2012, HEALTH POLICY, V104, P32, DOI 10.1016/j.healthpol.2011.09.006; Rutten F, 1996, HEALTH POLICY, V36, P215, DOI 10.1016/0168-8510(96)00814-7; Salas-Vega S, 2016, HEALTH POLICY, V120, P1104, DOI 10.1016/j.healthpol.2016.08.006; Simoens S, 2010, INT J ENV RES PUB HE, V7, P1835, DOI 10.3390/ijerph7041835; Whitty JA, 2015, HEALTH POLICY, V119, P127, DOI 10.1016/j.healthpol.2014.09.003; Yong JHE, 2013, PHARMACOECONOMICS, V31, P229, DOI 10.1007/s40273-012-0022-5	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206121	10.1371/journal.pone.0206121	http://dx.doi.org/10.1371/journal.pone.0206121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY3FL	30356251	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000074
J	Le Sciellour, M; Labussiere, E; Zemb, O; Renaudeau, D				Le Sciellour, Mathilde; Labussiere, Etienne; Zemb, Olivier; Renaudeau, David			Effect of dietary fiber content on nutrient digestibility and fecal microbiota composition in growing-finishing pigs	PLOS ONE			English	Article							GUT MICROBIOTA; GROWTH-PERFORMANCE; GASTROINTESTINAL TRANSIT; LACTOBACILLUS-REUTERI; DIGESTIVE UTILIZATION; CELL-WALLS; ENERGY; FERMENTATION; METABOLISM; LEVEL	Microbial population in the gastrointestinal tract plays a central role in health and nutrient digestion. The objective of the present study was to investigate the relationships between microbiota and apparent digestibility coefficients with respect to age and diet. Pigs from Large-White, Duroc or Pietrain breeds were raised under the same housing conditions and fed alternately a low-fiber (LF) and a high-fiber diet (HF) during 4 successive 3-week periods. Data collection for digestibility measurements was achieved during the last week of each period. At the end of each period, fecal microbiota was collected for 16S rRNA gene sequencing. The microbiota remained stable across periods whereas digestibility of energy, crude proteins and cell wall components increased. The microbiota was resilient to diet effect and pigs fed the LF diet were discriminated to those fed the HF diet using 31 predicting OTUs with a mean classification error-rate of 3.9%. Clostridiaceae and Turicibacter were negatively correlated whereas Lactobacillus was positively correlated with protein and energy digestibility coefficients in the LF group. In addition, Lachnospiraceae and Prevotella were negatively correlated with cell wall component digestibility. In contrast, no significant correlation was found between microbiota composition and digestibility coefficients when pigs were fed the HF diet. Interestingly, it was also no longer possible to distinguish animals from different breeds once the animals were fed a HF diet, so that the microbiota could only trace the breed origin in the first period and in the LF group. In our experimental conditions, 3 weeks of adaptation to a new diet seems to be sufficient to observe resilience in growing pigs' microbiota. We demonstrated that fecal microbiota can be used to classify pigs according to their dietary treatment. Some bacteria are favorable or unfavorable to digestibility. This suggests that manipulations of bacterial populations can improve digestibility and feed efficiency.	[Le Sciellour, Mathilde; Labussiere, Etienne; Renaudeau, David] Agrocampus Ouest, INRA, PEGASE, Rennes, France; [Zemb, Olivier] Univ Toulouse, INPT, INRA, INP ENVT,GenPhySE, Castanet Tolosan, France	INRAE; Institut Agro; Agrocampus Ouest; INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse	Zemb, O (corresponding author), Univ Toulouse, INPT, INRA, INP ENVT,GenPhySE, Castanet Tolosan, France.	olivier.zemb@inra.fr		Le Sciellour, Mathilde/0000-0003-3389-6854	European Union's H2020 Programme [633531]	European Union's H2020 Programme	This study is part of the Feed-a-Gene Project, funded from the European Union's H2020 Programme under grant agreement no 633531. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguita M, 2006, J ANIM SCI, V84, P2766, DOI 10.2527/jas.2005-212; [Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Chem. AOA, 1990, OFFICIAL METHODS ANA; Chung WSF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-015-0224-3; Cornick S, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.982426; Correa RO, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.17; Dalby MJ, 2017, CELL REP, V21, P1521, DOI 10.1016/j.celrep.2017.10.056; Dou S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169851; Dowarah R, 2017, ANIM NUTR, V3, P1, DOI 10.1016/j.aninu.2016.11.002; Durmic Z, 1998, J APPL MICROBIOL, V85, P574, DOI 10.1046/j.1365-2672.1998.853539.x; Emerson EL, 2017, APPL MICROBIOL BIOT, V101, P4269, DOI 10.1007/s00253-017-8150-7; Gorvitovskaia A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0160-7; Grieshop CM, 2001, SWINE NUTR, P187; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Heinritz SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154329; Heinritz SN, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050317; Holman DB, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00004-17; Holman DB, 2014, FEMS MICROBIOL ECOL, V90, P599, DOI 10.1111/1574-6941.12419; Hou CL, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0014-3; Jha R, 2015, ANIMAL, V9, P1441, DOI 10.1017/S1751731115000919; Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047; Kil DY, 2013, ASIAN AUSTRAL J ANIM, V26, P1205, DOI 10.5713/ajas.2013.r.02; Knudsen KEB, 2001, ANIM FEED SCI TECH, V90, P3, DOI 10.1016/S0377-8401(01)00193-6; Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001; Lan R, 2017, J SCI FOOD AGR, V97, P1310, DOI 10.1002/jsfa.7866; Larsen JM, 2017, IMMUNOLOGY, V151, P363, DOI 10.1111/imm.12760; Le Floc'h N, 2014, ANIMAL, V8, P1632, DOI 10.1017/S1751731114001608; Le Gall M, 2009, ANIMAL, V3, P352, DOI 10.1017/S1751731108003728; Le Goff G, 2002, ANIM SCI, V74, P503; Le Goff G, 2001, J ANIM SCI, V79, P2418; Le MHA, 2016, J ANIM SCI, V94, P4677, DOI 10.2527/jas.2016-0693; Liu J, 2014, FEMS MICROBIOL ECOL, V87, P576, DOI 10.1111/1574-6941.12246; Looft T, 2014, ISME J, V8, P1566, DOI 10.1038/ismej.2014.12; Mach N, 2015, ENV MICROBIOL REP, V7, P554, DOI 10.1111/1758-2229.12285; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Mignon-Grasteau S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135488; Montagne L, 2003, J DAIRY SCI, V86, P934, DOI 10.3168/jds.S0022-0302(03)73676-5; Muller V, 2001, BACTERIAL FERMENTATI; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Neis EPJG, 2015, NUTRIENTS, V7, P2930, DOI 10.3390/nu7042930; Ngoc TTB, 2012, ASIAN AUSTRAL J ANIM, V25, P1726, DOI 10.5713/ajas.2012.12305; Niu Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep09938; Noblet J, 2013, ANIMAL, V7, P1259, DOI 10.1017/S1751731113000463; NOBLET J, 1994, LIVEST PROD SCI, V37, P323, DOI 10.1016/0301-6226(94)90126-0; NOBLET J, 1993, BRIT J NUTR, V70, P407, DOI 10.1079/BJN19930135; Park J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156334; Pedersen R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-30; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramayo-Caldas Y, 2016, ISME J, V10, P2973, DOI 10.1038/ismej.2016.77; Rijnen MMJA, 2001, J ANIM SCI, V79, P148; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rolhion N, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0504; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Scott KP, 2008, NUTR BULL, V33, P201, DOI 10.1111/j.1467-3010.2008.00706.x; Simpson HL, 2015, ALIMENT PHARM THER, V42, P158, DOI 10.1111/apt.13248; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; SPILLER GA, 1986, J NUTR, V116, P778, DOI 10.1093/jn/116.5.778; STANOGIAS G, 1985, BRIT J NUTR, V53, P537, DOI 10.1079/BJN19850063; THEANDER O, 1989, ANIM FEED SCI TECH, V23, P205, DOI 10.1016/0377-8401(89)90098-9; Tilocca B, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0362-7; VANSOEST PJ, 1967, J ASSOC OFF ANA CHEM, V50, P50; VAREL VH, 1989, APPL ENVIRON MICROB, V55, P3080, DOI 10.1128/AEM.55.12.3080-3084.1989; Verschuren LMG, 2018, J ANIM SCI, V96, P1405, DOI 10.1093/jas/sky060; Vigors S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148145; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wilfart A, 2007, J ANIM SCI, V85, P976, DOI 10.2527/jas.2006-431; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xiao L, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.161, 10.1038/nmicrobiol.2016.161]; Yu HF, 2008, J ANIM FEED SCI, V17, P61, DOI 10.22358/jafs/66470/2008; Zhao JB, 2018, ASIAN AUSTRAL J ANIM, V31, P721, DOI 10.5713/ajas.17.0344; Zhao WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117441	72	27	27	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0206159	10.1371/journal.pone.0206159	http://dx.doi.org/10.1371/journal.pone.0206159			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356293	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000078
J	Narumi, T; Uemichi, K; Honda, H; Osaki, K				Narumi, Takayuki; Uemichi, Kenta; Honda, Hisao; Osaki, Koichi			Self-organization at the first stage of honeycomb construction: Analysis of an attachment-excavation model	PLOS ONE			English	Article							PATTERN-FORMATION; MATHEMATICAL-MODEL; BEE COLONIES; TEMPERATURE REGULATION; APIS-MELLIFERA; SIMPLE RULES; COMBS; THERMOREGULATION; ARCHITECTURE; EQUILIBRIUM	Honeybees construct nests that consist of regularly arrayed hexagonal cylinders. In the first stage of honeycomb construction, they build a linear sequence of tetrapod structures that form the basis of the comb. However, considering their physiological limitations, it is unknown how honeybees produce that initial pattern. Herein, in an attempt to understand the mechanisms of honeycomb construction, we propose an agent-based model, the attachment-excavation model, in which worker honeybees are classified into attachers who secrete and attach wax, and excavators who excise the attached wax. The model assumes that workers instinctively refrain from digging through the thin parts of a wax cluster. We then conduct two-dimensional (2D) simulations that show how a tripod pattern can be seen as a projection of tetrapods onto a plane. The simulation results show that the tripod pattern emerges due to competition between the attachers and excavators. As time advances, the isotropic wax growth causes the tripods to connect planarly. Because the homogeneously broadened structures do not match that of a natural comb, we employ anisotropic wax growth to obtain a linear sequence of constructed tripods, thus suggesting that anisotropy is a significant contributor to the first stage of honeycomb construction. From our simulation results, we conclude that honeybees utilize self-organization to achieve complexity during the first stage of honeycomb construction. It is anticipated that the results of our study will provide insights into how complexity can be achieved within a hierarchy.	[Narumi, Takayuki] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Ube, Yamaguchi, Japan; [Uemichi, Kenta; Osaki, Koichi] Kwansei Gakuin Univ, Dept Math Sci, Sanda, Hyogo, Japan; [Honda, Hisao] Kobe Univ, Grad Sch Med, Kobe, Hyogo, Japan; [Honda, Hisao] RIKEN, Ctr Biosyst Dynam Res, Kobe, Hyogo, Japan	Yamaguchi University; Kwansei Gakuin University; Kobe University; RIKEN	Narumi, T (corresponding author), Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Ube, Yamaguchi, Japan.	tnarumi@yamaguchi-u.ac.jp		Narumi, Takayuki/0000-0003-2258-4249; Osaki, Koichi/0000-0002-2051-9980	Japan Society for the Promotion of Science (JSPS) [JP26400180]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grant number JP26400180 from the Japan Society for the Promotion of Science (JSPS) (https://www.jsps.go.jp/english/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1877, DIFFERENT FORMS FLOW; Bauer D, 2013, NATURWISSENSCHAFTEN, V100, P45, DOI 10.1007/s00114-012-0992-3; BELIC MR, 1986, J MATH BIOL, V24, P437, DOI 10.1007/BF01236891; CAMAZINE S, 1991, BEHAV ECOL SOCIOBIOL, V28, P61, DOI 10.1007/BF00172140; CAMAZINE S, 1990, J THEOR BIOL, V147, P553, DOI 10.1016/S0022-5193(05)80264-4; CAMAZINE S, 1991, J THEOR BIOL, V149, P547, DOI 10.1016/S0022-5193(05)80098-0; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; DENEUBOURG JL, 1977, INSECT SOC, V24, P117, DOI 10.1007/BF02227166; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; Dobrescu R, 2011, J Med Life, V4, P82; Eden M., 1961, P 4 BERK S MATH STAT, V4, P223; Franks NR, 1997, ANIM BEHAV, V54, P779, DOI 10.1006/anbe.1996.0496; HEINRICH B, 1985, FORTS ZOOL, V31, P393; HEINRICH B, 1981, J EXP BIOL, V91, P25; HEINRICH B, 1981, SCIENCE, V212, P565, DOI 10.1126/science.212.4494.563; Hepburn H.R., 2014, HONEYBEE NESTS COMPO; Hepburn HR., 1986, HONEYBEES WAX EXPT N; JENKINS MJ, 1992, J MATH BIOL, V30, P281, DOI 10.1007/BF00176152; Johnson BR, 2009, P ROY SOC B-BIOL SCI, V276, P255, DOI 10.1098/rspb.2008.0793; Karihaloo BL, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0299; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; MARTIN H, 1966, Z VERGL PHYSIOL, V53, P372, DOI 10.1007/BF00298103; Montovan KJ, 2013, J THEOR BIOL, V336, P75, DOI 10.1016/j.jtbi.2013.07.010; MYERSCOUGH MR, 1993, J THEOR BIOL, V162, P381, DOI 10.1006/jtbi.1993.1094; Nazzi F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28341; Oeder R., 2017, OBERHESSISCHE NATURW, V67, P8; Oldroyd BP, 2015, ADV INSECT PHYSIOL, V49, P101, DOI 10.1016/bs.aiip.2015.06.001; Osaki K, 2016, HYOGO BIOL, V15, P59; Pirk CWW, 2004, NATURWISSENSCHAFTEN, V91, P350, DOI 10.1007/s00114-004-0539-3; Pratt SC, 2004, APIDOLOGIE, V35, P193, DOI 10.1051/apido:2004005; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Seeley T., 1995, WISDOM HIVE SOCIAL P; SKARKA V, 1990, J THEOR BIOL, V147, P1, DOI 10.1016/S0022-5193(05)80249-8; Tautz J., 2008, BUZZ BEES BIOL SUPER; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; WATMOUGH J, 1995, J THEOR BIOL, V176, P391, DOI 10.1006/jtbi.1995.0207; Yamaguchi T, 2015, SPRINGER SER MATER S, V217, P1, DOI 10.1007/978-3-319-19410-3_1; Yates, 1987, SELF ORG SYSTEMS EME	40	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205353	10.1371/journal.pone.0205353	http://dx.doi.org/10.1371/journal.pone.0205353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356288	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000055
J	Shih, TH; Lin, SH; Huang, MY; Sun, CW; Yang, CM				Shih, Tin-Han; Lin, Szu-Hsien; Huang, Meng-Yuan; Sun, Chih-Wen; Yang, Chi-Ming			Transcriptome profile of cup-shaped galls in Litsea acuminata leaves	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; ABIOTIC STRESS; PHYTOHORMONES; INDUCTION; PLANTS; PHOTOSYNTHESIS; METABOLISM; MANIPULATE; NETWORK; SUGARS	Background Insect galls are atypical plant tissues induced by the invasion of insects. Compared to the host leaf, gall tissues lose photosynthetic ability, but have higher soluble sugar content. Although the physiological and biochemical regulation of gall tissues have been demonstrated, the mechanism of genetic regulation has only been analyzed in few studies. Results In this study, the transcriptome of cup-shaped galls and its host leaf were de novo assembled. Cellular functional enrichment and differentially expressed gene groups in the gall tissues were analyzed. The genes associated with primary metabolism, including photosynthesis, cell wall turnover, and sugar degradation, were expressed differently in galls and leaves. The examination of gene expression demonstrated that the genes involved in brassinosteroid synthesis and responses exhibited a remarkable modulation in cup-shaped galls, suggesting a potential role of steroid hormones in regulating gall development. Conclusions This study revealed the genetic responses, including those involved in source-sink reallocation and phytohormone metabolism, of galls induced by a dipteran insect.	[Shih, Tin-Han; Lin, Szu-Hsien; Yang, Chi-Ming] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Huang, Meng-Yuan] Chinese Culture Univ, Dept Hort & Biotechnol, Taipei, Taiwan; [Sun, Chih-Wen] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; Chinese Culture University; National Taiwan Normal University	Yang, CM (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan.; Sun, CW (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	cwsun@ntnu.edu.tw; cmyang@gate.sinica.edu.tw		Huang, Meng-Yuan/0000-0002-3696-4827	Ministry of Science and Technology, Taiwan [104-2621-B-001- 007]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Our works were supported by the Ministry of Science and Technology, Taiwan (104-2621-B-001- 007).	Armero A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173300; Bailey S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2109-9; Bartlett L, 2014, ARTHROPOD-PLANT INTE, V8, P339, DOI 10.1007/s11829-014-9309-0; Diezel C, 2009, PLANT PHYSIOL, V150, P1576, DOI 10.1104/pp.109.139550; Eastmond PJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7659; Eichenseer H, 2010, J CHEM ECOL, V36, P885, DOI 10.1007/s10886-010-9830-2; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; Ferrari S, 2003, PLANT CELL, V15, P93, DOI 10.1105/tpc.005165; Florentine SK, 2005, BIOCONTROL, V50, P787, DOI 10.1007/s10526-004-5525-3; Giron D, 2016, J INSECT PHYSIOL, V84, P70, DOI 10.1016/j.jinsphys.2015.12.009; Huang MY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0446-0; Huang MY, 2014, PHYSIOL PLANTARUM, V152, P475, DOI 10.1111/ppl.12186; Kastner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086500; Kagale S, 2007, PLANTA, V225, P353, DOI 10.1007/s00425-006-0361-6; KNIGHT JS, 1994, MOL GEN GENET, V242, P586, DOI 10.1007/BF00285282; Krishna P, 2003, J PLANT GROWTH REGUL, V22, P289, DOI 10.1007/s00344-003-0058-z; MacRae E, 2007, PROTOCOLS FOR NUCLEI, V353; Mapes CC, 2001, NEW PHYTOL, V151, P195, DOI 10.1046/j.1469-8137.2001.00161.x; Nabity PD, 2013, P NATL ACAD SCI USA, V110, P16663, DOI 10.1073/pnas.1220219110; Oates CN, 2015, PLANT CELL PHYSIOL, V56, P1418, DOI 10.1093/pcp/pcv064; Ono H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2247-0; Pego JV, 2000, J EXP BOT, V51, P407, DOI 10.1093/jexbot/51.suppl_1.407; Rohfritsch O, 2008, ENTOMOL EXP APPL, V128, P208, DOI 10.1111/j.1570-7458.2008.00726.x; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; SAKURAI A, 1991, ACS SYM SER, V474, P97; Saltzmann KD, 2008, J CHEM ECOL, V34, P1401, DOI 10.1007/s10886-008-9544-x; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Tooker JF, 2011, ARTHROPOD-PLANT INTE, V5, P115, DOI 10.1007/s11829-010-9120-5; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Yamaguchi H, 2012, NEW PHYTOL, V196, P586, DOI 10.1111/j.1469-8137.2012.04264.x; Yokota T., 1999, RIKEN REV, V21, P1; Zhang H, 2016, J INSECT PHYSIOL, V84, P114, DOI 10.1016/j.jinsphys.2015.06.003; Zhu JY, 2013, DEVELOPMENT, V140, P1615, DOI 10.1242/dev.060590	35	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2018	13	10							e0205265	10.1371/journal.pone.0205265	http://dx.doi.org/10.1371/journal.pone.0205265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY3FL	30356295	Green Published, gold, Green Submitted			2022-12-26	WOS:000448434000048
